Intraocular	O
pressure	O
in	O
genetically	O
distinct	O
mice	O
:	O
an	O
update	O
and	O
strain	O
survey	O

Abstract	O

Background	O

Little	O
is	O
known	O
about	O
genetic	O
factors	O
affecting	O
intraocular	O
pressure	O
(	O
IOP	O
)	O
in	O
mice	O
and	O
other	O
mammals	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
IOPs	O
of	O
genetically	O
distinct	O
mouse	O
strains	O
,	O
assess	O
the	O
effects	O
of	O
factors	O
such	O
as	O
age	O
,	O
sex	O
and	O
time	O
of	O
day	O
on	O
IOP	O
in	O
specific	O
strain	O
backgrounds	O
,	O
and	O
to	O
assess	O
the	O
effects	O
of	O
specific	O
candidate	O
gene	O
mutations	O
on	O
IOP	O
.	O

Results	O

Based	O
on	O
over	O
30	O
studied	O
mouse	O
strains	O
,	O
average	O
IOP	O
ranges	O
from	O
approximately	O
10	O
to	O
20	O
mmHg	O
.	O

Gender	O
does	O
not	O
typically	O
affect	O
IOP	O
and	O
aging	O
results	O
in	O
an	O
IOP	O
decrease	O
in	O
some	O
strains	O
.	O

Most	O
tested	O
strains	O
exhibit	O
a	O
diurnal	O
rhythm	O
with	O
IOP	O
being	O
the	O
highest	O
during	O
the	O
dark	O
period	O
of	O
the	O
day	O
.	O

Homozygosity	O
for	O
a	O
null	O
allele	O
of	O
the	O
carbonic	B-CHEBI
anhydrase	O
II	O
gene	O
(	O
Car2n	O
)	O
does	O
not	O
alter	O
IOP	O
while	O
homozygosity	O
for	O
a	O
mutation	O
in	O
the	O
leptin	O
receptor	O
gene	O
(	O
Leprdb	O
)	O
that	O
causes	O
obesity	O
and	O
diabetes	O
results	O
in	O
increased	O
IOP	O
.	O

Albino	O
C57BL	O
/	O
6J	O
mice	O
homozygous	O
for	O
a	O
tyrosinase	O
mutation	O
(	O
Tyrc	O
-	O
2J	O
)	O
have	O
higher	O
IOPs	O
than	O
their	O
pigmented	B-CHEBI
counterparts	O
.	O

Conclusions	O

Genetically	O
distinct	O
mouse	O
strains	O
housed	O
in	O
the	O
same	O
environment	O
have	O
a	O
broad	O
range	O
of	O
IOPs	O
.	O

These	O
IOP	O
differences	O
are	O
likely	O
due	O
to	O
interstrain	O
genetic	O
differences	O
that	O
create	O
a	O
powerful	O
resource	O
for	O
studying	O
the	O
regulation	O
of	O
IOP	O
.	O

Age	O
,	O
time	O
of	O
day	O
,	O
obesity	O
and	O
diabetes	O
have	O
effects	O
on	O
mouse	O
IOP	O
similar	O
to	O
those	O
in	O
humans	O
and	O
other	O
species	O
.	O

Mutations	O
in	O
two	O
of	O
the	O
assessed	O
candidate	O
genes	O
(	O
Lepr	O
and	O
Tyr	O
)	O
result	O
in	O
increased	O
IOP	O
.	O

These	O
studies	O
demonstrate	O
that	O
mice	O
are	O
a	O
practical	O
and	O
powerful	O
experimental	O
system	O
to	O
study	O
the	O
genetics	O
of	O
IOP	O
regulation	O
and	O
disease	O
processes	O
that	O
raise	O
IOP	O
to	O
harmful	O
levels	O
.	O

Background	O

Glaucoma	O
is	O
a	O
leading	O
cause	O
of	O
blindness	O
but	O
its	O
molecular	B-CHEBI
etiology	O
is	O
poorly	O
understood	O
.	O

Glaucoma	O
involves	O
retinal	O
ganglion	O
cell	O
death	O
and	O
optic	O
nerve	O
damage	O
that	O
is	O
often	O
associated	O
with	O
elevated	O
intraocular	O
pressure	O
(	O
IOP	O
)	O
[	O
1	O
-	O
5	O
]	O
.	O

It	O
is	O
becoming	O
increasingly	O
clear	O
that	O
many	O
forms	O
of	O
glaucoma	O
have	O
a	O
genetic	O
component	O
[	O
6	O
,	O
7	O
]	O
,	O
and	O
much	O
current	O
research	O
is	O
focused	O
on	O
identifying	O
chromosomal	O
regions	O
and	O
genes	O
that	O
contribute	O
to	O
glaucoma	O
[	O
8	O
-	O
10	O
]	O
.	O

Identifying	O
such	O
loci	O
allows	O
screening	O
for	O
individuals	O
with	O
an	O
increased	O
risk	O
of	O
developing	O
glaucoma	O
[	O
11	O
]	O
.	O

Identifying	O
genes	O
contributing	O
to	O
elevated	O
IOP	O
and	O
glaucoma	O
is	O
only	O
the	O
first	O
step	O
,	O
however	O
,	O
and	O
animal	O
models	O
will	O
provide	O
systems	O
for	O
subsequent	O
hypothesis	O
testing	O
and	O
experimental	O
dissection	O
of	O
pathogenesis	O
.	O

Due	O
to	O
conservation	O
in	O
mammalian	O
physiology	O
and	O
the	O
powerful	O
tools	O
of	O
mouse	O
genetics	O
,	O
mice	O
are	O
a	O
very	O
important	O
experimental	O
system	O
for	O
probing	O
the	O
functions	O
(	O
both	O
in	O
health	O
and	O
disease	O
)	O
of	O
many	O
genes	O
recently	O
identified	O
by	O
sequencing	O
the	O
human	O
genome	O
[	O
12	O
]	O
.	O

We	O
have	O
focused	O
on	O
developing	O
the	O
mouse	O
system	O
for	O
IOP	O
and	O
glaucoma	O
studies	O
[	O
13	O
-	O
19	O
]	O
.	O

Mice	O
are	O
expected	O
to	O
be	O
extremely	O
helpful	O
in	O
characterizing	O
genes	O
and	O
mechanisms	O
that	O
affect	O
IOP	O
or	O
the	O
susceptibility	O
of	O
the	O
optic	O
nerve	O
and	O
retina	O
to	O
glaucomatous	O
damage	O
[	O
20	O
]	O
.	O

Very	O
little	O
is	O
known	O
about	O
the	O
magnitude	O
of	O
IOP	O
of	O
various	O
mouse	O
strains	O
or	O
IOP	O
fluctuation	O
in	O
mice	O
with	O
time	O
or	O
other	O
factors	O
.	O

Previously	O
,	O
we	O
developed	O
a	O
method	O
to	O
measure	O
IOP	O
in	O
mice	O
and	O
reported	O
initial	O
findings	O
on	O
the	O
magnitude	O
of	O
mouse	O
IOP	O
[	O
13	O
]	O
.	O

The	O
procedure	O
involves	O
direct	O
measurement	O
of	O
pressure	O
following	O
cannulation	O
of	O
the	O
anterior	O
chamber	O
.	O

The	O
initial	O
experiments	O
demonstrated	O
that	O
in	O
our	O
hands	O
careful	O
ocular	O
cannulation	O
has	O
a	O
very	O
minor	O
effect	O
on	O
IOP	O
(	O
average	O
of	O
-	O
0	O
.	O
3	O
mmHg	O
,	O
mode	O
-	O
0	O
.	O
5	O
mmHg	O
)	O
and	O
demonstrated	O
significant	O
differences	O
in	O
intraocular	O
pressure	O
levels	O
between	O
four	O
mouse	O
strains	O
.	O

Here	O
,	O
we	O
provide	O
an	O
update	O
,	O
including	O
an	O
extensive	O
strain	O
survey	O
,	O
and	O
show	O
that	O
the	O
methodology	O
is	O
reliable	O
and	O
produces	O
reproducible	O
data	O
over	O
extended	O
periods	O
of	O
time	O
.	O

Results	O

A	O
broad	O
range	O
of	O
IOPs	O
between	O
strains	O

Figure	O
1	O
shows	O
the	O
average	O
IOP	O
of	O
a	O
number	O
of	O
inbred	O
mouse	O
strains	O
that	O
were	O
housed	O
in	O
the	O
same	O
environmental	O
conditions	O
.	O

There	O
is	O
a	O
wide	O
range	O
of	O
IOP	O
with	O
strain	O
BALB	O
/	O
cJ	O
having	O
one	O
of	O
the	O
lowest	O
average	O
IOPs	O
(	O
11	O
.	O
1	O
+/-	O
0	O
.	O
5	O
mmHg	O
)	O
and	O
strain	O
CBA	O
/	O
CaJ	O
one	O
of	O
the	O
highest	O
IOPs	O
(	O
19	O
.	O
3	O
+/-	O
0	O
.	O
3	O
mmHg	O
)	O
.	O

Significant	O
differences	O
exist	O
among	O
various	O
strains	O
(	O
P	O
<	O
0	O
.	O
0001	O
for	O
all	O
groups	O
,	O
ANOVA	O
comparing	O
strains	O
within	O
each	O
sex	O
group	O
)	O
.	O

Figure	O
1	O

An	O
almost	O
two	O
-	O
fold	O
range	O
of	O
IOP	O
between	O
genetically	O
distinct	O
mouse	O
strains	O
.	O

Mean	O
IOP	O
+/-	O
SEM	O
is	O
shown	O
for	O
each	O
strain	O
.	O

Twelve	O
to	O
25	O
mice	O
were	O
analyzed	O
for	O
each	O
strain	O
(	O
typically	O
18	O
to	O
20	O
)	O
,	O
except	O
for	O
RIIIS	O
/	O
J	O
(	O
7	O
mice	O
)	O
.	O

Mice	O
of	O
most	O
strains	O
were	O
6	O
to	O
12	O
months	O
old	O
,	O
except	O
for	O
SEC	O
/	O
1ReJ	O
and	O
SB	O
/	O
Le	O
that	O
were	O
2	O
to	O
3	O
months	O
old	O
.	O

Approximately	O
half	O
of	O
the	O
CE	O
/	O
J	O
and	O
one	O
third	O
of	O
the	O
BUB	O
/	O
BnJ	O
mice	O
were	O
16	O
months	O
old	O
and	O
were	O
pooled	O
with	O
the	O
younger	O
mice	O
,	O
as	O
the	O
IOPs	O
of	O
both	O
ages	O
were	O
the	O
same	O
.	O

Strain	O
name	O
CBA	O
/	O
CaHN	O
-	O
Btkxid	O
/	O
J	O
is	O
abbreviated	O
to	O
CBA	O
/	O
CaHN	O
.	O

Clinical	O
and	O
histological	O
analysis	O
of	O
the	O
eyes	O
of	O
all	O
studied	O
strains	O
(	O
see	O
Table	O
1	O
)	O
did	O
not	O
identify	O
anatomic	O
or	O
pathologic	O
features	O
that	O
might	O
account	O
for	O
the	O
differences	O
in	O
IOP	O
.	O

For	O
example	O
,	O
the	O
iridocorneal	O
angle	O
and	O
aqueous	O
humor	O
drainage	O
structures	O
are	O
open	O
to	O
the	O
anterior	O
chamber	O
and	O
have	O
normal	O
morphology	O
in	O
both	O
BALB	O
/	O
cJ	O
and	O
CBA	O
/	O
CaJ	O
mice	O
(	O
Figure	O
2	O
)	O
.	O

More	O
than	O
20	O
%	O
of	O
CBA	O
/	O
CaJ	O
mice	O
had	O
IOPs	O
of	O
over	O
21	O
mmHg	O
,	O
which	O
increases	O
risk	O
for	O
glaucoma	O
in	O
humans	O
.	O

We	O
aged	O
a	O
small	O
group	O
of	O
these	O
mice	O
(	O
n	O
=	O
4	O
)	O
to	O
2	O
years	O
and	O
histologically	O
analyzed	O
their	O
optic	O
nerves	O
and	O
retinas	O
but	O
they	O
did	O
not	O
develop	O
glaucoma	O
.	O

Figure	O
2	O

Normal	O
iridocorneal	O
angles	O
in	O
strains	O
with	O
high	O
and	O
low	O
IOP	O
.	O

The	O
iridocorneal	O
angle	O
that	O
contains	O
the	O
aqueous	O
humor	O
drainage	O
structures	O
(	O
Schlemm	O
'	O
s	O
canal	O
(	O
SC	O
)	O
and	O
trabecular	O
meshwork	O
(	O
TM	O
)	O
had	O
a	O
normal	O
morphology	O
in	O
strains	O
CBA	O
/	O
CaJ	O
(	O
A	O
,	O
high	O
IOP	O
)	O
,	O
BALB	O
/	O
cJ	O
(	O
B	O
,	O
low	O
IOP	O
)	O
and	O
all	O
other	O
strains	O
.	O

Pigment	B-CHEBI
filled	O
macrophages	O
that	O
resemble	O
human	O
clump	O
cells	O
were	O
often	O
located	O
in	O
the	O
angle	O
of	O
CBA	O
/	O
CaJ	O
mice	O
but	O
were	O
never	O
sufficient	O
to	O
block	O
drainage	O
.	O

We	O
have	O
observed	O
similar	O
quantities	O
of	O
these	O
cells	O
at	O
this	O
location	O
in	O
other	O
strains	O
with	O
lower	O
IOP	O
.	O

The	O
angle	O
recess	O
between	O
the	O
cornea	O
(	O
C	O
)	O
and	O
iris	O
root	O
(	O
I	O
)	O
was	O
open	O
and	O
not	O
occluded	O
.	O

Aqueous	O
humor	O
passes	O
through	O
this	O
recess	O
before	O
entering	O
the	O
drainage	O
structures	O
.	O

Original	O
Magnification	O
630X	O
.	O

Table	O
1	O

Ocular	O
abnormalities	O
in	O
various	O
strains	O

All	O
strains	O
shown	O
in	O
Figure	O
1	O
were	O
evaluated	O
but	O
only	O
strains	O
with	O
abnormalities	O
are	O
shown	O
.	O

For	O
incidence	O
,	O
the	O
numerator	O
indicates	O
the	O
number	O
of	O
mice	O
or	O
eyes	O
affected	O
and	O
the	O
denominator	O
indicates	O
the	O
total	O
number	O
analyzed	O
.	O

The	O
mice	O
were	O
6	O
to	O
12	O
months	O
old	O
at	O
the	O
time	O
of	O
analysis	O
and	O
were	O
not	O
studied	O
at	O
other	O
ages	O
unless	O
indicated	O
.	O

Histological	O
analysis	O
confirmed	O
these	O
observations	O
and	O
also	O
identified	O
calcified	O
cyst	O
like	O
structures	O
in	O
the	O
iris	O
epithelium	O
of	O
strains	O
SB	O
/	O
Le	O
and	O
SEC	O
/	O
1ReJ	O
.	O

A	O
low	O
incidence	O
of	O
corneal	O
scarring	O
was	O
noted	O
in	O
some	O
strains	O
and	O
likely	O
resulted	O
from	O
a	O
scratched	O
cornea	O
.	O

Previously	O
described	O
retinal	O
degeneration	O
[	O
[	O
81	O
]	O
]	O
caused	O
by	O
homozygosity	O
for	O
the	O
Pde6brd1mutation	O
was	O
noted	O
in	O
strains	O
SB	O
/	O
Le	O
,	O
ST	O
/	O
bJ	O
,	O
BUB	O
/	O
BnJ	O
,	O
CBA	O
/	O
J	O
,	O
C3H	O
/	O
HeJ	O
,	O
SJL	O
/	O
J	O
and	O
SWR	O
/	O
J	O
.	O

Strain	O
differences	O
are	O
reproducible	O

To	O
assess	O
the	O
consistency	O
of	O
IOP	O
in	O
specific	O
strains	O
,	O
we	O
measured	O
IOP	O
in	O
different	O
cohorts	O
of	O
each	O
strain	O
maintained	O
under	O
similar	O
conditions	O
at	O
different	O
times	O
.	O

We	O
purposefully	O
included	O
strains	O
at	O
each	O
end	O
of	O
the	O
IOP	O
spectrum	O
,	O
and	O
strain	O
C57BL	O
/	O
6J	O
(	O
B6	O
)	O
that	O
is	O
commonly	O
used	O
for	O
genetic	O
experiments	O
(	O
Figure	O
3	O
)	O
.	O

The	O
average	O
IOP	O
of	O
different	O
cohorts	O
of	O
strains	O
CBA	O
/	O
CaJ	O
,	O
CBA	O
/	O
CaHN	O
(	O
both	O
high	O
end	O
of	O
spectrum	O
)	O
and	O
B6	O
were	O
consistent	O
over	O
time	O
.	O

This	O
was	O
true	O
of	O
most	O
strains	O
assessed	O
on	O
multiple	O
occasions	O
.	O

Average	O
IOP	O
for	O
age	O
matched	O
mice	O
of	O
the	O
same	O
strain	O
assessed	O
at	O
different	O
times	O
typically	O
differed	O
by	O
no	O
more	O
than	O
1	O
.	O
5	O
mmHg	O
,	O
and	O
the	O
differences	O
were	O
usually	O
smaller	O
.	O

Strain	O
129P3	O
/	O
J	O
was	O
the	O
most	O
variable	O
strain	O
with	O
the	O
average	O
IOP	O
fluctuating	O
by	O
up	O
to	O
2	O
.	O
5	O
mmHg	O
.	O

Figure	O
3	O

The	O
IOPs	O
of	O
different	O
strains	O
are	O
stable	O
and	O
reproducible	O
over	O
time	O
.	O

Mean	O
IOP	O
+/-	O
SEM	O
is	O
shown	O
for	O
the	O
indicated	O
strain	O
at	O
different	O
times	O
of	O
measurement	O
.	O

The	O
measurement	O
times	O
within	O
a	O
single	O
year	O
were	O
separated	O
by	O
a	O
few	O
months	O
.	O

The	O
IOPs	O
of	O
strains	O
that	O
were	O
analyzed	O
multiple	O
times	O
in	O
the	O
same	O
year	O
are	O
listed	O
in	O
the	O
chronological	O
order	O
that	O
they	O
were	O
obtained	O
with	O
the	O
earliest	O
measurement	O
on	O
left	O
.	O

The	O
sex	O
[	O
Male	O
(	O
M	O
)	O
or	O
Female	O
(	O
F	O
)	O
]	O
,	O
age	O
(	O
months	O
)	O
,	O
and	O
number	O
of	O
mice	O
(	O
n	O
)	O
analyzed	O
for	O
the	O
CBA	O
strains	O
are	O
listed	O
starting	O
with	O
the	O
earliest	O
measurement	O
and	O
ending	O
with	O
the	O
latest	O
:	O
CBA	O
/	O
CaJ	O
,	O
F	O
,	O
n	O
=	O
22	O
,	O
age	O
6	O
-	O
7	O
;	O
M	O
,	O
n	O
=	O
11	O
,	O
age	O
2	O
;	O
CBA	O
/	O
CaHN	O
,	O
F	O
,	O
n	O
=	O
16	O
,	O
age	O
3	O
;	O
M	O
,	O
n	O
=	O
8	O
,	O
age	O
3	O
.	O

For	O
BALB	O
/	O
cJ	O
and	O
C57BL	O
/	O
6J	O
,	O
all	O
groups	O
were	O
male	O
and	O
primarily	O
3	O
to	O
4	O
months	O
old	O
.	O

The	O
number	O
of	O
mice	O
analyzed	O
at	O
each	O
time	O
follows	O
:	O
BALB	O
/	O
cJ	O
8	O
,	O
10	O
,	O
11	O
,	O
15	O
,	O
18	O
and	O
14	O
,	O
C57BL	O
/	O
6J	O
10	O
,	O
14	O
,	O
21	O
,	O
40	O
,	O
40	O
and	O
42	O
.	O

Strain	O
name	O
CBA	O
/	O
CaHN	O
-	O
Btkxid	O
/	O
J	O
is	O
abbreviated	O
to	O
CBA	O
/	O
CaHN	O
.	O

Despite	O
the	O
general	O
consistency	O
of	O
IOP	O
,	O
the	O
average	O
IOPs	O
of	O
some	O
strains	O
have	O
changed	O
in	O
a	O
reproducible	O
manner	O
.	O

The	O
IOPs	O
of	O
BALB	O
/	O
cJ	O
mice	O
(	O
low	O
end	O
of	O
spectrum	O
)	O
were	O
very	O
similar	O
for	O
the	O
past	O
several	O
years	O
,	O
around	O
11	O
mmHg	O
.	O

Between	O
early	O
1996	O
and	O
1997	O
,	O
however	O
,	O
the	O
IOP	O
of	O
this	O
strain	O
did	O
jump	O
from	O
approximately	O
7	O
.	O
7	O
mmHg	O
to	O
approximately	O
11	O
mmHg	O
(	O
Figure	O
3	O
)	O
.	O

During	O
this	O
period	O
,	O
the	O
room	O
in	O
which	O
our	O
animals	O
were	O
housed	O
and	O
the	O
manufacturer	O
of	O
the	O
mouse	O
diet	O
were	O
changed	O
.	O

Over	O
the	O
same	O
period	O
,	O
the	O
IOP	O
of	O
A	O
/	O
J	O
also	O
increased	O
dramatically	O
,	O
from	O
9	O
.	O
4	O
+/-	O
0	O
.	O
5	O
mmHg	O
(	O
n	O
=	O
11	O
)	O
in	O
1996	O
to	O
14	O
.	O
2	O
+/-	O
0	O
.	O
4	O
mmHg	O
(	O
n	O
=	O
19	O
)	O
in	O
1997	O
.	O

The	O
increased	O
IOP	O
in	O
A	O
/	O
J	O
also	O
was	O
reproducible	O
,	O
with	O
the	O
average	O
IOP	O
of	O
mice	O
assessed	O
in	O
the	O
year	O
2000	O
being	O
14	O
.	O
5	O
+/-	O
0	O
.	O
4	O
mmHg	O
(	O
n	O
=	O
16	O
)	O
.	O

Importantly	O
,	O
the	O
IOPs	O
of	O
strains	O
B6	O
and	O
C3H	O
/	O
HeJ	O
did	O
not	O
change	O
during	O
this	O
time	O
(	O
B6	O
,	O
12	O
.	O
3	O
.	O
+/-	O
0	O
.	O
5	O
mmHg	O
in	O
1996	O
and	O
12	O
.	O
4	O
+/-	O
0	O
.	O
3	O
mmHg	O
in	O
1997	O
,	O
n	O
=	O
10	O
and	O
14	O
;	O
C3H	O
/	O
HeJ	O
,	O
13	O
.	O
7	O
+/-	O
0	O
.	O
8	O
mmHg	O
in	O
1996	O
and	O
13	O
.	O
6	O
+/-	O
0	O
.	O
2	O
mmHg	O
in	O
1997	O
,	O
n	O
=	O
9	O
and	O
19	O
)	O
.	O

Effect	O
of	O
age	O
on	O
IOP	O

We	O
focused	O
on	O
the	O
commonly	O
used	O
B6	O
,	O
129P3	O
/	O
J	O
and	O
C3H	O
/	O
HeJ	O
strains	O
to	O
determine	O
the	O
effects	O
of	O
age	O
on	O
IOP	O
(	O
Figure	O
4	O
)	O
.	O

In	O
B6	O
,	O
age	O
had	O
a	O
significant	O
effect	O
on	O
IOP	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

IOP	O
was	O
slightly	O
decreased	O
at	O
both	O
12	O
months	O
(	O
12	O
.	O
2	O
+/-	O
0	O
.	O
2	O
mmHg	O
)	O
and	O
19	O
months	O
(	O
12	O
.	O
2	O
+/-	O
0	O
.	O
3	O
mmHg	O
)	O
compared	O
to	O
3	O
months	O
(	O
13	O
.	O
1	O
+/-	O
0	O
.	O
3	O
mmHg	O
)	O
and	O
7	O
months	O
(	O
13	O
.	O
3	O
+/-	O
0	O
.	O
3	O
mmHg	O
)	O
.	O

Although	O
the	O
decrease	O
was	O
of	O
a	O
similar	O
level	O
to	O
the	O
variation	O
observed	O
in	O
3	O
month	O
old	O
mice	O
(	O
see	O
Figure	O
3	O
)	O
,	O
the	O
IOPs	O
of	O
control	O
young	O
mice	O
(	O
see	O
Methods	O
)	O
analyzed	O
at	O
the	O
same	O
times	O
as	O
the	O
various	O
B6	O
age	O
groups	O
did	O
not	O
decrease	O
.	O

For	O
example	O
,	O
control	O
mice	O
analyzed	O
at	O
the	O
same	O
time	O
as	O
the	O
3	O
month	O
,	O
12	O
month	O
and	O
18	O
month	O
B6	O
age	O
groups	O
had	O
IOPs	O
of	O
13	O
.	O
0	O
+/-	O
0	O
.	O
2	O
mmHg	O
(	O
n	O
=	O
14	O
)	O
,	O
13	O
.	O
3	O
+/-	O
0	O
.	O
2	O
mmHg	O
(	O
n	O
=	O
14	O
)	O
,	O
13	O
.	O
7	O
+/-	O
0	O
.	O
4	O
mmHg	O
(	O
n	O
=	O
12	O
)	O
,	O
respectively	O
.	O

IOP	O
was	O
even	O
lower	O
in	O
the	O
24	O
month	O
B6	O
mice	O
(	O
10	O
.	O
8	O
+/-	O
0	O
.	O
4	O
mmHg	O
)	O
,	O
and	O
again	O
the	O
average	O
IOP	O
of	O
young	O
controls	O
measured	O
at	O
the	O
same	O
time	O
was	O
not	O
changed	O
(	O
13	O
.	O
5	O
+/-	O
0	O
.	O
2	O
,	O
n	O
=	O
12	O
)	O
.	O

Figure	O
4	O

IOP	O
changes	O
with	O
increasing	O
Age	O
.	O

Mean	O
IOP	O
+/-	O
SEM	O
is	O
shown	O
for	O
the	O
indicated	O
strain	O
at	O
different	O
ages	O
.	O

IOP	O
decreased	O
significantly	O
in	O
strains	O
C57BL	O
/	O
6J	O
and	O
129P3	O
/	O
J	O
but	O
not	O
C3H	O
/	O
HeJ	O
.	O

The	O
C57BL	O
/	O
6J	O
and	O
129P3	O
/	O
J	O
groups	O
consisted	O
of	O
approximately	O
equal	O
numbers	O
of	O
males	O
and	O
females	O
.	O

The	O
3	O
months	O
old	O
C3H	O
/	O
HeJ	O
mice	O
were	O
male	O
while	O
the	O
other	O
ages	O
were	O
composed	O
of	O
males	O
and	O
females	O
.	O

The	O
number	O
of	O
mice	O
analyzed	O
at	O
each	O
age	O
,	O
listed	O
from	O
youngest	O
to	O
oldest	O
,	O
follow	O
:	O
C57BL	O
/	O
6J	O
,	O
18	O
,	O
18	O
,	O
18	O
,	O
18	O
,	O
13	O
;	O
129P3	O
/	O
J	O
,	O
18	O
,	O
15	O
,	O
16	O
,	O
14	O
,	O
21	O
;	O
C3H	O
/	O
HeJ	O
,	O
15	O
,	O
23	O
17	O
and	O
16	O
.	O

In	O
strain	O
129P3	O
/	O
J	O
,	O
IOP	O
did	O
not	O
differ	O
significantly	O
with	O
age	O
between	O
3	O
and	O
14	O
months	O
but	O
was	O
lower	O
in	O
18	O
month	O
old	O
mice	O
(	O
P	O
<	O
0	O
.	O
001	O
compared	O
to	O
all	O
younger	O
ages	O
,	O
Figure	O
4	O
)	O
.	O

Despite	O
a	O
1	O
mmHg	O
dip	O
in	O
IOP	O
at	O
8	O
months	O
,	O
there	O
were	O
no	O
significant	O
IOP	O
differences	O
between	O
C3H	O
/	O
HeJ	O
mice	O
at	O
each	O
age	O
tested	O
(	O
P	O
=	O
0	O
.	O
2	O
for	O
age	O
)	O
.	O

Although	O
the	O
effect	O
of	O
age	O
has	O
not	O
been	O
thoroughly	O
assessed	O
in	O
other	O
strains	O
,	O
no	O
obvious	O
age	O
-	O
related	O
differences	O
have	O
been	O
identified	O
in	O
other	O
strains	O
analyzed	O
at	O
multiple	O
ages	O
except	O
for	O
the	O
glaucomatous	O
DBA	O
/	O
2J	O
and	O
AKXD	O
-	O
28	O
/	O
Ty	O
strains	O
[	O
14	O
,	O
19	O
]	O
.	O

Effect	O
of	O
sex	O
on	O
IOP	O

Although	O
we	O
have	O
not	O
rigorously	O
assessed	O
the	O
effect	O
of	O
sex	O
on	O
IOP	O
in	O
many	O
strains	O
,	O
sex	O
specific	O
differences	O
have	O
not	O
been	O
detected	O
in	O
the	O
majority	O
of	O
strains	O
for	O
which	O
both	O
sexes	O
have	O
been	O
analyzed	O
,	O
and	O
have	O
proven	O
inconsistent	O
even	O
within	O
an	O
individual	O
strain	O
analyzed	O
multiple	O
times	O
.	O

Strains	O
B6	O
and	O
129P3	O
/	O
J	O
have	O
been	O
extensively	O
evaluated	O
at	O
multiple	O
ages	O
between	O
3	O
and	O
24	O
months	O
of	O
age	O
.	O

Sex	O
differences	O
were	O
always	O
absent	O
in	O
strain	O
129P3	O
/	O
J	O
and	O
typically	O
absent	O
in	O
strain	O
B6	O
.	O

In	O
strain	O
B6	O
,	O
however	O
,	O
males	O
infrequently	O
had	O
significantly	O
higher	O
IOP	O
than	O
females	O
.	O

For	O
example	O
,	O
in	O
one	O
experiment	O
,	O
B6	O
males	O
had	O
an	O
average	O
IOP	O
of	O
14	O
.	O
2	O
+/-	O
0	O
.	O
3	O
mmHg	O
(	O
n	O
=	O
12	O
)	O
whereas	O
the	O
average	O
IOP	O
of	O
females	O
was	O
13	O
.	O
1	O
+/-	O
0	O
.	O
3	O
mmHg	O
(	O
n	O
=	O
12	O
,	O
P	O
=	O
0	O
.	O
01	O
)	O
.	O

If	O
real	O
,	O
this	O
sporadic	O
sex	O
difference	O
was	O
not	O
dependent	O
on	O
age	O
,	O
sometimes	O
occurring	O
in	O
a	O
group	O
of	O
B6	O
mice	O
at	O
a	O
particular	O
age	O
and	O
sometimes	O
not	O
occurring	O
in	O
a	O
separate	O
group	O
of	O
the	O
same	O
age	O
.	O

Anesthesia	O
protocol	O
avoids	O
IOP	O
alteration	O
and	O
allows	O
detection	O
of	O
diurnal	O
differences	O

All	O
IOPs	O
were	O
assessed	O
using	O
an	O
anesthetic	B-CHEBI
regime	O
of	O
99	O
mg	O
/	O
kg	O
ketamine	O
and	O
9	O
mg	O
/	O
kg	O
xylazine	O
(	O
defined	O
as	O
1X	O
)	O
.	O

Initial	O
experiments	O
suggested	O
that	O
an	O
almost	O
identical	O
dose	O
(	O
100	O
mg	O
/	O
kg	O
ketamine	O
and	O
9	O
mg	O
/	O
kg	O
xylazine	O
)	O
of	O
anesthesia	O
had	O
no	O
effect	O
on	O
IOP	O
during	O
the	O
experimental	O
period	O
with	O
IOP	O
being	O
measured	O
as	O
soon	O
as	O
possible	O
after	O
the	O
mouse	O
was	O
unconscious	O
,	O
typically	O
minutes	O
.	O

[	O
13	O
]	O
.	O

To	O
further	O
assess	O
the	O
effects	O
of	O
anesthesia	O
,	O
we	O
measured	O
IOP	O
in	O
groups	O
of	O
genetically	O
identical	O
B6	O
mice	O
subjected	O
to	O
different	O
doses	O
(	O
1X	O
,	O
1	O
.	O
5X	O
and	O
2X	O
)	O
at	O
5	O
and	O
25	O
minutes	O
after	O
administration	O
(	O
Figure	O
5	O
)	O
.	O

For	O
all	O
doses	O
,	O
IOP	O
decreased	O
by	O
25	O
minutes	O
(	O
P	O
=	O
0	O
.	O
005	O
for	O
time	O
)	O
.	O

The	O
greater	O
the	O
dose	O
the	O
greater	O
the	O
decrease	O
in	O
IOP	O
.	O

At	O
the	O
5	O
minute	O
measurement	O
,	O
however	O
,	O
IOP	O
was	O
the	O
same	O
using	O
all	O
doses	O
suggesting	O
that	O
the	O
anesthetic	O
effect	O
on	O
IOP	O
had	O
not	O
yet	O
occurred	O
.	O

To	O
identify	O
any	O
early	O
window	O
when	O
it	O
may	O
be	O
possible	O
to	O
assess	O
IOP	O
without	O
an	O
obvious	O
anesthetic	O
effect	O
,	O
195	O
mice	O
of	O
strain	O
B6	O
were	O
anesthetized	O
with	O
the	O
1X	O
dose	O
and	O
IOP	O
was	O
measured	O
at	O
1	O
minute	O
time	O
points	O
between	O
4	O
and	O
12	O
minutes	O
after	O
administration	O
(	O
Figure	O
5	O
)	O
.	O

The	O
mean	O
IOP	O
of	O
groups	O
analyzed	O
at	O
each	O
time	O
point	O
did	O
not	O
differ	O
(	O
P	O
=	O
0	O
.	O
9	O
)	O
indicating	O
that	O
the	O
IOP	O
depressing	O
effect	O
of	O
anesthesia	O
occurs	O
later	O
than	O
12	O
minutes	O
after	O
administration	O
.	O

Similar	O
results	O
were	O
obtained	O
using	O
161	O
strain	O
129P3	O
/	O
J	O
and	O
145	O
strain	O
DBA	O
/	O
2J	O
mice	O
with	O
the	O
1X	O
dose	O
(	O
129P3	O
/	O
J	O
,	O
P	O
=	O
0	O
.	O
1	O
;	O
DBA	O
/	O
2J	O
,	O
P	O
=	O
0	O
.	O
2	O
)	O
.	O

In	O
support	O
of	O
a	O
later	O
effect	O
of	O
anesthesia	O
(	O
since	O
general	O
anesthesia	O
is	O
reported	O
to	O
mask	O
diurnal	O
variation	O
in	O
IOP	O
[	O
21	O
]	O
)	O
,	O
we	O
identified	O
increased	O
IOP	O
during	O
the	O
dark	O
compared	O
to	O
the	O
light	O
period	O
of	O
the	O
day	O
in	O
several	O
tested	O
strains	O
(	O
Figure	O
6	O
)	O
.	O

In	O
these	O
experiments	O
,	O
IOP	O
measurements	O
were	O
made	O
between	O
5	O
and	O
12	O
minutes	O
after	O
administration	O
of	O
anesthesia	O
.	O

Figure	O
5	O

No	O
effect	O
of	O
1X	O
anesthetic	B-CHEBI
dose	O
within	O
12	O
minutes	O
of	O
administration	O
.	O

A	O
Mean	O
IOP	O
+/-	O
SD	O
is	O
shown	O
for	O
C57BL	O
/	O
6J	O
mice	O
at	O
5	O
and	O
25	O
minutes	O
after	O
administration	O
of	O
various	O
doses	O
of	O
anesthetic	B-CHEBI
.	O

The	O
1X	O
dose	O
consisted	O
of	O
99	O
mg	O
/	O
kg	O
ketamine	O
and	O
9	O
mg	O
/	O
kg	O
xylazine	O
.	O

All	O
doses	O
decreased	O
IOP	O
by	O
25	O
minutes	O
.	O

At	O
all	O
doses	O
the	O
IOP	O
at	O
5	O
minutes	O
was	O
the	O
same	O
suggesting	O
that	O
the	O
effect	O
of	O
anesthesia	O
had	O
not	O
yet	O
occurred	O
.	O

Approximately	O
thirty	O
3	O
to	O
4	O
month	O
old	O
mice	O
were	O
analyzed	O
at	O
each	O
dose	O
and	O
time	O
B	O
-	O
D	O
.	O

Scatter	O
-	O
plots	O
demonstrating	O
no	O
change	O
in	O
IOP	O
over	O
the	O
12	O
minutes	O
following	O
anesthetic	B-CHEBI
administration	O
in	O
three	O
relatively	O
unrelated	O
mouse	O
strains	O
.	O

All	O
strains	O
consisted	O
of	O
males	O
and	O
females	O
that	O
ranged	O
from	O
3	O
to	O
6	O
months	O
of	O
age	O
.	O

The	O
sexes	O
and	O
ages	O
were	O
equally	O
represented	O
at	O
each	O
time	O
point	O
.	O

The	O
scatter	O
-	O
plots	O
include	O
195	O
C57BL	O
/	O
6J	O
,	O
161	O
129P3	O
/	O
J	O
and	O
145	O
DBA	O
/	O
2J	O
mice	O
.	O

Figure	O
6	O

IOP	O
is	O
increased	O
during	O
the	O
dark	O
compared	O
to	O
light	O
periods	O
in	O
several	O
strains	O
.	O

Mean	O
IOP	O
+/-	O
SEM	O
is	O
shown	O
for	O
the	O
indicated	O
strains	O
at	O
measurement	O
during	O
the	O
light	O
(	O
open	O
bars	O
)	O
or	O
dark	O
(	O
filled	O
bars	O
)	O
periods	O
of	O
the	O
day	O
.	O

All	O
mice	O
were	O
2	O
to	O
4	O
months	O
old	O
except	O
for	O
CBA	O
/	O
CaJ	O
that	O
were	O
5	O
to	O
6	O
months	O
old	O
.	O

129B6	O
refers	O
to	O
mice	O
of	O
a	O
mixed	O
129X1	O
/	O
SvJ	O
and	O
C57BL	O
/	O
6J	O
background	O
.	O

IOP	O
was	O
increased	O
during	O
the	O
dark	O
in	O
all	O
strains	O
except	O
CBA	O
/	O
CaJ	O
.	O

The	O
number	O
of	O
mice	O
successfully	O
analyzed	O
during	O
the	O
light	O
(	O
L	O
)	O
or	O
dark	O
(	O
D	O
)	O
periods	O
follows	O
,	O
DBA	O
/	O
2J	O
10L	O
,	O
10D	O
;	O
C57BL	O
/	O
6J	O
32L	O
,	O
22D	O
;	O
C57BR	O
/	O
cdJ	O
12L	O
,	O
10D	O
;	O
SWR	O
/	O
J	O
16L	O
,	O
16D	O
;	O
BALB	O
/	O
cByJ	O
15L	O
,	O
16D	O
;	O
129B6	O
10L	O
,	O
12D	O
;	O
CBA	O
/	O
CaJ	O
22L	O
,	O
16D	O
.	O

Blood	O
pressure	O
does	O
not	O
correlate	O
with	O
IOP	O

An	O
initial	O
study	O
of	O
the	O
relationship	O
between	O
blood	O
pressure	O
and	O
IOP	O
in	O
mice	O
did	O
not	O
detect	O
a	O
good	O
correlation	O
(	O
R2	O
=	O
0	O
.	O
1	O
,	O
Figure	O
7	O
)	O
.	O

Figure	O
7	O

No	O
correlation	O
between	O
blood	O
pressure	O
and	O
IOP	O
.	O

There	O
is	O
no	O
strong	O
correlation	O
between	O
the	O
average	O
systolic	O
blood	O
pressure	O
of	O
each	O
strain	O
and	O
the	O
average	O
IOP	O
of	O
that	O
strain	O
(	O
R2	O
=	O
0	O
.	O
1	O
)	O
.	O

All	O
mice	O
were	O
female	O
and	O
2	O
to	O
4	O
months	O
old	O
,	O
with	O
the	O
exception	O
that	O
the	O
female	O
CBA	O
/	O
CaJ	O
used	O
for	O
IOP	O
assessment	O
were	O
6	O
to	O
7	O
months	O
old	O
.	O

If	O
the	O
CBA	O
/	O
CaJ	O
mice	O
are	O
excluded	O
,	O
R2	O
drops	O
to	O
0	O
.	O
01	O
of	O
ARK	O
/	O
J	O
,	O
C57BL	O
/	O
6J	O
and	O
SJL	O
/	O
J	O
,	O
strain	O
ARK	O
/	O
J	O
had	O
the	O
lowest	O
IOP	O
.	O

Myoc	O
alleles	O
do	O
not	O
associate	O
with	O
the	O
magnitude	O
of	O
IOP	O

Mutations	O
in	O
the	O
myocilin	O
gene	O
(	O
MYOC	O
)	O
cause	O
human	O
glaucoma	O
.	O

To	O
determine	O
if	O
allelic	O
variation	O
in	O
the	O
mouse	O
Myoc	O
gene	O
associated	O
with	O
IOP	O
in	O
mouse	O
strains	O
,	O
we	O
analyzed	O
the	O
gene	O
in	O
an	O
assortment	O
of	O
strains	O
with	O
different	O
IOPs	O
.	O

Two	O
alleles	O
were	O
identified	O
.	O

One	O
of	O
these	O
alleles	O
had	O
a	O
12	O
nucleotide	B-CHEBI
insertion	O
in	O
the	O
promoter	O
region	O
(	O
ccagagcagggt	O
,	O
between	O
positions	O
-	O
340	O
and	O
-	O
341	O
)	O
compared	O
to	O
the	O
previously	O
published	O
sequence	O
and	O
is	O
called	O
the	O
insertion	O
allele	O
.	O

The	O
other	O
allele	O
was	O
identical	O
to	O
the	O
published	O
sequence	O
[	O
22	O
]	O
.	O

The	O
insertion	O
allele	O
also	O
had	O
a	O
previously	O
reported	O
substitution	O
(	O
A	B-CHEBI
to	O
G	B-CHEBI
,	O
Thr164Ala	O
)	O
in	O
exon	O
1	O
and	O
several	O
other	O
single	O
base	O
changes	O
in	O
the	O
promoter	O
region	O
[	O
22	O
]	O
.	O

The	O
presence	O
or	O
absence	O
of	O
this	O
allele	O
does	O
not	O
associate	O
with	O
IOP	O
as	O
it	O
is	O
present	O
in	O
strains	O
with	O
a	O
range	O
of	O
IOPs	O
(	O
Figure	O
8	O
)	O
.	O

Figure	O
8	O

Myoc	O
alleles	O
do	O
not	O
associate	O
with	O
IOP	O
.	O

Sequencing	O
identified	O
two	O
alleles	O
of	O
Myoc	O
in	O
these	O
mouse	O
strains	O
(	O
see	O
text	O
)	O
.	O

Mouse	O
strains	O
homozygous	O
for	O
an	O
allele	O
having	O
a	O
12	O
bp	O
insertion	O
in	O
the	O
promoter	O
region	O
are	O
shown	O
as	O
open	O
bars	O
and	O
strains	O
homozygous	O
for	O
the	O
allele	O
without	O
this	O
insertion	O
have	O
filled	O
bars	O
.	O

The	O
IOP	O
data	O
is	O
the	O
same	O
as	O
that	O
in	O
Figure	O
1	O
.	O

Genetic	O
alterations	O
and	O
IOP	O

Y	O
Chromosome	O

The	O
Y	O
chromosome	O
has	O
been	O
implicated	O
in	O
strain	O
specific	O
blood	O
pressure	O
differences	O
in	O
rats	O
[	O
23	O
,	O
24	O
]	O
.	O

To	O
test	O
if	O
the	O
Y	O
chromosome	O
of	O
strain	O
129	O
/	O
Ola	O
alters	O
IOP	O
in	O
relation	O
to	O
that	O
of	O
strain	O
B6	O
,	O
we	O
compared	O
the	O
IOPs	O
of	O
pure	O
B6	O
males	O
and	O
consomic	O
B6	O
males	O
that	O
had	O
the	O
129P2	O
/	O
Ola	O
Y	O
chromosome	O
(	O
backcrossed	O
for	O
11	O
generations	O
)	O
.	O

No	O
differences	O
in	O
IOP	O
were	O
detected	O
between	O
these	O
groups	O
of	O
mice	O
(	O
Figure	O
9	O
,	O
P	O
=	O
0	O
.	O
1	O
)	O
.	O

Figure	O
9	O

Effects	O
of	O
genetic	O
alterations	O
.	O

Mean	O
IOP	O
+/-	O
SEM	O
is	O
shown	O
.	O

There	O
is	O
no	O
difference	O
in	O
IOP	O
between	O
3	O
to	O
4	O
month	O
old	O
males	O
with	O
either	O
the	O
129P2	O
/	O
Ola	O
(	O
n	O
=	O
18	O
)	O
or	O
C57BL	O
/	O
6J	O
(	O
n	O
=	O
20	O
)	O
Y	O
chromosome	O
(	O
Y	O
Chr	O
)	O
.	O

The	O
129	O
Y	O
Chr	O
had	O
been	O
backcrossed	O
to	O
strain	O
C57BL	O
/	O
6J	O
for	O
11	O
generations	O
.	O

Similarly	O
,	O
6	O
to	O
9	O
month	O
old	O
males	O
and	O
females	O
that	O
are	O
homozygous	O
for	O
normal	O
(	O
+	O
)	O
or	O
mutant	O
(	O
n	O
)	O
alleles	O
of	O
Car2	O
have	O
similar	O
IOPs	O
(	O
n	O
=	O
18	O
and	O
14	O
,	O
respectively	O
)	O
.	O

However	O
,	O
4	O
months	O
old	O
males	O
homozygous	O
for	O
the	O
Lepr	O
diabetes	O
and	O
obesity	O
causing	O
mutation	O
(	O
db	O
)	O
had	O
significantly	O
higher	O
IOPs	O
than	O
their	O
heterozygous	O
age	O
and	O
sex	O
matched	O
littermates	O
.	O

The	O
average	O
body	O
weight	O
of	O
the	O
homozygotes	O
and	O
heterozygotes	O
was	O
59	O
g	O
(	O
range	O
50	O
to	O
64	O
g	O
)	O
and	O
35	O
g	O
(	O
range	O
28	O
to	O
41	O
g	O
)	O
respectively	O
.	O

Blood	O
sugar	O
levels	O
in	O
db	O
/	O
db	O
males	O
of	O
this	O
age	O
are	O
almost	O
always	O
in	O
the	O
diabetic	O
range	O
whereas	O
those	O
of	O
heterozygotes	O
are	O
not	O
[	O
[	O
27	O
]	O
]	O
.	O

This	O
was	O
recently	O
confirmed	O
in	O
cohorts	O
of	O
approximately	O
25	O
males	O
of	O
each	O
genotype	O
(	O
mean	O
+/-	O
SD	O
;	O
db	O
/	O
db	O
422	O
+/-	O
110	O
mg	O
/	O
dl	O
;	O
db	O
/	O
+	O
147	O
+/-	O
19	O
mg	O
/	O
dl	O
;	O
Anthony	O
Nicholson	O
,	O
The	O
Jackson	O
Laboratory	O
,	O
personal	O
communication	O
)	O

Car2	O

To	O
test	O
if	O
deficiency	O
of	O
carbonic	B-CHEBI
anhydrase	O
II	O
leads	O
to	O
decreased	O
IOP	O
,	O
we	O
analyzed	O
mice	O
of	O
a	O
B6	O
background	O
that	O
were	O
genetically	O
similar	O
but	O
with	O
normal	O
or	O
mutant	O
alleles	O
of	O
the	O
Car2	O
gene	O
[	O
25	O
,	O
26	O
]	O
.	O

There	O
was	O
no	O
difference	O
in	O
IOP	O
between	O
normal	O
and	O
mutant	O
mice	O
(	O
Figure	O
9	O
,	O
P	O
=	O
0	O
.	O
5	O
)	O
.	O

Lepr	O

To	O
test	O
if	O
genetic	O
perturbations	O
that	O
cause	O
obesity	O
and	O
diabetes	O
can	O
alter	O
IOP	O
,	O
we	O
compared	O
mice	O
that	O
were	O
genetically	O
similar	O
but	O
were	O
either	O
homozygous	O
or	O
heterozygous	O
for	O
a	O
leptin	O
receptor	O
mutation	O
(	O
db	O
)	O
that	O
results	O
in	O
obesity	O
and	O
diabetes	O
before	O
4	O
months	O
of	O
age	O
on	O
the	O
C57BLKS	O
/	O
J	O
strain	O
background	O
used	O
[	O
27	O
]	O
.	O

IOP	O
was	O
modestly	O
but	O
significantly	O
elevated	O
in	O
obese	O
,	O
diabetic	O
homozygous	O
mutants	O
(	O
14	O
.	O
7	O
+/-	O
0	O
.	O
3	O
mmHg	O
)	O
compared	O
to	O
non	O
-	O
obese	O
,	O
non	O
-	O
diabetic	O
heterozygotes	O
(	O
13	O
.	O
4	O
+/-	O
0	O
.	O
4	O
mmHg	O
,	O
P	O
<	O
0	O
.	O
01	O
,	O
Figure	O
9	O
)	O
.	O

Tyr	O

To	O
determine	O
if	O
albinism	O
alters	O
IOP	O
,	O
we	O
analyzed	O
B6	O
mice	O
that	O
were	O
either	O
pigmented	B-CHEBI
or	O
albino	O
.	O

The	O
albino	O
mice	O
were	O
homozygous	O
and	O
coisogenic	O
for	O
a	O
mutant	O
allele	O
of	O
tyrosinase	O
(	O
Tyrc	O
-	O
2J	O
)	O
that	O
arose	O
on	O
the	O
otherwise	O
pigmented	B-CHEBI
B6	O
background	O
.	O

In	O
2	O
month	O
old	O
mice	O
,	O
homozygosity	O
for	O
Tyrc	O
-	O
2J	O
resulted	O
in	O
increased	O
IOP	O
(	O
14	O
.	O
2	O
+/-	O
0	O
.	O
4	O
mmHg	O
)	O
compared	O
to	O
wild	O
type	O
,	O
pigmented	B-CHEBI
mice	O
(	O
12	O
.	O
4	O
+/-	O
0	O
.	O
3	O
mmHg	O
,	O
P	O
<	O
0	O
.	O
0001	O
)	O
.	O

The	O
same	O
was	O
true	O
for	O
independent	O
cohorts	O
of	O
mice	O
of	O
different	O
ages	O
that	O
were	O
analyzed	O
at	O
different	O
times	O
(	O
Figure	O
10A	O
)	O
.	O

In	O
contrast	O
to	O
pigmented	B-CHEBI
B6	O
mice	O
(	O
Figure	O
6	O
)	O
,	O
the	O
IOPs	O
of	O
the	O
albino	O
B6	O
mice	O
were	O
not	O
increased	O
at	O
measurement	O
during	O
the	O
dark	O
compared	O
to	O
light	O
period	O
of	O
the	O
day	O
(	O
P	O
=	O
0	O
.	O
6	O
,	O
Figure	O
10B	O
)	O
.	O

Figure	O
10	O

Tyr	O
mutation	O
results	O
in	O
increased	O
IOP	O
and	O
altered	O
diurnal	O
changes	O
A	O
.	O

Different	O
cohorts	O
of	O
C57BL	O
/	O
6J	O
mice	O
that	O
are	O
homozygous	O
for	O
the	O
spontaneous	O
Tyrc	O
-	O
2J	O
mutation	O
have	O
higher	O
IOP	O
than	O
their	O
normal	O
counterparts	O
at	O
all	O
tested	O
ages	O
.	O

All	O
groups	O
consisted	O
of	O
male	O
and	O
female	O
mice	O
.	O

B	O
.	O

IOP	O
is	O
not	O
increased	O
during	O
the	O
dark	O
period	O
of	O
the	O
day	O
in	O
Tyrc	O
-	O
2J	O
homozygotes	O
.	O

The	O
number	O
of	O
mice	O
analyzed	O
during	O
the	O
light	O
period	O
were	O
:	O
2	O
month	O
,	O
28	O
+	O
/	O
+	O
,	O
29	O
c	O
-	O
2J	O
/	O
c	O
-	O
2J	O
,	O
4	O
month	O
,	O
20	O
+	O
/	O
+	O
and	O
20	O
c	O
-	O
2J	O
/	O
c	O
-	O
2J	O
,	O
8	O
month	O
,	O
15	O
+	O
/	O
+	O
and	O
15	O
c	O
-	O
2J	O
/	O
c	O
-	O
2J	O
.	O

Fourteen	O
mice	O
of	O
each	O
genotype	O
were	O
successfully	O
analyzed	O
during	O
the	O
dark	O
period	O
of	O
the	O
day	O
.	O

Discussion	O

IOP	O
differences	O
are	O
reproducible	O
and	O
amenable	O
to	O
genetic	O
analyses	O

We	O
report	O
the	O
IOPs	O
of	O
over	O
30	O
genetically	O
different	O
mouse	O
strains	O
that	O
were	O
housed	O
in	O
the	O
same	O
environmental	O
conditions	O
.	O

The	O
magnitude	O
of	O
IOP	O
differences	O
between	O
strains	O
and	O
the	O
good	O
reproducibility	O
of	O
readings	O
over	O
time	O
will	O
allow	O
the	O
use	O
of	O
genetic	O
approaches	O
to	O
identify	O
genes	O
that	O
underlie	O
these	O
differences	O
.	O

Using	O
our	O
method	O
,	O
a	O
trained	O
investigator	O
can	O
measure	O
the	O
IOPs	O
of	O
10	O
mice	O
in	O
an	O
hour	O
.	O

Thus	O
it	O
is	O
feasible	O
to	O
assess	O
sufficient	O
numbers	O
of	O
mice	O
for	O
quantitative	O
trait	O
locus	O
(	O
QTL	O
)	O
analysis	O
methods	O
and	O
to	O
use	O
these	O
methods	O
to	O
identify	O
chromosomal	O
regions	O
contributing	O
to	O
strain	O
differences	O
in	O
IOP	O
.	O

The	O
strain	O
survey	O
we	O
report	O
provides	O
valuable	O
information	O
for	O
designing	O
these	O
experiments	O
.	O

The	O
throughput	O
and	O
reproducibility	O
also	O
is	O
sufficient	O
for	O
mutagenesis	O
screens	O
[	O
28	O
-	O
30	O
]	O
.	O

These	O
are	O
important	O
approaches	O
as	O
they	O
may	O
allow	O
the	O
association	O
of	O
genes	O
with	O
IOP	O
and	O
glaucoma	O
whose	O
currently	O
known	O
functions	O
do	O
not	O
suggest	O
that	O
they	O
affect	O
aqueous	O
humor	O
dynamics	O
or	O
do	O
not	O
immediately	O
identify	O
them	O
as	O
likely	O
glaucoma	O
candidates	O
.	O

No	O
effect	O
of	O
anesthetic	O
protocol	O
on	O
IOP	O
during	O
a	O
12	O
minute	O
measurement	O
window	O

Many	O
anesthetic	B-CHEBI
agents	I-CHEBI
including	O
xylazine	O
lower	O
IOP	O
.	O

Ketamine	O
usually	O
appears	O
to	O
increase	O
IOP	O
[	O
31	O
-	O
33	O
]	O
,	O
but	O
there	O
are	O
reports	O
of	O
ketamine	O
having	O
no	O
effect	O
on	O
IOP	O
or	O
even	O
reducing	O
IOP	O
[	O
31	O
,	O
34	O
]	O
.	O

Different	O
doses	O
,	O
species	O
used	O
,	O
routes	O
of	O
administration	O
or	O
environments	O
may	O
contribute	O
to	O
these	O
differences	O
.	O

The	O
relationship	O
between	O
the	O
IOPs	O
we	O
measure	O
and	O
those	O
in	O
conscious	O
mice	O
depends	O
upon	O
the	O
effect	O
of	O
our	O
anesthetic	O
protocol	O
(	O
intraperitoneal	O
injection	O
of	O
99	O
mg	O
/	O
kg	O
ketamine	O
and	O
9	O
mg	O
/	O
kg	O
xylazine	O
)	O
.	O

An	O
anesthetic	O
effect	O
could	O
potentially	O
alter	O
IOP	O
and	O
mask	O
genetically	O
determined	O
differences	O
in	O
IOP	O
.	O

Therefore	O
,	O
it	O
is	O
very	O
important	O
to	O
understand	O
this	O
effect	O
.	O

Here	O
,	O
we	O
show	O
that	O
,	O
despite	O
a	O
depressant	O
effect	O
on	O
IOP	O
by	O
25	O
minutes	O
,	O
our	O
anesthetic	O
protocol	O
has	O
no	O
detectable	O
effect	O
on	O
IOP	O
during	O
the	O
first	O
12	O
minutes	O
after	O
administration	O
.	O

Thus	O
,	O
to	O
avoid	O
effects	O
of	O
anesthesia	O
on	O
IOP	O
,	O
all	O
measurements	O
should	O
be	O
made	O
within	O
a	O
window	O
of	O
up	O
to	O
12	O
minutes	O
after	O
anesthetic	B-CHEBI
administration	O
.	O

Similarities	O
and	O
differences	O
to	O
rat	O
studies	O

Our	O
results	O
agree	O
with	O
the	O
time	O
course	O
of	O
cardiovascular	O
depression	O
caused	O
by	O
intraperitoneal	O
administration	O
of	O
ketamine	O
and	O
xylazine	O
in	O
rats	O
.	O

In	O
that	O
study	O
,	O
anesthesia	O
had	O
a	O
minor	O
effect	O
on	O
blood	O
pressure	O
during	O
the	O
first	O
15	O
minutes	O
following	O
injection	O
but	O
a	O
strong	O
hypotensive	O
effect	O
between	O
15	O
and	O
30	O
minutes	O
that	O
continued	O
for	O
more	O
than	O
an	O
hour	O
[	O
35	O
]	O
.	O

In	O
contrast	O
,	O
intraperitoneally	O
administered	O
ketamine	O
(	O
100	O
mg	O
/	O
kg	O
)	O
was	O
shown	O
to	O
rapidly	O
decrease	O
IOP	O
in	O
a	O
different	O
rat	O
study	O
[	O
36	O
]	O
.	O

IOP	O
decreased	O
significantly	O
between	O
a	O
conscious	O
measurement	O
and	O
the	O
first	O
possible	O
measurement	O
under	O
anesthesia	O
(	O
defined	O
as	O
time	O
0	O
)	O
.	O

IOP	O
decreased	O
further	O
by	O
the	O
next	O
reading	O
(	O
at	O
5	O
minutes	O
)	O
after	O
which	O
it	O
remained	O
stable	O
for	O
the	O
duration	O
of	O
the	O
experiment	O
(	O
20	O
minutes	O
)	O
[	O
36	O
]	O
.	O

The	O
time	O
0	O
measurement	O
in	O
that	O
study	O
was	O
at	O
a	O
very	O
similar	O
state	O
of	O
anesthesia	O
as	O
our	O
4	O
and	O
5	O
minute	O
time	O
points	O
(	O
starting	O
as	O
soon	O
as	O
possible	O
and	O
within	O
20	O
to	O
60	O
seconds	O
of	O
adequate	O
anesthesia	O
)	O
,	O
and	O
the	O
5	O
minute	O
rat	O
time	O
point	O
was	O
similar	O
to	O
our	O
9	O
and	O
10	O
minute	O
measurement	O
times	O
.	O

Thus	O
,	O
although	O
both	O
rat	O
and	O
mouse	O
studies	O
show	O
that	O
anesthesia	O
decreases	O
IOP	O
,	O
the	O
studies	O
do	O
not	O
agree	O
on	O
the	O
timing	O
of	O
the	O
effect	O
.	O

The	O
IOP	O
depression	O
occurred	O
very	O
soon	O
after	O
anesthesia	O
in	O
the	O
rats	O
but	O
was	O
delayed	O
in	O
the	O
mice	O
.	O

Environment	O
may	O
influence	O
the	O
effect	O
of	O
anesthesia	O

Factors	O
that	O
may	O
influence	O
the	O
effect	O
of	O
anesthesia	O
include	O
the	O
species	O
,	O
strain	O
and	O
environment	O
used	O
.	O

Essentially	O
the	O
same	O
dose	O
of	O
ketamine	O
and	O
route	O
of	O
administration	O
was	O
used	O
in	O
both	O
the	O
rat	O
and	O
mouse	O
IOP	O
studies	O
.	O

In	O
mice	O
,	O
the	O
strain	O
does	O
not	O
appear	O
to	O
be	O
important	O
as	O
no	O
early	O
effect	O
of	O
anesthesia	O
was	O
present	O
in	O
the	O
three	O
distantly	O
related	O
laboratory	O
strains	O
[	O
37	O
]	O
we	O
studied	O
in	O
detail	O
,	O
and	O
we	O
have	O
not	O
observed	O
any	O
obvious	O
effect	O
during	O
this	O
period	O
in	O
any	O
analyzed	O
strain	O
.	O

Environmental	O
differences	O
may	O
be	O
important	O
.	O

Cage	O
cleanliness	O
,	O
changing	O
frequency	O
and	O
housing	O
density	O
can	O
alter	O
drug	B-CHEBI
metabolism	O
and	O
the	O
effect	O
of	O
anesthesia	O
in	O
rats	O
[	O
38	O
,	O
39	O
]	O
.	O

The	O
type	O
of	O
bedding	O
used	O
also	O
may	O
be	O
important	O
.	O

We	O
use	O
wood	O
shavings	O
for	O
bedding	O
and	O
wood	O
shavings	O
expose	O
the	O
mice	O
to	O
terpenes	B-CHEBI
.	O

Terpene	B-CHEBI
administration	O
or	O
environmental	O
exposure	O
to	O
terpenes	B-CHEBI
in	O
wood	O
shavings	O
alters	O
drug	B-CHEBI
resistance	O
and	O
decreases	O
the	O
effect	O
of	O
anesthetic	B-CHEBI
agents	I-CHEBI
in	O
both	O
rats	O
and	O
mice	O
[	O
40	O
-	O
45	O
]	O
.	O

Risk	O
factors	O
for	O
increased	O
IOP	O

Some	O
epidemiological	O
studies	O
implicate	O
factors	O
such	O
as	O
diabetes	O
,	O
vascular	O
hypertension	O
,	O
arterial	O
hypotension	O
,	O
vasospasm	O
,	O
aberrant	O
autoregulation	O
of	O
blood	O
flow	O
and	O
sex	O
in	O
glaucoma	O
.	O

Other	O
studies	O
find	O
no	O
association	O
between	O
these	O
factors	O
and	O
glaucoma	O
[	O
2	O
,	O
46	O
-	O
48	O
]	O
.	O

Similarly	O
,	O
the	O
effects	O
of	O
various	O
factors	O
including	O
age	O
,	O
gender	O
,	O
blood	O
pressure	O
,	O
obesity	O
and	O
diabetes	O
have	O
been	O
variably	O
associated	O
with	O
elevated	O
IOP	O
.	O

We	O
evaluated	O
the	O
relationship	O
between	O
these	O
latter	O
factors	O
and	O
IOP	O
in	O
genetically	O
homogeneous	O
mouse	O
strains	O
in	O
a	O
controlled	O
environment	O
.	O

Age	O

Although	O
within	O
the	O
range	O
of	O
variability	O
observed	O
in	O
young	O
mice	O
,	O
the	O
IOP	O
of	O
B6	O
mice	O
modestly	O
decreased	O
around	O
1	O
year	O
of	O
age	O
.	O

This	O
decrease	O
was	O
statistically	O
significant	O
compared	O
to	O
young	O
mice	O
measured	O
at	O
the	O
same	O
time	O
.	O

At	O
2	O
years	O
of	O
age	O
the	O
IOP	O
of	O
B6	O
mice	O
had	O
decreased	O
further	O
,	O
though	O
an	O
effect	O
of	O
anesthesia	O
in	O
these	O
very	O
old	O
mice	O
cannot	O
be	O
ruled	O
out	O
[	O
49	O
]	O
.	O

The	O
IOP	O
of	O
129P3	O
/	O
J	O
mice	O
also	O
decreased	O
with	O
age	O
but	O
only	O
at	O
the	O
oldest	O
age	O
examined	O
(	O
18	O
months	O
)	O
.	O

Decreasing	O
IOP	O
correlates	O
with	O
increasing	O
age	O
in	O
the	O
human	O
Japanese	O
population	O
[	O
50	O
,	O
51	O
]	O
.	O

Further	O
studies	O
of	O
B6	O
mice	O
may	O
allow	O
experimental	O
investigation	O
of	O
this	O
effect	O
.	O

Additional	O
studies	O
may	O
also	O
identify	O
"	O
normal	O
"	O
mouse	O
strains	O
that	O
develop	O
increased	O
IOP	O
with	O
age	O
as	O
generally	O
occurs	O
in	O
Western	O
populations	O
[	O
52	O
,	O
53	O
]	O
.	O

We	O
previously	O
demonstrated	O
that	O
the	O
glaucomatous	O
strains	O
DBA	O
/	O
2J	O
and	O
AKXD	O
-	O
28	O
/	O
Ty	O
develop	O
elevated	O
IOP	O
with	O
age	O
[	O
14	O
,	O
19	O
]	O
.	O

Gender	O

In	O
the	O
examined	O
strains	O
,	O
we	O
found	O
no	O
consistent	O
differences	O
in	O
IOP	O
between	O
males	O
and	O
females	O
.	O

This	O
was	O
true	O
at	O
all	O
ages	O
for	O
the	O
3	O
strains	O
that	O
were	O
aged	O
to	O
18	O
months	O
or	O
older	O
.	O

This	O
is	O
in	O
agreement	O
with	O
a	O
number	O
of	O
human	O
studies	O
,	O
which	O
show	O
that	O
IOP	O
is	O
equal	O
between	O
the	O
sexes	O
[	O
52	O
,	O
53	O
]	O
.	O

However	O
,	O
some	O
studies	O
have	O
found	O
sex	O
-	O
specific	O
differences	O
(	O
typically	O
with	O
higher	O
IOP	O
in	O
females	O
and	O
the	O
magnitude	O
of	O
the	O
difference	O
increasing	O
after	O
40	O
years	O
of	O
age	O
)	O
[	O
53	O
,	O
54	O
]	O
.	O

Of	O
possible	O
relevance	O
,	O
we	O
previously	O
reported	O
that	O
female	O
mice	O
of	O
strains	O
DBA	O
/	O
2J	O
and	O
AKXD	O
-	O
28	O
/	O
Ty	O
develop	O
elevated	O
IOP	O
at	O
an	O
earlier	O
age	O
than	O
males	O
[	O
14	O
,	O
19	O
]	O
.	O

Blood	O
pressure	O

Some	O
but	O
not	O
all	O
human	O
studies	O
have	O
reported	O
a	O
positive	O
association	O
between	O
IOP	O
and	O
blood	O
pressure	O
[	O
48	O
,	O
52	O
]	O
.	O

Our	O
comparison	O
of	O
the	O
relationship	O
between	O
blood	O
pressure	O
and	O
IOP	O
in	O
young	O
,	O
adult	O
female	O
mice	O
of	O
different	O
mouse	O
strains	O
,	O
whose	O
blood	O
pressures	O
differed	O
up	O
to	O
36	O
mmHg	O
,	O
did	O
not	O
reveal	O
a	O
positive	O
correlation	O
.	O

Further	O
studies	O
are	O
needed	O
to	O
determine	O
if	O
blood	O
pressure	O
correlates	O
with	O
IOP	O
in	O
males	O
,	O
and	O
to	O
determine	O
the	O
relationship	O
between	O
blood	O
pressure	O
and	O
IOP	O
in	O
various	O
mouse	O
strains	O
with	O
age	O
.	O

Obesity	O
and	O
diabetes	O

Obesity	O
or	O
higher	O
body	O
mass	O
index	O
have	O
been	O
implicated	O
by	O
some	O
but	O
not	O
other	O
studies	O
as	O
risk	O
factors	O
for	O
increased	O
IOP	O
and	O
glaucoma	O
[	O
51	O
,	O
55	O
-	O
57	O
]	O
.	O

Similarly	O
,	O
diabetes	O
or	O
the	O
combination	O
of	O
diabetes	O
and	O
obesity	O
have	O
been	O
variably	O
associated	O
with	O
elevated	O
IOP	O
and	O
glaucoma	O
[	O
46	O
,	O
52	O
,	O
58	O
-	O
62	O
]	O
.	O

To	O
test	O
if	O
genetic	O
perturbations	O
that	O
cause	O
obesity	O
and	O
diabetes	O
can	O
alter	O
IOP	O
,	O
we	O
compared	O
groups	O
of	O
mice	O
that	O
were	O
genetically	O
similar	O
except	O
that	O
they	O
were	O
either	O
homozygous	O
or	O
heterozygous	O
for	O
a	O
leptin	O
receptor	O
mutation	O
(	O
db	O
)	O
that	O
results	O
in	O
early	O
onset	O
obesity	O
and	O
diabetes	O
.	O

The	O
obese	O
,	O
diabetic	O
mice	O
had	O
higher	O
IOPs	O
than	O
their	O
lean	O
,	O
non	O
-	O
diabetic	O
littermates	O
.	O

Thus	O
,	O
epidemiological	O
associations	O
between	O
increased	O
IOP	O
and	O
obesity	O
or	O
diabetes	O
are	O
supported	O
by	O
this	O
work	O
and	O
appear	O
to	O
be	O
functionally	O
relevant	O
.	O

Further	O
experiments	O
with	O
obese	O
non	O
-	O
diabetic	O
or	O
diabetic	O
non	O
-	O
obese	O
mice	O
will	O
help	O
to	O
characterize	O
the	O
separate	O
effects	O
of	O
these	O
risk	O
factors	O
.	O

IOP	O
is	O
increased	O
during	O
the	O
dark	O
period	O
of	O
the	O
day	O

Diurnal	O
variation	O
in	O
IOP	O
is	O
common	O
in	O
humans	O
and	O
laboratory	O
animals	O
[	O
53	O
]	O
.	O

The	O
molecular	B-CHEBI
mechanisms	O
underlying	O
the	O
diurnal	O
rhythm	O
are	O
not	O
defined	O
but	O
increased	O
aqueous	O
humor	O
production	O
or	O
flow	O
occurs	O
during	O
the	O
period	O
of	O
increased	O
IOP	O
in	O
both	O
rabbits	O
and	O
humans	O
[	O
63	O
-	O
65	O
]	O
.	O

Small	O
changes	O
in	O
the	O
resistance	O
to	O
aqueous	O
humor	O
drainage	O
may	O
also	O
contribute	O
to	O
diurnal	O
differences	O
in	O
IOP	O
[	O
66	O
,	O
67	O
]	O
.	O

We	O
first	O
suspected	O
IOP	O
changes	O
with	O
time	O
of	O
day	O
when	O
the	O
IOP	O
of	O
a	O
group	O
of	O
B6	O
mice	O
measured	O
in	O
the	O
hour	O
prior	O
to	O
onset	O
of	O
the	O
dark	O
period	O
appeared	O
to	O
be	O
higher	O
than	O
at	O
other	O
times	O
of	O
day	O
.	O

Previously	O
,	O
a	O
rise	O
of	O
IOP	O
was	O
reported	O
to	O
occur	O
before	O
onset	O
of	O
the	O
dark	O
period	O
in	O
rats	O
[	O
21	O
]	O
,	O
and	O
rats	O
and	O
rabbits	O
were	O
shown	O
to	O
have	O
higher	O
IOP	O
during	O
the	O
dark	O
period	O
compared	O
to	O
the	O
light	O
period	O
[	O
21	O
,	O
68	O
,	O
69	O
]	O
.	O

Thus	O
,	O
we	O
compared	O
the	O
IOPs	O
of	O
mice	O
at	O
different	O
times	O
of	O
day	O
and	O
identified	O
several	O
strains	O
with	O
significantly	O
higher	O
IOP	O
during	O
the	O
dark	O
compared	O
to	O
the	O
light	O
period	O
.	O

The	O
magnitude	O
of	O
the	O
difference	O
varies	O
with	O
strain	O
,	O
and	O
was	O
greatest	O
in	O
SWR	O
/	O
J	O
.	O

The	O
IOP	O
increase	O
in	O
the	O
dark	O
is	O
not	O
dependent	O
on	O
functional	O
rod	O
and	O
cone	O
photoreceptors	O
since	O
these	O
cells	O
degenerate	O
in	O
SWR	O
/	O
J	O
mice	O
due	O
to	O
homozygosity	O
for	O
the	O
Pde6brd1	O
mutation	O
.	O

In	O
agreement	O
with	O
this	O
finding	O
,	O
circadian	O
regulation	O
of	O
wheel	O
running	O
by	O
light	O
was	O
previously	O
reported	O
in	O
mice	O
lacking	O
rods	O
and	O
cones	O
[	O
70	O
]	O
.	O

Interestingly	O
,	O
the	O
IOP	O
of	O
strain	O
CBA	O
/	O
CaJ	O
,	O
which	O
has	O
one	O
of	O
the	O
highest	O
daytime	O
IOPs	O
does	O
not	O
appear	O
to	O
increase	O
in	O
the	O
dark	O
.	O

Further	O
more	O
detailed	O
studies	O
are	O
needed	O
to	O
define	O
the	O
characteristics	O
of	O
the	O
diurnal	O
rhythm	O
of	O
intraocular	O
pressure	O
in	O
mice	O
,	O
and	O
to	O
determine	O
whether	O
it	O
is	O
lacking	O
or	O
has	O
a	O
different	O
timing	O
in	O
strain	O
CBA	O
/	O
CaJ	O
.	O

Analysis	O
of	O
these	O
mouse	O
strains	O
may	O
increase	O
understanding	O
of	O
the	O
molecular	B-CHEBI
mechanisms	O
controlling	O
diurnal	O
rhythms	O
of	O
IOP	O
and	O
that	O
may	O
be	O
relevant	O
to	O
glaucoma	O
.	O

Car2	O
deficiency	O
does	O
not	O
alter	O
IOP	O

Bicarbonate	B-CHEBI
formation	O
is	O
important	O
for	O
aqueous	O
humor	O
secretion	O
from	O
the	O
ciliary	O
processes	O
and	O
carbonic	B-CHEBI
anhydrase	O
(	O
CA	O
)	O
facilitates	O
this	O
secretion	O
.	O

There	O
are	O
multiple	O
forms	O
of	O
CA	O
and	O
the	O
CAII	O
isoform	O
is	O
reported	O
to	O
be	O
the	O
predominant	O
form	O
in	O
the	O
ciliary	O
processes	O
[	O
71	O
,	O
72	O
]	O
.	O

Our	O
experiments	O
show	O
that	O
a	O
genetic	O
deficiency	O
of	O
CAII	O
in	O
mice	O
homozygous	O
for	O
a	O
mutation	O
in	O
the	O
Car2	O
gene	O
does	O
not	O
alter	O
IOP	O
.	O

CAIV	O
activity	O
was	O
recently	O
demonstrated	O
in	O
the	O
ciliary	O
processes	O
[	O
73	O
]	O
and	O
so	O
our	O
data	O
may	O
support	O
a	O
more	O
substantial	O
role	O
for	O
CAIV	O
compared	O
to	O
CAII	O
in	O
aqueous	O
humor	O
secretion	O
.	O

It	O
also	O
is	O
possible	O
that	O
CAII	O
substantially	O
contributes	O
to	O
aqueous	O
humor	O
secretion	O
but	O
that	O
functional	O
mouse	O
CAIV	O
is	O
sufficient	O
to	O
prevent	O
an	O
effect	O
of	O
CAII	O
deficiency	O
on	O
IOP	O
in	O
Car2	O
mutant	O
mice	O
.	O

In	O
support	O
of	O
a	O
role	O
for	O
both	O
enzymes	O
,	O
a	O
greater	O
than	O
90	O
%	O
inhibition	O
of	O
CA	O
is	O
required	O
for	O
significant	O
reduction	O
of	O
aqueous	O
secretion	O
[	O
71	O
,	O
72	O
]	O
.	O

Tyrosinase	O
deficiency	O
results	O
in	O
increased	O
IOP	O

Tyrosinase	O
is	O
the	O
first	O
enzyme	O
of	O
the	O
pigment	B-CHEBI
production	O
pathway	O
.	O

Tyrosinase	O
deficiency	O
causes	O
albinism	O
and	O
has	O
various	O
ocular	O
consequences	O
.	O

These	O
include	O
alteration	O
of	O
the	O
number	O
of	O
ipsilaterally	O
projecting	O
retinal	O
axons	O
and	O
substantially	O
increased	O
light	O
penetration	O
past	O
the	O
iris	O
[	O
74	O
]	O
.	O

It	O
is	O
not	O
known	O
if	O
these	O
abnormalities	O
affect	O
mammalian	O
IOP	O
.	O

Here	O
,	O
we	O
show	O
increased	O
IOP	O
in	O
mice	O
lacking	O
tyrosinase	O
activity	O
compared	O
to	O
otherwise	O
genetically	O
identical	O
pigmented	B-CHEBI
B6	O
mice	O
.	O

Additionally	O
,	O
IOP	O
differences	O
between	O
the	O
light	O
and	O
dark	O
period	O
of	O
the	O
day	O
were	O
detected	O
in	O
the	O
pigmented	B-CHEBI
but	O
not	O
the	O
albino	O
B6	O
mice	O
.	O

Thus	O
,	O
albinism	O
can	O
affect	O
the	O
diurnal	O
pattern	O
of	O
IOP	O
changes	O
.	O

In	O
agreement	O
with	O
this	O
result	O
,	O
mice	O
with	O
albino	O
eyes	O
that	O
are	O
homozygous	O
for	O
tyrosinase	O
or	O
pink	O
eye	O
dilution	O
mutations	O
have	O
altered	O
diurnal	O
rhythms	O
compared	O
to	O
pigmented	B-CHEBI
mice	O
[	O
75	O
]	O
.	O

Albinism	O
by	O
itself	O
is	O
either	O
not	O
sufficient	O
to	O
alter	O
the	O
diurnal	O
rhythm	O
of	O
IOP	O
or	O
alters	O
it	O
in	O
different	O
ways	O
depending	O
upon	O
genetic	O
background	O
,	O
however	O
,	O
since	O
the	O
albino	O
strains	O
BALB	O
/	O
cByJ	O
and	O
SWR	O
/	O
J	O
had	O
increased	O
IOP	O
during	O
the	O
dark	O
.	O

Diurnal	O
rhythms	O
are	O
known	O
to	O
depend	O
on	O
visual	O
pathways	O
and	O
to	O
respond	O
to	O
light	O
intensity	O
.	O

Exposing	O
rats	O
to	O
24	O
hours	O
of	O
low	O
light	O
abrogates	O
the	O
diurnal	O
fluctuation	O
of	O
IOP	O
and	O
results	O
in	O
constantly	O
elevated	O
IOP	O
[	O
36	O
]	O
.	O

Further	O
experiments	O
will	O
determine	O
the	O
nature	O
of	O
the	O
diurnal	O
rhythm	O
of	O
IOP	O
in	O
the	O
albino	O
B6	O
mice	O
and	O
if	O
its	O
alteration	O
or	O
other	O
mechanisms	O
result	O
in	O
IOP	O
elevation	O
.	O

Conclusions	O

A	O
broad	O
range	O
of	O
reproducible	O
IOP	O
differences	O
exists	O
between	O
inbred	O
mouse	O
strains	O
and	O
a	O
diurnal	O
rhythm	O
of	O
IOP	O
exists	O
in	O
different	O
strains	O
.	O

Various	O
factors	O
have	O
been	O
variably	O
associated	O
with	O
risk	O
for	O
increased	O
IOP	O
in	O
humans	O
.	O

Genetically	O
uniform	O
,	O
mice	O
can	O
be	O
used	O
to	O
study	O
the	O
effects	O
of	O
these	O
risk	O
factors	O
on	O
IOP	O
.	O

In	O
trained	O
hands	O
,	O
our	O
measurement	O
procedure	O
is	O
reliable	O
,	O
accurate	O
and	O
rapid	O
enough	O
to	O
allow	O
large	O
scale	O
genetic	O
studies	O
of	O
factors	O
determining	O
IOP	O
.	O

Mice	O
have	O
great	O
potential	O
for	O
helping	O
to	O
characterize	O
the	O
molecular	B-CHEBI
mechanisms	O
affecting	O
IOP	O
.	O

Materials	O
and	O
Methods	O

Animal	O
husbandry	O

All	O
experiments	O
were	O
performed	O
in	O
compliance	O
with	O
the	O
ARVO	O
statement	O
for	O
use	O
of	O
animals	O
in	O
ophthalmic	O
and	O
vision	O
research	O
.	O

All	O
mice	O
were	O
bred	O
and	O
maintained	O
at	O
The	O
Jackson	O
Laboratory	O
.	O

Mice	O
were	O
housed	O
in	O
cages	O
containing	O
white	O
pine	O
bedding	O
and	O
covered	O
with	O
polyester	O
filters	O
.	O

For	O
most	O
experiments	O
,	O
the	O
mice	O
were	O
fed	O
NIH31	O
(	O
6	O
%	O
fat	O
)	O
chow	B-CHEBI
ad	O
libitum	O
,	O
and	O
their	O
water	B-CHEBI
was	O
acidified	O
to	O
pH	O
2	O
.	O
8	O
to	O
3	O
.	O
2	O
.	O

B6	O
mice	O
develop	O
diet	O
induced	O
diabetes	O
when	O
maintained	O
on	O
a	O
high	O
fat	O
diet	O
[	O
76	O
]	O
.	O

To	O
ensure	O
that	O
we	O
were	O
analyzing	O
the	O
effect	O
of	O
age	O
and	O
not	O
diabetes	O
,	O
the	O
B6	O
mice	O
in	O
the	O
aging	O
experiment	O
were	O
fed	O
NIH31	O
(	O
4	O
%	O
fat	O
)	O
chow	B-CHEBI
.	O

We	O
have	O
found	O
no	O
differences	O
in	O
IOP	O
between	O
B6	O
mice	O
housed	O
on	O
the	O
4	O
%	O
fat	O
and	O
6	O
%	O
fat	O
versions	O
of	O
this	O
otherwise	O
identical	O
diet	O
.	O

The	O
mice	O
were	O
group	O
housed	O
and	O
the	O
cages	O
were	O
changed	O
one	O
time	O
per	O
week	O
.	O

If	O
any	O
cage	O
appeared	O
soiled	O
between	O
scheduled	O
changes	O
,	O
the	O
mice	O
were	O
placed	O
in	O
a	O
clean	O
cage	O
.	O

The	O
environment	O
was	O
kept	O
at	O
21	O
degrees	O
C	O
with	O
a	O
14	O
hour	O
light	O
:	O
10	O
hour	O
dark	O
cycle	O
.	O

The	O
colony	O
was	O
monitored	O
for	O
specific	O
pathogens	O
by	O
The	O
Jackson	O
Laboratory	O
'	O
s	O
routine	O
surveillance	O
program	O
(	O
see	O
for	O
specific	O
pathogens	O
)	O
.	O

Intraocular	O
pressure	O

Intraocular	O
pressures	O
were	O
measured	O
as	O
described	O
elsewhere	O
[	O
13	O
,	O
77	O
]	O
.	O

The	O
mice	O
were	O
typically	O
acclimatized	O
to	O
the	O
procedure	O
room	O
for	O
at	O
least	O
2	O
weeks	O
prior	O
to	O
measurement	O
,	O
but	O
sometimes	O
between	O
1	O
and	O
2	O
weeks	O
.	O

Although	O
it	O
was	O
not	O
possible	O
to	O
include	O
all	O
strains	O
in	O
each	O
measurement	O
period	O
,	O
mice	O
of	O
different	O
strains	O
were	O
intermixed	O
.	O

As	O
demonstrated	O
here	O
,	O
the	O
IOPs	O
of	O
C57BL	O
/	O
6J	O
are	O
very	O
consistent	O
over	O
time	O
and	O
so	O
these	O
animals	O
were	O
interspersed	O
with	O
experimental	O
mice	O
during	O
all	O
experiments	O
to	O
ensure	O
that	O
calibration	O
had	O
not	O
drifted	O
and	O
that	O
the	O
system	O
was	O
functioning	O
optimally	O
.	O

Whenever	O
possible	O
,	O
the	O
investigator	O
measuring	O
IOP	O
did	O
not	O
know	O
the	O
genotypes	O
of	O
the	O
animals	O
.	O

It	O
was	O
not	O
possible	O
to	O
analyze	O
all	O
age	O
groups	O
of	O
each	O
strain	O
at	O
the	O
same	O
time	O
in	O
the	O
aging	O
experiments	O
.	O

Therefore	O
,	O
to	O
control	O
for	O
potential	O
IOP	O
changes	O
due	O
to	O
measurement	O
time	O
and	O
not	O
age	O
,	O
approximately	O
3	O
month	O
old	O
B6	O
mice	O
were	O
assessed	O
at	O
the	O
same	O
time	O
as	O
each	O
age	O
group	O
.	O

All	O
dark	O
period	O
measurements	O
were	O
made	O
between	O
1	O
and	O
3	O
hours	O
after	O
the	O
lights	O
turned	O
off	O
.	O

The	O
room	O
was	O
equipped	O
with	O
dim	O
red	O
lights	O
and	O
mice	O
were	O
protected	O
from	O
all	O
light	O
exposure	O
during	O
set	O
up	O
.	O

Each	O
mouse	O
was	O
briefly	O
exposed	O
to	O
the	O
red	O
light	O
when	O
the	O
anesthetic	B-CHEBI
agents	I-CHEBI
were	O
administered	O
.	O

When	O
adequate	O
anesthesia	O
was	O
achieved	O
(	O
after	O
3	O
to	O
4	O
minutes	O
)	O
,	O
the	O
mouse	O
was	O
placed	O
on	O
the	O
measurement	O
platform	O
and	O
the	O
white	O
light	O
of	O
the	O
microscope	O
was	O
turned	O
on	O
(	O
for	O
approximately	O
1	O
and	O
a	O
half	O
minutes	O
)	O
to	O
allow	O
ocular	O
cannulation	O
,	O
IOP	O
measurement	O
and	O
post	O
-	O
measurement	O
tests	O
[	O
13	O
]	O
that	O
guard	O
against	O
artifactual	O
data	O
.	O

The	O
white	O
light	O
was	O
used	O
at	O
very	O
low	O
intensity	O
and	O
was	O
dim	O
but	O
we	O
cannot	O
rule	O
out	O
the	O
possibility	O
that	O
this	O
brief	O
exposure	O
altered	O
the	O
IOP	O
.	O

All	O
other	O
mice	O
were	O
protected	O
from	O
light	O
exposure	O
throughout	O
the	O
time	O
an	O
individual	O
mouse	O
was	O
analyzed	O
.	O

Blood	O
pressure	O

The	O
blood	O
pressures	O
of	O
conscious	O
mice	O
of	O
each	O
strain	O
(	O
6	O
to	O
12	O
females	O
per	O
strain	O
)	O
were	O
measured	O
with	O
a	O
tail	O
-	O
cuff	O
system	O
as	O
reported	O
[	O
78	O
]	O
,	O
except	O
that	O
5	O
days	O
of	O
training	O
were	O
used	O
.	O

The	O
mice	O
were	O
analyzed	O
in	O
the	O
same	O
procedure	O
room	O
as	O
was	O
used	O
for	O
IOP	O
measurment	O
.	O

Clinical	O
examinations	O

For	O
most	O
strains	O
,	O
anterior	O
chambers	O
were	O
examined	O
with	O
a	O
slit	O
lamp	O
biomicroscope	O
[	O
16	O
]	O
.	O

At	O
least	O
8	O
mice	O
of	O
each	O
strain	O
shown	O
in	O
figure	O
1	O
were	O
evaluated	O
.	O

However	O
,	O
the	O
anterior	O
chambers	O
of	O
C57BLKS	O
/	O
J	O
mice	O
were	O
only	O
evaluated	O
under	O
a	O
dissection	O
microscope	O
at	O
the	O
time	O
of	O
IOP	O
measurement	O
.	O

Histological	O
analysis	O

Eyes	O
from	O
at	O
least	O
2	O
mice	O
of	O
the	O
listed	O
strains	O
were	O
fixed	O
(	O
4	O
%	O
paraformaldehyde	O
or	O
Fekete	O
'	O
s	O
acid	B-CHEBI
-	O
alcohol	B-CHEBI
-	O
formalin	O
fixative	O
)	O
processed	O
,	O
paraffin	O
embedded	O
and	O
sectioned	O
as	O
previously	O
reported	O
[	O
15	O
,	O
79	O
]	O
,	O
except	O
that	O
the	O
paraformaldehyde	O
was	O
buffered	B-CHEBI
with	O
0	O
.	O
1	O
M	O
phosphate	B-CHEBI
buffer	O
.	O

All	O
strains	O
other	O
than	O
CBA	O
/	O
CaHN	O
and	O
C57BLKS	O
/	O
J	O
strains	O
were	O
evaluated	O
.	O

The	O
eyes	O
of	O
CBA	O
/	O
CaJ	O
and	O
BALB	O
/	O
cJ	O
mice	O
were	O
also	O
fixed	O
and	O
processed	O
for	O
plastic	O
embedding	O
(	O
Historesin	O
,	O
Leica	O
,	O
Heidelberg	O
,	O
Germany	O
)	O
,	O
and	O
sectioned	O
as	O
previously	O
reported	O
[	O
14	O
,	O
79	O
]	O
.	O

Saggital	O
sections	O
including	O
the	O
pupil	O
and	O
optic	O
nerve	O
were	O
collected	O
and	O
analyzed	O
as	O
they	O
contain	O
most	O
ocular	O
structures	O
.	O

Analysis	O
of	O
Myoc	O

Exons	O
and	O
the	O
proximal	O
promoter	O
of	O
the	O
mouse	O
Myoc	O
gene	O
were	O
amplified	O
from	O
mouse	O
genomic	O
DNA	O
using	O
the	O
following	O
combinations	O
of	O
primers	O
:	O

Exon	O
1	O
:	O
5	O
'	O
-	O
cttgcaggagaactttccagaa	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
atctcgaaggagattgttatagg	O
-	O
3	O
'	O

5	O
'	O
-	O
gaccagctggagacccaaaccag	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
gctcagatccactgacctaaa	O
-	O
3	O
'	O

Exon	O
2	O
:	O
5	O
'	O
-	O
tgaagccatactttaccaaccat	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
caaaagggagaagtctaacttc	O
-	O
3	O
'	O

Exon	O
3	O
:	O
5	O
'	O
-	O
agtcaaggctcacagagctaa	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
aagagtagctgctcaccgtgtacaag	O
-	O
3	O
'	O

5	O
'	O
-	O
agacattgacttagctgtggat	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
cggaacttcaccttttctggc	O
-	O
3	O
'	O

Promoter	O
:	O
5	O
'	O
-	O
taggagaagtctcattatactgc	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
ttcactggaccagcataagga	O
-	O
3	O
'	O

5	O
'	O
-	O
tctgaggatgttcacaggtttat	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
tcttctggaaagttctcctgca	O
-	O
3	O
'	O

Samples	O
underwent	O
30	O
cycles	O
of	O
amplification	O
with	O
Perkin	O
-	O
Elmer	O
Taq	O
polymerase	O
in	O
a	O
PTC	O
Thermal	O
Cycler	O
(	O
MJ	O
Research	O
,	O
MA	O
)	O
(	O
94	O
degrees	O
for	O
40	O
sec	O
,	O
57	O
degrees	O
for	O
1	O
min	O
,	O
72	O
degrees	O
for	O
2	O
min	O
)	O
.	O

The	O
PCR	O
products	O
we	O
purified	O
and	O
sequenced	O
as	O
described	O
[	O
22	O
]	O
.	O

Abbreviations	O

Intraocular	O
pressure	O
(	O
IOP	O
)	O
,	O
C57BL	O
/	O
6J	O
(	O
B6	O
)	O
,	O
chromosome	O
(	O
Chr	O
)	O
,	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
,	O
carbonic	B-CHEBI
anhydrase	O
(	O
CA	O
)	O

Acknowledgments	O

We	O
thank	O
Norma	O
Buckley	O
,	O
Felicia	O
Farley	O
and	O
Jennifer	O
Smith	O
for	O
their	O
assistance	O
with	O
data	O
entry	O
,	O
references	O
,	O
and	O
figures	O
.	O

We	O
also	O
thank	O
Jane	O
Barker	O
for	O
the	O
Car2	O
mice	O
,	O
Marianna	O
Mertts	O
for	O
her	O
help	O
with	O
analysis	O
of	O
Myoc	O
alleles	O
,	O
and	O
members	O
of	O
the	O
John	O
laboratory	O
,	O
Tatyana	O
Golovkina	O
,	O
Edward	O
Leiter	O
and	O
Timothy	O
O	O
'	O
Brien	O
for	O
critical	O
reading	O
of	O
the	O
manuscript	O
.	O

Supported	O
in	O
part	O
by	O
AHAF	O
97437	O
and	O
G1999023	O
,	O
NIH	O
EY11721	O
and	O
HL55001	O
.	O

Core	O
services	O
were	O
subsidized	O
by	O
grant	O
CA34196	O
.	O

Major	O
funding	O
was	O
provided	O
by	O
the	O
Howard	O
Hughes	O
Medical	O
Institute	O
.	O

SWMJ	O
is	O
an	O
Assistant	O
Investigator	O
of	O
The	O
Howard	O
Hughes	O
Medical	O
Institute	O
.	O

BRCA2	O
and	O
homologous	O
recombination	O

Abstract	O

Two	O
recent	O
papers	O
provide	O
new	O
evidence	O
relevant	O
to	O
the	O
role	O
of	O
the	O
breast	O
cancer	O
susceptibility	O
gene	O
BRCA2	O
in	O
DNA	O
repair	O
.	O

Moynahan	O
et	O
al	O
provide	O
genetic	O
data	O
indicating	O
a	O
requirement	O
for	O
BRCA2	O
in	O
homology	O
-	O
dependent	O
(	O
recombinational	O
)	O
repair	O
of	O
DNA	O
double	O
-	O
strand	O
breaks	O
.	O

The	O
second	O
paper	O
,	O
by	O
Davies	O
et	O
al	O
,	O
begins	O
to	O
address	O
the	O
mechanism	O
through	O
which	O
BRCA2	O
makes	O
its	O
contribution	O
to	O
recombinational	O
repair	O
.	O

BRCA2	O
appears	O
to	O
function	O
in	O
recombination	O
via	O
interactions	O
with	O
the	O
major	O
eukaryotic	O
recombinase	O
RAD51	O
[	O
1	O
,	O
2	O
,	O
3	O
]	O
.	O

We	O
briefly	O
review	O
the	O
context	O
in	O
which	O
the	O
two	O
studies	O
were	O
carried	O
out	O
,	O
we	O
comment	O
on	O
the	O
results	O
presented	O
,	O
and	O
we	O
discuss	O
models	O
designed	O
to	O
account	O
for	O
the	O
role	O
of	O
BRCA2	O
in	O
RAD51	O
-	O
mediated	O
repair	O
.	O

Keywords	O
:	O
breast	O
cancer	O
,	O
homologous	O
recombination	O

BRCA2	O

BRCA2	O
was	O
the	O
second	O
breast	O
cancer	O
susceptibility	O
gene	O
to	O
be	O
discovered	O
,	O
and	O
was	O
isolated	O
through	O
positional	O
cloning	O
using	O
data	O
from	O
families	O
with	O
inherited	O
breast	O
cancer	O
[	O
4	O
]	O
.	O

Cells	O
with	O
mutant	O
BRCA2	O
protein	B-CHEBI
are	O
,	O
like	O
many	O
cancer	O
cells	O
,	O
genetically	O
unstable	O
and	O
accumulate	O
gross	O
chromosomal	O
rearrangements	O
[	O
5	O
,	O
6	O
]	O
.	O

The	O
sequence	O
of	O
this	O
large	O
protein	B-CHEBI
(	O
3418	O
amino	B-CHEBI
acids	I-CHEBI
)	O
offers	O
very	O
little	O
clue	O
to	O
its	O
function	O
,	O
although	O
there	O
are	O
eight	O
repeated	O
segments	O
(	O
termed	O
BRC	O
repeats	O
)	O
in	O
the	O
middle	O
of	O
the	O
protein	B-CHEBI
that	O
are	O
highly	O
conserved	O
among	O
mammalian	O
orthologs	O
[	O
7	O
,	O
8	O
]	O
.	O

Breast	O
cancer	O
susceptibility	O
genes	O
and	O
DNA	O
repair	O

Following	O
the	O
landmark	O
discovery	O
by	O
Scully	O
et	O
al	O
that	O
the	O
homologous	O
recombinase	O
RAD51	O
colocalizes	O
at	O
subnuclear	O
sites	O
with	O
BRCA1	O
[	O
9	O
]	O
,	O
a	O
number	O
of	O
additional	O
results	O
have	O
provided	O
evidence	O
that	O
both	O
BRCA1	O
and	O
BRCA2	O
are	O
involved	O
in	O
recombinational	O
repair	O
of	O
DNA	O
damage	O
.	O

BRCA1	O
and	O
BRCA2	O
form	O
discrete	O
nuclear	O
foci	O
during	O
the	O
S	O
phase	O
and	O
after	O
exposure	O
to	O
DNA	O
damaging	O
agents	O
[	O
9	O
,	O
10	O
,	O
11	O
]	O
.	O

These	O
foci	O
are	O
probably	O
sites	O
of	O
repair	O
of	O
spontaneous	O
and	O
induced	O
DNA	O
damage	O
[	O
12	O
,	O
13	O
,	O
14	O
]	O
.	O

Cell	O
lines	O
defective	O
in	O
either	O
BRCA1	O
or	O
BRCA2	O
are	O
sensitive	O
to	O
damaging	O
agents	O
that	O
form	O
double	O
-	O
strand	O
breaks	O
(	O
DSBs	O
)	O
,	O
as	O
are	O
other	O
cell	O
lines	O
defective	O
in	O
recombinational	O
repair	O
(	O
reviewed	O
in	O
[	O
15	O
]	O
)	O
.	O

BRCA2	O
interacts	O
with	O
the	O
RAD51	O
recombinase	O
via	O
direct	O
protein	B-CHEBI
-	O
protein	B-CHEBI
contacts	O
[	O
16	O
,	O
17	O
,	O
18	O
,	O
19	O
]	O
.	O

Biochemical	O
analysis	O
also	O
showed	O
interaction	O
between	O
BRCA1	O
and	O
RAD51	O
,	O
although	O
these	O
detected	O
interactions	O
may	O
have	O
been	O
indirect	O
[	O
9	O
]	O
.	O

The	O
BRC	O
repeats	O
of	O
BRCA2	O
are	O
responsible	O
for	O
direct	O
RAD51	O
interaction	O
.	O

Cells	O
lacking	O
BRCA1	O
/	O
2	O
fail	O
to	O
form	O
damage	O
-	O
induced	O
subnuclear	O
RAD51	O
foci	O
with	O
normal	O
efficiency	O
,	O
suggesting	O
that	O
these	O
proteins	B-CHEBI
are	O
required	O
for	O
the	O
formation	O
of	O
recombinase	O
complexes	O
at	O
the	O
sites	O
of	O
DNA	O
damage	O
[	O
20	O
,	O
21	O
]	O
.	O

Finally	O
,	O
genetic	O
measurements	O
of	O
recombination	O
frequency	O
have	O
shown	O
that	O
Brca1	O
-	O
/	O
-	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
are	O
deficient	O
in	O
recombinational	O
DSB	O
repair	O
[	O
22	O
,	O
23	O
]	O
.	O

The	O
similarity	O
between	O
phenotypes	O
associated	O
with	O
BRCA1	O
and	O
BRCA2	O
deficiency	O
,	O
together	O
with	O
data	O
showing	O
a	O
similar	O
effect	O
of	O
DNA	O
damage	O
on	O
distribution	O
of	O
BRCA1	O
and	O
BRCA2	O
in	O
repair	O
-	O
proficient	O
cells	O
,	O
led	O
to	O
the	O
hypothesis	O
that	O
BRCA2	O
,	O
like	O
BRCA1	O
,	O
is	O
required	O
for	O
efficient	O
recombinational	O
repair	O
.	O

The	O
paper	O
by	O
Moynahan	O
et	O
al	O
[	O
24	O
]	O
provides	O
important	O
support	O
for	O
this	O
hypothesis	O
.	O

Measuring	O
DSB	O
-	O
induced	O
recombination	O
frequency	O
in	O
BRCA2	O
-	O
defective	O
cells	O

Pierce	O
et	O
al	O
have	O
designed	O
a	O
set	O
of	O
recombination	O
substrates	O
for	O
measuring	O
the	O
level	O
of	O
homologous	O
recombination	O
in	O
vivo	O
(	O
Fig	O
.	O
1	O
)	O
[	O
25	O
]	O
.	O

The	O
DNA	O
substrate	O
contains	O
a	O
pair	O
of	O
mutated	O
GFP	O
genes	O
(	O
GFP	O
encodes	O
the	O
easily	O
detected	O
green	O
fluorescent	O
protein	B-CHEBI
)	O
,	O
one	O
of	O
which	O
contains	O
a	O
restriction	O
site	O
for	O
I	O
-	O
SceI	O
,	O
a	O
yeast	O
intron	O
encoded	O
endonuclease	O
with	O
an	O
18	O
base	O
pair	O
recognition	O
site	O
.	O

Transient	O
transfection	O
of	O
an	O
I	O
-	O
SceI	O
expression	O
vector	O
results	O
in	O
the	O
production	O
of	O
a	O
DSB	O
in	O
the	O
first	O
mutated	O
copy	O
of	O
GFP	O
.	O

One	O
or	O
both	O
DNA	O
ends	O
formed	O
by	O
the	O
break	O
invade	O
(	O
s	O
)	O
the	O
homologous	O
sequence	O
in	O
the	O
second	O
mutant	O
GFP	O
copy	O
,	O
resulting	O
in	O
repair	O
of	O
the	O
DSB	O
via	O
a	O
homology	O
-	O
mediated	O
gene	O
conversion	O
event	O
.	O

The	O
configuration	O
of	O
the	O
GFP	O
construct	O
is	O
such	O
that	O
homology	O
-	O
mediated	O
repair	O
often	O
results	O
in	O
the	O
formation	O
of	O
a	O
functional	O
copy	O
of	O
GFP	O
.	O

Such	O
events	O
can	O
be	O
detected	O
by	O
fluorescence	O
-	O
activated	O
cell	O
sorting	O
analysis	O
by	O
virtue	O
of	O
their	O
expression	O
of	O
GFP	O
.	O

Moynahan	O
et	O
al	O
[	O
24	O
]	O
have	O
used	O
such	O
a	O
GFP	O
recombination	O
substrate	O
to	O
demonstrate	O
that	O
cells	O
with	O
defective	O
BRCA2	O
protein	B-CHEBI
are	O
deficient	O
in	O
their	O
ability	O
to	O
repair	O
the	O
I	O
-	O
SceI	O
-	O
induced	O
DSB	O
through	O
homologous	O
recombination	O
.	O

Expression	O
of	O
I	O
-	O
SceI	O
resulted	O
in	O
1	O
out	O
of	O
1400	O
cells	O
producing	O
GFP	O
via	O
homologous	O
recombination	O
in	O
the	O
human	O
pancreatic	O
tumor	O
cell	O
line	O
CAPAN	O
-	O
1	O
.	O

CAPAN	O
-	O
1	O
cells	O
carry	O
a	O
deletion	O
of	O
BRCA2	O
on	O
one	O
homolog	O
and	O
codes	O
for	O
a	O
protein	B-CHEBI
truncated	O
at	O
amino	B-CHEBI
acid	I-CHEBI
1981	O
on	O
the	O
other	O
homolog	O
.	O

The	O
authors	O
indicate	O
that	O
the	O
level	O
of	O
I	O
-	O
SceI	O
-	O
induced	O
recombination	O
in	O
CAPAN	O
-	O
1	O
is	O
over	O
100	O
-	O
fold	O
less	O
than	O
that	O
seen	O
using	O
other	O
(	O
BRCA2	O
+	O
)	O
human	O
tumor	O
cell	O
lines	O
.	O

The	O
different	O
lines	O
examined	O
,	O
however	O
,	O
are	O
very	O
likely	O
to	O
differ	O
genetically	O
from	O
CAPAN	O
-	O
1	O
cells	O
not	O
only	O
at	O
the	O
BRCA2	O
locus	O
,	O
but	O
also	O
at	O
a	O
very	O
large	O
number	O
of	O
additional	O
loci	O
.	O

This	O
raises	O
the	O
possibility	O
that	O
some	O
or	O
even	O
all	O
of	O
the	O
recombinational	O
repair	O
defect	O
seen	O
in	O
CAPAN	O
-	O
1	O
could	O
be	O
due	O
to	O
mutations	O
at	O
non	O
-	O
BRCA2	O
loci	O
.	O

While	O
Moynahan	O
et	O
al	O
were	O
careful	O
to	O
point	O
out	O
this	O
problem	O
,	O
two	O
sets	O
of	O
results	O
argue	O
against	O
the	O
possibility	O
that	O
the	O
recombinational	O
repair	O
deficiency	O
of	O
CAPAN	O
-	O
1	O
cells	O
is	O
completely	O
independent	O
of	O
its	O
defect	O
in	O
BRCA2	O
.	O

First	O
,	O
in	O
the	O
same	O
study	O
[	O
24	O
]	O
,	O
recombination	O
in	O
a	O
mouse	O
ES	O
cell	O
line	O
that	O
expresses	O
only	O
truncated	O
BRCA2	O
protein	B-CHEBI
was	O
measured	O
.	O

This	O
line	O
was	O
found	O
to	O
have	O
lower	O
recombination	O
efficiency	O
than	O
isogenic	O
cells	O
expressing	O
full	O
-	O
length	O
BRCA2	O
(	O
the	O
defect	O
observed	O
was	O
about	O
fivefold	O
to	O
sixfold	O
)	O
.	O

Second	O
,	O
in	O
an	O
independent	O
study	O
,	O
Powell	O
was	O
able	O
to	O
compare	O
derivatives	O
of	O
CAPAN	O
-	O
1	O
that	O
differed	O
only	O
in	O
their	O
ability	O
to	O
express	O
full	O
-	O
length	O
BRCA2	O
protein	B-CHEBI
(	O
S	O
.	O
Powell	O
,	O
personal	O
communication	O
,	O
2001	O
)	O
.	O

In	O
these	O
experiments	O
,	O
the	O
derivative	O
expressing	O
full	O
-	O
length	O
BRCA2	O
yielded	O
10	O
-	O
fold	O
more	O
recombinants	O
than	O
controls	O
expressing	O
only	O
truncated	O
BRCA2	O
(	O
S	O
.	O
Powell	O
,	O
personal	O
communication	O
,	O
2001	O
)	O
.	O

While	O
the	O
experimental	O
design	O
of	O
these	O
experiments	O
was	O
somewhat	O
different	O
from	O
that	O
of	O
Moyna	O
-	O
han	O
et	O
al	O
[	O
24	O
]	O
,	O
the	O
results	O
raise	O
the	O
possibility	O
that	O
CAPAN	O
-	O
1	O
cells	O
have	O
more	O
than	O
one	O
mutation	O
that	O
lowers	O
the	O
efficiency	O
of	O
recombinational	O
repair	O
relative	O
to	O
that	O
observed	O
in	O
other	O
human	O
cell	O
lines	O
.	O

Conversely	O
,	O
the	O
BRCA2	O
defect	O
in	O
CAPAN	O
-	O
1	O
could	O
be	O
fully	O
responsible	O
for	O
the	O
100	O
-	O
fold	O
defect	O
in	O
recombination	O
if	O
the	O
level	O
of	O
BRCA2	O
complementation	O
observed	O
by	O
Powell	O
was	O
incomplete	O
.	O

Furthermore	O
,	O
the	O
discrepancy	O
between	O
the	O
100	O
-	O
fold	O
difference	O
between	O
CAPAN	O
-	O
1	O
and	O
the	O
other	O
human	O
lines	O
as	O
compared	O
with	O
the	O
fivefold	O
to	O
sixfold	O
difference	O
between	O
the	O
Brca2lex1	O
/	O
lex2cells	O
and	O
Brca2	O
+	O
/	O
+	O
ES	O
cells	O
might	O
simply	O
be	O
accounted	O
for	O
by	O
the	O
fact	O
that	O
Brca2lex1	O
/	O
lex2	O
is	O
not	O
a	O
null	O
allele	O
.	O

Additional	O
studies	O
are	O
likely	O
to	O
shed	O
light	O
on	O
the	O
efficiency	O
of	O
BRCA2	O
-	O
independent	O
recombination	O
pathways	O
.	O

Taken	O
together	O
,	O
the	O
results	O
indicate	O
that	O
BRCA2	O
is	O
indeed	O
required	O
for	O
high	O
levels	O
of	O
recombinational	O
repair	O
in	O
both	O
human	O
and	O
mouse	O
.	O

The	O
function	O
of	O
BRCA2	O
-	O
RAD51	O
interaction	O

The	O
second	O
paper	O
providing	O
evidence	O
,	O
by	O
Davies	O
et	O
al	O
[	O
26	O
]	O
,	O
is	O
a	O
biochemical	O
study	O
of	O
the	O
interaction	O
between	O
the	O
homologous	O
recombinase	O
RAD51	O
and	O
a	O
peptide	O
consisting	O
of	O
one	O
of	O
the	O
eight	O
BRC	O
repeats	O
from	O
human	O
BRCA2	O
.	O

Expression	O
of	O
a	O
single	O
BRC	O
repeat	O
(	O
BRC4	O
)	O
had	O
previously	O
been	O
reported	O
to	O
act	O
as	O
an	O
inhibitor	B-CHEBI
of	O
DNA	O
repair	O
by	O
Chen	O
et	O
al	O
[	O
27	O
]	O
.	O

These	O
investigators	O
showed	O
that	O
expression	O
of	O
constructs	O
containing	O
the	O
BRC4	O
repeat	O
in	O
MCF	O
-	O
7	O
cells	O
enhances	O
the	O
radiosensitivity	O
of	O
cells	O
and	O
blocks	O
both	O
the	O
G2	O
/	O
M	O
delay	O
associated	O
with	O
damage	O
and	O
the	O
ability	O
of	O
the	O
transfected	O
cells	O
to	O
assembly	O
subnuclear	O
RAD51	O
foci	O
.	O

In	O
the	O
paper	O
by	O
Davies	O
et	O
al	O
,	O
data	O
provide	O
evidence	O
for	O
a	O
plausible	O
mechanism	O
of	O
the	O
dominant	O
negative	O
effect	O
associated	O
with	O
expression	O
of	O
a	O
single	O
BRC	O
repeat	O
.	O

DNA	O
binding	O
assays	O
and	O
electron	O
microscopy	O
methods	O
were	O
used	O
to	O
show	O
that	O
a	O
BRC3	O
peptide	O
interferes	O
with	O
the	O
ability	O
of	O
RAD51	O
to	O
assemble	O
into	O
oligomeric	O
filaments	O
on	O
DNA	O
.	O

A	O
BRC4	O
peptide	O
was	O
also	O
reported	O
to	O
inhibit	O
the	O
RAD51	O
-	O
DNA	O
interaction	O
.	O

These	O
experiments	O
raise	O
the	O
possibility	O
that	O
the	O
full	O
-	O
length	O
BRCA2	O
protein	B-CHEBI
could	O
act	O
as	O
a	O
negative	O
regulator	O
of	O
inappropriate	O
RAD51	O
-	O
DNA	O
interaction	O
.	O

The	O
final	O
experiment	O
reported	O
by	O
Davies	O
et	O
al	O
[	O
26	O
]	O
is	O
particularly	O
important	O
with	O
respect	O
to	O
understanding	O
the	O
mechanism	O
(	O
s	O
)	O
through	O
which	O
BRCA2	O
promotes	O
RAD51	O
-	O
dependent	O
recombination	O
.	O

The	O
localization	O
of	O
RAD51	O
was	O
examined	O
in	O
CAPAN	O
-	O
1	O
cells	O
,	O
the	O
same	O
human	O
tumor	O
line	O
examined	O
by	O
Moynahan	O
et	O
al	O
[	O
24	O
]	O
.	O

It	O
had	O
been	O
shown	O
previously	O
that	O
the	O
small	O
amount	O
of	O
truncated	O
BRCA2	O
protein	B-CHEBI
expressed	O
by	O
CAPAN	O
-	O
1	O
cells	O
was	O
mislocalized	O
to	O
the	O
cytoplasm	O
,	O
consistent	O
with	O
the	O
fact	O
that	O
the	O
truncation	O
protein	B-CHEBI
lacks	O
a	O
nuclear	O
localization	O
signal	O
[	O
28	O
]	O
.	O

Davies	O
et	O
al	O
showed	O
CAPAN	O
-	O
1	O
cells	O
to	O
be	O
defective	O
in	O
nuclear	O
localization	O
of	O
RAD51	O
,	O
raising	O
the	O
possibility	O
that	O
RAD51	O
is	O
normally	O
carried	O
to	O
the	O
nucleus	O
by	O
binding	O
BRCA2	O
.	O

It	O
is	O
possible	O
that	O
RAD51	O
may	O
alternatively	O
be	O
capable	O
of	O
BRCA2	O
-	O
independent	O
transport	O
,	O
but	O
mislocalization	O
of	O
BRCA2	O
to	O
the	O
cytoplasm	O
may	O
sequester	O
RAD51	O
and	O
block	O
its	O
normal	O
mode	O
of	O
transport	O
.	O

Support	O
for	O
the	O
hypothesis	O
that	O
the	O
observed	O
mislocalization	O
of	O
RAD51	O
is	O
an	O
indirect	O
consequence	O
of	O
the	O
BRCA2	O
defect	O
requires	O
reintroduction	O
of	O
functional	O
BRCA2	O
into	O
CAPAN	O
-	O
1	O
.	O

Given	O
the	O
elaborate	O
nature	O
of	O
the	O
RAD51	O
-	O
BRCA2	O
interaction	O
,	O
it	O
seems	O
somewhat	O
unlikely	O
that	O
the	O
only	O
role	O
of	O
BRCA2	O
in	O
promoting	O
recombination	O
is	O
to	O
serve	O
as	O
a	O
specific	O
nuclear	O
transporter	O
of	O
RAD51	O
.	O

An	O
attractive	O
alternative	O
,	O
favored	O
by	O
Davies	O
et	O
al	O
[	O
26	O
]	O
,	O
is	O
that	O
the	O
association	O
of	O
RAD51	O
-	O
BRCA2	O
is	O
required	O
to	O
maintain	O
RAD51	O
in	O
a	O
form	O
that	O
is	O
in	O
a	O
state	O
of	O
'	O
readiness	O
'	O
(	O
Fig	O
.	O
2a	O
)	O
.	O

In	O
the	O
absence	O
of	O
this	O
interaction	O
with	O
BRCA2	O
,	O
RAD51	O
might	O
exist	O
in	O
a	O
form	O
that	O
is	O
not	O
capable	O
of	O
being	O
recruited	O
into	O
a	O
functional	O
repair	O
complex	O
when	O
damage	O
occurs	O
.	O

For	O
example	O
,	O
previous	O
studies	O
indicated	O
that	O
RAD51	O
shows	O
little	O
binding	O
preference	O
for	O
single	O
-	O
strand	O
DNA	O
(	O
ssDNA	O
)	O
over	O
double	O
-	O
strand	O
DNA	O
(	O
dsDNA	O
)	O
[	O
3	O
,	O
29	O
]	O
.	O

This	O
result	O
could	O
mean	O
that	O
regulatory	O
factors	O
,	O
such	O
as	O
BRCA2	O
,	O
are	O
required	O
to	O
suppress	O
RAD51	O
-	O
dsDNA	O
interactions	O
to	O
prevent	O
sequestration	O
of	O
RAD51	O
in	O
a	O
nonfunctional	O
form	O
.	O

Alternatively	O
,	O
or	O
in	O
addition	O
,	O
suppression	O
of	O
RAD51	O
-	O
ssDNA	O
interaction	O
might	O
be	O
important	O
for	O
preventing	O
RAD51	O
from	O
binding	O
to	O
the	O
regions	O
of	O
ssDNA	O
that	O
form	O
during	O
normal	O
DNA	O
replication	O
.	O

BRCA2	O
may	O
thus	O
promote	O
RAD51	O
assembly	O
into	O
recombinational	O
repair	O
complexes	O
via	O
a	O
negative	O
regulatory	O
mechanism	O
(	O
i	O
.	O
e	O
.	O
by	O
blocking	O
RAD51	O
-	O
BRCA2	O
interaction	O
until	O
damage	O
has	O
occurred	O
and	O
factors	O
required	O
for	O
'	O
productive	O
'	O
assembly	O
of	O
RAD51	O
at	O
damaged	O
sites	O
are	O
in	O
place	O
)	O
.	O

As	O
mentioned	O
previously	O
,	O
the	O
ability	O
of	O
a	O
BRC	O
peptide	O
to	O
repress	O
the	O
RAD51	O
-	O
BRCA2	O
interaction	O
could	O
reflect	O
a	O
role	O
of	O
full	O
-	O
length	O
protein	B-CHEBI
in	O
suppressing	O
unwanted	O
RAD51	O
-	O
BRCA2	O
interactions	O
.	O

Yet	O
another	O
potential	O
role	O
for	O
BRCA2	O
in	O
promoting	O
RAD51	O
-	O
dependent	O
recombinational	O
repair	O
is	O
a	O
positive	O
role	O
in	O
assembly	O
of	O
RAD51	O
at	O
damaged	O
sites	O
(	O
Fig	O
.	O
2b	O
)	O
.	O

Several	O
proteins	B-CHEBI
that	O
interact	O
with	O
RAD51	O
are	O
thought	O
to	O
'	O
mediate	O
'	O
assembly	O
of	O
RAD51	O
at	O
sites	O
of	O
DNA	O
damage	O
(	O
reviewed	O
in	O
[	O
30	O
]	O
)	O
.	O

RAD51	O
paralogs	O
in	O
particular	O
,	O
including	O
XRCC2	O
,	O
XRCC3	O
,	O
RAD51B	O
,	O
RAD51C	O
and	O
RAD51D	O
,	O
may	O
function	O
as	O
a	O
complex	O
that	O
actively	O
promotes	O
RAD51	O
assembly	O
[	O
31	O
]	O
.	O

BRCA2	O
could	O
cooperate	O
with	O
RAD51	O
paralogs	O
in	O
promoting	O
RAD51	O
assembly	O
,	O
or	O
even	O
provide	O
an	O
alternative	O
assembly	O
pathway	O
.	O

The	O
observation	O
that	O
BRCA2	O
localizes	O
to	O
damage	O
-	O
induced	O
subnuclear	O
foci	O
with	O
RAD51	O
seems	O
consistent	O
with	O
the	O
possibility	O
that	O
BRCA2	O
plays	O
a	O
positive	O
role	O
in	O
assembly	O
of	O
the	O
recombination	O
complex	O
[	O
11	O
]	O
.	O

Finally	O
,	O
it	O
is	O
important	O
to	O
note	O
that	O
the	O
two	O
models	O
for	O
the	O
function	O
of	O
the	O
BRCA2	O
-	O
RAD51	O
interaction	O
shown	O
in	O
Figure	O
2	O
are	O
not	O
mutually	O
exclusive	O
.	O

BRCA2	O
could	O
prevent	O
inappropriate	O
RAD51	O
assembly	O
in	O
the	O
absence	O
of	O
damage	O
and	O
promote	O
functional	O
RAD51	O
assembly	O
at	O
DNA	O
lesions	O
during	O
the	O
damage	O
response	O
.	O

Further	O
experiments	O
are	O
clearly	O
required	O
to	O
clarify	O
the	O
functional	O
interactions	O
between	O
BRCA2	O
and	O
RAD51	O
during	O
recombinational	O
repair	O
.	O

It	O
should	O
be	O
relatively	O
straightforward	O
to	O
determine	O
whether	O
the	O
role	O
of	O
BRCA2	O
is	O
limited	O
to	O
transporting	O
RAD51	O
to	O
the	O
nucleus	O
.	O

If	O
this	O
were	O
the	O
case	O
,	O
addition	O
of	O
a	O
nuclear	O
localization	O
signal	O
to	O
RAD51	O
should	O
suppress	O
the	O
RAD51	O
-	O
mediated	O
phenotypes	O
associated	O
with	O
a	O
BRCA2	O
mutation	O
.	O

However	O
,	O
biochemical	O
experiments	O
are	O
needed	O
to	O
determine	O
whether	O
full	O
-	O
length	O
BRCA2	O
blocks	O
or	O
promotes	O
RAD51	O
-	O
BRCA2	O
interaction	O
.	O

Such	O
experiments	O
could	O
also	O
reveal	O
additional	O
roles	O
for	O
BRCA2	O
in	O
recombinational	O
repair	O
.	O

However	O
,	O
several	O
technical	O
obstacles	O
,	O
including	O
the	O
large	O
size	O
of	O
BRCA2	O
,	O
promise	O
to	O
make	O
biochemical	O
characterization	O
of	O
BRCA2	O
function	O
difficult	O
.	O

Abbreviations	O

DSB	O
=	O
double	O
-	O
strand	O
break	O
;	O
dsDNA	O
=	O
double	O
-	O
strand	O
DNA	O
;	O
ES	O
=	O
embryonic	O
stem	O
;	O
GFP	O
=	O
green	O
fluorescent	O
protein	B-CHEBI
;	O
ssDNA	O
=	O
single	O
-	O
strand	O
DNA	O
.	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Recombination	O
substrates	O
used	O
for	O
assaying	O
homology	O
-	O
directed	O
repair	O
.	O

Cutting	O
at	O
the	O
I	O
-	O
SceI	O
site	O
within	O
the	O
mutant	O
GFP	O
(	O
SceGFP	O
)	O
results	O
in	O
a	O
double	O
-	O
strand	O
break	O
that	O
can	O
be	O
repaired	O
through	O
homologous	O
gene	O
conversion	O
using	O
a	O
3	O
'	O
-	O
truncated	O
copy	O
of	O
GFP	O
as	O
sequence	O
donor	O
.	O

The	O
mechanism	O
results	O
in	O
the	O
formation	O
of	O
a	O
functional	O
copy	O
of	O
the	O
GFP	O
gene	O
.	O

The	O
model	O
shown	O
assumes	O
gene	O
conversion	O
occurs	O
via	O
the	O
synthesis	O
-	O
dependent	O
annealing	O
mechanism	O
.	O

Figure	O
2	O

Potential	O
roles	O
of	O
BRCA2	O
in	O
promoting	O
assembly	O
of	O
Rad51	O
at	O
sites	O
of	O
DNA	O
damage	O
.	O

Chromosomal	O
DNA	O
is	O
shown	O
as	O
pairs	O
of	O
straight	O
lines	O
,	O
Rad51	O
as	O
open	O
circles	O
,	O
and	O
BRCA2	O
as	O
grey	O
bars	O
.	O

(	O
a	O
)	O
Prevention	O
of	O
nonproductive	O
DNA	O
interactions	O
.	O

BRCA2	O
-	O
Rad51	O
interaction	O
is	O
proposed	O
to	O
suppress	O
RAD51	O
-	O
BRCA2	O
interactions	O
until	O
DNA	O
damage	O
is	O
present	O
.	O

When	O
damage	O
occurs	O
,	O
Rad51	O
is	O
recruited	O
to	O
damaged	O
sites	O
where	O
is	O
polymerizes	O
into	O
nucleoprotein	O
filaments	O
.	O

In	O
this	O
model	O
,	O
BRCA2	O
is	O
not	O
required	O
for	O
assembly	O
of	O
functional	O
complexes	O
at	O
damaged	O
sites	O
,	O
only	O
to	O
prevent	O
a	O
substantial	O
fraction	O
of	O
Rad51	O
from	O
being	O
sequestered	O
in	O
a	O
nonfunctional	O
form	O
.	O

In	O
a	O
BRCA2	O
-	O
defective	O
cell	O
,	O
mutant	O
Rad51	O
becomes	O
associated	O
with	O
DNA	O
at	O
random	O
sites	O
and	O
is	O
therefore	O
not	O
readily	O
recruited	O
to	O
sites	O
of	O
damage	O
.	O

(	O
b	O
)	O
Positive	O
regulation	O
.	O

BRCA2	O
is	O
proposed	O
to	O
be	O
required	O
for	O
Rad51	O
to	O
assemble	O
into	O
functional	O
recombinational	O
repair	O
complexes	O
at	O
sites	O
of	O
damage	O
.	O

In	O
BRCA	O
-	O
defective	O
cells	O
,	O
Rad51	O
fails	O
to	O
associate	O
with	O
sites	O
of	O
damage	O
due	O
to	O
lack	O
of	O
an	O
assembly	O
factor	O
.	O

Embryonic	O
stem	O
cells	O
and	O
mice	O
expressing	O
different	O
GFP	O
variants	O
for	O
multiple	O
non	O
-	O
invasive	O
reporter	O
usage	O
within	O
a	O
single	O
animal	O

Abstract	O

Background	O

Non	O
-	O
invasive	O
autofluorescent	O
reporters	O
have	O
revolutionized	O
lineage	O
labeling	O
in	O
an	O
array	O
of	O
different	O
organisms	O
.	O

In	O
recent	O
years	O
green	O
fluorescent	O
protein	B-CHEBI
(	O
GFP	O
)	O
from	O
the	O
bioluminescent	O
jellyfish	O
Aequoria	O
Victoria	O
has	O
gained	O
popularity	O
in	O
mouse	O
transgenic	O
and	O
gene	O
targeting	O
regimes	O
[	O
1	O
]	O
.	O

It	O
offers	O
several	O
advantages	O
over	O
conventional	O
gene	O
-	O
based	O
reporters	O
,	O
such	O
as	O
lacZ	O
and	O
alkaline	B-CHEBI
phosphatase	O
,	O
in	O
that	O
its	O
visualization	O
does	O
not	O
require	O
a	O
chromogenic	O
substrate	O
and	O
can	O
be	O
realized	O
in	O
vivo	O
.	O

We	O
have	O
previously	O
demonstrated	O
the	O
utility	O
and	O
developmental	O
neutrality	O
of	O
enhanced	O
green	O
fluorescent	O
protein	B-CHEBI
(	O
EGFP	O
)	O
in	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
and	O
mice	O
[	O
2	O
]	O
.	O

Results	O

In	O
this	O
study	O
we	O
have	O
used	O
embryonic	O
stem	O
(	O
ES	O
)	O
cell	O
-	O
mediated	O
transgenesis	O
to	O
test	O
the	O
enhanced	O
cyan	O
fluorescent	O
protein	B-CHEBI
(	O
ECFP	O
)	O
and	O
enhanced	O
yellow	O
fluorescent	O
protein	B-CHEBI
(	O
EYFP	O
)	O
,	O
two	O
mutant	O
and	O
spectrally	O
distinct	O
color	O
variants	O
of	O
wild	O
type	O
(	O
wt	O
)	O
GFP	O
.	O

We	O
have	O
also	O
tested	O
DsRed1	O
,	O
the	O
novel	O
red	O
fluorescent	O
protein	B-CHEBI
reporter	O
recently	O
cloned	O
from	O
the	O
Discostoma	O
coral	O
by	O
virtue	O
of	O
its	O
homology	O
to	O
GFP	O
.	O

To	O
this	O
end	O
,	O
we	O
have	O
established	O
lines	O
of	O
ES	O
cells	O
together	O
with	O
viable	O
and	O
fertile	O
mice	O
having	O
widespread	O
expression	O
of	O
either	O
the	O
ECFP	O
or	O
EYFP	O
GFP	O
-	O
variant	O
reporters	O
.	O

However	O
,	O
we	O
were	O
unable	O
to	O
generate	O
equivalent	O
DsRed1	O
lines	O
,	O
suggesting	O
that	O
DsRed1	O
is	O
not	O
developmentally	O
neutral	O
or	O
that	O
transgene	O
expression	O
cannot	O
be	O
sustained	O
constitutively	O
.	O

Balanced	O
(	O
diploid	O
<	O
-	O
>	O
diploid	O
)	O
and	O
polarized	O
(	O
tetraploid	O
<	O
-	O
>	O
diploid	O
)	O
chimeras	O
comprising	O
combinations	O
of	O
the	O
ECFP	O
and	O
EYFP	O
ES	O
cells	O
and	O
/	O
or	O
embryos	O
,	O
demonstrate	O
that	O
populations	O
of	O
cells	O
expressing	O
each	O
individual	O
reporter	O
can	O
be	O
distinguished	O
within	O
a	O
single	O
animal	O
.	O

Conclusions	O

GFP	O
variant	O
reporters	O
are	O
unique	O
in	O
allowing	O
non	O
-	O
invasive	O
multi	O
-	O
spectral	O
visualization	O
in	O
live	O
samples	O
.	O

The	O
ECFP	O
and	O
EYFP	O
-	O
expressing	O
transgenic	O
ES	O
cells	O
and	O
mice	O
that	O
we	O
have	O
generated	O
provide	O
sources	O
of	O
cells	O
and	O
tissues	O
for	O
combinatorial	O
,	O
double	O
-	O
tagged	O
recombination	O
experiments	O
,	O
chimeras	O
or	O
transplantations	O
.	O

Background	O

The	O
ease	O
of	O
manipulating	O
its	O
genome	O
has	O
helped	O
establish	O
the	O
mouse	O
as	O
the	O
premier	O
model	O
organism	O
for	O
mammalian	O
genetic	O
studies	O
.	O

Both	O
directed	O
and	O
random	O
mutagenesis	O
approaches	O
,	O
including	O
the	O
technologies	O
of	O
transgenesis	O
and	O
gene	O
targeting	O
in	O
ES	O
cells	O
,	O
have	O
become	O
commonplace	O
.	O

Genetically	O
manipulated	O
mice	O
,	O
often	O
incorporating	O
gene	O
-	O
based	O
reporters	O
,	O
are	O
frequently	O
being	O
used	O
to	O
model	O
and	O
understand	O
mammalian	O
development	O
and	O
disease	O
processes	O
.	O

Fluorescent	O
protein	B-CHEBI
reporters	O
currently	O
represent	O
a	O
superior	O
alternative	O
to	O
other	O
gene	O
-	O
based	O
reporters	O
such	O
as	O
the	O
bacterial	O
lacZ	O
or	O
human	O
placental	O
alkaline	B-CHEBI
phosphatase	O
in	O
that	O
their	O
visualization	O
is	O
non	O
-	O
invasive	O
,	O
and	O
as	O
such	O
does	O
not	O
require	O
chromogenic	O
substrates	O
.	O

Fluorescence	O
can	O
be	O
monitored	O
in	O
real	O
-	O
time	O
in	O
vivo	O
and	O
in	O
situ	O
,	O
and	O
has	O
the	O
added	O
advantage	O
in	O
that	O
it	O
can	O
be	O
quantified	O
.	O

The	O
prototype	O
fluorescent	O
protein	B-CHEBI
reporter	O
is	O
green	O
fluorescent	O
protein	B-CHEBI
(	O
GFP	O
,	O
reviewed	O
in	O
[	O
3	O
]	O
)	O
,	O
which	O
is	O
derived	O
from	O
the	O
bioluminescent	O
jellyfish	O
Aequorea	O
Victoria	O
[	O
1	O
]	O
.	O

Green	O
fluorescent	O
variants	O
of	O
wild	O
type	O
GFP	O
(	O
wtGFP	O
)	O
with	O
improved	O
thermostability	O
and	O
fluorescence	O
emission	O
,	O
including	O
enhanced	O
green	O
fluorescent	O
protein	B-CHEBI
(	O
EGFP	O
,	O
[	O
4	O
]	O
)	O
,	O
and	O
mMGFP	O
[	O
5	O
]	O
,	O
have	O
gained	O
popularity	O
for	O
use	O
in	O
mice	O
.	O

Recently	O
however	O
,	O
several	O
additional	O
mutants	O
of	O
wtGFP	O
,	O
with	O
altered	O
excitation	O
and	O
emission	O
spectral	O
profiles	O
(	O
i	O
.	O
e	O
.	O
fluoresce	O
in	O
colors	O
other	O
than	O
green	O
)	O
,	O
as	O
well	O
as	O
improved	O
thermostability	O
and	O
fluorescence	O
,	O
have	O
been	O
described	O
[	O
4	O
,	O
6	O
]	O
.	O

Dual	O
color	O
imaging	O
of	O
several	O
GFP	O
variant	O
proteins	B-CHEBI
is	O
a	O
very	O
attractive	O
prospect	O
and	O
has	O
become	O
a	O
standard	O
procedure	O
in	O
cell	O
biology	O
[	O
7	O
,	O
8	O
]	O
.	O

It	O
has	O
also	O
recently	O
been	O
demonstrated	O
in	O
a	O
subset	O
of	O
cells	O
within	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
of	O
mice	O
using	O
both	O
transgenic	O
and	O
viral	O
infection	O
-	O
based	O
approaches	O
[	O
9	O
,	O
10	O
]	O
.	O

We	O
therefore	O
wished	O
to	O
investigate	O
the	O
feasibility	O
of	O
non	O
-	O
invasive	O
multiple	O
reporter	O
imaging	O
in	O
mice	O
,	O
and	O
as	O
a	O
first	O
step	O
we	O
wanted	O
to	O
ascertain	O
whether	O
we	O
could	O
establish	O
viable	O
and	O
fertile	O
mice	O
with	O
widespread	O
expression	O
of	O
GFP	O
variant	O
reporters	O
.	O

Results	O
and	O
discussion	O

We	O
tested	O
several	O
of	O
the	O
available	O
wtGFP	O
variants	O
for	O
developmental	O
neutrality	O
and	O
stability	O
of	O
widespread	O
expression	O
.	O

An	O
ES	O
cell	O
-	O
mediated	O
transgenic	O
approach	O
was	O
used	O
to	O
evaluate	O
the	O
Enhanced	O
Cyan	O
Fluorescent	O
Protein	B-CHEBI
(	O
ECFP	O
)	O
and	O
Enhanced	O
Yellow	O
Fluorescent	O
Protein	B-CHEBI
(	O
EYFP	O
)	O
wtGFP	O
spectral	O
variants	O
[	O
4	O
,	O
11	O
]	O
.	O

ECFP	O
harbors	O
six	O
amino	B-CHEBI
substitutions	O
(	O
Y66W	O
,	O
F64L	O
,	O
S65T	O
,	O
N146I	O
,	O
M153T	O
,	O
V163A	O
)	O
as	O
compared	O
to	O
GFP	O
,	O
whereas	O
EYFP	O
harbors	O
four	O
(	O
S65G	O
,	O
V68L	O
,	O
S72A	O
and	O
T203Y	O
)	O
.	O

In	O
addition	O
to	O
increasing	O
the	O
quantum	O
yield	O
and	O
solubility	O
of	O
the	O
proteins	B-CHEBI
these	O
mutations	O
shift	O
the	O
spectral	O
profiles	O
of	O
the	O
translation	O
products	O
[	O
4	O
,	O
11	O
]	O
.	O

A	O
breakthrough	O
in	O
the	O
availability	O
of	O
spectrally	O
distinct	O
autofluorescent	O
proteins	B-CHEBI
came	O
with	O
the	O
cloning	O
of	O
six	O
anthozoan	O
fluorescent	O
proteins	B-CHEBI
all	O
having	O
20	O
-	O
30	O
%	O
identity	O
to	O
wtGFP	O
[	O
12	O
]	O
.	O

Of	O
these	O
,	O
DsRed1	O
(	O
referred	O
to	O
as	O
drFP585	O
by	O
Matz	O
et	O
al	O
.	O
,	O
[	O
12	O
]	O
)	O
,	O
a	O
28	O
kDa	O
protein	B-CHEBI
isolated	O
from	O
the	O
IndoPacific	O
sea	O
anemone	O
Discosoma	O
sp	O
,	O
posseses	O
the	O
longest	O
excitation	O
(	O
558	O
nm	O
)	O
and	O
emission	O
(	O
583	O
nm	O
)	O
wavelength	O
maxima	O
known	O
for	O
a	O
wild	O
-	O
type	O
autofluorescent	O
protein	B-CHEBI
.	O

The	O
sequence	O
of	O
DsRed1	O
has	O
recently	O
been	O
modified	O
and	O
optimized	O
for	O
high	O
levels	O
of	O
expression	O
in	O
mammalian	O
cells	O
by	O
the	O
introduction	O
of	O
144	O
silent	O
base	O
pair	O
changes	O
corresponding	O
to	O
human	O
codon	O
usage	O
preferences	O
.	O

We	O
therefore	O
also	O
tested	O
this	O
novel	O
red	O
fluorescent	O
protein	B-CHEBI
(	O
RFP	O
)	O
in	O
ES	O
cells	O
and	O
mice	O
.	O

Plasmids	O
were	O
constructed	O
for	O
driving	O
widespread	O
expression	O
of	O
each	O
of	O
the	O
gene	O
-	O
based	O
fluorescent	O
protein	B-CHEBI
(	O
FP	O
)	O
reporters	O
and	O
were	O
tested	O
in	O
ES	O
cell	O
-	O
mediated	O
transgenics	O
as	O
described	O
previously	O
[	O
2	O
]	O
.	O

Transgenic	O
ES	O
cells	O
exhibiting	O
robust	O
expression	O
of	O
ECFP	O
or	O
EYFP	O
were	O
obtained	O
at	O
the	O
same	O
frequency	O
as	O
we	O
had	O
previously	O
obtained	O
for	O
EGFP	O
.	O

Cells	O
expressing	O
one	O
or	O
other	O
of	O
the	O
two	O
GFP	O
variant	O
reporters	O
were	O
clearly	O
distinguishable	O
within	O
a	O
mixed	O
population	O
(	O
Fig	O
.	O
1a	O
,	O
1b	O
,	O
1c	O
,	O
1d	O
)	O
.	O

Interestingly	O
however	O
we	O
were	O
unable	O
to	O
recover	O
clones	O
expressing	O
DsRed1	O
at	O
the	O
same	O
frequency	O
as	O
for	O
the	O
GFP	O
variant	O
reporters	O
after	O
electroporation	O
and	O
selection	O
under	O
identical	O
conditions	O
.	O

Indeed	O
the	O
DsRed1	O
expressing	O
clones	O
that	O
we	O
were	O
able	O
to	O
recover	O
did	O
not	O
retain	O
their	O
characteristic	O
ES	O
cell	O
morphology	O
,	O
usually	O
appearing	O
smaller	O
and	O
more	O
spherical	O
(	O
Fig	O
.	O
1e	O
and	O
1f	O
)	O
,	O
or	O
occasionally	O
spindle	O
shaped	O
(	O
data	O
not	O
shown	O
)	O
.	O

Unlike	O
the	O
fluorescence	O
produced	O
by	O
the	O
GFP	O
variants	O
which	O
was	O
evenly	O
distributed	O
throughout	O
the	O
cells	O
,	O
the	O
DsRed	O
signal	O
was	O
never	O
homogenous	O
.	O

Red	O
fluorescence	O
was	O
often	O
aggregated	O
in	O
what	O
appeared	O
to	O
be	O
perinuclear	O
regions	O
of	O
the	O
cytoplasm	O
.	O

Similar	O
observations	O
have	O
been	O
made	O
by	O
Furuta	O
and	O
colleagues	O
when	O
they	O
used	O
recombinant	O
sindbis	O
virus	O
for	O
the	O
labeling	O
of	O
dendrites	O
and	O
axons	O
within	O
the	O
CNS	O
of	O
adult	O
mice	O
[	O
10	O
]	O
.	O

In	O
order	O
to	O
generate	O
a	O
DsRed	O
variant	O
that	O
may	O
be	O
amenable	O
to	O
use	O
in	O
ES	O
cells	O
and	O
mice	O
,	O
we	O
recently	O
introduced	O
various	O
sequences	O
that	O
direct	O
nuclear	O
localization	O
to	O
the	O
DsRed	O
coding	O
region	O
.	O

However	O
,	O
again	O
we	O
were	O
unable	O
to	O
generate	O
ES	O
cells	O
or	O
mice	O
exhibiting	O
robust	O
widespread	O
reporter	O
activity	O
(	O
A	O
.	O
-	O
K	O
.	O
H	O
.	O
and	O
V	O
.	O
E	O
.	O
Papaioannou	O
,	O
unpublished	O
observations	O
)	O
.	O

Figure	O
1	O

Non	O
-	O
invasive	O
multiple	O
reporter	O
visualization	O
in	O
ES	O
cells	O
.	O

(	O
a	O
-	O
d	O
)	O
a	O
mixture	O
of	O
CK6	O
/	O
ECFP	O
(	O
ECFP	O
+	O
)	O
and	O
YC5	O
/	O
EYFP	O
(	O
EYFP	O
+	O
)	O
ES	O
cells	O
at	O
low	O
density	O
.	O

(	O
a	O
)	O
image	O
taken	O
under	O
bright	O
field	O
with	O
no	O
epifluorescence	O
.	O

(	O
b	O
)	O
dark	O
field	O
image	O
taken	O
through	O
an	O
EYFP	O
filter	O
.	O

(	O
c	O
)	O
dark	O
field	O
image	O
taken	O
through	O
an	O
ECFP	O
filter	O
.	O

(	O
d	O
)	O
dark	O
field	O
double	O
exposure	O
image	O
acquired	O
by	O
consecutively	O
using	O
ECFP	O
and	O
EYFP	O
filters	O
.	O

ECFP	O
+	O
cells	O
can	O
clearly	O
be	O
discerned	O
from	O
EYFP	O
+	O
cells	O
.	O

(	O
e	O
-	O
f	O
)	O
culture	O
of	O
mixed	O
populations	O
of	O
ES	O
cells	O
comprising	O
ECFP	O
+	O
,	O
EYFP	O
+	O
and	O
RFP	O
+	O
cells	O
.	O

Scale	O
bars	O
represent	O
100	O
mu	O
m	O
.	O

Two	O
ECFP	O
+	O
and	O
two	O
EYFP	O
+	O
clones	O
exhibiting	O
robust	O
fluorescence	O
were	O
used	O
to	O
generate	O
chimeras	O
through	O
ES	O
cell	O
<	O
-	O
>	O
morula	O
stage	O
embryo	O
aggregation	O
[	O
13	O
]	O
.	O

All	O
four	O
ES	O
cell	O
lines	O
transmitted	O
through	O
the	O
germline	O
,	O
leading	O
to	O
the	O
establishment	O
of	O
,	O
CK4	O
/	O
ECFP	O
and	O
CK6	O
/	O
ECFP	O
,	O
two	O
strains	O
of	O
mice	O
having	O
cyan	O
fluorescent	O
protein	B-CHEBI
expression	O
and	O
,	O
YC5	O
/	O
EYFP	O
and	O
2A4	O
/	O
EYFP	O
,	O
two	O
strains	O
having	O
widespread	O
yellow	O
fluorescent	O
protein	B-CHEBI
expression	O
.	O

In	O
these	O
mice	O
the	O
respective	O
FP	O
expression	O
is	O
constituitive	O
,	O
starting	O
at	O
preimplantation	O
stages	O
and	O
continuing	O
through	O
postimplantation	O
embryogenesis	O
to	O
adulthood	O
(	O
Fig	O
.	O
2	O
)	O
.	O

One	O
line	O
expressing	O
each	O
color	O
was	O
chosen	O
for	O
further	O
analysis	O
and	O
breeding	O
to	O
homozygosity	O
.	O

The	O
availability	O
of	O
homozygous	O
animals	O
demonstrated	O
that	O
both	O
reporter	O
gene	O
expression	O
and	O
the	O
site	O
of	O
transgene	O
integration	O
were	O
developmentally	O
neutral	O
.	O

Figure	O
2	O

Dual	O
non	O
-	O
invasive	O
reporter	O
visualization	O
in	O
embryos	O
and	O
adult	O
mice	O
.	O

Transgenic	O
animals	O
are	O
hemizygous	O
for	O
either	O
the	O
CK6	O
/	O
ECFP	O
or	O
YC5	O
/	O
EYFP	O
transgenes	O
.	O

(	O
a	O
-	O
d	O
)	O
blastocyst	O
stage	O
(	O
E3	O
.	O
5	O
)	O
embryos	O
,	O
that	O
are	O
either	O
fluorescent	O
or	O
non	O
-	O
fluorescent	O
.	O

Fluorescent	O
embryos	O
are	O
either	O
blue	O
/	O
cyan	O
or	O
yellow	O
/	O
green	O
,	O
thereby	O
being	O
hemizygous	O
for	O
either	O
the	O
CK6	O
/	O
ECFP	O
or	O
YC5	O
/	O
EYFP	O
transgenes	O
respectively	O
.	O

Non	O
-	O
fluorescent	O
embryos	O
(	O
marked	O
with	O
an	O
asterix	O
on	O
panel	O
a	O
)	O
are	O
of	O
the	O
wild	O
type	O
outbred	O
ICR	O
strain	O
.	O

(	O
a	O
)	O
image	O
taken	O
under	O
bright	O
field	O
with	O
no	O
epifluorescence	O
.	O

(	O
b	O
)	O
dark	O
field	O
image	O
taken	O
through	O
an	O
EYFP	O
filter	O
.	O

(	O
c	O
)	O
dark	O
field	O
image	O
taken	O
through	O
an	O
ECFP	O
filter	O
.	O

(	O
d	O
)	O
dark	O
field	O
double	O
exposure	O
image	O
acquired	O
by	O
consecutively	O
using	O
ECFP	O
and	O
EYFP	O
filters	O
.	O

(	O
e	O
-	O
h	O
)	O
two	O
transgenic	O
(	O
TG	O
/	O
+	O
)	O
E13	O
.	O
5	O
embryos	O
dissected	O
free	O
of	O
their	O
extraembryonic	O
membranes	O
,	O
one	O
is	O
blue	O
/	O
cyan	O
fluorescent	O
(	O
CK6	O
/	O
ECFP	O
transgenic	O
,	O
left	O
)	O
and	O
the	O
other	O
is	O
yellow	O
/	O
green	O
fluorescent	O
(	O
7YC5	O
/	O
EYFP	O
transgenic	O
,	O
right	O
)	O
.	O

(	O
e	O
)	O
image	O
taken	O
under	O
bright	O
field	O
with	O
no	O
epifluorescence	O
.	O

(	O
f	O
)	O
dark	O
field	O
image	O
taken	O
through	O
an	O
EYFP	O
filter	O
.	O

(	O
g	O
)	O
,	O
dark	O
field	O
image	O
taken	O
through	O
an	O
ECFP	O
filter	O
.	O

(	O
h	O
)	O
double	O
exposure	O
acquired	O
by	O
consecutively	O
using	O
ECFP	O
and	O
EYFP	O
filters	O
.	O

(	O
i	O
-	O
k	O
)	O
two	O
three	O
week	O
old	O
transgenic	O
mice	O
each	O
exclusively	O
expressing	O
either	O
the	O
ECFP	O
or	O
EYFP	O
reporter	O
.	O

All	O
images	O
shown	O
are	O
double	O
exposures	O
taken	O
by	O
consecutively	O
using	O
ECFP	O
and	O
then	O
the	O
EYFP	O
filters	O
under	O
epifluorescence	O
.	O

(	O
i	O
)	O
CK6	O
/	O
ECFP	O
(	O
TG	O
/	O
+	O
)	O
transgenic	O
mouse	O
bottom	O
,	O
YC5	O
/	O
EYFP	O
(	O
TG	O
/	O
+	O
)	O
transgenic	O
mouse	O
bottom	O
.	O

(	O
j	O
)	O
CK6	O
/	O
ECFP	O
(	O
TG	O
/	O
+	O
)	O
transgenic	O
mouse	O
left	O
,	O
YC5	O
/	O
EYFP	O
(	O
TG	O
/	O
+	O
)	O
transgenic	O
mouse	O
right	O
.	O

(	O
k	O
)	O
higher	O
maginification	O
view	O
of	O
the	O
tails	O
of	O
the	O
mice	O
in	O
i	O
and	O
j	O
.	O

Zygotic	O
expression	O
of	O
the	O
FP	O
transgenes	O
is	O
clearly	O
evident	O
by	O
the	O
blastocyst	O
stage	O
(	O
Fig	O
.	O
2a	O
,	O
2b	O
,	O
2c	O
,	O
2d	O
)	O
and	O
remains	O
widespread	O
thereafter	O
(	O
Fig	O
.	O
2	O
)	O
.	O

Figure	O
2	O
demonstrates	O
that	O
ECFP	O
+	O
embryos	O
can	O
easily	O
be	O
distinguished	O
from	O
EYFP	O
+	O
embryos	O
and	O
from	O
non	O
-	O
transgenic	O
non	O
-	O
fluorescent	O
embryos	O
from	O
preimplantation	O
stages	O
(	O
Fig	O
.	O
2a	O
,	O
2b	O
,	O
2c	O
,	O
2d	O
)	O
to	O
postimplantation	O
stages	O
(	O
Fig	O
.	O
2e	O
,	O
2f	O
,	O
2g	O
,	O
2h	O
)	O
.	O

Additionally	O
adult	O
mice	O
can	O
also	O
be	O
discriminated	O
on	O
the	O
basis	O
of	O
the	O
color	O
of	O
their	O
fluorescence	O
(	O
Fig	O
.	O
2i	O
,	O
2j	O
,	O
2k	O
)	O
.	O

Even	O
though	O
our	O
RFP	O
transgenic	O
ES	O
cell	O
lines	O
failed	O
to	O
maintain	O
strong	O
uniform	O
expression	O
with	O
in	O
vitro	O
passage	O
,	O
we	O
selected	O
three	O
lines	O
exhibiting	O
the	O
most	O
robust	O
expression	O
for	O
making	O
chimeras	O
,	O
in	O
order	O
to	O
ascertain	O
whether	O
we	O
could	O
achieve	O
,	O
or	O
possibly	O
recover	O
,	O
RFP	O
expression	O
in	O
animals	O
.	O

Cells	O
were	O
flow	O
sorted	O
prior	O
to	O
aggregation	O
so	O
as	O
to	O
enrich	O
for	O
RFP	O
expression	O
.	O

Even	O
though	O
they	O
had	O
lost	O
their	O
characteristic	O
ES	O
cell	O
morphology	O
all	O
three	O
RFP	O
+	O
ES	O
cell	O
lines	O
went	O
gemline	O
as	O
detected	O
by	O
coat	O
color	O
and	O
PCR	O
for	O
the	O
DsRed1	O
transgene	O
(	O
data	O
not	O
shown	O
)	O
.	O

However	O
expression	O
of	O
the	O
RFP	O
reporter	O
could	O
not	O
be	O
detected	O
in	O
any	O
organ	O
of	O
adult	O
mice	O
nor	O
in	O
embryos	O
(	O
data	O
not	O
shown	O
)	O
.	O

This	O
suggests	O
that	O
the	O
DsRed1	O
RFP	O
reporter	O
was	O
unable	O
to	O
recapitulate	O
the	O
expression	O
profile	O
of	O
the	O
promoter	O
/	O
enhancer	O
combination	O
employed	O
.	O

Therefore	O
it	O
appears	O
that	O
GFP	O
variant	O
reporters	O
are	O
more	O
versatile	O
with	O
respect	O
to	O
their	O
application	O
in	O
mice	O
.	O

We	O
produced	O
double	O
FP	O
-	O
tagged	O
chimeras	O
in	O
order	O
to	O
assess	O
whether	O
the	O
ECFP	O
and	O
EYFP	O
reporters	O
could	O
be	O
co	O
-	O
visualized	O
within	O
the	O
same	O
animal	O
.	O

The	O
first	O
series	O
of	O
chimeras	O
were	O
generated	O
through	O
the	O
aggregation	O
of	O
tetraploid	O
embryos	O
with	O
FP	O
+	O
ES	O
cells	O
(	O
or	O
embryos	O
)	O
of	O
the	O
complementary	O
color	O
.	O

The	O
procedure	O
is	O
schematized	O
in	O
Fig	O
.	O

3a	O
.	O

It	O
is	O
evident	O
that	O
the	O
expression	O
of	O
the	O
two	O
FPs	O
can	O
easily	O
be	O
discerned	O
in	O
these	O
double	O
transgenic	O
embryos	O
where	O
the	O
diploid	O
,	O
embryo	O
-	O
proper	O
compartment	O
is	O
ECFP	O
+	O
and	O
the	O
tetraploid	O
extraembryonic	O
compartment	O
is	O
EYFP	O
+	O
(	O
Fig	O
.	O
3b	O
,	O
3c	O
,	O
3d	O
,	O
3e	O
,	O
3f	O
)	O
.	O

Secondly	O
we	O
investigated	O
reporter	O
co	O
-	O
visualization	O
in	O
balanced	O
adult	O
chimeras	O
comprised	O
of	O
both	O
ECFP	O
+	O
and	O
EYFP	O
+	O
compartments	O
.	O

These	O
were	O
generated	O
through	O
the	O
aggregation	O
of	O
diploid	O
embryos	O
with	O
diploid	O
embryos	O
(	O
or	O
ES	O
cells	O
)	O
of	O
the	O
complementary	O
color	O
.	O

The	O
aggregated	O
components	O
of	O
the	O
chimera	O
from	O
which	O
each	O
organ	O
originated	O
is	O
schematized	O
in	O
the	O
top	O
right	O
of	O
each	O
panel	O
in	O
Fig	O
.	O

4	O
.	O

These	O
chimeric	O
adult	O
organs	O
demonstrate	O
that	O
the	O
ECFP	O
+	O
and	O
EYFP	O
+	O
cells	O
comprising	O
these	O
chimeras	O
can	O
easily	O
be	O
discerned	O
(	O
Fig	O
.	O
4	O
)	O
.	O

It	O
can	O
therefore	O
be	O
envisaged	O
that	O
two	O
different	O
FP	O
colors	O
could	O
be	O
used	O
in	O
the	O
construction	O
of	O
chimeras	O
so	O
as	O
to	O
tag	O
both	O
mutant	O
and	O
wild	O
type	O
lineages	O
.	O

Figure	O
3	O

Dual	O
non	O
-	O
invasive	O
reporter	O
visualization	O
in	O
chimeric	O
embryos	O
generated	O
by	O
tetraploid	O
<	O
-	O
>	O
diploid	O
aggregation	O
.	O

In	O
all	O
panels	O
the	O
tetraploid	O
compartment	O
is	O
yellow	O
/	O
green	O
fluorescent	O
(	O
EYFP	O
+	O
)	O
and	O
the	O
diploid	O
is	O
blue	O
/	O
cyan	O
fluorescent	O
(	O
ECFP	O
+	O
)	O
.	O

(	O
a	O
)	O
schematic	O
representation	O
of	O
the	O
tetraploid	O
procedure	O
.	O

Electrofusion	O
of	O
E1	O
.	O
5	O
embryos	O
to	O
render	O
the	O
blastomeres	O
tetraploid	O
,	O
in	O
vitro	O
culture	O
,	O
and	O
subsequent	O
aggregation	O
schemes	O
using	O
double	O
-	O
tagged	O
compartments	O
.	O

Sandwich	O
aggregations	O
were	O
made	O
using	O
either	O
ECFP	O
+	O
(	O
diploid	O
)	O
morulae	O
or	O
ES	O
cells	O
.	O

(	O
b	O
-	O
d	O
)	O
anterior	O
view	O
of	O
an	O
E7	O
.	O
5	O
double	O
-	O
tagged	O
polarized	O
chimera	O
dissected	O
free	O
of	O
its	O
deciduum	O
and	O
therefore	O
missing	O
primary	O
giant	O
cells	O
and	O
parietal	O
endoderm	O
.	O

Here	O
the	O
epiblast	O
(	O
lower	O
half	O
of	O
embryo	O
)	O
and	O
its	O
derivatives	O
are	O
ECFP	O
+	O
whereas	O
the	O
extraembryonic	O
ectoderm	O
,	O
the	O
visceral	O
endoderm	O
and	O
trophoblast	O
are	O
EYFP	O
+	O
(	O
upper	O
half	O
or	O
embryo	O
)	O
.	O

(	O
b	O
)	O
dark	O
field	O
image	O
taken	O
through	O
an	O
EYFP	O
filter	O
.	O

(	O
c	O
)	O
dark	O
field	O
image	O
taken	O
through	O
an	O
ECFP	O
filter	O
.	O

(	O
d	O
)	O
dark	O
field	O
double	O
exposure	O
image	O
acquired	O
by	O
consecutively	O
using	O
ECFP	O
and	O
EYFP	O
filters	O
.	O

(	O
e	O
)	O
dark	O
field	O
double	O
filter	O
exposure	O
of	O
an	O
E9	O
chimera	O
dissected	O
free	O
of	O
all	O
extraembryonic	O
membranes	O
except	O
for	O
a	O
small	O
piece	O
of	O
yolk	O
sac	O
(	O
lower	O
left	O
)	O
.	O

The	O
embryo	O
itself	O
is	O
ECFP	O
+	O
whereas	O
the	O
yolk	O
sac	O
both	O
ECFP	O
+	O
and	O
EYFP	O
+	O
in	O
the	O
mesoderm	O
and	O
endoderm	O
respectively	O
.	O

A	O
small	O
number	O
of	O
EYFP	O
+	O
cells	O
are	O
also	O
observed	O
in	O
the	O
ventral	O
midline	O
of	O
the	O
embryo	O
(	O
arrowhead	O
)	O
.	O

This	O
observation	O
has	O
been	O
noted	O
previously	O
in	O
tetraploid	O
chimeras	O
,	O
and	O
is	O
presumed	O
to	O
represent	O
a	O
small	O
population	O
of	O
visceral	O
endoderm	O
cells	O
that	O
fail	O
to	O
be	O
displaced	O
by	O
the	O
definitive	O
endoderm	O
at	O
earlier	O
stages	O
.	O

(	O
f	O
)	O
dark	O
field	O
double	O
filter	O
exposure	O
of	O
an	O
E10	O
chimera	O
.	O

The	O
embryo	O
is	O
exclusively	O
ECFP	O
+	O
whereas	O
its	O
placenta	O
(	O
to	O
the	O
left	O
of	O
the	O
embryo	O
)	O
is	O
predominantly	O
EYFP	O
+	O
.	O

The	O
labyrinthine	O
trophoblast	O
layer	O
of	O
the	O
placenta	O
comprises	O
both	O
ECFP	O
+	O
and	O
EYFP	O
+	O
cells	O
.	O

Figure	O
4	O

Dual	O
non	O
-	O
invasive	O
reporter	O
visualization	O
in	O
the	O
organs	O
of	O
adult	O
chimeras	O
.	O

All	O
images	O
depict	O
dark	O
field	O
double	O
exposures	O
acquired	O
by	O
consecutively	O
using	O
ECFP	O
and	O
EYFP	O
filters	O
under	O
dark	O
field	O
epifluorescence	O
.	O

Details	O
of	O
aggregates	O
are	O
schematized	O
at	O
the	O
top	O
right	O
of	O
each	O
panel	O
.	O

(	O
a	O
-	O
c	O
)	O
heart	O
and	O
pancreas	O
from	O
double	O
-	O
tagged	O
double	O
-	O
compartment	O
adult	O
chimeras	O
.	O

(	O
a	O
)	O
view	O
of	O
the	O
surface	O
of	O
an	O
adult	O
heart	O
.	O

(	O
b	O
)	O
close	O
-	O
up	O
surface	O
view	O
of	O
ventricle	O
of	O
a	O
chimeric	O
heart	O
generated	O
by	O
aggregation	O
of	O
two	O
diploid	O
morulae	O
,	O
one	O
hemizygous	O
for	O
the	O
CK6	O
/	O
ECFP	O
(	O
ECFP	O
+	O
)	O
transgene	O
and	O
the	O
other	O
hemizygous	O
for	O
the	O
YC5	O
/	O
EYFP	O
(	O
EYFP	O
+	O
)	O
transgene	O
.	O

The	O
regions	O
of	O
yellow	O
/	O
green	O
and	O
cyan	O
fluorescence	O
are	O
clearly	O
mutually	O
exclusive	O
.	O

The	O
striations	O
in	O
the	O
fields	O
of	O
fluorescence	O
represent	O
the	O
proliferative	O
zones	O
present	O
within	O
the	O
ventricle	O
.	O

(	O
c	O
)	O
chimeric	O
pancreas	O
generated	O
by	O
aggregation	O
of	O
a	O
morula	O
hemizygous	O
for	O
the	O
YC5	O
/	O
EYFP	O
transgene	O
with	O
CK6	O
/	O
ECFP	O
ES	O
cells	O
.	O

The	O
restricted	O
fields	O
of	O
fluorescence	O
represent	O
the	O
proliferative	O
zones	O
present	O
within	O
the	O
pancreas	O
.	O

(	O
d	O
)	O
liver	O
from	O
a	O
double	O
-	O
tagged	O
triple	O
-	O
compartment	O
adult	O
chimera	O
.	O

A	O
non	O
-	O
fluorescent	O
morula	O
was	O
aggregated	O
with	O
two	O
clumps	O
of	O
ES	O
cells	O
,	O
one	O
carrying	O
the	O
CK6	O
/	O
ECFP	O
transgene	O
(	O
ECFP	O
+	O
)	O
and	O
the	O
other	O
carrying	O
the	O
YC5	O
/	O
EYFP	O
transgene	O
(	O
EYFP	O
+	O
)	O
.	O

An	O
ECFP	O
+	O
vessel	O
has	O
clonally	O
proliferated	O
and	O
infiltrated	O
the	O
liver	O
lobe	O
(	O
top	O
)	O
.	O

Note	O
that	O
unlike	O
in	O
heart	O
and	O
pancreas	O
there	O
appears	O
to	O
be	O
more	O
interspersed	O
blue	O
/	O
cyan	O
vs	O
green	O
/	O
yellow	O
fluorescence	O
present	O
in	O
the	O
liver	O
,	O
possibly	O
reflecting	O
greater	O
cell	O
intermingling	O
during	O
the	O
genesis	O
of	O
this	O
organ	O
.	O

Conclusions	O

From	O
these	O
observations	O
we	O
conclude	O
that	O
the	O
blue	O
-	O
shifted	O
ECFP	O
,	O
and	O
the	O
red	O
-	O
shifted	O
EYFP	O
variants	O
of	O
wtGFP	O
are	O
both	O
amenable	O
to	O
use	O
in	O
mice	O
.	O

Also	O
since	O
we	O
have	O
established	O
lines	O
of	O
viable	O
and	O
fertile	O
mice	O
having	O
widespread	O
FP	O
expression	O
we	O
have	O
demonstrated	O
that	O
ECFP	O
and	O
EYFP	O
represent	O
developmentally	O
neutral	O
reporters	O
.	O

Since	O
we	O
were	O
unable	O
to	O
obtain	O
ES	O
cells	O
,	O
embryos	O
or	O
mice	O
with	O
widespread	O
expression	O
of	O
a	O
RFP	O
(	O
DsRed1	O
)	O
we	O
conclude	O
that	O
this	O
reporter	O
is	O
not	O
developmentally	O
neutral	O
or	O
that	O
its	O
expression	O
cannot	O
be	O
sustained	O
at	O
levels	O
high	O
enough	O
for	O
detection	O
,	O
and	O
as	O
such	O
is	O
not	O
as	O
versatile	O
as	O
other	O
gene	O
-	O
based	O
fluorescent	O
reporters	O
.	O

ECFP	O
and	O
EYFP	O
can	O
be	O
distinguished	O
on	O
the	O
basis	O
of	O
their	O
unique	O
non	O
-	O
overlapping	O
spectral	O
profiles	O
,	O
and	O
chimeras	O
comprised	O
of	O
ECFP	O
and	O
EYFP	O
tagged	O
compartments	O
demonstrate	O
that	O
the	O
two	O
reporters	O
can	O
be	O
simultaneously	O
non	O
-	O
invasively	O
visualized	O
within	O
the	O
same	O
embryo	O
or	O
adult	O
organ	O
.	O

Therefore	O
it	O
should	O
be	O
possible	O
to	O
use	O
flow	O
cytometry	O
to	O
isolate	O
cells	O
expressing	O
either	O
or	O
both	O
of	O
the	O
reporters	O
from	O
embryos	O
or	O
adult	O
organs	O
[	O
14	O
]	O
.	O

These	O
two	O
reporters	O
can	O
also	O
be	O
used	O
to	O
create	O
pairs	O
of	O
donors	O
and	O
acceptors	O
for	O
in	O
vivo	O
fluorescence	O
energy	O
transfer	O
(	O
FRET	O
)	O
[	O
15	O
]	O
.	O

Since	O
the	O
emission	O
profiles	O
of	O
ECFP	O
and	O
EYFP	O
are	O
the	O
least	O
overlapping	O
of	O
all	O
the	O
usable	O
GFP	O
variants	O
,	O
these	O
ECFP	O
and	O
EYFP	O
currently	O
represent	O
the	O
best	O
combination	O
for	O
co	O
-	O
visualization	O
and	O
for	O
use	O
in	O
multi	O
-	O
spectral	O
double	O
-	O
tagged	O
transgenic	O
,	O
chimeric	O
and	O
/	O
or	O
in	O
vivo	O
FRET	O
experiments	O
(	O
reviewed	O
in	O
[	O
16	O
]	O
)	O
.	O

These	O
experiments	O
have	O
demonstrated	O
the	O
feasibility	O
of	O
monitoring	O
multiple	O
FP	O
reporters	O
non	O
-	O
invasively	O
within	O
a	O
single	O
animal	O
,	O
and	O
have	O
shown	O
the	O
developmental	O
neutrality	O
of	O
the	O
FP	O
reporters	O
employed	O
.	O

This	O
should	O
pave	O
the	O
way	O
for	O
novel	O
strategies	O
designed	O
to	O
incorporate	O
the	O
use	O
of	O
compound	O
transgenics	O
or	O
tissue	O
recombination	O
or	O
chimeric	O
analyses	O
where	O
several	O
compartments	O
are	O
to	O
be	O
tagged	O
.	O

This	O
technology	O
should	O
provide	O
new	O
possibilities	O
in	O
manipulating	O
the	O
mouse	O
genome	O
,	O
and	O
non	O
-	O
invasively	O
studying	O
the	O
consequences	O
.	O

Materials	O
and	O
methods	O

Vector	O
construction	O

cDNAs	O
encoding	O
ECFP	O
,	O
EYFP	O
and	O
DsRed	O
were	O
amplified	O
from	O
plasmids	O
pECFP	O
,	O
pEYFP	O
and	O
pDsRed1	O
-	O
N1	O
(	O
Clontech	O
,	O
Inc	O
.	O
)	O
by	O
PCR	O
using	O
HiFi	O
Taq	O
Polymerase	O
(	O
Invitrogen	O
)	O
.	O

For	O
ECFP	O
and	O
EYFP	O
primers	O
used	O
were	O
GFP	O
-	O
L	O
(	O
5	O
'	O
-	O
TTG	O
AAT	O
TCG	O
CCA	O
CCA	O
TGG	O
TGA	O
GC	O
)	O
and	O
GFP	O
-	O
R	O
(	O
5	O
'	O
-	O
TTG	O
AAT	O
TCT	O
TAC	O
TTG	O
TAC	O
AGC	O
TCG	O
TCC	O
)	O
,	O
for	O
dsRed	O
primers	O
were	O
red	O
-	O
L	O
(	O
5	O
'	O
-	O
TTG	O
AAT	O
TCG	O
CCA	O
CCA	O
TGG	O
TGC	O
GCT	O
C	O
)	O
and	O
red	O
-	O
R	O
(	O
5	O
'	O
-	O
TTG	O
AAT	O
TCT	O
TAC	O
GCT	O
ACA	O
GCT	O
ACA	O
GGA	O
ACA	O
GGT	O
G	O
)	O
.	O

All	O
5	O
'	O
primers	O
contain	O
a	O
Kozak	O
consensus	O
translation	O
initiation	O
site	O
upstream	O
of	O
the	O
ATG	O
for	O
increased	O
translation	O
efficiency	O
in	O
eukaryotic	O
cells	O
[	O
17	O
]	O
.	O

To	O
construct	O
vectors	O
driving	O
ubiquitous	O
transgene	O
expression	O
in	O
ES	O
cells	O
and	O
mice	O
,	O
the	O
PCR	O
amplified	O
cDNAs	O
were	O
digested	O
with	O
EcoRI	O
and	O
inserted	O
into	O
the	O
EcoRI	O
sites	O
of	O
pCAGGS	O
[	O
18	O
]	O
to	O
generate	O
pCX	O
-	O
ECFP	O
,	O
pCX	O
-	O
EYFP	O
and	O
pCX	O
-	O
DsRed	O
.	O

pCAGGS	O
contains	O
the	O
chicken	O
beta	O
-	O
actin	O
promoter	O
and	O
first	O
intron	O
coupled	O
to	O
the	O
CMV	O
immediate	O
early	O
enhancer	O
,	O
and	O
rabbit	O
beta	O
-	O
globin	O
polyadenylation	O
signal	O
.	O

This	O
promoter	O
/	O
enhancer	O
combination	O
has	O
previously	O
been	O
shown	O
to	O
drive	O
strong	O
and	O
widespread	O
transgene	O
expression	O
in	O
ES	O
cells	O
,	O
embryos	O
and	O
adult	O
mice	O
[	O
18	O
,	O
19	O
]	O
.	O

Tissue	O
culture	O

R1	O
ES	O
cells	O
[	O
20	O
]	O
were	O
maintained	O
under	O
standard	O
culture	O
conditions	O
in	O
the	O
presence	O
of	O
LIF	O
,	O
as	O
described	O
previously	O
[	O
21	O
]	O
.	O

20	O
mu	O
g	O
of	O
SalI	O
linearized	O
pCX	O
-	O
ECFP	O
,	O
pCX	O
-	O
EYFP	O
or	O
pCX	O
-	O
DsRed1	O
was	O
co	O
-	O
electroporated	O
into	O
2	O
x	O
107	O
cells	O
with	O
5	O
-	O
10	O
mu	O
g	O
of	O
circular	O
pPGKPuro	O
[	O
22	O
]	O
.	O

This	O
provided	O
transient	O
drug	B-CHEBI
resistance	O
which	O
could	O
be	O
used	O
as	O
a	O
selection	O
for	O
obtaining	O
individual	O
colonies	O
.	O

Selection	O
was	O
applied	O
24	O
hours	O
after	O
electroporation	O
and	O
maintained	O
for	O
5	O
days	O
,	O
thereafter	O
cells	O
were	O
propagated	O
in	O
in	O
the	O
absence	O
of	O
selection	O
.	O

Fluorescent	O
colonies	O
were	O
picked	O
into	O
96	O
-	O
well	O
plates	O
,	O
expanded	O
and	O
archived	O
as	O
described	O
previously	O
(	O
[	O
2	O
]	O
.	O

Clones	O
were	O
screened	O
for	O
strong	O
,	O
stable	O
,	O
and	O
homogenous	O
transgene	O
expression	O
during	O
culture	O
in	O
the	O
absence	O
of	O
drug	B-CHEBI
selection	O
.	O

Chimera	O
production	O
and	O
germline	O
transmission	O

ES	O
cell	O
lines	O
exhibiting	O
robust	O
transgene	O
expression	O
in	O
vitro	O
were	O
assessed	O
in	O
vivo	O
for	O
the	O
spatiotemporal	O
extent	O
of	O
transgene	O
expression	O
and	O
their	O
developmental	O
potential	O
in	O
chimeras	O
produced	O
by	O
aggregation	O
with	O
wild	O
type	O
tetraploid	O
ICR	O
embryos	O
so	O
as	O
to	O
produce	O
completely	O
ES	O
cell	O
-	O
derived	O
embryos	O
,	O
as	O
described	O
previously	O
[	O
20	O
,	O
23	O
]	O
.	O

A	O
detailed	O
protocol	O
can	O
be	O
found	O
on	O
the	O
world	O
wide	O
web	O
at	O
.	O

Clones	O
giving	O
fluorescent	O
E12	O
.	O
5	O
embryos	O
having	O
no	O
readily	O
identifiable	O
malformations	O
were	O
used	O
to	O
generate	O
germline	O
transmitting	O
chimeras	O
by	O
aggregation	O
with	O
diploid	O
wild	O
type	O
ICR	O
embryos	O
as	O
described	O
previously	O
[	O
21	O
,	O
23	O
]	O
.	O

After	O
germline	O
transmission	O
transgenes	O
were	O
bred	O
to	O
homozygosity	O
.	O

Transgenes	O
were	O
maintained	O
on	O
both	O
mixedbred	O
ICR	O
and	O
inbred	O
129	O
/	O
SvJ	O
genetic	O
backgrounds	O
[	O
24	O
]	O
.	O

Imaging	O

Photographs	O
of	O
live	O
samples	O
,	O
freshly	O
dissected	O
in	O
PBS	O
(	O
[	O
24	O
]	O
were	O
taken	O
on	O
a	O
Leica	O
MZFLIII	O
stereo	O
dissecting	O
microscope	O
equipped	O
with	O
epifluorescence	O
optics	O
.	O

Filter	O
sets	O
used	O
were	O
:	O
excitation	O
436	O
/	O
20	O
nm	O
,	O
dichroic	O
mirror	O
455	O
nm	O
,	O
barrier	O
480	O
/	O
40	O
nm	O
for	O
ECFP	O
,	O
excitation	O
500	O
/	O
20	O
nm	O
,	O
dichroic	O
mirror	O
515	O
nm	O
,	O
barrier	O
535	O
/	O
30	O
nm	O
for	O
EYFP	O
and	O
excitation	O
540	O
/	O
25	O
nm	O
,	O
dichroic	O
mirror	O
565	O
nm	O
,	O
barrier	O
605	O
/	O
55	O
for	O
DsRed	O
.	O

Adult	O
mice	O
were	O
anaesthetized	O
with	O
avertin	O
.	O

They	O
were	O
then	O
placed	O
on	O
the	O
stage	O
of	O
a	O
stereo	O
dissecting	O
microscope	O
(	O
Leica	O
MZFLIII	O
)	O
from	O
which	O
the	O
objective	O
had	O
been	O
removed	O
,	O
such	O
that	O
they	O
were	O
illuminated	O
using	O
the	O
epifluorescence	O
optics	O
(	O
lamp	O
and	O
excitation	O
filters	O
)	O
.	O

Photographs	O
were	O
taken	O
using	O
a	O
Nikon	O
FE10	O
35	O
mm	O
SLR	O
camera	O
fitted	O
with	O
individual	O
emission	O
filters	O
.	O

Images	O
were	O
processed	O
using	O
Photoshop	O
software	O
(	O
Adobe	O
Systems	O
)	O
.	O

Footnote	O

The	O
cyan	O
and	O
yellow	O
fluorescent	O
protein	B-CHEBI
-	O
expressing	O
mice	O
described	O
here	O
have	O
been	O
acquired	O
by	O
,	O
and	O
are	O
available	O
from	O
,	O
the	O
Jackson	O
Laboratory	O
Induced	O
Mutant	O
Resource	O
.	O

They	O
are	O
referred	O
to	O
therein	O
as	O
003373	O
Stock	O
TgN	O
(	O
ActbECFP	O
)	O
1Nagy	O
(	O
CK6	O
/	O
ECFP	O
)	O
and	O
003772	O
Stock	O
TgN	O
(	O
ActbEYFP	O
)	O
1Nagy	O
(	O
YC5	O
/	O
EYFP	O
)	O
.	O

Acknowledgements	O

We	O
thank	O
J	O
.	O
-	O
I	O
.	O

Miyazaki	O
for	O
the	O
pCAGGS	O
plasmid	O
.	O

A	O
.	O
-	O
K	O
.	O
H	O
.	O

is	O
particularly	O
indebted	O
to	O
V	O
.	O

E	O
.	O

Papaioannou	O
for	O
helpful	O
discussion	O
and	O
constructive	O
comments	O
on	O
the	O
manuscript	O
.	O

This	O
work	O
was	O
supported	O
by	O
grants	O
from	O
the	O
National	O
Cancer	O
Institute	O
of	O
Canada	O
.	O

Brn3c	O
null	O
mutant	O
mice	O
show	O
long	O
-	O
term	O
,	O
incomplete	O
retention	O
of	O
some	O
afferent	O
inner	O
ear	O
innervation	O

Abstract	O

Background	O

Ears	O
of	O
Brn3c	O
null	O
mutants	O
develop	O
immature	O
hair	O
cells	O
,	O
identifiable	O
only	O
by	O
certain	O
molecular	B-CHEBI
markers	O
,	O
and	O
undergo	O
apoptosis	O
in	O
neonates	O
.	O

This	O
partial	O
development	O
of	O
hair	O
cells	O
could	O
lead	O
to	O
enough	O
neurotrophin	O
expression	O
to	O
sustain	O
sensory	O
neurons	O
through	O
embryonic	O
development	O
.	O

We	O
have	O
therefore	O
investigated	O
in	O
these	O
mutants	O
the	O
patterns	O
of	O
innervation	O
and	O
of	O
expression	O
of	O
known	O
neurotrophins	O
.	O

Results	O

At	O
birth	O
there	O
is	O
a	O
limited	O
expression	O
of	O
BDNF	O
and	O
NT	O
-	O
3	O
in	O
the	O
mutant	O
sensory	O
epithelia	O
and	O
DiI	O
tracing	O
shows	O
no	O
specific	O
reduction	O
of	O
afferents	O
or	O
efferents	O
that	O
resembles	O
neurotrophin	O
null	O
mutations	O
.	O

At	O
postnatal	O
day	O
7	O
/	O
8	O
(	O
P7	O
/	O
8	O
)	O
,	O
innervation	O
is	O
severely	O
reduced	O
both	O
qualitatively	O
and	O
quantitatively	O
.	O

1	O
%	O
of	O
myosin	O
VIIa	O
-	O
positive	O
immature	O
hair	O
cells	O
are	O
present	O
in	O
the	O
mutant	O
cochlea	O
,	O
concentrated	O
in	O
the	O
base	O
.	O

Around	O
20	O
%	O
of	O
immature	O
hair	O
cells	O
exist	O
in	O
the	O
mutant	O
vestibular	O
sensory	O
epithelia	O
.	O

Despite	O
more	O
severe	O
loss	O
of	O
hair	O
cells	O
(	O
1	O
%	O
compared	O
to	O
20	O
%	O
)	O
,	O
the	O
cochlea	O
retains	O
many	O
more	O
sensory	O
neurons	O
(	O
46	O
%	O
compared	O
to	O
15	O
%	O
)	O
than	O
vestibular	O
epithelia	O
.	O

Even	O
6	O
months	O
old	O
mutant	O
mice	O
have	O
some	O
fibers	O
to	O
all	O
vestibular	O
sensory	O
epithelia	O
and	O
many	O
more	O
to	O
the	O
cochlear	O
apex	O
which	O
lacks	O
MyoVIIa	O
positive	O
hair	O
cells	O
.	O

Topologically	O
organized	O
central	O
cochlea	O
projections	O
exist	O
at	O
least	O
until	O
P8	O
,	O
suggesting	O
that	O
functional	O
hair	O
cells	O
are	O
not	O
required	O
to	O
establish	O
such	O
projections	O
.	O

Conclusion	O

The	O
limited	O
expression	O
of	O
neurotrophins	O
in	O
the	O
cochlea	O
of	O
Brn3c	O
null	O
mice	O
suffices	O
to	O
support	O
many	O
sensory	O
neurons	O
,	O
particularly	O
in	O
the	O
cochlea	O
,	O
until	O
birth	O
.	O

The	O
molecular	B-CHEBI
nature	O
of	O
the	O
long	O
term	O
survival	O
of	O
apical	O
spiral	O
neurons	O
remains	O
unclear	O
.	O

Keywords	O
:	O
ear	O
development	O
,	O
POU	O
factors	O
and	O
hair	O
cells	O
,	O
afferent	O
ear	O
innervation	O
,	O
efferent	O
ear	O
innervation	O

Background	O

Brn3c	O
is	O
a	O
POU	O
domain	O
factor	O
that	O
is	O
crucial	O
for	O
inner	O
ear	O
hair	O
cell	O
development	O
.	O

Targeted	O
null	O
Brn3c	O
mutants	O
have	O
no	O
mature	O
hair	O
cells	O
[	O
1	O
,	O
2	O
]	O
.	O

Close	O
examination	O
has	O
revealed	O
that	O
some	O
'	O
immature	O
'	O
hair	O
cells	O
form	O
in	O
Brn3c	O
null	O
mutants	O
and	O
express	O
cellular	O
markers	O
such	O
as	O
Myosin	O
VI	O
and	O
VIIa	O
,	O
calretinin	O
and	O
parvalbumin	O
[	O
3	O
]	O
.	O

Furthermore	O
,	O
these	O
immature	O
hair	O
cells	O
of	O
Brn3c	O
null	O
mutants	O
undergo	O
apoptosis	O
in	O
neonates	O
[	O
3	O
]	O
.	O

Consistent	O
with	O
an	O
apparent	O
absence	O
of	O
mature	O
hair	O
cells	O
,	O
initial	O
work	O
suggested	O
that	O
all	O
vestibular	O
and	O
most	O
spiral	O
ganglion	O
cells	O
are	O
lost	O
by	O
postnatal	O
day	O
14	O
(	O
P14	O
;	O
[	O
1	O
]	O
)	O
.	O

However	O
,	O
more	O
detailed	O
quantification	O
by	O
others	O
[	O
3	O
]	O
reported	O
that	O
at	O
P4	O
about	O
77	O
%	O
of	O
vestibular	O
neurons	O
and	O
only	O
29	O
%	O
of	O
spiral	O
neurons	O
are	O
lost	O
.	O

It	O
was	O
suggested	O
that	O
there	O
is	O
possibly	O
a	O
complete	O
loss	O
in	O
adults	O
[	O
3	O
]	O
.	O

Other	O
than	O
these	O
preliminary	O
statements	O
,	O
no	O
data	O
exists	O
concerning	O
the	O
detailed	O
pattern	O
of	O
loss	O
of	O
innervation	O
in	O
Brn3c	O
null	O
mutants	O
.	O

The	O
initial	O
development	O
and	O
partial	O
differentiation	O
of	O
hair	O
cells	O
in	O
Brn3c	O
mutants	O
could	O
possibly	O
lead	O
to	O
some	O
neurotrophin	O
expression	O
in	O
these	O
cells	O
to	O
sustain	O
sensory	O
neurons	O
through	O
embryonic	O
development	O
and	O
beyond	O
.	O

Data	O
on	O
various	O
single	O
and	O
compound	O
neurotrophin	O
null	O
mutants	O
have	O
shown	O
that	O
the	O
loss	O
of	O
a	O
specific	O
neurotrophin	O
leads	O
to	O
topologically	O
restricted	O
loss	O
of	O
sensory	O
neurons	O
in	O
the	O
embryonic	O
ear	O
[	O
4	O
,	O
5	O
]	O
.	O

Such	O
selective	O
loss	O
in	O
Brn3c	O
null	O
mutants	O
would	O
therefore	O
indicate	O
reduction	O
of	O
a	O
specific	O
neurotrophin	O
in	O
immature	O
hair	O
cells	O
.	O

Moreover	O
,	O
recent	O
work	O
shows	O
that	O
in	O
embryos	O
NT	O
-	O
3	O
is	O
primarily	O
expressed	O
in	O
supporting	O
cells	O
,	O
moving	O
only	O
around	O
birth	O
into	O
hair	O
cells	O
[	O
6	O
,	O
7	O
]	O
.	O

In	O
fact	O
,	O
the	O
selective	O
loss	O
of	O
vestibular	O
as	O
compared	O
to	O
cochlear	O
sensory	O
neurons	O
(	O
77	O
%	O
versus	O
29	O
%	O
;	O
[	O
3	O
]	O
)	O
suggests	O
that	O
NT	O
-	O
3	O
expression	O
may	O
be	O
less	O
downregulated	O
in	O
Brn3c	O
null	O
mutants	O
than	O
BDNF	O
[	O
6	O
,	O
8	O
,	O
9	O
]	O
,	O
provided	O
that	O
at	O
least	O
some	O
differentiation	O
of	O
supporting	O
cells	O
takes	O
place	O
.	O

In	O
the	O
ear	O
[	O
4	O
]	O
as	O
well	O
as	O
elsewhere	O
[	O
10	O
]	O
neurotrophins	O
are	O
progressively	O
downregulated	O
in	O
postnatal	O
mammals	O
and	O
possibly	O
replaced	O
by	O
other	O
factors	O
[	O
11	O
]	O
.	O

We	O
have	O
investigated	O
in	O
detail	O
the	O
pattern	O
of	O
innervation	O
in	O
the	O
Brn3c	O
mutants	O
,	O
as	O
well	O
as	O
the	O
expression	O
of	O
NT	O
-	O
3	O
and	O
BDNF	O
.	O

We	O
want	O
to	O
evaluate	O
a	O
possible	O
correlation	O
between	O
the	O
topology	O
of	O
sensory	O
neuron	O
loss	O
and	O
absence	O
of	O
a	O
specific	O
neurotrophin	O
or	O
topological	O
loss	O
of	O
hair	O
cells	O
at	O
birth	O
and	O
in	O
older	O
animals	O
.	O

This	O
information	O
could	O
be	O
important	O
for	O
an	O
in	O
-	O
depth	O
evaluation	O
of	O
the	O
human	O
deafness	O
related	O
to	O
the	O
Pou4f3	O
gene	O
,	O
DFNA15	O
[	O
12	O
]	O
.	O

We	O
report	O
here	O
long	O
term	O
retention	O
of	O
cochlear	O
sensory	O
neurons	O
for	O
at	O
least	O
6	O
months	O
,	O
in	O
particular	O
in	O
the	O
cochlear	O
apex	O
,	O
in	O
Brn3c	O
null	O
mutant	O
mice	O
.	O

This	O
retention	O
of	O
afferents	O
and	O
efferents	O
is	O
unrelated	O
to	O
hair	O
cell	O
differentiation	O
as	O
not	O
even	O
immature	O
hair	O
cells	O
can	O
be	O
detected	O
at	O
early	O
postnatal	O
stages	O
with	O
MyoVII	O
immunocytochemistry	O
in	O
this	O
part	O
of	O
the	O
cochlea	O
.	O

This	O
retention	O
of	O
apical	O
spiral	O
neurons	O
is	O
also	O
largely	O
unrelated	O
to	O
neurotrophins	O
which	O
are	O
known	O
to	O
be	O
reduced	O
in	O
their	O
expression	O
in	O
neonatal	O
rodents	O
[	O
4	O
]	O
.	O

Results	O

To	O
appreciate	O
the	O
effects	O
of	O
the	O
Brn3c	O
null	O
mutation	O
on	O
the	O
pattern	O
of	O
the	O
inner	O
ear	O
innervation	O
,	O
we	O
first	O
want	O
to	O
present	O
the	O
effects	O
of	O
BDNF	O
and	O
NT	O
-	O
3	O
null	O
mutations	O
at	O
birth	O
[	O
6	O
,	O
13	O
,	O
14	O
]	O
.	O

Null	O
mutants	O
of	O
BDNF	O
or	O
its	O
receptor	O
trkB	O
lose	O
all	O
innervation	O
to	O
the	O
semicircular	O
canals	O
and	O
have	O
a	O
reduced	O
innervation	O
to	O
the	O
utricle	O
,	O
saccule	O
and	O
apical	O
turn	O
of	O
the	O
cochlea	O
.	O

In	O
contrast	O
,	O
null	O
mutations	O
of	O
either	O
NT	O
-	O
3	O
or	O
its	O
receptor	O
trkC	O
result	O
in	O
loss	O
of	O
spiral	O
neurons	O
in	O
the	O
basal	O
turn	O
with	O
formation	O
of	O
an	O
inner	O
spiral	O
bundle	O
of	O
afferents	O
extending	O
to	O
the	O
basal	O
tip	O
.	O

Our	O
null	O
hypothesis	O
for	O
this	O
study	O
would	O
be	O
that	O
Brn3c	O
null	O
mice	O
show	O
severe	O
compromised	O
production	O
of	O
these	O
neurotrophins	O
and	O
should	O
therefore	O
show	O
a	O
comparable	O
pattern	O
of	O
nerve	O
fiber	O
loss	O
.	O

Brn3c	O
null	O
mutants	O
at	O
birth	O
(	O
P0	O
)	O

Vestibular	O
ganglia	O
are	O
smaller	O
in	O
Brn3c	O
null	O
mutants	O
(	O
Fig	O
.	O
1b	O
)	O
than	O
in	O
control	O
littermates	O
(	O
Fig	O
.	O
1a	O
)	O
,	O
but	O
larger	O
than	O
in	O
BDNF	O
or	O
trkB	O
null	O
mutants	O
of	O
the	O
same	O
age	O
[	O
13	O
,	O
15	O
]	O
.	O

The	O
reduction	O
in	O
apparent	O
size	O
of	O
the	O
vestibular	O
ganglia	O
is	O
in	O
agreement	O
with	O
quantitative	O
data	O
published	O
previously	O
[	O
3	O
,	O
13	O
]	O
.	O

These	O
data	O
suggest	O
a	O
loss	O
of	O
80	O
-	O
85	O
%	O
of	O
vestibular	O
sensory	O
neurons	O
in	O
BDNF	O
and	O
trkB	O
null	O
mutants	O
[	O
13	O
]	O
and	O
of	O
77	O
%	O
of	O
vestibular	O
sensory	O
neurons	O
in	O
P4	O
Brn3c	O
null	O
mutants	O
[	O
3	O
]	O
.	O

Thus	O
,	O
the	O
size	O
reduction	O
in	O
the	O
vestibular	O
sensory	O
ganglion	O
could	O
be	O
compatible	O
with	O
a	O
loss	O
of	O
BDNF	O
production	O
in	O
the	O
immature	O
hair	O
cells	O
.	O

Figure	O
1	O

Size	O
variations	O
of	O
vestibular	O
ganglia	O
in	O
control	O
and	O
mutant	O
littermates	O
labeled	O
with	O
DiI	O
.	O

In	O
newborn	O
animals	O
,	O
the	O
vestibular	O
ganglion	O
shows	O
a	O
dramatic	O
reduction	O
in	O
Brn3c	O
null	O
mutants	O
(	O
b	O
)	O
compared	O
to	O
control	O
littermates	O
(	O
a	O
)	O
.	O

Abbreviations	O
for	O
this	O
and	O
other	O
figures	O
:	O
AC	O
,	O
anterior	O
crista	O
;	O
ggl	O
,	O
ganglion	O
;	O
c	O
,	O
spiral	O
capillary	O
;	O
Genic	O
.	O
ggl	O
.	O
,	O
geniculate	O
ganglion	O
;	O
GER	O
,	O
greater	O
epithelial	O
ridge	O
;	O
HC	O
,	O
horizontal	O
crista	O
;	O
HaC	O
,	O
vestibular	O
hair	O
cell	O
;	O
IHC	O
,	O
inner	O
hair	O
cell	O
;	O
iHC	O
,	O
immature	O
hair	O
cell	O
;	O
IGSB	O
,	O
intraganglionic	O
spiral	O
bundle	O
;	O
OHC	O
,	O
outer	O
hair	O
cell	O
;	O
PC	O
,	O
posterior	O
crista	O
;	O
S	O
,	O
saccule	O
;	O
SG	O
,	O
spiral	O
ganglion	O
;	O
TM	O
,	O
tectorial	O
membrane	O
;	O
U	O
,	O
utricle	O
;	O
VCN	O
,	O
ventral	O
cochlear	O
nucleus	O
;	O
VG	O
,	O
vestibular	O
ganglion	O
.	O

Bar	O
indicates	O
1000	O
mu	O
m	O
.	O

However	O
,	O
the	O
Brn3c	O
null	O
mutants	O
show	O
only	O
a	O
reduced	O
density	O
of	O
afferent	O
and	O
efferent	O
fibers	O
to	O
all	O
vestibular	O
sensory	O
epithelia	O
.	O

There	O
is	O
no	O
specific	O
loss	O
of	O
all	O
afferent	O
and	O
efferent	O
innervation	O
to	O
the	O
canal	O
crista	O
(	O
Fig	O
.	O
2a	O
)	O
,	O
a	O
hallmark	O
of	O
both	O
BDNF	O
and	O
trkB	O
null	O
mutations	O
[	O
13	O
,	O
15	O
]	O
.	O

In	O
fact	O
,	O
the	O
reduction	O
of	O
fibers	O
seems	O
to	O
be	O
rather	O
uniform	O
throughout	O
a	O
given	O
sensory	O
epithelium	O
with	O
the	O
crista	O
innervation	O
being	O
qualitatively	O
no	O
more	O
reduced	O
than	O
the	O
innervation	O
of	O
the	O
utricle	O
and	O
saccule	O
.	O

No	O
loss	O
in	O
specific	O
areas	O
,	O
comparable	O
to	O
that	O
in	O
BDNF	O
null	O
mutant	O
mice	O
,	O
is	O
apparent	O
in	O
the	O
saccule	O
or	O
utricle	O
of	O
Brn3c	O
null	O
mice	O
.	O

Similar	O
patterns	O
of	O
innervation	O
are	O
obtained	O
using	O
acteylated	O
tubulin	O
immunocytochemistry	O
(	O
Fig	O
.	O
2b	O
)	O
.	O

Figure	O
2	O

Innervation	O
of	O
Brn3c	O
null	O
and	O
control	O
ears	O
are	O
shown	O
for	O
newborn	O
mice	O
.	O

There	O
is	O
no	O
specific	O
loss	O
of	O
fibers	O
to	O
any	O
vestibular	O
endorgan	O
,	O
as	O
visualized	O
by	O
DiI	O
labeling	O
(	O
a	O
)	O
or	O
acetylated	O
tubulin	O
immunoreactivity	O
(	O
b	O
)	O
.	O

No	O
major	O
differences	O
in	O
pattern	O
of	O
projection	O
through	O
radial	O
fibers	O
are	O
found	O
in	O
the	O
cochlea	O
of	O
Brn3c	O
null	O
mutants	O
(	O
d	O
,	O
f	O
)	O
as	O
compared	O
to	O
control	O
littermates	O
(	O
c	O
)	O
.	O

Note	O
,	O
however	O
,	O
the	O
lack	O
of	O
orderly	O
fiber	O
outgrowth	O
to	O
the	O
outer	O
hair	O
cells	O
(	O
c	O
,	O
d	O
)	O
.	O

Efferent	O
fibers	O
to	O
the	O
ear	O
show	O
a	O
well	O
developed	O
intraganglionic	O
spiral	O
bundle	O
(	O
IGSB	O
)	O
with	O
no	O
detectable	O
differences	O
compared	O
to	O
controls	O
(	O
e	O
)	O
.	O

Bar	O
indicates	O
100	O
mu	O
m	O
.	O

Consistent	O
with	O
the	O
finding	O
of	O
Xiang	O
et	O
al	O
.	O

[	O
3	O
]	O
of	O
only	O
a	O
29	O
%	O
loss	O
of	O
spiral	O
sensory	O
neurons	O
at	O
P4	O
,	O
our	O
data	O
show	O
little	O
difference	O
in	O
the	O
pattern	O
of	O
innervation	O
of	O
the	O
cochlea	O
in	O
P0	O
Brn3c	O
null	O
mutants	O
(	O
Fig	O
.	O
2c	O
,	O
2d	O
)	O
.	O

No	O
selective	O
loss	O
of	O
spiral	O
neurons	O
is	O
observed	O
in	O
Brn3c	O
null	O
mutants	O
in	O
the	O
basal	O
turn	O
,	O
a	O
feature	O
of	O
either	O
NT	O
-	O
3	O
or	O
trkC	O
loss	O
[	O
6	O
,	O
9	O
,	O
14	O
]	O
.	O

Likewise	O
,	O
the	O
innervation	O
of	O
the	O
apex	O
(	O
Fig	O
.	O
2f	O
)	O
shows	O
no	O
detectable	O
abnormality	O
in	O
overall	O
pattern	O
of	O
innervation	O
compared	O
to	O
control	O
animals	O
(	O
data	O
not	O
shown	O
)	O
,	O
an	O
indication	O
that	O
BDNF	O
could	O
be	O
expressed	O
in	O
the	O
apex	O
[	O
6	O
]	O
.	O

In	O
addition	O
,	O
the	O
pattern	O
of	O
efferent	O
innervation	O
shows	O
no	O
deviation	O
from	O
normal	O
either	O
(	O
Fig	O
.	O
2e	O
)	O
,	O
whereas	O
they	O
show	O
the	O
same	O
pattern	O
of	O
loss	O
as	O
afferent	O
fibers	O
in	O
neurotrophin	O
null	O
mutants	O
[	O
16	O
]	O
.	O

These	O
data	O
suggest	O
that	O
the	O
spiral	O
sensory	O
neurons	O
develop	O
qualitatively	O
normal	O
at	O
least	O
until	O
P0	O
and	O
therefore	O
allow	O
normal	O
pathfinding	O
of	O
efferents	O
.	O

Most	O
interestingly	O
,	O
there	O
is	O
no	O
increase	O
in	O
radial	O
fiber	O
spacing	O
in	O
the	O
apex	O
,	O
a	O
specific	O
problem	O
of	O
BDNF	O
null	O
mutants	O
[	O
6	O
,	O
13	O
]	O
.	O

However	O
,	O
there	O
is	O
one	O
qualitative	O
difference	O
not	O
recognized	O
in	O
any	O
single	O
neurotrophin	O
null	O
mutant	O
.	O

Afferents	O
reach	O
all	O
three	O
rows	O
of	O
outer	O
hair	O
cells	O
in	O
the	O
basal	O
turn	O
of	O
control	O
wildtype	O
littermates	O
(	O
Fig	O
.	O
2c	O
)	O
,	O
but	O
both	O
afferent	O
and	O
efferent	O
outgrowth	O
is	O
disorganized	O
to	O
outer	O
hair	O
cells	O
in	O
Brn3c	O
null	O
mutants	O
(	O
Fig	O
.	O
2d	O
)	O
and	O
does	O
not	O
show	O
any	O
clear	O
organization	O
into	O
three	O
distinct	O
longitudinal	O
fiber	O
bundles	O
paralleling	O
the	O
three	O
rows	O
in	O
the	O
outer	O
hair	O
cell	O
region	O
.	O

These	O
data	O
suggest	O
that	O
fiber	O
organization	O
in	O
the	O
outer	O
hair	O
cell	O
region	O
is	O
partly	O
disrupted	O
in	O
Brn3c	O
null	O
mutant	O
.	O

Brn3c	O
null	O
mutants	O
at	O
P7	O
/	O
8	O

Reduction	O
of	O
vestibular	O
innervation	O
is	O
more	O
pronounced	O
than	O
at	O
P0	O
.	O

Loss	O
of	O
afferents	O
and	O
,	O
even	O
more	O
clearly	O
of	O
efferents	O
,	O
is	O
most	O
pronounced	O
in	O
the	O
utricle	O
(	O
Fig	O
.	O
3a	O
,	O
3b	O
)	O
and	O
saccule	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
contrast	O
,	O
the	O
innervation	O
to	O
the	O
canal	O
cristae	O
,	O
while	O
reduced	O
,	O
has	O
changed	O
little	O
from	O
P0	O
.	O

In	O
particular	O
the	O
horizontal	O
canal	O
receives	O
a	O
rather	O
dense	O
afferent	O
and	O
efferent	O
innervation	O
in	O
Brn3c	O
null	O
mutants	O
.	O

Figure	O
3	O

Reduction	O
of	O
innervation	O
of	O
the	O
ear	O
is	O
shown	O
in	O
8	O
-	O
day	O
old	O
mice	O
.	O

While	O
all	O
vestibular	O
sensory	O
epithelia	O
retain	O
some	O
afferent	O
(	O
a	O
)	O
and	O
efferent	O
(	O
b	O
)	O
innervation	O
,	O
there	O
is	O
a	O
more	O
pronounced	O
reduction	O
,	O
in	O
particular	O
of	O
efferent	O
fibers	O
,	O
to	O
the	O
utricle	O
(	O
a	O
,	O
b	O
)	O
as	O
compared	O
to	O
the	O
canals	O
.	O

In	O
the	O
cochlea	O
there	O
is	O
an	O
increased	O
spacing	O
between	O
radial	O
fiber	O
bundles	O
in	O
the	O
basal	O
turn	O
(	O
c	O
,	O
e	O
)	O
.	O

No	O
afferents	O
can	O
be	O
traced	O
to	O
the	O
three	O
outer	O
spiral	O
bundles	O
along	O
outer	O
hair	O
cells	O
of	O
mutant	O
littermates	O
(	O
c	O
,	O
e	O
)	O
.	O

The	O
apex	O
shows	O
little	O
change	O
,	O
except	O
for	O
the	O
absence	O
of	O
fibers	O
to	O
the	O
area	O
of	O
outer	O
hair	O
cells	O
and	O
the	O
formation	O
of	O
inner	O
spiral	O
bundles	O
passing	O
along	O
the	O
few	O
immature	O
hair	O
cells	O
(	O
d	O
,	O
f	O
,	O
g	O
)	O
.	O

The	O
pattern	O
obtained	O
with	O
DiI	O
tracing	O
is	O
identical	O
to	O
that	O
obtained	O
by	O
acetylated	O
tubulin	O
immunoreactivity	O
(	O
f	O
,	O
g	O
)	O
.	O

Bar	O
indicates	O
1000	O
mu	O
m	O
in	O
a	O
,	O
100	O
mu	O
m	O
in	O
b	O
-	O
g	O
.	O

The	O
cochlea	O
at	O
P8	O
shows	O
more	O
qualitative	O
deviations	O
from	O
the	O
normal	O
pattern	O
of	O
innervation	O
.	O

For	O
example	O
,	O
all	O
three	O
rows	O
of	O
outer	O
hair	O
cells	O
now	O
receive	O
both	O
afferent	O
and	O
efferent	O
innervation	O
in	O
the	O
base	O
of	O
control	O
littermates	O
(	O
Fig	O
.	O
3c	O
)	O
.	O

However	O
,	O
no	O
fibers	O
extend	O
to	O
the	O
outer	O
hair	O
cell	O
region	O
in	O
Brn3c	O
null	O
mutants	O
(	O
Figs	O
.	O
3d	O
,	O
3e	O
,	O
3f	O
)	O
.	O

In	O
control	O
animals	O
there	O
is	O
dense	O
innervation	O
of	O
inner	O
hair	O
cells	O
,	O
whereas	O
Brn3c	O
null	O
mutants	O
show	O
a	O
curious	O
aggregation	O
of	O
fibers	O
near	O
focal	O
spots	O
around	O
the	O
habenula	O
perforata	O
.	O

The	O
apex	O
shows	O
less	O
pronounced	O
deviations	O
from	O
normal	O
(	O
Fig	O
.	O
3f	O
,	O
3g	O
)	O
.	O

However	O
,	O
as	O
in	O
the	O
base	O
,	O
afferents	O
and	O
efferents	O
extend	O
sparingly	O
to	O
the	O
outer	O
hair	O
cell	O
region	O
.	O

There	O
is	O
formation	O
of	O
an	O
inner	O
spiral	O
bundle	O
communicating	O
both	O
afferents	O
and	O
efferents	O
between	O
the	O
focal	O
points	O
where	O
fibers	O
appear	O
to	O
pass	O
through	O
the	O
habenula	O
perforata	O
(	O
Fig	O
.	O
3f	O
,	O
3g	O
)	O
.	O

As	O
in	O
newborn	O
animals	O
,	O
efferent	O
fibers	O
closely	O
follow	O
the	O
pattern	O
of	O
innervation	O
displayed	O
by	O
afferents	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
limited	O
qualitative	O
effect	O
of	O
Brn3c	O
null	O
mutations	O
on	O
fiber	O
loss	O
is	O
particularly	O
obvious	O
in	O
the	O
P8	O
Brn3c	O
null	O
mutant	O
apical	O
turn	O
(	O
Fig	O
.	O
3g	O
)	O
.	O

Immunocytochemical	O
and	O
histochemcial	O
data	O
show	O
the	O
presence	O
of	O
only	O
a	O
few	O
immature	O
hair	O
cells	O
in	O
the	O
cochlea	O
(	O
Fig	O
.	O
4	O
)	O
,	O
which	O
amounted	O
to	O
about	O
1	O
%	O
(	O
Table	O
1	O
)	O
.	O

Not	O
a	O
single	O
immature	O
hair	O
cell	O
forms	O
in	O
the	O
apex	O
of	O
the	O
cochlea	O
.	O

In	O
contrast	O
,	O
more	O
immature	O
hair	O
cells	O
are	O
found	O
in	O
the	O
appropriate	O
position	O
of	O
hair	O
cells	O
in	O
the	O
vestibular	O
endorgans	O
(	O
Table	O
1	O
)	O
.	O

In	O
fact	O
,	O
the	O
vestibular	O
end	O
organs	O
show	O
no	O
overt	O
morphological	O
defect	O
other	O
than	O
the	O
reduced	O
presence	O
of	O
these	O
immature	O
hair	O
cells	O
.	O

Nerve	O
fibers	O
can	O
be	O
traced	O
into	O
the	O
sensory	O
epithelium	O
of	O
P0	O
and	O
P8	O
Brn3c	O
null	O
mutants	O
past	O
the	O
habenula	O
perforata	O
and	O
there	O
is	O
a	O
normal	O
location	O
of	O
spiral	O
sensory	O
neurons	O
in	O
Rosenthal	O
'	O
s	O
canal	O
in	O
the	O
apex	O
of	O
P8	O
Brn3c	O
null	O
mutants	O
(	O
Fig	O
.	O
3d	O
,	O
3g	O
)	O
.	O

The	O
cochlea	O
shows	O
other	O
defects	O
as	O
well	O
.	O

For	O
example	O
,	O
the	O
spiral	O
capillary	O
is	O
not	O
found	O
underneath	O
the	O
organ	O
of	O
Corti	O
but	O
in	O
the	O
spiral	O
limbus	O
nearby	O
(	O
Fig	O
.	O
4	O
)	O
.	O

The	O
lack	O
of	O
immature	O
hair	O
cells	O
seems	O
to	O
affect	O
also	O
the	O
formation	O
of	O
pillar	O
cells	O
(	O
undifferentiated	O
almost	O
throughout	O
the	O
cochlea	O
;	O
Fig	O
.	O
4	O
)	O
and	O
Deiters	O
'	O
cells	O
(	O
not	O
recognizable	O
based	O
on	O
their	O
morphology	O
)	O
,	O
a	O
suggestion	O
consistent	O
with	O
recent	O
molecular	B-CHEBI
data	O
on	O
the	O
interaction	O
of	O
hair	O
cells	O
and	O
supporting	O
cells	O
[	O
17	O
,	O
18	O
]	O
.	O

Figure	O
4	O

The	O
distribution	O
of	O
hair	O
cells	O
as	O
identified	O
with	O
MyoVII	O
immunocytochemistry	O
is	O
shown	O
for	O
7	O
-	O
day	O
old	O
whole	O
mounted	O
cochlea	O
(	O
a	O
-	O
d	O
)	O
and	O
the	O
appearance	O
of	O
cytological	O
differentiation	O
is	O
shown	O
as	O
revealed	O
with	O
epoxy	B-CHEBI
resin	O
sections	O
in	O
7	O
-	O
day	O
old	O
(	O
e	O
-	O
g	O
)	O
and	O
6	O
-	O
month	O
old	O
(	O
h	O
)	O
control	O
(	O
a	O
,	O
c	O
,	O
e	O
)	O
and	O
Brn3c	O
mutant	O
cochleae	O
(	O
b	O
,	O
d	O
,	O
f	O
-	O
h	O
)	O
.	O

Note	O
the	O
uniform	O
staining	O
with	O
this	O
antibody	O
of	O
all	O
three	O
rows	O
of	O
outer	O
hair	O
cells	O
(	O
OHC	O
)	O
and	O
the	O
single	O
row	O
of	O
inner	O
hair	O
cells	O
(	O
IHC	O
)	O
in	O
the	O
wildtype	O
(	O
a	O
,	O
c	O
)	O
.	O

In	O
contrast	O
,	O
only	O
few	O
immature	O
hair	O
cells	O
(	O
iHC	O
)	O
are	O
found	O
in	O
the	O
basal	O
turn	O
of	O
the	O
mutant	O
littermate	O
(	O
b	O
)	O
and	O
only	O
an	O
occasional	O
cell	O
is	O
MyoVII	O
immunopositive	O
in	O
the	O
middle	O
turn	O
(	O
d	O
)	O
.	O

No	O
MyoVII	O
positive	O
immature	O
hair	O
cells	O
exist	O
in	O
the	O
apex	O
.	O

Sections	O
show	O
the	O
degree	O
of	O
differentiation	O
of	O
hair	O
cells	O
and	O
their	O
innervating	O
fibers	O
stained	O
with	O
tubulin	O
immunocytochemistry	O
(	O
arrow	O
;	O
e	O
-	O
h	O
)	O
.	O

Note	O
the	O
presence	O
of	O
a	O
spiral	O
capillary	O
(	O
C	O
)	O
under	O
the	O
tunnel	O
of	O
Corti	O
separating	O
the	O
inner	O
and	O
outer	O
hair	O
cells	O
in	O
the	O
P7	O
wildtype	O
(	O
e	O
)	O
.	O

In	O
contrast	O
,	O
no	O
such	O
capillary	O
is	O
present	O
underneath	O
the	O
organ	O
of	O
Corti	O
in	O
mutants	O
(	O
f	O
-	O
h	O
)	O
and	O
no	O
tunnel	O
of	O
Corti	O
is	O
found	O
either	O
.	O

A	O
tectorial	O
membrane	O
forms	O
(	O
TM	O
)	O
but	O
otherwise	O
there	O
is	O
little	O
cyotological	O
differentiation	O
.	O

Note	O
that	O
tubulin	O
-	O
positive	O
fibers	O
can	O
be	O
traced	O
to	O
the	O
immature	O
cells	O
until	O
6	O
months	O
(	O
h	O
)	O
.	O

Bar	O
in	O
c	O
indicates	O
100	O
mu	O
m	O
.	O

Table	O
1	O

Numbers	O
of	O
hair	O
cells	O
and	O
sensory	O
neurons	O
in	O
P7	O
wildtype	O
and	O
Brn3c	O
mutant	O
littermates	O

Differences	O
between	O
wildtype	O
and	O
mutants	O
are	O
all	O
highly	O
significant	O
.	O

Comparison	O
of	O
numbers	O
of	O
immature	O
hair	O
cells	O
in	O
the	O
vestibular	O
and	O
cochlear	O
areas	O
(	O
Fig	O
.	O
4	O
)	O
with	O
the	O
numbers	O
of	O
surviving	O
vestibular	O
and	O
cochlear	O
sensory	O
neurons	O
does	O
not	O
show	O
any	O
correlation	O
(	O
Table	O
1	O
;	O
Fig	O
.	O
5	O
)	O
.	O

Only	O
a	O
few	O
undifferentiated	O
hair	O
cells	O
were	O
detected	O
by	O
MyoVIIa	O
immunostaining	O
and	O
only	O
in	O
the	O
basal	O
region	O
of	O
the	O
cochlea	O
.	O

And	O
yet	O
only	O
about	O
50	O
%	O
of	O
cochlear	O
sensory	O
neurons	O
are	O
lost	O
overall	O
with	O
a	O
less	O
severe	O
loss	O
in	O
the	O
apex	O
in	O
which	O
we	O
could	O
not	O
detect	O
any	O
immature	O
hair	O
cells	O
with	O
MyoVIIa	O
immunocytochemistry	O
.	O

This	O
does	O
not	O
exclude	O
the	O
possibility	O
that	O
even	O
less	O
differentiated	O
hair	O
cells	O
may	O
form	O
in	O
the	O
apex	O
.	O

Figure	O
5	O

This	O
graph	O
shows	O
the	O
reduction	O
in	O
sensory	O
neurons	O
(	O
top	O
)	O
and	O
in	O
hair	O
cells	O
(	O
bottom	O
)	O
between	O
7	O
-	O
day	O
old	O
wildtype	O
and	O
Brn3c	O
null	O
mutant	O
littermates	O
.	O

Note	O
the	O
sharp	O
reduction	O
to	O
1	O
%	O
in	O
the	O
cochlear	O
immature	O
hair	O
cells	O
(	O
bottom	O
)	O
whereas	O
spiral	O
sensory	O
neurons	O
(	O
SG	O
)	O
are	O
only	O
reduced	O
by	O
50	O
%	O
(	O
top	O
)	O
.	O

In	O
contrast	O
,	O
20	O
%	O
immature	O
hair	O
cells	O
could	O
be	O
identified	O
in	O
vestibular	O
sensory	O
epithelia	O
(	O
saccule	O
has	O
been	O
selected	O
;	O
bottom	O
)	O
whereas	O
only	O
around	O
15	O
%	O
of	O
the	O
vestibular	O
sensory	O
neurons	O
survive	O
to	O
this	O
age	O
(	O
VG	O
;	O
top	O
)	O
.	O

For	O
details	O
on	O
the	O
data	O
see	O
Table	O
1	O
.	O

The	O
central	O
projection	O
of	O
DiI	O
and	O
DiA	O
traces	O
fibers	O
to	O
the	O
cochlear	O
nuclei	O
(	O
Fig	O
.	O
6	O
)	O
where	O
they	O
show	O
a	O
clear	O
segregation	O
of	O
apical	O
turn	O
afferents	O
(	O
Fig	O
.	O
6	O
,	O
green	O
)	O
and	O
basal	O
turn	O
afferents	O
(	O
Fig	O
.	O
6	O
,	O
red	O
)	O
in	O
both	O
the	O
entering	O
cochlear	O
nerve	O
(	O
Fig	O
.	O
6a	O
)	O
and	O
the	O
ventral	O
cochlear	O
nucleus	O
(	O
VCN	O
)	O
(	O
Fig	O
.	O
6b	O
)	O
.	O

Qualitative	O
comparable	O
central	O
projections	O
are	O
found	O
in	O
wildtype	O
control	O
littermates	O
(	O
data	O
not	O
shown	O
)	O
and	O
suggest	O
that	O
the	O
central	O
projection	O
to	O
cochlear	O
nuclei	O
is	O
at	O
least	O
until	O
P8	O
in	O
mice	O
not	O
critically	O
dependent	O
on	O
auditory	O
information	O
or	O
other	O
hair	O
cell	O
-	O
mediated	O
influences	O
,	O
in	O
agreement	O
with	O
recent	O
suggestions	O
[	O
5	O
,	O
19	O
]	O
.	O

Figure	O
6	O

These	O
confocal	O
images	O
show	O
the	O
projection	O
pattern	O
of	O
a	O
P8	O
Brn3c	O
null	O
mutant	O
mouse	O
.	O

DiI	O
(	O
red	O
)	O
was	O
inserted	O
into	O
the	O
basal	O
turn	O
,	O
DiA	O
(	O
green	O
)	O
was	O
inserted	O
into	O
the	O
apical	O
turn	O
.	O

Note	O
that	O
the	O
fibers	O
run	O
in	O
discrete	O
bundles	O
inside	O
the	O
cochlear	O
nerve	O
(	O
a	O
)	O
,	O
spiral	O
around	O
each	O
other	O
near	O
the	O
root	O
and	O
project	O
to	O
distinct	O
medial	O
and	O
lateral	O
divisions	O
of	O
the	O
ventral	O
cochlear	O
nucleus	O
(	O
b	O
)	O
.	O

These	O
data	O
suggest	O
that	O
a	O
crude	O
cochleotopic	O
projection	O
can	O
form	O
independently	O
of	O
any	O
signaling	O
from	O
the	O
immature	O
hair	O
cells	O
of	O
the	O
cochlea	O
.	O

Arrow	O
indicates	O
the	O
efferent	O
bundle	O
as	O
it	O
leaves	O
the	O
afferent	O
fiber	O
tract	O
.	O

Bar	O
indicates	O
100	O
mu	O
m	O
.	O

6	O
months	O
Brn3c	O
null	O
mutants	O

Very	O
few	O
fibers	O
(	O
both	O
afferent	O
and	O
efferent	O
)	O
to	O
the	O
vestibular	O
epithelia	O
remain	O
(	O
Fig	O
.	O
7a	O
)	O
,	O
thus	O
displaying	O
a	O
further	O
reduction	O
of	O
the	O
pattern	O
of	O
innervation	O
found	O
in	O
P8	O
Brn3c	O
null	O
mutants	O
.	O

Notably	O
,	O
there	O
are	O
still	O
a	O
number	O
of	O
fibers	O
extending	O
from	O
the	O
very	O
few	O
vestibular	O
sensory	O
neurons	O
to	O
the	O
canal	O
epithelia	O
,	O
in	O
particular	O
the	O
horizontal	O
canal	O
(	O
Fig	O
.	O
7a	O
,	O
7b	O
)	O
.	O

Only	O
very	O
few	O
fibers	O
extend	O
to	O
the	O
utricle	O
and	O
saccule	O
with	O
the	O
reduction	O
of	O
efferents	O
to	O
these	O
epithelia	O
being	O
almost	O
complete	O
(	O
Fig	O
.	O
7a	O
and	O
data	O
not	O
shown	O
)	O
.	O

Comparable	O
to	O
control	O
mice	O
,	O
there	O
is	O
some	O
transcellular	O
labeling	O
with	O
DiI	O
to	O
cells	O
apparently	O
contacted	O
by	O
the	O
afferent	O
fibers	O
in	O
the	O
Brn3c	O
null	O
mutant	O
utricle	O
(	O
Fig	O
.	O
7b	O
)	O
.	O

However	O
,	O
these	O
cells	O
could	O
not	O
be	O
clearly	O
identified	O
as	O
immature	O
hair	O
cells	O
based	O
on	O
their	O
morphology	O
.	O

Figure	O
7	O

The	O
innervation	O
of	O
sensory	O
epithelia	O
is	O
shown	O
in	O
6	O
-	O
month	O
old	O
Brn3c	O
null	O
mutant	O
mice	O
.	O

Compared	O
to	O
P8	O
animals	O
there	O
is	O
a	O
further	O
reduction	O
of	O
fiber	O
density	O
to	O
vestibular	O
sensory	O
epithelia	O
,	O
but	O
fibers	O
can	O
be	O
traced	O
to	O
all	O
sensory	O
epithelia	O
(	O
a	O
,	O
b	O
)	O
.	O

Transcellular	O
labeling	O
with	O
DiI	O
(	O
b	O
)	O
suggest	O
contacts	O
between	O
these	O
afferents	O
and	O
immature	O
hair	O
cells	O
.	O

The	O
cochlea	O
shows	O
a	O
much	O
reduced	O
density	O
of	O
radial	O
bundles	O
,	O
even	O
in	O
the	O
apex	O
(	O
c	O
,	O
d	O
)	O
.	O

However	O
,	O
spiral	O
sensory	O
neurons	O
are	O
present	O
in	O
Rosenthal	O
'	O
s	O
canal	O
(	O
c	O
,	O
d	O
)	O
and	O
fibers	O
extend	O
to	O
the	O
organ	O
of	O
Corti	O
where	O
they	O
form	O
longitudinal	O
tracts	O
in	O
the	O
immature	O
epithelium	O
.	O

Bar	O
indicates	O
100	O
mu	O
m	O
.	O

The	O
cochlea	O
,	O
most	O
prominently	O
the	O
apex	O
,	O
receives	O
many	O
afferent	O
fibers	O
,	O
which	O
form	O
an	O
interrupted	O
inner	O
spiral	O
bundle	O
(	O
Fig	O
.	O
7c	O
)	O
.	O

Some	O
of	O
the	O
radial	O
fiber	O
bundles	O
are	O
myelinated	O
(	O
Fig	O
.	O
7d	O
)	O
.	O

Only	O
an	O
occasional	O
fiber	O
extends	O
beyond	O
the	O
inner	O
spiral	O
bundle	O
into	O
the	O
area	O
of	O
the	O
outer	O
hair	O
cells	O
(	O
Fig	O
.	O
7d	O
)	O
.	O

Even	O
at	O
this	O
late	O
stage	O
in	O
maturation	O
there	O
are	O
still	O
numerous	O
spiral	O
neurons	O
present	O
in	O
the	O
apex	O
(	O
Fig	O
.	O
7c	O
,	O
7d	O
)	O
.	O

In	O
summary	O
,	O
these	O
tracing	O
data	O
suggest	O
that	O
mature	O
hair	O
cells	O
are	O
not	O
necessary	O
to	O
direct	O
fiber	O
outgrowth	O
and	O
to	O
maintain	O
some	O
fibers	O
at	O
least	O
up	O
to	O
6	O
months	O
in	O
the	O
apex	O
of	O
the	O
cochlea	O
.	O

Importantly	O
,	O
the	O
spatio	O
-	O
temporal	O
loss	O
of	O
innervation	O
does	O
not	O
follow	O
the	O
pattern	O
of	O
loss	O
known	O
from	O
neurotrophin	O
and	O
neurotrophin	O
receptor	O
null	O
mutations	O
as	O
it	O
starts	O
in	O
Brn3c	O
mutant	O
mice	O
after	O
birth	O
.	O

In	O
situ	O
hybridization	O
confirms	O
neonatal	O
neurotrophin	O
expression	O

We	O
processed	O
four	O
ears	O
of	O
P0	O
and	O
P8	O
Brn3c	O
null	O
and	O
control	O
littermates	O
for	O
expression	O
of	O
BDNF	O
and	O
NT	O
-	O
3	O
using	O
the	O
riboprobes	O
previously	O
described	O
[	O
7	O
]	O
.	O

We	O
did	O
not	O
analyze	O
neurotrophin	O
expression	O
in	O
6	O
-	O
month	O
old	O
animals	O
as	O
neurotrophins	O
are	O
downregulated	O
in	O
neonates	O
[	O
20	O
]	O
and	O
no	O
expression	O
can	O
be	O
found	O
even	O
in	O
normal	O
animals	O
[	O
4	O
]	O
.	O

In	O
the	O
canal	O
cristae	O
we	O
expected	O
,	O
and	O
found	O
,	O
only	O
a	O
BDNF	O
signal	O
.	O

This	O
signal	O
was	O
very	O
strong	O
over	O
hair	O
cells	O
of	O
the	O
P0	O
control	O
animals	O
(	O
Fig	O
.	O
8b	O
)	O
.	O

In	O
contrast	O
,	O
only	O
a	O
faint	O
signal	O
was	O
detected	O
in	O
the	O
Brn3c	O
null	O
mutant	O
(	O
Fig	O
.	O
8a	O
)	O
and	O
the	O
few	O
silver	O
grains	O
were	O
located	O
predominantly	O
over	O
the	O
area	O
of	O
the	O
immature	O
hair	O
cells	O
.	O

The	O
BDNF	O
signal	O
in	O
the	O
utricle	O
was	O
clearly	O
centered	O
on	O
the	O
hair	O
cells	O
in	O
the	O
control	O
animal	O
but	O
some	O
aggregation	O
of	O
silver	O
grains	O
appeared	O
also	O
in	O
the	O
Brn3c	O
null	O
mutants	O
(	O
data	O
not	O
shown	O
)	O
.	O

Figure	O
8	O

The	O
expression	O
of	O
BDNF	O
and	O
NT	O
-	O
3	O
mRNA	B-CHEBI
is	O
shown	O
in	O
the	O
P0	O
vestibular	O
sensory	O
epithelia	O
.	O

Silver	O
grains	O
are	O
false	O
colored	O
as	O
red	O
to	O
enhance	O
visibility	O
against	O
the	O
grey	O
Nissl	O
-	O
stained	O
background	O
.	O

Canal	O
cristae	O
contain	O
only	O
BDNF	O
(	O
a	O
,	O
b	O
)	O
,	O
but	O
gravistatic	O
endorgans	O
,	O
such	O
as	O
saccule	O
and	O
utricle	O
,	O
contain	O
both	O
BDNF	O
and	O
NT	O
-	O
3	O
(	O
c	O
-	O
f	O
)	O
.	O

Note	O
the	O
prominent	O
BDNF	O
expression	O
in	O
the	O
hair	O
cell	O
region	O
(	O
HaC	O
)	O
of	O
control	O
canal	O
(	O
b	O
)	O
and	O
saccule	O
(	O
d	O
)	O
and	O
low	O
levels	O
of	O
expression	O
in	O
the	O
Brn3c	O
null	O
mice	O
(	O
a	O
,	O
c	O
)	O
over	O
immature	O
hair	O
cells	O
(	O
iHC	O
)	O
.	O

The	O
NT	O
-	O
3	O
expression	O
is	O
much	O
more	O
diffuse	O
in	O
both	O
control	O
and	O
Brn3c	O
mutant	O
littermates	O
.	O

Bar	O
indicates	O
100	O
mu	O
m	O
.	O

In	O
the	O
saccule	O
,	O
we	O
directly	O
compared	O
the	O
BDNF	O
(	O
Fig	O
.	O
8c	O
,	O
8d	O
)	O
and	O
NT	O
-	O
3	O
signal	O
(	O
Fig	O
.	O
8e	O
,	O
8f	O
)	O
of	O
the	O
Brn3c	O
null	O
mutant	O
(	O
Fig	O
.	O
8c	O
,	O
8e	O
)	O
and	O
control	O
littermates	O
(	O
Fig	O
.	O
8d	O
,	O
8f	O
)	O
.	O

A	O
strong	O
BDNF	O
signal	O
was	O
found	O
over	O
the	O
hair	O
cells	O
of	O
control	O
animals	O
and	O
an	O
occasional	O
immature	O
hair	O
cell	O
also	O
showed	O
a	O
BDNF	O
signal	O
in	O
the	O
Brn3c	O
null	O
mutants	O
.	O

The	O
NT	O
-	O
3	O
signal	O
was	O
more	O
diffuse	O
in	O
both	O
the	O
control	O
and	O
the	O
Brn3c	O
null	O
littermates	O
but	O
showed	O
some	O
slightly	O
above	O
background	O
signal	O
in	O
the	O
area	O
of	O
the	O
sensory	O
epithelium	O
even	O
in	O
the	O
Brn3c	O
null	O
mutant	O
.	O

In	O
the	O
cochlea	O
,	O
the	O
BDNF	O
signal	O
was	O
very	O
weak	O
in	O
the	O
base	O
in	O
both	O
the	O
control	O
(	O
Fig	O
.	O
9b	O
)	O
and	O
the	O
Brn3c	O
null	O
littermates	O
(	O
Fig	O
.	O
9a	O
)	O
.	O

However	O
,	O
there	O
was	O
a	O
surprisingly	O
strong	O
NT	O
-	O
3	O
signal	O
over	O
the	O
organ	O
of	O
Corti	O
in	O
the	O
apex	O
of	O
Brn3c	O
null	O
littermates	O
(	O
Fig	O
.	O
9c	O
)	O
that	O
closely	O
matched	O
the	O
signal	O
found	O
in	O
the	O
control	O
littermates	O
(	O
Fig	O
.	O
9d	O
)	O
.	O

The	O
NT	O
-	O
3	O
signal	O
in	O
the	O
area	O
of	O
the	O
cochlea	O
that	O
corresponds	O
to	O
the	O
IHC	O
'	O
s	O
persisted	O
at	O
least	O
until	O
P8	O
in	O
the	O
apex	O
of	O
Brn3c	O
null	O
mice	O
(	O
Fig	O
.	O
9e	O
,	O
9f	O
)	O
.	O

Figure	O
9	O

BDNF	O
and	O
NT	O
-	O
3	O
mRNA	B-CHEBI
expression	O
is	O
shown	O
in	O
the	O
cochlea	O
of	O
P0	O
(	O
a	O
-	O
d	O
)	O
and	O
P8	O
(	O
e	O
,	O
f	O
)	O
Brn3c	O
null	O
and	O
control	O
littermates	O
.	O

Note	O
the	O
limited	O
expression	O
of	O
BDNF	O
in	O
the	O
basal	O
turn	O
of	O
both	O
wildtype	O
and	O
mutant	O
littermates	O
(	O
a	O
,	O
b	O
)	O
and	O
the	O
much	O
stronger	O
expression	O
of	O
NT	O
-	O
3	O
in	O
the	O
apex	O
over	O
the	O
region	O
of	O
the	O
inner	O
hair	O
cells	O
in	O
both	O
wildtype	O
and	O
control	O
littermates	O
(	O
c	O
,	O
d	O
)	O
.	O

NT	O
-	O
3	O
expression	O
persists	O
at	O
least	O
until	O
P8	O
in	O
the	O
apex	O
of	O
Brn3c	O
null	O
mice	O
in	O
an	O
area	O
that	O
topologically	O
compares	O
to	O
the	O
inner	O
hair	O
cells	O
of	O
control	O
animals	O
(	O
e	O
,	O
f	O
,	O
arrows	O
)	O
.	O

Bar	O
indicates	O
100	O
mu	O
m	O
.	O

Discussion	O

We	O
will	O
explore	O
five	O
points	O
in	O
this	O
discussion	O
:	O
How	O
the	O
limited	O
expression	O
of	O
neurotrophins	O
relates	O
to	O
the	O
apparent	O
survival	O
of	O
primary	O
neurons	O
until	O
P8	O
;	O
how	O
the	O
known	O
absence	O
of	O
apical	O
hair	O
cells	O
and	O
of	O
classical	O
neurotrophins	O
can	O
be	O
related	O
to	O
the	O
presence	O
of	O
large	O
numbers	O
of	O
apical	O
turn	O
spiral	O
neurons	O
;	O
how	O
absence	O
of	O
differentiated	O
hair	O
cells	O
affects	O
afferent	O
and	O
efferent	O
targeting	O
;	O
and	O
how	O
these	O
data	O
possibly	O
relate	O
to	O
other	O
mutant	O
animals	O
and	O
to	O
children	O
born	O
with	O
profound	O
hearing	O
loss	O
.	O

Immature	O
hair	O
cells	O
and	O
limited	O
expression	O
of	O
neurotrophins	O
rescue	O
afferent	O
projection	O
until	O
P8	O

The	O
neurotrophins	O
have	O
long	O
been	O
implicated	O
as	O
the	O
mediators	O
for	O
target	O
mediated	O
cell	O
death	O
.	O

In	O
essence	O
,	O
this	O
theory	O
of	O
regulation	O
of	O
neuronal	O
connections	O
via	O
neurotrophic	O
support	O
implies	O
that	O
only	O
limited	O
quantities	O
of	O
neurotrophins	O
are	O
released	O
by	O
the	O
target	O
tissue	O
to	O
support	O
only	O
properly	O
connected	O
sensory	O
neurons	O
by	O
providing	O
only	O
these	O
with	O
a	O
critical	O
amount	O
of	O
neurotrophins	O
[	O
21	O
]	O
.	O

Past	O
experiments	O
,	O
which	O
eliminated	O
one	O
or	O
more	O
neurotrophins	O
entirely	O
,	O
only	O
partially	O
tested	O
the	O
basic	O
assumption	O
of	O
this	O
theory	O
in	O
vivo	O
.	O

For	O
example	O
,	O
in	O
BDNF	O
heterozygotic	O
animals	O
there	O
is	O
a	O
small	O
decrease	O
in	O
the	O
number	O
of	O
sensory	O
neurons	O
in	O
the	O
ear	O
[	O
13	O
]	O
but	O
no	O
change	O
in	O
the	O
overall	O
pattern	O
of	O
innervation	O
.	O

Moreover	O
,	O
all	O
of	O
the	O
neurotrophin	O
/	O
neurotrophin	O
receptor	O
null	O
mutants	O
studied	O
to	O
date	O
eliminate	O
expression	O
in	O
both	O
the	O
peripheral	O
target	O
and	O
the	O
brain	O
simultaneously	O
and	O
achieve	O
their	O
effects	O
in	O
late	O
embryos	O
.	O

In	O
contrast	O
,	O
Brn3c	O
is	O
barely	O
expressed	O
during	O
embryogenesis	O
in	O
the	O
CNS	O
[	O
22	O
]	O
thus	O
arguing	O
that	O
the	O
survival	O
of	O
ear	O
primary	O
neurons	O
depends	O
crucially	O
on	O
the	O
periphery	O
.	O

We	O
suggest	O
that	O
limited	O
expression	O
of	O
neurotrophins	O
in	O
the	O
immature	O
target	O
leads	O
to	O
retention	O
of	O
primary	O
neurons	O
and	O
their	O
afferent	O
fibers	O
in	O
newborn	O
and	O
early	O
postnatal	O
Brn3c	O
null	O
mice	O
.	O

In	O
agreement	O
with	O
this	O
suggestion	O
,	O
our	O
in	O
situ	O
data	O
show	O
a	O
severe	O
reduction	O
in	O
expression	O
of	O
BDNF	O
(	O
Figs	O
.	O
8	O
,	O
9	O
)	O
.	O

Despite	O
this	O
reduction	O
,	O
some	O
,	O
apparently	O
biologically	O
significant	O
low	O
levels	O
of	O
neurotrophins	O
are	O
apparently	O
expressed	O
in	O
all	O
sensory	O
epithelia	O
in	O
embryonic	O
Brn3c	O
null	O
mutants	O
.	O

It	O
appears	O
that	O
even	O
these	O
low	O
levels	O
of	O
neurotrophins	O
in	O
the	O
vestibular	O
sensory	O
epithelia	O
can	O
sustain	O
normal	O
fiber	O
outgrowth	O
and	O
a	O
limited	O
maintenance	O
until	O
P0	O
.	O

The	O
comparatively	O
high	O
level	O
of	O
NT	O
-	O
3	O
expression	O
in	O
Brn3c	O
null	O
mutant	O
cochlea	O
,	O
which	O
has	O
been	O
shown	O
to	O
be	O
the	O
neurotrophin	O
most	O
prominently	O
supporting	O
spiral	O
sensory	O
neurons	O
[	O
6	O
,	O
9	O
,	O
14	O
]	O
,	O
is	O
in	O
agreement	O
with	O
the	O
normal	O
development	O
of	O
cochlear	O
innervation	O
in	O
newborn	O
Brn3c	O
null	O
mutants	O
.	O

Since	O
BDNF	O
appears	O
to	O
be	O
exclusively	O
produced	O
by	O
hair	O
cells	O
[	O
6	O
,	O
7	O
,	O
20	O
]	O
,	O
the	O
lack	O
of	O
terminal	O
differentiation	O
of	O
hair	O
cells	O
appears	O
to	O
be	O
accompanied	O
by	O
only	O
limited	O
expression	O
of	O
BDNF	O
,	O
as	O
is	O
the	O
case	O
in	O
the	O
canal	O
cristae	O
(	O
Fig	O
.	O
8	O
)	O
.	O

Past	O
research	O
has	O
shown	O
that	O
in	O
BDNF	O
and	O
trkB	O
null	O
mutants	O
this	O
innervation	O
to	O
canal	O
cristae	O
is	O
lost	O
before	O
birth	O
[	O
6	O
,	O
13	O
]	O
.	O

That	O
even	O
these	O
low	O
levels	O
of	O
expression	O
are	O
significant	O
is	O
clear	O
from	O
the	O
fact	O
that	O
all	O
canal	O
sensory	O
epithelia	O
receive	O
an	O
innervation	O
by	O
both	O
afferents	O
and	O
efferents	O
at	O
birth	O
and	O
later	O
(	O
Figs	O
.	O
2	O
,	O
3	O
)	O
.	O

The	O
situation	O
in	O
the	O
utricle	O
,	O
saccule	O
and	O
cochlea	O
is	O
less	O
clear	O
as	O
both	O
BDNF	O
and	O
NT	O
-	O
3	O
are	O
expressed	O
[	O
6	O
,	O
7	O
]	O
.	O

In	O
fact	O
,	O
it	O
appears	O
that	O
the	O
levels	O
of	O
NT	O
-	O
3	O
expression	O
hardly	O
differ	O
from	O
those	O
in	O
control	O
littermates	O
(	O
Figs	O
.	O
8	O
,	O
9	O
)	O
.	O

The	O
latter	O
is	O
particularly	O
obvious	O
in	O
the	O
apex	O
of	O
the	O
cochlea	O
.	O

In	O
fact	O
,	O
in	O
the	O
cochlea	O
of	O
embryos	O
and	O
neonates	O
as	O
well	O
as	O
in	O
the	O
saccule	O
and	O
utricle	O
of	O
embryos	O
,	O
NT	O
-	O
3	O
is	O
predominantly	O
expressed	O
in	O
supporting	O
cells	O
[	O
6	O
]	O
.	O

This	O
expression	O
of	O
NT	O
-	O
3	O
in	O
supporting	O
cells	O
in	O
embryos	O
and	O
neonates	O
may	O
even	O
preserve	O
in	O
Brn3c	O
null	O
mutants	O
the	O
numerous	O
spiral	O
sensory	O
neurons	O
in	O
the	O
apex	O
of	O
8	O
-	O
day	O
old	O
animals	O
(	O
Figs	O
.	O
3	O
,	O
4	O
)	O
.	O

Long	O
term	O
survival	O
of	O
apical	O
sensory	O
neurons	O
is	O
unrelated	O
to	O
differentiated	O
hair	O
cells	O
and	O
likely	O
is	O
independent	O
of	O
neurotrophins	O

Past	O
work	O
has	O
shown	O
that	O
BDNF	O
and	O
NT	O
-	O
3	O
appear	O
to	O
shift	O
in	O
their	O
expression	O
into	O
inner	O
hair	O
cells	O
around	O
birth	O
or	O
are	O
lost	O
in	O
the	O
ear	O
and	O
other	O
parts	O
of	O
the	O
nervous	O
system	O
[	O
6	O
,	O
10	O
,	O
20	O
,	O
23	O
]	O
.	O

It	O
has	O
been	O
suggested	O
that	O
other	O
neurotrophins	O
may	O
come	O
into	O
play	O
in	O
the	O
ear	O
[	O
11	O
]	O
.	O

However	O
,	O
the	O
apex	O
of	O
Brn3c	O
null	O
mutants	O
,	O
which	O
retains	O
most	O
of	O
the	O
spiral	O
neuron	O
afferents	O
at	O
6	O
-	O
month	O
,	O
shows	O
no	O
formation	O
of	O
mature	O
hair	O
cells	O
at	O
any	O
time	O
surveyed	O
here	O
(	O
P0	O
,	O
P8	O
,	O
P10	O
)	O
.	O

Thus	O
the	O
factor	O
(	O
s	O
)	O
cannot	O
be	O
released	O
by	O
differentiated	O
hair	O
cells	O
but	O
there	O
is	O
an	O
unexplored	O
possibility	O
of	O
generalized	O
expression	O
of	O
neurotrophins	O
at	O
low	O
levels	O
in	O
the	O
undifferentiated	O
epithelia	O
.	O

However	O
,	O
known	O
neurotrophins	O
are	O
largely	O
absent	O
in	O
the	O
adult	O
cochleae	O
[	O
4	O
]	O
and	O
significant	O
amounts	O
of	O
neurotrophin	O
expression	O
appear	O
to	O
develop	O
only	O
in	O
postnatal	O
animals	O
in	O
the	O
CNS	O
[	O
24	O
]	O
.	O

Such	O
expression	O
in	O
the	O
CNS	O
could	O
possibly	O
offset	O
to	O
some	O
extent	O
the	O
peripheral	O
loss	O
of	O
neutrophins	O
in	O
targeted	O
null	O
mutants	O
.	O

This	O
would	O
work	O
only	O
in	O
cases	O
in	O
which	O
the	O
loss	O
of	O
primary	O
neurons	O
would	O
not	O
already	O
be	O
completed	O
long	O
before	O
birth	O
as	O
is	O
the	O
case	O
in	O
the	O
ear	O
[	O
6	O
,	O
13	O
]	O
.	O

It	O
therefore	O
remains	O
unclear	O
what	O
supports	O
the	O
many	O
afferents	O
in	O
the	O
apex	O
of	O
the	O
Brn3c	O
null	O
mutants	O
until	O
6	O
months	O
of	O
age	O
or	O
longer	O
,	O
unknown	O
peripheral	O
neurotrophic	O
substances	B-CHEBI
or	O
neurotrophic	O
support	O
provided	O
by	O
the	O
CNS	O
.	O

Comparable	O
long	O
term	O
retention	O
of	O
apical	O
spiral	O
sensory	O
neurons	O
was	O
described	O
for	O
the	O
deaf	O
white	O
cat	O
[	O
25	O
]	O
and	O
may	O
also	O
be	O
the	O
case	O
in	O
humans	O
with	O
congenital	O
deafness	O
.	O

Growth	O
of	O
fibers	O
to	O
the	O
cochlea	O
does	O
not	O
require	O
mature	O
hair	O
cells	O

Formation	O
of	O
radial	O
fibers	O
that	O
bring	O
peripheral	O
processes	O
of	O
spiral	O
neurons	O
to	O
the	O
organ	O
of	O
Corti	O
seems	O
to	O
be	O
rather	O
normal	O
,	O
even	O
in	O
the	O
apex	O
of	O
the	O
cochlea	O
which	O
does	O
not	O
even	O
develop	O
immature	O
hair	O
cells	O
recognizable	O
by	O
Myo	O
VIIa	O
.	O

This	O
does	O
not	O
preclude	O
that	O
even	O
less	O
differentiated	O
hair	O
cell	O
precursors	O
may	O
form	O
in	O
the	O
apex	O
or	O
that	O
those	O
precursors	O
have	O
died	O
before	O
birth	O
.	O

Interestingly	O
,	O
the	O
growth	O
to	O
outer	O
hair	O
cells	O
is	O
most	O
affected	O
in	O
Brn3c	O
null	O
mutant	O
cochleae	O
.	O

Instead	O
of	O
extending	O
radially	O
through	O
the	O
tunnel	O
of	O
Corti	O
to	O
outer	O
hair	O
cells	O
,	O
afferents	O
appear	O
to	O
stall	O
and	O
extend	O
in	O
longitudinal	O
directions	O
as	O
inner	O
spiral	O
bundles	O
(	O
Figs	O
.	O
3	O
,	O
7	O
)	O
.	O

It	O
has	O
been	O
shown	O
that	O
the	O
differentiation	O
of	O
pillar	O
cells	O
depends	O
on	O
activation	O
of	O
Fgfr3	O
[	O
26	O
]	O
by	O
FGF	O
'	O
s	O
,	O
probably	O
Fgf8	O
,	O
a	O
factor	O
produced	O
by	O
developing	O
and	O
mature	O
inner	O
hair	O
cells	O
[	O
18	O
,	O
27	O
]	O
.	O

The	O
formation	O
of	O
supporting	O
cells	O
also	O
appears	O
to	O
depend	O
on	O
the	O
proper	O
expression	O
of	O
various	O
bHLH	O
factors	O
such	O
as	O
Hes	O
1	O
and	O
5	O
which	O
appear	O
to	O
be	O
regulated	O
by	O
the	O
Notch	O
signaling	O
pathway	O
[	O
17	O
,	O
28	O
,	O
29	O
]	O
.	O

It	O
is	O
possible	O
that	O
the	O
apparent	O
inability	O
of	O
fibers	O
to	O
extend	O
along	O
outer	O
hair	O
cells	O
is	O
related	O
to	O
the	O
lack	O
of	O
differentiation	O
of	O
supporting	O
cells	O
in	O
the	O
absence	O
of	O
mature	O
hair	O
cells	O
.	O

Probing	O
for	O
the	O
proper	O
expression	O
of	O
supporting	O
cell	O
specific	O
markers	O
in	O
Brn3c	O
null	O
mutants	O
is	O
necessary	O
to	O
further	O
evaluate	O
these	O
suggestions	O
.	O

Previous	O
work	O
has	O
suggested	O
that	O
efferent	O
fibers	O
,	O
derived	O
from	O
facial	O
branchial	O
motoneurons	O
,	O
follow	O
afferents	O
and	O
for	O
that	O
reason	O
reflect	O
in	O
detail	O
all	O
connectional	O
deviations	O
of	O
afferents	O
[	O
16	O
,	O
30	O
-	O
32	O
]	O
.	O

Our	O
data	O
agree	O
with	O
this	O
scenario	O
but	O
extend	O
it	O
.	O

Specifically	O
,	O
efferent	O
fibers	O
may	O
suffer	O
the	O
same	O
loss	O
of	O
their	O
molecularly	B-CHEBI
unknown	O
neurotrophic	O
support	O
as	O
do	O
afferents	O
and	O
therefore	O
show	O
the	O
same	O
spatio	O
-	O
temporal	O
profile	O
of	O
loss	O
(	O
Fig	O
.	O
3	O
)	O
.	O

Alternatively	O
,	O
efferent	O
fibers	O
can	O
sustain	O
established	O
connections	O
only	O
as	O
long	O
as	O
afferent	O
fibers	O
are	O
present	O
.	O

More	O
information	O
on	O
the	O
actual	O
molecular	B-CHEBI
support	O
of	O
efferent	O
fibers	O
in	O
the	O
ear	O
is	O
needed	O
before	O
those	O
two	O
possibilities	O
can	O
be	O
distinguished	O
.	O

The	O
onset	O
of	O
cochleotopic	O
projections	O
has	O
been	O
investigated	O
in	O
detail	O
in	O
only	O
very	O
few	O
mammals	O
[	O
19	O
]	O
.	O

These	O
data	O
suggest	O
that	O
a	O
cochleotopic	O
projection	O
develops	O
before	O
onset	O
of	O
hearing	O
.	O

Our	O
data	O
show	O
that	O
at	O
least	O
a	O
cochleotopic	O
projection	O
in	O
the	O
cochlear	O
nerve	O
and	O
the	O
cochlear	O
nuclei	O
develops	O
even	O
in	O
Brn	O
3c	O
null	O
mutants	O
(	O
Fig	O
.	O
6	O
)	O
.	O

Those	O
data	O
are	O
also	O
consistent	O
with	O
the	O
formation	O
of	O
a	O
crude	O
cochleotopic	O
projection	O
in	O
NT	O
-	O
3	O
null	O
mutants	O
[	O
6	O
,	O
14	O
]	O
.	O

Those	O
mutants	O
have	O
a	O
much	O
more	O
severely	O
reduced	O
density	O
of	O
innervation	O
in	O
the	O
developing	O
cochlea	O
[	O
6	O
,	O
14	O
]	O
than	O
the	O
reduction	O
we	O
found	O
in	O
Brn3c	O
null	O
mutants	O
at	O
P0	O
.	O

In	O
this	O
context	O
,	O
it	O
would	O
be	O
interesting	O
to	O
see	O
whether	O
the	O
recently	O
generated	O
transgenic	O
mouse	O
in	O
which	O
BDNF	O
is	O
expressed	O
under	O
NT	O
-	O
3	O
promoter	O
control	O
[	O
33	O
]	O
could	O
actually	O
perform	O
an	O
even	O
more	O
pronounced	O
rescue	O
in	O
a	O
Brn3c	O
null	O
mutant	O
background	O
.	O

Relevance	O
of	O
our	O
findings	O
to	O
other	O
mutations	O
with	O
hair	O
cell	O
loss	O

Vahava	O
et	O
al	O
.	O

[	O
12	O
]	O
and	O
Frydman	O
et	O
al	O
.	O

[	O
34	O
]	O
have	O
demonstrated	O
that	O
mutation	O
in	O
a	O
single	O
human	O
allele	O
of	O
Pou4f3	O
(	O
Brn3c	O
)	O
results	O
in	O
a	O
late	O
onset	O
of	O
high	O
frequency	O
hearing	O
loss	O
.	O

Thus	O
far	O
no	O
data	O
are	O
available	O
that	O
correlate	O
the	O
late	O
onset	O
of	O
hearing	O
loss	O
with	O
morphological	O
defects	O
in	O
the	O
cochlea	O
.	O

In	O
fact	O
,	O
an	O
investigation	O
of	O
Brn3c	O
heterozygotic	O
mice	O
showed	O
no	O
additional	O
effect	O
on	O
hearing	O
loss	O
due	O
to	O
haploinsufficiency	O
in	O
these	O
mice	O
[	O
35	O
]	O
.	O

Our	O
data	O
on	O
Brn3c	O
null	O
mouse	O
mutants	O
nevertheless	O
suggest	O
that	O
the	O
high	O
to	O
low	O
frequency	O
progressive	O
hearing	O
loss	O
in	O
humans	O
may	O
correlate	O
with	O
the	O
unknown	O
factor	O
(	O
s	O
)	O
that	O
mediate	O
apical	O
spiral	O
neuron	O
survival	O
into	O
adulthood	O
.	O

Quantitative	O
data	O
on	O
human	O
Pou4f3	O
cochleae	O
is	O
needed	O
to	O
verify	O
that	O
spiral	O
neuron	O
loss	O
is	O
more	O
pronounced	O
in	O
the	O
basal	O
,	O
high	O
frequency	O
area	O
of	O
these	O
hearing	O
-	O
deficient	O
patients	O
.	O

Similar	O
data	O
are	O
also	O
needed	O
for	O
other	O
congenitally	O
deaf	O
children	O
[	O
36	O
]	O
and	O
in	O
the	O
deaf	O
white	O
cat	O
[	O
25	O
]	O
.	O

Further	O
work	O
on	O
the	O
recently	O
available	O
mutant	O
mice	O
with	O
specific	O
absence	O
of	O
all	O
hair	O
cells	O
[	O
37	O
]	O
,	O
outer	O
hair	O
cells	O
in	O
the	O
base	O
[	O
38	O
]	O
or	O
apex	O
[	O
39	O
]	O
could	O
further	O
help	O
to	O
clarify	O
the	O
role	O
of	O
hair	O
cells	O
in	O
forming	O
and	O
maintaining	O
afferent	O
and	O
efferent	O
innervation	O
in	O
these	O
model	O
mice	O
.	O

Conclusion	O

The	O
progressive	O
loss	O
of	O
afferent	O
and	O
efferent	O
innervation	O
in	O
Brn3c	O
null	O
mutants	O
shows	O
neither	O
in	O
spatial	O
nor	O
in	O
temporal	O
pattern	O
a	O
resemblance	O
to	O
losses	O
reported	O
in	O
simple	O
BDNF	O
or	O
NT	O
-	O
3	O
null	O
mutations	O
[	O
6	O
]	O
.	O

Null	O
mutants	O
of	O
ear	O
specific	O
neurotrophins	O
have	O
completed	O
the	O
loss	O
of	O
sensory	O
neurons	O
before	O
birth	O
.	O

In	O
contrast	O
,	O
our	O
results	O
suggest	O
a	O
slow	O
loss	O
of	O
afferent	O
and	O
efferent	O
innervation	O
between	O
P0	O
and	O
at	O
least	O
6	O
months	O
.	O

This	O
late	O
sensory	O
neuron	O
loss	O
is	O
likely	O
not	O
related	O
to	O
known	O
neurotrophin	O
signaling	O
which	O
becomes	O
reduced	O
in	O
neonatal	O
wildtype	O
animals	O
.	O

Other	O
factors	O
,	O
such	O
as	O
GDNF	O
[	O
11	O
,	O
40	O
]	O
need	O
to	O
be	O
investigated	O
in	O
their	O
expression	O
in	O
these	O
mutants	O
and	O
their	O
functional	O
role	O
needs	O
to	O
be	O
assessed	O
,	O
in	O
particular	O
in	O
the	O
cochlear	O
apex	O
.	O

The	O
long	O
term	O
retention	O
of	O
afferents	O
in	O
the	O
cochlear	O
apex	O
in	O
the	O
absence	O
of	O
any	O
apparent	O
differentiation	O
of	O
hair	O
cells	O
raises	O
hopes	O
for	O
cochlear	O
implants	O
in	O
deaf	O
-	O
born	O
children	O
.	O

Similar	O
long	O
term	O
retention	O
of	O
apical	O
afferents	O
exists	O
in	O
the	O
deaf	O
white	O
cat	O
[	O
25	O
]	O
and	O
should	O
be	O
explored	O
in	O
other	O
model	O
systems	O
with	O
embryonic	O
and	O
neonatal	O
hair	O
cell	O
loss	O
[	O
37	O
,	O
38	O
]	O
.	O

Methods	O

Breeding	O
and	O
genotyping	O

Brn3c	O
mice	O
were	O
bred	O
as	O
previously	O
described	O
[	O
22	O
]	O
.	O

Mice	O
were	O
genotyped	O
and	O
Brn3c	O
null	O
mutants	O
were	O
raised	O
to	O
a	O
specific	O
age	O
(	O
P0	O
,	O
N	O
=	O
8	O
;	O
P7	O
,	O
N	O
=	O
6	O
;	O
P8	O
,	O
N	O
=	O
6	O
;	O
6	O
months	O
old	O
,	O
N	O
=	O
2	O
)	O
.	O

The	O
animals	O
were	O
deeply	O
anesthetized	O
with	O
pentobarbital	B-CHEBI
and	O
transcardially	O
perfused	O
with	O
4	O
%	O
paraformaldehyde	O
in	O
0	O
.	O
1	O
M	O
phosphate	B-CHEBI
buffer	O
(	O
pH	O
7	O
.	O
4	O
)	O
.	O

Ears	O
were	O
postfixed	O
in	O
the	O
same	O
fixative	O
for	O
at	O
least	O
one	O
day	O
prior	O
to	O
dissection	O
.	O

Tracing	O
of	O
nerve	O
fibers	O

DiI	O
tracing	O
from	O
the	O
brainstem	O
was	O
performed	O
as	O
previously	O
described	O
[	O
41	O
]	O
.	O

Small	O
filter	O
stripes	O
soaked	O
with	O
saturated	O
DiI	O
were	O
implanted	O
into	O
the	O
efferent	O
fiber	O
bundle	O
near	O
the	O
floor	O
plate	O
or	O
into	O
the	O
ascending	O
or	O
descending	O
afferents	O
in	O
the	O
alar	O
plate	O
[	O
42	O
]	O
.	O

After	O
appropriate	O
diffusion	O
time	O
of	O
the	O
dye	B-CHEBI
,	O
the	O
ears	O
were	O
dissected	O
and	O
mounted	O
flat	O
for	O
visualization	O
in	O
an	O
epifluorescent	O
microscope	O
.	O

Images	O
were	O
taken	O
on	O
black	O
and	O
white	O
film	O
or	O
acquired	O
with	O
a	O
cooled	O
CCD	O
camera	O
and	O
processed	O
using	O
ImagePro	O
software	O
(	O
Media	O
Cybernetics	O
)	O
.	O

Ears	O
were	O
subsequently	O
reacted	O
for	O
acetylated	O
tubulin	O
to	O
reveal	O
the	O
pattern	O
of	O
innervation	O
in	O
addition	O
to	O
the	O
DiI	O
tracing	O
with	O
a	O
different	O
technique	O
as	O
previously	O
described	O
[	O
14	O
]	O
.	O

Briefly	O
,	O
dissected	O
ears	O
were	O
incubated	O
with	O
1	O
:	O
500	O
anti	O
-	O
acetylated	O
tubulin	O
antibodies	O
(	O
Sigma	O
,	O
St	O
.	O
Louis	O
)	O
followed	O
by	O
secondary	O
antibodies	O
conjugated	O
to	O
HRP	O
.	O

Dissected	O
inner	O
ears	O
were	O
reacted	O
with	O
DAB	O
and	O
H2O2	B-CHEBI
for	O
HRP	O
distribution	O
and	O
subsequently	O
viewed	O
as	O
whole	O
mounts	O
.	O

After	O
photographing	O
as	O
whole	O
mounts	O
,	O
the	O
ears	O
were	O
embedded	O
in	O
epoxy	B-CHEBI
resin	O
and	O
sectioned	O
to	O
reveal	O
the	O
distribution	O
of	O
fibers	O
inside	O
the	O
sensory	O
epithelia	O
in	O
more	O
detail	O
.	O

Cochleotopic	O
projection	O
was	O
evaluated	O
by	O
inserting	O
DiI	O
soaked	O
filter	O
strips	O
into	O
the	O
base	O
and	O
DiA	O
soaked	O
filter	O
strips	O
into	O
the	O
apical	O
turn	O
of	O
2	O
P0	O
and	O
4	O
P8	O
Brn3c	O
null	O
mutants	O
and	O
a	O
similar	O
number	O
of	O
wildtype	O
littermates	O
.	O

After	O
appropriate	O
diffusion	O
time	O
[	O
43	O
]	O
,	O
the	O
brains	O
with	O
the	O
attached	O
cochlear	O
nerve	O
were	O
embedded	O
in	O
gelatin	O
,	O
hardened	O
in	O
4	O
%	O
PFA	O
over	O
night	O
,	O
sectioned	O
coronally	O
on	O
a	O
vibratome	O
(	O
100	O
mu	O
m	O
thickness	O
)	O
and	O
viewed	O
with	O
a	O
Biorad	O
Radiance	O
2000	O
confocal	O
system	O
attached	O
to	O
a	O
Nikon	O
Eclipse	O
800	O
microscope	O
.	O

Image	O
stacks	O
were	O
collapsed	O
to	O
view	O
the	O
entire	O
projection	O
in	O
one	O
section	O
in	O
one	O
focal	O
plane	O
.	O

In	O
situ	O
hybridization	O

Four	O
ears	O
each	O
of	O
Brn3c	O
null	O
mutants	O
(	O
P0	O
and	O
P8	O
)	O
and	O
control	O
littermates	O
were	O
embedded	O
in	O
paraffin	O
,	O
sectioned	O
and	O
probed	O
for	O
the	O
presence	O
of	O
BDNF	O
and	O
NT	O
-	O
3	O
mRNA	B-CHEBI
using	O
the	O
in	O
situ	O
technique	O
previously	O
described	O
[	O
7	O
]	O
.	O

Sections	O
were	O
lightly	O
counterstained	O
and	O
viewed	O
with	O
bright	O
and	O
dark	O
field	O
microscopy	O
.	O

Images	O
were	O
acquired	O
with	O
a	O
CCD	O
camera	O
and	O
displayed	O
as	O
false	O
color	O
images	O
as	O
previously	O
described	O
[	O
18	O
]	O
.	O

Immunocytochemistry	O
of	O
hair	O
cells	O
and	O
quantification	O
of	O
hair	O
cells	O
and	O
neurons	O

Immunostaining	O
of	O
P7	O
cochlear	O
whole	O
mounts	O
using	O
the	O
hair	O
cell	O
specific	O
-	O
myosin	O
VII	O
(	O
MyoVIIa	O
)	O
antibody	O
was	O
performed	O
as	O
previously	O
described	O
[	O
2	O
]	O
.	O

Images	O
of	O
labeled	O
organs	O
of	O
Corti	O
were	O
then	O
acquired	O
using	O
a	O
SPOT	O
digital	O
camera	O
(	O
Diagnostic	O
Instruments	O
Inc	O
.	O
)	O
and	O
the	O
number	O
of	O
hair	O
cells	O
was	O
scored	O
from	O
acquired	O
images	O
.	O

To	O
determine	O
the	O
number	O
of	O
hair	O
cells	O
or	O
neurons	O
in	O
vestibular	O
endorgans	O
or	O
sensory	O
ganglia	O
,	O
serial	O
sections	O
were	O
stained	O
with	O
Cresyl	O
Violet	O
and	O
images	O
were	O
similarly	O
acquired	O
and	O
scored	O
.	O

Every	O
other	O
section	O
was	O
scored	O
for	O
each	O
sensory	O
epithelium	O
and	O
every	O
forth	O
section	O
was	O
scored	O
for	O
each	O
ganglion	O
.	O

Only	O
neurons	O
or	O
cells	O
with	O
a	O
clear	O
nucleus	O
and	O
nucleoli	O
were	O
counted	O
and	O
4	O
-	O
6	O
samples	O
were	O
counted	O
for	O
each	O
epithelium	O
and	O
ganglion	O
.	O

All	O
data	O
were	O
tested	O
for	O
significance	O
using	O
two	O
-	O
sample	O
Student	O
'	O
s	O
t	O
-	O
test	O
with	O
unequal	O
variances	O
.	O

Authors	O
'	O
contributions	O

MX	O
generated	O
the	O
null	O
mutation	O
,	O
bred	O
all	O
the	O
mice	O
used	O
for	O
this	O
study	O
and	O
generated	O
the	O
statistical	O
data	O
and	O
the	O
immunocytochemical	O
data	O
with	O
MyoVII	O
,	O
AM	O
conducted	O
the	O
tract	O
tracing	O
studies	O
of	O
cochlear	O
afferents	O
and	O
helped	O
with	O
the	O
histological	O
analysis	O
and	O
assembly	O
of	O
image	O
plates	O
,	O
UP	O
carried	O
out	O
the	O
in	O
situ	O
hybridization	O
for	O
neurotrophins	O
and	O
assembled	O
the	O
plates	O
for	O
these	O
data	O
,	O
BF	O
wrote	O
the	O
manuscript	O
,	O
carried	O
out	O
most	O
of	O
the	O
neuronal	O
tracing	O
and	O
immunocytochemistry	O
for	O
acetylated	O
tubulin	O
and	O
data	O
presentation	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Acknowledgements	O

Supported	O
by	O
the	O
National	O
Eye	O
Institute	O
(	O
EY12020	O
,	O
MX	O
)	O
,	O
the	O
March	O
of	O
Dimes	O
Birth	O
Defects	O
Foundation	O
(	O
MX	O
)	O
,	O
the	O
Egyptian	O
Government	O
(	O
AM	O
)	O
,	O
the	O
Juselius	O
Foundation	O
(	O
UP	O
)	O
,	O
the	O
NIDCD	O
(	O
2	O
P01	O
DC00215	O
,	O
BF	O
;	O
DC04594	O
,	O
M	O
.	O
X	O
.	O
)	O
,	O
the	O
Taub	O
foundation	O
(	O
BF	O
)	O
and	O
NASA	O
(	O
01	O
-	O
OBPR	O
-	O
06	O
;	O
BF	O
)	O
.	O

Function	O
,	O
expression	O
and	O
localization	O
of	O
annexin	O
A7	O
in	O
platelets	O
and	O
red	O
blood	O
cells	O
:	O
Insights	O
derived	O
from	O
an	O
annexin	O
A7	O
mutant	O
mouse	O

Abstract	O

Background	O

Annexin	O
A7	O
is	O
a	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
and	O
phospholipid	B-CHEBI
-	O
binding	O
protein	B-CHEBI
expressed	O
as	O
a	O
47	O
and	O
51	O
kDa	O
isoform	O
,	O
which	O
is	O
thought	O
to	O
be	O
involved	O
in	O
membrane	O
fusion	O
processes	O
.	O

Recently	O
the	O
47	O
kDa	O
isoform	O
has	O
been	O
identified	O
in	O
erythrocytes	O
where	O
it	O
was	O
proposed	O
to	O
be	O
a	O
key	O
component	O
in	O
the	O
process	O
of	O
the	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
dependent	O
vesicle	O
release	O
,	O
a	O
process	O
with	O
which	O
red	O
blood	O
cells	O
might	O
protect	O
themselves	O
against	O
an	O
attack	O
by	O
for	O
example	O
complement	O
components	O
.	O

Results	O

The	O
role	O
of	O
annexin	O
A7	O
in	O
red	O
blood	O
cells	O
was	O
addressed	O
in	O
erythrocytes	O
from	O
anxA7	O
-	O
/	O
-	O
mice	O
.	O

Interestingly	O
,	O
the	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
mediated	O
vesiculation	O
process	O
was	O
not	O
impaired	O
.	O

Also	O
,	O
the	O
membrane	O
organization	O
appeared	O
not	O
to	O
be	O
disturbed	O
as	O
assessed	O
using	O
gradient	O
fractionation	O
studies	O
.	O

Instead	O
,	O
lack	O
of	O
annexin	O
A7	O
led	O
to	O
an	O
altered	O
cell	O
shape	O
and	O
increased	O
osmotic	O
resistance	O
of	O
red	O
blood	O
cells	O
.	O

Annexin	O
A7	O
was	O
also	O
identified	O
in	O
platelets	O
.	O

In	O
these	O
cells	O
its	O
loss	O
led	O
to	O
a	O
slightly	O
slower	O
aggregation	O
velocity	O
which	O
seems	O
to	O
be	O
compensated	O
by	O
an	O
increased	O
number	O
of	O
platelets	O
.	O

The	O
results	O
appear	O
to	O
rule	O
out	O
an	O
important	O
role	O
of	O
annexin	O
A7	O
in	O
membrane	O
fusion	O
processes	O
occurring	O
in	O
red	O
blood	O
cells	O
.	O

Instead	O
the	O
protein	B-CHEBI
might	O
be	O
involved	O
in	O
the	O
organization	O
of	O
the	O
membrane	O
cytoskeleton	O
.	O

Red	O
blood	O
cells	O
may	O
represent	O
an	O
appropriate	O
model	O
to	O
study	O
the	O
role	O
of	O
annexin	O
A7	O
in	O
cellular	O
processes	O
.	O

Conclusion	O

We	O
have	O
demonstrated	O
the	O
presence	O
of	O
both	O
annexin	O
A7	O
isoforms	O
in	O
red	O
blood	O
cells	O
and	O
the	O
presence	O
of	O
the	O
small	O
isoform	O
in	O
platelets	O
.	O

In	O
both	O
cell	O
types	O
the	O
loss	O
of	O
annexin	O
A7	O
impairs	O
cellular	O
functions	O
.	O

The	O
defects	O
observed	O
are	O
however	O
not	O
compatible	O
with	O
a	O
crucial	O
role	O
for	O
annexin	O
A7	O
in	O
membrane	O
fusion	O
processes	O
in	O
these	O
cell	O
types	O
.	O

Background	O

Annexin	O
A7	O
is	O
a	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
and	O
phospholipid	B-CHEBI
-	O
binding	O
protein	B-CHEBI
,	O
which	O
was	O
isolated	O
as	O
the	O
agent	O
that	O
mediated	O
aggregation	O
of	O
chromaffin	O
granules	O
and	O
fusion	O
of	O
phospholipid	B-CHEBI
membranes	O
in	O
the	O
presence	O
of	O
Ca2	B-CHEBI
+	I-CHEBI
.	O

This	O
activity	O
led	O
to	O
the	O
proposal	O
of	O
annexin	O
A7	O
'	O
s	O
involvement	O
in	O
the	O
exocytotic	O
secretion	O
of	O
catecholamines	B-CHEBI
[	O
1	O
]	O
.	O

The	O
protein	B-CHEBI
belongs	O
to	O
a	O
family	O
of	O
evolutionarily	O
conserved	O
proteins	B-CHEBI
of	O
a	O
bipartite	O
structure	O
with	O
a	O
variable	O
N	B-CHEBI
-	O
terminal	O
and	O
a	O
conserved	O
C	B-CHEBI
-	O
terminal	O
domain	O
.	O

The	O
C	B-CHEBI
-	O
terminal	O
domain	O
is	O
responsible	O
for	O
the	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
and	O
phospholipid	B-CHEBI
-	O
binding	O
,	O
the	O
N	B-CHEBI
-	O
terminal	O
domain	O
appears	O
to	O
confer	O
functional	O
diversity	O
[	O
2	O
-	O
4	O
]	O
.	O

The	O
binding	O
to	O
negatively	O
charged	O
phospholipids	B-CHEBI
is	O
thought	O
to	O
be	O
mediated	O
by	O
Ca2	B-CHEBI
+	I-CHEBI
ions	I-CHEBI
.	O

Annexin	O
A7	O
is	O
unique	O
in	O
that	O
it	O
carries	O
an	O
extraordinarily	O
long	O
and	O
hydrophobic	O
amino	B-CHEBI
terminus	O
with	O
more	O
than	O
100	O
amino	B-CHEBI
acids	I-CHEBI
.	O

Alternative	O
splicing	O
gives	O
rise	O
to	O
two	O
isoforms	O
of	O
47	O
and	O
51	O
kDa	O
.	O

Both	O
isoforms	O
differ	O
by	O
an	O
additional	O
cassette	O
exon	O
located	O
in	O
the	O
first	O
third	O
of	O
the	O
N	B-CHEBI
-	O
terminal	O
domain	O
.	O

Most	O
tissues	O
harbor	O
only	O
the	O
47	O
kDa	O
isoform	O
,	O
both	O
forms	O
are	O
found	O
in	O
brain	O
and	O
heart	O
,	O
while	O
the	O
large	O
isoform	O
is	O
exclusively	O
expressed	O
in	O
mature	O
skeletal	O
muscle	O
.	O

At	O
the	O
cellular	O
level	O
annexin	O
A7	O
can	O
be	O
detected	O
in	O
the	O
cytosol	O
,	O
at	O
the	O
plasma	O
membrane	O
,	O
around	O
the	O
nucleus	O
,	O
at	O
vesicular	O
structures	O
including	O
adrenal	O
chromaffin	O
granules	O
,	O
and	O
at	O
the	O
t	O
-	O
tubule	O
system	O
[	O
5	O
,	O
6	O
]	O
.	O

Annexin	O
A7	O
translocates	O
to	O
membranes	O
in	O
a	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
dependent	O
fashion	O
and	O
,	O
when	O
intracellular	O
Ca2	B-CHEBI
+	I-CHEBI
levels	O
rise	O
,	O
sequentially	O
redistributes	O
to	O
the	O
plasma	O
and	O
the	O
nuclear	O
membrane	O
as	O
well	O
as	O
to	O
intracellular	O
vesicles	O
.	O

Furthermore	O
,	O
annexin	O
A7	O
associates	O
with	O
lipid	B-CHEBI
rafts	O
[	O
7	O
]	O
.	O

Lipid	B-CHEBI
rafts	O
play	O
a	O
key	O
role	O
in	O
membrane	O
budding	O
and	O
in	O
vesiculation	O
processes	O
such	O
as	O
endo	O
-	O
and	O
exocytosis	O
[	O
8	O
-	O
10	O
]	O
.	O

Two	O
binding	O
partners	O
of	O
annexin	O
A7	O
have	O
been	O
identified	O
,	O
sorcin	O
and	O
galectin	O
-	O
3	O
[	O
11	O
-	O
13	O
]	O
.	O

Sorcin	O
is	O
a	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
binding	O
protein	B-CHEBI
and	O
belongs	O
to	O
the	O
penta	O
EF	O
-	O
hand	O
protein	B-CHEBI
family	O
[	O
14	O
]	O
.	O

Like	O
annexin	O
A7	O
it	O
binds	O
to	O
membranes	O
in	O
a	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
dependent	O
manner	O
.	O

Sorcin	O
also	O
has	O
been	O
described	O
as	O
interaction	O
partner	O
of	O
the	O
ryanodine	B-CHEBI
receptor	O
,	O
and	O
appears	O
to	O
modulate	O
its	O
function	O
[	O
15	O
]	O
.	O

The	O
influence	O
of	O
the	O
sorcin	O
/	O
annexin	O
A7	O
interaction	O
on	O
the	O
ryanodine	B-CHEBI
receptor	O
is	O
unknown	O
.	O

Sorcin	O
and	O
annexin	O
A7	O
are	O
coexpressed	O
in	O
all	O
tissues	O
examined	O
so	O
far	O
[	O
11	O
]	O
.	O

The	O
binding	O
of	O
annexin	O
A7	O
and	O
sorcin	O
is	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
dependent	O
and	O
occurs	O
at	O
micromolar	O
Ca2	B-CHEBI
+	I-CHEBI
concentrations	O
.	O

The	O
binding	O
sites	O
have	O
been	O
localised	O
to	O
the	O
amino	B-CHEBI
terminal	O
GGYY	O
and	O
GYGG	O
motifs	O
in	O
sorcin	O
and	O
to	O
the	O
GYPP	O
motif	O
in	O
the	O
amino	B-CHEBI
terminus	O
of	O
annexin	O
A7	O
.	O

The	O
proteins	B-CHEBI
bind	O
to	O
each	O
other	O
with	O
a	O
stoichiometry	O
of	O
two	O
sorcin	O
molecules	B-CHEBI
per	O
annexin	O
A7	O
molecule	B-CHEBI
[	O
12	O
]	O
.	O

Galectin	O
-	O
3	O
is	O
a	O
multifunctional	O
oncogenic	O
protein	B-CHEBI
with	O
an	O
anti	O
-	O
apoptotic	O
activity	O
found	O
in	O
the	O
extracellular	O
space	O
,	O
in	O
the	O
nucleus	O
and	O
cytoplasm	O
and	O
in	O
mitochondria	O
.	O

Cytoplasmic	O
galectin	O
-	O
3	O
correlates	O
with	O
tumor	O
progression	O
and	O
protects	O
mitochondrial	O
integrity	O
.	O

Down	O
regulation	O
of	O
annexin	O
A7	O
prevents	O
galectin	O
-	O
3	O
translocation	O
to	O
the	O
perinuclear	O
membrane	O
and	O
increases	O
galectin	O
-	O
3	O
secretion	O
.	O

For	O
annexin	O
A7	O
a	O
role	O
for	O
galectin	O
-	O
3	O
trafficking	O
,	O
apoptosis	O
regulation	O
,	O
and	O
mitochondrial	O
integrity	O
was	O
proposed	O
[	O
13	O
]	O
.	O

The	O
cellular	O
role	O
of	O
annexin	O
A7	O
is	O
not	O
well	O
understood	O
.	O

It	O
is	O
thought	O
to	O
regulate	O
and	O
stabilize	O
membrane	O
domains	O
and	O
to	O
have	O
a	O
role	O
in	O
Ca2	B-CHEBI
+	I-CHEBI
homeostasis	O
and	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
dependent	O
signaling	O
pathways	O
.	O

These	O
proposals	O
are	O
supported	O
by	O
data	O
obtained	O
from	O
analysis	O
of	O
annexin	O
A7	O
deficient	O
mouse	O
mutants	O
.	O

Two	O
annexin	O
A7	O
129Sv	O
null	O
mice	O
strains	O
were	O
generated	O
independently	O
using	O
a	O
different	O
strategy	O
.	O

The	O
one	O
of	O
Srivastava	O
et	O
al	O
.	O

[	O
16	O
]	O
is	O
lethal	O
.	O

Heterozygous	O
mice	O
exhibit	O
an	O
insulin	B-CHEBI
secretion	O
defect	O
and	O
tumor	O
phenotypes	O
.	O

The	O
null	O
strain	O
reported	O
by	O
Herr	O
et	O
al	O
.	O

[	O
17	O
]	O
is	O
viable	O
,	O
healthy	O
,	O
and	O
shows	O
no	O
insulin	B-CHEBI
secretion	O
defect	O
or	O
other	O
obvious	O
defects	O
.	O

However	O
,	O
in	O
isolated	O
cardiomyocytes	O
the	O
frequency	O
-	O
induced	O
shortening	O
is	O
disturbed	O
.	O

Here	O
we	O
have	O
focused	O
on	O
the	O
analysis	O
of	O
red	O
blood	O
cells	O
and	O
platelets	O
of	O
the	O
anxA7	O
-	O
/	O
-	O
mutant	O
.	O

Generally	O
,	O
red	O
blood	O
cells	O
and	O
platelets	O
were	O
thought	O
not	O
to	O
contain	O
annexin	O
A7	O
and	O
only	O
recently	O
the	O
47	O
kDa	O
isoform	O
has	O
been	O
reported	O
as	O
component	O
of	O
red	O
blood	O
cells	O
[	O
7	O
]	O
.	O

Red	O
blood	O
cells	O
undergo	O
various	O
biochemical	O
or	O
morphological	O
changes	O
that	O
appear	O
to	O
be	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
dependent	O
processes	O
[	O
18	O
,	O
19	O
]	O
.	O

One	O
of	O
them	O
is	O
the	O
release	O
of	O
hemoglobin	B-CHEBI
-	O
containing	O
exovesicles	O
occurring	O
in	O
vivo	O
as	O
well	O
as	O
in	O
vitro	O
[	O
7	O
,	O
20	O
]	O
.	O

This	O
process	O
is	O
thought	O
to	O
represent	O
a	O
protective	O
method	O
of	O
the	O
red	O
blood	O
cell	O
against	O
an	O
attack	O
by	O
for	O
example	O
complement	O
components	O
.	O

Red	O
blood	O
cells	O
which	O
lack	O
the	O
ability	O
to	O
vesiculate	O
cause	O
a	O
disease	O
with	O
red	O
blood	O
cell	O
destruction	O
and	O
haemoglobinuria	O
[	O
21	O
]	O
.	O

There	O
exist	O
two	O
types	O
of	O
vesicles	O
,	O
micro	O
-	O
and	O
nanovesicles	O
with	O
a	O
size	O
of	O
180	O
nm	O
and	O
60	O
nm	O
,	O
respectively	O
.	O

They	O
are	O
enriched	O
in	O
cholesterol	B-CHEBI
and	O
sphingolipid	B-CHEBI
rich	O
lipid	B-CHEBI
raft	O
domains	O
that	O
are	O
associated	O
with	O
proteins	B-CHEBI
like	O
acetylcholinesterase	O
,	O
cell	O
surface	O
proteins	B-CHEBI
including	O
a	O
complement	O
receptor	O
,	O
and	O
the	O
lipid	B-CHEBI
raft	O
proteins	B-CHEBI
stomatin	O
and	O
flotillin	O
,	O
but	O
they	O
lack	O
any	O
cytoskeletal	O
protein	B-CHEBI
[	O
7	O
]	O
.	O

Furthermore	O
,	O
they	O
contain	O
sorcin	O
and	O
annexin	O
A7	O
attached	O
to	O
the	O
lipid	B-CHEBI
rafts	O
.	O

Both	O
proteins	B-CHEBI
are	O
more	O
abundant	O
in	O
nanovesicles	O
.	O

The	O
vesicle	O
formation	O
goes	O
along	O
with	O
several	O
other	O
changes	O
in	O
the	O
red	O
blood	O
cell	O
like	O
cytoskeletal	O
rearrangements	O
and	O
changes	O
in	O
the	O
phospholipid	B-CHEBI
orientation	O
in	O
the	O
cellular	O
membrane	O
.	O

Results	O

Annexin	O
A7	O
expression	O
in	O
red	O
blood	O
cells	O
,	O
red	O
blood	O
cell	O
derived	O
exovesicles	O
and	O
in	O
platelets	O

Salzer	O
et	O
al	O
.	O
recently	O
reported	O
the	O
presence	O
of	O
the	O
47	O
kDa	O
isoform	O
of	O
annexin	O
A7	O
and	O
its	O
partner	O
sorcin	O
in	O
micro	O
-	O
and	O
nanovesicles	O
derived	O
from	O
red	O
blood	O
cells	O
where	O
they	O
are	O
located	O
in	O
the	O
lumen	O
and	O
are	O
also	O
enriched	O
in	O
membrane	O
rafts	O
[	O
7	O
]	O
.	O

We	O
have	O
now	O
extended	O
these	O
findings	O
and	O
show	O
here	O
that	O
the	O
51	O
kDa	O
isoform	O
is	O
present	O
as	O
well	O
.	O

In	O
western	O
blots	O
of	O
human	O
red	O
blood	O
cells	O
the	O
47	O
and	O
51	O
kDa	O
isoforms	O
were	O
detected	O
using	O
mAb	O
203	O
-	O
217	O
(	O
Fig	O
.	O
1	O
)	O
.	O

The	O
47	O
kDa	O
isoform	O
was	O
detected	O
in	O
silver	B-CHEBI
stained	O
gels	O
and	O
its	O
identity	O
with	O
annexin	O
A7	O
confirmed	O
by	O
peptide	O
mass	O
fingerprinting	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
51	O
kDa	O
isoform	O
was	O
only	O
detected	O
in	O
western	O
blots	O
.	O

Figure	O
1	O

Expression	O
of	O
annexin	O
A7	O
in	O
human	O
red	O
blood	O
cells	O
(	O
1	O
)	O
and	O
human	O
platelets	O
(	O
2	O
)	O
.	O

Protein	B-CHEBI
homogenates	O
were	O
separated	O
by	O
SDS	B-CHEBI
-	O
PAGE	O
(	O
12	O
%	O
acrylamide	B-CHEBI
)	O
.	O

The	O
resulting	O
western	O
blot	O
was	O
probed	O
with	O
mAb	O
203	O
-	O
217	O
,	O
visualization	O
was	O
by	O
a	O
secondary	O
peroxidase	O
coupled	O
antibody	O
followed	O
by	O
ECL	O
.	O

Both	O
isoforms	O
are	O
detected	O
in	O
red	O
blood	O
cells	O
,	O
in	O
platelets	O
only	O
the	O
small	O
isoform	O
is	O
present	O
.	O

Its	O
presence	O
in	O
vesicles	O
led	O
to	O
the	O
suggestion	O
,	O
that	O
,	O
along	O
with	O
raft	O
domains	O
,	O
annexin	O
A7	O
plays	O
a	O
role	O
in	O
membrane	O
organization	O
and	O
the	O
vesiculation	O
process	O
.	O

To	O
examine	O
this	O
,	O
we	O
analysed	O
the	O
ability	O
of	O
red	O
blood	O
cells	O
derived	O
from	O
the	O
annexin	O
A7	O
knock	O
out	O
mice	O
(	O
anxA7	O
-	O
/	O
-	O
)	O
to	O
form	O
exovesicles	O
.	O

Because	O
of	O
better	O
accessibility	O
and	O
larger	O
available	O
amounts	O
that	O
led	O
to	O
clear	O
results	O
,	O
we	O
included	O
our	O
data	O
obtained	O
with	O
human	O
blood	O
.	O

Independent	O
of	O
the	O
presence	O
of	O
annexin	O
A7	O
both	O
types	O
of	O
exovesicles	O
,	O
micro	O
-	O
and	O
nanovesicles	O
,	O
were	O
released	O
after	O
Ca2	B-CHEBI
+	I-CHEBI
/	O
ionophore	B-CHEBI
treatment	O
as	O
determined	O
by	O
acetylcholine	B-CHEBI
esterase	O
activity	O
and	O
microscopic	O
examination	O
.	O

Annexin	O
A7	O
is	O
present	O
in	O
both	O
vesicle	O
types	O
where	O
it	O
is	O
more	O
enriched	O
in	O
nanovesicles	O
(	O
Fig	O
.	O
2	O
)	O
.	O

The	O
51	O
kDa	O
isoform	O
is	O
only	O
detectable	O
in	O
nanovesicles	O
.	O

The	O
quantity	O
of	O
both	O
vesicle	O
types	O
did	O
not	O
differ	O
between	O
wild	O
type	O
and	O
knock	O
out	O
red	O
blood	O
cell	O
vesicles	O
as	O
determined	O
by	O
the	O
AChE	O
-	O
values	O
(	O
A405	O
nanovesicles	O
:	O
~	O
0	O
.	O
18	O
;	O
A405	O
microvesicles	O
:	O
~	O
0	O
.	O
9	O
;	O
both	O
,	O
for	O
wt	O
and	O
ko	O
)	O
.	O

It	O
appears	O
that	O
annexin	O
A7	O
,	O
although	O
it	O
has	O
been	O
described	O
to	O
fuse	O
membranes	O
,	O
is	O
not	O
a	O
key	O
component	O
in	O
the	O
process	O
of	O
the	O
formation	O
of	O
red	O
blood	O
cell	O
exovesicles	O
.	O

When	O
we	O
probed	O
for	O
the	O
presence	O
of	O
sorcin	O
in	O
wild	O
type	O
and	O
mutant	O
vesicles	O
we	O
found	O
that	O
the	O
sorcin	O
levels	O
were	O
reduced	O
in	O
the	O
mutant	O
nanovesicles	O
(	O
Fig	O
.	O
2	O
)	O
.	O

Figure	O
2	O

Enrichment	O
of	O
annexin	O
A7	O
and	O
sorcin	O
in	O
exovesicles	O
derived	O
from	O
red	O
blood	O
cells	O
.	O

Vesicles	O
from	O
wild	O
type	O
(	O
wt	O
)	O
and	O
anxA7	O
-	O
/	O
-	O
mutant	O
(	O
ko	O
)	O
were	O
generated	O
with	O
Ca2	B-CHEBI
+	I-CHEBI
/	O
ionophore	B-CHEBI
treatment	O
,	O
isolated	O
by	O
differential	O
centrifugation	O
and	O
analysed	O
by	O
immunoblotting	O
with	O
mAb	O
203	O
-	O
217	O
and	O
a	O
sorcin	O
polyclonal	O
antibody	O
.	O

In	O
general	O
,	O
annexin	O
A7	O
and	O
sorcin	O
are	O
more	O
abundant	O
in	O
nanovesicles	O
.	O

The	O
51	O
kDa	O
isoform	O
of	O
annexin	O
A7	O
(	O
arrows	O
)	O
is	O
only	O
observed	O
in	O
nanovesicles	O
.	O

Samples	O
of	O
both	O
vesicles	O
types	O
were	O
normalized	O
according	O
to	O
their	O
acetylcholine	B-CHEBI
esterase	O
activity	O
.	O

Human	O
red	O
blood	O
cells	O
(	O
co	O
)	O
were	O
used	O
for	O
control	O
and	O
normalized	O
independently	O
.	O

To	O
study	O
the	O
distribution	O
of	O
annexin	O
A7	O
in	O
red	O
blood	O
cells	O
we	O
used	O
self	O
forming	O
iodixanol	O
density	O
gradients	O
.	O

Both	O
isoforms	O
were	O
present	O
in	O
the	O
soluble	O
fraction	O
as	O
well	O
as	O
in	O
the	O
gradient	O
fractions	O
where	O
they	O
are	O
assumed	O
to	O
be	O
associated	O
with	O
membranes	O
.	O

These	O
membranes	O
are	O
exclusively	O
plasma	O
membranes	O
as	O
red	O
blood	O
cells	O
are	O
free	O
of	O
any	O
organelles	O
.	O

The	O
distribution	O
was	O
however	O
not	O
homogeneous	O
throughout	O
the	O
gradient	O
.	O

This	O
could	O
reflect	O
the	O
binding	O
of	O
annexin	O
A7	O
to	O
membrane	O
subdomains	O
that	O
have	O
different	O
lipid	B-CHEBI
or	O
lipid	B-CHEBI
/	O
protein	B-CHEBI
composition	O
as	O
discussed	O
by	O
Salzer	O
et	O
al	O
.	O

[	O
7	O
]	O
.	O

Likewise	O
,	O
sorcin	O
does	O
not	O
exhibit	O
a	O
homogeneous	O
distribution	O
in	O
the	O
gradient	O
.	O

Moreover	O
,	O
it	O
segregates	O
into	O
vesicles	O
which	O
are	O
not	O
associated	O
with	O
annexin	O
A7	O
(	O
Fig	O
.	O
3	O
)	O
.	O

We	O
also	O
tested	O
platelets	O
for	O
annexin	O
A7	O
expression	O
and	O
detected	O
the	O
47	O
kDa	O
isoform	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Figure	O
3	O

Association	O
of	O
annexin	O
A7	O
and	O
sorcin	O
with	O
distinct	O
red	O
blood	O
cell	O
plasma	O
membrane	O
fractions	O
.	O

Lysed	O
human	O
red	O
blood	O
cells	O
were	O
added	O
to	O
a	O
self	O
forming	O
iodixanol	O
density	O
gradient	O
.	O

The	O
density	O
of	O
the	O
gradient	O
increases	O
from	O
left	O
(	O
1	O
.	O
06	O
g	O
/	O
ml	O
)	O
to	O
right	O
(	O
1	O
.	O
20	O
g	O
/	O
ml	O
)	O
.	O

Fractions	O
were	O
analysed	O
by	O
immunoblotting	O
using	O
mAb	O
203	O
-	O
217	O
and	O
the	O
sorcin	O
polyclonal	O
antibody	O
.	O

The	O
lack	O
of	O
annexin	O
A7	O
changes	O
red	O
blood	O
cell	O
morphology	O
and	O
osmotic	O
resistance	O

As	O
annexin	O
A7	O
is	O
a	O
component	O
of	O
red	O
blood	O
cell	O
vesicles	O
we	O
studied	O
the	O
consequences	O
of	O
the	O
loss	O
of	O
the	O
protein	B-CHEBI
in	O
the	O
anxA7	O
-	O
/	O
-	O
mouse	O
for	O
red	O
blood	O
cell	O
morphology	O
and	O
osmotic	O
resistance	O
.	O

In	O
a	O
standard	O
'	O
blood	O
smear	O
'	O
we	O
did	O
not	O
note	O
a	O
deformation	O
of	O
the	O
cells	O
,	O
however	O
dark	O
field	O
microscopy	O
revealed	O
changes	O
in	O
shape	O
and	O
diameter	O
of	O
the	O
anxA7	O
-	O
/	O
-	O
red	O
blood	O
cells	O
.	O

They	O
had	O
a	O
statistically	O
significant	O
larger	O
cell	O
diameter	O
of	O
6	O
.	O
0	O
mu	O
m	O
compared	O
to	O
wild	O
type	O
with	O
5	O
.	O
7	O
mu	O
m	O
(	O
p	O
=	O
0	O
.	O
015	O
,	O
n	O
=	O
40	O
)	O
,	O
a	O
remarkably	O
lower	O
emphasized	O
central	O
impression	O
and	O
a	O
more	O
flat	O
shape	O
(	O
Fig	O
.	O
4	O
)	O
.	O

No	O
significant	O
change	O
in	O
the	O
mean	O
corpuscular	O
volume	O
(	O
MCV	O
)	O
was	O
measured	O
with	O
the	O
ADVIA	O
120	O
cell	O
counter	O
.	O

Figure	O
4	O

Dark	O
field	O
microscopy	O
of	O
red	O
blood	O
cells	O
from	O
anxA7	O
-	O
/	O
-	O
mutant	O
(	O
B	O
)	O
and	O
wild	O
type	O
mice	O
(	O
A	O
)	O
.	O

The	O
mean	O
cellular	O
diameters	O
are	O
6	O
.	O
0	O
mu	O
m	O
and	O
5	O
.	O
7	O
mu	O
m	O
,	O
respectively	O
.	O

The	O
size	O
differences	O
are	O
statistically	O
significant	O
(	O
p	O
=	O
0	O
.	O
015	O
;	O
n	O
=	O
40	O
)	O
.	O

Bar	O
,	O
3	O
mu	O
m	O
.	O

Shape	O
and	O
MCV	O
of	O
a	O
red	O
blood	O
cell	O
essentially	O
influence	O
its	O
function	O
and	O
capillary	O
passage	O
.	O

The	O
typical	O
biconcave	O
form	O
depends	O
on	O
various	O
influences	O
including	O
the	O
membrane	O
lipid	B-CHEBI
composition	O
and	O
the	O
submembranous	O
cytoskeleton	O
[	O
32	O
]	O
where	O
annexin	O
A7	O
might	O
play	O
a	O
role	O
.	O

The	O
osmotic	O
resistance	O
,	O
which	O
is	O
the	O
resistance	O
towards	O
changes	O
in	O
the	O
extracellular	O
ionic	B-CHEBI
strength	O
,	O
is	O
a	O
convenient	O
assay	O
for	O
analysis	O
of	O
the	O
red	O
blood	O
cell	O
integrity	O
.	O

It	O
is	O
measured	O
as	O
the	O
sodium	B-CHEBI
chloride	I-CHEBI
concentration	O
at	O
which	O
cellular	O
lysis	O
starts	O
(	O
minimal	O
resistance	O
)	O
up	O
to	O
a	O
complete	O
lysis	O
(	O
maximal	O
resistance	O
)	O
of	O
the	O
cells	O
[	O
33	O
]	O
.	O

Osmotic	O
resistance	O
increases	O
with	O
higher	O
MCV	O
,	O
larger	O
surface	O
area	O
and	O
a	O
higher	O
degree	O
of	O
cellular	O
metabolism	O
stabilizing	O
the	O
intracellular	O
ion	B-CHEBI
levels	O
.	O

Aged	O
red	O
blood	O
cells	O
show	O
a	O
lowered	O
MCV	O
and	O
lower	O
osmotic	O
resistance	O
[	O
33	O
]	O
.	O

Similar	O
properties	O
can	O
be	O
observed	O
in	O
red	O
blood	O
cells	O
with	O
lowered	O
membrane	O
permeability	O
.	O

The	O
osmotic	O
resistance	O
of	O
annexin	O
A7	O
deficient	O
red	O
blood	O
cells	O
is	O
significantly	O
increased	O
compared	O
to	O
wild	O
type	O
cells	O
.	O

The	O
minimal	O
resistance	O
value	O
of	O
knock	O
out	O
cells	O
is	O
observed	O
in	O
a	O
0	O
.	O
60	O
%	O
NaCl	B-CHEBI
solution	O
versus	O
0	O
.	O
65	O
%	O
for	O
wild	O
type	O
cells	O
.	O

50	O
%	O
haemolysis	O
is	O
achieved	O
at	O
0	O
.	O
516	O
%	O
NaCl	B-CHEBI
solution	O
for	O
knock	O
out	O
versus	O
0	O
.	O
564	O
%	O
NaCl	B-CHEBI
for	O
wild	O
type	O
cells	O
(	O
mean	O
values	O
,	O
p	O
=	O
0	O
.	O
00066	O
,	O
n	O
=	O
8	O
;	O
Fig	O
.	O
5	O
)	O
.	O

The	O
resistance	O
width	O
of	O
the	O
knock	O
out	O
cells	O
is	O
slightly	O
lower	O
(	O
0	O
.	O
20	O
%	O
instead	O
of	O
0	O
.	O
25	O
%	O
NaCl	B-CHEBI
solution	O
)	O
.	O

We	O
also	O
performed	O
direct	O
measurements	O
of	O
the	O
red	O
blood	O
cell	O
membrane	O
deformability	O
,	O
to	O
further	O
characterize	O
a	O
possible	O
role	O
of	O
annexin	O
A7	O
on	O
the	O
membrane	O
stability	O
.	O

With	O
micropipette	O
experiments	O
we	O
tried	O
to	O
correlate	O
mechanical	O
characteristics	O
of	O
the	O
red	O
blood	O
cells	O
with	O
their	O
morphology	O
.	O

We	O
could	O
not	O
observe	O
any	O
statistically	O
significant	O
difference	O
of	O
values	O
describing	O
membrane	O
rigidity	O
and	O
lysis	O
force	O
in	O
these	O
experiments	O
(	O
M	O
.	O
Heil	O
,	O
B	O
.	O
Hoffmann	O
and	O
R	O
.	O
Merkel	O
,	O
unpublished	O
results	O
)	O
.	O

However	O
,	O
the	O
distinction	O
observed	O
in	O
the	O
osmotic	O
resistance	O
experiments	O
was	O
highly	O
significant	O
and	O
reflects	O
a	O
mean	O
value	O
over	O
a	O
high	O
number	O
of	O
different	O
red	O
blood	O
cells	O
.	O

Figure	O
5	O

Osmotic	O
resistance	O
curves	O
of	O
red	O
blood	O
cells	O
from	O
wild	O
type	O
and	O
anxA7	O
-	O
/	O
-	O
mutant	O
mice	O
.	O

The	O
osmotic	O
resistance	O
towards	O
changes	O
in	O
the	O
extracellular	O
ionic	B-CHEBI
strength	O
is	O
a	O
convenient	O
assay	O
for	O
analysis	O
of	O
the	O
red	O
blood	O
cell	O
integrity	O
.	O

It	O
is	O
measured	O
as	O
a	O
sodium	B-CHEBI
chloride	I-CHEBI
concentration	O
in	O
which	O
cellular	O
lysis	O
starts	O
(	O
minimal	O
resistance	O
)	O
up	O
to	O
a	O
complete	O
lysis	O
(	O
maximal	O
resistance	O
)	O
of	O
a	O
red	O
blood	O
cell	O
.	O

The	O
osmotic	O
resistance	O
of	O
annexin	O
A7	O
deficient	O
red	O
blood	O
cells	O
is	O
significantly	O
increased	O
compared	O
to	O
the	O
one	O
of	O
wild	O
type	O
(	O
p	O
=	O
0	O
.	O
00066	O
;	O
n	O
=	O
8	O
)	O
.	O

These	O
data	O
suggest	O
that	O
annexin	O
A7	O
contributes	O
to	O
the	O
shape	O
of	O
red	O
blood	O
cells	O
and	O
the	O
osmotic	O
resistance	O
.	O

As	O
we	O
have	O
not	O
observed	O
a	O
binding	O
of	O
annexin	O
A7	O
to	O
F	O
-	O
actin	O
(	O
data	O
not	O
shown	O
)	O
it	O
could	O
do	O
so	O
either	O
by	O
alteration	O
of	O
the	O
membrane	O
rigidity	O
and	O
/	O
or	O
by	O
affecting	O
the	O
ion	B-CHEBI
homeostasis	O
.	O

The	O
lack	O
of	O
annexin	O
A7	O
affects	O
primary	O
haemostasis	O
ex	O
vivo	O

The	O
use	O
of	O
an	O
advanced	O
electronic	O
cell	O
counter	O
/	O
flow	O
cytometer	O
(	O
ADVIA	O
120	O
)	O
allowed	O
us	O
to	O
screen	O
other	O
parameters	O
as	O
well	O
despite	O
of	O
the	O
limited	O
murine	O
blood	O
volume	O
.	O

We	O
analysed	O
leukocytes	O
,	O
red	O
blood	O
cells	O
,	O
haemoglobin	B-CHEBI
content	O
,	O
haematocrit	O
,	O
mean	O
cellular	O
volume	O
,	O
mean	O
cellular	O
haemoglobin	B-CHEBI
,	O
mean	O
cellular	O
haemoglobin	B-CHEBI
concentration	O
,	O
platelets	O
,	O
neutrophiles	O
,	O
lymphocytes	O
,	O
monocytes	O
,	O
eosinophiles	O
and	O
basophiles	O
.	O

In	O
these	O
tests	O
of	O
whole	O
blood	O
we	O
found	O
only	O
a	O
change	O
in	O
the	O
platelet	O
numbers	O
,	O
whereas	O
all	O
other	O
haematological	O
parameters	O
were	O
not	O
affected	O
.	O

The	O
mean	O
platelet	O
counts	O
from	O
wild	O
type	O
and	O
anxA7	O
-	O
/	O
-	O
mutant	O
mice	O
are	O
determined	O
as	O
674	O
x	O
103	O
/	O
mu	O
l	O
and	O
774	O
x	O
103	O
/	O
mu	O
l	O
,	O
respectively	O
.	O

The	O
platelet	O
counts	O
in	O
knock	O
out	O
mice	O
are	O
significantly	O
higher	O
(	O
p	O
=	O
0	O
.	O
0275	O
;	O
n	O
knock	O
out	O
=	O
11	O
,	O
n	O
wild	O
type	O
=	O
14	O
)	O
.	O

An	O
increase	O
in	O
platelet	O
counts	O
is	O
a	O
rather	O
uncommon	O
disorder	O
.	O

In	O
humans	O
,	O
platelet	O
counts	O
normally	O
increase	O
only	O
transiently	O
as	O
in	O
reactive	O
thrombocytosis	O
and	O
under	O
postoperative	O
conditions	O
or	O
are	O
largely	O
increased	O
in	O
neoplastic	O
diseases	O
.	O

By	O
contrast	O
,	O
the	O
anxA7	O
-	O
/	O
-	O
mice	O
are	O
healthy	O
and	O
viable	O
.	O

Therefore	O
we	O
tested	O
the	O
platelet	O
function	O
and	O
performed	O
aggregometry	O
measurements	O
with	O
platelet	O
rich	O
plasma	O
.	O

Platelet	O
activation	O
is	O
observed	O
as	O
a	O
morphological	O
change	O
from	O
the	O
resting	O
discoid	O
state	O
to	O
activated	O
spherical	O
cells	O
with	O
pseudopods	O
.	O

The	O
morphological	O
changes	O
are	O
due	O
to	O
cytoskeletal	O
rearrangements	O
.	O

In	O
vitro	O
the	O
activated	O
cells	O
form	O
aggregates	O
recruiting	O
additional	O
cells	O
in	O
the	O
solution	O
thereby	O
reducing	O
its	O
cloudiness	O
.	O

Analysis	O
of	O
the	O
transmission	O
values	O
of	O
aggregation	O
curves	O
after	O
platelet	O
activation	O
by	O
ristocetin	O
addition	O
(	O
von	O
Willebrand	O
cofactor	B-CHEBI
)	O
showed	O
that	O
both	O
curves	O
differed	O
significantly	O
at	O
the	O
time	O
point	O
of	O
seven	O
seconds	O
after	O
platelet	O
initiation	O
(	O
p	O
=	O
0	O
.	O
0287	O
,	O
n	O
knock	O
out	O
=	O
16	O
,	O
n	O
wild	O
type	O
=	O
15	O
;	O
Fig	O
.	O
6	O
)	O
.	O

Annexin	O
A7	O
deficient	O
platelets	O
showed	O
a	O
slightly	O
lowered	O
aggregation	O
velocity	O
.	O

When	O
we	O
compared	O
the	O
aggregation	O
curves	O
of	O
human	O
platelets	O
from	O
a	O
healthy	O
donor	O
with	O
the	O
ones	O
obtained	O
from	O
an	O
individual	O
with	O
a	O
von	O
Willebrand	O
factor	O
type	O
1	O
defect	O
,	O
we	O
found	O
that	O
the	O
difference	O
in	O
the	O
curves	O
was	O
much	O
more	O
pronounced	O
as	O
observed	O
in	O
our	O
studies	O
of	O
healthy	O
mouse	O
platelets	O
and	O
anxA7	O
-	O
/	O
-	O
platelets	O
.	O

Furthermore	O
we	O
found	O
that	O
murine	O
platelets	O
responded	O
immediately	O
to	O
the	O
initiating	O
chemical	B-CHEBI
whereas	O
human	O
platelets	O
have	O
a	O
lag	O
phase	O
[	O
23	O
]	O
.	O

Figure	O
6	O

Platelet	O
aggregation	O
curves	O
from	O
platelet	O
rich	O
plasma	O
of	O
annexin	O
A7	O
knock	O
out	O
and	O
wild	O
type	O
mice	O
.	O

The	O
transmission	O
values	O
were	O
measured	O
with	O
an	O
APACT	O
photometer	O
and	O
aggregation	O
was	O
initiated	O
by	O
adding	O
ristocetin	O
.	O

The	O
first	O
thirty	O
seconds	O
are	O
given	O
.	O

Constant	O
platelet	O
counts	O
were	O
used	O
throughout	O
all	O
experiments	O
.	O

The	O
aggregation	O
curve	O
data	O
were	O
analysed	O
for	O
slope	O
values	O
,	O
the	O
maximal	O
aggregation	O
amplitude	O
of	O
every	O
single	O
curve	O
was	O
set	O
to	O
100	O
%	O
.	O

Both	O
murine	O
curves	O
differ	O
significantly	O
at	O
a	O
time	O
point	O
of	O
seven	O
seconds	O
after	O
platelet	O
initiation	O
,	O
the	O
mutant	O
shows	O
a	O
slightly	O
lower	O
aggregation	O
velocity	O
(	O
p	O
=	O
0	O
.	O
0287	O
,	O
n	O
knock	O
out	O
=	O
16	O
,	O
n	O
wild	O
type	O
=	O
15	O
,	O
mean	O
knock	O
out	O
=	O
67	O
.	O
7	O
%	O
transmission	O
,	O
mean	O
wild	O
type	O
=	O
77	O
.	O
1	O
%	O
transmission	O
,	O
standard	O
error	O
knock	O
out	O
=	O
8	O
.	O
3	O
%	O
transmission	O
,	O
standard	O
error	O
wild	O
type	O
=	O
13	O
.	O
8	O
%	O
transmission	O
)	O
.	O

Murine	O
platelets	O
react	O
immediately	O
to	O
the	O
initiating	O
chemical	B-CHEBI
and	O
show	O
no	O
lag	O
phase	O
like	O
the	O
normal	O
human	O
platelets	O
.	O

For	O
comparison	O
of	O
the	O
range	O
of	O
the	O
platelet	O
impairment	O
slightly	O
affected	O
human	O
platelets	O
are	O
shown	O
as	O
well	O
(	O
von	O
Willebrand	O
syndrome	O
)	O
.	O

Discussion	O

Annexin	O
A7	O
is	O
thought	O
to	O
have	O
a	O
role	O
in	O
vesicle	O
fusion	O
and	O
in	O
regulating	O
and	O
stabilizing	O
membrane	O
domains	O
[	O
1	O
]	O
.	O

The	O
protein	B-CHEBI
has	O
been	O
localized	O
to	O
the	O
plasma	O
membrane	O
including	O
raft	O
subdomains	O
,	O
furthermore	O
it	O
is	O
present	O
in	O
the	O
cytosol	O
where	O
it	O
is	O
found	O
on	O
subcellular	O
vesicle	O
-	O
like	O
structures	O
.	O

This	O
distribution	O
appears	O
to	O
be	O
independent	O
of	O
the	O
tissue	O
or	O
cell	O
type	O
analysed	O
.	O

In	O
specialized	O
or	O
terminally	O
differentiated	O
cells	O
,	O
expression	O
levels	O
increase	O
and	O
frequently	O
the	O
larger	O
of	O
the	O
two	O
isoforms	O
is	O
being	O
expressed	O
[	O
6	O
,	O
34	O
,	O
35	O
]	O
.	O

Red	O
blood	O
cells	O
,	O
which	O
were	O
thought	O
to	O
be	O
devoid	O
of	O
annexin	O
A7	O
,	O
were	O
recently	O
shown	O
to	O
harbor	O
the	O
47	O
kDa	O
isoform	O
together	O
with	O
its	O
binding	O
partner	O
sorcin	O
[	O
7	O
]	O
.	O

We	O
showed	O
the	O
presence	O
of	O
the	O
51	O
kDa	O
isoform	O
as	O
well	O
,	O
adding	O
red	O
blood	O
cells	O
to	O
the	O
list	O
of	O
cells	O
that	O
harbor	O
this	O
isoform	O
.	O

Salzer	O
et	O
al	O
.	O

[	O
7	O
]	O
not	O
only	O
demonstrated	O
the	O
presence	O
of	O
annexin	O
A7	O
in	O
red	O
blood	O
cells	O
,	O
they	O
also	O
showed	O
that	O
annexin	O
A7	O
and	O
sorcin	O
were	O
enriched	O
in	O
membrane	O
raft	O
domains	O
of	O
nanovesicles	O
formed	O
from	O
red	O
blood	O
cells	O
in	O
vitro	O
.	O

Raft	O
domains	O
in	O
general	O
are	O
considered	O
key	O
players	O
in	O
membrane	O
organization	O
and	O
in	O
mediating	O
the	O
vesiculation	O
process	O
.	O

They	O
result	O
from	O
the	O
clustering	O
of	O
sphingolipids	B-CHEBI
and	O
cholesterol	B-CHEBI
in	O
the	O
outer	O
leaflet	O
of	O
the	O
membrane	O
connected	O
to	O
phospholipids	B-CHEBI
and	O
cholesterol	B-CHEBI
in	O
the	O
inner	O
leaflet	O
and	O
are	O
enriched	O
in	O
special	O
proteins	B-CHEBI
.	O

Biochemically	O
rafts	O
are	O
defined	O
as	O
membranes	O
that	O
are	O
resistant	O
to	O
extraction	O
by	O
cold	O
Triton	O
X	O
-	O
100	O
and	O
can	O
be	O
floated	O
to	O
low	O
densities	O
in	O
sucrose	B-CHEBI
gradient	O
centrifugation	O
[	O
36	O
]	O
.	O

The	O
findings	O
of	O
Caohuy	O
et	O
al	O
.	O

[	O
37	O
]	O
that	O
annexin	O
A7	O
mediates	O
membrane	O
aggregation	O
also	O
suggested	O
that	O
annexin	O
A7	O
is	O
an	O
essential	O
component	O
during	O
vesiculation	O
.	O

In	O
addition	O
they	O
reported	O
a	O
further	O
activation	O
of	O
the	O
vesiculation	O
process	O
by	O
GTP	B-CHEBI
and	O
proposed	O
that	O
annexin	O
A7	O
acts	O
as	O
a	O
GTPase	O
.	O

Similarly	O
,	O
the	O
presence	O
of	O
GTP	B-CHEBI
enhanced	O
the	O
secretion	O
of	O
surfactant	B-CHEBI
by	O
annexin	O
A7	O
.	O

These	O
results	O
were	O
thought	O
to	O
support	O
a	O
direct	O
role	O
for	O
annexin	O
A7	O
in	O
surfactant	O
secretion	O
,	O
but	O
in	O
these	O
studies	O
annexin	O
A7	O
mediated	O
membrane	O
fusion	O
was	O
separated	O
from	O
a	O
second	O
GTP	B-CHEBI
-	O
dependent	O
mechanism	O
[	O
38	O
]	O
.	O

Having	O
an	O
annexin	O
A7	O
knockout	O
mouse	O
we	O
tested	O
the	O
involvement	O
of	O
annexin	O
A7	O
in	O
budding	O
of	O
red	O
blood	O
cell	O
vesicles	O
.	O

Our	O
data	O
suggest	O
that	O
the	O
efficiency	O
of	O
micro	O
-	O
and	O
nanovesicle	O
formation	O
is	O
not	O
significantly	O
different	O
in	O
wild	O
type	O
and	O
mutant	O
red	O
blood	O
cells	O
.	O

Likewise	O
,	O
Dictyostelium	O
discoideum	O
cells	O
,	O
in	O
which	O
the	O
single	O
annexin	O
gene	O
was	O
inactivated	O
,	O
were	O
not	O
impaired	O
in	O
processes	O
requiring	O
membrane	O
fusion	O
[	O
[	O
39	O
]	O
;	O
and	O
data	O
unpublished	O
]	O
.	O

It	O
might	O
well	O
be	O
that	O
the	O
observed	O
fusion	O
of	O
phospholipid	B-CHEBI
layers	O
by	O
annexin	O
A7	O
in	O
the	O
presence	O
of	O
high	O
Ca2	B-CHEBI
+	I-CHEBI
concentrations	O
may	O
turn	O
out	O
to	O
be	O
an	O
in	O
vitro	O
effect	O
.	O

Similarly	O
,	O
the	O
high	O
abundance	O
of	O
annexin	O
A7	O
in	O
micro	O
-	O
and	O
nanovesicles	O
might	O
be	O
fortuitous	O
as	O
a	O
significant	O
percentage	O
of	O
the	O
red	O
blood	O
cell	O
membrane	O
,	O
with	O
which	O
annexin	O
A7	O
associates	O
when	O
the	O
Ca2	B-CHEBI
+	I-CHEBI
levels	O
rise	O
,	O
appears	O
to	O
be	O
involved	O
in	O
the	O
formation	O
of	O
exovesicles	O
.	O

Furthermore	O
,	O
the	O
distribution	O
of	O
both	O
annexin	O
A7	O
isoforms	O
in	O
gradients	O
of	O
red	O
blood	O
cells	O
indicates	O
a	O
function	O
which	O
differs	O
from	O
organizing	O
subcellular	O
membranes	O
or	O
membrane	O
pathways	O
.	O

Whereas	O
annexin	O
A2	O
is	O
tightly	O
associated	O
with	O
endosomes	O
and	O
may	O
have	O
functions	O
in	O
membrane	O
fusion	O
and	O
the	O
endosomal	O
pathway	O
,	O
annexin	O
A7	O
distributes	O
with	O
plasma	O
membrane	O
raft	O
domains	O
of	O
different	O
types	O
and	O
densities	O
.	O

Interestingly	O
,	O
in	O
vesicles	O
of	O
red	O
blood	O
cells	O
lacking	O
annexin	O
A7	O
the	O
amount	O
of	O
sorcin	O
is	O
lowered	O
,	O
indicating	O
that	O
its	O
localisation	O
is	O
affected	O
by	O
the	O
loss	O
of	O
annexin	O
A7	O
or	O
its	O
expression	O
during	O
red	O
blood	O
cell	O
development	O
was	O
reduced	O
.	O

Having	O
excluded	O
a	O
direct	O
role	O
in	O
vesicle	O
formation	O
and	O
membrane	O
fusion	O
,	O
annexin	O
A7	O
might	O
act	O
by	O
its	O
property	O
as	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
binding	O
protein	B-CHEBI
[	O
17	O
]	O
.	O

Previous	O
results	O
in	O
which	O
annexin	O
A7	O
was	O
shown	O
to	O
play	O
a	O
role	O
in	O
membrane	O
aggregation	O
might	O
be	O
explained	O
by	O
a	O
supportive	O
function	O
of	O
annexin	O
A7	O
in	O
that	O
it	O
interferes	O
with	O
the	O
local	O
Ca2	B-CHEBI
+	I-CHEBI
homeostasis	O
thus	O
influencing	O
membrane	O
organization	O
.	O

As	O
the	O
annexins	O
belong	O
to	O
a	O
wide	O
spread	O
and	O
evolutionarily	O
conserved	O
protein	B-CHEBI
family	O
,	O
redundant	O
,	O
but	O
not	O
identical	O
functions	O
are	O
expected	O
.	O

However	O
,	O
so	O
far	O
no	O
other	O
members	O
of	O
the	O
annexin	O
family	O
,	O
which	O
may	O
substitute	O
for	O
annexin	O
A7	O
,	O
have	O
been	O
described	O
in	O
red	O
blood	O
cells	O
.	O

The	O
structural	O
basis	O
for	O
the	O
elasticy	O
of	O
red	O
blood	O
cells	O
in	O
circulation	O
are	O
long	O
range	O
molecular	B-CHEBI
functions	O
of	O
the	O
plasma	O
membrane	O
and	O
the	O
membrane	O
associated	O
part	O
of	O
the	O
cytoskeleton	O
[	O
40	O
-	O
43	O
]	O
.	O

Major	O
constituents	O
of	O
the	O
membrane	O
skeleton	O
are	O
spectrin	O
tetramers	O
linked	O
together	O
by	O
short	O
actin	O
filaments	O
and	O
several	O
other	O
proteins	B-CHEBI
covering	O
the	O
entire	O
cytoplasmic	O
surface	O
of	O
the	O
red	O
blood	O
cell	O
membrane	O
[	O
44	O
]	O
.	O

Membrane	O
cholesterol	B-CHEBI
diminishes	O
red	O
blood	O
cell	O
haemolysis	O
by	O
the	O
complement	O
complex	O
,	O
whereas	O
depletion	O
of	O
raft	O
cholesterol	B-CHEBI
abrogates	O
association	O
of	O
all	O
raft	O
proteins	B-CHEBI
with	O
no	O
significant	O
effect	O
on	O
areas	O
in	O
the	O
rest	O
of	O
the	O
cell	O
membrane	O
and	O
deformability	O
[	O
45	O
,	O
46	O
]	O
.	O

Annexin	O
A7	O
knock	O
out	O
mouse	O
red	O
blood	O
cells	O
show	O
a	O
more	O
flat	O
shape	O
and	O
have	O
a	O
higher	O
osmotic	O
resistance	O
.	O

The	O
presence	O
of	O
annexin	O
A7	O
may	O
alter	O
the	O
membrane	O
flexibility	O
in	O
that	O
it	O
supports	O
the	O
typical	O
biconcave	O
membrane	O
shape	O
and	O
leads	O
to	O
a	O
lower	O
minimal	O
osmotic	O
resistance	O
.	O

Annexin	O
A7	O
does	O
not	O
appear	O
to	O
have	O
an	O
influence	O
on	O
plasma	O
membrane	O
integrity	O
itself	O
as	O
the	O
maximal	O
osmotic	O
resistance	O
value	O
stays	O
constant	O
.	O

Ca2	B-CHEBI
+	I-CHEBI
and	O
membrane	O
skeletal	O
proteins	B-CHEBI
are	O
known	O
to	O
play	O
key	O
roles	O
on	O
the	O
red	O
blood	O
cell	O
membrane	O
shape	O
and	O
stability	O
[	O
47	O
]	O
.	O

Annexins	O
have	O
been	O
reported	O
to	O
bind	O
directly	O
to	O
F	O
-	O
actin	O
,	O
we	O
could	O
however	O
exclude	O
such	O
an	O
activity	O
for	O
annexin	O
A7	O
.	O

Nevertheless	O
it	O
might	O
interact	O
with	O
other	O
components	O
and	O
have	O
a	O
role	O
in	O
organizing	O
the	O
membrane	O
cytoskeleton	O
,	O
controlling	O
raft	O
protein	B-CHEBI
associations	O
or	O
influencing	O
the	O
ionic	B-CHEBI
strength	O
of	O
red	O
blood	O
cells	O
on	O
its	O
own	O
or	O
by	O
interfering	O
with	O
other	O
signaling	O
pathways	O
.	O

As	O
discussed	O
above	O
annexin	O
A7	O
could	O
be	O
involved	O
in	O
the	O
cytoplasmic	O
Ca2	B-CHEBI
+	I-CHEBI
homeostasis	O
.	O

It	O
has	O
been	O
demonstrated	O
that	O
micromolar	O
changes	O
of	O
the	O
intracellular	O
Ca2	B-CHEBI
+	I-CHEBI
concentration	O
exert	O
a	O
profound	O
effect	O
on	O
the	O
membrane	O
properties	O
that	O
regulate	O
red	O
blood	O
cell	O
deformability	O
[	O
48	O
,	O
49	O
]	O
.	O

Furthermore	O
,	O
the	O
intracellular	O
Ca2	B-CHEBI
+	I-CHEBI
was	O
shown	O
to	O
regulate	O
the	O
membrane	O
stability	O
through	O
modulation	O
of	O
cytoskeletal	O
protein	B-CHEBI
interactions	O
[	O
50	O
]	O
.	O

Ca2	B-CHEBI
+	I-CHEBI
also	O
induces	O
a	O
transbilayer	O
phospholipid	B-CHEBI
redistribution	O
inducing	O
a	O
shape	O
change	O
of	O
red	O
blood	O
cells	O
[	O
51	O
]	O
.	O

In	O
addition	O
,	O
Ca2	B-CHEBI
+	I-CHEBI
ions	I-CHEBI
can	O
drive	O
spiculation	O
of	O
the	O
membrane	O
bilayer	O
without	O
involving	O
the	O
cytoskeleton	O
[	O
52	O
]	O
.	O

We	O
have	O
also	O
observed	O
a	O
defect	O
in	O
platelet	O
function	O
in	O
the	O
annexin	O
A7	O
mutant	O
.	O

In	O
the	O
platelet	O
aggregation	O
experiments	O
the	O
initial	O
aggregation	O
velocity	O
was	O
slightly	O
,	O
but	O
significantly	O
lower	O
in	O
platelets	O
lacking	O
annexin	O
A7	O
.	O

These	O
data	O
are	O
not	O
reflected	O
by	O
a	O
change	O
in	O
the	O
in	O
vivo	O
bleeding	O
time	O
.	O

However	O
the	O
reaction	O
speed	O
of	O
murine	O
platelets	O
is	O
much	O
higher	O
than	O
those	O
of	O
human	O
and	O
due	O
to	O
the	O
technical	O
setup	O
we	O
might	O
have	O
missed	O
larger	O
changes	O
in	O
the	O
mouse	O
samples	O
.	O

The	O
immediate	O
reaction	O
of	O
mouse	O
platelets	O
and	O
the	O
absence	O
of	O
a	O
lag	O
phase	O
after	O
triggering	O
may	O
be	O
caused	O
by	O
an	O
immediately	O
initiated	O
thrombin	O
generation	O
[	O
22	O
]	O
.	O

As	O
known	O
from	O
the	O
frequent	O
human	O
vWF	O
-	O
syndrome	O
or	O
other	O
haemostatic	O
diseases	O
,	O
small	O
defects	O
often	O
are	O
clinically	O
silent	O
and	O
do	O
not	O
result	O
in	O
physiological	O
changes	O
under	O
normal	O
conditions	O
.	O

Only	O
in	O
situations	O
with	O
severe	O
physical	O
injury	O
,	O
distinct	O
environmental	O
influences	O
or	O
additional	O
platelet	O
attributes	O
like	O
the	O
platelet	O
antigen	O
polymorphism	O
[	O
53	O
]	O
differences	O
might	O
become	O
apparent	O
.	O

Conclusions	O

In	O
this	O
paper	O
we	O
report	O
the	O
presence	O
of	O
both	O
annexin	O
A7	O
isoforms	O
in	O
red	O
blood	O
cells	O
where	O
they	O
are	O
abundant	O
in	O
nanovesicles	O
that	O
form	O
upon	O
Ca2	B-CHEBI
+	I-CHEBI
addition	O
.	O

The	O
proteins	B-CHEBI
are	O
however	O
not	O
required	O
for	O
the	O
vesiculation	O
process	O
.	O

They	O
are	O
also	O
not	O
essential	O
for	O
the	O
formation	O
of	O
specific	O
membrane	O
domains	O
such	O
as	O
lipid	B-CHEBI
rafts	O
,	O
as	O
exogenously	O
added	O
recombinant	O
annexin	O
A7	O
redistributed	O
to	O
similar	O
positions	O
in	O
a	O
density	O
gradient	O
containing	O
membranes	O
derived	O
from	O
red	O
blood	O
cells	O
of	O
anxA7	O
-	O
/	O
-	O
mice	O
.	O

The	O
observed	O
cell	O
shape	O
change	O
of	O
erythrocytes	O
lacking	O
annexin	O
A7	O
might	O
be	O
due	O
to	O
alterations	O
in	O
the	O
erythrocyte	O
cytoskeleton	O
.	O

As	O
a	O
direct	O
interaction	O
with	O
F	O
-	O
actin	O
was	O
ruled	O
out	O
,	O
this	O
effect	O
might	O
be	O
mediated	O
by	O
annexin	O
'	O
s	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
binding	O
activity	O
.	O

Methods	O

Acquisition	O
of	O
murine	O
and	O
human	O
blood	O
samples	O

Blood	O
from	O
129Sv	O
wild	O
type	O
and	O
annexin	O
A7	O
knock	O
out	O
mice	O
(	O
anxA7	O
-	O
/	O
-	O
)	O
kept	O
under	O
pathogen	O
-	O
free	O
conditions	O
and	O
fed	O
with	O
regular	O
food	B-CHEBI
,	O
was	O
collected	O
in	O
1	O
ml	O
syringes	O
with	O
a	O
22	O
gauge	O
needle	O
punctating	O
the	O
right	O
cardiac	O
ventricle	O
immediately	O
after	O
they	O
had	O
been	O
killed	O
by	O
cervical	O
dislocation	O
.	O

Coagulation	O
generally	O
was	O
inhibited	O
with	O
1	O
/	O
10	O
volume	O
of	O
10	O
mM	O
NaEDTA	O
,	O
pH	O
7	O
.	O
5	O
,	O
already	O
present	O
in	O
the	O
syringe	O
.	O

The	O
mice	O
were	O
killed	O
by	O
cervical	O
dislocation	O
in	O
order	O
to	O
avoid	O
any	O
effect	O
of	O
anaesthetic	B-CHEBI
chemicals	I-CHEBI
on	O
blood	O
parameters	O
.	O

The	O
wild	O
type	O
and	O
mutant	O
mice	O
were	O
matched	O
regarding	O
their	O
age	O
,	O
weight	O
and	O
sex	O
.	O

The	O
daytime	O
of	O
blood	O
collection	O
,	O
sampling	O
site	O
and	O
collection	O
method	O
were	O
kept	O
constant	O
during	O
all	O
experiments	O
.	O

A	O
typical	O
murine	O
blood	O
sample	O
volume	O
consisted	O
of	O
550	O
mu	O
l	O
,	O
with	O
variations	O
ranging	O
from	O
200	O
mu	O
l	O
to	O
900	O
mu	O
l	O
.	O

Human	O
blood	O
samples	O
from	O
the	O
authors	O
were	O
collected	O
by	O
vein	O
puncture	O
using	O
common	O
EDTA	B-CHEBI
-	O
monovettes	O
(	O
Sarstedt	O
)	O
.	O

We	O
performed	O
our	O
studies	O
using	O
well	O
standardized	O
sampling	O
conditions	O
,	O
as	O
differences	O
in	O
the	O
blood	O
sampling	O
site	O
,	O
for	O
example	O
between	O
tail	O
and	O
heart	O
,	O
show	O
large	O
changes	O
in	O
all	O
cell	O
type	O
counts	O
.	O

First	O
and	O
second	O
sample	O
draw	O
affect	O
blood	O
measurements	O
,	O
too	O
[	O
22	O
]	O
.	O

Also	O
the	O
genetic	O
background	O
in	O
common	O
laboratory	O
and	O
transgenic	O
mice	O
affects	O
the	O
phenotype	O
.	O

A	O
change	O
from	O
one	O
strain	O
to	O
another	O
may	O
protect	O
mice	O
from	O
effects	O
of	O
the	O
primarily	O
induced	O
genetic	O
defect	O
.	O

For	O
example	O
,	O
BALB	O
/	O
c	O
mice	O
have	O
a	O
significantly	O
increased	O
velocity	O
of	O
platelet	O
aggregation	O
as	O
compared	O
to	O
129Sv	O
mice	O
,	O
which	O
were	O
used	O
throughout	O
this	O
study	O
[	O
23	O
]	O
.	O

Self	O
forming	O
iodixanol	O
density	O
gradients	O
of	O
human	O
red	O
blood	O
cells	O

The	O
subcellular	O
distribution	O
of	O
annexin	O
A7	O
was	O
addressed	O
according	O
to	O
[	O
24	O
]	O
.	O

Red	O
blood	O
cells	O
were	O
centrifuged	O
and	O
washed	O
in	O
isotonic	O
buffered	B-CHEBI
salt	B-CHEBI
solution	O
,	O
collected	O
in	O
ice	O
cold	O
lysis	O
buffer	O
(	O
20	O
mM	O
Hepes	B-CHEBI
,	O
pH	O
7	O
.	O
4	O
,	O
200	O
mu	O
M	O
CaCl2	B-CHEBI
,	O
0	O
.	O
25	O
M	O
sucrose	B-CHEBI
,	O
and	O
proteinase	B-CHEBI
inhibitors	I-CHEBI
(	O
Roche	O
)	O
)	O
,	O
homogenized	O
by	O
a	O
loosely	O
fitting	O
dounce	O
homogenizer	O
and	O
additional	O
passages	O
through	O
a	O
22	O
gauge	O
needle	O
.	O

A	O
50	O
%	O
iodixanol	O
solution	O
was	O
established	O
by	O
mixing	O
Optiprep	O
solution	O
(	O
60	O
%	O
iodixanol	O
;	O
Sigma	O
)	O
with	O
buffer	O
(	O
120	O
mM	O
Hepes	B-CHEBI
,	O
pH	O
7	O
.	O
4	O
,	O
1	O
.	O
2	O
mM	O
CaCl2	B-CHEBI
,	O
0	O
.	O
25	O
M	O
sucrose	B-CHEBI
)	O
.	O

Seven	O
parts	O
of	O
this	O
50	O
%	O
iodixanol	O
solution	O
were	O
mixed	O
with	O
thirteen	O
parts	O
of	O
the	O
red	O
blood	O
cell	O
solution	O
,	O
generating	O
a	O
gradient	O
solution	O
containing	O
17	O
.	O
5	O
%	O
iodixanol	O
.	O

The	O
mixture	O
was	O
filled	O
into	O
a	O
centrifuge	O
tube	O
underlayed	O
by	O
cushions	O
of	O
30	O
%	O
and	O
35	O
%	O
iodixanol	O
and	O
centrifuged	O
for	O
3	O
hours	O
at	O
270	O
,	O
000	O
x	O
g	O
in	O
a	O
SW41	O
Ti	O
swing	O
out	O
rotor	O
(	O
Beckman	O
)	O
to	O
achieve	O
a	O
nearly	O
linear	O
density	O
gradient	O
(	O
approximately	O
1	O
.	O
06	O
g	O
/	O
ml	O
to	O
1	O
.	O
20	O
g	O
/	O
ml	O
)	O
[	O
24	O
]	O
.	O

Fractions	O
of	O
0	O
.	O
6	O
ml	O
were	O
collected	O
from	O
the	O
top	O
of	O
the	O
gradient	O
by	O
a	O
1	O
ml	O
syringe	O
without	O
using	O
a	O
needle	O
and	O
immediately	O
frozen	O
in	O
liquid	O
nitrogen	B-CHEBI
for	O
further	O
use	O
.	O

Exovesicle	O
generation	O
from	O
human	O
and	O
murine	O
red	O
blood	O
cells	O

Red	O
blood	O
cells	O
naturally	O
can	O
form	O
hemoglobin	B-CHEBI
containing	O
exovesicles	O
.	O

In	O
vitro	O
these	O
vesicle	O
formation	O
is	O
Ca2	B-CHEBI
+	I-CHEBI
induced	O
.	O

Freshly	O
collected	O
lithium	B-CHEBI
-	O
heparin	B-CHEBI
anticoagulated	O
blood	O
samples	O
were	O
centrifuged	O
for	O
5	O
minutes	O
at	O
400	O
x	O
g	O
and	O
4	O
degrees	O
C	O
.	O

The	O
erythrocytes	O
were	O
washed	O
five	O
times	O
with	O
20	O
mM	O
Hepes	B-CHEBI
,	O
pH	O
7	O
.	O
5	O
,	O
and	O
150	O
mM	O
NaCl	B-CHEBI
(	O
washing	O
buffer	O
)	O
.	O

A	O
volume	O
of	O
500	O
mu	O
l	O
washed	O
red	O
blood	O
cells	O
were	O
combined	O
with	O
3	O
ml	O
of	O
vesiculation	O
buffer	O
(	O
20	O
mM	O
Hepes	B-CHEBI
,	O
pH	O
7	O
.	O
5	O
,	O
150	O
mM	O
NaCl	B-CHEBI
,	O
1	O
mM	O
CaCl2	B-CHEBI
adjusted	O
to	O
5	O
mu	O
M	O
Ca2	B-CHEBI
+	I-CHEBI
ionophore	B-CHEBI
A23187	O
)	O
and	O
incubated	O
for	O
30	O
minutes	O
at	O
37	O
degrees	O
C	O
.	O

After	O
incubation	O
EDTA	B-CHEBI
was	O
added	O
to	O
the	O
solution	O
to	O
a	O
final	O
concentration	O
of	O
5	O
mM	O
and	O
centrifuged	O
for	O
5	O
minutes	O
at	O
400	O
x	O
g	O
and	O
4	O
degrees	O
C	O
.	O

The	O
supernatant	O
was	O
collected	O
and	O
centrifuged	O
for	O
20	O
minutes	O
at	O
15	O
,	O
000	O
x	O
g	O
and	O
4	O
degrees	O
C	O
.	O

The	O
resulting	O
pellet	O
was	O
resuspended	O
in	O
washing	O
buffer	O
and	O
centrifuged	O
at	O
400	O
x	O
g	O
again	O
to	O
collect	O
a	O
supernatant	O
enriched	O
with	O
red	O
blood	O
cell	O
microvesicles	O
.	O

The	O
supernatant	O
of	O
the	O
15	O
,	O
000	O
x	O
g	O
step	O
was	O
further	O
centrifuged	O
for	O
60	O
minutes	O
at	O
100	O
,	O
000	O
x	O
g	O
and	O
4	O
degrees	O
C	O
.	O

The	O
final	O
pellet	O
of	O
this	O
step	O
was	O
resuspended	O
in	O
washing	O
buffer	O
and	O
centrifuged	O
at	O
15	O
,	O
000	O
x	O
g	O
again	O
to	O
purify	O
a	O
supernatant	O
enriched	O
in	O
nanovesicles	O
according	O
to	O
[	O
7	O
,	O
20	O
]	O
.	O

The	O
vesicles	O
were	O
assayed	O
for	O
acetylcholine	B-CHEBI
esterase	O
activity	O
and	O
used	O
for	O
further	O
analysis	O
.	O

Acetylcholine	B-CHEBI
esterase	O
assay	O

A	O
30	O
mu	O
l	O
sample	O
of	O
red	O
blood	O
cell	O
vesicles	O
was	O
mixed	O
with	O
an	O
equal	O
volume	O
of	O
buffer	O
(	O
20	O
mM	O
Hepes	B-CHEBI
,	O
pH	O
7	O
.	O
6	O
,	O
150	O
mM	O
NaCl	B-CHEBI
,	O
0	O
.	O
5	O
%	O
Triton	O
X	O
-	O
100	O
)	O
,	O
vortexed	O
and	O
incubated	O
for	O
5	O
minutes	O
at	O
37	O
degrees	O
C	O
.	O

Subsequently	O
640	O
mu	O
l	O
sodium	B-CHEBI
phosphate	I-CHEBI
buffer	O
(	O
100	O
mM	O
Na2PO4	O
,	O
pH	O
7	O
.	O
6	O
)	O
,	O
50	O
mu	O
l	O
DTNB	O
(	O
5	O
,	O
5	O
'	O
-	O
dithiobis	O
-	O
(	O
2	O
-	O
nitrobenzoic	O
acid	O
)	O
,	O
10	O
mM	O
in	O
sodium	B-CHEBI
phosphate	I-CHEBI
buffer	O
)	O
,	O
and	O
50	O
mu	O
l	O
acetylthiocholine	O
chloride	B-CHEBI
(	O
12	O
,	O
5	O
mM	O
in	O
H2O	B-CHEBI
)	O
were	O
added	O
.	O

The	O
reaction	O
took	O
place	O
at	O
room	O
temperature	O
and	O
was	O
measured	O
photometrically	O
at	O
a	O
wavelength	O
of	O
405	O
nm	O
according	O
to	O
the	O
Ellmann	O
'	O
method	O
[	O
25	O
]	O
.	O

Determination	O
of	O
the	O
osmotic	O
resistance	O
of	O
red	O
blood	O
cells	O

A	O
Na2HPO4	B-CHEBI
/	O
NaH2PO4	B-CHEBI
buffered	B-CHEBI
NaCl	B-CHEBI
gradient	O
(	O
pH	O
7	O
.	O
4	O
)	O
comprised	O
of	O
the	O
following	O
NaCl	B-CHEBI
steps	O
was	O
used	O
for	O
this	O
assay	O
:	O
0	O
.	O
90	O
%	O
,	O
0	O
.	O
65	O
%	O
,	O
0	O
.	O
60	O
%	O
,	O
0	O
.	O
55	O
%	O
,	O
0	O
.	O
50	O
%	O
,	O
0	O
.	O
45	O
%	O
,	O
0	O
.	O
40	O
%	O
,	O
0	O
.	O
35	O
%	O
,	O
0	O
.	O
30	O
%	O
,	O
0	O
.	O
10	O
%	O
.	O

For	O
each	O
step	O
5	O
ml	O
of	O
the	O
gradient	O
step	O
solution	O
and	O
50	O
mu	O
l	O
blood	O
sample	O
were	O
carefully	O
inverted	O
four	O
times	O
and	O
incubated	O
for	O
30	O
minutes	O
in	O
the	O
dark	O
.	O

Samples	O
were	O
carefully	O
inverted	O
again	O
and	O
centrifuged	O
at	O
1	O
,	O
500	O
x	O
g	O
for	O
10	O
minutes	O
.	O

From	O
1	O
ml	O
supernatant	O
of	O
each	O
step	O
the	O
extinction	O
at	O
546	O
nm	O
wavelength	O
was	O
measured	O
.	O

The	O
experiment	O
was	O
performed	O
at	O
room	O
temperature	O
.	O

Platelet	O
aggregation	O
assay	O

Approximately	O
500	O
mu	O
l	O
of	O
murine	O
blood	O
were	O
centrifuged	O
at	O
200	O
x	O
g	O
for	O
15	O
minutes	O
.	O

The	O
resulting	O
supernatants	O
were	O
transferred	O
to	O
new	O
tubes	O
and	O
used	O
as	O
platelet	O
rich	O
plasma	O
(	O
PRP	O
)	O
.	O

The	O
platelet	O
aggregation	O
measurements	O
were	O
done	O
according	O
to	O
the	O
method	O
developed	O
by	O
Born	O
and	O
Cross	O
[	O
26	O
]	O
using	O
an	O
APACT	O
photometer	O
(	O
Labor	O
,	O
Ahrendsburg	O
,	O
FRG	O
)	O
and	O
the	O
APACT	O
software	O
(	O
APACT	O
1	O
.	O
4	O
)	O
.	O

Subsequently	O
samples	O
of	O
the	O
PRP	O
were	O
adjusted	O
with	O
buffer	O
(	O
5	O
mM	O
Hepes	B-CHEBI
,	O
150	O
mM	O
NaCl	B-CHEBI
,	O
pH	O
7	O
.	O
3	O
)	O
to	O
250	O
,	O
000	O
platelets	O
/	O
mu	O
l	O
.	O

A	O
constant	O
platelet	O
count	O
was	O
used	O
throughout	O
allowing	O
comparisons	O
between	O
wild	O
type	O
and	O
knock	O
out	O
murine	O
and	O
human	O
samples	O
.	O

250	O
mu	O
l	O
adjusted	O
platelets	O
were	O
prewarmed	O
to	O
37	O
degrees	O
C	O
and	O
used	O
in	O
the	O
assay	O
,	O
and	O
the	O
aggregation	O
process	O
was	O
started	O
by	O
adding	O
25	O
mu	O
l	O
of	O
a	O
prewarmed	O
16	O
.	O
5	O
mg	O
/	O
ml	O
ristocetin	O
solution	O
(	O
DiaMed	O
Diagnostica	O
,	O
Bensheim	O
,	O
FRG	O
;	O
concentration	O
in	O
the	O
assay	O
:	O
1	O
.	O
5	O
mg	O
/	O
ml	O
)	O
,	O
a	O
reagent	B-CHEBI
which	O
worked	O
reliably	O
in	O
our	O
hands	O
with	O
mouse	O
and	O
human	O
platelets	O
.	O

Each	O
murine	O
assay	O
represents	O
a	O
different	O
animal	O
.	O

Analyses	O
of	O
human	O
blood	O
samples	O
were	O
performed	O
as	O
described	O
in	O
the	O
manufacturer	O
'	O
s	O
protocol	O
.	O

Several	O
repeated	O
measurements	O
were	O
done	O
per	O
human	O
individual	O
to	O
control	O
the	O
reproducibility	O
.	O

The	O
acquired	O
aggregation	O
curve	O
data	O
,	O
measured	O
as	O
ascending	O
degree	O
of	O
transmission	O
,	O
were	O
analysed	O
for	O
maximal	O
slope	O
values	O
,	O
while	O
the	O
maximal	O
aggregation	O
amplitude	O
of	O
every	O
single	O
curve	O
was	O
set	O
to	O
100	O
%	O
.	O

In	O
general	O
,	O
all	O
platelet	O
procedures	O
were	O
done	O
at	O
22	O
degrees	O
C	O
within	O
four	O
hours	O
after	O
collecting	O
the	O
blood	O
sample	O
.	O

Miscellaneous	O
methods	O

For	O
standard	O
haematopoetic	O
measurements	O
and	O
cell	O
counts	O
on	O
murine	O
and	O
human	O
blood	O
samples	O
about	O
300	O
mu	O
l	O
of	O
blood	O
were	O
analysed	O
with	O
an	O
ADVIA	O
120	O
electronic	O
cell	O
counter	O
(	O
Bayer	O
)	O
.	O

With	O
this	O
equipment	O
red	O
blood	O
cells	O
and	O
platelets	O
are	O
"	O
transformed	O
"	O
into	O
spherical	O
bodies	O
without	O
changing	O
their	O
volume	O
.	O

Therefore	O
number	O
and	O
volume	O
of	O
red	O
blood	O
cells	O
and	O
platelets	O
are	O
not	O
calculated	O
values	O
,	O
but	O
directly	O
measured	O
values	O
.	O

The	O
following	O
data	O
were	O
statistically	O
analysed	O
:	O
leucocytes	O
,	O
red	O
blood	O
cells	O
,	O
haemoglobin	B-CHEBI
,	O
haematocrit	O
,	O
mean	O
cellular	O
volume	O
,	O
mean	O
cellular	O
haemoglobin	B-CHEBI
,	O
mean	O
cellular	O
haemoglobin	B-CHEBI
concentration	O
,	O
platelet	O
number	O
,	O
neutrophiles	O
,	O
lymphocytes	O
,	O
monocytes	O
,	O
eosinophiles	O
,	O
basophiles	O
.	O

Peptide	O
mass	O
fingerprinting	O
was	O
performed	O
on	O
a	O
Bruker	O
Reflex	O
IV	O
MALDI	O
-	O
TOF	O
mass	O
spectrometer	O
.	O

Recombinant	O
annexin	O
A7	O
was	O
purified	O
according	O
to	O
[	O
27	O
]	O
,	O
F	O
-	O
actin	O
-	O
binding	O
of	O
recombinant	O
annexin	O
A7	O
was	O
done	O
as	O
described	O
[	O
28	O
]	O
.	O

SDS	B-CHEBI
-	O
PAGE	O
and	O
western	O
blotting	O
were	O
done	O
as	O
described	O
[	O
29	O
,	O
30	O
]	O
.	O

Detection	O
in	O
immunoblots	O
was	O
with	O
enhanced	O
chemiluminescence	O
[	O
17	O
]	O
.	O

Antibodies	O
employed	O
were	O
mab	O
203	O
-	O
217	O
directed	O
against	O
mouse	O
annexin	O
A7	O
core	O
domain	O
[	O
5	O
]	O
and	O
a	O
polyclonal	O
rabbit	O
anti	O
-	O
sorcin	O
antibody	O
[	O
31	O
]	O
.	O

For	O
statistical	O
analyses	O
the	O
following	O
tests	O
were	O
performed	O
:	O
David	O
et	O
al	O
.	O
range	O
test	O
to	O
ensure	O
samples	O
are	O
from	O
a	O
normal	O
distribution	O
,	O
F	O
-	O
test	O
looking	O
for	O
a	O
samples	O
'	O
homoscedascity	O
,	O
Student	O
'	O
s	O
T	O
-	O
test	O
to	O
judge	O
if	O
samples	O
of	O
different	O
groups	O
have	O
a	O
different	O
mean	O
value	O
and	O
are	O
parts	O
from	O
different	O
normal	O
distributions	O
.	O

The	O
exact	O
probability	O
values	O
and	O
the	O
significance	O
of	O
an	O
analysis	O
are	O
indicated	O
when	O
the	O
experiments	O
are	O
described	O
.	O

Authors	O
'	O
contributions	O

CH	O
and	O
CSC	O
planned	O
and	O
carried	O
out	O
the	O
experiments	O
with	O
the	O
red	O
blood	O
cells	O
and	O
platelets	O
and	O
the	O
fractionation	O
studies	O
and	O
drafted	O
the	O
manuscript	O
,	O
GL	O
was	O
responsible	O
for	O
platelets	O
,	O
RK	O
gave	O
support	O
on	O
the	O
ADVIA	O
120	O
cell	O
counter	O
,	O
evaluated	O
and	O
discussed	O
the	O
results	O
,	O
SMP	O
and	O
BSG	O
gave	O
support	O
on	O
the	O
APACT	O
system	O
,	O
platelet	O
aggregation	O
experiments	O
,	O
and	O
evaluated	O
the	O
results	O
,	O
CZ	O
was	O
responsible	O
for	O
the	O
sorcin	O
studies	O
,	O
MS	O
studied	O
the	O
cytoskeletal	O
activities	O
of	O
the	O
protein	B-CHEBI
,	O
AAN	O
conceived	O
of	O
the	O
studies	O
and	O
participated	O
in	O
its	O
design	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
manuscript	O
.	O

Acknowledgements	O

We	O
would	O
like	O
to	O
thank	O
M	O
.	O

Heil	O
,	O
B	O
.	O

Hoffmann	O
and	O
R	O
.	O

Merkel	O
for	O
the	O
biophysical	O
experiments	O
,	O
L	O
.	O

Eichinger	O
for	O
discussion	O
,	O
B	O
.	O

Gassen	O
for	O
expert	O
technical	O
assistance	O
and	O
R	O
.	O

M	O
u	O
ller	O
for	O
protein	B-CHEBI
purification	O
.	O

Mass	O
spectrometric	O
analysis	O
was	O
performed	O
in	O
the	O
central	O
service	O
facilities	O
of	O
the	O
ZMMK	O
.	O

This	O
worked	O
is	O
supported	O
by	O
a	O
grant	O
from	O
the	O
ZMMK	O
(	O
Center	O
of	O
Molecular	B-CHEBI
Medicine	O
Cologne	O
)	O
.	O

Odorant	O
receptor	O
expressed	O
sequence	O
tags	O
demonstrate	O
olfactory	O
expression	O
of	O
over	O
400	O
genes	O
,	O
extensive	O
alternate	O
splicing	O
and	O
unequal	O
expression	O
levels	O

Previous	O
computational	O
analyses	O
have	O
identified	O
approximately	O
1	O
,	O
500	O
mouse	O
olfactory	O
receptors	O
,	O
but	O
experimental	O
evidence	O
confirming	O
olfactory	O
function	O
is	O
available	O
for	O
very	O
few	O
receptors	O
.	O

A	O
mouse	O
olfactory	O
epithelium	O
cDNA	O
library	O
was	O
screened	O
to	O
obtain	O
olfactory	O
receptor	O
expressed	O
sequence	O
tags	O
,	O
providing	O
evidence	O
of	O
olfactory	O
function	O
for	O
many	O
additional	O
olfactory	O
receptors	O
,	O
as	O
well	O
as	O
identifying	O
gene	O
structure	O
and	O
putative	O
promoter	O
regions	O
.	O

Abstract	O

Background	O

The	O
olfactory	O
receptor	O
gene	O
family	O
is	O
one	O
of	O
the	O
largest	O
in	O
the	O
mammalian	O
genome	O
.	O

Previous	O
computational	O
analyses	O
have	O
identified	O
approximately	O
1	O
,	O
500	O
mouse	O
olfactory	O
receptors	O
,	O
but	O
experimental	O
evidence	O
confirming	O
olfactory	O
function	O
is	O
available	O
for	O
very	O
few	O
olfactory	O
receptors	O
.	O

We	O
therefore	O
screened	O
a	O
mouse	O
olfactory	O
epithelium	O
cDNA	O
library	O
to	O
obtain	O
olfactory	O
receptor	O
expressed	O
sequence	O
tags	O
,	O
providing	O
evidence	O
of	O
olfactory	O
function	O
for	O
many	O
additional	O
olfactory	O
receptors	O
,	O
as	O
well	O
as	O
identifying	O
gene	O
structure	O
and	O
putative	O
promoter	O
regions	O
.	O

Results	O

We	O
identified	O
more	O
than	O
1	O
,	O
200	O
odorant	O
receptor	O
cDNAs	O
representing	O
more	O
than	O
400	O
genes	O
.	O

Using	O
real	O
-	O
time	O
PCR	O
to	O
confirm	O
expression	O
level	O
differences	O
suggested	O
by	O
our	O
screen	O
,	O
we	O
find	O
that	O
transcript	O
levels	O
in	O
the	O
olfactory	O
epithelium	O
can	O
differ	O
between	O
olfactory	O
receptors	O
by	O
up	O
to	O
300	O
-	O
fold	O
.	O

Differences	O
for	O
one	O
gene	O
pair	O
are	O
apparently	O
due	O
to	O
both	O
unequal	O
numbers	O
of	O
expressing	O
cells	O
and	O
unequal	O
transcript	O
levels	O
per	O
expressing	O
cell	O
.	O

At	O
least	O
two	O
-	O
thirds	O
of	O
olfactory	O
receptors	O
exhibit	O
multiple	O
transcriptional	O
variants	O
,	O
with	O
alternative	O
isoforms	O
of	O
both	O
5	O
'	O
and	O
3	O
'	O
untranslated	O
regions	O
.	O

Some	O
transcripts	O
(	O
5	O
%	O
)	O
utilize	O
splice	O
sites	O
within	O
the	O
coding	O
region	O
,	O
contrary	O
to	O
the	O
stereotyped	O
olfactory	O
receptor	O
gene	O
structure	O
.	O

Most	O
atypical	O
transcripts	O
encode	O
nonfunctional	O
olfactory	O
receptors	O
,	O
but	O
can	O
occasionally	O
increase	O
receptor	O
diversity	O
.	O

Conclusions	O

Our	O
cDNA	O
collection	O
confirms	O
olfactory	O
function	O
of	O
over	O
one	O
-	O
third	O
of	O
the	O
intact	O
mouse	O
olfactory	O
receptors	O
.	O

Most	O
of	O
these	O
genes	O
were	O
previously	O
annotated	O
as	O
olfactory	O
receptors	O
based	O
solely	O
on	O
sequence	O
similarity	O
.	O

Our	O
finding	O
that	O
different	O
olfactory	O
receptors	O
have	O
different	O
expression	O
levels	O
is	O
intriguing	O
given	O
the	O
one	O
-	O
neuron	O
,	O
one	O
-	O
gene	O
expression	O
regime	O
of	O
olfactory	O
receptors	O
.	O

We	O
provide	O
5	O
'	O
untranslated	O
region	O
sequences	O
and	O
candidate	O
promoter	O
regions	O
for	O
more	O
than	O
300	O
olfactory	O
receptors	O
,	O
valuable	O
resources	O
for	O
computational	O
regulatory	O
motif	O
searches	O
and	O
for	O
designing	O
olfactory	O
receptor	O
microarrays	O
and	O
other	O
experimental	O
probes	O
.	O

Background	O

The	O
interaction	O
of	O
olfactory	O
(	O
or	O
odorant	O
)	O
receptors	O
with	O
their	O
odorant	O
ligands	O
is	O
the	O
first	O
step	O
in	O
a	O
signal	O
transduction	O
pathway	O
that	O
results	O
in	O
the	O
perception	O
of	O
smell	O
.	O

The	O
olfactory	O
receptor	O
gene	O
family	O
is	O
one	O
of	O
the	O
largest	O
in	O
the	O
mammalian	O
genome	O
,	O
comprising	O
about	O
1	O
,	O
500	O
members	O
in	O
the	O
mouse	O
genome	O
[	O
1	O
,	O
2	O
]	O
.	O

Olfactory	O
receptors	O
were	O
originally	O
identified	O
in	O
an	O
elegant	O
experiment	O
based	O
on	O
the	O
hypothesis	O
that	O
they	O
would	O
be	O
seven	O
-	O
transmembrane	O
-	O
domain	O
proteins	B-CHEBI
encoded	O
by	O
a	O
large	O
,	O
diverse	O
gene	O
family	O
whose	O
expression	O
is	O
restricted	O
to	O
the	O
olfactory	O
epithelium	O
[	O
3	O
]	O
.	O

Subsequent	O
studies	O
have	O
shown	O
that	O
some	O
of	O
these	O
receptors	O
do	O
indeed	O
respond	O
to	O
odorants	O
and	O
can	O
confer	O
that	O
responsivity	O
when	O
expressed	O
in	O
heterologous	O
cell	O
types	O
(	O
for	O
example	O
[	O
4	O
]	O
)	O
.	O

Recent	O
computational	O
investigations	O
have	O
provided	O
the	O
almost	O
complete	O
human	O
[	O
5	O
,	O
6	O
]	O
and	O
mouse	O
[	O
1	O
,	O
2	O
]	O
olfactory	O
receptor	O
-	O
gene	O
catalogs	O
.	O

However	O
,	O
the	O
assignment	O
of	O
most	O
of	O
these	O
genes	O
as	O
olfactory	O
receptors	O
is	O
based	O
solely	O
on	O
similarity	O
to	O
one	O
of	O
a	O
relatively	O
small	O
number	O
of	O
experimentally	O
confirmed	O
mouse	O
olfactory	O
receptors	O
or	O
,	O
worse	O
,	O
on	O
similarity	O
to	O
a	O
gene	O
that	O
in	O
turn	O
was	O
defined	O
as	O
an	O
olfactory	O
receptor	O
solely	O
by	O
similarity	O
.	O

While	O
similarity	O
-	O
based	O
genome	O
annotation	O
is	O
a	O
good	O
initial	O
method	O
to	O
identify	O
genes	O
and	O
predict	O
their	O
function	O
,	O
in	O
some	O
cases	O
it	O
can	O
be	O
misleading	O
,	O
as	O
genes	O
of	O
similar	O
sequence	O
can	O
carry	O
out	O
different	O
functions	O
and	O
be	O
expressed	O
in	O
different	O
tissues	O
(	O
for	O
example	O
,	O
the	O
sugar	O
transporter	O
gene	O
family	O
[	O
7	O
]	O
)	O
.	O

A	O
small	O
subset	O
of	O
olfactory	O
receptors	O
appears	O
to	O
be	O
expressed	O
in	O
non	O
-	O
olfactory	O
tissues	O
,	O
principally	O
the	O
testis	O
[	O
8	O
]	O
,	O
but	O
also	O
taste	O
tissues	O
[	O
9	O
]	O
,	O
prostate	O
[	O
10	O
]	O
,	O
erythroid	O
cells	O
[	O
11	O
]	O
,	O
notochord	O
[	O
12	O
]	O
and	O
perhaps	O
other	O
tissues	O
.	O

Expression	O
in	O
the	O
testis	O
has	O
led	O
some	O
investigators	O
to	O
suggest	O
that	O
a	O
subset	O
of	O
olfactory	O
receptors	O
may	O
function	O
as	O
spermatid	O
chemoreceptors	O
[	O
8	O
]	O
.	O

Recent	O
studies	O
of	O
one	O
human	O
testis	O
-	O
expressed	O
olfactory	O
receptor	O
indicate	O
that	O
it	O
does	O
indeed	O
function	O
in	O
sperm	O
chemotaxis	O
[	O
13	O
]	O
.	O

Due	O
to	O
the	O
paucity	O
of	O
experimental	O
evidence	O
of	O
the	O
olfactory	O
function	O
of	O
most	O
genes	O
in	O
the	O
family	O
and	O
suggestions	O
of	O
extra	O
-	O
olfactory	O
roles	O
,	O
we	O
embarked	O
on	O
an	O
olfactory	O
receptor	O
expressed	O
sequence	O
tag	O
(	O
EST	O
)	O
project	O
to	O
confirm	O
olfactory	O
epithelial	O
expression	O
of	O
hundreds	O
of	O
mouse	O
odorant	O
receptor	O
genes	O
.	O

Within	O
the	O
olfactory	O
epithelium	O
,	O
individual	O
olfactory	O
receptor	O
genes	O
show	O
an	O
intriguing	O
expression	O
pattern	O
.	O

Each	O
olfactory	O
receptor	O
is	O
expressed	O
in	O
a	O
subset	O
of	O
cells	O
in	O
one	O
of	O
four	O
zones	O
of	O
the	O
epithelium	O
[	O
14	O
,	O
15	O
]	O
.	O

Furthermore	O
,	O
each	O
olfactory	O
neuron	O
expresses	O
only	O
one	O
allele	O
[	O
16	O
]	O
of	O
a	O
single	O
olfactory	O
receptor	O
gene	O
[	O
17	O
,	O
18	O
]	O
,	O
and	O
the	O
remaining	O
approximately	O
1	O
,	O
499	O
genes	O
are	O
transcriptionally	O
inactive	O
.	O

While	O
the	O
mechanism	O
ensuring	O
singular	O
expression	O
is	O
unknown	O
,	O
many	O
hypotheses	O
have	O
been	O
proposed	O
[	O
14	O
,	O
16	O
,	O
19	O
]	O
.	O

In	O
one	O
model	O
,	O
somatic	O
DNA	O
recombination	O
would	O
bring	O
one	O
olfactory	O
receptor	O
gene	O
into	O
a	O
transcriptionally	O
active	O
genomic	O
configuration	O
,	O
as	O
observed	O
for	O
the	O
yeast	O
mating	O
type	O
locus	O
[	O
20	O
]	O
and	O
the	O
mammalian	O
immunoglobulin	O
genes	O
[	O
21	O
]	O
.	O

Alternatively	O
,	O
a	O
second	O
model	O
invokes	O
a	O
combinatorial	O
code	O
of	O
transcription	O
factor	O
binding	O
sites	O
unique	O
to	O
each	O
gene	O
.	O

This	O
is	O
unlikely	O
,	O
however	O
,	O
as	O
even	O
olfactory	O
receptor	O
transgenes	O
with	O
identical	O
upstream	O
regions	O
are	O
expressed	O
in	O
different	O
neurons	O
[	O
18	O
]	O
.	O

In	O
a	O
third	O
model	O
,	O
there	O
would	O
be	O
a	O
limiting	O
quantity	O
of	O
transcription	O
factors	O
-	O
the	O
cell	O
might	O
contain	O
a	O
single	O
transcriptional	O
'	O
machine	O
'	O
that	O
is	O
capable	O
of	O
accommodating	O
the	O
promoter	O
of	O
only	O
one	O
olfactory	O
receptor	O
gene	O
,	O
similar	O
to	O
the	O
expression	O
site	O
body	O
used	O
by	O
African	O
trypanosomes	O
to	O
ensure	O
singular	O
expression	O
of	O
only	O
one	O
set	O
of	O
variant	O
surface	O
glycoprotein	O
genes	O
[	O
22	O
]	O
.	O

Finally	O
,	O
in	O
a	O
fourth	O
model	O
,	O
transcriptional	O
activity	O
at	O
one	O
stochastically	O
chosen	O
olfactory	O
receptor	O
allele	O
might	O
send	O
negative	O
feedback	O
to	O
repress	O
activity	O
of	O
all	O
other	O
olfactory	O
receptors	O
and	O
/	O
or	O
positive	O
feedback	O
to	O
enhance	O
its	O
own	O
expression	O
.	O

In	O
the	O
latter	O
three	O
models	O
,	O
some	O
or	O
all	O
olfactory	O
receptor	O
genes	O
might	O
share	O
transcription	O
factor	O
binding	O
motifs	O
,	O
and	O
in	O
the	O
first	O
model	O
,	O
olfactory	O
receptor	O
genes	O
might	O
share	O
a	O
common	O
recombination	O
signal	O
.	O

In	O
order	O
to	O
perform	O
computational	O
and	O
experimental	O
searches	O
for	O
such	O
signals	O
,	O
it	O
is	O
important	O
to	O
have	O
a	O
better	O
idea	O
of	O
the	O
transcriptional	O
start	O
site	O
of	O
a	O
large	O
number	O
of	O
olfactory	O
receptor	O
genes	O
.	O

Our	O
olfactory	O
receptor	O
EST	O
collection	O
provides	O
5	O
'	O
untranslated	O
region	O
(	O
UTR	O
)	O
sequences	O
for	O
many	O
genes	O
and	O
,	O
therefore	O
,	O
a	O
large	O
dataset	O
of	O
candidate	O
promoter	O
regions	O
.	O

Olfactory	O
receptor	O
genes	O
have	O
an	O
intronless	O
coding	O
region	O
,	O
simplifying	O
both	O
computational	O
and	O
experimental	O
olfactory	O
receptor	O
identification	O
.	O

For	O
a	O
small	O
number	O
of	O
olfactory	O
receptors	O
,	O
gene	O
structure	O
has	O
been	O
determined	O
.	O

Additional	O
5	O
'	O
untranslated	O
exons	O
lie	O
upstream	O
of	O
the	O
coding	O
region	O
and	O
can	O
be	O
alternatively	O
spliced	O
[	O
19	O
,	O
23	O
-	O
26	O
]	O
.	O

The	O
3	O
'	O
untranslated	O
region	O
is	O
typically	O
intronless	O
.	O

Exceptions	O
to	O
this	O
stereotyped	O
structure	O
have	O
been	O
described	O
for	O
some	O
human	O
olfactory	O
receptors	O
,	O
but	O
are	O
thought	O
to	O
be	O
rare	O
[	O
25	O
-	O
27	O
]	O
.	O

cDNA	O
identification	O
and	O
RACE	O
data	O
have	O
been	O
used	O
to	O
determine	O
gene	O
structure	O
for	O
about	O
30	O
genes	O
,	O
see	O
,	O
for	O
example	O
,	O
[	O
19	O
,	O
23	O
]	O
.	O

However	O
,	O
computational	O
prediction	O
of	O
the	O
location	O
of	O
5	O
'	O
upstream	O
exons	O
and	O
the	O
extent	O
of	O
the	O
3	O
'	O
UTR	O
from	O
genomic	O
sequence	O
has	O
been	O
extremely	O
difficult	O
.	O

A	O
combination	O
of	O
splice	O
site	O
predictions	O
and	O
similarity	O
to	O
other	O
olfactory	O
receptors	O
has	O
allowed	O
some	O
investigators	O
to	O
predict	O
5	O
'	O
exon	O
locations	O
for	O
around	O
15	O
genes	O
[	O
25	O
,	O
28	O
]	O
.	O

Experimental	O
validation	O
shows	O
that	O
some	O
,	O
but	O
not	O
all	O
,	O
predictions	O
are	O
accurate	O
[	O
24	O
,	O
25	O
]	O
.	O

The	O
total	O
number	O
of	O
olfactory	O
receptors	O
for	O
which	O
gene	O
structure	O
is	O
known	O
is	O
vastly	O
increased	O
by	O
our	O
study	O
.	O

In	O
this	O
report	O
,	O
we	O
describe	O
the	O
isolation	O
and	O
analysis	O
of	O
over	O
1	O
,	O
200	O
cDNAs	O
representing	O
419	O
odorant	O
receptor	O
genes	O
.	O

We	O
screened	O
a	O
mouse	O
olfactory	O
epithelium	O
library	O
with	O
degenerate	O
olfactory	O
receptor	O
probes	O
and	O
obtained	O
5	O
'	O
end	O
sequences	O
(	O
ESTs	O
)	O
from	O
purified	O
cDNAs	O
.	O

These	O
clones	O
confirm	O
olfactory	O
expression	O
of	O
over	O
400	O
olfactory	O
receptors	O
,	O
provide	O
their	O
gene	O
structure	O
,	O
demonstrate	O
that	O
not	O
all	O
olfactory	O
receptors	O
are	O
expressed	O
at	O
the	O
same	O
level	O
and	O
show	O
that	O
most	O
olfactory	O
receptor	O
genes	O
have	O
multiple	O
transcriptional	O
isoforms	O
.	O

Results	O

At	O
least	O
419	O
mouse	O
olfactory	O
receptor	O
genes	O
are	O
expressed	O
in	O
the	O
olfactory	O
epithelium	O

We	O
have	O
isolated	O
1	O
,	O
264	O
olfactory	O
receptor	O
cDNA	O
clones	O
,	O
which	O
together	O
confirm	O
the	O
olfactory	O
epithelial	O
expression	O
of	O
419	O
annotated	O
olfactory	O
receptor	O
genes	O
.	O

We	O
used	O
low	O
-	O
stringency	O
hybridization	O
with	O
degenerate	O
olfactory	O
receptor	O
DNA	O
probes	O
to	O
screen	O
around	O
4	O
,	O
100	O
,	O
000	O
plaque	O
-	O
forming	O
units	O
(	O
pfu	O
)	O
of	O
an	O
adult	O
mouse	O
olfactory	O
epithelium	O
cDNA	O
library	O
and	O
around	O
640	O
,	O
000	O
pfu	O
of	O
an	O
embryonic	O
olfactory	O
epithelium	O
library	O
.	O

We	O
obtained	O
sequences	O
from	O
1	O
,	O
715	O
hybridization	O
-	O
positive	O
cDNAs	O
following	O
secondary	O
screens	O
to	O
isolate	O
single	O
clones	O
.	O

Of	O
these	O
clones	O
,	O
1	O
,	O
264	O
yielded	O
olfactory	O
receptor	O
-	O
containing	O
sequences	O
.	O

The	O
26	O
%	O
false	O
-	O
positive	O
rate	O
is	O
a	O
consequence	O
of	O
using	O
low	O
-	O
stringency	O
hybridization	O
to	O
obtain	O
maximal	O
sensitivity	O
.	O

Continuing	O
the	O
screen	O
would	O
have	O
resulted	O
in	O
cDNAs	O
from	O
additional	O
olfactory	O
receptors	O
,	O
but	O
we	O
reached	O
a	O
point	O
of	O
limiting	O
returns	O
:	O
our	O
final	O
batch	O
of	O
45	O
olfactory	O
receptor	O
-	O
positive	O
sequences	O
represented	O
33	O
different	O
olfactory	O
receptors	O
,	O
of	O
which	O
only	O
four	O
had	O
not	O
been	O
encountered	O
previously	O
in	O
our	O
screen	O
.	O

Sequence	O
analysis	O
shows	O
that	O
the	O
libraries	O
are	O
of	O
high	O
quality	O
.	O

Firstly	O
,	O
directional	O
cloning	O
was	O
successful	O
:	O
only	O
eight	O
out	O
of	O
1	O
,	O
430	O
cDNA	O
sequences	O
with	O
any	O
protein	B-CHEBI
homology	O
matched	O
that	O
protein	B-CHEBI
on	O
the	O
reverse	O
strand	O
.	O

Secondly	O
,	O
genomic	O
contamination	O
is	O
rare	O
:	O
when	O
the	O
83	O
olfactory	O
receptor	O
-	O
containing	O
sequences	O
that	O
had	O
a	O
5	O
'	O
UTR	O
of	O
400	O
bp	O
or	O
longer	O
were	O
aligned	O
to	O
genomic	O
sequence	O
,	O
80	O
spliced	O
across	O
at	O
least	O
one	O
intron	O
,	O
leaving	O
a	O
maximum	O
of	O
three	O
clones	O
(	O
3	O
.	O
6	O
%	O
)	O
that	O
potentially	O
represent	O
genomic	O
contamination	O
of	O
the	O
libraries	O
.	O

Thirdly	O
,	O
most	O
clones	O
are	O
of	O
a	O
reasonable	O
length	O
:	O
although	O
we	O
did	O
not	O
determine	O
whether	O
clones	O
are	O
full	O
-	O
length	O
,	O
881	O
of	O
1	O
,	O
264	O
(	O
70	O
%	O
)	O
olfactory	O
receptor	O
cDNAs	O
contain	O
the	O
gene	O
'	O
s	O
start	O
codon	O
and	O
at	O
least	O
some	O
5	O
'	O
UTR	O
sequence	O
.	O

In	O
order	O
to	O
match	O
cDNAs	O
to	O
their	O
genomic	O
counterparts	O
,	O
first	O
we	O
updated	O
our	O
catalog	O
of	O
mouse	O
olfactory	O
receptor	O
genes	O
[	O
1	O
]	O
based	O
on	O
Celera	O
'	O
s	O
most	O
recent	O
genome	O
assembly	O
(	O
Release	O
13	O
)	O
[	O
29	O
]	O
.	O

Previous	O
reports	O
of	O
the	O
mouse	O
olfactory	O
receptor	O
repertoire	O
[	O
1	O
,	O
2	O
]	O
were	O
based	O
on	O
the	O
Release	O
12	O
assembly	O
.	O

Release	O
13	O
consists	O
of	O
fewer	O
,	O
longer	O
scaffold	O
sequences	O
containing	O
fewer	O
,	O
smaller	O
gaps	O
than	O
Release	O
12	O
.	O

Using	O
the	O
BLAST	O
-	O
based	O
methods	O
detailed	O
previously	O
[	O
1	O
]	O
,	O
we	O
identified	O
1	O
,	O
490	O
olfactory	O
receptor	O
sequences	O
in	O
the	O
new	O
assembly	O
,	O
including	O
1	O
,	O
107	O
intact	O
olfactory	O
receptor	O
genes	O
(	O
compared	O
to	O
866	O
intact	O
olfactory	O
receptors	O
in	O
the	O
old	O
assembly	O
)	O
reflecting	O
the	O
reduced	O
sequence	O
error	O
rate	O
and	O
increased	O
coverage	O
of	O
the	O
new	O
assembly	O
(	O
Table	O
1	O
)	O
.	O

We	O
created	O
a	O
local	O
database	O
of	O
genomic	O
sequences	O
including	O
all	O
olfactory	O
receptor	O
loci	O
and	O
0	O
.	O
5	O
Mb	O
flanking	O
sequences	O
(	O
if	O
available	O
)	O
and	O
compared	O
each	O
cDNA	O
sequence	O
to	O
this	O
'	O
olfactory	O
subgenome	O
'	O
database	O
using	O
sim4	O
[	O
30	O
]	O
.	O

cDNAs	O
were	O
assigned	O
to	O
individual	O
genes	O
based	O
on	O
their	O
best	O
match	O
to	O
an	O
olfactory	O
receptor	O
coding	O
region	O
or	O
its	O
upstream	O
region	O
(	O
see	O
Materials	O
and	O
methods	O
)	O
.	O

Of	O
the	O
1	O
,	O
264	O
olfactory	O
receptor	O
cDNAs	O
,	O
1	O
,	O
176	O
matched	O
a	O
total	O
of	O
419	O
olfactory	O
receptor	O
genes	O
;	O
the	O
remaining	O
cDNAs	O
either	O
matched	O
an	O
olfactory	O
receptor	O
below	O
our	O
96	O
%	O
nucleotide	B-CHEBI
identity	O
threshold	O
or	O
had	O
ambiguous	O
matches	O
encompassing	O
more	O
than	O
one	O
olfactory	O
receptor	O
gene	O
region	O
(	O
see	O
below	O
)	O
.	O

A	O
class	O
I	O
olfactory	O
receptor	O
degenerate	O
primer	O
broadens	O
phylogenetic	O
distribution	O
of	O
confirmed	O
olfactory	O
receptor	O
genes	O

Previous	O
analyses	O
of	O
the	O
mammalian	O
olfactory	O
receptor	O
family	O
define	O
two	O
major	O
phylogenetic	O
clades	O
,	O
referred	O
to	O
as	O
class	O
I	O
and	O
II	O
olfactory	O
receptors	O
,	O
and	O
suggest	O
that	O
class	O
I	O
olfactory	O
receptors	O
are	O
more	O
similar	O
to	O
fish	O
olfactory	O
receptors	O
than	O
are	O
class	O
IIs	O
[	O
5	O
]	O
.	O

Figure	O
1	O
illustrates	O
the	O
phylogenetic	O
diversity	O
of	O
our	O
cDNA	O
collection	O
,	O
showing	O
that	O
we	O
have	O
confirmed	O
expression	O
of	O
at	O
least	O
one	O
olfactory	O
receptor	O
gene	O
in	O
each	O
major	O
clade	O
of	O
the	O
class	O
II	O
olfactory	O
receptor	O
genes	O
,	O
or	O
391	O
out	O
of	O
983	O
(	O
40	O
%	O
)	O
of	O
all	O
intact	O
class	O
II	O
olfactory	O
receptor	O
genes	O
where	O
full	O
-	O
length	O
genomic	O
sequence	O
data	O
are	O
available	O
(	O
blue	O
branches	O
)	O
.	O

The	O
screen	O
thus	O
appears	O
relatively	O
unbiased	O
in	O
its	O
coverage	O
of	O
class	O
II	O
olfactory	O
receptors	O
.	O

However	O
,	O
our	O
random	O
screen	O
provided	O
cDNAs	O
for	O
only	O
two	O
out	O
of	O
124	O
intact	O
,	O
full	O
-	O
length	O
class	O
I	O
olfactory	O
receptors	O
.	O

In	O
an	O
attempt	O
to	O
broaden	O
the	O
phylogenetic	O
coverage	O
of	O
our	O
hybridization	O
screen	O
,	O
we	O
used	O
additional	O
degenerate	O
probes	O
on	O
the	O
adult	O
library	O
and	O
screened	O
an	O
embryonic	O
library	O
(	O
Table	O
2	O
)	O
.	O

These	O
experiments	O
did	O
not	O
increase	O
the	O
diversity	O
of	O
clones	O
identified	O
(	O
not	O
shown	O
)	O
.	O

This	O
severe	O
class	O
I	O
underrepresentation	O
could	O
be	O
due	O
to	O
experimental	O
bias	O
-	O
a	O
consequence	O
of	O
using	O
degenerate	O
primers	O
to	O
create	O
our	O
hybridization	O
probe	O
.	O

Alternatively	O
,	O
class	O
I	O
genes	O
might	O
be	O
expressed	O
at	O
extremely	O
low	O
levels	O
in	O
the	O
olfactory	O
epithelium	O
.	O

In	O
order	O
to	O
determine	O
whether	O
class	O
I	O
olfactory	O
receptors	O
are	O
expressed	O
in	O
the	O
olfactory	O
epithelium	O
,	O
we	O
designed	O
a	O
reverse	O
-	O
strand	O
degenerate	O
primer	O
to	O
recognize	O
a	O
motif	O
in	O
transmembrane	O
domain	O
7	O
(	O
PP	O
{	O
V	O
/	O
M	O
/	O
A	O
/	O
T	O
}	O
{	O
F	O
/	O
L	O
/	O
I	O
/	O
M	O
}	O
NP	O
)	O
enriched	O
among	O
class	O
I	O
olfactory	O
receptor	O
sequences	O
.	O

Most	O
of	O
the	O
motif	O
is	O
shared	O
among	O
all	O
olfactory	O
receptors	O
,	O
but	O
the	O
first	O
proline	B-CHEBI
residue	I-CHEBI
(	O
at	O
the	O
primer	O
'	O
s	O
3	O
'	O
end	O
)	O
is	O
found	O
in	O
121	O
out	O
of	O
124	O
(	O
98	O
%	O
)	O
intact	O
class	O
I	O
genes	O
compared	O
to	O
only	O
37	O
out	O
of	O
983	O
(	O
4	O
%	O
)	O
intact	O
class	O
II	O
genes	O
.	O

When	O
combined	O
with	O
another	O
olfactory	O
receptor	O
degenerate	O
primer	O
,	O
P26	O
[	O
17	O
]	O
,	O
this	O
primer	O
preferentially	O
amplifies	O
class	O
I	O
olfactory	O
receptors	O
from	O
mouse	O
genomic	O
DNA	O
:	O
of	O
33	O
sequenced	O
,	O
cloned	O
PCR	O
products	O
,	O
17	O
represented	O
seven	O
different	O
class	O
I	O
olfactory	O
receptors	O
,	O
six	O
represented	O
three	O
different	O
class	O
II	O
olfactory	O
receptors	O
,	O
and	O
ten	O
represented	O
five	O
different	O
non	O
-	O
olfactory	O
receptor	O
contaminants	O
.	O

Degenerate	O
PCR	O
,	O
cloning	O
,	O
and	O
sequencing	O
from	O
reverse	O
-	O
transcribed	O
olfactory	O
epithelium	O
RNA	O
showed	O
that	O
at	O
least	O
seven	O
class	O
I	O
olfactory	O
receptors	O
are	O
expressed	O
,	O
as	O
well	O
as	O
one	O
additional	O
class	O
II	O
gene	O
(	O
colored	O
red	O
in	O
Figure	O
1	O
)	O
.	O

However	O
,	O
no	O
products	O
could	O
be	O
obtained	O
from	O
the	O
adult	O
or	O
the	O
fetal	O
olfactory	O
epithelium	O
cDNA	O
libraries	O
using	O
the	O
class	O
I	O
primer	O
,	O
suggesting	O
that	O
the	O
libraries	O
contain	O
very	O
low	O
levels	O
of	O
class	O
I	O
olfactory	O
receptors	O
.	O

We	O
also	O
confirmed	O
expression	O
of	O
nine	O
additional	O
olfactory	O
receptors	O
(	O
three	O
class	O
I	O
and	O
six	O
class	O
II	O
,	O
colored	O
red	O
in	O
Figure	O
1	O
)	O
from	O
subclades	O
that	O
were	O
poorly	O
represented	O
in	O
our	O
cDNA	O
screen	O
using	O
gene	O
-	O
specific	O
primer	O
pairs	O
to	O
amplify	O
cDNA	O
library	O
or	O
reverse	O
-	O
transcribed	O
RNA	O
templates	O
.	O

For	O
two	O
of	O
the	O
class	O
I	O
genes	O
we	O
had	O
shown	O
to	O
be	O
expressed	O
,	O
we	O
determined	O
relative	O
transcript	O
levels	O
using	O
quantitative	O
RT	O
-	O
PCR	O
(	O
see	O
below	O
)	O
.	O

Expression	O
levels	O
were	O
similar	O
to	O
those	O
observed	O
for	O
genes	O
that	O
were	O
represented	O
in	O
our	O
cDNA	O
collection	O
,	O
suggesting	O
that	O
class	O
I	O
olfactory	O
receptors	O
are	O
not	O
under	O
-	O
represented	O
in	O
the	O
olfactory	O
epithelium	O
,	O
and	O
that	O
the	O
dearth	O
of	O
class	O
I	O
cDNAs	O
in	O
our	O
screen	O
is	O
likely	O
to	O
be	O
due	O
to	O
bias	O
in	O
the	O
libraries	O
and	O
/	O
or	O
hybridization	O
probes	O
.	O

Some	O
olfactory	O
receptor	O
genes	O
are	O
expressed	O
at	O
higher	O
levels	O
than	O
others	O

Our	O
cDNA	O
screen	O
suggests	O
that	O
some	O
olfactory	O
receptor	O
genes	O
are	O
expressed	O
at	O
higher	O
levels	O
than	O
others	O
.	O

If	O
all	O
olfactory	O
receptor	O
genes	O
were	O
expressed	O
at	O
equal	O
levels	O
,	O
and	O
our	O
screen	O
and	O
library	O
were	O
unbiased	O
in	O
their	O
coverage	O
of	O
the	O
class	O
II	O
olfactory	O
receptors	O
,	O
the	O
number	O
of	O
cDNAs	O
detected	O
per	O
class	O
II	O
olfactory	O
receptor	O
should	O
follow	O
a	O
Poisson	O
distribution	O
,	O
calculated	O
based	O
on	O
the	O
assumption	O
that	O
all	O
983	O
intact	O
class	O
II	O
olfactory	O
receptors	O
have	O
an	O
equal	O
chance	O
of	O
being	O
represented	O
in	O
the	O
screen	O
,	O
but	O
that	O
class	O
I	O
olfactory	O
receptors	O
and	O
pseudogenes	O
cannot	O
be	O
found	O
(	O
Figure	O
2	O
)	O
.	O

We	O
calculate	O
a	O
low	O
probability	O
(	O
approximately	O
one	O
in	O
28	O
)	O
that	O
we	O
would	O
observe	O
any	O
gene	O
with	O
at	O
least	O
eight	O
matching	O
cDNAs	O
in	O
the	O
set	O
of	O
1	O
,	O
176	O
cDNAs	O
we	O
assigned	O
to	O
single	O
olfactory	O
receptor	O
sequences	O
.	O

However	O
,	O
for	O
17	O
olfactory	O
receptors	O
,	O
we	O
found	O
ten	O
or	O
more	O
matching	O
cDNAs	O
,	O
suggesting	O
that	O
they	O
might	O
be	O
expressed	O
at	O
higher	O
levels	O
than	O
other	O
olfactory	O
receptor	O
genes	O
(	O
Figure	O
2	O
)	O
.	O

The	O
two	O
genes	O
for	O
which	O
we	O
found	O
most	O
cDNAs	O
(	O
AY318726	O
/	O
MOR28	O
and	O
AY318727	O
/	O
MOR10	O
)	O
are	O
genomically	O
adjacent	O
and	O
in	O
the	O
well	O
-	O
studied	O
olfactory	O
receptor	O
cluster	O
next	O
to	O
the	O
T	O
-	O
cell	O
receptor	O
alpha	O
/	O
delta	O
locus	O
[	O
18	O
,	O
31	O
]	O
.	O

Quantitative	O
RT	O
-	O
PCR	O
of	O
six	O
olfactory	O
receptors	O
confirms	O
that	O
expression	O
levels	O
do	O
indeed	O
vary	O
considerably	O
between	O
genes	O
.	O

We	O
used	O
quantitative	O
(	O
real	O
-	O
time	O
)	O
PCR	O
to	O
measure	O
olfactory	O
epithelium	O
transcript	O
levels	O
of	O
six	O
olfactory	O
receptor	O
genes	O
and	O
the	O
ribosomal	O
S16	O
gene	O
in	O
three	O
mice	O
of	O
the	O
same	O
inbred	O
strain	O
(	O
Figure	O
3	O
)	O
.	O

These	O
genes	O
include	O
two	O
olfactory	O
receptors	O
with	O
more	O
than	O
20	O
matching	O
cDNAs	O
,	O
two	O
with	O
one	O
or	O
two	O
matching	O
cDNAs	O
and	O
two	O
class	O
I	O
olfactory	O
receptors	O
with	O
no	O
matching	O
cDNAs	O
.	O

In	O
these	O
assays	O
,	O
we	O
measure	O
transcript	O
level	O
per	O
genomic	O
copy	O
of	O
the	O
gene	O
by	O
comparing	O
how	O
well	O
a	O
gene	O
-	O
specific	O
primer	O
pair	O
amplifies	O
reverse	O
-	O
transcribed	O
RNA	O
,	O
relative	O
to	O
a	O
standard	O
curve	O
of	O
amplification	O
of	O
mouse	O
genomic	O
DNA	O
.	O

We	O
find	O
that	O
expression	O
levels	O
can	O
vary	O
by	O
almost	O
300	O
-	O
fold	O
between	O
genes	O
(	O
for	O
example	O
,	O
genes	O
A	O
and	O
D	O
,	O
Figure	O
3	O
)	O
.	O

However	O
,	O
cDNA	O
numbers	O
are	O
not	O
a	O
good	O
indicator	O
of	O
expression	O
level	O
,	O
a	O
discrepancy	O
that	O
is	O
likely	O
to	O
be	O
due	O
to	O
bias	O
in	O
the	O
screen	O
(	O
we	O
used	O
degenerate	O
primers	O
to	O
make	O
the	O
probes	O
,	O
which	O
will	O
favor	O
some	O
genes	O
over	O
others	O
)	O
and	O
in	O
the	O
libraries	O
(	O
oligo	O
-	O
dT	O
priming	O
will	O
favor	O
genes	O
with	O
shorter	O
3	O
'	O
UTRs	O
)	O
.	O

For	O
example	O
,	O
we	O
observe	O
large	O
expression	O
differences	O
in	O
all	O
three	O
mice	O
between	O
two	O
genes	O
for	O
which	O
similar	O
numbers	O
of	O
cDNAs	O
were	O
found	O
(	O
genes	O
A	O
and	O
B	O
,	O
Figure	O
3	O
)	O
,	O
and	O
conversely	O
,	O
similar	O
expression	O
levels	O
between	O
two	O
genes	O
with	O
a	O
ten	O
-	O
fold	O
difference	O
in	O
number	O
of	O
cDNAs	O
found	O
(	O
genes	O
B	O
and	O
C	O
,	O
Figure	O
3	O
)	O
.	O

Expression	O
levels	O
are	O
mostly	O
consistent	O
between	O
different	O
mice	O
:	O
we	O
find	O
similar	O
expression	O
-	O
level	O
differences	O
between	O
olfactory	O
receptor	O
genes	O
in	O
all	O
three	O
mice	O
examined	O
(	O
that	O
is	O
,	O
the	O
rank	O
order	O
of	O
the	O
six	O
genes	O
is	O
similar	O
among	O
the	O
three	O
mice	O
)	O
,	O
although	O
there	O
is	O
variation	O
in	O
expression	O
level	O
of	O
some	O
genes	O
between	O
mice	O
(	O
for	O
example	O
,	O
gene	O
E	O
,	O
Figure	O
3	O
)	O
.	O

In	O
situ	O
hybridization	O
(	O
Figure	O
4	O
)	O
shows	O
that	O
increased	O
numbers	O
of	O
expressing	O
cells	O
account	O
for	O
some	O
,	O
but	O
not	O
all	O
,	O
of	O
the	O
difference	O
in	O
transcript	O
levels	O
between	O
two	O
of	O
the	O
genes	O
tested	O
by	O
real	O
-	O
time	O
PCR	O
(	O
genes	O
A	O
and	O
D	O
in	O
Figure	O
3	O
)	O
.	O

We	O
hybridized	O
alternate	O
coronal	O
serial	O
sections	O
spanning	O
an	O
entire	O
olfactory	O
epithelium	O
of	O
a	O
young	O
mouse	O
(	O
P6	O
)	O
with	O
probes	O
for	O
gene	O
A	O
and	O
gene	O
D	O
.	O

Southern	O
blot	O
and	O
BLAST	O
analyses	O
show	O
that	O
both	O
probes	O
are	O
likely	O
to	O
hybridize	O
to	O
their	O
intended	O
target	O
genes	O
and	O
no	O
others	O
(	O
not	O
shown	O
)	O
.	O

Gene	O
A	O
is	O
expressed	O
in	O
zone	O
4	O
of	O
the	O
epithelium	O
according	O
to	O
the	O
nomenclature	O
of	O
Sullivan	O
et	O
al	O
.	O

[	O
32	O
]	O
(	O
Figure	O
4a	O
)	O
.	O

The	O
expression	O
pattern	O
of	O
gene	O
D	O
does	O
not	O
correspond	O
to	O
any	O
of	O
the	O
four	O
'	O
classical	O
'	O
olfactory	O
epithelial	O
zones	O
[	O
14	O
,	O
15	O
,	O
32	O
]	O
:	O
positive	O
cells	O
are	O
found	O
in	O
regions	O
of	O
endoturbinates	O
II	O
and	O
III	O
and	O
ectoturbinate	O
3	O
,	O
resembling	O
the	O
expression	O
pattern	O
seen	O
previously	O
for	O
the	O
OR37	O
subfamily	O
and	O
ORZ6	O
olfactory	O
receptors	O
[	O
33	O
,	O
34	O
]	O
(	O
Figure	O
4b	O
)	O
.	O

Counting	O
the	O
total	O
number	O
of	O
positive	O
cells	O
in	O
alternate	O
sections	O
across	O
the	O
entire	O
epithelium	O
,	O
we	O
find	O
that	O
gene	O
A	O
is	O
expressed	O
in	O
2	O
,	O
905	O
cells	O
,	O
about	O
12	O
times	O
more	O
cells	O
than	O
gene	O
D	O
,	O
which	O
is	O
expressed	O
in	O
a	O
total	O
of	O
249	O
cells	O
.	O

This	O
12	O
-	O
fold	O
difference	O
in	O
numbers	O
of	O
expressing	O
cells	O
does	O
not	O
account	O
for	O
the	O
almost	O
300	O
-	O
fold	O
difference	O
in	O
RNA	O
levels	O
observed	O
by	O
real	O
-	O
time	O
PCR	O
,	O
implying	O
that	O
the	O
transcript	O
level	O
per	O
expressing	O
cell	O
for	O
gene	O
A	O
is	O
about	O
25	O
times	O
higher	O
than	O
transcript	O
level	O
in	O
each	O
expressing	O
cell	O
for	O
gene	O
D	O
.	O

We	O
note	O
that	O
hybridization	O
intensities	O
per	O
positive	O
neuron	O
appear	O
stronger	O
for	O
gene	O
A	O
than	O
gene	O
D	O
after	O
comparable	O
exposure	O
times	O
,	O
in	O
accordance	O
with	O
the	O
idea	O
that	O
transcript	O
levels	O
are	O
higher	O
per	O
cell	O
.	O

Thus	O
,	O
we	O
suggest	O
that	O
expression	O
in	O
more	O
cells	O
and	O
in	O
higher	O
levels	O
per	O
cell	O
together	O
account	O
for	O
the	O
almost	O
300	O
-	O
fold	O
higher	O
olfactory	O
epithelial	O
RNA	O
levels	O
of	O
gene	O
A	O
relative	O
to	O
gene	O
D	O
(	O
Figure	O
3	O
)	O
.	O

Most	O
olfactory	O
receptor	O
genes	O
have	O
several	O
transcriptional	O
isoforms	O

Our	O
cDNA	O
collection	O
reveals	O
that	O
at	O
least	O
two	O
thirds	O
of	O
the	O
olfactory	O
receptors	O
sampled	O
show	O
alternative	O
splicing	O
of	O
their	O
5	O
'	O
untranslated	O
exons	O
.	O

Using	O
a	O
custom	O
script	O
to	O
process	O
sim4	O
alignments	O
of	O
cDNA	O
and	O
genomic	O
sequences	O
,	O
we	O
find	O
two	O
to	O
eight	O
different	O
splice	O
forms	O
for	O
85	O
(	O
45	O
%	O
)	O
of	O
the	O
191	O
genes	O
for	O
which	O
we	O
have	O
had	O
some	O
opportunity	O
to	O
observe	O
alternate	O
splicing	O
(	O
that	O
is	O
,	O
a	O
minimum	O
of	O
two	O
cDNAs	O
,	O
at	O
least	O
one	O
of	O
which	O
is	O
spliced	O
)	O
,	O
and	O
55	O
(	O
67	O
%	O
)	O
of	O
the	O
82	O
genes	O
for	O
which	O
we	O
have	O
four	O
or	O
more	O
cDNAs	O
(	O
and	O
thus	O
a	O
higher	O
chance	O
of	O
observing	O
any	O
alternate	O
splicing	O
)	O
(	O
Figure	O
5	O
)	O
.	O

These	O
alternative	O
splice	O
events	O
are	O
almost	O
all	O
restricted	O
to	O
the	O
5	O
'	O
UTR	O
and	O
include	O
exon	O
skipping	O
and	O
alternate	O
splice	O
-	O
donor	O
and	O
-	O
acceptor	O
use	O
.	O

At	O
least	O
half	O
of	O
the	O
olfactory	O
receptors	O
represented	O
in	O
our	O
cDNA	O
collection	O
utilize	O
more	O
than	O
one	O
polyadenylation	O
site	O
,	O
resulting	O
in	O
alternative	O
3	O
'	O
UTR	O
isoforms	O
.	O

We	O
have	O
crudely	O
estimated	O
3	O
'	O
UTR	O
size	O
for	O
1	O
,	O
169	O
cDNA	O
clones	O
by	O
combining	O
approximate	O
insert	O
size	O
information	O
with	O
5	O
'	O
sequence	O
data	O
.	O

More	O
than	O
one	O
3	O
'	O
UTR	O
isoform	O
is	O
predicted	O
for	O
43	O
of	O
the	O
77	O
(	O
56	O
%	O
)	O
genes	O
for	O
which	O
there	O
are	O
at	O
least	O
four	O
cDNAs	O
with	O
3	O
'	O
UTR	O
size	O
information	O
.	O

We	O
confirmed	O
the	O
alternative	O
polyadenylation	O
isoforms	O
of	O
four	O
out	O
of	O
five	O
selected	O
genes	O
by	O
sequencing	O
the	O
3	O
'	O
end	O
of	O
14	O
cDNA	O
clones	O
.	O

These	O
14	O
sequences	O
also	O
revealed	O
one	O
cDNA	O
where	O
the	O
poly	O
(	O
A	B-CHEBI
)	O
tail	O
was	O
added	O
27	O
bp	O
before	O
the	O
stop	O
codon	O
,	O
and	O
another	O
where	O
an	O
intron	O
was	O
spliced	O
out	O
of	O
the	O
3	O
'	O
UTR	O
,	O
contrary	O
to	O
the	O
conventional	O
stereotype	O
of	O
olfactory	O
receptor	O
gene	O
structure	O
.	O

A	O
subset	O
of	O
olfactory	O
receptors	O
shows	O
unusual	O
splicing	O

We	O
identified	O
62	O
cDNAs	O
(	O
5	O
%	O
of	O
all	O
olfactory	O
receptor	O
clones	O
)	O
from	O
38	O
intact	O
olfactory	O
receptors	O
and	O
one	O
olfactory	O
receptor	O
pseudogene	O
where	O
a	O
splice	O
site	O
within	O
the	O
protein	B-CHEBI
-	O
coding	O
region	O
is	O
used	O
.	O

For	O
two	O
genes	O
(	O
top	O
two	O
cDNAs	O
,	O
Figure	O
6	O
)	O
,	O
the	O
predicted	O
protein	B-CHEBI
appears	O
to	O
be	O
an	O
intact	O
olfactory	O
receptor	O
with	O
three	O
or	O
ten	O
amino	B-CHEBI
acids	I-CHEBI
,	O
including	O
the	O
initiating	O
methionine	B-CHEBI
,	O
contributed	O
by	O
an	O
upstream	O
exon	O
.	O

A	O
similar	O
gene	O
structure	O
was	O
described	O
previously	O
for	O
a	O
human	O
olfactory	O
receptor	O
[	O
25	O
]	O
.	O

One	O
of	O
these	O
two	O
mouse	O
genes	O
has	O
no	O
start	O
codon	O
in	O
its	O
otherwise	O
intact	O
main	O
coding	O
exon	O
.	O

The	O
unusual	O
splicing	O
thus	O
rescues	O
what	O
would	O
otherwise	O
be	O
a	O
dysfunctional	O
gene	O
.	O

In	O
most	O
cases	O
(	O
60	O
out	O
of	O
62	O
cDNAs	O
)	O
,	O
the	O
unusual	O
transcript	O
appears	O
to	O
be	O
an	O
aberrant	O
splice	O
form	O
-	O
the	O
transcript	O
would	O
probably	O
not	O
encode	O
a	O
functional	O
protein	B-CHEBI
because	O
the	O
splice	O
introduces	O
a	O
frameshift	O
or	O
removes	O
conserved	O
functional	O
residues	B-CHEBI
(	O
Figure	O
6	O
)	O
.	O

For	O
two	O
clones	O
(	O
bottom	O
two	O
cDNAs	O
,	O
Figure	O
6	O
)	O
,	O
exon	O
order	O
in	O
the	O
cDNA	O
clone	O
is	O
inconsistent	O
with	O
the	O
corresponding	O
genomic	O
sequence	O
.	O

It	O
is	O
difficult	O
to	O
imagine	O
what	O
kind	O
of	O
cloning	O
artefact	O
resulted	O
in	O
these	O
severely	O
scrambled	O
cDNAs	O
:	O
we	O
suggest	O
that	O
they	O
derive	O
from	O
real	O
but	O
rare	O
transcripts	O
.	O

However	O
,	O
their	O
low	O
frequency	O
in	O
our	O
cDNA	O
collection	O
suggests	O
that	O
splicing	O
contrary	O
to	O
genomic	O
organization	O
does	O
not	O
contribute	O
significantly	O
to	O
the	O
olfactory	O
receptor	O
transcript	O
repertoire	O
.	O

For	O
21	O
of	O
the	O
26	O
genes	O
for	O
which	O
unusually	O
spliced	O
cDNAs	O
were	O
found	O
,	O
we	O
also	O
observe	O
an	O
alternative	O
(	O
'	O
normal	O
'	O
)	O
isoform	O
that	O
does	O
not	O
use	O
splice	O
sites	O
within	O
the	O
coding	O
region	O
.	O

(	O
For	O
the	O
remaining	O
13	O
of	O
the	O
3	O
'	O
genes	O
showing	O
odd	O
splicing	O
,	O
we	O
have	O
identified	O
only	O
one	O
cDNA	O
so	O
have	O
not	O
determined	O
whether	O
normal	O
isoforms	O
are	O
present	O
.	O
)	O

We	O
were	O
intrigued	O
both	O
by	O
previous	O
reports	O
of	O
splicing	O
of	O
human	O
olfactory	O
receptors	O
near	O
the	O
major	O
histocompatibility	O
complex	O
(	O
MHC	O
)	O
cluster	O
,	O
where	O
several	O
genes	O
splice	O
over	O
long	O
distances	O
to	O
a	O
common	O
upstream	O
exon	O
[	O
26	O
,	O
27	O
]	O
and	O
by	O
the	O
idea	O
that	O
olfactory	O
receptor	O
transcriptional	O
control	O
could	O
be	O
achieved	O
by	O
DNA	O
recombination	O
mechanisms	O
,	O
perhaps	O
with	O
the	O
result	O
that	O
transcripts	O
would	O
contain	O
some	O
sequence	O
from	O
another	O
locus	O
.	O

We	O
therefore	O
verified	O
that	O
the	O
entire	O
sequence	O
of	O
each	O
olfactory	O
receptor	O
EST	O
matches	O
the	O
corresponding	O
gene	O
'	O
s	O
genomic	O
'	O
territory	O
'	O
(	O
defined	O
for	O
this	O
purpose	O
as	O
from	O
1	O
kb	O
after	O
the	O
preceding	O
gene	O
to	O
1	O
kb	O
after	O
the	O
gene	O
'	O
s	O
stop	O
codon	O
)	O
.	O

We	O
found	O
no	O
cDNAs	O
where	O
introns	O
encompassed	O
other	O
olfactory	O
receptor	O
genes	O
,	O
as	O
reported	O
for	O
olfactory	O
receptors	O
in	O
the	O
human	O
MHC	O
region	O
[	O
26	O
,	O
27	O
]	O
.	O

Six	O
cDNAs	O
do	O
extend	O
further	O
than	O
a	O
single	O
gene	O
'	O
s	O
'	O
territory	O
'	O
and	O
appear	O
not	O
to	O
be	O
artifacts	O
of	O
the	O
sequencing	O
or	O
analysis	O
process	O
.	O

In	O
each	O
of	O
these	O
cases	O
,	O
the	O
clones	O
use	O
splice	O
sites	O
within	O
the	O
3	O
'	O
UTR	O
and	O
thus	O
extend	O
further	O
than	O
the	O
arbitrary	O
1	O
kb	O
downstream	O
of	O
the	O
stop	O
codon	O
.	O

Five	O
of	O
these	O
six	O
cDNAs	O
also	O
use	O
splice	O
-	O
donor	O
sites	O
within	O
the	O
coding	O
region	O
and	O
encode	O
disrupted	O
olfactory	O
receptors	O
(	O
Figure	O
6	O
)	O
.	O

In	O
the	O
sixth	O
cDNA	O
,	O
a	O
2	O
.	O
6	O
-	O
kb	O
intron	O
is	O
spliced	O
out	O
of	O
the	O
3	O
'	O
UTR	O
,	O
leaving	O
the	O
coding	O
region	O
intact	O
.	O

If	O
olfactory	O
receptor	O
transcriptional	O
control	O
is	O
achieved	O
by	O
DNA	O
recombination	O
,	O
the	O
beginning	O
of	O
each	O
transcript	O
might	O
derive	O
from	O
a	O
donated	O
promoter	O
region	O
,	O
with	O
the	O
rest	O
of	O
the	O
transcript	O
coming	O
from	O
the	O
native	O
ORF	O
-	O
containing	O
locus	O
.	O

In	O
order	O
to	O
examine	O
the	O
recombination	O
hypothesis	O
,	O
we	O
analyzed	O
115	O
cDNA	O
clones	O
for	O
which	O
sim4	O
failed	O
to	O
align	O
20	O
bp	O
or	O
more	O
to	O
the	O
corresponding	O
genomic	O
locus	O
.	O

In	O
most	O
cases	O
,	O
the	O
missing	O
sequence	O
was	O
explained	O
by	O
gaps	O
in	O
the	O
genomic	O
sequence	O
or	O
by	O
matches	O
that	O
fell	O
below	O
our	O
percent	O
identity	O
-	O
based	O
cutoff	O
for	O
reporting	O
matches	O
.	O

For	O
three	O
cDNAs	O
(	O
from	O
three	O
different	O
olfactory	O
receptors	O
)	O
,	O
we	O
found	O
that	O
the	O
missing	O
piece	O
of	O
sequence	O
matched	O
elsewhere	O
in	O
the	O
genome	O
.	O

Comparison	O
with	O
the	O
public	O
mouse	O
genome	O
assembly	O
confirmed	O
the	O
distant	O
matches	O
.	O

With	O
such	O
a	O
small	O
number	O
of	O
cDNAs	O
exhibiting	O
a	O
possible	O
sign	O
of	O
DNA	O
recombination	O
(	O
a	O
sign	O
that	O
could	O
also	O
be	O
interpreted	O
as	O
chimeric	O
cDNA	O
clones	O
)	O
,	O
we	O
conclude	O
that	O
such	O
rearrangement	O
is	O
unlikely	O
to	O
occur	O
.	O

However	O
,	O
the	O
possibility	O
remains	O
that	O
DNA	O
recombination	O
is	O
responsible	O
for	O
olfactory	O
receptor	O
transcriptional	O
regulation	O
,	O
with	O
the	O
donated	O
region	O
contributing	O
only	O
promoter	O
sequences	O
but	O
no	O
part	O
of	O
the	O
transcript	O
.	O

Both	O
unclustered	O
olfactory	O
receptors	O
and	O
olfactory	O
receptor	O
pseudogenes	O
can	O
be	O
expressed	O

We	O
were	O
interested	O
in	O
whether	O
olfactory	O
receptors	O
need	O
to	O
be	O
part	O
of	O
a	O
cluster	O
in	O
the	O
genome	O
in	O
order	O
to	O
be	O
transcribed	O
,	O
or	O
if	O
the	O
clustered	O
genomic	O
organization	O
of	O
olfactory	O
receptors	O
is	O
simply	O
a	O
consequence	O
of	O
the	O
fact	O
that	O
local	O
duplication	O
is	O
the	O
major	O
mechanism	O
for	O
expanding	O
the	O
gene	O
family	O
[	O
1	O
]	O
.	O

'	O
Singleton	O
'	O
olfactory	O
receptors	O
(	O
defined	O
as	O
full	O
-	O
length	O
olfactory	O
receptors	O
without	O
another	O
olfactory	O
receptor	O
within	O
0	O
.	O
5	O
Mb	O
)	O
are	O
more	O
often	O
pseudogenes	O
than	O
are	O
olfactory	O
receptors	O
in	O
clusters	O
(	O
8	O
out	O
of	O
16	O
versus	O
271	O
out	O
of	O
1	O
,	O
358	O
;	O
chi	O
2	O
=	O
8	O
.	O
8	O
,	O
P	O
<	O
0	O
.	O
005	O
)	O
.	O

Of	O
the	O
eight	O
intact	O
singleton	O
olfactory	O
receptors	O
,	O
two	O
have	O
matching	O
cDNAs	O
in	O
our	O
collection	O
,	O
a	O
similar	O
proportion	O
as	O
found	O
for	O
olfactory	O
receptors	O
in	O
clusters	O
,	O
showing	O
that	O
clustering	O
is	O
not	O
an	O
absolute	O
requirement	O
for	O
olfactory	O
receptor	O
expression	O
.	O

However	O
,	O
it	O
is	O
possible	O
these	O
two	O
expressed	O
singleton	O
genes	O
are	O
part	O
of	O
'	O
extended	O
'	O
olfactory	O
receptor	O
clusters	O
-	O
their	O
nearest	O
olfactory	O
receptor	O
neighbors	O
are	O
1	O
.	O
7	O
Mb	O
and	O
2	O
.	O
6	O
Mb	O
away	O
,	O
respectively	O
.	O

We	O
also	O
find	O
that	O
some	O
olfactory	O
receptor	O
pseudogenes	O
are	O
expressed	O
,	O
albeit	O
with	O
a	O
lower	O
probability	O
than	O
intact	O
olfactory	O
receptors	O
.	O

Considering	O
the	O
1	O
,	O
392	O
olfactory	O
receptor	O
gene	O
sequences	O
for	O
which	O
reliable	O
full	O
-	O
length	O
data	O
are	O
available	O
,	O
15	O
out	O
of	O
285	O
(	O
5	O
%	O
)	O
apparent	O
pseudogenes	O
are	O
represented	O
in	O
our	O
cDNA	O
collection	O
,	O
compared	O
to	O
393	O
out	O
of	O
1	O
,	O
107	O
(	O
36	O
%	O
)	O
intact	O
olfactory	O
receptors	O
.	O

However	O
,	O
three	O
of	O
these	O
15	O
'	O
expressed	O
pseudogenes	O
'	O
are	O
intact	O
genes	O
in	O
the	O
public	O
mouse	O
genome	O
sequence	O
.	O

The	O
defects	O
in	O
Celera	O
'	O
s	O
version	O
of	O
these	O
genes	O
may	O
be	O
due	O
to	O
sequencing	O
errors	O
or	O
true	O
polymorphism	O
.	O

Publicly	O
available	O
mouse	O
sequence	O
confirms	O
that	O
11	O
of	O
the	O
12	O
remaining	O
expressed	O
pseudogenes	O
are	O
indeed	O
pseudogenes	O
.	O

No	O
public	O
sequence	O
matches	O
the	O
12th	O
'	O
expressed	O
pseudogene	O
'	O
with	O
99	O
%	O
identity	O
or	O
more	O
.	O

Discussion	O

We	O
have	O
identified	O
and	O
sequenced	O
1	O
,	O
264	O
odorant	O
receptor	O
cDNAs	O
from	O
419	O
olfactory	O
receptor	O
genes	O
,	O
confirming	O
their	O
expression	O
in	O
the	O
olfactory	O
epithelium	O
.	O

We	O
have	O
thus	O
validated	O
the	O
similarity	O
-	O
based	O
prediction	O
of	O
over	O
one	O
-	O
third	O
of	O
the	O
intact	O
olfactory	O
receptor	O
genes	O
annotated	O
in	O
the	O
mouse	O
genome	O
[	O
1	O
,	O
2	O
]	O
,	O
thereby	O
vastly	O
increasing	O
the	O
proportion	O
of	O
the	O
family	O
for	O
which	O
experimental	O
evidence	O
of	O
olfactory	O
function	O
is	O
available	O
.	O

We	O
have	O
not	O
found	O
cDNAs	O
for	O
all	O
olfactory	O
receptor	O
genes	O
or	O
an	O
even	O
phylogenetic	O
distribution	O
of	O
cDNAs	O
,	O
probably	O
because	O
the	O
libraries	O
and	O
/	O
or	O
our	O
screen	O
are	O
biased	O
toward	O
certain	O
olfactory	O
receptor	O
subfamilies	O
.	O

Using	O
RT	O
-	O
PCR	O
with	O
both	O
degenerate	O
and	O
specific	O
primers	O
,	O
we	O
have	O
confirmed	O
olfactory	O
expression	O
of	O
a	O
number	O
of	O
additional	O
olfactory	O
receptors	O
,	O
bringing	O
the	O
total	O
number	O
of	O
olfactory	O
receptor	O
genes	O
verified	O
in	O
this	O
study	O
to	O
436	O
,	O
and	O
ensuring	O
that	O
almost	O
all	O
phylogenetic	O
clades	O
have	O
at	O
least	O
one	O
representative	O
with	O
evidence	O
of	O
olfactory	O
function	O
.	O

Results	O
of	O
our	O
cDNA	O
library	O
screen	O
suggested	O
that	O
some	O
olfactory	O
receptors	O
are	O
expressed	O
at	O
significantly	O
higher	O
levels	O
than	O
others	O
.	O

We	O
used	O
quantitative	O
PCR	O
to	O
show	O
that	O
expression	O
levels	O
are	O
indeed	O
highly	O
variable	O
,	O
with	O
one	O
olfactory	O
receptor	O
expressed	O
at	O
almost	O
300	O
times	O
the	O
level	O
of	O
another	O
.	O

Higher	O
expression	O
levels	O
could	O
be	O
due	O
to	O
increased	O
transcript	O
number	O
per	O
cell	O
and	O
/	O
or	O
a	O
greater	O
number	O
of	O
olfactory	O
neurons	O
'	O
choosing	O
'	O
those	O
genes	O
.	O

For	O
one	O
pair	O
of	O
genes	O
we	O
tested	O
,	O
expression	O
level	O
differences	O
appear	O
to	O
be	O
due	O
to	O
both	O
factors	O
.	O

It	O
would	O
be	O
interesting	O
to	O
collect	O
data	O
for	O
additional	O
genes	O
to	O
determine	O
how	O
the	O
numbers	O
of	O
expressing	O
cells	O
and	O
transcript	O
levels	O
per	O
cell	O
vary	O
across	O
the	O
olfactory	O
receptor	O
family	O
.	O

Data	O
from	O
a	O
number	O
of	O
previous	O
studies	O
also	O
show	O
that	O
different	O
olfactory	O
receptor	O
genes	O
,	O
or	O
even	O
copies	O
of	O
the	O
same	O
olfactory	O
receptor	O
transgene	O
in	O
different	O
genomic	O
locations	O
are	O
expressed	O
in	O
different	O
numbers	O
of	O
cells	O
[	O
14	O
,	O
18	O
,	O
35	O
]	O
,	O
but	O
do	O
not	O
address	O
the	O
issue	O
of	O
transcript	O
level	O
per	O
cell	O
.	O

The	O
fact	O
that	O
some	O
genes	O
are	O
chosen	O
more	O
frequently	O
,	O
and	O
when	O
chosen	O
may	O
be	O
expressed	O
at	O
higher	O
levels	O
per	O
cell	O
,	O
is	O
intriguing	O
given	O
each	O
olfactory	O
neuron	O
'	O
s	O
single	O
-	O
allele	O
expression	O
regime	O
.	O

The	O
observation	O
of	O
unequal	O
expression	O
leads	O
to	O
a	O
number	O
of	O
questions	O
.	O

It	O
is	O
known	O
that	O
each	O
olfactory	O
receptor	O
is	O
expressed	O
in	O
one	O
of	O
four	O
zones	O
of	O
the	O
olfactory	O
epithelium	O
[	O
14	O
,	O
15	O
]	O
;	O
do	O
some	O
zones	O
choose	O
from	O
a	O
smaller	O
olfactory	O
receptor	O
sub	O
-	O
repertoire	O
and	O
thus	O
express	O
each	O
olfactory	O
receptor	O
in	O
a	O
larger	O
number	O
of	O
cells	O
?	O

We	O
note	O
that	O
several	O
apparently	O
highly	O
expressed	O
olfactory	O
receptors	O
(	O
gene	O
A	O
,	O
this	O
study	O
,	O
and	O
MOR10	O
and	O
MOR28	O
[	O
36	O
]	O
)	O
are	O
expressed	O
in	O
zone	O
4	O
of	O
the	O
olfactory	O
epithelium	O
.	O

Does	O
activity	O
-	O
dependent	O
neuronal	O
competition	O
[	O
37	O
]	O
contribute	O
to	O
increased	O
representation	O
of	O
the	O
olfactory	O
receptors	O
that	O
respond	O
to	O
common	O
environmental	O
odorants	O
?	O

Do	O
the	O
favored	O
olfactory	O
receptors	O
have	O
stronger	O
promoter	O
sequences	O
?	O

Are	O
some	O
olfactory	O
receptor	O
mRNAs	B-CHEBI
more	O
stable	O
than	O
others	O
,	O
leading	O
to	O
higher	O
transcript	O
levels	O
per	O
expressing	O
cell	O
?	O

Are	O
the	O
favored	O
olfactory	O
receptors	O
in	O
more	O
open	O
chromatin	O
conformation	O
or	O
more	O
accessible	O
genomic	O
locations	O
?	O

Transcription	O
of	O
apparent	O
'	O
singleton	O
'	O
olfactory	O
receptor	O
genes	O
(	O
0	O
.	O
5	O
Mb	O
or	O
more	O
from	O
the	O
nearest	O
other	O
olfactory	O
receptor	O
gene	O
)	O
suggests	O
that	O
there	O
is	O
no	O
absolute	O
requirement	O
for	O
genomic	O
clustering	O
for	O
an	O
olfactory	O
receptor	O
to	O
be	O
transcribed	O
,	O
consistent	O
with	O
observations	O
that	O
small	O
olfactory	O
receptor	O
transgenes	O
can	O
be	O
expressed	O
correctly	O
when	O
integrated	O
outside	O
native	O
olfactory	O
receptor	O
clusters	O
[	O
35	O
]	O
.	O

However	O
,	O
the	O
high	O
pseudogene	O
count	O
among	O
singleton	O
olfactory	O
receptor	O
genes	O
(	O
50	O
%	O
,	O
versus	O
20	O
%	O
for	O
clustered	O
olfactory	O
receptor	O
genes	O
)	O
suggests	O
that	O
not	O
all	O
genomic	O
locations	O
are	O
favorable	O
for	O
olfactory	O
receptor	O
gene	O
survival	O
,	O
perhaps	O
due	O
to	O
transcriptional	O
constraints	O
.	O

It	O
is	O
also	O
possible	O
that	O
evolutionary	O
factors	O
may	O
be	O
responsible	O
for	O
reduced	O
pseudogene	O
content	O
of	O
clustered	O
olfactory	O
receptors	O
-	O
gene	O
conversion	O
between	O
neighboring	O
olfactory	O
receptors	O
could	O
rescue	O
inactivating	O
mutations	O
in	O
clustered	O
genes	O
,	O
but	O
not	O
singletons	O
.	O

Before	O
these	O
questions	O
about	O
olfactory	O
receptor	O
gene	O
choice	O
can	O
be	O
answered	O
,	O
it	O
will	O
be	O
important	O
to	O
measure	O
expression	O
levels	O
of	O
a	O
larger	O
number	O
of	O
genes	O
,	O
perhaps	O
using	O
an	O
olfactory	O
receptor	O
gene	O
microarray	O
.	O

Our	O
study	O
provides	O
at	O
least	O
partial	O
data	O
about	O
the	O
upstream	O
transcript	O
structures	O
of	O
over	O
300	O
olfactory	O
receptor	O
genes	O
.	O

These	O
data	O
provide	O
tentative	O
locations	O
of	O
a	O
large	O
set	O
of	O
promoter	O
regions	O
,	O
allowing	O
computational	O
searches	O
for	O
shared	O
sequence	O
motifs	O
that	O
might	O
be	O
involved	O
in	O
the	O
intriguing	O
transcriptional	O
regulation	O
of	O
olfactory	O
receptors	O
.	O

However	O
,	O
given	O
that	O
not	O
all	O
cDNAs	O
are	O
full	O
-	O
length	O
clones	O
,	O
some	O
of	O
these	O
candidates	O
will	O
not	O
be	O
true	O
promoter	O
regions	O
.	O

The	O
5	O
'	O
UTR	O
sequences	O
we	O
obtained	O
will	O
also	O
aid	O
in	O
the	O
design	O
of	O
experimental	O
probes	O
,	O
for	O
example	O
,	O
for	O
in	O
situ	O
hybridizations	O
or	O
to	O
immobilize	O
on	O
an	O
olfactory	O
receptor	O
microarray	O
.	O

One	O
of	O
the	O
challenges	O
of	O
such	O
an	O
array	O
will	O
be	O
to	O
design	O
unique	O
probes	O
with	O
which	O
to	O
represent	O
each	O
gene	O
.	O

Often	O
,	O
the	O
coding	O
region	O
of	O
olfactory	O
receptors	O
is	O
highly	O
similar	O
between	O
recently	O
duplicated	O
genes	O
.	O

Many	O
pairs	O
of	O
similar	O
olfactory	O
receptors	O
show	O
more	O
sequence	O
divergence	O
in	O
the	O
UTRs	O
than	O
the	O
protein	B-CHEBI
-	O
coding	O
region	O
(	O
J	O
.	O
Y	O
.	O
,	O
unpublished	O
observations	O
)	O
.	O

The	O
UTRs	O
would	O
therefore	O
make	O
a	O
better	O
choice	O
of	O
sequence	O
from	O
which	O
to	O
design	O
unique	O
oligonucleotides	O
to	O
distinguish	O
closely	O
related	O
olfactory	O
receptor	O
genes	O
.	O

Locations	O
of	O
these	O
regions	O
in	O
genomic	O
sequence	O
are	O
difficult	O
to	O
predict	O
-	O
our	O
study	O
provides	O
5	O
'	O
UTR	O
sequences	O
of	O
343	O
genes	O
and	O
the	O
approximate	O
3	O
'	O
UTR	O
length	O
for	O
399	O
olfactory	O
receptor	O
genes	O
.	O

Probe	O
design	O
must	O
also	O
account	O
for	O
the	O
multiple	O
transcriptional	O
isoforms	O
observed	O
for	O
many	O
olfactory	O
receptors	O
-	O
depending	O
on	O
the	O
question	O
being	O
asked	O
,	O
probes	O
could	O
be	O
designed	O
in	O
shared	O
sequence	O
to	O
determine	O
the	O
total	O
level	O
of	O
all	O
isoforms	O
,	O
or	O
in	O
unique	O
exons	O
to	O
measure	O
the	O
level	O
of	O
each	O
isoform	O
separately	O
.	O

We	O
find	O
that	O
the	O
majority	O
of	O
the	O
olfactory	O
receptors	O
,	O
like	O
most	O
non	O
-	O
olfactory	O
receptor	O
genes	O
[	O
38	O
,	O
39	O
]	O
,	O
are	O
transcribed	O
as	O
multiple	O
isoforms	O
,	O
involving	O
alternative	O
splicing	O
of	O
5	O
'	O
untranslated	O
exons	O
and	O
alternate	O
polyadenylation	O
-	O
site	O
usage	O
.	O

The	O
act	O
of	O
splicing	O
itself	O
may	O
be	O
important	O
for	O
efficient	O
mRNA	B-CHEBI
export	O
from	O
the	O
nucleus	O
[	O
40	O
]	O
or	O
to	O
couple	O
olfactory	O
receptor	O
coding	O
regions	O
with	O
genomically	O
distant	O
promoters	O
.	O

The	O
exact	O
nature	O
of	O
the	O
spliced	O
transcript	O
might	O
be	O
unimportant	O
,	O
such	O
that	O
several	O
isoforms	O
might	O
be	O
produced	O
simply	O
because	O
multiple	O
functional	O
splice	O
sites	O
are	O
available	O
.	O

Alternatively	O
,	O
the	O
multiplicity	O
of	O
transcriptional	O
isoforms	O
might	O
have	O
functional	O
significance	O
,	O
as	O
UTRs	O
may	O
contain	O
signals	O
controlling	O
mRNA	B-CHEBI
stability	O
,	O
localization	O
or	O
degradation	O
[	O
41	O
,	O
42	O
]	O
.	O

Our	O
study	O
shows	O
that	O
about	O
5	O
%	O
of	O
olfactory	O
receptor	O
transcripts	O
do	O
not	O
fit	O
the	O
current	O
notion	O
of	O
olfactory	O
receptor	O
gene	O
structure	O
.	O

Occasionally	O
,	O
an	O
intron	O
is	O
spliced	O
out	O
of	O
the	O
3	O
'	O
untranslated	O
region	O
.	O

A	O
number	O
of	O
cDNAs	O
use	O
splice	O
sites	O
within	O
the	O
olfactory	O
receptor	O
'	O
s	O
ORF	O
,	O
meaning	O
that	O
their	O
protein	B-CHEBI
product	I-CHEBI
is	O
different	O
from	O
that	O
predicted	O
on	O
the	O
basis	O
of	O
genomic	O
sequence	O
alone	O
.	O

In	O
two	O
such	O
cases	O
,	O
the	O
transcript	O
would	O
encode	O
a	O
functional	O
olfactory	O
receptor	O
,	O
with	O
the	O
initiating	O
methionine	B-CHEBI
and	O
first	O
few	O
amino	B-CHEBI
acids	I-CHEBI
encoded	O
by	O
an	O
upstream	O
exon	O
,	O
as	O
has	O
been	O
observed	O
previously	O
for	O
a	O
subtelomeric	O
human	O
olfactory	O
receptor	O
gene	O
[	O
25	O
]	O
.	O

Such	O
within	O
-	O
ORF	O
splicing	O
might	O
increase	O
protein	B-CHEBI
-	O
coding	O
diversity	O
,	O
although	O
,	O
given	O
the	O
small	O
number	O
of	O
genes	O
involved	O
,	O
splicing	O
is	O
unlikely	O
to	O
significantly	O
affect	O
the	O
functional	O
receptor	O
repertoire	O
.	O

Most	O
of	O
the	O
atypical	O
splice	O
forms	O
we	O
observe	O
appear	O
to	O
encode	O
non	O
-	O
functional	O
transcripts	O
,	O
containing	O
frameshifts	O
or	O
lacking	O
a	O
start	O
codon	O
or	O
other	O
functional	O
residues	B-CHEBI
conserved	O
throughout	O
the	O
olfactory	O
receptor	O
family	O
.	O

These	O
nonfunctional	O
transcripts	O
are	O
probably	O
aberrant	O
by	O
-	O
products	O
of	O
the	O
splicing	O
system	O
[	O
43	O
]	O
that	O
have	O
not	O
yet	O
been	O
degraded	O
by	O
RNA	O
surveillance	O
systems	O
[	O
40	O
,	O
41	O
]	O
.	O

The	O
neurons	O
expressing	O
these	O
aberrant	O
transcripts	O
might	O
also	O
make	O
normal	O
transcripts	O
for	O
the	O
same	O
genes	O
and	O
thus	O
produce	O
a	O
functional	O
olfactory	O
receptor	O
.	O

Alternatively	O
,	O
the	O
unusual	O
transcriptional	O
regulation	O
of	O
olfactory	O
receptors	O
might	O
ensure	O
that	O
only	O
one	O
splice	O
isoform	O
is	O
expressed	O
per	O
cell	O
(	O
unlikely	O
,	O
but	O
possible	O
if	O
an	O
RNA	O
-	O
based	O
feedback	O
mechanism	O
operates	O
)	O
,	O
thus	O
condemning	O
cells	O
expressing	O
these	O
aberrant	O
isoforms	O
to	O
be	O
dysfunctional	O
.	O

We	O
also	O
observe	O
transcripts	O
from	O
a	O
small	O
number	O
of	O
olfactory	O
receptor	O
pseudogenes	O
,	O
as	O
previously	O
described	O
for	O
three	O
human	O
olfactory	O
receptor	O
pseudogenes	O
[	O
26	O
,	O
44	O
]	O
.	O

Although	O
many	O
fewer	O
pseudogenes	O
than	O
intact	O
genes	O
were	O
represented	O
in	O
our	O
cDNA	O
collection	O
,	O
some	O
neurons	O
in	O
the	O
olfactory	O
epithelium	O
evidently	O
express	O
disrupted	O
olfactory	O
receptors	O
and	O
thus	O
might	O
be	O
unable	O
to	O
respond	O
to	O
odorants	O
or	O
to	O
correctly	O
innervate	O
the	O
olfactory	O
bulb	O
.	O

Wang	O
,	O
Axel	O
and	O
coworkers	O
have	O
shown	O
that	O
an	O
artificial	O
transgenic	O
olfactory	O
receptor	O
gene	O
containing	O
two	O
nonsense	O
mutations	O
can	O
support	O
development	O
of	O
an	O
olfactory	O
neuron	O
,	O
but	O
that	O
pseudogene	O
-	O
expressing	O
neurons	O
fail	O
to	O
converge	O
on	O
a	O
glomerulus	O
in	O
the	O
olfactory	O
bulb	O
[	O
45	O
]	O
.	O

By	O
analogy	O
with	O
an	O
olfactory	O
receptor	O
deletion	O
mutant	O
[	O
45	O
]	O
,	O
it	O
is	O
likely	O
that	O
most	O
pseudogene	O
-	O
expressing	O
neurons	O
die	O
or	O
switch	O
to	O
express	O
a	O
different	O
olfactory	O
receptor	O
gene	O
,	O
leaving	O
a	O
small	O
number	O
of	O
pseudogene	O
-	O
expressing	O
neurons	O
in	O
adult	O
mice	O
,	O
but	O
at	O
greatly	O
reduced	O
levels	O
compared	O
to	O
neurons	O
expressing	O
intact	O
olfactory	O
receptors	O
.	O

Conclusions	O

Our	O
study	O
has	O
provided	O
an	O
olfactory	O
receptor	O
cDNA	O
resource	O
representing	O
over	O
one	O
-	O
third	O
of	O
the	O
olfactory	O
receptor	O
gene	O
family	O
.	O

We	O
have	O
thus	O
established	O
over	O
400	O
annotated	O
olfactory	O
receptor	O
genes	O
as	O
having	O
olfactory	O
function	O
.	O

The	O
sequences	O
we	O
generated	O
demonstrate	O
that	O
the	O
majority	O
of	O
the	O
olfactory	O
receptor	O
gene	O
family	O
has	O
multiple	O
transcriptional	O
isoforms	O
.	O

Most	O
olfactory	O
receptor	O
transcripts	O
encode	O
functional	O
receptor	O
proteins	B-CHEBI
,	O
with	O
rare	O
exceptions	O
.	O

We	O
show	O
that	O
individual	O
olfactory	O
receptor	O
genes	O
can	O
have	O
vastly	O
different	O
expression	O
levels	O
,	O
an	O
intriguing	O
finding	O
in	O
light	O
of	O
the	O
unusual	O
one	O
-	O
neuron	O
one	O
-	O
gene	O
transcriptional	O
regime	O
of	O
the	O
olfactory	O
epithelium	O
.	O

Our	O
results	O
and	O
the	O
sequences	O
we	O
provide	O
will	O
facilitate	O
future	O
global	O
studies	O
of	O
the	O
mechanisms	O
and	O
dynamics	O
of	O
olfactory	O
receptor	O
gene	O
expression	O
.	O

Materials	O
and	O
methods	O

Identification	O
of	O
olfactory	O
receptor	O
cDNAs	O

An	O
adult	O
mouse	O
cDNA	O
library	O
made	O
from	O
the	O
olfactory	O
epithelium	O
of	O
a	O
single	O
animal	O
was	O
provided	O
by	O
Leslie	O
Vosshall	O
(	O
Rockefeller	O
University	O
,	O
New	O
York	O
,	O
NY	O
,	O
USA	O
)	O
,	O
and	O
an	O
embryonic	O
library	O
(	O
made	O
from	O
the	O
olfactory	O
epithelia	O
of	O
several	O
E16	O
.	O
5	O
-	O
E18	O
.	O
5	O
embryos	O
)	O
was	O
provided	O
by	O
Tyler	O
Cutforth	O
(	O
Columbia	O
University	O
,	O
New	O
York	O
,	O
NY	O
,	O
USA	O
)	O
.	O

Both	O
libraries	O
were	O
oligo	O
-	O
dT	O
primed	O
and	O
directionally	O
cloned	O
into	O
the	O
lambdaZAP	O
-	O
XR	O
vector	O
(	O
Stratagene	O
,	O
La	O
Jolla	O
,	O
CA	O
,	O
USA	O
)	O
.	O

The	O
adult	O
library	O
has	O
a	O
complexity	O
of	O
6	O
.	O
5	O
x	O
106	O
primary	O
clones	O
,	O
and	O
the	O
embryonic	O
library	O
has	O
a	O
complexity	O
of	O
1	O
.	O
65	O
x	O
106	O
.	O

Libraries	O
were	O
amplified	O
to	O
give	O
titers	O
of	O
5	O
x	O
109	O
pfu	O
/	O
ml	O
(	O
adult	O
)	O
or	O
2	O
x	O
1010	O
pfu	O
/	O
ml	O
(	O
embryonic	O
)	O
.	O

Hybridization	O
probes	O
were	O
made	O
by	O
degenerate	O
PCR	O
of	O
mouse	O
genomic	O
DNA	O
,	O
in	O
a	O
fashion	O
similar	O
to	O
those	O
described	O
previously	O
[	O
1	O
]	O
,	O
with	O
primer	O
pairs	O
and	O
annealing	O
temperatures	O
given	O
in	O
Table	O
2	O
.	O

Low	O
-	O
stringency	O
hybridization	O
conditions	O
were	O
as	O
described	O
[	O
1	O
]	O
.	O

Clonally	O
-	O
pure	O
plaques	O
were	O
obtained	O
through	O
secondary	O
screens	O
using	O
the	O
same	O
probe	O
as	O
the	O
corresponding	O
primary	O
screen	O
.	O

PCR	O
with	O
vector	O
primers	O
(	O
M13F	O
/	O
R	O
)	O
was	O
performed	O
to	O
prepare	O
sequencing	O
templates	O
.	O

cDNA	O
size	O
estimates	O
were	O
obtained	O
by	O
agarose	B-CHEBI
gel	O
electrophoresis	O
,	O
and	O
inserts	O
were	O
sequenced	O
from	O
the	O
5	O
'	O
end	O
using	O
the	O
M13R	O
primer	O
and	O
big	O
-	O
dye	B-CHEBI
terminator	O
chemistry	O
according	O
to	O
ABI	O
'	O
s	O
protocols	O
(	O
Applied	O
Biosystems	O
,	O
Foster	O
City	O
,	O
CA	O
,	O
USA	O
)	O
.	O

In	O
order	O
to	O
obtain	O
3	O
'	O
sequence	O
,	O
selected	O
phage	O
clones	O
were	O
converted	O
to	O
plasmid	O
stocks	O
following	O
a	O
scaled	O
-	O
down	O
version	O
of	O
Stratagene	O
'	O
s	O
in	O
vivo	O
excision	O
protocol	O
.	O

Plasmid	O
DNA	O
gave	O
better	O
3	O
'	O
-	O
end	O
sequence	O
than	O
PCR	O
products	O
,	O
which	O
often	O
suffered	O
from	O
polymerase	O
stuttering	O
through	O
the	O
poly	O
(	O
A	B-CHEBI
)	O
tract	O
.	O

cDNA	O
sequences	O
and	O
associated	O
information	O
are	O
available	O
through	O
dbEST	O
(	O
Genbank	O
accessions	O
CB172832	O
-	O
CB174569	O
)	O
and	O
our	O
olfactory	O
receptor	O
database	O
[	O
46	O
]	O
.	O

The	O
updated	O
olfactory	O
receptor	O
gene	O
catalog	O
is	O
available	O
through	O
Genbank	O
(	O
accessions	O
AY317244	O
-	O
AY318733	O
)	O
.	O

Throughout	O
the	O
manuscript	O
,	O
genes	O
are	O
referred	O
to	O
by	O
their	O
Genbank	O
accession	O
numbers	O
.	O

Sequence	O
analysis	O

cDNA	O
sequences	O
were	O
base	O
-	O
called	O
and	O
quality	O
-	O
trimmed	O
using	O
phred	O
(	O
trim	O
_	O
cutoff	O
=	O
0	O
.	O
05	O
)	O
[	O
47	O
]	O
,	O
and	O
vector	O
sequences	O
were	O
removed	O
using	O
cross	O
_	O
match	O
[	O
48	O
]	O
.	O

Any	O
sequences	O
of	O
less	O
than	O
50	O
bp	O
after	O
trimming	O
were	O
discarded	O
.	O

3	O
'	O
UTR	O
lengths	O
were	O
estimated	O
by	O
combining	O
approximate	O
insert	O
sizes	O
determined	O
by	O
PCR	O
with	O
5	O
'	O
sequence	O
data	O
where	O
possible	O
(	O
if	O
the	O
5	O
'	O
sequence	O
did	O
not	O
extend	O
into	O
the	O
coding	O
region	O
we	O
could	O
not	O
estimate	O
3	O
'	O
UTR	O
size	O
)	O
.	O

We	O
counted	O
cDNAs	O
from	O
a	O
given	O
gene	O
as	O
showing	O
alternative	O
polyadenylation	O
site	O
usage	O
if	O
3	O
'	O
UTR	O
length	O
estimates	O
varied	O
by	O
at	O
least	O
400	O
bp	O
-	O
smaller	O
variation	O
could	O
be	O
real	O
,	O
but	O
may	O
not	O
be	O
distinguishable	O
from	O
error	O
in	O
our	O
size	O
estimates	O
.	O

To	O
assign	O
cDNAs	O
to	O
their	O
corresponding	O
olfactory	O
receptor	O
genes	O
,	O
we	O
first	O
defined	O
a	O
genomic	O
'	O
territory	O
'	O
for	O
each	O
gene	O
,	O
with	O
the	O
following	O
attributes	O
:	O
strand	O
,	O
start	O
position	O
(	O
100	O
kb	O
upstream	O
of	O
the	O
start	O
codon	O
or	O
1	O
kb	O
after	O
the	O
previous	O
gene	O
upstream	O
on	O
the	O
same	O
strand	O
,	O
whichever	O
is	O
closer	O
)	O
and	O
end	O
position	O
(	O
1	O
kb	O
downstream	O
of	O
the	O
stop	O
codon	O
)	O
.	O

Trimmed	O
sequences	O
were	O
compared	O
with	O
genomic	O
sequences	O
using	O
sim4	O
[	O
30	O
]	O
(	O
settings	O
P	O
=	O
1	O
to	O
remove	O
polyA	O
tails	O
and	O
N	O
=	O
1	O
to	O
perform	O
an	O
intensive	O
search	O
for	O
small	O
exons	O
)	O
.	O

The	O
sim4	O
algorithm	O
uses	O
splice	O
-	O
site	O
consensus	O
sequences	O
to	O
refine	O
alignments	O
.	O

Only	O
matches	O
of	O
96	O
%	O
or	O
greater	O
nucleotide	B-CHEBI
identity	O
were	O
considered	O
.	O

RepeatMasked	O
sequences	O
[	O
49	O
]	O
were	O
also	O
compared	O
to	O
genomic	O
sequences	O
;	O
cDNA	O
:	O
genomic	O
sequence	O
pairings	O
not	O
found	O
in	O
both	O
masked	O
and	O
unmasked	O
alignments	O
were	O
rejected	O
.	O

Coordinates	O
from	O
the	O
unmasked	O
alignment	O
were	O
used	O
for	O
further	O
analysis	O
.	O

Any	O
cDNA	O
sequence	O
matching	O
entirely	O
within	O
a	O
territory	O
was	O
assigned	O
to	O
that	O
gene	O
.	O

If	O
a	O
cDNA	O
matched	O
more	O
than	O
one	O
gene	O
territory	O
,	O
the	O
best	O
match	O
was	O
chosen	O
(	O
that	O
is	O
,	O
the	O
one	O
with	O
highest	O
'	O
score	O
'	O
,	O
where	O
score	O
is	O
the	O
total	O
of	O
all	O
exons	O
'	O
lengths	O
multiplied	O
by	O
their	O
respective	O
percent	O
identities	O
)	O
.	O

We	O
found	O
27	O
cDNAs	O
that	O
spanned	O
a	O
larger	O
genomic	O
range	O
than	O
one	O
gene	O
territory	O
and	O
flagged	O
them	O
for	O
more	O
careful	O
analysis	O
.	O

Of	O
these	O
,	O
six	O
cDNAs	O
showed	O
unusual	O
splicing	O
within	O
the	O
3	O
'	O
UTR	O
,	O
but	O
the	O
remaining	O
'	O
territory	O
violators	O
'	O
were	O
found	O
to	O
be	O
artifacts	O
of	O
the	O
analysis	O
process	O
which	O
fell	O
into	O
three	O
types	O
.	O

These	O
included	O
:	O
cDNAs	O
where	O
the	O
insert	O
appeared	O
to	O
be	O
cloned	O
in	O
the	O
reverse	O
orientation	O
(	O
six	O
cDNAs	O
)	O
;	O
sequences	O
from	O
recently	O
duplicated	O
gene	O
pairs	O
,	O
where	O
sim4	O
assigned	O
coding	O
region	O
and	O
upstream	O
exons	O
to	O
different	O
members	O
of	O
the	O
pair	O
,	O
although	O
exons	O
could	O
equally	O
well	O
have	O
been	O
aligned	O
closer	O
to	O
one	O
another	O
(	O
six	O
cDNAs	O
)	O
;	O
and	O
artifacts	O
due	O
to	O
use	O
of	O
sim4	O
'	O
s	O
N	O
=	O
1	O
parameter	O
(	O
nine	O
cDNAs	O
)	O
.	O

This	O
parameter	O
instructs	O
the	O
program	O
to	O
make	O
extra	O
effort	O
to	O
match	O
small	O
upstream	O
exons	O
,	O
allowing	O
a	O
greater	O
total	O
length	O
of	O
EST	O
sequence	O
to	O
be	O
matched	O
.	O

However	O
,	O
occasionally	O
the	O
N	O
=	O
1	O
parameter	O
caused	O
the	O
program	O
to	O
assign	O
very	O
small	O
sequences	O
(	O
1	O
-	O
4	O
bp	O
)	O
to	O
distant	O
upstream	O
exons	O
,	O
when	O
they	O
probably	O
match	O
nearer	O
to	O
the	O
corresponding	O
coding	O
sequence	O
.	O

The	O
expected	O
distribution	O
shown	O
in	O
Figure	O
2	O
was	O
calculated	O
using	O
the	O
equation	O
P	O
(	O
x	O
)	O
=	O
e	O
-	O
mu	O
mu	O
x	O
/	O
x	O
!	O
,	O
where	O
P	O
(	O
x	O
)	O
is	O
the	O
Poisson	O
probability	O
of	O
observing	O
x	O
cDNAs	O
per	O
gene	O
,	O
and	O
mu	O
is	O
the	O
mean	O
number	O
of	O
cDNAs	O
observed	O
per	O
gene	O
(	O
mu	O
=	O
1	O
,	O
176	O
/	O
983	O
:	O
1	O
,	O
176	O
cDNAs	O
matching	O
olfactory	O
receptor	O
genes	O
in	O
our	O
dataset	O
and	O
983	O
intact	O
class	O
II	O
olfactory	O
receptors	O
)	O
.	O

In	O
our	O
analysis	O
of	O
expressed	O
pseudogenes	O
,	O
we	O
ignored	O
two	O
olfactory	O
receptor	O
pseudogenes	O
found	O
very	O
near	O
the	O
ends	O
of	O
genomic	O
sequences	O
and	O
thus	O
likely	O
to	O
be	O
error	O
-	O
prone	O
.	O

A	O
protein	B-CHEBI
sequence	O
alignment	O
of	O
intact	O
mouse	O
olfactory	O
receptors	O
was	O
generated	O
using	O
CLUSTALW	O
[	O
50	O
]	O
,	O
edited	O
by	O
hand	O
,	O
and	O
used	O
to	O
produce	O
the	O
phylogenetic	O
tree	O
shown	O
in	O
Figure	O
1	O
using	O
PAUP	O
'	O
s	O
neighbor	O
-	O
joining	O
algorithm	O
(	O
v4	O
.	O
0b6	O
Version	O
4	O
,	O
Sinauer	O
Associates	O
,	O
Sunderland	O
,	O
MA	O
)	O
.	O

The	O
tree	O
was	O
colored	O
using	O
a	O
custom	O
script	O
.	O

Information	O
content	O
(	O
the	O
measure	O
of	O
sequence	O
conservation	O
shown	O
in	O
Figure	O
6	O
)	O
was	O
calculated	O
for	O
each	O
position	O
in	O
the	O
alignment	O
using	O
alpro	O
[	O
51	O
]	O
.	O

To	O
determine	O
the	O
number	O
of	O
transcriptional	O
isoforms	O
for	O
each	O
gene	O
,	O
we	O
examined	O
the	O
sim4	O
output	O
for	O
every	O
matching	O
cDNA	O
in	O
decreasing	O
order	O
of	O
number	O
of	O
exons	O
.	O

The	O
first	O
cDNA	O
was	O
counted	O
as	O
one	O
splice	O
form	O
,	O
and	O
for	O
each	O
subsequent	O
cDNA	O
,	O
we	O
determined	O
whether	O
exon	O
structure	O
was	O
mutually	O
exclusive	O
to	O
isoforms	O
already	O
counted	O
.	O

We	O
were	O
conservative	O
in	O
our	O
definition	O
of	O
mutually	O
exclusive	O
,	O
and	O
thus	O
our	O
count	O
represents	O
the	O
minimum	O
number	O
of	O
isoforms	O
represented	O
in	O
the	O
cDNA	O
collection	O
.	O

RT	O
-	O
PCR	O

The	O
olfactory	O
epithelia	O
were	O
dissected	O
from	O
three	O
adult	O
female	O
C57BL	O
/	O
6	O
mice	O
,	O
including	O
tissues	O
attached	O
to	O
the	O
skull	O
and	O
septum	O
.	O

RNA	O
was	O
isolated	O
using	O
the	O
Qiagen	O
RNeasy	O
midi	O
kit	O
(	O
Qiagen	O
,	O
Valencia	O
,	O
CA	O
,	O
USA	O
)	O
,	O
including	O
a	O
DNase	O
treatment	O
step	O
.	O

First	O
-	O
strand	O
cDNA	O
was	O
produced	O
from	O
2	O
.	O
5	O
mu	O
g	O
of	O
RNA	O
in	O
a	O
volume	O
of	O
50	O
mu	O
l	O
using	O
random	O
hexamers	O
and	O
Invitrogen	O
'	O
s	O
Superscript	O
II	O
reverse	O
transcriptase	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
CA	O
,	O
USA	O
)	O
,	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
recommendations	O
.	O

One	O
-	O
twenty	O
-	O
fifth	O
of	O
the	O
resulting	O
cDNA	O
was	O
used	O
as	O
template	O
in	O
subsequent	O
PCR	O
reactions	O
.	O

PCR	O
amplification	O
biased	O
towards	O
class	O
I	O
olfactory	O
receptors	O
was	O
performed	O
using	O
degenerate	O
primers	O
P26	O
[	O
17	O
]	O
and	O
classI	O
_	O
R1	O
(	O
5	O
'	O
-	O
GGRTTIADIRYIGGNGG	O
-	O
3	O
'	O
)	O
with	O
an	O
annealing	O
temperature	O
of	O
44	O
degrees	O
C	O
.	O

The	O
product	O
was	O
cloned	O
(	O
TA	O
cloning	O
kit	O
,	O
Invitrogen	O
)	O
,	O
and	O
individual	O
clones	O
were	O
sequenced	O
.	O

Specific	O
PCR	O
primers	O
used	O
to	O
confirm	O
expression	O
of	O
individual	O
olfactory	O
receptor	O
genes	O
are	O
given	O
in	O
Additional	O
data	O
file	O
1	O
.	O

Each	O
PCR	O
product	O
was	O
sequenced	O
to	O
confirm	O
that	O
the	O
expected	O
gene	O
and	O
no	O
others	O
had	O
been	O
amplified	O
.	O

Control	O
reactions	O
on	O
a	O
template	O
made	O
by	O
omitting	O
reverse	O
transcriptase	O
gave	O
no	O
product	O
,	O
indicating	O
that	O
the	O
RNA	O
preparation	O
was	O
uncontaminated	O
by	O
genomic	O
DNA	O
.	O

Relative	O
transcript	O
levels	O
were	O
estimated	O
using	O
real	O
-	O
time	O
PCR	O
according	O
to	O
Applied	O
Biosystems	O
'	O
protocols	O
,	O
with	O
magnesium	B-CHEBI
concentration	O
,	O
primer	O
pair	O
and	O
fluorescent	B-CHEBI
probe	I-CHEBI
given	O
in	O
Additional	O
data	O
file	O
2	O
.	O

The	O
increase	O
in	O
fluorescence	O
during	O
thermocycling	O
was	O
measured	O
on	O
an	O
ABI	O
PRISM	O
7900HT	O
.	O

Standard	O
curves	O
were	O
constructed	O
for	O
each	O
primer	O
pair	O
using	O
triplicate	O
samples	O
of	O
mouse	O
genomic	O
DNA	O
of	O
nine	O
known	O
concentrations	O
(	O
range	O
0	O
.	O
01	O
-	O
100	O
ng	O
,	O
or	O
about	O
3	O
-	O
30	O
,	O
000	O
copies	O
of	O
the	O
haploid	O
genome	O
)	O
.	O

Relative	O
expression	O
level	O
of	O
each	O
gene	O
was	O
determined	O
by	O
comparing	O
the	O
mean	O
Ct	O
(	O
cycle	O
where	O
fluorescence	O
reaches	O
an	O
arbitrary	O
threshold	O
value	O
)	O
obtained	O
with	O
six	O
replicate	O
samples	O
of	O
reverse	O
-	O
transcribed	O
RNA	O
to	O
the	O
standard	O
curve	O
for	O
the	O
corresponding	O
primers	O
.	O

Relative	O
RNA	O
levels	O
of	O
a	O
housekeeping	O
gene	O
,	O
ribosomal	O
S16	O
,	O
were	O
measured	O
as	O
previously	O
described	O
[	O
52	O
]	O
.	O

Control	O
reactions	O
on	O
template	O
prepared	O
by	O
omitting	O
reverse	O
transcriptase	O
amplified	O
at	O
a	O
relative	O
level	O
of	O
0	O
.	O
03	O
+/-	O
0	O
.	O
01	O
ng	O
or	O
less	O
in	O
each	O
case	O
.	O

Expression	O
measurements	O
of	O
the	O
seven	O
genes	O
were	O
normalized	O
for	O
each	O
mouse	O
so	O
that	O
S16	O
levels	O
were	O
equal	O
to	O
1	O
(	O
arbitrary	O
units	O
)	O
.	O

In	O
situ	O
hybridization	O

Coronal	O
sections	O
were	O
cut	O
from	O
the	O
olfactory	O
epithelia	O
of	O
an	O
adult	O
mouse	O
(	O
Figure	O
4	O
)	O
and	O
a	O
young	O
(	O
P6	O
)	O
C57BL	O
/	O
6	O
mouse	O
.	O

RNA	O
in	O
situ	O
hybridization	O
was	O
carried	O
out	O
as	O
described	O
previously	O
[	O
15	O
,	O
53	O
]	O
with	O
digoxigenin	B-CHEBI
-	O
labeled	O
antisense	O
riboprobes	O
specific	O
for	O
the	O
3	O
'	O
UTRs	O
of	O
genes	O
AY318555	O
(	O
0	O
.	O
5	O
kb	O
)	O
and	O
AY317365	O
(	O
0	O
.	O
5	O
kb	O
)	O
.	O

Riboprobe	O
sequences	O
were	O
generated	O
by	O
PCR	O
using	O
primer	O
pairs	O
5	O
'	O
-	O
TCTTCCAAACCTGGACCCCCC	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
ATCTCTCCAGCACCTTACTTG	O
-	O
3	O
'	O
for	O
AY318555	O
and	O
primer	O
pairs	O
5	O
'	O
-	O
TAAGATGTAAGTGATAATTTAGATTACAGG	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
TTTCTGCCTCAGCTATGACAG	O
-	O
3	O
'	O
for	O
AY317365	O
.	O

Hybridization	O
was	O
carried	O
out	O
in	O
50	O
%	O
formamide	B-CHEBI
at	O
65	O
degrees	O
C	O
,	O
and	O
slides	O
were	O
washed	O
at	O
high	O
stringency	O
(	O
65	O
degrees	O
C	O
,	O
0	O
.	O
2	O
x	O
SSC	O
)	O
.	O

The	O
probes	O
each	O
hybridize	O
to	O
only	O
one	O
band	O
on	O
a	O
Southern	O
blot	O
,	O
indicating	O
that	O
each	O
probe	O
only	O
detects	O
one	O
olfactory	O
receptor	O
gene	O
.	O

BLAST	O
analyses	O
show	O
that	O
the	O
AY318555	O
probe	O
is	O
unique	O
in	O
Celera	O
'	O
s	O
mouse	O
genome	O
assembly	O
(	O
Release	O
13	O
)	O
,	O
and	O
that	O
the	O
AY317365	O
probe	O
is	O
similar	O
to	O
only	O
one	O
other	O
genomic	O
region	O
.	O

This	O
potential	O
cross	O
-	O
hybridizing	O
region	O
is	O
over	O
10	O
Mb	O
from	O
the	O
nearest	O
olfactory	O
receptor	O
coding	O
region	O
and	O
is	O
thus	O
highly	O
unlikely	O
to	O
be	O
included	O
in	O
any	O
olfactory	O
receptor	O
transcript	O
.	O

Low	O
-	O
power	O
images	O
are	O
composed	O
of	O
three	O
overlapping	O
micrographs	O
(	O
40	O
x	O
)	O
assembled	O
in	O
Adobe	O
Photoshop	O
7	O
.	O
0	O
.	O

Additional	O
data	O
files	O

A	O
list	O
of	O
the	O
primers	O
used	O
to	O
confirm	O
the	O
expression	O
of	O
olfactory	O
receptor	O
genes	O
by	O
RT	O
-	O
PCR	O
and	O
PCR	O
from	O
cDNA	O
library	O
templates	O
can	O
be	O
found	O
in	O
Additional	O
data	O
file	O
1	O
.	O

The	O
experimental	O
conditions	O
used	O
for	O
real	O
-	O
time	O
PCR	O
can	O
be	O
found	O
in	O
Additional	O
data	O
file	O
2	O
.	O

Supplementary	O
Material	O

Additional	O
data	O
file	O
1	O

A	O
list	O
of	O
the	O
primers	O
used	O
to	O
confirm	O
the	O
expression	O
of	O
olfactory	O
receptor	O
genes	O
by	O
RT	O
-	O
PCR	O
and	O
PCR	O
from	O
cDNA	O
library	O
templates	O

Click	O
here	O
for	O
additional	O
data	O
file	O

Additional	O
data	O
file	O
2	O

The	O
experimental	O
conditions	O
used	O
for	O
real	O
-	O
time	O
PCR	O

Click	O
here	O
for	O
additional	O
data	O
file	O

Acknowledgements	O

We	O
thank	O
Leslie	O
Vosshall	O
and	O
Tyler	O
Cutforth	O
for	O
providing	O
cDNA	O
libraries	O
,	O
staff	O
of	O
the	O
core	O
facilities	O
at	O
the	O
Fred	O
Hutchinson	O
Cancer	O
Research	O
Center	O
and	O
the	O
University	O
of	O
Washington	O
'	O
s	O
former	O
Department	O
of	O
Molecular	B-CHEBI
Biotechnology	O
for	O
sequencing	O
assistance	O
,	O
Linda	O
Buck	O
and	O
Michael	O
Schlador	O
for	O
comments	O
on	O
the	O
manuscript	O
and	O
Colin	O
Pritchard	O
for	O
S16	O
primers	O
.	O

The	O
data	O
in	O
this	O
paper	O
were	O
analyzed	O
in	O
part	O
through	O
use	O
of	O
the	O
Celera	O
Discovery	O
System	O
(TM)	O
and	O
Celera	O
Genomics	O
'	O
associated	O
databases	O
.	O

This	O
work	O
was	O
supported	O
by	O
NIH	O
grant	O
R01	O
DC04209	O
.	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Olfactory	O
receptor	O
genes	O
whose	O
expression	O
in	O
the	O
mouse	O
olfactory	O
epithelium	O
was	O
confirmed	O
in	O
this	O
study	O
.	O

Genes	O
whose	O
expression	O
has	O
been	O
confirmed	O
by	O
our	O
cDNA	O
screen	O
are	O
colored	O
blue	O
on	O
a	O
phylogenetic	O
tree	O
of	O
1	O
,	O
107	O
intact	O
mouse	O
olfactory	O
receptors	O
.	O

Genes	O
whose	O
expression	O
was	O
confirmed	O
by	O
PCR	O
methods	O
are	O
colored	O
red	O
(	O
genes	O
listed	O
in	O
Additional	O
data	O
file	O
1	O
were	O
confirmed	O
by	O
specific	O
PCR	O
of	O
the	O
cDNA	O
library	O
or	O
reverse	O
-	O
transcribed	O
RNA	O
,	O
and	O
genes	O
confirmed	O
using	O
the	O
class	O
I	O
degenerate	O
primer	O
for	O
RT	O
-	O
PCR	O
are	O
AY317681	O
,	O
AY317698	O
,	O
AY317700	O
,	O
AY317767	O
,	O
AY317773	O
,	O
AY317774	O
,	O
AY317797	O
and	O
AY317923	O
)	O
.	O

Other	O
olfactory	O
receptors	O
are	O
colored	O
gray	O
,	O
and	O
a	O
chemokine	O
outgroup	O
is	O
colored	O
black	O
.	O

Class	O
I	O
olfactory	O
receptors	O
are	O
bracketed	O
,	O
and	O
the	O
remaining	O
olfactory	O
receptors	O
are	O
class	O
II	O
.	O

Figure	O
2	O

The	O
cDNA	O
screen	O
suggests	O
different	O
expression	O
levels	O
for	O
different	O
olfactory	O
receptors	O
.	O

Distribution	O
of	O
number	O
of	O
cDNAs	O
observed	O
(	O
dots	O
)	O
and	O
expected	O
(	O
triangles	O
,	O
line	O
)	O
per	O
olfactory	O
receptor	O
gene	O
among	O
1	O
,	O
176	O
olfactory	O
receptor	O
cDNAs	O
identified	O
,	O
based	O
on	O
a	O
Poisson	O
distribution	O
.	O

Figure	O
3	O

Differential	O
expression	O
levels	O
among	O
six	O
olfactory	O
receptor	O
genes	O
determined	O
by	O
quantitative	O
PCR	O
.	O

(	O
a	O
)	O
Expression	O
levels	O
of	O
olfactory	O
receptor	O
genes	O
can	O
vary	O
by	O
almost	O
300	O
-	O
fold	O
(	O
for	O
example	O
,	O
genes	O
A	O
and	O
D	O
)	O
.	O

Relative	O
expression	O
levels	O
of	O
six	O
selected	O
olfactory	O
receptor	O
genes	O
(	O
A	O
,	O
AY318555	O
;	O
B	O
,	O
AY318107	O
;	O
C	O
,	O
AY318644	O
;	O
D	O
,	O
AY317365	O
;	O
E	O
,	O
AY317773	O
;	O
and	O
F	O
,	O
AY317797	O
)	O
were	O
determined	O
in	O
olfactory	O
epithelium	O
RNA	O
samples	O
from	O
three	O
mice	O
.	O

Expression	O
levels	O
for	O
each	O
gene	O
were	O
first	O
determined	O
relative	O
to	O
a	O
standard	O
curve	O
made	O
using	O
mouse	O
genomic	O
DNA	O
templates	O
,	O
and	O
then	O
values	O
for	O
each	O
mouse	O
were	O
normalized	O
so	O
that	O
a	O
housekeeping	O
gene	O
,	O
ribosomal	O
S16	O
,	O
had	O
a	O
value	O
of	O
1	O
(	O
arbitrary	O
units	O
)	O
(	O
not	O
shown	O
)	O
.	O

Error	O
bars	O
show	O
one	O
standard	O
deviation	O
(	O
six	O
replicate	O
reactions	O
)	O
.	O

Genes	O
E	O
and	O
F	O
(	O
AY317773	O
and	O
AY317797	O
)	O
are	O
class	O
I	O
olfactory	O
receptors	O
.	O

Numbers	O
of	O
cDNAs	O
observed	O
in	O
our	O
screen	O
are	O
shown	O
under	O
each	O
gene	O
name	O
.	O

(	O
b	O
)	O
Expression	O
levels	O
of	O
each	O
gene	O
are	O
similar	O
,	O
with	O
some	O
variation	O
,	O
among	O
the	O
three	O
mice	O
sampled	O
.	O

Graphs	O
show	O
pairwise	O
comparisons	O
between	O
the	O
three	O
mice	O
sampled	O
,	O
with	O
relative	O
expression	O
levels	O
(	O
arbitrary	O
units	O
)	O
in	O
one	O
mouse	O
plotted	O
along	O
the	O
x	O
-	O
axis	O
and	O
in	O
a	O
second	O
on	O
the	O
y	O
-	O
axis	O
.	O

Figure	O
4	O

Olfactory	O
receptors	O
showing	O
different	O
expression	O
levels	O
.	O

Different	O
expression	O
levels	O
of	O
one	O
pair	O
of	O
olfactory	O
receptors	O
is	O
due	O
to	O
different	O
numbers	O
of	O
expressing	O
cells	O
and	O
different	O
transcript	O
levels	O
per	O
cell	O
.	O

RNA	O
in	O
situ	O
hybridization	O
with	O
digoxigenin	B-CHEBI
-	O
labeled	O
probes	O
for	O
(	O
a	O
)	O
gene	O
A	O
(	O
AY318555	O
)	O
and	O
(	O
b	O
)	O
gene	O
D	O
(	O
AY317365	O
)	O
on	O
coronal	O
sections	O
of	O
the	O
olfactory	O
turbinates	O
of	O
an	O
adult	O
mouse	O
,	O
shown	O
at	O
low	O
magnification	O
and	O
inset	O
(	O
boxed	O
)	O
at	O
high	O
magnification	O
.	O

Endoturbinates	O
II	O
and	O
III	O
and	O
ectoturbinate	O
3	O
are	O
labeled	O
in	O
(	O
b	O
)	O
.	O

Figure	O
5	O

Many	O
olfactory	O
receptor	O
genes	O
show	O
alternate	O
splicing	O
.	O

Distribution	O
of	O
the	O
number	O
of	O
transcriptional	O
isoforms	O
observed	O
for	O
the	O
82	O
olfactory	O
receptors	O
for	O
which	O
we	O
have	O
identified	O
at	O
least	O
four	O
cDNAs	O
.	O

Figure	O
6	O

Sixty	O
-	O
two	O
olfactory	O
receptor	O
cDNAs	O
use	O
splice	O
sites	O
within	O
the	O
coding	O
region	O
.	O

The	O
bar	O
at	O
the	O
top	O
represents	O
an	O
alignment	O
of	O
all	O
olfactory	O
receptor	O
proteins	B-CHEBI
,	O
with	O
transmembrane	O
(	O
TM	O
)	O
regions	O
shaded	O
gray	O
and	O
intracellular	O
(	O
IC	O
)	O
and	O
extracellular	O
(	O
EC	O
)	O
loops	O
in	O
white	O
.	O

Above	O
the	O
bar	O
,	O
the	O
jagged	O
line	O
plots	O
information	O
content	O
[	O
51	O
]	O
for	O
each	O
alignment	O
position	O
,	O
with	O
higher	O
values	O
representing	O
residues	B-CHEBI
conserved	O
across	O
more	O
olfactory	O
receptors	O
.	O

cDNAs	O
with	O
atypical	O
splicing	O
are	O
plotted	O
below	O
,	O
aligned	O
appropriately	O
to	O
the	O
consensus	O
representation	O
.	O

Genbank	O
accessions	O
for	O
each	O
cDNA	O
are	O
shown	O
on	O
the	O
right	O
,	O
and	O
where	O
more	O
than	O
one	O
clone	O
represents	O
the	O
same	O
isoform	O
,	O
both	O
names	O
are	O
given	O
,	O
but	O
a	O
composite	O
sequence	O
is	O
drawn	O
.	O

Multiple	O
isoforms	O
from	O
the	O
same	O
gene	O
are	O
grouped	O
by	O
gray	O
background	O
shading	O
.	O

Thick	O
black	O
lines	O
represent	O
cDNA	O
sequence	O
,	O
and	O
thin	O
lines	O
represent	O
intronic	O
sequence	O
(	O
with	O
diagonal	O
slash	O
marks	O
if	O
not	O
drawn	O
to	O
scale	O
)	O
.	O

The	O
uppermost	O
two	O
cDNAs	O
encode	O
potentially	O
functional	O
olfactory	O
receptors	O
.	O

A	O
single	O
cDNA	O
drawn	O
as	O
white	O
boxes	O
(	O
CB173065	O
)	O
is	O
cloned	O
into	O
the	O
vector	O
in	O
the	O
reverse	O
orientation	O
.	O

Introns	O
that	O
result	O
in	O
a	O
frameshift	O
relative	O
to	O
the	O
olfactory	O
receptor	O
consensus	O
are	O
drawn	O
as	O
single	O
dashed	O
lines	O
.	O

The	O
first	O
in	O
-	O
frame	O
methionine	B-CHEBI
in	O
the	O
cDNA	O
is	O
marked	O
with	O
an	O
'	O
M	B-CHEBI
'	O
,	O
and	O
the	O
first	O
stop	O
codon	O
5	O
'	O
to	O
this	O
methionine	B-CHEBI
(	O
if	O
any	O
)	O
is	O
marked	O
with	O
*	O
.	O

Most	O
sequences	O
are	O
incomplete	O
at	O
the	O
3	O
'	O
end	O
,	O
as	O
represented	O
by	O
paired	O
dotted	O
lines	O
,	O
although	O
two	O
sequences	O
(	O
CB174400	O
and	O
CB174364	O
)	O
,	O
marked	O
with	O
'	O
(	O
A	B-CHEBI
)	O
n	O
'	O
,	O
contain	O
the	O
cDNA	O
'	O
s	O
poly	O
(	O
A	B-CHEBI
)	O
tail	O
.	O

The	O
'	O
X	O
'	O
on	O
sequence	O
CB173500	O
marks	O
an	O
exon	O
that	O
does	O
not	O
align	O
with	O
genomic	O
sequence	O
near	O
the	O
rest	O
of	O
the	O
gene	O
or	O
anywhere	O
else	O
in	O
Celera	O
'	O
s	O
mouse	O
genome	O
sequence	O
,	O
and	O
'	O
TM4	O
'	O
on	O
sequence	O
CB172879	O
notes	O
an	O
exon	O
that	O
matches	O
to	O
the	O
reverse	O
-	O
complement	O
of	O
the	O
fourth	O
transmembrane	O
domain	O
of	O
the	O
next	O
downstream	O
olfactory	O
receptor	O
gene	O
.	O

For	O
the	O
two	O
lowermost	O
cDNAs	O
,	O
exon	O
order	O
in	O
the	O
cDNA	O
clone	O
is	O
inconsistent	O
with	O
the	O
corresponding	O
genomic	O
sequence	O
,	O
as	O
represented	O
by	O
the	O
curved	O
intron	O
lines	O
.	O

Table	O
1	O

Number	O
of	O
olfactory	O
receptors	O
in	O
old	O
(	O
Release	O
12	O
)	O
and	O
new	O
(	O
Release	O
13	O
)	O
Celera	O
mouse	O
genome	O
assemblies	O

Table	O
2	O

Summary	O
of	O
cDNA	O
screen	O
for	O
each	O
library	O
and	O
probe	O
.	O

Probe	O
names	O
comprise	O
the	O
names	O
of	O
the	O
two	O
primers	O
and	O
the	O
annealing	O
temperature	O
used	O
during	O
PCR	O
to	O
generate	O
the	O
probes	O
,	O
separated	O
by	O
underscores	O

Molecular	B-CHEBI
cloning	O
and	O
characterization	O
of	O
the	O
mouse	O
Acdp	O
gene	O
family	O

Abstract	O

Background	O

We	O
have	O
recently	O
cloned	O
and	O
characterized	O
a	O
novel	O
gene	O
family	O
named	O
ancient	O
conserved	O
domain	O
protein	B-CHEBI
(	O
ACDP	O
)	O
in	O
humans	O
.	O

To	O
facilitate	O
the	O
functional	O
study	O
of	O
this	O
novel	O
gene	O
family	O
,	O
we	O
have	O
cloned	O
and	O
characterized	O
Acdp	O
,	O
the	O
mouse	O
homologue	O
of	O
the	O
human	O
ACDP	O
gene	O
family	O
.	O

Results	O

The	O
four	O
Acdp	O
genes	O
(	O
Acdp1	O
,	O
Acdp2	O
,	O
Acdp3	O
and	O
Acdp4	O
)	O
contain	O
3	O
,	O
631	O
bp	O
,	O
3	O
,	O
244	O
bp	O
,	O
2	O
,	O
684	O
bp	O
and	O
2	O
,	O
743	O
bp	O
of	O
cDNA	O
sequences	O
,	O
and	O
encode	O
deduced	O
proteins	B-CHEBI
of	O
951	O
,	O
874	O
,	O
713	O
and	O
771	O
amino	B-CHEBI
acids	I-CHEBI
,	O
respectively	O
.	O

The	O
mouse	O
Acdp	O
genes	O
showed	O
very	O
strong	O
homologies	O
(	O
>	O
90	O
%	O
)	O
in	O
both	O
nucleotide	B-CHEBI
and	O
amino	B-CHEBI
acid	I-CHEBI
sequences	O
to	O
their	O
human	O
counterparts	O
.	O

In	O
addition	O
,	O
both	O
nucleotide	B-CHEBI
and	O
amino	B-CHEBI
acid	I-CHEBI
sequences	O
within	O
the	O
Ancient	O
Conserved	O
Domain	O
(	O
ACD	O
)	O
are	O
highly	O
conserved	O
in	O
many	O
different	O
taxonomic	O
species	O
.	O

Particularly	O
,	O
Acdp	O
proteins	B-CHEBI
showed	O
very	O
strong	O
AA	B-CHEBI
homologies	O
to	O
the	O
bacteria	O
CorC	O
protein	B-CHEBI
(	O
35	O
%	O
AA	B-CHEBI
identity	O
with	O
55	O
%	O
homology	O
)	O
,	O
which	O
is	O
involved	O
in	O
magnesium	B-CHEBI
and	O
cobalt	B-CHEBI
efflux	O
.	O

The	O
Acdp	O
genes	O
are	O
widely	O
expressed	O
in	O
all	O
tissues	O
tested	O
except	O
for	O
Acdp1	O
,	O
which	O
is	O
only	O
highly	O
expressed	O
in	O
the	O
brain	O
with	O
low	O
levels	O
of	O
expression	O
in	O
kidney	O
and	O
testis	O
.	O

Immunostaining	O
of	O
Acdp1	O
in	O
hippocampus	O
neurons	O
revealed	O
a	O
predominant	O
localization	O
on	O
the	O
plasma	O
membrane	O
.	O

Conclusion	O

The	O
Acdp	O
genes	O
are	O
evolutionarily	O
conserved	O
in	O
diverse	O
species	O
and	O
ubiquitously	O
expressed	O
throughout	O
development	O
and	O
adult	O
tissues	O
suggesting	O
that	O
Acdp	O
may	O
be	O
an	O
essential	O
gene	O
.	O

Acdp	O
showed	O
strong	O
homology	O
to	O
bacteria	O
CorC	O
protein	B-CHEBI
and	O
predominantly	O
localized	O
on	O
the	O
plasma	O
membrane	O
.	O

These	O
results	O
suggest	O
that	O
Acdp	O
is	O
probably	O
a	O
family	O
of	O
proteins	B-CHEBI
involved	O
in	O
ion	B-CHEBI
transport	O
in	O
mammalian	O
cells	O

Background	O

We	O
have	O
recently	O
cloned	O
and	O
characterized	O
a	O
novel	O
gene	O
family	O
named	O
ancient	O
conserved	O
domain	O
protein	B-CHEBI
(	O
ACDP	O
)	O
which	O
encodes	O
four	O
protein	B-CHEBI
members	O
in	O
humans	O
[	O
1	O
]	O
.	O

We	O
found	O
that	O
this	O
gene	O
family	O
is	O
evolutionarily	O
conserved	O
in	O
diverse	O
species	O
ranging	O
from	O
bacteria	O
,	O
yeast	O
,	O
C	O
.	O
elegans	O
,	O
and	O
D	O
.	O
melanogaster	O
to	O
mammals	O
.	O

The	O
sequence	O
conservation	O
and	O
the	O
presence	O
of	O
multiple	O
members	O
within	O
a	O
species	O
may	O
imply	O
functional	O
importance	O
associated	O
with	O
the	O
genes	O
.	O

To	O
facilitate	O
the	O
functional	O
analysis	O
of	O
the	O
ACDP	O
gene	O
family	O
,	O
we	O
cloned	O
and	O
characterized	O
Acdp	O
,	O
the	O
mouse	O
homologue	O
of	O
the	O
human	O
ACDP	O
gene	O
family	O
.	O

Results	O

Molecular	B-CHEBI
cloning	O
of	O
the	O
Acdp	O
gene	O
family	O

To	O
clone	O
the	O
mouse	O
Acdp	O
genes	O
,	O
the	O
human	O
ACDP	O
cDNA	O
and	O
predicted	O
protein	B-CHEBI
sequences	O
were	O
used	O
to	O
search	O
the	O
mouse	O
EST	O
database	O
with	O
the	O
blastn	O
and	O
tblastn	O
programs	O
.	O

Mouse	O
EST	O
markers	O
corresponding	O
to	O
each	O
Acdp	O
member	O
were	O
then	O
identified	O
.	O

For	O
example	O
,	O
EST	O
H3086H12	O
-	O
5	O
corresponds	O
to	O
Acdp1	O
,	O
W98010	O
for	O
Acdp2	O
,	O
603299135F1	O
for	O
Acdp3	O
and	O
BG083791	O
for	O
Acdp4	O
.	O

A	O
modified	O
oligo	O
-	O
dT	O
with	O
a	O
M13	O
tail	O
was	O
used	O
for	O
the	O
RT	O
reaction	O
.	O

A	O
forward	O
primer	O
from	O
each	O
EST	O
marker	O
and	O
the	O
M13	O
primer	O
(	O
olig	O
-	O
dT	O
tail	O
)	O
were	O
used	O
to	O
amplify	O
the	O
3	O
'	O
UTR	O
sequence	O
for	O
each	O
corresponding	O
Acdp	O
gene	O
from	O
the	O
RT	O
products	O
.	O

To	O
obtain	O
5	O
'	O
-	O
end	O
coding	O
sequences	O
for	O
the	O
Acdp	O
genes	O
,	O
we	O
conducted	O
a	O
series	O
nested	O
PCR	O
with	O
combinations	O
of	O
mouse	O
and	O
human	O
primers	O
.	O

The	O
5	O
'	O
UTR	O
sequences	O
were	O
identified	O
by	O
directly	O
sequencing	O
BAC	O
DNA	O
containing	O
the	O
corresponding	O
Acdp	O
genes	O
.	O

The	O
BAC	O
clones	O
were	O
identified	O
by	O
screening	O
a	O
CITB	O
mouse	O
BAC	O
DNA	O
library	O
(	O
Research	O
Genetics	O
)	O
.	O

The	O
5	O
'	O
UTR	O
sequences	O
obtained	O
from	O
above	O
were	O
further	O
confirmed	O
by	O
RT	O
-	O
PCR	O
.	O

The	O
Acdp1	O
gene	O
contains	O
3	O
,	O
631	O
bp	O
of	O
nucleotide	B-CHEBI
sequence	O
and	O
encodes	O
a	O
predicted	O
protein	B-CHEBI
with	O
951	O
amino	B-CHEBI
acids	I-CHEBI
(	O
AA	B-CHEBI
)	O
.	O

The	O
other	O
three	O
Acdp	O
genes	O
(	O
Acdp2	O
,	O
3	O
and	O
4	O
)	O
contain	O
3	O
,	O
244	O
bp	O
,	O
2	O
,	O
684	O
bp	O
and	O
2	O
,	O
743	O
bp	O
of	O
cDNA	O
sequences	O
,	O
and	O
encode	O
deduced	O
proteins	B-CHEBI
of	O
874	O
amino	B-CHEBI
acids	I-CHEBI
,	O
713	O
amino	B-CHEBI
acids	I-CHEBI
and	O
771	O
amino	B-CHEBI
acids	I-CHEBI
,	O
respectively	O
.	O

Tissue	O
distribution	O

Northern	O
blot	O
analyses	O
of	O
the	O
Acdp	O
gene	O
family	O
were	O
carried	O
out	O
using	O
membranes	O
purchased	O
from	O
Origene	O
.	O

A	O
total	O
of	O
12	O
mouse	O
tissues	O
were	O
included	O
in	O
the	O
study	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Due	O
to	O
sequence	O
homologies	O
between	O
each	O
Acdp	O
member	O
within	O
the	O
conserved	O
domain	O
,	O
probes	O
for	O
Northern	O
bolts	O
were	O
PCR	O
fragments	O
from	O
the	O
last	O
exon	O
and	O
the	O
3	O
'	O
untranslated	O
region	O
sequences	O
.	O

The	O
mouse	O
Acdp	O
messages	O
showed	O
almost	O
the	O
same	O
tissue	O
distributions	O
as	O
the	O
human	O
ACDP	O
genes	O
.	O

Acdp1	O
message	O
is	O
highly	O
expressed	O
in	O
the	O
brain	O
,	O
while	O
kidney	O
and	O
testis	O
also	O
showed	O
low	O
levels	O
of	O
expression	O
.	O

Acdp2	O
showed	O
higher	O
expressions	O
in	O
the	O
brain	O
,	O
kidney	O
and	O
liver	O
.	O

However	O
,	O
the	O
Acdp2	O
transcript	O
was	O
not	O
present	O
in	O
the	O
skeleton	O
muscle	O
and	O
skin	O
,	O
and	O
it	O
showed	O
very	O
low	O
levels	O
of	O
expression	O
in	O
the	O
rest	O
of	O
tissues	O
.	O

Acdp3	O
and	O
Acdp4	O
showed	O
different	O
levels	O
of	O
expression	O
in	O
all	O
tissues	O
tested	O
;	O
the	O
highest	O
expressions	O
for	O
Acdp3	O
were	O
observed	O
in	O
the	O
brain	O
,	O
kidney	O
,	O
liver	O
and	O
heart	O
,	O
and	O
the	O
highest	O
expressions	O
for	O
Acdp4	O
were	O
observed	O
in	O
the	O
kidney	O
,	O
small	O
intestine	O
and	O
testis	O
.	O

The	O
expression	O
levels	O
for	O
Acdp3	O
and	O
4	O
in	O
skeleton	O
muscle	O
were	O
barely	O
detectable	O
;	O
however	O
,	O
beta	O
-	O
actin	O
showed	O
normal	O
expression	O
suggesting	O
that	O
the	O
results	O
were	O
not	O
a	O
consequence	O
of	O
bad	O
RNA	O
quality	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
ubiquitous	O
expression	O
pattern	O
may	O
be	O
taken	O
as	O
another	O
indication	O
of	O
the	O
functional	O
importance	O
of	O
Acdp	O
proteins	B-CHEBI
in	O
fundamental	O
biological	O
processes	O
in	O
addition	O
to	O
the	O
sequence	O
conservation	O
in	O
evolutionarily	O
divergent	O
species	O
.	O

Figure	O
1	O

Northern	O
blot	O
analyses	O
of	O
the	O
Acdp	O
gene	O
family	O
.	O

S	O
.	O
muscle	O
represents	O
skeletal	O
muscle	O
,	O
Sm	O
.	O

Int	O
.	O
represents	O
small	O
intestine	O
.	O

Multiple	O
Choice	O
Northern	O
Blot	O
filters	O
were	O
purchased	O
from	O
Origene	O
.	O

Chromosomal	O
location	O

Radiation	O
hybrid	O
mapping	O
indicated	O
that	O
the	O
Acdp1	O
gene	O
maps	O
to	O
chromosome	O
19	O
between	O
markers	O
D19Mit119	O
(	O
34	O
.	O
3	O
cR	O
proximal	O
)	O
and	O
D19Mit112	O
(	O
13	O
.	O
6	O
cR	O
distal	O
)	O
.	O

The	O
Acdp2	O
gene	O
maps	O
slightly	O
more	O
distal	O
to	O
the	O
Acdp1	O
on	O
chromosome	O
19	O
between	O
D19Mit9	O
(	O
2	O
.	O
4	O
cR	O
proximal	O
)	O
and	O
D19Mit38	O
(	O
15	O
.	O
1	O
cR	O
distal	O
)	O
.	O

The	O
Acdp3	O
and	O
Acdp4	O
genes	O
map	O
to	O
chromosome	O
1	O
within	O
one	O
BAC	O
clone	O
(	O
RP23	O
-	O
294I17	O
)	O
,	O
proximal	O
to	O
marker	O
D1Mit171	O
(	O
17	O
.	O
4	O
cR	O
)	O
.	O

These	O
regions	O
are	O
syntenic	O
to	O
the	O
human	O
counterparts	O
.	O

Sequence	O
homology	O
and	O
molecular	B-CHEBI
characteristics	O

The	O
mouse	O
Acdp	O
genes	O
showed	O
very	O
strong	O
homologies	O
of	O
both	O
nucleotide	B-CHEBI
and	O
AA	B-CHEBI
sequences	O
to	O
the	O
human	O
ACDP	O
genes	O
(	O
Table	O
1	O
)	O
.	O

The	O
highest	O
homologies	O
were	O
observed	O
between	O
the	O
human	O
ACDP2	O
and	O
the	O
mouse	O
Acdp2	O
gene	O
(	O
91	O
%	O
of	O
nucleotide	B-CHEBI
identity	O
,	O
97	O
%	O
of	O
AA	B-CHEBI
identity	O
and	O
99	O
.	O
4	O
%	O
of	O
AA	B-CHEBI
homology	O
)	O
.	O

In	O
addition	O
,	O
the	O
5	O
'	O
UTR	O
nucleotide	B-CHEBI
sequences	O
(	O
20	O
bp	O
of	O
nucleotides	B-CHEBI
before	O
start	O
codon	O
)	O
also	O
showed	O
high	O
homologies	O
to	O
the	O
human	O
homologs	O
,	O
for	O
example	O
,	O
the	O
Acdp2	O
5	O
'	O
UTR	O
sequence	O
showed	O
95	O
%	O
identities	O
to	O
its	O
human	O
homolog	O
.	O

However	O
,	O
the	O
homologies	O
in	O
the	O
3	O
'	O
UTR	O
sequences	O
(	O
20	O
bp	O
of	O
nucleotides	B-CHEBI
after	O
stop	O
codon	O
)	O
were	O
much	O
lower	O
(	O
40	O
-	O
55	O
%	O
)	O
for	O
all	O
Acdp	O
genes	O
except	O
Acdp4	O
(	O
90	O
%	O
identity	O
to	O
its	O
human	O
homolog	O
)	O
.	O

The	O
ancient	O
conserved	O
domain	O
(	O
ACD	O
)	O
has	O
55	O
.	O
3	O
%	O
of	O
AA	B-CHEBI
identity	O
and	O
83	O
.	O
3	O
%	O
of	O
homology	O
between	O
all	O
mouse	O
and	O
human	O
ACDP	O
proteins	B-CHEBI
(	O
Fig	O
.	O
2	O
)	O
.	O

The	O
ACD	O
domain	O
is	O
evolutionarily	O
conserved	O
in	O
divergent	O
species	O
ranging	O
from	O
bacteria	O
,	O
yeast	O
,	O
C	O
.	O
elegans	O
,	O
D	O
.	O
melanogaster	O
,	O
mouse	O
to	O
human	O
(	O
Fig	O
.	O
3	O
)	O
.	O

Particularly	O
,	O
as	O
shown	O
in	O
Fig	O
.	O

3	O
,	O
Acdp	O
proteins	B-CHEBI
showed	O
very	O
strong	O
AA	B-CHEBI
homology	O
to	O
bacteria	O
CorC	O
protein	B-CHEBI
(	O
35	O
%	O
AA	B-CHEBI
identity	O
with	O
55	O
%	O
homology	O
)	O
,	O
which	O
is	O
involved	O
in	O
magnesium	B-CHEBI
and	O
cobalt	B-CHEBI
efflux	O
[	O
7	O
]	O
.	O

High	O
AA	B-CHEBI
homology	O
was	O
also	O
observed	O
between	O
the	O
Acdp	O
proteins	B-CHEBI
and	O
the	O
yeast	O
Amip3	O
protein	B-CHEBI
(	O
35	O
%	O
AA	B-CHEBI
identity	O
with	O
56	O
%	O
homology	O
)	O
.	O

The	O
Amip3	O
is	O
likely	O
to	O
be	O
a	O
homologous	O
to	O
the	O
bacteria	O
CorC	O
protein	B-CHEBI
.	O

The	O
Amip3	O
mutants	O
confer	O
resistance	O
to	O
copper	B-CHEBI
toxicity	O
(	O
Personal	O
communication	O
with	O
Dr	O
.	O
V	O
.	O
C	O
.	O
Culotte	O
,	O
John	O
Hopkins	O
Bloomberg	O
,	O
School	O
of	O
Public	O
Health	O
)	O
.	O

The	O
evolutionary	O
relationships	O
among	O
those	O
proteins	B-CHEBI
are	O
illustrated	O
by	O
a	O
phylogenetic	O
tree	O
constructed	O
based	O
on	O
the	O
AA	B-CHEBI
homology	O
of	O
proteins	B-CHEBI
(	O
Fig	O
.	O
4	O
)	O
.	O

Table	O
1	O

Nucleotide	B-CHEBI
and	O
amino	B-CHEBI
acid	I-CHEBI
homologies	O
(	O
%	O
)	O
between	O
human	O
ACDP	O
and	O
mouse	O
Acdp	O
members	O
.	O

Figure	O
2	O

Amino	B-CHEBI
acid	I-CHEBI
sequence	O
homology	O
alignment	O
for	O
all	O
of	O
the	O
ACDP	O
and	O
Acdp	O
genes	O
within	O
the	O
ACD	O
domain	O
.	O

The	O
sequence	O
data	O
for	O
the	O
Acdp	O
genes	O
have	O
been	O
deposited	O
in	O
GenBank	O
under	O
accession	O
number	O
AF202994	O
(	O
Acdp1	O
)	O
,	O
AF216961	O
(	O
Acdp2	O
)	O
,	O
AF216964	O
(	O
Acdp3	O
)	O
and	O
AF216963	O
(	O
Acdp4	O
)	O
.	O

Identical	O
amino	B-CHEBI
acids	I-CHEBI
or	O
amino	B-CHEBI
acids	I-CHEBI
with	O
very	O
strong	O
homologies	O
among	O
all	O
proteins	B-CHEBI
were	O
shaded	O
black	O
.	O

Identical	O
amino	B-CHEBI
acids	I-CHEBI
or	O
amino	B-CHEBI
acids	I-CHEBI
with	O
very	O
strong	O
homologies	O
in	O
most	O
of	O
the	O
proteins	B-CHEBI
were	O
shaded	O
grey	O
.	O

Dot	O
lines	O
represent	O
gaps	O
for	O
the	O
alignment	O
.	O

Figure	O
3	O

Amino	B-CHEBI
acid	I-CHEBI
sequence	O
alignment	O
showing	O
the	O
conservation	O
of	O
ACD	O
domain	O
in	O
various	O
species	O
.	O

Amip3	O
is	O
a	O
protein	B-CHEBI
from	O
Saccharomyces	O
cerevisiae	O
(	O
NP	O
_	O
014581	O
)	O
.	O

CanG	O
is	O
a	O
protein	B-CHEBI
from	O
Candida	O
glabrata	O
(	O
AAF33142	O
)	O
.	O

NeuC	O
(	O
EAA31204	O
)	O
is	O
a	O
hypothetical	O
protein	B-CHEBI
from	O
Neurospora	O
crassa	O
.	O

DroM	O
is	O
a	O
gene	O
product	O
from	O
D	O
.	O
melanogaster	O
.	O

The	O
accession	O
number	O
for	O
this	O
gene	O
is	O
CG40084	O
in	O
BDGP	O
(	O
Berkeley	O
Drosophila	O
Genome	O
Project	O
)	O
.	O

AnoG	O
represents	O
a	O
protein	B-CHEBI
from	O
the	O
anopheles	O
gambiae	O
str	O
.	O

(	O
EAA01004	O
)	O
.	O

CaeE	O
(	O
AAK77203	O
)	O
is	O
a	O
hypothetical	O
protein	B-CHEBI
from	O
the	O
Caenohabditis	O
elegans	O
.	O

CorC	O
represents	O
bacteria	O
magnesium	B-CHEBI
and	O
cobalt	B-CHEBI
efflux	O
protein	B-CHEBI
from	O
the	O
Shewanella	O
oneidensis	O
.	O

XyFD	O
is	O
a	O
hypothetical	O
protein	B-CHEBI
from	O
the	O
Xylella	O
fastidiosa	O
Dixon	O
(	O
ZP	O
_	O
00038107	O
)	O
.	O

Figure	O
4	O

Phylogenetic	O
tree	O
showing	O
relationships	O
among	O
proteins	B-CHEBI
containing	O
the	O
ACD	O
domain	O
from	O
figure	O
2	O
and	O
3	O
.	O

The	O
phylogenetic	O
tree	O
was	O
constructed	O
according	O
to	O
the	O
calculation	O
of	O
the	O
best	O
match	O
for	O
the	O
selected	O
sequences	O
.	O

Abbreviations	O
for	O
each	O
protein	B-CHEBI
are	O
the	O
same	O
as	O
presented	O
in	O
figure	O
3	O
.	O

We	O
found	O
that	O
all	O
mouse	O
Acdp	O
members	O
contain	O
four	O
distinct	O
transmembrane	O
domains	O
(	O
Fig	O
.	O
5	O
)	O
,	O
two	O
CBS	O
domains	O
and	O
a	O
DUF21	O
domain	O
that	O
are	O
found	O
in	O
bacteria	O
CorC	O
and	O
yeast	O
Amip3	O
proteins	B-CHEBI
.	O

CBS	O
domains	O
are	O
small	O
intracellular	O
modules	O
that	O
are	O
mostly	O
found	O
in	O
2	O
or	O
four	O
copies	O
within	O
a	O
protein	B-CHEBI
.	O

Pairs	O
of	O
CBS	O
domains	O
dimerise	O
to	O
form	O
a	O
stable	O
globular	O
domain	O
[	O
8	O
]	O
.	O

DUF21	O
(	O
CD	O
:	O
pfam01959	O
.	O
9	O
)	O
is	O
a	O
newly	O
defined	O
domain	O
with	O
unknown	O
function	O
.	O

This	O
domain	O
is	O
a	O
transmembrane	O
region	O
and	O
found	O
to	O
be	O
located	O
in	O
the	O
N	B-CHEBI
-	O
terminus	O
of	O
the	O
proteins	B-CHEBI
adjacent	O
to	O
two	O
intracellular	O
CBS	O
domains	O
.	O

A	O
cNMP	O
-	O
binding	O
domain	O
(	O
cyclic	B-CHEBI
nucleotide	I-CHEBI
-	O
monophosphate	O
-	O
binding	O
domain	O
)	O
was	O
found	O
in	O
all	O
Acdp	O
members	O
.	O

Figure	O
5	O

Four	O
transmembrane	O
domains	O
within	O
Acdp4	O
protein	B-CHEBI
.	O

Transmembrane	O
domains	O
were	O
predicted	O
by	O
the	O
TMHMM	O
program	O
.	O

The	O
plot	O
shows	O
the	O
posterior	O
probabilities	O
of	O
inside	O
/	O
outside	O
/	O
TM	O
helix	O
.	O

At	O
the	O
top	O
of	O
the	O
plot	O
(	O
between	O
1	O
and	O
1	O
.	O
2	O
)	O
the	O
N	O
-	O
best	O
prediction	O
is	O
shown	O
.	O

The	O
plot	O
is	O
obtained	O
by	O
calculating	O
the	O
total	O
probability	O
that	O
a	O
residue	B-CHEBI
sits	O
in	O
helix	O
,	O
inside	O
,	O
or	O
outside	O
summed	O
over	O
all	O
possible	O
paths	O
through	O
the	O
model	O
.	O

In	O
addition	O
,	O
Acdp1	O
contains	O
an	O
Alanine	B-CHEBI
-	O
rich	O
region	O
(	O
2	O
-	O
10	O
:	O
AAAAAAAAA	O
)	O
,	O
a	O
Leucine	B-CHEBI
-	O
rich	O
region	O
(	O
204	O
-	O
257	O
:	O
LLRVRPRLYGPGGDLLPPAWLRALGALLLLALSALF	O
SGLRLSLLSLDPVELRVL	O
)	O
,	O
a	O
Proline	B-CHEBI
-	O
rich	O
region	O
(	O
78	O
-	O
130	O
:	O
PGPPVPAAPVPAPSLA	O
PGENGTGDWAPRLVFIEEPPGAGGAAPSAVPTRPPGP	O
)	O
,	O
and	O
two	O
amidation	O
sites	O
(	O
917	O
-	O
920	O
:	O
MGKK	O
;	O
926	O
-	O
929	O
:	O
SGRK	O
)	O
.	O

Acdp2	O
has	O
a	O
glycine	B-CHEBI
-	O
rich	O
region	O
(	O
201	O
-	O
222	O
:	O
GAGGSGSASGTVGGKGGAGVAG	O
)	O
.	O

Acdp3	O
possesses	O
a	O
large	O
alanine	B-CHEBI
-	O
rich	O
region	O
(	O
2	O
-	O
261	O
)	O
and	O
a	O
large	O
leucine	B-CHEBI
-	O
rich	O
region	O
(	O
201	O
-	O
299	O
)	O
.	O

Acdp4	O
contains	O
a	O
leucine	B-CHEBI
zipper	O
pattern	O
(	O
185	O
-	O
206	O
:	O
LVMVLLVLSGIFSGLNLGLMAL	O
)	O
and	O
an	O
amidation	O
site	O
(	O
7	O
-	O
10	O
:	O
GGRR	O
)	O
.	O

Antibody	O
production	O
,	O
Western	O
results	O
and	O
subcellular	O
localization	O

Peptides	O
from	O
Acdp1	O
N	B-CHEBI
-	O
(	O
TSFLLRVYFQPGPPATAAPVPSPT	O
)	O
and	O
C	B-CHEBI
-	O
(	O
TQQLTLSPAAVPTR	O
)	O
terminuses	O
,	O
conserved	O
peptide	O
from	O
ACD	O
domain	O
of	O
Acdp1	O
(	O
HNIVDILFVKDLAFVDPDDCTPLLTVTRF	O
)	O
were	O
commercially	O
synthesized	O
(	O
Sigma	O
Genosys	O
)	O
.	O

These	O
antigenic	O
sites	O
were	O
predicted	O
by	O
software	O
from	O
Sigma	O
Genosys	O
and	O
polyclonal	O
antibodies	O
for	O
each	O
peptide	O
were	O
produced	O
by	O
immunizing	O
rabbits	O
.	O

To	O
test	O
the	O
specificity	O
of	O
the	O
antibodies	O
,	O
we	O
conducted	O
Western	O
-	O
blot	O
analysis	O
of	O
mouse	O
brain	O
tissue	O
extracts	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

6A	O
,	O
the	O
antibody	O
produced	O
by	O
C	B-CHEBI
-	O
terminal	O
peptide	O
specifically	O
detected	O
Acdp1	O
(	O
lane	O
3	O
)	O
.	O

The	O
antibody	O
generated	O
by	O
N	B-CHEBI
-	O
terminal	O
peptide	O
recognized	O
Acdp4	O
in	O
addition	O
to	O
Acdp1	O
,	O
although	O
the	O
reactivity	O
to	O
latter	O
was	O
significantly	O
higher	O
(	O
Fig	O
.	O
6A	O
,	O
lane	O
2	O
)	O
.	O

As	O
expected	O
,	O
the	O
antibody	O
produced	O
by	O
the	O
conserved	O
sequence	O
peptide	O
detected	O
all	O
Acdp	O
proteins	B-CHEBI
(	O
Fig	O
.	O
6A	O
,	O
lane	O
1	O
)	O
.	O

To	O
further	O
determine	O
the	O
specificity	O
of	O
the	O
antibody	O
against	O
the	O
Acdp1	O
C	B-CHEBI
-	O
terminus	O
,	O
we	O
analyzed	O
extracts	O
of	O
HEK293	O
,	O
3T3	O
and	O
PC12	O
cells	O
.	O

The	O
results	O
are	O
shown	O
in	O
Fig	O
.	O

6B	O
.	O

Apparently	O
,	O
this	O
antibody	O
detected	O
a	O
specific	O
band	O
of	O
Acdp1	O
in	O
all	O
cell	O
lysates	O
.	O

Of	O
note	O
,	O
shown	O
in	O
Fig	O
.	O

6B	O
are	O
signals	O
of	O
10	O
mu	O
g	O
extracts	O
of	O
HEK293	O
cell	O
lysates	O
,	O
100	O
mu	O
g	O
extracts	O
of	O
3T3	O
and	O
PC12	O
cell	O
lysates	O
.	O

Thus	O
,	O
the	O
expression	O
levels	O
of	O
Acdp1	O
in	O
these	O
cell	O
types	O
vary	O
a	O
lot	O
,	O
with	O
the	O
highest	O
expression	O
in	O
HEK293	O
cells	O
.	O

Nevertheless	O
,	O
these	O
immunoblot	O
results	O
support	O
our	O
analysis	O
of	O
brain	O
tissue	O
extracts	O
that	O
the	O
antibody	O
against	O
Acdp1	O
C	B-CHEBI
-	O
terminus	O
specifically	O
recognizes	O
Acdp	O
-	O
1	O
.	O

The	O
specificity	O
of	O
the	O
Acdp1	O
C	B-CHEBI
-	O
terminus	O
antibody	O
suggests	O
the	O
possibility	O
of	O
using	O
it	O
to	O
localize	O
Acdp	O
-	O
1	O
within	O
cells	O
.	O

Since	O
Northern	O
blot	O
revealed	O
almost	O
exclusive	O
expression	O
of	O
Acdp1	O
in	O
the	O
brain	O
,	O
we	O
examined	O
its	O
subcellular	O
localization	O
in	O
hippocampus	O
neurons	O
isolated	O
from	O
mouse	O
embryos	O
.	O

The	O
neurons	O
were	O
cultured	O
on	O
glass	O
coverslips	O
coated	O
with	O
a	O
confluent	O
monolayer	O
of	O
mouse	O
cortical	O
astrocytes	O
in	O
dishes	O
.	O

Immunostaining	O
was	O
using	O
the	O
Acdp1	O
C	B-CHEBI
-	O
terminus	O
specific	O
antibody	O
.	O

Confocal	O
imaging	O
revealed	O
that	O
Acdp1	O
is	O
predominantly	O
localized	O
on	O
the	O
plasma	O
membrane	O
.	O

A	O
series	O
of	O
sections	O
of	O
a	O
cell	O
at	O
the	O
thickness	O
of	O
0	O
.	O
5	O
micrometer	O
clearly	O
showed	O
membrane	O
location	O
of	O
Acdp1	O
-	O
immunoreactivity	O
(	O
Fig	O
.	O
7	O
)	O
,	O
which	O
is	O
consistent	O
with	O
the	O
observation	O
of	O
transmembrane	O
domains	O
within	O
the	O
Acdp	O
proteins	B-CHEBI
.	O

Figure	O
6	O

Fig	O
.	O

6A	O
:	O
Immunoblot	O
analysis	O
of	O
Acdp	O
proteins	B-CHEBI
in	O
brain	O
tissue	O
extracts	O
.	O

Immunoblotting	O
were	O
carried	O
out	O
using	O
a	O
Western	O
blotting	O
detection	O
system	O
(	O
ECL	O
)	O
(	O
PIERCE	O
)	O
.	O

Lane	O
1	O
,	O
probed	O
with	O
antibody	O
generated	O
by	O
conserved	O
peptide	O
.	O

From	O
top	O
to	O
bottom	O
,	O
each	O
band	O
corresponding	O
to	O
Acdp1	O
(	O
115	O
kD	O
)	O
,	O
Acdp2	O
(	O
100	O
kD	O
)	O
,	O
Acdp4	O
(	O
90	O
kD	O
)	O
and	O
Acdp3	O
(	O
80	O
kD	O
)	O
.	O

Lane	O
2	O
and	O
3	O
,	O
probed	O
with	O
the	O
Acdp1	O
antibodies	O
generated	O
by	O
N	B-CHEBI
-	O
terminal	O
and	O
C	B-CHEBI
-	O
terminal	O
peptides	O
,	O
respectively	O
.	O

Fig	O
.	O

6B	O
:	O
Immunoblot	O
analysis	O
of	O
Acdp1	O
in	O
HEK293	O
,	O
3T3	O
and	O
PC12	O
cells	O
.	O

The	O
blots	O
were	O
probed	O
with	O
the	O
antibody	O
against	O
the	O
C	B-CHEBI
-	O
terminus	O
of	O
Acdp	O
-	O
1	O
.	O

Lane	O
1	O
,	O
10	O
mu	O
g	O
of	O
HEK293	O
cell	O
lysates	O
.	O

Lane	O
2	O
and	O
3	O
,	O
100	O
mu	O
g	O
of	O
3T3	O
and	O
PC12	O
cell	O
lysates	O
.	O

Figure	O
7	O

Subcellular	O
localization	O
of	O
Acdp1	O
in	O
hippocampus	O
neurons	O
.	O

A	O
series	O
of	O
confocal	O
images	O
from	O
a	O
cultured	O
neuron	O
stained	O
with	O
an	O
anti	O
-	O
Acdp1	O
antibody	O
.	O

The	O
step	O
of	O
each	O
imaging	O
section	O
is	O
0	O
.	O
5	O
mu	O
m	O
,	O
from	O
the	O
surface	O
of	O
the	O
neuron	O
(	O
0	O
mu	O
m	O
)	O
to	O
the	O
middle	O
plan	O
(	O
4	O
.	O
5	O
mu	O
m	O
)	O
.	O

Discussion	O

Although	O
the	O
exact	O
functions	O
of	O
the	O
ACDP	O
gene	O
family	O
are	O
not	O
yet	O
elucidated	O
,	O
several	O
lines	O
of	O
evidence	O
suggest	O
that	O
ACDP	O
genes	O
may	O
play	O
an	O
important	O
role	O
in	O
biological	O
processes	O
.	O

First	O
,	O
these	O
genes	O
are	O
evolutionarily	O
conserved	O
in	O
many	O
phylogenetically	O
divergent	O
species	O
;	O
Second	O
,	O
multiple	O
genes	O
are	O
present	O
in	O
a	O
species	O
;	O
Third	O
,	O
these	O
genes	O
are	O
ubiquitously	O
expressed	O
throughout	O
development	O
and	O
adult	O
tissues	O
(	O
unpublished	O
data	O
)	O
.	O

The	O
cloning	O
and	O
characterization	O
of	O
the	O
mouse	O
Acdp	O
gene	O
family	O
are	O
a	O
very	O
important	O
step	O
towards	O
the	O
elucidation	O
of	O
the	O
functions	O
of	O
this	O
multigene	O
family	O
.	O

Sequence	O
homology	O
analyses	O
revealed	O
that	O
Acdp	O
proteins	B-CHEBI
shared	O
very	O
strong	O
AA	B-CHEBI
homologies	O
to	O
the	O
bacteria	O
CorC	O
protein	B-CHEBI
and	O
yeast	O
Amip3	O
protein	B-CHEBI
.	O

CorA	O
,	O
B	O
,	O
C	O
and	O
D	O
belong	O
to	O
a	O
protein	B-CHEBI
family	O
involved	O
in	O
both	O
influx	O
and	O
efflux	O
of	O
magnesium	B-CHEBI
and	O
cobalt	B-CHEBI
.	O

It	O
has	O
been	O
shown	O
that	O
CorA	O
mutants	O
confer	O
resistance	O
to	O
cobalt	B-CHEBI
toxicity	O
[	O
9	O
]	O
.	O

Amip3	O
appears	O
to	O
be	O
a	O
homologous	O
to	O
CorC	O
protein	B-CHEBI
which	O
is	O
involved	O
in	O
efflux	O
of	O
magnesium	B-CHEBI
and	O
cobalt	B-CHEBI
in	O
bacteria	O
.	O

Amip3	O
mutants	O
confer	O
resistant	O
to	O
copper	B-CHEBI
toxicity	O
.	O

Acdp	O
proteins	B-CHEBI
also	O
possess	O
the	O
domains	O
that	O
are	O
found	O
in	O
bacteria	O
CorC	O
and	O
yeast	O
Amip3	O
proteins	B-CHEBI
,	O
such	O
as	O
the	O
CBS	O
domains	O
,	O
DUF21	O
domain	O
and	O
transmembrane	O
domains	O
.	O

In	O
addition	O
,	O
a	O
cNMP	O
-	O
binding	O
domain	O
was	O
found	O
in	O
all	O
Acdp	O
proteins	B-CHEBI
,	O
which	O
is	O
usually	O
present	O
in	O
ion	B-CHEBI
channels	O
and	O
cNMP	O
-	O
dependent	O
kinases	O
[	O
10	O
-	O
13	O
]	O
.	O

Using	O
antibody	O
produced	O
by	O
Acdp1	O
C	B-CHEBI
-	O
terminal	O
peptide	O
,	O
we	O
have	O
shown	O
that	O
Acdp1	O
is	O
predominantly	O
localized	O
on	O
the	O
plasma	O
membrane	O
in	O
hippocampus	O
neurons	O
.	O

In	O
our	O
previous	O
study	O
,	O
we	O
found	O
human	O
ACDP	O
proteins	B-CHEBI
are	O
predominantly	O
localized	O
in	O
the	O
nucleus	O
in	O
HeLa	O
cells	O
[	O
1	O
]	O
.	O

The	O
discrepancy	O
for	O
Acdp	O
localization	O
in	O
neuronal	O
cells	O
could	O
be	O
caused	O
by	O
non	O
-	O
specificity	O
for	O
previous	O
antibody	O
which	O
was	O
produced	O
by	O
the	O
recombinant	O
ACD	O
domain	O
,	O
or	O
different	O
cells	O
used	O
.	O

In	O
current	O
study	O
,	O
the	O
Acdp1	O
C	B-CHEBI
-	O
terminus	O
antibody	O
only	O
recognizes	O
Acdp1	O
in	O
brain	O
tissue	O
extracts	O
as	O
well	O
as	O
in	O
HEK293	O
,	O
3T3	O
and	O
PC12	O
cell	O
lysates	O
,	O
suggesting	O
the	O
specificity	O
of	O
the	O
antibody	O
.	O

Our	O
observations	O
suggested	O
that	O
Acdp	O
might	O
be	O
involved	O
in	O
ion	B-CHEBI
transport	O
in	O
mammalian	O
cells	O
.	O

However	O
,	O
more	O
detailed	O
functional	O
studies	O
are	O
needed	O
to	O
demonstrate	O
the	O
real	O
functions	O
of	O
these	O
proteins	B-CHEBI
.	O

Conclusions	O

Our	O
previous	O
work	O
has	O
described	O
human	O
ACDP	O
genes	O
[	O
1	O
]	O
.	O

The	O
new	O
information	O
of	O
the	O
current	O
work	O
includes	O
:	O
1	O
)	O
.	O

It	O
is	O
the	O
first	O
time	O
to	O
report	O
the	O
existence	O
of	O
multiple	O
Acdp	O
genes	O
in	O
other	O
mammals	O
in	O
addition	O
to	O
human	O
,	O
while	O
Acdp	O
appears	O
to	O
be	O
a	O
single	O
copy	O
gene	O
in	O
lower	O
organisms	O
such	O
as	O
in	O
C	O
.	O
elegans	O
,	O
yeasts	O
and	O
bacteria	O
.	O

We	O
have	O
also	O
suggested	O
the	O
evolutionary	O
relationships	O
of	O
Acdp	O
genes	O
in	O
different	O
species	O
(	O
phylogenetic	O
tree	O
)	O
;	O
2	O
)	O
.	O

Molecular	B-CHEBI
cloning	O
and	O
characterization	O
of	O
murine	O
Acdp	O
gene	O
family	O
are	O
essential	O
for	O
study	O
of	O
this	O
novel	O
gene	O
family	O
in	O
animal	O
model	O
,	O
e	O
.	O
g	O
.	O
for	O
generation	O
of	O
knockout	O
or	O
transgenic	O
models	O
;	O
3	O
)	O
.	O

We	O
have	O
demonstrated	O
both	O
DNA	O
and	O
amino	B-CHEBI
acid	I-CHEBI
conservations	O
between	O
mouse	O
and	O
human	O
for	O
each	O
Acdp	O
gene	O
and	O
the	O
whole	O
Acdp	O
gene	O
family	O
,	O
which	O
provide	O
important	O
information	O
for	O
the	O
possibility	O
of	O
functional	O
redundancy	O
or	O
overlap	O
between	O
Acdp	O
members	O
;	O
4	O
)	O
.	O

We	O
have	O
generated	O
antibodies	O
specific	O
for	O
Acdp1	O
and	O
all	O
Acdp	O
proteins	B-CHEBI
.	O

The	O
Acdp1	O
C	B-CHEBI
-	O
terminus	O
antibody	O
appears	O
to	O
specifically	O
recognize	O
Acdp1	O
.	O

Using	O
this	O
antibody	O
,	O
we	O
have	O
demonstrated	O
that	O
Acdp1	O
is	O
predominantly	O
localized	O
on	O
the	O
plasma	O
membrane	O
in	O
hippocampus	O
neurons	O
.	O

These	O
results	O
represent	O
an	O
important	O
step	O
towards	O
the	O
characterization	O
of	O
functions	O
for	O
the	O
Acdp	O
gene	O
family	O
.	O

Methods	O

cDNA	O
cloning	O

cDNA	O
cloning	O
of	O
the	O
Acdp	O
gene	O
family	O
was	O
performed	O
based	O
on	O
human	O
homologue	O
sequences	O
as	O
previously	O
reported	O
[	O
2	O
]	O
.	O

Briefly	O
,	O
the	O
human	O
ACDP	O
cDNAs	O
and	O
predicted	O
AA	B-CHEBI
sequences	O
were	O
used	O
to	O
search	O
the	O
mouse	O
EST	O
database	O
for	O
EST	O
markers	O
corresponding	O
to	O
each	O
Acdp	O
member	O
.	O

A	O
forward	O
primer	O
within	O
the	O
human	O
ACDP	O
5	O
'	O
cDNA	O
coding	O
region	O
(	O
after	O
start	O
codon	O
)	O
and	O
a	O
mouse	O
reverse	O
primer	O
from	O
the	O
mouse	O
EST	O
marker	O
were	O
used	O
to	O
amplify	O
the	O
homologue	O
sequence	O
from	O
mouse	O
cDNA	O
at	O
very	O
low	O
annealing	O
temperature	O
(	O
45	O
-	O
50	O
degrees	O
C	O
)	O
.	O

A	O
nested	O
PCR	O
using	O
an	O
inside	O
reverse	O
primer	O
from	O
the	O
mouse	O
EST	O
sequence	O
and	O
the	O
same	O
human	O
forward	O
primer	O
was	O
then	O
carried	O
out	O
to	O
amplify	O
the	O
specific	O
mouse	O
gene	O
from	O
the	O
first	O
round	O
PCR	O
products	O
at	O
high	O
annealing	O
temperature	O
(	O
62	O
degrees	O
C	O
)	O
.	O

The	O
expected	O
PCR	O
products	O
were	O
directly	O
excised	O
from	O
agarose	B-CHEBI
gel	O
and	O
sequenced	O
by	O
an	O
ABI377	O
automatic	O
sequencer	O
.	O

The	O
sequence	O
was	O
further	O
confirmed	O
using	O
a	O
forward	O
primer	O
from	O
newly	O
identified	O
sequence	O
and	O
a	O
reverse	O
primer	O
from	O
known	O
sequence	O
.	O

Once	O
most	O
of	O
the	O
coding	O
sequences	O
were	O
identified	O
,	O
partial	O
sequence	O
of	O
exon	O
1	O
and	O
the	O
5	O
'	O
UTR	O
sequences	O
were	O
obtained	O
by	O
BAC	O
DNA	O
sequencing	O
.	O

Northern	O
blot	O
analyses	O

Multiple	O
Choice	O
Northern	O
Blot	O
filters	O
containing	O
12	O
different	O
mouse	O
tissues	O
were	O
purchased	O
from	O
Origene	O
.	O

The	O
filters	O
were	O
probed	O
for	O
each	O
Acdp	O
gene	O
with	O
a	O
PCR	O
fragment	O
(	O
around	O
350	O
bp	O
)	O
from	O
last	O
exon	O
and	O
the	O
3	O
'	O
untranslated	O
region	O
labeled	O
with	O
alpha	O
-	O
32P	B-CHEBI
dCTP	O
using	O
the	O
random	O
primer	O
extension	O
system	O
(	O
Life	O
Technologies	O
)	O
.	O

Hybridizations	O
were	O
carried	O
out	O
overnight	O
.	O

The	O
filters	O
were	O
washed	O
twice	O
with	O
washing	O
buffer	O
I	O
(	O
2	O
x	O
SSC	O
,	O
0	O
.	O
1	O
%	O
SDS	B-CHEBI
)	O
at	O
42	O
degrees	O
C	O
for	O
15	O
-	O
min	O
,	O
and	O
then	O
washed	O
twice	O
with	O
washing	O
buffer	O
II	O
(	O
0	O
.	O
25	O
x	O
SSC	O
,	O
0	O
.	O
1	O
%	O
SDS	B-CHEBI
)	O
at	O
65	O
degrees	O
C	O
for	O
15	O
-	O
min	O
.	O

Washed	O
filters	O
were	O
exposed	O
to	O
X	O
-	O
ray	O
films	O
for	O
overnight	O
or	O
longer	O
[	O
3	O
,	O
4	O
]	O
.	O

Antibody	O
production	O
and	O
Western	O
blot	O
analyses	O

Peptides	O
linked	O
to	O
KLH	O
(	O
keyhole	O
limpet	O
hemacyanin	O
)	O
from	O
Acdp1	O
N	B-CHEBI
-	O
and	O
C	B-CHEBI
-	O
terminals	O
and	O
the	O
conserved	O
domain	O
(	O
ACD	O
)	O
were	O
used	O
for	O
generation	O
of	O
antibodies	O
specifically	O
for	O
Acdp1	O
and	O
all	O
Acdp	O
members	O
as	O
reported	O
,	O
respectively	O
[	O
5	O
]	O
.	O

Western	O
blots	O
were	O
carried	O
out	O
Using	O
ECL	O
(	O
PIERCE	O
)	O
as	O
described	O
previously	O
[	O
1	O
]	O
.	O

The	O
membranes	O
were	O
washed	O
extensively	O
after	O
incubation	O
with	O
primary	O
and	O
secondary	O
antibodies	O
and	O
were	O
then	O
developed	O
with	O
X	O
-	O
ray	O
films	O
with	O
optimal	O
exposure	O
time	O
.	O

Chromosome	O
localization	O

The	O
T31	O
mouse	O
radiation	O
hybrid	O
panel	O
from	O
Research	O
Genetics	O
was	O
used	O
to	O
map	O
the	O
chromosome	O
location	O
of	O
each	O
Acdp	O
member	O
.	O

Primers	O
from	O
3	O
'	O
UTR	O
of	O
each	O
Acdp	O
member	O
were	O
used	O
to	O
amplify	O
the	O
100	O
radiation	O
hybrid	O
clones	O
representing	O
the	O
mouse	O
genome	O
.	O

The	O
data	O
were	O
submitted	O
to	O
the	O
Jackson	O
Laboratory	O
Mouse	O
Radiation	O
Hybrid	O
Database	O
for	O
analysis	O
.	O

Sequence	O
analyses	O

Sequence	O
assembly	O
was	O
performed	O
with	O
program	O
Sequencher	O
(	O
Gene	O
Codes	O
Corp	O
)	O
.	O

Protein	B-CHEBI
and	O
DNA	O
homology	O
searches	O
were	O
carried	O
out	O
with	O
tblastn	O
,	O
tblastx	O
,	O
blastp	O
and	O
blastn	O
programs	O
.	O

Multiple	O
sequence	O
alignments	O
were	O
performed	O
with	O
GeneDoc	O
and	O
pairwise	O
sequence	O
alignment	O
.	O

Multiple	O
programs	O
including	O
BCM	O
Search	O
Launcher	O
,	O
ProfileScan	O
,	O
sequence	O
motif	O
search	O
,	O
ExPASy	O
and	O
3Dpssm	O
were	O
used	O
for	O
searching	O
sequence	O
features	O
of	O
known	O
protein	B-CHEBI
.	O

Phylogenetic	O
tree	O
was	O
constructed	O
by	O
Clustalw	O
program	O
(	O
version	O
1	O
.	O
81	O
)	O
using	O
UPGMA	O
(	O
Unweighted	O
Pair	O
Group	O
Method	O
using	O
Arithmetic	O
averages	O
)	O
algorithm	O
[	O
14	O
]	O
.	O

Neuronal	O
cell	O
preparation	O
and	O
immunostanining	O

Hippocampal	O
neuron	O
cultures	O
were	O
prepared	O
as	O
previously	O
reported	O
[	O
6	O
]	O
.	O

In	O
brief	O
,	O
the	O
hippocampuses	O
were	O
dissected	O
out	O
from	O
mouse	O
embryos	O
at	O
16	O
days	O
in	O
utero	O
.	O

The	O
tissues	O
were	O
then	O
incubated	O
for	O
20	O
min	O
at	O
37	O
degrees	O
C	O
in	O
MEM	O
(	O
minimum	O
essential	O
medium	O
)	O
modified	O
for	O
suspension	O
culture	O
(	O
Life	O
Technologies	O
)	O
plus	O
0	O
.	O
25	O
%	O
trypsin	O
(	O
Life	O
Technologies	O
)	O
.	O

The	O
dissociated	O
hippocampal	O
neurons	O
were	O
plated	O
on	O
glass	O
coverslips	O
coated	O
with	O
a	O
confluent	O
monolayer	O
of	O
mouse	O
cortical	O
astrocytes	O
obtained	O
as	O
described	O
below	O
.	O

The	O
neurons	O
were	O
maintained	O
at	O
37	O
degrees	O
C	O
in	O
a	O
humidified	O
atmosphere	O
with	O
5	O
%	O
CO2	B-CHEBI
.	O

Cortical	O
astrocytes	O
dissociated	O
from	O
newborn	O
mouse	O
cortices	O
were	O
grown	O
in	O
culture	O
flasks	O
at	O
37	O
degrees	O
C	O
in	O
a	O
humidified	O
atmosphere	O
with	O
5	O
%	O
CO2	B-CHEBI
until	O
confluent	O
.	O

The	O
cells	O
were	O
exposed	O
to	O
10	O
-	O
5	O
M	O
cytosine	B-CHEBI
arabinoside	I-CHEBI
(	O
Sigma	O
)	O
and	O
cultured	O
for	O
additional	O
12	O
-	O
24	O
hrs	O
at	O
37	O
degrees	O
C	O
.	O

After	O
remove	O
of	O
the	O
media	O
with	O
cellular	O
debris	O
,	O
the	O
cells	O
were	O
used	O
for	O
coating	O
coverslips	O
.	O

For	O
immunostaining	O
,	O
neuronal	O
cells	O
on	O
the	O
coverslips	O
were	O
first	O
fixed	O
in	O
PBS	O
containing	O
4	O
%	O
paraformaldehyde	O
(	O
PFA	O
)	O
for	O
12	O
hrs	O
at	O
4	O
degrees	O
C	O
and	O
then	O
incubated	O
in	O
a	O
solution	O
containing	O
4	O
%	O
PFA	O
and	O
0	O
.	O
4	O
%	O
Triton	O
X	O
-	O
100	O
at	O
4	O
degrees	O
C	O
for	O
1	O
hr	O
.	O

After	O
washing	O
with	O
PBS	O
three	O
times	O
,	O
the	O
cells	O
were	O
incubated	O
with	O
a	O
blocking	O
solution	O
containing	O
1	O
:	O
30	O
normal	O
goat	O
serum	O
,	O
and	O
subsequently	O
incubated	O
with	O
a	O
rabbit	O
polyclonal	O
anti	O
-	O
ACDP	O
antibody	O
(	O
1	O
:	O
3000	O
)	O
overnight	O
at	O
4	O
degrees	O
C	O
.	O

After	O
extensive	O
washing	O
with	O
1	O
%	O
goat	O
serum	O
PBS	O
solution	O
,	O
the	O
cells	O
were	O
incubated	O
with	O
an	O
Alex	O
488	O
conjugated	O
secondary	O
antibody	O
(	O
1	O
:	O
100	O
in	O
1	O
%	O
goat	O
serum	O
PBS	O
solution	O
,	O
Molecular	B-CHEBI
Probes	O
)	O
for	O
3	O
hrs	O
at	O
room	O
temperature	O
.	O

Following	O
final	O
washes	O
with	O
1	O
%	O
goat	O
serum	O
PBS	O
solution	O
,	O
the	O
neuronal	O
cells	O
on	O
the	O
coverslips	O
were	O
cover	O
-	O
slipped	O
with	O
a	O
glycerol	B-CHEBI
-	O
based	O
anti	O
-	O
photobleach	O
medium	O
.	O

The	O
cells	O
were	O
viewed	O
under	O
a	O
confocal	O
microscope	O
(	O
Carl	O
Zeiss	O
)	O
.	O

Images	O
were	O
captured	O
with	O
a	O
CCD	O
camera	O
and	O
acquired	O
by	O
the	O
Scion	O
Image	O
software	O
(	O
Scion	O
Corporation	O
,	O
Frederick	O
,	O
MD	O
)	O
.	O

Gene	O
bank	O
accession	O
number	O

The	O
cDNA	O
sequences	O
for	O
the	O
Acdp	O
gene	O
family	O
have	O
already	O
been	O
deposited	O
in	O
gene	O
bank	O
with	O
accession	O
numbers	O
AF202994	O
(	O
Acdp1	O
)	O
,	O
AF216961	O
(	O
Acdp2	O
)	O
,	O
AF216964	O
(	O
Acdp3	O
)	O
and	O
AF216963	O
(	O
Acdp4	O
)	O
.	O

Authors	O
'	O
contributions	O

This	O
study	O
was	O
designed	O
by	O
CYW	O
and	O
JXS	O
.	O

The	O
study	O
was	O
performed	O
as	O
follows	O
:	O
CYW	O
,	O
PY	O
,	O
JDS	O
and	O
HA	O
contributed	O
to	O
the	O
molecular	B-CHEBI
cloning	O
part	O
of	O
the	O
manuscript	O
.	O

CYW	O
and	O
SP	O
were	O
responsible	O
for	O
the	O
Acdp	O
antibody	O
production	O
.	O

JGG	O
and	O
JLG	O
did	O
immunostaining	O
for	O
Acdp1	O
localization	O
in	O
neuronal	O
cells	O
.	O

CYW	O
,	O
DG	O
and	O
ZD	O
carried	O
out	O
the	O
Western	O
analyses	O
.	O

Acknowledgements	O

This	O
work	O
was	O
partly	O
supported	O
by	O
a	O
CIGP	O
grant	O
to	O
C	O
.	O
Y	O
.	O
W	O
.	O

A	O
mouse	O
model	O
of	O
sitosterolemia	O
:	O
absence	O
of	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
results	O
in	O
failure	O
to	O
secrete	O
biliary	O
cholesterol	B-CHEBI

Abstract	O

Background	O

Mutations	O
in	O
either	O
of	O
two	O
genes	O
comprising	O
the	O
STSL	O
locus	O
,	O
ATP	B-CHEBI
-	O
binding	O
cassette	O
(	O
ABC	O
)	O
-	O
transporters	O
ABCG5	O
(	O
encoding	O
sterolin	O
-	O
1	O
)	O
and	O
ABCG8	O
(	O
encoding	O
sterolin	O
-	O
2	O
)	O
,	O
result	O
in	O
sitosterolemia	O
,	O
a	O
rare	O
autosomal	O
recessive	O
disorder	O
of	O
sterol	B-CHEBI
trafficking	O
characterized	O
by	O
increased	O
plasma	O
plant	B-CHEBI
sterol	I-CHEBI
levels	O
.	O

Based	O
upon	O
the	O
genetics	O
of	O
sitosterolemia	O
,	O
ABCG5	O
/	O
sterolin	O
-	O
1	O
and	O
ABCG8	O
/	O
sterolin	O
-	O
2	O
are	O
hypothesized	O
to	O
function	O
as	O
obligate	O
heterodimers	O
.	O

No	O
phenotypic	O
difference	O
has	O
yet	O
been	O
described	O
in	O
humans	O
with	O
complete	O
defects	O
in	O
either	O
ABCG5	O
or	O
ABCG8	O
.	O

These	O
proteins	B-CHEBI
,	O
based	O
upon	O
the	O
defects	O
in	O
humans	O
,	O
are	O
responsible	O
for	O
regulating	O
dietary	O
sterol	B-CHEBI
entry	O
and	O
biliary	O
sterol	B-CHEBI
secretion	O
.	O

Methods	O

In	O
order	O
to	O
mimic	O
the	O
human	O
disease	O
,	O
we	O
created	O
,	O
by	O
a	O
targeted	O
disruption	O
,	O
a	O
mouse	O
model	O
of	O
sitosterolemia	O
resulting	O
in	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
deficiency	O
alone	O
.	O

Homozygous	O
knockout	O
mice	O
are	O
viable	O
and	O
exhibit	O
sitosterolemia	O
.	O

Results	O

Mice	O
deficient	O
in	O
Abcg8	O
have	O
significantly	O
increased	O
plasma	O
and	O
tissue	O
plant	B-CHEBI
sterol	I-CHEBI
levels	O
(	O
sitosterol	B-CHEBI
and	O
campesterol	B-CHEBI
)	O
consistent	O
with	O
sitosterolemia	O
.	O

Interestingly	O
,	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
was	O
expressed	O
in	O
both	O
liver	O
and	O
intestine	O
in	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
deficient	O
mice	O
and	O
continued	O
to	O
show	O
an	O
apical	O
expression	O
.	O

Remarkably	O
,	O
Abcg8	O
deficient	O
mice	O
had	O
an	O
impaired	O
ability	O
to	O
secrete	O
cholesterol	B-CHEBI
into	O
bile	O
,	O
but	O
still	O
maintained	O
the	O
ability	O
to	O
secrete	O
sitosterol	B-CHEBI
.	O

We	O
also	O
report	O
an	O
intermediate	O
phenotype	O
in	O
the	O
heterozygous	O
Abcg8	O
+	O
/	O
-	O
mice	O
that	O
are	O
not	O
sitosterolemic	O
,	O
but	O
have	O
a	O
decreased	O
level	O
of	O
biliary	O
sterol	B-CHEBI
secretion	O
relative	O
to	O
wild	O
-	O
type	O
mice	O
.	O

Conclusion	O

These	O
data	O
indicate	O
that	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
is	O
necessary	O
for	O
biliary	O
sterol	B-CHEBI
secretion	O
and	O
that	O
loss	O
of	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
has	O
a	O
more	O
profound	O
effect	O
upon	O
biliary	O
cholesterol	B-CHEBI
secretion	O
than	O
sitosterol	B-CHEBI
.	O

Since	O
biliary	O
sitosterol	B-CHEBI
secretion	O
is	O
preserved	O
,	O
although	O
not	O
elevated	O
in	O
the	O
sitosterolemic	O
mice	O
,	O
this	O
observation	O
suggests	O
that	O
mechanisms	O
other	O
than	O
by	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
may	O
be	O
responsible	O
for	O
its	O
secretion	O
into	O
bile	O
.	O

Background	O

Absorption	O
of	O
dietary	O
cholesterol	B-CHEBI
from	O
the	O
intestine	O
is	O
an	O
important	O
part	O
of	O
cholesterol	B-CHEBI
homeostasis	O
and	O
represents	O
the	O
initial	O
step	O
that	O
allows	O
dietary	O
cholesterol	B-CHEBI
to	O
exert	O
its	O
metabolic	O
effects	O
.	O

A	O
typical	O
western	O
diet	O
contains	O
relatively	O
equal	O
amounts	O
of	O
cholesterol	B-CHEBI
and	O
non	O
-	O
cholesterol	B-CHEBI
sterols	B-CHEBI
,	O
mainly	O
plant	B-CHEBI
sterols	I-CHEBI
,	O
of	O
which	O
about	O
55	O
%	O
of	O
the	O
dietary	O
cholesterol	B-CHEBI
is	O
absorbed	O
and	O
retained	O
compared	O
to	O
~	O
1	O
%	O
of	O
the	O
dietary	O
non	O
-	O
cholesterol	B-CHEBI
sterols	B-CHEBI
[	O
1	O
-	O
3	O
]	O
.	O

Schoenheimer	O
recognized	O
more	O
than	O
75	O
years	O
ago	O
that	O
only	O
cholesterol	B-CHEBI
,	O
not	O
non	O
-	O
cholesterol	B-CHEBI
sterols	B-CHEBI
,	O
is	O
absorbed	O
in	O
the	O
intestine	O
,	O
although	O
the	O
exact	O
molecular	B-CHEBI
mechanisms	O
by	O
which	O
preferential	O
cholesterol	B-CHEBI
absorption	O
occurs	O
has	O
not	O
been	O
fully	O
elucidated	O
[	O
4	O
]	O
.	O

Similarly	O
,	O
although	O
the	O
liver	O
secretes	O
free	O
cholesterol	B-CHEBI
into	O
bile	O
,	O
it	O
can	O
preferentially	O
excrete	O
non	O
-	O
cholesterol	B-CHEBI
sterols	B-CHEBI
into	O
bile	O
and	O
the	O
mechanism	O
(	O
s	O
)	O
of	O
this	O
process	O
has	O
yet	O
to	O
be	O
elucidated	O
as	O
well	O
.	O

Only	O
recently	O
,	O
through	O
the	O
study	O
of	O
a	O
rare	O
human	O
disease	O
,	O
have	O
clues	O
to	O
this	O
process	O
been	O
revealed	O
.	O

Sitosterolemia	O
(	O
MIM	O
210250	O
,	O
also	O
known	O
as	O
phytosterolemia	O
)	O
is	O
a	O
rare	O
autosomal	O
,	O
recessively	O
inherited	O
disorder	O
characterized	O
by	O
elevated	O
blood	O
and	O
tissue	O
plant	B-CHEBI
sterol	I-CHEBI
levels	O
[	O
5	O
]	O
.	O

Affected	O
individuals	O
can	O
develop	O
tendon	O
and	O
/	O
or	O
tuberous	O
xanthomas	O
,	O
hemolytic	O
episodes	O
,	O
arthralgias	O
,	O
arthritis	O
,	O
and	O
premature	O
atherosclerosis	O
[	O
6	O
,	O
7	O
]	O
.	O

Sitosterolemic	O
patients	O
have	O
diagnostically	O
elevated	O
plasma	O
plant	B-CHEBI
sterol	I-CHEBI
levels	O
(	O
for	O
example	O
,	O
sitosterol	B-CHEBI
,	O
campesterol	B-CHEBI
,	O
stigmasterol	O
,	O
and	O
avenosterol	O
,	O
etc	O
.	O
)	O
and	O
their	O
5	O
-	O
saturated	O
stanol	O
metabolites	O
,	O
particularly	O
sitostanol	O
,	O
with	O
normal	O
or	O
only	O
moderately	O
increased	O
cholesterol	B-CHEBI
levels	O
.	O

Clinical	O
studies	O
have	O
shown	O
that	O
affected	O
individuals	O
hyperabsorb	O
all	O
dietary	O
sterols	B-CHEBI
(	O
thus	O
have	O
lost	O
the	O
ability	O
to	O
restrict	O
the	O
sterol	B-CHEBI
species	O
absorbed	O
)	O
and	O
have	O
lost	O
the	O
ability	O
to	O
excrete	O
sterols	B-CHEBI
into	O
bile	O
[	O
8	O
,	O
9	O
]	O
.	O

Infusion	O
of	O
sitosterol	B-CHEBI
and	O
cholesterol	B-CHEBI
into	O
normal	O
individuals	O
leads	O
to	O
a	O
rapid	O
and	O
preferential	O
excretion	O
of	O
sitosterol	B-CHEBI
into	O
bile	O
,	O
but	O
in	O
sitosterolemic	O
individuals	O
biliary	O
sterol	B-CHEBI
secretion	O
is	O
almost	O
absent	O
[	O
7	O
,	O
9	O
]	O
.	O

Previous	O
studies	O
on	O
sitosterolemia	O
have	O
suggested	O
a	O
defect	O
involving	O
a	O
putative	O
sterol	B-CHEBI
'	O
transporter	O
'	O
expressed	O
in	O
the	O
intestinal	O
brush	O
border	O
and	O
/	O
or	O
the	O
hepatic	O
canalicular	O
membrane	O
[	O
10	O
,	O
11	O
]	O
.	O

Genetic	O
analyses	O
of	O
sitosterolemia	O
pedigrees	O
allowed	O
the	O
mapping	O
of	O
the	O
STSL	O
locus	O
to	O
human	O
chromosome	O
2p21	O
,	O
between	O
D2S2294	O
and	O
D2S2298	O
[	O
12	O
,	O
13	O
]	O
.	O

By	O
using	O
positional	O
cloning	O
procedures	O
or	O
by	O
screening	O
for	O
genes	O
induced	O
by	O
exposure	O
to	O
LXR	O
agonists	B-CHEBI
,	O
two	O
groups	O
identified	O
not	O
one	O
but	O
two	O
genes	O
,	O
ABCG5	O
and	O
ABCG8	O
,	O
which	O
encode	O
the	O
proteins	B-CHEBI
sterolin	O
-	O
1	O
and	O
sterolin	O
-	O
2	O
,	O
mutations	O
of	O
which	O
cause	O
sitosterolemia	O
[	O
14	O
-	O
16	O
]	O
.	O

Interestingly	O
,	O
complete	O
mutation	O
in	O
either	O
ABCG5	O
alone	O
or	O
ABCG8	O
alone	O
is	O
not	O
only	O
necessary	O
,	O
but	O
sufficient	O
to	O
cause	O
the	O
disease	O
[	O
14	O
]	O
.	O

To	O
date	O
,	O
no	O
patient	O
with	O
sitosterolemia	O
has	O
been	O
identified	O
with	O
mutations	O
in	O
both	O
genes	O
.	O

Based	O
upon	O
these	O
data	O
,	O
and	O
the	O
similarity	O
of	O
the	O
clinical	O
and	O
biochemical	O
phenotype	O
,	O
sterolin	O
-	O
1	O
and	O
sterolin	O
-	O
2	O
are	O
hypothesized	O
to	O
function	O
as	O
obligate	O
heterodimers	O
.	O

This	O
is	O
also	O
supported	O
by	O
the	O
fact	O
that	O
each	O
of	O
these	O
proteins	B-CHEBI
is	O
a	O
'	O
half	O
-	O
transporter	O
'	O
,	O
containing	O
six	O
transmembrane	O
domains	O
,	O
and	O
not	O
the	O
classical	O
12	O
transmembrane	O
characteristic	O
of	O
functional	O
ABC	O
transporters	O
.	O

The	O
exact	O
function	O
of	O
these	O
two	O
proteins	B-CHEBI
still	O
remains	O
unknown	O
but	O
recent	O
studies	O
have	O
shown	O
that	O
overexpression	O
of	O
ABCG5	O
/	O
ABCG8	O
in	O
a	O
transgenic	O
mouse	O
model	O
results	O
in	O
an	O
increased	O
biliary	O
cholesterol	B-CHEBI
concentration	O
and	O
a	O
50	O
%	O
reduction	O
in	O
the	O
fractional	O
absorption	O
of	O
dietary	O
cholesterol	B-CHEBI
[	O
17	O
]	O
.	O

It	O
has	O
been	O
suggested	O
that	O
ABCG5	O
and	O
ABCG8	O
act	O
as	O
mutual	O
chaperones	O
for	O
both	O
maturation	O
and	O
correct	O
apical	O
targeting	O
.	O

Co	O
-	O
expression	O
of	O
both	O
was	O
required	O
for	O
apical	O
trafficking	O
in	O
a	O
polarized	O
cell	O
line	O
,	O
as	O
well	O
in	O
vivo	O
using	O
Abcg5	O
/	O
Abcg8	O
double	O
-	O
knockout	O
mice	O
[	O
18	O
,	O
19	O
]	O
.	O

However	O
,	O
no	O
functional	O
assay	O
has	O
yet	O
been	O
developed	O
to	O
demonstrate	O
whether	O
or	O
not	O
the	O
two	O
half	O
-	O
transporters	O
function	O
as	O
homo	O
-	O
or	O
heterodimers	O
and	O
whether	O
they	O
selectively	O
pump	O
sterols	B-CHEBI
.	O

Likewise	O
,	O
the	O
cellular	O
localization	O
of	O
these	O
two	O
proteins	B-CHEBI
has	O
yet	O
to	O
be	O
shown	O
in	O
a	O
model	O
deficient	O
in	O
either	O
Abcg5	O
or	O
Abcg8	O
alone	O
.	O

A	O
mouse	O
model	O
disrupting	O
both	O
Abcg5	O
and	O
Abcg8	O
simultaneously	O
results	O
in	O
a	O
phenotype	O
similar	O
to	O
that	O
of	O
the	O
human	O
disease	O
[	O
20	O
]	O
.	O

However	O
,	O
it	O
is	O
important	O
to	O
point	O
out	O
that	O
the	O
human	O
disease	O
is	O
caused	O
by	O
complete	O
mutation	O
in	O
one	O
or	O
the	O
other	O
gene	O
,	O
but	O
not	O
both	O
simultaneously	O
.	O

We	O
hypothesized	O
that	O
disruption	O
of	O
only	O
one	O
of	O
the	O
half	O
-	O
transporters	O
would	O
result	O
in	O
sitosterolemia	O
and	O
selective	O
loss	O
of	O
either	O
sterolin	O
may	O
show	O
a	O
differential	O
effect	O
on	O
the	O
biliary	O
secretion	O
of	O
sterols	B-CHEBI
or	O
intestinal	O
absorption	O
of	O
sterols	B-CHEBI
.	O

These	O
studies	O
are	O
difficult	O
to	O
test	O
in	O
humans	O
,	O
as	O
the	O
target	O
organs	O
are	O
relatively	O
inaccessible	O
.	O

In	O
order	O
to	O
test	O
this	O
hypothesis	O
,	O
we	O
report	O
a	O
mouse	O
model	O
that	O
has	O
a	O
selective	O
genetic	O
mutation	O
of	O
Abcg8	O
.	O

Mice	O
homozygous	O
for	O
Abcg8	O
loss	O
exhibit	O
many	O
of	O
the	O
characteristics	O
of	O
the	O
human	O
disease	O
sitosterolemia	O
.	O

In	O
addition	O
,	O
we	O
report	O
studies	O
of	O
biliary	O
sterol	B-CHEBI
secretion	O
that	O
show	O
that	O
despite	O
forced	O
secretion	O
,	O
Abcg8	O
-	O
deficient	O
animals	O
cannot	O
secrete	O
cholesterol	B-CHEBI
into	O
bile	O
,	O
although	O
sitosterol	B-CHEBI
secretion	O
seemed	O
unaffected	O
.	O

Methods	O

Targeting	O
vector	O
construction	O
and	O
generation	O
of	O
knockout	O
mice	O

A	O
mouse	O
genomic	O
bacterial	O
artificial	O
chromosome	O
(	O
BAC	O
)	O
library	O
(	O
CitbCJ7	O
,	O
ES	O
cell	O
line	O
/	O
129Sv	O
,	O
Research	O
Genetics	O
,	O
Inc	O
.	O
,	O
Huntsville	O
,	O
AL	O
,	O
USA	O
)	O
was	O
screened	O
by	O
using	O
primers	O
designed	O
from	O
the	O
sequences	O
of	O
mouse	O
Abcg5	O
and	O
Abcg8	O
cDNA	O
as	O
previously	O
reported	O
[	O
21	O
]	O
.	O

A	O
positive	O
BAC	O
clone	O
was	O
used	O
as	O
a	O
template	O
to	O
amplify	O
genomic	O
DNA	O
fragments	O
of	O
Abcg8	O
.	O

Long	O
-	O
fragment	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
was	O
performed	O
using	O
Expanded	O
Long	O
Template	O
PCR	O
system	O
kit	O
(	O
Roche	O
Applied	O
Science	O
,	O
Indianapolis	O
,	O
IA	O
,	O
USA	O
)	O
.	O

An	O
approximately	O
4	O
.	O
5	O
kb	O
'	O
long	O
-	O
arm	O
'	O
genomic	O
fragment	O
containing	O
partial	O
exon	O
1	O
to	O
partial	O
exon	O
3	O
was	O
inserted	O
into	O
the	O
Pml	O
I	O
restriction	O
-	O
cloning	O
site	O
A	O
of	O
OSDUPDEL	O
vector	O
.	O

The	O
'	O
short	O
-	O
arm	O
'	O
genomic	O
fragment	O
,	O
containing	O
partial	O
exon	O
4	O
to	O
partial	O
exon	O
6	O
,	O
was	O
cloned	O
into	O
the	O
Not	O
I	O
-	O
Kpn	O
I	O
of	O
cloning	O
site	O
B	O
.	O

Homologous	O
targeting	O
would	O
result	O
in	O
complete	O
intron	O
3	O
,	O
partial	O
exon	O
3	O
and	O
partial	O
exon	O
4	O
replacement	O
by	O
the	O
neomycin	B-CHEBI
-	O
resistance	O
cassette	O
,	O
resulting	O
in	O
the	O
disruption	O
of	O
the	O
ABC	O
Walker	O
A	O
motif	O
(	O
Figure	O
1a	O
)	O
.	O

ES	O
cells	O
(	O
129	O
/	O
SvEvTac	O
-	O
cell	O
line	O
)	O
were	O
electroporated	O
with	O
the	O
linearized	O
targeting	O
vector	O
DNA	O
and	O
cultured	O
on	O
sub	O
-	O
confluent	O
embryonic	O
fibroblasts	O
.	O

Transfected	O
cell	O
colonies	O
were	O
selected	O
by	O
culturing	O
cells	O
in	O
medium	O
containing	O
200	O
mu	O
g	O
/	O
mL	O
G418	O
(	O
Life	O
Technologies	O
,	O
Rockville	O
,	O
MD	O
,	O
USA	O
)	O
.	O

The	O
ES	O
cells	O
were	O
screened	O
for	O
homologous	O
recombination	O
by	O
PCR	O
with	O
the	O
forward	O
primer	O
,	O
neoF	O
(	O
5	O
'	O
-	O
GGGTCGTTTGTTCGGATCAA	O
-	O
3	O
'	O
)	O
from	O
neo	O
cassette	O
,	O
and	O
reverse	O
primer	O
intron	O
6R	O
(	O
5	O
'	O
-	O
ACCAGTTGGTCCTAGCTCGA	O
-	O
3	O
'	O
)	O
,	O
which	O
is	O
located	O
outside	O
the	O
targeting	O
construct	O
in	O
mouse	O
Abcg8	O
intron	O
6	O
.	O

Positively	O
targeted	O
ES	O
cell	O
clones	O
were	O
confirmed	O
by	O
Southern	O
blotting	O
,	O
using	O
ES	O
cell	O
DNA	O
digested	O
by	O
BamHI	O
and	O
a	O
probe	O
comprising	O
of	O
a	O
562	O
bp	O
PCR	O
fragment	O
from	O
partial	O
intron	O
2	O
and	O
exon	O
3	O
of	O
Abcg8	O
gene	O
.	O

Positively	O
targeted	O
ES	O
cells	O
were	O
microinjected	O
into	O
C57BL6	O
blastocysts	O
and	O
transplanted	O
into	O
pseudopregnant	O
recipients	O
.	O

Five	O
highly	O
chimeric	O
mice	O
(	O
agouti	O
coat	O
color	O
,	O
three	O
males	O
and	O
two	O
females	O
)	O
were	O
isolated	O
and	O
bred	O
with	O
C57BL	O
/	O
6J	O
mice	O
to	O
generate	O
germ	O
-	O
line	O
transmission	O
heterozygous	O
mice	O
of	O
Abcg8	O
gene	O
disruption	O
.	O

Heterozygous	O
offspring	O
mice	O
were	O
back	O
-	O
crossed	O
to	O
C57BL	O
/	O
6J	O
mice	O
(	O
n	O
>	O
5	O
)	O
to	O
produce	O
disrupted	O
line	O
and	O
inter	O
-	O
crossed	O
to	O
generate	O
knockout	O
mice	O
.	O

Animals	O
and	O
diets	O

All	O
mice	O
were	O
maintained	O
on	O
a	O
standard	O
rodent	O
chow	B-CHEBI
(	O
Harlan	O
Teklad	O
mouse	O
/	O
rat	O
diet	O
LM	O
-	O
485	O
)	O
which	O
contained	O
61	O
mg	O
/	O
kg	O
cholesterol	B-CHEBI
,	O
31	O
mg	O
/	O
kg	O
campesterol	B-CHEBI
,	O
and	O
105	O
mg	O
/	O
kg	O
sitosterol	B-CHEBI
,	O
given	O
free	O
access	O
to	O
water	B-CHEBI
and	O
maintained	O
at	O
25	O
degrees	O
C	O
with	O
a	O
12	O
-	O
h	O
light	O
,	O
12	O
-	O
h	O
dark	O
cycle	O
.	O

All	O
animals	O
were	O
housed	O
in	O
the	O
facilities	O
for	O
laboratory	O
animals	O
provided	O
by	O
the	O
Division	O
of	O
Laboratory	O
Animal	O
Resources	O
ACLAM	O
.	O

The	O
Institutional	O
Animal	O
Care	O
and	O
Research	O
Advisory	O
Committee	O
at	O
Medical	O
University	O
of	O
South	O
Carolina	O
approved	O
all	O
experiments	O
.	O

Genotyping	O
by	O
PCR	O

Mouse	O
tail	O
DNA	O
was	O
isolated	O
and	O
purified	O
by	O
cutting	O
approximately	O
0	O
.	O
5	O
cm	O
of	O
mouse	O
tail	O
and	O
digesting	O
it	O
in	O
500	O
mu	O
l	O
lysis	O
buffer	O
(	O
50	O
mM	O
Tris	B-CHEBI
-	O
HCl	B-CHEBI
,	O
pH8	O
.	O
0	O
,	O
100	O
mM	O
EDTA	B-CHEBI
,	O
125	O
mM	O
NaCl	B-CHEBI
,	O
1	O
%	O
SDS	B-CHEBI
,	O
200	O
mu	O
g	O
Proteinase	O
K	O
)	O
with	O
rocking	O
overnight	O
at	O
55	O
degrees	O
C	O
.	O

200	O
mu	O
l	O
saturated	O
NaCl	B-CHEBI
was	O
added	O
into	O
digested	O
solution	O
with	O
vigorous	O
shaking	O
for	O
at	O
least	O
60	O
seconds	O
.	O

Mixed	O
solution	O
was	O
spun	O
down	O
at	O
maximum	O
speed	O
in	O
top	O
micro	O
-	O
centrifuge	O
for	O
20	O
min	O
.	O

The	O
supernatant	O
was	O
transferred	O
to	O
a	O
new	O
tube	O
with	O
equal	O
volume	O
100	O
%	O
EtOH	B-CHEBI
and	O
mixed	O
by	O
inversion	O
.	O

The	O
DNA	O
pellet	O
was	O
washed	O
in	O
70	O
%	O
EtOH	B-CHEBI
and	O
resuspended	O
in	O
100	O
-	O
150	O
mu	O
l	O
TE	O
buffer	O
.	O

UV	O
spectrophotometry	O
and	O
electrophoresis	O
were	O
used	O
to	O
analyze	O
the	O
quality	O
and	O
quantity	O
of	O
the	O
genomic	O
DNA	O
.	O

Genotyping	O
was	O
performed	O
by	O
multiplex	O
PCR	O
reaction	O
using	O
three	O
separate	O
primers	O
(	O
two	O
Abcg8	O
gene	O
specific	O
primers	O
,	O
mg8	O
-	O
in3F	O
5	O
'	O
-	O
CCCAATGATGAATGAGACGCT	O
-	O
3	O
'	O
,	O
mg8	O
-	O
R9	O
5	O
'	O
-	O
TTTGTCACGCTGGGCCTGG	O
-	O
3	O
'	O
and	O
neoF	O
for	O
identification	O
of	O
Abcg8	O
target	O
status	O
)	O
.	O

The	O
PCR	O
reaction	O
consisted	O
of	O
1x	O
PCR	O
buffer	O
(	O
1	O
.	O
5	O
mM	O
MgCl2	B-CHEBI
,	O
16	O
mM	O
(	O
NH4	B-CHEBI
)	O
2SO4	O
,	O
0	O
.	O
1	O
mM	O
dNTPs	B-CHEBI
,	O
67	O
mM	O
Tris	B-CHEBI
-	O
HCl	B-CHEBI
(	O
pH8	O
.	O
8	O
)	O
)	O
1	O
mu	O
M	O
of	O
each	O
primer	O
,	O
water	B-CHEBI
and	O
1	O
.	O
0	O
units	O
of	O
Taq	O
polymerase	O
.	O

The	O
reactions	O
were	O
cycled	O
as	O
follows	O
:	O
94	O
degrees	O
C	O
for	O
30	O
sec	O
,	O
60	O
degrees	O
C	O
for	O
30	O
sec	O
,	O
72	O
degrees	O
C	O
for	O
1	O
min	O
for	O
35	O
cycles	O
.	O

The	O
PCR	O
products	O
were	O
identified	O
by	O
electrophoresis	O
.	O

Southern	O
blot	O
analysis	O

To	O
confirm	O
PCR	O
results	O
,	O
DNAs	O
were	O
digested	O
with	O
Bam	O
HI	O
,	O
subjected	O
to	O
electrophoresis	O
in	O
a	O
0	O
.	O
6	O
%	O
agarose	B-CHEBI
gel	O
and	O
transferred	O
to	O
nylon	B-CHEBI
membrane	O
.	O

Southern	O
blot	O
filters	O
were	O
hybridized	O
with	O
a	O
562	O
bp	O
PCR	O
fragment	O
from	O
partial	O
intron	O
2	O
and	O
exon	O
3	O
of	O
Abcg8	O
32P	B-CHEBI
-	O
randomly	O
-	O
labeled	O
probe	O
as	O
previously	O
described	O
[	O
22	O
]	O
.	O

Northern	O
blot	O
analysis	O

Isolation	O
of	O
liver	O
and	O
intestinal	O
total	O
RNA	O
from	O
Abcg8	O
+	O
/	O
+	O
,	O
Abcg8	O
+	O
/	O
-	O
and	O
Abcg8	O
-	O
/	O
-	O
mice	O
and	O
Northern	O
blot	O
analyses	O
were	O
performed	O
as	O
previously	O
described	O
[	O
23	O
]	O
.	O

The	O
probe	O
for	O
Abcg5	O
was	O
1964	O
bp	O
(	O
nt	B-CHEBI
136	O
-	O
2099	O
,	O
GeneBank	O
(TM)	O
accession	O
no	O
.	O
AH011511	O
)	O
and	O
the	O
probe	O
for	O
Abcg8	O
was	O
2019	O
bp	O
(	O
nt	B-CHEBI
103	O
-	O
2126	O
,	O
GeneBank	O
(TM)	O
accession	O
no	O
.	O
AH011518	O
)	O
.	O

Reverse	O
Transcription	O
(	O
RT	O
)	O
-	O
PCR	O

To	O
confirm	O
that	O
there	O
was	O
no	O
alternative	O
splicing	O
of	O
the	O
disrupted	O
allele	O
,	O
RT	O
-	O
PCR	O
was	O
performed	O
on	O
cDNAs	O
of	O
pooled	O
mouse	O
liver	O
.	O

Briefly	O
,	O
samples	O
of	O
total	O
RNA	O
(	O
0	O
.	O
5	O
mu	O
g	O
)	O
from	O
pooled	O
mouse	O
livers	O
(	O
n	O
=	O
4	O
)	O
were	O
reverse	O
transcribed	O
according	O
to	O
the	O
SuperScript	O
(TM)	O
First	O
-	O
Strand	O
Synthesis	O
System	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
CA	O
,	O
USA	O
)	O
using	O
random	O
hexamers	O
in	O
a	O
final	O
total	O
reaction	O
volume	O
of	O
20	O
mu	O
l	O
.	O

RT	O
-	O
PCR	O
was	O
performed	O
using	O
primers	O
located	O
outside	O
of	O
the	O
targeted	O
region	O
:	O
F1	O
(	O
CCTCAGCTGGTGAGGAGGTG	O
)	O
with	O
R1	O
(	O
GATGGAGAAGGTGAAGTTGCC	O
)	O
,	O
F2	O
(	O
ATTTCCAATGACTTCCGGGAC	O
)	O
with	O
R1	O
and	O
F3	O
(	O
CTGGAAGACGGGCTGTACACT	O
)	O
with	O
R1	O
,	O
to	O
produce	O
expected	O
product	O
lengths	O
of	O
1449	O
,	O
654	O
and	O
429	O
bp	O
respectively	O
in	O
wild	O
-	O
type	O
cDNA	O
.	O

Quantitative	O
RT	O
-	O
PCR	O

Primers	O
were	O
based	O
upon	O
previously	O
published	O
primer	O
sets	O
[	O
24	O
-	O
26	O
]	O
or	O
designed	O
using	O
MacVector	O
,	O
which	O
were	O
designed	O
from	O
either	O
mRNA	B-CHEBI
or	O
cDNA	O
to	O
avoid	O
the	O
amplification	O
of	O
potentially	O
contaminating	O
genomic	O
DNA	O
in	O
the	O
total	O
RNA	O
sample	O
(	O
Table	O
1	O
)	O
.	O

Samples	O
of	O
total	O
RNA	O
(	O
0	O
.	O
5	O
mu	O
g	O
)	O
from	O
pooled	O
mouse	O
livers	O
(	O
n	O
=	O
4	O
)	O
were	O
reverse	O
transcribed	O
according	O
to	O
the	O
SuperScript	O
(TM)	O
First	O
-	O
Strand	O
Synthesis	O
System	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
CA	O
,	O
USA	O
)	O
using	O
random	O
hexamers	O
with	O
a	O
final	O
total	O
reaction	O
volume	O
of	O
20	O
mu	O
l	O
.	O

Quantitative	O
RT	O
-	O
PCR	O
was	O
performed	O
on	O
a	O
PE	O
Biosystems	O
GeneAmp	O
(R)	O
5700	O
sequence	O
Detection	O
System	O
(	O
Forest	O
City	O
,	O
CA	O
,	O
USA	O
)	O
.	O

Standard	O
reaction	O
volume	O
was	O
10	O
mu	O
l	O
containing	O
1	O
x	O
QuantiTect	O
SYBR	O
Green	O
PCR	O
master	O
mix	O
(	O
Qiagen	O
,	O
Valencia	O
,	O
CA	O
,	O
USA	O
)	O
,	O
0	O
.	O
002	O
U	O
AmpErase	O
UNG	O
enzyme	O
(	O
PE	O
Biosystems	O
,	O
Forest	O
City	O
,	O
CA	O
,	O
USA	O
)	O
,	O
0	O
.	O
7	O
mu	O
l	O
of	O
cDNA	O
template	O
from	O
reverse	O
transcription	O
reaction	O
as	O
above	O
and	O
100	O
-	O
500	O
nM	O
of	O
oligonucleotide	O
primers	O
.	O

Initial	O
steps	O
of	O
RT	O
-	O
PCR	O
were	O
two	O
minutes	O
at	O
50	O
degrees	O
C	O
for	O
UNG	O
activation	O
,	O
followed	O
by	O
a	O
15	O
minute	O
hold	O
at	O
95	O
degrees	O
C	O
.	O

Cycles	O
(	O
n	O
=	O
40	O
)	O
consisted	O
of	O
a	O
15	O
second	O
melt	O
at	O
95	O
degrees	O
C	O
,	O
followed	O
by	O
a	O
1	O
minute	O
annealing	O
/	O
extension	O
at	O
60	O
degrees	O
C	O
.	O

The	O
final	O
step	O
was	O
a	O
60	O
degrees	O
C	O
incubation	O
for	O
1	O
minute	O
.	O

At	O
the	O
end	O
of	O
the	O
run	O
,	O
samples	O
were	O
heated	O
to	O
95	O
degrees	O
C	O
with	O
a	O
ramp	O
time	O
of	O
20	O
minutes	O
to	O
construct	O
dissociation	O
curves	O
to	O
ensure	O
that	O
single	O
PCR	O
products	O
were	O
obtained	O
.	O

All	O
reactions	O
were	O
performed	O
in	O
triplicate	O
.	O

Threshold	O
cycle	O
(	O
CT	O
)	O
analysis	O
of	O
all	O
samples	O
was	O
set	O
at	O
0	O
.	O
5	O
relative	O
fluorescence	O
units	O
.	O

The	O
relative	O
quantities	O
of	O
message	O
of	O
genes	O
of	O
interest	O
from	O
the	O
mouse	O
liver	O
samples	O
used	O
in	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
were	O
normalized	O
to	O
cyclophilin	O
to	O
compensate	O
for	O
variations	O
in	O
input	O
RNA	O
amounts	O
.	O

The	O
data	O
were	O
analyzed	O
using	O
the	O
comparative	O
threshold	O
cycle	O
method	O
(	O
CT	O
)	O
.	O

Briefly	O
,	O
the	O
CT	O
values	O
are	O
averaged	O
,	O
from	O
the	O
triplicates	O
defining	O
a	O
Delta	O
-	O
CT	O
value	O
calculated	O
by	O
taking	O
the	O
average	O
CT	O
of	O
the	O
gene	O
of	O
interest	O
and	O
subtracting	O
it	O
from	O
the	O
average	O
CT	O
of	O
cyclophilin	O
.	O

The	O
Delta	O
Delta	O
-	O
CT	O
was	O
calculated	O
by	O
subtracting	O
the	O
average	O
Delta	O
-	O
CT	O
(	O
calibrator	O
)	O
values	O
from	O
the	O
Delta	O
-	O
CT	O
(	O
sample	O
)	O
.	O

The	O
relative	O
quantification	O
was	O
then	O
calculated	O
by	O
the	O
expression	O
2	O
-	O
Average	O
Delta	O
Delta	O
-	O
CT	O
.	O

The	O
mRNA	B-CHEBI
quantity	O
for	O
the	O
calibrator	O
(	O
wild	O
type	O
)	O
was	O
expressed	O
as	O
1	O
and	O
all	O
other	O
quantities	O
were	O
expressed	O
as	O
a	O
fold	O
difference	O
relative	O
to	O
the	O
calibrator	O
(	O
wild	O
type	O
)	O
.	O

Plasma	O
lipid	B-CHEBI
analysis	O
by	O
fast	O
protein	B-CHEBI
liquid	O
chromatography	O

Following	O
16	O
hrs	O
of	O
fasting	O
,	O
blood	O
samples	O
(	O
n	O
=	O
3	O
)	O
from	O
each	O
of	O
the	O
Abcg8	O
+	O
/	O
+	O
,	O
Abcg8	O
+	O
/	O
-	O
and	O
Abcg8	O
-	O
/	O
-	O
mice	O
were	O
collected	O
from	O
the	O
retro	O
-	O
orbital	O
venous	O
plexus	O
using	O
heparinized	O
capillary	O
tubes	O
under	O
isoflurane	O
anesthesia	O
,	O
and	O
placed	O
into	O
precooled	O
tubes	O
containing	O
10	O
mu	O
l	O
of	O
0	O
.	O
5	O
M	O
EDTA	B-CHEBI
.	O

Equal	O
volumes	O
of	O
plasma	O
from	O
each	O
genotype	O
were	O
pooled	O
and	O
100	O
mu	O
L	O
of	O
the	O
pooled	O
sample	O
were	O
injected	O
and	O
fractionated	O
by	O
fast	O
protein	B-CHEBI
liquid	O
chromatography	O
(	O
FPLC	O
)	O
using	O
a	O
Superose	O
6	O
HR10	O
/	O
30	O
column	O
(	O
Pharmacia	O
Biotech	O
Inc	O
.	O
,	O
Piscataway	O
,	O
NJ	O
,	O
USA	O
)	O
and	O
analyzed	O
as	O
described	O
[	O
27	O
]	O
.	O

Sterol	B-CHEBI
composition	O
of	O
plasma	O
and	O
tissues	O

Following	O
a	O
four	O
-	O
hour	O
fast	O
of	O
12	O
-	O
week	O
-	O
old	O
mice	O
fed	O
on	O
regular	O
rodent	O
chow	B-CHEBI
diet	O
;	O
blood	O
and	O
tissues	O
were	O
collected	O
under	O
isofluorane	O
anesthesia	O
from	O
each	O
of	O
the	O
Abcg8	O
+	O
/	O
+	O
,	O
Abcg8	O
+	O
/	O
-	O
and	O
Abcg8	O
-	O
/	O
-	O
mice	O
(	O
n	O
=	O
3	O
for	O
each	O
group	O
)	O
.	O

Blood	O
was	O
collected	O
from	O
the	O
retro	O
-	O
orbital	O
venous	O
plexus	O
by	O
heparinized	O
glass	O
tube	O
.	O

The	O
animals	O
were	O
sacrificed	O
by	O
cervical	O
dislocation	O
for	O
tissue	O
collection	O
.	O

Plasma	O
(	O
100	O
mu	O
l	O
)	O
was	O
saponified	O
in	O
1	O
N	O
NaOH	B-CHEBI
for	O
one	O
hour	O
,	O
1	O
.	O
5	O
mL	O
water	B-CHEBI
added	O
and	O
sterols	B-CHEBI
extracted	O
with	O
three	O
sequential	O
portions	O
of	O
1	O
.	O
5	O
mL	O
ethyl	B-CHEBI
acetate	I-CHEBI
,	O
containing	O
70	O
mu	O
g	O
5	B-CHEBI
alpha	I-CHEBI
-	I-CHEBI
cholestane	I-CHEBI
as	O
an	O
internal	O
standard	O
,	O
pooled	O
and	O
dried	O
.	O

Mouse	O
tissues	O
(	O
liver	O
,	O
spleen	O
and	O
brain	O
)	O
were	O
weighed	O
,	O
homogenized	O
in	O
1	O
mL	O
phosphate	B-CHEBI
buffer	B-CHEBI
saline	O
(	O
PBS	O
)	O
with	O
a	O
dounce	O
homogenizer	O
(	O
15	O
strokes	O
at	O
500	O
rpm	O
)	O
and	O
a	O
small	O
aliquot	O
of	O
the	O
whole	O
homogenate	O
assayed	O
for	O
protein	B-CHEBI
concentration	O
.	O

Aliquots	O
for	O
sterol	B-CHEBI
analysis	O
from	O
whole	O
tissue	O
homogenates	O
were	O
extracted	O
as	O
described	O
above	O
.	O

Dried	O
sterol	B-CHEBI
samples	O
were	O
derivatized	O
as	O
trimethylsilylethers	O
,	O
redissolved	O
in	O
10	O
mu	O
L	O
hexane	B-CHEBI
and	O
2	O
mu	O
L	O
samples	O
were	O
injected	O
into	O
a	O
capillary	O
column	O
(	O
26	O
m	O
length	O
,	O
0	O
.	O
32	O
mm	O
ID	O
,	O
0	O
.	O
45	O
mm	O
OD	O
)	O
coated	O
with	O
liquid	O
CpWAX	O
57	O
CB	O
(	O
Chrompak	O
,	O
Bridgewater	O
,	O
NJ	O
,	O
USA	O
)	O
in	O
a	O
Hewlett	O
-	O
Packard	O
Gas	O
Chromatograph	O
equipped	O
with	O
a	O
flame	O
ionization	O
detector	O
[	O
28	O
]	O
.	O

Concentrations	O
of	O
plasma	O
and	O
tissue	O
sterols	B-CHEBI
were	O
reported	O
as	O
mg	O
/	O
dL	O
and	O
mu	O
g	O
/	O
g	O
wet	O
weight	O
tissue	O
,	O
respectively	O
.	O

Polyclonal	O
antibody	O
production	O

Three	O
separate	O
polyclonal	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
antibodies	O
have	O
been	O
raised	O
as	O
previously	O
described	O
[	O
20	O
,	O
29	O
,	O
30	O
]	O
.	O

In	O
experiments	O
,	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
antibodies	O
are	O
labelled	O
as	O
follows	O
:	O

1	O
)	O
SC	O
-	O
from	O
the	O
Patel	O
group	O
,	O
2	O
)	O
AMC	O
-	O
from	O
the	O
AMC	O
Liver	O
Center	O
group	O
,	O
and	O
3	O
)	O
UTSW	O
-	O
from	O
the	O
Hobbs	O
group	O
.	O

Membrane	O
protein	B-CHEBI
preparations	O

Total	O
membranes	O
were	O
prepared	O
by	O
taking	O
approximately	O
500	O
mg	O
of	O
liver	O
tissue	O
cut	O
into	O
small	O
pieces	O
and	O
homogenized	O
in	O
ice	O
cold	O
lysis	O
buffer	O
(	O
5	O
mM	O
Tris	B-CHEBI
-	O
pH7	O
.	O
5	O
,	O
250	O
mM	O
sucrose	B-CHEBI
with	O
protease	B-CHEBI
inhibitors	I-CHEBI
)	O
by	O
a	O
dounce	O
homogenizer	O
times	O
10	O
strokes	O
.	O

Samples	O
were	O
then	O
subjected	O
to	O
centrifugation	O
-	O
1300	O
g	O
for	O
10	O
minutes	O
at	O
4	O
degrees	O
C	O
.	O

The	O
supernant	O
was	O
saved	O
and	O
the	O
pellet	O
was	O
resuspended	O
and	O
again	O
subjected	O
to	O
dounce	O
homogenization	O
times	O
10	O
strokes	O
then	O
centrifuged	O
1000	O
g	O
for	O
10	O
minutes	O
at	O
4	O
degrees	O
C	O
.	O

This	O
step	O
was	O
repeated	O
twice	O
each	O
time	O
with	O
the	O
supernant	O
being	O
collected	O
and	O
kept	O
on	O
ice	O
.	O

The	O
supernants	O
were	O
then	O
pooled	O
and	O
subjected	O
to	O
ultracentrifugation	O
at	O
100	O
,	O
000	O
g	O
for	O
60	O
minutes	O
at	O
4	O
degrees	O
C	O
.	O

The	O
supernant	O
was	O
removed	O
and	O
the	O
pellet	O
was	O
resuspended	O
in	O
lysis	O
buffer	O
.	O

Plasma	O
membranes	O
were	O
prepared	O
as	O
previously	O
described	O
[	O
31	O
]	O
.	O

Protein	B-CHEBI
sample	O
concentrations	O
were	O
then	O
determined	O
by	O
Bio	O
-	O
Rad	O
protein	B-CHEBI
colormetric	O
assay	O
per	O
manufacturer	O
'	O
s	O
protocol	O
(	O
BioRad	O
,	O
Hercules	O
,	O
CA	O
,	O
USA	O
)	O
.	O

50	O
mu	O
g	O
of	O
membrane	O
proteins	B-CHEBI
were	O
then	O
resolved	O
on	O
7	O
.	O
5	O
%	O
SDS	B-CHEBI
acrylamide	B-CHEBI
gel	O
.	O

Immunoblotting	O

Proteins	B-CHEBI
resolved	O
by	O
SDS	B-CHEBI
-	O
PAGE	O
were	O
transferred	O
to	O
nitrocellulose	O
membranes	O
.	O

Membranes	O
were	O
then	O
blocked	O
for	O
one	O
hour	O
in	O
5	O
%	O
dry	O
milk	O
in	O
PBS	O
-	O
T	O
(	O
Phosphate	B-CHEBI
Buffered	B-CHEBI
saline	O
and	O
0	O
.	O
1	O
%	O
Tween	O
20	O
)	O
.	O

Blots	O
were	O
then	O
probed	O
with	O
primary	O
antibody	O
against	O
Abcg5	O
in	O
5	O
%	O
milk	O
in	O
PBS	O
-	O
T	O
overnight	O
at	O
4	O
degrees	O
C	O
.	O

The	O
blot	O
was	O
then	O
washed	O
three	O
times	O
for	O
five	O
minutes	O
in	O
TBS	O
-	O
T	O
(	O
Tris	B-CHEBI
Buffered	B-CHEBI
Saline	O
/	O
0	O
.	O
1	O
%	O
Tween	O
-	O
20	O
)	O
with	O
150	O
mM	O
NaCl	B-CHEBI
,	O
and	O
secondarily	O
stained	O
with	O
goat	O
-	O
anti	O
-	O
rabbit	O
conjugated	O
HRP	O
1	O
:	O
10	O
,	O
000	O
dilution	O
in	O
5	O
%	O
milk	O
in	O
PBS	O
-	O
T	O
for	O
one	O
hour	O
.	O

The	O
blot	O
was	O
again	O
washed	O
three	O
times	O
for	O
five	O
minutes	O
in	O
TBS	O
-	O
T	O
with	O
150	O
mM	O
NaCl	B-CHEBI
then	O
covered	O
in	O
Western	O
Lightning	O
(R)	O
Chemiluminescence	O
Reagent	B-CHEBI
Plus	O
(	O
PerkinElmer	O
Life	O
Sciences	O
,	O
Inc	O
.	O
Boston	O
,	O
MA	O
,	O
USA	O
)	O
,	O
wrapped	O
in	O
plastic	O
,	O
exposed	O
to	O
film	O
and	O
developed	O
.	O

Immunohistochemical	O
analysis	O

Snap	O
-	O
frozen	O
liver	O
and	O
intestine	O
tissue	O
were	O
cut	O
to	O
produce	O
8	O
mu	O
m	O
thick	O
frozen	O
sections	O
,	O
air	O
-	O
dried	O
for	O
30	O
minutes	O
onto	O
glass	O
slides	O
and	O
stored	O
at	O
-	O
80	O
degrees	O
C	O
until	O
required	O
.	O

The	O
slides	O
were	O
stained	O
with	O
hematoxylin	O
,	O
rinsed	O
three	O
times	O
with	O
PBS	O
,	O
fixed	O
for	O
10	O
min	O
with	O
cooled	O
methanol	B-CHEBI
at	O
-	O
20	O
degrees	O
C	O
and	O
then	O
rinsed	O
three	O
times	O
with	O
PBS	O
.	O

Slides	O
for	O
antibody	O
staining	O
were	O
initially	O
blocked	O
in	O
PBS	O
/	O
0	O
.	O
1	O
M	O
glycine	B-CHEBI
/	O
10	O
%	O
goat	O
serum	O
for	O
60	O
min	O
at	O
room	O
temperature	O
then	O
incubated	O
with	O
anti	O
-	O
sterolin	O
-	O
1	O
antibody	O
(	O
1	O
:	O
15	O
dilution	O
)	O
overnight	O
at	O
4	O
degrees	O
C	O
.	O

The	O
slides	O
were	O
washed	O
with	O
1	O
x	O
PBS	O
and	O
incubated	O
with	O
secondary	O
antibody	O
(	O
goat	O
-	O
anti	O
-	O
rabbit	O
IgG	O
conjugated	O
with	O
rhodamine	O
,	O
1	O
:	O
1000	O
dilution	O
)	O
for	O
30	O
min	O
at	O
room	O
temperature	O
,	O
washed	O
and	O
then	O
observed	O
under	O
an	O
Olympus	O
BX	O
-	O
5	O
confocal	O
microscope	O
with	O
Fluoview	O
.	O

The	O
sections	O
stained	O
at	O
the	O
AMC	O
Liver	O
Center	O
were	O
fixed	O
in	O
100	O
%	O
acetone	B-CHEBI
for	O
30	O
min	O
at	O
room	O
temperature	O
,	O
blocked	O
in	O
a	O
solution	O
of	O
PBS	O
/	O
0	O
.	O
05	O
%	O
Tween	O
-	O
20	O
/	O
5	O
%	O
goat	O
serum	O
(	O
GS	O
)	O
for	O
one	O
hour	O
,	O
then	O
incubated	O
with	O
Anti	O
-	O
sterolin	O
-	O
1	O
(	O
1	O
:	O
40	O
dilution	O
)	O
and	O
anti	O
-	O
Bsep	O
(	O
1	O
:	O
200	O
dilution	O
)	O
diluted	O
in	O
PBS	O
/	O
Tween	O
/	O
GS	O
,	O
for	O
one	O
hour	O
.	O

Thereafter	O
,	O
slides	O
were	O
washed	O
3	O
x	O
10	O
min	O
in	O
PBS	O
/	O
Tween	O
and	O
the	O
secondary	O
antibody	O
(	O
goat	O
-	O
anti	O
-	O
rabbit	O
Alexa	O
488	O
)	O
was	O
applied	O
in	O
1	O
:	O
1000	O
dilution	O
in	O
PBST	O
/	O
GS	O
for	O
one	O
hour	O
at	O
room	O
temperature	O
.	O

After	O
washing	O
for	O
3	O
x	O
10	O
min	O
the	O
sections	O
were	O
mounted	O
in	O
Dapi	O
/	O
Dapco	O
solution	O
.	O

Fluorescence	O
microscopy	O
was	O
done	O
with	O
a	O
Leica	O
DM	O
RA2	O
microscope	O
equipped	O
with	O
a	O
Leica	O
DC350F	O
photo	O
camera	O
.	O

For	O
Dapi	O
staining	O
,	O
359	O
nm	O
(	O
30	O
.	O
38	O
ms	O
exposure	O
)	O
was	O
used	O
and	O
for	O
Abcg5	O
and	O
Bsep	O
staining	O
,	O
514	O
nm	O
(	O
for	O
both	O
:	O
1654	O
.	O
34	O
ms	O
exposure	O
)	O
was	O
used	O
and	O
the	O
pictures	O
were	O
analyzed	O
and	O
overlaid	O
using	O
FW4000	O
software	O
(	O
Leica	O
)	O
.	O

Transfection	O
and	O
immunostaining	O
of	O
COS	O
-	O
1	O
cells	O

COS	O
-	O
1	O
cells	O
were	O
transiently	O
transfected	O
with	O
pCMV	O
-	O
mouse	O
Abcg5	O
and	O
pCMV	O
-	O
mouse	O
Abcg8	O
expression	O
constructs	O
using	O
the	O
Qiagen	O
SuperFect	O
reagent	O
per	O
protocol	O
(	O
Valencia	O
,	O
CA	O
,	O
USA	O
)	O
.	O

Briefly	O
,	O
COS	O
-	O
1	O
cells	O
were	O
seeded	O
onto	O
a	O
six	O
-	O
well	O
plate	O
the	O
day	O
prior	O
to	O
transfection	O
to	O
generate	O
60	O
%	O
confluence	O
when	O
grown	O
at	O
37	O
degrees	O
C	O
and	O
5	O
%	O
CO2	B-CHEBI
in	O
DMEM	O
supplemented	O
with	O
10	O
%	O
FBS	O
,	O
100	O
U	O
/	O
ml	O
penicillin	B-CHEBI
,	O
100	O
mu	O
g	O
/	O
ml	O
streptomycin	B-CHEBI
and	O
1	O
x	O
glutamine	B-CHEBI
.	O

On	O
the	O
day	O
of	O
transfection	O
,	O
2	O
mu	O
g	O
of	O
DNA	O
was	O
mixed	O
with	O
Qiagen	O
SuperFect	O
reagent	O
and	O
incubated	O
for	O
10	O
minutes	O
.	O

This	O
mixture	O
was	O
then	O
added	O
to	O
serum	O
-	O
free	O
media	O
and	O
placed	O
on	O
the	O
cells	O
to	O
incubate	O
for	O
two	O
hours	O
.	O

The	O
cells	O
were	O
washed	O
once	O
with	O
1x	O
PBS	O
and	O
fresh	O
media	O
was	O
added	O
.	O

The	O
transfected	O
cells	O
were	O
then	O
incubated	O
for	O
48	O
hours	O
to	O
ensure	O
expression	O
and	O
subsequently	O
fixed	O
with	O
a	O
1	O
:	O
1	O
mixture	O
of	O
acetone	B-CHEBI
:	O
methanol	B-CHEBI
.	O

In	O
preparation	O
for	O
immunostaining	O
,	O
cells	O
were	O
blocked	O
with	O
2	O
%	O
goat	O
serum	O
in	O
PBS	O
for	O
30	O
minutes	O
,	O
then	O
incubated	O
with	O
1	O
:	O
50	O
dilution	O
of	O
primary	O
antibody	O
anti	O
-	O
Abcg5	O
in	O
2	O
%	O
goat	O
serum	O
-	O
PBS	O
for	O
1	O
.	O
5	O
hours	O
,	O
and	O
subsequently	O
incubated	O
with	O
secondary	O
rhodamine	O
anti	O
-	O
rabbit	O
IgG	O
antibody	O
for	O
30	O
minutes	O
.	O

Cells	O
were	O
then	O
observed	O
under	O
an	O
Olympus	O
BX	O
-	O
5	O
confocal	O
microscope	O
with	O
Fluoview	O
.	O

Dynamic	O
biliary	O
lipid	B-CHEBI
collection	O
and	O
analysis	O

Mice	O
were	O
anaesthetized	O
by	O
intraperitoneal	O
injection	O
of	O
1	O
mL	O
/	O
kg	O
fentanyl	O
/	O
fluanisone	O
and	O
10	O
mg	O
/	O
kg	O
Diazepam	B-CHEBI
.	O

The	O
abdomen	O
was	O
opened	O
and	O
,	O
after	O
distal	O
ligation	O
of	O
the	O
bile	O
duct	O
,	O
the	O
gallbladder	O
was	O
cannulated	O
.	O

Bile	O
sampling	O
started	O
directly	O
after	O
cannulation	O
and	O
was	O
collected	O
for	O
10	O
min	O
.	O

Bile	O
flow	O
was	O
determined	O
gravimetrically	O
.	O

Biliary	O
bile	B-CHEBI
salt	I-CHEBI
,	O
sterol	B-CHEBI
and	O
phospholipid	B-CHEBI
concentrations	O
were	O
determined	O
as	O
described	O
previously	O
[	O
32	O
]	O
.	O

To	O
determine	O
maximal	O
secretion	O
rates	O
of	O
biliary	O
lipid	B-CHEBI
secretion	O
,	O
bile	O
was	O
diverted	O
for	O
90	O
min	O
to	O
deplete	O
the	O
endogenous	O
bile	B-CHEBI
salt	I-CHEBI
pool	O
.	O

Subsequently	O
,	O
tauroursodeoxycholate	O
(	O
Sigma	O
Chemical	B-CHEBI
Co	O
.	O
,	O
MO	O
,	O
USA	O
)	O
dissolved	O
in	O
PBS	O
was	O
infused	O
into	O
the	O
jugular	O
vein	O
in	O
stepwise	O
increasing	O
rates	O
from	O
600	O
-	O
1	O
,	O
800	O
nmol	O
/	O
min	O
/	O
100	O
g	O
body	O
weight	O
.	O

Bile	O
was	O
collected	O
in	O
10	O
min	O
fractions	O
and	O
analyzed	O
for	O
bile	B-CHEBI
salt	I-CHEBI
and	O
lipid	B-CHEBI
content	O
.	O

In	O
separate	O
experiments	O
,	O
following	O
distal	O
ligation	O
of	O
the	O
bile	O
duct	O
and	O
cannulation	O
of	O
gallbladder	O
,	O
bile	O
was	O
diverted	O
for	O
30	O
minutes	O
while	O
mice	O
were	O
infused	O
with	O
sterile	O
PBS	O
.	O

Subsequently	O
,	O
the	O
mice	O
were	O
infused	O
continuously	O
with	O
1	O
,	O
200	O
nmol	O
/	O
min	O
/	O
100	O
g	O
body	O
weight	O
of	O
tauroursodeoxycholate	O
and	O
two	O
30	O
-	O
minute	O
fractions	O
were	O
collected	O
.	O

Sterol	B-CHEBI
analyses	O
of	O
bile	O
was	O
performed	O
by	O
GC	O
analysis	O
as	O
described	O
above	O
.	O

Assay	O
of	O
HMG	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
and	O
cholesterol	B-CHEBI
7	O
alpha	O
-	O
hydroxylase	O
enzyme	O
activity	O

Mouse	O
liver	O
microsomes	O
were	O
prepared	O
by	O
differential	O
centrifugation	O
[	O
33	O
]	O
.	O

Briefly	O
,	O
0	O
.	O
1	O
-	O
0	O
.	O
2	O
g	O
liver	O
was	O
homogenized	O
in	O
a	O
Potter	O
-	O
Elvjhem	O
homogenizer	O
with	O
five	O
volumes	O
of	O
buffer	O
(	O
0	O
.	O
25	O
M	O
sucrose	B-CHEBI
,	O
0	O
.	O
1	O
M	O
Tris	B-CHEBI
,	O
0	O
.	O
1	O
mM	O
disodium	O
EDTA	B-CHEBI
,	O
0	O
.	O
1	O
mM	O
DTT	B-CHEBI
,	O
pH	O
7	O
.	O
4	O
)	O
.	O

Microsomes	O
were	O
isolated	O
by	O
differential	O
centrifugation	O
(	O
10	O
,	O
000	O
g	O
to	O
100	O
,	O
000	O
g	O
)	O
.	O

The	O
pellets	O
were	O
washed	O
and	O
resuspended	O
in	O
storage	O
buffer	O
(	O
0	O
.	O
1	O
M	O
dipotassium	O
phosphate	B-CHEBI
,	O
0	O
.	O
05	O
M	O
KCl	B-CHEBI
,	O
1	O
mM	O
DTT	B-CHEBI
,	O
5	O
mM	O
disodium	O
EDTA	B-CHEBI
,	O
20	O
%	O
glycerol	B-CHEBI
,	O
pH	O
7	O
.	O
4	O
)	O
at	O
25	O
-	O
30	O
mg	O
protein	B-CHEBI
/	O
ml	O
.	O

Protein	B-CHEBI
concentrations	O
were	O
determined	O
according	O
to	O
the	O
method	O
of	O
Lowry	O
et	O
al	O
.	O

[	O
34	O
]	O
.	O

The	O
activity	O
of	O
cholesterol	B-CHEBI
7	O
alpha	O
-	O
hydroxylase	O
(	O
EC	O
1	O
.	O
14	O
.	O
12	O
.	O
17	O
)	O
was	O
measured	O
by	O
an	O
isotope	O
incorporation	O
method	O
according	O
to	O
Shefer	O
et	O
al	O
.	O

[	O
33	O
]	O
with	O
some	O
modifications	O
.	O

The	O
reaction	O
mixture	O
(	O
final	O
volume	O
0	O
.	O
5	O
ml	O
)	O
consisted	O
of	O
potassium	B-CHEBI
phosphate	B-CHEBI
buffer	O
(	O
100	O
mM	O
K2HPO4	O
,	O
0	O
.	O
1	O
mM	O
EDTA	B-CHEBI
,	O
5	O
mM	O
DTT	B-CHEBI
,	O
30	O
mM	O
nicotinamide	B-CHEBI
,	O
pH	O
7	O
.	O
4	O
)	O
,	O
[	O
14C	B-CHEBI
]	O
-	O
cholesterol	B-CHEBI
(	O
5	O
x	O
105	O
dpm	O
)	O
solubilized	O
in	O
50	O
mu	O
l	O
of	O
25	O
%	O
(	O
wt	O
/	O
vol	O
)	O
beta	O
-	O
cyclodextrin	B-CHEBI
(	O
final	O
concentration	O
0	O
.	O
8	O
%	O
)	O
,	O
and	O
50	O
-	O
200	O
mu	O
g	O
of	O
microsomal	O
protein	B-CHEBI
.	O

The	O
reaction	O
was	O
initiated	O
by	O
the	O
addition	O
of	O
NADPH	B-CHEBI
or	O
an	O
NADPH	B-CHEBI
-	O
generating	O
system	O
(	O
3	O
.	O
4	O
mM	O
NADP	B-CHEBI
+	I-CHEBI
,	O
30	O
mM	O
glucose	B-CHEBI
-	I-CHEBI
6	I-CHEBI
-	I-CHEBI
phosphate	I-CHEBI
,	O
0	O
.	O
3	O
U	O
of	O
glucose	B-CHEBI
-	I-CHEBI
6	I-CHEBI
-	I-CHEBI
phosphate	I-CHEBI
dehydrogenase	O
)	O
and	O
continued	O
for	O
15	O
min	O
at	O
37	O
degrees	O
C	O
.	O

The	O
reaction	O
was	O
stopped	O
with	O
0	O
.	O
5	O
ml	O
of	O
1	O
N	O
KOH	B-CHEBI
,	O
5	O
mu	O
g	O
of	O
butylated	O
hydroxytoluene	B-CHEBI
,	O
and	O
10	O
mu	O
l	O
of	O
ethanolic	B-CHEBI
potassium	B-CHEBI
hydroxide	I-CHEBI
.	O

[	O
3H	B-CHEBI
]	O
7	B-CHEBI
alpha	I-CHEBI
-	I-CHEBI
hydroxycholesterol	I-CHEBI
(	O
1	O
x	O
104	O
dpm	O
/	O
5	O
mu	O
g	O
)	O
was	O
added	O
as	O
an	O
internal	O
recovery	O
standard	O
.	O

After	O
saponification	O
at	O
37	O
degrees	O
C	O
for	O
one	O
hour	O
,	O
sterols	B-CHEBI
were	O
extracted	O
twice	O
with	O
3	O
ml	O
of	O
n	B-CHEBI
-	I-CHEBI
hexane	I-CHEBI
and	O
the	O
extracts	O
were	O
evaporated	O
to	O
dryness	O
under	O
nitrogen	B-CHEBI
.	O

The	O
residue	O
was	O
dissolved	O
in	O
0	O
.	O
3	O
ml	O
of	O
n	B-CHEBI
-	I-CHEBI
hexane	I-CHEBI
:	O
2	B-CHEBI
-	I-CHEBI
propanol	I-CHEBI
(	O
97	O
.	O
3	O
vol	O
/	O
vol	O
)	O
and	O
applied	O
to	O
a	O
silica	B-CHEBI
column	O
(	O
500	O
mg	O
;	O
sep	O
-	O
pak	O
,	O
by	O
4	O
ml	O
of	O
n	B-CHEBI
-	I-CHEBI
hexane	I-CHEBI
:	O
2	B-CHEBI
-	I-CHEBI
propanol	I-CHEBI
(	O
97	O
.	O
3	O
vol	O
/	O
vol	O
)	O
)	O
.	O

7	B-CHEBI
alpha	I-CHEBI
-	I-CHEBI
hydroxycholesterol	I-CHEBI
was	O
eluted	O
with	O
3	O
ml	O
of	O
n	B-CHEBI
-	I-CHEBI
hexane	I-CHEBI
:	O
2	B-CHEBI
-	I-CHEBI
propanol	I-CHEBI
(	O
80	O
:	O
20	O
vol	O
:	O
vol	O
)	O
and	O
further	O
isolated	O
by	O
TLC	O
on	O
silica	B-CHEBI
gel	O
plates	O
(	O
Silica	B-CHEBI
gel	O
60	O
,	O
EM	O
Science	O
,	O
Gibbestown	O
,	O
NJ	O
,	O
USA	O
)	O
with	O
diethyl	B-CHEBI
ether	I-CHEBI
,	O
and	O
quantified	O
by	O
liquid	O
scintillation	O
counting	O
using	O
Ecolume	O
(	O
ICN	O
Radiochemicals	O
Irvine	O
,	O
CA	O
,	O
USA	O
)	O
.	O

Assays	O
were	O
carried	O
out	O
in	O
duplicate	O
with	O
correction	O
for	O
zero	O
-	O
time	O
controls	O
.	O

HMG	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
reductase	O
(	O
EC	O
1	O
.	O
1	O
.	O
1	O
.	O
3	O
.	O
4	O
)	O
activity	O
was	O
determined	O
according	O
to	O
the	O
method	O
of	O
Xu	O
et	O
al	O
.	O

[	O
35	O
]	O
with	O
modifications	O
as	O
described	O
[	O
36	O
]	O
.	O

Statistical	O
analysis	O

Data	O
are	O
shown	O
as	O
means	O
+/-	O
SD	O
.	O

The	O
Student	O
'	O
s	O
t	O
test	O
was	O
used	O
to	O
determine	O
the	O
statistical	O
significance	O
of	O
differences	O
between	O
the	O
groups	O
of	O
animals	O
.	O

Significance	O
was	O
set	O
at	O
P	O
values	O
<	O
0	O
.	O
05	O
.	O

Results	O

Isolation	O
of	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
deficient	O
mice	O

The	O
targeting	O
construct	O
(	O
Figure	O
1a	O
)	O
results	O
in	O
the	O
potential	O
disruption	O
of	O
normal	O
splicing	O
,	O
as	O
well	O
as	O
loss	O
of	O
some	O
coding	O
sequences	O
involving	O
exons	O
3	O
and	O
4	O
.	O

After	O
ES	O
cell	O
electroporation	O
with	O
the	O
linearized	O
targeted	O
plasmid	O
DNA	O
,	O
two	O
homologous	O
recombinant	O
ES	O
clones	O
(	O
out	O
of	O
58	O
ES	O
clones	O
screened	O
)	O
were	O
identified	O
.	O

Blastocyst	O
injection	O
of	O
these	O
resulted	O
in	O
five	O
highly	O
chimeric	O
mice	O
(	O
three	O
males	O
,	O
two	O
females	O
)	O
.	O

One	O
male	O
and	O
one	O
female	O
,	O
both	O
from	O
the	O
same	O
ES	O
clone	O
,	O
showed	O
germline	O
transmission	O
and	O
the	O
female	O
line	O
was	O
used	O
to	O
establish	O
a	O
multi	O
-	O
generational	O
colony	O
bred	O
onto	O
a	O
C57Bl	O
/	O
6J	O
background	O
.	O

Heterozygous	O
mice	O
were	O
fertile	O
and	O
gave	O
rise	O
to	O
normal	O
litter	O
sizes	O
.	O

Breeding	O
heterozygous	O
animals	O
led	O
to	O
wild	O
-	O
type	O
,	O
heterozygous	O
and	O
homozygous	O
knockout	O
mice	O
in	O
the	O
expected	O
Mendelian	O
distribution	O
(	O
data	O
not	O
shown	O
)	O
.	O

Although	O
not	O
quantitative	O
,	O
Northern	O
analyses	O
showed	O
that	O
while	O
the	O
knockout	O
mice	O
showed	O
no	O
detectable	O
mRNA	B-CHEBI
for	O
Abcg8	O
,	O
expression	O
of	O
Abcg5	O
appeared	O
unaltered	O
(	O
Figure	O
1c	O
)	O
.	O

To	O
exclude	O
the	O
possibility	O
of	O
alternative	O
splicing	O
with	O
the	O
production	O
of	O
a	O
non	O
-	O
functional	O
but	O
truncated	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
protein	B-CHEBI
that	O
may	O
serve	O
as	O
a	O
chaperone	O
for	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
,	O
RT	O
-	O
PCR	O
was	O
performed	O
on	O
cDNA	O
reverse	O
transcribed	O
from	O
total	O
liver	O
RNA	O
from	O
Abcg8	O
-	O
deficient	O
mice	O
.	O

No	O
mRNA	B-CHEBI
for	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
was	O
detected	O
containing	O
any	O
sequences	O
downstream	O
of	O
exon	O
4	O
in	O
the	O
Abcg8	O
-	O
deficient	O
mice	O
,	O
whether	O
primers	O
were	O
located	O
in	O
exons	O
4	O
and	O
13	O
,	O
exons	O
9	O
and	O
13	O
or	O
exons	O
10	O
and	O
13	O
(	O
Figure	O
1d	O
,	O
1e	O
)	O
.	O

This	O
demonstrates	O
that	O
if	O
an	O
alternatively	O
spliced	O
message	O
could	O
potentially	O
code	O
for	O
a	O
truncated	O
protein	B-CHEBI
,	O
it	O
is	O
not	O
detectable	O
in	O
the	O
Abcg8	O
-	O
deficient	O
mice	O
.	O

The	O
membrane	O
-	O
spanning	O
domains	O
of	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
are	O
encoded	O
by	O
exons	O
9	O
-	O
13	O
.	O

Sterol	B-CHEBI
levels	O
in	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
deficient	O
animals	O

Elevated	O
plant	B-CHEBI
sterols	I-CHEBI
in	O
tissue	O
and	O
plasma	O
are	O
diagnostic	O
of	O
sitosterolemia	O
.	O

Sterol	B-CHEBI
levels	O
,	O
as	O
determined	O
by	O
gas	O
chromatography	O
(	O
GC	O
)	O
analysis	O
,	O
in	O
plasma	O
and	O
tissues	O
of	O
the	O
Abcg8	O
-	O
/	O
-	O
mice	O
are	O
shown	O
in	O
Table	O
2	O
.	O

There	O
were	O
no	O
differences	O
in	O
tissue	O
weights	O
between	O
wild	O
types	O
,	O
heterozygotes	O
and	O
knockouts	O
.	O

Plasma	O
cholesterol	B-CHEBI
levels	O
of	O
the	O
homozygous	O
and	O
heterozygous	O
mice	O
were	O
decreased	O
by	O
52	O
%	O
and	O
26	O
%	O
,	O
respectively	O
,	O
compared	O
to	O
those	O
of	O
wild	O
-	O
type	O
mice	O
(	O
n	O
=	O
3	O
all	O
groups	O
,	O
Table	O
2	O
)	O
.	O

Plant	B-CHEBI
sterols	I-CHEBI
were	O
almost	O
undetectable	O
in	O
wild	O
-	O
type	O
and	O
heterozygous	O
mice	O
,	O
but	O
were	O
significantly	O
elevated	O
in	O
Abcg8	O
-	O
/	O
-	O
mice	O
.	O

Plasma	O
campesterol	B-CHEBI
and	O
sitosterol	B-CHEBI
levels	O
were	O
eight	O
-	O
and	O
36	O
-	O
fold	O
higher	O
in	O
Abcg8	O
-	O
/	O
-	O
mice	O
compared	O
to	O
wild	O
-	O
type	O
mice	O
(	O
8	O
.	O
76	O
+/-	O
2	O
.	O
10	O
and	O
18	O
.	O
52	O
+/-	O
5	O
.	O
03	O
mg	O
/	O
dL	O
,	O
respectively	O
,	O
versus	O
1	O
.	O
14	O
+/-	O
0	O
.	O
69	O
and	O
0	O
.	O
50	O
+/-	O
0	O
.	O
55	O
mg	O
/	O
dL	O
)	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
the	O
plasma	O
plant	B-CHEBI
sterol	I-CHEBI
levels	O
between	O
heterozygous	O
and	O
wild	O
-	O
type	O
mice	O
.	O

Liver	O
cholesterol	B-CHEBI
content	O
of	O
the	O
Abcg8	O
-	O
/	O
-	O
mice	O
was	O
reduced	O
by	O
~	O
50	O
%	O
relative	O
to	O
wild	O
-	O
type	O
liver	O
(	O
1202	O
+/-	O
264	O
mu	O
g	O
/	O
g	O
wet	O
weight	O
tissue	O
,	O
versus	O
2280	O
+/-	O
310	O
mu	O
g	O
/	O
g	O
wet	O
weight	O
tissue	O
,	O
respectively	O
)	O
.	O

The	O
reduced	O
cholesterol	B-CHEBI
content	O
was	O
offset	O
by	O
a	O
five	O
-	O
fold	O
increase	O
in	O
campesterol	B-CHEBI
and	O
a	O
22	O
-	O
fold	O
increase	O
in	O
sitosterol	B-CHEBI
(	O
233	O
.	O
9	O
+/-	O
48	O
.	O
1	O
and	O
376	O
.	O
3	O
+/-	O
96	O
.	O
1	O
mu	O
g	O
/	O
g	O
wet	O
weight	O
tissue	O
,	O
respectively	O
)	O
in	O
Abcg8	O
-	O
/	O
-	O
knockout	O
mice	O
compared	O
to	O
wild	O
-	O
type	O
mice	O
(	O
52	O
.	O
2	O
+/-	O
15	O
.	O
0	O
and	O
16	O
.	O
7	O
+/-	O
8	O
.	O
6	O
mu	O
g	O
/	O
g	O
wet	O
weight	O
tissue	O
,	O
respectively	O
,	O
Table	O
2	O
)	O
.	O

There	O
were	O
no	O
significant	O
differences	O
of	O
liver	O
cholesterol	B-CHEBI
or	O
plant	B-CHEBI
sterol	I-CHEBI
contents	O
between	O
Abcg8	O
+	O
/	O
+	O
and	O
Abcg8	O
+	O
/	O
-	O
mice	O
.	O

Spleen	O
sterol	B-CHEBI
contents	O
reflected	O
the	O
liver	O
profiles	O
(	O
Table	O
2	O
)	O
.	O

No	O
significant	O
differences	O
in	O
brain	O
sterol	B-CHEBI
contents	O
were	O
observed	O
,	O
as	O
would	O
be	O
expected	O
,	O
since	O
the	O
blood	O
brain	O
barrier	O
is	O
intact	O
and	O
prevents	O
entry	O
of	O
these	O
sterols	B-CHEBI
in	O
sitosterolemia	O
(	O
Table	O
2	O
)	O
.	O

There	O
were	O
only	O
traces	O
of	O
plant	B-CHEBI
sterols	I-CHEBI
in	O
the	O
brains	O
from	O
knockout	O
animals	O
,	O
reflecting	O
blood	O
contamination	O
during	O
tissue	O
harvesting	O
.	O

Interestingly	O
,	O
the	O
majority	O
of	O
the	O
elevated	O
tissue	O
plant	B-CHEBI
sterols	I-CHEBI
are	O
unesterified	O
.	O

The	O
livers	O
of	O
Abcg8	O
+	O
/	O
+	O
,	O
+	O
/	O
-	O
and	O
-	O
/	O
-	O
mice	O
have	O
relatively	O
similar	O
levels	O
of	O
esterified	O
cholesterol	B-CHEBI
(	O
Figure	O
2a	O
)	O
.	O

However	O
,	O
there	O
is	O
little	O
if	O
any	O
esterification	O
of	O
sitosterol	B-CHEBI
or	O
campesterol	B-CHEBI
(	O
Figure	O
2b	O
,	O
2c	O
)	O
consistent	O
with	O
previous	O
findings	O
[	O
37	O
,	O
38	O
]	O
.	O

Thus	O
all	O
of	O
the	O
expansion	O
of	O
tissue	O
sterol	B-CHEBI
pools	O
are	O
as	O
free	O
sterols	B-CHEBI
.	O

FPLC	O
analyses	O
for	O
sterols	B-CHEBI
(	O
measured	O
enzymatically	O
and	O
thus	O
reflecting	O
total	O
sterols	B-CHEBI
)	O
and	O
triglycerides	B-CHEBI
were	O
performed	O
on	O
plasma	O
samples	O
from	O
fasted	O
animals	O
fed	O
a	O
regular	O
chow	B-CHEBI
diet	O
.	O

No	O
significant	O
differences	O
were	O
observed	O
for	O
the	O
sterol	B-CHEBI
profiles	O
(	O
Figure	O
3a	O
)	O
,	O
but	O
surprisingly	O
,	O
the	O
Abcg8	O
-	O
/	O
-	O
knockout	O
mice	O
had	O
a	O
significantly	O
higher	O
triglyceride	B-CHEBI
level	O
in	O
the	O
LDL	B-CHEBI
lipoprotein	I-CHEBI
fractions	O
compared	O
to	O
wild	O
-	O
type	O
and	O
heterozygous	O
mice	O
(	O
Figure	O
3b	O
)	O
.	O

The	O
size	O
of	O
this	O
peak	O
was	O
variable	O
between	O
different	O
littermate	O
analyses	O
,	O
but	O
is	O
always	O
increased	O
in	O
the	O
knockout	O
animals	O
.	O

Total	O
plasma	O
triglyceride	B-CHEBI
levels	O
of	O
the	O
Abcg8	O
-	O
/	O
-	O
mice	O
were	O
slightly	O
higher	O
(	O
79	O
.	O
2	O
+/-	O
14	O
mg	O
/	O
dL	O
compared	O
to	O
the	O
wild	O
type	O
63	O
.	O
4	O
+/-	O
13	O
mg	O
/	O
dL	O
and	O
heterozygotes	O
46	O
.	O
6	O
+/-	O
12	O
mg	O
/	O
dL	O
,	O
n	O
=	O
3	O
for	O
all	O
genotypes	O
)	O
.	O

Preliminary	O
analyses	O
of	O
proteins	B-CHEBI
in	O
the	O
isolated	O
FPLC	O
fractions	O
did	O
not	O
show	O
any	O
qualitative	O
changes	O
in	O
apolipoproteins	B-CHEBI
B	O
,	O
E	O
,	O
AI	O
,	O
or	O
AII	O
.	O

The	O
significance	O
of	O
this	O
triglyceride	B-CHEBI
rich	O
peak	O
remains	O
unclear	O
at	O
present	O
.	O

Liver	O
gene	O
expression	O
and	O
enzyme	O
activity	O
change	O
in	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
deficient	O
mice	O

To	O
investigate	O
the	O
effects	O
of	O
a	O
deficiency	O
of	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
on	O
the	O
genes	O
that	O
regulate	O
sterol	B-CHEBI
metabolism	O
,	O
quantitative	O
RT	O
-	O
PCR	O
was	O
performed	O
looking	O
at	O
the	O
expression	O
levels	O
of	O
Abcg5	O
,	O
Abcg8	O
,	O
Hmgr	O
,	O
Cyp7a1	O
,	O
Abca1	O
,	O
Mdr2	O
,	O
Lxr	O
,	O
Srebp	O
-	O
1c	O
,	O
and	O
Srebp	O
-	O
2	O
mRNA	B-CHEBI
in	O
the	O
livers	O
of	O
mice	O
fed	O
a	O
regular	O
chow	B-CHEBI
diet	O
(	O
Figure	O
4a	O
)	O
.	O

As	O
expected	O
,	O
Abcg8	O
mRNA	B-CHEBI
expression	O
levels	O
were	O
undetectable	O
in	O
the	O
Abcg8	O
-	O
/	O
-	O
mice	O
and	O
were	O
reduced	O
by	O
~	O
50	O
%	O
in	O
the	O
heterozygous	O
mice	O
,	O
relative	O
to	O
wild	O
-	O
type	O
mice	O
.	O

Interestingly	O
,	O
by	O
quantitative	O
RT	O
-	O
PCR	O
,	O
the	O
mRNA	B-CHEBI
expression	O
of	O
Abcg5	O
in	O
the	O
knock	O
-	O
out	O
mice	O
was	O
also	O
reduced	O
by	O
more	O
than	O
60	O
%	O
compared	O
to	O
the	O
wild	O
-	O
type	O
mice	O
,	O
although	O
no	O
changes	O
were	O
noted	O
in	O
the	O
heterozygous	O
mice	O
.	O

Expression	O
of	O
HMG	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
reductase	O
mRNA	B-CHEBI
was	O
decreased	O
by	O
~	O
50	O
%	O
and	O
~	O
80	O
%	O
in	O
the	O
heterozygote	O
and	O
knockout	O
mice	O
respectively	O
,	O
in	O
keeping	O
with	O
limited	O
observations	O
in	O
human	O
patients	O
with	O
this	O
disorder	O
[	O
7	O
]	O
.	O

To	O
verify	O
whether	O
the	O
mRNA	B-CHEBI
changes	O
resulted	O
in	O
alteration	O
of	O
the	O
enzyme	O
activity	O
changes	O
,	O
liver	O
samples	O
were	O
analyzed	O
for	O
HMG	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
reductase	O
activity	O
and	O
Cyp7a1	O
activity	O
(	O
Figure	O
4b	O
)	O
.	O

HMG	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
reductase	O
activity	O
was	O
reduced	O
by	O
30	O
%	O
and	O
60	O
%	O
in	O
the	O
Abcg8	O
+	O
/	O
-	O
and	O
Abcg8	O
-	O
/	O
-	O
mice	O
,	O
respectively	O
(	O
Figure	O
4b	O
)	O
,	O
and	O
thus	O
reflected	O
the	O
changes	O
in	O
mRNA	B-CHEBI
expression	O
.	O

In	O
contrast	O
,	O
although	O
the	O
Cyp7a1	O
mRNA	B-CHEBI
expression	O
levels	O
were	O
essentially	O
unchanged	O
in	O
the	O
knockout	O
mouse	O
,	O
Cyp7a1	O
activity	O
was	O
significantly	O
decreased	O
by	O
37	O
%	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

In	O
the	O
heterozygous	O
mice	O
,	O
both	O
the	O
mRNA	B-CHEBI
and	O
activity	O
of	O
Cyp7a1	O
were	O
decreased	O
.	O

Sitosterol	B-CHEBI
is	O
known	O
to	O
be	O
a	O
direct	O
competitive	O
inhibitor	B-CHEBI
of	O
Cyp7a1	O
and	O
it	O
is	O
likely	O
that	O
the	O
elevated	O
plant	B-CHEBI
sterols	I-CHEBI
in	O
the	O
liver	O
are	O
responsible	O
for	O
the	O
inhibition	O
in	O
the	O
knockout	O
mouse	O
[	O
39	O
]	O
.	O

Localization	O
of	O
Abcg5	O
protein	B-CHEBI
in	O
Abcg8	O
-	O
/	O
-	O
knockout	O
mice	O

Does	O
the	O
loss	O
of	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
result	O
in	O
loss	O
of	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
expression	O
,	O
as	O
might	O
be	O
predicted	O
from	O
the	O
genetic	O
studies	O
and	O
more	O
recently	O
from	O
the	O
in	O
vitro	O
and	O
in	O
vivo	O
expression	O
studies	O
?	O

A	O
robust	O
antibody	O
to	O
mouse	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
is	O
not	O
currently	O
available	O
.	O

However	O
,	O
three	O
separate	O
groups	O
have	O
developed	O
rabbit	O
polyclonal	O
antibody	O
to	O
mouse	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
.	O

These	O
three	O
antibodies	O
were	O
used	O
in	O
Western	O
blotting	O
and	O
immunohistochemistry	O
experiments	O
on	O
the	O
liver	O
and	O
intestine	O
of	O
Abcg8	O
-	O
/	O
-	O
mice	O
.	O

Western	O
blotting	O
of	O
liver	O
total	O
membrane	O
preparations	O
using	O
the	O
three	O
separately	O
-	O
developed	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
antibodies	O
showed	O
different	O
results	O
.	O

As	O
has	O
been	O
previously	O
published	O
,	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
exists	O
in	O
two	O
separate	O
forms	O
,	O
the	O
'	O
immature	O
'	O
75	O
kDa	O
protein	B-CHEBI
and	O
a	O
fully	O
glycosylated	O
'	O
mature	O
'	O
93	O
kDa	O
protein	B-CHEBI
[	O
18	O
,	O
30	O
]	O
.	O

Using	O
the	O
SC	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
peptide	O
antibody	O
,	O
a	O
75	O
kDa	O
band	O
is	O
detected	O
(	O
Figure	O
5a	O
)	O
.	O

This	O
antibody	O
does	O
not	O
detect	O
a	O
'	O
mature	O
'	O
93	O
kDa	O
band	O
in	O
either	O
wild	O
-	O
type	O
or	O
knockout	O
animals	O
nor	O
is	O
the	O
75	O
kDa	O
band	O
sensitive	O
to	O
either	O
Endo	O
-	O
H	O
or	O
PNGaseF	O
(	O
lower	O
panel	O
shows	O
same	O
aliquots	O
probed	O
with	O
anti	O
-	O
transferrin	O
)	O
.	O

The	O
AMC	O
antibody	O
detects	O
the	O
'	O
mature	O
'	O
form	O
of	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
in	O
wild	O
-	O
type	O
animals	O
but	O
not	O
the	O
knockouts	O
.	O

Interestingly	O
,	O
the	O
'	O
immature	O
'	O
75	O
kDa	O
band	O
is	O
detected	O
by	O
this	O
antibody	O
but	O
the	O
band	O
shifts	O
with	O
Endo	O
-	O
H	O
and	O
PNGase	O
F	O
treatment	O
(	O
Figure	O
5b	O
)	O
.	O

The	O
UTSW	O
antibody	O
detects	O
the	O
'	O
mature	O
'	O
and	O
'	O
immature	O
'	O
forms	O
of	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
in	O
wild	O
-	O
type	O
animals	O
but	O
detects	O
no	O
forms	O
in	O
the	O
knockout	O
mouse	O
(	O
Figure	O
5c	O
)	O
.	O

What	O
does	O
hold	O
true	O
for	O
all	O
antibodies	O
used	O
against	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
is	O
the	O
detection	O
of	O
a	O
75	O
kDa	O
band	O
.	O

Immunohistochemistry	O
experiments	O
were	O
carried	O
out	O
using	O
all	O
three	O
antibodies	O
.	O

In	O
acute	O
transfection	O
studies	O
,	O
the	O
SC	O
antibody	O
recognized	O
over	O
-	O
expressed	O
mouse	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
in	O
COS	O
-	O
1	O
cells	O
,	O
but	O
not	O
mouse	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
(	O
Figure	O
6b	O
,	O
6c	O
)	O
.	O

Co	O
-	O
transfection	O
of	O
COS	O
-	O
1	O
cells	O
with	O
both	O
Abcg5	O
and	O
Abcg8	O
cDNAs	O
did	O
not	O
alter	O
the	O
pattern	O
of	O
immunofluorescence	O
,	O
although	O
we	O
are	O
not	O
able	O
to	O
confirm	O
simultaneous	O
expression	O
of	O
Abcg8	O
in	O
cells	O
expressing	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
,	O
as	O
we	O
have	O
no	O
suitable	O
antibody	O
for	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
(	O
Figure	O
6d	O
)	O
.	O

Nevertheless	O
,	O
this	O
experiment	O
indicates	O
that	O
the	O
SC	O
antibody	O
can	O
recognize	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
but	O
does	O
not	O
cross	O
-	O
react	O
with	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
.	O

Serial	O
sections	O
of	O
intestinal	O
tissue	O
were	O
incubated	O
with	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
to	O
determine	O
the	O
cellular	O
location	O
of	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
.	O

The	O
pattern	O
of	O
staining	O
of	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
in	O
the	O
intestinal	O
sections	O
is	O
clearly	O
apical	O
and	O
localized	O
to	O
the	O
villi	O
of	O
the	O
enterocytes	O
(	O
Figure	O
6g	O
,	O
6h	O
,	O
6i	O
)	O
.	O

Loss	O
of	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
does	O
not	O
seem	O
to	O
affect	O
this	O
pattern	O
of	O
staining	O
.	O

To	O
further	O
confirm	O
that	O
the	O
antibody	O
used	O
recognizes	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
;	O
this	O
pattern	O
is	O
blocked	O
if	O
the	O
antibody	O
is	O
pre	O
-	O
incubated	O
with	O
the	O
peptide	O
to	O
which	O
it	O
was	O
raised	O
(	O
Figure	O
6f	O
)	O
.	O

To	O
further	O
confirm	O
that	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
expression	O
is	O
preserved	O
and	O
may	O
be	O
apical	O
,	O
immunohistochemistry	O
was	O
performed	O
in	O
Amsterdam	O
using	O
the	O
AMC	O
antibody	O
to	O
stain	O
liver	O
sections	O
from	O
wild	O
-	O
type	O
and	O
knockout	O
mice	O
[	O
30	O
]	O
.	O

As	O
a	O
control	O
,	O
the	O
expression	O
of	O
Abcb11	O
,	O
an	O
ABC	O
transporter	O
known	O
to	O
be	O
responsible	O
for	O
the	O
export	O
of	O
bile	B-CHEBI
salts	I-CHEBI
,	O
was	O
compared	O
to	O
that	O
of	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
(	O
Figure	O
6j	O
,	O
6k	O
)	O
.	O

Again	O
,	O
both	O
proteins	B-CHEBI
are	O
apically	O
localized	O
in	O
liver	O
sections	O
from	O
wild	O
-	O
type	O
mice	O
and	O
this	O
pattern	O
is	O
essentially	O
unperturbed	O
in	O
liver	O
from	O
knockout	O
mice	O
,	O
although	O
the	O
expression	O
level	O
of	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
seems	O
to	O
be	O
less	O
robust	O
qualitatively	O
(	O
Figure	O
6l	O
,	O
6m	O
)	O
.	O

To	O
further	O
confirm	O
the	O
apical	O
expression	O
of	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
in	O
the	O
knockout	O
mice	O
,	O
the	O
UTSW	O
antibody	O
was	O
used	O
to	O
stain	O
liver	O
sections	O
of	O
wild	O
-	O
type	O
and	O
knockout	O
mice	O
.	O

Again	O
,	O
there	O
is	O
apical	O
expression	O
of	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
in	O
both	O
wild	O
-	O
type	O
and	O
knockout	O
livers	O
(	O
Figure	O
7a	O
,	O
7b	O
)	O
.	O

Biliary	O
secretion	O
of	O
bile	B-CHEBI
salts	I-CHEBI
,	O
sterol	B-CHEBI
and	O
phospholipids	B-CHEBI
in	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
deficient	O
mice	O

Sitosterolemic	O
individuals	O
have	O
an	O
impaired	O
ability	O
to	O
secrete	O
cholesterol	B-CHEBI
and	O
plant	B-CHEBI
sterols	I-CHEBI
into	O
bile	O
[	O
40	O
,	O
41	O
]	O
.	O

We	O
analyzed	O
the	O
knockout	O
mice	O
for	O
any	O
alterations	O
in	O
biliary	O
sterol	B-CHEBI
handling	O
.	O

Analyses	O
of	O
the	O
initial	O
basal	O
bile	O
secretion	O
showed	O
that	O
the	O
sterol	B-CHEBI
and	O
phospholipid	B-CHEBI
contents	O
in	O
Abcg8	O
-	O
/	O
-	O
mice	O
were	O
reduced	O
as	O
compared	O
to	O
wild	O
-	O
type	O
mice	O
,	O
(	O
Figure	O
8a	O
,	O
8b	O
,	O
8c	O
,	O
bile	B-CHEBI
salt	I-CHEBI
secretion	O
not	O
statistically	O
significant	O
,	O
for	O
sterol	B-CHEBI
secretion	O
P	O
=	O
0	O
.	O
01	O
and	O
for	O
phospholipid	B-CHEBI
secretion	O
P	O
=	O
0	O
.	O
03	O
)	O
.	O

To	O
investigate	O
whether	O
the	O
defect	O
in	O
biliary	O
sterol	B-CHEBI
secretion	O
could	O
be	O
(	O
partly	O
)	O
restored	O
by	O
forced	O
biliary	O
sterol	B-CHEBI
secretion	O
,	O
we	O
infused	O
mice	O
with	O
stepwise	O
increasing	O
doses	O
of	O
tauroursodeoxycholic	O
acid	O
(	O
TUDC	O
)	O
.	O

Mice	O
were	O
first	O
depleted	O
of	O
their	O
endogenous	O
bile	B-CHEBI
salt	I-CHEBI
pools	O
for	O
90	O
min	O
and	O
subsequently	O
infused	O
via	O
the	O
jugular	O
vein	O
with	O
increasing	O
doses	O
of	O
TUDC	O
.	O

As	O
shown	O
in	O
Figure	O
8d	O
,	O
bile	B-CHEBI
salt	I-CHEBI
secretion	O
was	O
no	O
different	O
between	O
the	O
different	O
genotypes	O
during	O
the	O
depletion	O
or	O
the	O
TUDC	O
infusion	O
phases	O
of	O
the	O
experiment	O
.	O

However	O
,	O
a	O
different	O
pattern	O
emerged	O
for	O
the	O
secretion	O
of	O
phospholipid	B-CHEBI
(	O
Figure	O
8f	O
)	O
.	O

There	O
was	O
no	O
difference	O
between	O
wild	O
-	O
type	O
and	O
heterozygous	O
mice	O
,	O
but	O
knockout	O
mice	O
showed	O
a	O
trend	O
of	O
lower	O
phospholipid	B-CHEBI
secretion	O
during	O
both	O
the	O
depletion	O
and	O
infusion	O
phase	O
.	O

Even	O
more	O
dramatic	O
was	O
the	O
effect	O
on	O
biliary	O
sterol	B-CHEBI
secretion	O
although	O
the	O
sterol	B-CHEBI
contents	O
were	O
determined	O
enzymatically	O
and	O
no	O
distinction	O
is	O
made	O
as	O
to	O
whether	O
this	O
is	O
sitosterol	B-CHEBI
or	O
cholesterol	B-CHEBI
(	O
Figure	O
8e	O
,	O
but	O
see	O
below	O
)	O
.	O

In	O
the	O
knockout	O
mice	O
,	O
almost	O
no	O
stimulated	O
sterol	B-CHEBI
secretion	O
was	O
noted	O
,	O
with	O
an	O
intermediate	O
phenotype	O
in	O
the	O
heterozygous	O
mice	O
.	O

In	O
the	O
heterozygous	O
mice	O
,	O
sterol	B-CHEBI
secretion	O
increased	O
to	O
reach	O
a	O
maximal	O
level	O
of	O
about	O
50	O
%	O
of	O
the	O
wild	O
type	O
suggesting	O
that	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
is	O
a	O
rate	O
-	O
limiting	O
step	O
for	O
biliary	O
'	O
cholesterol	B-CHEBI
'	O
secretion	O
.	O

In	O
the	O
knockout	O
mice	O
,	O
sterol	B-CHEBI
secretion	O
remained	O
at	O
a	O
constant	O
level	O
during	O
the	O
depletion	O
phase	O
and	O
increased	O
minimally	O
upon	O
infusion	O
of	O
TUDC	O
.	O

Since	O
the	O
Abcg8	O
-	O
/	O
-	O
mice	O
still	O
secreted	O
some	O
sterols	B-CHEBI
we	O
were	O
interested	O
in	O
which	O
biliary	O
sterol	B-CHEBI
species	O
were	O
being	O
secreted	O
.	O

Therefore	O
bile	O
was	O
collected	O
from	O
mice	O
during	O
a	O
constant	O
infusion	O
of	O
TUDC	O
and	O
analyzed	O
by	O
GC	O
.	O

Mice	O
were	O
first	O
depleted	O
of	O
their	O
endogenous	O
bile	B-CHEBI
acid	I-CHEBI
pools	O
for	O
30	O
minutes	O
then	O
infused	O
with	O
a	O
continuous	O
dose	O
of	O
TUDC	O
(	O
1	O
,	O
200	O
nmol	O
/	O
min	O
/	O
100	O
g	O
body	O
weight	O
)	O
.	O

The	O
knockout	O
mice	O
showed	O
a	O
significantly	O
diminished	O
ability	O
to	O
secrete	O
cholesterol	B-CHEBI
,	O
yet	O
still	O
maintained	O
the	O
ability	O
to	O
secrete	O
sitosterol	B-CHEBI
and	O
campesterol	B-CHEBI
compared	O
to	O
wild	O
-	O
type	O
mice	O
(	O
Figure	O
9	O
)	O
.	O

Surprisingly	O
,	O
the	O
Abcg8	O
+	O
/	O
-	O
mice	O
tended	O
to	O
show	O
an	O
increased	O
ability	O
to	O
secrete	O
all	O
sterols	B-CHEBI
above	O
the	O
levels	O
seen	O
in	O
the	O
wild	O
-	O
type	O
mice	O
,	O
although	O
this	O
was	O
not	O
statistically	O
significant	O
.	O

Discussion	O

The	O
mechanism	O
by	O
which	O
dietary	O
cholesterol	B-CHEBI
is	O
specifically	O
absorbed	O
and	O
dietary	O
non	O
-	O
cholesterol	B-CHEBI
sterols	B-CHEBI
primarily	O
excluded	O
or	O
the	O
mechanism	O
(	O
s	O
)	O
by	O
which	O
the	O
liver	O
can	O
selectively	O
secrete	O
sterols	B-CHEBI
has	O
not	O
been	O
elucidated	O
.	O

Identification	O
of	O
the	O
genetic	O
defect	O
(	O
s	O
)	O
in	O
a	O
rare	O
human	O
disorder	O
,	O
sitosterolemia	O
,	O
where	O
these	O
processes	O
are	O
specifically	O
disrupted	O
,	O
may	O
finally	O
have	O
led	O
to	O
the	O
identification	O
of	O
the	O
'	O
transporters	O
'	O
responsible	O
for	O
these	O
processes	O
.	O

Complete	O
defects	O
in	O
one	O
of	O
two	O
genes	O
(	O
but	O
not	O
both	O
)	O
,	O
organized	O
in	O
a	O
head	O
-	O
to	O
-	O
head	O
configuration	O
at	O
the	O
STSL	O
locus	O
,	O
causes	O
sitosterolemia	O
.	O

We	O
report	O
a	O
mouse	O
model	O
of	O
sitosterolemia	O
,	O
with	O
a	O
selective	O
,	O
but	O
complete	O
,	O
defect	O
in	O
one	O
of	O
these	O
genes	O
,	O
Abcg8	O
.	O

This	O
mouse	O
reflects	O
the	O
known	O
defects	O
described	O
in	O
human	O
sitosterolemia	O
[	O
5	O
,	O
7	O
,	O
42	O
]	O
.	O

Plasma	O
and	O
all	O
tissues	O
,	O
apart	O
from	O
the	O
brain	O
,	O
have	O
significantly	O
elevated	O
sitosterol	B-CHEBI
levels	O
.	O

Homozygous	O
knockout	O
mice	O
are	O
viable	O
,	O
fertile	O
and	O
sitosterolemic	O
.	O

However	O
,	O
fertility	O
seems	O
to	O
be	O
reduced	O
when	O
homozygous	O
mice	O
are	O
bred	O
together	O
(	O
S	O
Patel	O
and	O
J	O
Oatis	O
,	O
unpublished	O
observation	O
)	O
.	O

This	O
model	O
reflects	O
many	O
other	O
observed	O
changes	O
described	O
in	O
limited	O
studies	O
in	O
humans	O
.	O

For	O
example	O
,	O
in	O
humans	O
,	O
the	O
activity	O
of	O
HMG	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
reductase	O
and	O
CYP7a1	O
have	O
been	O
reported	O
to	O
be	O
low	O
[	O
7	O
,	O
39	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
the	O
mRNA	B-CHEBI
and	O
enzyme	O
activities	O
in	O
the	O
livers	O
from	O
knockout	O
animals	O
are	O
also	O
significantly	O
reduced	O
.	O

Additionally	O
,	O
the	O
activity	O
of	O
the	O
rate	O
-	O
limiting	O
enzyme	O
for	O
bile	B-CHEBI
acid	I-CHEBI
synthesis	O
,	O
CYP7a1	O
,	O
is	O
reduced	O
,	O
although	O
no	O
changes	O
at	O
the	O
mRNA	B-CHEBI
level	O
are	O
noted	O
.	O

This	O
is	O
also	O
in	O
keeping	O
with	O
previous	O
studies	O
that	O
show	O
that	O
sitosterol	B-CHEBI
is	O
a	O
direct	O
inhibitor	B-CHEBI
of	I-CHEBI
this	I-CHEBI
enzyme	I-CHEBI
in	O
vitro	O
[	O
39	O
]	O
.	O

Biliary	O
sterols	B-CHEBI
of	O
Abcg8	O
-	O
deficient	O
mice	O
were	O
dramatically	O
different	O
compared	O
to	O
wild	O
-	O
type	O
mice	O
.	O

Measurement	O
of	O
biliary	O
sterol	B-CHEBI
secretion	O
rates	O
in	O
Abcg8	O
-	O
/	O
-	O
mice	O
demonstrated	O
a	O
failure	O
to	O
increase	O
sterol	B-CHEBI
secretion	O
into	O
bile	O
despite	O
exogenous	O
infusion	O
of	O
bile	B-CHEBI
acids	I-CHEBI
.	O

Furthermore	O
,	O
complete	O
loss	O
of	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
results	O
in	O
an	O
inability	O
to	O
secrete	O
cholesterol	B-CHEBI
into	O
bile	O
,	O
although	O
secretion	O
of	O
sitosterol	B-CHEBI
seemed	O
to	O
be	O
preserved	O
.	O

Arguably	O
,	O
since	O
the	O
body	O
pools	O
and	O
plasma	O
sitosterol	B-CHEBI
levels	O
in	O
the	O
knockout	O
mice	O
are	O
so	O
considerably	O
elevated	O
,	O
perhaps	O
the	O
biliary	O
sitosterol	B-CHEBI
levels	O
could	O
be	O
considered	O
to	O
be	O
inappropriately	O
low	O
.	O

Despite	O
this	O
reservation	O
,	O
the	O
finding	O
that	O
sitosterol	B-CHEBI
is	O
present	O
in	O
the	O
bile	O
suggests	O
that	O
plant	B-CHEBI
sterols	I-CHEBI
may	O
be	O
secreted	O
independent	O
of	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
.	O

The	O
ability	O
of	O
Abcg8	O
-	O
/	O
-	O
mice	O
to	O
secrete	O
bile	B-CHEBI
salt	I-CHEBI
and	O
phospholipid	B-CHEBI
into	O
bile	O
as	O
compared	O
to	O
wild	O
-	O
type	O
mice	O
was	O
not	O
significantly	O
impaired	O
.	O

Collectively	O
these	O
data	O
suggest	O
that	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
is	O
necessary	O
for	O
hepatobiliary	O
cholesterol	B-CHEBI
secretion	O
in	O
mice	O
.	O

Abcg8	O
-	O
/	O
-	O
mice	O
appeared	O
normal	O
and	O
healthy	O
maintained	O
on	O
a	O
regular	O
rodent	O
chow	B-CHEBI
diet	O
.	O

Their	O
phenotypic	O
features	O
are	O
very	O
similar	O
to	O
those	O
recently	O
reported	O
for	O
a	O
mouse	O
deficient	O
in	O
both	O
sterolins	O
simultaneously	O
[	O
7	O
,	O
20	O
]	O
.	O

Plasma	O
and	O
hepatic	O
plant	B-CHEBI
sterol	I-CHEBI
levels	O
in	O
Abcg8	O
-	O
/	O
-	O
and	O
Abcg5	O
/	O
Abcg8	O
knockout	O
are	O
increased	O
similarly	O
with	O
marked	O
decreases	O
in	O
cholesterol	B-CHEBI
levels	O
.	O

Interestingly	O
,	O
plasma	O
triglyceride	B-CHEBI
levels	O
of	O
the	O
Abcg8	O
-	O
/	O
-	O
mice	O
were	O
slightly	O
higher	O
than	O
wild	O
-	O
type	O
animals	O
and	O
this	O
increased	O
triglyceride	B-CHEBI
is	O
carried	O
in	O
the	O
LDL	B-CHEBI
fraction	O
range	O
,	O
as	O
measured	O
by	O
FPLC	O
.	O

The	O
significance	O
of	O
this	O
is	O
not	O
clear	O
,	O
although	O
preliminary	O
SDS	B-CHEBI
-	O
PAGE	O
analyses	O
of	O
all	O
the	O
fractions	O
failed	O
to	O
reveal	O
any	O
differences	O
between	O
wild	O
-	O
type	O
and	O
knockout	O
samples	O
.	O

Hepatic	O
levels	O
of	O
GC	O
-	O
measured	O
cholesterol	B-CHEBI
were	O
greatly	O
reduced	O
in	O
Abcg8	O
-	O
/	O
-	O
mice	O
compared	O
to	O
wild	O
-	O
type	O
mice	O
,	O
yet	O
mRNA	B-CHEBI
levels	O
of	O
HMG	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
reductase	O
and	O
enzyme	O
activity	O
are	O
also	O
reduced	O
without	O
any	O
significant	O
change	O
in	O
mRNA	B-CHEBI
of	O
the	O
Srebps	O
.	O

The	O
basis	O
for	O
this	O
is	O
not	O
clear	O
at	O
present	O
,	O
unless	O
the	O
increase	O
in	O
non	O
-	O
plant	B-CHEBI
sterols	I-CHEBI
leads	O
to	O
a	O
suppression	O
of	O
SREBP	O
activation	O
.	O

Sitosterol	B-CHEBI
has	O
been	O
shown	O
to	O
directly	O
inhibit	O
Cyp7a1	O
activity	O
in	O
vitro	O
and	O
we	O
presume	O
this	O
may	O
account	O
for	O
the	O
reduced	O
enzyme	O
activity	O
[	O
39	O
]	O
.	O

In	O
preliminary	O
studies	O
,	O
when	O
knockout	O
mice	O
are	O
placed	O
on	O
a	O
low	O
sitosterol	B-CHEBI
diet	O
,	O
the	O
activity	O
of	O
this	O
enzyme	O
,	O
as	O
well	O
as	O
the	O
mRNA	B-CHEBI
levels	O
are	O
increased	O
(	O
E	O
Klett	O
and	O
S	O
Patel	O
,	O
unpublished	O
observations	O
)	O
.	O

Another	O
prediction	O
,	O
based	O
upon	O
the	O
enzyme	O
and	O
mRNA	B-CHEBI
levels	O
in	O
knockout	O
mice	O
,	O
is	O
that	O
if	O
these	O
mice	O
are	O
placed	O
on	O
a	O
high	O
cholesterol	B-CHEBI
/	O
high	O
sitosterol	B-CHEBI
diet	O
,	O
they	O
may	O
show	O
significant	O
accumulation	O
of	O
both	O
sterols	B-CHEBI
in	O
the	O
body	O
.	O

This	O
may	O
also	O
be	O
relevant	O
to	O
the	O
human	O
disorder	O
where	O
some	O
,	O
although	O
not	O
all	O
affected	O
individuals	O
,	O
manifest	O
premature	O
coronary	O
artery	O
disease	O
.	O

Abcg8	O
/	O
sterolin	O
-	O
2	O
deficient	O
mice	O
also	O
allow	O
us	O
to	O
examine	O
the	O
role	O
of	O
this	O
protein	B-CHEBI
in	O
biliary	O
sterol	B-CHEBI
secretion	O
.	O

The	O
bile	O
is	O
sterol	B-CHEBI
poor	O
and	O
upon	O
stimulation	O
by	O
increasing	O
bile	B-CHEBI
salt	I-CHEBI
excretion	O
,	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
deficient	O
mice	O
cannot	O
respond	O
,	O
in	O
contrast	O
to	O
the	O
wild	O
-	O
type	O
mice	O
.	O

Thus	O
,	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
is	O
necessary	O
for	O
cholesterol	B-CHEBI
secretion	O
but	O
not	O
necessary	O
for	O
plant	B-CHEBI
sterol	I-CHEBI
secretion	O
.	O

It	O
could	O
be	O
argued	O
that	O
although	O
the	O
biliary	O
sterol	B-CHEBI
output	O
is	O
comparable	O
to	O
that	O
seen	O
in	O
wild	O
-	O
type	O
mice	O
that	O
this	O
is	O
inappropriately	O
low	O
,	O
since	O
the	O
tissue	O
and	O
plasma	O
pools	O
of	O
sitosterol	B-CHEBI
are	O
so	O
elevated	O
in	O
the	O
knockout	O
mice	O
.	O

Despite	O
this	O
caveat	O
,	O
the	O
findings	O
of	O
sitosterol	B-CHEBI
in	O
significant	O
quantities	O
in	O
the	O
bile	O
suggests	O
that	O
mechanisms	O
other	O
than	O
via	O
the	O
sterolins	O
can	O
'	O
export	O
'	O
some	O
of	O
these	O
sterols	B-CHEBI
.	O

Interestingly	O
,	O
although	O
humans	O
who	O
are	O
heterozygous	O
for	O
genetic	O
defects	O
in	O
either	O
ABCG5	O
or	O
ABCG8	O
seem	O
to	O
be	O
phenotypically	O
normal	O
,	O
mice	O
heterozygous	O
for	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
deficiency	O
show	O
that	O
sterol	B-CHEBI
secretion	O
is	O
impaired	O
,	O
but	O
not	O
absent	O
.	O

Note	O
that	O
under	O
steady	O
-	O
state	O
conditions	O
on	O
a	O
rodent	O
chow	B-CHEBI
diet	O
,	O
heterozygous	O
animals	O
show	O
no	O
significant	O
elevations	O
in	O
plasma	O
or	O
tissue	O
sitosterol	B-CHEBI
levels	O
,	O
suggesting	O
that	O
the	O
activity	O
of	O
these	O
proteins	B-CHEBI
may	O
not	O
be	O
rate	O
limiting	O
.	O

Furthermore	O
,	O
the	O
heterozygous	O
Abcg8	O
+	O
/	O
-	O
mice	O
showed	O
higher	O
levels	O
of	O
biliary	O
sitosterol	B-CHEBI
relative	O
to	O
the	O
wild	O
-	O
type	O
mice	O
.	O

While	O
the	O
rate	O
of	O
total	O
biliary	O
sterol	B-CHEBI
secretion	O
is	O
reduced	O
compared	O
to	O
wild	O
-	O
type	O
mice	O
,	O
since	O
the	O
heterozygous	O
mice	O
are	O
not	O
sitosterolemic	O
,	O
either	O
the	O
activity	O
of	O
these	O
proteins	B-CHEBI
is	O
not	O
rate	O
limiting	O
or	O
other	O
mechanisms	O
can	O
compensate	O
for	O
a	O
50	O
%	O
loss	O
of	O
activity	O
.	O

On	O
the	O
other	O
hand	O
,	O
since	O
feeding	O
is	O
intermittent	O
,	O
a	O
slow	O
,	O
but	O
continuous	O
secretion	O
during	O
post	O
-	O
prandial	O
periods	O
could	O
easily	O
negate	O
any	O
mild	O
temporary	O
increase	O
in	O
tissue	O
and	O
plasma	O
plant	B-CHEBI
sterol	I-CHEBI
levels	O
in	O
heterozygous	O
animals	O
.	O

This	O
may	O
be	O
amenable	O
to	O
testing	O
by	O
placing	O
these	O
animals	O
on	O
a	O
high	O
plant	B-CHEBI
sterol	I-CHEBI
diet	O
and	O
measuring	O
the	O
plasma	O
sterol	B-CHEBI
levels	O
.	O

Recently	O
,	O
Kosters	O
et	O
al	O
.	O
reported	O
that	O
Abcg5	O
/	O
Abcg8	O
mRNA	B-CHEBI
expression	O
in	O
a	O
variety	O
of	O
different	O
mouse	O
strains	O
correlated	O
with	O
biliary	O
cholesterol	B-CHEBI
secretion	O
rates	O
[	O
30	O
]	O
.	O

In	O
their	O
studies	O
,	O
although	O
diosgenin	O
-	O
fed	O
mice	O
showed	O
a	O
marked	O
increase	O
in	O
biliary	O
cholesterol	B-CHEBI
output	O
,	O
mRNA	B-CHEBI
levels	O
of	O
Abcg5	O
and	O
Abcg8	O
were	O
not	O
altered	O
.	O

Using	O
Western	O
blot	O
analyses	O
,	O
the	O
protein	B-CHEBI
level	O
of	O
Abcg5	O
was	O
also	O
not	O
altered	O
by	O
diosgenin	O
,	O
although	O
Abcg8	O
was	O
not	O
measured	O
.	O

They	O
concluded	O
that	O
a	O
parallel	O
route	O
for	O
biliary	O
cholesterol	B-CHEBI
secretion	O
might	O
be	O
operational	O
,	O
independent	O
of	O
the	O
sterolins	O
.	O

While	O
biliary	O
cholesterol	B-CHEBI
secretion	O
is	O
not	O
completely	O
absent	O
in	O
the	O
Abcg8	O
-	O
deficient	O
mice	O
it	O
would	O
appear	O
that	O
sterolin	O
-	O
2	O
plays	O
a	O
major	O
role	O
in	O
this	O
process	O
.	O

In	O
a	O
genetic	O
screen	O
of	O
plasma	O
plant	B-CHEBI
sterol	I-CHEBI
levels	O
,	O
Sehayek	O
et	O
al	O
.	O
identified	O
three	O
loci	O
that	O
may	O
be	O
responsible	O
for	O
controlling	O
plasma	O
plant	B-CHEBI
sterol	I-CHEBI
levels	O
and	O
not	O
one	O
of	O
these	O
loci	O
mapped	O
to	O
the	O
murine	O
STSL	O
region	O
[	O
43	O
]	O
.	O

Thus	O
,	O
there	O
is	O
support	O
for	O
at	O
least	O
four	O
loci	O
that	O
may	O
be	O
involved	O
in	O
regulating	O
plasma	O
plant	B-CHEBI
sterol	I-CHEBI
levels	O
.	O

To	O
date	O
the	O
STSL	O
locus	O
is	O
the	O
only	O
one	O
proven	O
to	O
be	O
involved	O
in	O
dietary	O
sterol	B-CHEBI
trafficking	O
and	O
the	O
identity	O
of	O
the	O
others	O
remains	O
to	O
be	O
elucidated	O
.	O

We	O
,	O
as	O
well	O
as	O
others	O
,	O
have	O
proposed	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
and	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
to	O
function	O
as	O
obligate	O
heterodimers	O
.	O

Thus	O
knocking	O
out	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
alone	O
is	O
equivalent	O
to	O
a	O
functional	O
loss	O
of	O
both	O
sterolins	O
.	O

It	O
has	O
been	O
shown	O
that	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
expression	O
is	O
required	O
for	O
correct	O
apical	O
trafficking	O
of	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
to	O
the	O
apical	O
surface	O
in	O
a	O
polarized	O
cell	O
line	O
and	O
more	O
recently	O
in	O
vivo	O
by	O
over	O
-	O
expression	O
experiments	O
[	O
18	O
,	O
19	O
]	O
.	O

In	O
experiments	O
shown	O
here	O
,	O
using	O
three	O
separately	O
developed	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
antibodies	O
,	O
we	O
have	O
obtained	O
inconsistent	O
data	O
regarding	O
the	O
trafficking	O
of	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
in	O
Abcg8	O
-	O
/	O
-	O
mice	O
.	O

Based	O
upon	O
classical	O
N	O
-	O
glycosylation	O
maturation	O
it	O
would	O
appear	O
that	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
,	O
in	O
the	O
Abcg8	O
-	O
/	O
-	O
mice	O
,	O
does	O
not	O
exit	O
the	O
endoplasmic	O
reticulum	O
.	O

However	O
,	O
by	O
immunohistochemistry	O
it	O
appears	O
that	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
is	O
apically	O
expressed	O
in	O
the	O
Abcg8	O
-	O
deficient	O
mice	O
regardless	O
of	O
the	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
antibody	O
used	O
.	O

Interestingly	O
,	O
in	O
a	O
report	O
of	O
Abcg5	O
/	O
Abcg8	O
localization	O
in	O
canine	O
gallbladder	O
epithelial	O
cells	O
,	O
these	O
two	O
proteins	B-CHEBI
were	O
found	O
intracellularly	O
under	O
baseline	O
conditions	O
[	O
44	O
]	O
.	O

But	O
when	O
given	O
liver	O
X	O
receptor	O
alpha	O
(	O
LXR	O
alpha	O
)	O
agonist	B-CHEBI
,	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
and	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
appeared	O
to	O
be	O
expressed	O
at	O
the	O
apical	O
surface	O
.	O

In	O
these	O
studies	O
the	O
UTSW	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
antibody	O
was	O
used	O
.	O

It	O
is	O
apparent	O
with	O
these	O
conflicting	O
data	O
that	O
the	O
trafficking	O
of	O
these	O
transporters	O
is	O
not	O
as	O
clear	O
-	O
cut	O
.	O

In	O
a	O
recent	O
paper	O
,	O
Mangrivite	O
et	O
al	O
.	O
showed	O
that	O
the	O
apical	O
sorting	O
of	O
rat	O
SPNT	O
in	O
polarized	O
renal	O
epithelial	O
cells	O
was	O
independent	O
of	O
N	O
-	O
glycosylation	O
[	O
45	O
]	O
.	O

Therefore	O
,	O
at	O
this	O
time	O
,	O
we	O
can	O
neither	O
exclude	O
the	O
possibility	O
that	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
expression	O
is	O
functional	O
in	O
our	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
deficient	O
mice	O
nor	O
can	O
we	O
rule	O
it	O
out	O
.	O

We	O
have	O
no	O
functional	O
assay	O
for	O
these	O
proteins	B-CHEBI
at	O
present	O
.	O

More	O
extensive	O
fractionation	O
experiments	O
are	O
underway	O
to	O
better	O
determine	O
the	O
exact	O
compartmental	O
location	O
of	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
in	O
the	O
Abcg8	O
-	O
/	O
-	O
mice	O
.	O

In	O
this	O
context	O
,	O
Pl	O
o	O
sch	O
et	O
al	O
.	O
have	O
described	O
an	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
deficient	O
mouse	O
that	O
maintains	O
the	O
ability	O
to	O
secrete	O
biliary	O
cholesterol	B-CHEBI
to	O
the	O
same	O
extent	O
as	O
the	O
wild	O
-	O
type	O
mice	O
and	O
,	O
when	O
fed	O
a	O
LXR	O
agonist	B-CHEBI
,	O
had	O
higher	O
Abcg8	O
mRNA	B-CHEBI
expression	O
and	O
tended	O
to	O
secrete	O
more	O
biliary	O
cholesterol	B-CHEBI
than	O
wild	O
-	O
type	O
mice	O
[	O
46	O
]	O
.	O

It	O
has	O
been	O
argued	O
that	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
and	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
are	O
dependent	O
upon	O
each	O
other	O
for	O
secretion	O
of	O
hepatic	O
sterols	B-CHEBI
into	O
bile	O
[	O
19	O
]	O
.	O

Given	O
the	O
data	O
presented	O
here	O
and	O
from	O
the	O
Abcg5	O
-	O
deficient	O
mouse	O
this	O
does	O
not	O
appear	O
to	O
be	O
the	O
case	O
.	O

Perhaps	O
in	O
the	O
previously	O
published	O
model	O
a	O
non	O
-	O
physiologic	O
state	O
has	O
been	O
made	O
that	O
generates	O
these	O
data	O
.	O

Taken	O
together	O
,	O
these	O
animal	O
models	O
suggest	O
that	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
and	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
have	O
independent	O
function	O
in	O
vivo	O
or	O
that	O
there	O
are	O
proteins	B-CHEBI
other	O
than	O
the	O
sterolins	O
that	O
can	O
secrete	O
biliary	O
sterols	B-CHEBI
.	O

Conclusions	O

The	O
major	O
findings	O
in	O
this	O
study	O
are	O
:	O
(	O
1	O
)	O
disruption	O
of	O
only	O
one	O
of	O
the	O
two	O
genes	O
comprising	O
the	O
STSL	O
locus	O
is	O
necessary	O
and	O
sufficient	O
to	O
cause	O
sitosterolemia	O
,	O
(	O
2	O
)	O
that	O
the	O
loss	O
of	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
leads	O
to	O
the	O
loss	O
of	O
biliary	O
cholesterol	B-CHEBI
secretion	O
and	O
(	O
3	O
)	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
appears	O
to	O
be	O
still	O
apically	O
-	O
expressed	O
despite	O
the	O
absence	O
of	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
.	O

These	O
data	O
strongly	O
support	O
the	O
direct	O
role	O
of	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
as	O
a	O
key	O
player	O
in	O
biliary	O
cholesterol	B-CHEBI
secretion	O
,	O
although	O
biliary	O
sitosterol	B-CHEBI
secretion	O
was	O
apparently	O
preserved	O
.	O

These	O
data	O
suggest	O
that	O
there	O
are	O
mechanisms	O
other	O
than	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
that	O
allow	O
for	O
the	O
secretion	O
of	O
sitosterol	B-CHEBI
into	O
bile	O
.	O

Competing	O
interests	O

None	O
declared	O
.	O

Authors	O
'	O
contributions	O

ELK	O
carried	O
out	O
molecular	B-CHEBI
genetics	O
studies	O
,	O
quantitative	O
RT	O
-	O
PCR	O
,	O
and	O
dynamic	O
bile	O
collection	O
for	O
Figure	O
9	O
.	O

KL	O
carried	O
out	O
molecular	B-CHEBI
genetic	O
studies	O
and	O
made	O
the	O
targeting	O
construct	O
.	O

The	O
knockout	O
mice	O
were	O
isolated	O
in	O
the	O
NM	O
laboratory	O
.	O

HY	O
performed	O
Northern	O
blotting	O
.	O

ELK	O
,	O
AK	O
,	O
EV	O
and	O
MHL	O
performed	O
Western	O
blotting	O
and	O
immunohistochemistry	O
experiments	O
.	O

AK	O
and	O
NL	O
performed	O
bile	O
collection	O
experiments	O
and	O
bile	O
characterization	O
for	O
Figure	O
8	O
.	O

MA	O
performed	O
FPLC	O
analysis	O
.	O

SS	O
,	O
AK	O
and	O
RK	O
performed	O
GC	O
sterol	B-CHEBI
analyses	O
.	O

JC	O
assisted	O
with	O
dynamic	O
bile	O
collection	O
and	O
mouse	O
surgery	O
.	O

ROE	O
,	O
AG	O
,	O
NM	O
,	O
GS	O
and	O
SBP	O
were	O
responsible	O
for	O
supervision	O
,	O
data	O
analyses	O
of	O
experiments	O
and	O
for	O
providing	O
funding	O
of	O
these	O
experiments	O
.	O

ELK	O
and	O
SBP	O
wrote	O
the	O
paper	O
.	O

Pre	O
-	O
publication	O
history	O

The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O

Acknowledgements	O

We	O
would	O
like	O
to	O
thank	O
Dr	O
B	O
Stieger	O
for	O
kindly	O
providing	O
anti	O
-	O
Bsep	O
antibody	O
and	O
Dr	O
H	O
Hobbs	O
for	O
providing	O
the	O
UTSW	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
antibody	O
.	O

We	O
would	O
also	O
like	O
to	O
thank	O
John	O
Oatis	O
,	O
III	O
for	O
his	O
excellent	O
animal	O
husbandry	O
.	O

Grants	O
from	O
the	O
American	O
Heart	O
Association	O
,	O
Beginning	O
Grant	O
-	O
In	O
-	O
Aid	O
Mid	O
-	O
Atlantic	O
Affiliate	O
(	O
KL	O
)	O
,	O
NIH	O
Postdoctoral	O
Training	O
Grant	O
T32	O
HL07260	O
(	O
ELK	O
)	O
,	O
the	O
Netherlands	O
Organization	O
for	O
Scientific	O
Research	O
(	O
NOW	O
)	O
902	O
-	O
23	O
-	O
193	O
(	O
AK	O
)	O
as	O
well	O
as	O
the	O
National	O
Institutes	O
of	O
Health	O
Grant	O
HL60613	O
(	O
SBP	O
)	O
and	O
DK56830	O
(	O
GS	O
)	O
supported	O
this	O
work	O
.	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Generation	O
of	O
mice	O
deficient	O
in	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
.	O

The	O
targeted	O
disruption	O
strategy	O
of	O
Abcg8	O
is	O
as	O
shown	O
(	O
panel	O
a	O
)	O
.	O

Southern	O
blot	O
analysis	O
of	O
BamHI	O
digested	O
mouse	O
genomic	O
DNA	O
,	O
probed	O
with	O
[	O
32P	B-CHEBI
]	O
-	O
randomly	O
labelled	O
probe	O
resulting	O
in	O
a	O
6	O
.	O
0	O
kb	O
band	O
for	O
wild	O
type	O
,	O
a	O
2	O
.	O
7	O
kb	O
band	O
for	O
homozygous	O
and	O
two	O
bands	O
of	O
5	O
.	O
9	O
and	O
2	O
.	O
6	O
kb	O
for	O
the	O
heterozygote	O
(	O
panel	O
b	O
)	O
.	O

Northern	O
blot	O
analysis	O
of	O
hepatic	O
RNA	O
showed	O
a	O
loss	O
of	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
mRNA	B-CHEBI
in	O
the	O
homozygote	O
and	O
decreased	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
mRNA	B-CHEBI
in	O
the	O
heterozygote	O
,	O
although	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
mRNA	B-CHEBI
appeared	O
relatively	O
unaffected	O
in	O
the	O
knockout	O
mice	O
(	O
panel	O
c	O
)	O
.	O

Probes	O
were	O
approximately	O
1	O
.	O
9	O
kb	O
for	O
Abcg5	O
and	O
2	O
kb	O
for	O
Abcg8	O
(	O
see	O
Methods	O
for	O
more	O
detail	O
)	O
.	O

RT	O
-	O
PCR	O
analyses	O
of	O
hepatic	O
cDNA	O
showed	O
no	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
message	O
,	O
downstream	O
of	O
exon	O
4	O
in	O
the	O
Abcg8	O
-	O
/	O
-	O
mice	O
,	O
whether	O
primers	O
were	O
located	O
in	O
exons	O
4	O
and	O
13	O
(	O
panel	O
d	O
)	O
,	O
exons	O
9	O
and	O
13	O
or	O
exons	O
10	O
and	O
13	O
(	O
panel	O
e	O
)	O
.	O

Figure	O
2	O

Free	O
versus	O
esterified	O
sterol	B-CHEBI
levels	O
in	O
the	O
livers	O
of	O
Abcg8	O
+	O
/	O
+	O
,	O
Abcg8	O
+	O
/	O
-	O
and	O
Abcg8	O
-	O
/	O
-	O
mice	O
.	O

Sterol	B-CHEBI
contents	O
of	O
liver	O
extracts	O
of	O
12	O
-	O
week	O
-	O
old	O
female	O
mice	O
fed	O
a	O
regular	O
chow	B-CHEBI
diet	O
,	O
determined	O
by	O
GC	O
analysis	O
show	O
that	O
the	O
majority	O
of	O
sterols	B-CHEBI
in	O
all	O
genotypes	O
are	O
unesterified	O
.	O

Esterified	O
cholesterol	B-CHEBI
(	O
panel	O
a	O
)	O
remains	O
relatively	O
constant	O
for	O
each	O
genotype	O
.	O

However	O
,	O
no	O
esterified	O
sitosterol	B-CHEBI
in	O
the	O
livers	O
from	O
Abcg8	O
+	O
/	O
+	O
and	O
Abcg8	O
+	O
/	O
-	O
mice	O
and	O
very	O
little	O
from	O
Abcg8	O
-	O
/	O
-	O
mice	O
was	O
detected	O
(	O
panel	O
b	O
)	O
.	O

Small	O
amounts	O
of	O
esterified	O
campesterol	B-CHEBI
were	O
detected	O
in	O
each	O
of	O
the	O
genotypes	O
(	O
panel	O
c	O
)	O
.	O

Figure	O
3	O

Lipid	B-CHEBI
profiles	O
of	O
the	O
plasma	O
of	O
Abcg8	O
+	O
/	O
+	O
,	O
Abcg8	O
+	O
/	O
-	O
and	O
Abcg8	O
-	O
/	O
-	O
mice	O
.	O

Lipoproteins	B-CHEBI
were	O
separated	O
from	O
pooled	O
mouse	O
plasma	O
samples	O
by	O
FPLC	O
.	O

Total	O
sterols	B-CHEBI
(	O
panel	O
a	O
)	O
and	O
triglyceride	B-CHEBI
(	O
panel	O
b	O
)	O
profiles	O
of	O
the	O
fractions	O
are	O
shown	O
.	O

There	O
was	O
no	O
difference	O
of	O
cholesterol	B-CHEBI
profiles	O
in	O
the	O
groups	O
,	O
but	O
there	O
was	O
a	O
small	O
triglyceride	B-CHEBI
peak	O
in	O
Abcg8	O
-	O
/	O
-	O
mice	O
in	O
fractions	O
21	O
-	O
25	O
,	O
corresponding	O
to	O
the	O
LDL	B-CHEBI
-	O
size	O
range	O
,	O
the	O
significance	O
of	O
which	O
is	O
not	O
known	O
at	O
present	O
.	O

Figure	O
4	O

Analyses	O
of	O
mRNA	B-CHEBI
expression	O
and	O
enzyme	O
activity	O
in	O
mouse	O
livers	O
.	O

Panel	O
(	O
a	O
)	O
shows	O
RT	O
-	O
PCR	O
quantitation	O
of	O
mRNA	B-CHEBI
levels	O
for	O
Abcg5	O
,	O
Abcg8	O
,	O
Hmgr	O
,	O
Cyp7a1	O
,	O
Abca1	O
,	O
Mdr2	O
,	O
Lxr	O
,	O
Srebp	O
-	O
1c	O
and	O
Srebp	O
-	O
2	O
in	O
mouse	O
livers	O
from	O
Abcg8	O
+	O
/	O
+	O
(	O
open	O
bars	O
)	O
,	O
Abcg8	O
+	O
/	O
-	O
(	O
hatched	O
bars	O
)	O
and	O
Abcg8	O
-	O
/	O
-	O
(	O
filled	O
bars	O
)	O
.	O

Knockout	O
mice	O
showed	O
an	O
~	O
60	O
%	O
reduction	O
in	O
mRNA	B-CHEBI
for	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
and	O
an	O
80	O
%	O
reduction	O
in	O
the	O
message	O
for	O
HMG	O
CoA	O
reductase	O
.	O

Relatively	O
no	O
message	O
for	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
was	O
detected	O
in	O
the	O
knockout	O
mice	O
.	O

Panel	O
(	O
b	O
)	O
shows	O
the	O
enzyme	O
activities	O
for	O
HMG	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
reductase	O
and	O
CYP7a1	O
in	O
livers	O
from	O
Abcg8	O
+	O
/	O
+	O
,	O
Abcg8	O
+	O
/	O
-	O
and	O
Abcg8	O
-	O
/	O
-	O
mice	O
.	O

Activities	O
of	O
HMG	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
reductase	O
and	O
CYP7a1	O
were	O
significantly	O
reduced	O
in	O
the	O
Abcg8	O
-	O
/	O
-	O
mouse	O
liver	O
(	O
*	O
P	O
<	O
0	O
.	O
05	O
,	O
see	O
text	O
for	O
discussion	O
)	O
.	O

Figure	O
5	O

N	O
-	O
glycosylation	O
of	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
analyses	O
in	O
Abcg8	O
-	O
/	O
-	O
mouse	O
liver	O
.	O

Mouse	O
liver	O
homogenate	O
stained	O
with	O
SC	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
after	O
treatment	O
with	O
Endo	O
-	O
H	O
or	O
PNGaseF	O
shows	O
a	O
75	O
kDa	O
band	O
present	O
in	O
both	O
genotypes	O
,	O
which	O
is	O
resistant	O
to	O
deglycosylation	O
(	O
panel	O
a	O
)	O
.	O

Staining	O
of	O
wild	O
-	O
type	O
liver	O
homogenate	O
with	O
preimmune	O
serum	O
showed	O
no	O
detectable	O
bands	O
.	O

Lower	O
portion	O
of	O
panel	O
(	O
a	O
)	O
shows	O
the	O
same	O
aliquots	O
stained	O
for	O
anti	O
-	O
transferrin	O
as	O
a	O
control	O
for	O
deglycosylation	O
.	O

AMC	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
staining	O
of	O
mouse	O
liver	O
homogenate	O
shows	O
a	O
'	O
mature	O
'	O
~	O
90	O
kDa	O
band	O
in	O
the	O
wild	O
-	O
type	O
mice	O
but	O
not	O
in	O
the	O
Abcg8	O
-	O
/	O
-	O
mice	O
(	O
panel	O
b	O
)	O
.	O

A	O
75	O
kDa	O
form	O
is	O
present	O
which	O
is	O
sensitive	O
to	O
deglycosylation	O
.	O

Mouse	O
liver	O
homogenate	O
stained	O
with	O
UTSW	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
shows	O
a	O
'	O
mature	O
'	O
~	O
90	O
kDa	O
band	O
and	O
an	O
'	O
immature	O
'	O
75	O
kDa	O
band	O
in	O
the	O
wild	O
-	O
type	O
mice	O
but	O
no	O
signal	O
is	O
detected	O
in	O
the	O
Abcg8	O
-	O
/	O
-	O
mice	O
.	O

Treatment	O
with	O
Endo	O
-	O
H	O
or	O
PNGaseF	O
results	O
in	O
a	O
lower	O
molecular	B-CHEBI
weight	O
protein	B-CHEBI
in	O
the	O
wild	O
-	O
type	O
mice	O
.	O

Abcg5	O
/	O
Abcg8	O
-	O
/	O
-	O
liver	O
homogenate	O
used	O
for	O
negative	O
control	O
.	O

Figure	O
6	O

Immunohistochemical	O
evaluation	O
of	O
mouse	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
expression	O
in	O
liver	O
and	O
intestine	O
.	O

COS	O
-	O
1	O
cells	O
were	O
transiently	O
transfected	O
with	O
pCMV	O
-	O
mouse	O
Abcg5	O
or	O
pCMV	O
-	O
mouse	O
Abcg8	O
constructs	O
,	O
allowed	O
to	O
express	O
for	O
48	O
hours	O
then	O
fixed	O
and	O
incubated	O
with	O
antibody	O
.	O

pCMV	O
empty	O
vector	O
transfected	O
COS	O
-	O
1	O
cells	O
incubated	O
with	O
SC	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
showed	O
no	O
significant	O
fluorescence	O
(	O
panel	O
a	O
)	O
.	O

Abcg5	O
transfected	O
COS	O
-	O
1	O
cells	O
incubated	O
with	O
SC	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
antibody	O
showed	O
a	O
membrane	O
distribution	O
(	O
panel	O
b	O
)	O
,	O
where	O
as	O
Abcg8	O
transfected	O
cells	O
incubated	O
with	O
SC	O
anti	O
-	O
Abcg5	O
antibody	O
showed	O
no	O
significant	O
fluorescence	O
(	O
panel	O
c	O
)	O
.	O

Abcg5	O
and	O
Abcg8	O
co	O
-	O
transfected	O
COS	O
-	O
1	O
cells	O
incubated	O
with	O
SC	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
antibody	O
resulted	O
in	O
a	O
fluorescence	O
pattern	O
similar	O
to	O
Abcg5	O
alone	O
(	O
panel	O
d	O
)	O
.	O

The	O
yellow	O
bar	O
represents	O
20	O
mu	O
m	O
.	O

Wild	O
-	O
type	O
intestine	O
incubated	O
with	O
SC	O
pre	O
-	O
immune	O
serum	O
(	O
panel	O
e	O
)	O
,	O
or	O
SC	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
antibody	O
pre	O
-	O
incubated	O
with	O
the	O
blocking	O
peptide	O
(	O
panel	O
f	O
)	O
showed	O
no	O
specific	O
signals	O
.	O

Wild	O
-	O
type	O
,	O
Abcg8	O
+	O
/	O
-	O
and	O
Abcg8	O
-	O
/	O
-	O
intestine	O
(	O
panels	O
g	O
,	O
h	O
and	O
i	O
respectively	O
)	O
incubated	O
with	O
SC	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
antibody	O
,	O
showed	O
no	O
difference	O
in	O
expression	O
patterns	O
,	O
despite	O
the	O
loss	O
of	O
Abcg8	O
/	O
sterolin	O
-	O
2	O
in	O
the	O
knockout	O
mice	O
.	O

Single	O
arrowhead	O
shows	O
intestinal	O
villus	O
and	O
double	O
arrowhead	O
shows	O
crypt	O
.	O

The	O
yellow	O
bar	O
represents	O
50	O
mu	O
m	O
.	O

Antibody	O
staining	O
of	O
liver	O
sections	O
was	O
also	O
performed	O
at	O
the	O
AMC	O
Liver	O
Center	O
.	O

As	O
a	O
control	O
,	O
an	O
antibody	O
to	O
Bsep	O
/	O
Abcb11	O
was	O
used	O
and	O
showed	O
a	O
clear	O
apical	O
distribution	O
in	O
both	O
wild	O
-	O
type	O
(	O
panel	O
j	O
)	O
and	O
Abcg8	O
knockout	O
mice	O
(	O
panel	O
k	O
)	O
.	O

Using	O
AMC	O
antibody	O
against	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
(	O
see	O
text	O
)	O
,	O
in	O
both	O
wild	O
-	O
type	O
(	O
panel	O
l	O
)	O
and	O
Abcg8	O
knockout	O
liver	O
(	O
panel	O
m	O
)	O
,	O
the	O
pattern	O
of	O
expression	O
was	O
also	O
apical	O
and	O
unchanged	O
although	O
the	O
signal	O
is	O
fainter	O
compared	O
to	O
that	O
for	O
Bsep	O
/	O
Abcb11	O
(	O
see	O
text	O
for	O
discussion	O
)	O
.	O

Arrows	O
indicate	O
bile	O
canaliculi	O
.	O

Figure	O
7	O

Immunohistochemical	O
evaluation	O
of	O
mouse	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
expression	O
in	O
liver	O
.	O

Wild	O
-	O
type	O
liver	O
incubated	O
with	O
UTSW	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
resulted	O
in	O
apical	O
expression	O
(	O
panel	O
a	O
)	O
.	O

Merged	O
image	O
clearly	O
shows	O
the	O
apical	O
distribution	O
.	O

Likewise	O
Abcg8	O
-	O
/	O
-	O
liver	O
incubated	O
with	O
the	O
same	O
UTSW	O
anti	O
-	O
Abcg5	O
/	O
sterolin	O
-	O
1	O
antibody	O
resulted	O
in	O
a	O
similar	O
apical	O
expression	O
pattern	O
relative	O
to	O
the	O
wild	O
type	O
(	O
panel	O
b	O
)	O
.	O

White	O
arrows	O
indicate	O
bile	O
canaliculi	O
and	O
asterisk	O
indicates	O
a	O
bile	O
duct	O
.	O

The	O
yellow	O
bar	O
represents	O
50	O
mu	O
m	O
.	O

Figure	O
8	O

Biliary	O
sterol	B-CHEBI
,	O
phospholipid	B-CHEBI
and	O
bile	B-CHEBI
salt	I-CHEBI
analyses	O
.	O

Bile	B-CHEBI
salt	I-CHEBI
,	O
sterol	B-CHEBI
and	O
phospholipid	B-CHEBI
contents	O
from	O
male	O
Abcg8	O
+	O
/	O
+	O
(	O
n	O
=	O
8	O
)	O
,	O
Abcg8	O
+	O
/	O
-	O
(	O
n	O
=	O
7	O
)	O
,	O
and	O
Abcg8	O
-	O
/	O
-	O
(	O
n	O
=	O
5	O
)	O
mice	O
were	O
examined	O
as	O
described	O
in	O
Methods	O
.	O

Bile	B-CHEBI
salt	I-CHEBI
secretion	O
following	O
a	O
10	O
minute	O
collection	O
was	O
lower	O
in	O
Abcg8	O
+	O
/	O
-	O
and	O
Abcg8	O
-	O
/	O
-	O
mice	O
compared	O
to	O
wild	O
type	O
(	O
panel	O
a	O
)	O
,	O
but	O
these	O
differences	O
were	O
not	O
statistically	O
significant	O
.	O

Biliary	O
sterol	B-CHEBI
and	O
phospholipid	B-CHEBI
were	O
significantly	O
reduced	O
in	O
the	O
Abcg8	O
-	O
/	O
-	O
mice	O
compared	O
to	O
the	O
wild	O
-	O
type	O
(	O
panels	O
b	O
and	O
c	O
)	O
.	O

*	O
P	O
<	O
0	O
.	O
05	O
.	O

The	O
lower	O
panel	O
shows	O
biliary	O
bile	B-CHEBI
salt	I-CHEBI
,	O
sterol	B-CHEBI
and	O
phospholipid	B-CHEBI
secretion	O
rates	O
from	O
female	O
Abcg8	O
+	O
/	O
+	O
(	O
n	O
=	O
5	O
)	O
,	O
Abcg8	O
+	O
/	O
-	O
(	O
n	O
=	O
4	O
)	O
,	O
and	O
Abcg8	O
-	O
/	O
-	O
(	O
n	O
=	O
3	O
)	O
mice	O
measured	O
following	O
90	O
-	O
minute	O
bile	B-CHEBI
salt	I-CHEBI
depletion	O
followed	O
by	O
stepwise	O
TUDC	O
infusion	O
as	O
described	O
in	O
the	O
text	O
.	O

Bars	O
represent	O
phase	O
TUDC	O
infusion	O
rates	O
.	O

No	O
differences	O
were	O
observed	O
in	O
the	O
ability	O
of	O
the	O
Abcg8	O
-	O
/	O
-	O
mice	O
to	O
secrete	O
bile	B-CHEBI
salts	I-CHEBI
(	O
panel	O
d	O
)	O
,	O
but	O
there	O
is	O
a	O
marked	O
inability	O
of	O
the	O
knockout	O
mice	O
to	O
secrete	O
sterols	B-CHEBI
(	O
panel	O
e	O
)	O
and	O
a	O
trend	O
towards	O
a	O
reduced	O
ability	O
to	O
secrete	O
phospholipid	B-CHEBI
(	O
panel	O
f	O
)	O
compared	O
to	O
wild	O
type	O
.	O

Figure	O
9	O

Biliary	O
cholesterol	B-CHEBI
and	O
sitosterol	B-CHEBI
secretion	O
.	O

Biliary	O
sterols	B-CHEBI
were	O
analyzed	O
by	O
GC	O
analyses	O
in	O
Abcg8	O
+	O
/	O
+	O
(	O
n	O
=	O
4	O
)	O
,	O
Abcg8	O
+	O
/	O
-	O
(	O
n	O
=	O
3	O
)	O
and	O
Abcg8	O
-	O
/	O
-	O
(	O
n	O
=	O
4	O
)	O
mice	O
following	O
30	O
-	O
minute	O
bile	B-CHEBI
salt	I-CHEBI
depletion	O
followed	O
by	O
a	O
continuous	O
TUDC	O
infusion	O
as	O
described	O
in	O
Methods	O
.	O

Abcg8	O
-	O
/	O
-	O
mice	O
were	O
unable	O
to	O
secrete	O
cholesterol	B-CHEBI
into	O
bile	O
with	O
forced	O
TUDC	O
administration	O
relative	O
to	O
the	O
wild	O
-	O
type	O
mice	O
(	O
panel	O
a	O
,	O
*	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Interestingly	O
,	O
the	O
Abcg8	O
-	O
/	O
-	O
mice	O
were	O
able	O
to	O
still	O
secrete	O
sitosterol	B-CHEBI
(	O
panel	O
b	O
)	O
and	O
campesterol	B-CHEBI
(	O
panel	O
c	O
)	O
.	O

Heterozygous	O
mice	O
showed	O
an	O
increased	O
ability	O
to	O
secrete	O
all	O
sterols	B-CHEBI
with	O
forced	O
TUDC	O
administration	O
,	O
although	O
the	O
results	O
were	O
not	O
statistically	O
significant	O
.	O

Table	O
1	O

Oligonucleotide	O
primers	O
used	O
for	O
quantitative	O
RT	O
-	O
PCR	O

Table	O
2	O

Mouse	O
plasma	O
and	O
tissue	O
sterol	B-CHEBI
analyses	O

Animals	O
used	O
in	O
these	O
studies	O
were	O
12	O
weeks	O
of	O
age	O
,	O
a	O
mixture	O
of	O
male	O
and	O
female	O
and	O
fed	O
a	O
regular	O
chow	O
diet	O
.	O

*	O
P	O
<	O
0	O
.	O
05	O
for	O
-	O
/	O
-	O
versus	O
+	O
/	O
+	O
and	O
-	O
/	O
-	O
versus	O
+	O
/	O
-	O
.	O

ND	O
,	O
not	O
detectable	O
.	O

Loss	O
of	O
KCNJ10	O
protein	B-CHEBI
expression	O
abolishes	O
endocochlear	O
potential	O
and	O
causes	O
deafness	O
in	O
Pendred	O
syndrome	O
mouse	O
model	O

Abstract	O

Background	O

Pendred	O
syndrome	O
,	O
a	O
common	O
autosomal	O
-	O
recessive	O
disorder	O
characterized	O
by	O
congenital	O
deafness	O
and	O
goiter	O
,	O
is	O
caused	O
by	O
mutations	O
of	O
SLC26A4	O
,	O
which	O
codes	O
for	O
pendrin	O
.	O

We	O
investigated	O
the	O
relationship	O
between	O
pendrin	O
and	O
deafness	O
using	O
mice	O
that	O
have	O
(	O
Slc26a4	O
+	O
/	O
+	O
)	O
or	O
lack	O
a	O
complete	O
Slc26a4	O
gene	O
(	O
Slc26a4	O
-	O
/	O
-	O
)	O
.	O

Methods	O

Expression	O
of	O
pendrin	O
and	O
other	O
proteins	B-CHEBI
was	O
determined	O
by	O
confocal	O
immunocytochemistry	O
.	O

Expression	O
of	O
mRNA	B-CHEBI
was	O
determined	O
by	O
quantitative	O
RT	O
-	O
PCR	O
.	O

The	O
endocochlear	O
potential	O
and	O
the	O
endolymphatic	O
K	B-CHEBI
+	I-CHEBI
concentration	O
were	O
measured	O
with	O
double	O
-	O
barreled	O
microelectrodes	O
.	O

Currents	O
generated	O
by	O
the	O
stria	O
marginal	O
cells	O
were	O
recorded	O
with	O
a	O
vibrating	O
probe	O
.	O

Tissue	O
masses	O
were	O
evaluated	O
by	O
morphometric	O
distance	O
measurements	O
and	O
pigmentation	O
was	O
quantified	O
by	O
densitometry	O
.	O

Results	O

Pendrin	O
was	O
found	O
in	O
the	O
cochlea	O
in	O
apical	O
membranes	O
of	O
spiral	O
prominence	O
cells	O
and	O
spindle	O
-	O
shaped	O
cells	O
of	O
stria	O
vascularis	O
,	O
in	O
outer	O
sulcus	O
and	O
root	O
cells	O
.	O

Endolymph	O
volume	O
in	O
Slc26a4	O
-	O
/	O
-	O
mice	O
was	O
increased	O
and	O
tissue	O
masses	O
in	O
areas	O
normally	O
occupied	O
by	O
type	O
I	O
and	O
II	O
fibrocytes	O
were	O
reduced	O
.	O

Slc26a4	O
-	O
/	O
-	O
mice	O
lacked	O
the	O
endocochlear	O
potential	O
,	O
which	O
is	O
generated	O
across	O
the	O
basal	O
cell	O
barrier	O
by	O
the	O
K	B-CHEBI
+	I-CHEBI
channel	O
KCNJ10	O
localized	O
in	O
intermediate	O
cells	O
.	O

Stria	O
vascularis	O
was	O
hyperpigmented	O
,	O
suggesting	O
unalleviated	O
free	B-CHEBI
radical	I-CHEBI
damage	O
.	O

The	O
basal	O
cell	O
barrier	O
appeared	O
intact	O
;	O
intermediate	O
cells	O
and	O
KCNJ10	O
mRNA	B-CHEBI
were	O
present	O
but	O
KCNJ10	O
protein	B-CHEBI
was	O
absent	O
.	O

Endolymphatic	O
K	B-CHEBI
+	I-CHEBI
concentrations	O
were	O
normal	O
and	O
membrane	O
proteins	B-CHEBI
necessary	O
for	O
K	B-CHEBI
+	I-CHEBI
secretion	O
were	O
present	O
,	O
including	O
the	O
K	B-CHEBI
+	I-CHEBI
channel	O
KCNQ1	O
and	O
KCNE1	O
,	O
Na	B-CHEBI
+	I-CHEBI
/	O
2Cl	O
-	O
/	O
K	B-CHEBI
+	I-CHEBI
cotransporter	O
SLC12A2	O
and	O
the	O
gap	O
junction	O
GJB2	O
.	O

Conclusions	O

These	O
observations	O
demonstrate	O
that	O
pendrin	O
dysfunction	O
leads	O
to	O
a	O
loss	O
of	O
KCNJ10	O
protein	B-CHEBI
expression	O
and	O
a	O
loss	O
of	O
the	O
endocochlear	O
potential	O
,	O
which	O
may	O
be	O
the	O
direct	O
cause	O
of	O
deafness	O
in	O
Pendred	O
syndrome	O
.	O

Background	O

Pendred	O
syndrome	O
is	O
a	O
relatively	O
common	O
autosomal	O
-	O
recessive	O
disorder	O
characterized	O
by	O
deafness	O
and	O
goiter	O
[	O
1	O
]	O
.	O

The	O
syndrome	O
is	O
caused	O
by	O
mutations	O
of	O
the	O
PDS	O
gene	O
SLC26A4	O
,	O
which	O
codes	O
for	O
the	O
protein	B-CHEBI
pendrin	O
[	O
2	O
]	O
.	O

Deafness	O
is	O
congenital	O
and	O
generally	O
profound	O
although	O
sometimes	O
late	O
in	O
onset	O
and	O
provoked	O
by	O
light	O
head	O
injury	O
.	O

Vestibular	O
dysfunction	O
is	O
uncommon	O
.	O

Goiter	O
is	O
variable	O
and	O
generally	O
develops	O
around	O
puberty	O
[	O
3	O
]	O
.	O

The	O
cause	O
of	O
goiter	O
appears	O
to	O
be	O
an	O
impairment	O
of	O
iodide	B-CHEBI
fixation	O
in	O
the	O
follicular	O
lumen	O
due	O
to	O
a	O
reduced	O
rate	O
of	O
iodide	B-CHEBI
transport	O
across	O
the	O
apical	O
membrane	O
of	O
thyroid	O
gland	O
epithelial	O
cells	O
[	O
4	O
]	O
.	O

A	O
positive	O
perchlorate	B-CHEBI
discharge	O
test	O
and	O
an	O
enlarged	O
vestibular	O
aqueduct	O
appear	O
to	O
be	O
the	O
most	O
reliable	O
clinical	O
signs	O
of	O
Pendred	O
syndrome	O
[	O
5	O
]	O
.	O

Pendrin	O
is	O
an	O
anion	B-CHEBI
exchanger	O
that	O
can	O
transport	O
Cl	B-CHEBI
-	I-CHEBI
,	O
I	B-CHEBI
-	I-CHEBI
,	O
HCO3	B-CHEBI
-	I-CHEBI
and	O
formate	B-CHEBI
[	O
6	O
,	O
7	O
]	O
.	O

Expression	O
has	O
been	O
found	O
in	O
the	O
inner	O
ear	O
and	O
thyroid	O
gland	O
consistent	O
with	O
the	O
clinical	O
signs	O
of	O
deafness	O
and	O
goiter	O
[	O
2	O
,	O
3	O
,	O
8	O
]	O
.	O

In	O
addition	O
,	O
pendrin	O
expression	O
has	O
been	O
found	O
in	O
the	O
kidney	O
[	O
9	O
]	O
,	O
mammary	O
gland	O
[	O
10	O
]	O
,	O
uterus	O
[	O
11	O
]	O
,	O
testes	O
[	O
12	O
]	O
and	O
placenta	O
[	O
13	O
]	O
.	O

No	O
expression	O
was	O
found	O
in	O
fetal	O
or	O
adult	O
brain	O
,	O
consistent	O
with	O
a	O
peripheral	O
cause	O
of	O
deafness	O
[	O
2	O
,	O
11	O
]	O
.	O

Expression	O
of	O
pendrin	O
mRNA	B-CHEBI
in	O
the	O
inner	O
ear	O
has	O
been	O
found	O
in	O
several	O
places	O
including	O
the	O
cochlea	O
,	O
the	O
vestibular	O
labyrinth	O
and	O
the	O
endolymphatic	O
sac	O
[	O
8	O
]	O
.	O

The	O
precise	O
location	O
of	O
pendrin	O
protein	B-CHEBI
expression	O
,	O
however	O
,	O
has	O
not	O
yet	O
been	O
determined	O
.	O

The	O
variability	O
of	O
deafness	O
in	O
Pendred	O
syndrome	O
and	O
the	O
observation	O
that	O
deafness	O
is	O
sometimes	O
late	O
in	O
onset	O
suggest	O
that	O
pendrin	O
dysfunction	O
may	O
not	O
be	O
the	O
direct	O
cause	O
of	O
deafness	O
.	O

It	O
is	O
conceivable	O
that	O
pendrin	O
dysfunction	O
favors	O
changes	O
in	O
the	O
expression	O
levels	O
of	O
proteins	B-CHEBI
that	O
are	O
critical	O
for	O
the	O
maintenance	O
of	O
the	O
hearing	O
function	O
.	O

Detailed	O
studies	O
aimed	O
at	O
identifying	O
the	O
direct	O
cause	O
of	O
deafness	O
in	O
Pendred	O
syndrome	O
have	O
recently	O
become	O
possible	O
due	O
to	O
the	O
generation	O
of	O
a	O
pendrin	O
-	O
specific	O
polyclonal	O
antibody	O
[	O
9	O
]	O
and	O
the	O
development	O
of	O
Slc26a4	O
-	O
/	O
-	O
mice	O
,	O
which	O
bear	O
a	O
targeted	O
disruption	O
of	O
the	O
mouse	O
Slc26a4	O
gene	O
[	O
14	O
]	O
.	O

The	O
aim	O
in	O
the	O
present	O
study	O
was	O
to	O
determine	O
the	O
location	O
of	O
pendrin	O
and	O
the	O
cause	O
of	O
deafness	O
in	O
Slc26a4	O
-	O
/	O
-	O
mice	O
.	O

Methods	O

The	O
endocochlear	O
potential	O
and	O
the	O
endolymphatic	O
and	O
perilymphatic	O
K	B-CHEBI
+	I-CHEBI
concentrations	O
were	O
measured	O
in	O
young	O
adult	O
mice	O
(	O
1	O
-	O
4	O
month	O
of	O
age	O
)	O
that	O
either	O
have	O
(	O
Slc26a4	O
+	O
/	O
+	O
)	O
or	O
lack	O
(	O
Slc26a4	O
-	O
/	O
-	O
)	O
a	O
functional	O
gene	O
for	O
pendrin	O
[	O
14	O
]	O
.	O

The	O
mouse	O
strain	O
129Sv	O
/	O
Ev	O
(	O
Taconic	O
,	O
Germantown	O
,	O
NY	O
)	O
was	O
chosen	O
as	O
the	O
source	O
of	O
Slc26a4	O
+	O
/	O
+	O
controls	O
,	O
since	O
Slc26a4	O
-	O
/	O
-	O
mice	O
were	O
propagated	O
in	O
the	O
this	O
strain	O
and	O
generated	O
using	O
a	O
stem	O
cell	O
line	O
derived	O
from	O
129Sv	O
/	O
Ev	O
.	O

Slc26a4	O
+	O
/	O
+	O
and	O
Slc26a4	O
-	O
/	O
-	O
were	O
agouti	O
.	O

They	O
did	O
not	O
differ	O
in	O
coat	O
color	O
.	O

Differences	O
in	O
pigmentation	O
were	O
verified	O
using	O
coisogenic	O
age	O
-	O
matched	O
Slc26a4	O
+	O
/	O
+	O
and	O
Slc26a4	O
-	O
/	O
-	O
that	O
were	O
bred	O
in	O
parallel	O
.	O

Expression	O
of	O
key	O
proteins	B-CHEBI
involved	O
in	O
the	O
generation	O
of	O
the	O
endocochlear	O
potential	O
and	O
the	O
transport	O
of	O
K	B-CHEBI
+	I-CHEBI
was	O
studied	O
using	O
confocal	O
immunocytochemistry	O
and	O
quantitative	O
RT	O
-	O
PCR	O
.	O

K	B-CHEBI
+	I-CHEBI
secretion	O
and	O
the	O
generation	O
of	O
the	O
endocochlear	O
potential	O
were	O
measured	O
using	O
electrophysiological	O
techniques	O
.	O

All	O
experiments	O
were	O
approved	O
by	O
the	O
Institutional	O
Animal	O
Care	O
and	O
Use	O
Committee	O
of	O
Kansas	O
State	O
University	O
.	O

Confocal	O
immunocytochemistry	O

Animals	O
were	O
deeply	O
anesthetized	O
with	O
sodium	B-CHEBI
pentobarbital	B-CHEBI
(	O
100	O
mg	O
/	O
kg	O
i	O
.	O
p	O
.	O
)	O
and	O
transcardially	O
perfused	O
with	O
a	O
Cl	B-CHEBI
-	I-CHEBI
-	O
free	O
phosphate	B-CHEBI
-	O
buffered	B-CHEBI
Na	B-CHEBI
-	O
gluconate	B-CHEBI
solution	O
containing	O
4	O
%	O
paraformaldehyde	O
.	O

Temporal	O
bones	O
were	O
removed	O
and	O
cochleae	O
fixed	O
by	O
perilymphatic	O
perfusion	O
,	O
decalcified	O
in	O
EDTA	B-CHEBI
,	O
processed	O
through	O
a	O
sucrose	B-CHEBI
gradient	O
and	O
infiltrated	O
with	O
polyethylene	B-CHEBI
glycol	I-CHEBI
.	O

Mid	O
-	O
modiolar	O
cryosections	O
(	O
12	O
mu	O
m	O
,	O
CM3050S	O
,	O
Leica	O
,	O
Nussloch	O
,	O
Germany	O
)	O
were	O
blocked	O
in	O
PBS	O
with	O
0	O
.	O
2	O
%	O
Triton	O
-	O
X	O
(	O
PBS	O
-	O
TX	O
)	O
and	O
10	O
%	O
bovine	O
serum	O
albumin	O
.	O

Slides	O
were	O
incubated	O
overnight	O
at	O
4	O
degrees	O
C	O
with	O
primary	O
antibodies	O
in	O
PBS	O
-	O
TX	O
with	O
1	O
-	O
3	O
%	O
BSA	O
[	O
rabbit	O
anti	O
-	O
pendrin	O
,	O
1	O
:	O
500	O
(	O
h766	O
-	O
780	O
)	O
;	O
rat	O
anti	O
-	O
ZO	O
-	O
1	O
,	O
1	O
:	O
100	O
(	O
Chemicon	O
,	O
Temecula	O
,	O
CA	O
)	O
;	O
goat	O
anti	O
-	O
KCNQ1	O
,	O
1	O
:	O
200	O
(	O
C20	O
,	O
Santa	O
Cruz	O
Biotechnology	O
,	O
Santa	O
Cruz	O
,	O
CA	O
)	O
,	O
rabbit	O
anti	O
-	O
KCNE1	O
,	O
1	O
:	O
200	O
(	O
Alomone	O
,	O
Jerusalem	O
,	O
Israel	O
)	O
;	O
rabbit	O
anti	O
-	O
KCNJ10	O
,	O
1	O
:	O
300	O
(	O
Alomone	O
)	O
;	O
rabbit	O
anti	O
-	O
SLC12A2	O
,	O
1	O
:	O
100	O
(	O
Chemicon	O
)	O
;	O
and	O
rabbit	O
anti	O
-	O
connexin	O
26	O
,	O
1	O
:	O
100	O
(	O
Zymed	O
,	O
San	O
Francisco	O
,	O
CA	O
)	O
]	O
.	O

Slides	O
were	O
washed	O
in	O
PBS	O
-	O
TX	O
and	O
incubated	O
for	O
1	O
h	O
at	O
25	O
degrees	O
C	O
with	O
appropriate	O
secondary	O
antibodies	O
at	O
a	O
1	O
:	O
1000	O
dilution	O
in	O
PBS	O
-	O
TX	O
with	O
1	O
-	O
3	O
%	O
BSA	O
[	O
donkey	O
anti	O
-	O
rabbit	O
Alexa	O
488	O
,	O
chicken	O
anti	O
-	O
rat	O
Alexa	O
594	O
,	O
and	O
chicken	O
anti	O
-	O
goat	O
Alexa	O
594	O
(	O
Molecular	B-CHEBI
Probes	O
,	O
Eugene	O
,	O
OR	O
)	O
]	O
.	O

Actin	O
filaments	O
were	O
visualized	O
by	O
staining	O
with	O
Alexa	O
488	O
conjugated	O
phalloidin	B-CHEBI
(	O
Molecular	B-CHEBI
Probes	O
)	O
.	O

After	O
incubation	O
,	O
slides	O
were	O
washed	O
with	O
PBS	O
-	O
TX	O
,	O
mounted	O
with	O
FluorSave	O
(	O
Calbiochem	O
,	O
La	O
Jolla	O
,	O
CA	O
)	O
,	O
and	O
viewed	O
by	O
confocal	O
microscopy	O
(	O
LSM	O
5	O
Pascal	O
or	O
LSM	O
510	O
Meta	O
,	O
Carl	O
Zeiss	O
,	O
Jena	O
or	O
G	O
o	O
ttingen	O
,	O
Germany	O
)	O
.	O

Laser	O
scanning	O
brightfield	O
images	O
were	O
collected	O
to	O
document	O
structural	O
preservation	O
,	O
for	O
morphometric	O
analysis	O
and	O
for	O
analysis	O
of	O
pigmentation	O
.	O

Quantitative	O
RT	O
-	O
PCR	O

Animals	O
were	O
deeply	O
anesthetized	O
with	O
sodium	B-CHEBI
pentobarbital	B-CHEBI
(	O
100	O
mg	O
/	O
kg	O
i	O
.	O
p	O
.	O
)	O
.	O

Kidneys	O
and	O
brain	O
were	O
removed	O
and	O
pulverized	O
in	O
liquid	O
N2	B-CHEBI
.	O

Temporal	O
bones	O
were	O
removed	O
and	O
two	O
preparations	O
of	O
inner	O
ear	O
tissues	O
were	O
obtained	O
by	O
microdissection	O
:	O
(	O
1	O
)	O
stria	O
vascularis	O
without	O
spiral	O
ligament	O
,	O
and	O
(	O
2	O
)	O
spiral	O
ganglia	O
including	O
the	O
surrounding	O
bone	O
and	O
the	O
organ	O
of	O
Corti	O
.	O

The	O
dissection	O
medium	O
was	O
changed	O
twice	O
during	O
the	O
microdissection	O
and	O
isolated	O
tissues	O
were	O
washed	O
three	O
times	O
to	O
minimize	O
cross	O
-	O
contamination	O
.	O

The	O
Slc26a4	O
-	O
/	O
-	O
genotype	O
was	O
verified	O
by	O
the	O
observation	O
of	O
large	O
otoconia	O
in	O
the	O
utricular	O
macula	O
[	O
14	O
]	O
.	O

Total	O
RNA	O
was	O
isolated	O
and	O
residual	O
DNA	O
contamination	O
was	O
removed	O
by	O
enzymatic	O
digestion	O
(	O
RNeasy	O
micro	O
,	O
Qiagen	O
,	O
Valencia	O
,	O
CA	O
)	O
.	O

Quality	O
and	O
quantity	O
of	O
18S	O
rRNA	B-CHEBI
obtained	O
from	O
kidneys	O
and	O
brain	O
were	O
determined	O
(	O
Nano	O
Assay	O
,	O
2100	O
Bioanalyzer	O
,	O
Agilent	O
,	O
Palo	O
Alto	O
,	O
CA	O
)	O
.	O

Further	O
,	O
the	O
quality	O
of	O
RNA	O
preparations	O
obtained	O
from	O
stria	O
vascularis	O
and	O
spiral	O
ganglia	O
was	O
assessed	O
(	O
Pico	O
Assay	O
,	O
2100	O
Bioanalyzer	O
)	O
.	O

Real	O
time	O
RT	O
-	O
PCR	O
was	O
performed	O
on	O
RNA	O
obtained	O
from	O
individual	O
animals	O
(	O
OneStep	O
RT	O
-	O
PCR	O
,	O
Qiagen	O
;	O
Smart	O
Cycler	O
,	O
Cepheid	O
,	O
Sunnyvale	O
,	O
CA	O
)	O
in	O
the	O
presence	O
of	O
0	O
.	O
2	O
x	O
SYBR	O
green	O
I	O
(	O
Molecular	B-CHEBI
Probes	O
)	O
.	O

Transcripts	O
of	O
18S	O
rRNA	B-CHEBI
and	O
mRNA	B-CHEBI
for	O
the	O
K	B-CHEBI
+	I-CHEBI
channels	O
KCNJ10	O
,	O
KCNQ1	O
and	O
KCNQ4	O
were	O
amplified	O
using	O
gene	O
-	O
specific	O
primers	O
(	O
Table	O
1	O
)	O
.	O

RT	O
was	O
performed	O
for	O
30	O
min	O
at	O
50	O
degrees	O
C	O
and	O
15	O
min	O
at	O
95	O
degrees	O
C	O
.	O

PCR	O
consisted	O
of	O
50	O
cycles	O
of	O
1	O
min	O
at	O
60	O
degrees	O
C	O
,	O
1	O
min	O
at	O
72	O
degrees	O
C	O
,	O
7s	O
heating	O
to	O
hot	O
-	O
measurement	O
temperature	O
,	O
13s	O
hot	O
-	O
measurement	O
at	O
3	O
-	O
5	O
degrees	O
C	O
below	O
product	O
melting	O
temperature	O
(	O
Table	O
1	O
)	O
and	O
1	O
min	O
at	O
94	O
degrees	O
C	O
.	O

Hot	O
-	O
measurements	O
were	O
performed	O
to	O
eliminate	O
the	O
detection	O
of	O
primer	O
-	O
dimers	O
that	O
had	O
melting	O
temperatures	O
between	O
72	O
and	O
75	O
degrees	O
C	O
[	O
15	O
]	O
.	O

PCR	O
was	O
followed	O
by	O
a	O
melt	O
(	O
60	O
to	O
95	O
degrees	O
C	O
)	O
.	O

The	O
generation	O
of	O
a	O
single	O
product	O
of	O
appropriate	O
size	O
was	O
routinely	O
checked	O
by	O
the	O
presence	O
of	O
a	O
single	O
melt	O
peak	O
and	O
by	O
agarose	B-CHEBI
gel	O
-	O
electrophoresis	O
.	O

Product	O
identity	O
was	O
confirmed	O
by	O
sequencing	O
.	O

Table	O
1	O

Primers	O

Template	O
molecules	B-CHEBI
(	O
T	O
)	O
were	O
quantified	O
according	O
to	O
T	O
=	O
P	O
/	O
(	O
F	O
^	O
Ct	O
)	O
where	O
P	O
is	O
the	O
number	O
of	O
product	O
molecules	B-CHEBI
,	O
F	O
is	O
the	O
fidelity	O
of	O
the	O
reaction	O
and	O
Ct	O
is	O
the	O
cycle	O
at	O
which	O
the	O
number	O
of	O
product	O
molecules	B-CHEBI
reaches	O
a	O
chosen	O
threshold	O
[	O
15	O
]	O
.	O

Fidelity	O
(	O
F	O
)	O
was	O
obtained	O
from	O
the	O
slope	O
(	O
S	O
)	O
of	O
the	O
log	O
-	O
linear	O
phase	O
of	O
the	O
growth	O
curve	O
via	O
a	O
best	O
-	O
fit	O
fifth	O
-	O
order	O
polynomial	O
:	O
F	O
=	O
7	O
.	O
39	O
+	O
3	O
.	O
80	O
x	O
S	O
+	O
1	O
.	O
05	O
x	O
S2	O
+	O
0	O
.	O
15	O
x	O
S3	O
+	O
11	O
.	O
38	O
x	O
10	O
-	O
3	O
*	O
S4	O
+	O
3	O
.	O
39	O
x	O
10	O
-	O
4	O
x	O
S5	O
.	O

The	O
number	O
of	O
product	O
molecules	B-CHEBI
at	O
threshold	O
(	O
PCt	O
)	O
was	O
determined	O
by	O
amplification	O
of	O
known	O
amounts	O
of	O
18S	O
rRNA	B-CHEBI
according	O
to	O
PCt	O
=	O
T	O
x	O
F	O
^	O
Ct	O
.	O

Quantifications	O
of	O
18S	O
rRNA	B-CHEBI
were	O
used	O
to	O
compare	O
tissue	O
amounts	O
.	O

Genomic	O
contamination	O
of	O
inner	O
ear	O
samples	O
was	O
assessed	O
to	O
be	O
<	O
0	O
.	O
02	O
%	O
by	O
omission	O
of	O
the	O
RT	O
step	O
.	O

In	O
vitro	O
electrophysiology	O

Animals	O
were	O
deeply	O
anesthetized	O
with	O
sodium	B-CHEBI
pentobarbital	B-CHEBI
(	O
100	O
mg	O
/	O
kg	O
i	O
.	O
p	O
.	O
)	O
.	O

Stria	O
vascularis	O
without	O
spiral	O
ligament	O
was	O
obtained	O
by	O
microdissection	O
.	O

Currents	O
generated	O
by	O
the	O
stria	O
marginal	O
epithelium	O
were	O
recorded	O
[	O
16	O
]	O
.	O

A	O
Pt	O
-	O
Ir	O
wire	O
microelectrode	O
with	O
a	O
Pt	O
-	O
black	O
tip	O
was	O
positioned	O
20	O
-	O
30	O
mu	O
m	O
from	O
the	O
apical	O
surface	O
of	O
the	O
epithelium	O
and	O
vibrated	O
at	O
200	O
-	O
400	O
Hz	O
by	O
piezo	O
-	O
electric	O
bimorph	O
elements	O
(	O
Applicable	O
Electronics	O
,	O
Forest	O
Dale	O
,	O
MA	O
;	O
ASET	O
version	O
1	O
.	O
05	O
,	O
Science	O
Wares	O
,	O
East	O
Falmouth	O
,	O
MA	O
)	O
.	O

A	O
Pt	O
-	O
black	O
electrode	O
(	O
26	O
-	O
gauge	O
)	O
served	O
as	O
reference	O
in	O
the	O
bath	O
chamber	O
.	O

The	O
signals	O
from	O
the	O
phase	O
-	O
sensitive	O
detectors	O
were	O
digitized	O
(	O
16	O
bit	O
)	O
at	O
a	O
rate	O
of	O
0	O
.	O
5	O
Hz	O
.	O

The	O
output	O
was	O
expressed	O
as	O
current	O
density	O
at	O
the	O
electrode	O
.	O

In	O
situ	O
electrophysiology	O

Animals	O
were	O
anesthetized	O
with	O
inactin	O
(	O
thiobutabarbital	O
sodium	B-CHEBI
salt	I-CHEBI
,	O
140	O
mg	O
/	O
kg	O
ip	O
)	O
.	O

The	O
endocochlear	O
potential	O
and	O
the	O
endolymphatic	O
[	O
K	B-CHEBI
+	I-CHEBI
]	O
were	O
measured	O
with	O
double	O
-	O
barreled	O
microelectrodes	O
[	O
17	O
]	O
.	O

Measurements	O
were	O
made	O
in	O
the	O
basal	O
turn	O
by	O
a	O
round	O
-	O
window	O
approach	O
through	O
the	O
basilar	O
membrane	O
and	O
in	O
the	O
apical	O
turn	O
after	O
thinning	O
the	O
bone	O
over	O
the	O
stria	O
vascularis	O
and	O
picking	O
a	O
small	O
hole	O
(	O
~	O
30	O
mu	O
m	O
)	O
.	O

K	B-CHEBI
+	I-CHEBI
-	O
selective	O
electrodes	O
were	O
calibrated	O
in	O
solutions	O
of	O
constant	O
cation	B-CHEBI
(	O
K	B-CHEBI
+	I-CHEBI
and	O
Na	B-CHEBI
+	I-CHEBI
)	O
concentration	O
of	O
150	O
mM	O
.	O

The	O
minor	O
selectivity	O
of	O
the	O
K	B-CHEBI
+	I-CHEBI
electrodes	O
for	O
Na	B-CHEBI
+	I-CHEBI
produced	O
a	O
nonlinearity	O
in	O
the	O
calibration	O
curve	O
,	O
which	O
was	O
closely	O
fitted	O
by	O
the	O
Nicolski	O
equation	O
using	O
nonlinear	O
curve	O
-	O
fitting	O
software	O
(	O
OriginLab	O
,	O
Northampton	O
,	O
MA	O
)	O
:	O
V	O
=	O
Vi	O
+	O
S	O
x	O
log	O
(	O
[	O
K	B-CHEBI
+	I-CHEBI
]	O
+	O
A	O
x	O
[	O
Na	B-CHEBI
+	I-CHEBI
]	O
)	O
,	O
where	O
Vi	O
is	O
an	O
offset	O
term	O
,	O
S	O
is	O
slope	O
,	O
A	O
is	O
selectivity	O
,	O
and	O
[	O
Na	B-CHEBI
+	I-CHEBI
]	O
is	O
Na	B-CHEBI
+	I-CHEBI
concentration	O
.	O

Calibrations	O
were	O
made	O
immediately	O
after	O
withdrawal	O
of	O
the	O
electrodes	O
from	O
the	O
cochlea	O
.	O

Plasma	O
K	B-CHEBI
+	I-CHEBI
concentrations	O
were	O
obtained	O
using	O
a	O
blood	O
analyzer	O
(	O
Stat	O
Profile	O
M	O
,	O
Nova	O
Biomedical	O
,	O
Waltham	O
,	O
MA	O
)	O
.	O

Data	O
are	O
presented	O
as	O
mean	O
+/-	O
sem	O
;	O
n	O
denotes	O
the	O
number	O
of	O
experiments	O
.	O

Differences	O
were	O
considered	O
significant	O
when	O
p	O
<	O
0	O
.	O
05	O
.	O

Results	O
and	O
Discussion	O

In	O
situ	O
hybridization	O
in	O
the	O
cochlea	O
has	O
suggested	O
that	O
pendrin	O
mRNA	B-CHEBI
is	O
expressed	O
in	O
cells	O
that	O
reside	O
immediately	O
beneath	O
the	O
spiral	O
prominence	O
on	O
the	O
lateral	O
wall	O
of	O
the	O
external	O
sulcus	O
[	O
8	O
]	O
.	O

To	O
determine	O
the	O
location	O
of	O
pendrin	O
protein	B-CHEBI
expression	O
,	O
we	O
performed	O
confocal	O
immunocytochemistry	O
on	O
cryosections	O
prepared	O
from	O
temporal	O
bones	O
of	O
normal	O
(	O
Slc26a4	O
+	O
/	O
+	O
)	O
mice	O
using	O
an	O
established	O
antibody	O
[	O
3	O
]	O
.	O

Staining	O
was	O
absent	O
when	O
the	O
primary	O
antibody	O
was	O
pre	O
-	O
absorbed	O
with	O
the	O
antigenic	O
peptide	O
(	O
data	O
not	O
shown	O
)	O
.	O

Strong	O
expression	O
of	O
pendrin	O
was	O
observed	O
not	O
only	O
in	O
outer	O
sulcus	O
epithelial	O
cells	O
,	O
as	O
predicted	O
from	O
in	O
situ	O
hybridization	O
data	O
,	O
but	O
also	O
in	O
root	O
cells	O
,	O
in	O
apical	O
membranes	O
of	O
spiral	O
prominence	O
surface	O
epithelial	O
cells	O
and	O
in	O
apical	O
membranes	O
of	O
spindle	O
-	O
shaped	O
cells	O
that	O
are	O
part	O
of	O
stria	O
vascularis	O
(	O
Fig	O
.	O
1a	O
,	O
1b	O
,	O
1c	O
)	O
.	O

The	O
presence	O
of	O
pendrin	O
in	O
spindle	O
-	O
shaped	O
cells	O
suggests	O
that	O
these	O
cells	O
secrete	O
HCO3	B-CHEBI
-	I-CHEBI
into	O
endolymph	O
.	O

Pendrin	O
-	O
mediated	O
HCO3	B-CHEBI
-	I-CHEBI
transport	O
has	O
previously	O
been	O
shown	O
in	O
the	O
kidney	O
[	O
9	O
]	O
.	O

HCO3	B-CHEBI
-	I-CHEBI
in	O
the	O
cochlea	O
may	O
be	O
generated	O
from	O
CO2	B-CHEBI
by	O
carbonic	B-CHEBI
anhydrase	O
located	O
in	O
strial	O
intermediate	O
cells	O
[	O
18	O
,	O
19	O
]	O
.	O

CO2	B-CHEBI
may	O
be	O
supplied	O
by	O
the	O
metabolically	O
highly	O
active	O
stria	O
marginal	O
cells	O
.	O

It	O
is	O
conceivable	O
that	O
pendrin	O
dysfunction	O
interrupts	O
HCO3	B-CHEBI
-	I-CHEBI
secretion	O
and	O
leads	O
to	O
an	O
accumulation	O
of	O
HCO3	B-CHEBI
-	I-CHEBI
in	O
stria	O
vascularis	O
.	O

Preliminary	O
data	O
(	O
Wangemann	O
et	O
al	O
.	O
,	O
unpublished	O
)	O
support	O
a	O
role	O
for	O
pendrin	O
in	O
HCO3	B-CHEBI
-	I-CHEBI
secretion	O
into	O
endolymph	O
.	O

Figure	O
1	O

Protein	B-CHEBI
localization	O
of	O
pendrin	O
,	O
KCNQ1	O
,	O
ZO	O
-	O
1	O
and	O
F	O
actin	O
in	O
cochlea	O
and	O
vestibular	O
labyrinth	O
of	O
Slc26a4	O
+	O
/	O
+	O
and	O
Slc26a4	O
-	O
/	O
-	O
mice	O
.	O

a	O
:	O
Overview	O
of	O
cochlea	O
;	O
bar	O
=	O
100	O
mu	O
m	O
.	O

b	O
-	O
f	O
:	O
Detail	O
of	O
cochlear	O
lateral	O
wall	O
;	O
bar	O
=	O
10	O
mu	O
m	O
.	O

g	O
:	O
Detail	O
of	O
utricle	O
;	O
bar	O
=	O
10	O
mu	O
m	O
.	O

h	O
-	O
i	O
:	O
Detail	O
of	O
ampulla	O
;	O
bar	O
=	O
10	O
mu	O
m	O
.	O

RM	O
,	O
Reissner	O
'	O
s	O
membrane	O
;	O
SC	O
,	O
spindle	O
-	O
shaped	O
cells	O
,	O
SMC	O
,	O
strial	O
marginal	O
cells	O
;	O
SV	O
,	O
stria	O
vascularis	O
;	O
SL	O
,	O
spiral	O
ligament	O
;	O
LIM	O
,	O
spiral	O
limbus	O
.	O

BC	O
,	O
basal	O
cells	O
;	O
SP	O
,	O
spiral	O
prominence	O
epithelial	O
cells	O
;	O
RC	O
,	O
root	O
cells	O
;	O
OS	O
,	O
outer	O
sulcus	O
epithelial	O
cells	O
;	O
VHC	O
,	O
vestibular	O
hair	O
cells	O
;	O
VTC	O
,	O
vestibular	O
transitional	O
cells	O
;	O
VDC	O
,	O
vestibular	O
dark	O
cells	O
;	O
arrows	O
,	O
basal	O
cells	O
at	O
the	O
top	O
and	O
bottom	O
of	O
stria	O
vascularis	O
form	O
tight	O
junctions	O
with	O
surface	O
epithelial	O
cells	O
.	O

The	O
extent	O
of	O
pendrin	O
expression	O
in	O
spiral	O
prominence	O
cells	O
and	O
stria	O
vascularis	O
was	O
determined	O
by	O
labeling	O
KCNQ1	O
,	O
a	O
K	B-CHEBI
+	I-CHEBI
channel	O
that	O
is	O
expressed	O
in	O
strial	O
marginal	O
cells	O
,	O
and	O
ZO	O
-	O
1	O
,	O
a	O
tight	O
junction	O
protein	B-CHEBI
that	O
labels	O
basal	O
cells	O
and	O
thereby	O
delineates	O
the	O
boundaries	O
of	O
stria	O
vascularis	O
.	O

Dual	O
labeling	O
experiments	O
demonstrated	O
that	O
pendrin	O
is	O
expressed	O
in	O
spindle	O
-	O
shaped	O
cells	O
,	O
which	O
are	O
surface	O
epithelial	O
cells	O
in	O
stria	O
vascularis	O
adjacent	O
to	O
strial	O
marginal	O
cells	O
near	O
the	O
borders	O
of	O
both	O
the	O
spiral	O
prominence	O
and	O
Reissner	O
'	O
s	O
membrane	O
(	O
Fig	O
.	O
1c	O
)	O
.	O

In	O
situ	O
hybridization	O
in	O
the	O
vestibular	O
labyrinth	O
suggested	O
that	O
pendrin	O
mRNA	B-CHEBI
is	O
expressed	O
in	O
non	O
-	O
sensory	O
cells	O
[	O
8	O
]	O
.	O

Using	O
confocal	O
immunocytochemistry	O
on	O
cryosections	O
,	O
we	O
observed	O
strong	O
expression	O
of	O
the	O
pendrin	O
protein	B-CHEBI
in	O
the	O
apical	O
membrane	O
of	O
vestibular	O
transitional	O
cells	O
in	O
the	O
utricle	O
and	O
ampullae	O
(	O
Fig	O
.	O
1g	O
,	O
1h	O
,	O
1i	O
)	O
.	O

Dual	O
labeling	O
with	O
KCNQ1	O
demonstrated	O
that	O
pendrin	O
expression	O
was	O
clearly	O
limited	O
to	O
vestibular	O
transitional	O
cells	O
and	O
did	O
not	O
extend	O
to	O
other	O
non	O
-	O
sensory	O
cells	O
such	O
as	O
vestibular	O
dark	O
cells	O
,	O
which	O
were	O
clearly	O
identified	O
by	O
the	O
expression	O
of	O
KCNQ1	O
and	O
KCNE1	O
in	O
their	O
apical	O
membranes	O
.	O

The	O
onset	O
of	O
pendrin	O
expression	O
during	O
development	O
of	O
the	O
mouse	O
inner	O
ear	O
has	O
been	O
determined	O
to	O
be	O
embryonic	O
day	O
(	O
ED	O
)	O
13	O
[	O
14	O
]	O
.	O

Morphologically	O
detectable	O
differences	O
in	O
the	O
inner	O
ears	O
of	O
Slc26a4	O
+	O
/	O
+	O
and	O
Slc26a4	O
-	O
/	O
-	O
mice	O
become	O
evident	O
as	O
early	O
as	O
ED	O
15	O
,	O
when	O
Slc26a4	O
-	O
/	O
-	O
mice	O
start	O
to	O
develop	O
an	O
enlarged	O
endolymphatic	O
space	O
that	O
persists	O
into	O
adulthood	O
[	O
14	O
]	O
.	O

Interestingly	O
,	O
sensory	O
hair	O
cells	O
in	O
the	O
cochlea	O
appear	O
normal	O
until	O
postnatal	O
day	O
(	O
PD	O
)	O
7	O
but	O
show	O
clear	O
evidence	O
of	O
degeneration	O
by	O
PD	O
15	O
[	O
14	O
]	O
.	O

These	O
observations	O
suggest	O
that	O
the	O
cochlear	O
environment	O
supports	O
the	O
survival	O
of	O
sensory	O
hair	O
cells	O
in	O
spite	O
of	O
the	O
enlargement	O
of	O
the	O
endolymphatic	O
duct	O
.	O

A	O
normal	O
endolymphatic	O
K	B-CHEBI
+	I-CHEBI
concentration	O
,	O
which	O
is	O
critical	O
for	O
hair	O
cell	O
survival	O
[	O
20	O
]	O
,	O
is	O
established	O
at	O
PD	O
3	O
[	O
21	O
]	O
and	O
may	O
persist	O
in	O
Slc26a4	O
-	O
/	O
-	O
at	O
least	O
until	O
PD	O
7	O
.	O

The	O
time	O
period	O
between	O
PD	O
7	O
and	O
15	O
is	O
the	O
time	O
when	O
the	O
endocochlear	O
potential	O
develops	O
at	O
the	O
onset	O
of	O
hearing	O
[	O
22	O
]	O
.	O

We	O
hypothesized	O
that	O
a	O
lack	O
of	O
a	O
normal	O
endocochlear	O
potential	O
or	O
an	O
alteration	O
of	O
the	O
endolymphatic	O
K	B-CHEBI
+	I-CHEBI
concentration	O
could	O
account	O
for	O
deafness	O
in	O
Slc26a4	O
-	O
/	O
-	O
mice	O
.	O

Measurements	O
revealed	O
that	O
the	O
endocochlear	O
potential	O
was	O
absent	O
but	O
that	O
the	O
endolymphatic	O
K	B-CHEBI
+	I-CHEBI
concentration	O
was	O
normal	O
in	O
adult	O
Slc26a4	O
-	O
/	O
-	O
(	O
Fig	O
.	O
2a	O
)	O
.	O

No	O
significant	O
differences	O
between	O
Slc26a4	O
+	O
/	O
+	O
and	O
Slc26a4	O
-	O
/	O
-	O
mice	O
were	O
found	O
in	O
perilymphatic	O
(	O
Fig	O
.	O
2a	O
)	O
or	O
plasma	O
K	B-CHEBI
+	I-CHEBI
concentrations	O
(	O
Slc26a4	O
+	O
/	O
+	O
,	O
4	O
.	O
9	O
+/-	O
0	O
.	O
3	O
mM	O
,	O
n	O
=	O
6	O
;	O
Slc26a4	O
-	O
/	O
-	O
,	O
5	O
.	O
1	O
+/-	O
0	O
.	O
3	O
mM	O
,	O
n	O
=	O
6	O
)	O
.	O

These	O
observations	O
suggest	O
that	O
a	O
primary	O
event	O
leading	O
to	O
deafness	O
in	O
Slc26a4	O
-	O
/	O
-	O
mice	O
,	O
and	O
potentially	O
in	O
patients	O
suffering	O
from	O
Pendred	O
syndrome	O
,	O
is	O
the	O
loss	O
of	O
the	O
endocochlear	O
potential	O
.	O

Degeneration	O
of	O
hair	O
cells	O
is	O
probably	O
a	O
response	O
to	O
the	O
loss	O
of	O
the	O
endocochlear	O
potential	O
.	O

Figure	O
2	O

Potential	O
,	O
K	B-CHEBI
+	I-CHEBI
concentrations	O
and	O
pigmentation	O
of	O
stria	O
vascularis	O
in	O
Slc26a4	O
+	O
/	O
+	O
and	O
Slc26a4	O
-	O
/	O
-	O
mice	O
.	O

a	O
:	O
Endocochlear	O
potential	O
and	O
K	B-CHEBI
+	I-CHEBI
concentrations	O
in	O
endolymph	O
and	O
perilymph	O
at	O
the	O
apex	O
(	O
A	O
)	O
and	O
base	O
(	O
B	O
)	O
of	O
the	O
cochlea	O
.	O

Numbers	O
adjacent	O
to	O
symbols	O
denote	O
number	O
of	O
measurements	O
.	O

b	O
-	O
d	O
:	O
Pigmentation	O
of	O
stria	O
vascularis	O
in	O
Slc26a4	O
+	O
/	O
+	O
and	O
Slc26a4	O
-	O
/	O
-	O
mice	O
.	O

b	O
:	O
View	O
of	O
stria	O
vascularis	O
through	O
the	O
bony	O
capsule	O
of	O
the	O
cochlea	O
.	O

OW	O
,	O
oval	O
window	O
,	O
RW	O
,	O
round	O
window	O
;	O
arrows	O
,	O
stria	O
vascularis	O
.	O

c	O
-	O
d	O
:	O
Whole	O
-	O
mounts	O
of	O
stria	O
vascularis	O
isolated	O
from	O
age	O
-	O
matched	O
mice	O
.	O

c	O
:	O
Laser	O
-	O
scanning	O
images	O
,	O
bar	O
=	O
10	O
mu	O
m	O
,	O
d	O
:	O
Quantification	O
of	O
pigmentation	O
based	O
on	O
optical	O
density	O
.	O

The	O
endocochlear	O
potential	O
is	O
generated	O
by	O
stria	O
vascularis	O
in	O
the	O
lateral	O
wall	O
of	O
the	O
cochlea	O
[	O
17	O
,	O
23	O
]	O
.	O

The	O
potential	O
is	O
generated	O
across	O
the	O
basal	O
cell	O
barrier	O
of	O
stria	O
vascularis	O
by	O
the	O
K	B-CHEBI
+	I-CHEBI
channel	O
KCNJ10	O
located	O
in	O
intermediate	O
cells	O
[	O
24	O
]	O
,	O
which	O
are	O
connected	O
to	O
basal	O
cells	O
by	O
a	O
high	O
density	O
of	O
gap	O
junctions	O
[	O
25	O
]	O
.	O

Marginal	O
cells	O
of	O
stria	O
vascularis	O
,	O
which	O
form	O
the	O
barrier	O
toward	O
endolymph	O
,	O
transport	O
K	B-CHEBI
+	I-CHEBI
from	O
the	O
intrastrial	O
space	O
into	O
endolymph	O
and	O
keep	O
the	O
K	B-CHEBI
+	I-CHEBI
concentration	O
low	O
adjacent	O
to	O
the	O
KCNJ10	O
K	B-CHEBI
+	I-CHEBI
channel	O
[	O
26	O
]	O
.	O

To	O
determine	O
the	O
cause	O
of	O
the	O
loss	O
of	O
the	O
endocochlear	O
potential	O
in	O
Slc26a4	O
-	O
/	O
-	O
mice	O
,	O
we	O
first	O
determined	O
whether	O
intermediate	O
cells	O
are	O
present	O
in	O
stria	O
vascularis	O
,	O
since	O
a	O
loss	O
of	O
intermediate	O
cells	O
is	O
known	O
to	O
lead	O
to	O
a	O
loss	O
of	O
the	O
endocochlear	O
potential	O
[	O
27	O
,	O
28	O
]	O
.	O

Intermediate	O
cells	O
of	O
stria	O
vascularis	O
were	O
visualized	O
by	O
their	O
pigmentation	O
.	O

Pigmentation	O
was	O
present	O
in	O
stria	O
vascularis	O
of	O
Slc26a4	O
-	O
/	O
-	O
mice	O
(	O
Fig	O
.	O
2b	O
)	O
,	O
which	O
suggests	O
that	O
intermediate	O
cells	O
are	O
present	O
.	O

Interestingly	O
,	O
pigmentation	O
of	O
stria	O
vascularis	O
was	O
much	O
stronger	O
in	O
Slc26a4	O
-	O
/	O
-	O
than	O
in	O
Slc26a4	O
+	O
/	O
+	O
mice	O
.	O

To	O
determine	O
in	O
greater	O
detail	O
the	O
cause	O
of	O
the	O
loss	O
of	O
the	O
endocochlear	O
potential	O
in	O
Slc26a4	O
-	O
/	O
-	O
mice	O
,	O
we	O
isolated	O
total	O
RNA	O
from	O
stria	O
vascularis	O
and	O
spiral	O
ganglia	O
of	O
young	O
(	O
1	O
-	O
4	O
month	O
)	O
Slc26a4	O
+	O
/	O
+	O
and	O
both	O
young	O
and	O
old	O
(	O
~	O
12	O
month	O
)	O
Slc26a4	O
-	O
/	O
-	O
mice	O
,	O
assessed	O
amounts	O
of	O
isolated	O
tissues	O
by	O
quantification	O
of	O
18S	O
rRNA	B-CHEBI
,	O
and	O
quantified	O
the	O
expression	O
of	O
KCNJ10	O
mRNA	B-CHEBI
.	O

Quantities	O
of	O
stria	O
vascularis	O
isolated	O
from	O
these	O
different	O
mice	O
were	O
similar	O
,	O
since	O
no	O
significant	O
differences	O
were	O
found	O
in	O
the	O
numbers	O
of	O
18S	O
rRNA	B-CHEBI
molecules	I-CHEBI
(	O
log	O
(	O
rRNA	B-CHEBI
)	O
=	O
9	O
.	O
46	O
+/-	O
0	O
.	O
08	O
,	O
n	O
=	O
17	O
,	O
pooled	O
data	O
)	O
.	O

In	O
contrast	O
,	O
quantities	O
of	O
spiral	O
ganglia	O
isolated	O
from	O
young	O
and	O
old	O
Slc26a4	O
-	O
/	O
-	O
mice	O
(	O
log	O
(	O
rRNA	B-CHEBI
)	O
=	O
9	O
.	O
04	O
+/-	O
0	O
.	O
18	O
,	O
n	O
=	O
4	O
and	O
9	O
.	O
29	O
+/-	O
0	O
.	O
15	O
,	O
n	O
=	O
6	O
)	O
were	O
significantly	O
smaller	O
than	O
in	O
Slc26a4	O
+	O
/	O
+	O
mice	O
(	O
log	O
(	O
rRNA	B-CHEBI
)	O
=	O
9	O
.	O
48	O
+/-	O
0	O
.	O
19	O
,	O
n	O
=	O
7	O
)	O
,	O
consistent	O
with	O
morphometric	O
data	O
(	O
see	O
below	O
)	O
.	O

Expression	O
of	O
KCNJ10	O
mRNA	B-CHEBI
was	O
normal	O
in	O
stria	O
vascularis	O
and	O
spiral	O
ganglia	O
of	O
young	O
Slc26a4	O
-	O
/	O
-	O
mice	O
but	O
significantly	O
reduced	O
in	O
old	O
Slc26a4	O
-	O
/	O
-	O
mice	O
(	O
Fig	O
.	O
3	O
)	O
.	O

Quantifications	O
of	O
KCNQ1	O
and	O
KCNQ4	O
mRNA	B-CHEBI
were	O
used	O
to	O
assess	O
possible	O
cross	O
-	O
contamination	O
between	O
the	O
stria	O
vascularis	O
and	O
spiral	O
ganglia	O
preparations	O
based	O
on	O
the	O
assumptions	O
that	O
(	O
1	O
)	O
KCNQ1	O
is	O
expressed	O
in	O
cells	O
of	O
the	O
stria	O
vascularis	O
but	O
not	O
the	O
spiral	O
ganglia	O
preparation	O
and	O
(	O
2	O
)	O
KCNQ4	O
is	O
expressed	O
in	O
cells	O
of	O
the	O
spiral	O
ganglia	O
but	O
not	O
the	O
stria	O
vascularis	O
preparation	O
.	O

The	O
number	O
of	O
KCNQ1	O
mRNA	B-CHEBI
molecules	I-CHEBI
in	O
stria	O
vascularis	O
was	O
24	O
-	O
fold	O
greater	O
than	O
in	O
spiral	O
ganglia	O
,	O
and	O
the	O
number	O
of	O
KCNQ4	O
mRNA	B-CHEBI
molecules	I-CHEBI
in	O
spiral	O
ganglia	O
was	O
5	O
-	O
fold	O
greater	O
than	O
in	O
stria	O
vascularis	O
.	O

These	O
observations	O
validate	O
our	O
measurements	O
of	O
KCNJ10	O
and	O
KCNQ1	O
by	O
demonstrating	O
that	O
the	O
microdissected	O
preparations	O
of	O
stria	O
vascularis	O
and	O
spiral	O
ganglia	O
were	O
98	O
%	O
and	O
78	O
%	O
pure	O
,	O
respectively	O
.	O

Figure	O
3	O

Quantification	O
of	O
KCNJ10	O
and	O
KCNQ1	O
mRNA	B-CHEBI
expression	O
in	O
stria	O
vascularis	O
and	O
spiral	O
ganglia	O
of	O
Slc26a4	O
+	O
/	O
+	O
and	O
Slc26a4	O
-	O
/	O
-	O
mice	O
.	O

a	O
:	O
Electropherogram	O
of	O
total	O
RNA	O
isolated	O
from	O
stria	O
vascularis	O
microdissected	O
from	O
one	O
mouse	O
.	O

The	O
amount	O
of	O
total	O
RNA	O
was	O
obtained	O
from	O
the	O
total	O
integral	O
(	O
shaded	O
)	O
and	O
the	O
amount	O
of	O
18S	O
rRNA	B-CHEBI
was	O
obtained	O
from	O
the	O
integral	O
of	O
the	O
18S	O
peak	O
.	O

Sharp	O
peaks	O
representing	O
18S	O
and	O
28S	O
rRNA	B-CHEBI
demonstrate	O
the	O
high	O
quality	O
of	O
RNA	O
.	O

Insert	O
:	O
Genotype	O
of	O
Slc26a4	O
-	O
/	O
-	O
mice	O
was	O
verified	O
by	O
the	O
observation	O
of	O
one	O
or	O
few	O
very	O
large	O
rhomboedric	O
otoconia	O
in	O
the	O
utricular	O
macula	O
(	O
arrow	O
)	O
.	O

A	O
,	O
crista	O
ampullaris	O
;	O
U	O
,	O
utricular	O
macula	O
.	O

Scale	O
bar	O
:	O
100	O
mu	O
m	O
.	O

b	O
:	O
Example	O
of	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
data	O
used	O
for	O
quantification	O
of	O
18S	O
,	O
KCNJ10	O
,	O
KCNQ1	O
and	O
KCNQ4	O
.	O

Known	O
quantities	O
of	O
18S	O
rRNA	B-CHEBI
were	O
used	O
to	O
calibrate	O
the	O
threshold	O
.	O

SV	O
,	O
stria	O
vascularis	O
;	O
SG	O
,	O
spiral	O
ganglia	O
.	O

c	O
:	O
Quantification	O
of	O
KCNJ10	O
and	O
KCNQ1	O
mRNA	B-CHEBI
in	O
young	O
Slc26a4	O
+	O
/	O
+	O
and	O
young	O
and	O
old	O
Slc26a4	O
-	O
/	O
-	O
mice	O
.	O

The	O
presence	O
of	O
KCNJ10	O
mRNA	B-CHEBI
in	O
stria	O
vascularis	O
of	O
Slc26a4	O
-	O
/	O
-	O
mice	O
supports	O
the	O
finding	O
that	O
intermediate	O
cells	O
are	O
present	O
.	O

Expression	O
of	O
the	O
KCNJ10	O
protein	B-CHEBI
was	O
assessed	O
in	O
young	O
Slc26a4	O
-	O
/	O
-	O
mice	O
by	O
confocal	O
immunocytochemistry	O
.	O

Interestingly	O
,	O
expression	O
of	O
the	O
KCNJ10	O
protein	B-CHEBI
was	O
absent	O
in	O
stria	O
vascularis	O
but	O
normal	O
in	O
spiral	O
ganglia	O
(	O
Fig	O
.	O
4	O
)	O
.	O

The	O
absence	O
of	O
the	O
KCNJ10	O
K	B-CHEBI
+	I-CHEBI
channel	O
in	O
stria	O
vascularis	O
is	O
sufficient	O
to	O
explain	O
the	O
loss	O
of	O
the	O
endocochlear	O
potential	O
[	O
17	O
]	O
.	O

Figure	O
4	O

Protein	B-CHEBI
localization	O
of	O
KCNJ10	O
in	O
the	O
cochlea	O
of	O
Slc26a4	O
+	O
/	O
+	O
and	O
Slc26a4	O
-	O
/	O
-	O
mice	O
.	O

a	O
:	O
Overview	O
of	O
cochlea	O
;	O
bar	O
=	O
100	O
mu	O
m	O
.	O

Compare	O
to	O
Fig	O
.	O

1a	O
to	O
note	O
the	O
enlarged	O
scala	O
media	O
and	O
the	O
distended	O
Reissner	O
'	O
s	O
membrane	O
.	O

b	O
-	O
c	O
:	O
Detail	O
of	O
lateral	O
wall	O
and	O
spiral	O
ganglia	O
(	O
insert	O
)	O
;	O
main	O
bar	O
:	O
10	O
mu	O
m	O
,	O
insert	O
:	O
5	O
mu	O
m	O
.	O

Expression	O
of	O
KCNJ10	O
in	O
Slc26a4	O
-	O
/	O
-	O
mice	O
was	O
absent	O
in	O
stria	O
vascularis	O
but	O
unchanged	O
in	O
spiral	O
ganglion	O
cells	O
.	O

RM	O
,	O
Reissner	O
'	O
s	O
membrane	O
,	O
SV	O
,	O
stria	O
vascularis	O
;	O
SP	O
,	O
spiral	O
prominence	O
;	O
SL	O
,	O
spiral	O
ligament	O
;	O
LIM	O
,	O
spiral	O
limbus	O
;	O
SG	O
,	O
spiral	O
ganglion	O
.	O

Histological	O
evaluation	O
of	O
cryosections	O
revealed	O
an	O
enlargement	O
of	O
scala	O
media	O
with	O
a	O
large	O
bulging	O
of	O
Reissner	O
'	O
s	O
membrane	O
and	O
an	O
apparent	O
degeneration	O
of	O
the	O
organ	O
of	O
Corti	O
,	O
as	O
described	O
earlier	O
[	O
14	O
]	O
.	O

Tissue	O
height	O
of	O
stria	O
vascularis	O
was	O
normal	O
(	O
Fig	O
.	O
5	O
)	O
,	O
consistent	O
with	O
the	O
similar	O
numbers	O
of	O
18S	O
rRNA	B-CHEBI
molecules	I-CHEBI
in	O
isolated	O
preparations	O
(	O
see	O
above	O
)	O
.	O

The	O
absence	O
of	O
a	O
change	O
in	O
tissue	O
height	O
is	O
consistent	O
with	O
the	O
presence	O
of	O
intermediate	O
cells	O
[	O
28	O
]	O
.	O

Further	O
,	O
we	O
observed	O
an	O
apparent	O
loss	O
of	O
tissue	O
masses	O
in	O
areas	O
that	O
are	O
normally	O
occupied	O
primarily	O
by	O
type	O
I	O
and	O
II	O
fibrocytes	O
.	O

Spiral	O
prominence	O
in	O
Slc26a4	O
-	O
/	O
-	O
mice	O
was	O
less	O
prominent	O
,	O
spiral	O
ligament	O
thinner	O
and	O
spiral	O
limbus	O
flatter	O
(	O
Fig	O
.	O
5	O
)	O
.	O

The	O
observation	O
that	O
tissue	O
masses	O
were	O
lost	O
in	O
the	O
spiral	O
limbus	O
region	O
is	O
consistent	O
with	O
the	O
finding	O
of	O
a	O
reduced	O
number	O
of	O
18S	O
rRNA	B-CHEBI
molecules	I-CHEBI
in	O
the	O
spiral	O
ganglia	O
preparation	O
(	O
see	O
above	O
)	O
.	O

In	O
addition	O
,	O
we	O
observed	O
an	O
apparent	O
degeneration	O
of	O
stria	O
vascularis	O
,	O
including	O
an	O
increase	O
in	O
pigmentation	O
and	O
an	O
irregular	O
pattern	O
of	O
the	O
tight	O
junctions	O
of	O
marginal	O
cells	O
(	O
Fig	O
.	O
2c	O
,	O
6	O
,	O
7	O
)	O
.	O

Tight	O
junctions	O
were	O
visualized	O
by	O
F	O
-	O
actin	O
expression	O
.	O

Marginal	O
cells	O
appeared	O
to	O
form	O
a	O
continuous	O
layer	O
.	O

Figure	O
5	O

Morphometric	O
analysis	O
of	O
cochlear	O
tissue	O
masses	O
in	O
Slc26a4	O
+	O
/	O
+	O
and	O
Slc26a4	O
-	O
/	O
-	O
mice	O
.	O

a	O
:	O
locations	O
of	O
measurements	O
.	O

Thickness	O
of	O
stria	O
vascularis	O
(	O
SV	O
)	O
was	O
obtained	O
as	O
average	O
of	O
three	O
distance	O
measurements	O
perpendicular	O
to	O
the	O
surface	O
of	O
marginal	O
cells	O
.	O

Thickness	O
of	O
spiral	O
prominence	O
(	O
SP	O
)	O
was	O
measured	O
perpendicular	O
to	O
a	O
tangential	O
line	O
(	O
dashed	O
)	O
that	O
connects	O
the	O
surface	O
of	O
the	O
outer	O
sulcus	O
(	O
OS	O
)	O
with	O
the	O
basal	O
layer	O
of	O
stria	O
vascularis	O
.	O

Thickness	O
of	O
spiral	O
ligament	O
(	O
SL	O
)	O
was	O
measured	O
perpendicular	O
to	O
the	O
tangential	O
line	O
as	O
distance	O
between	O
the	O
surface	O
of	O
spiral	O
prominence	O
and	O
the	O
interface	O
between	O
spiral	O
ligament	O
and	O
bone	O
(	O
B	O
)	O
.	O

Thickness	O
of	O
spiral	O
limbus	O
(	O
LIM	O
)	O
was	O
obtained	O
perpendicular	O
to	O
the	O
surface	O
of	O
the	O
bone	O
as	O
a	O
tangential	O
line	O
that	O
touches	O
the	O
inner	O
sulcus	O
(	O
IS	O
)	O
and	O
reaches	O
from	O
the	O
surface	O
of	O
the	O
spiral	O
limbus	O
to	O
the	O
interface	O
between	O
spiral	O
limbus	O
connective	O
tissue	O
and	O
bone	O
.	O

b	O
:	O
Summary	O
.	O

Data	O
from	O
7	O
-	O
8	O
animals	O
contributed	O
to	O
each	O
column	O
.	O

Figure	O
6	O

Analysis	O
of	O
marginal	O
and	O
basal	O
cell	O
barriers	O
by	O
in	O
Slc26a4	O
-	O
/	O
-	O
mice	O
.	O

Tight	O
junctions	O
were	O
visualized	O
by	O
F	O
actin	O
.	O

Whole	O
-	O
mounts	O
of	O
stria	O
vascularis	O
were	O
viewed	O
either	O
from	O
the	O
basal	O
cell	O
side	O
(	O
a	O
-	O
f	O
)	O
or	O
from	O
the	O
marginal	O
cell	O
side	O
(	O
g	O
-	O
l	O
)	O
.	O

Bright	O
field	O
images	O
verify	O
that	O
the	O
same	O
area	O
was	O
viewed	O
from	O
either	O
side	O
(	O
b	O
and	O
h	O
)	O
.	O

Colored	O
bright	O
field	O
images	O
were	O
mixed	O
with	O
images	O
of	O
F	O
actin	O
staining	O
to	O
indicate	O
the	O
position	O
of	O
pigment	O
granules	O
(	O
d	O
,	O
j	O
,	O
f	O
and	O
l	O
)	O
.	O

Focus	O
was	O
varied	O
to	O
either	O
visualize	O
the	O
marginal	O
cell	O
barrier	O
(	O
SMC	O
,	O
c	O
-	O
d	O
and	O
i	O
-	O
j	O
)	O
or	O
the	O
basal	O
cell	O
barrier	O
(	O
BC	O
,	O
e	O
-	O
f	O
and	O
k	O
-	O
l	O
)	O
.	O

Both	O
the	O
marginal	O
cell	O
(	O
e	O
-	O
f	O
)	O
and	O
the	O
basal	O
cell	O
barrier	O
(	O
i	O
-	O
f	O
)	O
appeared	O
to	O
be	O
intact	O
.	O

It	O
was	O
critical	O
for	O
this	O
finding	O
that	O
pigmentation	O
did	O
not	O
block	O
the	O
path	O
of	O
the	O
laser	O
.	O

Blockage	O
of	O
the	O
laser	O
by	O
pigmentation	O
produces	O
the	O
untrue	O
impression	O
of	O
a	O
discontinuous	O
marginal	O
cell	O
barrier	O
(	O
c	O
-	O
d	O
)	O
or	O
basal	O
cell	O
barrier	O
(	O
k	O
-	O
l	O
)	O
.	O

Comparison	O
of	O
images	O
is	O
aided	O
by	O
marking	O
a	O
significant	O
area	O
with	O
a	O
star	O
.	O

Bars	O
=	O
10	O
mu	O
m	O
.	O

Figure	O
7	O

Analysis	O
of	O
marginal	O
and	O
basal	O
cell	O
barriers	O
in	O
Slc26a4	O
+	O
/	O
+	O
and	O
Slc26a4	O
-	O
/	O
-	O
mice	O
.	O

Tight	O
junctions	O
were	O
visualized	O
by	O
F	O
actin	O
in	O
whole	O
-	O
mounts	O
of	O
stria	O
vascularis	O
.	O

Bright	O
field	O
images	O
were	O
taken	O
to	O
evaluate	O
pigmentation	O
(	O
a	O
,	O
d	O
and	O
g	O
)	O
.	O

Note	O
the	O
intact	O
marginal	O
cell	O
(	O
b	O
)	O
and	O
basal	O
cell	O
(	O
c	O
)	O
barriers	O
in	O
Slc26a4	O
+	O
/	O
+	O
mice	O
.	O

Minimal	O
pigmentation	O
of	O
Slc26a4	O
+	O
/	O
+	O
mice	O
did	O
not	O
compromise	O
F	O
actin	O
localization	O
.	O

Whole	O
-	O
mounts	O
of	O
stria	O
vascularis	O
from	O
Slc26a4	O
-	O
/	O
-	O
mice	O
were	O
viewed	O
either	O
from	O
the	O
basal	O
cell	O
side	O
(	O
e	O
-	O
f	O
)	O
or	O
from	O
the	O
marginal	O
cell	O
side	O
(	O
h	O
-	O
i	O
)	O
.	O

Bright	O
field	O
images	O
verify	O
that	O
the	O
same	O
area	O
was	O
viewed	O
from	O
either	O
side	O
(	O
d	O
and	O
g	O
)	O
.	O

Focus	O
was	O
varied	O
to	O
either	O
visualize	O
the	O
marginal	O
cell	O
barrier	O
(	O
SMC	O
,	O
b	O
,	O
e	O
and	O
h	O
)	O
or	O
the	O
basal	O
cell	O
barrier	O
(	O
BC	O
,	O
c	O
,	O
f	O
and	O
i	O
)	O
.	O

Both	O
the	O
basal	O
cell	O
(	O
f	O
)	O
and	O
the	O
marginal	O
cell	O
(	O
h	O
)	O
barriers	O
appeared	O
to	O
be	O
intact	O
.	O

Blockage	O
of	O
the	O
laser	O
by	O
pigmentation	O
produces	O
the	O
untrue	O
impression	O
of	O
'	O
holes	O
'	O
in	O
the	O
marginal	O
cell	O
barrier	O
(	O
e	O
)	O
or	O
basal	O
cell	O
barrier	O
(	O
i	O
)	O
.	O

Comparison	O
of	O
images	O
is	O
aided	O
by	O
marking	O
three	O
significant	O
areas	O
with	O
colored	O
stars	O
.	O

Bars	O
=	O
10	O
mu	O
m	O
.	O

Pendrin	O
-	O
expressing	O
surface	O
epithelial	O
cells	O
in	O
the	O
spiral	O
prominence	O
region	O
are	O
located	O
in	O
an	O
area	O
where	O
basal	O
cells	O
,	O
which	O
are	O
interconnected	O
by	O
tight	O
junctions	O
,	O
form	O
additional	O
tight	O
junctions	O
with	O
surface	O
epithelial	O
cells	O
[	O
29	O
]	O
.	O

A	O
discontinuity	O
of	O
this	O
complex	O
junction	O
in	O
Slc26a4	O
-	O
/	O
-	O
mice	O
would	O
explain	O
the	O
absence	O
of	O
the	O
endocochlear	O
potential	O
.	O

To	O
evaluate	O
the	O
presence	O
of	O
this	O
connection	O
,	O
we	O
determined	O
by	O
confocal	O
immunocytochemistry	O
the	O
expression	O
of	O
ZO	O
-	O
1	O
and	O
of	O
F	O
-	O
actin	O
,	O
which	O
associate	O
with	O
tight	O
junction	O
complexes	O
.	O

ZO	O
-	O
1	O
and	O
F	O
-	O
actin	O
expression	O
revealed	O
a	O
continuous	O
layer	O
of	O
basal	O
cells	O
,	O
including	O
a	O
junction	O
of	O
basal	O
cells	O
with	O
surface	O
epithelial	O
cells	O
in	O
Slc26a4	O
-	O
/	O
-	O
mice	O
,	O
as	O
observed	O
in	O
normal	O
mice	O
(	O
Fig	O
.	O
1c	O
,	O
1d	O
,	O
1e	O
,	O
1f	O
,	O
6	O
,	O
7	O
)	O
.	O

These	O
observations	O
make	O
it	O
unlikely	O
that	O
the	O
primary	O
cause	O
of	O
the	O
loss	O
of	O
the	O
endocochlear	O
potential	O
is	O
a	O
compromise	O
in	O
the	O
basal	O
cell	O
barrier	O
.	O

The	O
observation	O
that	O
endolymphatic	O
and	O
perilymphatic	O
K	B-CHEBI
+	I-CHEBI
concentrations	O
were	O
normal	O
in	O
Slc26a4	O
-	O
/	O
-	O
mice	O
suggests	O
that	O
stria	O
vascularis	O
was	O
able	O
to	O
secrete	O
K	B-CHEBI
+	I-CHEBI
in	O
spite	O
of	O
the	O
apparent	O
signs	O
of	O
degeneration	O
.	O

The	O
rate	O
of	O
K	B-CHEBI
+	I-CHEBI
secretion	O
necessary	O
to	O
maintain	O
endolymphatic	O
K	B-CHEBI
+	I-CHEBI
concentration	O
,	O
however	O
,	O
may	O
be	O
less	O
than	O
necessary	O
in	O
Slc26a4	O
+	O
/	O
+	O
mice	O
given	O
the	O
reduced	O
numbers	O
of	O
sensory	O
hair	O
cells	O
,	O
which	O
provide	O
a	O
major	O
pathway	O
for	O
K	B-CHEBI
+	I-CHEBI
exit	O
from	O
endolymph	O
[	O
30	O
,	O
31	O
]	O
.	O

In	O
order	O
to	O
substantiate	O
the	O
view	O
that	O
stria	O
vascularis	O
in	O
Slc26a4	O
-	O
/	O
-	O
secretes	O
K	B-CHEBI
+	I-CHEBI
,	O
we	O
measured	O
the	O
magnitude	O
of	O
the	O
bumetanide	O
-	O
sensitive	O
current	O
exiting	O
stria	O
vascularis	O
across	O
the	O
apical	O
membrane	O
of	O
strial	O
marginal	O
cells	O
and	O
determined	O
the	O
expression	O
of	O
the	O
proteins	B-CHEBI
KCNQ1	O
,	O
KCNE1	O
and	O
SLC12A2	O
,	O
which	O
are	O
essential	O
for	O
K	B-CHEBI
+	I-CHEBI
secretion	O
[	O
20	O
,	O
32	O
,	O
33	O
]	O
,	O
and	O
of	O
GJB2	O
(	O
Cx26	O
)	O
,	O
which	O
is	O
thought	O
to	O
contribute	O
to	O
K	B-CHEBI
+	I-CHEBI
cycling	O
[	O
23	O
]	O
.	O

K	B-CHEBI
+	I-CHEBI
secretion	O
is	O
known	O
to	O
be	O
sensitive	O
to	O
10	O
-	O
5	O
M	O
bumetanide	O
,	O
a	O
loop	O
-	O
diuretic	B-CHEBI
that	O
inhibits	O
the	O
Na	B-CHEBI
+	I-CHEBI
/	O
2Cl	O
-	O
/	O
K	B-CHEBI
+	I-CHEBI
cotransporter	O
SLC12A2	O
[	O
26	O
]	O
.	O

Bumetanide	O
-	O
sensitive	O
currents	O
were	O
found	O
in	O
both	O
Slc26a4	O
+	O
/	O
+	O
and	O
Slc26a4	O
-	O
/	O
-	O
mice	O
although	O
the	O
magnitude	O
of	O
the	O
current	O
was	O
significantly	O
smaller	O
in	O
Slc26a4	O
-	O
/	O
-	O
mice	O
(	O
22	O
+/-	O
6	O
mu	O
A	O
/	O
cm2	O
,	O
n	O
=	O
4	O
versus	O
14	O
+/-	O
2	O
mu	O
A	O
/	O
cm2	O
,	O
n	O
=	O
4	O
)	O
.	O

KCNQ1	O
and	O
KCNE1	O
,	O
subunits	O
of	O
the	O
secretory	O
K	B-CHEBI
+	I-CHEBI
channel	O
,	O
were	O
co	O
-	O
localized	O
in	O
the	O
apical	O
membrane	O
of	O
strial	O
marginal	O
cells	O
;	O
the	O
Na	B-CHEBI
+	I-CHEBI
/	O
2Cl	O
-	O
/	O
K	B-CHEBI
+	I-CHEBI
cotransporter	O
SLC12A2	O
,	O
which	O
is	O
located	O
in	O
the	O
basolateral	O
membrane	O
of	O
strial	O
marginal	O
cells	O
,	O
was	O
found	O
in	O
stria	O
vascularis	O
;	O
and	O
the	O
gap	O
junction	O
protein	B-CHEBI
GJB2	O
was	O
found	O
in	O
spiral	O
ligament	O
of	O
Slc26a4	O
+	O
/	O
+	O
and	O
Slc26a4	O
-	O
/	O
-	O
mice	O
(	O
Fig	O
.	O
8	O
)	O
.	O

Co	O
-	O
localization	O
of	O
KCNQ1	O
and	O
KCNE1	O
proteins	B-CHEBI
was	O
also	O
observed	O
in	O
vestibular	O
dark	O
cells	O
(	O
Fig	O
.	O
1i	O
)	O
.	O

Expression	O
of	O
KCNQ1	O
protein	B-CHEBI
in	O
stria	O
vascularis	O
of	O
Slc26a4	O
-	O
/	O
-	O
mice	O
is	O
consistent	O
with	O
the	O
finding	O
of	O
KCNQ1	O
mRNA	B-CHEBI
expression	O
(	O
Fig	O
.	O
3	O
)	O
.	O

These	O
observations	O
make	O
it	O
unlikely	O
that	O
the	O
primary	O
cause	O
of	O
the	O
loss	O
of	O
the	O
endocochlear	O
potential	O
is	O
a	O
compromise	O
of	O
K	B-CHEBI
+	I-CHEBI
secretion	O
by	O
strial	O
marginal	O
cells	O
or	O
a	O
compromise	O
of	O
gap	O
junction	O
mediated	O
K	B-CHEBI
+	I-CHEBI
cycling	O
.	O

Figure	O
8	O

Protein	B-CHEBI
localization	O
of	O
KCNQ1	O
,	O
KCNE1	O
,	O
SLC12A2	O
and	O
GJB2	O
in	O
the	O
cochlear	O
lateral	O
wall	O
of	O
Slc26a4	O
+	O
/	O
+	O
and	O
Slc26a4	O
-	O
/	O
-	O
mice	O
.	O

a	O
-	O
f	O
:	O
bars	O
:	O
10	O
mu	O
m	O
.	O

SMC	O
,	O
strial	O
marginal	O
cells	O
;	O
SV	O
,	O
stria	O
vascularis	O
;	O
BC	O
,	O
basal	O
cells	O
;	O
SL	O
,	O
spiral	O
ligament	O
.	O

Conclusions	O

We	O
described	O
locations	O
of	O
pendrin	O
expression	O
in	O
the	O
cochlea	O
and	O
vestibular	O
labyrinth	O
and	O
detected	O
normal	O
endolymphatic	O
K	B-CHEBI
+	I-CHEBI
concentrations	O
in	O
spite	O
of	O
an	O
enlargement	O
of	O
this	O
fluid	O
compartment	O
.	O

We	O
found	O
that	O
Slc26a4	O
-	O
/	O
-	O
mice	O
lack	O
the	O
endocochlear	O
potential	O
because	O
they	O
do	O
not	O
express	O
KCNJ10	O
protein	B-CHEBI
.	O

Intermediate	O
cells	O
protect	O
stria	O
vascularis	O
by	O
converting	O
CO2	B-CHEBI
to	O
HCO3	B-CHEBI
-	I-CHEBI
and	O
by	O
detoxifying	O
free	B-CHEBI
radicals	I-CHEBI
(	O
Fig	O
.	O
9	O
)	O
.	O

CO2	B-CHEBI
and	O
free	B-CHEBI
radicals	I-CHEBI
are	O
generated	O
by	O
the	O
large	O
numbers	O
of	O
mitochondria	O
in	O
the	O
metabolically	O
highly	O
active	O
strial	O
marginal	O
cells	O
.	O

Intermediate	O
cells	O
employ	O
carbonic	B-CHEBI
anhydrase	O
to	O
convert	O
CO2	B-CHEBI
to	O
HCO3	B-CHEBI
-	I-CHEBI
[	O
18	O
,	O
19	O
]	O
and	O
catalase	O
to	O
detoxify	O
free	B-CHEBI
radicals	I-CHEBI
.	O

To	O
protect	O
themselves	O
from	O
free	B-CHEBI
radical	I-CHEBI
damage	O
,	O
intermediate	O
cells	O
generate	O
glutathione	B-CHEBI
and	O
melanin	B-CHEBI
pigment	I-CHEBI
[	O
34	O
-	O
37	O
]	O
.	O

It	O
is	O
conceivable	O
that	O
loss	O
of	O
pendrin	O
,	O
which	O
may	O
secrete	O
HCO3	B-CHEBI
-	I-CHEBI
into	O
endolymph	O
,	O
results	O
in	O
an	O
accumulation	O
of	O
HCO3	B-CHEBI
-	I-CHEBI
and	O
an	O
alkalinization	O
of	O
the	O
intrastrial	O
spaces	O
.	O

This	O
extracellular	O
alkalinization	O
may	O
enhance	O
free	B-CHEBI
radical	I-CHEBI
stress	O
,	O
since	O
it	O
may	O
inhibit	O
the	O
uptake	O
of	O
cysteine	B-CHEBI
and	O
thereby	O
limit	O
production	O
of	O
the	O
protective	O
glutathione	B-CHEBI
[	O
38	O
]	O
.	O

Support	O
for	O
the	O
hypothesis	O
of	O
enhanced	O
free	B-CHEBI
radical	I-CHEBI
stress	O
comes	O
from	O
the	O
observed	O
hyperpigmentation	O
in	O
mice	O
lacking	O
pendrin	O
.	O

Strial	O
hyperpigmentation	O
has	O
also	O
been	O
observed	O
in	O
other	O
conditions	O
that	O
are	O
associated	O
with	O
free	B-CHEBI
radical	I-CHEBI
stress	O
,	O
such	O
as	O
acoustic	O
trauma	O
[	O
37	O
]	O
.	O

Alterations	O
in	O
the	O
cytosolic	O
pH	O
in	O
conjunction	O
with	O
free	B-CHEBI
radical	I-CHEBI
stress	O
may	O
lead	O
to	O
the	O
loss	O
of	O
KCNJ10	O
protein	B-CHEBI
expression	O
in	O
strial	O
intermediate	O
cells	O
.	O

Function	O
and	O
expression	O
of	O
other	O
K	B-CHEBI
+	I-CHEBI
channels	O
has	O
been	O
shown	O
to	O
be	O
controlled	O
by	O
the	O
cytosolic	O
pH	O
and	O
free	B-CHEBI
radicals	I-CHEBI
,	O
which	O
encode	O
the	O
metabolic	O
state	O
of	O
the	O
cell	O
[	O
39	O
]	O
.	O

Suppression	O
of	O
the	O
KCNJ10	O
K	B-CHEBI
+	I-CHEBI
channel	O
in	O
strial	O
intermediate	O
cells	O
,	O
which	O
is	O
essential	O
for	O
the	O
generation	O
of	O
the	O
endocochlear	O
potential	O
,	O
is	O
probably	O
the	O
direct	O
cause	O
of	O
deafness	O
in	O
Slc26a4	O
-	O
/	O
-	O
mice	O
and	O
patients	O
suffering	O
from	O
Pendred	O
syndrome	O
.	O

Figure	O
9	O

Model	O
for	O
the	O
loss	O
of	O
KCNJ10	O
in	O
the	O
absence	O
of	O
pendrin	O
expression	O
in	O
stria	O
vascularis	O
.	O

Cys	B-CHEBI
,	O
cysteine	B-CHEBI
,	O
Glu	B-CHEBI
,	O
glutamate	B-CHEBI
,	O
Gly	B-CHEBI
,	O
glycine	B-CHEBI
,	O
CA	O
,	O
carbonic	B-CHEBI
anhydrase	O
,	O
GST	O
,	O
glutathione	B-CHEBI
-	O
S	B-CHEBI
-	O
transferase	O
,	O
GSH	B-CHEBI
,	O
glutathione	B-CHEBI
.	O

Competing	O
interests	O

None	O
declared	O
.	O

Authors	O
'	O
contributions	O

PW	O
designed	O
and	O
coordinated	O
the	O
immunocytochemical	O
,	O
morphometrical	O
and	O
molecular	B-CHEBI
biological	O
experiments	O
.	O

EMI	O
and	O
BA	O
carried	O
out	O
confocal	O
immunocytochemistry	O
on	O
cryosections	O
.	O

SJ	O
and	O
SVJ	O
carried	O
out	O
confocal	O
microscopy	O
on	O
whole	O
-	O
mounts	O
of	O
stria	O
vascularis	O
.	O

SVJ	O
and	O
RJM	O
carried	O
out	O
quantitative	O
RT	O
-	O
PCR	O
.	O

DCM	O
designed	O
and	O
coordinated	O
electrophysiological	O
experiments	O
.	O

TW	O
carried	O
out	O
measurements	O
of	O
the	O
endocochlear	O
potential	O
and	O
the	O
endolymphatic	O
K	B-CHEBI
+	I-CHEBI
concentration	O
.	O

JHL	O
carried	O
out	O
current	O
measurements	O
on	O
strial	O
marginal	O
cells	O
.	O

SMW	O
,	O
LAE	O
,	O
IER	O
and	O
EDG	O
provided	O
the	O
mice	O
and	O
the	O
pendrin	O
-	O
specific	O
antibody	O
.	O

PW	O
and	O
DCM	O
conceived	O
the	O
study	O
.	O

PW	O
wrote	O
the	O
manuscript	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Pre	O
-	O
publication	O
history	O

The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O

Acknowledgements	O

This	O
work	O
was	O
supported	O
by	O
NIH	O
-	O
R01	O
-	O
DC01098	O
(	O
PW	O
)	O
,	O
NIH	O
-	O
R01	O
-	O
DC00212	O
(	O
DCM	O
)	O
,	O
NIH	O
-	O
R01	O
-	O
DK52935	O
(	O
SMW	O
)	O
and	O
Core	O
facilities	O
funded	O
by	O
NIH	O
-	O
P20	O
-	O
RR017686	O
(	O
Confocal	O
Microfluorometry	O
and	O
Microscopy	O
Core	O
,	O
Molecular	B-CHEBI
Biology	O
Core	O
)	O
are	O
gratefully	O
acknowledged	O
.	O

Regulation	O
of	O
Muscle	O
Fiber	O
Type	O
and	O
Running	O
Endurance	O
by	O
PPAR	O
delta	O

Abstract	O

Endurance	O
exercise	O
training	O
can	O
promote	O
an	O
adaptive	O
muscle	O
fiber	O
transformation	O
and	O
an	O
increase	O
of	O
mitochondrial	O
biogenesis	O
by	O
triggering	O
scripted	O
changes	O
in	O
gene	O
expression	O
.	O

However	O
,	O
no	O
transcription	O
factor	O
has	O
yet	O
been	O
identified	O
that	O
can	O
direct	O
this	O
process	O
.	O

We	O
describe	O
the	O
engineering	O
of	O
a	O
mouse	O
capable	O
of	O
continuous	O
running	O
of	O
up	O
to	O
twice	O
the	O
distance	O
of	O
a	O
wild	O
-	O
type	O
littermate	O
.	O

This	O
was	O
achieved	O
by	O
targeted	O
expression	O
of	O
an	O
activated	O
form	O
of	O
peroxisome	O
proliferator	O
-	O
activated	O
receptor	O
delta	O
(	O
PPAR	O
delta	O
)	O
in	O
skeletal	O
muscle	O
,	O
which	O
induces	O
a	O
switch	O
to	O
form	O
increased	O
numbers	O
of	O
type	O
I	O
muscle	O
fibers	O
.	O

Treatment	O
of	O
wild	O
-	O
type	O
mice	O
with	O
PPAR	O
delta	O
agonist	B-CHEBI
elicits	O
a	O
similar	O
type	O
I	O
fiber	O
gene	O
expression	O
profile	O
in	O
muscle	O
.	O

Moreover	O
,	O
these	O
genetically	O
generated	O
fibers	O
confer	O
resistance	O
to	O
obesity	O
with	O
improved	O
metabolic	O
profiles	O
,	O
even	O
in	O
the	O
absence	O
of	O
exercise	O
.	O

These	O
results	O
demonstrate	O
that	O
complex	O
physiologic	O
properties	O
such	O
as	O
fatigue	O
,	O
endurance	O
,	O
and	O
running	O
capacity	O
can	O
be	O
molecularly	B-CHEBI
analyzed	O
and	O
manipulated	O
.	O

Introduction	O

Skeletal	O
muscle	O
fibers	O
are	O
generally	O
classified	O
as	O
type	O
I	O
(	O
oxidative	O
/	O
slow	O
)	O
or	O
type	O
II	O
(	O
glycolytic	O
/	O
fast	O
)	O
fibers	O
.	O

They	O
display	O
marked	O
differences	O
in	O
respect	O
to	O
contraction	O
,	O
metabolism	O
,	O
and	O
susceptibility	O
to	O
fatigue	O
.	O

Type	O
I	O
fibers	O
are	O
mitochondria	O
-	O
rich	O
and	O
mainly	O
use	O
oxidative	O
metabolism	O
for	O
energy	O
production	O
,	O
which	O
provides	O
a	O
stable	O
and	O
long	O
-	O
lasting	O
supply	O
of	O
ATP	B-CHEBI
,	O
and	O
thus	O
are	O
fatigue	O
-	O
resistant	O
.	O

Type	O
II	O
fibers	O
comprise	O
three	O
subtypes	O
,	O
IIa	O
,	O
IIx	O
,	O
and	O
IIb	O
.	O

Type	O
IIb	O
fibers	O
have	O
the	O
lowest	O
levels	O
of	O
mitochondrial	O
content	O
and	O
oxidative	O
enzymes	O
,	O
rely	O
on	O
glycolytic	O
metabolism	O
as	O
a	O
major	O
energy	O
source	O
,	O
and	O
are	O
susceptible	O
to	O
fatigue	O
,	O
while	O
the	O
oxidative	O
and	O
contraction	O
functions	O
of	O
type	O
IIa	O
and	O
IIx	O
lie	O
between	O
type	O
I	O
and	O
IIb	O
(	O
Booth	O
and	O
Thomason	O
1991	O
;	O
Berchtold	O
et	O
al	O
.	O
2000	O
;	O
Olson	O
and	O
Williams	O
2000	O
)	O
.	O

Adult	O
skeletal	O
muscle	O
shows	O
plasticity	O
and	O
can	O
undergo	O
conversion	O
between	O
different	O
fiber	O
types	O
in	O
response	O
to	O
exercise	O
training	O
or	O
modulation	O
of	O
motoneuron	O
activity	O
(	O
Booth	O
and	O
Thomason	O
1991	O
,	O
Jarvis	O
et	O
al	O
.	O
1996	O
;	O
Pette	O
1998	O
;	O
Olson	O
and	O
Williams	O
2000	O
;	O
Hood	O
2001	O
)	O
.	O

This	O
conversion	O
of	O
muscle	O
fiber	O
from	O
type	O
IIb	O
to	O
type	O
IIa	O
and	O
type	O
I	O
is	O
likely	O
to	O
be	O
mediated	O
by	O
a	O
calcium	B-CHEBI
signaling	O
pathway	O
that	O
involves	O
calcineurin	O
,	O
calmodulin	O
-	O
dependent	O
kinase	O
,	O
and	O
the	O
transcriptional	O
cofactor	O
Peroxisome	O
proliferator	O
-	O
activated	O
receptor	O
-	O
gamma	O
coactivator	O
1	O
alpha	O
(	O
PGC	O
-	O
1	O
alpha	O
)	O
(	O
Naya	O
et	O
al	O
.	O
2000	O
;	O
Olson	O
and	O
Williams	O
2000	O
;	O
Lin	O
et	O
al	O
.	O
2002	O
;	O
Wu	O
et	O
al	O
.	O
2002	O
)	O
.	O

However	O
,	O
the	O
targeted	O
transcriptional	O
factors	O
directly	O
responsible	O
for	O
reprogramming	O
the	O
fiber	O
-	O
specific	O
contractile	O
and	O
metabolic	O
genes	O
remain	O
to	O
be	O
identified	O
.	O

Muscle	O
fiber	O
specification	O
appears	O
to	O
be	O
associated	O
with	O
obesity	O
and	O
diabetes	O
.	O

For	O
instance	O
,	O
rodents	O
that	O
gain	O
the	O
most	O
weight	O
on	O
high	O
-	O
fat	O
diets	O
possess	O
fewer	O
type	O
I	O
fibers	O
(	O
Abou	O
et	O
al	O
.	O
1992	O
)	O
.	O

In	O
obese	O
patients	O
,	O
skeletal	O
muscle	O
has	O
been	O
observed	O
to	O
have	O
reduced	O
oxidative	O
capacity	O
,	O
increased	O
glycolytic	O
capacity	O
,	O
and	O
a	O
decreased	O
percentage	O
of	O
type	O
I	O
fibers	O
(	O
Hickey	O
et	O
al	O
.	O
1995	O
;	O
Tanner	O
et	O
al	O
.	O
2002	O
)	O
.	O

Similar	O
observations	O
have	O
been	O
made	O
in	O
type	O
2	O
diabetic	O
patients	O
(	O
Lillioja	O
et	O
al	O
.	O
1987	O
;	O
Hickey	O
et	O
al	O
.	O
1995	O
)	O
.	O

Recently	O
,	O
it	O
has	O
been	O
shown	O
that	O
increasing	O
oxidative	O
fibers	O
can	O
lead	O
to	O
improved	O
insulin	B-CHEBI
action	O
and	O
reduced	O
adipocyte	O
size	O
(	O
Luquet	O
et	O
al	O
.	O
2003	O
;	O
Ryder	O
et	O
al	O
.	O
2003	O
)	O
.	O

We	O
have	O
previously	O
established	O
that	O
peroxisome	O
proliferator	O
-	O
activated	O
receptor	O
(	O
PPAR	O
)	O
delta	O
is	O
a	O
major	O
transcriptional	O
regulator	O
of	O
fat	O
burning	O
in	O
adipose	O
tissue	O
through	O
activation	O
of	O
enzymes	O
associated	O
with	O
long	B-CHEBI
-	I-CHEBI
chain	I-CHEBI
fatty	I-CHEBI
-	I-CHEBI
acid	I-CHEBI
beta	O
-	O
oxidation	O
(	O
Wang	O
et	O
al	O
.	O
2003	O
)	O
.	O

Although	O
PPAR	O
delta	O
is	O
the	O
predominant	O
PPAR	O
isoform	O
present	O
in	O
skeletal	O
muscle	O
,	O
its	O
in	O
vivo	O
function	O
has	O
not	O
been	O
determined	O
.	O

Our	O
current	O
study	O
uncovers	O
PPAR	O
delta	O
as	O
the	O
first	O
transcription	O
factor	O
able	O
to	O
drive	O
the	O
formation	O
of	O
functional	O
type	O
I	O
muscle	O
fibers	O
,	O
whose	O
activation	O
entrains	O
complex	O
pathways	O
both	O
enhancing	O
physical	O
performance	O
and	O
creating	O
a	O
state	O
of	O
obesity	O
resistance	O
.	O

Results	O

Activation	O
of	O
PPAR	O
delta	O
Leads	O
to	O
Muscle	O
Fiber	O
Transformation	O

A	O
role	O
of	O
PPAR	O
delta	O
in	O
muscle	O
fiber	O
was	O
suggested	O
by	O
its	O
enhanced	O
expression	O
--	O
at	O
levels	O
10	O
-	O
fold	O
and	O
50	O
-	O
fold	O
greater	O
than	O
PPAR	O
alpha	O
and	O
gamma	O
isoforms	O
,	O
respectively	O
(	O
unpublished	O
data	O
)	O
.	O

An	O
examination	O
of	O
PPAR	O
delta	O
in	O
different	O
muscle	O
fibers	O
reveals	O
a	O
significantly	O
higher	O
level	O
in	O
type	O
I	O
muscle	O
(	O
soleus	O
)	O
relative	O
to	O
type	O
II	O
-	O
rich	O
muscle	O
(	O
extensor	O
digitorum	O
longus	O
)	O
or	O
type	O
I	O
and	O
type	O
II	O
mixed	O
muscle	O
(	O
gastrocnemius	O
)	O
(	O
Figure	O
1A	O
)	O
;	O
this	O
expression	O
pattern	O
closely	O
resembles	O
that	O
of	O
PGC	O
-	O
1	O
alpha	O
(	O
Lin	O
et	O
al	O
.	O
2002	O
)	O
.	O

A	O
similar	O
pattern	O
but	O
with	O
more	O
pronounced	O
differences	O
was	O
found	O
at	O
the	O
protein	B-CHEBI
level	O
(	O
Figure	O
1B	O
)	O
.	O

To	O
directly	O
assess	O
the	O
role	O
of	O
activation	O
of	O
PPAR	O
delta	O
in	O
control	O
of	O
muscle	O
fiber	O
plasticity	O
and	O
mitochondrial	O
biogenesis	O
,	O
we	O
generated	O
mice	O
expressing	O
a	O
transgene	O
in	O
which	O
the	O
78	O
-	O
amino	B-CHEBI
-	I-CHEBI
acid	I-CHEBI
VP16	O
activation	O
domain	O
was	O
fused	O
to	O
the	O
N	B-CHEBI
-	O
terminus	O
of	O
full	O
-	O
length	O
PPAR	O
delta	O
,	O
under	O
control	O
of	O
the	O
2	O
.	O
2	O
-	O
kb	O
human	O
alpha	O
-	O
skeletal	O
actin	O
promoter	O
.	O

In	O
agreement	O
with	O
the	O
previous	O
characterization	O
of	O
this	O
promoter	O
(	O
Brennan	O
and	O
Hardeman	O
1993	O
;	O
Clapham	O
et	O
al	O
.	O
2000	O
)	O
,	O
the	O
VP16	O
-	O
PPAR	O
delta	O
transgene	O
was	O
selectively	O
expressed	O
in	O
skeletal	O
muscle	O
,	O
with	O
10	O
-	O
fold	O
less	O
in	O
the	O
heart	O
(	O
Figure	O
1C	O
)	O
.	O

Among	O
different	O
types	O
of	O
muscle	O
fibers	O
,	O
the	O
levels	O
of	O
VP16	O
-	O
PPAR	O
delta	O
expression	O
appeared	O
to	O
be	O
similar	O
(	O
unpublished	O
data	O
)	O
.	O

As	O
shown	O
in	O
Figure	O
1D	O
for	O
gastrocnemius	O
muscle	O
,	O
VP16	O
-	O
PPAR	O
delta	O
fusion	O
protein	B-CHEBI
was	O
produced	O
at	O
a	O
level	O
similar	O
to	O
that	O
of	O
endogenous	O
PPAR	O
delta	O
in	O
wild	O
-	O
type	O
littermates	O
.	O

Interestingly	O
,	O
the	O
level	O
of	O
endogenous	O
muscle	O
PPAR	O
delta	O
protein	B-CHEBI
in	O
the	O
transgenic	O
mice	O
was	O
much	O
higher	O
than	O
in	O
the	O
control	O
littermates	O
.	O

The	O
substantial	O
increase	O
of	O
endogenous	O
PPAR	O
delta	O
may	O
have	O
been	O
caused	O
by	O
a	O
switch	O
to	O
type	O
I	O
fiber	O
(	O
see	O
below	O
)	O
,	O
which	O
intrinsically	O
expresses	O
higher	O
levels	O
of	O
PPAR	O
delta	O
(	O
Figure	O
1A	O
and	O
1B	O
)	O
.	O

Type	O
I	O
muscle	O
can	O
be	O
readily	O
distinguished	O
from	O
type	O
II	O
or	O
mixed	O
muscle	O
by	O
its	O
red	O
color	O
,	O
because	O
of	O
its	O
high	O
concentration	O
of	O
myoglobin	B-CHEBI
,	O
a	O
protein	B-CHEBI
typically	O
expressed	O
in	O
oxidative	O
muscle	O
fibers	O
.	O

We	O
found	O
that	O
muscles	O
in	O
the	O
transgenic	O
mice	O
appeared	O
redder	O
(	O
Figure	O
2A	O
)	O
,	O
which	O
is	O
particularly	O
evident	O
in	O
the	O
mixed	O
type	O
I	O
/	O
II	O
fibers	O
of	O
the	O
hindlimb	O
(	O
Figure	O
2B	O
)	O
.	O

Indeed	O
,	O
metachromatic	O
staining	O
revealed	O
a	O
substantial	O
muscle	O
fiber	O
transformation	O
(	O
Figure	O
2C	O
)	O
.	O

In	O
gastrocnemius	O
muscle	O
,	O
we	O
estimated	O
that	O
there	O
was	O
a	O
2	O
-	O
fold	O
increase	O
of	O
type	O
I	O
fibers	O
.	O

A	O
diagnostic	O
component	O
of	O
oxidative	O
fibers	O
is	O
their	O
high	O
myoglobin	B-CHEBI
and	O
mitochondrial	O
content	O
,	O
which	O
is	O
supported	O
by	O
the	O
mRNA	B-CHEBI
analysis	O
shown	O
in	O
Figure	O
3A	O
.	O

In	O
addition	O
to	O
myoglobin	B-CHEBI
,	O
mitochondrial	O
components	O
for	O
electron	B-CHEBI
transfer	O
(	O
cytochrome	B-CHEBI
c	I-CHEBI
and	O
cytochrome	B-CHEBI
c	I-CHEBI
oxidase	O
[	O
COX	O
]	O
II	O
and	O
IV	O
)	O
and	O
fatty	B-CHEBI
-	I-CHEBI
acid	I-CHEBI
beta	O
-	O
oxidation	O
enzymes	O
were	O
elevated	O
(	O
Figure	O
3A	O
;	O
unpublished	O
data	O
)	O
.	O

These	O
effects	O
appear	O
to	O
be	O
direct	O
consequences	O
of	O
PPAR	O
delta	O
activation	O
,	O
as	O
levels	O
of	O
PGC	O
-	O
1	O
alpha	O
,	O
a	O
coactivator	O
involved	O
in	O
muscle	O
fiber	O
switch	O
and	O
mitochondrial	O
biogenesis	O
(	O
Wu	O
et	O
al	O
.	O
1999	O
;	O
Lehman	O
et	O
al	O
.	O
2000	O
;	O
Lin	O
et	O
al	O
.	O
2002	O
)	O
,	O
remained	O
unchanged	O
.	O

Southern	O
blot	O
analysis	O
detected	O
a	O
substantially	O
higher	O
copy	O
number	O
of	O
the	O
mitochondrial	O
genome	O
-	O
encoded	O
COXII	O
DNA	O
in	O
the	O
transgenic	O
mice	O
(	O
Figure	O
3B	O
)	O
.	O

Mitochondrial	O
DNA	O
was	O
increased	O
2	O
.	O
3	O
-	O
fold	O
in	O
gastrocnemius	O
muscle	O
of	O
the	O
transgenic	O
mice	O
(	O
Figure	O
3C	O
)	O
.	O

These	O
results	O
reveal	O
a	O
marked	O
stimulation	O
of	O
mitochondrial	O
biogenesis	O
and	O
further	O
support	O
the	O
idea	O
that	O
there	O
is	O
a	O
muscle	O
fiber	O
switch	O
.	O

This	O
conclusion	O
was	O
also	O
confirmed	O
by	O
Western	O
blot	O
analysis	O
.	O

As	O
shown	O
in	O
Figure	O
3D	O
,	O
the	O
characteristic	O
type	O
I	O
fiber	O
proteins	B-CHEBI
,	O
such	O
as	O
myoglobin	B-CHEBI
and	O
cytochrome	B-CHEBI
c	I-CHEBI
and	I-CHEBI
b	I-CHEBI
,	O
were	O
significantly	O
increased	O
.	O

More	O
importantly	O
,	O
the	O
specialized	O
contraction	O
protein	B-CHEBI
troponin	O
I	O
(	O
slow	O
)	O
of	O
type	O
I	O
fiber	O
was	O
robustly	O
induced	O
;	O
this	O
was	O
accompanied	O
by	O
a	O
marked	O
reduction	O
of	O
the	O
specialized	O
contraction	O
protein	B-CHEBI
troponin	O
I	O
(	O
fast	O
)	O
of	O
type	O
II	O
fiber	O
,	O
indicating	O
a	O
high	O
degree	O
of	O
fiber	O
transformation	O
.	O

We	O
next	O
examined	O
whether	O
acute	O
activation	O
of	O
endogenous	O
PPAR	O
delta	O
would	O
induce	O
similar	O
target	O
genes	O
.	O

In	O
agreement	O
with	O
the	O
chronic	O
effects	O
in	O
the	O
transgenic	O
mice	O
,	O
we	O
found	O
that	O
,	O
after	O
treatment	O
of	O
wild	O
-	O
type	O
C57B6J	O
mice	O
with	O
the	O
PPAR	O
delta	O
-	O
specific	O
agonist	B-CHEBI
GW501516	O
for	O
only	O
10	O
d	O
,	O
genes	O
for	O
slow	O
fiber	O
contractile	O
proteins	B-CHEBI
,	O
mitochondrial	O
biogenesis	O
,	O
and	O
beta	O
-	O
oxidation	O
were	O
all	O
upregulated	O
(	O
Figure	O
3E	O
)	O
.	O

This	O
indicates	O
that	O
rapid	O
,	O
systematic	O
,	O
and	O
coordinated	O
changes	O
of	O
muscle	O
fiber	O
properties	O
toward	O
type	O
I	O
can	O
be	O
achieved	O
by	O
activation	O
of	O
the	O
endogenous	O
PPAR	O
delta	O
pathway	O
.	O

Muscle	O
Fiber	O
Switch	O
by	O
PPAR	O
delta	O
Protects	O
Against	O
Obesity	O

A	O
number	O
of	O
previous	O
studies	O
have	O
shown	O
that	O
obese	O
individuals	O
have	O
fewer	O
oxidative	O
fibers	O
,	O
implying	O
that	O
the	O
presence	O
of	O
oxidative	O
fibers	O
alone	O
may	O
play	O
a	O
part	O
in	O
obesity	O
resistance	O
.	O

To	O
test	O
this	O
possibility	O
,	O
we	O
fed	O
the	O
transgenic	O
mice	O
and	O
their	O
wild	O
-	O
type	O
littermates	O
with	O
a	O
high	O
-	O
fat	O
diet	O
for	O
97	O
d	O
.	O

Although	O
the	O
initial	O
body	O
weights	O
of	O
the	O
two	O
groups	O
were	O
very	O
similar	O
,	O
the	O
transgenic	O
mice	O
had	O
gained	O
less	O
than	O
50	O
%	O
at	O
day	O
47	O
,	O
and	O
only	O
one	O
-	O
third	O
at	O
day	O
97	O
,	O
of	O
the	O
weight	O
gained	O
by	O
the	O
wild	O
-	O
type	O
animals	O
(	O
Figure	O
4A	O
)	O
.	O

The	O
transgenic	O
mice	O
displayed	O
significantly	O
higher	O
oxygen	B-CHEBI
consumption	O
on	O
the	O
high	O
-	O
fat	O
diet	O
than	O
the	O
control	O
littermates	O
(	O
unpublished	O
data	O
)	O
.	O

By	O
the	O
end	O
of	O
this	O
experiment	O
,	O
the	O
control	O
littermates	O
became	O
obese	O
,	O
whereas	O
the	O
transgenic	O
mice	O
still	O
maintained	O
a	O
normal	O
body	O
weight	O
and	O
fat	O
mass	O
composition	O
(	O
Figure	O
4A	O
)	O
.	O

A	O
histological	O
analysis	O
of	O
inguinal	O
fat	O
pad	O
revealed	O
a	O
much	O
smaller	O
cell	O
size	O
in	O
the	O
transgenic	O
mice	O
(	O
Figure	O
4B	O
)	O
,	O
due	O
to	O
the	O
increased	O
muscle	O
oxidative	O
capacity	O
.	O

While	O
there	O
was	O
no	O
significant	O
difference	O
in	O
intramuscular	O
glycogen	B-CHEBI
content	O
,	O
the	O
triglyceride	B-CHEBI
content	O
was	O
much	O
less	O
in	O
the	O
transgenic	O
mice	O
(	O
Figure	O
4C	O
and	O
4D	O
)	O
,	O
which	O
may	O
explain	O
their	O
improved	O
glucose	B-CHEBI
tolerance	O
(	O
Figure	O
4E	O
)	O
.	O

We	O
also	O
placed	O
wild	O
-	O
type	O
C57BJ6	O
mice	O
on	O
the	O
high	O
-	O
fat	O
diet	O
and	O
treated	O
them	O
with	O
either	O
vehicle	O
or	O
the	O
PPAR	O
delta	O
agonist	B-CHEBI
GW501516	O
for	O
2	O
mo	O
.	O

GW501516	O
produced	O
a	O
sustained	O
induction	O
of	O
genes	O
for	O
type	O
I	O
muscle	O
fibers	O
;	O
this	O
,	O
at	O
least	O
in	O
part	O
,	O
resulted	O
in	O
an	O
only	O
30	O
%	O
gain	O
in	O
body	O
weight	O
,	O
a	O
dramatically	O
reduced	O
fat	O
mass	O
accumulation	O
,	O
and	O
improved	O
glucose	B-CHEBI
tolerance	O
,	O
compared	O
to	O
the	O
vehicle	O
-	O
treated	O
group	O
(	O
Figure	O
5	O
)	O
.	O

Thus	O
,	O
muscle	O
fiber	O
conversion	O
by	O
stimulation	O
with	O
the	O
PPAR	O
delta	O
agonist	B-CHEBI
or	O
the	O
activated	O
transgene	O
has	O
a	O
protective	O
role	O
against	O
obesity	O
.	O

Activation	O
of	O
PPAR	O
delta	O
Enhances	O
Physical	O
Performance	O

Muscle	O
oxidative	O
capacity	O
is	O
a	O
crucial	O
factor	O
for	O
determining	O
endurance	O
and	O
fatigue	O
.	O

Indeed	O
,	O
type	O
I	O
fibers	O
adaptively	O
generated	O
through	O
exercise	O
training	O
are	O
considered	O
to	O
be	O
fatigue	O
resistant	O
.	O

However	O
,	O
whether	O
the	O
type	O
I	O
fibers	O
generated	O
molecularly	B-CHEBI
via	O
PPAR	O
delta	O
expression	O
can	O
contribute	O
to	O
enhanced	O
performance	O
in	O
the	O
absence	O
of	O
previous	O
training	O
is	O
unclear	O
.	O

In	O
fact	O
,	O
the	O
consequence	O
of	O
genetically	O
induced	O
fiber	O
switch	O
on	O
running	O
capacity	O
has	O
to	O
our	O
knowledge	O
never	O
been	O
evaluated	O
.	O

We	O
thus	O
compared	O
exercise	O
performance	O
between	O
untrained	O
,	O
body	O
-	O
weight	O
-	O
matched	O
transgenic	O
and	O
wild	O
-	O
type	O
littermates	O
.	O

Mice	O
were	O
run	O
on	O
oxygen	B-CHEBI
-	O
infused	O
,	O
enclosed	O
treadmills	O
until	O
exhaustion	O
.	O

Strikingly	O
,	O
the	O
running	O
time	O
and	O
distance	O
the	O
transgenic	O
mice	O
were	O
able	O
to	O
sustain	O
were	O
increased	O
by	O
67	O
%	O
and	O
92	O
%	O
,	O
respectively	O
(	O
Figure	O
6A	O
;	O
also	O
see	O
Videos	O
S1	O
and	O
S2	O
)	O
.	O

The	O
transgenic	O
mice	O
ran	O
about	O
1	O
h	O
longer	O
than	O
the	O
controls	O
,	O
which	O
translates	O
to	O
nearly	O
a	O
kilometer	O
further	O
.	O

No	O
significant	O
differences	O
in	O
muscle	O
mass	O
(	O
unpublished	O
data	O
)	O
and	O
daily	O
activity	O
(	O
total	O
counts	O
of	O
activity	O
per	O
hour	O
:	O
1618	O
+/-	O
209	O
for	O
transgenic	O
versus	O
1987	O
+/-	O
301	O
for	O
wild	O
-	O
type	O
,	O
p	O
>	O
0	O
.	O
35	O
,	O
n	O
=	O
4	O
)	O
were	O
observed	O
between	O
the	O
transgenic	O
and	O
control	O
mice	O
.	O

Thus	O
,	O
the	O
remarkable	O
increase	O
in	O
endurance	O
is	O
the	O
physiologic	O
manifestation	O
of	O
muscle	O
fiber	O
transformation	O
.	O

This	O
suggests	O
that	O
genetically	O
directed	O
muscle	O
fiber	O
switch	O
is	O
physiologically	O
and	O
functionally	O
relevant	O
.	O

In	O
addition	O
,	O
we	O
looked	O
at	O
what	O
effect	O
the	O
absence	O
of	O
PPAR	O
delta	O
function	O
has	O
on	O
exercise	O
endurance	O
.	O

In	O
the	O
treadmill	O
test	O
,	O
the	O
PPAR	O
delta	O
-	O
null	O
mice	O
could	O
sustain	O
only	O
38	O
%	O
of	O
the	O
running	O
time	O
and	O
34	O
%	O
of	O
the	O
distance	O
of	O
their	O
age	O
-	O
and	O
weight	O
-	O
matched	O
wild	O
-	O
type	O
counterparts	O
(	O
Figure	O
6B	O
)	O
.	O

These	O
results	O
further	O
support	O
a	O
role	O
for	O
PPAR	O
delta	O
in	O
enhancement	O
of	O
physical	O
performance	O
.	O

Discussion	O

Our	O
data	O
reveal	O
that	O
a	O
PPAR	O
delta	O
-	O
mediated	O
transcriptional	O
pathway	O
can	O
regulate	O
muscle	O
fiber	O
specification	O
,	O
enabling	O
the	O
generation	O
of	O
a	O
strain	O
of	O
mice	O
with	O
a	O
"	O
long	O
-	O
distance	O
running	O
"	O
phenotype	O
.	O

We	O
show	O
that	O
targeted	O
expression	O
of	O
an	O
activated	O
form	O
of	O
PPAR	O
delta	O
produces	O
profound	O
and	O
coordinated	O
increases	O
in	O
oxidation	O
enzymes	O
,	O
mitochondrial	O
biogenesis	O
,	O
and	O
production	O
of	O
specialized	O
type	O
I	O
fiber	O
contractile	O
proteins	B-CHEBI
--	O
the	O
three	O
hallmarks	O
for	O
muscle	O
fiber	O
type	O
switching	O
(	O
Figure	O
6C	O
)	O
.	O

While	O
induction	O
of	O
muscle	O
oxidation	O
enzymes	O
by	O
PPAR	O
delta	O
has	O
been	O
seen	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
(	O
Muoio	O
et	O
al	O
.	O
2002	O
;	O
Dressel	O
et	O
al	O
.	O
2003	O
;	O
Luquet	O
et	O
al	O
.	O
2003	O
;	O
Tanaka	O
et	O
al	O
.	O
2003	O
;	O
Wang	O
et	O
al	O
.	O
2003	O
)	O
,	O
its	O
effects	O
shown	O
here	O
on	O
muscle	O
fiber	O
switching	O
are	O
unexpected	O
.	O

These	O
progressive	O
changes	O
in	O
oxidative	O
capacity	O
in	O
conjunction	O
with	O
eventual	O
changes	O
in	O
type	O
I	O
muscle	O
fiber	O
lead	O
to	O
a	O
dramatically	O
improved	O
exercise	O
profile	O
and	O
protection	O
against	O
obesity	O
.	O

This	O
does	O
not	O
solely	O
depend	O
on	O
achieving	O
a	O
directed	O
muscle	O
fiber	O
type	O
switch	O
but	O
also	O
requires	O
all	O
the	O
associated	O
changes	O
in	O
neural	O
innervation	O
,	O
motor	O
neuron	O
function	O
,	O
and	O
peripheral	O
metabolic	O
adaptation	O
to	O
enable	O
a	O
new	O
integrated	O
physiological	O
response	O
.	O

Accordingly	O
,	O
activation	O
of	O
muscle	O
PPAR	O
delta	O
essentially	O
recapitulates	O
the	O
effects	O
of	O
exercise	O
training	O
even	O
in	O
the	O
absence	O
of	O
training	O
itself	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
has	O
not	O
been	O
directly	O
described	O
for	O
any	O
other	O
transcriptional	O
factor	O
.	O

The	O
muscle	O
phenotypes	O
described	O
here	O
are	O
remarkably	O
similar	O
to	O
those	O
of	O
transgenic	O
mice	O
expressing	O
either	O
calcineurin	O
,	O
calmodulin	O
-	O
dependent	O
kinase	O
,	O
or	O
PGC	O
-	O
1	O
alpha	O
(	O
Naya	O
et	O
al	O
.	O
2000	O
;	O
Lin	O
et	O
al	O
.	O
2002	O
;	O
Wu	O
et	O
al	O
.	O
2002	O
)	O
,	O
indicating	O
that	O
PPAR	O
delta	O
could	O
be	O
one	O
of	O
the	O
hypothetical	O
downstream	O
transcription	O
factors	O
of	O
these	O
pathways	O
.	O

It	O
is	O
important	O
to	O
note	O
that	O
,	O
from	O
our	O
ligand	O
and	O
gain	O
-	O
of	O
-	O
function	O
transgenic	O
studies	O
,	O
PPAR	O
delta	O
needs	O
to	O
be	O
activated	O
in	O
order	O
to	O
direct	O
the	O
muscle	O
fiber	O
switch	O
.	O

Indeed	O
,	O
in	O
a	O
recent	O
report	O
by	O
Luquet	O
et	O
al	O
.	O

(	O
2003	O
)	O
,	O
simple	O
overexpression	O
of	O
wild	O
-	O
type	O
PPAR	O
delta	O
in	O
muscle	O
was	O
found	O
not	O
to	O
be	O
sufficient	O
to	O
promote	O
a	O
fiber	O
switch	O
or	O
obesity	O
resistance	O
,	O
although	O
certain	O
oxidation	O
enzymes	O
were	O
increased	O
.	O

This	O
supports	O
the	O
model	O
in	O
Figure	O
6C	O
that	O
the	O
activating	O
signal	O
or	O
ligand	O
,	O
but	O
not	O
the	O
receptor	O
,	O
is	O
limiting	O
.	O

Thus	O
,	O
PPAR	O
delta	O
activation	O
,	O
rather	O
than	O
merely	O
an	O
increase	O
of	O
PPAR	O
delta	O
levels	O
,	O
is	O
an	O
essential	O
element	O
for	O
fiber	O
switching	O
and	O
its	O
associated	O
functional	O
manifestations	O
.	O

How	O
might	O
endogenous	O
PPAR	O
delta	O
become	O
activated	O
naturally	O
by	O
exercise	O
training	O
?	O

First	O
,	O
it	O
is	O
possible	O
that	O
exercise	O
generates	O
or	O
increases	O
endogenous	O
ligands	O
for	O
PPAR	O
delta	O
as	O
tissues	O
are	O
undergoing	O
substantial	O
increases	O
in	O
fatty	B-CHEBI
-	I-CHEBI
acid	I-CHEBI
internalization	O
and	O
burning	O
.	O

Fatty	B-CHEBI
acids	I-CHEBI
and	O
their	O
metabolites	B-CHEBI
can	O
activate	O
PPAR	O
delta	O
.	O

A	O
second	O
model	O
is	O
that	O
exercise	O
may	O
induce	O
expression	O
of	O
PGC	O
-	O
1	O
alpha	O
(	O
Goto	O
et	O
al	O
.	O
2000	O
)	O
and	O
thereby	O
activate	O
PPAR	O
delta	O
.	O

This	O
is	O
consistent	O
with	O
previous	O
work	O
in	O
which	O
we	O
have	O
shown	O
that	O
PGC	O
-	O
1	O
alpha	O
physically	O
associates	O
with	O
PPAR	O
delta	O
in	O
muscle	O
tissue	O
and	O
can	O
powerfully	O
activate	O
it	O
even	O
in	O
the	O
absence	O
of	O
ligands	O
(	O
Wang	O
et	O
al	O
.	O
2003	O
)	O
.	O

Alternatively	O
,	O
PPAR	O
delta	O
may	O
be	O
activated	O
by	O
a	O
distal	O
upstream	O
signaling	O
component	O
such	O
as	O
a	O
kinase	O
cascade	O
.	O

Further	O
dissecting	O
the	O
interactions	O
between	O
PPAR	O
delta	O
and	O
its	O
regulatory	O
components	O
will	O
be	O
necessary	O
to	O
fully	O
understand	O
the	O
molecular	B-CHEBI
basis	O
of	O
muscle	O
fiber	O
determination	O
pertinent	O
to	O
exercise	O
training	O
.	O

Skeletal	O
muscle	O
is	O
a	O
major	O
site	O
to	O
regulate	O
whole	O
-	O
body	O
fatty	B-CHEBI
-	I-CHEBI
acid	I-CHEBI
and	O
glucose	B-CHEBI
metabolism	O
.	O

We	O
show	O
that	O
mice	O
with	O
increased	O
oxidative	O
fibers	O
are	O
resistant	O
to	O
high	O
-	O
fat	O
-	O
induced	O
obesity	O
and	O
glucose	B-CHEBI
intolerance	O
.	O

Moreover	O
,	O
ligand	O
studies	O
provide	O
compelling	O
evidence	O
that	O
activation	O
of	O
endogenous	O
PPAR	O
delta	O
can	O
produce	O
similar	O
effects	O
.	O

Might	O
PPAR	O
delta	O
have	O
any	O
beneficial	O
effects	O
on	O
glucose	B-CHEBI
metabolism	O
in	O
the	O
lean	O
condition	O
?	O

This	O
has	O
not	O
been	O
explored	O
;	O
however	O
,	O
insulin	B-CHEBI
resistance	O
in	O
the	O
elderly	O
is	O
confined	O
mostly	O
to	O
skeletal	O
muscle	O
and	O
may	O
be	O
due	O
to	O
reduction	O
of	O
mitochondrial	O
number	O
and	O
/	O
or	O
function	O
(	O
Petersen	O
et	O
al	O
.	O
2003	O
)	O
.	O

The	O
ability	O
of	O
PPAR	O
delta	O
to	O
stimulate	O
mitochondrial	O
biogenesis	O
and	O
oxidative	O
function	O
suggests	O
that	O
PPAR	O
delta	O
could	O
be	O
important	O
for	O
control	O
of	O
insulin	B-CHEBI
resistance	O
during	O
normal	O
aging	O
.	O

Together	O
,	O
these	O
data	O
indicate	O
that	O
PPAR	O
delta	O
and	O
its	O
ligands	O
comprise	O
a	O
key	O
molecular	B-CHEBI
switch	O
to	O
regulate	O
muscle	O
fiber	O
specification	O
,	O
obesity	O
resistance	O
,	O
insulin	B-CHEBI
sensitivity	O
,	O
and	O
,	O
most	O
surprisingly	O
,	O
physical	O
endurance	O
.	O

This	O
work	O
demonstrates	O
that	O
complex	O
physiologic	O
properties	O
such	O
as	O
fatigue	O
,	O
endurance	O
,	O
and	O
running	O
capacity	O
can	O
be	O
genetically	O
manipulated	O
.	O

Materials	O
and	O
Methods	O

Animals	O
.	O

The	O
transactivation	O
domain	O
(	O
78	O
amino	B-CHEBI
acid	I-CHEBI
residues	I-CHEBI
,	O
corresponding	O
to	O
residues	B-CHEBI
413	O
-	O
490	O
)	O
of	O
VP16	O
was	O
fused	O
in	O
frame	O
with	O
the	O
N	B-CHEBI
-	O
terminus	O
of	O
mouse	O
PPAR	O
delta	O
.	O

The	O
VP16	O
-	O
PPAR	O
delta	O
fusion	O
cDNA	O
was	O
placed	O
downstream	O
of	O
the	O
human	O
alpha	O
-	O
skeletal	O
actin	O
promoter	O
(	O
Brennan	O
and	O
Hardeman	O
1993	O
)	O
,	O
and	O
upstream	O
of	O
the	O
SV40	O
intron	O
/	O
poly	O
(	O
A	B-CHEBI
)	O
sequence	O
.	O

The	O
transgene	O
was	O
purified	O
and	O
injected	O
into	O
C57BL	O
/	O
6J	O
x	O
CBA	O
F1	O
zygotes	O
.	O

Transgenic	O
mice	O
were	O
backcrossed	O
with	O
C57BL	O
/	O
6J	O
for	O
two	O
generations	O
.	O

Wild	O
-	O
type	O
littermates	O
were	O
used	O
as	O
controls	O
throughout	O
the	O
study	O
.	O

On	O
normal	O
chow	B-CHEBI
diet	O
,	O
the	O
transgenic	O
mice	O
and	O
control	O
littermates	O
used	O
here	O
had	O
similar	O
body	O
weights	O
.	O

PPAR	O
delta	O
-	O
null	O
mice	O
were	O
previously	O
generated	O
(	O
Barak	O
et	O
al	O
.	O
2002	O
)	O
.	O

Mice	O
were	O
fed	O
either	O
a	O
standard	O
chow	B-CHEBI
with	O
4	O
%	O
(	O
w	O
/	O
w	O
)	O
fat	O
content	O
(	O
Harlan	O
Teklad	O
,	O
Harlan	O
,	O
Indianapolis	O
,	O
Indiana	O
,	O
United	O
States	O
)	O
or	O
a	O
high	O
-	O
fat	O
diet	O
containing	O
35	O
%	O
(	O
w	O
/	O
w	O
)	O
fat	O
content	O
(	O
product	O
F3282	O
,	O
Bioserv	O
,	O
Frenchtown	O
,	O
New	O
Jersey	O
,	O
United	O
States	O
)	O
as	O
indicated	O
.	O

For	O
ligand	O
experiments	O
,	O
we	O
synthesized	O
the	O
GW501516	O
compound	B-CHEBI
and	O
mice	O
were	O
orally	O
gavaged	O
daily	O
(	O
10	O
mg	O
/	O
kg	O
or	O
vehicle	O
alone	O
)	O
.	O

Gene	O
expression	O
analysis	O
and	O
physiological	O
studies	O

Mouse	O
EST	O
clones	O
were	O
obtained	O
from	O
ATCC	O
(	O
Manassas	O
,	O
Virginia	O
,	O
United	O
States	O
)	O
,	O
verified	O
by	O
sequencing	O
,	O
and	O
used	O
as	O
Northern	O
probes	O
.	O

Antibodies	O
were	O
obtained	O
from	O
Santa	O
Cruz	O
Biotechnology	O
(	O
Santa	O
Cruz	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Total	O
muscle	O
protein	B-CHEBI
extracts	O
(	O
Lin	O
et	O
al	O
.	O
2002	O
)	O
and	O
nuclear	O
proteins	B-CHEBI
(	O
Wang	O
et	O
al	O
.	O
2003	O
)	O
were	O
prepared	O
as	O
described	O
.	O

Prior	O
to	O
the	O
exercise	O
performance	O
test	O
,	O
the	O
mice	O
were	O
accustomed	O
to	O
the	O
treadmill	O
(	O
Columbus	O
Instruments	O
,	O
Columbus	O
,	O
Ohio	O
,	O
United	O
States	O
)	O
with	O
a	O
5	O
-	O
min	O
run	O
at	O
7	O
m	O
/	O
min	O
once	O
per	O
day	O
for	O
2	O
d	O
.	O

The	O
exercise	O
test	O
regimen	O
was	O
10	O
m	O
/	O
min	O
for	O
the	O
first	O
60	O
min	O
,	O
followed	O
by	O
1	O
m	O
/	O
min	O
increment	O
increases	O
at	O
15	O
-	O
min	O
intervals	O
.	O

Exhaustion	O
was	O
defined	O
when	O
mice	O
were	O
unable	O
to	O
avoid	O
repetitive	O
electrical	O
shocks	O
.	O

Muscle	O
fiber	O
typing	O
and	O
mitochondrial	O
DNA	O
isolation	O

Muscle	O
fiber	O
typing	O
was	O
essentially	O
performed	O
using	O
metachromatic	O
dye	B-CHEBI
-	O
ATPase	O
methods	O
as	O
described	O
(	O
Ogilvie	O
and	O
Feeback	O
1990	O
)	O
.	O

Muscle	O
mitochondria	O
were	O
isolated	O
(	O
Scholte	O
et	O
al	O
.	O
1997	O
)	O
.	O

Mitochondrial	O
DNA	O
was	O
prepared	O
and	O
analyzed	O
on	O
1	O
%	O
agarose	B-CHEBI
gel	O
.	O

Statistical	O
analysis	O

Number	O
of	O
mice	O
for	O
each	O
group	O
used	O
in	O
experiments	O
is	O
indicated	O
in	O
figure	O
legends	O
.	O

Values	O
are	O
presented	O
as	O
mean	O
+/-	O
SEM	O
.	O

A	O
two	O
-	O
tailed	O
Student	O
'	O
s	O
t	O
test	O
was	O
used	O
to	O
calculate	O
p	O
-	O
values	O
.	O

Supporting	O
Information	O

Video	O
S1	O

Beginning	O
of	O
Running	O
Test	O

This	O
video	O
shows	O
the	O
exercise	O
performance	O
of	O
a	O
representative	O
of	O
the	O
transgenic	O
mice	O
(	O
right	O
chamber	O
)	O
and	O
a	O
representative	O
of	O
wild	O
-	O
type	O
control	O
littermates	O
(	O
left	O
chamber	O
)	O
on	O
the	O
treadmill	O
15	O
min	O
into	O
the	O
exercise	O
challenge	O
.	O

(	O
52	O
.	O
4	O
MB	O
MOV	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Video	O
S2	O

Running	O
Test	O
90	O
Min	O
Later	O

This	O
video	O
shows	O
the	O
exercise	O
performance	O
of	O
a	O
representative	O
of	O
the	O
transgenic	O
mice	O
(	O
right	O
chamber	O
)	O
and	O
a	O
representative	O
of	O
wild	O
-	O
type	O
control	O
littermates	O
(	O
left	O
chamber	O
)	O
on	O
the	O
treadmill	O
90	O
min	O
into	O
the	O
exercise	O
challenge	O
.	O

(	O
41	O
.	O
7	O
MB	O
MOV	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Acknowledgements	O

We	O
thank	O
Dr	O
.	O
M	O
.	O

Downes	O
for	O
providing	O
the	O
alpha	O
-	O
skeletal	O
actin	O
promoter	O
;	O
Dr	O
.	O
G	O
.	O

D	O
.	O

Barish	O
for	O
comments	O
on	O
the	O
manuscript	O
;	O
M	O
.	O
A	O
.	O

Lawrence	O
for	O
histology	O
;	O
Dr	O
.	O
S	O
.	O

Pfaff	O
for	O
the	O
use	O
of	O
microscopes	O
and	O
photographic	O
equipment	O
;	O
M	O
.	O

Lieberman	O
and	O
K	O
.	O
L	O
.	O

Schnoeker	O
for	O
photography	O
;	O
J	O
.	O
M	O
.	O

Shelton	O
for	O
advice	O
on	O
fiber	O
staining	O
;	O
and	O
E	O
.	O

Stevens	O
and	O
E	O
.	O

Ong	O
for	O
administrative	O
assistance	O
.	O

YXW	O
was	O
supported	O
by	O
a	O
postdoctoral	O
fellowship	O
from	O
California	O
Tobacco	O
-	O
Related	O
Disease	O
Research	O
Program	O
.	O

JH	O
was	O
supported	O
by	O
the	O
BK21	O
program	O
,	O
Ministry	O
of	O
Education	O
,	O
Korea	O
.	O

HK	O
was	O
supported	O
by	O
grant	O
M1	O
-	O
0311	O
-	O
00	O
-	O
0145	O
from	O
the	O
Molecular	B-CHEBI
and	O
Cellular	O
BioDiscovery	O
Research	O
Program	O
,	O
Ministry	O
of	O
Science	O
and	O
Technology	O
,	O
Korea	O
.	O

RME	O
is	O
an	O
Investigator	O
of	O
the	O
Howard	O
Hughes	O
Medical	O
Institute	O
at	O
the	O
Salk	O
Institute	O
for	O
Biological	O
Studies	O
and	O
March	O
of	O
Dimes	O
Chair	O
in	O
Molecular	O
and	O
Developmental	O
Biology	O
.	O

This	O
work	O
was	O
supported	O
by	O
the	O
Howard	O
Hughes	O
Medical	O
Institute	O
and	O
the	O
Hillblom	O
Foundation	O
.	O

Abbreviations	O

COX	O
-	O
cytochrome	B-CHEBI
c	I-CHEBI
oxidase	O

mCPT1	O
-	O
muscle	O
carnitine	B-CHEBI
palmitoyltransferase	O
-	O
1	O

PGC	O
-	O
1	O
alpha	O
-	O
Peroxisome	O
proliferator	O
-	O
activated	O
receptor	O
-	O
gamma	O
coactivator	O
1	O
alpha	O

PPAR	O
-	O
peroxisome	O
proliferator	O
-	O
activated	O
receptor	O

UCP	O
-	O
uncoupling	O
protein	B-CHEBI

Figures	O
and	O
Tables	O

Figure	O
1	O

Expression	O
of	O
Endogenous	O
PPAR	O
delta	O
and	O
VP16	O
-	O
PPAR	O
delta	O
Transgene	O
in	O
Muscle	O

(	O
A	O
)	O
Pooled	O
RNA	O
isolated	O
from	O
various	O
muscles	O
of	O
five	O
wild	O
-	O
type	O
male	O
C57B6	O
mice	O
was	O
hybridized	O
with	O
indicated	O
probes	O
.	O

EDL	O
,	O
extensor	O
digitorum	O
longus	O
;	O
Gastro	O
,	O
gastrocnemius	O
.	O

(	O
B	O
)	O
Pooled	O
nuclear	O
proteins	B-CHEBI
(	O
15	O
mu	O
g	O
/	O
lane	O
)	O
isolated	O
from	O
muscles	O
of	O
five	O
wild	O
-	O
type	O
male	O
C57B6	O
were	O
probed	O
with	O
anti	O
-	O
PPAR	O
delta	O
antibody	O
.	O

RNA	O
polymerase	O
II	O
(	O
Pol	O
II	O
)	O
is	O
shown	O
as	O
a	O
loading	O
control	O
.	O

(	O
C	O
)	O
Expression	O
of	O
the	O
VP16	O
-	O
PPAR	O
delta	O
transgene	O
in	O
various	O
tissues	O
.	O

10	O
mu	O
g	O
of	O
total	O
RNA	O
from	O
each	O
tissue	O
was	O
hybridized	O
with	O
a	O
VP16	O
cDNA	O
probe	O
.	O

Gastrocnemius	O
muscle	O
was	O
used	O
here	O
.	O

(	O
D	O
)	O
Nuclear	O
proteins	B-CHEBI
(	O
15	O
mu	O
g	O
/	O
lane	O
)	O
isolated	O
from	O
gastrocnemius	O
muscle	O
of	O
the	O
transgenic	O
mice	O
(	O
TG	O
)	O
and	O
the	O
wild	O
-	O
type	O
littermates	O
(	O
WT	O
)	O
were	O
probed	O
with	O
indicated	O
antibodies	O
.	O

The	O
upper	O
,	O
nonspecific	O
band	O
that	O
cross	O
-	O
reacted	O
with	O
the	O
anti	O
-	O
PPAR	O
delta	O
antibody	O
serves	O
a	O
loading	O
control	O
.	O

Figure	O
2	O

Increased	O
Oxidative	O
Type	O
I	O
Fibers	O
in	O
the	O
Transgenic	O
Mice	O

(	O
A	O
and	O
B	O
)	O
Muscles	O
in	O
transgenic	O
mice	O
(	O
TG	O
)	O
are	O
redder	O
than	O
those	O
in	O
wild	O
-	O
type	O
mice	O
(	O
WT	O
)	O
.	O

(	O
C	O
)	O
Metachromatic	O
staining	O
of	O
the	O
type	O
II	O
plantaris	O
muscle	O
.	O

Type	O
I	O
fibers	O
are	O
stained	O
dark	O
blue	O
.	O

Figure	O
3	O

Activation	O
of	O
PPAR	O
delta	O
Induces	O
Genes	O
Typical	O
for	O
Type	O
I	O
Fibers	O
and	O
Promotes	O
Mitochondrial	O
Biogenesis	O

(	O
A	O
)	O
Total	O
RNA	O
(	O
10	O
mu	O
g	O
/	O
lane	O
)	O
prepared	O
from	O
gastrocnemius	O
muscle	O
of	O
transgenic	O
(	O
TG	O
)	O
and	O
wild	O
-	O
type	O
(	O
WT	O
)	O
littermates	O
was	O
probed	O
with	O
indicated	O
probes	O
.	O

The	O
fold	O
increase	O
of	O
induction	O
of	O
each	O
gene	O
is	O
shown	O
.	O

(	O
B	O
)	O
Total	O
genomic	O
DNA	O
(	O
10	O
mu	O
g	O
/	O
lane	O
)	O
prepared	O
from	O
gastrocnemius	O
muscle	O
was	O
digested	O
with	O
Nco1	O
and	O
subjected	O
to	O
Southern	O
analysis	O
with	O
COXII	O
(	O
mitochondrial	O
genome	O
-	O
encoded	O
)	O
and	O
MCIP1	O
(	O
nuclear	O
genome	O
-	O
encoded	O
)	O
DNA	O
probes	O
.	O

(	O
C	O
)	O
Equal	O
amounts	O
of	O
gastrocnemius	O
muscle	O
were	O
collected	O
from	O
both	O
transgenic	O
mice	O
and	O
control	O
littermates	O
.	O

Total	O
mitochondrial	O
DNA	O
was	O
isolated	O
and	O
separated	O
on	O
1	O
%	O
agarose	B-CHEBI
gel	O
.	O

The	O
relative	O
abundance	O
of	O
mitochondrial	O
DNA	O
in	O
transgenic	O
and	O
wild	O
-	O
type	O
mice	O
is	O
presented	O
.	O

(	O
D	O
)	O
Western	O
blot	O
analysis	O
of	O
muscle	O
fiber	O
markers	O
and	O
mitochondrial	O
components	O
.	O

Each	O
lane	O
was	O
loaded	O
with	O
80	O
mu	O
g	O
of	O
total	O
gastrocnemius	O
muscle	O
extracts	O
.	O

(	O
E	O
)	O
Wild	O
-	O
type	O
C57B6	O
mice	O
were	O
treated	O
with	O
vehicle	O
or	O
PPAR	O
delta	O
agonist	B-CHEBI
GW501516	O
for	O
10	O
d	O
.	O

Total	O
RNA	O
(	O
10	O
mu	O
g	O
/	O
lane	O
)	O
prepared	O
from	O
the	O
gastrocnemius	O
muscle	O
was	O
probed	O
with	O
indicated	O
probes	O
.	O

Figure	O
4	O

Resistance	O
to	O
High	O
-	O
Fat	O
-	O
Induced	O
Obesity	O
in	O
the	O
Transgenic	O
Mice	O

(	O
A	O
)	O
Seven	O
-	O
week	O
-	O
old	O
transgenic	O
(	O
TG	O
)	O
and	O
wild	O
-	O
type	O
(	O
WT	O
)	O
littermates	O
(	O
n	O
=	O
5	O
-	O
6	O
for	O
each	O
group	O
)	O
were	O
fed	O
with	O
a	O
high	O
-	O
fat	O
diet	O
for	O
97	O
d	O
.	O

Left	O
panel	O
shows	O
net	O
body	O
weight	O
gain	O
,	O
which	O
was	O
calculated	O
for	O
individual	O
mice	O
and	O
then	O
averaged	O
.	O

Right	O
panel	O
shows	O
the	O
body	O
weights	O
before	O
(	O
Day	O
0	O
)	O
and	O
after	O
(	O
Day	O
97	O
)	O
high	O
-	O
fat	O
feeding	O
.	O

(	O
B	O
)	O
Histology	O
of	O
inguinal	O
fat	O
pad	O
in	O
the	O
transgenic	O
and	O
wild	O
-	O
type	O
littermates	O
under	O
a	O
high	O
-	O
fat	O
diet	O
for	O
2	O
mo	O
.	O

(	O
C	O
and	O
D	O
)	O
Intramuscular	O
glycogen	B-CHEBI
content	O
(	O
C	O
)	O
and	O
triglyceride	B-CHEBI
content	O
(	O
D	O
)	O
of	O
mice	O
in	O
(	O
A	O
)	O
after	O
high	O
-	O
fat	O
feeding	O
(	O
n	O
=	O
6	O
)	O
.	O

(	O
E	O
)	O
Glucose	B-CHEBI
tolerance	O
test	O
.	O

Mice	O
in	O
(	O
A	O
)	O
after	O
high	O
-	O
fat	O
feeding	O
were	O
fasted	O
for	O
6	O
h	O
and	O
then	O
injected	O
with	O
glucose	B-CHEBI
at	O
a	O
concentration	O
of	O
1g	O
/	O
kg	O
body	O
weight	O
.	O

Then	O
blood	O
glucose	B-CHEBI
levels	O
were	O
measured	O
periodically	O
over	O
2	O
h	O
(	O
n	O
=	O
6	O
)	O
.	O

Figure	O
5	O

PPAR	O
delta	O
Agonists	B-CHEBI
Counteract	O
Obesity	O
Induced	O
by	O
High	O
-	O
Fat	O
Diet	O

(	O
A	O
)	O
Eleven	O
-	O
week	O
-	O
old	O
wild	O
-	O
type	O
C57B6	O
mice	O
were	O
fed	O
a	O
high	O
-	O
fat	O
diet	O
in	O
combination	O
with	O
vehicle	O
or	O
GW501516	O
for	O
57	O
d	O
.	O

Total	O
RNA	O
(	O
10	O
mu	O
g	O
/	O
lane	O
)	O
prepared	O
from	O
the	O
gastrocnemius	O
muscle	O
was	O
probed	O
with	O
indicated	O
probes	O
.	O

(	O
B	O
)	O
Net	O
body	O
weight	O
gain	O
for	O
mice	O
in	O
(	O
A	O
)	O
after	O
treatment	O
was	O
calculated	O
for	O
individual	O
mice	O
and	O
averaged	O
.	O

Initial	O
body	O
weights	O
were	O
28	O
.	O
54	O
+/-	O
1	O
.	O
04	O
g	O
for	O
vehicle	O
group	O
(	O
n	O
=	O
5	O
)	O
and	O
28	O
.	O
86	O
+/-	O
0	O
.	O
80	O
g	O
for	O
GW501516	O
group	O
(	O
n	O
=	O
5	O
)	O
.	O

(	O
C	O
)	O
Various	O
tissue	O
weights	O
for	O
mice	O
in	O
(	O
A	O
)	O
after	O
treatment	O
.	O
ifat	O
,	O
inguinal	O
fat	O
;	O
rdfat	O
,	O
reproductive	O
fat	O
;	O
retrofat	O
,	O
retroperitoneal	O
fat	O
.	O

(	O
D	O
)	O
Glucose	B-CHEBI
tolerance	O
test	O
.	O

Mice	O
in	O
(	O
A	O
)	O
after	O
treatment	O
were	O
fasted	O
for	O
6	O
h	O
and	O
then	O
injected	O
with	O
glucose	B-CHEBI
at	O
a	O
concentration	O
of	O
1g	O
/	O
kg	O
body	O
weight	O
.	O

Blood	O
glucose	B-CHEBI
levels	O
were	O
then	O
measured	O
periodically	O
over	O
2	O
h	O
.	O

Figure	O
6	O

PPAR	O
delta	O
Regulates	O
Exercise	O
Endurance	O

(	O
A	O
)	O
Enhanced	O
exercise	O
performance	O
in	O
the	O
transgenic	O
mice	O
.	O

Fourteen	O
-	O
week	O
-	O
old	O
male	O
transgenic	O
and	O
wild	O
-	O
type	O
littermates	O
with	O
similar	O
body	O
weights	O
(	O
n	O
=	O
4	O
for	O
each	O
group	O
)	O
were	O
subjected	O
to	O
a	O
forced	O
treadmill	O
exercise	O
test	O
.	O

(	O
B	O
)	O
Compromised	O
exercise	O
performance	O
in	O
PPAR	O
delta	O
-	O
null	O
mice	O
.	O

Two	O
-	O
month	O
-	O
old	O
male	O
PPAR	O
delta	O
-	O
null	O
mice	O
and	O
wild	O
-	O
type	O
controls	O
with	O
similar	O
body	O
weights	O
(	O
n	O
=	O
6	O
for	O
each	O
group	O
)	O
were	O
subjected	O
to	O
a	O
forced	O
treadmill	O
exercise	O
test	O
.	O

(	O
C	O
)	O
Functions	O
of	O
PPAR	O
delta	O
in	O
skeletal	O
muscle	O
.	O

Footnotes	O

Conflicts	O
of	O
interest	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
conflicts	O
of	O
interest	O
exist	O
.	O

Author	O
contributions	O
.	O

YXW	O
and	O
RME	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

YXW	O
,	O
CLZ	O
,	O
RTY	O
,	O
MCN	O
,	O
and	O
CRBO	O
performed	O
the	O
experiments	O
.	O

YXW	O
,	O
CLZ	O
,	O
and	O
RME	O
analyzed	O
the	O
data	O
.	O

HKC	O
,	O
JH	O
,	O
and	O
HK	O
contributed	O
reagents	B-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

YXW	O
and	O
RME	O
wrote	O
the	O
paper	O
.	O

Academic	O
Editor	O
:	O
Steve	O
O	O
'	O
Rahilly	O
,	O
University	O
of	O
Cambridge	O

Citation	O
:	O
Wang	O
YX	O
,	O
Zhang	O
CL	O
,	O
Yu	O
RT	O
,	O
Cho	O
HK	O
,	O
Nelson	O
MC	O
,	O
et	O
al	O
.	O

(	O
2004	O
)	O
Regulation	O
of	O
muscle	O
fiber	O
type	O
and	O
running	O
endurance	O
by	O
PPAR	O
delta	O
.	O

PLoS	O
Biol	O
2	O
(	O
10	O
)	O
:	O
e294	O
.	O

Membrane	O
trafficking	O
and	O
mitochondrial	O
abnormalities	O
precede	O
subunit	O
c	O
deposition	O
in	O
a	O
cerebellar	O
cell	O
model	O
of	O
juvenile	O
neuronal	O
ceroid	O
lipofuscinosis	O

Abstract	O

Background	O

JNCL	O
is	O
a	O
recessively	O
inherited	O
,	O
childhood	O
-	O
onset	O
neurodegenerative	O
disease	O
most	O
-	O
commonly	O
caused	O
by	O
a	O
~	O
1	O
kb	O
CLN3	O
mutation	O
.	O

The	O
resulting	O
loss	O
of	O
battenin	O
activity	O
leads	O
to	O
deposition	O
of	O
mitochondrial	O
ATP	B-CHEBI
synthase	O
,	O
subunit	O
c	O
and	O
a	O
specific	O
loss	O
of	O
CNS	O
neurons	O
.	O

We	O
previously	O
generated	O
Cln3	O
Delta	O
ex7	O
/	O
8	O
knock	O
-	O
in	O
mice	O
,	O
which	O
replicate	O
the	O
common	O
JNCL	O
mutation	O
,	O
express	O
mutant	O
battenin	O
and	O
display	O
JNCL	O
-	O
like	O
pathology	O
.	O

Results	O

To	O
elucidate	O
the	O
consequences	O
of	O
the	O
common	O
JNCL	O
mutation	O
in	O
neuronal	O
cells	O
,	O
we	O
used	O
P4	O
knock	O
-	O
in	O
mouse	O
cerebella	O
to	O
establish	O
conditionally	O
immortalized	O
CbCln3	O
wild	O
-	O
type	O
,	O
heterozygous	O
,	O
and	O
homozygous	O
neuronal	O
precursor	O
cell	O
lines	O
,	O
which	O
can	O
be	O
differentiated	O
into	O
MAP	O
-	O
2	O
and	O
NeuN	O
-	O
positive	O
,	O
neuron	O
-	O
like	O
cells	O
.	O

Homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
precursor	O
cells	O
express	O
low	O
levels	O
of	O
mutant	O
battenin	O
and	O
,	O
when	O
aged	O
at	O
confluency	O
,	O
accumulate	O
ATPase	O
subunit	O
c	O
.	O

Recessive	O
phenotypes	O
are	O
also	O
observed	O
at	O
sub	O
-	O
confluent	O
growth	O
;	O
cathepsin	O
D	O
transport	O
and	O
processing	O
are	O
altered	O
,	O
although	O
enzyme	O
activity	O
is	O
not	O
significantly	O
affected	O
,	O
lysosomal	O
size	O
and	O
distribution	O
are	O
altered	O
,	O
and	O
endocytosis	O
is	O
reduced	O
.	O

In	O
addition	O
,	O
mitochondria	O
are	O
abnormally	O
elongated	O
,	O
cellular	O
ATP	B-CHEBI
levels	O
are	O
decreased	O
,	O
and	O
survival	O
following	O
oxidative	O
stress	O
is	O
reduced	O
.	O

Conclusions	O

These	O
findings	O
reveal	O
that	O
battenin	O
is	O
required	O
for	O
intracellular	O
membrane	O
trafficking	O
and	O
mitochondrial	O
function	O
.	O

Moreover	O
,	O
these	O
deficiencies	O
are	O
likely	O
to	O
be	O
early	O
events	O
in	O
the	O
JNCL	O
disease	O
process	O
and	O
may	O
particularly	O
impact	O
neuronal	O
survival	O
.	O

Background	O

Juvenile	O
neuronal	O
ceroid	O
lipofuscinosis	O
(	O
JNCL	O
)	O
,	O
or	O
Batten	O
disease	O
,	O
is	O
a	O
recessively	O
inherited	O
childhood	O
-	O
onset	O
neurodegenerative	O
disorder	O
characterized	O
by	O
progressive	O
blindness	O
,	O
seizures	O
,	O
motor	O
and	O
cognitive	O
decline	O
,	O
and	O
early	O
death	O
[	O
1	O
]	O
.	O

The	O
primary	O
genetic	O
defect	O
(	O
>	O
80	O
%	O
disease	O
chromosomes	O
)	O
leading	O
to	O
JNCL	O
is	O
a	O
1	O
.	O
02	O
kb	O
genomic	O
DNA	O
deletion	O
in	O
the	O
CLN3	O
gene	O
,	O
which	O
eliminates	O
exons	O
7	O
and	O
8	O
and	O
surrounding	O
intronic	O
DNA	O
,	O
predicting	O
a	O
non	O
-	O
functional	O
protein	B-CHEBI
product	I-CHEBI
[	O
2	O
]	O
.	O

The	O
pathological	O
hallmark	O
of	O
JNCL	O
is	O
autofluorescent	O
ceroid	O
lipofuscin	O
deposits	O
within	O
autolysosomes	O
that	O
are	O
enriched	O
in	O
subunit	O
c	O
of	O
the	O
mitochondrial	O
ATP	B-CHEBI
synthase	O
complex	O
[	O
3	O
-	O
5	O
]	O
.	O

Remarkably	O
,	O
these	O
deposits	O
are	O
not	O
only	O
found	O
in	O
CNS	O
neurons	O
but	O
are	O
also	O
abundant	O
in	O
non	O
-	O
neuronal	O
cells	O
outside	O
of	O
the	O
nervous	O
system	O
.	O

The	O
relationship	O
of	O
subunit	O
c	O
deposits	O
to	O
the	O
JNCL	O
disease	O
process	O
,	O
and	O
the	O
underlying	O
reason	O
for	O
the	O
neuronal	O
specificity	O
of	O
the	O
disease	O
remain	O
poorly	O
understood	O
.	O

The	O
CLN3	O
-	O
encoded	O
protein	B-CHEBI
(	O
battenin	O
,	O
also	O
called	O
CLN3	O
or	O
cln3	O
p	O
)	O
is	O
a	O
highly	O
conserved	O
,	O
ubiquitously	O
expressed	O
,	O
multi	O
-	O
pass	O
membrane	O
protein	B-CHEBI
[	O
6	O
]	O
that	O
localizes	O
to	O
the	O
lysosome	O
and	O
other	O
vesicular	O
compartments	O
[	O
7	O
-	O
9	O
]	O
.	O

Battenin	O
function	O
remains	O
to	O
be	O
elucidated	O
,	O
although	O
studies	O
of	O
btn1	O
,	O
the	O
yeast	O
CLN3	O
ortholog	O
,	O
have	O
implicated	O
battenin	O
in	O
lysosomal	O
pH	O
homeostasis	O
and	O
amino	B-CHEBI
acid	I-CHEBI
transport	O
[	O
10	O
,	O
11	O
]	O
.	O

To	O
explore	O
JNCL	O
pathogenesis	O
and	O
battenin	O
function	O
,	O
we	O
previously	O
generated	O
a	O
genetically	O
precise	O
JNCL	O
mouse	O
model	O
.	O

Cln3	O
Delta	O
ex7	O
/	O
8	O
knock	O
-	O
in	O
mice	O
harbor	O
the	O
~	O
1	O
kb	O
common	O
JNCL	O
mutation	O
and	O
express	O
a	O
non	O
-	O
truncated	O
mutant	O
battenin	O
isoform	O
that	O
is	O
detectable	O
with	O
antibodies	O
recognizing	O
C	B-CHEBI
-	O
terminal	O
epitopes	O
.	O

Homozygous	O
Cln3	O
Delta	O
ex7	O
/	O
8	O
knock	O
-	O
in	O
mice	O
exhibit	O
a	O
progressive	O
JNCL	O
-	O
like	O
disease	O
,	O
with	O
perinatal	O
onset	O
of	O
subunit	O
c	O
deposition	O
in	O
many	O
cell	O
types	O
and	O
later	O
onset	O
of	O
neuronal	O
dysfunction	O
and	O
behavioral	O
deficits	O
[	O
12	O
]	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
major	O
JNCL	O
defect	O
leads	O
to	O
abnormal	O
turnover	O
of	O
mitochondrial	O
subunit	O
c	O
,	O
in	O
a	O
manner	O
that	O
selectively	O
compromises	O
CNS	O
neurons	O
.	O

Currently	O
,	O
there	O
is	O
no	O
suitable	O
neuronal	O
cell	O
system	O
to	O
investigate	O
the	O
impact	O
of	O
the	O
common	O
JNCL	O
mutation	O
on	O
biological	O
processes	O
.	O

Therefore	O
,	O
we	O
have	O
established	O
cerebellar	O
neuronal	O
precursor	O
cell	O
lines	O
from	O
Cln3	O
Delta	O
ex7	O
/	O
8	O
knock	O
-	O
in	O
mice	O
.	O

Homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
exhibit	O
pathological	O
hallmarks	O
of	O
the	O
disease	O
,	O
and	O
a	O
survey	O
of	O
membrane	O
organelles	O
revealed	O
membrane	O
trafficking	O
defects	O
and	O
mitochondrial	O
dysfunction	O
in	O
homozygous	O
mutant	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
.	O

Results	O

Generation	O
of	O
a	O
genetically	O
precise	O
cerebellar	O
JNCL	O
cell	O
model	O

To	O
generate	O
a	O
precise	O
genetic	O
,	O
neuron	O
-	O
derived	O
JNCL	O
cell	O
culture	O
system	O
,	O
we	O
immortalized	O
granule	O
neurons	O
cultured	O
from	O
postnatal	O
day	O
4	O
(	O
P4	O
)	O
cerebella	O
of	O
homozygous	O
and	O
heterozygous	O
Cln3	O
Delta	O
ex7	O
/	O
8	O
knock	O
-	O
in	O
mice	O
,	O
and	O
wild	O
-	O
type	O
littermates	O
.	O

Primary	O
cell	O
cultures	O
enriched	O
for	O
granule	O
neurons	O
were	O
transduced	O
with	O
retroviral	O
vector	O
bearing	O
a	O
selection	O
cassette	O
and	O
temperature	O
-	O
sensitive	O
tsA58	O
SV40	O
large	O
T	O
antigen	O
.	O

Growth	O
in	O
G418	O
containing	O
medium	O
at	O
the	O
permissive	O
temperature	O
(	O
33	O
degrees	O
C	O
)	O
allowed	O
for	O
selection	O
and	O
isolation	O
of	O
multiple	O
clonal	O
nestin	O
-	O
positive	O
(	O
Fig	O
.	O
1a	O
)	O
,	O
and	O
GFAP	O
-	O
negative	O
(	O
Fig	O
.	O
1b	O
)	O
,	O
cell	O
lines	O
for	O
each	O
genotype	O
.	O

No	O
genotype	O
specific	O
differences	O
were	O
observed	O
in	O
cellular	O
morphology	O
or	O
doubling	O
time	O
(	O
~	O
46	O
hours	O
)	O
(	O
data	O
not	O
shown	O
)	O
.	O

As	O
expected	O
,	O
SV40	O
large	O
T	O
antigen	O
expression	O
was	O
rapidly	O
lost	O
and	O
cell	O
division	O
ceased	O
when	O
cells	O
were	O
shifted	O
to	O
the	O
non	O
-	O
permissive	O
temperature	O
(	O
39	O
degrees	O
C	O
)	O
(	O
data	O
not	O
shown	O
)	O
.	O

Upon	O
addition	O
of	O
neuronal	O
differentiation	O
cocktail	O
,	O
precursor	O
cells	O
became	O
neuron	O
-	O
like	O
in	O
morphology	O
and	O
exhibited	O
decreased	O
nestin	O
expression	O
(	O
data	O
not	O
shown	O
)	O
and	O
increased	O
MAP2	O
and	O
NeuN	O
expression	O
(	O
Fig	O
.	O
1c	O
,	O
1d	O
)	O
,	O
but	O
not	O
expression	O
of	O
the	O
Purkinje	O
marker	O
,	O
calbindin	O
(	O
Fig	O
.	O
1e	O
)	O
.	O

Figure	O
1	O

Neuronal	O
marker	O
expression	O
in	O
CbCln3	O
+	O
/	O
+	O
cells	O
Characterization	O
of	O
CbCln3	O
+	O
/	O
+	O
cells	O
by	O
immunofluorescence	O
with	O
marker	O
antibodies	O
is	O
shown	O
.	O

CbCln3	O
+	O
/	O
+	O
precursors	O
exhibit	O
nestin	O
expression	O
(	O
a	O
)	O
but	O
not	O
GFAP	O
expression	O
(	O
b	O
)	O
,	O
consistent	O
with	O
a	O
neuronal	O
precursor	O
identity	O
.	O

Upon	O
stimulation	O
with	O
a	O
differentiation	O
cocktail	O
(	O
see	O
Methods	O
)	O
,	O
CbCln3	O
+	O
/	O
+	O
cells	O
achieved	O
neuron	O
-	O
like	O
morphology	O
,	O
with	O
rounded	O
cell	O
bodies	O
and	O
extension	O
of	O
processes	O
,	O
and	O
MAP2	O
(	O
c	O
)	O
and	O
NeuN	O
(	O
d	O
)	O
expression	O
was	O
increased	O
.	O

CbCln3	O
+	O
/	O
+	O
cells	O
are	O
negative	O
for	O
the	O
Purkinje	O
neuron	O
marker	O
calbindin	O
(	O
e	O
)	O
.	O

CbCln3	O
+	O
/	O
Delta	O
ex7	O
/	O
8	O
and	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
/	O
Delta	O
ex7	O
/	O
8	O
cell	O
lines	O
exhibited	O
identical	O
marker	O
immunofluorescence	O
results	O
.	O

a	O
,	O
b	O
)	O
20	O
x	O
magnification	O
;	O
c	O
,	O
d	O
,	O
e	O
)	O
40	O
x	O
magnification	O
.	O

Homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
express	O
mutant	O
battenin	O
and	O
display	O
JNCL	O
-	O
like	O
pathology	O

Homozygous	O
Cb	O
Cln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
were	O
first	O
examined	O
for	O
JNCL	O
-	O
like	O
characteristics	O
.	O

Homozygous	O
Cln3	O
Delta	O
ex7	O
/	O
8	O
knock	O
-	O
in	O
mice	O
express	O
multiple	O
Cln3	O
mRNA	B-CHEBI
splice	O
variants	O
and	O
mutant	O
battenin	O
protein	B-CHEBI
that	O
is	O
detectable	O
by	O
batp1	O
antibody	O
recognizing	O
C	B-CHEBI
-	O
terminal	O
epitopes	O
[	O
12	O
]	O
.	O

To	O
assess	O
this	O
molecular	B-CHEBI
phenotype	O
in	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
,	O
RT	O
-	O
PCR	O
and	O
anti	O
-	O
battenin	O
(	O
batp1	O
)	O
immunostaining	O
were	O
performed	O
.	O

As	O
shown	O
in	O
Figure	O
2	O
,	O
Cln3	O
mRNA	B-CHEBI
isoforms	O
in	O
wild	O
-	O
type	O
and	O
homozygous	O
cells	O
were	O
similar	O
to	O
those	O
observed	O
in	O
total	O
RNA	O
isolated	O
from	O
wild	O
-	O
type	O
or	O
homozygous	O
Cln3	O
Delta	O
ex7	O
/	O
8	O
knock	O
-	O
in	O
brain	O
,	O
respectively	O
(	O
Fig	O
.	O
2	O
)	O
.	O

In	O
addition	O
,	O
batp1	O
immunostaining	O
detected	O
mutant	O
battenin	O
product	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
,	O
in	O
a	O
similar	O
albeit	O
reduced	O
cytoplasmic	O
,	O
vesicular	O
staining	O
pattern	O
as	O
that	O
seen	O
in	O
wild	O
-	O
type	O
cells	O
.	O

Batp1	O
signal	O
exhibited	O
some	O
overlap	O
with	O
the	O
lysosomal	O
marker	O
,	O
Lamp1	O
,	O
but	O
had	O
more	O
significant	O
overlap	O
with	O
early	O
endosome	O
antigen	O
1	O
(	O
EEA1	O
)	O
and	O
the	O
late	O
endosomal	O
marker	O
,	O
Rab7	O
(	O
Fig	O
.	O
3	O
)	O
.	O

Only	O
limited	O
overlap	O
was	O
observed	O
with	O
recycling	O
endosomes	O
,	O
as	O
determined	O
by	O
transferrin	O
receptor	O
co	O
-	O
staining	O
(	O
data	O
not	O
shown	O
)	O
.	O

Intriguingly	O
,	O
Lamp1	O
and	O
EEA1	O
immunocytochemical	O
distribution	O
were	O
altered	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
,	O
with	O
less	O
perinuclear	O
clustering	O
than	O
in	O
wild	O
-	O
type	O
cells	O
,	O
and	O
Rab7	O
staining	O
was	O
frequently	O
less	O
intense	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
(	O
Fig	O
.	O
3	O
)	O
.	O

Heterozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
contained	O
a	O
mixture	O
of	O
Cln3	O
mRNA	B-CHEBI
products	I-CHEBI
from	O
both	O
the	O
wild	O
-	O
type	O
allele	O
and	O
the	O
mutant	O
allele	O
,	O
and	O
batp1	O
signal	O
was	O
similar	O
to	O
that	O
seen	O
in	O
wild	O
-	O
type	O
cells	O
(	O
data	O
not	O
shown	O
)	O
.	O

Figure	O
2	O

RT	O
-	O
PCR	O
of	O
Cln3	O
mRNA	B-CHEBI
in	O
wild	O
-	O
type	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
Cln3	O
Exon1	O
-	O
forward	O
,	O
Exon	O
15	O
-	O
reverse	O
RT	O
-	O
PCR	O
products	O
are	O
shown	O
,	O
from	O
total	O
wild	O
-	O
type	O
(	O
+	O
/	O
+	O
)	O
or	O
homozygous	O
mutant	O
(	O
Delta	O
ex7	O
/	O
8	O
/	O
Delta	O
ex7	O
/	O
8	O
)	O
brain	O
and	O
cell	O
line	O
RNA	O
.	O

Brain	O
and	O
cell	O
line	O
RT	O
-	O
PCR	O
reaction	O
products	O
had	O
identical	O
band	O
patterns	O
on	O
ethidium	B-CHEBI
-	I-CHEBI
bromide	I-CHEBI
stained	O
agarose	B-CHEBI
gels	O
.	O

Wild	O
-	O
type	O
RT	O
-	O
PCR	O
product	O
was	O
a	O
single	O
~	O
1	O
.	O
6	O
kb	O
band	O
and	O
mutant	O
products	O
were	O
~	O
1	O
.	O
6	O
,	O
~	O
1	O
.	O
5	O
,	O
~	O
1	O
.	O
4	O
,	O
~	O
1	O
.	O
35	O
,	O
and	O
~	O
1	O
.	O
3	O
kb	O
,	O
representing	O
multiple	O
mutant	O
splice	O
variants	O
.	O

Figure	O
3	O

Battenin	O
and	O
lysosomal	O
and	O
endosomal	O
marker	O
co	O
-	O
staining	O
in	O
wild	O
-	O
type	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cerebellar	O
precursor	O
cells	O
Batp1	O
immunostaining	O
of	O
wild	O
-	O
type	O
(	O
CbCln3	O
+	O
/	O
+	O
)	O
and	O
homozygous	O
mutant	O
(	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
/	O
Delta	O
ex7	O
/	O
8	O
)	O
cerebellar	O
precursor	O
cells	O
is	O
shown	O
,	O
with	O
co	O
-	O
staining	O
for	O
lysosomes	O
(	O
Lamp	O
1	O
)	O
,	O
early	O
endosomes	O
(	O
EEA1	O
)	O
,	O
and	O
late	O
endosomes	O
(	O
Rab7	O
)	O
.	O

Significant	O
overlap	O
of	O
Batp1	O
signal	O
(	O
red	O
)	O
with	O
EEA1	O
(	O
green	O
,	O
middle	O
panels	O
)	O
and	O
Rab7	O
(	O
green	O
,	O
bottom	O
panels	O
)	O
can	O
be	O
seen	O
as	O
yellow	O
when	O
the	O
two	O
channels	O
are	O
merged	O
(	O
Merge	O
)	O
.	O

The	O
degree	O
of	O
Batp1	O
overlap	O
is	O
greatest	O
with	O
Rab7	O
.	O

Only	O
limited	O
overlap	O
between	O
Batp1	O
(	O
red	O
)	O
and	O
Lamp	O
1	O
(	O
green	O
,	O
top	O
panels	O
)	O
can	O
be	O
seen	O
.	O

Batp1	O
signal	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
is	O
significantly	O
reduced	O
,	O
but	O
significant	O
overlap	O
with	O
EEA1	O
and	O
Rab7	O
,	O
and	O
very	O
little	O
Lamp	O
1	O
overlap	O
,	O
can	O
be	O
seen	O
as	O
yellow	O
in	O
the	O
respective	O
merged	O
panels	O
.	O

Notably	O
,	O
Lamp	O
1	O
and	O
EEA1	O
localization	O
appear	O
altered	O
,	O
and	O
Rab7	O
staining	O
was	O
frequently	O
less	O
intense	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
.	O

Wild	O
-	O
type	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
confocal	O
images	O
were	O
captured	O
with	O
identical	O
exposure	O
settings	O
.	O

60	O
x	O
magnification	O
.	O

During	O
sub	O
-	O
confluent	O
growth	O
conditions	O
,	O
neither	O
wild	O
-	O
type	O
nor	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
displayed	O
autofluorescence	O
or	O
subunit	O
c	O
inclusion	O
formation	O
(	O
data	O
not	O
shown	O
)	O
.	O

However	O
,	O
when	O
cells	O
were	O
aged	O
at	O
confluency	O
(	O
3	O
+	O
days	O
post	O
-	O
confluency	O
)	O
,	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cellular	O
subunit	O
c	O
levels	O
were	O
elevated	O
beyond	O
normal	O
wild	O
-	O
type	O
levels	O
by	O
immunostaining	O
(	O
Fig	O
.	O
4a	O
)	O
and	O
immunoblot	O
analysis	O
(	O
Fig	O
.	O
4b	O
)	O
.	O

Autofluorescent	O
signal	O
sometimes	O
overlapped	O
with	O
subunit	O
c	O
signal	O
,	O
but	O
also	O
was	O
elevated	O
more	O
diffusely	O
(	O
Fig	O
.	O
4a	O
)	O
.	O

Moreover	O
,	O
although	O
multilamellar	O
"	O
fingerprint	O
"	O
profiles	O
were	O
not	O
detected	O
,	O
confluency	O
-	O
aged	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
displayed	O
numerous	O
ultrastructural	O
abnormalities	O
including	O
electron	B-CHEBI
dense	O
inclusions	O
characteristic	O
of	O
lipofuscin	O
and	O
large	O
autophagosomes	O
that	O
contained	O
dense	O
core	O
structures	O
,	O
degenerating	O
mitochondria	O
,	O
and	O
many	O
smaller	O
vesicles	O
(	O
Fig	O
.	O
4c	O
)	O
.	O

Inclusion	O
bodies	O
and	O
autophagosomes	O
were	O
infrequently	O
observed	O
in	O
confluency	O
-	O
aged	O
wild	O
-	O
type	O
cultures	O
(	O
data	O
not	O
shown	O
)	O
.	O

Figure	O
4	O

Subunit	O
c	O
accumulation	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cerebellar	O
precursor	O
cells	O
a	O
.	O

Subunit	O
c	O
immunostaining	O
and	O
autofluorescence	O
of	O
7	O
-	O
day	O
confluency	O
-	O
aged	O
wild	O
-	O
type	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
is	O
shown	O
.	O

Wild	O
-	O
type	O
cultures	O
(	O
CbCln3	O
+	O
/	O
+	O
)	O
exhibited	O
limited	O
subunit	O
c	O
immunostaining	O
and	O
autofluorescence	O
.	O

However	O
,	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
/	O
Delta	O
ex7	O
/	O
8	O
cells	O
contained	O
numerous	O
subunit	O
c	O
puncta	O
.	O

Autofluorescence	O
(	O
7	O
days	O
AF	O
)	O
was	O
also	O
significantly	O
elevated	O
(	O
right	O
panels	O
)	O
,	O
although	O
limited	O
overlap	O
with	O
subunit	O
c	O
puncta	O
was	O
observed	O
(	O
arrows	O
)	O
.	O

40	O
x	O
magnification	O
.	O

b	O
.	O

Immunoblot	O
analysis	O
of	O
subunit	O
c	O
protein	B-CHEBI
at	O
sub	O
-	O
confluency	O
or	O
7	O
-	O
day	O
confluency	O
incubation	O
is	O
shown	O
.	O

Total	O
protein	B-CHEBI
extracts	O
from	O
sub	O
-	O
confluency	O
wild	O
-	O
type	O
(	O
+	O
/	O
+	O
)	O
and	O
homozygous	O
mutant	O
(	O
Delta	O
ex7	O
/	O
8	O
/	O
Delta	O
ex7	O
/	O
8	O
)	O
cultures	O
contained	O
approximately	O
equal	O
levels	O
of	O
subunit	O
c	O
protein	B-CHEBI
(	O
alpha	O
-	O
sub	O
c	O
)	O
.	O

7	O
-	O
day	O
confluency	O
extract	O
from	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
(	O
Delta	O
ex7	O
/	O
8	O
/	O
Delta	O
ex7	O
/	O
8	O
)	O
had	O
elevated	O
levels	O
of	O
subunit	O
c	O
protein	B-CHEBI
(	O
~	O
1	O
.	O
5X	O
)	O
,	O
relative	O
to	O
wild	O
-	O
type	O
extract	O
(	O
+	O
/	O
+	O
)	O
.	O

Protein	B-CHEBI
levels	O
were	O
normalized	O
to	O
cytochrome	B-CHEBI
c	I-CHEBI
oxidase	O
subunit	O
IV	O
(	O
alpha	O
-	O
cox4	O
)	O
.	O

c	O
.	O

TEM	O
analysis	O
of	O
inclusions	O
in	O
7	O
-	O
day	O
confluency	O
-	O
aged	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
is	O
shown	O
.	O

A	O
large	O
autophagosome	O
contained	O
by	O
double	O
membrane	O
(	O
arrows	O
)	O
is	O
filled	O
with	O
degenerating	O
mitochondria	O
(	O
Md	O
)	O
,	O
electron	B-CHEBI
dense	O
cores	O
(	O
left	O
and	O
right	O
of	O
*	O
)	O
and	O
other	O
smaller	O
vesicular	O
structures	O
.	O

A	O
large	O
electron	B-CHEBI
-	O
dense	O
inclusion	O
,	O
with	O
a	O
lipofuscin	O
(	O
Ln	O
)	O
appearance	O
,	O
is	O
also	O
present	O
.	O

M	O
,	O
mitochondria	O
.	O

10	O
,	O
000	O
x	O
magnification	O
.	O

Homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
and	O
Cln3	O
Delta	O
ex7	O
/	O
8	O
knock	O
-	O
in	O
mice	O
process	O
cathepsin	O
D	O
abnormally	O

We	O
next	O
investigated	O
the	O
basis	O
for	O
subunit	O
c	O
accumulation	O
,	O
testing	O
the	O
hypothesis	O
that	O
cathepsin	O
D	O
is	O
abnormal	O
since	O
it	O
is	O
required	O
for	O
ATP	B-CHEBI
synthase	O
subunit	O
c	O
degradation	O
in	O
the	O
lysosome	O
[	O
13	O
]	O
.	O

We	O
first	O
tested	O
cathepsin	O
D	O
transport	O
and	O
processing	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
and	O
Cln3	O
Delta	O
ex7	O
/	O
8	O
mice	O
using	O
anti	O
-	O
cathepsin	O
D	O
antibody	O
that	O
recognizes	O
unprocessed	O
and	O
processed	O
cathepsin	O
D	O
isoforms	O
.	O

Immunostaining	O
of	O
wild	O
-	O
type	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
revealed	O
a	O
perinuclear	O
and	O
punctate	O
vesicular	O
cathepsin	O
D	O
distribution	O
,	O
consistent	O
with	O
its	O
transport	O
and	O
processing	O
through	O
the	O
secretory	O
pathway	O
and	O
delivery	O
to	O
the	O
lysosome	O
(	O
Fig	O
.	O
5a	O
)	O
.	O

However	O
,	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
,	O
cathepsin	O
D	O
distribution	O
was	O
less	O
vesicular	O
and	O
more	O
perinuclear	O
-	O
clustered	O
than	O
in	O
wild	O
-	O
type	O
cells	O
.	O

Immunoblots	O
of	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cell	O
and	O
Cln3	O
Delta	O
ex7	O
/	O
8	O
tissue	O
extracts	O
also	O
showed	O
altered	O
relative	O
levels	O
of	O
cathepsin	O
D	O
isoforms	O
(	O
Fig	O
.	O
5b	O
)	O
.	O

Cathepsin	O
D	O
isoforms	O
,	O
identified	O
by	O
relative	O
molecular	B-CHEBI
weights	O
,	O
represent	O
the	O
~	O
45	O
kDa	O
precursor	O
,	O
the	O
~	O
43	O
kDa	O
intermediate	O
single	O
chain	O
form	O
of	O
the	O
enzyme	O
,	O
and	O
the	O
31	O
kDa	O
heavy	O
chain	O
of	O
the	O
double	O
-	O
chain	O
form	O
of	O
the	O
mature	O
enzyme	O
[	O
14	O
]	O
.	O

In	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cell	O
and	O
Cln3	O
Delta	O
ex7	O
/	O
8	O
tissue	O
extracts	O
,	O
the	O
precursor	O
and	O
heavy	O
chains	O
were	O
reduced	O
,	O
and	O
the	O
single	O
chain	O
was	O
slightly	O
elevated	O
compared	O
to	O
wild	O
-	O
type	O
extracts	O
.	O

The	O
cellular	O
growth	O
media	O
did	O
not	O
contain	O
altered	O
levels	O
of	O
cathepsin	O
D	O
,	O
indicating	O
enzyme	O
secretion	O
was	O
not	O
affected	O
.	O

Heterozygous	O
Cln3	O
Delta	O
ex7	O
/	O
8	O
mice	O
and	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
were	O
indistinguishable	O
from	O
wild	O
-	O
type	O
,	O
as	O
expected	O
for	O
a	O
recessive	O
disease	O
phenotype	O
(	O
data	O
not	O
shown	O
)	O
.	O

Figure	O
5	O

Cathepsin	O
D	O
localization	O
and	O
processing	O
in	O
wild	O
-	O
type	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
a	O
.	O

Immunostaining	O
of	O
wild	O
-	O
type	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
precursor	O
cells	O
with	O
anti	O
-	O
cathepsin	O
D	O
antibody	O
,	O
recognizing	O
unprocessed	O
and	O
processed	O
forms	O
of	O
cathepsin	O
D	O
protein	B-CHEBI
is	O
shown	O
.	O

CbCln3	O
+	O
/	O
+	O
cells	O
(	O
left	O
panel	O
)	O
exhibited	O
a	O
perinuclear	O
and	O
cytoplasmic	O
punctate	O
signal	O
.	O

Cathepsin	O
D	O
signal	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
(	O
right	O
panel	O
)	O
was	O
more	O
often	O
perinuclear	O
,	O
with	O
less	O
cytoplasmic	O
punctate	O
signal	O
,	O
compared	O
to	O
wild	O
-	O
type	O
CbCln3	O
+	O
/	O
+	O
cells	O
.	O

40	O
x	O
magnification	O
.	O

b	O
.	O

alpha	O
-	O
Cathepsin	O
D	O
-	O
probed	O
immunoblots	O
of	O
total	O
wild	O
-	O
type	O
versus	O
homozygous	O
Cln3	O
Delta	O
ex7	O
/	O
8	O
knock	O
-	O
in	O
tissue	O
or	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cellular	O
extracts	O
are	O
shown	O
.	O

The	O
~	O
45	O
kDa	O
cathepsin	O
D	O
band	O
,	O
representing	O
precursor	O
,	O
was	O
the	O
predominant	O
band	O
in	O
wild	O
-	O
type	O
(	O
wt	O
)	O
tissue	O
and	O
cellular	O
extracts	O
,	O
with	O
lower	O
levels	O
of	O
mature	O
enzyme	O
(	O
single	O
chain	O
,	O
~	O
43	O
kDa	O
,	O
and	O
heavy	O
chain	O
,	O
~	O
31	O
kDa	O
)	O
.	O

Conversely	O
,	O
homozygous	O
Cln3	O
Delta	O
ex7	O
/	O
8	O
and	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
mutant	O
(	O
m	O
)	O
extracts	O
exhibited	O
reduced	O
levels	O
of	O
precursor	O
and	O
heavy	O
chain	O
of	O
the	O
double	O
-	O
chain	O
form	O
of	O
the	O
enzyme	O
,	O
with	O
elevated	O
levels	O
of	O
single	O
-	O
chain	O
mature	O
enzyme	O
.	O

The	O
impact	O
of	O
the	O
altered	O
cathepsin	O
D	O
processing	O
on	O
enzymatic	O
activity	O
was	O
next	O
tested	O
to	O
determine	O
if	O
altered	O
enzymatic	O
activity	O
accounts	O
for	O
inefficient	O
subunit	O
c	O
turnover	O
.	O

In	O
a	O
fluorogenic	O
in	O
vitro	O
assay	O
,	O
cathepsin	O
D	O
activity	O
in	O
total	O
cellular	O
extracts	O
was	O
not	O
significantly	O
altered	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
(	O
376	O
+/-	O
89	O
RFU	O
/	O
mu	O
g	O
total	O
protein	B-CHEBI
)	O
,	O
versus	O
wild	O
-	O
type	O
cells	O
(	O
324	O
+/-	O
58	O
RFU	O
/	O
mu	O
g	O
total	O
protein	B-CHEBI
)	O
,	O
although	O
a	O
consistent	O
trend	O
towards	O
increased	O
enzymatic	O
activity	O
in	O
mutant	O
cells	O
was	O
observed	O
.	O

Thus	O
,	O
cathepsin	O
D	O
transport	O
and	O
processing	O
are	O
disrupted	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
in	O
a	O
manner	O
such	O
that	O
enzymatic	O
activity	O
appears	O
to	O
be	O
relatively	O
unaffected	O
.	O

Homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
show	O
abnormal	O
membrane	O
organelles	O

The	O
abnormal	O
transport	O
and	O
processing	O
of	O
cathepsin	O
D	O
suggested	O
membrane	O
trafficking	O
disruptions	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
;	O
therefore	O
,	O
we	O
surveyed	O
the	O
subcellular	O
distribution	O
and	O
morphology	O
of	O
membrane	O
organelles	O
.	O

Components	O
of	O
the	O
secretory	O
pathway	O
,	O
including	O
the	O
ER	O
,	O
cis	O
-	O
Golgi	O
,	O
and	O
trans	O
-	O
Golgi	O
,	O
did	O
not	O
appear	O
altered	O
from	O
wild	O
-	O
type	O
appearance	O
when	O
labeled	O
with	O
the	O
respective	O
markers	O
,	O
protein	B-CHEBI
disulfide	I-CHEBI
isomerase	O
(	O
PDI	O
)	O
,	O
GM130	O
,	O
and	O
VVL	O
(	O
data	O
not	O
shown	O
)	O
.	O

By	O
contrast	O
,	O
the	O
lysosomal	O
markers	O
,	O
Lysotracker	O
and	O
Lamp	O
2	O
had	O
significantly	O
altered	O
signal	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
,	O
versus	O
wild	O
-	O
type	O
cells	O
.	O

Wild	O
-	O
type	O
cells	O
exhibited	O
brightly	O
stained	O
lysosomes	O
that	O
were	O
large	O
and	O
clustered	O
in	O
the	O
perinuclear	O
region	O
whereas	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
lysosomes	O
were	O
lightly	O
stained	O
,	O
smaller	O
vesicles	O
that	O
were	O
more	O
diffusely	O
scattered	O
in	O
the	O
cytoplasm	O
of	O
the	O
cell	O
(	O
Fig	O
.	O
6	O
)	O
.	O

Lamp	O
1	O
distribution	O
was	O
also	O
altered	O
,	O
as	O
previously	O
noted	O
(	O
Fig	O
.	O
3	O
)	O
.	O

However	O
,	O
Lamp	O
1	O
and	O
Lamp	O
2	O
total	O
protein	B-CHEBI
levels	O
were	O
similar	O
in	O
wild	O
-	O
type	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
by	O
immunoblot	O
analysis	O
,	O
indicating	O
the	O
altered	O
signal	O
likely	O
reflects	O
dispersed	O
lysosomes	O
or	O
altered	O
localization	O
and	O
/	O
or	O
epitope	O
availability	O
(	O
data	O
not	O
shown	O
)	O
.	O

It	O
is	O
noteworthy	O
that	O
Lysotracker	O
dye	B-CHEBI
,	O
which	O
selectively	O
accumulates	O
in	O
acidic	B-CHEBI
compartments	O
,	O
exhibited	O
the	O
most	O
marked	O
reduction	O
in	O
lysosomal	O
labeling	O
.	O

This	O
observation	O
may	O
reflect	O
altered	O
lysosomal	O
pH	O
,	O
an	O
established	O
finding	O
in	O
JNCL	O
[	O
10	O
,	O
15	O
]	O
.	O

Figure	O
6	O

Lysotracker	O
and	O
Lamp	O
2	O
labeling	O
of	O
wild	O
-	O
type	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
lysosomes	O
Lysosomal	O
labeling	O
of	O
wild	O
-	O
type	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
precursor	O
cells	O
with	O
lysotracker	O
and	O
Lamp	O
2	O
antibody	O
is	O
shown	O
.	O

Lysotracker	O
dye	B-CHEBI
(	O
top	O
panels	O
)	O
labeled	O
large	O
,	O
perinuclear	O
-	O
clustered	O
lysosomes	O
and	O
scattered	O
lysosomes	O
in	O
the	O
periphery	O
of	O
wild	O
-	O
type	O
cells	O
(	O
CbCln3	O
+	O
/	O
+	O
)	O
.	O

Lysotracker	O
stain	O
was	O
dramatically	O
reduced	O
in	O
homozygous	O
mutant	O
cells	O
(	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
/	O
Delta	O
ex7	O
/	O
8	O
)	O
,	O
with	O
smaller	O
labeled	O
vesicles	O
and	O
less	O
apparent	O
perinuclear	O
clustering	O
.	O

Lamp	O
2	O
(	O
bottom	O
panels	O
)	O
immunostaining	O
also	O
showed	O
reduced	O
signal	O
intensity	O
with	O
less	O
perinuclear	O
clustering	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
,	O
although	O
the	O
effect	O
was	O
somewhat	O
less	O
dramatic	O
than	O
that	O
observed	O
with	O
Lysotracker	O
dye	B-CHEBI
.	O

Wild	O
-	O
type	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
confocal	O
images	O
were	O
captured	O
with	O
identical	O
exposure	O
settings	O
.	O

60	O
x	O
magnification	O
.	O

Consistent	O
with	O
the	O
altered	O
early	O
endosome	O
marker	O
(	O
EEA1	O
)	O
signal	O
observed	O
by	O
immunostaining	O
(	O
Fig	O
.	O
3	O
)	O
,	O
fluid	O
-	O
phase	O
endocytosis	O
was	O
also	O
altered	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
,	O
as	O
measured	O
by	O
dextran	O
-	O
FITC	B-CHEBI
uptake	O
(	O
Fig	O
.	O
7	O
)	O
.	O

Following	O
a	O
15	O
-	O
minute	O
incubation	O
in	O
media	O
containing	O
dextran	O
-	O
FITC	B-CHEBI
,	O
wild	O
-	O
type	O
and	O
heterozygote	O
cells	O
displayed	O
brightly	O
stained	O
,	O
large	O
endocytic	O
vesicles	O
that	O
were	O
clustered	O
in	O
the	O
perinuclear	O
region	O
.	O

However	O
,	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
were	O
less	O
brightly	O
stained	O
with	O
most	O
dextran	O
-	O
FITC	B-CHEBI
signal	O
localizing	O
to	O
smaller	O
vesicles	O
scattered	O
throughout	O
the	O
cytoplasm	O
of	O
the	O
cell	O
.	O

Figure	O
7	O

Endocytosis	O
in	O
wild	O
-	O
type	O
,	O
heterozygous	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
Dextran	O
-	O
FITC	B-CHEBI
uptake	O
in	O
wild	O
-	O
type	O
,	O
heterozygous	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
precursor	O
cells	O
is	O
shown	O
.	O

In	O
wild	O
-	O
type	O
(	O
CbCln3	O
+	O
/	O
+	O
,	O
left	O
panel	O
)	O
and	O
heterozygous	O
(	O
CbCln3	O
+	O
/	O
Delta	O
ex7	O
/	O
8	O
,	O
middle	O
panel	O
)	O
cells	O
,	O
dextran	O
-	O
FITC	B-CHEBI
label	O
was	O
observed	O
in	O
a	O
perinuclear	O
-	O
clustered	O
vesicular	O
pattern	O
with	O
scattered	O
labeled	O
vesicles	O
also	O
present	O
in	O
the	O
periphery	O
.	O

In	O
contrast	O
,	O
dextran	O
-	O
FITC	B-CHEBI
label	O
of	O
homozygous	O
mutant	O
(	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
/	O
Delta	O
ex7	O
/	O
8	O
,	O
right	O
panel	O
)	O
cells	O
was	O
reduced	O
overall	O
and	O
exhibited	O
smaller	O
stained	O
vesicles	O
with	O
less	O
perinuclear	O
clustering	O
.	O

Confocal	O
images	O
were	O
captured	O
with	O
identical	O
exposure	O
settings	O
.	O

40	O
x	O
magnification	O
.	O

Finally	O
,	O
because	O
subunit	O
c	O
is	O
a	O
mitochondrial	O
protein	B-CHEBI
and	O
its	O
turnover	O
proceeds	O
through	O
autophagic	O
engulfment	O
of	O
mitochondria	O
[	O
13	O
]	O
,	O
we	O
analyzed	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cell	O
mitochondrial	O
morphology	O
and	O
function	O
.	O

Mitochondrial	O
distribution	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
was	O
indistinguishable	O
from	O
wild	O
-	O
type	O
and	O
heterozygous	O
cells	O
;	O
however	O
,	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
mitochondria	O
appeared	O
more	O
elongated	O
by	O
grp75	O
marker	O
immunostaining	O
and	O
TEM	O
analysis	O
(	O
Fig	O
.	O
8a	O
)	O
.	O

72	O
%	O
of	O
homozygous	O
mutant	O
mitochondria	O
were	O
greater	O
than	O
0	O
.	O
6	O
mu	O
m	O
in	O
length	O
(	O
range	O
=	O
0	O
.	O
26	O
mu	O
m	O
to	O
2	O
.	O
75	O
mu	O
m	O
)	O
,	O
while	O
fewer	O
wild	O
-	O
type	O
mitochondria	O
(	O
51	O
%	O
)	O
reached	O
this	O
length	O
(	O
range	O
=	O
0	O
.	O
15	O
mu	O
m	O
to	O
2	O
.	O
29	O
mu	O
m	O
)	O
.	O

Mitochondrial	O
width	O
was	O
not	O
altered	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
(	O
data	O
not	O
shown	O
)	O
.	O

Moreover	O
,	O
compared	O
to	O
wild	O
-	O
type	O
or	O
heterozygous	O
cells	O
,	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
had	O
significantly	O
reduced	O
cellular	O
ATP	B-CHEBI
levels	O
(	O
1	O
.	O
3	O
fold	O
less	O
,	O
Fig	O
.	O
8b	O
)	O
and	O
exhibited	O
reduced	O
survival	O
following	O
hydrogen	B-CHEBI
peroxide	I-CHEBI
treatment	O
(	O
~	O
50	O
%	O
of	O
wild	O
-	O
type	O
survival	O
,	O
Fig	O
.	O
8c	O
)	O
,	O
suggesting	O
impaired	O
energy	O
metabolism	O
and	O
oxidative	O
stress	O
response	O
.	O

Taken	O
together	O
,	O
these	O
data	O
support	O
impaired	O
mitochondrial	O
function	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
.	O

Figure	O
8	O

Mitochondrial	O
morphology	O
and	O
function	O
in	O
wild	O
-	O
type	O
,	O
heterozygous	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
a	O
.	O

Confocal	O
and	O
TEM	O
micrographs	O
of	O
wild	O
-	O
type	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
mitochondrial	O
morphology	O
are	O
shown	O
.	O

Immunostaining	O
with	O
the	O
inner	O
mitochondrial	O
membrane	O
marker	O
,	O
grp75	O
(	O
top	O
panels	O
)	O
highlighted	O
elongated	O
mitochondria	O
in	O
homozygous	O
mutant	O
cells	O
(	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
/	O
Delta	O
ex7	O
/	O
8	O
)	O
,	O
relative	O
to	O
wild	O
-	O
type	O
mitochondria	O
(	O
CbCln3	O
+	O
/	O
+	O
)	O
(	O
insets	O
,	O
zoom	O
=	O
2	O
.	O
75x	O
)	O
.	O

Mitochondrial	O
distribution	O
was	O
not	O
altered	O
from	O
the	O
wild	O
-	O
type	O
pattern	O
.	O

Elongated	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
mitochondria	O
were	O
also	O
observed	O
by	O
TEM	O
analysis	O
.	O

60	O
x	O
magnification	O
.	O

b	O
.	O

Cellular	O
ATP	B-CHEBI
levels	O
in	O
wild	O
-	O
type	O
,	O
heterozygous	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
precursor	O
cells	O
are	O
shown	O
.	O

Wild	O
-	O
type	O
(	O
open	O
bar	O
)	O
and	O
heterozygous	O
(	O
gray	O
bar	O
)	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
contained	O
~	O
39	O
mu	O
M	O
ATP	B-CHEBI
,	O
while	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
(	O
black	O
bar	O
)	O
contained	O
~	O
1	O
.	O
3	O
fold	O
reduced	O
levels	O
of	O
ATP	B-CHEBI
(	O
~	O
30	O
mu	O
M	O
)	O
,	O
which	O
was	O
statistically	O
significant	O
in	O
a	O
t	O
-	O
test	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O

Wild	O
-	O
type	O
and	O
heterozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cellular	O
ATP	B-CHEBI
levels	O
were	O
not	O
statistically	O
different	O
from	O
each	O
other	O
(	O
p	O
>	O
0	O
.	O
4	O
)	O
.	O

A	O
representative	O
of	O
triplicate	O
experiments	O
is	O
shown	O
(	O
n	O
=	O
6	O
in	O
each	O
experiment	O
)	O
.	O

c	O
.	O

Cell	O
survival	O
following	O
24	O
-	O
hour	O
hydrogen	B-CHEBI
peroxide	I-CHEBI
treatment	O
is	O
shown	O
.	O

Homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
were	O
~	O
2	O
-	O
fold	O
more	O
sensitive	O
to	O
oxidative	O
stress	O
by	O
hydrogen	B-CHEBI
peroxide	I-CHEBI
treatment	O
.	O

Wild	O
-	O
type	O
(	O
circle	O
)	O
and	O
heterozygous	O
(	O
triangle	O
)	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
exhibited	O
~	O
50	O
%	O
survival	O
rates	O
with	O
75	O
-	O
100	O
mu	O
M	O
H2O2	B-CHEBI
,	O
whereas	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
(	O
squares	O
)	O
had	O
a	O
~	O
50	O
%	O
survival	O
rate	O
with	O
50	O
mu	O
M	O
H2O2	B-CHEBI
.	O

A	O
representative	O
of	O
triplicate	O
experiments	O
is	O
shown	O
(	O
n	O
=	O
4	O
in	O
each	O
experiment	O
)	O
.	O

Discussion	O

CbCln3	O
Delta	O
ex7	O
/	O
8	O
cerebellar	O
precursor	O
cells	O
represent	O
the	O
first	O
genetically	O
accurate	O
neuron	O
-	O
derived	O
culture	O
model	O
of	O
JNCL	O
.	O

Homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
express	O
mutant	O
battenin	O
and	O
JNCL	O
-	O
hallmark	O
mitochondrial	O
ATPase	O
subunit	O
c	O
accumulation	O
,	O
upon	O
aging	O
of	O
cells	O
at	O
confluency	O
.	O

Moreover	O
,	O
this	O
is	O
the	O
first	O
study	O
to	O
indicate	O
recessive	O
endosomal	O
/	O
lysosomal	O
membrane	O
trafficking	O
defects	O
and	O
mitochondrial	O
dysfunction	O
that	O
precedes	O
subunit	O
c	O
deposition	O
in	O
an	O
accurate	O
JNCL	O
model	O
.	O

Importantly	O
,	O
these	O
defects	O
are	O
likely	O
to	O
be	O
early	O
events	O
in	O
the	O
JNCL	O
disease	O
process	O
and	O
may	O
particularly	O
impact	O
neuronal	O
function	O
.	O

Abnormal	O
cathepsin	O
D	O
localization	O
and	O
processing	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
and	O
Cln3	O
Delta	O
ex7	O
/	O
8	O
mice	O
likely	O
reflects	O
altered	O
vesicular	O
trafficking	O
and	O
/	O
or	O
lysosomal	O
pH	O
,	O
which	O
is	O
known	O
to	O
impact	O
cathepsin	O
D	O
processing	O
[	O
14	O
,	O
16	O
]	O
.	O

Indeed	O
,	O
CLN3	O
overexpression	O
in	O
HEK	O
-	O
293	O
cells	O
altered	O
lysosomal	O
pH	O
and	O
cathepsin	O
D	O
processing	O
[	O
17	O
]	O
,	O
and	O
lysosomal	O
pH	O
homeostasis	O
is	O
disrupted	O
in	O
JNCL	O
[	O
10	O
,	O
15	O
]	O
.	O

It	O
is	O
noteworthy	O
that	O
cathepsin	O
B	O
and	O
the	O
CLN2	O
-	O
encoded	O
enzyme	O
,	O
TPPI	O
,	O
are	O
also	O
altered	O
in	O
JNCL	O
[	O
18	O
-	O
20	O
]	O
.	O

Nevertheless	O
,	O
despite	O
the	O
cathepsin	O
D	O
protein	B-CHEBI
alterations	O
that	O
are	O
observed	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
,	O
cathepsin	O
D	O
enzymatic	O
activity	O
does	O
not	O
appear	O
to	O
be	O
reduced	O
.	O

Thus	O
,	O
decreased	O
cathepsin	O
D	O
activity	O
is	O
unlikely	O
to	O
account	O
for	O
subunit	O
c	O
accumulation	O
in	O
JNCL	O
.	O

Aging	O
of	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
at	O
confluency	O
is	O
necessary	O
to	O
induce	O
significantly	O
accumulated	O
subunit	O
c	O
protein	B-CHEBI
.	O

However	O
,	O
membrane	O
organelle	O
disruptions	O
precede	O
subunit	O
c	O
accumulation	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
,	O
since	O
they	O
are	O
observed	O
without	O
aging	O
at	O
confluency	O
.	O

Lysosomal	O
and	O
endosomal	O
size	O
and	O
distribution	O
are	O
altered	O
,	O
and	O
mitochondria	O
are	O
abnormally	O
elongated	O
and	O
functionally	O
compromised	O
in	O
sub	O
-	O
confluent	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cultures	O
.	O

These	O
observations	O
argue	O
that	O
membrane	O
trafficking	O
defects	O
do	O
not	O
result	O
from	O
excessive	O
subunit	O
c	O
accumulation	O
compromising	O
the	O
lysosome	O
,	O
but	O
rather	O
are	O
early	O
events	O
in	O
the	O
disease	O
process	O
preceding	O
subunit	O
c	O
accumulation	O
.	O

Mitochondrial	O
abnormalities	O
,	O
which	O
have	O
also	O
been	O
reported	O
in	O
JNCL	O
patients	O
and	O
other	O
animal	O
models	O
[	O
21	O
-	O
23	O
]	O
,	O
may	O
result	O
from	O
ineffective	O
turnover	O
by	O
autophagy	O
,	O
a	O
lysosomal	O
-	O
targeted	O
pathway	O
[	O
24	O
]	O
.	O

Alternatively	O
,	O
or	O
simultaneously	O
,	O
battenin	O
deficiency	O
may	O
impact	O
mitochondrial	O
function	O
upstream	O
of	O
turnover	O
,	O
affecting	O
mitochondrial	O
biogenesis	O
and	O
/	O
or	O
altered	O
transport	O
and	O
processing	O
of	O
mitochondrial	O
proteins	B-CHEBI
.	O

In	O
wild	O
-	O
type	O
CbCln3	O
neuronal	O
precursor	O
cells	O
battenin	O
primarily	O
co	O
-	O
localizes	O
with	O
early	O
and	O
late	O
endosomes	O
.	O

Battenin	O
immunostaining	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
neuronal	O
precursors	O
is	O
significantly	O
reduced	O
in	O
abundance	O
,	O
but	O
mutant	O
signal	O
also	O
co	O
-	O
localizes	O
with	O
endosomal	O
markers	O
suggesting	O
mutant	O
battenin	O
protein	B-CHEBI
with	O
C	B-CHEBI
-	O
terminal	O
epitopes	O
is	O
trafficked	O
similar	O
to	O
wild	O
-	O
type	O
protein	B-CHEBI
.	O

In	O
other	O
studies	O
,	O
CLN3	O
/	O
battenin	O
protein	B-CHEBI
localization	O
has	O
been	O
reported	O
to	O
partially	O
overlap	O
with	O
late	O
endosomes	O
and	O
lysosomes	O
in	O
non	O
-	O
neuronal	O
cells	O
[	O
7	O
]	O
,	O
and	O
to	O
lysosomes	O
,	O
synaptosomes	O
[	O
8	O
]	O
and	O
endosomes	O
[	O
9	O
,	O
25	O
]	O
in	O
neurons	O
.	O

These	O
data	O
jointly	O
indicate	O
that	O
battenin	O
resides	O
in	O
a	O
subset	O
of	O
vesicular	O
compartments	O
linking	O
multiple	O
membrane	O
trafficking	O
pathways	O
,	O
perhaps	O
functioning	O
in	O
vesicular	O
transport	O
and	O
/	O
or	O
fusion	O
.	O

Endocytic	O
and	O
lysosomal	O
-	O
targeted	O
pathways	O
,	O
including	O
mitochondrial	O
autophagy	O
,	O
are	O
specifically	O
implicated	O
in	O
this	O
study	O
.	O

Conclusions	O

The	O
membrane	O
trafficking	O
and	O
mitochondrial	O
deficits	O
uncovered	O
in	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cells	O
are	O
likely	O
to	O
particularly	O
impact	O
neuronal	O
function	O
.	O

Neurotransmission	O
heavily	O
relies	O
on	O
membrane	O
vesicle	O
transport	O
,	O
and	O
a	O
high	O
-	O
energy	O
metabolism	O
may	O
further	O
sensitize	O
neurons	O
to	O
the	O
loss	O
of	O
battenin	O
activity	O
.	O

Thus	O
,	O
our	O
panel	O
of	O
wild	O
-	O
type	O
,	O
heterozygous	O
,	O
and	O
homozygous	O
CbCln3	O
Delta	O
ex7	O
/	O
8	O
cerebellar	O
cells	O
provide	O
an	O
ideal	O
model	O
system	O
to	O
further	O
elucidate	O
battenin	O
function	O
and	O
JNCL	O
pathogenesis	O
.	O

Methods	O

Antibody	O
and	O
cell	O
staining	O
reagents	B-CHEBI

Nestin	O
(	O
clone	O
Rat	O
401	O
,	O
2	O
mu	O
g	O
/	O
ml	O
)	O
,	O
Lamp	O
1	O
(	O
clone	O
1D4B	O
,	O
6	O
mu	O
g	O
/	O
ml	O
)	O
,	O
and	O
Lamp	O
2	O
(	O
clone	O
Abl	O
-	O
93	O
;	O
6	O
mu	O
g	O
/	O
ml	O
)	O
monoclonal	O
antibodies	O
were	O
obtained	O
from	O
the	O
Developmental	O
Studies	O
Hybridoma	O
Bank	O
,	O
maintained	O
by	O
The	O
University	O
of	O
Iowa	O
,	O
Department	O
of	O
Biological	O
Sciences	O
.	O

Batp1	O
(	O
1	O
mu	O
g	O
/	O
ml	O
)	O
was	O
previously	O
described	O
[	O
12	O
]	O
.	O

Anti	O
-	O
subunit	O
c	O
antibody	O
(	O
0	O
.	O
7	O
mu	O
g	O
/	O
ml	O
)	O
was	O
kindly	O
provided	O
by	O
Dr	O
.	O
Kominami	O
(	O
Juntendo	O
University	O
,	O
Tokyo	O
,	O
Japan	O
)	O
.	O

Additional	O
antibodies	O
were	O
as	O
follows	O
:	O
GFAP	O
,	O
1	O
:	O
2000	O
(	O
DAKO	O
Corporation	O
)	O
;	O
calbindin	O
,	O
1	O
:	O
5000	O
(	O
Sigma	O
)	O
;	O
NeuN	O
,	O
10	O
mu	O
g	O
/	O
ml	O
(	O
Chemicon	O
)	O
;	O
SV40	O
T	O
antigen	O
(	O
Pab	O
101	O
)	O
,	O
2	O
mu	O
g	O
/	O
ml	O
(	O
Santa	O
Cruz	O
Biotechnology	O
)	O
;	O
cathepsin	O
D	O
(	O
C	O
-	O
20	O
)	O
,	O
2	O
mu	O
g	O
/	O
ml	O
(	O
Santa	O
Cruz	O
Biotechnology	O
)	O
;	O
cytochrome	B-CHEBI
c	I-CHEBI
oxidase	O
subunit	O
IV	O
(	O
cox4	O
)	O
,	O
1	O
:	O
1000	O
(	O
BD	O
Biosciences	O
Clontech	O
)	O
;	O
PDI	O
(	O
H	O
-	O
160	O
)	O
,	O
2	O
mu	O
g	O
/	O
ml	O
(	O
Santa	O
Cruz	O
Biotechnology	O
)	O
;	O
GM130	O
,	O
1	O
mu	O
g	O
/	O
ml	O
(	O
BD	O
Transduction	O
Labs	O
)	O
;	O
alpha	O
-	O
tubulin	O
,	O
1	O
:	O
15	O
,	O
000	O
(	O
Sigma	O
)	O
;	O
grp75	O
,	O
1	O
:	O
200	O
(	O
Stressgen	O
)	O
;	O
early	O
endosome	O
antigen	O
-	O
1	O
(	O
EEA1	O
)	O
,	O
2	O
mu	O
g	O
/	O
ml	O
(	O
Santa	O
Cruz	O
Biotechnology	O
)	O
;	O
rab	O
7	O
,	O
4	O
mu	O
g	O
/	O
ml	O
(	O
Santa	O
Cruz	O
Biotechnology	O
)	O
.	O

All	O
fluorescent	O
secondary	O
antibodies	O
were	O
obtained	O
from	O
Jackson	O
ImmunoResearch	O
Laboratories	O
and	O
HRP	O
-	O
conjugated	O
secondary	O
antibodies	O
were	O
obtained	O
from	O
Amersham	O
Biosciences	O
.	O

Additional	O
cell	O
markers	O
were	O
as	O
follows	O
:	O
VVL	O
-	O
biotin	B-CHEBI
,	O
1	O
:	O
2000	O
(	O
Vector	O
Laboratories	O
)	O
,	O
10	O
,	O
000	O
MW	O
dextran	O
-	O
FITC	B-CHEBI
,	O
1	O
mg	O
/	O
ml	O
and	O
Lysotracker	O
Red	O
DND	O
-	O
99	O
,	O
500	O
nM	O
(	O
Molecular	B-CHEBI
Probes	O
)	O
.	O

Generation	O
,	O
maintenance	O
and	O
differentiation	O
of	O
CbCln3	O
cerebellar	O
neuronal	O
precursor	O
lines	O

Cln3	O
Delta	O
ex7	O
/	O
8	O
knock	O
-	O
in	O
mice	O
have	O
been	O
previously	O
described	O
[	O
12	O
]	O
.	O

Littermate	O
pups	O
from	O
heterozygote	O
crosses	O
were	O
used	O
for	O
primary	O
culture	O
establishment	O
,	O
by	O
previously	O
described	O
methods	O
that	O
yield	O
cerebellar	O
granule	O
neuron	O
-	O
enriched	O
cultures	O
[	O
26	O
]	O
.	O

Postnatal	O
day	O
4	O
(	O
P4	O
)	O
cerebella	O
were	O
dissected	O
in	O
Hank	O
'	O
s	O
Balanced	O
Salt	B-CHEBI
Solution	O
(	O
HBSS	O
,	O
Sigma	O
)	O
,	O
supplemented	O
with	O
35	O
mM	O
glucose	B-CHEBI
.	O

Tail	O
biopsies	O
were	O
also	O
collected	O
for	O
genomic	O
DNA	O
isolation	O
and	O
genotypic	O
analysis	O
.	O

Trypsin	O
/	O
EDTA	B-CHEBI
(	O
10	O
mg	O
/	O
ml	O
,	O
Sigma	O
)	O
and	O
DNase	O
I	O
(	O
100	O
mu	O
g	O
/	O
ml	O
,	O
Sigma	O
)	O
,	O
suspended	O
in	O
HBSS	O
,	O
helped	O
dissociate	O
cerebella	O
for	O
primary	O
culture	O
plating	O
onto	O
0	O
.	O
01	O
%	O
poly	O
-	O
ornithine	B-CHEBI
(	O
Sigma	O
)	O
coated	O
100	O
mm	O
dishes	O
.	O

Primary	O
cultures	O
from	O
individual	O
cerebella	O
were	O
cultured	O
overnight	O
at	O
37	O
degrees	O
C	O
,	O
5	O
%	O
CO2	B-CHEBI
,	O
in	O
granule	O
neuron	O
growth	O
media	O
(	O
Dulbecco	O
'	O
s	O
Modified	O
Eagle	O
Medium	O
[	O
DMEM	O
,	O
Gibco	O
BRL	O
#	O
11995	O
-	O
065	O
]	O
,	O
10	O
%	O
fetal	O
bovine	O
serum	O
[	O
Sigma	O
#	O
F	O
-	O
2442	O
]	O
,	O
supplemented	O
with	O
24	O
mM	O
KCl	B-CHEBI
)	O
.	O

Infection	O
was	O
performed	O
the	O
following	O
day	O
with	O
defective	O
retrovirus	O
transducing	O
the	O
temperature	O
-	O
sensitive	O
tsA58	O
/	O
U19	O
large	O
T	O
antigen	O
and	O
a	O
selection	O
neomycin	B-CHEBI
-	O
resistance	O
cassette	O
[	O
27	O
]	O
,	O
as	O
previously	O
described	O
[	O
28	O
]	O
.	O

Following	O
infection	O
,	O
cultures	O
were	O
shifted	O
to	O
the	O
tsA58	O
/	O
U19	O
permissive	O
growth	O
temperature	O
of	O
33	O
degrees	O
C	O
and	O
selection	O
was	O
in	O
the	O
same	O
growth	O
media	O
as	O
above	O
,	O
with	O
200	O
mu	O
g	O
/	O
ml	O
G418	O
.	O

Conditionally	O
immortalized	O
colonies	O
were	O
isolated	O
3	O
-	O
9	O
weeks	O
post	O
-	O
infection	O
and	O
expanded	O
for	O
frozen	O
stocks	O
and	O
further	O
sub	O
-	O
clone	O
isolation	O
.	O

Multiple	O
clonal	O
lines	O
were	O
obtained	O
for	O
each	O
genotype	O
and	O
all	O
phenotypes	O
were	O
confirmed	O
in	O
at	O
least	O
2	O
independent	O
CbCln3	O
cell	O
lines	O
.	O

CbCln3	O
cell	O
lines	O
were	O
maintained	O
on	O
0	O
.	O
01	O
%	O
poly	O
-	O
ornithine	B-CHEBI
coated	O
dishes	O
at	O
30	O
-	O
90	O
%	O
confluency	O
,	O
in	O
33	O
degrees	O
C	O
and	O
5	O
%	O
CO2	B-CHEBI
atmosphere	O
.	O

Passage	O
number	O
was	O
recorded	O
(	O
up	O
to	O
~	O
20	O
passages	O
)	O
,	O
but	O
had	O
no	O
apparent	O
impact	O
on	O
phenotype	O
.	O

Neuronal	O
differentiation	O
was	O
as	O
previously	O
described	O
[	O
29	O
]	O
with	O
the	O
following	O
cocktail	O
:	O
10	O
ng	O
/	O
ml	O
alpha	O
-	O
FGF	O
,	O
250	O
mu	O
M	O
IBMX	B-CHEBI
,	O
200	O
nM	O
TPA	O
,	O
50	O
mu	O
M	O
forskolin	B-CHEBI
,	O
5	O
mu	O
M	O
dopamine	B-CHEBI
(	O
Sigma	O
)	O
.	O

Genotyping	O
and	O
RT	O
-	O
PCR	O

Genomic	O
DNA	O
was	O
extracted	O
from	O
tail	O
biopsies	O
and	O
cell	O
pellets	O
as	O
described	O
(	O
Cotman	O
et	O
al	O
.	O
,	O
2002	O
)	O
.	O

Cln3	O
Delta	O
ex7	O
/	O
8	O
knock	O
-	O
in	O
allele	O
PCR	O
genotyping	O
was	O
with	O
wild	O
-	O
type	O
primers	O
,	O
WtF	O
(	O
5	O
'	O
-	O
CAGCATCTCCTCAGGGCTA	O
-	O
3	O
'	O
)	O
and	O
WtR	O
(	O
5	O
'	O
-	O
CCAACATAGAAAGTAGGGTGTGC	O
-	O
3	O
'	O
)	O
to	O
yield	O
a	O
~	O
250	O
bp	O
band	O
and	O
knock	O
-	O
in	O
primers	O
,	O
552F	O
(	O
5	O
'	O
-	O
GAGCTTTGTTCTGGTTGCCTTC	O
-	O
3	O
'	O
)	O
and	O
Ex9RA	O
(	O
5	O
'	O
-	O
GCAGTCTCTGCCTCGTTTTCT	O
-	O
3	O
'	O
)	O
to	O
yield	O
a	O
~	O
500	O
bp	O
band	O
.	O

PCR	O
cycling	O
conditions	O
were	O
95	O
degrees	O
C	O
for	O
30	O
seconds	O
,	O
58	O
degrees	O
C	O
for	O
30	O
seconds	O
,	O
and	O
72	O
degrees	O
C	O
for	O
35	O
seconds	O
,	O
repeated	O
for	O
34	O
cycles	O
.	O

Total	O
RNA	O
isolation	O
and	O
Cln3	O
RT	O
-	O
PCR	O
primers	O
and	O
procedures	O
have	O
been	O
previously	O
described	O
[	O
12	O
]	O
.	O

Subunit	O
c	O
accumulation	O
assay	O

Cells	O
were	O
seeded	O
into	O
4	O
-	O
well	O
chamber	O
-	O
slides	O
(	O
Falcon	O
)	O
at	O
a	O
density	O
of	O
5	O
x	O
104	O
cells	O
per	O
well	O
for	O
microscopy	O
studies	O
,	O
or	O
into	O
100	O
mm	O
dishes	O
(	O
Falcon	O
)	O
at	O
a	O
density	O
of	O
5	O
x	O
105	O
cells	O
per	O
dish	O
for	O
protein	B-CHEBI
extraction	O
.	O

Cells	O
were	O
typically	O
>	O
95	O
%	O
confluent	O
one	O
day	O
post	O
-	O
plating	O
,	O
and	O
the	O
following	O
day	O
was	O
considered	O
1	O
-	O
day	O
post	O
-	O
confluency	O
.	O

At	O
the	O
indicated	O
times	O
,	O
cells	O
were	O
either	O
fixed	O
with	O
4	O
%	O
formaldehyde	B-CHEBI
in	O
phosphate	B-CHEBI
buffered	B-CHEBI
saline	O
(	O
PBS	O
)	O
,	O
pH	O
7	O
.	O
4	O
,	O
for	O
20	O
minutes	O
and	O
processed	O
for	O
autofluorescence	O
/	O
subunit	O
c	O
immunostaining	O
,	O
or	O
cell	O
pellets	O
were	O
collected	O
for	O
total	O
protein	B-CHEBI
extraction	O
.	O

Alternatively	O
,	O
cells	O
were	O
fixed	O
with	O
2	O
.	O
5	O
%	O
glutaraldehyde	O
/	O
2	O
%	O
paraformaldehyde	O
in	O
0	O
.	O
1	O
M	O
cacodylate	B-CHEBI
buffer	O
,	O
pH	O
7	O
.	O
4	O
for	O
1	O
hour	O
and	O
subsequently	O
post	O
-	O
fixed	O
and	O
processed	O
for	O
TEM	O
analysis	O
as	O
described	O
[	O
12	O
]	O
.	O

In	O
confocal	O
microscopy	O
studies	O
,	O
autofluorescent	O
signal	O
was	O
observed	O
over	O
multiple	O
wavelengths	O
.	O

For	O
co	O
-	O
staining	O
,	O
settings	O
were	O
reduced	O
such	O
that	O
autofluorescent	O
signal	O
did	O
not	O
contribute	O
to	O
antibody	O
label	O
signal	O
.	O

Immunostaining	O
and	O
Immunoblot	O
analysis	O

For	O
immunostaining	O
,	O
cells	O
were	O
seeded	O
at	O
a	O
density	O
of	O
3	O
-	O
5	O
x	O
104	O
cells	O
per	O
well	O
in	O
4	O
-	O
well	O
chamber	O
-	O
slides	O
and	O
grown	O
overnight	O
at	O
33	O
degrees	O
C	O
,	O
unless	O
indicated	O
otherwise	O
.	O

Fixation	O
was	O
with	O
ice	O
-	O
cold	O
4	O
%	O
formaldehyde	B-CHEBI
in	O
PBS	O
,	O
pH	O
7	O
.	O
4	O
,	O
for	O
20	O
minutes	O
,	O
or	O
with	O
ice	O
-	O
cold	O
methanol	B-CHEBI
/	O
acetone	B-CHEBI
(	O
1	O
:	O
1	O
)	O
for	O
10	O
minutes	O
at	O
-	O
20	O
degrees	O
C	O
followed	O
by	O
air	O
-	O
drying	O
(	O
antibody	O
-	O
dependent	O
)	O
.	O

Cells	O
were	O
washed	O
with	O
PBS	O
at	O
least	O
2	O
times	O
,	O
5	O
minutes	O
per	O
wash	O
,	O
between	O
each	O
of	O
the	O
following	O
steps	O
of	O
the	O
staining	O
procedure	O
:	O
0	O
.	O
1	O
M	O
glycine	B-CHEBI
in	O
PBS	O
for	O
5	O
minutes	O
,	O
0	O
.	O
05	O
%	O
or	O
0	O
.	O
1	O
%	O
(	O
antibody	O
-	O
dependent	O
)	O
Triton	O
X	O
-	O
100	O
(	O
Fisher	O
Scientific	O
)	O
in	O
PBS	O
for	O
5	O
minutes	O
,	O
2	O
%	O
bovine	O
serum	O
albumin	O
(	O
BSA	O
)	O
in	O
PBS	O
for	O
30	O
minutes	O
,	O
primary	O
antibody	O
diluted	O
in	O
2	O
%	O
BSA	O
/	O
PBS	O
for	O
90	O
minutes	O
,	O
secondary	O
antibody	O
diluted	O
in	O
2	O
%	O
BSA	O
/	O
PBS	O
for	O
60	O
minutes	O
.	O

All	O
incubations	O
were	O
carried	O
out	O
at	O
room	O
temperature	O
.	O

Following	O
staining	O
procedures	O
,	O
slides	O
were	O
coverslipped	O
with	O
Vectashield	O
mounting	O
medium	O
(	O
Vector	O
Laboratories	O
)	O
and	O
analyzed	O
on	O
a	O
BioRad	O
Radiance	O
2100	O
confocal	O
microscope	O
(	O
Biorad	O
)	O
,	O
with	O
identical	O
exposure	O
settings	O
for	O
wild	O
-	O
type	O
and	O
mutant	O
like	O
images	O
.	O

All	O
comparisons	O
of	O
wild	O
-	O
type	O
and	O
mutant	O
staining	O
were	O
performed	O
in	O
Adobe	O
Photoshop	O
with	O
identical	O
brightness	O
and	O
contrast	O
adjustments	O
.	O

Total	O
proteins	B-CHEBI
were	O
isolated	O
from	O
cell	O
pellets	O
by	O
extraction	O
with	O
ice	O
-	O
cold	O
20	O
mM	O
Tris	B-CHEBI
,	O
pH	O
7	O
.	O
4	O
,	O
1	O
%	O
Triton	O
X	O
-	O
100	O
(	O
membrane	O
-	O
research	O
grade	O
,	O
Roche	O
)	O
,	O
plus	O
protease	B-CHEBI
inhibitors	I-CHEBI
(	O
Complete	O
mini	O
tablet	O
,	O
0	O
.	O
7	O
mu	O
g	O
/	O
ml	O
pepstatin	O
A	O
,	O
2	O
mu	O
g	O
/	O
ml	O
aprotinin	O
,	O
5	O
mu	O
g	O
/	O
ml	O
leupeptin	O
[	O
Roche	O
]	O
)	O
.	O

Following	O
homogenization	O
through	O
a	O
25	O
-	O
gauge	O
needle	O
(	O
~	O
10	O
passes	O
)	O
,	O
extracts	O
were	O
centrifuged	O
at	O
1000	O
x	O
g	O
for	O
10	O
minutes	O
,	O
at	O
4	O
degrees	O
C	O
,	O
to	O
remove	O
debris	O
.	O

Typically	O
,	O
20	O
-	O
40	O
mu	O
g	O
of	O
protein	B-CHEBI
(	O
determined	O
by	O
Bio	O
-	O
rad	O
Dc	O
Protein	B-CHEBI
Assay	O
)	O
was	O
separated	O
by	O
SDS	B-CHEBI
-	O
PAGE	O
,	O
for	O
subsequent	O
immunoblotting	O
,	O
as	O
described	O
[	O
12	O
]	O
.	O

16	O
.	O
5	O
%	O
tris	B-CHEBI
-	O
tricine	B-CHEBI
SDS	B-CHEBI
-	O
PAGE	O
gels	O
were	O
used	O
for	O
subunit	O
c	O
immunoblotting	O
experiments	O
.	O

Cathepsin	O
D	O
activity	O
assay	O

100	O
mm	O
tissue	O
culture	O
dishes	O
,	O
which	O
were	O
approximately	O
80	O
-	O
90	O
%	O
confluent	O
,	O
were	O
washed	O
briefly	O
with	O
ice	O
-	O
cold	O
PBS	O
,	O
and	O
total	O
protein	B-CHEBI
extracts	O
were	O
isolated	O
by	O
scraping	O
cells	O
into	O
10	O
mM	O
Tris	B-CHEBI
,	O
pH	O
7	O
.	O
4	O
,	O
0	O
.	O
1	O
%	O
Triton	O
X	O
-	O
100	O
followed	O
by	O
incubation	O
on	O
ice	O
,	O
for	O
20	O
minutes	O
.	O

The	O
insoluble	O
material	O
was	O
centrifuged	O
at	O
14	O
,	O
000	O
g	O
,	O
the	O
supernatant	O
was	O
isolated	O
,	O
and	O
protein	B-CHEBI
concentration	O
was	O
determined	O
using	O
the	O
Bio	O
-	O
rad	O
Dc	O
Protein	B-CHEBI
Assay	O
.	O

50	O
-	O
70	O
mu	O
g	O
of	O
total	O
protein	B-CHEBI
extract	O
were	O
used	O
to	O
measure	O
cathepsin	O
D	O
activity	O
using	O
the	O
Fluorogenic	O
Innozyme	O
(TM)	O
Cathepsin	O
D	O
Immunocapture	O
Activity	O
Assay	O
Kit	O
(	O
EMD	O
Biosciences	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
recommendations	O
.	O

Relative	O
fluorescence	O
was	O
measured	O
using	O
an	O
Analyst	O
AD	O
plate	O
reader	O
(	O
Molecular	B-CHEBI
Devices	O
)	O
with	O
the	O
following	O
filters	O
and	O
settings	O
:	O
excitation	O
filter	O
,	O
360	O
-	O
35	O
;	O
emission	O
filter	O
,	O
400	O
-	O
20	O
,	O
Flash	O
lamp	O
with	O
100	O
readings	O
/	O
well	O
,	O
100	O
ms	O
between	O
readings	O
,	O
and	O
100	O
,	O
000	O
mu	O
s	O
integration	O
time	O
.	O

Lysosomal	O
staining	O
and	O
endocytic	O
uptake	O

Cells	O
were	O
seeded	O
at	O
a	O
density	O
of	O
3	O
-	O
5	O
x	O
104	O
cells	O
per	O
well	O
in	O
4	O
-	O
well	O
chamber	O
-	O
slides	O
and	O
grown	O
overnight	O
at	O
33	O
degrees	O
C	O
.	O

Growth	O
media	O
was	O
exchanged	O
for	O
fresh	O
,	O
pre	O
-	O
warmed	O
growth	O
media	O
containing	O
500	O
nM	O
Lysotracker	O
or	O
1	O
mg	O
/	O
ml	O
dextran	O
-	O
FITC	B-CHEBI
,	O
and	O
cells	O
were	O
incubated	O
at	O
33	O
degrees	O
C	O
for	O
45	O
minutes	O
or	O
15	O
minutes	O
,	O
respectively	O
.	O

Following	O
labeling	O
,	O
cells	O
were	O
immediately	O
placed	O
on	O
ice	O
and	O
washed	O
for	O
10	O
minutes	O
in	O
ice	O
-	O
cold	O
dye	B-CHEBI
-	O
free	O
media	O
,	O
and	O
fixed	O
with	O
4	O
%	O
formaldehyde	B-CHEBI
in	O
PBS	O
,	O
for	O
20	O
minutes	O
on	O
ice	O
.	O

Chambers	O
were	O
removed	O
and	O
slides	O
were	O
coverslipped	O
with	O
Vectashield	O
mounting	O
media	O
for	O
confocal	O
microscopy	O
analysis	O
,	O
as	O
described	O
above	O
.	O

Morphometric	O
analysis	O
of	O
mitochondria	O

TEM	O
photomicrographs	O
(	O
10	O
,	O
000	O
x	O
-	O
40	O
,	O
000	O
x	O
magnification	O
)	O
were	O
taken	O
from	O
random	O
grid	O
fields	O
.	O

For	O
length	O
measurements	O
,	O
the	O
longest	O
side	O
of	O
each	O
mitochondria	O
was	O
measured	O
in	O
centimeters	O
,	O
and	O
along	O
the	O
length	O
of	O
the	O
mitochondria	O
,	O
width	O
measurements	O
were	O
taken	O
every	O
2	O
.	O
5	O
-	O
4	O
mm	O
(	O
dependent	O
on	O
the	O
magnification	O
of	O
the	O
micrograph	O
image	O
)	O
.	O

Following	O
measurement	O
,	O
all	O
numbers	O
were	O
normalized	O
to	O
reflect	O
one	O
magnification	O
and	O
data	O
was	O
analyzed	O
using	O
Microsoft	O
Excel	O
software	O
.	O

To	O
ascertain	O
unmagnified	O
mitochondrial	O
size	O
,	O
final	O
measurement	O
data	O
,	O
in	O
centimeters	O
,	O
was	O
converted	O
to	O
nanometers	O
according	O
to	O
scale	O
bar	O
representation	O
.	O

ATP	B-CHEBI
measurement	O

ATP	B-CHEBI
was	O
measured	O
by	O
using	O
the	O
CellTiter	O
-	O
GLO	O
(R)	O
Luminescent	O
Cell	O
Viability	O
kit	O
(	O
Promega	O
)	O
,	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
recommendations	O
.	O

Briefly	O
,	O
cells	O
were	O
plated	O
in	O
a	O
black	O
opaque	O
-	O
walled	O
96	O
well	O
plate	O
(	O
Packard	O
Bioscience	O
)	O
at	O
a	O
density	O
of	O
20000	O
/	O
well	O
and	O
incubated	O
at	O
33	O
degrees	O
C	O
overnight	O
.	O

The	O
following	O
day	O
,	O
CellTiter	O
-	O
GLO	O
(R)	O
Reagent	B-CHEBI
was	O
added	O
to	O
each	O
well	O
and	O
cell	O
lysis	O
was	O
induced	O
by	O
mixing	O
2	O
minutes	O
.	O

An	O
ATP	B-CHEBI
standard	O
curve	O
was	O
prepared	O
in	O
the	O
same	O
plate	O
.	O

Before	O
recording	O
luminescence	O
with	O
a	O
microplate	O
luminometer	O
(	O
MicroLumat	O
Plus	O
LB	O
96V	O
,	O
Berthold	O
Techonologies	O
)	O
,	O
the	O
plate	O
was	O
dark	O
adapted	O
for	O
10	O
minutes	O
at	O
room	O
temperature	O
to	O
stabilize	O
the	O
luminescence	O
signal	O
.	O

Hydrogen	B-CHEBI
peroxide	I-CHEBI
treatment	O
assay	O

Cells	O
were	O
plated	O
at	O
a	O
density	O
of	O
10	O
,	O
000	O
cells	O
/	O
well	O
in	O
96	O
-	O
well	O
plates	O
and	O
incubated	O
at	O
33	O
degrees	O
C	O
overnight	O
.	O

The	O
following	O
day	O
,	O
fresh	O
media	O
containing	O
varying	O
concentrations	O
of	O
hydrogen	B-CHEBI
peroxide	I-CHEBI
was	O
dispersed	O
to	O
each	O
well	O
.	O

Cells	O
were	O
incubated	O
in	O
the	O
presence	O
of	O
hydrogen	B-CHEBI
peroxide	I-CHEBI
for	O
24	O
hours	O
,	O
at	O
33	O
degrees	O
C	O
,	O
and	O
viability	O
was	O
measured	O
using	O
the	O
CellTiter	O
-	O
96	O
(R)	O
AQueous	O
Non	O
-	O
Radioactive	O
Cell	O
Proliferation	O
Assay	O
(	O
Promega	O
)	O
,	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
specifications	O
.	O

Authors	O
'	O
contributions	O

EF	O
participated	O
in	O
establishment	O
and	O
characterization	O
of	O
cell	O
lines	O
and	O
performed	O
ATP	B-CHEBI
determinations	O
.	O

PW	O
participated	O
in	O
mitochondrial	O
analysis	O
and	O
immunocytochemistry	O
.	O

JE	O
,	O
TL	O
-	O
N	O
,	O
AMT	O
,	O
and	O
HG	O
participated	O
in	O
genotypic	O
and	O
additional	O
phenotypic	O
analysis	O
of	O
cell	O
lines	O
.	O

DR	O
and	O
EC	O
generated	O
virus	O
-	O
conditioned	O
medium	O
for	O
conditional	O
immortalization	O
of	O
cells	O
.	O

MEM	O
co	O
-	O
conceived	O
of	O
the	O
study	O
and	O
assisted	O
on	O
drafting	O
of	O
the	O
manuscript	O
.	O

SLC	O
co	O
-	O
conceived	O
of	O
the	O
study	O
,	O
participated	O
in	O
establishment	O
and	O
phenotypic	O
analysis	O
of	O
cell	O
lines	O
,	O
and	O
drafted	O
the	O
manuscript	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Acknowledgements	O

The	O
authors	O
thank	O
Dr	O
.	O
E	O
.	O

Kominami	O
for	O
antibody	O
to	O
subunit	O
c	O
of	O
mitochondrial	O
ATPase	O
,	O
L	O
.	O

Trakimas	O
and	O
M	O
.	O

Ericsson	O
of	O
the	O
Harvard	O
Medical	O
School	O
Electron	B-CHEBI
Microscope	O
Facility	O
,	O
Dr	O
.	O
David	O
Sulzer	O
for	O
assistance	O
with	O
TEM	O
analysis	O
,	O
Dr	O
.	O
Sylvie	O
Breton	O
for	O
assistance	O
with	O
endocytosis	O
experiments	O
,	O
and	O
Dr	O
.	O
Andre	O
Bernards	O
and	O
James	O
Follen	O
for	O
assistance	O
with	O
the	O
cathepsin	O
D	O
activity	O
assay	O
.	O

This	O
work	O
was	O
supported	O
by	O
NIH	O
/	O
NINDS	O
grant	O
#	O
NS	O
33648	O
.	O

Dr	O
.	O
S	O
.	O
L	O
.	O

Cotman	O
received	O
fellowship	O
funding	O
from	O
the	O
Batten	O
Disease	O
Support	O
and	O
Research	O
Association	O
(	O
BDSRA	O
)	O
.	O

A	O
Signaling	O
Pathway	O
Involving	O
TGF	O
-	O
beta	O
2	O
and	O
Snail	O
in	O
Hair	O
Follicle	O
Morphogenesis	O

Abstract	O

In	O
a	O
common	O
theme	O
of	O
organogenesis	O
,	O
certain	O
cells	O
within	O
a	O
multipotent	O
epithelial	O
sheet	O
exchange	O
signals	O
with	O
their	O
neighbors	O
and	O
develop	O
into	O
a	O
bud	O
structure	O
.	O

Using	O
hair	O
bud	O
morphogenesis	O
as	O
a	O
paradigm	O
,	O
we	O
employed	O
mutant	O
mouse	O
models	O
and	O
cultured	O
keratinocytes	O
to	O
dissect	O
the	O
contributions	O
of	O
multiple	O
extracellular	O
cues	O
in	O
orchestrating	O
adhesion	O
dynamics	O
and	O
proliferation	O
to	O
shape	O
the	O
cluster	O
of	O
cells	O
involved	O
.	O

We	O
found	O
that	O
transforming	O
growth	O
factor	O
beta	O
2	O
signaling	O
is	O
necessary	O
to	O
transiently	O
induce	O
the	O
transcription	O
factor	O
Snail	O
and	O
activate	O
the	O
Ras	O
-	O
mitogen	O
-	O
activated	O
protein	B-CHEBI
kinase	O
(	O
MAPK	O
)	O
pathway	O
in	O
the	O
bud	O
.	O

In	O
the	O
epidermis	O
,	O
Snail	O
misexpression	O
leads	O
to	O
hyperproliferation	O
and	O
a	O
reduction	O
in	O
intercellular	O
adhesion	O
.	O

When	O
E	O
-	O
cadherin	O
is	O
transcriptionally	O
down	O
-	O
regulated	O
,	O
associated	O
adhesion	O
proteins	B-CHEBI
with	O
dual	O
functions	O
in	O
signaling	O
are	O
released	O
from	O
cell	O
-	O
cell	O
contacts	O
,	O
a	O
process	O
which	O
we	O
demonstrate	O
leads	O
to	O
Ras	O
-	O
MAPK	O
activation	O
.	O

These	O
studies	O
provide	O
insights	O
into	O
how	O
multipotent	O
cells	O
within	O
a	O
sheet	O
are	O
stimulated	O
to	O
undergo	O
transcriptional	O
changes	O
that	O
result	O
in	O
proliferation	O
,	O
junctional	O
remodeling	O
,	O
and	O
bud	O
formation	O
.	O

This	O
novel	O
signaling	O
pathway	O
further	O
weaves	O
together	O
the	O
web	O
of	O
different	O
morphogens	O
and	O
downstream	O
transcriptional	O
events	O
that	O
guide	O
hair	O
bud	O
formation	O
within	O
the	O
developing	O
skin	O
.	O

Introduction	O

Mammalian	O
development	O
involves	O
the	O
morphogenesis	O
of	O
complex	O
three	O
-	O
dimensional	O
structures	O
from	O
seemingly	O
uniform	O
sheets	O
or	O
masses	O
of	O
cells	O
.	O

A	O
simple	O
bud	O
-	O
like	O
structure	O
initiates	O
the	O
formation	O
of	O
many	O
organs	O
,	O
including	O
lungs	O
,	O
spinal	O
cord	O
,	O
mammary	O
glands	O
,	O
and	O
hair	O
follicles	O
[	O
1	O
]	O
.	O

The	O
multipotent	O
,	O
adhering	O
epithelial	O
cells	O
are	O
typically	O
attached	O
to	O
an	O
underlying	O
basal	O
lamina	O
that	O
polarizes	O
the	O
epithelial	O
sheet	O
and	O
separates	O
it	O
from	O
surrounding	O
mesenchyme	O
.	O

Budding	O
morphogenesis	O
is	O
guided	O
by	O
a	O
reciprocal	O
exchange	O
of	O
signals	O
between	O
epithelium	O
and	O
mesenchyme	O
to	O
specify	O
the	O
identity	O
of	O
the	O
organ	O
that	O
will	O
form	O
and	O
to	O
govern	O
its	O
growth	O
.	O

At	O
the	O
helm	O
of	O
these	O
molecular	B-CHEBI
communication	O
pathways	O
are	O
Wnts	O
,	O
bone	O
morphogenic	O
proteins	B-CHEBI
(	O
BMPs	O
)	O
,	O
transforming	O
growth	O
factor	O
beta	O
s	O
(	O
TGF	O
-	O
beta	O
s	O
)	O
,	O
and	O
fibroblast	O
growth	O
factors	O
(	O
FGFs	O
)	O
.	O

Through	O
activation	O
of	O
cell	O
surface	O
transmembrane	O
receptors	O
,	O
these	O
external	O
signaling	O
molecules	B-CHEBI
trigger	O
distinct	O
cascades	O
of	O
intracellular	O
events	O
that	O
culminate	O
in	O
changes	O
in	O
gene	O
expression	O
,	O
growth	O
,	O
and	O
differentiation	O
[	O
2	O
]	O
.	O

How	O
this	O
constellation	O
of	O
signals	O
collaborates	O
in	O
tailoring	O
each	O
budding	O
process	O
so	O
that	O
it	O
executes	O
a	O
distinct	O
morphogenetic	O
program	O
has	O
yet	O
to	O
be	O
comprehensively	O
defined	O
.	O

However	O
,	O
the	O
process	O
appears	O
to	O
be	O
patterned	O
at	O
the	O
initial	O
stages	O
of	O
bud	O
formation	O
,	O
since	O
the	O
relative	O
importance	O
of	O
these	O
pathways	O
and	O
their	O
downstream	O
effectors	B-CHEBI
differ	O
as	O
buds	O
begin	O
to	O
develop	O
and	O
cell	O
fates	O
are	O
specified	O
.	O

The	O
development	O
of	O
a	O
bud	O
requires	O
a	O
number	O
of	O
coordinated	O
changes	O
in	O
the	O
behavior	O
of	O
the	O
targeted	O
cells	O
within	O
an	O
epithelial	O
sheet	O
.	O

The	O
process	O
must	O
be	O
accompanied	O
by	O
alterations	O
in	O
the	O
proliferation	O
,	O
polarity	O
,	O
shape	O
,	O
and	O
adhesiveness	O
of	O
selected	O
cells	O
,	O
as	O
well	O
as	O
by	O
modifications	O
in	O
their	O
underlying	O
basal	O
lamina	O
.	O

Thus	O
,	O
extracellular	O
epithelial	O
-	O
mesenchymal	O
crosstalk	O
must	O
be	O
intricately	O
orchestrated	O
to	O
couple	O
the	O
determination	O
of	O
distinct	O
cell	O
fates	O
with	O
the	O
contemporaneous	O
remodeling	O
of	O
the	O
physical	O
and	O
structural	O
properties	O
of	O
the	O
cell	O
.	O

Among	O
the	O
few	O
dispensable	O
organs	O
,	O
hair	O
follicles	O
offer	O
an	O
excellent	O
model	O
system	O
to	O
study	O
epithelial	O
bud	O
formation	O
.	O

Mammalian	O
skin	O
epithelium	O
begins	O
as	O
a	O
single	O
sheet	O
of	O
multipotent	O
ectodermal	O
cells	O
.	O

During	O
development	O
,	O
specialized	O
mesenchymal	O
cells	O
populate	O
the	O
skin	O
in	O
a	O
spatially	O
defined	O
pattern	O
to	O
initiate	O
the	O
complex	O
epithelial	O
-	O
mesenchymal	O
crosstalk	O
that	O
will	O
specify	O
the	O
bud	O
[	O
3	O
]	O
.	O

Once	O
committed	O
,	O
a	O
small	O
cluster	O
of	O
epithelial	O
cells	O
,	O
the	O
placode	O
,	O
instructs	O
a	O
group	O
of	O
underlying	O
mesenchymal	O
cells	O
to	O
condense	O
and	O
form	O
the	O
nascent	O
dermal	O
papilla	O
,	O
which	O
will	O
be	O
a	O
permanent	O
fixture	O
of	O
the	O
hair	O
follicle	O
.	O

Subsequent	O
exchanges	O
between	O
the	O
placode	O
and	O
nascent	O
dermal	O
papilla	O
result	O
in	O
further	O
growth	O
of	O
the	O
follicle	O
into	O
the	O
underlying	O
dermis	O
,	O
or	O
down	O
-	O
growth	O
,	O
and	O
eventual	O
differentiation	O
into	O
the	O
six	O
concentric	O
layers	O
of	O
the	O
mature	O
follicle	O
.	O

Previously	O
,	O
we	O
delineated	O
how	O
two	O
respective	O
epithelial	O
and	O
mesenchymal	O
signals	O
,	O
Wnts	O
and	O
the	O
BMP	O
-	O
inhibitory	O
factor	O
noggin	O
,	O
function	O
in	O
concert	O
to	O
induce	O
lymphoid	O
enhancer	O
factor	O
-	O
1	O
/	O
beta	O
-	O
catenin	O
(	O
LEF	O
-	O
1	O
/	O
beta	O
-	O
catenin	O
)	O
-	O
mediated	O
gene	O
transcription	O
within	O
the	O
follicle	O
placode	O
[	O
4	O
]	O
.	O

The	O
downstream	O
changes	O
elicited	O
through	O
convergence	O
of	O
these	O
two	O
early	O
signaling	O
pathways	O
include	O
down	O
-	O
regulation	O
of	O
the	O
gene	O
encoding	O
E	O
-	O
cadherin	O
,	O
the	O
prototypical	O
epithelial	O
cadherin	O
that	O
forms	O
the	O
transmembrane	O
core	O
of	O
intercellular	O
adherens	O
junctions	O
(	O
AJs	O
)	O
[	O
5	O
]	O
.	O

We	O
subsequently	O
showed	O
that	O
when	O
E	O
-	O
cadherin	O
is	O
transgenically	O
elevated	O
in	O
mouse	O
skin	O
,	O
hair	O
follicle	O
morphogenesis	O
is	O
blocked	O
,	O
suggesting	O
that	O
E	O
-	O
cadherin	O
down	O
-	O
regulation	O
is	O
a	O
critical	O
event	O
in	O
governing	O
the	O
adhesion	O
dynamics	O
necessary	O
for	O
budding	O
morphogenesis	O
[	O
4	O
]	O
.	O

Like	O
LEF	O
-	O
1	O
,	O
E	O
-	O
cadherin	O
also	O
binds	O
to	O
beta	O
-	O
catenin	O
.	O

At	O
sites	O
of	O
cell	O
-	O
cell	O
contact	O
,	O
however	O
,	O
E	O
-	O
cadherin	O
-	O
beta	O
-	O
catenin	O
complexes	O
recruit	O
alpha	O
-	O
catenin	O
,	O
which	O
in	O
turn	O
coordinates	O
the	O
associated	O
actin	O
polymerization	O
dynamics	O
necessary	O
to	O
stabilize	O
nascent	O
AJs	O
and	O
integrate	O
the	O
cytoskeleton	O
across	O
an	O
epithelial	O
sheet	O
[	O
6	O
,	O
7	O
,	O
8	O
]	O
.	O

alpha	O
-	O
Catenin	O
also	O
binds	O
to	O
the	O
class	O
III	O
Lin	O
-	O
1	O
,	O
Isl	O
-	O
1	O
,	O
Mec	O
-	O
3	O
(	O
LIM	O
)	O
protein	B-CHEBI
Ajuba	O
(	O
a	O
member	O
of	O
the	O
zyxin	O
family	O
of	O
proteins	B-CHEBI
)	O
,	O
which	O
appears	O
to	O
function	O
dually	O
in	O
both	O
adhesion	O
and	O
in	O
activation	O
of	O
the	O
Ras	O
-	O
mitogen	O
-	O
activated	O
protein	B-CHEBI
kinase	O
(	O
MAPK	O
)	O
pathway	O
[	O
9	O
,	O
10	O
]	O
.	O

Through	O
these	O
links	O
,	O
AJs	O
appear	O
able	O
to	O
couple	O
adhesion	O
with	O
cytoskeletal	O
dynamics	O
as	O
well	O
as	O
with	O
nuclear	O
and	O
cytoplasmic	O
signaling	O
.	O

This	O
provides	O
a	O
framework	O
for	O
conceptualizing	O
why	O
E	O
-	O
cadherin	O
levels	O
appear	O
to	O
impact	O
upon	O
a	O
plethora	O
of	O
developmental	O
processes	O
(	O
reviewed	O
in	O
[	O
11	O
]	O
)	O
.	O

As	O
we	O
probed	O
more	O
deeply	O
into	O
the	O
underlying	O
mechanisms	O
governing	O
E	O
-	O
cadherin	O
promoter	O
activity	O
,	O
we	O
were	O
intrigued	O
by	O
the	O
close	O
proximity	O
of	O
the	O
LEF	O
-	O
1	O
/	O
beta	O
-	O
catenin	O
binding	O
site	O
to	O
a	O
site	O
known	O
to	O
bind	O
the	O
Snail	O
/	O
Slug	O
family	O
of	O
zinc	B-CHEBI
finger	O
transcriptional	O
repressor	O
proteins	B-CHEBI
[	O
12	O
,	O
13	O
,	O
14	O
,	O
15	O
]	O
.	O

Both	O
activity	O
of	O
Snail	O
and	O
down	O
-	O
regulation	O
of	O
E	O
-	O
cadherin	O
play	O
pivotal	O
roles	O
in	O
epithelial	O
to	O
mesenchymal	O
transitions	O
(	O
EMTs	O
)	O
,	O
typified	O
by	O
the	O
transformation	O
of	O
polarized	O
,	O
adhering	O
epithelial	O
cells	O
into	O
motile	O
mesenchymal	O
cells	O
[	O
16	O
,	O
17	O
]	O
.	O

Bud	O
formation	O
differs	O
from	O
an	O
EMT	O
in	O
that	O
E	O
-	O
cadherin	O
activity	O
needs	O
to	O
be	O
down	O
-	O
regulated	O
but	O
not	O
prevented	O
,	O
so	O
that	O
adhesive	O
junctions	O
are	O
remodeled	O
rather	O
than	O
quantitatively	O
impaired	O
.	O

Supportive	O
of	O
an	O
underlying	O
ability	O
to	O
fine	O
-	O
tune	O
cadherin	O
expression	O
at	O
the	O
transcriptional	O
level	O
,	O
Snail	O
seems	O
to	O
have	O
an	O
additive	O
effect	O
with	O
LEF	O
-	O
1	O
/	O
beta	O
-	O
catenin	O
in	O
negatively	O
modulating	O
E	O
-	O
cadherin	O
promoter	O
activity	O
[	O
4	O
]	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
discovered	O
that	O
Snail	O
is	O
expressed	O
briefly	O
at	O
an	O
early	O
stage	O
of	O
hair	O
bud	O
formation	O
,	O
when	O
E	O
-	O
cadherin	O
down	O
-	O
regulation	O
and	O
activation	O
of	O
proliferation	O
take	O
place	O
.	O

Thereafter	O
,	O
Snail	O
disappears	O
and	O
remains	O
absent	O
during	O
subsequent	O
follicle	O
down	O
-	O
growth	O
and	O
maturation	O
.	O

This	O
exquisite	O
pattern	O
appears	O
to	O
be	O
functionally	O
relevant	O
since	O
altering	O
it	O
in	O
vivo	O
correspondingly	O
affects	O
features	O
associated	O
with	O
hair	O
bud	O
formation	O
,	O
including	O
down	O
-	O
regulation	O
of	O
E	O
-	O
cadherin	O
,	O
increased	O
proliferation	O
,	O
and	O
repressed	O
terminal	O
differentiation	O
.	O

Although	O
the	O
temporal	O
spike	O
of	O
Snail	O
in	O
the	O
hair	O
bud	O
is	O
reflected	O
at	O
the	O
mRNA	B-CHEBI
level	O
and	O
seems	O
to	O
follow	O
Wnt	O
signaling	O
and	O
BMP	O
inhibition	O
,	O
LEF	O
-	O
1	O
/	O
beta	O
-	O
catenin	O
activation	O
does	O
not	O
appear	O
to	O
induce	O
Snail	O
gene	O
expression	O
in	O
embryonic	O
skin	O
keratinocytes	O
.	O

In	O
contrast	O
,	O
we	O
provide	O
in	O
vitro	O
,	O
transgenic	O
(	O
Tg	O
)	O
,	O
and	O
gene	O
targeting	O
evidence	O
to	O
show	O
that	O
TGF	O
-	O
beta	O
2	O
and	O
small	O
phenotype	O
-	O
and	O
mothers	O
against	O
decapentaplegic	O
-	O
related	O
protein	B-CHEBI
2	O
(	O
SMAD2	O
)	O
signaling	O
are	O
upstream	O
inducers	O
of	O
Snail	O
gene	O
expression	O
in	O
skin	O
epithelium	O
.	O

In	O
the	O
absence	O
of	O
TGF	O
-	O
beta	O
2	O
signaling	O
and	O
Snail	O
gene	O
expression	O
,	O
hair	O
placodes	O
can	O
form	O
,	O
but	O
further	O
follicle	O
down	O
-	O
growth	O
is	O
blocked	O
.	O

Our	O
studies	O
point	O
to	O
the	O
view	O
that	O
Snail	O
likely	O
functions	O
downstream	O
of	O
cell	O
fate	O
specification	O
,	O
at	O
a	O
stage	O
where	O
the	O
bud	O
begins	O
to	O
exhibit	O
enhanced	O
proliferation	O
and	O
migration	O
.	O

Results	O

Snail	O
mRNA	B-CHEBI
and	O
Protein	B-CHEBI
Are	O
Expressed	O
Transiently	O
at	O
the	O
Hair	O
Bud	O
Stage	O
of	O
Follicle	O
Morphogenesis	O

Although	O
Snail	O
family	O
members	O
are	O
most	O
frequently	O
associated	O
with	O
EMTs	O
,	O
they	O
also	O
participate	O
in	O
many	O
malignant	O
processes	O
involving	O
a	O
down	O
-	O
regulation	O
but	O
not	O
a	O
quantitative	O
abrogation	O
of	O
intercellular	O
junctions	O
[	O
18	O
]	O
.	O

The	O
range	O
of	O
developmental	O
processes	O
in	O
which	O
Snail	O
family	O
members	O
have	O
been	O
implicated	O
thus	O
includes	O
the	O
type	O
of	O
epithelial	O
remodeling	O
that	O
is	O
observed	O
in	O
hair	O
follicle	O
bud	O
formation	O
.	O

Given	O
our	O
prior	O
observation	O
that	O
exogenously	O
added	O
Snail	O
can	O
participate	O
with	O
LEF	O
-	O
1	O
/	O
beta	O
-	O
catenin	O
in	O
down	O
-	O
regulating	O
E	O
-	O
cadherin	O
expression	O
in	O
keratinocytes	O
[	O
4	O
]	O
,	O
coupled	O
with	O
the	O
established	O
requirement	O
for	O
LEF	O
-	O
1	O
/	O
beta	O
-	O
catenin	O
in	O
hair	O
follicle	O
morphogenesis	O
[	O
4	O
,	O
19	O
]	O
,	O
we	O
turned	O
to	O
addressing	O
whether	O
Snail	O
/	O
Slug	O
family	O
members	O
might	O
also	O
participate	O
in	O
the	O
process	O
.	O

PCR	O
analyses	O
identified	O
transient	O
Snail	O
mRNA	B-CHEBI
expression	O
during	O
a	O
period	O
of	O
skin	O
embryogenesis	O
when	O
waves	O
of	O
hair	O
follicles	O
are	O
forming	O
(	O
unpublished	O
data	O
)	O
.	O
To	O
pinpoint	O
specifically	O
where	O
Snail	O
mRNA	B-CHEBI
is	O
expressed	O
in	O
the	O
developing	O
skin	O
,	O
we	O
conducted	O
in	O
situ	O
hybridization	O
using	O
a	O
cRNA	O
probe	O
unique	O
to	O
the	O
Snail	O
3	O
'	O
untranslated	O
region	O
(	O
UTR	O
)	O
.	O

Embryonic	O
day	O
17	O
.	O
5	O
(	O
E17	O
.	O
5	O
)	O
was	O
chosen	O
,	O
since	O
the	O
multiple	O
waves	O
of	O
follicle	O
morphogenesis	O
occurring	O
at	O
this	O
time	O
enabled	O
us	O
to	O
evaluate	O
Snail	O
expression	O
at	O
different	O
stages	O
of	O
the	O
process	O
.	O

As	O
shown	O
in	O
Figure	O
1A	O
,	O
specific	O
hybridization	O
was	O
detected	O
within	O
the	O
epithelium	O
of	O
nascent	O
hair	O
buds	O
.	O

By	O
contrast	O
,	O
as	O
follicles	O
progressed	O
further	O
through	O
their	O
development	O
(	O
e	O
.	O
g	O
.	O
,	O
germ	O
and	O
peg	O
stages	O
)	O
,	O
they	O
exhibited	O
no	O
signs	O
of	O
hybridization	O
(	O
Figure	O
1A	O
)	O
.	O

The	O
transient	O
nature	O
of	O
Snail	O
mRNA	B-CHEBI
expression	O
during	O
follicle	O
development	O
was	O
most	O
apparent	O
in	O
hybridized	O
skin	O
sections	O
containing	O
follicles	O
from	O
two	O
different	O
waves	O
of	O
morphogenesis	O
(	O
as	O
shown	O
in	O
Figure	O
1	O
)	O
.	O

Hybridizing	O
hair	O
buds	O
from	O
a	O
later	O
wave	O
appeared	O
juxtaposed	O
with	O
nonhybridizing	O
follicles	O
from	O
an	O
earlier	O
wave	O
.	O

To	O
determine	O
whether	O
this	O
transient	O
nature	O
of	O
Snail	O
mRNA	B-CHEBI
expression	O
is	O
reflected	O
at	O
the	O
protein	B-CHEBI
level	O
,	O
we	O
generated	O
an	O
antibody	O
against	O
the	O
N	B-CHEBI
-	O
terminal	O
sequence	O
that	O
resides	O
upstream	O
of	O
the	O
more	O
conserved	O
zinc	B-CHEBI
finger	O
domains	O
.	O

As	O
judged	O
by	O
Western	O
blot	O
analysis	O
,	O
the	O
antibody	O
did	O
not	O
detect	O
endogenous	O
proteins	B-CHEBI
from	O
cultured	O
keratinocytes	O
,	O
but	O
it	O
did	O
yield	O
a	O
band	O
of	O
the	O
expected	O
size	O
from	O
keratinocytes	O
transiently	O
expressing	O
a	O
hemagglutinin	O
(	O
HA	O
)	O
-	O
tagged	O
Snail	O
protein	B-CHEBI
(	O
Figure	O
1B	O
)	O
.	O

The	O
antibody	O
also	O
recognized	O
a	O
band	O
corresponding	O
to	O
the	O
size	O
of	O
endogenous	O
Snail	O
(	O
approximately	O
28	O
kDa	O
)	O
in	O
lysates	O
from	O
embryonic	O
mouse	O
skin	O
,	O
the	O
temporal	O
appearance	O
of	O
which	O
corresponded	O
to	O
the	O
waves	O
of	O
hair	O
follicle	O
morphogenesis	O
from	O
E15	O
.	O
5	O
to	O
newborn	O
when	O
over	O
90	O
%	O
of	O
the	O
hair	O
on	O
the	O
mouse	O
is	O
formed	O
(	O
Figure	O
1B	O
)	O
.	O

Consistent	O
with	O
the	O
Western	O
blot	O
data	O
,	O
immunohistochemical	O
analysis	O
did	O
not	O
detect	O
Snail	O
in	O
single	O
-	O
layered	O
E13	O
.	O
5	O
epidermis	O
(	O
Figure	O
1C	O
)	O
nor	O
in	O
the	O
placode	O
,	O
which	O
is	O
the	O
earliest	O
morphological	O
sign	O
of	O
the	O
commitment	O
of	O
multipotent	O
cells	O
of	O
the	O
embryonic	O
ectoderm	O
to	O
a	O
hair	O
cell	O
fate	O
(	O
Figure	O
1D	O
)	O
.	O

Consistent	O
with	O
the	O
in	O
situ	O
hybridization	O
results	O
,	O
anti	O
-	O
Snail	O
antibody	O
labeled	O
only	O
hair	O
buds	O
and	O
not	O
follicles	O
at	O
more	O
mature	O
stages	O
of	O
development	O
(	O
Figure	O
1E	O
)	O
.	O

Taken	O
together	O
,	O
the	O
anti	O
-	O
Snail	O
antibody	O
appeared	O
to	O
be	O
specific	O
for	O
its	O
target	O
protein	B-CHEBI
.	O

It	O
did	O
not	O
detect	O
other	O
Snail	O
family	O
members	O
known	O
to	O
be	O
expressed	O
in	O
keratinocytes	O
and	O
/	O
or	O
skin	O
(	O
unpublished	O
data	O
)	O
.	O

Furthermore	O
,	O
the	O
immunohistochemical	O
data	O
paralleled	O
our	O
Snail	O
in	O
situ	O
hybridization	O
data	O
revealing	O
transient	O
Snail	O
expression	O
at	O
the	O
hair	O
bud	O
stage	O
(	O
Figure	O
1A	O
)	O
.	O

As	O
judged	O
by	O
immunohistochemistry	O
,	O
Snail	O
protein	B-CHEBI
was	O
localized	O
to	O
the	O
nuclei	O
of	O
the	O
hair	O
bud	O
cells	O
(	O
Figure	O
1E	O
)	O
.	O

This	O
feature	O
was	O
consistent	O
with	O
Snail	O
'	O
s	O
known	O
function	O
as	O
a	O
transcriptional	O
repressor	O
[	O
12	O
,	O
13	O
]	O
.	O

Additionally	O
,	O
anti	O
-	O
Snail	O
labeling	O
was	O
detected	O
in	O
only	O
three	O
of	O
the	O
four	O
major	O
waves	O
of	O
follicle	O
morphogenesis	O
.	O

Snail	O
was	O
not	O
found	O
in	O
the	O
buds	O
of	O
guard	O
hairs	O
that	O
are	O
the	O
earliest	O
of	O
all	O
hairs	O
to	O
form	O
(	O
at	O
E13	O
.	O
5	O
)	O
,	O
and	O
which	O
constitute	O
less	O
than	O
5	O
%	O
of	O
the	O
mouse	O
coat	O
(	O
unpublished	O
data	O
)	O
.	O

As	O
judged	O
by	O
immunofluorescence	O
with	O
antibodies	O
against	O
the	O
proliferating	O
nuclear	O
antigen	O
Ki67	O
,	O
the	O
timing	O
of	O
Snail	O
expression	O
coincided	O
with	O
the	O
stage	O
at	O
which	O
the	O
developing	O
follicle	O
enhanced	O
its	O
proliferation	O
and	O
down	O
-	O
growth	O
(	O
Figure	O
1F	O
)	O
.	O

Immunohistochemistry	O
with	O
antibodies	O
against	O
the	O
active	O
(	O
phosphorylated	O
)	O
form	O
of	O
MAPK	O
(	O
pMAPK	O
)	O
marked	O
a	O
subset	O
of	O
the	O
proliferating	O
(	O
Ki67	O
-	O
positive	O
)	O
cells	O
,	O
and	O
pMAPK	O
-	O
positive	O
cells	O
were	O
enriched	O
in	O
the	O
hair	O
bud	O
(	O
Figure	O
1G	O
)	O
.	O

The	O
timing	O
of	O
Snail	O
induction	O
and	O
Ki67	O
and	O
pMAPK	O
enrichment	O
in	O
the	O
hair	O
bud	O
appeared	O
to	O
follow	O
closely	O
the	O
induction	O
of	O
LEF	O
-	O
1	O
/	O
beta	O
-	O
catenin	O
activity	O
,	O
known	O
to	O
initiate	O
in	O
the	O
hair	O
placode	O
stage	O
[	O
20	O
]	O
.	O

However	O
,	O
like	O
placodes	O
,	O
hair	O
buds	O
exhibited	O
down	O
-	O
regulation	O
in	O
E	O
-	O
cadherin	O
expression	O
(	O
Figure	O
1H	O
;	O
see	O
also	O
[	O
4	O
]	O
)	O
.	O

Sustained	O
Expression	O
of	O
Snail	O
Results	O
in	O
Epidermal	O
Hyperproliferation	O
and	O
Differentiation	O
Defects	O
in	O
Tg	O
Mouse	O
Skin	O

The	O
striking	O
spike	O
of	O
Snail	O
expression	O
coincident	O
with	O
hair	O
bud	O
formation	O
and	O
enhanced	O
proliferation	O
prompted	O
us	O
to	O
examine	O
the	O
consequences	O
of	O
ectopically	O
expressing	O
Snail	O
elsewhere	O
in	O
mouse	O
skin	O
epidermis	O
.	O

To	O
distinguish	O
Tg	O
from	O
endogenous	O
Snail	O
,	O
we	O
used	O
the	O
HA	O
-	O
epitope	O
,	O
shown	O
previously	O
not	O
to	O
alter	O
Snail	O
'	O
s	O
transcriptional	O
activity	O
[	O
12	O
]	O
.	O

Of	O
20	O
K14	O
-	O
Snail	O
[	O
HA	O
]	O
Tg	O
animals	O
generated	O
,	O
three	O
expressed	O
the	O
transgene	O
and	O
all	O
exhibited	O
analogous	O
phenotypes	O
.	O

Mice	O
that	O
integrated	O
the	O
transgene	O
at	O
the	O
single	O
-	O
cell	O
stage	O
died	O
at	O
or	O
shortly	O
after	O
birth	O
.	O

The	O
three	O
surviving	O
full	O
-	O
Tg	O
founder	O
mice	O
harbored	O
transgene	O
integrations	O
that	O
gave	O
stable	O
transmission	O
of	O
mosaic	O
Snail	O
gene	O
expression	O
through	O
the	O
germline	O
.	O

Progressively	O
poor	O
health	O
necessitated	O
our	O
sacrificing	O
most	O
offspring	O
from	O
these	O
lines	O
within	O
a	O
year	O
of	O
birth	O
.	O

As	O
Snail	O
Tg	O
animals	O
grew	O
,	O
they	O
became	O
distinguished	O
by	O
their	O
small	O
size	O
,	O
short	O
tails	O
,	O
and	O
flaky	O
skin	O
(	O
Figure	O
2A	O
)	O
.	O

Histological	O
analyses	O
of	O
3	O
-	O
d	O
old	O
(	O
P3	O
)	O
mice	O
revealed	O
mosaic	O
patches	O
marked	O
by	O
epidermal	O
thickening	O
(	O
Figure	O
2B	O
)	O
.	O

The	O
mosaic	O
morphology	O
was	O
reflected	O
at	O
the	O
level	O
of	O
Tg	O
Snail	O
protein	B-CHEBI
,	O
with	O
only	O
the	O
hyperthickened	O
regions	O
expressing	O
nuclear	O
HA	O
-	O
tagged	O
Snail	O
(	O
Figure	O
2C	O
)	O
.	O

These	O
hyperthickened	O
areas	O
were	O
marked	O
by	O
excessive	O
proliferation	O
,	O
as	O
revealed	O
by	O
antibodies	O
against	O
the	O
proliferating	O
nuclear	O
antigen	O
Ki67	O
(	O
Figure	O
2D	O
and	O
2E	O
)	O
.	O

Activated	O
,	O
pMAPK	O
-	O
positive	O
cells	O
were	O
also	O
prevalent	O
in	O
these	O
areas	O
(	O
Figure	O
2F	O
and	O
2G	O
)	O
,	O
as	O
were	O
cells	O
expressing	O
keratin	O
6	O
,	O
a	O
keratin	O
induced	O
in	O
the	O
suprabasal	O
layers	O
of	O
hyperproliferative	O
skin	O
(	O
Figure	O
2H	O
and	O
2I	O
)	O
.	O

Expression	O
of	O
the	O
Snail	O
transgene	O
did	O
not	O
block	O
terminal	O
differentiation	O
in	O
the	O
hyperproliferative	O
epidermis	O
,	O
but	O
it	O
distorted	O
it	O
markedly	O
(	O
Figure	O
3A	O
-	O
3H	O
)	O
.	O

Typical	O
of	O
most	O
hyperproliferating	O
conditions	O
,	O
Snail	O
expression	O
led	O
to	O
a	O
large	O
expansion	O
in	O
layers	O
with	O
spinous	O
and	O
granular	O
morphology	O
.	O

Additionally	O
,	O
however	O
,	O
was	O
a	O
marked	O
and	O
variable	O
expansion	O
of	O
keratin	O
5	O
(	O
K5	O
)	O
,	O
normally	O
restricted	O
to	O
the	O
innermost	O
basal	O
layer	O
(	O
see	O
Figure	O
3	O
)	O
.	O

Although	O
the	O
failure	O
of	O
Snail	O
-	O
null	O
mice	O
to	O
develop	O
past	O
gastrulation	O
[	O
21	O
]	O
precluded	O
our	O
ability	O
to	O
study	O
the	O
loss	O
of	O
Snail	O
function	O
in	O
skin	O
development	O
,	O
a	O
good	O
correlation	O
emerged	O
between	O
the	O
expression	O
of	O
Snail	O
protein	B-CHEBI
and	O
the	O
extension	O
of	O
K5	O
,	O
Ki67	O
,	O
and	O
pMAPK	O
suprabasally	O
(	O
compare	O
data	O
in	O
Figures	O
2	O
and	O
3	O
)	O
.	O

The	O
changes	O
in	O
hyperproliferation	O
and	O
differentiation	O
were	O
not	O
initially	O
accompanied	O
by	O
gross	O
signs	O
of	O
epithelial	O
invaginations	O
.	O

With	O
age	O
,	O
however	O
,	O
epidermal	O
folds	O
and	O
undulations	O
developed	O
in	O
areas	O
where	O
Snail	O
was	O
expressed	O
,	O
and	O
proliferative	O
markers	O
persisted	O
in	O
these	O
regions	O
(	O
Figure	O
3I	O
and	O
3J	O
;	O
anti	O
-	O
cyclin	O
D	O
staining	O
)	O
.	O

The	O
undulations	O
were	O
accompanied	O
by	O
partial	O
dissolution	O
of	O
the	O
underlying	O
basement	O
membrane	O
(	O
Figure	O
3K	O
and	O
3L	O
)	O
.	O

Aberrant	O
staining	O
was	O
also	O
observed	O
with	O
antibodies	O
against	O
components	O
of	O
the	O
hemidesmosomes	O
,	O
which	O
provide	O
strong	O
adhesion	O
of	O
basal	O
epidermal	O
cells	O
to	O
the	O
underlying	O
basal	O
lamina	O
(	O
Figure	O
3M	O
and	O
3N	O
)	O
.	O

Interestingly	O
,	O
similar	O
types	O
of	O
alterations	O
occur	O
in	O
the	O
basement	O
membrane	O
in	O
the	O
hair	O
bud	O
of	O
embryonic	O
and	O
newborn	O
mice	O
when	O
Snail	O
is	O
normally	O
expressed	O
.	O

The	O
fact	O
that	O
the	O
basement	O
membrane	O
separating	O
the	O
epidermis	O
from	O
the	O
dermis	O
is	O
altered	O
only	O
in	O
the	O
adult	O
Tg	O
animals	O
suggests	O
the	O
involvement	O
of	O
intermediary	O
factors	O
not	O
as	O
readily	O
available	O
in	O
the	O
epidermis	O
as	O
they	O
are	O
in	O
the	O
follicle	O
.	O

Possible	O
Links	O
between	O
Epidermal	O
Hyperproliferation	O
and	O
Down	O
-	O
regulation	O
of	O
AJ	O
Proteins	B-CHEBI
in	O
Snail	O
Tg	O
Mice	O

Given	O
that	O
the	O
E	O
-	O
cadherin	O
promoter	O
is	O
a	O
direct	O
target	O
for	O
Snail	O
-	O
mediated	O
repression	O
in	O
vitro	O
[	O
4	O
,	O
12	O
,	O
13	O
]	O
,	O
and	O
that	O
E	O
-	O
cadherin	O
was	O
down	O
-	O
regulated	O
in	O
Snail	O
-	O
expressing	O
hair	O
buds	O
,	O
we	O
examined	O
the	O
status	O
of	O
E	O
-	O
cadherin	O
and	O
other	O
AJ	O
proteins	B-CHEBI
within	O
regions	O
of	O
hyperproliferative	O
epidermis	O
where	O
Tg	O
Snail	O
was	O
present	O
(	O
Figure	O
4A	O
)	O
.	O

In	O
these	O
regions	O
,	O
immunofluorescence	O
staining	O
of	O
E	O
-	O
cadherin	O
and	O
alpha	O
-	O
catenin	O
were	O
markedly	O
diminished	O
.	O

In	O
contrast	O
,	O
the	O
intensity	O
of	O
antibody	O
staining	O
for	O
two	O
other	O
AJ	O
proteins	B-CHEBI
,	O
beta	O
-	O
catenin	O
and	O
Ajuba	O
,	O
was	O
still	O
strong	O
.	O

Interestingly	O
,	O
however	O
,	O
despite	O
appreciable	O
immunofluorescence	O
,	O
localization	O
of	O
beta	O
-	O
catenin	O
and	O
Ajuba	O
appeared	O
to	O
be	O
largely	O
cytoplasmic	O
rather	O
than	O
at	O
cell	O
-	O
cell	O
borders	O
(	O
Figure	O
4A	O
insets	O
)	O
.	O

Architectural	O
differences	O
in	O
the	O
epidermis	O
made	O
Western	O
blot	O
analyses	O
somewhat	O
difficult	O
to	O
gauge	O
.	O

However	O
,	O
in	O
regions	O
such	O
as	O
ear	O
skin	O
,	O
where	O
the	O
highest	O
levels	O
of	O
Snail	O
protein	B-CHEBI
were	O
expressed	O
,	O
the	O
effects	O
were	O
accentuated	O
.	O

In	O
both	O
back	O
skin	O
and	O
ear	O
skin	O
,	O
overall	O
levels	O
of	O
E	O
-	O
cadherin	O
and	O
alpha	O
-	O
catenin	O
were	O
reduced	O
,	O
under	O
conditions	O
where	O
beta	O
-	O
catenin	O
and	O
Ajuba	O
levels	O
remained	O
unchanged	O
relative	O
to	O
controls	O
(	O
Figure	O
4B	O
)	O
.	O

Taken	O
together	O
,	O
these	O
data	O
were	O
consistent	O
with	O
our	O
results	O
obtained	O
from	O
immunofluorescence	O
microscopy	O
.	O

A	O
priori	O
,	O
the	O
decrease	O
in	O
alpha	O
-	O
catenin	O
levels	O
could	O
be	O
due	O
to	O
either	O
direct	O
transcriptional	O
repression	O
by	O
Snail	O
or	O
perturbations	O
in	O
AJ	O
formation	O
caused	O
by	O
the	O
decrease	O
in	O
E	O
-	O
cadherin	O
gene	O
expression	O
.	O

To	O
distinguish	O
between	O
these	O
possibilities	O
,	O
we	O
tested	O
whether	O
alpha	O
-	O
catenin	O
levels	O
could	O
be	O
restored	O
by	O
exogenous	O
expression	O
of	O
E	O
-	O
cadherin	O
in	O
Snail	O
-	O
expressing	O
keratinocytes	O
.	O

As	O
shown	O
in	O
Figure	O
4C	O
,	O
transiently	O
transfected	O
keratinocytes	O
expressing	O
HA	O
-	O
tagged	O
Snail	O
displayed	O
a	O
loss	O
of	O
E	O
-	O
cadherin	O
and	O
alpha	O
-	O
catenin	O
at	O
cell	O
-	O
cell	O
borders	O
.	O

Coexpression	O
of	O
exogenous	O
HA	O
-	O
tagged	O
E	O
-	O
cadherin	O
not	O
only	O
enabled	O
cell	O
-	O
cell	O
border	O
localization	O
of	O
E	O
-	O
cadherin	O
protein	B-CHEBI
,	O
but	O
also	O
rescued	O
the	O
cell	O
-	O
cell	O
border	O
staining	O
of	O
alpha	O
-	O
catenin	O
(	O
Figure	O
4C	O
)	O
.	O

The	O
ability	O
to	O
restore	O
alpha	O
-	O
catenin	O
expression	O
and	O
localization	O
under	O
these	O
conditions	O
argues	O
against	O
the	O
notion	O
that	O
Snail	O
transcriptionally	O
represses	O
alpha	O
-	O
catenin	O
.	O

Rather	O
,	O
the	O
findings	O
are	O
consistent	O
with	O
a	O
previous	O
report	O
that	O
E	O
-	O
cadherin	O
is	O
required	O
for	O
the	O
translation	O
of	O
alpha	O
-	O
catenin	O
mRNA	B-CHEBI
[	O
22	O
]	O
.	O

Despite	O
the	O
reductions	O
in	O
AJ	O
markers	O
,	O
Tg	O
skin	O
still	O
displayed	O
sealed	O
membranes	O
and	O
intercellular	O
junctions	O
that	O
were	O
largely	O
intact	O
,	O
as	O
judged	O
by	O
ultrastructural	O
analyses	O
(	O
unpublished	O
data	O
)	O
.	O

In	O
this	O
respect	O
,	O
the	O
skin	O
epithelium	O
resembled	O
that	O
of	O
the	O
hair	O
bud	O
,	O
where	O
the	O
down	O
-	O
regulation	O
in	O
junction	O
proteins	B-CHEBI
is	O
permissive	O
for	O
cell	O
-	O
cell	O
remodeling	O
without	O
abrogating	O
intercellular	O
adhesion	O
.	O

The	O
similarities	O
between	O
Snail	O
Tg	O
epidermis	O
and	O
hair	O
buds	O
extended	O
to	O
the	O
hyperproliferative	O
state	O
,	O
leading	O
us	O
to	O
wonder	O
whether	O
the	O
down	O
-	O
regulation	O
of	O
AJ	O
proteins	B-CHEBI
might	O
contribute	O
to	O
this	O
condition	O
.	O

Given	O
the	O
increase	O
in	O
pMAPK	O
staining	O
in	O
Snail	O
Tg	O
epidermis	O
(	O
see	O
Figure	O
2G	O
)	O
,	O
we	O
used	O
pMAPK	O
levels	O
as	O
our	O
assay	O
to	O
test	O
whether	O
the	O
loss	O
of	O
E	O
-	O
cadherin	O
contributed	O
to	O
the	O
Snail	O
-	O
mediated	O
increase	O
in	O
proliferation	O
.	O

Consistent	O
with	O
our	O
in	O
vivo	O
observations	O
,	O
transfected	O
keratinocytes	O
expressing	O
Snail	O
exhibited	O
a	O
substantial	O
increase	O
in	O
pMAPK	O
levels	O
relative	O
to	O
control	O
cells	O
(	O
Figure	O
4D	O
)	O
.	O

Coexpression	O
of	O
E	O
-	O
cadherin	O
with	O
Snail	O
appeared	O
to	O
abrogate	O
this	O
effect	O
.	O

Together	O
,	O
these	O
findings	O
raised	O
the	O
possibility	O
that	O
an	O
AJ	O
-	O
associated	O
protein	B-CHEBI
that	O
is	O
normally	O
sequestered	O
at	O
the	O
plasma	O
membrane	O
may	O
participate	O
in	O
a	O
proliferation	O
signaling	O
pathway	O
when	O
AJs	O
are	O
deconstructed	O
.	O

Numerous	O
studies	O
have	O
correlated	O
a	O
down	O
-	O
regulation	O
of	O
E	O
-	O
cadherin	O
with	O
a	O
translocation	O
of	O
beta	O
-	O
catenin	O
to	O
the	O
nucleus	O
and	O
a	O
transactivation	O
of	O
genes	O
that	O
are	O
regulated	O
by	O
the	O
LEF	O
-	O
1	O
/	O
T	O
cell	O
factor	O
(	O
TCF	O
)	O
family	O
of	O
DNA	O
binding	O
proteins	B-CHEBI
[	O
23	O
,	O
24	O
,	O
25	O
]	O
.	O

The	O
presence	O
of	O
nuclear	O
cyclin	O
D	O
in	O
hyperproliferative	O
Snail	O
Tg	O
epidermis	O
was	O
particularly	O
intriguing	O
since	O
prior	O
studies	O
have	O
reported	O
cyclin	O
D	O
gene	O
as	O
a	O
direct	O
target	O
of	O
TCF	O
/	O
beta	O
-	O
catenin	O
transcription	O
[	O
26	O
]	O
.	O

This	O
said	O
,	O
we	O
did	O
not	O
detect	O
nuclear	O
beta	O
-	O
catenin	O
in	O
our	O
Tg	O
epidermis	O
,	O
and	O
mating	O
the	O
Snail	O
Tg	O
mice	O
against	O
the	O
TOPGal	O
reporter	O
mouse	O
[	O
20	O
]	O
gave	O
no	O
signs	O
of	O
ectopic	O
LEF	O
-	O
1	O
/	O
Tcf	O
/	O
beta	O
-	O
catenin	O
activity	O
(	O
unpublished	O
data	O
)	O
.	O

We	O
next	O
turned	O
to	O
the	O
presence	O
of	O
cytoplasmic	O
Ajuba	O
for	O
a	O
possible	O
mechanistic	O
link	O
to	O
the	O
proliferative	O
increase	O
in	O
our	O
Snail	O
Tg	O
epidermis	O
.	O

In	O
addition	O
to	O
its	O
documented	O
ability	O
to	O
bind	O
alpha	O
-	O
catenin	O
[	O
10	O
]	O
,	O
Ajuba	O
can	O
also	O
associate	O
with	O
growth	O
factor	O
receptor	O
-	O
bound	O
protein	B-CHEBI
-	O
2	O
(	O
Grb	O
-	O
2	O
)	O
/	O
son	O
of	O
sevenless	O
(	O
Sos	O
)	O
,	O
the	O
nucleotide	B-CHEBI
exchange	O
factor	O
for	O
Ras	O
,	O
which	O
is	O
upstream	O
from	O
activation	O
of	O
MAPK	O
[	O
9	O
]	O
.	O

Given	O
the	O
increase	O
in	O
pMAPK	O
staining	O
in	O
Tg	O
skin	O
,	O
we	O
examined	O
the	O
possibility	O
that	O
Ajuba	O
might	O
have	O
changed	O
its	O
binding	O
partner	O
in	O
Snail	O
-	O
expressing	O
epidermis	O
.	O

Interestingly	O
,	O
Ajuba	O
was	O
readily	O
detected	O
in	O
anti	O
-	O
Grb	O
-	O
2	O
immunoprecipitates	O
of	O
protein	B-CHEBI
lysates	O
from	O
skins	O
of	O
Snail	O
Tg	O
mice	O
but	O
not	O
from	O
the	O
corresponding	O
wild	O
-	O
type	O
(	O
WT	O
)	O
animals	O
(	O
Figure	O
4E	O
)	O
.	O

When	O
these	O
experiments	O
were	O
repeated	O
with	O
alpha	O
-	O
catenin	O
-	O
null	O
epidermis	O
,	O
a	O
similar	O
Grb	O
-	O
2	O
-	O
Ajuba	O
association	O
was	O
detected	O
,	O
and	O
again	O
,	O
this	O
interaction	O
was	O
not	O
detected	O
in	O
the	O
protein	B-CHEBI
extracts	O
from	O
control	O
littermate	O
skin	O
(	O
Figure	O
4E	O
)	O
.	O

Together	O
,	O
these	O
data	O
demonstrate	O
that	O
the	O
reduction	O
in	O
alpha	O
-	O
catenin	O
levels	O
,	O
either	O
by	O
Snail	O
-	O
mediated	O
down	O
-	O
regulation	O
of	O
E	O
-	O
cadherin	O
or	O
by	O
alpha	O
-	O
catenin	O
conditional	O
targeting	O
,	O
allows	O
Ajuba	O
to	O
interact	O
with	O
Grb	O
-	O
2	O
/	O
Sos	O
.	O

If	O
the	O
competition	O
between	O
Grb	O
-	O
2	O
/	O
Sos	O
and	O
alpha	O
-	O
catenin	O
for	O
Ajuba	O
is	O
functionally	O
relevant	O
to	O
the	O
hyperproliferative	O
state	O
of	O
a	O
keratinocyte	O
,	O
then	O
overexpression	O
of	O
Ajuba	O
would	O
be	O
expected	O
to	O
bypass	O
the	O
competition	O
and	O
promote	O
activation	O
of	O
the	O
Ras	O
-	O
MAPK	O
pathway	O
in	O
WT	O
keratinocytes	O
.	O

Indeed	O
,	O
when	O
serum	O
-	O
starved	O
keratinocytes	O
were	O
transiently	O
transfected	O
with	O
an	O
Ajuba	O
expression	O
vector	O
,	O
the	O
levels	O
of	O
pMAPK	O
were	O
not	O
only	O
elevated	O
but	O
also	O
comparable	O
to	O
those	O
transfected	O
with	O
the	O
K14	O
-	O
HASnail	O
transgene	O
(	O
Figure	O
4F	O
)	O
.	O

This	O
activation	O
was	O
abolished	O
when	O
cells	O
were	O
treated	O
with	O
a	O
small	O
peptide	O
inhibitor	B-CHEBI
that	O
specifically	O
interrupts	O
the	O
Grb	O
-	O
2	O
/	O
Sos	O
interaction	O
(	O
Figure	O
4F	O
;	O
see	O
lanes	O
marked	O
"	O
inh	O
"	O
)	O
[	O
27	O
]	O
.	O

Ajuba	O
'	O
s	O
pre	O
-	O
LIM	O
domain	O
is	O
the	O
segment	O
that	O
associates	O
with	O
Grb	O
-	O
2	O
'	O
s	O
Src	O
-	O
homology	O
3	O
domain	O
[	O
9	O
]	O
.	O

When	O
this	O
domain	O
was	O
overexpressed	O
in	O
serum	O
-	O
starved	O
keratinocytes	O
,	O
a	O
comparable	O
elevation	O
in	O
pMAPK	O
was	O
observed	O
(	O
Figure	O
4F	O
)	O
.	O

As	O
expected	O
,	O
the	O
small	O
peptide	O
inhibitor	B-CHEBI
that	O
interrupts	O
the	O
Grb	O
-	O
2	O
/	O
Sos	O
association	O
blocked	O
the	O
effects	O
.	O

These	O
data	O
suggested	O
that	O
by	O
elevating	O
cytosolic	O
Ajuba	O
levels	O
,	O
Ajuba	O
'	O
s	O
pre	O
-	O
LIM	O
domain	O
may	O
associate	O
with	O
Grb	O
-	O
2	O
/	O
Sos	O
in	O
a	O
manner	O
that	O
stimulates	O
its	O
nucleotide	B-CHEBI
exchange	O
activity	O
and	O
leads	O
to	O
activation	O
of	O
the	O
Ras	O
-	O
MAPK	O
pathway	O
.	O

Although	O
this	O
pathway	O
provides	O
one	O
mechanism	O
by	O
which	O
Snail	O
expression	O
and	O
proliferation	O
may	O
be	O
coupled	O
in	O
skin	O
epithelium	O
,	O
proliferative	O
circuitries	O
involving	O
AJs	O
are	O
known	O
to	O
be	O
complex	O
and	O
often	O
interwoven	O
.	O

Future	O
studies	O
will	O
be	O
needed	O
to	O
systematically	O
dissect	O
these	O
putative	O
intricacies	O
at	O
a	O
molecular	B-CHEBI
level	O
.	O

Probing	O
the	O
Regulation	O
of	O
Snail	O
Gene	O
Expression	O
Reveals	O
an	O
Essential	O
Link	O
to	O
TGF	O
-	O
beta	O
2	O
Signaling	O
in	O
the	O
Developing	O
Hair	O
Bud	O

The	O
temporal	O
spike	O
of	O
Snail	O
mRNA	B-CHEBI
expression	O
in	O
the	O
hair	O
bud	O
prompted	O
us	O
to	O
consider	O
what	O
factor	O
(	O
s	O
)	O
may	O
be	O
regulating	O
the	O
Snail	O
gene	O
.	O

A	O
variety	O
of	O
extracellular	O
signals	O
have	O
an	O
impact	O
on	O
the	O
cell	O
type	O
-	O
specific	O
expression	O
of	O
different	O
Snail	O
family	O
members	O
,	O
and	O
many	O
of	O
them	O
,	O
including	O
Wnts	O
,	O
BMPs	O
,	O
FGFs	O
,	O
and	O
TGF	O
-	O
beta	O
s	O
,	O
also	O
affect	O
hair	O
bud	O
development	O
[	O
2	O
,	O
16	O
,	O
28	O
]	O
.	O

Since	O
Snail	O
is	O
not	O
expressed	O
in	O
cultured	O
skin	O
keratinocytes	O
that	O
secrete	O
active	O
BMPs	O
and	O
FGFs	O
(	O
see	O
Figure	O
1B	O
)	O
,	O
we	O
focused	O
our	O
attention	O
on	O
Wnt	O
and	O
TGF	O
-	O
beta	O
signaling	O
as	O
more	O
likely	O
candidates	O
for	O
Snail	O
induction	O
in	O
this	O
cell	O
type	O
.	O

Previously	O
,	O
we	O
showed	O
that	O
effective	O
transmission	O
of	O
a	O
Wnt	O
-	O
3a	O
signal	O
in	O
cultured	O
keratinocytes	O
can	O
be	O
achieved	O
through	O
their	O
exposure	O
to	O
the	O
BMP	O
inhibitor	B-CHEBI
noggin	O
,	O
which	O
induces	O
LEF	O
-	O
1	O
expression	O
[	O
4	O
]	O
.	O

In	O
vitro	O
,	O
these	O
conditions	O
down	O
-	O
regulated	O
the	O
E	O
-	O
cadherin	O
promoter	O
and	O
induced	O
a	O
LEF	O
-	O
1	O
/	O
beta	O
-	O
catenin	O
-	O
sensitive	O
reporter	O
gene	O
,	O
TOPFLASH	O
[	O
4	O
]	O
.	O

In	O
contrast	O
,	O
Snail	O
expression	O
was	O
not	O
induced	O
by	O
these	O
conditions	O
(	O
Figure	O
5A	O
)	O
.	O

Thus	O
,	O
despite	O
essential	O
roles	O
for	O
Wnts	O
and	O
noggin	O
in	O
hair	O
follicle	O
specification	O
[	O
4	O
,	O
29	O
,	O
30	O
]	O
,	O
our	O
studies	O
did	O
not	O
support	O
an	O
essential	O
role	O
for	O
these	O
signals	O
in	O
governing	O
Snail	O
expression	O
in	O
keratinocytes	O
.	O

TGF	O
-	O
beta	O
1	O
has	O
been	O
shown	O
to	O
induce	O
Snail	O
family	O
members	O
in	O
hepatocytes	O
and	O
heart	O
[	O
15	O
,	O
31	O
]	O
.	O

In	O
keratinocytes	O
,	O
however	O
,	O
TGF	O
-	O
beta	O
1	O
inhibits	O
keratinocyte	O
growth	O
and	O
seems	O
to	O
be	O
involved	O
in	O
triggering	O
the	O
destructive	O
phase	O
of	O
the	O
cycling	O
hair	O
follicle	O
[	O
32	O
]	O
.	O

Of	O
the	O
loss	O
-	O
of	O
-	O
function	O
mutations	O
generated	O
in	O
each	O
of	O
the	O
TGF	O
-	O
beta	O
genes	O
,	O
only	O
the	O
TGF	O
-	O
beta	O
2	O
null	O
state	O
blocked	O
follicle	O
development	O
at	O
the	O
hair	O
bud	O
stage	O
[	O
32	O
]	O
.	O

Thus	O
,	O
we	O
turned	O
towards	O
addressing	O
whether	O
TGF	O
-	O
beta	O
2	O
might	O
be	O
involved	O
in	O
regulating	O
Snail	O
expression	O
in	O
keratinocytes	O
isolated	O
from	O
the	O
basal	O
layer	O
of	O
the	O
epidermis	O
.	O

Though	O
there	O
is	O
no	O
cell	O
culture	O
system	O
available	O
to	O
specifically	O
study	O
placodal	O
cells	O
,	O
these	O
keratinocytes	O
are	O
their	O
progenitors	O
and	O
are	O
the	O
closest	O
approximation	O
available	O
to	O
study	O
the	O
behavior	O
of	O
epithelial	O
cells	O
of	O
the	O
placode	O
.	O

Interestingly	O
,	O
treatment	O
of	O
cultured	O
keratinocytes	O
with	O
as	O
little	O
as	O
5	O
ng	O
/	O
ml	O
of	O
TGF	O
-	O
beta	O
2	O
caused	O
a	O
rapid	O
and	O
transient	O
induction	O
of	O
Snail	O
(	O
Figure	O
5B	O
)	O
.	O

Following	O
this	O
treatment	O
,	O
Snail	O
protein	B-CHEBI
was	O
detected	O
within	O
30	O
min	O
,	O
peaked	O
at	O
2	O
h	O
,	O
and	O
then	O
declined	O
thereafter	O
.	O

The	O
induction	O
of	O
Snail	O
appeared	O
to	O
be	O
specific	O
for	O
the	O
active	O
form	O
of	O
the	O
growth	O
factor	O
,	O
as	O
pretreatment	O
of	O
TGF	O
-	O
beta	O
2	O
for	O
10	O
min	O
at	O
100	O
degrees	O
C	O
obliterated	O
the	O
response	O
[	O
Figure	O
5B	O
,	O
lanes	O
marked	O
(	O
-	O
)	O
]	O
.	O

By	O
contrast	O
,	O
although	O
TGF	O
-	O
beta	O
receptor	O
activation	O
remained	O
elevated	O
during	O
the	O
duration	O
of	O
the	O
experiment	O
(	O
as	O
measured	O
by	O
the	O
sustained	O
phosphorylation	O
of	O
the	O
downstream	O
effector	B-CHEBI
SMAD2	O
)	O
Snail	O
expression	O
could	O
not	O
be	O
maintained	O
(	O
Figure	O
5B	O
)	O
.	O

Thus	O
,	O
although	O
Snail	O
expression	O
correlated	O
with	O
phosphorylated	O
SMAD2	O
(	O
pSMAD2	O
)	O
induction	O
,	O
its	O
decline	O
seemed	O
to	O
rely	O
on	O
secondary	O
downstream	O
events	O
.	O

The	O
rapid	O
kinetics	O
of	O
Snail	O
expression	O
were	O
reflected	O
at	O
the	O
mRNA	B-CHEBI
level	O
,	O
suggesting	O
that	O
Snail	O
promoter	O
activity	O
in	O
keratinocytes	O
might	O
be	O
sensitive	O
to	O
TGF	O
-	O
beta	O
2	O
signaling	O
(	O
Figure	O
5C	O
)	O
.	O

To	O
test	O
this	O
possibility	O
,	O
we	O
engineered	O
a	O
transgene	O
driving	O
the	O
beta	O
-	O
galactosidase	O
reporter	O
under	O
the	O
control	O
of	O
approximately	O
2	O
.	O
2	O
kb	O
of	O
promoter	O
sequence	O
located	O
5	O
'	O
from	O
the	O
transcription	O
initiation	O
site	O
of	O
the	O
mouse	O
Snail	O
gene	O
.	O

At	O
2	O
d	O
after	O
transient	O
transfection	O
,	O
keratinocytes	O
were	O
treated	O
with	O
TGF	O
-	O
beta	O
2	O
(	O
t	O
=	O
0	O
)	O
and	O
then	O
assayed	O
for	O
transgene	O
activity	O
over	O
the	O
same	O
time	O
course	O
in	O
which	O
we	O
had	O
observed	O
Snail	O
protein	B-CHEBI
induction	O
.	O

The	O
results	O
of	O
this	O
experiment	O
are	O
presented	O
in	O
Figure	O
5D	O
.	O

Within	O
0	O
.	O
5	O
h	O
of	O
TGF	O
-	O
beta	O
2	O
treatment	O
,	O
Snail	O
promoter	O
activity	O
had	O
increased	O
3	O
-	O
fold	O
,	O
and	O
by	O
2	O
h	O
,	O
it	O
peaked	O
to	O
approximately	O
10	O
-	O
fold	O
over	O
control	O
levels	O
(	O
Figure	O
5D	O
)	O
.	O

Thereafter	O
,	O
Snail	O
promoter	O
activity	O
rapidly	O
returned	O
to	O
the	O
basal	O
levels	O
seen	O
in	O
unstimulated	O
keratinocytes	O
.	O

The	O
kinetics	O
of	O
Snail	O
promoter	O
activity	O
closely	O
paralleled	O
those	O
observed	O
for	O
Snail	O
protein	B-CHEBI
induction	O
.	O

Moreover	O
,	O
the	O
stimulatory	O
effects	O
appeared	O
to	O
be	O
specific	O
to	O
TGF	O
-	O
beta	O
2	O
,	O
since	O
they	O
were	O
abrogated	O
either	O
by	O
heat	O
inactivation	O
of	O
the	O
TGF	O
-	O
beta	O
2	O
protein	B-CHEBI
or	O
by	O
mutation	O
of	O
a	O
putative	O
SMAD	O
binding	O
element	O
located	O
about	O
1	O
.	O
8	O
kb	O
5	O
'	O
from	O
the	O
Snail	O
transcription	O
start	O
site	O
(	O
Figure	O
5D	O
)	O
.	O

Taken	O
together	O
,	O
these	O
results	O
suggested	O
that	O
in	O
keratinocytes	O
,	O
TGF	O
-	O
beta	O
2	O
signaling	O
results	O
in	O
a	O
pSMAD2	O
-	O
dependent	O
transient	O
activation	O
of	O
the	O
Snail	O
gene	O
,	O
and	O
that	O
maintenance	O
of	O
Snail	O
protein	B-CHEBI
relies	O
,	O
in	O
part	O
,	O
upon	O
sustained	O
promoter	O
activity	O
.	O

The	O
brevity	O
of	O
Snail	O
gene	O
and	O
protein	B-CHEBI
induction	O
in	O
TGF	O
-	O
beta	O
2	O
treated	O
cultured	O
keratinocytes	O
resembled	O
the	O
temporal	O
appearance	O
of	O
Snail	O
mRNA	B-CHEBI
and	O
protein	B-CHEBI
at	O
the	O
initiation	O
of	O
hair	O
follicle	O
morphogenesis	O
in	O
embryonic	O
mouse	O
skin	O
.	O

To	O
test	O
whether	O
TGF	O
-	O
beta	O
2	O
might	O
be	O
required	O
for	O
Snail	O
induction	O
in	O
hair	O
bud	O
formation	O
in	O
vivo	O
,	O
we	O
first	O
analyzed	O
whether	O
TGF	O
-	O
beta	O
2	O
was	O
expressed	O
in	O
or	O
around	O
the	O
hair	O
bud	O
.	O

Consistent	O
with	O
previous	O
observations	O
[	O
33	O
]	O
,	O
an	O
anti	O
-	O
TGF	O
-	O
beta	O
2	O
antibody	O
labeled	O
developing	O
hair	O
buds	O
(	O
Figure	O
6A	O
)	O
.	O

This	O
labeling	O
appeared	O
to	O
be	O
specific	O
as	O
judged	O
by	O
the	O
lack	O
of	O
staining	O
in	O
follicle	O
buds	O
from	O
mice	O
homozygous	O
for	O
a	O
TGF	O
-	O
beta	O
2	O
null	O
mutation	O
(	O
Figure	O
6A	O
;	O
[	O
34	O
]	O
)	O
.	O

Moreover	O
,	O
the	O
downstream	O
effector	B-CHEBI
of	O
TGF	O
-	O
beta	O
2	O
signaling	O
,	O
pSMAD2	O
,	O
was	O
also	O
expressed	O
in	O
WT	O
,	O
but	O
not	O
TGF	O
-	O
beta	O
2	O
-	O
null	O
,	O
hair	O
buds	O
(	O
Figure	O
6B	O
)	O
.	O

Together	O
,	O
these	O
data	O
underscore	O
the	O
importance	O
of	O
the	O
TGF	O
-	O
beta	O
2	O
isoform	O
despite	O
expression	O
of	O
both	O
TGF	O
-	O
beta	O
1	O
and	O
TGF	O
-	O
beta	O
2	O
in	O
developing	O
hair	O
buds	O
at	O
this	O
stage	O
.	O

To	O
further	O
explore	O
the	O
possible	O
relation	O
between	O
Snail	O
and	O
TGF	O
-	O
beta	O
2	O
,	O
we	O
examined	O
the	O
status	O
of	O
Snail	O
expression	O
in	O
TGF	O
-	O
beta	O
2	O
-	O
null	O
hair	O
buds	O
.	O

As	O
judged	O
by	O
immunohistochemistry	O
,	O
Snail	O
protein	B-CHEBI
was	O
absent	O
from	O
E17	O
.	O
5	O
skin	O
of	O
TGF	O
-	O
beta	O
2	O
-	O
null	O
embryos	O
but	O
not	O
from	O
that	O
of	O
control	O
littermates	O
(	O
Figure	O
6C	O
)	O
.	O

This	O
effect	O
appeared	O
to	O
be	O
exerted	O
at	O
the	O
transcriptional	O
level	O
,	O
since	O
Snail	O
mRNAs	B-CHEBI
were	O
also	O
not	O
found	O
in	O
TGF	O
-	O
beta	O
2	O
null	O
hair	O
buds	O
under	O
conditions	O
in	O
which	O
the	O
signal	O
was	O
readily	O
detected	O
in	O
the	O
hair	O
buds	O
of	O
littermate	O
skin	O
(	O
Figure	O
6D	O
)	O
.	O

Conversely	O
,	O
in	O
2	O
-	O
wk	O
-	O
old	O
K14	O
-	O
Smad2	O
Tg	O
mice	O
,	O
which	O
display	O
elevated	O
TGF	O
-	O
beta	O
signaling	O
in	O
skin	O
[	O
35	O
]	O
,	O
Snail	O
protein	B-CHEBI
was	O
readily	O
detected	O
by	O
Western	O
blot	O
analyses	O
,	O
where	O
it	O
was	O
not	O
found	O
in	O
postnatal	O
skin	O
(	O
Figure	O
6E	O
)	O
.	O

Taken	O
together	O
,	O
these	O
results	O
provide	O
compelling	O
evidence	O
that	O
TGF	O
-	O
beta	O
2	O
is	O
functionally	O
important	O
for	O
inducing	O
Snail	O
gene	O
expression	O
in	O
a	O
pSMAD	O
-	O
dependent	O
manner	O
in	O
developing	O
hair	O
buds	O
.	O

Whether	O
pMARK	O
activity	O
also	O
contributes	O
to	O
Snail	O
induction	O
was	O
not	O
addressed	O
in	O
the	O
present	O
study	O
[	O
15	O
]	O
.	O

Although	O
some	O
hair	O
buds	O
still	O
formed	O
in	O
TGF	O
-	O
beta	O
2	O
null	O
skin	O
,	O
their	O
number	O
was	O
reduced	O
by	O
approximately	O
50	O
%	O
[	O
32	O
]	O
.	O

Thus	O
,	O
although	O
the	O
pathway	O
mediated	O
by	O
TGF	O
-	O
beta	O
2	O
signaling	O
impacts	O
the	O
earliest	O
step	O
of	O
epithelial	O
invagination	O
,	O
it	O
does	O
not	O
appear	O
to	O
be	O
essential	O
for	O
bud	O
morphogenesis	O
.	O

Consistent	O
with	O
this	O
notion	O
,	O
basement	O
membrane	O
remodeling	O
still	O
took	O
place	O
in	O
the	O
TGF	O
-	O
beta	O
2	O
-	O
null	O
buds	O
,	O
as	O
judged	O
by	O
immunofluorescence	O
with	O
antibodies	O
against	O
beta	O
4	O
integrin	O
,	O
an	O
integral	O
component	O
of	O
keratinocyte	O
-	O
mediated	O
adhesion	O
to	O
its	O
underlying	O
basement	O
membrane	O
(	O
Figure	O
6F	O
)	O
.	O

In	O
contrast	O
,	O
TGF	O
-	O
beta	O
2	O
signaling	O
appeared	O
to	O
be	O
an	O
important	O
factor	O
for	O
the	O
early	O
proliferation	O
that	O
occurs	O
in	O
the	O
developing	O
hair	O
buds	O
,	O
as	O
judged	O
by	O
anti	O
-	O
Ki67	O
and	O
anti	O
-	O
pMAPK	O
immunofluorescence	O
(	O
Figure	O
6F	O
and	O
6G	O
)	O
.	O

If	O
TGF	O
-	O
beta	O
2	O
stimulates	O
Snail	O
expression	O
in	O
developing	O
buds	O
,	O
loss	O
of	O
this	O
morphogen	O
would	O
be	O
expected	O
to	O
affect	O
the	O
expression	O
of	O
genes	O
that	O
are	O
typically	O
repressed	O
by	O
Snail	O
.	O

Since	O
a	O
major	O
target	O
for	O
Snail	O
-	O
mediated	O
repression	O
is	O
the	O
E	O
-	O
cadherin	O
gene	O
[	O
12	O
,	O
13	O
]	O
,	O
we	O
investigated	O
the	O
status	O
of	O
E	O
-	O
cadherin	O
in	O
TGF	O
-	O
beta	O
2	O
-	O
null	O
buds	O
.	O

As	O
shown	O
in	O
Figure	O
6H	O
,	O
hair	O
buds	O
in	O
TGF	O
-	O
beta	O
2	O
null	O
skin	O
displayed	O
elevated	O
immunofluorescence	O
staining	O
relative	O
to	O
their	O
WT	O
counterparts	O
.	O

Previously	O
we	O
demonstrated	O
that	O
the	O
concerted	O
action	O
of	O
the	O
extracellular	O
signals	O
Wnt	O
and	O
noggin	O
are	O
required	O
for	O
the	O
generation	O
of	O
a	O
LEF	O
-	O
1	O
/	O
beta	O
-	O
catenin	O
transcription	O
complex	O
to	O
repress	O
E	O
-	O
cadherin	O
transcription	O
at	O
the	O
onset	O
of	O
hair	O
fate	O
specification	O
.	O

As	O
shown	O
in	O
Figure	O
6I	O
and	O
6J	O
,	O
both	O
WT	O
and	O
TGF	O
-	O
beta	O
2	O
null	O
buds	O
exhibited	O
nuclear	O
LEF	O
-	O
1	O
and	O
beta	O
-	O
catenin	O
localization	O
,	O
signs	O
that	O
the	O
Wnt	O
-	O
noggin	O
signaling	O
pathway	O
was	O
intact	O
.	O

These	O
data	O
suggest	O
that	O
during	O
hair	O
follicle	O
morphogenesis	O
,	O
TGF	O
-	O
beta	O
2	O
functions	O
subsequently	O
to	O
Wnt	O
/	O
noggin	O
-	O
mediated	O
determination	O
of	O
hair	O
fate	O
.	O

Moreover	O
,	O
through	O
activation	O
of	O
Snail	O
gene	O
expression	O
,	O
TGF	O
-	O
beta	O
2	O
appears	O
to	O
work	O
in	O
tandem	O
with	O
these	O
other	O
morphogens	O
to	O
down	O
-	O
regulate	O
E	O
-	O
cadherin	O
levels	O
,	O
which	O
contributes	O
to	O
the	O
activation	O
of	O
proliferative	O
circuitries	O
.	O

Discussion	O

During	O
budding	O
morphogenesis	O
,	O
intersecting	O
signaling	O
networks	O
from	O
the	O
epithelium	O
and	O
mesenchyme	O
govern	O
transcriptional	O
,	O
adhesive	O
,	O
polarity	O
,	O
and	O
motility	O
programs	O
in	O
these	O
select	O
groups	O
of	O
cells	O
.	O

The	O
dynamic	O
nuclear	O
and	O
cytosolic	O
changes	O
that	O
take	O
place	O
during	O
this	O
time	O
form	O
the	O
cornerstone	O
for	O
organ	O
morphogenesis	O
.	O

Two	O
major	O
challenges	O
in	O
understanding	O
the	O
mechanisms	O
underlying	O
a	O
particular	O
budding	O
process	O
are	O
to	O
order	O
the	O
temporal	O
sequence	O
of	O
external	O
cues	O
involved	O
and	O
then	O
to	O
dissect	O
how	O
the	O
cells	O
of	O
the	O
developing	O
bud	O
translate	O
these	O
signals	O
into	O
the	O
downstream	O
events	O
of	O
cellular	O
remodeling	O
,	O
proliferation	O
,	O
and	O
differentiation	O
.	O

Our	O
studies	O
here	O
provide	O
some	O
insights	O
into	O
how	O
these	O
events	O
are	O
orchestrated	O
during	O
hair	O
bud	O
formation	O
in	O
developing	O
skin	O
.	O

Signaling	O
during	O
Early	O
Hair	O
Follicle	O
Morphogenesis	O

Recent	O
studies	O
on	O
hair	O
bud	O
morphogenesis	O
suggest	O
that	O
Wnt	O
signals	O
likely	O
from	O
the	O
epithelium	O
and	O
BMP	O
inhibitory	O
signals	O
from	O
the	O
underlying	O
mesenchyme	O
converge	O
to	O
produce	O
an	O
active	O
transcription	O
factor	O
complex	O
involving	O
beta	O
-	O
catenin	O
and	O
LEF	O
-	O
1	O
,	O
which	O
in	O
turn	O
plays	O
a	O
key	O
role	O
in	O
specifying	O
the	O
hair	O
follicle	O
fate	O
[	O
4	O
,	O
29	O
,	O
30	O
,	O
36	O
,	O
37	O
]	O
.	O

Sonic	O
hedgehog	O
(	O
Shh	O
)	O
and	O
TGF	O
-	O
beta	O
2	O
signaling	O
also	O
play	O
essential	O
roles	O
in	O
follicle	O
morphogenesis	O
,	O
but	O
in	O
contrast	O
to	O
beta	O
-	O
catenin	O
null	O
skin	O
,	O
in	O
which	O
follicle	O
invaginations	O
are	O
absent	O
[	O
30	O
]	O
,	O
some	O
hair	O
buds	O
still	O
form	O
in	O
the	O
absence	O
of	O
LEF	O
-	O
1	O
,	O
Shh	O
,	O
or	O
TGF	O
-	O
beta	O
2	O
[	O
32	O
,	O
38	O
]	O
.	O

These	O
likely	O
reflect	O
the	O
first	O
wave	O
of	O
follicle	O
(	O
i	O
.	O
e	O
.	O
,	O
guard	O
hair	O
)	O
morphogenesis	O
,	O
which	O
accounts	O
for	O
a	O
small	O
number	O
(	O
fewer	O
than	O
5	O
%	O
)	O
of	O
hairs	O
and	O
is	O
under	O
distinct	O
regulatory	O
control	O
.	O

Guard	O
hairs	O
form	O
in	O
the	O
absence	O
of	O
LEF	O
-	O
1	O
and	O
TGF	O
-	O
beta	O
2	O
,	O
and	O
we	O
have	O
found	O
that	O
they	O
also	O
fail	O
to	O
express	O
Snail	O
at	O
the	O
budding	O
stage	O
of	O
development	O
(	O
unpublished	O
data	O
)	O
.	O

How	O
E	O
-	O
cadherin	O
is	O
regulated	O
in	O
guard	O
hairs	O
remains	O
to	O
be	O
determined	O
.	O

Several	O
candidates	O
include	O
other	O
Snail	O
family	O
members	O
such	O
as	O
Slug	O
or	O
twist	O
,	O
or	O
alternatively	O
,	O
transcription	O
factors	O
involving	O
beta	O
-	O
catenin	O
and	O
a	O
different	O
member	O
of	O
the	O
LEF	O
-	O
1	O
/	O
TCF	O
/	O
Sry	O
-	O
type	O
HMG	O
box	O
(	O
commonly	O
known	O
as	O
SOX	O
)	O
family	O
[	O
39	O
,	O
40	O
]	O
.	O

Further	O
investigation	O
will	O
be	O
required	O
to	O
determine	O
whether	O
the	O
signaling	O
pathway	O
we	O
have	O
elucidated	O
here	O
is	O
a	O
theme	O
with	O
multiple	O
variations	O
.	O

TGF	O
-	O
beta	O
s	O
are	O
known	O
to	O
promote	O
withdrawal	O
of	O
keratinocytes	O
from	O
the	O
cell	O
cycle	O
[	O
41	O
]	O
.	O

Hence	O
,	O
when	O
TGF	O
-	O
beta	O
2	O
protein	B-CHEBI
was	O
detected	O
at	O
the	O
transition	O
between	O
the	O
growing	O
and	O
destructive	O
phases	O
of	O
the	O
adult	O
hair	O
cycle	O
,	O
research	O
initially	O
and	O
naturally	O
focused	O
on	O
a	O
role	O
for	O
this	O
family	O
member	O
in	O
cessation	O
of	O
growth	O
and	O
/	O
or	O
triggering	O
apoptosis	O
(	O
[	O
42	O
]	O
and	O
references	O
therein	O
)	O
.	O

However	O
,	O
in	O
contrast	O
to	O
TGF	O
-	O
beta	O
1	O
-	O
null	O
skin	O
,	O
which	O
exhibits	O
an	O
extended	O
growing	O
phase	O
of	O
postnatal	O
hair	O
follicles	O
,	O
TGF	O
-	O
beta	O
2	O
-	O
null	O
skin	O
displays	O
an	O
embryonic	O
block	O
in	O
follicle	O
bud	O
progression	O
[	O
32	O
]	O
.	O

Although	O
this	O
phenotype	O
is	O
consistent	O
with	O
TGF	O
-	O
beta	O
2	O
'	O
s	O
embryonic	O
expression	O
patterns	O
[	O
33	O
]	O
,	O
about	O
50	O
%	O
of	O
TGF	O
-	O
beta	O
2	O
null	O
buds	O
appear	O
unable	O
to	O
progress	O
to	O
the	O
down	O
-	O
growth	O
phase	O
,	O
a	O
feature	O
that	O
cannot	O
be	O
explained	O
readily	O
on	O
the	O
basis	O
of	O
previously	O
established	O
effects	O
of	O
TGF	O
-	O
beta	O
s	O
.	O

Our	O
finding	O
that	O
TGF	O
-	O
beta	O
2	O
is	O
upstream	O
from	O
Ki67	O
expression	O
and	O
MAPK	O
activation	O
lends	O
further	O
support	O
to	O
the	O
notion	O
that	O
hair	O
follicle	O
keratinocytes	O
at	O
this	O
early	O
stage	O
of	O
development	O
react	O
to	O
TGF	O
-	O
beta	O
2	O
signaling	O
in	O
a	O
fashion	O
opposite	O
to	O
that	O
typically	O
expected	O
for	O
TGF	O
-	O
beta	O
factors	O
.	O

This	O
said	O
,	O
based	O
upon	O
pSMAD2	O
immunohistochemistry	O
,	O
the	O
immediate	O
steps	O
of	O
downstream	O
signaling	O
appeared	O
to	O
be	O
intact	O
.	O

Thus	O
,	O
we	O
surmise	O
that	O
the	O
proliferative	O
outcome	O
is	O
likely	O
to	O
be	O
rooted	O
in	O
differences	O
in	O
the	O
repertoire	O
of	O
activated	O
SMAD	O
target	O
genes	O
.	O

In	O
this	O
regard	O
,	O
the	O
positive	O
effects	O
of	O
TGF	O
-	O
beta	O
2	O
on	O
proliferation	O
within	O
the	O
hair	O
bud	O
may	O
be	O
more	O
analogous	O
to	O
what	O
has	O
been	O
seen	O
in	O
progression	O
of	O
squamous	O
cell	O
carcinoma	O
to	O
metastatic	O
carcinoma	O
[	O
43	O
]	O
rather	O
than	O
that	O
typically	O
observed	O
for	O
keratinocytes	O
[	O
44	O
,	O
45	O
,	O
46	O
]	O
.	O

The	O
prior	O
identification	O
of	O
the	O
Snail	O
gene	O
as	O
a	O
potential	O
target	O
of	O
TGF	O
-	O
beta	O
signaling	O
[	O
15	O
]	O
was	O
intriguing	O
,	O
given	O
the	O
temporal	O
wave	O
of	O
Snail	O
gene	O
expression	O
that	O
occurs	O
in	O
the	O
developing	O
hair	O
bud	O
.	O

The	O
additional	O
correlation	O
between	O
epithelial	O
hyperproliferation	O
and	O
Snail	O
transgene	O
expression	O
further	O
fostered	O
our	O
interest	O
in	O
a	O
possible	O
link	O
between	O
TGF	O
-	O
beta	O
2	O
and	O
Snail	O
.	O

Our	O
functional	O
studies	O
demonstrate	O
that	O
without	O
TGF	O
-	O
beta	O
2	O
,	O
Snail	O
expression	O
is	O
abolished	O
in	O
the	O
mutant	O
hair	O
buds	O
,	O
and	O
conversely	O
,	O
in	O
K14	O
-	O
Smad2	O
skin	O
,	O
Snail	O
is	O
ectopically	O
activated	O
.	O

Moreover	O
,	O
our	O
in	O
vitro	O
studies	O
indicate	O
that	O
even	O
sustained	O
TGF	O
-	O
beta	O
2	O
exposure	O
may	O
cause	O
only	O
a	O
transient	O
induction	O
of	O
Snail	O
,	O
offering	O
a	O
possible	O
explanation	O
as	O
to	O
why	O
Snail	O
is	O
so	O
briefly	O
expressed	O
during	O
hair	O
follicle	O
morphogenesis	O
.	O

An	O
additional	O
point	O
worth	O
mentioning	O
is	O
that	O
prolonged	O
expression	O
of	O
Tg	O
Snail	O
in	O
postnatal	O
skin	O
resulted	O
in	O
morphological	O
and	O
biochemical	O
signs	O
of	O
epithelial	O
to	O
mesenchymal	O
transitions	O
(	O
unpublished	O
data	O
)	O
,	O
underscoring	O
why	O
transient	O
Snail	O
expression	O
may	O
be	O
so	O
important	O
during	O
normal	O
hair	O
follicle	O
morphogenesis	O
[	O
18	O
]	O
.	O

At	O
first	O
glance	O
,	O
the	O
sparsity	O
in	O
hair	O
coat	O
of	O
K14	O
-	O
Snail	O
Tg	O
mice	O
seemed	O
indicative	O
of	O
a	O
defect	O
in	O
follicle	O
formation	O
(	O
see	O
Figure	O
2A	O
)	O
.	O

Closer	O
inspection	O
,	O
however	O
,	O
revealed	O
that	O
not	O
all	O
hairs	O
penetrated	O
the	O
hyperthickened	O
Tg	O
epidermis	O
.	O

Several	O
factors	O
may	O
contribute	O
to	O
the	O
seemingly	O
normal	O
follicle	O
development	O
in	O
these	O
mice	O
.	O

One	O
obvious	O
factor	O
is	O
the	O
K14	O
promoter	O
,	O
which	O
is	O
elevated	O
in	O
the	O
basal	O
layer	O
of	O
the	O
epidermis	O
and	O
the	O
outer	O
root	O
sheath	O
(	O
ORS	O
)	O
of	O
the	O
hair	O
follicle	O
,	O
but	O
is	O
markedly	O
down	O
-	O
regulated	O
in	O
developing	O
embryonic	O
hair	O
buds	O
as	O
well	O
as	O
in	O
the	O
postnatal	O
hair	O
progenitor	O
cells	O
.	O

The	O
K14	O
promoter	O
is	O
also	O
less	O
active	O
in	O
the	O
ORS	O
than	O
epidermis	O
and	O
hence	O
this	O
might	O
also	O
account	O
for	O
the	O
lack	O
of	O
apparent	O
response	O
of	O
the	O
ORS	O
to	O
ectopic	O
Snail	O
.	O

Additional	O
contributing	O
factors	O
could	O
be	O
the	O
multiplicity	O
of	O
Snail	O
family	O
members	O
and	O
their	O
differential	O
expression	O
,	O
the	O
saturation	O
,	O
and	O
/	O
or	O
diversity	O
of	O
regulatory	O
mechanisms	O
that	O
govern	O
AJ	O
formation	O
,	O
migration	O
,	O
and	O
proliferation	O
in	O
the	O
follicle	O
ORS	O
.	O

Distinguishing	O
between	O
these	O
possibilities	O
must	O
await	O
the	O
generation	O
of	O
mice	O
harboring	O
skin	O
-	O
specific	O
loss	O
-	O
of	O
-	O
function	O
Snail	O
mutations	O
.	O

Links	O
between	O
Signaling	O
,	O
Transcriptional	O
Cascades	O
,	O
Epithelial	O
Remodeling	O
,	O
and	O
Proliferation	O
in	O
the	O
Hair	O
Bud	O

Previously	O
,	O
we	O
discovered	O
that	O
early	O
during	O
hair	O
follicle	O
morphogenesis	O
,	O
E	O
-	O
cadherin	O
gene	O
expression	O
is	O
down	O
-	O
regulated	O
concomitantly	O
with	O
the	O
invagination	O
of	O
developing	O
bud	O
cells	O
into	O
the	O
skin	O
[	O
4	O
]	O
.	O

Because	O
the	O
timing	O
of	O
this	O
event	O
correlated	O
with	O
the	O
activation	O
of	O
a	O
LEF	O
-	O
1	O
/	O
beta	O
-	O
catenin	O
transcription	O
factor	O
complex	O
[	O
20	O
]	O
,	O
we	O
were	O
intrigued	O
by	O
the	O
presence	O
of	O
a	O
putative	O
LEF	O
-	O
1	O
/	O
TCF	O
binding	O
site	O
in	O
the	O
E	O
-	O
cadherin	O
promoter	O
.	O

This	O
prompted	O
an	O
investigation	O
that	O
subsequently	O
led	O
to	O
our	O
discovery	O
that	O
LEF	O
-	O
1	O
/	O
beta	O
-	O
catenin	O
can	O
contribute	O
to	O
repression	O
of	O
E	O
-	O
cadherin	O
gene	O
expression	O
in	O
skin	O
keratinocytes	O
[	O
4	O
]	O
.	O

In	O
the	O
course	O
of	O
these	O
studies	O
,	O
we	O
also	O
noted	O
that	O
Snail	O
can	O
also	O
contribute	O
to	O
this	O
process	O
in	O
keratinocytes	O
in	O
vitro	O
,	O
and	O
our	O
present	O
studies	O
revealed	O
that	O
Snail	O
is	O
expressed	O
at	O
the	O
right	O
place	O
and	O
time	O
to	O
be	O
physiologically	O
relevant	O
in	O
the	O
process	O
.	O

In	O
noggin	O
-	O
null	O
embryonic	O
skin	O
,	O
LEF	O
-	O
1	O
expression	O
and	O
subsequent	O
activation	O
of	O
the	O
LEF	O
-	O
1	O
/	O
beta	O
-	O
catenin	O
reporter	O
gene	O
is	O
abrogated	O
in	O
the	O
developing	O
placodes	O
.	O

The	O
corresponding	O
failure	O
of	O
E	O
-	O
cadherin	O
down	O
-	O
regulation	O
underscores	O
the	O
importance	O
of	O
Wnt	O
/	O
noggin	O
signaling	O
in	O
regulating	O
this	O
event	O
in	O
follicle	O
morphogenesis	O
[	O
4	O
]	O
.	O

Conditional	O
gene	O
targeting	O
studies	O
will	O
be	O
necessary	O
to	O
establish	O
whether	O
Snail	O
family	O
members	O
also	O
contribute	O
to	O
the	O
down	O
-	O
regulation	O
in	O
E	O
-	O
cadherin	O
gene	O
expression	O
that	O
occurs	O
during	O
follicle	O
formation	O
.	O

However	O
,	O
it	O
is	O
intriguing	O
that	O
K14	O
-	O
Snail	O
Tg	O
epidermis	O
displayed	O
a	O
marked	O
down	O
-	O
regulation	O
in	O
E	O
-	O
cadherin	O
expression	O
,	O
thereby	O
demonstrating	O
its	O
potential	O
to	O
do	O
so	O
in	O
skin	O
.	O

Our	O
prior	O
findings	O
showed	O
that	O
by	O
elevating	O
E	O
-	O
cadherin	O
levels	O
or	O
by	O
conditionally	O
ablating	O
alpha	O
-	O
catenin	O
,	O
hair	O
follicle	O
morphogenesis	O
can	O
be	O
impaired	O
[	O
4	O
,	O
7	O
]	O
.	O

The	O
marked	O
epidermal	O
hyperproliferation	O
seen	O
in	O
the	O
K14	O
-	O
Snail	O
Tg	O
skin	O
,	O
coupled	O
with	O
the	O
converse	O
suppression	O
of	O
proliferation	O
and	O
Snail	O
in	O
TGF	O
-	O
beta	O
2	O
-	O
null	O
hair	O
buds	O
led	O
us	O
to	O
wonder	O
whether	O
the	O
down	O
-	O
regulation	O
of	O
E	O
-	O
cadherin	O
during	O
follicle	O
morphogenesis	O
might	O
have	O
a	O
direct	O
impact	O
on	O
elevating	O
the	O
proliferative	O
state	O
of	O
these	O
cells	O
.	O

Our	O
Tg	O
studies	O
suggested	O
that	O
,	O
at	O
least	O
in	O
part	O
through	O
its	O
regulation	O
of	O
E	O
-	O
cadherin	O
,	O
Snail	O
is	O
able	O
to	O
influence	O
the	O
subcellular	O
localization	O
of	O
a	O
variety	O
of	O
AJ	O
-	O
associated	O
proteins	B-CHEBI
.	O

One	O
of	O
these	O
appears	O
to	O
be	O
Ajuba	O
,	O
which	O
was	O
previously	O
shown	O
to	O
have	O
the	O
dual	O
capacity	O
to	O
bind	O
Grb	O
-	O
2	O
as	O
well	O
as	O
alpha	O
-	O
catenin	O
[	O
9	O
,	O
10	O
]	O
.	O

Our	O
studies	O
revealed	O
that	O
in	O
skin	O
keratinocytes	O
that	O
either	O
harbor	O
a	O
conditional	O
null	O
mutation	O
in	O
alpha	O
-	O
catenin	O
or	O
that	O
overexpress	O
Snail	O
,	O
Ajuba	O
develops	O
an	O
interaction	O
with	O
Grb	O
-	O
2	O
that	O
is	O
otherwise	O
not	O
observed	O
in	O
WT	O
keratinocytes	O
.	O

The	O
corresponding	O
abilities	O
of	O
either	O
Snail	O
-	O
transfected	O
or	O
Ajuba	O
-	O
transfected	O
keratinocytes	O
to	O
exhibit	O
elevated	O
activation	O
of	O
the	O
Ras	O
-	O
MAPK	O
pathway	O
suggest	O
that	O
the	O
Grb	O
-	O
2	O
association	O
of	O
Ajuba	O
under	O
conditions	O
of	O
reduced	O
levels	O
of	O
AJ	O
proteins	B-CHEBI
may	O
be	O
directly	O
relevant	O
to	O
the	O
parallel	O
in	O
hyperproliferation	O
.	O

In	O
stable	O
epithelial	O
(	O
i	O
.	O
e	O
.	O
,	O
Madin	O
-	O
Darby	O
canine	O
kidney	O
,	O
or	O
MDCK	O
)	O
cell	O
lines	O
,	O
Snail	O
has	O
been	O
shown	O
to	O
block	O
cell	O
cycle	O
progression	O
and	O
promote	O
motility	O
and	O
shape	O
changes	O
for	O
invasion	O
[	O
47	O
]	O
.	O

While	O
our	O
in	O
vivo	O
studies	O
are	O
consistent	O
with	O
a	O
role	O
for	O
Snail	O
in	O
motility	O
and	O
epithelial	O
remodeling	O
,	O
they	O
differ	O
with	O
respect	O
to	O
Snail	O
'	O
s	O
apparent	O
proliferative	O
effects	O
.	O

A	O
priori	O
,	O
this	O
could	O
be	O
simply	O
due	O
to	O
variations	O
in	O
the	O
response	O
of	O
different	O
cell	O
types	O
to	O
Snail	O
expression	O
.	O

Alternatively	O
,	O
these	O
differences	O
may	O
be	O
relevant	O
to	O
the	O
benefit	O
of	O
using	O
mouse	O
models	O
to	O
reveal	O
functions	O
not	O
always	O
recapitulated	O
in	O
stable	O
cell	O
line	O
models	O
.	O

Future	O
studies	O
should	O
highlight	O
the	O
underlying	O
reasons	O
for	O
these	O
opposing	O
results	O
.	O

Irrespective	O
of	O
these	O
differences	O
,	O
our	O
in	O
vivo	O
studies	O
do	O
not	O
stand	O
alone	O
,	O
as	O
there	O
are	O
many	O
situations	O
in	O
which	O
a	O
down	O
-	O
regulation	O
in	O
AJ	O
proteins	B-CHEBI
correlate	O
with	O
enhanced	O
proliferation	O
.	O

In	O
fact	O
,	O
a	O
myriad	O
of	O
diverse	O
mechanisms	O
have	O
been	O
implicated	O
in	O
activating	O
epithelial	O
proliferation	O
upon	O
down	O
-	O
regulation	O
of	O
AJ	O
proteins	B-CHEBI
[	O
7	O
,	O
23	O
,	O
24	O
,	O
48	O
]	O
.	O

Sifting	O
through	O
these	O
converging	O
pathways	O
is	O
likely	O
to	O
be	O
a	O
difficult	O
and	O
painstaking	O
process	O
.	O

This	O
said	O
,	O
by	O
identifying	O
the	O
status	O
of	O
different	O
players	O
involved	O
in	O
specific	O
cell	O
types	O
and	O
at	O
specific	O
stages	O
in	O
development	O
,	O
our	O
mechanistic	O
understanding	O
of	O
how	O
intercellular	O
remodeling	O
is	O
linked	O
to	O
proliferation	O
in	O
epithelial	O
morphogenesis	O
should	O
begin	O
to	O
surface	O
in	O
the	O
future	O
.	O

Elucidating	O
the	O
molecular	B-CHEBI
mechanisms	O
through	O
which	O
these	O
networks	O
converge	O
is	O
also	O
a	O
prerequisite	O
for	O
understanding	O
how	O
these	O
processes	O
go	O
awry	O
during	O
tumorigenesis	O
.	O

Materials	O
and	O
Methods	O

Reagents	B-CHEBI

Primary	O
antibodies	O
used	O
were	O
against	O
:	O
E	O
-	O
cadherin	O
(	O
M	O
.	O
Takeichi	O
,	O
Kyoto	O
University	O
,	O
Japan	O
)	O
;	O
alpha	O
-	O
catenin	O
,	O
beta	O
-	O
catenin	O
,	O
pMAPK	O
,	O
tubulin	O
(	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
,	O
Ajuba	O
(	O
G	O
.	O
Longmore	O
,	O
Washington	O
University	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
;	O
beta	O
4	O
integrin	O
/	O
CD104	O
(	O
BD	O
Pharmingen	O
,	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
laminin	O
5	O
(	O
R	O
.	O
Burgeson	O
,	O
Harvard	O
University	O
,	O
Cambridge	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
,	O
K5	O
,	O
K1	O
,	O
loricrin	O
(	O
Fuchs	O
Lab	O
)	O
,	O
involucrin	O
,	O
fillagrin	O
(	O
Covance	O
,	O
Berkeley	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
MAPK	O
,	O
pSMAD2	O
(	O
Cell	O
Signaling	O
,	O
Beverly	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
;	O
Grb	O
-	O
2	O
(	O
Santa	O
Cruz	O
Biotech	O
,	O
Santa	O
Cruz	O
,	O
California	O
,	O
United	O
States	O
)	O
;	O
P	O
-	O
cadherin	O
(	O
Zymed	O
Laboratories	O
,	O
South	O
San	O
Francisco	O
,	O
California	O
,	O
United	O
States	O
)	O
;	O
HA	O
(	O
Roche	O
Biochemicals	O
)	O
,	O
vimentin	O
(	O
Chemicon	O
,	O
Temecula	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
Ki67	O
(	O
Novo	O
Castra	O
,	O
Newcastle	O
Upon	O
Tyne	O
,	O
United	O
Kingdom	O
)	O
,	O
keratin	O
6	O
(	O
P	O
.	O
Coulombe	O
,	O
John	O
Hopkins	O
University	O
,	O
Baltimore	O
,	O
Maryland	O
,	O
United	O
States	O
)	O
,	O
cyclin	O
D	O
(	O
Oncogene	O
,	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
and	O
TGF	O
-	O
beta	O
2	O
(	O
L	O
.	O
Gold	O
,	O
New	O
York	O
University	O
,	O
New	O
York	O
,	O
New	O
York	O
,	O
United	O
States	O
)	O
.	O

FITC	B-CHEBI
-	O
,	O
Texas	O
Red	O
-	O
,	O
or	O
HRP	O
-	O
conjugated	O
secondary	O
antibodies	O
were	O
from	O
Jackson	O
ImmunoResearch	O
(	O
West	O
Grove	O
,	O
Pennsylvania	O
,	O
United	O
States	O
)	O
.	O

Biotinylated	O
secondary	O
antibodies	O
were	O
from	O
Vector	O
Labs	O
(	O
Burlingame	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Dilutions	O
were	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
recommendation	O
.	O

The	O
Snail	O
antibody	O
was	O
generated	O
in	O
Guinea	O
pigs	O
by	O
inoculating	O
them	O
with	O
the	O
N	B-CHEBI
-	O
terminal	O
sequence	O
of	O
murine	O
Snail	O
fused	O
to	O
GST	O
(	O
Covance	O
,	O
Princeton	O
,	O
New	O
Jersey	O
,	O
United	O
States	O
)	O
.	O

Recombinant	O
human	O
TGF	O
-	O
beta	O
2	O
was	O
purchased	O
from	O
R	O
&	O
D	O
(	O
Minneapolis	O
,	O
Minnesota	O
,	O
United	O
States	O
)	O
.	O

Heat	O
inactivated	O
TGF	O
-	O
beta	O
2	O
was	O
generated	O
by	O
heating	O
the	O
recombinant	O
protein	B-CHEBI
at	O
100	O
degrees	O
C	O
for	O
10	O
min	O
.	O

Mice	O

The	O
K14	O
-	O
Snail	O
Tg	O
mouse	O
was	O
generated	O
by	O
digesting	O
the	O
pcDNA3	O
-	O
mm	O
Snail	O
-	O
HA	O
plasmid	O
(	O
G	O
.	O
de	O
Herreros	O
,	O
Universitat	O
Pompeu	O
,	O
Fabra	O
,	O
Barcelona	O
,	O
Spain	O
)	O
with	O
BamHI	O
and	O
NotI	O
and	O
subcloned	O
into	O
the	O
K14	O
vector	O
[	O
49	O
]	O
.	O

The	O
linearized	O
construct	O
was	O
injected	O
into	O
the	O
nucleus	O
of	O
embryos	O
from	O
CD1	O
mice	O
.	O

The	O
K14	O
-	O
Smad	O
2	O
Tg	O
mouse	O
was	O
reported	O
in	O
Ito	O
et	O
al	O
.	O
,	O
2001	O
.	O

The	O
TGF	O
-	O
beta	O
2	O
knockout	O
(	O
KO	O
)	O
mouse	O
was	O
described	O
in	O
[	O
34	O
]	O
.	O

The	O
shh	O
KO	O
mouse	O
[	O
38	O
]	O
and	O
TOPGal	O
mouse	O
[	O
20	O
]	O
have	O
previously	O
been	O
reported	O
.	O

Western	O
blot	O
and	O
immunoprecipitation	O

Protein	B-CHEBI
extracts	O
from	O
primary	O
keratinocytes	O
were	O
generated	O
either	O
by	O
lysing	O
cells	O
in	O
lysis	O
buffer	O
(	O
1	O
%	O
NP	O
-	O
40	O
,	O
1	O
%	O
sodium	B-CHEBI
deoxycholate	I-CHEBI
,	O
20	O
mM	O
Tris	B-CHEBI
-	O
Cl	B-CHEBI
[	O
pH	O
7	O
.	O
4	O
]	O
,	O
140	O
mM	O
NaCl	B-CHEBI
containing	O
1	O
mM	O
sodium	B-CHEBI
vanadate	I-CHEBI
,	O
2	O
mM	O
phenylmethylsulfonyl	B-CHEBI
fluoride	I-CHEBI
,	O
and	O
protease	B-CHEBI
inhibitors	I-CHEBI
)	O
or	O
directly	O
in	O
Laemmli	O
b	O
beta	O
uffer	O
and	O
boiled	O
.	O

For	O
skin	O
tissue	O
:	O
Frozen	O
tissue	O
was	O
pulverized	O
in	O
a	O
liquid	O
nitrogen	B-CHEBI
-	O
cooled	O
Gevebesmascher	O
and	O
the	O
powder	O
scraped	O
into	O
a	O
chilled	O
microcentrifuge	O
tube	O
.	O

RIPA	O
buffer	O
(	O
1	O
%	O
Triton	O
X	O
-	O
100	O
in	O
PBS	O
with	O
10	O
mM	O
EDTA	B-CHEBI
,	O
150	O
mN	O
NaCl	B-CHEBI
,	O
1	O
%	O
sodium	B-CHEBI
deoxycholate	I-CHEBI
,	O
and	O
0	O
.	O
1	O
%	O
SDS	B-CHEBI
)	O
and	O
protease	B-CHEBI
inhibitors	I-CHEBI
or	O
Laemmli	O
buffer	O
was	O
added	O
.	O

The	O
cell	O
suspension	O
was	O
sonicated	O
three	O
times	O
for	O
15	O
s	O
and	O
centrifuged	O
at	O
14	O
,	O
000	O
rpm	O
at	O
4	O
degrees	O
C	O
.	O

The	O
supernatant	O
was	O
separated	O
from	O
the	O
pellet	O
and	O
used	O
in	O
the	O
experiments	O
.	O

Extracts	O
subjected	O
to	O
immunoprecipitation	O
were	O
precleared	O
with	O
Protein	B-CHEBI
G	O
Sepharose	O
(	O
Amersham	O
,	O
Piscataway	O
,	O
New	O
York	O
,	O
United	O
States	O
)	O
and	O
incubated	O
with	O
antibody	O
with	O
rocking	O
overnight	O
at	O
4	O
degrees	O
C	O
.	O

Protein	B-CHEBI
G	O
Sepharose	O
was	O
added	O
and	O
samples	O
were	O
incubated	O
for	O
1	O
h	O
at	O
4	O
degrees	O
C	O
with	O
rocking	O
.	O

Samples	O
were	O
washed	O
three	O
times	O
for	O
5	O
min	O
each	O
in	O
lysis	O
buffer	O
,	O
and	O
the	O
Protein	B-CHEBI
G	O
Sepharose	O
-	O
antibody	O
-	O
antigen	O
pellet	O
was	O
resuspended	O
in	O
Laemmli	O
buffer	O
and	O
boiled	O
for	O
10	O
min	O
.	O

Samples	O
were	O
run	O
on	O
SDS	B-CHEBI
-	O
PAGE	O
and	O
transferred	O
to	O
nitrocellulose	O
membrane	O
(	O
Schleicher	O
and	O
Schuell	O
Bioscience	O
,	O
Keene	O
,	O
New	O
Hampshire	O
,	O
United	O
States	O
)	O
.	O

Western	O
blot	O
signals	O
were	O
developed	O
using	O
the	O
enhanced	O
chemiluminescence	O
kit	O
from	O
Amersham	O

Cell	O
culture	O

Primary	O
keratinocytes	O
were	O
culture	O
in	O
low	O
-	O
calcium	O
medium	O
as	O
previously	O
described	O
[	O
4	O
]	O
.	O

Transient	O
transfections	O
were	O
carried	O
out	O
with	O
FuGENE6	O
reagent	B-CHEBI
(	O
Roche	O
,	O
Indianapolis	O
,	O
Indiana	O
,	O
United	O
States	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
protocol	O
.	O

Measurement	O
of	O
beta	O
-	O
galactosidase	O
or	O
luciferase	O
levels	O
in	O
promoter	O
activity	O
studies	O
were	O
carried	O
out	O
with	O
the	O
Galacto	O
-	O
Lite	O
assay	O
kit	O
(	O
TROPIX	O
,	O
Bedford	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
and	O
the	O
Dual	O
luciferase	O
(	O
Promega	O
,	O
Madison	O
,	O
Wisconsin	O
,	O
United	O
States	O
)	O
,	O
respectively	O
.	O

Runella	O
luciferase	O
was	O
cotransfected	O
into	O
cells	O
to	O
correct	O
for	O
transfection	O
efficiency	O
.	O

Experiments	O
were	O
done	O
in	O
triplicate	O
and	O
repeated	O
at	O
least	O
three	O
times	O
.	O

Measurements	O
were	O
done	O
on	O
a	O
luminometer	O
(	O
MGM	O
Instruments	O
,	O
Hamden	O
,	O
Connecticut	O
,	O
United	O
States	O
)	O
.	O

For	O
experiments	O
measuring	O
phosphorylation	O
of	O
MAPK	O
,	O
keratinocytes	O
were	O
serum	O
starved	O
for	O
3	O
h	O
prior	O
to	O
harvesting	O
of	O
cells	O
by	O
incubation	O
in	O
medium	O
lacking	O
serum	O
.	O

Treatment	O
of	O
cells	O
with	O
Wnt	O
-	O
and	O
noggin	O
-	O
conditioned	O
medium	O
was	O
previously	O
described	O
[	O
4	O
]	O
.	O

Constructs	O

The	O
2	O
.	O
2	O
-	O
kb	O
murine	O
Snail	O
promoter	O
was	O
generated	O
by	O
PCR	O
using	O
a	O
forward	O
primer	O
with	O
an	O
XbaI	O
linker	O
sequence	O
,	O
5	O
'	O
-	O
TCTAGAATTGTTTGCTGCTGTATGGTCTTC	O
-	O
3	O
'	O
,	O
along	O
with	O
a	O
reverse	O
primer	O
with	O
a	O
BglII	O
linker	O
sequence	O
,	O
5	O
'	O
-	O
AGATCTGTTGGCCAGAGCGACCTAG	O
-	O
GTAG	O
-	O
3	O
'	O
,	O
and	O
mouse	O
genomic	O
DNA	O
as	O
a	O
template	O
.	O

The	O
PCR	O
product	O
was	O
purified	O
with	O
the	O
Gel	O
Extraction	O
Kit	O
(	O
Qiagen	O
,	O
Valencia	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
ligated	O
into	O
pCRII	O
-	O
TOPO	O
TA	O
vector	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

The	O
promoter	O
was	O
verified	O
by	O
sequencing	O
and	O
digested	O
with	O
XbaI	O
and	O
BglII	O
and	O
subcloned	O
into	O
the	O
p	O
beta	O
-	O
gal	O
BASIC	O
vector	O
(	O
BD	O
Biosciences	O
Clontech	O
,	O
Palo	O
Alto	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

The	O
point	O
mutations	O
in	O
the	O
SMAD	O
binding	O
element	O
was	O
generated	O
with	O
the	O
Quik	O
-	O
Change	O
Kit	O
(	O
Stratagene	O
,	O
La	O
Jolla	O
,	O
California	O
,	O
United	O
States	O
)	O
using	O
the	O
forward	O
primer	O
5	O
'	O
-	O
GGGCGGGCTTAGGTGTTTTCATTTACTCTTGAGGAAAAGCTTGGC	O
-	O
3	O
'	O
and	O
the	O
reverse	O
primer	O
5	O
'	O
-	O
GCTTTT	O
-	O
CCTCAAGAGTAAATGAAAACACCTAAGCCCGCCCTGCCC	O
-	O
3	O
'	O
.	O

The	O
probes	O
for	O
the	O
Snail	O
in	O
situ	O
hybridization	O
were	O
generated	O
against	O
the	O
3	O
'	O
UTR	O
by	O
PCR	O
using	O
the	O
forward	O
primer	O
5	O
'	O
-	O
ACCTTCTCCCGCATGTCCTTGCTCC	O
-	O
3	O
'	O
and	O
the	O
reverse	O
primer	O
5	O
'	O
-	O
CTGCTGAGGCATGGTTACAGCTGG	O
-	O
3	O
'	O
,	O
and	O
genomic	O
DNA	O
as	O
a	O
template	O
.	O

The	O
PCR	O
product	O
was	O
gel	O
purified	O
and	O
ligated	O
into	O
pCRII	O
-	O
TOPO	O
TA	O
vector	O
.	O

The	O
pre	O
-	O
LIM	O
domain	O
of	O
Ajuba	O
was	O
generated	O
essentially	O
as	O
described	O
[	O
9	O
]	O
,	O
but	O
was	O
fused	O
to	O
GFP	O
by	O
subcloning	O
from	O
the	O
pEGFP	O
-	O
N1	O
20	O
vector	O
(	O
BD	O
Biosciences	O
Clontech	O
)	O

In	O
situ	O
hybridization	O

The	O
pCRII	O
-	O
TOPO	O
TA	O
vector	O
containing	O
a	O
region	O
of	O
the	O
3	O
'	O
UTR	O
of	O
Snail	O
was	O
used	O
as	O
a	O
template	O
to	O
generate	O
digoxigenin	B-CHEBI
-	O
labeled	O
sense	O
and	O
antisense	O
riboprobes	O
(	O
Roche	O
)	O
.	O

The	O
respective	O
probes	O
were	O
obtained	O
by	O
XhoI	O
and	O
BamH1	O
digestions	O
.	O

In	O
situ	O
hybridizations	O
were	O
performed	O
on	O
10	O
-	O
mu	O
m	O
thick	O
sections	O
of	O
E17	O
.	O
5	O
mouse	O
embryos	O
.	O

The	O
sections	O
were	O
fixed	O
with	O
4	O
%	O
PFA	O
for	O
10	O
min	O
at	O
room	O
temperature	O
,	O
prehybridized	O
at	O
room	O
temperature	O
for	O
4	O
.	O
5	O
h	O
,	O
hybridized	O
with	O
the	O
probe	O
(	O
2	O
mu	O
g	O
/	O
ml	O
)	O
at	O
55	O
degrees	O
C	O
for	O
12	O
-	O
14	O
h	O
,	O
blocked	O
with	O
10	O
%	O
NGS	O
,	O
and	O
treated	O
with	O
anti	O
-	O
dig	B-CHEBI
Fab	O
-	O
AP	O
antibody	O
(	O
Roche	O
#	O
1093274	O
)	O
at	O
a	O
1	O
:	O
2	O
,	O
500	O
dilution	O
for	O
3	O
h	O
.	O

The	O
sections	O
were	O
incubated	O
with	O
NBT	O
and	O
BCIP	O
until	O
adequate	O
signal	O
was	O
detected	O
.	O

Immunofluorescence	O
and	O
immunohistochemistry	O

Tissue	O
samples	O
for	O
immunofluorescence	O
were	O
frozen	O
in	O
OCT	O
and	O
sectioned	O
10	O
mu	O
m	O
thick	O
on	O
a	O
cryostat	O
.	O

Sections	O
were	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
for	O
10	O
min	O
at	O
room	O
temperature	O
,	O
blocked	O
,	O
and	O
stained	O
with	O
antibodies	O
.	O

Tissue	O
samples	O
for	O
immunohistochemistry	O
were	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
,	O
dehydrated	O
,	O
and	O
embedded	O
in	O
paraffin	O
.	O

Samples	O
were	O
sectioned	O
on	O
a	O
microtome	O
(	O
10	O
mu	O
m	O
thick	O
)	O
and	O
rehydrated	O
prior	O
to	O
staining	O
with	O
antibody	O
.	O

Samples	O
stained	O
with	O
Snail	O
,	O
pMAPK	O
,	O
pSmad2	O
,	O
and	O
cyclin	O
D	O
were	O
antigen	O
unmasked	O
with	O
10	O
mM	O
sodium	B-CHEBI
citrate	B-CHEBI
(	O
pH	O
6	O
)	O
in	O
an	O
Antigen	O
Retriever	O
2100	O
(	O
Pickcell	O
Laboratories	O
,	O
Leiden	O
,	O
Netherlands	O
)	O
.	O

The	O
DAB	O
substrate	O
kit	O
(	O
Vector	O
Labs	O
)	O
was	O
used	O
according	O
to	O
manufacturer	O
'	O
s	O
instructions	O
to	O
develop	O
the	O
signal	O
.	O

RT	O
-	O
PCR	O

RNA	O
was	O
extracted	O
from	O
keratinocytes	O
or	O
skin	O
tissue	O
with	O
Trizol	O
(	O
Invitrogen	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
protocol	O
.	O

cDNA	O
was	O
generated	O
using	O
oligo	O
-	O
dT	O
primers	O
and	O
the	O
Superscript	O
II	O
kit	O
(	O
Invitrogen	O
)	O
.	O

The	O
primers	O
used	O
for	O
PCR	O
were	O
Snail	O
forward	O
:	O
5	O
'	O
-	O
CAGCTGGCCAGGCTCTCGGT	O
-	O
3	O
'	O
;	O
Snail	O
reverse	O
:	O
5	O
'	O
-	O
GCGAGGGCCTCCGGAGCA	O
-	O
3	O
'	O
;	O
GAPDH	O
forward	O
5	O
'	O
-	O
CGTAGACAAAATGGTGAAGGTCGG	O
-	O
3	O
'	O
;	O
and	O
GAPDH	O
reverse	O
:	O
5	O
'	O
-	O
AAGCAGTTGGTGGTGCAGGATG	O
-	O
3	O
'	O
.	O

Acknowledgements	O

We	O
thank	O
M	O
Takeichi	O
,	O
P	O
Coulombe	O
,	O
G	O
Longmore	O
,	O
and	O
L	O
Gold	O
for	O
sharing	O
their	O
antibodies	O
,	O
and	O
AG	O
de	O
Herreros	O
for	O
the	O
Snail	O
construct	O
.	O

L	O
Degenstein	O
and	O
L	O
Polak	O
from	O
the	O
Fuchs	O
laboratory	O
provided	O
outstanding	O
technical	O
assistance	O
with	O
transgenic	O
work	O
and	O
animal	O
husbandry	O
.	O

T	O
Doetschman	O
and	O
Y	O
Chai	O
are	O
acknowledged	O
for	O
the	O
TGF	O
-	O
beta	O
2	O
KO	O
and	O
K14	O
-	O
Smad2	O
mice	O
,	O
respectively	O
.	O

We	O
thank	O
additional	O
members	O
of	O
the	O
Fuchs	O
lab	O
for	O
generously	O
sharing	O
their	O
reagents	B-CHEBI
and	O
ideas	O
.	O

CJ	O
was	O
partially	O
supported	O
by	O
a	O
fellowship	O
from	O
the	O
Helen	O
Hay	O
Whitney	O
Foundation	O
.	O

EF	O
is	O
an	O
investigator	O
at	O
the	O
Howard	O
Hughes	O
Medical	O
Institute	O
.	O

This	O
work	O
was	O
supported	O
by	O
the	O
Howard	O
Hughes	O
Medical	O
Institute	O
and	O
a	O
grant	O
from	O
the	O
National	O
Institutes	O
of	O
Health	O
.	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Abbreviations	O

AJ	O
-	O
adherens	O
junction	O

BMP	O
-	O
bone	O
morphogenic	O
protein	B-CHEBI

EMT	O
-	O
epithelial	O
to	O
mesenchymal	O
transition	O

E	O
[	O
number	O
]	O
-	O
embryonic	O
day	O
[	O
number	O
]	O

FGF	O
-	O
fibroblast	O
growth	O
factor	O

Grb	O
-	O
2	O
-	O
growth	O
factor	O
receptor	O
-	O
bound	O
protein	B-CHEBI
-	O
2	O

HA	O
-	O
hemaglutinin	O

K1	O
-	O
keratin	O
1	O

K5	O
-	O
keratin	O
5	O

KO	O
-	O
knockout	O

LEF	O
-	O
1	O
-	O
lymphoid	O
enhancer	O
factor	O
-	O
1	O

LIM	O
-	O
Lin	O
-	O
1	O

MAPK	O
-	O
mitogen	O
-	O
activated	O
protein	B-CHEBI
kinase	O

ORS	O
-	O
outer	O
root	O
sheath	O

pMAPK	O
-	O
phosphorylated	O
MAPK	O

P	O
[	O
number	O
]	O
-	O
postnatal	O
day	O
[	O
number	O
]	O

pSMAD	O
-	O
phosphorylated	O
SMAD	O

Shh	O
-	O
sonic	O
hedgehog	O

SMADs	O
-	O
small	O
phenotype	O
-	O
and	O
mothers	O
against	O
decapentaplegic	O
-	O
related	O
proteins	B-CHEBI

Sos	O
-	O
son	O
of	O
sevenless	O

SOX	O
-	O
Sry	O
-	O
type	O
HMG	O
box	O

TCF	O
-	O
T	O
cell	O
factor	O

Tg	O
-	O
transgenic	O

TGF	O
-	O
beta	O
-	O
transforming	O
growth	O
factor	O
beta	O

TOP	O
-	O
TCF	O
-	O
optimal	O
-	O
promoter	O

UTR	O
-	O
untranslated	O
region	O

WT	O
-	O
wild	O
-	O
type	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Snail	O
Is	O
Expressed	O
Exclusively	O
in	O
the	O
Hair	O
Bud	O
during	O
Morphogenesis	O

Embryos	O
were	O
either	O
frozen	O
in	O
OCT	O
embedding	O
compound	B-CHEBI
(	O
A	O
,	O
F	O
,	O
and	O
H	O
)	O
or	O
embedded	O
in	O
paraffin	O
(	O
C	O
,	O
D	O
,	O
E	O
,	O
and	O
G	O
)	O
,	O
and	O
then	O
sectioned	O
(	O
8	O
mu	O
m	O
)	O
.	O

(	O
A	O
)	O
In	O
situ	O
hybridizations	O
with	O
Snail	O
sense	O
or	O
antisense	O
cRNA	O
probes	O
.	O

Black	O
dotted	O
lines	O
demarcate	O
the	O
basement	O
membrane	O
that	O
separates	O
the	O
epidermis	O
(	O
epi	O
)	O
from	O
dermis	O
(	O
der	O
)	O
.	O

Arrows	O
point	O
to	O
Snail	O
RNA	O
expression	O
,	O
restricted	O
to	O
the	O
hair	O
bud	O
stage	O
of	O
follicle	O
morphogenesis	O
.	O

It	O
was	O
not	O
seen	O
in	O
later	O
hair	O
germ	O
or	O
peg	O
stages	O
.	O

(	O
B	O
)	O
Expression	O
of	O
Snail	O
protein	B-CHEBI
coincides	O
with	O
hair	O
development	O
.	O

Protein	B-CHEBI
extracts	O
were	O
prepared	O
from	O
keratinocytes	O
transfected	O
with	O
empty	O
expression	O
vector	O
(	O
K14	O
)	O
,	O
containing	O
the	O
K14	O
promoter	O
or	O
with	O
the	O
vector	O
driving	O
HA	O
-	O
tagged	O
Snail	O
(	O
K14	O
-	O
Snail	O
)	O
;	O
or	O
from	O
whole	O
skin	O
from	O
E13	O
.	O
5	O
to	O
P5	O
animals	O
,	O
including	O
newborn	O
(	O
nb	O
)	O
.	O

Equal	O
amounts	O
of	O
proteins	B-CHEBI
were	O
then	O
resolved	O
by	O
SDS	B-CHEBI
-	O
PAGE	O
through	O
12	O
%	O
gels	O
and	O
subjected	O
to	O
Western	O
blotting	O
using	O
either	O
an	O
affinity	O
-	O
purified	O
Snail	O
polyclonal	O
antiserum	O
,	O
which	O
we	O
generated	O
,	O
or	O
anti	O
-	O
tubulin	O
(	O
loading	O
control	O
)	O
.	O

(	O
C	O
-	O
E	O
)	O
Immunohistochemistry	O
shows	O
expression	O
of	O
Snail	O
protein	B-CHEBI
in	O
the	O
nuclei	O
of	O
cells	O
within	O
the	O
hair	O
and	O
skin	O
.	O

(	O
C	O
)	O
E13	O
.	O
5	O
skin	O
with	O
a	O
single	O
layered	O
epidermis	O
(	O
epi	O
)	O
shows	O
no	O
Snail	O
expression	O
.	O

(	O
D	O
)	O
The	O
first	O
morphological	O
sign	O
that	O
cells	O
have	O
adopted	O
a	O
hair	O
follicle	O
fate	O
is	O
a	O
cluster	O
of	O
cells	O
called	O
a	O
placode	O
in	O
E16	O
.	O
5	O
skin	O
.	O

Snail	O
is	O
not	O
expressed	O
at	O
this	O
stage	O
of	O
development	O
.	O

(	O
E	O
)	O
Snail	O
is	O
expressed	O
in	O
the	O
hair	O
bud	O
of	O
E17	O
.	O
5	O
skin	O
but	O
not	O
in	O
later	O
stages	O
of	O
development	O
such	O
as	O
the	O
germ	O
or	O
peg	O
.	O

(	O
F	O
)	O
Immunofluorescence	O
with	O
anti	O
-	O
Ki67	O
(	O
green	O
)	O
identifies	O
the	O
proliferating	O
cells	O
of	O
the	O
skin	O
,	O
restricted	O
to	O
the	O
basal	O
layer	O
of	O
the	O
epidermis	O
and	O
developing	O
hair	O
follicles	O
.	O

Anti	O
-	O
beta	O
4	O
int	O
labeling	O
reveals	O
the	O
presence	O
of	O
the	O
hemidesmosomal	O
integrin	O
beta	O
4	O
,	O
restricted	O
to	O
the	O
base	O
of	O
cells	O
adhering	O
to	O
the	O
underlying	O
basement	O
membrane	O
.	O

The	O
white	O
dotted	O
line	O
marks	O
the	O
outermost	O
surface	O
of	O
the	O
skin	O
.	O

(	O
G	O
)	O
Immunohistochemistry	O
with	O
pMAPK	O
marks	O
a	O
subset	O
of	O
proliferating	O
cells	O
within	O
the	O
epidermis	O
and	O
hair	O
bud	O
.	O

Anti	O
-	O
pMAPK	O
labeling	O
was	O
consistently	O
robust	O
within	O
the	O
hair	O
bud	O
.	O

(	O
H	O
)	O
Immunofluorescence	O
with	O
anti	O
-	O
laminin	O
5	O
(	O
lam5	O
)	O
,	O
which	O
demarcates	O
the	O
basement	O
membrane	O
,	O
and	O
anti	O
-	O
E	O
-	O
cadherin	O
(	O
E	O
-	O
cad	O
)	O
,	O
a	O
component	O
of	O
AJs	O
.	O

At	O
the	O
leading	O
edge	O
of	O
the	O
growing	O
bud	O
,	O
cell	O
-	O
cell	O
borders	O
show	O
markedly	O
diminished	O
anti	O
-	O
E	O
-	O
cadherin	O
labeling	O
(	O
arrowheads	O
)	O
.	O

Figure	O
2	O

Misexpression	O
of	O
Snail	O
in	O
Mouse	O
Skin	O
Epidermis	O
Results	O
in	O
Hyperproliferation	O

Three	O
different	O
surviving	O
Tg	O
founder	O
mice	O
harbored	O
a	O
K14	O
-	O
Snail	O
transgene	O
that	O
was	O
integrated	O
into	O
a	O
locus	O
that	O
resulted	O
in	O
inheritable	O
,	O
mosaic	O
expression	O
of	O
the	O
transgene	O
in	O
skin	O
epidermis	O
.	O

All	O
displayed	O
similar	O
abnormalities	O
,	O
as	O
did	O
their	O
offspring	O
.	O

(	O
A	O
)	O
P16	O
WT	O
and	O
K14	O
-	O
Snail	O
Tg	O
mice	O
.	O

Insets	O
denote	O
magnified	O
tail	O
segments	O
,	O
which	O
displayed	O
a	O
mosaic	O
,	O
flaky	O
appearance	O
in	O
Tg	O
mice	O
.	O

Size	O
differences	O
appeared	O
with	O
age	O
,	O
and	O
are	O
likely	O
due	O
to	O
K14	O
-	O
promoter	O
activity	O
in	O
the	O
tongue	O
and	O
oral	O
epithelium	O
,	O
resulting	O
in	O
progressive	O
defects	O
and	O
reduced	O
food	B-CHEBI
intake	O
.	O

Hence	O
,	O
skin	O
sections	O
from	O
young	O
(	O
P3	O
)	O
mice	O
were	O
analyzed	O
(	O
B	O
-	O
I	O
)	O
.	O

(	O
B	O
)	O
Hematoxylin	O
-	O
and	O
eosin	O
-	O
stained	O
Tg	O
skin	O
section	O
.	O

Double	O
arrows	O
demarcate	O
the	O
border	O
of	O
mosaic	O
histology	O
,	O
with	O
seemingly	O
normal	O
epidermis	O
(	O
epi	O
)	O
and	O
a	O
mature	O
hair	O
follicle	O
(	O
hf	O
)	O
at	O
left	O
and	O
hyperthickened	O
epidermis	O
at	O
right	O
.	O

(	O
C	O
)	O
Immunofluorescence	O
of	O
Tg	O
skin	O
section	O
labeled	O
with	O
antibodies	O
as	O
color	O
-	O
coded	O
on	O
frame	O
.	O

Double	O
arrows	O
demarcate	O
the	O
border	O
of	O
mosaic	O
anti	O
-	O
Snail	O
(	O
green	O
)	O
,	O
revealing	O
Snail	O
expression	O
coincident	O
with	O
regions	O
of	O
hyperthickened	O
epidermis	O
(	O
at	O
left	O
)	O
and	O
absent	O
in	O
regions	O
of	O
normal	O
epidermis	O
(	O
at	O
right	O
)	O
.	O

(	O
D	O
-	O
I	O
)	O
Sections	O
of	O
P3	O
WT	O
or	O
Tg	O
skin	O
(	O
affected	O
region	O
)	O
subjected	O
to	O
either	O
immunofluorescence	O
(	O
D	O
,	O
E	O
,	O
H	O
,	O
and	O
I	O
)	O
or	O
immunohistochemistry	O
(	O
F	O
and	O
G	O
)	O
with	O
antibodies	O
as	O
indicated	O
on	O
the	O
panel	O
.	O

Anti	O
-	O
keratin	O
5	O
indicates	O
K5	O
,	O
normally	O
restricted	O
to	O
the	O
basal	O
layer	O
of	O
the	O
epidermis	O
;	O
anti	O
-	O
keratin	O
6	O
detects	O
keratin	O
6	O
,	O
expressed	O
in	O
postnatal	O
epidermis	O
under	O
conditions	O
such	O
as	O
wounding	O
,	O
in	O
which	O
hyperproliferation	O
occurs	O
.	O

All	O
other	O
antibodies	O
are	O
as	O
in	O
the	O
legend	O
to	O
Figure	O
2	O
.	O

Comparison	O
of	O
D	O
and	O
E	O
provide	O
representative	O
examples	O
that	O
illustrate	O
that	O
pMAPK	O
is	O
found	O
in	O
only	O
a	O
subset	O
of	O
all	O
proliferating	O
(	O
Ki67	O
-	O
positive	O
)	O
cells	O
.	O

Note	O
also	O
the	O
presence	O
of	O
Ki67	O
-	O
(	O
E	O
)	O
and	O
pMAPK	O
-	O
positive	O
(	O
G	O
)	O
cells	O
in	O
some	O
suprabasal	O
areas	O
;	O
Ki67	O
-	O
positive	O
cells	O
colabeled	O
with	O
anti	O
-	O
Snail	O
(	O
E	O
)	O
.	O

Figure	O
3	O

Alterations	O
in	O
the	O
Differentiation	O
Program	O
and	O
Basement	O
Membrane	O
Organization	O
in	O
Snail	O
-	O
Expressing	O
Tg	O
Epidermis	O

(	O
A	O
-	O
H	O
)	O
Immunofluorescence	O
of	O
skin	O
sections	O
from	O
P3	O
WT	O
and	O
Tg	O
mice	O
.	O

Shown	O
are	O
affected	O
areas	O
of	O
Tg	O
skin	O
;	O
in	O
areas	O
where	O
Snail	O
protein	B-CHEBI
was	O
not	O
expressed	O
,	O
stainings	O
were	O
normal	O
.	O

Sections	O
were	O
labeled	O
with	O
antibodies	O
as	O
indicated	O
and	O
color	O
-	O
coded	O
on	O
each	O
frame	O
.	O

Antibodies	O
are	O
against	O
markers	O
of	O
normal	O
epidermal	O
differentiation	O
,	O
and	O
include	O
K5	O
(	O
a	O
basally	O
expressed	O
keratin	O
)	O
,	O
K1	O
(	O
a	O
suprabasal	O
keratin	O
,	O
expressed	O
in	O
spinous	O
layer	O
cells	O
)	O
,	O
involucrin	O
(	O
Inv	O
;	O
a	O
suprabasally	O
expressed	O
cornified	O
envelope	O
protein	B-CHEBI
found	O
in	O
upper	O
spinous	O
and	O
granular	O
layer	O
cells	O
)	O
,	O
loricrin	O
(	O
Lor	O
;	O
a	O
cornified	O
envelope	O
protein	B-CHEBI
expressed	O
in	O
the	O
granular	O
layer	O
)	O
,	O
and	O
filaggrin	O
(	O
Fil	O
;	O
a	O
protein	B-CHEBI
that	O
bundles	O
keratin	O
filaments	O
in	O
the	O
granular	O
layer	O
and	O
stratum	O
corneum	O
)	O
.	O

Note	O
abnormal	O
extension	O
of	O
anti	O
-	O
K5	O
suprabasally	O
,	O
often	O
present	O
in	O
anti	O
-	O
K1	O
positive	O
suprabasal	O
Tg	O
cells	O
.	O

(	O
I	O
-	O
N	O
)	O
Immunohistochemistry	O
(	O
I	O
and	O
J	O
)	O
or	O
immunofluorescence	O
(	O
K	O
-	O
N	O
)	O
of	O
sections	O
of	O
P30	O
Wt	O
(	O
I	O
,	O
K	O
,	O
and	O
M	O
)	O
and	O
Tg	O
(	O
J	O
,	O
L	O
,	O
and	O
N	O
)	O
(	O
affected	O
areas	O
)	O
skins	O
using	O
the	O
antibodies	O
indicated	O
.	O

Note	O
that	O
with	O
age	O
,	O
affected	O
areas	O
of	O
the	O
Tg	O
epidermis	O
became	O
increasingly	O
undulating	O
,	O
often	O
exhibiting	O
papilloma	O
-	O
like	O
invaginations	O
(	O
J	O
)	O
.	O

Insets	O
in	O
I	O
and	O
J	O
are	O
magnified	O
views	O
of	O
the	O
boxed	O
areas	O
,	O
illustrating	O
the	O
absence	O
(	O
Wt	O
)	O
or	O
presence	O
(	O
Tg	O
)	O
of	O
nuclear	O
anti	O
-	O
cyclin	O
D	O
staining	O
.	O

With	O
age	O
,	O
affected	O
areas	O
of	O
the	O
Tg	O
epidermis	O
also	O
displayed	O
perturbations	O
within	O
the	O
basement	O
membrane	O
,	O
as	O
judged	O
by	O
antibody	O
labeling	O
against	O
either	O
basement	O
membrane	O
(	O
K	O
and	O
L	O
)	O
or	O
hemidesmosomal	O
(	O
M	O
and	O
N	O
)	O
components	O
.	O

Double	O
arrows	O
in	O
L	O
demarcate	O
mosaic	O
zones	O
,	O
revealing	O
that	O
perturbations	O
were	O
restricted	O
to	O
hyperthickened	O
,	O
i	O
.	O
e	O
.	O
,	O
Snail	O
-	O
positive	O
zones	O
(	O
to	O
left	O
of	O
double	O
arrows	O
)	O
.	O

Other	O
abbreviations	O
are	O
as	O
noted	O
in	O
the	O
legend	O
to	O
Figure	O
2	O
.	O

Figure	O
4	O

Snail	O
-	O
Mediated	O
Remodeling	O
of	O
AJs	O
Contributes	O
to	O
Hyperproliferation	O

(	O
A	O
)	O
Immunofluorescence	O
of	O
skin	O
sections	O
from	O
P30	O
Wt	O
and	O
Tg	O
mice	O
.	O

Shown	O
are	O
affected	O
areas	O
of	O
Tg	O
skin	O
;	O
in	O
areas	O
where	O
Snail	O
protein	B-CHEBI
was	O
not	O
expressed	O
,	O
stainings	O
were	O
normal	O
.	O

Antibodies	O
used	O
are	O
against	O
AJ	O
proteins	B-CHEBI
and	O
include	O
E	O
-	O
cadherin	O
(	O
E	O
-	O
cad	O
)	O
,	O
the	O
transmembrane	O
core	O
protein	B-CHEBI
;	O
beta	O
-	O
catenin	O
(	O
beta	O
-	O
cat	O
)	O
,	O
which	O
binds	O
E	O
-	O
cadherin	O
at	O
AJs	O
and	O
which	O
can	O
also	O
participate	O
as	O
a	O
transcription	O
cofactor	O
when	O
associated	O
with	O
LEF	O
-	O
1	O
/	O
TCF	O
proteins	B-CHEBI
in	O
the	O
nucleus	O
;	O
alpha	O
-	O
catenin	O
(	O
alpha	O
-	O
cat	O
)	O
which	O
binds	O
to	O
both	O
beta	O
-	O
catenin	O
and	O
Ajuba	O
,	O
a	O
close	O
relative	O
of	O
zyxin	O
;	O
and	O
Ajuba	O
,	O
which	O
can	O
associate	O
with	O
proteins	B-CHEBI
that	O
bind	O
to	O
the	O
actin	O
cytoskeleton	O
,	O
as	O
well	O
as	O
with	O
Grb	O
-	O
2	O
,	O
a	O
mediator	O
of	O
the	O
GTP	B-CHEBI
nucleotide	B-CHEBI
-	O
exchange	O
protein	B-CHEBI
Sos	O
,	O
involved	O
in	O
activation	O
of	O
the	O
Ras	O
-	O
MAPK	O
signaling	O
cascade	O
.	O

In	O
Snail	O
-	O
expressing	O
Tg	O
regions	O
,	O
there	O
was	O
a	O
reduced	O
staining	O
with	O
anti	O
-	O
E	O
-	O
cad	O
and	O
anti	O
-	O
alpha	O
-	O
cat	O
and	O
a	O
more	O
diffuse	O
staining	O
with	O
anti	O
-	O
Ajuba	O
.	O

Insets	O
in	O
the	O
panels	O
for	O
beta	O
-	O
catenin	O
and	O
Ajuba	O
staining	O
are	O
magnified	O
views	O
of	O
the	O
boxed	O
areas	O
.	O

Arrows	O
mark	O
membrane	O
localization	O
of	O
the	O
protein	B-CHEBI
and	O
asterisks	O
mark	O
cells	O
with	O
elevated	O
levels	O
of	O
cytoplasmic	O
beta	O
-	O
catenin	O
or	O
Ajuba	O
.	O

(	O
B	O
)	O
Western	O
blot	O
analyses	O
of	O
protein	B-CHEBI
extracts	O
from	O
P30	O
Wt	O
and	O
Tg	O
back	O
and	O
ear	O
skins	O
.	O

Antibodies	O
are	O
as	O
in	O
(	O
A	O
)	O
except	O
anti	O
-	O
P	O
-	O
cad	O
,	O
which	O
detects	O
P	O
-	O
cadherin	O
,	O
whose	O
expression	O
in	O
the	O
hair	O
follicle	O
was	O
not	O
affected	O
,	O
and	O
anti	O
-	O
tubulin	O
,	O
which	O
detects	O
tubulin	O
,	O
a	O
control	O
for	O
equal	O
protein	B-CHEBI
loadings	O
.	O

Note	O
that	O
the	O
reductions	O
seen	O
in	O
E	O
-	O
cadherin	O
and	O
alpha	O
-	O
catenin	O
are	O
likely	O
to	O
be	O
underestimates	O
of	O
the	O
actual	O
differences	O
in	O
affected	O
regions	O
,	O
since	O
the	O
Tg	O
skin	O
expressed	O
Snail	O
mosaically	O
.	O

(	O
C	O
)	O
In	O
the	O
presence	O
of	O
elevated	O
Snail	O
,	O
alpha	O
-	O
catenin	O
levels	O
can	O
be	O
restored	O
by	O
overexpression	O
of	O
E	O
-	O
cadherin	O
.	O

Keratinocytes	O
were	O
transfected	O
with	O
either	O
HA	O
-	O
tagged	O
Snail	O
(	O
Snail	O
[	O
HA	O
]	O
;	O
images	O
on	O
the	O
left	O
)	O
or	O
Snail	O
(	O
HA	O
)	O
and	O
Ecad	O
(	O
HA	O
)	O
(	O
images	O
on	O
the	O
right	O
)	O
.	O

2	O
d	O
after	O
transfection	O
,	O
cells	O
were	O
switched	O
from	O
low	O
-	O
calcium	B-CHEBI
growth	O
medium	O
to	O
high	O
-	O
calcium	B-CHEBI
medium	O
for	O
6	O
h	O
to	O
induce	O
AJ	O
formation	O
.	O

Cells	O
were	O
stained	O
with	O
antibodies	O
as	O
indicated	O
on	O
the	O
panels	O
.	O

Arrowheads	O
point	O
to	O
sites	O
of	O
intercellular	O
contact	O
between	O
a	O
Snail	O
-	O
transfected	O
keratinocyte	O
and	O
its	O
neighboring	O
untransfected	O
cell	O
.	O

(	O
D	O
)	O
Reintroduction	O
of	O
E	O
-	O
cadherin	O
in	O
keratinocytes	O
expressing	O
Snail	O
returns	O
pMAPK	O
to	O
basal	O
levels	O
.	O

Keratinocytes	O
were	O
transfected	O
with	O
control	O
vector	O
(	O
K14	O
)	O
,	O
or	O
Snail	O
(	O
HA	O
)	O
,	O
or	O
Snail	O
(	O
HA	O
)	O
+	O
E	O
-	O
cad	O
(	O
HA	O
)	O
.	O

After	O
2	O
d	O
,	O
cells	O
were	O
serum	O
starved	O
for	O
4	O
h	O
and	O
whole	O
cell	O
lysates	O
were	O
made	O
and	O
Western	O
blotted	O
with	O
antibodies	O
to	O
pMAPK	O
,	O
HA	O
to	O
recognize	O
the	O
HA	O
-	O
tagged	O
Snail	O
and	O
E	O
-	O
cadherin	O
protein	B-CHEBI
,	O
20or	O
tubulin	O
as	O
a	O
loading	O
control	O
.	O

(	O
E	O
)	O
Ajuba	O
interacts	O
with	O
Grb	O
-	O
2	O
under	O
conditions	O
where	O
alpha	O
-	O
catenin	O
levels	O
are	O
reduced	O
.	O

Protein	B-CHEBI
extracts	O
were	O
made	O
from	O
skins	O
of	O
P30	O
Wt	O
and	O
K14	O
-	O
Snail	O
Tg	O
P30	O
mice	O
(	O
blots	O
on	O
the	O
left	O
)	O
and	O
of	O
newborn	O
Wt	O
and	O
K14	O
-	O
Cre	O
/	O
alpha	O
-	O
catenin	O
(	O
fl	O
/	O
fl	O
)	O
conditionally	O
null	O
animals	O
(	O
blots	O
on	O
the	O
right	O
)	O
[	O
7	O
]	O
.	O

Equal	O
amounts	O
of	O
protein	B-CHEBI
extracts	O
were	O
treated	O
with	O
anti	O
-	O
Grb	O
-	O
2	O
antibody	O
(	O
+	O
)	O
or	O
control	O
isotype	O
antibody	O
(	O
-	O
)	O
,	O
and	O
following	O
centrifugation	O
,	O
immunoprecipitates	O
were	O
subjected	O
to	O
SDS	B-CHEBI
-	O
PAGE	O
and	O
Western	O
blot	O
analysis	O
with	O
anti	O
-	O
Ajuba	O
and	O
anti	O
-	O
Grb	O
-	O
2	O
antibodies	O
.	O

Note	O
the	O
presence	O
of	O
Ajuba	O
only	O
under	O
conditions	O
where	O
levels	O
of	O
alpha	O
-	O
catenin	O
and	O
other	O
AJ	O
proteins	B-CHEBI
were	O
aberrantly	O
low	O
or	O
absent	O
.	O

(	O
F	O
)	O
Transgene	O
expression	O
of	O
excess	O
Ajuba	O
or	O
the	O
Grb	O
-	O
2	O
-	O
interacting	O
domain	O
(	O
pre	O
-	O
LIM	O
)	O
of	O
Ajuba	O
in	O
keratinocytes	O
results	O
in	O
the	O
activation	O
of	O
the	O
Ras	O
-	O
MAPK	O
pathway	O
.	O

Primary	O
newborn	O
mouse	O
keratinocytes	O
were	O
transfected	O
with	O
either	O
the	O
empty	O
K14	O
expression	O
vector	O
(	O
K14	O
)	O
,	O
or	O
the	O
expression	O
vector	O
driving	O
Snail	O
,	O
full	O
length	O
Ajuba	O
,	O
or	O
the	O
pre	O
-	O
LIM	O
domain	O
of	O
Ajuba	O
in	O
the	O
absence	O
or	O
presence	O
of	O
a	O
peptide	O
inhibitor	B-CHEBI
(	O
inh	O
)	O
that	O
disrupts	O
the	O
interaction	O
between	O
Grb	O
-	O
2	O
and	O
Sos	O
.	O

48	O
h	O
posttransfection	O
,	O
protein	B-CHEBI
extracts	O
were	O
prepared	O
and	O
subjected	O
to	O
SDS	B-CHEBI
-	O
PAGE	O
and	O
Western	O
blot	O
analyses	O
with	O
antibodies	O
against	O
pMAPK	O
,	O
total	O
MAPK	O
,	O
Ajuba	O
(	O
also	O
recognizing	O
the	O
smaller	O
,	O
pre	O
-	O
LIM	O
domain	O
)	O
,	O
and	O
Snail	O
.	O

Figure	O
5	O

TGF	O
-	O
beta	O
2	O
,	O
but	O
Not	O
Wnt	O
/	O
noggin	O
,	O
Transiently	O
Induces	O
Snail	O
Expression	O
In	O
Vitro	O

(	O
A	O
)	O
Failure	O
of	O
Wnt	O
and	O
noggin	O
signaling	O
to	O
induce	O
Snail	O
in	O
cultured	O
keratinocytes	O
.	O

Primary	O
mouse	O
keratinocytes	O
were	O
treated	O
with	O
Wnt	O
-	O
and	O
/	O
or	O
noggin	O
-	O
conditioned	O
medium	O
(	O
+	O
)	O
or	O
the	O
corresponding	O
control	O
medium	O
(	O
-	O
)	O
.	O

These	O
conditions	O
are	O
known	O
to	O
activate	O
the	O
LEF	O
-	O
1	O
/	O
beta	O
-	O
catenin	O
reporter	O
TOPGal	O
and	O
down	O
-	O
regulate	O
the	O
E	O
-	O
cadherin	O
promoter	O
(	O
see	O
[	O
4	O
]	O
for	O
details	O
)	O
.	O

Using	O
Western	O
blot	O
analyses	O
,	O
cellular	O
proteins	B-CHEBI
were	O
then	O
analyzed	O
for	O
Snail	O
,	O
LEF	O
-	O
1	O
,	O
beta	O
-	O
catenin	O
,	O
and	O
tubulin	O
.	O

Proteins	B-CHEBI
from	O
keratinocytes	O
transfected	O
with	O
K14	O
-	O
Snail	O
were	O
used	O
as	O
a	O
positive	O
control	O
for	O
Snail	O
expression	O
.	O

(	O
B	O
)	O
TGF	O
-	O
beta	O
2	O
can	O
induce	O
Snail	O
protein	B-CHEBI
.	O

Primary	O
keratinocytes	O
were	O
treated	O
for	O
the	O
indicated	O
times	O
with	O
recombinant	O
TGF	O
-	O
beta	O
2	O
(	O
+	O
)	O
or	O
heat	O
inactivated	O
TGF	O
-	O
beta	O
2	O
(	O
-	O
)	O
.	O
Total	O
cellular	O
proteins	B-CHEBI
were	O
then	O
isolated	O
and	O
analyzed	O
by	O
Western	O
blot	O
for	O
Snail	O
,	O
pSMAD2	O
(	O
reflective	O
of	O
activated	O
TGF	O
-	O
signaling	O
)	O
,	O
and	O
tubulin	O
.	O

Note	O
the	O
activation	O
of	O
Snail	O
expression	O
,	O
peaking	O
at	O
2	O
h	O
post	O
-	O
TGF	O
-	O
beta	O
2	O
treatment	O
and	O
then	O
disappearing	O
thereafter	O
.	O

(	O
C	O
)	O
Snail	O
mRNA	B-CHEBI
expression	O
is	O
transiently	O
induced	O
by	O
TGF	O
-	O
beta	O
2	O
.	O

The	O
experiment	O
in	O
(	O
B	O
)	O
was	O
repeated	O
,	O
and	O
this	O
time	O
,	O
total	O
RNAs	O
were	O
isolated	O
from	O
keratinocytes	O
treated	O
with	O
TGF	O
-	O
beta	O
2	O
for	O
the	O
indicated	O
times	O
.	O

RT	O
-	O
PCR	O
was	O
then	O
used	O
with	O
(	O
+	O
)	O
or	O
without	O
(	O
-	O
)	O
reverse	O
transcriptase	O
(	O
RT	O
)	O
and	O
with	O
primer	O
sets	O
specific	O
for	O
Snail	O
and	O
GAPDH	O
mRNAs	B-CHEBI
.	O

Note	O
that	O
Snail	O
mRNA	B-CHEBI
expression	O
also	O
peaked	O
at	O
2	O
h	O
,	O
paralleling	O
Snail	O
protein	B-CHEBI
.	O

(	O
D	O
)	O
TGF	O
-	O
beta	O
2	O
treatment	O
results	O
in	O
enhanced	O
activity	O
of	O
a	O
Snail	O
promoter	O
-	O
beta	O
-	O
galactosidase	O
reporter	O
.	O

Keratinocytes	O
were	O
transfected	O
with	O
a	O
beta	O
-	O
galactosidase	O
reporter	O
driven	O
by	O
a	O
Snail	O
promoter	O
that	O
is	O
either	O
WT	O
(	O
wt	O
prom	O
)	O
or	O
harbors	O
a	O
mutation	O
in	O
a	O
putative	O
pSMAD2	O
/	O
pSMAD4	O
binding	O
site	O
(	O
mt	O
prom	O
)	O
.	O

At	O
2	O
d	O
posttransfection	O
,	O
cells	O
were	O
treated	O
with	O
either	O
TGF	O
-	O
beta	O
or	O
heat	O
-	O
inactivated	O
TGF	O
-	O
beta	O
2	O
(	O
inact	O
)	O
for	O
the	O
times	O
indicated	O
.	O

beta	O
-	O
galactosidase	O
assays	O
were	O
then	O
conducted	O
,	O
and	O
results	O
are	O
reported	O
as	O
fold	O
increase	O
over	O
a	O
basal	O
level	O
of	O
activity	O
of	O
1	O
.	O

The	O
experiment	O
was	O
repeated	O
three	O
times	O
in	O
triplicate	O
,	O
and	O
error	O
bars	O
reflect	O
variations	O
in	O
the	O
results	O
.	O

Figure	O
6	O

TGF	O
-	O
beta	O
2	O
Is	O
Necessary	O
to	O
Induce	O
Snail	O
Expression	O
and	O
Regulate	O
Proliferation	O
and	O
E	O
-	O
Cadherin	O
in	O
the	O
Hair	O
Bud	O

(	O
A	O
-	O
D	O
)	O
Skins	O
from	O
TGF	O
-	O
beta	O
2	O
WT	O
or	O
KO	O
E17	O
.	O
5	O
embryos	O
were	O
analyzed	O
for	O
expression	O
of	O
TGF	O
-	O
beta	O
2	O
protein	B-CHEBI
(	O
A	O
)	O
,	O
which	O
is	O
present	O
in	O
the	O
epidermis	O
and	O
dermis	O
as	O
previously	O
described	O
[	O
33	O
]	O
and	O
in	O
the	O
hair	O
bud	O
,	O
pSMAD2	O
(	O
B	O
)	O
,	O
Snail	O
(	O
C	O
)	O
,	O
and	O
Snail	O
mRNA	B-CHEBI
(	O
D	O
)	O
.	O

Arrows	O
point	O
to	O
the	O
hair	O
buds	O
.	O

(	O
E	O
)	O
Western	O
blot	O
analyses	O
of	O
Snail	O
expression	O
in	O
the	O
skins	O
of	O
2	O
-	O
wk	O
-	O
old	O
K14	O
-	O
Smad2	O
transgenic	O
(	O
SMAD2	O
TG	O
)	O
and	O
WT	O
littermate	O
(	O
WT	O
)	O
mice	O
.	O

Antibody	O
to	O
tubulin	O
was	O
used	O
as	O
a	O
control	O
for	O
equal	O
protein	B-CHEBI
loadings	O
.	O

The	O
K14	O
-	O
Smad2	O
Tg	O
mouse	O
was	O
previously	O
shown	O
to	O
possess	O
activated	O
TGF	O
-	O
beta	O
signaling	O
[	O
35	O
]	O
.	O

(	O
F	O
-	O
G	O
)	O
Proliferation	O
markers	O
Ki67	O
(	O
F	O
)	O
and	O
pMAPK	O
(	O
G	O
)	O
are	O
diminished	O
in	O
TGF	O
-	O
beta	O
2	O
-	O
null	O
hair	O
relative	O
to	O
its	O
WT	O
counterpart	O
.	O

(	O
H	O
-	O
J	O
)	O
TGF	O
-	O
beta	O
2	O
-	O
null	O
hair	O
fails	O
to	O
down	O
-	O
regulate	O
E	O
-	O
cadherin	O
(	O
H	O
)	O
.	O

Wnt	O
and	O
noggin	O
signaling	O
pathways	O
are	O
still	O
intact	O
in	O
the	O
TGF	O
-	O
beta	O
2	O
null	O
hair	O
as	O
nuclear	O
LEF	O
-	O
1	O
(	O
I	O
)	O
and	O
nuclear	O
beta	O
-	O
catenin	O
(	O
J	O
)	O
are	O
still	O
expressed	O
.	O

Footnotes	O

Author	O
contributions	O
.	O

CJ	O
and	O
EF	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

CJ	O
,	O
PL	O
,	O
and	O
PK	O
performed	O
the	O
experiments	O
.	O

CJ	O
and	O
EF	O
analyzed	O
the	O
data	O
.	O

MA	O
,	O
RH	O
,	O
YC	O
,	O
and	O
EF	O
contributed	O
reagents	B-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

CJ	O
and	O
EF	O
wrote	O
the	O
paper	O
.	O

Note	O
Added	O
in	O
Proof	O

Our	O
results	O
are	O
particularly	O
interesting	O
in	O
light	O
of	O
the	O
recent	O
implication	O
that	O
GSK	O
-	O
3	O
beta	O
controls	O
Snail	O
'	O
s	O
stability	O
and	O
subcellular	O
localization	O
[	O
50	O
]	O
.	O

Since	O
Wnts	O
are	O
known	O
to	O
deactivate	O
GSK	O
-	O
3	O
beta	O
,	O
Wnt	O
and	O
TGF	O
-	O
beta	O
2	O
signaling	O
may	O
contribute	O
to	O
Snail	O
'	O
s	O
transient	O
induction	O
and	O
accumulation	O
.	O

Moreover	O
,	O
since	O
inhibition	O
of	O
GSK	O
-	O
3	O
beta	O
results	O
in	O
Snail	O
upregulation	O
and	O
E	O
-	O
cadherin	O
downregulation	O
,	O
Snail	O
and	O
GSK	O
-	O
3	O
beta	O
may	O
function	O
at	O
a	O
crossroads	O
in	O
controlling	O
hair	O
bud	O
development	O
.	O

Citation	O
:	O
Jamora	O
C	O
,	O
Lee	O
P	O
,	O
Kocieniewski	O
P	O
,	O
Azhar	O
M	O
,	O
Hosokawa	O
R	O
,	O
et	O
al	O
.	O

(	O
2004	O
)	O
A	O
signaling	O
pathway	O
involving	O
TGF	O
-	O
beta	O
2	O
and	O
Snail	O
in	O
hair	O
follicle	O
morphogenesis	O
.	O

PLoS	O
Biol	O
3	O
(	O
1	O
)	O
:	O
e11	O
.	O

Synaptogenesis	O
and	O
outer	O
segment	O
formation	O
are	O
perturbed	O
in	O
the	O
neural	O
retina	O
of	O
Crx	O
mutant	O
mice	O

Abstract	O

Background	O

In	O
Leber	O
'	O
s	O
congenital	O
amaurosis	O
(	O
LCA	O
)	O
,	O
affected	O
individuals	O
are	O
blind	O
,	O
or	O
nearly	O
so	O
,	O
from	O
birth	O
.	O

This	O
early	O
onset	O
suggests	O
abnormal	O
development	O
of	O
the	O
neural	O
retina	O
.	O

Mutations	O
in	O
genes	O
that	O
affect	O
the	O
development	O
and	O
/	O
or	O
function	O
of	O
photoreceptor	O
cells	O
have	O
been	O
found	O
to	O
be	O
responsible	O
in	O
some	O
families	O
.	O

These	O
examples	O
include	O
mutations	O
in	O
the	O
photoreceptor	O
transcription	O
factor	O
,	O
Crx	O
.	O

Results	O

A	O
Crx	O
mutant	O
strain	O
of	O
mice	O
was	O
created	O
to	O
serve	O
as	O
a	O
model	O
for	O
LCA	O
and	O
to	O
provide	O
more	O
insight	O
into	O
Crx	O
'	O
s	O
function	O
.	O

In	O
this	O
study	O
,	O
an	O
ultrastructural	O
analysis	O
of	O
the	O
developing	O
retina	O
in	O
Crx	O
mutant	O
mice	O
was	O
performed	O
.	O

Outer	O
segment	O
morphogenesis	O
was	O
found	O
to	O
be	O
blocked	O
at	O
the	O
elongation	O
stage	O
,	O
leading	O
to	O
a	O
failure	O
in	O
production	O
of	O
the	O
phototransduction	O
apparatus	O
.	O

Further	O
,	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
demonstrated	O
severely	O
abnormal	O
synaptic	O
endings	O
in	O
the	O
outer	O
plexiform	O
layer	O
.	O

Conclusions	O

This	O
is	O
the	O
first	O
report	O
of	O
a	O
synaptogenesis	O
defect	O
in	O
an	O
animal	O
model	O
for	O
LCA	O
.	O

These	O
data	O
confirm	O
the	O
essential	O
role	O
this	O
gene	O
plays	O
in	O
multiple	O
aspects	O
of	O
photoreceptor	O
development	O
and	O
extend	O
our	O
understanding	O
of	O
the	O
basic	O
pathology	O
of	O
LCA	O
.	O

Background	O

Photoreceptor	O
cells	O
play	O
a	O
primary	O
role	O
in	O
vision	O
by	O
capturing	O
light	O
energy	O
and	O
converting	O
it	O
into	O
neural	O
stimuli	O
.	O

These	O
sensory	O
neurons	O
are	O
a	O
shared	O
element	O
in	O
all	O
organisms	O
capable	O
of	O
sensing	O
light	O
.	O

In	O
humans	O
,	O
genetic	O
diseases	O
of	O
the	O
eye	O
are	O
common	O
and	O
the	O
primary	O
site	O
of	O
disease	O
is	O
most	O
frequently	O
photoreceptors	O
(	O
for	O
review	O
see	O
[	O
1	O
-	O
3	O
]	O
)	O
.	O

Photoreceptors	O
have	O
been	O
well	O
studied	O
,	O
particularly	O
with	O
respect	O
to	O
the	O
biochemistry	O
and	O
physiology	O
of	O
phototransduction	O
.	O

Insight	O
into	O
the	O
development	O
of	O
vertebrate	O
photoreceptors	O
,	O
however	O
,	O
has	O
lagged	O
behind	O
our	O
understanding	O
of	O
function	O
.	O

Only	O
recently	O
have	O
the	O
first	O
molecular	B-CHEBI
mechanisms	O
regulating	O
photoreceptor	O
development	O
been	O
identified	O
(	O
for	O
review	O
see	O
,	O
[	O
2	O
,	O
4	O
]	O
)	O
.	O

Crx	O
(	O
cone	O
-	O
rod	O
homeobox	O
)	O
is	O
an	O
otx	O
-	O
family	O
homeobox	O
gene	O
expressed	O
predominantly	O
in	O
photoreceptors	O
,	O
from	O
early	O
in	O
their	O
development	O
through	O
to	O
the	O
adult	O
ages	O
[	O
5	O
-	O
7	O
]	O
.	O

Crx	O
gene	O
expression	O
is	O
critically	O
dependent	O
upon	O
Otx2	O
,	O
another	O
member	O
of	O
the	O
same	O
homeobox	O
family	O
which	O
is	O
expressed	O
in	O
early	O
photoreceptor	O
cells	O
[	O
8	O
]	O
.	O

In	O
rod	O
photoreceptors	O
,	O
Crx	O
appears	O
to	O
work	O
in	O
concert	O
with	O
Nrl	O
,	O
a	O
leucine	B-CHEBI
zipper	O
protein	B-CHEBI
that	O
is	O
also	O
restricted	O
in	O
its	O
expression	O
in	O
the	O
retina	O
to	O
rod	O
photoreceptors	O
[	O
9	O
]	O
.	O

Many	O
photoreceptor	O
-	O
specific	O
genes	O
have	O
putative	O
Crx	O
-	O
binding	O
elements	O
in	O
their	O
regulatory	O
regions	O
[	O
10	O
]	O
,	O
including	O
rhodopsin	O
[	O
11	O
]	O
and	O
arrestin	O
[	O
12	O
]	O
.	O

Mutations	O
in	O
Crx	O
have	O
been	O
associated	O
with	O
several	O
human	O
diseases	O
that	O
lead	O
to	O
blindness	O
,	O
including	O
cone	O
-	O
rod	O
dystrophy	O
2	O
[	O
6	O
,	O
13	O
,	O
14	O
]	O
,	O
retinitis	O
pigmentosa	O
[	O
14	O
]	O
,	O
and	O
LCA	O
[	O
14	O
-	O
16	O
]	O
.	O

Based	O
on	O
these	O
data	O
,	O
Crx	O
was	O
hypothesized	O
to	O
play	O
a	O
critical	O
role	O
in	O
the	O
differentiation	O
and	O
maintainance	O
of	O
photoreceptor	O
cells	O
[	O
5	O
,	O
7	O
]	O
.	O

LCA	O
is	O
the	O
most	O
severe	O
genetic	O
disease	O
of	O
photoreceptors	O
(	O
see	O
[	O
17	O
]	O
,	O
for	O
recent	O
review	O
)	O
.	O

Affected	O
infants	O
exhibit	O
a	O
complete	O
or	O
near	O
complete	O
absence	O
of	O
vision	O
from	O
birth	O
.	O

Mutations	O
in	O
retinal	O
specific	O
genes	O
,	O
such	O
as	O
Crx	O
,	O
have	O
been	O
associated	O
with	O
LCA	O
[	O
14	O
,	O
15	O
]	O
,	O
as	O
well	O
as	O
GUCY2D	O
[	O
18	O
]	O
,	O
RPE65	O
[	O
19	O
]	O
,	O
AIPL	O
-	O
1	O
[	O
20	O
]	O
,	O
CRB	O
-	O
1	O
[	O
21	O
]	O
,	O
and	O
RPGRIP	O
-	O
1	O
[	O
22	O
]	O
.	O

There	O
also	O
may	O
be	O
as	O
many	O
as	O
three	O
additional	O
genetically	O
linked	O
loci	O
where	O
genes	O
have	O
not	O
been	O
identified	O
[	O
23	O
]	O
.	O

Crx	O
mutations	O
in	O
LCA	O
are	O
varied	O
,	O
and	O
include	O
a	O
putative	O
dominant	O
mutation	O
that	O
is	O
proposed	O
to	O
encode	O
a	O
dominant	O
-	O
negative	O
form	O
of	O
Crx	O
[	O
14	O
,	O
15	O
]	O
.	O

Recessive	O
mutations	O
also	O
have	O
been	O
reported	O
and	O
at	O
least	O
one	O
allele	O
encodes	O
a	O
protein	B-CHEBI
with	O
decreased	O
DNA	O
-	O
binding	O
activity	O
[	O
16	O
]	O
.	O

Histopathological	O
and	O
ultrastructural	O
studies	O
of	O
LCA	O
should	O
enable	O
a	O
better	O
understanding	O
of	O
the	O
disease	O
process	O
,	O
and	O
the	O
design	O
of	O
suitable	O
therapies	O
.	O

Few	O
such	O
studies	O
exist	O
for	O
human	O
LCA	O
(	O
reviewed	O
in	O
[	O
17	O
]	O
)	O
and	O
the	O
majority	O
of	O
such	O
studies	O
examine	O
the	O
globes	O
of	O
adults	O
with	O
LCA	O
,	O
after	O
the	O
tissue	O
has	O
undergone	O
secondary	O
changes	O
.	O

Only	O
a	O
single	O
study	O
exists	O
where	O
the	O
developing	O
eye	O
of	O
an	O
infant	O
was	O
examined	O
[	O
24	O
]	O
.	O

Animal	O
models	O
for	O
LCA	O
have	O
recently	O
been	O
reported	O
and	O
have	O
already	O
served	O
to	O
broaden	O
our	O
understanding	O
of	O
the	O
pathology	O
of	O
this	O
disease	O
[	O
25	O
-	O
28	O
]	O
.	O

Since	O
LCA	O
is	O
a	O
clinically	O
and	O
genetically	O
heterogeneous	O
disorder	O
,	O
additional	O
mouse	O
models	O
are	O
in	O
order	O
to	O
allow	O
a	O
full	O
understanding	O
of	O
the	O
many	O
ways	O
in	O
which	O
photoreceptor	O
development	O
can	O
go	O
awry	O
.	O

In	O
addition	O
to	O
their	O
importance	O
as	O
a	O
locus	O
of	O
disease	O
,	O
photoreceptor	O
cells	O
serve	O
as	O
an	O
excellent	O
model	O
for	O
studies	O
in	O
neuronal	O
differentiation	O
.	O

Photoreceptor	O
cells	O
are	O
highly	O
polarized	O
.	O

At	O
their	O
apex	O
,	O
these	O
neurons	O
have	O
a	O
membranous	O
outer	O
segment	O
,	O
which	O
contains	O
proteins	B-CHEBI
involved	O
in	O
the	O
phototransduction	O
cascade	O
.	O

Loss	O
of	O
function	O
mutations	O
in	O
rhodopsin	O
[	O
29	O
]	O
,	O
or	O
the	O
structural	O
protein	B-CHEBI
,	O
peripherin	O
[	O
30	O
]	O
,	O
result	O
in	O
an	O
inability	O
to	O
form	O
outer	O
segments	O
.	O

At	O
the	O
other	O
extremity	O
,	O
photoreceptors	O
terminate	O
with	O
synaptic	O
endings	O
that	O
make	O
contact	O
with	O
the	O
processes	O
of	O
horizontal	O
and	O
bipolar	O
cells	O
[	O
31	O
,	O
32	O
]	O
.	O

Rod	O
spherules	O
establish	O
an	O
invaginating	O
synapse	O
with	O
rod	O
bipolar	O
dendrites	O
and	O
axonal	O
endings	O
of	O
horizontal	O
cells	O
.	O

This	O
synapse	O
is	O
characterized	O
by	O
the	O
presence	O
of	O
a	O
ribbon	O
in	O
the	O
presynaptic	O
cytoplasm	O
.	O

Cone	O
pedicles	O
make	O
invaginating	O
synapses	O
with	O
the	O
dendrites	O
of	O
on	O
-	O
cone	O
bipolar	O
cells	O
and	O
horizontal	O
cells	O
and	O
basal	O
junctions	O
with	O
the	O
dendrites	O
of	O
off	O
-	O
cone	O
bipolar	O
cells	O
.	O

The	O
factors	O
regulating	O
the	O
formation	O
of	O
the	O
photoreceptor	O
synapses	O
are	O
completely	O
unknown	O
.	O

At	O
least	O
one	O
photoreceptor	O
synaptic	O
protein	B-CHEBI
,	O
HRG4	O
,	O
contains	O
a	O
potential	O
Crx	O
target	O
sequence	O
in	O
its	O
transcriptional	O
regulatory	O
sequence	O
[	O
33	O
]	O
.	O

Few	O
studies	O
of	O
LCA	O
animal	O
models	O
have	O
extended	O
their	O
examination	O
of	O
retinal	O
pathology	O
to	O
the	O
ultrastructural	O
level	O
.	O

Certain	O
features	O
of	O
neuronal	O
differentiation	O
,	O
such	O
as	O
synapse	O
formation	O
,	O
can	O
be	O
detected	O
definitively	O
at	O
this	O
level	O
of	O
analysis	O
.	O

With	O
the	O
hope	O
of	O
understanding	O
the	O
neuropathology	O
of	O
LCA	O
in	O
greater	O
detail	O
,	O
we	O
have	O
analyzed	O
the	O
differentiation	O
of	O
the	O
outer	O
retina	O
in	O
Crx	O
-	O
/	O
-	O
mice	O
at	O
the	O
ultrastructural	O
level	O
.	O

These	O
retinas	O
exhibit	O
several	O
prominent	O
defects	O
.	O

Crx	O
-	O
/	O
-	O
photoreceptors	O
demonstrate	O
a	O
complete	O
block	O
in	O
outer	O
segment	O
formation	O
at	O
the	O
elongation	O
stage	O
.	O

Further	O
,	O
these	O
cells	O
exhibit	O
abnormal	O
synaptic	O
morphology	O
,	O
thereby	O
broadening	O
the	O
function	O
of	O
Crx	O
to	O
photoreceptor	O
synaptogenesis	O
.	O

This	O
represents	O
the	O
first	O
report	O
strongly	O
implicating	O
the	O
process	O
of	O
synapse	O
formation	O
in	O
LCA	O
.	O

Results	O

Multiple	O
pathologies	O
in	O
the	O
outer	O
segment	O
layer	O
in	O
Crx	O
-	O
/	O
-	O
mice	O

A	O
standard	O
knock	O
-	O
out	O
protocol	O
was	O
used	O
to	O
generate	O
mice	O
in	O
which	O
the	O
homeodomain	O
of	O
Crx	O
-	O
/	O
-	O
was	O
targeted	O
and	O
deleted	O
.	O

Generation	O
of	O
these	O
Crx	O
-	O
/	O
-	O
mice	O
has	O
been	O
reported	O
elsewhere	O
[	O
34	O
]	O
.	O

In	O
this	O
study	O
,	O
in	O
order	O
to	O
characterize	O
further	O
the	O
role	O
of	O
Crx	O
in	O
photoreceptor	O
morphogenesis	O
,	O
the	O
outer	O
retinae	O
from	O
Crx	O
-	O
/	O
-	O
mice	O
were	O
examined	O
using	O
transmission	O
electron	B-CHEBI
microscopy	O
.	O

At	O
postnatal	O
day	O
21	O
(	O
P21	O
)	O
,	O
when	O
Crx	O
+	O
/	O
+	O
photoreceptors	O
exhibited	O
robust	O
outer	O
segments	O
(	O
Figure	O
1A	O
,	O
os	O
)	O
,	O
Crx	O
-	O
/	O
-	O
retinas	O
were	O
without	O
a	O
recognizable	O
outer	O
segment	O
layer	O
(	O
Figure	O
1B	O
)	O
.	O

Crx	O
-	O
/	O
-	O
photoreceptors	O
had	O
inner	O
segments	O
,	O
demonstrating	O
at	O
least	O
limited	O
photoreceptor	O
polarization	O
in	O
the	O
Crx	O
mutant	O
,	O
but	O
the	O
inner	O
segments	O
were	O
extremely	O
short	O
(	O
Figure	O
2	O
)	O
.	O

Furthermore	O
,	O
the	O
majority	O
of	O
inner	O
segments	O
showed	O
some	O
morphological	O
differentiation	O
,	O
having	O
approximately	O
as	O
many	O
mitochondria	O
as	O
the	O
control	O
(	O
Figure	O
1	O
and	O
2	O
)	O
.	O

Occasionally	O
,	O
an	O
inner	O
segment	O
undergoing	O
lysis	O
was	O
noted	O
,	O
appearing	O
swollen	O
or	O
with	O
vacuoles	O
and	O
swollen	O
mitochondria	O
(	O
data	O
not	O
shown	O
)	O
.	O

Figure	O
1	O

Transmission	O
electron	B-CHEBI
microscopy	O
of	O
the	O
outer	O
retina	O
at	O
P21	O
in	O
(	O
A	O
)	O
Crx	O
+	O
/	O
+	O
and	O
(	O
B	O
)	O
Crx	O
-	O
/	O
-	O
retinas	O
.	O

pe	O
,	O
pigmented	O
epithelium	O
.	O

os	O
,	O
outer	O
segments	O
.	O

is	O
,	O
inner	O
segments	O
.	O
onl	O
,	O
outer	O
nuclear	O
layer	O
with	O
photoreceptor	O
nuclei	O
.	O

Scale	O
bar	O
=	O
5	O
mu	O
m	O
for	O
A	O
and	O
B	O
.	O

Figure	O
2	O

Transmission	O
electron	B-CHEBI
micrograph	O
of	O
the	O
outer	O
segment	O
layer	O
of	O
Crx	O
-	O
/	O
-	O
retina	O
at	O
P21	O
.	O

Inner	O
segments	O
of	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
exhibit	O
numerous	O
mitochondria	O
(	O
m	O
indicated	O
by	O
arrow	O
)	O
as	O
in	O
Crx	O
+	O
/	O
+	O
(	O
Figure	O
1A	O
)	O
.	O

pe	O
,	O
pigmented	O
epithelium	O
.	O

is	O
,	O
inner	O
segments	O
.	O
onl	O
,	O
outer	O
nuclear	O
layer	O
.	O

Scale	O
bar	O
=	O
2	O
mu	O
m	O
.	O

Photoreceptor	O
inner	O
segments	O
and	O
outer	O
segments	O
are	O
joined	O
by	O
a	O
non	O
-	O
motile	O
connecting	O
cilium	O
that	O
exhibits	O
a	O
characteristic	O
9	O
+	O
0	O
arrangement	O
of	O
microtubule	O
doublets	O
when	O
viewed	O
in	O
cross	O
-	O
section	O
.	O

At	O
P21	O
,	O
in	O
Crx	O
-	O
/	O
-	O
retinas	O
,	O
numerous	O
cross	O
sections	O
of	O
connecting	O
cilia	O
were	O
noted	O
(	O
Figure	O
3A	O
and	O
3B	O
)	O
.	O

Sporadically	O
,	O
connecting	O
cilia	O
contained	O
other	O
than	O
the	O
typical	O
complement	O
of	O
microtubule	O
doublets	O
.	O

For	O
example	O
,	O
in	O
Figure	O
3A	O
,	O
the	O
connecting	O
cilium	O
labelled	O
by	O
arrowhead	O
1	O
,	O
shows	O
7	O
+	O
0	O
doublets	O
.	O

The	O
majority	O
exhibited	O
the	O
characteristic	O
9	O
+	O
0	O
doublets	O
(	O
arrowhead	O
2	O
and	O
3	O
in	O
Figure	O
3A	O
and	O
Figure	O
3B	O
)	O
.	O

These	O
observations	O
indicate	O
that	O
in	O
addition	O
to	O
inner	O
segment	O
formation	O
,	O
ciliogenesis	O
is	O
also	O
largely	O
intact	O
in	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
.	O

Further	O
,	O
in	O
Crx	O
-	O
/	O
-	O
retinas	O
the	O
retinal	O
pigmented	O
epithelium	O
(	O
PE	O
)	O
appeared	O
normal	O
,	O
at	O
least	O
up	O
to	O
P21	O
(	O
data	O
not	O
shown	O
)	O
,	O
the	O
oldest	O
age	O
examined	O
.	O

Figure	O
3	O

Transmission	O
electron	B-CHEBI
micrograph	O
of	O
Crx	O
-	O
/	O
-	O
retina	O
at	O
P21	O
(	O
A	O
and	O
B	O
)	O
,	O
and	O
scanning	O
electron	B-CHEBI
micrograph	O
of	O
Crx	O
-	O
/	O
-	O
at	O
P10	O
(	O
C	O
)	O
of	O
outer	O
segment	O
layer	O
.	O

(	O
A	O
)	O
Evidence	O
of	O
ciliogenesis	O
in	O
the	O
photoreceptor	O
layer	O
of	O
Crx	O
-	O
/	O
-	O
retina	O
.	O

Nonmotile	O
connecting	O
cilia	O
were	O
observed	O
in	O
cross	O
section	O
(	O
arrowheads	O
1	O
,	O
2	O
,	O
and	O
3	O
,	O
for	O
examples	O
)	O
.	O

Connecting	O
cilium	O
1	O
(	O
arrowhead	O
1	O
)	O
demonstrated	O
seven	O
microtuble	O
doublets	O
,	O
while	O
cilium	O
2	O
and	O
cilium	O
3	O
exhibited	O
nine	O
.	O

In	O
A	O
,	O
a	O
displaced	O
cell	O
nucleus	O
(	O
n	O
)	O
appearing	O
pyknotic	O
and	O
abnormal	O
deposition	O
of	O
matrix	O
(	O
mx	O
)	O
material	O
of	O
unknown	O
identity	O
were	O
seen	O
,	O
along	O
with	O
large	O
amounts	O
of	O
membranous	O
vesicles	O
(	O
arrow	O
)	O
which	O
filled	O
the	O
photoreceptor	O
space	O
and	O
appeared	O
to	O
be	O
released	O
from	O
inner	O
segments	O
.	O

Scale	O
bar	O
=	O
3	O
.	O
7	O
mu	O
m	O
.	O

(	O
B	O
)	O
Nonmotile	O
connecting	O
cilium	O
in	O
cross	O
section	O
,	O
from	O
a	O
Crx	O
-	O
/	O
-	O
photoreceptor	O
,	O
demonstrating	O
characteristic	O
9	O
+	O
0	O
radial	O
array	O
of	O
microtubule	O
doublets	O
.	O

Scale	O
bar	O
=	O
88	O
nm	O
.	O

(	O
C	O
)	O
Scanning	O
electron	B-CHEBI
micrograph	O
(	O
SEM	O
)	O
of	O
membranous	O
vesicles	O
(	O
arrow	O
shows	O
one	O
example	O
)	O
shed	O
from	O
inner	O
segments	O
of	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
at	O
P10	O
.	O

Figure	O
shows	O
inner	O
segments	O
viewed	O
from	O
the	O
scleral	O
side	O
with	O
the	O
pigmented	O
epithelium	O
removed	O
.	O

Scale	O
bar	O
=	O
1	O
mu	O
m	O
.	O

In	O
addition	O
to	O
the	O
complete	O
absence	O
of	O
outer	O
segments	O
,	O
Crx	O
-	O
/	O
-	O
retinas	O
exhibited	O
three	O
other	O
notable	O
pathologies	O
in	O
the	O
outer	O
segment	O
layer	O
.	O

First	O
,	O
an	O
abnormal	O
deposition	O
of	O
matrix	O
of	O
unknown	O
identity	O
was	O
noted	O
(	O
Figure	O
3A	O
,	O
mx	O
)	O
.	O

Second	O
,	O
sporadically	O
displaced	O
nuclei	O
were	O
found	O
residing	O
in	O
the	O
space	O
abutting	O
the	O
PE	O
.	O

Occasionally	O
,	O
these	O
nuclei	O
appeared	O
pyknotic	O
(	O
Figure	O
3A	O
,	O
n	O
)	O
;	O
but	O
,	O
more	O
frequently	O
exhibited	O
the	O
heterochromatin	O
pattern	O
typical	O
of	O
photoreceptors	O
(	O
data	O
not	O
shown	O
)	O
,	O
strongly	O
suggesting	O
that	O
they	O
belonged	O
to	O
ectopic	O
photoreceptors	O
.	O

The	O
third	O
pathological	O
entity	O
noted	O
in	O
the	O
outer	O
segment	O
layer	O
were	O
numerous	O
small	O
vesicles	O
(	O
Figure	O
3A	O
arrow	O
)	O
100	O
to	O
200	O
nm	O
in	O
diameter	O
.	O

They	O
appeared	O
to	O
be	O
emerging	O
from	O
the	O
inner	O
segments	O
,	O
as	O
scanning	O
electron	B-CHEBI
microscopic	O
images	O
showed	O
spherical	O
structures	O
budding	O
from	O
the	O
inner	O
segments	O
(	O
Figure	O
3C	O
,	O
arrow	O
)	O
.	O

In	O
order	O
to	O
characterize	O
further	O
the	O
morphogenesis	O
of	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
,	O
the	O
developing	O
outer	O
segment	O
layer	O
was	O
viewed	O
by	O
scanning	O
electron	B-CHEBI
microscopy	O
at	O
P7	O
,	O
P14	O
and	O
P21	O
(	O
Figure	O
4	O
)	O
.	O

In	O
Crx	O
+	O
/	O
+	O
retinas	O
,	O
photoreceptor	O
inner	O
segments	O
,	O
connecting	O
cilia	O
,	O
and	O
the	O
first	O
rudimentary	O
outer	O
segment	O
structures	O
were	O
noted	O
at	O
P7	O
.	O

In	O
the	O
Crx	O
-	O
/	O
-	O
retina	O
,	O
only	O
an	O
occassional	O
connecting	O
cilium	O
was	O
noted	O
emerging	O
from	O
inner	O
segments	O
at	O
this	O
stage	O
(	O
Figure	O
4A	O
and	O
4B	O
)	O
.	O

This	O
observation	O
was	O
confirmed	O
by	O
comparison	O
with	O
transmission	O
electron	B-CHEBI
micrographs	O
(	O
Figure	O
5	O
)	O
.	O

These	O
differences	O
are	O
the	O
earliest	O
noted	O
differences	O
between	O
Crx	O
+	O
/	O
+	O
and	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
.	O

At	O
P14	O
,	O
elongating	O
outer	O
segments	O
were	O
noted	O
on	O
Crx	O
+	O
/	O
+	O
photoreceptors	O
,	O
occasionally	O
demonstrating	O
a	O
paddle	O
-	O
like	O
structure	O
at	O
their	O
apex	O
(	O
Figure	O
4C	O
,	O
os	O
)	O
.	O

In	O
Crx	O
-	O
/	O
-	O
retinae	O
,	O
the	O
vast	O
majority	O
of	O
photoreceptors	O
at	O
this	O
stage	O
demonstrated	O
connecting	O
cilia	O
without	O
outer	O
segments	O
(	O
Figure	O
4D	O
,	O
cc	O
)	O
.	O

Sporadically	O
,	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
would	O
exhibit	O
an	O
irregular	O
structure	O
extending	O
from	O
a	O
connecting	O
cilium	O
(	O
Figure	O
4D	O
,	O
cc	O
*	O
)	O
perhaps	O
representing	O
a	O
malformed	O
outer	O
segment	O
.	O

Such	O
structures	O
were	O
also	O
observed	O
at	O
P21	O
(	O
Figure	O
4F	O
,	O
cc	O
*	O
)	O
.	O

These	O
putative	O
,	O
abnormal	O
outer	O
segments	O
were	O
only	O
rarely	O
noted	O
in	O
Crx	O
+	O
/	O
+	O
at	O
P14	O
,	O
and	O
never	O
at	O
P21	O
(	O
Figure	O
4C	O
and	O
4E	O
,	O
cc	O
*	O
)	O
.	O

Further	O
,	O
in	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
,	O
unusually	O
long	O
connecting	O
cilia	O
were	O
noted	O
(	O
Figure	O
4F	O
,	O
cc	O
)	O
.	O

Serial	O
examination	O
of	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
at	O
P7	O
,	O
P10	O
,	O
P14	O
,	O
and	O
P21	O
by	O
TEM	O
,	O
demonstrated	O
a	O
distinctive	O
lack	O
of	O
any	O
structure	O
interpretable	O
as	O
orderly	O
stacks	O
of	O
discs	O
or	O
forming	O
discs	O
.	O

These	O
data	O
demonstrate	O
a	O
complete	O
absence	O
of	O
normal	O
outer	O
segment	O
formation	O
in	O
the	O
Crx	O
mutant	O
mouse	O
,	O
and	O
the	O
arrest	O
of	O
development	O
of	O
the	O
photoreceptor	O
appendage	O
at	O
the	O
elongation	O
stage	O
of	O
outer	O
segment	O
formation	O
.	O

Figure	O
4	O

Outer	O
segment	O
morphogenesis	O
in	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
.	O

Scanning	O
electron	B-CHEBI
microscopy	O
of	O
developing	O
photoreceptors	O
viewed	O
from	O
the	O
scleral	O
side	O
with	O
the	O
pigmented	O
epithelium	O
removed	O
at	O
P7	O
,	O
P14	O
,	O
and	O
P21	O
for	O
Crx	O
+	O
/	O
+	O
(	O
A	O
,	O
C	O
,	O
and	O
E	O
)	O
and	O
Crx	O
-	O
/	O
-	O
(	O
B	O
,	O
D	O
,	O
F	O
)	O
littermates	O
.	O

In	O
Crx	O
+	O
/	O
+	O
retina	O
,	O
numerous	O
connecting	O
cilia	O
(	O
A	O
,	O
cc	O
)	O
were	O
evident	O
at	O
P7	O
with	O
rudimentary	O
outer	O
segments	O
.	O

After	O
P7	O
,	O
in	O
Crx	O
+	O
/	O
+	O
outer	O
segment	O
elongation	O
occurs	O
.	O

Initially	O
,	O
outer	O
segments	O
have	O
a	O
paddle	O
-	O
like	O
structure	O
(	O
C	O
,	O
os	O
)	O
which	O
is	O
later	O
shed	O
(	O
E	O
,	O
os	O
)	O
.	O

In	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
,	O
few	O
connecting	O
cilia	O
were	O
observed	O
at	O
P7	O
(	O
B	O
,	O
cc	O
)	O
.	O

After	O
P7	O
,	O
connecting	O
cilia	O
were	O
more	O
numerous	O
and	O
occasionally	O
a	O
malformed	O
outer	O
segment	O
was	O
noted	O
extending	O
from	O
a	O
connecting	O
cilium	O
(	O
D	O
and	O
F	O
,	O
cc	O
*	O
)	O
.	O

These	O
were	O
rarely	O
observed	O
in	O
Crx	O
+	O
/	O
+	O
and	O
only	O
at	O
P14	O
(	O
C	O
,	O
cc	O
*	O
)	O
.	O

At	O
P21	O
,	O
abnormally	O
long	O
connecting	O
cilia	O
are	O
noted	O
in	O
Crx	O
-	O
/	O
-	O
(	O
F	O
,	O
cc	O
)	O
.	O

Scale	O
bars	O
=	O
10	O
mu	O
m	O

Figure	O
5	O

Transmission	O
electron	B-CHEBI
micrographs	O
of	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
in	O
the	O
photoreceptor	O
layer	O
at	O
P7	O
.	O

(	O
A	O
)	O
Photoreceptor	O
layer	O
of	O
Crx	O
+	O
/	O
+	O
retina	O
demonstrating	O
nascent	O
outer	O
segment	O
structures	O
(	O
arrow	O
)	O
emerging	O
from	O
photoreceptor	O
connecting	O
cilia	O
(	O
cc	O
)	O
.	O

(	O
B	O
)	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
exhibited	O
connecting	O
cilia	O
(	O
cc	O
)	O
at	O
this	O
early	O
stage	O
,	O
however	O
,	O
nascent	O
outer	O
segment	O
structures	O
were	O
not	O
observed	O
.	O

Scale	O
Bar	O
=	O
1	O
mu	O
m	O
.	O

Finally	O
,	O
the	O
morphology	O
of	O
the	O
malformed	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
was	O
compared	O
to	O
rhodopsin	O
-	O
/	O
-	O
and	O
peripherin	O
-	O
/	O
-	O
photoreceptors	O
.	O

Rhodopsin	O
and	O
peripherin	O
are	O
two	O
photoreceptor	O
-	O
specific	O
genes	O
whose	O
expression	O
is	O
significantly	O
downregulated	O
in	O
the	O
Crx	O
-	O
/	O
-	O
retinae	O
[	O
10	O
,	O
34	O
,	O
35	O
]	O
.	O

Loss	O
of	O
function	O
mutations	O
in	O
each	O
of	O
these	O
genes	O
separately	O
have	O
been	O
reported	O
to	O
result	O
in	O
a	O
failure	O
to	O
elaborate	O
outer	O
segments	O
[	O
29	O
,	O
30	O
]	O
.	O

Photoreceptors	O
from	O
these	O
two	O
mutant	O
mice	O
examined	O
by	O
SEM	O
from	O
the	O
scleral	O
side	O
appeared	O
highly	O
similar	O
to	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
(	O
compare	O
Figure	O
4F	O
to	O
Figure	O
6A	O
and	O
6B	O
)	O
.	O

Figure	O
6	O

Scanning	O
electron	B-CHEBI
microscopy	O
of	O
peripherin	O
-	O
/	O
-	O
(	O
A	O
)	O
and	O
rhodopsin	O
-	O
/	O
-	O
(	O
B	O
)	O
photoreceptors	O
at	O
P21	O
,	O
viewed	O
from	O
the	O
scleral	O
side	O
with	O
the	O
pigmented	O
epithelium	O
removed	O
.	O

cc	O
,	O
connecting	O
cilium	O
.	O

is	O
,	O
inner	O
segment	O
.	O

Scale	O
bar	O
=	O
10	O
mu	O
m	O
.	O

Crx	O
is	O
necessary	O
for	O
the	O
formation	O
of	O
photoreceptor	O
terminals	O

In	O
a	O
previous	O
study	O
,	O
we	O
demonstrated	O
that	O
forced	O
expression	O
of	O
a	O
dominant	O
-	O
negative	O
allele	O
of	O
Crx	O
in	O
developing	O
rods	O
blocked	O
formation	O
of	O
both	O
rod	O
spherules	O
in	O
the	O
outer	O
plexiform	O
layer	O
(	O
OPL	O
)	O
and	O
outer	O
segments	O
[	O
7	O
]	O
.	O

To	O
expand	O
on	O
these	O
studies	O
,	O
the	O
ultrastructure	O
of	O
photoreceptor	O
synapses	O
was	O
examined	O
in	O
Crx	O
-	O
/	O
-	O
retinas	O
.	O

In	O
Crx	O
+	O
/	O
+	O
retinas	O
at	O
P21	O
,	O
newly	O
mature	O
rod	O
spherules	O
were	O
abundant	O
(	O
Figure	O
7A	O
)	O
.	O

The	O
sperules	O
were	O
blunt	O
or	O
club	O
-	O
shaped	O
structures	O
with	O
a	O
single	O
ribbon	O
associated	O
with	O
a	O
single	O
invaginating	O
synapse	O
(	O
Figure	O
7A	O
,	O
arrow	O
indicates	O
one	O
example	O
;	O
Figure	O
8A	O
and	O
8B	O
)	O
.	O

Two	O
processes	O
from	O
horizontal	O
cells	O
were	O
situated	O
on	O
either	O
side	O
of	O
the	O
synaptic	O
ridge	O
(	O
Figure	O
8B	O
,	O
labelled	O
H	O
)	O
and	O
one	O
or	O
more	O
dendrites	O
of	O
rod	O
bipolar	O
cells	O
occupied	O
a	O
central	O
position	O
(	O
Figure	O
8B	O
,	O
bipolar	O
labelled	O
B	O
)	O
.	O

Cone	O
terminals	O
are	O
large	O
,	O
flat	O
pedicles	O
that	O
exhibit	O
many	O
invaginating	O
synapses	O
containing	O
separate	O
sets	O
of	O
horizontal	O
and	O
bipolar	O
cell	O
processes	O
.	O

Each	O
pedicle	O
contains	O
numerous	O
ribbons	O
.	O

These	O
terminals	O
were	O
much	O
less	O
common	O
than	O
spherules	O
in	O
Crx	O
+	O
/	O
+	O
retinas	O
at	O
P21	O
(	O
Figure	O
7	O
,	O
box	O
)	O
.	O

In	O
the	O
OPL	O
of	O
Crx	O
-	O
/	O
-	O
retinas	O
,	O
photoreceptor	O
terminals	O
were	O
highly	O
disorganized	O
at	O
P21	O
(	O
Figure	O
7B	O
,	O
arrows	O
)	O
.	O

Processes	O
containing	O
synaptic	O
vesicles	O
and	O
ribbon	O
-	O
like	O
structures	O
were	O
apparent	O
,	O
suggesting	O
at	O
least	O
limited	O
generation	O
of	O
synapse	O
components	O
.	O

However	O
,	O
well	O
formed	O
spherules	O
and	O
pedicles	O
were	O
not	O
observed	O
.	O

In	O
addition	O
,	O
many	O
terminals	O
appeared	O
to	O
contain	O
multiple	O
ribbons	O
(	O
Figure	O
8C	O
and	O
8D	O
,	O
r	O
)	O
not	O
tethered	O
to	O
the	O
plasma	O
membrane	O
and	O
occasionally	O
in	O
perinuclear	O
positions	O
(	O
Figure	O
8D	O
)	O
.	O

Figure	O
7	O

Transmission	O
electron	B-CHEBI
micrographs	O
of	O
the	O
outer	O
plexiform	O
layer	O
in	O
Crx	O
-	O
/	O
-	O
retinas	O
.	O

(	O
A	O
)	O
In	O
Crx	O
+	O
/	O
+	O
retina	O
at	O
P21	O
,	O
newly	O
formed	O
rod	O
spherules	O
were	O
abundant	O
(	O
arrow	O
demonstrates	O
one	O
example	O
)	O
.	O

The	O
spherules	O
were	O
club	O
-	O
shaped	O
and	O
contained	O
a	O
single	O
invaginating	O
synapse	O
with	O
one	O
ribbon	O
complex	O
.	O

Cone	O
terminals	O
form	O
large	O
,	O
flat	O
pedicles	O
that	O
contain	O
many	O
invaginating	O
synapses	O
with	O
separate	O
ribbon	O
structures	O
.	O

These	O
terminals	O
were	O
more	O
scarce	O
,	O
but	O
apparent	O
in	O
Crx	O
+	O
/	O
+	O
retinas	O
at	O
P21	O
(	O
one	O
example	O
in	O
box	O
)	O
.	O

(	O
B	O
)	O
In	O
the	O
outer	O
plexiform	O
layer	O
(	O
OPL	O
)	O
of	O
Crx	O
-	O
/	O
-	O
retinas	O
,	O
photoreceptor	O
terminals	O
appeared	O
highly	O
disorganized	O
at	O
P21	O
(	O
arrows	O
)	O
.	O

Well	O
-	O
formed	O
pedicles	O
and	O
spherules	O
were	O
not	O
evident	O
.	O

Putative	O
terminals	O
containing	O
ribbon	O
-	O
like	O
structures	O
were	O
apparent	O
,	O
suggesting	O
at	O
least	O
limited	O
generation	O
of	O
synapse	O
components	O
.	O

Many	O
terminals	O
appeared	O
to	O
contain	O
multiple	O
ribbon	O
-	O
like	O
structures	O
,	O
instead	O
of	O
a	O
singule	O
ribbon	O
.	O

For	O
example	O
,	O
terminal	O
1	O
and	O
2	O
contained	O
two	O
ribbons	O
each	O
,	O
whereas	O
terminal	O
3	O
appeared	O
to	O
contain	O
only	O
one	O
.	O
opl	O
,	O
outer	O
plexiform	O
layer	O
.	O

Scale	O
bar	O
=	O
2	O
mu	O
m	O
.	O

Figure	O
8	O

Transmission	O
electron	B-CHEBI
micrographs	O
of	O
the	O
outer	O
plexiform	O
layer	O
in	O
Crx	O
-	O
/	O
-	O
retinas	O
at	O
P21	O
.	O

(	O
A	O
)	O
Crx	O
+	O
/	O
+	O
rod	O
spherules	O
contained	O
a	O
single	O
invaginating	O
synapse	O
with	O
one	O
ribbon	O
complex	O
.	O

The	O
spherule	O
was	O
a	O
blunt	O
or	O
club	O
-	O
shaped	O
structure	O
.	O

(	O
B	O
)	O
Crx	O
+	O
/	O
+	O
rod	O
terminals	O
contained	O
a	O
single	O
ribbon	O
structure	O
(	O
r	O
)	O
.	O

Two	O
processes	O
,	O
from	O
horizontal	O
cells	O
(	O
h	O
)	O
,	O
contacted	O
the	O
rod	O
laterally	O
.	O

An	O
additional	O
process	O
,	O
the	O
postsynaptic	O
bipolar	O
dendrite	O
(	O
b	O
)	O
,	O
was	O
situated	O
more	O
centrally	O
.	O

Terminals	O
were	O
filled	O
with	O
synaptic	O
vesicles	O
.	O

One	O
coated	O
vesicle	O
originatinf	O
from	O
the	O
cell	O
membrane	O
was	O
observed	O
(	O
arrow	O
)	O
.	O

(	O
C	O
)	O
In	O
the	O
OPL	O
of	O
Crx	O
-	O
/	O
-	O
retinas	O
,	O
photoreceptor	O
terminals	O
appeared	O
highly	O
disorganized	O
.	O

Putative	O
terminals	O
containing	O
synaptic	O
vesicles	O
and	O
ribbon	O
-	O
like	O
structures	O
were	O
apparent	O
(	O
arrows	O
)	O
,	O
suggesting	O
at	O
least	O
limited	O
generation	O
of	O
synapse	O
components	O
.	O

However	O
,	O
well	O
formed	O
spherules	O
and	O
pedicles	O
were	O
not	O
observed	O
.	O

Further	O
,	O
many	O
terminals	O
appeared	O
to	O
contain	O
multiple	O
ribbon	O
-	O
like	O
structures	O
(	O
r	O
)	O
.	O

The	O
majority	O
of	O
these	O
ribbons	O
were	O
not	O
associated	O
with	O
the	O
synaptic	O
membrane	O
,	O
but	O
instead	O
were	O
found	O
free	O
floating	O
and	O
,	O
in	O
some	O
instances	O
,	O
were	O
perinuclear	O
(	O
D	O
,	O
arrow	O
)	O
.	O

H	O
,	O
horizontal	O
cell	O
;	O
B	O
,	O
bipolar	O
cell	O
;	O
N	O
,	O
nucleus	O
;	O
r	O
,	O
ribbon	O
.	O

(	O
A	O
)	O
Scale	O
bar	O
=	O
500	O
nm	O
,	O
(	O
B	O
)	O
Scale	O
bar	O
=	O
250	O
nm	O
,	O
(	O
C	O
and	O
D	O
)	O
Scale	O
bar	O
=	O
500	O
nm	O
.	O

Discussion	O

In	O
this	O
study	O
,	O
an	O
ultrastructural	O
analysis	O
of	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
was	O
carried	O
out	O
.	O

As	O
Crx	O
mutations	O
have	O
been	O
associated	O
with	O
Leber	O
'	O
s	O
congenital	O
amaurosis	O
,	O
the	O
findings	O
in	O
this	O
study	O
broaden	O
our	O
understanding	O
of	O
the	O
pathology	O
of	O
this	O
disease	O
.	O

Two	O
prominent	O
pathologies	O
were	O
characterized	O
in	O
the	O
Crx	O
-	O
/	O
-	O
retina	O
:	O
(	O
1	O
)	O
An	O
absolute	O
block	O
in	O
outer	O
segment	O
morphogenesis	O
was	O
noted	O
,	O
with	O
the	O
block	O
occuring	O
at	O
the	O
elongation	O
stage	O
of	O
outer	O
segment	O
formation	O
;	O
(	O
2	O
)	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
exhibited	O
a	O
severe	O
perturbation	O
in	O
synapse	O
formation	O
.	O

This	O
represents	O
the	O
first	O
report	O
of	O
a	O
synaptogenesis	O
defect	O
in	O
an	O
animal	O
model	O
of	O
LCA	O
.	O

Crx	O
-	O
/	O
-	O
photoreceptors	O
cannot	O
complete	O
outer	O
segment	O
morphogenesis	O

Mutations	O
in	O
Crx	O
represent	O
one	O
of	O
a	O
collection	O
of	O
gene	O
mutations	O
that	O
lead	O
to	O
an	O
outer	O
segment	O
formation	O
defect	O
.	O

Homozygous	O
null	O
mutations	O
in	O
the	O
peripherin	O
/	O
RDS	O
gene	O
[	O
36	O
]	O
or	O
in	O
rhodopsin	O
[	O
29	O
]	O
lead	O
to	O
a	O
failure	O
of	O
outer	O
segment	O
formation	O
.	O

The	O
deficits	O
in	O
peripherin	O
-	O
/	O
-	O
and	O
Crx	O
-	O
/	O
-	O
photoreceptor	O
morphogenesis	O
were	O
found	O
to	O
be	O
very	O
similar	O
.	O

Vesicular	O
structures	O
in	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
were	O
observed	O
that	O
were	O
similar	O
to	O
those	O
previously	O
noted	O
in	O
the	O
rds	O
/	O
peripherin	O
-	O
/	O
-	O
mouse	O
.	O

It	O
was	O
initially	O
proposed	O
that	O
these	O
vesicles	O
were	O
due	O
to	O
the	O
breakdown	O
of	O
outer	O
segment	O
membranes	O
that	O
were	O
not	O
properly	O
recruited	O
to	O
the	O
outer	O
segments	O
in	O
the	O
absence	O
of	O
peripherin	O
,	O
or	O
were	O
from	O
the	O
result	O
of	O
the	O
breakdown	O
of	O
the	O
microvilli	O
of	O
M	O
u	O
ller	O
cells	O
[	O
30	O
]	O
.	O

Strong	O
support	O
in	O
favor	O
of	O
the	O
former	O
explanation	O
was	O
provided	O
by	O
Nir	O
and	O
colleagues	O
who	O
demonstrated	O
the	O
presence	O
of	O
rhodopsin	O
protein	B-CHEBI
in	O
these	O
vesicles	O
using	O
immunoelectron	O
microscopy	O
against	O
a	O
rhodopsin	O
epitope	O
[	O
37	O
]	O
.	O

Further	O
,	O
as	O
shown	O
here	O
,	O
the	O
vesicles	O
appear	O
to	O
bud	O
from	O
the	O
inner	O
segments	O
themselves	O
.	O

In	O
developing	O
photoreceptors	O
,	O
an	O
extraordinary	O
growth	O
process	O
occurs	O
whereby	O
the	O
outer	O
segment	O
is	O
generated	O
from	O
the	O
nascent	O
connecting	O
cilium	O
(	O
see	O
[	O
38	O
]	O
and	O
references	O
therein	O
)	O
.	O

Peripherin	O
/	O
RDS	O
and	O
ROM	O
-	O
1	O
proteins	B-CHEBI
(	O
localized	O
in	O
disc	O
rims	O
)	O
and	O
the	O
opsin	O
proteins	B-CHEBI
(	O
localized	O
throughout	O
the	O
discs	O
)	O
have	O
important	O
roles	O
in	O
the	O
structural	O
integrity	O
of	O
mature	O
outer	O
segments	O
(	O
see	O
[	O
39	O
,	O
29	O
]	O
)	O
.	O

ROM	O
-	O
1	O
-	O
/	O
-	O
mice	O
produce	O
disorganized	O
outer	O
segments	O
with	O
large	O
disks	O
[	O
40	O
]	O
.	O

Crx	O
,	O
by	O
virtue	O
of	O
being	O
a	O
transcription	O
factor	O
,	O
presumably	O
controls	O
genes	O
that	O
are	O
responsible	O
for	O
the	O
building	O
and	O
perhaps	O
maintenance	O
of	O
the	O
outer	O
segment	O
structure	O
,	O
including	O
rhodopsin	O
and	O
peripherin	O
.	O

Using	O
northern	O
blots	O
[	O
34	O
]	O
,	O
microarrays	O
[	O
10	O
]	O
,	O
and	O
serial	O
analysis	O
of	O
gene	O
expression	O
(	O
SAGE	O
)	O
[	O
35	O
]	O
,	O
we	O
have	O
defined	O
a	O
large	O
number	O
of	O
genes	O
that	O
are	O
altered	O
in	O
their	O
expression	O
level	O
in	O
Crx	O
-	O
/	O
-	O
mice	O
.	O

We	O
found	O
that	O
rhodopsin	O
expression	O
was	O
severely	O
diminished	O
in	O
Crx	O
-	O
/	O
-	O
animals	O
,	O
and	O
peripherin	O
mRNA	B-CHEBI
was	O
reduced	O
by	O
approximately	O
30	O
%	O
.	O

Transgenic	O
mice	O
with	O
variable	O
levels	O
of	O
expression	O
of	O
wild	O
type	O
rhodopsin	O
exhibit	O
rod	O
degeneration	O
[	O
41	O
]	O
,	O
indicating	O
the	O
importance	O
of	O
the	O
level	O
of	O
rhodopsin	O
expression	O
.	O

In	O
addition	O
,	O
the	O
timing	O
of	O
rhodopsin	O
expression	O
may	O
be	O
very	O
important	O
,	O
as	O
indicated	O
by	O
studies	O
in	O
Drosophila	O
.	O

In	O
Drosophila	O
,	O
rhodopsin	O
(	O
ninaE	O
)	O
is	O
expressed	O
in	O
photoreceptors	O
R1	O
-	O
R6	O
.	O

In	O
ninaE	O
null	O
mutants	O
,	O
the	O
rhabdomere	O
,	O
a	O
structure	O
analogous	O
to	O
vertebrate	O
outer	O
segments	O
,	O
fails	O
to	O
develop	O
in	O
R1	O
-	O
R6	O
photoreceptors	O
[	O
42	O
]	O
,	O
reminiscent	O
of	O
the	O
situation	O
in	O
rhodopsin	O
-	O
/	O
-	O
mice	O
[	O
29	O
]	O
.	O

An	O
intriguing	O
experiment	O
by	O
Kumar	O
et	O
al	O
.	O

[	O
43	O
]	O
demonstrated	O
a	O
temporal	O
requirement	O
for	O
rhodopsin	O
expression	O
during	O
rhabdomere	O
development	O
.	O

In	O
ninaE	O
null	O
flies	O
,	O
a	O
ninaE	O
transgene	O
under	O
the	O
control	O
of	O
a	O
heat	O
shock	O
promoter	O
was	O
subjected	O
to	O
various	O
temperature	O
shifts	O
during	O
development	O
.	O

Heat	O
shock	O
during	O
the	O
normal	O
time	O
of	O
rhodopsin	O
onset	O
resulted	O
in	O
substantial	O
and	O
long	O
-	O
lasting	O
rescue	O
of	O
photoreceptor	O
structure	O
and	O
transient	O
rescue	O
of	O
photoreceptor	O
physiology	O
.	O

However	O
,	O
expression	O
shortly	O
before	O
or	O
after	O
this	O
critical	O
period	O
failed	O
to	O
rescue	O
,	O
suggesting	O
that	O
rhodopsin	O
expression	O
during	O
a	O
discrete	O
window	O
of	O
time	O
in	O
development	O
is	O
essential	O
for	O
proper	O
rhabdomere	O
morphogenesis	O
.	O

This	O
result	O
is	O
consistent	O
with	O
observations	O
in	O
the	O
rat	O
wherein	O
rhodopsin	O
onset	O
occurs	O
with	O
strict	O
timing	O
in	O
the	O
developmental	O
history	O
of	O
most	O
rods	O
in	O
vivo	O
[	O
44	O
]	O
.	O

Thus	O
,	O
through	O
its	O
regulation	O
of	O
rhodopsin	O
levels	O
,	O
or	O
perhaps	O
through	O
control	O
of	O
the	O
kinetics	O
of	O
the	O
up	O
-	O
regulation	O
of	O
rhodopsin	O
beginning	O
at	O
about	O
P6	O
,	O
Crx	O
may	O
be	O
regulating	O
outer	O
segment	O
morphogenesis	O
.	O

The	O
similarty	O
of	O
the	O
two	O
cases	O
may	O
extend	O
further	O
.	O

At	O
present	O
,	O
the	O
closest	O
Crx	O
relative	O
in	O
Drosophila	O
is	O
Otd	O
,	O
the	O
founding	O
member	O
of	O
the	O
class	O
of	O
homeobox	O
genes	O
to	O
which	O
Crx	O
belongs	O
.	O

Interestingly	O
,	O
in	O
one	O
hypomorphic	O
allele	O
of	O
Drosophila	O
otd	O
,	O
otduvi	O
,	O
photoreceptor	O
morphogenesis	O
is	O
also	O
disrupted	O
[	O
45	O
]	O
.	O

We	O
found	O
that	O
there	O
are	O
many	O
other	O
genes	O
that	O
are	O
dependent	O
upon	O
Crx	O
.	O

Those	O
that	O
are	O
expressed	O
at	O
a	O
lower	O
level	O
in	O
the	O
Crx	O
-	O
/	O
-	O
retina	O
,	O
such	O
as	O
rhodopsin	O
and	O
peripherin	O
,	O
comprise	O
many	O
that	O
are	O
either	O
enriched	O
or	O
specific	O
to	O
photoreceptors	O
in	O
their	O
expression	O
[	O
35	O
]	O
.	O

They	O
include	O
enzymes	O
that	O
are	O
important	O
in	O
lipid	B-CHEBI
metabolism	O
,	O
protein	B-CHEBI
folding	O
and	O
transport	O
,	O
as	O
well	O
as	O
in	O
other	O
processes	O
that	O
one	O
might	O
envision	O
would	O
be	O
important	O
in	O
building	O
a	O
structure	O
such	O
as	O
the	O
outer	O
segment	O
.	O

In	O
situ	O
hybridization	O
using	O
probes	O
from	O
this	O
collection	O
of	O
genes	O
has	O
revealed	O
that	O
some	O
of	O
them	O
have	O
their	O
RNA	O
localized	O
to	O
the	O
inner	O
segment	O
,	O
a	O
finding	O
typical	O
for	O
proteins	B-CHEBI
targeted	O
to	O
the	O
outer	O
segment	O
.	O

Future	O
analyses	O
of	O
the	O
function	O
of	O
these	O
genes	O
might	O
reveal	O
their	O
role	O
in	O
outer	O
segment	O
biogenesis	O
.	O

Finally	O
,	O
polarization	O
of	O
photoreceptors	O
was	O
found	O
to	O
be	O
largely	O
intact	O
,	O
as	O
was	O
ciliogenesis	O
.	O

Another	O
LCA	O
gene	O
,	O
CRB1	O
,	O
and	O
a	O
related	O
gene	O
CRB3	O
,	O
have	O
been	O
implicated	O
in	O
ciliogenesis	O
in	O
in	O
vitro	O
models	O
[	O
46	O
]	O
.	O

The	O
Drosophila	O
homologue	O
of	O
CRB1	O
,	O
Crumbs	O
,	O
has	O
been	O
implicated	O
in	O
photoreceptor	O
morphogenesis	O
[	O
47	O
]	O
.	O

However	O
,	O
the	O
spontaneously	O
occurring	O
mouse	O
mutant	O
in	O
CRB1	O
,	O
the	O
Rd8	O
mouse	O
,	O
develops	O
shortened	O
outer	O
segments	O
that	O
subsequently	O
degenerate	O
[	O
48	O
]	O
,	O
suggesting	O
that	O
photoreceptor	O
polarization	O
and	O
synaptogenesis	O
are	O
intact	O
in	O
this	O
mutant	O
.	O

While	O
CRB1	O
and	O
Crx	O
have	O
been	O
both	O
linked	O
to	O
LCA	O
,	O
further	O
work	O
is	O
necessary	O
to	O
determine	O
if	O
their	O
function	O
is	O
linked	O
in	O
retinal	O
development	O
.	O

Synaptogenesis	O
is	O
perturbed	O
in	O
Crx	O
-	O
/	O
-	O
photoreceptors	O

The	O
Crx	O
-	O
/	O
-	O
mouse	O
demonstrates	O
the	O
most	O
severe	O
abnormality	O
of	O
photoreceptor	O
synapses	O
reported	O
to	O
date	O
.	O

The	O
peripherin	O
-	O
/	O
-	O
mouse	O
develops	O
a	O
normal	O
complement	O
of	O
photoreceptor	O
terminals	O
which	O
then	O
degenerate	O
as	O
the	O
photoreceptors	O
are	O
lost	O
[	O
30	O
]	O
.	O

Also	O
,	O
similarly	O
in	O
rhodopsin	O
(	O
Rho	O
)	O
and	O
cyclic	B-CHEBI
nucleotide	I-CHEBI
-	O
gated	O
channel	O
,	O
alpha	O
-	O
3	O
(	O
CNGA3	O
)	O
double	O
knockout	O
mice	O
(	O
Rho	O
-	O
/	O
-	O
,	O
CNGA3	O
-	O
/	O
-	O
)	O
,	O
synapses	O
are	O
reported	O
to	O
form	O
normally	O
[	O
49	O
]	O
.	O

These	O
observations	O
demonstrate	O
that	O
photoreceptor	O
synaptogenesis	O
can	O
occur	O
in	O
the	O
absence	O
of	O
outer	O
segment	O
formation	O
.	O

In	O
keeping	O
with	O
this	O
observation	O
is	O
the	O
fact	O
that	O
some	O
electroretinogram	O
activity	O
is	O
present	O
in	O
peripherin	O
-	O
/	O
-	O
mice	O
,	O
suggesting	O
that	O
minimal	O
phototransduction	O
is	O
present	O
in	O
these	O
mice	O
,	O
enough	O
to	O
drive	O
activity	O
at	O
the	O
photoreceptor	O
synapse	O
.	O

In	O
vitro	O
studies	O
wherein	O
synapse	O
elements	O
are	O
formed	O
in	O
the	O
absence	O
of	O
proper	O
outer	O
segment	O
development	O
and	O
,	O
therefore	O
,	O
possible	O
absence	O
of	O
light	O
-	O
dependent	O
photoreceptor	O
activity	O
,	O
have	O
indicated	O
the	O
independence	O
of	O
phototransduction	O
and	O
synapse	O
formation	O
,	O
at	O
least	O
for	O
the	O
initial	O
stages	O
[	O
50	O
,	O
51	O
]	O
.	O

These	O
data	O
then	O
suggest	O
that	O
the	O
fact	O
that	O
the	O
Crx	O
-	O
/	O
-	O
photoreceptors	O
do	O
not	O
have	O
proper	O
synaptic	O
endings	O
is	O
not	O
due	O
to	O
a	O
lack	O
of	O
outer	O
segment	O
formation	O
.	O

A	O
more	O
likely	O
explanation	O
is	O
that	O
Crx	O
plays	O
a	O
role	O
in	O
photoreceptor	O
synapse	O
formation	O
,	O
perhaps	O
by	O
regulating	O
directly	O
,	O
or	O
indirectly	O
,	O
important	O
genes	O
in	O
this	O
process	O
.	O

Using	O
immunohistochemistry	O
,	O
we	O
examined	O
the	O
expression	O
of	O
common	O
pre	O
-	O
synaptic	O
terminal	O
proteins	B-CHEBI
,	O
including	O
KIF3a	O
,	O
SV2	O
,	O
and	O
synaptophysin	O
,	O
and	O
were	O
unable	O
to	O
observe	O
qualitative	O
differences	O
between	O
Crx	O
-	O
/	O
-	O
and	O
control	O
tissue	O
at	O
P14	O
(	O
data	O
not	O
shown	O
)	O
.	O

Examination	O
of	O
their	O
RNA	O
levels	O
by	O
SAGE	O
showed	O
no	O
significant	O
difference	O
for	O
all	O
3	O
genes	O
,	O
though	O
very	O
few	O
tags	O
were	O
recovered	O
from	O
these	O
genes	O
and	O
thus	O
the	O
analysis	O
of	O
RNA	O
levels	O
may	O
not	O
be	O
significant	O
[	O
35	O
]	O
.	O

However	O
,	O
since	O
other	O
genes	O
expressed	O
in	O
photoreceptors	O
were	O
significantly	O
altered	O
in	O
their	O
expression	O
level	O
in	O
the	O
Crx	O
-	O
/	O
-	O
mouse	O
,	O
there	O
are	O
many	O
candidates	O
that	O
could	O
be	O
important	O
for	O
photoreceptor	O
morphogenesis	O
.	O

Tags	O
from	O
three	O
genes	O
from	O
proteins	B-CHEBI
expressed	O
in	O
photoreceptor	O
terminals	O
were	O
found	O
to	O
be	O
decreased	O
in	O
a	O
statistically	O
significant	O
fashion	O
,	O
namely	O
the	O
HGF	O
-	O
regulated	O
tyrosine	B-CHEBI
kinase	O
substrate	O
,	O
the	O
CRIPT	O
protein	B-CHEBI
,	O
and	O
synaptotagmin	O
1	O
(	O
Blackshaw	O
and	O
Cepko	O
,	O
unpublished	O
data	O
)	O
.	O

An	O
example	O
of	O
a	O
gene	O
that	O
was	O
increased	O
in	O
the	O
Crx	O
-	O
/	O
-	O
retina	O
is	O
HRG4	O
(	O
a	O
homologue	O
of	O
the	O
C	O
.	O
elegans	O
Unc119	O
gene	O
)	O
(	O
Blackshaw	O
and	O
Cepko	O
,	O
unpublished	O
data	O
)	O
which	O
encodes	O
a	O
component	O
of	O
the	O
ribbon	O
synapse	O
[	O
33	O
]	O
.	O

The	O
fact	O
that	O
it	O
is	O
upregulated	O
might	O
indicate	O
a	O
response	O
to	O
the	O
lack	O
of	O
proper	O
terminal	O
structures	O
.	O

Several	O
other	O
genes	O
encoding	O
putative	O
cytoskeletal	O
elements	O
also	O
were	O
increased	O
(	O
e	O
.	O
g	O
.	O
microtubule	O
associated	O
protein	B-CHEBI
4	O
)	O
or	O
decreased	O
(	O
e	O
.	O
g	O
.	O
cofilin	O
1	O
)	O
in	O
the	O
Crx	O
-	O
/	O
-	O
retina	O
,	O
with	O
P	O
values	O
of	O
<	O
.	O
005	O
.	O

It	O
is	O
not	O
known	O
whether	O
any	O
of	O
these	O
genes	O
are	O
involved	O
in	O
building	O
or	O
regulating	O
synaptic	O
structures	O
,	O
but	O
they	O
are	O
now	O
genes	O
that	O
might	O
lead	O
to	O
a	O
better	O
understanding	O
of	O
the	O
construction	O
and	O
function	O
of	O
the	O
relatively	O
unique	O
structure	O
of	O
the	O
ribbon	O
synapse	O
.	O

Abnormal	O
photoreceptor	O
terminal	O
formation	O
was	O
noted	O
in	O
a	O
study	O
that	O
examined	O
retinal	O
development	O
in	O
the	O
laminin	O
beta2	O
chain	O
-	O
deficient	O
mouse	O
[	O
52	O
]	O
.	O

Several	O
pathologies	O
were	O
noted	O
in	O
these	O
mice	O
.	O

First	O
,	O
laminin	O
beta2	O
chain	O
-	O
deficient	O
mice	O
displayed	O
abnormal	O
outer	O
segment	O
elongation	O
,	O
but	O
a	O
more	O
mild	O
phenotype	O
than	O
that	O
of	O
the	O
Crx	O
-	O
/	O
-	O
mice	O
;	O
the	O
outer	O
segments	O
were	O
reduced	O
by	O
50	O
%	O
in	O
length	O
.	O

Also	O
photoreceptor	O
terminals	O
were	O
perturbed	O
in	O
laminin	O
beta2	O
mutants	O
,	O
but	O
again	O
the	O
phenotype	O
was	O
more	O
subtle	O
then	O
that	O
of	O
Crx	O
-	O
/	O
-	O
mice	O
.	O

The	O
outer	O
plexiform	O
layer	O
of	O
the	O
beta2	O
-	O
deficient	O
retinas	O
demonstrated	O
only	O
7	O
%	O
normal	O
invaginating	O
synapses	O
,	O
while	O
the	O
remainder	O
had	O
various	O
pathologies	O
,	O
including	O
floating	O
synaptic	O
ribbons	O
,	O
as	O
seen	O
here	O
.	O

The	O
mechanistic	O
relationship	O
of	O
these	O
two	O
molecules	B-CHEBI
,	O
if	O
any	O
,	O
in	O
photoreceptor	O
morphogenesis	O
is	O
unknown	O
to	O
date	O
.	O

The	O
mRNA	B-CHEBI
for	O
laminin	O
beta2	O
was	O
not	O
detected	O
in	O
the	O
SAGE	O
study	O
of	O
the	O
relative	O
RNA	O
levels	O
in	O
Crx	O
-	O
/	O
-	O
and	O
Crx	O
+	O
/	O
+	O
and	O
thus	O
we	O
cannot	O
comment	O
on	O
whether	O
the	O
levels	O
of	O
RNA	O
for	O
laminin	O
beta2	O
were	O
altered	O
.	O

Crx	O
-	O
/	O
-	O
mice	O
are	O
a	O
model	O
for	O
LCA	O

Crx	O
has	O
been	O
implicated	O
in	O
three	O
photoreceptor	O
diseases	O
that	O
result	O
in	O
human	O
blindness	O
,	O
cone	O
-	O
rod	O
dystrophy2	O
,	O
Leber	O
'	O
s	O
congenital	O
amaurosis	O
,	O
and	O
retinitis	O
pigmentosa	O
(	O
for	O
review	O
,	O
see	O
[	O
53	O
]	O
)	O
.	O

The	O
cone	O
-	O
rod	O
dystrophies	O
(	O
CRDs	O
)	O
are	O
characterized	O
by	O
loss	O
of	O
cone	O
-	O
mediated	O
vision	O
in	O
the	O
first	O
decade	O
of	O
life	O
or	O
later	O
,	O
with	O
concomitant	O
or	O
subsequent	O
loss	O
of	O
rod	O
-	O
mediated	O
vision	O
[	O
54	O
]	O
.	O

Conversely	O
,	O
RP	O
is	O
notable	O
for	O
initial	O
loss	O
of	O
rod	O
function	O
,	O
followed	O
by	O
loss	O
of	O
cone	O
-	O
mediated	O
vision	O
[	O
55	O
]	O
.	O

The	O
majority	O
of	O
known	O
genes	O
responsible	O
for	O
human	O
genetic	O
blindness	O
,	O
encode	O
proteins	B-CHEBI
expressed	O
almost	O
exclusively	O
,	O
or	O
exclusively	O
,	O
in	O
photoreceptors	O
,	O
particularly	O
in	O
the	O
outer	O
segment	O
[	O
35	O
]	O
.	O

Many	O
of	O
these	O
proteins	B-CHEBI
are	O
required	O
for	O
phototransduction	O
or	O
outer	O
segment	O
structure	O
.	O

The	O
mechanisms	O
whereby	O
mutations	O
in	O
rod	O
-	O
specific	O
genes	O
,	O
such	O
as	O
rhodopsin	O
,	O
lead	O
eventually	O
to	O
cone	O
degeneration	O
in	O
RP	O
remain	O
obscure	O
.	O

Mutations	O
in	O
Crx	O
were	O
the	O
first	O
,	O
and	O
still	O
one	O
of	O
a	O
very	O
few	O
examples	O
of	O
a	O
transcription	O
factor	O
mutation	O
leading	O
to	O
photoreceptor	O
disease	O
.	O

LCA	O
is	O
a	O
disease	O
in	O
which	O
there	O
is	O
little	O
or	O
no	O
photoreceptor	O
function	O
in	O
infancy	O
;	O
thereby	O
,	O
likely	O
developmental	O
in	O
etiology	O
(	O
[	O
17	O
,	O
56	O
]	O
for	O
review	O
)	O
.	O

The	O
Crx	O
-	O
/	O
-	O
mouse	O
may	O
be	O
an	O
excellent	O
model	O
for	O
studying	O
the	O
pathology	O
of	O
this	O
disorder	O
,	O
particularly	O
the	O
subtype	O
of	O
the	O
disorder	O
where	O
Crx	O
mutations	O
are	O
involved	O
.	O

The	O
vast	O
majority	O
of	O
histopathological	O
studies	O
of	O
LCA	O
in	O
human	O
tissue	O
have	O
been	O
derived	O
from	O
adult	O
patients	O
with	O
LCA	O
where	O
secondary	O
changes	O
are	O
likely	O
to	O
be	O
present	O
.	O

Indeed	O
in	O
animal	O
models	O
of	O
LCA	O
,	O
secondary	O
reactive	O
and	O
/	O
or	O
degenerative	O
changes	O
occur	O
early	O
after	O
the	O
abnormal	O
formation	O
of	O
retinal	O
tissue	O
[	O
57	O
]	O
.	O

The	O
only	O
study	O
in	O
human	O
tissue	O
derived	O
from	O
a	O
human	O
33	O
-	O
week	O
retina	O
with	O
proposed	O
RPE65	O
mutations	O
was	O
reported	O
to	O
have	O
abnormal	O
retinae	O
at	O
this	O
early	O
stage	O
[	O
24	O
]	O
.	O

These	O
authors	O
report	O
cell	O
loss	O
,	O
including	O
thinning	O
of	O
the	O
photoreceptor	O
layer	O
.	O

In	O
addition	O
,	O
they	O
claim	O
in	O
the	O
text	O
to	O
have	O
seen	O
aberrant	O
synaptic	O
and	O
inner	O
retinal	O
organization	O
,	O
although	O
their	O
examination	O
of	O
photoreceptor	O
synapses	O
unfortunately	O
are	O
not	O
presented	O
in	O
the	O
data	O
section	O
of	O
the	O
paper	O
.	O

Given	O
the	O
scarcity	O
of	O
available	O
human	O
tissue	O
,	O
the	O
characterization	O
of	O
the	O
primary	O
pathology	O
of	O
LCA	O
will	O
require	O
animal	O
models	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
present	O
data	O
that	O
argue	O
that	O
,	O
in	O
addition	O
to	O
outer	O
segment	O
morphogenesis	O
,	O
synaptogenesis	O
may	O
also	O
be	O
critically	O
impaired	O
in	O
at	O
least	O
a	O
subset	O
of	O
LCA	O
.	O

Methods	O

Mice	O

Crx	O
-	O
/	O
-	O
mice	O
were	O
generated	O
as	O
reported	O
elsewhere	O
[	O
34	O
]	O
.	O

Rhodosin	O
-	O
null	O
mice	O
[	O
29	O
]	O
were	O
obtained	O
from	O
Paul	O
Sieving	O
(	O
University	O
of	O
Michigan	O
)	O
.	O

Rds	O
mice	O
were	O
acquired	O
from	O
Jackson	O
Laboratory	O
.	O

Transmission	O
electron	B-CHEBI
microscopy	O

Littermate	O
Crx	O
-	O
/	O
-	O
and	O
wildtype	O
pups	O
were	O
perfused	O
in	O
1	O
%	O
formaldehyde	B-CHEBI
and	O
0	O
.	O
5	O
%	O
glutaraldehyde	O
at	O
various	O
postnatal	O
stages	O
.	O

The	O
eyes	O
were	O
then	O
enucleated	O
,	O
and	O
the	O
cornea	O
and	O
lens	O
were	O
removed	O
.	O

The	O
eye	O
cup	O
was	O
immersed	O
in	O
fixative	O
(	O
1	O
%	O
formaldehyde	B-CHEBI
and	O
2	O
.	O
5	O
%	O
glutaraldehyde	O
)	O
for	O
3	O
to	O
4	O
hours	O
at	O
4	O
degrees	O
C	O
.	O

The	O
sclera	O
was	O
then	O
partially	O
removed	O
and	O
the	O
retinas	O
were	O
sliced	O
into	O
small	O
pieces	O
and	O
fixed	O
(	O
1	O
%	O
paraformaldehyde	O
and	O
2	O
.	O
5	O
%	O
glutaraldehyde	O
)	O
overnight	O
at	O
4	O
degrees	O
C	O
.	O

These	O
procedures	O
were	O
found	O
optimal	O
for	O
maintaining	O
the	O
structural	O
integrity	O
of	O
the	O
photoreceptor	O
outer	O
segments	O
.	O

After	O
fixing	O
,	O
the	O
tissue	O
was	O
washed	O
2X	O
in	O
PBS	O
for	O
thirty	O
minutes	O
per	O
wash	O
.	O

The	O
tissue	O
was	O
then	O
postfixed	O
in	O
a	O
1	O
%	O
osmium	B-CHEBI
tetroxide	O
/	O
1	O
.	O
5	O
%	O
potassium	B-CHEBI
ferrocyanide	B-CHEBI
mixture	O
for	O
2	O
hours	O
at	O
4	O
degrees	O
C	O
.	O

Staining	O
was	O
carried	O
out	O
for	O
30	O
minutes	O
in	O
1	O
%	O
uranyl	B-CHEBI
acetate	B-CHEBI
in	O
maleate	B-CHEBI
buffer	O
(	O
pH	O
=	O
6	O
.	O
0	O
)	O
at	O
room	O
temperature	O
followed	O
by	O
1	O
%	O
tannic	O
acid	B-CHEBI
in	O
0	O
.	O
1	O
M	O
cacodylate	B-CHEBI
buffer	O
(	O
pH	O
=	O
7	O
.	O
4	O
)	O
for	O
thirty	O
minutes	O
.	O

The	O
specimens	O
were	O
then	O
dehydrated	O
and	O
embedded	O
in	O
Epon	O
/	O
Araldite	O
.	O

Thin	O
sections	O
were	O
stained	O
with	O
uranyl	B-CHEBI
acetate	B-CHEBI
and	O
lead	B-CHEBI
citrate	B-CHEBI
,	O
and	O
examined	O
in	O
a	O
Jeol	O
JEM	O
-	O
1200EX	O
electron	B-CHEBI
microscope	O
.	O

Scanning	O
electron	B-CHEBI
microscopy	O

Specimens	O
used	O
for	O
SEM	O
required	O
removal	O
of	O
the	O
retinal	O
pigment	O
epithelium	O
(	O
PE	O
)	O
,	O
enabling	O
visualization	O
of	O
the	O
outer	O
surface	O
of	O
the	O
neural	O
retina	O
.	O

Retinae	O
from	O
Crx	O
-	O
/	O
-	O
,	O
rhodopsin	O
-	O
/	O
-	O
,	O
RDS	O
,	O
or	O
wildtype	O
eyes	O
were	O
dissected	O
free	O
from	O
PE	O
in	O
a	O
dispase	O
solution	O
and	O
fixed	O
in	O
1	O
.	O
25	O
%	O
glutaraldehyde	O
and	O
1	O
.	O
0	O
%	O
formaldehyde	B-CHEBI
overnight	O
at	O
4	O
degrees	O
C	O
.	O

Tissue	O
was	O
then	O
washed	O
5X	O
in	O
cacodylate	B-CHEBI
buffer	O
and	O
dehydrated	O
in	O
ascending	O
grades	O
of	O
ethanol	B-CHEBI
.	O

Tissues	O
were	O
subsequently	O
critical	O
point	O
dried	O
in	O
carbon	B-CHEBI
dioxide	I-CHEBI
.	O

All	O
specimens	O
were	O
mounted	O
and	O
coated	O
with	O
sublimated	O
gold	B-CHEBI
-	O
palladium	B-CHEBI
by	O
the	O
sputtering	O
technique	O
.	O

Micrographs	O
were	O
obtained	O
with	O
a	O
Jeol	O
JSM	O
-	O
35CF	O
scanning	O
electron	B-CHEBI
microscope	O
.	O

Authors	O
'	O
contributions	O

EM	O
and	O
ER	O
conducted	O
transmission	O
electron	B-CHEBI
microscopy	O
.	O

EM	O
performed	O
scanning	O
electron	B-CHEBI
microscopy	O
.	O

TF	O
and	O
EM	O
generated	O
,	O
characterized	O
and	O
maintained	O
the	O
Crx	O
-	O
/	O
-	O
mouse	O
line	O
.	O

CC	O
participated	O
in	O
the	O
design	O
and	O
coordination	O
of	O
the	O
study	O
and	O
all	O
data	O
analysis	O
.	O

EM	O
and	O
CC	O
drafted	O
the	O
manuscript	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Acknowledgements	O

We	O
would	O
like	O
to	O
thank	O
Heather	O
Regan	O
and	O
Dr	O
.	O
Susumu	O
Ito	O
for	O
helping	O
with	O
ultrastructural	O
analyses	O
and	O
Dr	O
.	O
David	O
Papermaster	O
for	O
helpful	O
discussions	O
on	O
the	O
formation	O
of	O
outer	O
segments	O
.	O

PGC	O
-	O
1	O
alpha	O
Deficiency	O
Causes	O
Multi	O
-	O
System	O
Energy	O
Metabolic	O
Derangements	O
:	O
Muscle	O
Dysfunction	O
,	O
Abnormal	O
Weight	O
Control	O
and	O
Hepatic	O
Steatosis	O

Abstract	O

The	O
gene	O
encoding	O
the	O
transcriptional	O
coactivator	O
peroxisome	O
proliferator	O
-	O
activated	O
receptor	O
-	O
gamma	O
coactivator	O
-	O
1	O
alpha	O
(	O
PGC	O
-	O
1	O
alpha	O
)	O
was	O
targeted	O
in	O
mice	O
.	O

PGC	O
-	O
1	O
alpha	O
null	O
(	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
)	O
mice	O
were	O
viable	O
.	O

However	O
,	O
extensive	O
phenotyping	O
revealed	O
multi	O
-	O
system	O
abnormalities	O
indicative	O
of	O
an	O
abnormal	O
energy	O
metabolic	O
phenotype	O
.	O

The	O
postnatal	O
growth	O
of	O
heart	O
and	O
slow	O
-	O
twitch	O
skeletal	O
muscle	O
,	O
organs	O
with	O
high	O
mitochondrial	O
energy	O
demands	O
,	O
is	O
blunted	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

With	O
age	O
,	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
develop	O
abnormally	O
increased	O
body	O
fat	O
,	O
a	O
phenotype	O
that	O
is	O
more	O
severe	O
in	O
females	O
.	O

Mitochondrial	O
number	O
and	O
respiratory	O
capacity	O
is	O
diminished	O
in	O
slow	O
-	O
twitch	O
skeletal	O
muscle	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
,	O
leading	O
to	O
reduced	O
muscle	O
performance	O
and	O
exercise	O
capacity	O
.	O

PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
exhibit	O
a	O
modest	O
diminution	O
in	O
cardiac	O
function	O
related	O
largely	O
to	O
abnormal	O
control	O
of	O
heart	O
rate	O
.	O

The	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
were	O
unable	O
to	O
maintain	O
core	O
body	O
temperature	O
following	O
exposure	O
to	O
cold	O
,	O
consistent	O
with	O
an	O
altered	O
thermogenic	O
response	O
.	O

Following	O
short	O
-	O
term	O
starvation	O
,	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
develop	O
hepatic	O
steatosis	O
due	O
to	O
a	O
combination	O
of	O
reduced	O
mitochondrial	O
respiratory	O
capacity	O
and	O
an	O
increased	O
expression	O
of	O
lipogenic	O
genes	O
.	O

Surprisingly	O
,	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
were	O
less	O
susceptible	O
to	O
diet	O
-	O
induced	O
insulin	B-CHEBI
resistance	O
than	O
wild	O
-	O
type	O
controls	O
.	O

Lastly	O
,	O
vacuolar	O
lesions	O
were	O
detected	O
in	O
the	O
central	O
nervous	O
system	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

These	O
results	O
demonstrate	O
that	O
PGC	O
-	O
1	O
alpha	O
is	O
necessary	O
for	O
appropriate	O
adaptation	O
to	O
the	O
metabolic	O
and	O
physiologic	O
stressors	O
of	O
postnatal	O
life	O
.	O

Introduction	O

Mitochondrial	O
functional	O
capacity	O
is	O
dynamically	O
regulated	O
to	O
meet	O
the	O
diverse	O
energy	O
demands	O
imposed	O
on	O
the	O
mammalian	O
organism	O
following	O
birth	O
.	O

Postnatal	O
mitochondrial	O
biogenesis	O
involves	O
multiple	O
signaling	O
and	O
transcriptional	O
regulatory	O
pathways	O
that	O
control	O
the	O
coordinate	O
expression	O
of	O
nuclear	O
and	O
mitochondrial	O
genes	O
involved	O
in	O
mitochondrial	O
structure	O
,	O
metabolism	O
,	O
and	O
proliferation	O
[	O
1	O
]	O
.	O

Recent	O
evidence	O
points	O
toward	O
a	O
transcriptional	O
coactivator	O
,	O
peroxisome	O
proliferator	O
-	O
activated	O
receptor	O
-	O
gamma	O
(	O
PPAR	O
gamma	O
)	O
coactivator	O
-	O
1	O
alpha	O
(	O
PGC	O
-	O
1	O
alpha	O
)	O
,	O
as	O
an	O
integrator	O
of	O
the	O
molecular	B-CHEBI
regulatory	O
circuitry	O
involved	O
in	O
the	O
transcriptional	O
control	O
of	O
cellular	O
energy	O
metabolism	O
,	O
including	O
mitochondrial	O
function	O
and	O
biogenesis	O
[	O
1	O
,	O
2	O
]	O
.	O

PGC	O
-	O
1	O
alpha	O
was	O
discovered	O
in	O
a	O
yeast	O
two	O
-	O
hybrid	O
screen	O
for	O
brown	O
adipose	O
-	O
specific	O
factors	O
that	O
interact	O
with	O
the	O
adipogenic	O
nuclear	O
receptor	O
PPAR	O
gamma	O
[	O
2	O
]	O
.	O

Subsequently	O
,	O
two	O
additional	O
PGC	O
-	O
1	O
family	O
members	O
were	O
identified	O
,	O
PGC	O
-	O
1	O
related	O
coactivator	O
(	O
PRC	O
)	O
[	O
3	O
]	O
and	O
PGC	O
-	O
1	O
beta	O
[	O
4	O
,	O
5	O
]	O
.	O

PGC	O
-	O
1	O
alpha	O
serves	O
as	O
a	O
direct	O
transcriptional	O
coactivator	O
of	O
nuclear	O
and	O
nonnuclear	O
receptor	O
transcription	O
factors	O
involved	O
in	O
cellular	O
energy	O
metabolism	O
[	O
6	O
]	O
.	O

PGC	O
-	O
1	O
alpha	O
is	O
distinct	O
among	O
most	O
coactivators	O
in	O
that	O
it	O
exhibits	O
a	O
tissue	O
-	O
enriched	O
expression	O
pattern	O
and	O
is	O
highly	O
inducible	O
by	O
physiologic	O
conditions	O
known	O
to	O
increase	O
the	O
demand	O
for	O
mitochondrial	O
ATP	B-CHEBI
or	O
heat	O
production	O
[	O
2	O
,	O
6	O
,	O
7	O
]	O
.	O

PGC	O
-	O
1	O
alpha	O
is	O
enriched	O
in	O
brown	O
adipose	O
tissue	O
(	O
BAT	O
)	O
,	O
heart	O
,	O
slow	O
-	O
twitch	O
skeletal	O
muscle	O
,	O
and	O
kidney	O
--	O
all	O
tissues	O
with	O
high	O
-	O
capacity	O
mitochondrial	O
systems	O
.	O

The	O
expression	O
of	O
the	O
gene	O
encoding	O
PGC	O
-	O
1	O
alpha	O
is	O
rapidly	O
induced	O
by	O
cold	O
exposure	O
,	O
short	O
-	O
term	O
exercise	O
,	O
and	O
fasting	O
[	O
2	O
,	O
8	O
,	O
9	O
,	O
10	O
,	O
11	O
,	O
12	O
,	O
13	O
,	O
14	O
,	O
15	O
]	O
.	O

These	O
latter	O
observations	O
suggest	O
that	O
PGC	O
-	O
1	O
alpha	O
is	O
involved	O
in	O
the	O
physiologic	O
control	O
of	O
energy	O
metabolism	O
.	O

Several	O
lines	O
of	O
evidence	O
,	O
based	O
on	O
the	O
results	O
of	O
overexpression	O
studies	O
,	O
indicate	O
that	O
PGC	O
-	O
1	O
alpha	O
is	O
sufficient	O
to	O
promote	O
mitochondrial	O
biogenesis	O
and	O
regulate	O
mitochondrial	O
respiratory	O
capacity	O
.	O

First	O
,	O
PGC	O
-	O
1	O
alpha	O
activates	O
the	O
transcription	O
of	O
mitochondrial	O
uncoupling	O
protein	B-CHEBI
-	O
1	O
(	O
UCP	O
-	O
1	O
)	O
in	O
BAT	O
through	O
interactions	O
with	O
the	O
nuclear	O
hormone	B-CHEBI
receptors	O
PPAR	O
gamma	O
and	O
thyroid	O
receptor	O
[	O
2	O
]	O
.	O

Second	O
,	O
forced	O
expression	O
studies	O
in	O
adipogenic	O
and	O
myogenic	O
mammalian	O
cell	O
lines	O
demonstrated	O
that	O
PGC	O
-	O
1	O
alpha	O
activates	O
mitochondrial	O
biogenesis	O
through	O
a	O
group	O
of	O
transcription	O
factor	O
targets	O
including	O
nuclear	O
respiratory	O
factors	O
1	O
and	O
2	O
(	O
NRF	O
-	O
1	O
and	O
-	O
2	O
)	O
and	O
mitochondrial	O
transcription	O
factor	O
A	O
(	O
Tfam	O
)	O
,	O
key	O
transcriptional	O
regulators	O
of	O
mitochondrial	O
DNA	O
transcription	O
and	O
replication	O
[	O
8	O
]	O
.	O

Third	O
,	O
studies	O
in	O
primary	O
cardiac	O
myocytes	O
in	O
culture	O
and	O
in	O
the	O
hearts	O
of	O
transgenic	O
mice	O
have	O
demonstrated	O
that	O
overexpression	O
of	O
PGC	O
-	O
1	O
alpha	O
promotes	O
mitochondrial	O
biogenesis	O
[	O
10	O
,	O
16	O
]	O
.	O

Lastly	O
,	O
forced	O
expression	O
of	O
PGC	O
-	O
1	O
alpha	O
in	O
skeletal	O
muscle	O
of	O
transgenic	O
mice	O
triggers	O
mitochondrial	O
proliferation	O
and	O
the	O
formation	O
of	O
mitochondrial	O
-	O
rich	O
type	O
I	O
,	O
oxidative	O
(	O
"	O
slow	O
-	O
twitch	O
"	O
)	O
muscle	O
fibers	O
[	O
17	O
]	O
.	O

Collectively	O
,	O
these	O
results	O
indicate	O
that	O
PGC	O
-	O
1	O
alpha	O
is	O
sufficient	O
to	O
drive	O
mitochondrial	O
biogenesis	O
.	O

Recent	O
evidence	O
also	O
implicates	O
PGC	O
-	O
1	O
alpha	O
in	O
the	O
homeostatic	O
control	O
of	O
systemic	O
energy	O
metabolism	O
.	O

PGC	O
-	O
1	O
alpha	O
has	O
been	O
shown	O
to	O
regulate	O
several	O
key	O
hepatic	O
gluconeogenic	O
genes	O
[	O
18	O
,	O
19	O
,	O
20	O
,	O
21	O
]	O
.	O

Recent	O
studies	O
have	O
also	O
shown	O
altered	O
expression	O
of	O
PGC	O
-	O
1	O
alpha	O
and	O
downstream	O
mitochondrial	O
target	O
pathways	O
in	O
skeletal	O
muscle	O
of	O
humans	O
with	O
insulin	B-CHEBI
resistance	O
and	O
diabetes	O
[	O
22	O
,	O
23	O
,	O
24	O
]	O
.	O

In	O
addition	O
,	O
single	O
nucleotide	B-CHEBI
polymorphisms	O
within	O
the	O
human	O
PGC	O
-	O
1	O
alpha	O
gene	O
have	O
been	O
shown	O
to	O
be	O
associated	O
with	O
obesity	O
,	O
hypertension	O
,	O
and	O
diabetes	O
[	O
25	O
,	O
26	O
,	O
27	O
,	O
28	O
,	O
29	O
,	O
30	O
]	O
.	O

The	O
gain	O
-	O
of	O
-	O
function	O
studies	O
described	O
to	O
date	O
provide	O
compelling	O
evidence	O
that	O
PGC	O
-	O
1	O
alpha	O
is	O
capable	O
of	O
regulating	O
postnatal	O
energy	O
metabolism	O
.	O

However	O
,	O
the	O
necessity	O
of	O
PGC	O
-	O
1	O
alpha	O
for	O
energy	O
metabolic	O
homeostasis	O
,	O
mitochondrial	O
biogenesis	O
,	O
development	O
,	O
and	O
growth	O
can	O
only	O
be	O
addressed	O
using	O
loss	O
-	O
of	O
-	O
function	O
strategies	O
.	O

To	O
this	O
end	O
,	O
we	O
have	O
established	O
and	O
characterized	O
mice	O
with	O
targeted	O
deletion	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
gene	O
.	O

Our	O
studies	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
demonstrate	O
that	O
PGC	O
-	O
1	O
alpha	O
is	O
not	O
absolutely	O
required	O
for	O
prenatal	O
viability	O
including	O
mitochondrial	O
biogenesis	O
.	O

However	O
,	O
our	O
findings	O
indicate	O
that	O
the	O
coactivator	O
PGC	O
-	O
1	O
alpha	O
serves	O
a	O
critical	O
role	O
in	O
the	O
normal	O
metabolic	O
function	O
of	O
multiple	O
organs	O
and	O
for	O
appropriate	O
adaptation	O
to	O
physiologic	O
stress	O
during	O
postnatal	O
life	O
.	O

Results	O

Disruption	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
Gene	O
in	O
Mice	O

A	O
neomycin	B-CHEBI
-	O
based	O
gene	O
targeting	O
vector	O
was	O
generated	O
to	O
delete	O
exons	O
4	O
and	O
5	O
of	O
the	O
murine	O
PGC	O
-	O
1	O
alpha	O
gene	O
.	O

The	O
targeting	O
event	O
resulted	O
in	O
a	O
3	O
'	O
homologous	O
recombination	O
with	O
insertion	O
of	O
the	O
remainder	O
of	O
the	O
construct	O
(	O
Figure	O
1A	O
)	O
.	O

The	O
insertion	O
/	O
recombination	O
event	O
was	O
confirmed	O
by	O
Southern	O
blotting	O
and	O
DNA	O
sequencing	O
.	O

The	O
insertion	O
caused	O
an	O
exon	O
3	O
duplication	O
between	O
exons	O
5	O
and	O
6	O
that	O
creates	O
a	O
coding	O
region	O
frameshift	O
resulting	O
in	O
a	O
premature	O
termination	O
at	O
amino	B-CHEBI
acid	I-CHEBI
255	O
.	O

Germline	O
transmission	O
of	O
the	O
mutant	O
allele	O
was	O
confirmed	O
using	O
Southern	O
blotting	O
(	O
Figure	O
1B	O
)	O
and	O
PCR	O
(	O
unpublished	O
data	O
)	O
.	O

The	O
PGC	O
-	O
1	O
alpha	O
gene	O
disruption	O
resulted	O
in	O
an	O
unstable	O
transcript	O
that	O
could	O
not	O
be	O
detected	O
by	O
RNA	O
blot	O
analysis	O
in	O
heart	O
and	O
other	O
tissues	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
Figure	O
1C	O
and	O
unpublished	O
data	O
)	O
.	O

Quantitative	O
RT	O
-	O
PCR	O
was	O
utilized	O
to	O
further	O
evaluate	O
the	O
efficacy	O
of	O
the	O
gene	O
targeting	O
.	O

For	O
these	O
studies	O
,	O
PCR	O
primers	O
were	O
designed	O
to	O
amplify	O
a	O
region	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
gene	O
transcript	O
containing	O
the	O
exon	O
5	O
-	O
6	O
border	O
(	O
predicted	O
to	O
be	O
absent	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
)	O
or	O
the	O
exon	O
5	O
-	O
3	O
border	O
(	O
predicted	O
to	O
be	O
present	O
only	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
)	O
.	O

The	O
exon	O
5	O
-	O
6	O
amplicon	O
was	O
detected	O
in	O
heart	O
and	O
BAT	O
of	O
wild	O
-	O
type	O
(	O
WT	O
)	O
but	O
not	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
Figure	O
1D	O
)	O
.	O

Conversely	O
,	O
the	O
exon	O
5	O
-	O
3	O
product	O
was	O
present	O
only	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
Figure	O
1D	O
)	O
.	O

An	O
exon	O
10	O
-	O
11	O
border	O
amplicon	O
(	O
predicted	O
to	O
be	O
present	O
in	O
both	O
genotypes	O
)	O
was	O
detected	O
in	O
WT	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
,	O
but	O
was	O
greatly	O
diminished	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
,	O
indicating	O
that	O
the	O
mutant	O
transcript	O
is	O
unstable	O
.	O

PGC	O
-	O
1	O
alpha	O
protein	B-CHEBI
was	O
not	O
detected	O
in	O
whole	O
cell	O
(	O
Figure	O
1E	O
)	O
or	O
nuclear	O
protein	B-CHEBI
extracts	O
(	O
unpublished	O
data	O
)	O
isolated	O
from	O
BAT	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
under	O
basal	O
conditions	O
or	O
in	O
response	O
to	O
cold	O
exposure	O
,	O
a	O
condition	O
known	O
to	O
markedly	O
induce	O
the	O
expression	O
of	O
PGC	O
-	O
1	O
alpha	O
in	O
BAT	O
.	O

Smaller	O
mutant	O
PGC	O
-	O
1	O
alpha	O
proteins	B-CHEBI
were	O
also	O
not	O
detected	O
by	O
Western	O
blot	O
analysis	O
(	O
unpublished	O
data	O
)	O
.	O

Lastly	O
,	O
expression	O
of	O
the	O
genes	O
encoding	O
the	O
other	O
known	O
PGC	O
-	O
1	O
family	O
members	O
,	O
PGC	O
-	O
1	O
beta	O
and	O
PRC	O
,	O
was	O
not	O
significantly	O
altered	O
in	O
heart	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
Figure	O
1C	O
)	O
.	O

Taken	O
together	O
,	O
these	O
results	O
support	O
the	O
conclusion	O
that	O
the	O
gene	O
targeting	O
event	O
resulted	O
in	O
a	O
PGC	O
-	O
1	O
alpha	O
null	O
allele	O
.	O

General	O
Characteristics	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O
:	O
Age	O
-	O
and	O
Sex	O
-	O
Dependent	O
Obesity	O

Heterozygous	O
(	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
-	O
)	O
mice	O
were	O
bred	O
to	O
generate	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
offspring	O
.	O

The	O
observed	O
genotype	O
ratios	O
of	O
the	O
offspring	O
were	O
consistent	O
with	O
the	O
expected	O
Mendelian	O
ratios	O
(	O
unpublished	O
data	O
)	O
.	O

Unexpected	O
deaths	O
of	O
the	O
offspring	O
were	O
not	O
observed	O
,	O
and	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
-	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
offspring	O
appeared	O
normal	O
.	O

Total	O
body	O
weights	O
obtained	O
1	O
wk	O
after	O
birth	O
revealed	O
a	O
15	O
%	O
-	O
20	O
%	O
reduction	O
in	O
total	O
body	O
mass	O
for	O
male	O
and	O
female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
relative	O
to	O
sex	O
-	O
matched	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
littermates	O
(	O
Figure	O
2	O
)	O
.	O

The	O
weight	O
decrement	O
between	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
and	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
littermates	O
disappeared	O
by	O
3	O
wk	O
of	O
age	O
(	O
Figure	O
2A	O
)	O
.	O

At	O
18	O
wk	O
of	O
age	O
,	O
body	O
weight	O
was	O
modestly	O
but	O
significantly	O
greater	O
in	O
male	O
and	O
female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
compared	O
to	O
sex	O
-	O
matched	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
controls	O
(	O
Figure	O
2A	O
)	O
.	O

This	O
weight	O
difference	O
was	O
also	O
significant	O
for	O
female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
at	O
24	O
wk	O
of	O
age	O
(	O
Figure	O
2A	O
)	O
.	O

The	O
abnormal	O
weight	O
gain	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
was	O
not	O
associated	O
with	O
differences	O
in	O
food	B-CHEBI
intake	O
(	O
unpublished	O
data	O
)	O
or	O
alterations	O
in	O
general	O
activity	O
as	O
monitored	O
for	O
48	O
h	O
(	O
Figure	O
S1	O
)	O
.	O

Percent	O
body	O
fat	O
,	O
as	O
determined	O
by	O
dual	O
-	O
energy	O
X	O
-	O
ray	O
absorption	O
(	O
DEXA	O
)	O
,	O
was	O
greater	O
in	O
18	O
-	O
and	O
24	O
-	O
wk	O
-	O
old	O
female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
compared	O
to	O
age	O
-	O
matched	O
female	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
counterparts	O
,	O
indicating	O
that	O
the	O
body	O
weight	O
difference	O
was	O
due	O
,	O
at	O
least	O
in	O
part	O
,	O
to	O
increased	O
body	O
fat	O
(	O
Figure	O
2A	O
)	O
.	O

Lean	O
mass	O
was	O
not	O
significantly	O
different	O
between	O
the	O
genotypes	O
(	O
unpublished	O
data	O
)	O
.	O

Although	O
DEXA	O
did	O
not	O
detect	O
excess	O
body	O
fat	O
in	O
male	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
at	O
18	O
or	O
24	O
wk	O
of	O
age	O
,	O
older	O
male	O
mutant	O
mice	O
(	O
over	O
7	O
mo	O
of	O
age	O
)	O
accumulated	O
more	O
body	O
fat	O
than	O
male	O
WT	O
controls	O
(	O
Figure	O
2A	O
and	O
unpublished	O
data	O
)	O
.	O

Individual	O
organ	O
weights	O
were	O
assessed	O
,	O
given	O
the	O
importance	O
of	O
mitochondrial	O
energy	O
metabolism	O
for	O
postnatal	O
growth	O
in	O
certain	O
organs	O
.	O

The	O
weights	O
of	O
heart	O
and	O
slow	O
-	O
twitch	O
fiber	O
-	O
enriched	O
skeletal	O
muscles	O
,	O
including	O
gastrocnemius	O
and	O
soleus	O
,	O
but	O
not	O
the	O
less	O
oxidative	O
tibialis	O
anterior	O
,	O
were	O
significantly	O
lower	O
in	O
male	O
and	O
female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
compared	O
with	O
age	O
and	O
sex	O
-	O
matched	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
controls	O
at	O
3	O
and	O
8	O
wk	O
of	O
age	O
(	O
Figure	O
2B	O
and	O
unpublished	O
data	O
)	O
.	O

In	O
contrast	O
,	O
the	O
weights	O
of	O
brain	O
,	O
liver	O
,	O
kidney	O
,	O
and	O
BAT	O
were	O
not	O
significantly	O
different	O
between	O
the	O
genotypes	O
at	O
the	O
3	O
-	O
wk	O
time	O
point	O
(	O
Figure	O
2B	O
)	O
.	O

Thus	O
,	O
certain	O
tissues	O
with	O
high	O
mitochondrial	O
energy	O
requirements	O
,	O
such	O
as	O
heart	O
and	O
slow	O
-	O
twitch	O
skeletal	O
muscle	O
,	O
exhibit	O
modest	O
growth	O
defects	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

Abnormal	O
Muscle	O
Mitochondrial	O
Phenotype	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O

General	O
histologic	O
analyses	O
were	O
performed	O
to	O
begin	O
to	O
evaluate	O
the	O
mild	O
growth	O
defect	O
found	O
in	O
postnatal	O
heart	O
and	O
skeletal	O
muscle	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

There	O
were	O
no	O
obvious	O
abnormalities	O
in	O
cellularity	O
,	O
cell	O
size	O
,	O
or	O
extracellular	O
matrix	O
in	O
the	O
tissues	O
of	O
1	O
-	O
2	O
-	O
mo	O
-	O
old	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
unpublished	O
data	O
)	O
.	O

Given	O
the	O
important	O
role	O
of	O
PGC	O
-	O
1	O
alpha	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
we	O
examined	O
mitochondrial	O
ultrastructure	O
in	O
the	O
relevant	O
tissues	O
.	O

Electron	B-CHEBI
microscopic	O
analysis	O
revealed	O
fewer	O
and	O
smaller	O
mitochondria	O
in	O
soleus	O
muscle	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
compared	O
to	O
sex	O
-	O
and	O
age	O
-	O
matched	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
controls	O
(	O
Figure	O
3A	O
)	O
.	O

Quantitative	O
morphometry	O
of	O
the	O
electron	B-CHEBI
micrographs	O
confirmed	O
that	O
the	O
cellular	O
volume	O
density	O
of	O
soleus	O
mitochondria	O
was	O
significantly	O
lower	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
compared	O
to	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
controls	O
independent	O
of	O
changes	O
in	O
the	O
myofibrillar	O
component	O
(	O
Figure	O
3B	O
)	O
.	O

Consistent	O
with	O
a	O
defect	O
in	O
mitochondrial	O
biogenesis	O
,	O
we	O
found	O
a	O
reduction	O
in	O
the	O
expression	O
of	O
nuclear	O
genes	O
encoding	O
proteins	B-CHEBI
involved	O
in	O
mitochondrial	O
electron	B-CHEBI
transport	O
(	O
cytochrome	B-CHEBI
c	I-CHEBI
and	O
cytochrome	B-CHEBI
oxidase	O
IV	O
)	O
and	O
oxidative	O
phosphorylation	O
(	O
beta	O
subunit	O
of	O
ATP	B-CHEBI
synthase	O
)	O
in	O
soleus	O
muscle	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
compared	O
with	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
controls	O
.	O

In	O
addition	O
,	O
the	O
expression	O
of	O
Tfam	O
,	O
a	O
known	O
PGC	O
-	O
1	O
alpha	O
target	O
involved	O
in	O
mitochondrial	O
DNA	O
replication	O
/	O
transcription	O
,	O
was	O
diminished	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
soleus	O
,	O
providing	O
one	O
potential	O
mechanism	O
for	O
defective	O
mitochondrial	O
biogenesis	O
(	O
Figure	O
3C	O
)	O
.	O

In	O
contrast	O
to	O
the	O
results	O
with	O
soleus	O
,	O
no	O
significant	O
differences	O
in	O
mitochondrial	O
ultrastructure	O
or	O
volume	O
density	O
were	O
noted	O
in	O
heart	O
or	O
BAT	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
unpublished	O
data	O
)	O
.	O

To	O
determine	O
whether	O
mitochondrial	O
function	O
was	O
altered	O
in	O
the	O
skeletal	O
muscle	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
,	O
mitochondrial	O
respiration	O
rates	O
were	O
measured	O
using	O
tissue	O
strips	O
prepared	O
from	O
soleus	O
muscle	O
.	O

In	O
soleus	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
,	O
a	O
significant	O
defect	O
in	O
state	O
3	O
(	O
ADP	B-CHEBI
-	O
stimulated	O
)	O
respiration	O
,	O
but	O
not	O
state	O
2	O
(	O
basal	O
)	O
,	O
was	O
detected	O
using	O
succinate	B-CHEBI
as	O
the	O
substrate	O
(	O
Figure	O
3D	O
)	O
.	O

State	O
4	O
respiration	O
rates	O
(	O
in	O
the	O
presence	O
of	O
oligomycin	B-CHEBI
)	O
were	O
also	O
similar	O
between	O
the	O
genotypes	O
,	O
indicating	O
that	O
the	O
coupling	O
of	O
respiration	O
to	O
ATP	B-CHEBI
production	O
was	O
not	O
significantly	O
altered	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

These	O
results	O
are	O
consistent	O
with	O
the	O
modest	O
but	O
significant	O
reduction	O
in	O
mitochondrial	O
volume	O
density	O
.	O

Altered	O
Skeletal	O
Muscle	O
Function	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O

The	O
abnormality	O
in	O
mitochondrial	O
number	O
and	O
respiratory	O
function	O
in	O
skeletal	O
muscle	O
led	O
us	O
to	O
further	O
evaluate	O
the	O
skeletal	O
muscle	O
phenotype	O
.	O

As	O
an	O
initial	O
step	O
,	O
we	O
measured	O
locomotor	O
activity	O
levels	O
over	O
a	O
1	O
-	O
h	O
period	O
using	O
a	O
high	O
-	O
resolution	O
photobeam	O
system	O
.	O

PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
male	O
mice	O
exhibited	O
a	O
significantly	O
lower	O
mean	O
number	O
of	O
ambulations	O
and	O
rearings	O
during	O
the	O
hour	O
compared	O
to	O
the	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
age	O
-	O
matched	O
controls	O
(	O
Figure	O
4	O
)	O
.	O

However	O
,	O
an	O
analysis	O
of	O
exploratory	O
behavior	O
showed	O
that	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
were	O
reluctant	O
to	O
go	O
into	O
the	O
center	O
of	O
the	O
"	O
field	O
"	O
compared	O
to	O
controls	O
.	O

Specifically	O
,	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
made	O
significantly	O
fewer	O
entries	O
into	O
,	O
spent	O
significantly	O
less	O
time	O
in	O
,	O
and	O
traveled	O
a	O
significantly	O
shorter	O
distance	O
in	O
the	O
central	O
area	O
of	O
the	O
"	O
field	O
,	O
"	O
although	O
differences	O
in	O
distance	O
traveled	O
in	O
the	O
peripheral	O
zone	O
of	O
the	O
"	O
field	O
"	O
was	O
not	O
significantly	O
different	O
between	O
groups	O
(	O
Figure	O
S2	O
)	O
.	O

These	O
data	O
suggest	O
that	O
the	O
general	O
activity	O
level	O
may	O
have	O
been	O
affected	O
by	O
the	O
reluctance	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
to	O
go	O
into	O
the	O
central	O
area	O
of	O
the	O
field	O
and	O
thus	O
remain	O
in	O
the	O
periphery	O
(	O
thigmotaxis	O
)	O
,	O
possibly	O
reflecting	O
altered	O
emotionality	O
such	O
as	O
increased	O
fear	O
.	O

A	O
battery	O
of	O
tests	O
was	O
performed	O
to	O
further	O
evaluate	O
the	O
general	O
sensorimotor	O
phenotype	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

No	O
differences	O
were	O
found	O
between	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
and	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
controls	O
on	O
the	O
ledge	O
,	O
platform	O
,	O
walking	O
initiation	O
,	O
and	O
60	O
degrees	O
and	O
90	O
degrees	O
inclined	O
screen	O
tests	O
(	O
unpublished	O
data	O
)	O
,	O
suggesting	O
that	O
several	O
sensorimotor	O
functions	O
were	O
intact	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

However	O
,	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
were	O
unable	O
to	O
remain	O
on	O
an	O
inverted	O
screen	O
for	O
as	O
long	O
as	O
the	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
controls	O
(	O
Figure	O
4A	O
)	O
.	O

Since	O
the	O
groups	O
did	O
not	O
differ	O
on	O
the	O
times	O
it	O
took	O
to	O
turn	O
around	O
and	O
climb	O
to	O
the	O
top	O
of	O
60	O
degrees	O
and	O
90	O
degrees	O
inclined	O
screens	O
,	O
the	O
differences	O
on	O
the	O
inverted	O
screen	O
test	O
suggest	O
that	O
impaired	O
strength	O
rather	O
than	O
deficits	O
in	O
coordination	O
were	O
responsible	O
for	O
these	O
differences	O
.	O

To	O
further	O
evaluate	O
the	O
skeletal	O
muscle	O
phenotype	O
,	O
exercise	O
capacity	O
was	O
assessed	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

To	O
this	O
end	O
,	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
were	O
exercised	O
on	O
a	O
motorized	O
treadmill	O
apparatus	O
using	O
a	O
run	O
-	O
to	O
-	O
exhaustion	O
format	O
.	O

PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
6	O
-	O
8	O
mo	O
of	O
age	O
)	O
exhibited	O
a	O
markedly	O
reduced	O
capacity	O
to	O
sustain	O
running	O
exercise	O
(	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
,	O
64	O
+/-	O
6	O
s	O
;	O
age	O
-	O
matched	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O
,	O
586	O
+/-	O
104	O
s	O
;	O
Figure	O
4B	O
)	O
.	O

The	O
same	O
result	O
was	O
obtained	O
with	O
younger	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
,	O
i	O
.	O
e	O
.	O
,	O
at	O
3	O
.	O
5	O
mo	O
of	O
age	O
(	O
unpublished	O
data	O
)	O
.	O

To	O
quantify	O
aerobic	O
exercise	O
capacity	O
,	O
VO2max	O
(	O
maximum	O
oxygen	B-CHEBI
consumption	O
,	O
measured	O
in	O
milliliters	O
of	O
oxygen	B-CHEBI
per	O
kilogram	O
of	O
body	O
weight	O
per	O
minute	O
)	O
was	O
measured	O
with	O
the	O
treadmill	O
-	O
running	O
protocol	O
using	O
indirect	O
calorimetry	O
.	O

VO2max	O
was	O
significantly	O
lower	O
for	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
120	O
.	O
9	O
+/-	O
2	O
.	O
0	O
ml	O
O2	B-CHEBI
.	O
kg	O
-	O
1	O
.	O
min	O
-	O
1	O
)	O
compared	O
to	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
controls	O
(	O
141	O
.	O
6	O
+/-	O
2	O
.	O
1	O
ml	O
O2	B-CHEBI
.	O
kg	O
-	O
1	O
.	O
min	O
-	O
1	O
)	O
(	O
Figure	O
4B	O
)	O
.	O

To	O
directly	O
evaluate	O
muscle	O
fatigability	O
,	O
the	O
force	O
response	O
to	O
repetitive	O
stimulation	O
of	O
isolated	O
soleus	O
muscle	O
was	O
determined	O
.	O

The	O
capacity	O
to	O
generate	O
force	O
following	O
a	O
series	O
of	O
tetani	O
is	O
dependent	O
upon	O
mitochondrial	O
ATP	B-CHEBI
production	O
.	O

During	O
the	O
initial	O
phase	O
of	O
the	O
stimulation	O
period	O
,	O
there	O
was	O
no	O
difference	O
in	O
force	O
generation	O
in	O
muscles	O
isolated	O
from	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
and	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
controls	O
.	O

However	O
,	O
fatigue	O
resistance	O
index	O
,	O
defined	O
as	O
the	O
percent	O
of	O
initial	O
force	O
generated	O
following	O
a	O
2	O
-	O
min	O
series	O
of	O
fatiguing	O
contractions	O
,	O
was	O
significantly	O
lower	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
14	O
.	O
6	O
+/-	O
1	O
.	O
5	O
%	O
)	O
compared	O
to	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
controls	O
(	O
24	O
.	O
8	O
+/-	O
2	O
.	O
9	O
%	O
)	O
(	O
Figure	O
4C	O
)	O
.	O

These	O
results	O
,	O
together	O
with	O
the	O
observed	O
abnormalities	O
in	O
skeletal	O
muscle	O
mitochondrial	O
structure	O
and	O
function	O
,	O
indicate	O
that	O
PGC	O
-	O
1	O
alpha	O
is	O
necessary	O
for	O
functional	O
adaptation	O
of	O
skeletal	O
muscle	O
to	O
physiologic	O
demands	O
.	O

Functional	O
Abnormalities	O
in	O
Hearts	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O

PGC	O
-	O
1	O
alpha	O
expression	O
is	O
enriched	O
in	O
heart	O
,	O
a	O
tissue	O
that	O
relies	O
heavily	O
on	O
mitochondrial	O
energy	O
metabolism	O
to	O
maintain	O
pump	O
function	O
throughout	O
the	O
postnatal	O
life	O
of	O
the	O
mammalian	O
organism	O
.	O

Echocardiographic	O
screening	O
studies	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
at	O
ages	O
4	O
-	O
6	O
mo	O
did	O
not	O
reveal	O
any	O
significant	O
differences	O
in	O
chamber	O
sizes	O
or	O
ventricular	O
function	O
compared	O
to	O
WT	O
controls	O
(	O
unpublished	O
data	O
)	O
.	O

Cardiac	O
functional	O
and	O
metabolic	O
reserve	O
was	O
evaluated	O
using	O
exercise	O
echocardiographic	O
stress	O
testing	O
(	O
EST	O
)	O
.	O

Given	O
that	O
the	O
exercise	O
capacity	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
is	O
diminished	O
,	O
a	O
series	O
of	O
preliminary	O
treadmill	O
exercise	O
studies	O
were	O
performed	O
to	O
define	O
a	O
reasonable	O
exercise	O
duration	O
for	O
run	O
-	O
to	O
-	O
exhaustion	O
to	O
be	O
used	O
as	O
a	O
target	O
duration	O
for	O
the	O
EST	O
.	O

Based	O
on	O
the	O
results	O
of	O
these	O
studies	O
,	O
an	O
EST	O
regimen	O
was	O
performed	O
in	O
which	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
control	O
animals	O
were	O
exercised	O
for	O
a	O
duration	O
of	O
60	O
s	O
to	O
match	O
the	O
predicted	O
average	O
for	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
ages	O
6	O
-	O
8	O
mo	O
)	O
.	O

Echocardiographic	O
images	O
were	O
obtained	O
immediately	O
following	O
60	O
s	O
of	O
exercise	O
for	O
the	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
controls	O
or	O
at	O
the	O
point	O
of	O
exhaustion	O
for	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
mean	O
60	O
+/-	O
6	O
.	O
1	O
s	O
,	O
range	O
45	O
-	O
90	O
s	O
)	O
.	O

Echocardiographic	O
-	O
determined	O
left	O
ventricular	O
fractional	O
shortening	O
and	O
heart	O
rate	O
were	O
monitored	O
for	O
the	O
10	O
-	O
min	O
period	O
immediately	O
post	O
exercise	O
.	O

The	O
mean	O
heart	O
rate	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
exhibited	O
an	O
inappropriate	O
decline	O
during	O
the	O
post	O
exercise	O
period	O
(	O
Figure	O
5A	O
)	O
.	O

In	O
addition	O
,	O
echocardiographically	O
determined	O
left	O
ventricular	O
fractional	O
shortening	O
was	O
decreased	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
,	O
but	O
not	O
the	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O
during	O
the	O
first	O
4	O
min	O
of	O
the	O
post	O
exercise	O
period	O
(	O
Figure	O
5A	O
)	O
.	O

The	O
results	O
of	O
the	O
EST	O
did	O
not	O
distinguish	O
between	O
a	O
primary	O
cardiac	O
abnormality	O
versus	O
effects	O
secondary	O
to	O
the	O
exhaustion	O
caused	O
by	O
reduced	O
exercise	O
tolerance	O
related	O
to	O
skeletal	O
muscle	O
dysfunction	O
.	O

To	O
directly	O
assess	O
cardiac	O
function	O
,	O
the	O
hearts	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
and	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O
were	O
isolated	O
and	O
perfused	O
in	O
the	O
working	O
mode	O
.	O

Hearts	O
isolated	O
from	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
generated	O
lower	O
cardiac	O
work	O
(	O
cardiac	O
output	O
multiplied	O
by	O
peak	O
systolic	O
pressure	O
)	O
compared	O
to	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O
at	O
identical	O
loading	O
conditions	O
(	O
Table	O
1	O
)	O
.	O

This	O
reduction	O
in	O
cardiac	O
work	O
was	O
due	O
to	O
a	O
reduced	O
cardiac	O
output	O
(	O
Table	O
1	O
)	O
.	O

The	O
relative	O
contribution	O
of	O
heart	O
rate	O
and	O
stroke	O
volume	O
to	O
diminished	O
cardiac	O
output	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
could	O
not	O
be	O
delineated	O
,	O
because	O
both	O
were	O
decreased	O
but	O
neither	O
to	O
a	O
significant	O
degree	O
(	O
Table	O
1	O
)	O
.	O

To	O
further	O
distinguish	O
between	O
abnormalities	O
in	O
heart	O
rate	O
and	O
ventricular	O
function	O
,	O
in	O
vivo	O
hemodynamic	O
response	O
to	O
the	O
beta	O
1	O
,	O
alpha	O
1	O
-	O
adrenergic	B-CHEBI
-	I-CHEBI
selective	I-CHEBI
agonist	I-CHEBI
dobutamine	O
was	O
evaluated	O
using	O
a	O
miniaturized	O
Millar	O
catheter	O
.	O

The	O
ventricular	O
functional	O
response	O
to	O
dobutamine	O
was	O
similar	O
in	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
Figure	O
5B	O
,	O
right	O
graph	O
)	O
.	O

However	O
,	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
exhibited	O
a	O
significantly	O
blunted	O
heart	O
rate	O
response	O
to	O
beta	O
-	O
adrenergic	O
stimulation	O
(	O
Figure	O
5B	O
,	O
left	O
graph	O
)	O
.	O

Taken	O
together	O
with	O
the	O
EST	O
,	O
these	O
results	O
strongly	O
suggest	O
that	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
hearts	O
are	O
unable	O
to	O
mount	O
an	O
appropriate	O
chronotropic	O
response	O
to	O
exercise	O
and	O
other	O
physiologic	O
stimuli	O
that	O
activate	O
beta	O
-	O
adrenergic	O
input	O
to	O
the	O
heart	O
.	O

However	O
,	O
our	O
results	O
did	O
not	O
reveal	O
evidence	O
for	O
contractile	O
dysfunction	O
.	O

PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O
Exhibit	O
an	O
Abnormal	O
Thermogenic	O
Response	O

PGC	O
-	O
1	O
alpha	O
has	O
been	O
implicated	O
as	O
an	O
inducible	O
regulator	O
of	O
mitochondrial	O
respiratory	O
uncoupling	O
,	O
an	O
important	O
source	O
of	O
heat	O
production	O
in	O
BAT	O
[	O
2	O
]	O
.	O

To	O
determine	O
whether	O
PGC	O
-	O
1	O
alpha	O
is	O
necessary	O
for	O
an	O
appropriate	O
thermogenic	O
response	O
,	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
were	O
subjected	O
to	O
cold	O
exposure	O
(	O
4	O
degrees	O
C	O
)	O
for	O
a	O
5	O
-	O
h	O
period	O
while	O
core	O
body	O
temperature	O
was	O
monitored	O
.	O

PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
exhibited	O
a	O
markedly	O
abnormal	O
drop	O
in	O
core	O
temperature	O
compared	O
to	O
the	O
WT	O
controls	O
(	O
Figure	O
6A	O
)	O
.	O

Specifically	O
,	O
the	O
mean	O
decline	O
in	O
core	O
temperature	O
was	O
greater	O
than	O
12	O
degrees	O
C	O
at	O
the	O
5	O
-	O
h	O
time	O
point	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
,	O
compared	O
to	O
an	O
approximately	O
3	O
degrees	O
C	O
decrement	O
in	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
controls	O
.	O

Although	O
this	O
thermogenic	O
phenotype	O
was	O
consistently	O
present	O
in	O
mice	O
aged	O
28	O
-	O
37	O
d	O
,	O
it	O
was	O
absent	O
in	O
older	O
mice	O
(	O
unpublished	O
data	O
)	O
.	O

The	O
histologic	O
appearance	O
and	O
neutral	O
lipid	B-CHEBI
stores	O
of	O
BAT	O
were	O
assessed	O
as	O
an	O
initial	O
step	O
to	O
characterize	O
the	O
thermogenic	O
phenotype	O
exhibited	O
by	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

Histologic	O
and	O
lipid	B-CHEBI
quantification	O
studies	O
were	O
performed	O
.	O

Electron	B-CHEBI
microscopic	O
analyses	O
indicated	O
that	O
the	O
mitochondrial	O
ultrastructure	O
was	O
similar	O
in	O
BAT	O
isolated	O
from	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
and	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O
before	O
and	O
after	O
cold	O
exposure	O
(	O
unpublished	O
data	O
)	O
.	O

In	O
addition	O
,	O
levels	O
of	O
BAT	O
triglyceride	B-CHEBI
were	O
similar	O
between	O
the	O
two	O
genotypes	O
(	O
unpublished	O
data	O
)	O
.	O

UCP	O
-	O
1	O
is	O
a	O
cold	O
-	O
inducible	O
protein	B-CHEBI
involved	O
in	O
mitochondrial	O
respiratory	O
uncoupling	O
to	O
generate	O
heat	O
in	O
BAT	O
.	O

UCP	O
-	O
1	O
gene	O
transcription	O
is	O
known	O
to	O
be	O
activated	O
by	O
PGC	O
-	O
1	O
alpha	O
[	O
2	O
]	O
.	O

Surprisingly	O
,	O
basal	O
and	O
cold	O
-	O
induced	O
BAT	O
UCP	O
-	O
1	O
mRNA	B-CHEBI
levels	O
were	O
similar	O
in	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
Figure	O
6B	O
)	O
.	O

These	O
results	O
suggest	O
that	O
PGC	O
-	O
1	O
alpha	O
is	O
not	O
necessary	O
for	O
the	O
induction	O
of	O
the	O
expression	O
of	O
UCP	O
-	O
1	O
with	O
cold	O
exposure	O
,	O
and	O
that	O
other	O
factors	O
,	O
such	O
as	O
reduced	O
capacity	O
for	O
mitochondrial	O
respiration	O
,	O
likely	O
contribute	O
to	O
the	O
abnormal	O
thermogenic	O
response	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

Thermogenesis	O
in	O
rodents	O
related	O
to	O
mitochondrial	O
uncoupling	O
is	O
under	O
the	O
control	O
of	O
beta	O
3	O
-	O
adrenergic	O
receptor	O
coupled	O
signaling	O
.	O

Accordingly	O
,	O
the	O
in	O
vivo	O
oxygen	B-CHEBI
consumption	O
response	O
to	O
beta	O
3	O
-	O
adrenergic	O
stimulation	O
was	O
examined	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

For	O
these	O
experiments	O
,	O
VO2	O
(	O
oxygen	B-CHEBI
consumption	O
)	O
was	O
measured	O
following	O
administration	O
of	O
the	O
beta	O
3	O
-	O
agonist	B-CHEBI
BRL	O
37344	O
using	O
indirect	O
calorimetry	O
.	O

VO2	O
was	O
significantly	O
increased	O
in	O
response	O
to	O
BRL	O
3744	O
in	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
but	O
not	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
Figure	O
6C	O
)	O
.	O

These	O
results	O
indicate	O
that	O
the	O
metabolic	O
response	O
of	O
BAT	O
to	O
an	O
acute	O
stimulus	O
such	O
as	O
cold	O
and	O
/	O
or	O
beta	O
3	O
-	O
adrenergic	O
stimulation	O
is	O
altered	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
null	O
mice	O
,	O
likely	O
related	O
to	O
reduced	O
capacity	O
for	O
mitochondrial	O
respiratory	O
uncoupling	O
.	O

Fasting	O
-	O
Induced	O
Hepatic	O
Steatosis	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O

Previous	O
studies	O
have	O
implicated	O
PGC	O
-	O
1	O
alpha	O
in	O
several	O
hepatic	O
metabolic	O
functions	O
including	O
fatty	B-CHEBI
acid	I-CHEBI
oxidation	O
and	O
gluconeogenesis	O
[	O
18	O
,	O
19	O
,	O
20	O
,	O
21	O
]	O
.	O

Accordingly	O
,	O
the	O
hepatic	O
phenotype	O
was	O
evaluated	O
under	O
basal	O
conditions	O
and	O
following	O
a	O
24	O
-	O
h	O
fast	O
,	O
a	O
stimulus	O
known	O
to	O
induce	O
fatty	B-CHEBI
acid	I-CHEBI
oxidation	O
and	O
gluconeogenic	O
rates	O
in	O
liver	O
.	O

Under	O
basal	O
fed	O
conditions	O
,	O
the	O
livers	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
appeared	O
grossly	O
normal	O
and	O
did	O
not	O
exhibit	O
histologic	O
abnormalities	O
(	O
unpublished	O
data	O
)	O
.	O

However	O
,	O
following	O
a	O
24	O
h	O
-	O
fast	O
,	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
exhibited	O
marked	O
hepatic	O
steatosis	O
as	O
determined	O
by	O
gross	O
inspection	O
,	O
oil	O
red	O
O	O
staining	O
,	O
electron	B-CHEBI
microscopy	O
,	O
and	O
measurements	O
of	O
liver	O
triglyceride	B-CHEBI
(	O
TAG	B-CHEBI
)	O
levels	O
(	O
Figure	O
7	O
)	O
.	O

There	O
were	O
no	O
differences	O
in	O
plasma	O
triglycerides	B-CHEBI
or	O
free	O
fatty	B-CHEBI
acids	I-CHEBI
between	O
the	O
genotypes	O
in	O
fed	O
or	O
fasted	O
states	O
(	O
unpublished	O
data	O
)	O
.	O

To	O
further	O
investigate	O
the	O
mechanisms	O
involved	O
in	O
the	O
fasting	O
-	O
induced	O
hepatic	O
steatotic	O
response	O
,	O
hepatocytes	O
were	O
isolated	O
from	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
and	O
WT	O
controls	O
.	O

Oleate	B-CHEBI
loading	O
experiments	O
revealed	O
that	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
hepatocytes	O
accumulated	O
neutral	O
lipid	B-CHEBI
to	O
a	O
significantly	O
greater	O
extent	O
than	O
the	O
WT	O
cells	O
(	O
Figure	O
8A	O
)	O
.	O

3H	B-CHEBI
-	O
palmitate	B-CHEBI
oxidation	O
rates	O
were	O
significantly	O
lower	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
hepatocytes	O
compared	O
to	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
hepatocytes	O
under	O
basal	O
conditions	O
and	O
following	O
exposure	O
to	O
oleate	B-CHEBI
(	O
Figure	O
8B	O
)	O
.	O

Taken	O
together	O
,	O
these	O
latter	O
results	O
indicate	O
a	O
cell	O
-	O
autonomous	O
defect	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
hepatocytes	O
that	O
results	O
in	O
an	O
inability	O
to	O
maintain	O
cellular	O
lipid	B-CHEBI
balance	O
in	O
the	O
context	O
of	O
increased	O
delivery	O
of	O
lipid	B-CHEBI
such	O
as	O
occurs	O
with	O
fasting	O
.	O

PPAR	O
,	O
a	O
known	O
regulator	O
of	O
hepatic	O
mitochondrial	O
fatty	B-CHEBI
acid	I-CHEBI
oxidation	O
enzyme	O
gene	O
expression	O
,	O
is	O
a	O
target	O
for	O
coactivation	O
by	O
PGC	O
-	O
1	O
alpha	O
[	O
31	O
]	O
.	O

Therefore	O
,	O
we	O
sought	O
to	O
determine	O
whether	O
the	O
steatotic	O
phenotype	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
related	O
to	O
reduced	O
expression	O
of	O
PPAR	O
target	O
genes	O
.	O

To	O
this	O
end	O
,	O
a	O
survey	O
of	O
candidate	O
genes	O
and	O
gene	O
expression	O
profiling	O
experiments	O
were	O
performed	O
.	O

Surprisingly	O
,	O
the	O
hepatic	O
expression	O
of	O
PPAR	O
target	O
genes	O
involved	O
in	O
cellular	O
fatty	B-CHEBI
acid	I-CHEBI
and	O
oxidation	O
(	O
MCPT	O
and	O
MCAD	O
)	O
were	O
not	O
significantly	O
different	O
between	O
the	O
genotypes	O
under	O
fed	O
or	O
fasted	O
conditions	O
(	O
Table	O
2	O
)	O
.	O

Next	O
,	O
we	O
performed	O
experiments	O
to	O
determine	O
whether	O
the	O
reduced	O
capacity	O
for	O
fat	O
oxidation	O
in	O
the	O
hepatocytes	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
was	O
related	O
to	O
altered	O
mitochondrial	O
respiratory	O
function	O
.	O

Compared	O
to	O
the	O
WT	O
controls	O
,	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
hepatocytes	O
exhibited	O
a	O
modest	O
but	O
significant	O
reduction	O
in	O
both	O
state	O
2	O
and	O
state	O
3	O
respiration	O
rates	O
(	O
Figure	O
8C	O
)	O
.	O

These	O
results	O
identify	O
one	O
potential	O
mechanism	O
responsible	O
for	O
the	O
fasting	O
-	O
induced	O
hepatic	O
steatosis	O
:	O
reduced	O
capacity	O
for	O
fat	O
oxidation	O
due	O
to	O
mitochondrial	O
respiratory	O
dysfunction	O
.	O

Although	O
the	O
liver	O
gene	O
expression	O
profiling	O
studies	O
did	O
not	O
reveal	O
abnormalities	O
in	O
the	O
fatty	B-CHEBI
acid	I-CHEBI
oxidation	O
pathway	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
,	O
several	O
interesting	O
differences	O
in	O
the	O
activity	O
of	O
the	O
sterol	B-CHEBI
regulatory	O
element	O
binding	O
protein	B-CHEBI
-	O
1c	O
(	O
SREBP	O
-	O
1c	O
)	O
pathway	O
were	O
noted	O
.	O

Specifically	O
,	O
the	O
fasting	O
-	O
mediated	O
down	O
-	O
regulation	O
of	O
SREBP	O
-	O
1c	O
and	O
its	O
target	O
gene	O
stearoyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
desaturase	O
(	O
SCD1	O
)	O
,	O
was	O
abolished	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
Table	O
2	O
)	O
.	O

Furthermore	O
,	O
expression	O
of	O
the	O
gene	O
encoding	O
diglyceride	B-CHEBI
acyltransferase	O
(	O
DGAT	O
)	O
,	O
which	O
catalyzes	O
the	O
last	O
step	O
in	O
TAG	B-CHEBI
synthesis	O
,	O
was	O
activated	O
at	O
baseline	O
and	O
induced	O
by	O
fasting	O
to	O
a	O
greater	O
level	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
Table	O
2	O
)	O
.	O

These	O
results	O
suggest	O
that	O
,	O
in	O
addition	O
to	O
a	O
defect	O
in	O
oxidation	O
,	O
components	O
of	O
the	O
TAG	B-CHEBI
synthesis	O
pathway	O
are	O
activated	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

To	O
evaluate	O
this	O
possibility	O
directly	O
,	O
rates	O
of	O
3H	B-CHEBI
-	O
glycerol	B-CHEBI
incorporation	O
into	O
TAG	B-CHEBI
were	O
determined	O
in	O
isolated	O
hepatocytes	O
.	O

3H	B-CHEBI
-	O
TAG	B-CHEBI
incorporation	O
was	O
increased	O
nearly	O
50	O
%	O
in	O
hepatocytes	O
isolated	O
from	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
compared	O
to	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
controls	O
(	O
Figure	O
8D	O
)	O
,	O
confirming	O
that	O
TAG	B-CHEBI
synthesis	O
rates	O
are	O
increased	O
in	O
PGC	O
-	O
1	O
alpha	O
null	O
hepatocytes	O
,	O
identifying	O
a	O
second	O
potential	O
mechanism	O
contributing	O
to	O
the	O
fasting	O
-	O
induced	O
hepatic	O
steatosis	O
.	O

Despite	O
a	O
Mild	O
Obese	O
Phenotype	O
,	O
Female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O
Do	O
Not	O
Exhibit	O
Insulin	B-CHEBI
Resistance	O

Recent	O
studies	O
have	O
suggested	O
that	O
specific	O
PGC	O
-	O
1	O
alpha	O
single	O
nucleotide	B-CHEBI
polymorphisms	O
and	O
haplotypes	O
may	O
influence	O
the	O
development	O
of	O
insulin	B-CHEBI
resistance	O
and	O
diabetes	O
[	O
27	O
,	O
30	O
]	O
and	O
that	O
PGC	O
-	O
1	O
activity	O
is	O
diminished	O
in	O
insulin	B-CHEBI
-	O
resistant	O
and	O
diabetic	O
muscle	O
[	O
22	O
,	O
23	O
]	O
.	O

Accordingly	O
,	O
peripheral	O
glucose	B-CHEBI
disposal	O
and	O
insulin	B-CHEBI
responsiveness	O
were	O
examined	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

Glucose	B-CHEBI
tolerance	O
testing	O
of	O
2	O
-	O
mo	O
-	O
old	O
male	O
and	O
female	O
mice	O
revealed	O
no	O
significant	O
difference	O
in	O
blood	O
glucose	B-CHEBI
excursion	O
between	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
groups	O
(	O
unpublished	O
data	O
)	O
.	O

Given	O
that	O
older	O
female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
develop	O
an	O
increase	O
in	O
body	O
fat	O
stores	O
,	O
glucose	B-CHEBI
tolerance	O
and	O
insulin	B-CHEBI
responsiveness	O
were	O
further	O
evaluated	O
in	O
this	O
group	O
.	O

Glucose	B-CHEBI
tolerance	O
testing	O
in	O
4	O
.	O
5	O
-	O
mo	O
-	O
old	O
female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
revealed	O
that	O
,	O
despite	O
increased	O
body	O
weight	O
[	O
mean	O
+/-	O
standard	O
error	O
of	O
the	O
mean	O
(	O
SEM	O
)	O
weight	O
of	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O
=	O
22	O
.	O
4	O
+/-	O
0	O
.	O
79	O
g	O
;	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
=	O
25	O
.	O
2	O
+/-	O
1	O
.	O
04	O
g	O
)	O
,	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
exhibited	O
similar	O
levels	O
of	O
glucose	B-CHEBI
tolerance	O
compared	O
to	O
WT	O
mice	O
on	O
standard	O
rodent	O
chow	B-CHEBI
(	O
Figure	O
9	O
)	O
.	O

To	O
examine	O
glucose	B-CHEBI
homeostasis	O
in	O
response	O
to	O
high	O
-	O
fat	O
diet	O
,	O
female	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
were	O
placed	O
on	O
high	O
-	O
fat	O
chow	B-CHEBI
(	O
43	O
%	O
calories	O
from	O
fat	O
)	O
for	O
6	O
wk	O
starting	O
at	O
8	O
wk	O
of	O
age	O
.	O

The	O
weight	O
gained	O
on	O
the	O
high	O
-	O
fat	O
diet	O
was	O
similar	O
for	O
the	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
groups	O
(	O
Figure	O
S3	O
)	O
.	O

Surprisingly	O
,	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
on	O
a	O
high	O
-	O
fat	O
diet	O
were	O
significantly	O
more	O
glucose	B-CHEBI
-	O
tolerant	O
and	O
insulin	B-CHEBI
-	O
sensitive	O
compared	O
to	O
the	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O
(	O
Figure	O
9B	O
)	O
.	O

Taken	O
together	O
,	O
these	O
results	O
indicate	O
that	O
,	O
despite	O
excess	O
body	O
fat	O
under	O
standard	O
conditions	O
,	O
the	O
female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
do	O
not	O
exhibit	O
insulin	B-CHEBI
resistance	O
.	O

Moreover	O
,	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
are	O
more	O
glucose	B-CHEBI
-	O
tolerant	O
and	O
insulin	B-CHEBI
-	O
sensitive	O
than	O
WT	O
mice	O
on	O
a	O
high	O
-	O
fat	O
diet	O
.	O

Structural	O
Abnormalities	O
of	O
the	O
Central	O
Nervous	O
System	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O

In	O
surveying	O
the	O
tissues	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
,	O
structural	O
abnormalities	O
of	O
the	O
brain	O
were	O
observed	O
.	O

Light	O
microscopic	O
examination	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
brain	O
tissue	O
samples	O
demonstrated	O
a	O
well	O
-	O
preserved	O
cerebral	O
cortical	O
neuronal	O
complement	O
,	O
a	O
result	O
confirmed	O
by	O
measurement	O
of	O
neuron	O
density	O
in	O
sections	O
of	O
the	O
parietal	O
lobe	O
(	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
,	O
1	O
,	O
261	O
+/-	O
91	O
neurons	O
/	O
mm2	O
versus	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
,	O
1	O
,	O
299	O
+/-	O
82	O
neurons	O
/	O
mm2	O
;	O
not	O
significant	O
)	O
.	O

Patchy	O
areas	O
of	O
microvacuolation	O
involving	O
the	O
neuropil	O
and	O
individual	O
pyramidal	O
neurons	O
of	O
the	O
deep	O
layers	O
of	O
the	O
cerebral	O
cortex	O
were	O
noted	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
but	O
not	O
the	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O
(	O
Figure	O
10A	O
)	O
.	O

Immunolocalization	O
of	O
an	O
astrocytic	O
marker	O
,	O
glial	O
fibrillary	O
acidic	B-CHEBI
protein	B-CHEBI
,	O
failed	O
to	O
show	O
an	O
increase	O
in	O
numbers	O
of	O
astrocytic	O
processes	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mouse	O
cerebral	O
cortex	O
(	O
unpublished	O
data	O
)	O
.	O

The	O
hippocampus	O
also	O
showed	O
neuronal	O
microvacuolation	O
,	O
albeit	O
to	O
a	O
lesser	O
degree	O
than	O
the	O
parietal	O
cortex	O
.	O

Microvacuolation	O
of	O
the	O
neuropil	O
and	O
neurons	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
basal	O
ganglia	O
(	O
caudate	O
and	O
putamen	O
)	O
was	O
also	O
noted	O
in	O
association	O
with	O
a	O
patchy	O
increase	O
in	O
the	O
number	O
and	O
intensity	O
of	O
glial	O
fibrillary	O
acidic	B-CHEBI
protein	B-CHEBI
-	O
immunoreactive	O
astrocytic	O
processes	O
(	O
unpublished	O
data	O
)	O
.	O

Areas	O
of	O
microvacuolation	O
also	O
involved	O
multiple	O
brainstem	O
regions	O
.	O

Only	O
rare	O
vacuolated	O
Purkinje	O
and	O
granule	O
cell	O
neurons	O
were	O
identified	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
cerebellar	O
cortex	O
.	O

Neither	O
microglial	O
proliferation	O
nor	O
perivascular	O
lymphocytic	O
inflammatory	O
infiltrates	O
were	O
noted	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
CNS	O
.	O

Ultrastructural	O
examination	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
parietal	O
cerebral	O
cortex	O
confirmed	O
the	O
presence	O
of	O
microvacuolated	O
neurons	O
and	O
neuropil	O
(	O
Figure	O
10B	O
)	O
.	O

Vacuoles	O
containing	O
aggregates	O
of	O
membranous	O
material	O
were	O
present	O
in	O
a	O
subset	O
of	O
cortical	O
neurons	O
.	O

Subcellular	O
localization	O
of	O
the	O
vacuoles	O
was	O
difficult	O
to	O
establish	O
;	O
some	O
may	O
represent	O
vacuolated	O
elements	O
of	O
the	O
neuropil	O
,	O
material	O
in	O
phagocytic	O
cells	O
,	O
presynaptic	O
nerve	O
terminals	O
compressing	O
the	O
soma	O
,	O
or	O
genuine	O
intraperikaryal	O
deposits	O
.	O

Discussion	O

Previous	O
studies	O
using	O
gain	O
-	O
of	O
-	O
function	O
strategies	O
have	O
shown	O
that	O
the	O
coactivator	O
PGC	O
-	O
1	O
alpha	O
is	O
capable	O
of	O
coactivating	O
an	O
array	O
of	O
transcription	O
factors	O
involved	O
in	O
energy	O
metabolic	O
processes	O
including	O
fatty	B-CHEBI
acid	I-CHEBI
oxidation	O
,	O
electron	B-CHEBI
transport	O
,	O
and	O
oxidative	O
phosphorylation	O
[	O
6	O
]	O
.	O

Forced	O
expression	O
of	O
PGC	O
-	O
1	O
alpha	O
triggers	O
mitochondrial	O
biogenesis	O
by	O
activating	O
a	O
complex	O
circuitry	O
of	O
factors	O
including	O
NRF	O
-	O
1	O
,	O
NRF	O
-	O
2	O
,	O
and	O
the	O
orphan	O
nuclear	O
receptor	O
estrogen	O
-	O
related	O
receptor	O
alpha	O
[	O
23	O
,	O
32	O
]	O
.	O

However	O
,	O
gain	O
-	O
of	O
-	O
function	O
strategies	O
cannot	O
determine	O
whether	O
PGC	O
-	O
1	O
alpha	O
is	O
essential	O
for	O
critical	O
energy	O
metabolic	O
processes	O
including	O
mitochondrial	O
biogenesis	O
and	O
function	O
.	O

Using	O
targeted	O
gene	O
deletion	O
in	O
mice	O
,	O
we	O
show	O
here	O
that	O
PGC	O
-	O
1	O
alpha	O
is	O
not	O
essential	O
for	O
normal	O
embryologic	O
development	O
or	O
the	O
fundamental	O
events	O
of	O
mitochondrial	O
biogenesis	O
.	O

However	O
,	O
several	O
lines	O
of	O
evidence	O
support	O
the	O
conclusion	O
that	O
PGC	O
-	O
1	O
alpha	O
is	O
necessary	O
for	O
the	O
programs	O
that	O
regulate	O
postnatal	O
mitochondrial	O
function	O
and	O
cellular	O
energy	O
metabolism	O
,	O
processes	O
that	O
equip	O
the	O
organism	O
for	O
the	O
energy	O
metabolic	O
rigors	O
of	O
the	O
postnatal	O
environment	O
.	O

First	O
,	O
mitochondrial	O
volume	O
density	O
is	O
diminished	O
in	O
slow	O
-	O
twitch	O
skeletal	O
muscle	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

Second	O
,	O
mitochondrial	O
respiratory	O
capacity	O
is	O
modestly	O
but	O
significantly	O
altered	O
in	O
skeletal	O
muscle	O
and	O
liver	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

Third	O
,	O
the	O
growth	O
of	O
heart	O
and	O
soleus	O
muscle	O
,	O
tissues	O
with	O
high	O
reliance	O
on	O
mitochondrial	O
energy	O
production	O
,	O
is	O
blunted	O
.	O

Fourth	O
,	O
control	O
of	O
body	O
fat	O
mass	O
is	O
abnormal	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

Finally	O
,	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
do	O
not	O
respond	O
normally	O
to	O
a	O
variety	O
of	O
physiologic	O
and	O
dietary	O
stresses	O
known	O
to	O
increase	O
oxidative	O
energy	O
demands	O
.	O

Taken	O
together	O
,	O
these	O
results	O
strongly	O
suggest	O
that	O
PGC	O
-	O
1	O
alpha	O
is	O
necessary	O
for	O
the	O
terminal	O
stages	O
of	O
mitochondrial	O
maturation	O
necessary	O
to	O
meet	O
the	O
energy	O
demands	O
of	O
the	O
postnatal	O
environment	O
.	O

Extensive	O
phenotypic	O
analyses	O
demonstrated	O
that	O
mice	O
lacking	O
PGC	O
-	O
1	O
alpha	O
are	O
unable	O
to	O
cope	O
with	O
physiologic	O
stressors	O
relevant	O
to	O
postnatal	O
survival	O
.	O

For	O
example	O
,	O
a	O
skeletal	O
muscle	O
phenotype	O
was	O
unveiled	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
under	O
conditions	O
in	O
which	O
energy	O
supply	O
becomes	O
limiting	O
.	O

This	O
was	O
most	O
clearly	O
demonstrated	O
by	O
the	O
profound	O
abnormalities	O
exhibited	O
by	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
with	O
exercise	O
-	O
to	O
-	O
exhaustion	O
and	O
repetitive	O
muscle	O
stimulation	O
studies	O
.	O

Similarly	O
,	O
cardiac	O
performance	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
was	O
compromised	O
following	O
severe	O
exertion	O
.	O

This	O
effect	O
was	O
largely	O
due	O
to	O
an	O
abnormal	O
heart	O
rate	O
response	O
.	O

The	O
basis	O
for	O
the	O
observed	O
abnormalities	O
of	O
cardiac	O
heart	O
rate	O
,	O
including	O
a	O
blunted	O
response	O
to	O
beta	O
-	O
adrenergic	O
stimulation	O
,	O
is	O
unknown	O
,	O
but	O
could	O
be	O
related	O
to	O
the	O
effects	O
of	O
late	O
-	O
stage	O
growth	O
arrest	O
and	O
corresponding	O
derangements	O
in	O
energy	O
metabolism	O
on	O
sinus	O
node	O
function	O
.	O

PGC	O
-	O
1	O
alpha	O
was	O
first	O
identified	O
as	O
a	O
coactivator	O
in	O
BAT	O
[	O
2	O
]	O
.	O

Indeed	O
,	O
we	O
found	O
that	O
exposure	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
to	O
cold	O
,	O
another	O
relevant	O
physiologic	O
stress	O
,	O
resulted	O
in	O
an	O
untoward	O
drop	O
in	O
core	O
body	O
temperature	O
consistent	O
with	O
an	O
abnormality	O
in	O
thermogenesis	O
despite	O
normal	O
cold	O
induction	O
of	O
UCP	O
-	O
1	O
mRNA	B-CHEBI
in	O
BAT	O
.	O

Studies	O
with	O
a	O
beta	O
3	O
-	O
adrenergic	B-CHEBI
agonist	I-CHEBI
confirmed	O
that	O
the	O
peak	O
oxygen	B-CHEBI
consumption	O
rate	O
in	O
thermogenic	O
tissue	O
is	O
diminished	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

We	O
propose	O
that	O
the	O
thermogenic	O
phenotype	O
is	O
related	O
to	O
reduced	O
capacity	O
for	O
mitochondrial	O
respiration	O
in	O
BAT	O
.	O

Interestingly	O
,	O
this	O
phenotype	O
was	O
only	O
evident	O
during	O
a	O
rather	O
narrow	O
window	O
of	O
postnatal	O
life	O
.	O

Animals	O
at	O
an	O
older	O
age	O
did	O
not	O
exhibit	O
cold	O
intolerance	O
,	O
possibly	O
due	O
to	O
the	O
insulating	O
properties	O
of	O
increased	O
body	O
mass	O
.	O

Collectively	O
,	O
these	O
results	O
demonstrate	O
the	O
importance	O
of	O
PGC	O
-	O
1	O
alpha	O
as	O
a	O
key	O
transducer	O
of	O
physiologic	O
stimuli	O
to	O
the	O
control	O
of	O
energy	O
metabolism	O
.	O

The	O
observation	O
of	O
fasting	O
-	O
induced	O
hepatic	O
steatosis	O
is	O
another	O
example	O
of	O
the	O
inability	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
to	O
respond	O
to	O
postnatal	O
environmental	O
metabolic	O
demands	O
.	O

Following	O
short	O
-	O
term	O
starvation	O
,	O
we	O
found	O
that	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
developed	O
marked	O
hepatocyte	O
triglyceride	B-CHEBI
accumulation	O
.	O

Further	O
analysis	O
revealed	O
that	O
palmitate	B-CHEBI
oxidation	O
rates	O
were	O
reduced	O
in	O
hepatocytes	O
isolated	O
from	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
,	O
which	O
would	O
predispose	O
to	O
lipid	B-CHEBI
accumulation	O
.	O

Surprisingly	O
,	O
the	O
reduction	O
in	O
fatty	B-CHEBI
acid	I-CHEBI
oxidation	O
rates	O
in	O
PGC	O
-	O
1	O
alpha	O
null	O
hepatocytes	O
was	O
not	O
due	O
to	O
altered	O
expression	O
of	O
PGC	O
-	O
1	O
alpha	O
/	O
PPAR	O
target	O
genes	O
involved	O
in	O
mitochondrial	O
fatty	B-CHEBI
acid	I-CHEBI
oxidation	O
.	O

However	O
,	O
mitochondrial	O
respiratory	O
rates	O
were	O
diminished	O
.	O

In	O
addition	O
,	O
we	O
found	O
that	O
triglyceride	B-CHEBI
synthesis	O
was	O
abnormally	O
activated	O
,	O
and	O
the	O
expression	O
of	O
genes	O
encoding	O
SREBP	O
-	O
1c	O
and	O
SCD	O
-	O
1	O
,	O
key	O
proteins	B-CHEBI
in	O
the	O
hepatic	O
lipogenic	O
pathway	O
,	O
failed	O
to	O
be	O
appropriately	O
down	O
-	O
regulated	O
in	O
fasted	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

The	O
mechanism	O
involved	O
in	O
this	O
latter	O
finding	O
is	O
unknown	O
.	O

Indeed	O
,	O
the	O
relative	O
contribution	O
of	O
increased	O
triglyceride	B-CHEBI
synthesis	O
rates	O
to	O
the	O
steatotic	O
phenotype	O
cannot	O
be	O
fully	O
discerned	O
from	O
our	O
data	O
,	O
given	O
that	O
this	O
response	O
could	O
reflect	O
the	O
direct	O
effects	O
of	O
PGC	O
-	O
1	O
alpha	O
deficiency	O
on	O
target	O
genes	O
or	O
a	O
secondary	O
compensatory	O
response	O
to	O
hepatocyte	O
fatty	B-CHEBI
acid	I-CHEBI
accumulation	O
.	O

Consistent	O
with	O
the	O
former	O
possibility	O
,	O
recent	O
evidence	O
indicates	O
that	O
PGC	O
-	O
1	O
alpha	O
coactivates	O
the	O
nuclear	O
receptor	O
FXR	O
,	O
a	O
negative	O
regulator	O
of	O
SREBP	O
-	O
1c	O
expression	O
and	O
triglyceride	B-CHEBI
synthesis	O
[	O
33	O
]	O
.	O

We	O
conclude	O
that	O
reduced	O
hepatocyte	O
mitochondrial	O
respiratory	O
capacity	O
,	O
and	O
possibly	O
activation	O
of	O
lipogenic	O
programs	O
,	O
result	O
in	O
hepatocyte	O
triglyceride	B-CHEBI
accumulation	O
in	O
the	O
context	O
of	O
increased	O
hepatic	O
delivery	O
of	O
fatty	B-CHEBI
acids	I-CHEBI
such	O
as	O
occurs	O
with	O
fasting	O
.	O

We	O
found	O
that	O
after	O
18	O
wk	O
of	O
age	O
,	O
female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
exhibit	O
a	O
mild	O
but	O
significantly	O
abnormal	O
weight	O
increase	O
associated	O
with	O
increased	O
fat	O
stores	O
.	O

Lean	O
mass	O
was	O
unchanged	O
at	O
the	O
time	O
points	O
examined	O
.	O

With	O
further	O
aging	O
,	O
a	O
modest	O
but	O
significant	O
increase	O
in	O
body	O
fat	O
was	O
also	O
noted	O
in	O
male	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
unpublished	O
data	O
)	O
.	O

The	O
basis	O
for	O
the	O
observed	O
abnormalities	O
in	O
weight	O
control	O
is	O
unknown	O
.	O

We	O
did	O
not	O
find	O
differences	O
in	O
food	B-CHEBI
intake	O
or	O
activity	O
levels	O
in	O
female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

It	O
is	O
possible	O
that	O
a	O
reduction	O
in	O
systemic	O
energy	O
utilization	O
,	O
related	O
to	O
the	O
mitochondrial	O
dysfunction	O
,	O
leads	O
to	O
increased	O
fat	O
mass	O
and	O
weight	O
gain	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

Interestingly	O
,	O
an	O
association	O
between	O
PGC	O
-	O
1	O
alpha	O
gene	O
polymorphisms	O
and	O
obesity	O
in	O
humans	O
has	O
been	O
recently	O
reported	O
[	O
26	O
]	O
.	O

Clearly	O
,	O
future	O
studies	O
of	O
male	O
and	O
female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
in	O
pure	O
-	O
strain	O
backgrounds	O
over	O
a	O
range	O
of	O
ages	O
will	O
be	O
necessary	O
to	O
fully	O
investigate	O
the	O
observed	O
abnormalities	O
in	O
weight	O
control	O
and	O
fat	O
distribution	O
.	O

We	O
did	O
not	O
find	O
evidence	O
for	O
glucose	B-CHEBI
intolerance	O
or	O
insulin	B-CHEBI
resistance	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
animals	O
on	O
standard	O
chow	B-CHEBI
.	O

Moreover	O
,	O
female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
were	O
more	O
glucose	B-CHEBI
-	O
tolerant	O
and	O
insulin	B-CHEBI
-	O
sensitive	O
than	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
controls	O
when	O
consuming	O
a	O
high	O
-	O
fat	O
diet	O
.	O

These	O
findings	O
are	O
surprising	O
,	O
given	O
the	O
results	O
of	O
several	O
recent	O
studies	O
demonstrating	O
reduced	O
expression	O
of	O
PGC	O
-	O
1	O
alpha	O
in	O
human	O
diabetic	O
skeletal	O
muscle	O
[	O
24	O
,	O
34	O
]	O
.	O

It	O
is	O
certainly	O
possible	O
that	O
compensatory	O
metabolic	O
regulatory	O
mechanisms	O
have	O
been	O
activated	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
deficient	O
mice	O
,	O
accounting	O
for	O
this	O
observation	O
.	O

Alternatively	O
,	O
PGC	O
-	O
1	O
alpha	O
could	O
serve	O
as	O
a	O
coactivator	O
of	O
factors	O
that	O
mediate	O
diet	O
-	O
induced	O
insulin	B-CHEBI
resistance	O
.	O

Consistent	O
with	O
this	O
notion	O
,	O
we	O
and	O
others	O
have	O
shown	O
that	O
mice	O
lacking	O
the	O
PGC	O
-	O
1	O
alpha	O
target	O
PPAR	O
exhibit	O
resistance	O
to	O
diet	O
-	O
induced	O
glucose	B-CHEBI
intolerance	O
[	O
21	O
,	O
35	O
,	O
36	O
]	O
.	O

Histologic	O
surveys	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
revealed	O
ultrastructural	O
abnormalities	O
in	O
the	O
central	O
nervous	O
system	O
.	O

Inspection	O
of	O
sections	O
prepared	O
from	O
the	O
brains	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
revealed	O
patchy	O
areas	O
of	O
microvacuolation	O
in	O
the	O
pyramidal	O
neurons	O
of	O
the	O
cerebral	O
cortex	O
,	O
accompanied	O
by	O
a	O
mild	O
increase	O
in	O
the	O
number	O
of	O
astrocytes	O
in	O
the	O
basal	O
ganglia	O
.	O

The	O
basis	O
for	O
this	O
interesting	O
but	O
relatively	O
nonspecific	O
finding	O
is	O
unknown	O
.	O

It	O
is	O
possible	O
that	O
PGC	O
-	O
1	O
alpha	O
plays	O
an	O
important	O
role	O
in	O
lipid	B-CHEBI
metabolism	O
related	O
to	O
membrane	O
synthesis	O
.	O

Alternatively	O
,	O
the	O
normal	O
process	O
of	O
cellular	O
debris	O
turnover	O
could	O
be	O
altered	O
due	O
to	O
a	O
defect	O
in	O
the	O
energetics	O
of	O
the	O
microglial	O
component	O
of	O
the	O
central	O
nervous	O
system	O
.	O

Although	O
overt	O
neurologic	O
dysfunction	O
was	O
not	O
apparent	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
during	O
the	O
first	O
6	O
mo	O
of	O
life	O
(	O
no	O
group	O
differences	O
were	O
found	O
on	O
five	O
of	O
six	O
sensorimotor	O
tests	O
)	O
,	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
showed	O
clear	O
deficits	O
on	O
the	O
inverted	O
screen	O
test	O
.	O

These	O
deficits	O
are	O
likely	O
due	O
to	O
impaired	O
muscle	O
strength	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
,	O
but	O
contributions	O
by	O
peripheral	O
or	O
central	O
nervous	O
system	O
determinants	O
(	O
or	O
both	O
)	O
could	O
be	O
contributory	O
.	O

Moreover	O
,	O
evidence	O
of	O
altered	O
emotionality	O
from	O
the	O
1	O
-	O
h	O
locomotor	O
activity	O
test	O
also	O
suggests	O
the	O
possibility	O
of	O
altered	O
brain	O
function	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

It	O
will	O
be	O
of	O
interest	O
to	O
determine	O
whether	O
the	O
neurologic	O
abnormalities	O
contribute	O
to	O
the	O
systemic	O
metabolic	O
abnormalities	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
null	O
mice	O
.	O

During	O
the	O
preparation	O
of	O
this	O
manuscript	O
,	O
Lin	O
et	O
al	O
.	O
reported	O
an	O
independent	O
mouse	O
line	O
in	O
which	O
the	O
PGC	O
-	O
1	O
alpha	O
gene	O
was	O
targeted	O
[	O
37	O
]	O
.	O

Phenotypic	O
comparison	O
of	O
the	O
our	O
PGC	O
-	O
1	O
alpha	O
-	O
deficient	O
line	O
with	O
that	O
of	O
Lin	O
et	O
al	O
.	O
reveals	O
a	O
number	O
of	O
similarities	O
and	O
several	O
interesting	O
differences	O
.	O

Both	O
PGC	O
-	O
1	O
alpha	O
-	O
deficient	O
lines	O
exhibit	O
cold	O
intolerance	O
,	O
reduced	O
hepatocyte	O
respiration	O
rates	O
,	O
and	O
neurologic	O
lesions	O
.	O

However	O
,	O
a	O
number	O
of	O
interesting	O
differences	O
are	O
notable	O
.	O

First	O
,	O
in	O
contrast	O
to	O
Lin	O
et	O
al	O
.	O
,	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
described	O
here	O
do	O
not	O
exhibit	O
any	O
postnatal	O
mortality	O
.	O

Second	O
,	O
we	O
did	O
not	O
find	O
evidence	O
for	O
a	O
defect	O
in	O
gluconeogenesis	O
based	O
on	O
fasting	O
blood	O
glucose	B-CHEBI
levels	O
(	O
unpublished	O
data	O
)	O
.	O

In	O
addition	O
,	O
whereas	O
Lin	O
et	O
al	O
.	O
found	O
an	O
abnormal	O
expression	O
profile	O
forCCAAT	O
-	O
enhancer	O
-	O
binding	O
protein	B-CHEBI
beta	O
and	O
delta	O
and	O
the	O
gluconeogenic	O
genes	O
encoding	O
phosphoenolpyruvate	B-CHEBI
carboxykinase	O
and	O
glucose	B-CHEBI
-	O
6	O
-	O
phosphatase	O
at	O
baseline	O
and	O
with	O
fasting	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
,	O
we	O
did	O
not	O
(	O
unpublished	O
data	O
)	O
.	O

Third	O
,	O
we	O
found	O
evidence	O
for	O
an	O
age	O
-	O
related	O
increase	O
in	O
body	O
fat	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
females	O
earlier	O
than	O
males	O
)	O
,	O
whereas	O
Lin	O
et	O
al	O
.	O
identified	O
a	O
male	O
-	O
specific	O
resistance	O
to	O
diet	O
-	O
induced	O
obesity	O
and	O
insulin	B-CHEBI
resistance	O
.	O

We	O
have	O
also	O
found	O
that	O
male	O
PGC	O
-	O
1	O
alpha	O
-	O
deficient	O
mice	O
are	O
somewhat	O
protected	O
against	O
diet	O
-	O
induced	O
obesity	O
(	O
Figure	O
S4	O
)	O
.	O

However	O
,	O
we	O
observed	O
that	O
the	O
insulin	B-CHEBI
-	O
sensitive	O
phenotype	O
of	O
the	O
female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
occurred	O
in	O
the	O
context	O
of	O
normal	O
weight	O
gain	O
with	O
high	O
-	O
fat	O
diet	O
.	O

These	O
latter	O
results	O
indicate	O
that	O
the	O
insulin	B-CHEBI
-	O
sensitive	O
phenotype	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
cannot	O
be	O
fully	O
explained	O
by	O
a	O
lean	O
phenotype	O
.	O

Of	O
interest	O
,	O
mice	O
lacking	O
the	O
nuclear	O
receptor	O
estrogen	O
-	O
related	O
receptor	O
alpha	O
,	O
a	O
known	O
target	O
of	O
PGC	O
-	O
1	O
alpha	O
,	O
exhibit	O
resistance	O
to	O
diet	O
-	O
induced	O
obesity	O
similar	O
to	O
that	O
of	O
male	O
PGC	O
-	O
1	O
alpha	O
null	O
mice	O
[	O
38	O
]	O
.	O

Fourth	O
,	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
described	O
here	O
exhibit	O
a	O
dramatic	O
fasting	O
-	O
induced	O
hepatic	O
steatotic	O
phenotype	O
,	O
whereas	O
the	O
Lin	O
et	O
al	O
.	O
mouse	O
does	O
not	O
.	O

Fifth	O
,	O
Lin	O
et	O
al	O
.	O
found	O
a	O
neurologic	O
phenotype	O
in	O
males	O
characterized	O
by	O
hyperactivity	O
,	O
whereas	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
described	O
here	O
show	O
reduced	O
locomotor	O
activity	O
.	O

However	O
,	O
it	O
should	O
be	O
noted	O
that	O
we	O
did	O
not	O
study	O
activity	O
levels	O
over	O
an	O
extended	O
period	O
of	O
time	O
in	O
males	O
as	O
did	O
Lin	O
et	O
al	O
.	O
,	O
so	O
it	O
is	O
possible	O
that	O
our	O
findings	O
reflect	O
an	O
emotional	O
disturbance	O
that	O
manifests	O
only	O
when	O
the	O
animals	O
are	O
placed	O
in	O
a	O
new	O
environment	O
.	O

Finally	O
,	O
we	O
report	O
significant	O
skeletal	O
muscle	O
and	O
cardiac	O
functional	O
abnormalities	O
(	O
although	O
the	O
report	O
by	O
Lin	O
et	O
al	O
.	O
did	O
not	O
address	O
these	O
phenotypes	O
,	O
so	O
this	O
may	O
not	O
represent	O
a	O
true	O
difference	O
)	O
.	O

The	O
reasons	O
for	O
the	O
interesting	O
differences	O
between	O
the	O
two	O
PGC	O
-	O
1	O
alpha	O
-	O
deficient	O
mouse	O
lines	O
are	O
not	O
clear	O
.	O

It	O
is	O
possible	O
that	O
distinct	O
genetic	O
backgrounds	O
related	O
to	O
hybrid	O
strains	O
confer	O
different	O
degrees	O
of	O
secondary	O
compensatory	O
responses	O
.	O

In	O
addition	O
,	O
the	O
incompletely	O
penetrant	O
postnatal	O
mortality	O
noted	O
in	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
reported	O
by	O
Lin	O
et	O
al	O
.	O
could	O
have	O
resulted	O
in	O
a	O
selection	O
bias	O
toward	O
greater	O
levels	O
of	O
compensatory	O
responses	O
in	O
liver	O
and	O
other	O
tissues	O
in	O
the	O
surviving	O
group	O
.	O

It	O
is	O
also	O
possible	O
that	O
the	O
method	O
of	O
gene	O
targeting	O
led	O
to	O
different	O
phenotypes	O
.	O

Lin	O
et	O
al	O
.	O
generated	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
by	O
Cre	O
recombinase	O
-	O
mediated	O
excision	O
of	O
exons	O
3	O
-	O
5	O
in	O
oocytes	O
.	O

The	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
described	O
here	O
were	O
generated	O
by	O
a	O
targeting	O
event	O
that	O
involved	O
a	O
3	O
'	O
homologous	O
recombination	O
leading	O
to	O
an	O
insertion	O
of	O
the	O
targeting	O
vector	O
including	O
an	O
extra	O
exon	O
3	O
between	O
exons	O
5	O
and	O
6	O
.	O

The	O
exon	O
3	O
insertion	O
,	O
which	O
was	O
confirmed	O
by	O
RT	O
-	O
PCR	O
,	O
results	O
in	O
a	O
mutant	O
transcript	O
that	O
encodes	O
a	O
truncated	O
protein	B-CHEBI
.	O

We	O
were	O
unable	O
to	O
detect	O
normal	O
transcript	O
containing	O
an	O
exon	O
5	O
-	O
6	O
border	O
,	O
indicating	O
that	O
the	O
targeting	O
was	O
accurate	O
and	O
complete	O
.	O

In	O
addition	O
,	O
we	O
could	O
not	O
detect	O
full	O
-	O
length	O
or	O
smaller	O
PGC	O
-	O
1	O
alpha	O
proteins	B-CHEBI
by	O
Western	O
blotting	O
.	O

However	O
,	O
we	O
cannot	O
exclude	O
the	O
possibility	O
that	O
the	O
sensitivity	O
of	O
the	O
immunoblotting	O
was	O
not	O
high	O
enough	O
to	O
pick	O
up	O
a	O
small	O
amount	O
of	O
mutant	O
(	O
truncated	O
)	O
PGC	O
-	O
1	O
alpha	O
protein	B-CHEBI
that	O
could	O
have	O
some	O
activity	O
,	O
given	O
that	O
it	O
would	O
contain	O
nuclear	O
receptor	O
-	O
interacting	O
domains	O
and	O
the	O
amino	B-CHEBI
-	O
terminal	O
activation	O
domain	O
.	O

If	O
small	O
amounts	O
of	O
PGC	O
-	O
1	O
alpha	O
activity	O
are	O
present	O
in	O
the	O
mice	O
reported	O
here	O
,	O
it	O
could	O
explain	O
some	O
of	O
the	O
observed	O
differences	O
between	O
the	O
models	O
.	O

However	O
,	O
the	O
bulk	O
of	O
data	O
presented	O
here	O
support	O
the	O
conclusion	O
that	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
described	O
are	O
completely	O
deficient	O
in	O
PGC	O
-	O
1	O
alpha	O
.	O

Future	O
direct	O
comparison	O
of	O
the	O
two	O
mouse	O
lines	O
in	O
pure	O
background	O
strains	O
will	O
be	O
of	O
interest	O
.	O

In	O
summary	O
,	O
this	O
body	O
of	O
work	O
provides	O
evidence	O
that	O
PGC	O
-	O
l	O
alpha	O
is	O
critical	O
for	O
the	O
adaptive	O
responses	O
necessary	O
to	O
meet	O
postnatal	O
energy	O
demands	O
.	O

Our	O
results	O
also	O
suggest	O
a	O
broader	O
role	O
for	O
inducible	O
transcriptional	O
coactivators	O
such	O
as	O
PGC	O
-	O
1	O
alpha	O
in	O
transducing	O
cellular	O
signals	O
triggered	O
by	O
physiologic	O
and	O
developmental	O
cues	O
to	O
the	O
transcriptional	O
control	O
of	O
energy	O
metabolism	O
and	O
other	O
dynamic	O
cellular	O
processes	O
.	O

In	O
this	O
regard	O
,	O
the	O
inducible	O
coactivator	O
PGC	O
-	O
1	O
alpha	O
serves	O
as	O
a	O
transcriptional	O
"	O
booster	O
"	O
to	O
augment	O
the	O
capacity	O
of	O
downstream	O
metabolic	O
pathways	O
critical	O
for	O
metabolic	O
maturation	O
and	O
postnatal	O
growth	O
.	O

Indeed	O
,	O
although	O
PGC	O
-	O
1	O
alpha	O
null	O
mice	O
survive	O
in	O
the	O
protected	O
environment	O
of	O
the	O
laboratory	O
,	O
our	O
results	O
indicate	O
that	O
in	O
the	O
rigors	O
of	O
a	O
typical	O
external	O
environment	O
,	O
PGC	O
-	O
1	O
alpha	O
would	O
be	O
necessary	O
for	O
survival	O
.	O

Lastly	O
,	O
we	O
propose	O
that	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
should	O
serve	O
as	O
a	O
useful	O
murine	O
model	O
to	O
investigate	O
the	O
role	O
of	O
altered	O
energy	O
metabolism	O
in	O
obesity	O
,	O
diabetes	O
,	O
hepatic	O
steatosis	O
,	O
and	O
diseases	O
of	O
the	O
heart	O
,	O
skeletal	O
muscle	O
,	O
and	O
central	O
nervous	O
system	O
.	O

Materials	O
and	O
Methods	O

Targeting	O
the	O
PGC	O
-	O
1	O
alpha	O
gene	O
in	O
mice	O

A	O
BAC	O
genomic	O
clone	O
containing	O
the	O
murine	O
PGC	O
-	O
1	O
alpha	O
gene	O
,	O
isolated	O
from	O
an	O
Sv129	O
genomic	O
library	O
,	O
was	O
obtained	O
from	O
Incyte	O
Genomics	O
(	O
Palo	O
Alto	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

A	O
3	O
-	O
kb	O
region	O
spanning	O
exon	O
3	O
was	O
amplified	O
from	O
the	O
genomic	O
clone	O
.	O

A	O
5	O
'	O
primer	O
was	O
designed	O
to	O
amplify	O
a	O
fragment	O
with	O
the	O
5	O
'	O
end	O
beginning	O
732	O
bp	O
upstream	O
of	O
exon	O
3	O
just	O
upstream	O
of	O
an	O
endogenous	O
Kpn1	O
restriction	O
site	O
(	O
5	O
'	O
-	O
AGTTTCCTTAGCAACTTCATA	O
-	O
3	O
'	O
)	O
.	O

The	O
3	O
'	O
primer	O
contained	O
a	O
BamH1	O
site	O
engineered	O
by	O
mutating	O
the	O
bases	O
shown	O
in	O
lowercase	O
(	O
5	O
'	O
-	O
AAGGATTTTAgGATccCAGTAC	O
-	O
3	O
'	O
)	O
.	O

A	O
second	O
fragment	O
downstream	O
of	O
exon	O
5	O
was	O
amplified	O
.	O

In	O
this	O
latter	O
amplicon	O
,	O
Not1	O
and	O
Xho1	O
sites	O
were	O
engineered	O
into	O
the	O
5	O
'	O
and	O
3	O
'	O
primers	O
,	O
respectively	O
(	O
5	O
'	O
-	O
TGGAGTgcGGCCGCTGGGA	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
AAAGAGTCTCgAgAATAGTTTCT	O
-	O
3	O
'	O
)	O
.	O

The	O
fragments	O
were	O
cloned	O
into	O
p1339	O
-	O
PGK	O
-	O
Neomycin	B-CHEBI
targeting	O
vector	O
.	O

The	O
construct	O
was	O
linearized	O
with	O
Xho1	O
and	O
electroporated	O
into	O
RW4	O
ES	O
cells	O
(	O
Sv129	O
derived	O
)	O
using	O
G418	O
selection	O
.	O

The	O
electroporation	O
was	O
performed	O
by	O
the	O
Siteman	O
Cancer	O
Center	O
ES	O
Cell	O
Core	O
at	O
Washington	O
University	O
(	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
.	O

The	O
clones	O
were	O
screened	O
by	O
Southern	O
blot	O
using	O
an	O
Xba1	O
digest	O
(	O
see	O
Figure	O
1A	O
and	O
1B	O
)	O
.	O

One	O
clone	O
out	O
of	O
approximately	O
400	O
screened	O
was	O
positive	O
for	O
the	O
homologous	O
recombination	O
on	O
the	O
3	O
'	O
end	O
and	O
an	O
insertion	O
on	O
the	O
5	O
'	O
end	O
.	O

This	O
clone	O
was	O
injected	O
into	O
a	O
C57BL6	O
/	O
J	O
blastocyst	O
.	O

Chimeras	O
were	O
mated	O
to	O
C57BL6	O
/	O
J	O
mice	O
and	O
germline	O
transmission	O
was	O
confirmed	O
by	O
Southern	O
blotting	O
of	O
tail	O
DNA	O
(	O
see	O
Figure	O
1B	O
)	O
.	O

All	O
experiments	O
were	O
performed	O
using	O
sex	O
-	O
and	O
age	O
-	O
matched	O
or	O
littermate	O
controls	O
as	O
noted	O
.	O

General	O
animal	O
studies	O

All	O
animal	O
experiments	O
and	O
euthanasia	O
protocols	O
were	O
conducted	O
in	O
strict	O
accordance	O
with	O
the	O
National	O
Institutes	O
of	O
Health	O
guidelines	O
for	O
humane	O
treatment	O
of	O
animals	O
and	O
were	O
reviewed	O
and	O
approved	O
by	O
the	O
Animal	O
Care	O
Committee	O
of	O
Washington	O
University	O
.	O

Animals	O
were	O
weighed	O
at	O
different	O
time	O
points	O
.	O

Male	O
and	O
female	O
3	O
-	O
to	O
8	O
-	O
wk	O
-	O
old	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
were	O
euthanized	O
,	O
and	O
tissues	O
were	O
dissected	O
and	O
weighed	O
on	O
an	O
analytical	O
balance	O
.	O

Tissue	O
weights	O
were	O
corrected	O
for	O
total	O
body	O
weight	O
before	O
comparison	O
.	O

DEXA	O
studies	O
were	O
performed	O
as	O
previously	O
described	O
[	O
39	O
]	O
using	O
a	O
Lunar	O
PIXIMUS	O
DEXA	O
system	O
at	O
10	O
,	O
18	O
,	O
and	O
24	O
wk	O
in	O
male	O
and	O
female	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

For	O
cold	O
exposure	O
experiments	O
,	O
male	O
and	O
female	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
were	O
singly	O
housed	O
and	O
placed	O
at	O
4	O
degrees	O
C	O
for	O
5	O
h	O
without	O
food	B-CHEBI
.	O

Core	O
body	O
temperatures	O
were	O
monitored	O
by	O
rectal	O
probe	O
at	O
baseline	O
and	O
every	O
hour	O
thereafter	O
.	O

Mice	O
were	O
monitored	O
at	O
least	O
every	O
30	O
min	O
to	O
check	O
for	O
lethargy	O
.	O

At	O
the	O
end	O
of	O
5	O
h	O
,	O
mice	O
were	O
sacrificed	O
and	O
tissues	O
harvested	O
for	O
RNA	O
and	O
protein	B-CHEBI
extraction	O
.	O

For	O
fasting	O
studies	O
,	O
animals	O
were	O
singly	O
housed	O
and	O
given	O
water	B-CHEBI
ad	O
libitum	O
.	O

Food	B-CHEBI
was	O
removed	O
from	O
cages	O
in	O
the	O
morning	O
and	O
tissues	O
harvested	O
at	O
24	O
h	O
for	O
RNA	O
and	O
histology	O
.	O

Photography	O
of	O
the	O
mice	O
was	O
performed	O
by	O
MedPic	O
at	O
Washington	O
University	O
School	O
of	O
Medicine	O
.	O

48	O
-	O
h	O
activity	O
monitoring	O
was	O
performed	O
by	O
JAX	O
Services	O
(	O
The	O
Jackson	O
Laboratory	O
,	O
West	O
Sacramento	O
,	O
California	O
,	O
United	O
States	O
)	O
using	O
a	O
Comprehensive	O
Laboratory	O
Animal	O
Monitoring	O
System	O
(	O
CLAMS	O
,	O
Columbus	O
Instruments	O
,	O
Columbus	O
,	O
Ohio	O
,	O
United	O
States	O
)	O
.	O

Briefly	O
,	O
3	O
-	O
mo	O
-	O
old	O
female	O
mice	O
were	O
acclimated	O
for	O
17	O
h	O
before	O
data	O
collection	O
.	O

Data	O
were	O
collected	O
every	O
30	O
min	O
.	O

Total	O
beam	O
breaks	O
in	O
the	O
XY	O
direction	O
were	O
tabulated	O
for	O
the	O
12	O
-	O
h	O
light	O
and	O
dark	O
cycles	O
and	O
compared	O
across	O
genotypes	O
.	O

RNA	O
,	O
DNA	O
,	O
and	O
protein	B-CHEBI
analyses	O

Total	O
RNA	O
was	O
isolated	O
by	O
the	O
RNAzol	O
method	O
(	O
Tel	O
-	O
Test	O
,	O
Friendswood	O
,	O
Texas	O
)	O
and	O
Northern	O
blotting	O
was	O
performed	O
as	O
previously	O
described	O
[	O
40	O
]	O
.	O

The	O
PGC	O
-	O
1	O
beta	O
and	O
PRC	O
cDNAs	O
were	O
generous	O
gifts	O
from	O
Bruce	O
Spiegelman	O
and	O
Richard	O
Scarpulla	O
,	O
respectively	O
.	O

The	O
UCP	O
-	O
1	O
cDNA	O
was	O
a	O
gift	O
from	O
Daniel	O
Ricquier	O
.	O

RT	O
-	O
PCR	O
was	O
performed	O
as	O
described	O
[	O
41	O
]	O
.	O

In	O
brief	O
,	O
total	O
RNA	O
isolated	O
from	O
soleus	O
muscle	O
,	O
BAT	O
,	O
and	O
heart	O
of	O
1	O
-	O
2	O
-	O
mo	O
-	O
old	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
or	O
PGC	O
alpha	O
-	O
/	O
-	O
mice	O
was	O
reverse	O
transcribed	O
with	O
Taqman	O
reverse	O
transcription	O
reagents	B-CHEBI
(	O
Applied	O
Biosystems	O
,	O
Foster	O
City	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Reactions	O
were	O
performed	O
in	O
triplicate	O
in	O
96	O
-	O
well	O
format	O
using	O
Taqman	O
core	O
reagents	B-CHEBI
and	O
a	O
Prism	O
7500	O
Sequence	O
Detector	O
(	O
Applied	O
Biosystems	O
)	O
.	O

The	O
mouse	O
-	O
specific	O
primer	O
-	O
probe	O
sets	O
used	O
to	O
detect	O
specific	O
gene	O
expression	O
can	O
be	O
found	O
in	O
Table	O
S1	O
.	O

The	O
primers	O
for	O
UCP	O
-	O
1	O
have	O
been	O
previously	O
described	O
[	O
42	O
]	O
.	O

Actin	O
primer	O
-	O
probe	O
set	O
(	O
Applied	O
Biosystems	O
)	O
was	O
included	O
in	O
a	O
separate	O
well	O
and	O
used	O
to	O
normalize	O
the	O
soleus	O
,	O
BAT	O
,	O
and	O
heart	O
gene	O
expression	O
data	O
.	O

GAPDH	O
Rodent	O
primers	O
(	O
Applied	O
Biosystems	O
)	O
were	O
used	O
in	O
the	O
same	O
well	O
to	O
normalize	O
the	O
liver	O
gene	O
expression	O
data	O
.	O

For	O
Southern	O
blot	O
studies	O
,	O
5	O
mu	O
g	O
of	O
genomic	O
DNA	O
was	O
digested	O
with	O
Pst1	O
or	O
Xba1	O
,	O
electrophoresed	O
on	O
a	O
0	O
.	O
8	O
%	O
TAE	O
gel	O
and	O
transferred	O
to	O
a	O
Gene	O
Screen	O
(	O
Perkin	O
Elmer	O
,	O
Wellesley	O
,	O
California	O
,	O
United	O
States	O
)	O
membrane	O
for	O
hybridization	O
.	O

Western	O
blotting	O
was	O
performed	O
as	O
described	O
[	O
43	O
]	O
using	O
the	O
Enhanced	O
Chemiluminescence	O
detection	O
system	O
(	O
Amersham	O
Pharmacia	O
Biotech	O
,	O
Piscataway	O
,	O
New	O
Jersey	O
,	O
United	O
States	O
)	O
.	O

Ponceau	O
S	O
(	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
staining	O
of	O
the	O
membrane	O
was	O
used	O
as	O
a	O
control	O
.	O

Mitochondrial	O
respiration	O
studies	O

Mitochondrial	O
respiration	O
was	O
assessed	O
in	O
saponin	O
-	O
skinned	O
soleus	O
fibers	O
with	O
succinate	B-CHEBI
as	O
substrate	O
and	O
in	O
the	O
presence	O
of	O
rotenone	B-CHEBI
as	O
previously	O
described	O
[	O
44	O
]	O
.	O

In	O
brief	O
,	O
3	O
-	O
mo	O
-	O
old	O
female	O
mice	O
were	O
anesthetized	O
with	O
chloral	B-CHEBI
hydrate	I-CHEBI
(	O
400	O
mg	O
/	O
kg	O
of	O
body	O
weight	O
)	O
.	O

Soleus	O
fibers	O
were	O
separated	O
and	O
then	O
transferred	O
to	O
a	O
buffer	O
(	O
2	O
.	O
77	O
mM	O
K2Ca	O
-	O
EGTA	B-CHEBI
,	O
7	O
.	O
23	O
mM	O
K2EGTA	O
,	O
6	O
.	O
56	O
mM	O
MgCl2	B-CHEBI
,	O
20	O
mM	O
imidazole	B-CHEBI
,	O
53	O
.	O
3	O
mM	O
K	B-CHEBI
-	O
MES	B-CHEBI
,	O
20	O
mM	O
taurine	B-CHEBI
,	O
5	O
.	O
3	O
mM	O
ATP	B-CHEBI
,	O
15	O
mM	O
PCr	B-CHEBI
,	O
3	O
mM	O
KH2PO4	O
,	O
0	O
.	O
5	O
mM	O
DTT	B-CHEBI
[	O
pH	O
7	O
.	O
1	O
]	O
)	O
supplemented	O
with	O
50	O
mu	O
g	O
/	O
ml	O
saponin	O
and	O
permeabilized	O
for	O
30	O
min	O
at	O
4	O
degrees	O
C	O
with	O
gentle	O
stirring	O
.	O

Fibers	O
were	O
then	O
washed	O
twice	O
for	O
10	O
min	O
each	O
(	O
2	O
.	O
77	O
mM	O
K2Ca	O
-	O
EGTA	B-CHEBI
,	O
7	O
.	O
23	O
mM	O
K2EGTA	O
,	O
1	O
.	O
38	O
mM	O
MgCl2	B-CHEBI
,	O
20	O
mM	O
imidazole	B-CHEBI
,	O
100	O
mM	O
K	B-CHEBI
-	O
MES	B-CHEBI
,	O
20	O
mM	O
taurine	B-CHEBI
,	O
3	O
mM	O
KH2PO4	O
,	O
0	O
.	O
5	O
mM	O
DTT	B-CHEBI
,	O
2	O
mg	O
/	O
ml	O
BSA	O
[	O
pH	O
7	O
.	O
1	O
]	O
)	O
.	O

Respiration	O
was	O
measured	O
at	O
25	O
degrees	O
C	O
using	O
an	O
optical	O
probe	O
(	O
Oxygen	B-CHEBI
FOXY	O
Probe	O
,	O
Ocean	O
Optics	O
,	O
Dunedin	O
,	O
Florida	O
,	O
United	O
States	O
)	O
.	O

Following	O
measurement	O
of	O
basal	O
state	O
2	O
respiration	O
,	O
maximal	O
(	O
ADP	B-CHEBI
-	O
stimulated	O
)	O
state	O
3	O
respiration	O
was	O
determined	O
by	O
exposing	O
fibers	O
to	O
1	O
mM	O
ADP	B-CHEBI
.	O

The	O
integrity	O
of	O
the	O
outer	O
mitochondrial	O
membrane	O
was	O
assessed	O
by	O
adding	O
8	O
mu	O
M	O
exogenous	O
cytochrome	B-CHEBI
c	I-CHEBI
to	O
ADP	B-CHEBI
-	O
stimulated	O
fibers	O
.	O

State	O
4	O
respiration	O
(	O
uncoupled	O
)	O
was	O
evaluated	O
following	O
addition	O
of	O
oligomycin	B-CHEBI
(	O
1	O
mu	O
g	O
/	O
ml	O
)	O
.	O

The	O
solubility	O
of	O
oxygen	B-CHEBI
in	O
the	O
respiration	O
buffer	O
at	O
25	O
degrees	O
C	O
was	O
taken	O
as	O
246	O
.	O
87	O
nmol	O
O2	B-CHEBI
.	O
ml	O
-	O
1	O
.	O

Respiration	O
rates	O
were	O
expressed	O
as	O
nmol	O
O2	B-CHEBI
.	O
min	O
-	O
1	O
.	O
mgdw	O
-	O
1	O
.	O

Insulin	B-CHEBI
and	O
glucose	B-CHEBI
tolerance	O
tests	O

Glucose	B-CHEBI
and	O
Insulin	B-CHEBI
tolerance	O
tests	O
were	O
performed	O
as	O
described	O
[	O
35	O
]	O
.	O

Prior	O
to	O
studies	O
,	O
mice	O
were	O
fasted	O
overnight	O
(	O
GTT	O
)	O
or	O
6	O
h	O
(	O
ITT	O
)	O
.	O

In	O
GTT	O
studies	O
,	O
mice	O
were	O
injected	O
with	O
a	O
10	O
%	O
solution	O
of	O
D	B-CHEBI
-	I-CHEBI
glucose	I-CHEBI
(	O
1	O
g	O
/	O
kg	O
)	O
.	O

For	O
ITT	O
,	O
mice	O
received	O
an	O
IP	O
injection	O
of	O
human	O
regular	O
insulin	B-CHEBI
(	O
Eli	O
Lilly	O
,	O
Indianapolis	O
,	O
Indiana	O
,	O
United	O
States	O
)	O
at	O
a	O
dose	O
of	O
0	O
.	O
75	O
units	O
/	O
kg	O
of	O
body	O
weight	O
.	O

Tail	O
blood	O
glucose	B-CHEBI
was	O
determined	O
at	O
0	O
,	O
30	O
,	O
60	O
,	O
and	O
120	O
min	O
after	O
challenge	O
using	O
a	O
B	O
-	O
GLUCOSE	B-CHEBI
Analyzer	O
(	O
Hemacue	O
AB	O
,	O
Angelholm	O
,	O
Sweden	O
)	O
.	O

Indirect	O
calorimetry	O

Oxygen	B-CHEBI
consumption	O
rates	O
(	O
VO2	O
)	O
of	O
5	O
-	O
wk	O
-	O
old	O
female	O
mice	O
were	O
measured	O
using	O
a	O
Columbus	O
Instruments	O
Oxymax	O
System	O
.	O

Resting	O
baseline	O
oxygen	B-CHEBI
consumption	O
rates	O
were	O
assessed	O
for	O
at	O
least	O
1	O
.	O
0	O
h	O
.	O

For	O
beta	O
3	O
-	O
adrenergic	O
stimulation	O
studies	O
,	O
BRL	O
37344	O
(	O
Sigma	O
)	O
was	O
dissolved	O
in	O
sterile	O
saline	O
and	O
injected	O
IP	O
(	O
2	O
mu	O
g	O
/	O
g	O
of	O
body	O
weight	O
)	O
[	O
45	O
]	O
.	O

Postagonist	O
assessment	O
of	O
oxygen	B-CHEBI
consumption	O
was	O
recorded	O
for	O
an	O
additional	O
1	O
.	O
0	O
h	O
,	O
with	O
data	O
collected	O
at	O
the	O
40	O
-	O
min	O
time	O
point	O
.	O

Histology	O
and	O
electron	B-CHEBI
microscopy	O

Soleus	O
muscle	O
and	O
liver	O
were	O
dissected	O
and	O
fixed	O
overnight	O
in	O
2	O
%	O
glutaraldehyde	O
,	O
1	O
%	O
paraformaldehyde	O
,	O
and	O
0	O
.	O
08	O
%	O
sodium	B-CHEBI
cacodylate	B-CHEBI
buffer	O
.	O

The	O
tissues	O
were	O
postfixed	O
in	O
1	O
%	O
osmium	B-CHEBI
tetroxide	O
,	O
dehydrated	O
in	O
graded	O
ethanol	B-CHEBI
,	O
embedded	O
in	O
Poly	O
Bed	O
plastic	O
resin	O
,	O
and	O
sectioned	O
for	O
electron	B-CHEBI
microscopy	O
.	O

Cardiac	O
and	O
skeletal	O
muscle	O
mitochondrial	O
and	O
myofibrillar	O
volume	O
densities	O
were	O
determined	O
from	O
electron	B-CHEBI
micrographs	O
as	O
described	O
previously	O
[	O
10	O
]	O
.	O

For	O
each	O
animal	O
,	O
three	O
different	O
fields	O
at	O
the	O
magnification	O
of	O
7500	O
x	O
were	O
quantified	O
in	O
blinded	O
fashion	O
.	O

Data	O
were	O
expressed	O
as	O
mean	O
volume	O
density	O
of	O
mitochondria	O
or	O
myofibrils	O
in	O
each	O
field	O
.	O

For	O
electron	B-CHEBI
microscopic	O
analysis	O
of	O
the	O
brain	O
,	O
tissue	O
was	O
prepared	O
as	O
previously	O
described	O
[	O
46	O
]	O
.	O

Ultrathin	O
sections	O
of	O
cortex	O
were	O
cut	O
onto	O
formvar	O
-	O
coated	O
slot	O
grids	O
stained	O
with	O
uranyl	B-CHEBI
acetate	B-CHEBI
and	O
lead	B-CHEBI
citrate	B-CHEBI
and	O
examined	O
with	O
a	O
JEOL	O
1200	O
electron	B-CHEBI
microscope	O
.	O

For	O
H	O
&	O
E	O
staining	O
,	O
sections	O
of	O
brain	O
,	O
including	O
cerebral	O
cortex	O
,	O
brainstem	O
,	O
and	O
cerebellum	O
,	O
were	O
dehydrated	O
in	O
graded	O
concentrations	O
of	O
alcohol	B-CHEBI
and	O
embedded	O
in	O
paraffin	O
from	O
which	O
5	O
-	O
mu	O
m	O
sections	O
were	O
prepared	O
.	O

Primary	O
mouse	O
hepatocyte	O
studies	O

Primary	O
cultures	O
of	O
mouse	O
hepatocytes	O
were	O
prepared	O
from	O
male	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
essentially	O
as	O
described	O
[	O
47	O
]	O
.	O

Fatty	B-CHEBI
acid	I-CHEBI
oxidation	O
and	O
triglyceride	B-CHEBI
synthesis	O
experiments	O
were	O
commenced	O
2	O
-	O
3	O
h	O
after	O
the	O
cells	O
were	O
plated	O
.	O

Triglyceride	B-CHEBI
synthesis	O
studies	O
,	O
were	O
performed	O
as	O
previously	O
described	O
[	O
47	O
]	O
.	O

Palmitate	B-CHEBI
oxidation	O
rates	O
were	O
quantified	O
using	O
[	O
9	O
,	O
10	O
-	O
3H	B-CHEBI
]	O
-	O
palmitic	B-CHEBI
acid	I-CHEBI
as	O
described	O
[	O
48	O
]	O
and	O
corrected	O
for	O
total	O
cellular	O
protein	B-CHEBI
content	O
.	O

For	O
respiration	O
studies	O
,	O
cells	O
were	O
spun	O
down	O
prior	O
to	O
plating	O
and	O
resuspended	O
in	O
a	O
permeabilization	O
buffer	O
(	O
described	O
above	O
)	O
containing	O
50	O
mu	O
g	O
/	O
ml	O
saponin	O
.	O

Respiration	O
studies	O
were	O
performed	O
in	O
the	O
presence	O
of	O
5	O
mM	O
succinate	B-CHEBI
in	O
the	O
presence	O
of	O
10	O
mu	O
M	O
rotenone	B-CHEBI
.	O

Respiration	O
rates	O
were	O
expressed	O
as	O
nmol	O
O2	B-CHEBI
.	O
min	O
-	O
1	O
.	O
mg	O
of	O
protein	B-CHEBI
-	O
1	O
.	O

Evaluation	O
of	O
locomotor	O
activity	O
,	O
sensorimotor	O
capabilities	O
,	O
and	O
muscle	O
function	O

To	O
evaluate	O
general	O
activity	O
levels	O
and	O
muscle	O
use	O
,	O
mice	O
were	O
evaluated	O
over	O
a	O
1	O
-	O
h	O
period	O
in	O
transparent	O
(	O
47	O
.	O
6	O
cm	O
x	O
25	O
.	O
4	O
cm	O
x	O
20	O
.	O
6	O
cm	O
)	O
polystyrene	O
enclosures	O
as	O
previously	O
described	O
[	O
49	O
]	O
using	O
a	O
high	O
-	O
resolution	O
photobeam	O
system	O
(	O
Motor	O
Monitor	O
,	O
Hamilton	O
-	O
Kinder	O
,	O
Poway	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Each	O
enclosure	O
was	O
surrounded	O
by	O
a	O
frame	O
containing	O
a	O
4	O
x	O
8	O
matrix	O
of	O
photocell	O
pairs	O
,	O
the	O
output	O
of	O
which	O
was	O
fed	O
to	O
an	O
on	O
-	O
line	O
computer	O
.	O

The	O
system	O
software	O
(	O
Hamilton	O
-	O
Kinder	O
)	O
was	O
used	O
to	O
define	O
a	O
33	O
cm	O
x	O
11	O
cm	O
central	O
zone	O
and	O
a	O
peripheral	O
or	O
surrounding	O
zone	O
that	O
was	O
5	O
.	O
5	O
cm	O
wide	O
with	O
the	O
sides	O
of	O
the	O
cage	O
being	O
the	O
outermost	O
boundary	O
.	O

This	O
peripheral	O
area	O
extended	O
along	O
the	O
entire	O
perimeter	O
of	O
the	O
cage	O
.	O

Variables	O
that	O
were	O
analyzed	O
included	O
the	O
total	O
number	O
of	O
ambulations	O
,	O
as	O
well	O
as	O
the	O
number	O
of	O
entries	O
,	O
the	O
time	O
spent	O
,	O
and	O
the	O
distance	O
traveled	O
in	O
the	O
center	O
area	O
as	O
well	O
as	O
the	O
distance	O
traveled	O
in	O
the	O
periphery	O
surrounding	O
the	O
center	O
.	O

The	O
total	O
number	O
of	O
ambulations	O
and	O
rearings	O
were	O
recorded	O
.	O

For	O
the	O
inverted	O
screen	O
test	O
,	O
mice	O
were	O
placed	O
on	O
a	O
wire	O
mesh	O
grid	O
(	O
16	O
squares	O
per	O
10	O
cm	O
)	O
and	O
the	O
screen	O
was	O
inverted	O
to	O
180	O
degrees	O
.	O

A	O
maximum	O
score	O
of	O
60	O
s	O
was	O
given	O
if	O
an	O
animal	O
did	O
not	O
fall	O
.	O

The	O
tests	O
included	O
in	O
the	O
sensorimotor	O
battery	O
[	O
50	O
]	O
and	O
accompanying	O
protocols	O
were	O
designed	O
as	O
follows	O
.	O

(	O
1	O
)	O
Inclined	O
screen	O
and	O
inverted	O
screen	O
tests	O
:	O
For	O
the	O
inclined	O
screen	O
tests	O
,	O
each	O
mouse	O
was	O
placed	O
on	O
top	O
of	O
an	O
elevated	O
(	O
47	O
cm	O
above	O
the	O
floor	O
)	O
wire	O
mesh	O
grid	O
(	O
16	O
squares	O
per	O
10	O
cm	O
)	O
that	O
was	O
inclined	O
to	O
60	O
degrees	O
or	O
90	O
degrees	O
.	O

Each	O
animal	O
was	O
placed	O
in	O
the	O
middle	O
of	O
the	O
screen	O
with	O
its	O
head	O
oriented	O
down	O
and	O
was	O
timed	O
for	O
how	O
long	O
it	O
remained	O
on	O
the	O
screen	O
and	O
how	O
long	O
it	O
took	O
to	O
climb	O
to	O
the	O
top	O
of	O
the	O
screen	O
.	O

For	O
the	O
inverted	O
screen	O
test	O
,	O
mice	O
were	O
placed	O
as	O
above	O
and	O
then	O
the	O
screen	O
was	O
inverted	O
to	O
180	O
degrees	O
.	O

A	O
maximum	O
score	O
of	O
60	O
s	O
was	O
given	O
if	O
an	O
animal	O
did	O
not	O
fall	O
;	O
(	O
2	O
)	O
Platform	O
test	O
:	O
Each	O
mouse	O
was	O
timed	O
for	O
how	O
long	O
it	O
remained	O
on	O
an	O
elevated	O
(	O
47	O
cm	O
above	O
the	O
floor	O
)	O
circular	O
platform	O
(	O
1	O
.	O
0	O
cm	O
thick	O
and	O
3	O
.	O
0	O
cm	O
in	O
diameter	O
)	O
.	O

A	O
maximum	O
score	O
of	O
60	O
s	O
was	O
assigned	O
if	O
the	O
mouse	O
remained	O
on	O
the	O
platform	O
for	O
the	O
maximum	O
amount	O
of	O
time	O
or	O
if	O
it	O
could	O
climb	O
down	O
on	O
a	O
very	O
thin	O
pole	O
that	O
supported	O
the	O
platform	O
,	O
without	O
falling	O
;	O
(	O
3	O
)	O
Ledge	O
test	O
:	O
Each	O
mouse	O
was	O
timed	O
for	O
how	O
long	O
it	O
could	O
maintain	O
its	O
balance	O
on	O
a	O
0	O
.	O
75	O
-	O
cm	O
wide	O
Plexiglas	O
ledge	O
without	O
falling	O
(	O
60	O
s	O
maximum	O
)	O
.	O

A	O
score	O
of	O
60	O
s	O
was	O
also	O
assigned	O
if	O
the	O
mouse	O
traversed	O
the	O
entire	O
length	O
(	O
51	O
cm	O
)	O
of	O
the	O
Plexiglas	O
ledge	O
and	O
returned	O
to	O
the	O
starting	O
place	O
in	O
less	O
than	O
60	O
s	O
without	O
falling	O
;	O
(	O
4	O
)	O
Walking	O
initiation	O
test	O
:	O
Each	O
mouse	O
was	O
placed	O
in	O
the	O
middle	O
of	O
a	O
square	O
outlined	O
by	O
white	O
cloth	O
tape	O
(	O
21	O
cm	O
x	O
21	O
cm	O
)	O
on	O
a	O
smooth	O
black	O
surface	O
of	O
a	O
large	O
tabletop	O
.	O

The	O
time	O
it	O
took	O
each	O
mouse	O
to	O
leave	O
the	O
square	O
(	O
place	O
all	O
four	O
paws	O
outside	O
of	O
the	O
tape	O
)	O
was	O
recorded	O
.	O

The	O
maximum	O
time	O
allowed	O
was	O
60	O
s	O
.	O

6	O
-	O
8	O
-	O
mo	O
-	O
old	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
n	O
=	O
4	O
)	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
(	O
n	O
=	O
8	O
)	O
mice	O
were	O
run	O
to	O
exhaustion	O
employing	O
a	O
motorized	O
,	O
speed	O
controlled	O
,	O
modular	O
treadmill	O
system	O
(	O
Columbus	O
Instruments	O
)	O
.	O

The	O
treadmill	O
was	O
equipped	O
with	O
an	O
electric	O
shock	O
stimulus	O
and	O
an	O
adjustable	O
inclination	O
angle	O
.	O

Running	O
velocity	O
was	O
set	O
at	O
35	O
m	O
/	O
min	O
,	O
with	O
a	O
level	O
inclination	O
angle	O
.	O

VO2max	O
studies	O

VO2max	O
was	O
determined	O
while	O
the	O
mice	O
were	O
running	O
on	O
a	O
treadmill	O
using	O
an	O
open	O
flow	O
system	O
(	O
Columbus	O
Instruments	O
Oxymax	O
System	O
)	O
.	O

All	O
measurements	O
of	O
oxygen	B-CHEBI
consumption	O
took	O
place	O
at	O
an	O
elevation	O
of	O
150	O
m	O
(	O
ambient	O
PBAR	O
=	O
745	O
torr	O
)	O
.	O

Animals	O
were	O
placed	O
into	O
the	O
metabolic	O
chamber	O
for	O
3	O
-	O
5	O
min	O
to	O
allow	O
the	O
system	O
to	O
equilibrate	O
.	O

Mice	O
were	O
then	O
induced	O
to	O
run	O
up	O
an	O
18	O
degrees	O
incline	O
at	O
a	O
speed	O
of	O
40	O
m	O
/	O
min	O
using	O
a	O
shock	O
grid	O
in	O
the	O
rear	O
of	O
the	O
chamber	O
.	O

The	O
speed	O
was	O
increased	O
by	O
5	O
m	O
/	O
min	O
every	O
2	O
min	O
until	O
the	O
animals	O
were	O
unable	O
to	O
continue	O
.	O

Maximal	O
effort	O
was	O
determined	O
when	O
oxygen	B-CHEBI
uptake	O
did	O
not	O
increase	O
with	O
power	O
output	O
and	O
subsequently	O
the	O
mouse	O
failed	O
to	O
maintain	O
effort	O
.	O

VO2max	O
was	O
calculated	O
using	O
the	O
averaged	O
values	O
over	O
1	O
min	O
during	O
which	O
the	O
animal	O
'	O
s	O
O2	B-CHEBI
consumption	O
reached	O
a	O
plateau	O
.	O

Isolated	O
muscle	O
stimulation	O
studies	O

Animals	O
were	O
anesthetized	O
with	O
ketamine	O
/	O
xylazine	O
and	O
the	O
soleus	O
muscle	O
was	O
removed	O
from	O
one	O
leg	O
.	O

Upon	O
removal	O
,	O
the	O
muscle	O
was	O
suspended	O
in	O
a	O
Krebs	O
solution	O
aerated	O
with	O
95	O
%	O
O2	B-CHEBI
and	O
5	O
%	O
CO2	B-CHEBI
.	O

The	O
muscle	O
and	O
Krebs	O
solution	O
were	O
suspended	O
within	O
a	O
water	B-CHEBI
bath	O
maintained	O
at	O
37	O
degrees	O
C	O
,	O
and	O
the	O
muscle	O
was	O
anchored	O
to	O
a	O
Grass	O
(	O
West	O
Warwick	O
,	O
Rhode	O
Island	O
,	O
United	O
States	O
)	O
isometric	O
force	O
transducer	O
(	O
model	O
FTO3C	O
)	O
.	O

Muscles	O
were	O
stimulated	O
to	O
contract	O
with	O
a	O
Grass	O
stimulator	O
(	O
model	O
S88	O
)	O
generating	O
a	O
field	O
stimulus	O
through	O
electrodes	O
located	O
at	O
both	O
ends	O
of	O
the	O
muscle	O
.	O

Force	O
-	O
voltage	O
(	O
maximal	O
force	O
at	O
about	O
100	O
V	O
)	O
and	O
length	O
-	O
tension	O
relationships	O
were	O
determined	O
using	O
single	O
twitch	O
stimuli	O
.	O

The	O
stimulator	O
then	O
delivered	O
repeating	O
trains	O
of	O
stimuli	O
at	O
one	O
per	O
second	O
at	O
40	O
Hz	O
for	O
2	O
min	O
.	O

Each	O
train	O
lasted	O
330	O
ms	O
,	O
and	O
were	O
digitally	O
recorded	O
using	O
MacLab	O
(	O
AD	O
Instruments	O
,	O
Colorado	O
Springs	O
,	O
Colorado	O
,	O
United	O
States	O
)	O
.	O

Fatigue	O
resistance	O
was	O
calculated	O
as	O
the	O
ratio	O
of	O
the	O
force	O
generated	O
by	O
the	O
last	O
tetanus	O
divided	O
by	O
the	O
highest	O
force	O
generated	O
multiplied	O
by	O
100	O
to	O
give	O
the	O
percent	O
of	O
force	O
generation	O
that	O
remained	O
after	O
the	O
fatigue	O
protocol	O
.	O

Exercise	O
echocardiography	O

Adult	O
female	O
mice	O
(	O
6	O
-	O
8	O
mo	O
old	O
)	O
were	O
exercised	O
on	O
the	O
motorized	O
treadmill	O
using	O
the	O
run	O
-	O
to	O
-	O
exhaustion	O
settings	O
described	O
above	O
for	O
60	O
s	O
or	O
until	O
exhaustion	O
,	O
whichever	O
came	O
first	O
.	O

Immediately	O
following	O
its	O
treadmill	O
run	O
,	O
the	O
mouse	O
was	O
subjected	O
to	O
serial	O
echocardiography	O
using	O
an	O
Acuson	O
Sequoia	O
Echocardiography	O
System	O
performed	O
as	O
previously	O
described	O
[	O
51	O
]	O
.	O

In	O
vivo	O
cardiac	O
hemodynamic	O
studies	O

Hemodynamic	O
studies	O
were	O
performed	O
as	O
previously	O
described	O
with	O
some	O
modifications	O
[	O
52	O
]	O
.	O

In	O
brief	O
,	O
adult	O
mice	O
(	O
10	O
-	O
12	O
wk	O
)	O
were	O
anesthetized	O
intraperitoneally	O
(	O
IP	O
)	O
with	O
thiopental	O
sodium	B-CHEBI
(	O
60	O
mg	O
/	O
kg	O
)	O
.	O

The	O
mice	O
were	O
intubated	O
and	O
ventilated	O
with	O
a	O
Harvard	O
ventilator	O
.	O

The	O
right	O
carotid	O
artery	O
was	O
isolated	O
in	O
the	O
region	O
of	O
the	O
trachea	O
and	O
cannulated	O
with	O
a	O
1	O
.	O
4	O
-	O
French	O
high	O
-	O
fidelity	O
micromanometer	O
catheter	O
(	O
Millar	O
Instruments	O
,	O
Houston	O
,	O
Texas	O
,	O
United	O
States	O
)	O
,	O
which	O
was	O
inserted	O
into	O
the	O
left	O
ventricle	O
retrograde	O
across	O
the	O
aortic	O
valve	O
.	O

Hemodynamic	O
measurements	O
were	O
recorded	O
at	O
baseline	O
and	O
3	O
min	O
following	O
continuous	O
infusion	O
of	O
incremental	O
doses	O
of	O
dobutamine	O
(	O
beta	O
1	O
,	O
beta	O
2	O
,	O
and	O
alpha	O
1	O
-	O
adrenergic	B-CHEBI
agonist	I-CHEBI
)	O
up	O
to	O
32	O
ng	O
.	O
gBW	O
-	O
1	O
.	O
min	O
-	O
1	O
[	O
53	O
]	O
.	O

Continuous	O
pressure	O
-	O
volume	O
data	O
were	O
acquired	O
and	O
digitized	O
with	O
the	O
BioBench	O
computer	O
software	O
data	O
acquisition	O
system	O
(	O
National	O
Instruments	O
,	O
Austin	O
,	O
Texas	O
,	O
United	O
States	O
)	O
.	O

Isolated	O
working	O
mouse	O
heart	O
perfusion	O

Isolated	O
working	O
mouse	O
heart	O
perfusion	O
was	O
based	O
on	O
a	O
previously	O
described	O
procedure	O
[	O
54	O
]	O
.	O

Adult	O
mice	O
(	O
4	O
-	O
7	O
mo	O
old	O
)	O
were	O
heparinized	O
(	O
100	O
units	O
IP	O
)	O
10	O
min	O
prior	O
to	O
anesthesia	O
.	O

Animals	O
were	O
then	O
deeply	O
anesthetized	O
with	O
5	O
-	O
10	O
mg	O
of	O
sodium	B-CHEBI
pentobarbital	B-CHEBI
IP	O
.	O

Hearts	O
were	O
excised	O
and	O
placed	O
in	O
an	O
ice	O
-	O
cold	O
Krebs	O
-	O
Henseleit	O
bicarbonate	B-CHEBI
(	O
KHB	O
)	O
solution	O
[	O
118	O
mM	O
NaCl	B-CHEBI
,	O
25	O
mM	O
NaHCO3	B-CHEBI
,	O
4	O
.	O
7	O
mM	O
KCl	B-CHEBI
,	O
1	O
.	O
2	O
mM	O
KH2PO4	O
,	O
2	O
.	O
5	O
mM	O
CaCl2	B-CHEBI
,	O
5	O
.	O
0	O
mM	O
glucose	B-CHEBI
,	O
and	O
100	O
units	O
/	O
L	O
insulin	B-CHEBI
(	O
pH	O
7	O
.	O
4	O
)	O
]	O
.	O

Hearts	O
were	O
cannulated	O
first	O
via	O
the	O
aorta	O
and	O
perfused	O
retrogradely	O
by	O
the	O
Langendorff	O
method	O
.	O

Following	O
left	O
atrial	O
cannulation	O
,	O
perfusion	O
was	O
switched	O
to	O
the	O
working	O
mode	O
with	O
KHB	O
solution	O
containing	O
1	O
.	O
2	O
mM	O
palmitate	B-CHEBI
bound	O
to	O
3	O
%	O
fatty	B-CHEBI
acid	I-CHEBI
-	O
free	O
BSA	O
with	O
a	O
preload	O
pressure	O
of	O
11	O
.	O
5	O
mm	O
Hg	B-CHEBI
and	O
an	O
afterload	O
pressure	O
of	O
50	O
mm	O
Hg	B-CHEBI
for	O
60	O
min	O
with	O
oxygenated	O
buffer	O
solution	O
.	O

Functional	O
measurements	O
,	O
namely	O
cardiac	O
output	O
,	O
aortic	O
flows	O
,	O
peak	O
systolic	O
pressure	O
,	O
and	O
heart	O
rate	O
were	O
acquired	O
every	O
10	O
min	O
using	O
inline	O
flow	O
probes	O
(	O
Transonic	O
Systems	O
,	O
Ithaca	O
,	O
New	O
York	O
,	O
United	O
States	O
)	O
,	O
a	O
pressure	O
transducer	O
(	O
TSD	O
104A	O
,	O
BIOPAC	O
Systems	O
,	O
Santa	O
Barbara	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
data	O
acquired	O
with	O
the	O
MP100	O
system	O
from	O
AcqKnowledge	O
(	O
BIOPAC	O
Systems	O
)	O
.	O

Cardiac	O
work	O
was	O
calculated	O
as	O
the	O
product	O
of	O
peak	O
systolic	O
pressure	O
and	O
cardiac	O
output	O
.	O

Statistics	O

Data	O
were	O
analyzed	O
using	O
T	O
-	O
tests	O
or	O
ANOVAs	O
(	O
measures	O
of	O
general	O
activity	O
and	O
sensorimotor	O
battery	O
)	O
.	O

The	O
level	O
of	O
significance	O
was	O
set	O
at	O
p	O
<	O
0	O
.	O
05	O
in	O
all	O
cases	O
.	O

Data	O
are	O
reported	O
as	O
mean	O
values	O
+/-	O
SEM	O
,	O
unless	O
otherwise	O
noted	O
.	O

The	O
ANOVA	O
model	O
used	O
to	O
analyze	O
each	O
sensorimotor	O
test	O
included	O
one	O
between	O
-	O
subjects	O
variable	O
(	O
genotype	O
)	O
,	O
and	O
one	O
within	O
-	O
subjects	O
variable	O
(	O
trials	O
)	O
.	O

When	O
ANOVAs	O
with	O
repeated	O
measures	O
were	O
conducted	O
,	O
the	O
Huynh	O
-	O
Feldt	O
(	O
H	O
-	O
F	O
)	O
adjustment	O
of	O
alpha	O
levels	O
was	O
used	O
for	O
all	O
within	O
-	O
subjects	O
effects	O
containing	O
more	O
than	O
two	O
levels	O
,	O
in	O
order	O
to	O
protect	O
against	O
violations	O
of	O
the	O
sphericity	O
/	O
compound	O
symmetry	O
assumptions	O
underlying	O
this	O
ANOVA	O
model	O
.	O

In	O
addition	O
,	O
Bonferroni	O
correction	O
was	O
used	O
when	O
appropriate	O
to	O
help	O
maintain	O
prescribed	O
alpha	O
levels	O
(	O
e	O
.	O
g	O
.	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
when	O
multiple	O
comparisons	O
were	O
conducted	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Activity	O
Levels	O
in	O
Female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O
Is	O
Unchanged	O

Using	O
a	O
CLAMS	O
system	O
,	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
n	O
=	O
4	O
)	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
(	O
n	O
=	O
3	O
)	O
female	O
mice	O
were	O
monitored	O
for	O
48	O
h	O
after	O
a	O
17	O
-	O
h	O
period	O
of	O
acclimation	O
.	O

XY	O
beam	O
breaks	O
were	O
tabulated	O
over	O
the	O
12	O
-	O
h	O
light	O
and	O
dark	O
cycles	O
as	O
denoted	O
on	O
the	O
bottom	O
.	O

The	O
bars	O
represent	O
mean	O
(	O
+/-	O
SEM	O
)	O
beam	O
breaks	O
per	O
each	O
12	O
-	O
h	O
cycle	O
.	O

(	O
342	O
KB	O
EPS	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

Altered	O
Emotionality	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O

An	O
analysis	O
of	O
exploratory	O
behavior	O
included	O
the	O
number	O
of	O
entries	O
into	O
the	O
center	O
of	O
the	O
cage	O
(	O
upper	O
left	O
)	O
,	O
the	O
time	O
spent	O
in	O
the	O
center	O
of	O
the	O
cage	O
in	O
seconds	O
(	O
sec	O
)	O
(	O
upper	O
right	O
)	O
,	O
the	O
distance	O
traveled	O
in	O
the	O
center	O
of	O
the	O
cage	O
in	O
meters	O
(	O
m	O
)	O
(	O
lower	O
left	O
)	O
as	O
well	O
as	O
the	O
distance	O
traveled	O
in	O
the	O
periphery	O
(	O
lower	O
right	O
)	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
compared	O
to	O
the	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O
.	O

(	O
620	O
KB	O
EPS	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

No	O
Difference	O
in	O
Weight	O
Gain	O
on	O
a	O
High	O
-	O
Fat	O
Diet	O
in	O
Female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O
Compared	O
to	O
WT	O
Controls	O

8	O
-	O
wk	O
-	O
old	O
female	O
mice	O
were	O
fed	O
a	O
diet	O
high	O
in	O
fat	O
(	O
43	O
%	O
calories	O
from	O
fat	O
)	O
for	O
6	O
wk	O
.	O

The	O
change	O
in	O
body	O
weight	O
(	O
grams	O
)	O
after	O
6	O
wk	O
on	O
a	O
high	O
-	O
fat	O
diet	O
is	O
shown	O
for	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
n	O
=	O
8	O
)	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
(	O
n	O
=	O
11	O
)	O
mice	O
.	O

NS	O
,	O
not	O
significant	O
.	O

(	O
264	O
KB	O
EPS	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S4	O

Male	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O
Are	O
Somewhat	O
Resistant	O
to	O
Diet	O
-	O
Induced	O
Obesity	O

Male	O
and	O
female	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
n	O
>=	O
6	O
)	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
(	O
n	O
>=	O
6	O
)	O
mice	O
were	O
fed	O
a	O
high	O
-	O
fat	O
diet	O
(	O
43	O
%	O
calories	O
from	O
fat	O
)	O
beginning	O
at	O
4	O
wk	O
of	O
age	O
.	O

Body	O
weight	O
was	O
monitored	O
weekly	O
as	O
shown	O
on	O
the	O
graph	O
on	O
the	O
left	O
.	O

The	O
mean	O
(	O
+/-	O
SEM	O
)	O
change	O
in	O
body	O
weight	O
is	O
shown	O
in	O
the	O
bar	O
graph	O
on	O
the	O
right	O
.	O

*	O
,	O
significant	O
difference	O
compared	O
to	O
the	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
controls	O
,	O
p	O
<	O
0	O
.	O
05	O
.	O

(	O
794	O
KB	O
EPS	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S1	O

Probes	O
and	O
Primers	O

Sequences	O
of	O
mouse	O
-	O
specific	O
probes	O
and	O
primers	O
used	O
for	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
.	O

(	O
25	O
KB	O
DOC	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Accession	O
Numbers	O

The	O
GenBank	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
)	O
accession	O
numbers	O
of	O
the	O
vector	O
discussed	O
in	O
this	O
paper	O
is	O
p1339	O
-	O
PGK	O
-	O
Neomycin	B-CHEBI
targeting	O
vector	O
(	O
AF335420	O
)	O
.	O

Acknowledgements	O

We	O
would	O
like	O
to	O
thank	O
Deanna	O
Young	O
and	O
Karen	O
Hemker	O
for	O
help	O
with	O
mouse	O
husbandry	O
,	O
Carolyn	O
Mansfield	O
for	O
ES	O
cell	O
and	O
mouse	O
genotyping	O
,	O
Anthony	O
Nardi	O
for	O
assistance	O
with	O
the	O
studies	O
to	O
assess	O
general	O
activity	O
and	O
muscle	O
strength	O
,	O
Bill	O
Kraft	O
for	O
expert	O
technical	O
assistance	O
with	O
electron	B-CHEBI
microscopy	O
,	O
Carla	O
Weinheimer	O
for	O
performing	O
cardiac	O
catheterizations	O
,	O
Trey	O
Coleman	O
for	O
performing	O
the	O
TAG	B-CHEBI
assays	O
,	O
Krista	O
Olson	O
for	O
expert	O
technical	O
assistance	O
with	O
the	O
Langendorff	O
method	O
,	O
and	O
Mary	O
Wingate	O
for	O
assistance	O
with	O
manuscript	O
preparation	O
.	O

This	O
work	O
was	O
supported	O
by	O
National	O
Institutes	O
of	O
Health	O
grants	O
RO1	O
DK45416	O
,	O
RO1	O
HL58427	O
,	O
PO1	O
HL57278	O
,	O
Digestive	O
Diseases	O
Research	O
Core	O
Center	O
(	O
P30	O
DK52574	O
)	O
,	O
Clinical	O
Nutrition	O
Research	O
Unit	O
Core	O
Center	O
(	O
P30	O
DK56341	O
)	O
,	O
and	O
K08	O
AG24844	O
.	O

SB	O
is	O
supported	O
by	O
a	O
postdoctoral	O
fellowship	O
from	O
the	O
Juvenile	O
Diabetes	O
Foundation	O
.	O

EDA	O
is	O
supported	O
by	O
the	O
American	O
Heart	O
Association	O
(	O
Established	O
Investigator	O
)	O
and	O
RO1	O
HL70070	O
.	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Abbreviations	O

BAT	O
-	O
brown	O
adipose	O
tissue	O

DEXA	O
-	O
dual	O
-	O
energy	O
X	O
-	O
ray	O
absorption	O

EST	O
-	O
echocardiographic	O
stress	O
testing	O

IP	O
-	O
intraperitoneal	O
(	O
ly	O
)	O

NRF	O
-	O
nuclear	O
respiratory	O
factor	O

PGC	O
-	O
PPAR	O
gamma	O
coactivator	O

PPAR	O
-	O
peroxisome	O
proliferator	O
-	O
activated	O
receptor	O

PRC	O
-	O
PGC	O
-	O
1	O
related	O
coactivator	O

SCD	O
-	O
steroyl	B-CHEBI
CoA	I-CHEBI
desaturase	O

SREBP	O
-	O
sterol	B-CHEBI
regulatory	O
element	O
binding	O
protein	B-CHEBI

SEM	O
-	O
standard	O
error	O
of	O
the	O
mean	O

TAG	B-CHEBI
-	O
triglyceride	B-CHEBI

Tfam	O
-	O
mitochondrial	O
transcription	O
factor	O
A	O

UCP	O
-	O
uncoupling	O
protein	B-CHEBI

WT	O
-	O
wild	O
-	O
type	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Deletion	O
of	O
the	O
PGC	O
-	O
1	O
alpha	O
Gene	O

(	O
A	O
)	O
Schematic	O
of	O
the	O
gene	O
targeting	O
strategy	O
.	O

A	O
region	O
of	O
the	O
murine	O
PGC	O
-	O
1	O
alpha	O
gene	O
containing	O
exons	O
3	O
-	O
6	O
is	O
shown	O
schematically	O
at	O
the	O
top	O
.	O

Relevant	O
restriction	O
endonuclease	O
sites	O
are	O
also	O
shown	O
.	O

The	O
targeting	O
construct	O
containing	O
a	O
neomycin	O
(	O
Neo	O
)	O
cassette	O
is	O
shown	O
below	O
the	O
PGC	O
-	O
1	O
alpha	O
gene	O
with	O
dashed	O
lines	O
indicating	O
the	O
regions	O
targeted	O
for	O
homologous	O
recombination	O
.	O

Homologous	O
recombination	O
between	O
the	O
3	O
'	O
end	O
of	O
the	O
targeting	O
vector	O
and	O
the	O
PGC	O
-	O
1	O
alpha	O
gene	O
is	O
indicated	O
by	O
the	O
solid	O
lines	O
.	O

The	O
targeting	O
construct	O
inserted	O
into	O
the	O
PGC	O
-	O
1	O
alpha	O
gene	O
resulting	O
in	O
a	O
duplication	O
of	O
exon	O
3	O
and	O
incorporation	O
of	O
the	O
targeting	O
construct	O
DNA	O
into	O
the	O
final	O
recombinant	O
as	O
shown	O
.	O

Probes	O
used	O
for	O
the	O
Southern	O
blot	O
studies	O
and	O
relevant	O
restriction	O
fragments	O
predicted	O
by	O
digestion	O
of	O
the	O
recombinant	O
are	O
also	O
shown	O
.	O

(	O
B	O
)	O
Southern	O
blot	O
analysis	O
of	O
embryonic	O
stem	O
cells	O
(	O
ESC	O
)	O
(	O
digested	O
with	O
Xba1	O
)	O
and	O
tail	O
DNA	O
(	O
digested	O
with	O
Pst1	O
)	O
is	O
shown	O
.	O

The	O
blots	O
were	O
hybridized	O
with	O
the	O
probes	O
shown	O
in	O
Figure	O
1A	O
.	O

Results	O
for	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
+	O
/	O
+	O
)	O
,	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
-	O
(	O
+	O
/	O
-	O
)	O
,	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
(	O
-	O
/	O
-	O
)	O
genotypes	O
are	O
shown	O
as	O
denoted	O
at	O
the	O
bottom	O
.	O

(	O
C	O
)	O
Northern	O
blot	O
analysis	O
using	O
RNA	O
isolated	O
from	O
the	O
hearts	O
of	O
the	O
three	O
relevant	O
PGC	O
-	O
1	O
alpha	O
genotypes	O
(	O
as	O
in	O
Figure	O
1B	O
)	O
is	O
shown	O
using	O
PGC	O
-	O
1	O
alpha	O
cDNA	O
as	O
a	O
probe	O
.	O

In	O
addition	O
,	O
PGC	O
-	O
1	O
beta	O
and	O
PRC	O
cDNA	O
probes	O
were	O
used	O
as	O
shown	O
.	O

Ethidium	B-CHEBI
bromide	I-CHEBI
staining	O
of	O
18S	O
ribosomal	B-CHEBI
RNA	I-CHEBI
is	O
shown	O
at	O
the	O
bottom	O
.	O

(	O
D	O
)	O
Quantitative	O
real	O
time	O
RT	O
-	O
PCR	O
(	O
Sybr	O
green	O
)	O
was	O
used	O
to	O
detect	O
PGC	O
-	O
1	O
alpha	O
transcripts	O
using	O
primer	O
sets	O
crossing	O
different	O
exon	O
borders	O
as	O
denoted	O
.	O

The	O
exon	O
5	O
-	O
3	O
primer	O
set	O
detects	O
only	O
the	O
mutant	O
transcript	O
(	O
-	O
/	O
-	O
)	O
,	O
whereas	O
the	O
exon	O
5	O
-	O
6	O
primer	O
set	O
detects	O
only	O
the	O
WT	O
transcript	O
.	O

The	O
values	O
represent	O
arbitrary	O
units	O
for	O
RNA	O
isolated	O
from	O
the	O
tissues	O
shown	O
for	O
the	O
three	O
amplicons	O
comparing	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
.	O

N	O
.	O
D	O
.	O

=	O
not	O
detectable	O
.	O

The	O
exon	O
10	O
-	O
11	O
amplicon	O
was	O
evaluated	O
to	O
assess	O
levels	O
of	O
mutant	O
versus	O
WT	O
transcripts	O
.	O

The	O
values	O
represent	O
arbitrary	O
units	O
normalized	O
to	O
actin	O
control	O
.	O

(	O
E	O
)	O
Western	O
blot	O
analysis	O
using	O
whole	O
-	O
cell	O
protein	B-CHEBI
extracts	O
prepared	O
from	O
BAT	O
under	O
basal	O
conditions	O
and	O
following	O
exposure	O
to	O
4	O
degrees	O
C	O
for	O
8	O
h	O
.	O

The	O
signal	O
shown	O
was	O
obtained	O
with	O
polyclonal	O
anti	O
-	O
PGC	O
-	O
1	O
alpha	O
antibody	O
[	O
10	O
]	O
.	O

An	O
epitope	O
-	O
tagged	O
PGC	O
-	O
1	O
alpha	O
,	O
overexpressed	O
in	O
neonatal	O
cardiac	O
myocytes	O
using	O
an	O
adenoviral	O
vector	O
(	O
Ad	O
-	O
PGC	O
-	O
1	O
alpha	O
)	O
,	O
is	O
shown	O
as	O
a	O
positive	O
control	O
.	O

The	O
Ponceau	O
S	O
stain	O
of	O
the	O
protein	B-CHEBI
gel	O
is	O
shown	O
at	O
the	O
bottom	O
.	O

Figure	O
2	O

Evidence	O
for	O
Tissue	O
-	O
Specific	O
Growth	O
Abnormalities	O
and	O
Mild	O
Sex	O
-	O
Limited	O
,	O
Age	O
-	O
Dependent	O
Obesity	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O

(	O
A	O
)	O
The	O
bars	O
represent	O
total	O
body	O
weight	O
for	O
the	O
ages	O
indicated	O
for	O
male	O
(	O
left	O
graph	O
)	O
and	O
female	O
(	O
center	O
graph	O
)	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

The	O
body	O
weight	O
(	O
BW	O
)	O
of	O
the	O
1	O
-	O
wk	O
-	O
old	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
was	O
normalized	O
to	O
that	O
of	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
littermates	O
,	O
which	O
was	O
assigned	O
a	O
value	O
of	O
100	O
(	O
left	O
axis	O
)	O
.	O

For	O
the	O
3	O
-	O
,	O
18	O
-	O
,	O
and	O
24	O
-	O
wk	O
time	O
points	O
,	O
absolute	O
weights	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
were	O
compared	O
to	O
age	O
-	O
matched	O
controls	O
(	O
right	O
axis	O
)	O
.	O

Percent	O
fat	O
as	O
determined	O
by	O
DEXA	O
scanning	O
for	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
right	O
graph	O
)	O
.	O

The	O
results	O
represent	O
n	O
=	O
4	O
(	O
males	O
)	O
and	O
n	O
>=	O
11	O
(	O
females	O
)	O
for	O
each	O
genotype	O
at	O
24	O
wk	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
compared	O
to	O
corresponding	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O
.	O

(	O
B	O
)	O
The	O
bars	O
represent	O
organ	O
weights	O
corrected	O
to	O
body	O
weight	O
for	O
3	O
-	O
wk	O
-	O
old	O
male	O
and	O
female	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

The	O
error	O
bars	O
represent	O
+/-	O
SEM	O
.	O

Results	O
represent	O
n	O
>=	O
14	O
for	O
each	O
group	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
compared	O
to	O
corresponding	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O
.	O

Figure	O
3	O

Abnormal	O
Mitochondrial	O
Phenotype	O
in	O
Slow	O
-	O
Twitch	O
Skeletal	O
Muscle	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O

(	O
A	O
)	O
Representative	O
electron	B-CHEBI
micrograph	O
of	O
soleus	O
muscle	O
from	O
1	O
-	O
mo	O
-	O
old	O
female	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
.	O

(	O
B	O
)	O
Quantitative	O
morphometric	O
measurements	O
of	O
the	O
cellular	O
volume	O
density	O
for	O
the	O
mitochondrial	O
(	O
Mito	O
)	O
and	O
myofibrillar	O
(	O
Myo	O
)	O
fractions	O
based	O
on	O
analysis	O
of	O
electron	B-CHEBI
micrographs	O
(	O
three	O
sections	O
from	O
three	O
animals	O
per	O
group	O
)	O
.	O

The	O
bars	O
represent	O
mean	O
+/-	O
SEM	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
compared	O
to	O
corresponding	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
values	O
.	O

(	O
C	O
)	O
Gene	O
expression	O
data	O
.	O

The	O
results	O
of	O
real	O
-	O
time	O
PCR	O
analysis	O
of	O
nuclear	O
and	O
mitochondrial	O
genes	O
involved	O
in	O
various	O
components	O
of	O
mitochondrial	O
metabolism	O
and	O
mitochondrial	O
biogenesis	O
:	O
cytochrome	B-CHEBI
C	I-CHEBI
(	O
Cyto	B-CHEBI
c	I-CHEBI
)	O
,	O
ATP	B-CHEBI
synthase	O
beta	O
,	O
Tfam	O
,	O
and	O
cytochrome	B-CHEBI
oxidase	O
IV	O
(	O
COX	O
IV	O
)	O
.	O

Eight	O
littermate	O
pairs	O
were	O
used	O
for	O
analysis	O
at	O
1	O
-	O
2	O
mo	O
of	O
age	O
and	O
normalized	O
to	O
the	O
WT	O
value	O
,	O
which	O
was	O
assigned	O
a	O
value	O
of	O
100	O
,	O
in	O
each	O
case	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
compared	O
to	O
corresponding	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
values	O
.	O

(	O
D	O
)	O
Mitochondrial	O
respiration	O
rates	O
as	O
determined	O
by	O
oxygen	B-CHEBI
consumption	O
(	O
VO2	O
)	O
performed	O
on	O
saponin	O
-	O
permeabilized	O
muscle	O
strips	O
prepared	O
from	O
soleus	O
of	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
(	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
)	O
.	O

The	O
results	O
are	O
based	O
on	O
six	O
female	O
animals	O
in	O
each	O
group	O
,	O
using	O
succinate	B-CHEBI
as	O
a	O
substrate	O
in	O
the	O
presence	O
of	O
rotenone	B-CHEBI
.	O

Mean	O
values	O
(	O
+/-	O
SEM	O
)	O
are	O
shown	O
for	O
state	O
2	O
(	O
basal	O
)	O
,	O
state	O
3	O
(	O
ADP	B-CHEBI
-	O
stimulated	O
)	O
,	O
and	O
state	O
4	O
respiration	O
(	O
presence	O
of	O
oligomycin	B-CHEBI
)	O
.	O

Figure	O
4	O

PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O
Exhibit	O
an	O
Abnormal	O
Skeletal	O
Muscle	O
Functional	O
Phenotype	O

(	O
A	O
)	O
Measures	O
of	O
general	O
activity	O
and	O
muscle	O
strength	O
.	O

General	O
activity	O
levels	O
were	O
measured	O
in	O
3	O
.	O
5	O
-	O
mo	O
-	O
old	O
male	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
n	O
=	O
8	O
)	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
(	O
n	O
=	O
11	O
)	O
mice	O
using	O
a	O
photobeam	O
system	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
.	O

Total	O
ambulations	O
(	O
left	O
graph	O
)	O
,	O
and	O
rearings	O
(	O
center	O
graph	O
)	O
provide	O
a	O
general	O
measure	O
of	O
locomotor	O
activity	O
.	O

Time	O
spent	O
on	O
an	O
inverted	O
screen	O
(	O
right	O
graph	O
)	O
represents	O
a	O
general	O
measure	O
of	O
extremity	O
muscle	O
strength	O
.	O

The	O
results	O
from	O
two	O
trials	O
are	O
shown	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
compared	O
to	O
corresponding	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
.	O

(	O
B	O
)	O
Exercise	O
studies	O
.	O

Male	O
6	O
-	O
8	O
-	O
mo	O
-	O
old	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
and	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O
were	O
subjected	O
to	O
a	O
run	O
-	O
to	O
-	O
exhaustion	O
protocol	O
on	O
a	O
motorized	O
treadmill	O
(	O
left	O
graph	O
)	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
.	O

*	O
p	O
<	O
0	O
.	O
001	O
compared	O
to	O
corresponding	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
values	O
.	O

VO2max	O
measurements	O
were	O
determined	O
for	O
2	O
-	O
mo	O
-	O
old	O
male	O
mice	O
for	O
each	O
genotype	O
using	O
a	O
motorized	O
treadmill	O
at	O
an	O
elevation	O
of	O
150	O
m	O
and	O
indirect	O
calorimetry	O
set	O
-	O
up	O
(	O
right	O
graph	O
)	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
compared	O
to	O
corresponding	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
values	O
.	O

(	O
C	O
)	O
Time	O
course	O
of	O
fatigue	O
following	O
repeated	O
stimulation	O
of	O
soleus	O
muscle	O
is	O
shown	O
for	O
4	O
-	O
mo	O
-	O
old	O
male	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
(	O
n	O
=	O
5	O
)	O
and	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
n	O
=	O
5	O
)	O
mice	O
(	O
left	O
graph	O
)	O
.	O

The	O
mean	O
percent	O
force	O
remaining	O
at	O
2	O
min	O
(	O
Fatigue	O
Resistance	O
Index	O
)	O
is	O
shown	O
(	O
right	O
graph	O
)	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
compared	O
to	O
corresponding	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
values	O
.	O

Figure	O
5	O

Abnormal	O
Cardiac	O
Response	O
to	O
Physiologic	O
Stress	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O

(	O
A	O
)	O
Exercise	O
echocardiographic	O
studies	O
.	O

PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
n	O
=	O
4	O
)	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
(	O
n	O
=	O
8	O
)	O
female	O
mice	O
aged	O
6	O
-	O
8	O
mo	O
were	O
subjected	O
to	O
an	O
exercise	O
protocol	O
on	O
a	O
motorized	O
treadmill	O
.	O

This	O
protocol	O
was	O
designed	O
such	O
that	O
the	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
ran	O
to	O
exhaustion	O
based	O
on	O
the	O
results	O
of	O
the	O
exercise	O
studies	O
shown	O
in	O
Figure	O
4	O
.	O

Accordingly	O
,	O
an	O
exercise	O
regimen	O
of	O
60	O
s	O
was	O
used	O
for	O
both	O
groups	O
.	O

The	O
graphs	O
depict	O
the	O
heart	O
rate	O
(	O
left	O
graph	O
)	O
and	O
echocardiographically	O
-	O
determined	O
ventricular	O
fractional	O
shortening	O
(	O
FS	O
)	O
as	O
a	O
percent	O
(	O
right	O
graph	O
)	O
.	O

Responses	O
were	O
monitored	O
for	O
10	O
min	O
immediately	O
post	O
exercise	O
.	O

(	O
B	O
)	O
In	O
vivo	O
hemodynamic	O
response	O
to	O
the	O
beta	O
1	O
,	O
alpha	O
1	O
-	O
adrenergic	B-CHEBI
agonist	I-CHEBI
dobutamine	O
.	O

Male	O
and	O
female	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
n	O
=	O
6	O
)	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
(	O
n	O
=	O
6	O
)	O
mice	O
at	O
10	O
-	O
12	O
wk	O
of	O
age	O
were	O
anesthetized	O
and	O
a	O
1	O
.	O
4	O
-	O
French	O
Millar	O
catheter	O
was	O
placed	O
through	O
the	O
carotid	O
artery	O
into	O
the	O
left	O
ventricle	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
.	O

Heart	O
rate	O
(	O
left	O
graph	O
)	O
and	O
a	O
measurement	O
of	O
ventricular	O
systolic	O
performance	O
,	O
dP	O
/	O
dt	O
(	O
right	O
graph	O
)	O
,	O
were	O
measured	O
following	O
infusion	O
of	O
dobutamine	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
.	O

Figure	O
6	O

PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O
Exhibit	O
an	O
Abnormal	O
Thermogenic	O
Response	O

(	O
A	O
)	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
n	O
=	O
15	O
)	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
(	O
n	O
=	O
21	O
)	O
mice	O
aged	O
28	O
-	O
37	O
d	O
were	O
subjected	O
to	O
cold	O
(	O
4	O
degrees	O
C	O
)	O
.	O

Core	O
rectal	O
temperature	O
was	O
monitored	O
over	O
a	O
5	O
-	O
h	O
period	O
.	O

The	O
change	O
in	O
core	O
temperature	O
+/-	O
SEM	O
is	O
shown	O
in	O
the	O
graph	O
(	O
left	O
)	O
as	O
a	O
function	O
of	O
time	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
.	O

(	O
B	O
)	O
Representative	O
Northern	O
blot	O
analysis	O
(	O
blot	O
and	O
gel	O
at	O
top	O
)	O
performed	O
with	O
RNA	O
isolated	O
from	O
BAT	O
to	O
detect	O
UCP	O
-	O
1	O
transcript	O
at	O
baseline	O
(	O
RT	O
)	O
and	O
after	O
5	O
h	O
of	O
exposure	O
to	O
cold	O
(	O
4	O
degrees	O
C	O
)	O
(	O
UCP1	O
)	O
.	O

Ethidium	B-CHEBI
bromide	I-CHEBI
(	O
Eth	B-CHEBI
Br	I-CHEBI
)	O
staining	O
of	O
ribosomal	B-CHEBI
RNA	I-CHEBI
is	O
shown	O
as	O
a	O
control	O
.	O

Quantitative	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
for	O
UCP	O
-	O
1	O
transcript	O
is	O
shown	O
on	O
the	O
graph	O
at	O
the	O
bottom	O
.	O

The	O
values	O
represent	O
mean	O
arbitrary	O
units	O
normalized	O
to	O
a	O
36B4	O
transcript	O
(	O
control	O
)	O
.	O

(	O
C	O
)	O
Altered	O
response	O
to	O
beta	O
3	O
-	O
adrenergic	B-CHEBI
agonist	I-CHEBI
.	O

To	O
evaluate	O
the	O
oxygen	B-CHEBI
consumption	O
(	O
VO2	O
)	O
in	O
response	O
to	O
the	O
stimulation	O
of	O
BAT	O
uncoupled	O
respiration	O
,	O
the	O
beta	O
3	O
-	O
adrenergic	B-CHEBI
agonist	I-CHEBI
BRL	O
37344	O
was	O
administered	O
to	O
littermate	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
n	O
=	O
5	O
)	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
(	O
n	O
=	O
5	O
)	O
female	O
mice	O
followed	O
by	O
measurement	O
of	O
VO2	O
by	O
indirect	O
calorimetry	O
.	O

Mean	O
+/-	O
SEM	O
VO2	O
is	O
shown	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
.	O

Figure	O
7	O

Fasting	O
-	O
Induced	O
Hepatic	O
Steatosis	O
Develops	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O

(	O
A	O
)	O
The	O
photograph	O
depicts	O
the	O
development	O
of	O
a	O
pale	O
liver	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
subjected	O
to	O
a	O
24	O
-	O
h	O
fast	O
.	O

(	O
B	O
)	O
Oil	O
red	O
O	O
staining	O
of	O
histologic	O
sections	O
of	O
liver	O
taken	O
from	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
under	O
fed	O
and	O
24	O
h	O
fasted	O
conditions	O
.	O

The	O
red	O
staining	O
indicates	O
neutral	O
lipid	B-CHEBI
.	O

(	O
C	O
)	O
Representative	O
electron	B-CHEBI
micrographs	O
of	O
the	O
liver	O
from	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
following	O
a	O
24	O
-	O
h	O
fast	O
.	O

The	O
droplets	O
are	O
indicative	O
of	O
neutral	O
lipid	B-CHEBI
accumulation	O
.	O

(	O
D	O
)	O
Mean	O
liver	O
TAG	B-CHEBI
levels	O
in	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
n	O
=	O
5	O
)	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
(	O
n	O
=	O
5	O
)	O
mice	O
under	O
fed	O
and	O
24	O
-	O
h	O
fasted	O
conditions	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
.	O

Figure	O
8	O

Hepatocytes	O
Isolated	O
from	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O
Exhibit	O
Reduced	O
Oxidative	O
Capacity	O

(	O
A	O
)	O
Oil	O
red	O
O	O
staining	O
of	O
isolated	O
hepatocytes	O
exposed	O
to	O
BSA	O
alone	O
(	O
BSA	O
)	O
or	O
50	O
mu	O
M	O
oleate	B-CHEBI
complexed	O
to	O
BSA	O
(	O
oleate	B-CHEBI
)	O
.	O

(	O
B	O
)	O
3H	B-CHEBI
-	O
palmitate	B-CHEBI
oxidation	O
rates	O
.	O

3H	B-CHEBI
-	O
palmitate	B-CHEBI
oxidation	O
rates	O
determined	O
in	O
hepatocytes	O
isolated	O
from	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
under	O
cell	O
culture	O
conditions	O
containing	O
BSA	O
or	O
BSA	O
+	O
50	O
mu	O
M	O
oleate	B-CHEBI
(	O
2	O
:	O
1	O
oleate	B-CHEBI
/	O
BSA	O
ratio	O
)	O
.	O

Values	O
were	O
derived	O
from	O
ten	O
sets	O
of	O
triplicates	O
for	O
each	O
group	O
using	O
hepatocytes	O
from	O
5	O
mice	O
of	O
each	O
genotype	O
.	O

The	O
bars	O
represent	O
mean	O
oxidation	O
rates	O
(	O
n	O
=	O
100	O
)	O
normalized	O
to	O
the	O
condition	O
of	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
in	O
BSA	O
alone	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
compared	O
to	O
the	O
corresponding	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O
.	O

+	O
p	O
<	O
0	O
.	O
05	O
compared	O
to	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
with	O
BSA	O
treatment	O
.	O

(	O
C	O
)	O
State	O
2	O
and	O
3	O
respiration	O
rates	O
determined	O
for	O
hepatocytes	O
isolated	O
from	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
n	O
=	O
3	O
)	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
(	O
n	O
=	O
3	O
)	O
mice	O
using	O
succinate	B-CHEBI
/	O
rotenone	B-CHEBI
as	O
a	O
substrate	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
compared	O
to	O
corresponding	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
.	O

(	O
D	O
)	O
TAG	B-CHEBI
synthesis	O
rates	O
in	O
isolated	O
hepatocytes	O
.	O

The	O
bars	O
represent	O
mean	O
TAG	B-CHEBI
synthesis	O
rates	O
(	O
glycerol	B-CHEBI
incorporation	O
,	O
see	O
Materials	O
and	O
Methods	O
)	O
for	O
hepatocytes	O
isolated	O
from	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
n	O
=	O
6	O
)	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
(	O
n	O
=	O
6	O
)	O
mice	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
compared	O
to	O
the	O
corresponding	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
condition	O
.	O

Figure	O
9	O

Female	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O
Are	O
More	O
Glucose	B-CHEBI
Tolerant	O
and	O
Insulin	B-CHEBI
Sensitive	O
Compared	O
to	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
on	O
High	O
-	O
Fat	O
Diet	O

(	O
A	O
)	O
At	O
4	O
.	O
5	O
mo	O
of	O
age	O
,	O
glucose	B-CHEBI
tolerance	O
testing	O
(	O
GTT	O
)	O
was	O
performed	O
on	O
female	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
n	O
=	O
6	O
)	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
(	O
n	O
=	O
6	O
)	O
mice	O
maintained	O
on	O
standard	O
chow	B-CHEBI
.	O

(	O
B	O
)	O
At	O
8	O
wk	O
of	O
age	O
,	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
n	O
=	O
8	O
)	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
(	O
n	O
=	O
11	O
)	O
mice	O
were	O
provided	O
a	O
diet	O
containing	O
43	O
%	O
of	O
its	O
calories	O
from	O
fat	O
(	O
HF	O
chow	B-CHEBI
)	O
.	O

The	O
graphs	O
depict	O
blood	O
glucose	B-CHEBI
levels	O
+/-	O
SEM	O
in	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
during	O
GTT	O
(	O
left	O
graph	O
)	O
and	O
ITT	O
(	O
right	O
graph	O
)	O
studies	O
.	O

Studies	O
were	O
performed	O
5	O
wk	O
(	O
GTT	O
)	O
and	O
6	O
wk	O
(	O
ITT	O
)	O
after	O
the	O
initiation	O
of	O
the	O
high	O
-	O
fat	O
diet	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
compared	O
to	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O
at	O
the	O
same	O
time	O
point	O
.	O

Figure	O
10	O

Neuropathology	O
of	O
the	O
Central	O
Nervous	O
System	O
of	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O

(	O
A	O
)	O
Light	O
microscopic	O
appearance	O
of	O
representative	O
cerebral	O
cortex	O
of	O
2	O
-	O
mo	O
-	O
old	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mice	O
demonstrates	O
marked	O
vacuolation	O
of	O
the	O
neuropil	O
(	O
arrows	O
)	O
and	O
scattered	O
neuronal	O
perikarya	O
,	O
which	O
are	O
absent	O
in	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O
(	O
hematoxylin	O
and	O
eosin	O
)	O
.	O

The	O
scale	O
bar	O
shown	O
is	O
applicable	O
to	O
all	O
sections	O
.	O

(	O
B	O
)	O
Ultrastructural	O
appearance	O
of	O
typical	O
vacuoles	O
containing	O
membranous	O
debris	O
,	O
denoted	O
by	O
the	O
arrow	O
,	O
in	O
the	O
cerebral	O
cortex	O
of	O
a	O
representative	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
mouse	O
in	O
comparison	O
to	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
(	O
magnification	O
4000	O
x	O
)	O
.	O

Table	O
1	O

Cardiac	O
Hemodynamics	O
Measured	O
in	O
Isolated	O
Working	O
Hearts	O
of	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O

Values	O
represent	O
mean	O
+/-	O
SEM	O

a	O
p	O
<	O
0	O
.	O
05	O

Table	O
2	O

Metabolic	O
Gene	O
Expression	O
in	O
Liver	O
of	O
Fed	O
and	O
Fasted	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
and	O
PGC	O
-	O
1	O
alpha	O
-	O
/	O
-	O
Mice	O

Values	O
represent	O
mean	O
(	O
+/-	O
SEM	O
)	O
(	O
n	O
>=	O
6	O
for	O
each	O
group	O
)	O
mRNA	B-CHEBI
levels	O
as	O
determined	O
by	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
corrected	O
for	O
GAPDH	O
signal	O
intensity	O
and	O
normalized	O
(	O
to	O
1	O
.	O
0	O
)	O
to	O
the	O
value	O
of	O
fed	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O

a	O
p	O
<	O
0	O
.	O
05	O
versus	O
fed	O
mice	O
of	O
the	O
same	O
genotype	O

b	O
p	O
<	O
0	O
.	O
05	O
versus	O
PGC	O
-	O
1	O
alpha	O
+	O
/	O
+	O
mice	O
of	O
the	O
same	O
dietary	O
treatment	O

L	O
-	O
CPT	O
I	O
,	O
liver	O
-	O
type	O
carnitine	B-CHEBI
palmitoyltransferase	O
;	O
MCAD	O
,	O
medium	O
-	O
chain	O
acyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
dehydrogenase	O
;	O
SREBP	O
,	O
sterol	B-CHEBI
regulatory	O
element	O
binding	O
protein	B-CHEBI
;	O
SCD	O
,	O
steroyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
desaturase	O
;	O
FAS	O
,	O
fatty	B-CHEBI
acid	I-CHEBI
synthase	O
;	O
GPAT	O
,	O
glycerol	B-CHEBI
-	O
3	O
-	O
phosphate	B-CHEBI
acyltransferase	O
;	O
DGAT	O
,	O
diacylglycerol	B-CHEBI
acyltransferase	O

Footnotes	O

Author	O
contributions	O
.	O

TCL	O
,	O
JJL	O
,	O
BNF	O
,	O
PJS	O
,	O
and	O
DPK	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

TCL	O
,	O
JJL	O
,	O
BNF	O
,	O
PJS	O
,	O
ARW	O
,	O
SB	O
,	O
MC	O
,	O
DFW	O
,	O
NS	O
,	O
CBM	O
,	O
ZC	O
,	O
DMM	O
,	O
RES	O
,	O
and	O
EDA	O
performed	O
the	O
experiments	O
.	O

TCL	O
,	O
JJL	O
,	O
BNF	O
,	O
PJS	O
,	O
ARW	O
,	O
SB	O
,	O
MC	O
,	O
DFW	O
,	O
NS	O
,	O
CBM	O
,	O
ZC	O
,	O
JOH	O
,	O
DMM	O
,	O
RES	O
,	O
JES	O
,	O
EDA	O
,	O
CFS	O
,	O
and	O
DPK	O
analyzed	O
the	O
data	O
.	O

TCL	O
,	O
BNF	O
,	O
and	O
DPK	O
wrote	O
the	O
paper	O
.	O

Citation	O
:	O
Leone	O
TC	O
,	O
Lehman	O
JJ	O
,	O
Finck	O
BN	O
,	O
Schaeffer	O
PJ	O
,	O
Wende	O
AR	O
,	O
et	O
al	O
.	O

(	O
2005	O
)	O
PGC	O
-	O
1	O
alpha	O
-	O
deficiency	O
causes	O
multi	O
-	O
system	O
energy	O
metabolic	O
derangements	O
:	O
Muscle	O
dysfunction	O
,	O
abnormal	O
weight	O
control	O
and	O
hepatic	O
steatosis	O
.	O

PLoS	O
Biol	O
3	O
(	O
4	O
)	O
:	O
e101	O
.	O

Nuclear	O
localization	O
of	O
Annexin	O
A7	O
during	O
murine	O
brain	O
development	O

Abstract	O

Background	O

Annexin	O
A7	O
is	O
a	O
member	O
of	O
the	O
annexin	O
protein	B-CHEBI
family	O
,	O
which	O
is	O
characterized	O
by	O
its	O
ability	O
to	O
interact	O
with	O
phospholipids	B-CHEBI
in	O
the	O
presence	O
of	O
Ca2	B-CHEBI
+	I-CHEBI
-	I-CHEBI
ions	I-CHEBI
and	O
which	O
is	O
thought	O
to	O
function	O
in	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
homeostasis	O
.	O

Results	O
from	O
mutant	O
mice	O
showed	O
altered	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
wave	O
propagation	O
in	O
astrocytes	O
.	O

As	O
the	O
appearance	O
and	O
distribution	O
of	O
Annexin	O
A7	O
during	O
brain	O
development	O
has	O
not	O
been	O
investigated	O
so	O
far	O
,	O
we	O
focused	O
on	O
the	O
distribution	O
of	O
Annexin	O
A7	O
protein	B-CHEBI
during	O
mouse	O
embryogenesis	O
in	O
the	O
developing	O
central	O
nervous	O
system	O
and	O
in	O
the	O
adult	O
mouse	O
brain	O
.	O

Results	O

Annexin	O
A7	O
is	O
expressed	O
in	O
cells	O
of	O
the	O
developing	O
brain	O
where	O
a	O
change	O
in	O
its	O
subcellular	O
localization	O
from	O
cytoplasm	O
to	O
nucleus	O
was	O
observed	O
.	O

In	O
the	O
adult	O
CNS	O
,	O
the	O
subcellular	O
distribution	O
of	O
Annexin	O
A7	O
depends	O
on	O
the	O
cell	O
type	O
.	O

By	O
immunohistochemistry	O
analysis	O
Annexin	O
A7	O
was	O
detected	O
in	O
the	O
cytosol	O
of	O
undifferentiated	O
cells	O
at	O
embryonic	O
days	O
E5	O
-	O
E8	O
.	O

At	O
E11	O
-	O
E15	O
the	O
protein	B-CHEBI
is	O
still	O
present	O
in	O
the	O
cytosol	O
of	O
cells	O
predominantly	O
located	O
in	O
the	O
ventricular	O
germinative	O
zone	O
surrounding	O
the	O
lateral	O
ventricle	O
.	O

Later	O
on	O
,	O
at	O
embryonic	O
day	O
E16	O
,	O
Annexin	O
A7	O
in	O
cells	O
of	O
the	O
intermediate	O
and	O
marginal	O
zone	O
of	O
the	O
neopallium	O
translocates	O
to	O
the	O
nucleus	O
.	O

Neuronal	O
cells	O
of	O
all	O
areas	O
in	O
the	O
adult	O
brain	O
present	O
Annexin	O
A7	O
in	O
the	O
nucleus	O
,	O
whereas	O
glial	O
fibrillary	O
acidic	B-CHEBI
protein	B-CHEBI
(	O
GFAP	O
)	O
-	O
positive	O
astrocytes	O
exhibit	O
both	O
,	O
a	O
cytoplasmic	O
and	O
nuclear	O
staining	O
.	O

The	O
presence	O
of	O
nuclear	O
Annexin	O
A7	O
was	O
confirmed	O
by	O
extraction	O
of	O
the	O
nucleoplasm	O
from	O
isolated	O
nuclei	O
obtained	O
from	O
neuronal	O
and	O
astroglial	O
cell	O
lines	O
.	O

Conclusion	O

We	O
have	O
demonstrated	O
a	O
translocation	O
of	O
Annexin	O
A7	O
to	O
nuclei	O
of	O
cells	O
in	O
early	O
murine	O
brain	O
development	O
and	O
the	O
presence	O
of	O
Annexin	O
A7	O
in	O
nuclei	O
of	O
neuronal	O
cells	O
in	O
the	O
adult	O
animal	O
.	O

The	O
role	O
of	O
Annexin	O
A7	O
in	O
nuclei	O
of	O
differentiating	O
and	O
mature	O
neuronal	O
cells	O
remains	O
elusive	O
.	O

Background	O

Annexins	O
form	O
a	O
family	O
of	O
structurally	O
related	O
proteins	B-CHEBI
,	O
which	O
bind	O
to	O
negatively	O
charged	O
phospholipids	B-CHEBI
in	O
a	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
dependent	O
manner	O
[	O
1	O
]	O
.	O

They	O
are	O
characterized	O
by	O
a	O
bipartite	O
structure	O
with	O
a	O
conserved	O
C	B-CHEBI
-	O
terminal	O
core	O
domain	O
and	O
a	O
unique	O
N	B-CHEBI
-	O
terminal	O
domain	O
that	O
varies	O
in	O
length	O
and	O
amino	B-CHEBI
acid	I-CHEBI
composition	O
.	O

The	O
C	B-CHEBI
-	O
terminal	O
domain	O
is	O
formed	O
by	O
either	O
a	O
four	O
-	O
or	O
eightfold	O
repeat	O
of	O
approximately	O
70	O
amino	B-CHEBI
acids	I-CHEBI
,	O
each	O
repeat	O
carrying	O
a	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
binding	O
site	O
,	O
and	O
is	O
responsible	O
for	O
phospholipid	B-CHEBI
binding	O
.	O

The	O
N	B-CHEBI
-	O
terminal	O
regions	O
are	O
thought	O
to	O
confer	O
functional	O
diversity	O
to	O
the	O
annexin	O
proteins	B-CHEBI
[	O
2	O
]	O
.	O

The	O
biochemical	O
features	O
in	O
vitro	O
were	O
analyzed	O
extensively	O
,	O
but	O
the	O
in	O
vivo	O
functions	O
of	O
annexins	O
remain	O
unclear	O
.	O

Annexin	O
A7	O
,	O
the	O
first	O
annexin	O
to	O
be	O
described	O
,	O
was	O
isolated	O
as	O
the	O
agent	O
that	O
mediated	O
aggregation	O
of	O
chromaffin	O
granules	O
and	O
fusion	O
of	O
membranes	O
and	O
phospholipids	B-CHEBI
in	O
the	O
presence	O
of	O
Ca2	B-CHEBI
+	I-CHEBI
-	I-CHEBI
ions	I-CHEBI
[	O
3	O
]	O
.	O

Expression	O
studies	O
demonstrated	O
the	O
distribution	O
of	O
Annexin	O
A7	O
in	O
a	O
wide	O
variety	O
of	O
tissues	O
and	O
cells	O
mainly	O
enriched	O
in	O
the	O
cytosol	O
in	O
close	O
association	O
with	O
membranous	O
structures	O
,	O
but	O
it	O
was	O
also	O
described	O
in	O
the	O
nucleus	O
of	O
adrenal	O
chromaffin	O
cells	O
[	O
4	O
]	O
.	O

The	O
presence	O
of	O
an	O
alternatively	O
spliced	O
cassette	O
exon	O
gives	O
rise	O
to	O
two	O
Annexin	O
A7	O
isoforms	O
corresponding	O
in	O
molecular	B-CHEBI
mass	O
to	O
47	O
kDa	O
and	O
51	O
kDa	O
.	O

The	O
isoforms	O
differ	O
in	O
their	O
N	B-CHEBI
-	O
terminal	O
domain	O
and	O
exhibit	O
a	O
tissue	O
-	O
specific	O
expression	O
pattern	O
.	O

The	O
47	O
kDa	O
isoform	O
is	O
present	O
in	O
all	O
tissues	O
except	O
for	O
skeletal	O
muscle	O
,	O
where	O
the	O
51	O
kDa	O
isoform	O
is	O
exclusively	O
present	O
.	O

Heart	O
muscle	O
,	O
brain	O
tissue	O
and	O
red	O
blood	O
cells	O
contain	O
both	O
isoforms	O
[	O
5	O
-	O
8	O
]	O
.	O

Previous	O
studies	O
indicated	O
that	O
the	O
subcellular	O
localization	O
of	O
Annexin	O
A7	O
changes	O
during	O
myoblast	O
differentiation	O
.	O

In	O
undifferentiated	O
cells	O
the	O
protein	B-CHEBI
is	O
equally	O
distributed	O
between	O
cytosol	O
and	O
membrane	O
fractions	O
while	O
in	O
differentiated	O
cells	O
it	O
is	O
exclusively	O
present	O
in	O
the	O
membrane	O
fraction	O
[	O
7	O
]	O
.	O

Reports	O
by	O
Clemen	O
et	O
al	O
.	O

[	O
9	O
]	O
and	O
Herr	O
et	O
al	O
.	O

[	O
8	O
,	O
10	O
]	O
demonstrated	O
roles	O
for	O
Annexin	O
A7	O
in	O
shape	O
and	O
osmotic	O
resistance	O
of	O
red	O
blood	O
cells	O
,	O
platelet	O
aggregation	O
velocity	O
,	O
and	O
in	O
the	O
velocity	O
of	O
spreading	O
astrocytic	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
waves	O
.	O

Annexin	O
A7	O
is	O
also	O
involved	O
in	O
the	O
maintenance	O
of	O
regular	O
cardiac	O
electrophysiology	O
and	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
homeostasis	O
[	O
Schrickel	O
et	O
al	O
.	O
,	O
submitted	O
]	O
.	O

Detailed	O
reports	O
on	O
appearance	O
and	O
distribution	O
of	O
Annexin	O
A7	O
during	O
brain	O
development	O
are	O
not	O
available	O
.	O

In	O
the	O
present	O
study	O
we	O
focus	O
on	O
the	O
distribution	O
of	O
Annexin	O
A7	O
in	O
the	O
developing	O
brain	O
of	O
mice	O
embryos	O
between	O
E5	O
and	O
E16	O
,	O
and	O
in	O
the	O
adult	O
mouse	O
brain	O
.	O

Results	O

Annexin	O
A7	O
is	O
expressed	O
in	O
the	O
early	O
mouse	O
embryo	O

First	O
we	O
examined	O
the	O
expression	O
of	O
Annexin	O
A7	O
in	O
ES	O
cells	O
(	O
Bruce4	O
,	O
established	O
from	O
C57BL	O
/	O
6J	O
mice	O
)	O
and	O
the	O
early	O
stages	O
of	O
mouse	O
embryonic	O
development	O
at	O
the	O
mRNA	B-CHEBI
level	O
by	O
northern	O
blot	O
analysis	O
and	O
at	O
the	O
protein	B-CHEBI
level	O
by	O
Western	O
blotting	O
and	O
immunohistochemistry	O
,	O
respectively	O
.	O

Northern	O
blot	O
analysis	O
shows	O
in	O
ES	O
-	O
cells	O
and	O
at	O
embryonic	O
days	O
E7	O
,	O
E11	O
,	O
E15	O
,	O
and	O
E17	O
two	O
mRNA	B-CHEBI
species	O
of	O
1	O
.	O
8	O
kb	O
and	O
2	O
.	O
4	O
kb	O
,	O
which	O
result	O
from	O
alternative	O
splicing	O
in	O
the	O
untranslated	O
3	O
'	O
end	O
(	O
Fig	O
.	O
1A	O
)	O
[	O
11	O
]	O
.	O

We	O
found	O
similar	O
Annexin	O
A7	O
mRNA	B-CHEBI
levels	O
in	O
the	O
four	O
embryonic	O
stages	O
.	O

Reprobing	O
with	O
a	O
beta	O
-	O
actin	O
probe	O
verified	O
equal	O
loading	O
;	O
the	O
appearance	O
of	O
a	O
faster	O
migrating	O
mRNA	B-CHEBI
species	O
in	O
addition	O
to	O
the	O
2	O
.	O
0	O
kb	O
species	O
is	O
characteristic	O
for	O
beta	O
-	O
actin	O
[	O
12	O
]	O
.	O

On	O
the	O
protein	B-CHEBI
level	O
,	O
ES	O
cells	O
express	O
only	O
the	O
smaller	O
Annexin	O
A7	O
isoform	O
of	O
47	O
kDa	O
(	O
Fig	O
.	O
1B	O
,	O
neuro	O
-	O
2a	O
cells	O
and	O
heart	O
tissue	O
are	O
included	O
for	O
control	O
)	O
.	O

Figure	O
1	O

Expression	O
of	O
Annexin	O
A7	O
.	O

(	O
A	O
)	O
Northern	O
blot	O
analysis	O
of	O
RNA	O
from	O
ES	O
-	O
cells	O
and	O
embryos	O
E7	O
,	O
E11	O
,	O
E15	O
,	O
E17	O
probed	O
with	O
a	O
full	O
length	O
annexin	O
A7	O
cDNA	O
.	O

Transcripts	O
of	O
1	O
.	O
8	O
and	O
2	O
.	O
4	O
kb	O
are	O
detected	O
in	O
all	O
stages	O
examined	O
(	O
upper	O
panel	O
)	O
.	O

Reprobing	O
with	O
a	O
beta	O
-	O
actin	O
probe	O
verified	O
equal	O
loading	O
(	O
lower	O
panel	O
,	O
2	O
.	O
0	O
kb	O
band	O
)	O
.	O

(	O
B	O
)	O
Murine	O
ES	O
cells	O
(	O
ES	O
)	O
express	O
only	O
the	O
small	O
Annexin	O
A7	O
isoform	O
.	O

Both	O
isoforms	O
are	O
expressed	O
in	O
neuroblastoma	O
neuro	O
-	O
2a	O
cells	O
(	O
N2A	O
)	O
,	O
heart	O
(	O
HRT	O
)	O
and	O
brain	O
tissue	O
(	O
CNS	O
)	O
from	O
adult	O
mice	O
.	O

Proteins	B-CHEBI
from	O
neuro	O
-	O
2a	O
and	O
ES	O
cells	O
,	O
heart	O
and	O
brain	O
were	O
resolved	O
by	O
SDS	B-CHEBI
polyacrylamide	O
gel	O
electrophoresis	O
(	O
12	O
%	O
acrylamide	B-CHEBI
)	O
and	O
transferred	O
to	O
nitrocellulose	O
membranes	O
.	O

The	O
Western	O
blot	O
was	O
probed	O
with	O
mAb	O
203	O
-	O
217	O
followed	O
by	O
incubation	O
with	O
a	O
peroxidase	O
coupled	O
secondary	O
antibody	O
.	O

Detection	O
was	O
with	O
enhanced	O
chemiluminescence	O
.	O

Immunohistochemistry	O
confirmed	O
the	O
presence	O
of	O
the	O
protein	B-CHEBI
during	O
early	O
development	O
.	O

Annexin	O
A7	O
immunoreactivity	O
using	O
mAb	O
203	O
-	O
217	O
,	O
which	O
specifically	O
recognizes	O
both	O
isoforms	O
of	O
Annexin	O
A7	O
,	O
can	O
be	O
observed	O
in	O
the	O
two	O
cell	O
types	O
of	O
the	O
cylinder	O
stage	O
at	O
E5	O
with	O
a	O
weaker	O
Annexin	O
A7	O
expression	O
in	O
the	O
ectoderm	O
(	O
Fig	O
.	O
2A	O
-	O
C	O
)	O
.	O

At	O
E8	O
Annexin	O
A7	O
can	O
be	O
detected	O
in	O
almost	O
all	O
tissues	O
of	O
the	O
embryo	O
(	O
data	O
not	O
shown	O
)	O
.	O

A	O
correlation	O
between	O
the	O
presence	O
of	O
Annexin	O
A7	O
and	O
the	O
origin	O
of	O
a	O
cell	O
type	O
from	O
one	O
of	O
the	O
three	O
germ	O
layers	O
is	O
not	O
apparent	O
.	O

We	O
specifically	O
noted	O
the	O
localization	O
of	O
the	O
protein	B-CHEBI
in	O
the	O
neuroepithelium	O
of	O
the	O
neural	O
fold	O
and	O
tube	O
(	O
Fig	O
.	O
2D	O
-	O
F	O
,	O
proximal	O
,	O
E8	O
;	O
Fig	O
.	O
2G	O
-	O
I	O
,	O
distal	O
,	O
E13	O
)	O
.	O

At	O
the	O
subcellular	O
level	O
,	O
Annexin	O
A7	O
was	O
present	O
in	O
punctate	O
structures	O
mainly	O
in	O
the	O
cytosol	O
of	O
all	O
examined	O
cells	O
(	O
Fig	O
.	O
2E	O
,	O
F	O
)	O
.	O

This	O
distribution	O
was	O
also	O
observed	O
during	O
subsequent	O
development	O
.	O

Figure	O
2	O

Annexin	O
A7	O
immunoreactivity	O
in	O
early	O
mouse	O
embryos	O
.	O

(	O
A	O
)	O
Phase	O
contrast	O
,	O
embryo	O
E5	O
:	O
The	O
egg	O
cylinder	O
consists	O
of	O
an	O
inner	O
cell	O
mass	O
(	O
a	O
)	O
representing	O
the	O
ectoderm	O
and	O
an	O
outer	O
layer	O
of	O
endoderm	O
cells	O
(	O
b	O
)	O
.	O

(	O
B	O
)	O
Immunostaining	O
of	O
the	O
paraffin	O
section	O
was	O
performed	O
using	O
purified	O
mAb	O
203	O
-	O
217	O
and	O
Cy3	O
-	O
conjugated	O
anti	O
-	O
mouse	O
IgG	O
.	O

Annexin	O
A7	O
is	O
expressed	O
in	O
both	O
cell	O
types	O
of	O
the	O
egg	O
cylinder	O
with	O
a	O
strong	O
staining	O
of	O
the	O
endoderm	O
and	O
a	O
weaker	O
staining	O
of	O
the	O
ectoderm	O
.	O

The	O
nuclei	O
are	O
devoid	O
of	O
immune	O
reactions	O
.	O

(	O
C	O
)	O
Negative	O
control	O
using	O
the	O
secondary	O
Cy3	O
-	O
antibody	O
only	O
.	O

(	O
D	O
-	O
F	O
)	O
Annexin	O
A7	O
expression	O
in	O
the	O
proximal	O
neural	O
tube	O
(	O
D	O
)	O
and	O
nearby	O
neural	O
fold	O
(	O
E	O
,	O
F	O
)	O
,	O
embryo	O
E8	O
,	O
transverse	O
section	O
.	O

Immunolabeling	O
of	O
Annexin	O
A7	O
was	O
performed	O
with	O
purified	O
mAb	O
203	O
-	O
217	O
and	O
visualization	O
was	O
with	O
an	O
Alexa	O
Fluor	O
488	O
-	O
conjugated	O
anti	O
-	O
mouse	O
IgG	O
.	O

(	O
D	O
)	O
An	O
intense	O
Annexin	O
A7	O
immunostaining	O
is	O
detectable	O
in	O
the	O
neuroepithelium	O
of	O
the	O
neural	O
tube	O
(	O
a	O
,	O
lumen	O
of	O
neural	O
tube	O
)	O
.	O

(	O
E	O
,	O
F	O
)	O
Higher	O
magnifications	O
of	O
the	O
neuroepithelium	O
show	O
that	O
Annexin	O
A7	O
is	O
expressed	O
in	O
the	O
cytosol	O
.	O

Arrowheads	O
point	O
to	O
Annexin	O
A7	O
immunoreactivity	O
in	O
the	O
cytosol	O
.	O

(	O
G	O
)	O
Phase	O
contrast	O
,	O
embryo	O
E13	O
,	O
caudal	O
neural	O
tube	O
.	O

(	O
H	O
)	O
Immunostaining	O
of	O
the	O
paraffin	O
section	O
was	O
performed	O
using	O
purified	O
mAb	O
203	O
-	O
217	O
and	O
Alexa	O
Fluor	O
488	O
-	O
conjugated	O
anti	O
-	O
mouse	O
IgG	O
.	O

(	O
I	O
)	O
Negative	O
control	O
using	O
the	O
secondary	O
Alexa	O
Fluor	O
488	O
-	O
antibody	O
only	O
.	O

Bar	O
,	O
20	O
mu	O
m	O
.	O

Annexin	O
A7	O
changes	O
its	O
subcellular	O
localization	O
in	O
the	O
embryonic	O
brain	O
at	O
E16	O

Next	O
we	O
analysed	O
the	O
cellular	O
and	O
subcellular	O
distribution	O
of	O
Annexin	O
A7	O
in	O
the	O
developing	O
mouse	O
brain	O
(	O
Fig	O
.	O
3	O
)	O
.	O

At	O
E13	O
-	O
E16	O
in	O
transverse	O
sections	O
of	O
the	O
embryonic	O
brain	O
,	O
most	O
of	O
the	O
immunoreactive	O
cells	O
are	O
present	O
in	O
the	O
ventricular	O
germinative	O
zone	O
surrounding	O
the	O
lateral	O
ventricle	O
(	O
Fig	O
.	O
3A	O
,	O
overview	O
E16	O
;	O
Fig	O
.	O
3H	O
,	O
overview	O
E13	O
)	O
.	O

A	O
closer	O
inspection	O
revealed	O
that	O
Annexin	O
A7	O
is	O
mainly	O
localized	O
in	O
the	O
cytosol	O
at	O
E13	O
(	O
Fig	O
.	O
3B	O
,	O
E	O
)	O
.	O

During	O
further	O
development	O
the	O
immature	O
cells	O
have	O
rounded	O
up	O
two	O
days	O
later	O
,	O
but	O
they	O
retain	O
Annexin	O
A7	O
in	O
the	O
cytosol	O
at	O
E15	O
(	O
Fig	O
.	O
3C	O
,	O
F	O
)	O
.	O

At	O
E16	O
we	O
observed	O
the	O
first	O
prominent	O
nuclear	O
staining	O
of	O
Annexin	O
A7	O
(	O
Fig	O
.	O
3D	O
,	O
G	O
)	O
in	O
cells	O
of	O
the	O
intermediate	O
zone	O
(	O
Fig	O
.	O
3I	O
,	O
oval	O
)	O
,	O
which	O
contains	O
neurons	O
radially	O
migrating	O
towards	O
the	O
growing	O
neopallium	O
cortex	O
[	O
13	O
,	O
14	O
]	O
and	O
also	O
glial	O
cells	O
forming	O
the	O
white	O
matter	O
of	O
the	O
adult	O
cortex	O
.	O

Cells	O
located	O
marginally	O
in	O
the	O
neopallial	O
cortex	O
also	O
exhibit	O
a	O
nuclear	O
stain	O
.	O

Labelling	O
in	O
the	O
ventricular	O
germinative	O
zone	O
is	O
less	O
prominent	O
and	O
the	O
cytosol	O
is	O
no	O
longer	O
more	O
strongly	O
stained	O
than	O
the	O
nucleus	O
.	O

Figure	O
3	O

Subcellular	O
localization	O
of	O
Annexin	O
A7	O
in	O
embryos	O
E13	O
,	O
E15	O
and	O
E16	O
.	O

Paraffin	O
sections	O
of	O
embryonic	O
brain	O
were	O
stained	O
with	O
purified	O
mAb	O
203	O
-	O
217	O
.	O

Annexin	O
A7	O
was	O
visualized	O
with	O
Alexa	O
Fluor	O
488	O
-	O
conjugated	O
secondary	O
antibody	O
.	O

(	O
A	O
)	O
Overview	O
,	O
at	O
E16	O
the	O
immature	O
GFAP	O
-	O
negative	O
cells	O
of	O
the	O
forming	O
cerebral	O
neocortex	O
(	O
b	O
)	O
surrounding	O
the	O
lateral	O
ventricle	O
(	O
a	O
)	O
are	O
strongly	O
stained	O
;	O
square	O
,	O
a	O
higher	O
magnification	O
of	O
this	O
area	O
is	O
given	O
in	O
(	O
I	O
)	O
.	O

(	O
B	O
)	O
Higher	O
magnification	O
of	O
the	O
earlier	O
stage	O
E13	O
(	O
H	O
)	O
shows	O
,	O
that	O
the	O
cells	O
are	O
stained	O
in	O
the	O
cytosol	O
(	O
arrowhead	O
)	O
.	O

(	O
C	O
)	O
Two	O
days	O
later	O
at	O
E15	O
the	O
cells	O
have	O
rounded	O
up	O
,	O
and	O
Annexin	O
A7	O
stays	O
in	O
the	O
cytosol	O
.	O

(	O
D	O
)	O
At	O
E16	O
the	O
first	O
nuclear	O
staining	O
becomes	O
apparent	O
(	O
arrowhead	O
)	O
in	O
cells	O
of	O
the	O
intermediate	O
zone	O
located	O
between	O
ventricular	O
germinative	O
zone	O
and	O
marginal	O
neopallial	O
cortex	O
as	O
seen	O
in	O
(	O
I	O
)	O
,	O
oval	O
.	O

(	O
E	O
-	O
G	O
)	O
Confocal	O
microscopy	O
confirms	O
the	O
results	O
in	O
B	O
-	O
D	O
.	O

(	O
H	O
)	O
Overview	O
,	O
at	O
E13	O
the	O
immature	O
GFAP	O
-	O
negative	O
cells	O
are	O
strongly	O
stained	O
;	O
a	O
,	O
lateral	O
ventricle	O
.	O

(	O
I	O
)	O
Higher	O
magnification	O
of	O
a	O
cortical	O
section	O
of	O
(	O
A	O
,	O
square	O
)	O
demonstrating	O
ventricular	O
,	O
intermediate	O
,	O
and	O
marginal	O
zones	O
;	O
oval	O
,	O
a	O
higher	O
magnification	O
of	O
this	O
area	O
is	O
given	O
in	O
(	O
D	O
,	O
G	O
)	O
.	O

Mature	O
neurons	O
in	O
adult	O
mouse	O
brain	O
show	O
an	O
intense	O
nuclear	O
staining	O
of	O
Annexin	O
A7	O

Both	O
Annexin	O
A7	O
isoforms	O
are	O
found	O
in	O
adult	O
brain	O
tissue	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

In	O
general	O
,	O
we	O
observed	O
two	O
characteristic	O
staining	O
patterns	O
for	O
Annexin	O
A7	O
,	O
a	O
prominent	O
nuclear	O
stain	O
in	O
neurons	O
(	O
determined	O
by	O
lack	O
of	O
GFAP	O
-	O
immunoreactivity	O
,	O
localization	O
,	O
morphology	O
)	O
and	O
a	O
cytoplasmic	O
and	O
nuclear	O
stain	O
in	O
astrocytes	O
(	O
GFAP	O
-	O
positive	O
)	O
in	O
all	O
areas	O
of	O
the	O
mature	O
murine	O
brain	O
.	O

In	O
the	O
neocortex	O
(	O
isocortex	O
)	O
Annexin	O
A7	O
was	O
strongly	O
enriched	O
in	O
nuclei	O
of	O
neurons	O
of	O
all	O
six	O
cortical	O
laminae	O
(	O
Fig	O
.	O
4A	O
,	O
section	O
derived	O
from	O
cortex	O
temporalis	O
)	O
.	O

For	O
control	O
,	O
in	O
the	O
adult	O
brain	O
type	O
-	O
1	O
astrocytes	O
can	O
be	O
characterized	O
by	O
a	O
positive	O
GFAP	O
-	O
stain	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

Fig	O
.	O

4F	O
demonstrates	O
the	O
presence	O
of	O
nuclear	O
Annexin	O
A7	O
in	O
a	O
neocortical	O
neuron	O
of	O
the	O
external	O
granular	O
layer	O
(	O
layer	O
II	O
)	O
and	O
in	O
an	O
astrocytic	O
cell	O
of	O
the	O
neocortical	O
molecular	B-CHEBI
layer	O
(	O
layer	O
I	O
)	O
which	O
additionally	O
exhibits	O
an	O
intense	O
signal	O
in	O
the	O
cytoplasm	O
and	O
in	O
cellular	O
branches	O
.	O

A	O
further	O
cell	O
type	O
of	O
the	O
isocortex	O
showed	O
a	O
strong	O
immunoreactivity	O
in	O
both	O
,	O
nucleus	O
and	O
cytosol	O
,	O
and	O
was	O
identified	O
as	O
pyramidal	O
neuron	O
based	O
on	O
morphology	O
and	O
absence	O
of	O
GFAP	O
immunoreactivity	O
.	O

However	O
,	O
Annexin	O
A7	O
apparently	O
is	O
more	O
enriched	O
in	O
the	O
nucleus	O
(	O
Fig	O
.	O
4E	O
)	O
.	O

Figure	O
4	O

Annexin	O
A7	O
is	O
present	O
in	O
neurons	O
and	O
astrocytes	O
of	O
the	O
cortex	O
temporalis	O
and	O
hippocampal	O
formation	O
of	O
10	O
-	O
weeks	O
-	O
old	O
mice	O
.	O

(	O
A	O
)	O
Low	O
magnification	O
of	O
the	O
cortex	O
temporalis	O
presents	O
an	O
Annexin	O
A7	O
expression	O
in	O
cells	O
of	O
the	O
pial	O
border	O
,	O
in	O
neurons	O
of	O
all	O
six	O
isocortical	O
laminae	O
,	O
and	O
a	O
weak	O
signal	O
in	O
the	O
adjacent	O
white	O
matter	O
.	O

(	O
B	O
)	O
Corresponding	O
section	O
stained	O
with	O
GFAP	O
.	O

(	O
C	O
)	O
Staining	O
in	O
the	O
Stratum	O
pyramidalis	O
(	O
a	O
)	O
and	O
in	O
the	O
dentate	O
gyrus	O
of	O
the	O
hippocampus	O
;	O
square	O
,	O
a	O
higher	O
magnification	O
of	O
acorresponding	O
area	O
is	O
given	O
in	O
(	O
G	O
,	O
H	O
)	O
.	O

An	O
intense	O
Annexin	O
A7	O
immunostaining	O
is	O
detectable	O
.	O

(	O
D	O
)	O
Corresponding	O
section	O
stained	O
with	O
secondary	O
antibody	O
only	O
.	O

(	O
E	O
)	O
Presence	O
of	O
Annexin	O
A7	O
in	O
pyramidal	O
neurons	O
(	O
lamina	O
pyramidalis	O
externa	O
)	O
of	O
the	O
isocortex	O
temporalis	O
.	O

These	O
neurons	O
were	O
identified	O
based	O
on	O
their	O
morphology	O
,	O
distribution	O
and	O
lack	O
of	O
GFAP	O
staining	O
.	O

AnnexinA7	O
exhibits	O
a	O
punctate	O
staining	O
,	O
which	O
is	O
pronounced	O
in	O
the	O
nucleus	O
(	O
arrowhead	O
)	O
.	O

(	O
F	O
)	O
Higher	O
magnification	O
of	O
image	O
(	O
A	O
)	O
also	O
shows	O
Annexin	O
A7	O
in	O
nuclei	O
of	O
neurons	O
(	O
lamina	O
granularis	O
externa	O
(	O
corpuscularis	O
)	O
,	O
arrowhead	O
)	O
and	O
in	O
the	O
cytoplasm	O
and	O
nuclei	O
of	O
astrocytes	O
(	O
lamina	O
molecularis	O
,	O
arrow	O
;	O
GFAP	O
-	O
confirmed	O
)	O
.	O

(	O
G	O
)	O
Higher	O
magnification	O
of	O
the	O
pyramidal	O
neurons	O
in	O
the	O
hippocampus	O
confirms	O
the	O
presence	O
of	O
the	O
Annexin	O
A7	O
protein	B-CHEBI
in	O
the	O
nucleus	O
(	O
arrowhead	O
)	O
of	O
mature	O
neurons	O
.	O

(	O
H	O
)	O
To	O
further	O
confirm	O
this	O
,	O
a	O
similar	O
section	O
derived	O
from	O
an	O
AnxA7	O
-	O
/	O
-	O
mouse	O
was	O
stained	O
with	O
the	O
annexin	O
specific	O
antibody	O
and	O
lacked	O
the	O
nuclear	O
signal	O
.	O

The	O
residual	O
stain	O
of	O
the	O
tissue	O
is	O
unspecific	O
,	O
as	O
it	O
is	O
also	O
observed	O
in	O
controls	O
of	O
the	O
AnxA7	O
-	O
/	O
-	O
brain	O
omitting	O
the	O
primary	O
antibody	O
(	O
data	O
not	O
shown	O
)	O
.	O

All	O
paraffin	O
sections	O
were	O
stained	O
with	O
mAb	O
203	O
-	O
217	O
(	O
A	O
,	O
C	O
,	O
E	O
,	O
F	O
,	O
G	O
)	O
or	O
anti	O
-	O
GFAP	O
-	O
antibody	O
(	O
B	O
)	O
.	O

The	O
hippocampal	O
control	O
section	O
(	O
D	O
)	O
lacks	O
the	O
primary	O
antibody	O
.	O

In	O
the	O
hippocampal	O
formation	O
we	O
detected	O
prominent	O
Annexin	O
A7	O
immunostaining	O
in	O
the	O
stratum	O
pyramidalis	O
and	O
in	O
the	O
dentate	O
gyrus	O
and	O
also	O
a	O
weak	O
astrocytic	O
staining	O
(	O
Fig	O
.	O
4C	O
)	O
.	O

The	O
astrocytes	O
are	O
mainly	O
localized	O
in	O
the	O
area	O
between	O
cells	O
exhibiting	O
nuclear	O
Annexin	O
A7	O
staining	O
and	O
show	O
the	O
protein	B-CHEBI
also	O
in	O
the	O
nucleus	O
and	O
the	O
cytoplasm	O
(	O
data	O
not	O
shown	O
)	O
.	O

When	O
we	O
analyzed	O
the	O
pyramidal	O
neurons	O
in	O
the	O
hippocampus	O
at	O
a	O
higher	O
magnification	O
we	O
found	O
that	O
Annexin	O
A7	O
again	O
mainly	O
localized	O
to	O
the	O
nuclei	O
(	O
Fig	O
.	O
4G	O
)	O
.	O

Polyclonal	O
antibodies	O
gave	O
a	O
similar	O
staining	O
pattern	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
intense	O
nuclear	O
staining	O
was	O
absent	O
in	O
controls	O
either	O
stained	O
only	O
with	O
the	O
secondary	O
antibody	O
(	O
Fig	O
.	O
4D	O
)	O
or	O
in	O
brain	O
sections	O
derived	O
from	O
AnxA7	O
-	O
/	O
-	O
mice	O
stained	O
for	O
Annexin	O
A7	O
(	O
Fig	O
.	O
4H	O
)	O
.	O

The	O
residual	O
staining	O
seen	O
in	O
the	O
AnxA7	O
-	O
/	O
-	O
brain	O
is	O
unspecific	O
as	O
it	O
is	O
also	O
present	O
in	O
corresponding	O
negative	O
controls	O
lacking	O
the	O
primary	O
antibody	O
.	O

The	O
absence	O
of	O
Annexin	O
A7	O
protein	B-CHEBI
in	O
brain	O
and	O
other	O
tissues	O
of	O
the	O
AnxA7	O
-	O
/	O
-	O
mouse	O
has	O
been	O
verified	O
in	O
[	O
10	O
]	O
.	O

In	O
another	O
actual	O
study	O
of	O
the	O
knock	O
out	O
mouse	O
we	O
detected	O
a	O
thickened	O
basal	O
membrane	O
and	O
a	O
widened	O
intercellular	O
space	O
.	O

This	O
may	O
cause	O
unspecific	O
binding	O
of	O
the	O
secondary	O
antibody	O
.	O

An	O
equal	O
staining	O
of	O
Annexin	O
A7	O
was	O
also	O
found	O
in	O
the	O
cerebellum	O
(	O
Fig	O
.	O
5A	O
)	O
.	O

Nuclei	O
of	O
neurons	O
in	O
the	O
stratum	O
granulosum	O
show	O
the	O
most	O
prominent	O
staining	O
(	O
Fig	O
.	O
5C	O
,	O
D	O
)	O
.	O

In	O
the	O
stratum	O
moleculare	O
,	O
which	O
is	O
poor	O
in	O
cell	O
bodies	O
of	O
neurons	O
,	O
only	O
a	O
few	O
dots	O
appear	O
which	O
also	O
correspond	O
to	O
nuclei	O
of	O
neurons	O
.	O

Astrocytes	O
are	O
also	O
positive	O
for	O
Annexin	O
A7	O
in	O
the	O
nuclei	O
and	O
cytoplasm	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
signal	O
of	O
the	O
pial	O
border	O
and	O
the	O
prominent	O
stain	O
of	O
the	O
white	O
matter	O
tracts	O
(	O
laminae	O
medullares	O
)	O
are	O
due	O
to	O
Annexin	O
A7	O
positive	O
astrocytes	O
(	O
Fig	O
.	O
5	O
A	O
-	O
C	O
)	O
.	O

Higher	O
magnification	O
of	O
the	O
boundary	O
layer	O
between	O
stratum	O
moleculare	O
and	O
granulosum	O
(	O
Fig	O
.	O
5D	O
)	O
revealed	O
an	O
Annexin	O
A7	O
signal	O
in	O
nuclei	O
,	O
but	O
also	O
in	O
the	O
cytoplasm	O
and	O
at	O
the	O
plasma	O
membrane	O
of	O
Purkinje	O
cells	O
(	O
Fig	O
.	O
5E	O
)	O
.	O

The	O
typical	O
pair	O
of	O
dendrites	O
points	O
to	O
the	O
margin	O
of	O
the	O
cerebellar	O
cortex	O
.	O

The	O
specificity	O
of	O
the	O
Annexin	O
A7	O
signal	O
was	O
further	O
confirmed	O
in	O
similar	O
brain	O
sections	O
of	O
the	O
AnxA7	O
-	O
/	O
-	O
mouse	O
(	O
Fig	O
.	O
5F	O
)	O
.	O

Fig	O
.	O

5G	O
shows	O
Annexin	O
A7	O
in	O
neurites	O
(	O
axons	O
)	O
connecting	O
the	O
laminae	O
medullares	O
with	O
the	O
Purkinje	O
-	O
cell	O
layer	O
.	O

Most	O
likely	O
these	O
are	O
the	O
axons	O
of	O
the	O
Purkinje	O
-	O
cells	O
.	O

Apart	O
from	O
these	O
efferent	O
neurites	O
the	O
laminae	O
medullares	O
(	O
lamina	O
alba	O
,	O
white	O
matter	O
)	O
contain	O
afferent	O
mossy	O
and	O
climbing	O
fibers	O
.	O

Thus	O
,	O
the	O
intense	O
stain	O
of	O
the	O
cerebellar	O
white	O
matter	O
arises	O
from	O
Annexin	O
A7	O
located	O
in	O
astrocytes	O
and	O
neurites	O
.	O

Figure	O
5	O

Annexin	O
A7	O
immunostaining	O
in	O
the	O
cerebellum	O
of	O
adult	O
mice	O
.	O

(	O
A	O
)	O
Low	O
magnification	O
of	O
the	O
cerebellum	O
presents	O
an	O
Annexin	O
A7	O
expression	O
mainly	O
in	O
cells	O
of	O
the	O
stratum	O
granulosum	O
and	O
laminae	O
medullares	O
.	O

(	O
B	O
)	O
Corresponding	O
section	O
stained	O
for	O
GFAP	O
.	O

(	O
C	O
)	O
Higher	O
magnification	O
of	O
folia	O
of	O
the	O
cerebellum	O
,	O
where	O
a	O
polyclonal	O
anti	O
-	O
AnnexinA7	O
antibody	O
was	O
used	O
;	O
square	O
,	O
a	O
higher	O
magnification	O
of	O
acorresponding	O
area	O
stained	O
with	O
mAb	O
203	O
-	O
217	O
is	O
given	O
in	O
(	O
D	O
)	O
.	O

Between	O
stratum	O
granulosum	O
and	O
stratum	O
moleculare	O
the	O
layer	O
of	O
Purkinje	O
-	O
cells	O
(	O
stratum	O
neuronorum	O
piriformium	O
(	O
ganglionare	O
)	O
)	O
can	O
be	O
observed	O
.	O

(	O
D	O
)	O
Staining	O
of	O
the	O
band	O
of	O
Purkinje	O
-	O
cells	O
(	O
arrows	O
)	O
.	O

The	O
positive	O
Annexin	O
A7	O
-	O
stain	O
in	O
the	O
stratum	O
granulosum	O
is	O
due	O
to	O
staining	O
of	O
the	O
nuclei	O
of	O
neurons	O
.	O

(	O
E	O
)	O
In	O
addition	O
to	O
an	O
intense	O
staining	O
of	O
the	O
nucleus	O
,	O
the	O
cell	O
body	O
is	O
AnnexinA7	O
-	O
positive	O
including	O
both	O
dendrites	O
of	O
the	O
Purkinje	O
-	O
cell	O
shown	O
.	O

(	O
F	O
)	O
Corresponding	O
section	O
from	O
an	O
AnxA7	O
-	O
/	O
-	O
mouse	O
.	O

(	O
G	O
)	O
AnnexinA7	O
staining	O
of	O
axons	O
(	O
arrowheads	O
)	O
running	O
from	O
the	O
laminae	O
medullares	O
to	O
the	O
Purkinje	O
-	O
cell	O
layer	O
located	O
in	O
the	O
round	O
end	O
of	O
a	O
convolution	O
.	O

Sections	O
A	O
,	O
D	O
,	O
E	O
,	O
F	O
,	O
G	O
were	O
stained	O
with	O
mAb	O
203	O
-	O
217	O
.	O

Expression	O
of	O
Annexin	O
A7	O
in	O
the	O
adult	O
human	O
isocortex	O

In	O
the	O
human	O
parietal	O
neocortex	O
of	O
aged	O
individuals	O
without	O
any	O
neuropathological	O
alterations	O
,	O
subpial	O
astrocytes	O
exhibited	O
a	O
staining	O
of	O
Annexin	O
A7	O
in	O
the	O
cytoplasm	O
.	O

A	O
nuclear	O
presence	O
of	O
Annexin	O
A7	O
was	O
limited	O
to	O
single	O
astrocytes	O
(	O
Fig	O
.	O
6B	O
)	O
.	O

Pyramidal	O
neurons	O
,	O
predominantly	O
those	O
of	O
layer	O
V	O
exhibited	O
Annexin	O
A7	O
at	O
the	O
plasma	O
membrane	O
of	O
their	O
perikaryon	O
as	O
well	O
as	O
of	O
the	O
apical	O
dendrite	O
(	O
Fig	O
.	O
6A	O
,	O
C	O
)	O
.	O

The	O
neurons	O
lacked	O
a	O
signal	O
for	O
Annexin	O
A7	O
in	O
their	O
nuclei	O
.	O

Apical	O
dendrites	O
within	O
the	O
molecular	B-CHEBI
layer	O
also	O
indicated	O
a	O
positive	O
staining	O
for	O
Annexin	O
A7	O
(	O
Fig	O
.	O
6B	O
)	O
.	O

The	O
staining	O
pattern	O
of	O
Annexin	O
A7	O
in	O
the	O
human	O
autopsy	O
brain	O
did	O
not	O
change	O
after	O
pre	O
-	O
treatment	O
with	O
trypsin	O
.	O

Figure	O
6	O

Annexin	O
A7	O
immunostaining	O
in	O
human	O
isocortex	O
.	O

(	O
A	O
)	O
Pyramidal	O
neurons	O
(	O
bold	O
arrow	O
)	O
and	O
apical	O
dendrites	O
(	O
small	O
arrows	O
)	O
were	O
clearly	O
labeled	O
with	O
the	O
antibody	O
against	O
Annexin	O
A7	O
in	O
the	O
human	O
parietal	O
cortex	O
.	O

(	O
B	O
)	O
A	O
dendritic	O
staining	O
was	O
also	O
seen	O
in	O
the	O
molecular	B-CHEBI
layer	O
(	O
small	O
arrows	O
)	O
.	O

In	O
addition	O
the	O
subpial	O
astrocytes	O
were	O
weakly	O
labeled	O
(	O
double	O
headed	O
arrows	O
)	O
.	O

The	O
staining	O
was	O
cytoplasmic	O
,	O
only	O
few	O
astrocytes	O
showed	O
a	O
nuclear	O
staining	O
as	O
well	O
(	O
inset	O
)	O
.	O

(	O
C	O
)	O
Enlargement	O
of	O
(	O
A	O
)	O
:	O
Annexin	O
A7	O
was	O
seen	O
at	O
the	O
cell	O
membrane	O
of	O
the	O
perikaryon	O
(	O
bold	O
arrow	O
)	O
and	O
the	O
apical	O
dendrite	O
(	O
small	O
arrows	O
)	O
.	O

(	O
D	O
)	O
A	O
blank	O
control	O
lacking	O
the	O
primary	O
antibody	O
did	O
not	O
show	O
a	O
specific	O
labeling	O
,	O
but	O
autofluorescent	O
lipofuscin	O
was	O
detectable	O
in	O
the	O
neurons	O
(	O
arrowheads	O
)	O
.	O

Bar	O
,	O
(	O
A	O
)	O
70	O
mu	O
m	O
,	O
(	O
B	O
)	O
50	O
mu	O
m	O
,	O
(	O
B	O
-	O
inset	O
,	O
C	O
)	O
17	O
mu	O
m	O
,	O
(	O
D	O
)	O
20	O
mu	O
m	O
.	O

Presence	O
of	O
Annexin	O
A7	O
in	O
nuclei	O
from	O
neuronal	O
and	O
astroglial	O
cells	O

The	O
nuclear	O
localisation	O
of	O
Annexin	O
A7	O
in	O
mice	O
observed	O
in	O
immature	O
cells	O
at	O
E16	O
and	O
differentiated	O
adult	O
neurons	O
could	O
be	O
only	O
detected	O
as	O
a	O
strong	O
signal	O
when	O
the	O
brain	O
sections	O
were	O
pre	O
-	O
treated	O
with	O
trypsin	O
before	O
antibody	O
staining	O
.	O

This	O
procedure	O
is	O
thought	O
to	O
allow	O
the	O
antibodies	O
to	O
access	O
epitopes	O
masked	O
by	O
the	O
formaldehyde	B-CHEBI
fixation	O
.	O

Methanol	B-CHEBI
fixation	O
of	O
cultured	O
cells	O
led	O
to	O
inconsistent	O
results	O
.	O

Antigen	O
retrieval	O
in	O
formalin	O
-	O
fixed	O
and	O
paraffin	O
-	O
embedded	O
tissue	O
sections	O
employs	O
various	O
heating	O
or	O
proteolytic	O
pre	O
-	O
treatment	O
methods	O
[	O
[	O
15	O
-	O
17	O
]	O
;	O
Ein	O
Handbuch	O
f	O
u	O
r	O
die	O
Histologie	O
,	O
dianova	O
GmbH	O
,	O
Hamburg	O
,	O
Germany	O
]	O
.	O

These	O
methods	O
can	O
result	O
in	O
moderate	O
or	O
strong	O
specific	O
antibody	O
staining	O
,	O
but	O
the	O
detectability	O
of	O
other	O
antigens	O
might	O
be	O
decreased	O
.	O

Moreover	O
,	O
the	O
optimal	O
pre	O
-	O
treatment	O
has	O
to	O
be	O
individualised	O
for	O
each	O
antigen	O
.	O

To	O
verify	O
the	O
presence	O
of	O
endogenous	O
Annexin	O
A7	O
in	O
nuclei	O
,	O
we	O
used	O
a	O
biochemical	O
approach	O
and	O
purified	O
nuclei	O
from	O
neuro	O
-	O
2a	O
,	O
PC	O
-	O
12	O
,	O
and	O
C6	O
cells	O
and	O
treated	O
them	O
with	O
a	O
hypotonic	O
extraction	O
buffer	O
to	O
obtain	O
the	O
nucleoplasm	O
(	O
Fig	O
.	O
7A	O
)	O
.	O

The	O
nucleoplasm	O
and	O
the	O
remaining	O
nuclei	O
,	O
from	O
which	O
the	O
nucleoplasm	O
has	O
been	O
extracted	O
partially	O
,	O
were	O
subjected	O
to	O
SDS	B-CHEBI
-	O
PAGE	O
and	O
Western	O
blotting	O
.	O

Western	O
blots	O
probed	O
with	O
mAb	O
203	O
-	O
217	O
showed	O
Annexin	O
A7	O
in	O
the	O
nucleoplasm	O
of	O
neuronal	O
(	O
neuro	O
-	O
2a	O
,	O
PC	O
-	O
12	O
)	O
and	O
astroglial	O
(	O
C6	O
)	O
cell	O
lines	O
(	O
Fig	O
.	O
7A	O
)	O
,	O
however	O
,	O
the	O
large	O
isoform	O
could	O
only	O
be	O
clearly	O
extracted	O
with	O
nucleoplasm	O
from	O
C6	O
cells	O
.	O

For	O
control	O
,	O
antibodies	O
against	O
LAP2	O
alpha	O
,	O
Emerin	O
and	O
tubulin	O
were	O
used	O
to	O
verify	O
that	O
the	O
nucleoplasm	O
(	O
marker	O
:	O
LAP2	O
alpha	O
,	O
which	O
is	O
anon	O
-	O
membrane	O
-	O
bound	O
isoform	O
of	O
LAP2	O
)	O
was	O
successfully	O
extracted	O
and	O
also	O
not	O
contaminated	O
by	O
nuclear	O
membranes	O
(	O
marker	O
:	O
Emerin	O
)	O
or	O
by	O
cytoplasm	O
(	O
marker	O
:	O
tubulin	O
)	O
.	O

Likewise	O
,	O
in	O
these	O
neuronal	O
and	O
astroglial	O
cell	O
lines	O
Annexin	O
A7	O
had	O
been	O
observed	O
in	O
the	O
nucleus	O
by	O
immunofluorescence	O
(	O
Fig	O
.	O
7B	O
and	O
data	O
not	O
shown	O
)	O
.	O

We	O
noticed	O
no	O
difference	O
between	O
PC	O
-	O
12	O
and	O
neuro	O
-	O
2a	O
cells	O
,	O
however	O
,	O
as	O
for	O
the	O
brain	O
sections	O
,	O
we	O
found	O
an	O
increase	O
of	O
the	O
Annexin	O
A7	O
staining	O
after	O
pre	O
-	O
treatment	O
with	O
trypsin	O
.	O

Figure	O
7	O

Nuclear	O
localization	O
of	O
Annexin	O
A7	O
.	O

(	O
A	O
)	O
Extraction	O
of	O
Annexin	O
A7	O
from	O
nuclei	O
of	O
neuronal	O
(	O
PC	O
-	O
12	O
,	O
N2A	O
)	O
and	O
an	O
astroglial	O
(	O
C6	O
)	O
cell	O
line	O
using	O
a	O
hypotonic	O
buffer	O
.	O

Samples	O
of	O
total	O
cells	O
(	O
c	O
)	O
,	O
and	O
corresponding	O
amounts	O
of	O
nuclear	O
membranes	O
(	O
m	O
)	O
and	O
nucleoplasm	O
(	O
p	O
)	O
were	O
subjected	O
to	O
SDS	B-CHEBI
-	O
PAGE	O
and	O
Western	O
blotting	O
.	O

Annexin	O
A7	O
(	O
AnxA7	O
)	O
isoforms	O
are	O
extractable	O
from	O
the	O
nucleus	O
of	O
the	O
indicated	O
cells	O
(	O
47	O
kDa	O
and	O
51	O
kDa	O
isoform	O
,	O
arrowhead	O
)	O
.	O

For	O
control	O
,	O
immunoblotting	O
of	O
LAP2	O
alpha	O
(	O
75	O
kDa	O
;	O
non	O
-	O
membrane	O
-	O
bound	O
isoform	O
)	O
,	O
Emerin	O
(	O
EM	O
,	O
34	O
kDa	O
)	O
,	O
and	O
tubulin	O
(	O
TB	O
,	O
55	O
kDa	O
)	O
which	O
are	O
specific	O
for	O
nucleoplasm	O
(	O
LAP2	O
alpha	O
)	O
,	O
nuclear	O
membranes	O
(	O
Emerin	O
)	O
,	O
and	O
the	O
cytoplasm	O
(	O
tubulin	O
)	O
are	O
shown	O
.	O

Note	O
that	O
the	O
nucleoplasm	O
is	O
only	O
partially	O
extractable	O
.	O

(	O
B	O
)	O
Immunofluorescence	O
images	O
of	O
the	O
PC	O
-	O
12	O
cells	O
used	O
.	O

Cells	O
were	O
fixed	O
with	O
paraformaldehyde	O
,	O
permeabilized	O
with	O
Triton	O
X	O
-	O
100	O
,	O
pretreated	O
with	O
trypsin	O
as	O
indicated	O
,	O
and	O
stained	O
with	O
Annexin	O
A7	O
specific	O
mAb	O
203	O
-	O
217	O
,	O
DAPI	O
in	O
blue	O
,	O
bar	O
10	O
mu	O
m	O
.	O

Discussion	O

In	O
the	O
present	O
study	O
we	O
explored	O
the	O
appearance	O
of	O
Annexin	O
A7	O
during	O
mouse	O
development	O
at	O
the	O
mRNA	B-CHEBI
and	O
protein	B-CHEBI
level	O
and	O
focused	O
on	O
the	O
central	O
nervous	O
system	O
during	O
embryogenesis	O
.	O

Northern	O
blot	O
and	O
immunohistochemistry	O
analysis	O
show	O
the	O
expression	O
of	O
Annexin	O
A7	O
in	O
all	O
embryonic	O
tissues	O
from	O
day	O
E5	O
on	O
,	O
the	O
earliest	O
day	O
studied	O
.	O

Differentiating	O
cells	O
,	O
like	O
the	O
neural	O
ectoderm	O
,	O
which	O
is	O
the	O
origin	O
of	O
the	O
cells	O
belonging	O
to	O
the	O
nervous	O
system	O
,	O
show	O
Annexin	O
A7	O
immunoreactivity	O
mainly	O
in	O
the	O
cytosol	O
.	O

Endodermal	O
as	O
well	O
as	O
mesodermal	O
cells	O
exhibit	O
a	O
similar	O
subcellular	O
localization	O
of	O
the	O
protein	B-CHEBI
.	O

In	O
the	O
developing	O
brain	O
we	O
noted	O
a	O
striking	O
change	O
in	O
the	O
subcellular	O
distribution	O
of	O
Annexin	O
A7	O
.	O

Cells	O
in	O
the	O
stratum	O
germinativum	O
of	O
the	O
neopallial	O
cortex	O
,	O
which	O
surrounds	O
the	O
lateral	O
ventricle	O
,	O
show	O
at	O
E13	O
and	O
E15	O
a	O
staining	O
for	O
Annexin	O
A7	O
mainly	O
in	O
the	O
cytosol	O
.	O

But	O
this	O
staining	O
largely	O
disappears	O
and	O
at	O
the	O
following	O
day	O
E16	O
we	O
detect	O
Annexin	O
A7	O
in	O
the	O
nucleus	O
of	O
cells	O
in	O
the	O
intermediate	O
and	O
marginal	O
zone	O
of	O
the	O
neopallium	O
.	O

The	O
different	O
expression	O
patterns	O
of	O
Annexin	O
A7	O
-	O
positive	O
cells	O
from	O
the	O
ventricular	O
germinative	O
zone	O
to	O
the	O
marginal	O
zone	O
of	O
the	O
later	O
neocortex	O
observed	O
in	O
this	O
study	O
are	O
similar	O
to	O
the	O
developmental	O
patterns	O
of	O
Tenascin	O
-	O
C	O
-	O
positive	O
astroglial	O
precursors	O
following	O
the	O
guidance	O
of	O
the	O
radial	O
glial	O
cells	O
[	O
18	O
]	O
.	O

Moreover	O
,	O
the	O
patterns	O
resemble	O
that	O
of	O
migrating	O
and	O
differentiated	O
neurons	O
described	O
by	O
Berry	O
et	O
al	O
.	O

[	O
13	O
]	O
.	O

Neurons	O
that	O
are	O
generated	O
prenatally	O
in	O
the	O
proliferative	O
ventricular	O
layer	O
of	O
the	O
neopallial	O
cortex	O
subsequently	O
migrate	O
through	O
the	O
intermediate	O
zone	O
to	O
form	O
the	O
different	O
cortical	O
cell	O
layers	O
in	O
a	O
declining	O
inside	O
-	O
out	O
gradient	O
of	O
cell	O
maturation	O
.	O

These	O
observations	O
suggested	O
that	O
the	O
subcellular	O
localization	O
of	O
Annexin	O
A7	O
depends	O
on	O
developmental	O
stage	O
and	O
cell	O
type	O
.	O

In	O
the	O
adult	O
brain	O
we	O
generally	O
observed	O
a	O
nuclear	O
localization	O
for	O
Annexin	O
A7	O
in	O
neurons	O
whereas	O
astrocytes	O
exhibited	O
both	O
a	O
cytosolic	O
as	O
well	O
as	O
a	O
nuclear	O
staining	O
.	O

However	O
,	O
pyramidal	O
neurons	O
of	O
the	O
isocortex	O
and	O
Purkinje	O
-	O
cells	O
of	O
the	O
cerebellum	O
exhibited	O
a	O
cytosolic	O
stain	O
of	O
intermediate	O
intensity	O
including	O
their	O
neurites	O
and	O
dendrites	O
.	O

We	O
have	O
previously	O
reported	O
the	O
expression	O
of	O
Annexin	O
A7	O
in	O
human	O
temporal	O
neocortex	O
and	O
hippocampus	O
obtained	O
from	O
neurosurgery	O
for	O
therapy	O
-	O
refractory	O
epilepsy	O
and	O
found	O
the	O
two	O
Annexin	O
A7	O
isoforms	O
restricted	O
to	O
the	O
cytoplasm	O
and	O
nuclei	O
of	O
astrocytes	O
,	O
whereas	O
neurons	O
lacked	O
any	O
signal	O
[	O
19	O
]	O
.	O

The	O
hippocampal	O
area	O
showed	O
typical	O
signs	O
of	O
Ammon	O
'	O
s	O
horn	O
sclerosis	O
,	O
but	O
the	O
adjacent	O
temporal	O
neocortex	O
tissue	O
did	O
not	O
show	O
any	O
histopathological	O
alterations	O
.	O

This	O
data	O
is	O
in	O
discrepancy	O
with	O
our	O
actual	O
observation	O
in	O
the	O
murine	O
brain	O
.	O

To	O
determine	O
if	O
this	O
is	O
due	O
to	O
different	O
methods	O
in	O
immunofluorescence	O
staining	O
or	O
indeed	O
different	O
expression	O
patterns	O
in	O
mouse	O
and	O
human	O
,	O
we	O
repeated	O
the	O
immunofluorescence	O
of	O
human	O
brain	O
.	O

This	O
time	O
we	O
investigated	O
sections	O
from	O
human	O
parietal	O
cortex	O
of	O
autopsy	O
brain	O
.	O

The	O
astroglial	O
expression	O
of	O
Annexin	O
A7	O
could	O
be	O
confirmed	O
,	O
although	O
not	O
all	O
astrocytes	O
exhibited	O
the	O
nuclear	O
staining	O
.	O

Pyramidal	O
neurons	O
however	O
indicated	O
a	O
distinct	O
staining	O
of	O
Annexin	O
A7	O
most	O
prominent	O
along	O
their	O
dendrites	O
.	O

The	O
different	O
results	O
obtained	O
for	O
the	O
neurons	O
may	O
be	O
explained	O
by	O
the	O
fact	O
that	O
we	O
previously	O
used	O
frozen	O
tissue	O
sections	O
or	O
that	O
they	O
were	O
derived	O
from	O
patients	O
suffering	O
from	O
temporal	O
lobe	O
epilepsia	O
.	O

On	O
the	O
other	O
hand	O
the	O
actual	O
human	O
brain	O
tissue	O
used	O
was	O
from	O
aged	O
patients	O
and	O
did	O
not	O
correspond	O
to	O
the	O
age	O
of	O
the	O
mice	O
included	O
in	O
this	O
study	O
.	O

In	O
cultured	O
cells	O
after	O
cell	O
damage	O
or	O
apoptosis	O
(	O
unpublished	O
observations	O
)	O
or	O
in	O
cells	O
treated	O
with	O
a	O
Ca2	B-CHEBI
+	I-CHEBI
-	I-CHEBI
ionophore	I-CHEBI
Annexin	O
A7	O
translocated	O
from	O
the	O
cytoplasm	O
to	O
cellular	O
membranes	O
[	O
19	O
]	O
.	O

We	O
therefore	O
favor	O
the	O
hypothesis	O
that	O
Annexin	O
A7	O
in	O
the	O
sensitive	O
neurons	O
of	O
the	O
human	O
autopsy	O
brain	O
may	O
have	O
similarly	O
translocated	O
to	O
the	O
cellular	O
membrane	O
.	O

This	O
property	O
of	O
translocation	O
and	O
membrane	O
binding	O
is	O
common	O
to	O
all	O
annexins	O
and	O
commercially	O
available	O
kits	O
for	O
apoptosis	O
detection	O
employ	O
recombinant	O
AnnexinA5	O
.	O

The	O
presence	O
of	O
nuclear	O
Annexin	O
A7	O
in	O
murine	O
brain	O
was	O
confirmed	O
by	O
controls	O
using	O
sections	O
from	O
the	O
AnxA7	O
-	O
/	O
-	O
mouse	O
and	O
by	O
a	O
biochemical	O
extraction	O
of	O
the	O
protein	B-CHEBI
from	O
the	O
nucleus	O
.	O

Both	O
Annexin	O
A7	O
isoforms	O
described	O
in	O
brain	O
tissue	O
seemingly	O
are	O
expressed	O
by	O
neurons	O
and	O
astrocytes	O
,	O
which	O
was	O
shown	O
using	O
total	O
cell	O
extracts	O
of	O
cultured	O
neuo	O
-	O
2a	O
,	O
PC	O
-	O
12	O
,	O
and	O
C6	O
cells	O
.	O

In	O
addition	O
to	O
their	O
expression	O
in	O
brain	O
,	O
both	O
Annexin	O
A7	O
isoforms	O
have	O
only	O
been	O
described	O
in	O
heart	O
muscle	O
and	O
red	O
blood	O
cells	O
[	O
5	O
-	O
8	O
]	O
.	O

Although	O
the	O
inactivation	O
of	O
the	O
annexin	O
A7	O
gene	O
did	O
not	O
interfere	O
with	O
the	O
viability	O
and	O
development	O
of	O
knock	O
out	O
mice	O
[	O
10	O
]	O
,	O
their	O
generation	O
allowed	O
us	O
to	O
address	O
the	O
role	O
of	O
Annexin	O
A7	O
in	O
specific	O
cell	O
types	O
[	O
8	O
,	O
9	O
]	O
.	O

Indeed	O
,	O
when	O
we	O
analyzed	O
primary	O
astrocytes	O
from	O
an	O
AnxA7	O
-	O
/	O
-	O
mouse	O
for	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
dependent	O
signaling	O
processes	O
,	O
we	O
found	O
that	O
they	O
exhibited	O
a	O
significantly	O
increased	O
velocity	O
of	O
mechanically	O
induced	O
astrocytic	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
waves	O
as	O
compared	O
to	O
wild	O
type	O
[	O
9	O
]	O
.	O

This	O
led	O
us	O
to	O
propose	O
,	O
that	O
Annexin	O
A7	O
can	O
act	O
as	O
a	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
buffer	B-CHEBI
and	O
is	O
involved	O
in	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
homeostasis	O
.	O

In	O
neurons	O
Ca2	B-CHEBI
+	I-CHEBI
ions	I-CHEBI
play	O
major	O
roles	O
in	O
various	O
physiological	O
and	O
pathophysiological	O
processes	O
[	O
20	O
-	O
25	O
]	O
.	O

One	O
can	O
speculate	O
about	O
an	O
involvement	O
of	O
Annexin	O
A7	O
in	O
the	O
regulation	O
of	O
these	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
dependent	O
processes	O
,	O
propositions	O
that	O
need	O
further	O
investigation	O
.	O

However	O
,	O
such	O
roles	O
are	O
confirmed	O
for	O
heart	O
function	O
by	O
studies	O
of	O
Schrickel	O
et	O
al	O
.	O

[	O
submitted	O
]	O
,	O
who	O
described	O
an	O
involvement	O
of	O
Annexin	O
A7	O
in	O
the	O
maintenance	O
of	O
a	O
regular	O
cardiac	O
electrophysiology	O
and	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
homeostasis	O
.	O

An	O
altered	O
subcellular	O
location	O
during	O
embryogenesis	O
was	O
also	O
reported	O
for	O
Annexin	O
A11	O
.	O

The	O
developing	O
gray	O
matter	O
of	O
the	O
rat	O
embryonic	O
spinal	O
cord	O
exhibited	O
primarily	O
nuclear	O
localization	O
of	O
Annexin	O
A11	O
,	O
while	O
immunoreactivity	O
was	O
lost	O
from	O
the	O
nuclei	O
in	O
the	O
adult	O
spinal	O
cord	O
[	O
26	O
]	O
.	O

In	O
contrast	O
,	O
our	O
studies	O
show	O
a	O
relocation	O
of	O
Annexin	O
A7	O
from	O
the	O
cytosol	O
to	O
the	O
nucleus	O
in	O
cells	O
of	O
the	O
embryonic	O
neuronal	O
tissue	O
.	O

The	O
Annexin	O
A7	O
distribution	O
is	O
determined	O
by	O
a	O
variety	O
of	O
factors	O
.	O

An	O
important	O
one	O
appears	O
to	O
be	O
Ca2	B-CHEBI
+	I-CHEBI
,	O
which	O
promotes	O
binding	O
of	O
Annexin	O
A7	O
to	O
membranes	O
and	O
also	O
allows	O
aggregation	O
of	O
annexins	O
[	O
27	O
]	O
.	O

Binding	O
partners	O
of	O
Annexin	O
A7	O
such	O
as	O
sorcin	O
might	O
represent	O
additional	O
factors	O
[	O
28	O
]	O
.	O

Although	O
the	O
members	O
of	O
the	O
annexin	O
family	O
are	O
generally	O
found	O
at	O
the	O
plasma	O
membrane	O
,	O
in	O
the	O
cytoplasm	O
or	O
in	O
association	O
with	O
the	O
cytoskeleton	O
,	O
Annexins	O
A1	O
,	O
A2	O
,	O
A4	O
,	O
A5	O
and	O
A11	O
have	O
been	O
described	O
to	O
be	O
localized	O
at	O
least	O
partially	O
in	O
the	O
nucleus	O
[	O
26	O
,	O
29	O
,	O
30	O
]	O
.	O

Studies	O
with	O
human	O
foreskin	O
fibroblasts	O
demonstrated	O
that	O
Annexin	O
A1	O
,	O
A4	O
and	O
A5	O
are	O
all	O
present	O
in	O
the	O
nucleus	O
at	O
higher	O
concentration	O
than	O
in	O
the	O
cytosol	O
[	O
31	O
]	O
.	O

Raising	O
intracellular	O
Ca2	B-CHEBI
+	I-CHEBI
led	O
to	O
relocation	O
of	O
these	O
annexins	O
to	O
the	O
nuclear	O
membrane	O
.	O

An	O
important	O
role	O
for	O
annexins	O
in	O
mediating	O
the	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
signal	O
within	O
the	O
nuclei	O
of	O
the	O
fibroblasts	O
was	O
proposed	O
.	O

These	O
results	O
mirror	O
studies	O
with	O
stably	O
transfected	O
C6	O
cells	O
,	O
in	O
which	O
high	O
intracellular	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
concentrations	O
induced	O
a	O
marked	O
redistribution	O
of	O
Annexin	O
A7	O
from	O
its	O
localization	O
in	O
the	O
nucleoplasm	O
to	O
the	O
nuclear	O
membrane	O
[	O
19	O
]	O
.	O

None	O
of	O
the	O
annexins	O
contains	O
a	O
typical	O
nuclear	O
localization	O
signal	O
and	O
their	O
mechanism	O
of	O
nuclear	O
import	O
remains	O
to	O
be	O
elucidated	O
.	O

For	O
Annexin	O
A11	O
it	O
was	O
shown	O
that	O
nuclear	O
localization	O
is	O
mediated	O
by	O
its	O
N	B-CHEBI
-	O
terminal	O
region	O
,	O
which	O
also	O
contains	O
a	O
binding	O
side	O
for	O
the	O
S100	O
protein	B-CHEBI
calcyclin	O
[	O
29	O
]	O
.	O

More	O
recently	O
Tomas	O
and	O
Moss	O
[	O
32	O
]	O
showed	O
,	O
that	O
Annexin	O
A11	O
and	O
S100A6	O
assemble	O
at	O
the	O
nuclear	O
envelope	O
during	O
nuclear	O
breakdown	O
.	O

Their	O
role	O
in	O
this	O
process	O
is	O
not	O
known	O
.	O

In	O
general	O
it	O
seems	O
that	O
the	O
nuclear	O
localization	O
of	O
the	O
annexins	O
is	O
actively	O
regulated	O
.	O

For	O
example	O
the	O
nucleocytoplasmic	O
compartmentalization	O
of	O
Annexin	O
A2	O
is	O
controlled	O
by	O
sequestration	O
of	O
the	O
AnxA2	O
/	O
p11	O
complex	O
modulated	O
by	O
phosphorylation	O
and	O
by	O
a	O
nuclear	O
export	O
signal	O
found	O
in	O
the	O
AnxA2	O
3	O
-	O
12	O
region	O
[	O
33	O
]	O
.	O

One	O
function	O
of	O
Annexin	O
A2	O
in	O
the	O
nucleus	O
,	O
that	O
appears	O
not	O
to	O
involve	O
binding	O
of	O
p11	O
,	O
has	O
been	O
suggested	O
by	O
its	O
purification	O
as	O
part	O
of	O
a	O
primer	O
recognition	O
protein	B-CHEBI
complex	O
that	O
enhances	O
DNA	O
polymerase	O
alpha	O
-	O
activity	O
in	O
vitro	O
[	O
34	O
]	O
.	O

The	O
annexins	O
may	O
participate	O
in	O
a	O
nuclear	O
response	O
to	O
initial	O
cell	O
stimulation	O
or	O
to	O
a	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
transient	O
,	O
presumably	O
by	O
regulating	O
DNA	O
replication	O
.	O

For	O
Annexin	O
A7	O
such	O
a	O
pathway	O
is	O
very	O
speculative	O
at	O
the	O
moment	O
.	O

Future	O
studies	O
are	O
however	O
directed	O
by	O
these	O
findings	O
and	O
will	O
concentrate	O
on	O
the	O
identification	O
of	O
the	O
nuclear	O
localization	O
signal	O
of	O
Annexin	O
A7	O
as	O
well	O
as	O
on	O
the	O
role	O
of	O
Annexin	O
A7	O
in	O
the	O
nuclear	O
compartment	O
.	O

Conclusion	O

In	O
this	O
article	O
we	O
report	O
the	O
translocation	O
of	O
Annexin	O
A7	O
to	O
nuclei	O
of	O
differentiating	O
cells	O
in	O
the	O
developing	O
murine	O
brain	O
.	O

In	O
the	O
adult	O
brain	O
Annexin	O
A7	O
generally	O
was	O
detected	O
in	O
nuclei	O
of	O
neurons	O
.	O

Astrocytes	O
,	O
cerebellar	O
Purkinje	O
-	O
cells	O
and	O
neocortical	O
pyramidal	O
neurons	O
exhibited	O
both	O
,	O
Annexin	O
A7	O
in	O
the	O
cytosol	O
and	O
in	O
the	O
nuclei	O
.	O

Thus	O
,	O
the	O
subcellular	O
localisation	O
of	O
Annexin	O
A7	O
depends	O
on	O
the	O
developmental	O
stage	O
and	O
the	O
cell	O
type	O
.	O

A	O
role	O
of	O
Annexin	O
A7	O
as	O
well	O
as	O
of	O
other	O
annexins	O
in	O
nuclei	O
remains	O
speculative	O
.	O

The	O
results	O
obtained	O
by	O
immunofluorescence	O
were	O
confirmed	O
by	O
extraction	O
of	O
Annexin	O
A7	O
from	O
nuclei	O
of	O
neuronal	O
and	O
glial	O
cell	O
lines	O
.	O

Methods	O

Animals	O
and	O
tissue	O
preparation	O

129SV	O
strain	O
mice	O
were	O
used	O
.	O

The	O
day	O
on	O
which	O
the	O
vaginal	O
plug	O
was	O
confirmed	O
was	O
defined	O
as	O
E0	O
.	O

All	O
the	O
animal	O
experiments	O
were	O
performed	O
in	O
accordance	O
with	O
the	O
Guide	O
for	O
the	O
Care	O
and	O
Use	O
of	O
Laboratory	O
Animals	O
(	O
NIH	O
Publication	O
No	O
.	O
85	O
-	O
23	O
)	O
.	O

Pregnant	O
females	O
were	O
sacrificed	O
by	O
cervical	O
dislocation	O
at	O
various	O
intervals	O
between	O
E5	O
and	O
E17	O
.	O

Before	O
E9	O
,	O
embryos	O
were	O
embedded	O
within	O
the	O
maternal	O
uterus	O
.	O

After	O
E9	O
,	O
embryos	O
were	O
removed	O
from	O
their	O
membranes	O
and	O
embedded	O
separately	O
.	O

Experiments	O
were	O
performed	O
with	O
four	O
to	O
six	O
animals	O
at	O
each	O
developmental	O
stage	O
.	O

The	O
mature	O
brain	O
used	O
was	O
derived	O
from	O
mice	O
of	O
three	O
to	O
four	O
month	O
of	O
age	O
.	O

The	O
embryos	O
and	O
tissues	O
were	O
fixed	O
in	O
freshly	O
prepared	O
4	O
%	O
paraformaldehyde	O
solution	O
for	O
2	O
-	O
12	O
h	O
depending	O
on	O
the	O
tissue	O
thickness	O
[	O
35	O
]	O
.	O

They	O
were	O
dehydrated	O
with	O
ethanol	B-CHEBI
and	O
embedded	O
in	O
paraffin	O
according	O
to	O
standard	O
procedures	O
.	O

Microtome	O
sections	O
were	O
cut	O
at	O
7	O
-	O
10	O
mu	O
m	O
,	O
placed	O
on	O
slides	O
and	O
stored	O
until	O
further	O
processing	O
.	O

Human	O
brain	O
tissue	O

Five	O
human	O
autopsy	O
brains	O
of	O
male	O
and	O
female	O
patients	O
without	O
any	O
neuropathological	O
changes	O
(	O
age	O
61	O
-	O
77	O
years	O
;	O
post	O
mortem	O
interval	O
:	O
12	O
-	O
72	O
h	O
)	O
were	O
fixed	O
in	O
an	O
aqueous	O
solution	O
of	O
formaldehyde	B-CHEBI
for	O
three	O
weeks	O
.	O

Blocks	O
of	O
the	O
parietal	O
neocortex	O
were	O
embedded	O
in	O
paraffin	O
and	O
microtomed	O
at	O
12	O
mu	O
m	O
thickness	O
.	O

Sections	O
were	O
stained	O
with	O
aldehydefuchsin	O
Darrow	O
-	O
red	O
to	O
confirm	O
the	O
absence	O
of	O
neuropathological	O
alterations	O
.	O

All	O
procedures	O
were	O
conducted	O
in	O
accordance	O
with	O
the	O
Declaration	O
of	O
Helsinki	O
and	O
approved	O
by	O
the	O
ethics	O
committee	O
of	O
the	O
University	O
of	O
Bonn	O
Medical	O
Center	O
.	O

Antibodies	O

Antibodies	O
used	O
in	O
this	O
study	O
were	O
mAb	O
203	O
-	O
217	O
directed	O
against	O
the	O
core	O
domain	O
of	O
mouse	O
Annexin	O
A7	O
[	O
6	O
]	O
(	O
purified	O
IgG	O
,	O
1	O
:	O
50	O
)	O
specifically	O
recognizing	O
both	O
Annexin	O
A7	O
isoforms	O
[	O
[	O
6	O
,	O
10	O
]	O
,	O
and	O
data	O
not	O
shown	O
]	O
,	O
a	O
polyclonal	O
antibody	O
against	O
mouse	O
Annexin	O
A7	O
[	O
10	O
]	O
(	O
1	O
:	O
200	O
)	O
,	O
a	O
polyclonal	O
antiserum	O
raised	O
against	O
the	O
astrocyte	O
-	O
specific	O
intermediate	O
filament	O
glial	O
fibrillary	O
acidic	B-CHEBI
protein	B-CHEBI
(	O
GFAP	O
;	O
DAKO	O
,	O
1	O
:	O
400	O
)	O
,	O
anti	O
-	O
beta	O
-	O
tubulin	O
(	O
Sigma	O
,	O
1	O
:	O
1000	O
)	O
,	O
anti	O
-	O
Emerin	O
(	O
novocastra	O
,	O
1	O
:	O
2000	O
)	O
,	O
and	O
polyclonal	O
anti	O
-	O
LAP2	O
alpha	O
(	O
kindly	O
provided	O
by	O
Ronald	O
Foisner	O
,	O
1	O
:	O
5000	O
)	O
.	O

Immunofluorescence	O
microscopy	O

Immunohistochemical	O
staining	O
using	O
mAb	O
203	O
-	O
217	O
as	O
the	O
primary	O
antibody	O
was	O
with	O
AlexaFluor488	O
-	O
conjugated	O
goat	O
anti	O
-	O
mouse	O
IgG	O
(	O
Molecular	B-CHEBI
Probes	O
,	O
Leiden	O
,	O
The	O
Nether	O
-	O
lands	O
)	O
or	O
Cy3	O
-	O
labeled	O
goat	O
anti	O
-	O
mouse	O
IgG	O
as	O
the	O
secondary	O
antibodies	O
.	O

Polyclonal	O
anti	O
-	O
Annexin	O
A7	O
antibody	O
and	O
anti	O
-	O
GFAP	O
-	O
antibody	O
were	O
combined	O
with	O
Alexa	O
Fluor	O
568	O
-	O
conjugated	O
goat	O
anti	O
-	O
rabbit	O
IgG	O
(	O
Molecular	B-CHEBI
Probes	O
)	O
.	O

The	O
specific	O
labelling	O
of	O
Annexin	O
A7	O
detected	O
with	O
the	O
anti	O
-	O
mouse	O
-	O
IgG	O
secondary	O
antibodies	O
in	O
mouse	O
tissue	O
sections	O
was	O
confirmed	O
using	O
primary	O
antibodies	O
,	O
which	O
were	O
directly	O
coupled	O
to	O
Alexa	O
Fluor488	O
.	O

The	O
paraffin	O
-	O
embedded	O
sections	O
were	O
first	O
treated	O
three	O
times	O
for	O
2	O
min	O
in	O
xylene	B-CHEBI
to	O
remove	O
paraffin	O
and	O
then	O
rehydrated	O
step	O
by	O
step	O
with	O
descending	O
concentrations	O
of	O
ethanol	B-CHEBI
for	O
antibody	O
staining	O
[	O
35	O
]	O
.	O

After	O
three	O
washings	O
in	O
PBS	O
(	O
137	O
mM	O
NaCl	B-CHEBI
,	O
2	O
.	O
7	O
mM	O
KCl	B-CHEBI
,	O
8	O
.	O
1	O
mM	O
Na2HPO4	B-CHEBI
,	O
1	O
.	O
5	O
mM	O
KH2PO4	O
,	O
pH	O
7	O
.	O
4	O
)	O
,	O
the	O
tissue	O
sections	O
were	O
incubated	O
in	O
PBS	O
containing	O
0	O
.	O
1	O
%	O
trypsin	O
for	O
10	O
min	O
at	O
room	O
temperature	O
to	O
free	O
formaldehyde	B-CHEBI
-	O
crosslinked	O
epitopes	O
[	O
15	O
-	O
17	O
]	O
.	O

After	O
additional	O
three	O
washes	O
with	O
PBS	O
,	O
non	O
-	O
specific	O
binding	O
sites	O
were	O
blocked	O
by	O
incubating	O
the	O
slides	O
with	O
PBG	O
(	O
0	O
.	O
5	O
%	O
BSA	O
,	O
0	O
.	O
045	O
%	O
fish	O
gelatine	O
in	O
PBS	O
)	O
in	O
10	O
%	O
normal	O
goat	O
serum	O
(	O
NGS	O
)	O
for	O
2	O
h	O
.	O

Incubation	O
with	O
the	O
primary	O
antibodies	O
was	O
performed	O
at	O
4	O
degrees	O
C	O
overnight	O
diluted	O
in	O
PBG	O
supplemented	O
with	O
1	O
%	O
NGS	O
.	O

After	O
five	O
washes	O
in	O
PBG	O
for	O
5	O
min	O
each	O
,	O
the	O
slides	O
were	O
incubated	O
for	O
1	O
h	O
with	O
the	O
secondary	O
antibody	O
at	O
room	O
temperature	O
,	O
washed	O
three	O
times	O
in	O
PBG	O
and	O
three	O
times	O
in	O
PBS	O
,	O
5	O
min	O
each	O
,	O
rinsed	O
in	O
water	B-CHEBI
and	O
embedded	O
in	O
gelvatol	B-CHEBI
[	O
36	O
]	O
.	O

For	O
control	O
,	O
sections	O
were	O
incubated	O
only	O
with	O
the	O
secondary	O
antibody	O
or	O
sections	O
obtained	O
from	O
an	O
annexin	O
A7	O
knockout	O
mouse	O
were	O
used	O
[	O
10	O
]	O
.	O

Samples	O
were	O
examined	O
with	O
a	O
confocal	O
laser	O
scan	O
microscope	O
(	O
Leica	O
TCS	O
SP	O
;	O
Leica	O
,	O
Bensheim	O
,	O
FRG	O
)	O
.	O

Immunofluorescence	O
microscopy	O
of	O
human	O
brain	O

The	O
paraffin	O
-	O
embedded	O
human	O
brain	O
sections	O
were	O
deparaffinzed	O
likewise	O
.	O

Immunostaining	O
for	O
Annexin	O
A7	O
was	O
performed	O
using	O
the	O
monoclonal	O
antibody	O
mAb	O
203	O
-	O
217	O
.	O

Microwave	O
pre	O
-	O
treatment	O
was	O
used	O
for	O
all	O
sections	O
[	O
15	O
]	O
.	O

Trypsin	O
pre	O
-	O
treatment	O
was	O
used	O
as	O
indicated	O
.	O

Carbocyanine	O
2	O
and	O
3	O
labeled	O
anti	O
-	O
mouse	O
IgG	O
secondary	O
antibodies	O
(	O
Dianova	O
,	O
Hamburg	O
,	O
Germany	O
)	O
were	O
used	O
to	O
detect	O
the	O
primary	O
antibody	O
and	O
showed	O
similar	O
staining	O
patterns	O
.	O

Blank	O
controls	O
were	O
performed	O
,	O
too	O
.	O

Cell	O
culture	O
and	O
growth	O
conditions	O

The	O
cell	O
lines	O
used	O
were	O
cultured	O
according	O
to	O
the	O
instructions	O
provided	O
by	O
ATCC	O
:	O
murine	O
neuroblastoma	O
neuro	O
-	O
2a	O
(	O
ATCC	O
CCL	O
-	O
131	O
)	O
,	O
rat	O
pheochromocytoma	O
PC	O
-	O
12	O
(	O
ATCC	O
CRL	O
-	O
1721	O
)	O
,	O
and	O
rat	O
glioblastoma	O
C6	O
(	O
ATCC	O
CCL	O
-	O
107	O
)	O
.	O

One	O
day	O
before	O
fixation	O
with	O
4	O
%	O
paraformaldehyde	O
and	O
permeabilization	O
with	O
0	O
.	O
5	O
%	O
Triton	O
X	O
-	O
100	O
,	O
cells	O
were	O
seeded	O
on	O
coverslips	O
.	O

Immunostaining	O
was	O
performed	O
as	O
described	O
for	O
the	O
tissue	O
sections	O
with	O
or	O
without	O
the	O
trypsin	O
treatment	O
.	O

Extraction	O
of	O
nuclear	O
Annexin	O
A7	O

Cultured	O
cells	O
were	O
trypsinized	O
,	O
counted	O
and	O
washed	O
once	O
in	O
PBS	O
.	O

They	O
were	O
resuspended	O
in	O
buffer1	O
(	O
0	O
.	O
32	O
M	O
sucrose	B-CHEBI
,	O
10	O
mM	O
Tris	B-CHEBI
,	O
pH8	O
.	O
0	O
,	O
3	O
mM	O
CaCl2	B-CHEBI
,	O
2	O
mM	O
Mg	B-CHEBI
-	O
acetate	B-CHEBI
,	O
0	O
.	O
1	O
mM	O
EDTA	B-CHEBI
,	O
0	O
.	O
5	O
%	O
NP40	O
,	O
1	O
mM	O
DTT	B-CHEBI
,	O
0	O
.	O
5	O
mM	O
PMSF	B-CHEBI
;	O
1	O
x	O
107cells	O
/	O
400	O
mu	O
l	O
buffer	O
)	O
and	O
sonified	O
on	O
ice	O
(	O
sonifier	O
UP200S	O
,	O
dr	O
.	O
hielscher	O
,	O
40	O
s	O
,	O
amplitude	O
50	O
%	O
,	O
cycle	O
0	O
.	O
5	O
)	O
.	O

This	O
step	O
was	O
repeated	O
until	O
no	O
more	O
intact	O
cells	O
were	O
observed	O
by	O
light	O
microscopy	O
.	O

The	O
resulting	O
homogenate	O
was	O
centrifuged	O
at	O
500	O
g	O
for	O
5	O
minutes	O
,	O
washed	O
twice	O
in	O
1	O
ml	O
buffer	O
1	O
without	O
NP40	O
and	O
centrifuged	O
again	O
.	O

The	O
resulting	O
pellet	O
contains	O
purified	O
nuclei	O
.	O

For	O
partial	O
extraction	O
of	O
the	O
nucleoplasm	O
according	O
to	O
[	O
37	O
]	O
,	O
nuclei	O
were	O
resuspended	O
in	O
buffer	O
2	O
(	O
20	O
mM	O
Hepes	B-CHEBI
,	O
pH	O
7	O
.	O
9	O
,	O
1	O
.	O
5	O
mM	O
MgCl2	B-CHEBI
,	O
20	O
mM	O
KCl	B-CHEBI
,	O
0	O
.	O
2	O
mM	O
EDTA	B-CHEBI
,	O
25	O
%	O
v	O
/	O
v	O
glycerine	B-CHEBI
,	O
0	O
.	O
5	O
mM	O
DTT	B-CHEBI
,	O
0	O
.	O
5	O
mM	O
PMSF	B-CHEBI
;	O
nuclei	O
of	O
107cells	O
/	O
30	O
mu	O
l	O
buffer	O
)	O
and	O
incubated	O
on	O
ice	O
for	O
30	O
minutes	O
.	O

An	O
equal	O
volume	O
of	O
buffer	O
3	O
was	O
added	O
in	O
aliquots	O
(	O
20	O
mM	O
Hepes	B-CHEBI
,	O
pH	O
7	O
.	O
9	O
,	O
1	O
.	O
5	O
mM	O
MgCl2	B-CHEBI
,	O
800	O
mM	O
KCl	B-CHEBI
,	O
0	O
.	O
2	O
mM	O
EDTA	B-CHEBI
,	O
25	O
%	O
v	O
/	O
v	O
glycerine	B-CHEBI
,	O
0	O
.	O
5	O
mM	O
DTT	B-CHEBI
,	O
0	O
.	O
5	O
mM	O
PMSF	B-CHEBI
,	O
1	O
%	O
NP40	O
,	O
protease	B-CHEBI
inhibitor	I-CHEBI
cocktail	O
(	O
Sigma	O
)	O
)	O
and	O
the	O
solution	O
was	O
incubated	O
while	O
shaking	O
for	O
further	O
30	O
minutes	O
on	O
ice	O
.	O

Then	O
the	O
solution	O
was	O
centrifuged	O
for	O
15	O
minutes	O
at	O
14	O
.	O
000	O
g	O
,	O
the	O
resulting	O
supernatant	O
was	O
used	O
as	O
nucleoplasm	O
,	O
and	O
the	O
pellet	O
was	O
washed	O
once	O
and	O
adjusted	O
to	O
an	O
equal	O
volume	O
with	O
PBS	O
.	O

Nucleoplasm	O
and	O
nuclear	O
pellet	O
were	O
subjected	O
to	O
SDS	B-CHEBI
-	O
PAGE	O
and	O
Western	O
blotting	O
.	O

Western	O
blotting	O

Cells	O
or	O
cellular	O
fractions	O
were	O
lysed	O
in	O
SDS	B-CHEBI
sample	O
buffer	O
and	O
homogenates	O
were	O
subjected	O
to	O
SDS	B-CHEBI
-	O
PAGE	O
.	O

Western	O
blotting	O
was	O
carried	O
out	O
using	O
the	O
method	O
of	O
Towbin	O
et	O
al	O
.	O

[	O
38	O
]	O
.	O

Peroxidase	O
-	O
coupled	O
secondary	O
antibodies	O
(	O
Sigma	O
)	O
and	O
the	O
supersignal	O
enhanced	O
chemiluminescence	O
system	O
(	O
Pierce	O
,	O
Rockford	O
,	O
IL	O
,	O
USA	O
)	O
were	O
used	O
.	O

Embryo	O
Multiple	O
Tissue	O
Northern	O
Blot	O

The	O
presence	O
of	O
Annexin	O
A7	O
mRNA	B-CHEBI
in	O
mouse	O
ES	O
cells	O
and	O
embryos	O
E7	O
,	O
E11	O
,	O
E15	O
and	O
E17	O
was	O
analyzed	O
by	O
northern	O
blot	O
analysis	O
.	O

An	O
Embryo	O
Multiple	O
Tissue	O
Northern	O
Blot	O
membrane	O
was	O
obtained	O
from	O
Clontech	O
Laboratories	O
(	O
Heidelberg	O
,	O
FRG	O
)	O
.	O

It	O
contained	O
approximately	O
2	O
mu	O
g	O
of	O
poly	O
(	O
A	B-CHEBI
)	O
+	O
RNA	O
per	O
lane	O
from	O
four	O
different	O
stages	O
of	O
mouse	O
development	O
.	O

RNA	O
from	O
ES	O
cells	O
was	O
isolated	O
with	O
the	O
RNeasy	O
kit	O
(	O
Qiagen	O
)	O
.	O

The	O
membranes	O
were	O
hybridized	O
with	O
a	O
random	O
-	O
primed	O
[	O
alpha	O
-	O
32P	B-CHEBI
]	O
-	O
dATP	B-CHEBI
-	O
labelled	O
full	O
length	O
annexin	O
A7	O
cDNA	O
probe	O
and	O
with	O
a	O
beta	O
-	O
actin	O
specific	O
probe	O
for	O
control	O
in	O
ExpressHyb	O
solution	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
directions	O
.	O

Authors	O
'	O
contributions	O

MR	O
,	O
SIRG	O
,	O
and	O
CSC	O
planned	O
and	O
carried	O
out	O
the	O
experiments	O
,	O
evaluated	O
the	O
results	O
,	O
and	O
drafted	O
the	O
manuscript	O
.	O

CH	O
provided	O
polyclonal	O
anti	O
-	O
Annexin	O
A7	O
antibodies	O
and	O
brain	O
sections	O
of	O
the	O
AnxA7	O
knock	O
out	O
mouse	O
,	O
and	O
contributed	O
to	O
the	O
analysis	O
of	O
data	O
.	O

DT	O
provided	O
the	O
sections	O
the	O
human	O
autopsy	O
brain	O
,	O
analyzed	O
them	O
by	O
immunofluorescence	O
,	O
and	O
contributed	O
to	O
the	O
analysis	O
of	O
data	O
.	O

AAN	O
conceived	O
of	O
the	O
studies	O
and	O
participated	O
in	O
its	O
design	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
manuscript	O
.	O

Acknowledgements	O

We	O
thank	O
Maria	O
Stumpf	O
,	O
Rolf	O
M	O
u	O
ller	O
and	O
Berthold	O
Gassen	O
for	O
technical	O
assistance	O
,	O
Drs	O
.	O

Andreas	O
Hasse	O
and	O
Rolf	O
Schr	O
o	O
der	O
for	O
helpful	O
discussion	O
and	O
Bettina	O
Lauss	O
for	O
help	O
with	O
the	O
manuscript	O
.	O

This	O
work	O
is	O
supported	O
by	O
the	O
Center	O
of	O
Molecular	B-CHEBI
Medicine	O
Cologne	O
.	O

A	O
Developmental	O
Switch	O
in	O
the	O
Response	O
of	O
DRG	O
Neurons	O
to	O
ETS	O
Transcription	O
Factor	O
Signaling	O

Abstract	O

Two	O
ETS	O
transcription	O
factors	O
of	O
the	O
Pea3	O
subfamily	O
are	O
induced	O
in	O
subpopulations	O
of	O
dorsal	O
root	O
ganglion	O
(	O
DRG	O
)	O
sensory	O
and	O
spinal	O
motor	O
neurons	O
by	O
target	O
-	O
derived	O
factors	O
.	O

Their	O
expression	O
controls	O
late	O
aspects	O
of	O
neuronal	O
differentiation	O
such	O
as	O
target	O
invasion	O
and	O
branching	O
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
late	O
onset	O
of	O
ETS	O
gene	O
expression	O
is	O
an	O
essential	O
requirement	O
for	O
normal	O
sensory	O
neuron	O
differentiation	O
.	O

We	O
provide	O
genetic	O
evidence	O
in	O
the	O
mouse	O
that	O
precocious	O
ETS	O
expression	O
in	O
DRG	O
sensory	O
neurons	O
perturbs	O
axonal	O
projections	O
,	O
the	O
acquisition	O
of	O
terminal	O
differentiation	O
markers	O
,	O
and	O
their	O
dependence	O
on	O
neurotrophic	O
support	O
.	O

Together	O
,	O
our	O
findings	O
indicate	O
that	O
DRG	O
sensory	O
neurons	O
exhibit	O
a	O
temporal	O
developmental	O
switch	O
that	O
can	O
be	O
revealed	O
by	O
distinct	O
responses	O
to	O
ETS	O
transcription	O
factor	O
signaling	O
at	O
sequential	O
steps	O
of	O
neuronal	O
maturation	O
.	O

Introduction	O

Neuronal	O
differentiation	O
is	O
a	O
protracted	O
process	O
during	O
which	O
newly	O
generated	O
neurons	O
express	O
distinct	O
cellular	O
and	O
molecular	B-CHEBI
programs	O
at	O
precise	O
times	O
during	O
their	O
maturation	O
:	O
long	O
-	O
distance	O
axon	O
outgrowth	O
,	O
subsequent	O
terminal	O
branching	O
,	O
and	O
finally	O
synaptogenesis	O
.	O

Many	O
important	O
aspects	O
of	O
neuronal	O
character	O
appear	O
to	O
be	O
acquired	O
through	O
the	O
expression	O
of	O
transcription	O
factors	O
at	O
progenitor	O
cell	O
stages	O
,	O
whereas	O
others	O
depend	O
on	O
expression	O
immediately	O
upon	O
cell	O
cycle	O
exit	O
[	O
1	O
]	O
.	O

But	O
whether	O
the	O
orderly	O
expression	O
and	O
activity	O
of	O
transcriptional	O
programs	O
at	O
much	O
later	O
developmental	O
stages	O
,	O
well	O
after	O
cell	O
cycle	O
exit	O
,	O
is	O
an	O
essential	O
step	O
in	O
the	O
progression	O
of	O
neuronal	O
differentiation	O
and	O
circuit	O
assembly	O
has	O
yet	O
to	O
be	O
resolved	O
.	O

The	O
differentiation	O
of	O
sensory	O
neurons	O
of	O
dorsal	O
root	O
ganglia	O
(	O
DRG	O
)	O
has	O
been	O
studied	O
extensively	O
with	O
respect	O
to	O
inductive	O
events	O
that	O
specify	O
neuronal	O
fate	O
[	O
2	O
,	O
3	O
]	O
,	O
as	O
well	O
as	O
the	O
involvement	O
of	O
late	O
target	O
-	O
derived	O
neurotrophic	O
factors	O
in	O
the	O
control	O
of	O
neuronal	O
survival	O
[	O
4	O
]	O
.	O

Recent	O
evidence	O
has	O
begun	O
to	O
emerge	O
that	O
target	O
-	O
derived	O
factors	O
are	O
also	O
involved	O
in	O
regulating	O
later	O
aspects	O
of	O
neuronal	O
differentiation	O
[	O
5	O
,	O
6	O
,	O
7	O
]	O
.	O

In	O
particular	O
,	O
genetic	O
experiments	O
have	O
addressed	O
the	O
survival	O
-	O
independent	O
role	O
of	O
neurotrophic	O
factors	O
during	O
development	O
by	O
exploiting	O
strains	O
of	O
mice	O
defective	O
both	O
in	O
neurotrophin	O
signaling	O
and	O
in	O
the	O
function	O
of	O
the	O
proapoptotic	O
gene	O
Bax	O
[	O
8	O
,	O
9	O
]	O
.	O

These	O
studies	O
,	O
for	O
example	O
,	O
have	O
revealed	O
that	O
neurotrophin	O
signaling	O
controls	O
the	O
acquisition	O
of	O
peptidergic	O
traits	O
in	O
nociceptive	O
DRG	O
neurons	O
and	O
the	O
control	O
of	O
target	O
innervation	O
[	O
8	O
,	O
9	O
]	O
.	O

The	O
onset	O
of	O
some	O
transcriptional	O
programs	O
in	O
neurons	O
,	O
however	O
,	O
has	O
also	O
been	O
shown	O
to	O
occur	O
long	O
after	O
neurons	O
exit	O
the	O
cell	O
cycle	O
.	O

An	O
emerging	O
principle	O
from	O
work	O
in	O
Drosophila	O
and	O
vertebrates	O
is	O
that	O
target	O
-	O
derived	O
factors	O
play	O
a	O
crucial	O
role	O
in	O
the	O
induction	O
of	O
these	O
transcriptional	O
programs	O
[	O
10	O
]	O
.	O

In	O
Drosophila	O
,	O
retrograde	O
BMP	O
signals	O
from	O
the	O
target	O
region	O
control	O
the	O
terminal	O
differentiation	O
of	O
a	O
subpopulation	O
of	O
peptidergic	O
neurons	O
expressing	O
Apterous	O
and	O
Squeeze	O
[	O
11	O
,	O
12	O
]	O
.	O

In	O
vertebrates	O
,	O
peripheral	O
neurotrophic	O
signals	O
have	O
been	O
shown	O
to	O
direct	O
the	O
onset	O
of	O
expression	O
of	O
the	O
ETS	O
transcription	O
factors	O
Er81	O
and	O
Pea3	O
in	O
DRG	O
sensory	O
neurons	O
and	O
motor	O
neuron	O
pools	O
several	O
days	O
after	O
these	O
neurons	O
have	O
become	O
post	O
-	O
mitotic	O
[	O
9	O
,	O
13	O
,	O
14	O
,	O
15	O
,	O
16	O
]	O
.	O

Moreover	O
,	O
the	O
induction	O
of	O
Er81	O
expression	O
in	O
proprioceptive	O
afferents	O
is	O
known	O
to	O
be	O
mediated	O
by	O
peripheral	O
neurotrophin	O
3	O
(	O
NT	O
-	O
3	O
)	O
[	O
9	O
]	O
.	O

These	O
two	O
ETS	O
proteins	B-CHEBI
control	O
late	O
aspects	O
of	O
spinal	O
monosynaptic	O
circuit	O
assembly	O
,	O
with	O
Er81	O
directing	O
proprioceptive	O
sensory	O
neuron	O
differentiation	O
and	O
Pea3	O
directing	O
motor	O
neuron	O
pool	O
differentiation	O
,	O
respectively	O
[	O
14	O
,	O
15	O
]	O
.	O

In	O
particular	O
,	O
in	O
the	O
absence	O
of	O
Er81	O
,	O
achieved	O
by	O
mutation	O
in	O
the	O
gene	O
or	O
by	O
deprivation	O
of	O
peripheral	O
neurotrophin	O
signaling	O
,	O
group	O
Ia	O
proprioceptive	O
afferents	O
fail	O
to	O
invade	O
the	O
ventral	O
spinal	O
cord	O
and	O
to	O
make	O
effective	O
synaptic	O
connections	O
with	O
motor	O
neurons	O
[	O
9	O
,	O
14	O
]	O
.	O

The	O
involvement	O
of	O
target	O
-	O
derived	O
signals	O
in	O
induction	O
of	O
ETS	O
transcription	O
factor	O
expression	O
raises	O
the	O
question	O
of	O
the	O
necessity	O
for	O
the	O
observed	O
delay	O
in	O
the	O
onset	O
of	O
ETS	O
signaling	O
for	O
neuronal	O
maturation	O
.	O

Would	O
precocious	O
expression	O
of	O
ETS	O
proteins	B-CHEBI
in	O
post	O
-	O
mitotic	O
neurons	O
also	O
direct	O
the	O
appropriate	O
sensory	O
neuron	O
developmental	O
programs	O
?	O

In	O
this	O
study	O
,	O
we	O
have	O
used	O
mouse	O
genetics	O
to	O
test	O
this	O
general	O
idea	O
,	O
by	O
investigating	O
whether	O
the	O
precise	O
timing	O
of	O
onset	O
of	O
ETS	O
transcription	O
factor	O
signaling	O
is	O
essential	O
for	O
normal	O
sensory	O
neuron	O
development	O
.	O

We	O
have	O
assessed	O
the	O
biological	O
effects	O
of	O
inducing	O
ETS	O
signaling	O
either	O
at	O
the	O
correct	O
developmental	O
time	O
,	O
or	O
precociously	O
.	O

We	O
find	O
that	O
within	O
proprioceptive	O
sensory	O
neurons	O
,	O
the	O
late	O
onset	O
of	O
ETS	O
signaling	O
is	O
essential	O
for	O
the	O
establishment	O
of	O
normal	O
sensory	O
afferent	O
projections	O
in	O
the	O
spinal	O
cord	O
.	O

Precocious	O
initiation	O
of	O
ETS	O
signaling	O
in	O
post	O
-	O
mitotic	O
DRG	O
neurons	O
leads	O
to	O
abnormal	O
DRG	O
neuron	O
differentiation	O
characterized	O
by	O
neurotrophin	O
-	O
independent	O
neurite	O
outgrowth	O
and	O
inappropriate	O
profiles	O
of	O
gene	O
expression	O
.	O

Our	O
findings	O
reveal	O
that	O
target	O
-	O
triggered	O
inductive	O
signals	O
provide	O
an	O
effective	O
means	O
of	O
ensuring	O
the	O
late	O
onset	O
of	O
expression	O
of	O
transcription	O
factors	O
,	O
and	O
thus	O
an	O
orderly	O
temporal	O
transcriptional	O
sequence	O
that	O
is	O
crucial	O
for	O
neuronal	O
maturation	O
and	O
circuit	O
assembly	O
.	O

Results	O

To	O
test	O
the	O
hypothesis	O
that	O
a	O
temporal	O
delay	O
in	O
the	O
onset	O
of	O
transcriptional	O
programs	O
is	O
crucial	O
for	O
the	O
control	O
of	O
appropriate	O
neuronal	O
maturation	O
,	O
we	O
studied	O
the	O
development	O
of	O
proprioceptive	O
DRG	O
neurons	O
,	O
since	O
transcriptional	O
effectors	B-CHEBI
regulated	O
by	O
target	O
-	O
derived	O
signals	O
,	O
as	O
well	O
as	O
some	O
of	O
their	O
downstream	O
biological	O
actions	O
,	O
have	O
been	O
identified	O
for	O
these	O
neurons	O
.	O

Er81	O
controls	O
proprioceptive	O
afferent	O
connectivity	O
[	O
14	O
]	O
,	O
and	O
we	O
therefore	O
sought	O
to	O
identify	O
an	O
ETS	O
transcriptional	O
regulator	O
that	O
,	O
when	O
expressed	O
over	O
the	O
normal	O
time	O
course	O
of	O
Er81	O
expression	O
,	O
is	O
able	O
to	O
substitute	O
for	O
Er81	O
function	O
within	O
group	O
Ia	O
afferent	O
sensory	O
neurons	O
.	O

With	O
this	O
reference	O
point	O
,	O
we	O
then	O
designed	O
experiments	O
to	O
examine	O
the	O
effects	O
of	O
precocious	O
post	O
-	O
mitotic	O
expression	O
of	O
the	O
same	O
ETS	O
transcription	O
factor	O
on	O
sensory	O
neuron	O
differentiation	O
.	O

EWS	O
-	O
Pea3	O
Can	O
Replace	O
Er81	O
Function	O
in	O
Controlling	O
Ia	O
Afferent	O
Projections	O

We	O
first	O
defined	O
an	O
ETS	O
transcription	O
regulator	O
that	O
is	O
able	O
to	O
replace	O
the	O
function	O
of	O
Er81	O
within	O
proprioceptive	O
afferents	O
to	O
direct	O
projections	O
into	O
the	O
ventral	O
spinal	O
cord	O
.	O

Er81	O
,	O
Pea3	O
,	O
and	O
Erm	O
constitute	O
the	O
Pea3	O
subfamily	O
of	O
ETS	O
transcription	O
factors	O
,	O
show	O
a	O
high	O
degree	O
of	O
amino	B-CHEBI
acid	I-CHEBI
identity	O
,	O
and	O
bind	O
to	O
very	O
similar	O
DNA	O
target	O
sequences	O
[	O
17	O
,	O
18	O
,	O
19	O
]	O
.	O

Nevertheless	O
,	O
when	O
introduced	O
into	O
the	O
Er81	O
locus	O
in	O
analogy	O
to	O
a	O
previously	O
used	O
targeting	O
strategy	O
(	O
data	O
not	O
shown	O
;	O
[	O
14	O
]	O
)	O
,	O
neither	O
Pea3	O
nor	O
Erm	O
could	O
rescue	O
Ia	O
proprioceptive	O
afferent	O
projections	O
to	O
extensively	O
invade	O
the	O
ventral	O
horn	O
of	O
the	O
spinal	O
cord	O
(	O
data	O
not	O
shown	O
)	O
.	O

These	O
findings	O
prompted	O
us	O
to	O
analyze	O
mice	O
in	O
which	O
we	O
integrated	O
EWS	O
-	O
Pea3	O
,	O
a	O
break	O
-	O
point	O
fusion	O
product	O
between	O
the	O
amino	B-CHEBI
-	O
terminal	O
domain	O
of	O
the	O
Ewing	O
sarcoma	O
(	O
EWS	O
)	O
gene	O
and	O
the	O
Pea3	O
DNA	O
binding	O
domain	O
[	O
20	O
,	O
21	O
]	O
,	O
into	O
the	O
Er81	O
locus	O
(	O
Figure	O
1	O
)	O
.	O

We	O
found	O
that	O
in	O
a	O
luciferase	O
-	O
enzyme	O
-	O
based	O
cell	O
culture	O
transfection	O
assay	O
,	O
EWS	O
-	O
Pea3	O
showed	O
stronger	O
transactivation	O
activity	O
than	O
Er81	O
or	O
Pea3	O
(	O
Figure	O
1J	O
;	O
data	O
not	O
shown	O
)	O
,	O
in	O
agreement	O
with	O
previous	O
studies	O
[	O
22	O
,	O
23	O
,	O
24	O
]	O
.	O

Moreover	O
,	O
transactivation	O
by	O
EWS	O
-	O
Pea3	O
was	O
abolished	O
by	O
mutation	O
of	O
ETS	O
-	O
binding	O
sites	O
in	O
the	O
reporter	O
plasmid	O
,	O
demonstrating	O
ETS	O
-	O
binding	O
-	O
site	O
dependence	O
(	O
data	O
not	O
shown	O
)	O
.	O

Expression	O
of	O
Er81	O
in	O
DRG	O
neurons	O
of	O
embryos	O
containing	O
integration	O
of	O
EWS	O
-	O
Pea3	O
in	O
the	O
Er81	O
locus	O
(	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
)	O
was	O
abolished	O
(	O
Figure	O
1E	O
)	O
,	O
and	O
the	O
expression	O
level	O
of	O
the	O
calcium	B-CHEBI
-	O
binding	O
protein	B-CHEBI
Parvalbumin	O
(	O
PV	O
)	O
in	O
proprioceptive	O
afferents	O
,	O
which	O
is	O
decreased	O
approximately	O
5	O
-	O
to	O
10	O
-	O
fold	O
in	O
Er81	O
mutants	O
[	O
14	O
]	O
,	O
was	O
comparable	O
to	O
wild	O
-	O
type	O
levels	O
in	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
embryos	O
(	O
Figure	O
1F	O
-	O
1H	O
)	O
.	O

To	O
further	O
define	O
DRG	O
neuron	O
differentiation	O
in	O
the	O
presence	O
of	O
EWS	O
-	O
Pea3	O
in	O
proprioceptive	O
afferents	O
in	O
vivo	O
,	O
we	O
assessed	O
whether	O
replacement	O
of	O
Er81	O
by	O
EWS	O
-	O
Pea3	O
had	O
an	O
influence	O
on	O
neuronal	O
survival	O
or	O
on	O
the	O
expression	O
of	O
proprioceptive	O
-	O
afferent	O
-	O
specific	O
genes	O
.	O

Er81EWS	O
-	O
Pea3	O
/	O
-	O
mice	O
did	O
not	O
differ	O
from	O
wild	O
-	O
type	O
in	O
the	O
number	O
of	O
proprioceptive	O
afferent	O
cell	O
bodies	O
within	O
the	O
DRG	O
of	O
L1	O
to	O
L5	O
,	O
the	O
expression	O
of	O
several	O
genes	O
normally	O
expressed	O
by	O
proprioceptive	O
afferents	O
,	O
and	O
the	O
lack	O
of	O
expression	O
of	O
genes	O
not	O
normally	O
expressed	O
in	O
proprioceptive	O
afferents	O
(	O
Figure	O
S1	O
;	O
data	O
not	O
shown	O
)	O
.	O

Together	O
,	O
these	O
findings	O
suggest	O
that	O
the	O
expression	O
of	O
EWS	O
-	O
Pea3	O
from	O
the	O
normal	O
time	O
of	O
onset	O
mimics	O
the	O
function	O
of	O
Er81	O
as	O
assessed	O
by	O
induction	O
and	O
maintenance	O
of	O
gene	O
expression	O
within	O
proprioceptive	O
afferents	O
.	O

To	O
determine	O
the	O
extent	O
of	O
rescue	O
of	O
Ia	O
proprioceptive	O
afferent	O
projections	O
into	O
the	O
ventral	O
spinal	O
cord	O
of	O
Er81	O
mutant	O
mice	O
achieved	O
by	O
expression	O
of	O
EWS	O
-	O
Pea3	O
,	O
we	O
traced	O
intraspinal	O
afferent	O
projections	O
by	O
axonal	O
labeling	O
of	O
PV	O
(	O
Figure	O
2A	O
-	O
2C	O
)	O
.	O

In	O
addition	O
,	O
to	O
analyze	O
axon	O
ingrowth	O
independent	O
of	O
the	O
level	O
of	O
PV	O
expression	O
in	O
DRG	O
neurons	O
,	O
we	O
used	O
anterograde	O
labeling	O
of	O
afferent	O
fibers	O
by	O
applying	O
fluorescently	B-CHEBI
labeled	I-CHEBI
dextran	O
to	O
cut	O
dorsal	O
roots	O
(	O
Figure	O
2D	O
-	O
2F	O
)	O
.	O

Using	O
both	O
assays	O
,	O
we	O
found	O
extensive	O
rescue	O
of	O
the	O
projections	O
into	O
the	O
ventral	O
horn	O
of	O
the	O
spinal	O
cord	O
in	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
mice	O
(	O
Figure	O
2C	O
and	O
2F	O
)	O
.	O

Within	O
the	O
ventral	O
horn	O
,	O
Ia	O
afferents	O
in	O
both	O
wild	O
-	O
type	O
and	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
mice	O
formed	O
vGlut1	O
+	O
terminals	O
that	O
were	O
absent	O
in	O
Er81	O
mutant	O
mice	O
(	O
Figure	O
2G	O
-	O
2I	O
)	O
.	O

To	O
assess	O
whether	O
synapses	O
between	O
Ia	O
afferents	O
and	O
motor	O
neurons	O
are	O
functional	O
in	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
mice	O
,	O
we	O
performed	O
intracellular	O
recordings	O
from	O
identified	O
quadriceps	O
motor	O
neurons	O
after	O
stimulation	O
of	O
nerves	O
innervating	O
the	O
quadriceps	O
muscle	O
group	O
.	O

We	O
found	O
no	O
significant	O
difference	O
in	O
the	O
input	O
amplitude	O
to	O
quadriceps	O
motor	O
neurons	O
when	O
comparing	O
wild	O
-	O
type	O
to	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
mice	O
(	O
Figure	O
S2	O
;	O
wild	O
-	O
type	O
,	O
10	O
.	O
6	O
+/-	O
0	O
.	O
9	O
mV	O
,	O
n	O
=	O
11	O
;	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
,	O
10	O
.	O
9	O
+/-	O
1	O
mV	O
,	O
n	O
=	O
8	O
)	O
.	O

Together	O
,	O
these	O
findings	O
suggest	O
that	O
in	O
the	O
absence	O
of	O
Er81	O
,	O
EWS	O
-	O
Pea3	O
can	O
direct	O
the	O
complex	O
biological	O
process	O
of	O
correct	O
laminar	O
termination	O
within	O
the	O
ventral	O
spinal	O
cord	O
and	O
the	O
formation	O
of	O
synapses	O
with	O
motor	O
neurons	O
(	O
Figure	O
2J	O
-	O
2L	O
)	O
,	O
thus	O
identifying	O
an	O
ETS	O
transcription	O
factor	O
suitable	O
for	O
heterochronic	O
expression	O
experiments	O
in	O
DRG	O
neurons	O
.	O

Precocious	O
Expression	O
of	O
EWS	O
-	O
Pea3	O
in	O
DRG	O
Neurons	O
Leads	O
to	O
Axonal	O
Projection	O
Defects	O

To	O
address	O
the	O
consequences	O
of	O
precocious	O
ETS	O
signaling	O
for	O
proprioceptive	O
afferent	O
differentiation	O
,	O
we	O
next	O
expressed	O
EWS	O
-	O
Pea3	O
in	O
DRG	O
neurons	O
as	O
soon	O
as	O
they	O
became	O
post	O
-	O
mitotic	O
.	O

We	O
used	O
a	O
binary	O
mouse	O
genetic	O
system	O
based	O
on	O
Cre	O
-	O
recombinase	O
-	O
mediated	O
excision	O
of	O
a	O
transcriptional	O
stop	O
cassette	O
flanked	O
by	O
loxP	O
sites	O
.	O

Targeting	O
cassettes	O
were	O
integrated	O
into	O
the	O
Tau	O
locus	O
to	O
generate	O
two	O
strains	O
of	O
mice	O
conditionally	O
expressing	O
either	O
EWS	O
-	O
Pea3	O
or	O
a	O
membrane	O
-	O
targeted	O
green	O
fluorescent	O
protein	B-CHEBI
(	O
mGFP	O
)	O
to	O
trace	O
axonal	O
projections	O
of	O
DRG	O
neurons	O
(	O
Figure	O
S3	O
;	O
[	O
25	O
]	O
)	O
.	O

Embryos	O
positive	O
for	O
either	O
Isl1Cre	O
/	O
+	O
and	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
or	O
Isl1Cre	O
/	O
+	O
and	O
TaumGFP	O
/	O
+	O
alleles	O
showed	O
efficient	O
activation	O
of	O
the	O
silent	O
Tau	O
allele	O
in	O
95	O
%	O
or	O
more	O
of	O
all	O
DRG	O
neurons	O
,	O
including	O
proprioceptive	O
afferents	O
,	O
at	O
all	O
segmental	O
levels	O
(	O
Figure	O
S3	O
)	O
.	O

We	O
first	O
assessed	O
the	O
influence	O
of	O
EWS	O
-	O
Pea3	O
expression	O
in	O
early	O
post	O
-	O
mitotic	O
DRG	O
neurons	O
on	O
the	O
establishment	O
of	O
afferent	O
projections	O
into	O
the	O
spinal	O
cord	O
using	O
the	O
TaumGFP	O
/	O
+	O
allele	O
or	O
a	O
Thy1	O
-	O
promoter	O
-	O
driven	O
synaptophysin	O
green	O
fluorescent	O
protein	B-CHEBI
(	O
spGFP	O
)	O
with	O
an	O
expression	O
profile	O
restricted	O
to	O
DRG	O
sensory	O
neurons	O
at	O
embryonic	O
day	O
(	O
E	O
)	O
13	O
.	O
5	O
(	O
Thy1spGFP	O
;	O
[	O
25	O
]	O
)	O
(	O
Figure	O
3	O
)	O
.	O

In	O
contrast	O
to	O
wild	O
-	O
type	O
proprioceptive	O
afferent	O
projections	O
(	O
Figure	O
3A	O
-	O
3C	O
)	O
,	O
GFP	O
+	O
sensory	O
afferents	O
in	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
failed	O
to	O
invade	O
the	O
spinal	O
cord	O
and	O
instead	O
were	O
found	O
in	O
an	O
extreme	O
lateral	O
position	O
at	O
the	O
dorsal	O
root	O
entry	O
zone	O
,	O
a	O
phenotype	O
observed	O
at	O
least	O
up	O
to	O
E18	O
.	O
5	O
(	O
Figure	O
3A	O
-	O
3C	O
and	O
3G	O
-	O
3I	O
;	O
data	O
not	O
shown	O
)	O
.	O

We	O
next	O
visualized	O
the	O
path	O
of	O
sensory	O
afferent	O
projections	O
towards	O
the	O
dorsal	O
root	O
entry	O
zone	O
in	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
by	O
injecting	O
fluorescently	B-CHEBI
labeled	I-CHEBI
dextran	O
into	O
an	O
individual	O
DRG	O
(	O
L3	O
;	O
n	O
=	O
3	O
;	O
Figure	O
3M	O
-	O
3Q	O
)	O
.	O

Sensory	O
afferents	O
in	O
E13	O
.	O
5	O
wild	O
-	O
type	O
embryos	O
bifurcated	O
at	O
their	O
lateral	O
spinal	O
entry	O
point	O
,	O
and	O
projected	O
rostrally	O
and	O
caudally	O
over	O
six	O
or	O
more	O
segmental	O
levels	O
while	O
gradually	O
approaching	O
the	O
midline	O
(	O
Figure	O
3M	O
)	O
.	O

Sensory	O
afferents	O
in	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
also	O
bifurcated	O
at	O
the	O
entry	O
point	O
,	O
although	O
approximately	O
5	O
%	O
of	O
afferent	O
fibers	O
continued	O
to	O
grow	O
towards	O
the	O
midline	O
(	O
Figure	O
3O	O
and	O
3Q	O
)	O
.	O

While	O
rostro	O
-	O
caudal	O
projections	O
were	O
present	O
in	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
,	O
afferent	O
fibers	O
failed	O
to	O
approach	O
the	O
midline	O
at	O
distal	O
segments	O
and	O
continued	O
to	O
occupy	O
an	O
extreme	O
lateral	O
position	O
(	O
Figure	O
3O	O
)	O
,	O
consistent	O
with	O
the	O
analysis	O
of	O
transverse	O
sections	O
.	O

We	O
next	O
examined	O
the	O
establishment	O
of	O
peripheral	O
projections	O
upon	O
precocious	O
EWS	O
-	O
Pea3	O
expression	O
in	O
DRG	O
neurons	O
.	O

While	O
sensory	O
axons	O
in	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
reached	O
the	O
skin	O
and	O
established	O
major	O
nerve	O
trunks	O
by	O
E16	O
.	O
5	O
,	O
only	O
rudimentary	O
sensory	O
axon	O
branching	O
was	O
established	O
within	O
the	O
skin	O
(	O
Figure	O
3D	O
and	O
3J	O
)	O
.	O

In	O
addition	O
,	O
there	O
was	O
a	O
significant	O
reduction	O
in	O
the	O
number	O
of	O
muscle	O
spindles	O
in	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
(	O
approximately	O
25	O
%	O
of	O
wild	O
-	O
type	O
complement	O
;	O
n	O
=	O
3	O
)	O
as	O
assessed	O
by	O
innervation	O
and	O
expression	O
of	O
genes	O
specific	O
for	O
intrafusal	O
muscle	O
fibers	O
such	O
as	O
Egr3	O
(	O
Figure	O
3E	O
,	O
3F	O
,	O
3K	O
,	O
and	O
3L	O
;	O
[	O
26	O
]	O
)	O
.	O

In	O
summary	O
,	O
whereas	O
isochronic	O
expression	O
of	O
EWS	O
-	O
Pea3	O
promoted	O
the	O
establishment	O
of	O
proprioceptive	O
afferent	O
projections	O
into	O
the	O
ventral	O
spinal	O
cord	O
,	O
precocious	O
expression	O
of	O
the	O
same	O
ETS	O
signaling	O
factor	O
in	O
DRG	O
neurons	O
interfered	O
with	O
establishment	O
of	O
projections	O
into	O
the	O
spinal	O
cord	O
as	O
well	O
as	O
to	O
peripheral	O
targets	O
.	O

Precocious	O
EWS	O
-	O
Pea3	O
Expression	O
Promotes	O
Neurotrophin	O
-	O
Independent	O
Survival	O
and	O
Neurite	O
Outgrowth	O

To	O
begin	O
to	O
address	O
the	O
cellular	O
and	O
molecular	B-CHEBI
mechanisms	O
involved	O
in	O
the	O
distinct	O
biological	O
actions	O
of	O
EWS	O
-	O
Pea3	O
at	O
different	O
developmental	O
stages	O
,	O
we	O
first	O
turned	O
to	O
in	O
vitro	O
culture	O
experiments	O
.	O

These	O
experiments	O
permit	O
assessment	O
of	O
whether	O
precocious	O
ETS	O
transcription	O
factor	O
signaling	O
influences	O
neuronal	O
survival	O
and	O
in	O
vitro	O
neurite	O
outgrowth	O
of	O
DRG	O
neurons	O
,	O
two	O
parameters	O
prominently	O
influenced	O
by	O
target	O
-	O
derived	O
neurotrophic	O
factors	O
and	O
their	O
receptors	O
.	O

We	O
cultured	O
E13	O
.	O
5	O
whole	O
DRG	O
explants	O
from	O
wild	O
-	O
type	O
and	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
in	O
the	O
presence	O
of	O
NGF	O
or	O
NT	O
-	O
3	O
or	O
in	O
the	O
absence	O
of	O
neurotrophins	O
and	O
analyzed	O
neuronal	O
survival	O
and	O
neurite	O
outgrowth	O
on	O
matrigel	O
substrate	O
after	O
48	O
h	O
in	O
vitro	O
.	O

Without	O
neurotrophic	O
support	O
,	O
very	O
few	O
wild	O
-	O
type	O
DRG	O
neurons	O
survived	O
(	O
Figure	O
4A	O
)	O
.	O

In	O
contrast	O
,	O
culturing	O
wild	O
-	O
type	O
DRG	O
with	O
neurotrophic	O
factors	O
led	O
to	O
neuronal	O
survival	O
and	O
neurite	O
outgrowth	O
.	O

Addition	O
of	O
NGF	O
,	O
which	O
supports	O
survival	O
of	O
cutaneous	O
afferents	O
,	O
resulted	O
in	O
straight	O
and	O
unbranched	O
neurite	O
outgrowth	O
(	O
Figure	O
4B	O
)	O
,	O
while	O
cultures	O
grown	O
in	O
the	O
presence	O
of	O
NT	O
-	O
3	O
,	O
which	O
supports	O
survival	O
of	O
proprioceptive	O
afferents	O
,	O
resulted	O
in	O
a	O
highly	O
branched	O
neurite	O
outgrowth	O
pattern	O
after	O
48	O
h	O
in	O
vitro	O
(	O
Figure	O
4C	O
)	O
.	O

Surprisingly	O
,	O
DRG	O
neurons	O
isolated	O
from	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
and	O
cultured	O
without	O
neurotrophic	O
support	O
survived	O
after	O
48	O
h	O
in	O
vitro	O
and	O
had	O
established	O
long	O
and	O
highly	O
branched	O
neurites	O
(	O
Figure	O
4D	O
)	O
.	O

Neither	O
the	O
pattern	O
of	O
neurite	O
outgrowth	O
nor	O
neuronal	O
survival	O
changed	O
significantly	O
after	O
application	O
of	O
either	O
NGF	O
or	O
NT	O
-	O
3	O
(	O
Figure	O
4E	O
and	O
4F	O
)	O
.	O

To	O
directly	O
compare	O
neurotrophin	O
dependence	O
of	O
DRG	O
neurons	O
expressing	O
EWS	O
-	O
Pea3	O
from	O
the	O
Tau	O
locus	O
at	O
a	O
precocious	O
versus	O
isochronic	O
time	O
of	O
onset	O
,	O
we	O
generated	O
a	O
strain	O
of	O
mice	O
in	O
which	O
Cre	O
recombinase	O
is	O
expressed	O
from	O
the	O
PV	O
locus	O
(	O
Figure	O
S4	O
)	O
.	O

The	O
expression	O
of	O
GFP	O
in	O
TaumGFP	O
/	O
+	O
PVCre	O
/	O
+	O
was	O
restricted	O
to	O
PV	O
+	O
proprioceptive	O
DRG	O
neurons	O
and	O
mirrored	O
the	O
onset	O
of	O
expression	O
of	O
PV	O
at	O
approximately	O
E14	O
(	O
Figure	O
S4	O
;	O
data	O
not	O
shown	O
)	O
.	O

We	O
next	O
cultured	O
E14	O
.	O
5	O
whole	O
DRG	O
explants	O
from	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
PVCre	O
/	O
+	O
and	O
TaumGFP	O
/	O
+	O
PVCre	O
/	O
+	O
mice	O
for	O
48	O
h	O
in	O
vitro	O
in	O
the	O
presence	O
or	O
absence	O
of	O
NT	O
-	O
3	O
(	O
Figure	O
5	O
)	O
.	O

We	O
found	O
that	O
DRG	O
neurons	O
from	O
both	O
genotypes	O
survived	O
and	O
extended	O
neurites	O
only	O
in	O
the	O
presence	O
of	O
NT	O
-	O
3	O
,	O
whereas	O
they	O
died	O
in	O
the	O
absence	O
of	O
NT	O
-	O
3	O
(	O
Figure	O
5	O
)	O
.	O

Together	O
,	O
these	O
findings	O
suggest	O
that	O
only	O
precocious	O
but	O
not	O
isochronic	O
ETS	O
signaling	O
in	O
DRG	O
neurons	O
is	O
capable	O
of	O
uncoupling	O
survival	O
and	O
neurite	O
outgrowth	O
from	O
a	O
requirement	O
for	O
neurotrophin	O
signaling	O
normally	O
observed	O
in	O
wild	O
-	O
type	O
DRG	O
.	O

To	O
determine	O
whether	O
neuronal	O
survival	O
of	O
DRG	O
neurons	O
from	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
in	O
the	O
absence	O
of	O
neurotrophic	O
support	O
is	O
sufficient	O
to	O
explain	O
the	O
observed	O
neuronal	O
outgrowth	O
,	O
we	O
analyzed	O
DRG	O
isolated	O
from	O
mice	O
mutant	O
in	O
the	O
proapoptotic	O
gene	O
Bax	O
[	O
27	O
]	O
.	O

Consistent	O
with	O
previous	O
results	O
,	O
Bax	O
-	O
/	O
-	O
DRG	O
neurons	O
survived	O
without	O
neurotrophic	O
support	O
[	O
28	O
]	O
.	O

In	O
contrast	O
,	O
neurite	O
outgrowth	O
of	O
Bax	O
-	O
/	O
-	O
DRG	O
neurons	O
was	O
significantly	O
less	O
(	O
see	O
Figure	O
4G	O
)	O
than	O
that	O
of	O
either	O
DRG	O
from	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
cultured	O
in	O
the	O
absence	O
of	O
neurotrophic	O
support	O
(	O
see	O
Figure	O
4D	O
)	O
or	O
Bax	O
-	O
/	O
-	O
DRG	O
neurons	O
cultured	O
in	O
the	O
presence	O
of	O
neurotrophic	O
support	O
(	O
see	O
Figure	O
4H	O
and	O
4I	O
)	O
.	O

These	O
findings	O
suggest	O
that	O
in	O
addition	O
to	O
mediating	O
neurotrophin	O
-	O
independent	O
neuronal	O
survival	O
,	O
expression	O
of	O
EWS	O
-	O
Pea3	O
in	O
early	O
post	O
-	O
mitotic	O
neurons	O
also	O
promotes	O
neurite	O
outgrowth	O
in	O
a	O
neurotrophin	O
-	O
independent	O
manner	O
.	O

To	O
begin	O
to	O
assess	O
at	O
which	O
step	O
of	O
the	O
neurotrophin	O
signaling	O
cascade	O
DRG	O
neurons	O
from	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
become	O
unresponsive	O
to	O
the	O
addition	O
of	O
neurotrophins	O
,	O
we	O
assayed	O
the	O
expression	O
of	O
neurotrophin	O
receptors	O
in	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
(	O
Figure	O
6	O
)	O
.	O

Whereas	O
expression	O
of	O
the	O
neurotrophin	O
receptors	O
TrkA	O
,	O
TrkB	O
,	O
and	O
TrkC	O
marks	O
afferents	O
of	O
distinct	O
sensory	O
modalities	O
in	O
DRG	O
of	O
wild	O
-	O
type	O
embryos	O
(	O
Figure	O
6A	O
-	O
6C	O
)	O
[	O
4	O
,	O
29	O
]	O
,	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
showed	O
complete	O
absence	O
of	O
expression	O
of	O
TrkA	O
,	O
TrkB	O
,	O
and	O
TrkC	O
in	O
DRG	O
neurons	O
at	O
E16	O
.	O
5	O
(	O
Figure	O
6G	O
-	O
6I	O
)	O
.	O

This	O
absence	O
of	O
Trk	O
receptor	O
expression	O
in	O
DRG	O
of	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
provides	O
a	O
likely	O
explanation	O
for	O
the	O
lack	O
of	O
responsiveness	O
of	O
these	O
neurons	O
to	O
the	O
addition	O
of	O
neurotrophic	O
factors	O
.	O

We	O
next	O
assayed	O
whether	O
the	O
complete	O
absence	O
of	O
Trk	O
receptor	O
expression	O
in	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
had	O
an	O
influence	O
on	O
naturally	O
occurring	O
cell	O
death	O
in	O
vivo	O
using	O
TUNEL	O
on	O
DRG	O
sections	O
.	O

Surprisingly	O
,	O
we	O
found	O
that	O
apoptosis	O
was	O
decreased	O
by	O
approximately	O
50	O
%	O
(	O
n	O
=	O
3	O
embryos	O
,	O
average	O
of	O
>	O
50	O
sections	O
)	O
in	O
DRG	O
of	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
in	O
comparison	O
to	O
wild	O
-	O
type	O
(	O
Figure	O
6D	O
,	O
6J	O
,	O
and	O
6M	O
)	O
.	O

Quantitative	O
analysis	O
of	O
the	O
number	O
of	O
neurons	O
in	O
lumbar	O
DRG	O
of	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
revealed	O
a	O
significant	O
increase	O
to	O
approximately	O
170	O
%	O
of	O
wild	O
-	O
type	O
levels	O
(	O
Figure	O
6E	O
,	O
6K	O
,	O
and	O
6N	O
)	O
.	O

Moreover	O
,	O
BrdU	O
pulse	O
-	O
chase	O
experiments	O
ruled	O
out	O
the	O
possibility	O
that	O
DRG	O
neurons	O
in	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
reenter	O
the	O
cell	O
cycle	O
(	O
no	O
BrdU	O
+	O
/	O
LacZ	O
+	O
cells	O
,	O
n	O
=	O
3	O
embryos	O
,	O
analysis	O
of	O
>	O
50	O
sections	O
each	O
;	O
Figure	O
6F	O
and	O
6L	O
)	O
.	O

Together	O
with	O
the	O
in	O
vitro	O
culture	O
experiments	O
,	O
these	O
findings	O
suggest	O
that	O
DRG	O
neurons	O
from	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
remain	O
post	O
-	O
mitotic	O
but	O
fail	O
to	O
become	O
sensitive	O
to	O
naturally	O
occurring	O
cell	O
death	O
,	O
and	O
survive	O
in	O
the	O
absence	O
of	O
Trk	O
receptors	O
and	O
neurotrophic	O
support	O
.	O

We	O
next	O
analyzed	O
whether	O
changes	O
in	O
the	O
expression	O
of	O
proteins	B-CHEBI
known	O
to	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
neuronal	O
survival	O
or	O
cell	O
death	O
could	O
be	O
detected	O
in	O
DRG	O
of	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
.	O

We	O
found	O
no	O
significant	O
quantitative	O
changes	O
in	O
the	O
level	O
of	O
Akt	O
/	O
p	O
-	O
Akt	O
or	O
CREB	O
/	O
p	O
-	O
CREB	O
in	O
DRG	O
(	O
Figure	O
6O	O
and	O
6P	O
)	O
both	O
of	O
which	O
have	O
been	O
shown	O
to	O
be	O
key	O
regulators	O
of	O
neuronal	O
survival	O
[	O
29	O
]	O
.	O

Moreover	O
,	O
the	O
level	O
of	O
the	O
proapoptotic	O
Bcl2	O
family	O
member	O
Bax	O
was	O
not	O
significantly	O
reduced	O
(	O
Figure	O
6O	O
and	O
6P	O
)	O
.	O

In	O
contrast	O
,	O
the	O
expression	O
level	O
of	O
the	O
anti	O
-	O
apoptotic	O
Bcl2	O
family	O
members	O
Bcl	O
-	O
xl	O
and	O
Bcl2	O
was	O
significantly	O
increased	O
when	O
compared	O
to	O
wild	O
-	O
type	O
levels	O
(	O
Bcl2	O
,	O
157	O
%	O
;	O
Bcl	O
-	O
xl	O
,	O
259	O
%	O
;	O
average	O
of	O
n	O
=	O
3	O
independent	O
experiments	O
;	O
Figure	O
6O	O
and	O
6P	O
)	O
,	O
providing	O
a	O
potential	O
molecular	B-CHEBI
explanation	O
for	O
the	O
enhanced	O
neuronal	O
survival	O
of	O
DRG	O
neurons	O
of	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
in	O
the	O
absence	O
of	O
Trk	O
receptor	O
expression	O
[	O
30	O
]	O
.	O

Only	O
Precocious	O
but	O
Not	O
Isochronic	O
ETS	O
Signaling	O
in	O
DRG	O
Neurons	O
Interferes	O
with	O
Neuronal	O
Fate	O
Acquisition	O

The	O
observed	O
differences	O
in	O
neuronal	O
survival	O
and	O
neurite	O
outgrowth	O
between	O
precocious	O
and	O
isochronic	O
expression	O
of	O
EWS	O
-	O
Pea3	O
prompted	O
us	O
to	O
perform	O
a	O
direct	O
comparative	O
analysis	O
of	O
gene	O
expression	O
between	O
mice	O
with	O
precocious	O
EWS	O
-	O
Pea3	O
expression	O
and	O
mice	O
in	O
which	O
the	O
expression	O
of	O
EWS	O
-	O
Pea3	O
is	O
initiated	O
in	O
DRG	O
sensory	O
neurons	O
from	O
the	O
time	O
of	O
normal	O
onset	O
of	O
Er81	O
expression	O
.	O

Moreover	O
,	O
to	O
rule	O
out	O
the	O
possibility	O
that	O
a	O
differential	O
effect	O
may	O
be	O
due	O
to	O
the	O
different	O
genetic	O
strategies	O
by	O
which	O
expression	O
of	O
EWS	O
-	O
Pea3	O
in	O
proprioceptive	O
afferents	O
is	O
achieved	O
,	O
we	O
performed	O
this	O
analysis	O
both	O
in	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
and	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
PVCre	O
/	O
+	O
embryos	O
.	O

We	O
first	O
analyzed	O
expression	O
of	O
TrkC	O
,	O
a	O
gene	O
downregulated	O
in	O
DRG	O
neurons	O
of	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
(	O
Figure	O
7A	O
and	O
7B	O
)	O
.	O

The	O
level	O
of	O
expression	O
of	O
TrkC	O
was	O
indistinguishable	O
from	O
wild	O
-	O
type	O
in	O
DRG	O
neurons	O
of	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
and	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
PVCre	O
/	O
+	O
embryos	O
(	O
Figure	O
7A	O
,	O
7C	O
,	O
and	O
7D	O
)	O
.	O

Moreover	O
,	O
PV	O
was	O
not	O
expressed	O
in	O
DRG	O
neurons	O
of	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
(	O
Figure	O
S5	O
)	O
but	O
was	O
expressed	O
by	O
proprioceptive	O
afferents	O
in	O
both	O
wild	O
-	O
type	O
and	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
embryos	O
(	O
see	O
Figures	O
1	O
and	O
S5	O
)	O
[	O
14	O
]	O
.	O

We	O
also	O
found	O
several	O
genes	O
that	O
were	O
ectopically	O
upregulated	O
in	O
DRG	O
neurons	O
of	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
(	O
Figure	O
7	O
)	O
.	O

Calretinin	O
and	O
Calbindin	O
,	O
two	O
different	O
calcium	B-CHEBI
-	O
binding	O
proteins	B-CHEBI
expressed	O
by	O
subpopulations	O
of	O
DRG	O
neurons	O
in	O
wild	O
-	O
type	O
,	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
,	O
and	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
PVCre	O
/	O
+	O
embryos	O
(	O
Figure	O
7E	O
,	O
7G	O
,	O
and	O
7H	O
;	O
data	O
not	O
shown	O
)	O
[	O
31	O
,	O
32	O
]	O
,	O
were	O
induced	O
in	O
more	O
than	O
95	O
%	O
of	O
all	O
DRG	O
neurons	O
of	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
(	O
Figures	O
7F	O
and	O
S5	O
)	O
.	O

These	O
findings	O
suggest	O
that	O
DRG	O
neurons	O
in	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
fail	O
to	O
differentiate	O
to	O
a	O
normal	O
fate	O
and	O
instead	O
acquire	O
an	O
aberrant	O
identity	O
distinct	O
from	O
any	O
subpopulation	O
of	O
wild	O
-	O
type	O
DRG	O
neurons	O
.	O

Finally	O
,	O
to	O
assess	O
whether	O
EWS	O
-	O
Pea3	O
expressed	O
precociously	O
acts	O
exclusively	O
cell	O
-	O
autonomously	O
or	O
whether	O
it	O
may	O
also	O
influence	O
neighboring	O
DRG	O
neurons	O
,	O
we	O
activated	O
expression	O
of	O
EWS	O
-	O
Pea3	O
using	O
Hb9Cre	O
mice	O
[	O
33	O
]	O
.	O

Due	O
to	O
a	O
transient	O
and	O
rostro	O
-	O
caudally	O
graded	O
expression	O
of	O
Hb9	O
at	O
neural	O
plate	O
stages	O
,	O
very	O
few	O
DRG	O
neurons	O
at	O
brachial	O
levels	O
and	O
increasingly	O
more	O
neurons	O
progressing	O
caudally	O
undergo	O
recombination	O
in	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Hb9Cre	O
/	O
+	O
and	O
TaumGFP	O
/	O
+	O
Hb9Cre	O
/	O
+	O
embryos	O
(	O
Figure	O
8	O
)	O
.	O

Nevertheless	O
,	O
downregulation	O
of	O
Trk	O
receptor	O
expression	O
or	O
upregulation	O
of	O
Calretinin	O
is	O
restricted	O
exclusively	O
to	O
neurons	O
that	O
have	O
undergone	O
recombination	O
and	O
cannot	O
be	O
observed	O
in	O
TaumGFP	O
/	O
+	O
Hb9Cre	O
/	O
+	O
embryos	O
(	O
Figure	O
8	O
)	O
.	O

Together	O
,	O
these	O
results	O
and	O
the	O
findings	O
obtained	O
from	O
in	O
vitro	O
culture	O
experiments	O
(	O
see	O
Figures	O
4	O
and	O
5	O
)	O
demonstrate	O
that	O
precocious	O
or	O
isochronic	O
expression	O
of	O
EWS	O
-	O
Pea3	O
in	O
the	O
same	O
neurons	O
leads	O
to	O
significantly	O
different	O
cell	O
-	O
autonomous	O
cellular	O
responses	O
with	O
respect	O
to	O
gene	O
expression	O
,	O
neuronal	O
survival	O
,	O
and	O
neurite	O
outgrowth	O
(	O
Figure	O
9	O
)	O
.	O

Discussion	O

Target	O
-	O
derived	O
signals	O
exhibit	O
a	O
conserved	O
role	O
in	O
the	O
induction	O
of	O
defined	O
programs	O
of	O
transcription	O
factor	O
expression	O
late	O
in	O
post	O
-	O
mitotic	O
neuronal	O
differentiation	O
[	O
10	O
]	O
.	O

This	O
study	O
provides	O
evidence	O
that	O
the	O
late	O
onset	O
of	O
transcription	O
factor	O
expression	O
is	O
essential	O
for	O
many	O
later	O
aspects	O
of	O
neuronal	O
differentiation	O
and	O
circuit	O
formation	O
.	O

Our	O
data	O
indicate	O
that	O
DRG	O
neurons	O
undergo	O
a	O
temporal	O
change	O
in	O
their	O
competence	O
to	O
respond	O
to	O
ETS	O
transcription	O
factor	O
signaling	O
,	O
as	O
assessed	O
by	O
changes	O
in	O
gene	O
expression	O
and	O
axonal	O
target	O
invasion	O
(	O
Figure	O
9	O
)	O
.	O

Our	O
findings	O
argue	O
for	O
the	O
necessity	O
of	O
target	O
-	O
induced	O
,	O
and	O
therefore	O
temporally	O
controlled	O
,	O
upregulation	O
of	O
ETS	O
transcription	O
factor	O
signaling	O
.	O

More	O
generally	O
,	O
they	O
suggest	O
that	O
temporally	O
regulated	O
activation	O
of	O
transcriptional	O
programs	O
coupled	O
to	O
a	O
particular	O
fate	O
induced	O
in	O
neurons	O
at	O
early	O
developmental	O
stages	O
represents	O
an	O
important	O
mechanism	O
of	O
neuronal	O
maturation	O
.	O

One	O
striking	O
observation	O
of	O
this	O
study	O
is	O
that	O
precocious	O
induction	O
of	O
ETS	O
signaling	O
promotes	O
neuronal	O
survival	O
without	O
a	O
requirement	O
for	O
neurotrophic	O
support	O
and	O
in	O
complete	O
absence	O
of	O
Trk	O
receptor	O
expression	O
.	O

In	O
contrast	O
,	O
ETS	O
signaling	O
at	O
the	O
normal	O
time	O
of	O
onset	O
of	O
Er81	O
expression	O
does	O
not	O
result	O
in	O
enhanced	O
neuronal	O
survival	O
in	O
the	O
absence	O
of	O
neurotrophins	O
and	O
also	O
does	O
not	O
lead	O
to	O
downregulation	O
of	O
TrkC	O
expression	O
in	O
proprioceptive	O
afferents	O
.	O

These	O
findings	O
demonstrate	O
very	O
distinct	O
activities	O
of	O
one	O
transcriptional	O
regulator	O
at	O
different	O
developmental	O
steps	O
within	O
a	O
committed	O
post	O
-	O
mitotic	O
neuronal	O
lineage	O
.	O

The	O
absence	O
of	O
Trk	O
receptor	O
expression	O
upon	O
precocious	O
induction	O
of	O
ETS	O
signaling	O
can	O
only	O
partially	O
explain	O
the	O
observed	O
phenotype	O
in	O
axonal	O
projections	O
.	O

Elimination	O
of	O
TrkA	O
receptor	O
signaling	O
in	O
Bax	O
mutant	O
mice	O
perturbs	O
establishment	O
of	O
peripheral	O
projections	O
of	O
cutaneous	O
afferents	O
,	O
whereas	O
establishment	O
of	O
central	O
projections	O
does	O
not	O
appear	O
to	O
be	O
affected	O
[	O
8	O
]	O
.	O

In	O
the	O
absence	O
of	O
NT	O
-	O
3	O
signaling	O
,	O
development	O
of	O
central	O
as	O
well	O
as	O
peripheral	O
proprioceptive	O
afferent	O
projections	O
is	O
perturbed	O
[	O
9	O
]	O
.	O

In	O
contrast	O
,	O
upon	O
precocious	O
induction	O
of	O
ETS	O
signaling	O
,	O
we	O
found	O
more	O
pronounced	O
defects	O
in	O
the	O
establishment	O
of	O
central	O
rather	O
than	O
peripheral	O
projections	O
for	O
all	O
DRG	O
neurons	O
.	O

Induction	O
of	O
Er81	O
expression	O
in	O
proprioceptive	O
afferents	O
is	O
controlled	O
by	O
peripheral	O
NT	O
-	O
3	O
as	O
axons	O
reach	O
the	O
vicinity	O
of	O
target	O
muscles	O
,	O
and	O
thus	O
occurs	O
only	O
approximately	O
3	O
d	O
after	O
proprioceptive	O
neurons	O
become	O
post	O
-	O
mitotic	O
[	O
9	O
,	O
14	O
]	O
.	O

This	O
temporally	O
delayed	O
and	O
target	O
-	O
induced	O
upregulation	O
of	O
ETS	O
transcription	O
factor	O
expression	O
several	O
days	O
after	O
a	O
neuronal	O
lineage	O
of	O
a	O
specific	O
identity	O
first	O
emerges	O
is	O
not	O
restricted	O
to	O
DRG	O
sensory	O
neurons	O
,	O
but	O
is	O
also	O
found	O
in	O
motor	O
neuron	O
pools	O
[	O
13	O
]	O
.	O

Target	O
-	O
derived	O
factors	O
have	O
also	O
been	O
implicated	O
in	O
controlling	O
neuronal	O
maturation	O
of	O
predetermined	O
neurons	O
in	O
Drosophila	O
,	O
in	O
which	O
expression	O
of	O
members	O
of	O
the	O
BMP	O
family	O
in	O
the	O
target	O
region	O
is	O
essential	O
for	O
the	O
induction	O
of	O
mature	O
peptidergic	O
properties	O
in	O
a	O
subpopulation	O
of	O
neurons	O
marked	O
by	O
the	O
coordinate	O
expression	O
of	O
the	O
two	O
transcription	O
factors	O
Apterous	O
and	O
Squeeze	O
[	O
11	O
,	O
12	O
]	O
.	O

Thus	O
,	O
both	O
in	O
Drosophila	O
and	O
vertebrates	O
,	O
target	O
-	O
derived	O
factors	O
appear	O
to	O
act	O
permissively	O
to	O
induce	O
the	O
expression	O
of	O
transcriptional	O
programs	O
involved	O
in	O
terminal	O
neuronal	O
maturation	O
.	O

Our	O
findings	O
are	O
compatible	O
with	O
a	O
model	O
in	O
which	O
DRG	O
neurons	O
acquire	O
their	O
mature	O
fate	O
by	O
sequential	O
and	O
temporally	O
controlled	O
addition	O
of	O
lineage	O
-	O
specific	O
features	O
(	O
Figure	O
9	O
)	O
.	O

Target	O
-	O
derived	O
factors	O
act	O
on	O
predetermined	O
neuronal	O
lineages	O
to	O
switch	O
their	O
developmental	O
programs	O
to	O
become	O
compatible	O
with	O
processes	O
such	O
as	O
target	O
invasion	O
and	O
branching	O
.	O

Such	O
a	O
transition	O
state	O
in	O
the	O
acquisition	O
of	O
a	O
defined	O
neuronal	O
fate	O
would	O
be	O
accompanied	O
by	O
the	O
induction	O
of	O
appropriate	O
transcriptional	O
programs	O
through	O
the	O
expression	O
of	O
specific	O
transcription	O
factors	O
.	O

Mechanisms	O
such	O
as	O
chromosomal	O
remodeling	O
that	O
restrict	O
or	O
expand	O
access	O
to	O
certain	O
target	O
genes	O
[	O
34	O
]	O
or	O
activation	O
by	O
cofactors	B-CHEBI
responsible	O
for	O
changing	O
the	O
action	O
of	O
particular	O
transcription	O
factors	O
[	O
35	O
]	O
could	O
represent	O
possible	O
mechanisms	O
by	O
which	O
the	O
downstream	O
transcriptional	O
profile	O
of	O
a	O
transcription	O
factor	O
could	O
be	O
temporally	O
shifted	O
towards	O
the	O
selection	O
and	O
control	O
of	O
distinct	O
target	O
genes	O
.	O

Interestingly	O
,	O
several	O
ETS	O
transcription	O
factors	O
are	O
activated	O
through	O
release	O
of	O
autoinhibition	O
via	O
interaction	O
with	O
cofactors	B-CHEBI
and	O
/	O
or	O
via	O
post	O
-	O
translational	O
modifications	O
[	O
35	O
,	O
36	O
,	O
37	O
]	O
.	O

The	O
fusion	O
of	O
EWS	O
with	O
Pea3	O
could	O
circumvent	O
a	O
need	O
for	O
activation	O
through	O
specific	O
cofactors	B-CHEBI
while	O
still	O
maintaining	O
ETS	O
site	O
dependence	O
,	O
thus	O
rendering	O
EWS	O
-	O
Pea3	O
less	O
sensitive	O
to	O
the	O
cellular	O
context	O
than	O
endogenous	O
ETS	O
transcription	O
factors	O
.	O

Using	O
this	O
fusion	O
protein	B-CHEBI
,	O
our	O
experiments	O
demonstrate	O
a	O
profound	O
change	O
in	O
the	O
action	O
of	O
ETS	O
signaling	O
at	O
the	O
level	O
of	O
transcriptional	O
regulation	O
within	O
post	O
-	O
mitotic	O
DRG	O
neurons	O
over	O
time	O
.	O

Moreover	O
,	O
the	O
observed	O
transcriptional	O
shift	O
in	O
ETS	O
signaling	O
is	O
paired	O
with	O
the	O
onset	O
of	O
appropriate	O
regulation	O
of	O
neuronal	O
subtype	O
specification	O
and	O
establishment	O
of	O
axonal	O
projections	O
into	O
the	O
target	O
area	O
.	O

Recent	O
experiments	O
addressing	O
the	O
temporal	O
constraints	O
of	O
transcription	O
factor	O
action	O
in	O
proliferating	O
neural	O
progenitor	O
cells	O
adds	O
to	O
the	O
idea	O
that	O
defined	O
temporal	O
windows	O
,	O
during	O
which	O
transcription	O
factors	O
act	O
to	O
control	O
distinct	O
downstream	O
target	O
genes	O
,	O
are	O
of	O
key	O
importance	O
to	O
neuronal	O
fate	O
acquisition	O
.	O

During	O
Drosophila	O
neuroblast	O
generation	O
,	O
the	O
transcription	O
factor	O
Hunchback	O
controls	O
specification	O
and	O
differentiation	O
of	O
early	O
-	O
born	O
neuroblasts	O
[	O
38	O
]	O
.	O

Over	O
time	O
,	O
however	O
,	O
neuroblasts	O
progressively	O
lose	O
their	O
competence	O
to	O
generate	O
cells	O
of	O
an	O
early	O
fate	O
in	O
response	O
to	O
Hunchback	O
expression	O
[	O
39	O
]	O
.	O

These	O
findings	O
thus	O
also	O
argue	O
for	O
a	O
change	O
in	O
cellular	O
competence	O
to	O
respond	O
to	O
a	O
specific	O
transcription	O
factor	O
over	O
time	O
albeit	O
in	O
an	O
early	O
precursor	O
context	O
.	O

More	O
generally	O
,	O
during	O
the	O
differentiation	O
of	O
hematopoietic	O
lineages	O
,	O
several	O
transcription	O
factors	O
have	O
also	O
been	O
shown	O
to	O
exhibit	O
distinct	O
functions	O
at	O
progressive	O
steps	O
of	O
lineage	O
specification	O
[	O
40	O
]	O
.	O

Analysis	O
of	O
the	O
mechanisms	O
by	O
which	O
transcription	O
factor	O
programs	O
can	O
be	O
shifted	O
over	O
time	O
to	O
control	O
different	O
complements	O
of	O
downstream	O
genes	O
and	O
thus	O
different	O
aspects	O
of	O
neuronal	O
and	O
cellular	O
fates	O
in	O
progenitor	O
cells	O
or	O
post	O
-	O
mitotic	O
neurons	O
may	O
provide	O
further	O
insight	O
into	O
the	O
way	O
in	O
which	O
transcription	O
factors	O
act	O
to	O
control	O
the	O
assembly	O
of	O
neuronal	O
circuits	O
.	O

Materials	O
and	O
Methods	O

Generation	O
of	O
transgenic	O
mice	O
and	O
mouse	O
genetics	O

Er81EWS	O
-	O
Pea3	O
mice	O
were	O
generated	O
following	O
a	O
strategy	O
similar	O
to	O
that	O
described	O
for	O
the	O
generation	O
of	O
Er81NLZ	O
mice	O
[	O
14	O
]	O
.	O

In	O
brief	O
,	O
a	O
targeting	O
vector	O
with	O
a	O
cDNA	O
coding	O
for	O
EWS	O
-	O
Pea3	O
was	O
inserted	O
in	O
frame	O
with	O
the	O
endogenous	O
start	O
ATG	O
into	O
exon	O
2	O
of	O
the	O
Er81	O
genomic	O
locus	O
and	O
used	O
for	O
homologous	O
recombination	O
in	O
W95	O
ES	O
cells	O
.	O

EWS	O
-	O
Pea3	O
represents	O
a	O
fusion	O
gene	O
between	O
the	O
amino	B-CHEBI
terminal	O
of	O
EWS	O
and	O
the	O
ETS	O
domain	O
of	O
Pea3	O
[	O
20	O
]	O
.	O

The	O
primer	O
pair	O
used	O
to	O
specifically	O
detect	O
the	O
Er81EWS	O
-	O
Pea3	O
allele	O
was	O
5	O
'	O
-	O
CAGCCACTGCACCTACAAGAC	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
CTTCCTGCTTGATGTCTCCTTC	O
-	O
3	O
'	O
.	O

For	O
the	O
generation	O
of	O
TaumGFP	O
and	O
TauEWS	O
-	O
Pea3	O
mice	O
,	O
lox	O
-	O
STOP	O
-	O
lox	O
-	O
mGFP	O
-	O
IRES	O
-	O
NLS	O
-	O
LacZ	O
-	O
pA	O
and	O
lox	O
-	O
STOP	O
-	O
lox	O
-	O
EWS	O
-	O
Pea3	O
-	O
IRES	O
-	O
NLS	O
-	O
LacZ	O
-	O
pA	O
targeting	O
cassettes	O
were	O
integrated	O
into	O
exon	O
2	O
of	O
the	O
Tau	O
genomic	O
locus	O
(	O
the	O
endogenous	O
start	O
ATG	O
was	O
removed	O
in	O
the	O
targeting	O
vectors	O
;	O
details	O
available	O
upon	O
request	O
)	O
.	O

mGFP	O
was	O
provided	O
by	O
P	O
.	O

Caroni	O
[	O
25	O
]	O
.	O

ES	O
cell	O
recombinants	O
were	O
screened	O
by	O
Southern	O
blot	O
analysis	O
using	O
the	O
probe	O
in	O
the	O
5	O
'	O
region	O
as	O
described	O
previously	O
[	O
41	O
]	O
.	O

Frequency	O
of	O
recombination	O
in	O
129	O
/	O
Ola	O
ES	O
cells	O
was	O
approximately	O
1	O
/	O
3	O
for	O
both	O
Tau	O
constructs	O
.	O

For	O
the	O
generation	O
of	O
PVCre	O
mice	O
,	O
mouse	O
genomic	O
clones	O
were	O
obtained	O
by	O
screening	O
a	O
129SV	O
/	O
J	O
genomic	O
library	O
(	O
Incyte	O
,	O
Wilmington	O
,	O
Delaware	O
,	O
United	O
States	O
)	O
.	O

For	O
details	O
on	O
the	O
genomic	O
structure	O
of	O
the	O
mouse	O
PV	O
locus	O
see	O
[	O
42	O
]	O
.	O

An	O
IRES	O
-	O
Cre	O
-	O
pA	O
targeting	O
cassette	O
[	O
33	O
]	O
was	O
integrated	O
into	O
the	O
3	O
'	O
UTR	O
of	O
exon	O
5	O
,	O
and	O
ES	O
cell	O
recombinants	O
were	O
screened	O
with	O
a	O
5	O
'	O
probe	O
(	O
oligos	O
,	O
5	O
'	O
-	O
GAGATGACCCAGCCAGGATGCCTC	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
CTGACCACTCTCGCTCCGGTGTCC	O
-	O
3	O
'	O
;	O
genomic	O
DNA	O
,	O
HindIII	O
digest	O
)	O
.	O

The	O
frequency	O
of	O
recombination	O
in	O
129	O
/	O
Ola	O
ES	O
cells	O
was	O
approximately	O
1	O
/	O
20	O
.	O

Recombinant	O
clones	O
were	O
aggregated	O
with	O
morula	O
stage	O
embryos	O
to	O
generate	O
chimeric	O
founder	O
mice	O
that	O
transmitted	O
the	O
mutant	O
alleles	O
.	O

In	O
all	O
experiments	O
performed	O
in	O
this	O
study	O
,	O
animals	O
were	O
of	O
mixed	O
genetic	O
background	O
(	O
129	O
/	O
Ola	O
and	O
C57Bl6	O
)	O
.	O

Thy1spGFP	O
transgenic	O
mice	O
were	O
generated	O
in	O
analogy	O
to	O
De	O
Paola	O
et	O
al	O
.	O

[	O
25	O
]	O
,	O
and	O
for	O
these	O
experiments	O
a	O
strain	O
of	O
mice	O
with	O
early	O
embryonic	O
expression	O
was	O
selected	O
.	O

Isl1Cre	O
and	O
Hb9Cre	O
mouse	O
strains	O
have	O
been	O
described	O
[	O
33	O
,	O
43	O
]	O
and	O
Bax	O
+	O
/	O
-	O
animals	O
were	O
from	O
Jackson	O
Laboratory	O
(	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
United	O
States	O
)	O
[	O
27	O
]	O
.	O

Timed	O
pregnancies	O
were	O
set	O
up	O
to	O
generate	O
embryos	O
of	O
different	O
developmental	O
stages	O
with	O
all	O
genotypes	O
described	O
throughout	O
the	O
study	O
.	O

Transcriptional	O
transactivation	O
assays	O

The	O
following	O
plasmids	O
were	O
used	O
for	O
transcriptional	O
transactivation	O
assays	O
:	O
pRc	O
/	O
RSV	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
pRc	O
/	O
RSV	O
-	O
Er81	O
,	O
pRc	O
/	O
RSV	O
-	O
EWS	O
-	O
Pea3	O
,	O
pTP	O
-	O
5xETS	O
,	O
and	O
pTP	O
-	O
5xETSmut	O
.	O

pRc	O
/	O
RSV	O
-	O
Er81	O
and	O
pRc	O
/	O
RSV	O
-	O
EWS	O
-	O
Pea3	O
were	O
obtained	O
by	O
insertion	O
of	O
the	O
cDNAs	O
for	O
Er81	O
or	O
EWS	O
-	O
Pea3	O
(	O
gift	O
from	O
J	O
.	O
A	O
.	O
Hassell	O
)	O
into	O
pRc	O
/	O
RSV	O
.	O

pTP	O
-	O
5xETS	O
was	O
constructed	O
by	O
inserting	O
a	O
cassette	O
of	O
five	O
repetitive	O
copies	O
of	O
high	O
-	O
affinity	O
Pea3	O
binding	O
sites	O
(	O
5	O
'	O
-	O
GCCGGAAGC	O
-	O
3	O
'	O
)	O
[	O
18	O
,	O
19	O
]	O
into	O
a	O
modified	O
version	O
of	O
pTK	O
-	O
Luc	O
.	O

pTP	O
-	O
5xETSmut	O
was	O
generated	O
as	O
pTP	O
-	O
5xETS	O
but	O
using	O
a	O
mutated	O
complement	O
of	O
the	O
Pea3	O
binding	O
sites	O
(	O
5	O
'	O
-	O
GCCTATGGC	O
-	O
3	O
'	O
)	O
.	O

A	O
control	O
plasmid	O
to	O
normalize	O
for	O
transfection	O
efficiency	O
(	O
placZ	O
)	O
and	O
pTK	O
-	O
Luc	O
were	O
a	O
gift	O
from	O
D	O
.	O

Kressler	O
.	O

COS	O
-	O
7	O
cells	O
were	O
co	O
-	O
transfected	O
with	O
1	O
-	O
1	O
.	O
2	O
mu	O
g	O
of	O
total	O
DNA	O
including	O
one	O
of	O
the	O
effector	B-CHEBI
plasmids	O
pRc	O
/	O
RSV	O
-	O
empty	O
,	O
pRc	O
/	O
RSV	O
-	O
Er81	O
,	O
or	O
pRc	O
/	O
RSV	O
-	O
EWS	O
-	O
Pea3	O
;	O
one	O
of	O
the	O
reporter	O
plasmids	O
pTP	O
-	O
5xETS	O
or	O
pTP	O
-	O
5xETSmut	O
;	O
and	O
placZ	O
.	O

Cells	O
were	O
harvested	O
after	O
25	O
h	O
and	O
processed	O
for	O
assays	O
to	O
determine	O
luciferase	O
and	O
LacZ	O
activity	O
as	O
described	O
previously	O
[	O
44	O
]	O
.	O

Luciferase	O
values	O
normalized	O
to	O
LacZ	O
activity	O
are	O
referred	O
to	O
as	O
luciferase	O
units	O
.	O

In	O
situ	O
hybridization	O
and	O
immunohistochemistry	O

For	O
in	O
situ	O
hybridization	O
analysis	O
,	O
cryostat	O
sections	O
were	O
hybridized	O
using	O
digoxigenin	B-CHEBI
-	O
labeled	O
probes	O
[	O
45	O
]	O
directed	O
against	O
mouse	O
TrkA	O
or	O
TrkB	O
,	O
or	O
rat	O
TrkC	O
(	O
gift	O
from	O
L	O
.	O
F	O
.	O
Parada	O
)	O
.	O

Antibodies	O
used	O
in	O
this	O
study	O
were	O
as	O
follows	O
:	O
rabbit	O
anti	O
-	O
Er81	O
[	O
14	O
]	O
,	O
rabbit	O
anti	O
-	O
Pea3	O
[	O
14	O
]	O
,	O
rabbit	O
anti	O
-	O
PV	O
[	O
14	O
]	O
,	O
rabbit	O
anti	O
-	O
eGFP	O
(	O
Molecular	B-CHEBI
Probes	O
,	O
Eugene	O
,	O
Oregon	O
,	O
United	O
States	O
)	O
,	O
rabbit	O
anti	O
-	O
Calbindin	O
,	O
rabbit	O
anti	O
-	O
Calretinin	O
(	O
Swant	O
,	O
Bellinzona	O
,	O
Switzerland	O
)	O
,	O
rabbit	O
anti	O
-	O
CGRP	O
(	O
Chemicon	O
,	O
Temecula	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
rabbit	O
anti	O
-	O
vGlut1	O
(	O
Synaptic	O
Systems	O
,	O
Goettingen	O
,	O
Germany	O
)	O
,	O
rabbit	O
anti	O
-	O
Brn3a	O
(	O
gift	O
from	O
E	O
.	O
Turner	O
)	O
,	O
rabbit	O
anti	O
-	O
TrkA	O
and	O
-	O
p75	O
(	O
gift	O
from	O
L	O
.	O
F	O
.	O
Reichardt	O
)	O
,	O
rabbit	O
anti	O
-	O
Runx3	O
(	O
Kramer	O
and	O
Arber	O
,	O
unpublished	O
reagent	B-CHEBI
)	O
,	O
rabbit	O
anti	O
-	O
Rhodamine	O
(	O
Molecular	B-CHEBI
Probes	O
)	O
,	O
mouse	O
anti	O
-	O
neurofilament	O
(	O
American	O
Type	O
Culture	O
Collection	O
,	O
Manassas	O
,	O
Virginia	O
,	O
United	O
States	O
)	O
,	O
sheep	O
anti	O
-	O
eGFP	O
(	O
Biogenesis	O
,	O
Poole	O
,	O
United	O
Kingdom	O
)	O
,	O
goat	O
anti	O
-	O
LacZ	O
[	O
14	O
]	O
,	O
goat	O
anti	O
-	O
TrkC	O
(	O
gift	O
from	O
L	O
.	O
F	O
.	O
Reichardt	O
)	O
,	O
and	O
guinea	O
pig	O
anti	O
-	O
Isl1	O
[	O
14	O
]	O
.	O

Terminal	O
deoxynucleotidyl	B-CHEBI
transferase	O
-	O
mediated	O
biotinylated	O
UTP	B-CHEBI
nick	O
end	O
labeling	O
(	O
TUNEL	O
)	O
to	O
detect	O
apoptotic	O
cells	O
in	O
E13	O
.	O
5	O
DRG	O
on	O
cryostat	O
sections	O
was	O
performed	O
as	O
described	O
by	O
the	O
manufacturer	O
(	O
Roche	O
,	O
Basel	O
,	O
Switzerland	O
)	O
.	O

Quantitative	O
analysis	O
of	O
TUNEL	O
+	O
DRG	O
cells	O
was	O
performed	O
essentially	O
as	O
described	O
[	O
27	O
]	O
.	O

BrdU	O
pulse	O
-	O
chase	O
experiments	O
and	O
LacZ	O
wholemount	O
stainings	O
were	O
performed	O
as	O
previously	O
described	O
[	O
46	O
]	O
.	O

For	O
anterograde	O
tracing	O
experiments	O
to	O
visualize	O
projections	O
of	O
sensory	O
neurons	O
,	O
rhodamine	O
-	O
conjugated	O
dextran	O
(	O
Molecular	B-CHEBI
Probes	O
)	O
was	O
injected	O
into	O
single	O
lumbar	O
(	O
L3	O
)	O
DRG	O
at	O
E13	O
.	O
5	O
or	O
applied	O
to	O
whole	O
lumbar	O
dorsal	O
roots	O
(	O
L3	O
)	O
at	O
postnatal	O
day	O
(	O
P	O
)	O
5	O
using	O
glass	O
capillaries	O
.	O

After	O
injection	O
,	O
animals	O
were	O
incubated	O
for	O
2	O
-	O
3	O
h	O
(	O
E13	O
.	O
5	O
)	O
or	O
overnight	O
(	O
P5	O
)	O
.	O

Cryostat	O
sections	O
were	O
processed	O
for	O
immunohistochemistry	O
as	O
described	O
[	O
14	O
]	O
using	O
fluorophore	O
-	O
conjugated	O
secondary	O
antibodies	O
(	O
1	O
:	O
1	O
,	O
000	O
,	O
Molecular	B-CHEBI
Probes	O
)	O
.	O

Images	O
were	O
collected	O
on	O
an	O
Olympus	O
(	O
Tokyo	O
,	O
Japan	O
)	O
confocal	O
microscope	O
.	O

Images	O
from	O
in	O
situ	O
hybridization	O
experiments	O
were	O
collected	O
with	O
an	O
RT	O
-	O
SPOT	O
camera	O
(	O
Diagnostic	O
Instruments	O
,	O
Sterling	O
Heights	O
,	O
Michigan	O
,	O
United	O
States	O
)	O
,	O
and	O
Corel	O
(	O
Eden	O
Prairie	O
,	O
Minnesota	O
,	O
United	O
States	O
)	O
Photo	O
Paint	O
10	O
.	O
0	O
was	O
used	O
for	O
digital	O
processing	O
of	O
images	O
.	O

In	O
vitro	O
cultures	O
of	O
DRG	O

Individual	O
lumbar	O
DRG	O
were	O
dissected	O
from	O
E13	O
.	O
5	O
or	O
E14	O
.	O
5	O
embryos	O
and	O
placed	O
on	O
Matrigel	O
(	O
BD	O
Biosciences	O
,	O
San	O
Jose	O
,	O
California	O
,	O
United	O
States	O
)	O
coated	O
coverslips	O
in	O
DMEM	O
/	O
F12	O
(	O
Gibco	O
,	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
2	O
mM	O
L	B-CHEBI
-	I-CHEBI
Gln	I-CHEBI
(	O
Gibco	O
)	O
,	O
N2	O
(	O
Gibco	O
)	O
,	O
and	O
1	O
mg	O
/	O
ml	O
BSA	O
(	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
without	O
neurotrophins	O
,	O
or	O
supplemented	O
with	O
either	O
NGF	O
(	O
100	O
ng	O
/	O
ml	O
,	O
Gibco	O
)	O
or	O
NT	O
-	O
3	O
(	O
20	O
ng	O
/	O
ml	O
,	O
Sigma	O
)	O
.	O

DRG	O
explants	O
(	O
n	O
>=	O
20	O
for	O
each	O
condition	O
)	O
were	O
cultured	O
for	O
48	O
h	O
,	O
processed	O
for	O
immunocytochemistry	O
,	O
and	O
analyzed	O
using	O
confocal	O
microscopy	O
.	O

Western	O
blot	O
analysis	O

Lumbar	O
DRG	O
from	O
E16	O
.	O
5	O
embryos	O
were	O
isolated	O
,	O
mechanically	O
disrupted	O
,	O
homogenized	O
using	O
glass	O
beads	O
(	O
Sigma	O
)	O
,	O
and	O
lysed	O
in	O
standard	O
lysis	O
buffer	O
supplemented	O
with	O
protease	B-CHEBI
and	I-CHEBI
phosphatase	I-CHEBI
inhibitors	I-CHEBI
as	O
described	O
[	O
47	O
]	O
.	O

Protein	B-CHEBI
extracts	O
were	O
resolved	O
by	O
SDS	B-CHEBI
-	O
PAGE	O
,	O
and	O
immunoblotting	O
was	O
performed	O
using	O
antibodies	O
against	O
Akt	O
,	O
p	O
-	O
Akt	O
(	O
Ser473	O
)	O
,	O
CREB	O
,	O
p	O
-	O
CREB	O
(	O
Ser133	O
)	O
,	O
Bax	O
,	O
Bcl	O
-	O
xl	O
(	O
Cell	O
Signaling	O
Technology	O
,	O
Beverly	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
,	O
and	O
Bcl2	O
(	O
BD	O
Pharmingen	O
,	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

For	O
quantification	O
,	O
films	O
(	O
X	O
-	O
OMAT	O
AR	O
,	O
Eastman	O
Kodak	O
,	O
Rochester	O
,	O
New	O
York	O
,	O
United	O
States	O
)	O
were	O
scanned	O
and	O
densitometry	O
was	O
performed	O
using	O
IMAGEQUANT	O
5	O
.	O
2	O
(	O
Molecular	B-CHEBI
Dynamics	O
,	O
Amersham	O
,	O
Uppsala	O
,	O
Sweden	O
)	O
.	O

Electrophysiology	O

Electrophysiological	O
analysis	O
was	O
performed	O
as	O
previously	O
described	O
[	O
48	O
]	O
.	O

Briefly	O
,	O
intracellular	O
recordings	O
from	O
identified	O
quadriceps	O
motor	O
neurons	O
were	O
made	O
using	O
sharp	O
electrodes	O
(	O
75	O
-	O
120	O
M	O
Omega	O
,	O
3M	O
KCl	O
)	O
.	O

Average	O
responses	O
(	O
10	O
-	O
20	O
trials	O
)	O
from	O
suprathreshold	O
nerve	O
stimulation	O
(	O
1	O
.	O
5	O
times	O
the	O
strength	O
that	O
evokes	O
maximal	O
monosynaptic	O
response	O
)	O
of	O
the	O
quadriceps	O
nerve	O
were	O
acquired	O
with	O
LTP	O
software	O
[	O
49	O
]	O
.	O

Only	O
cells	O
with	O
stable	O
resting	O
potentials	O
more	O
negative	O
than	O
-	O
50	O
mV	O
were	O
considered	O
for	O
analysis	O
.	O

Monosynaptic	O
amplitudes	O
were	O
determined	O
offline	O
using	O
custom	O
routines	O
in	O
the	O
Matlab	O
environment	O
(	O
The	O
Mathworks	O
,	O
Natick	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
as	O
previously	O
described	O
[	O
48	O
]	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Gene	O
Expression	O
Analysis	O
in	O
DRG	O
Neurons	O
of	O
Er81EWS	O
-	O
Pea3	O
Mice	O

Analysis	O
of	O
TrkC	O
expression	O
by	O
in	O
situ	O
hybridization	O
(	O
A	O
and	O
E	O
)	O
,	O
and	O
Runx3	O
(	O
red	O
;	O
B	O
and	O
F	O
)	O
,	O
Brn3A	O
(	O
red	O
;	O
C	O
and	O
G	O
)	O
,	O
Isl1	O
(	O
red	O
;	O
D	O
and	O
H	O
)	O
,	O
p75	O
(	O
red	O
;	O
I	O
and	O
M	O
)	O
,	O
TrkA	O
(	O
red	O
;	O
J	O
and	O
N	O
)	O
,	O
CGRP	O
(	O
red	O
;	O
K	O
and	O
O	O
)	O
,	O
Calretinin	O
(	O
CR	O
;	O
red	O
;	O
L	O
and	O
P	O
)	O
,	O
and	O
LacZ	O
(	O
green	O
;	O
B	O
-	O
D	O
and	O
F	O
-	O
P	O
)	O
by	O
immunohistochemistry	O
on	O
E16	O
.	O
5	O
lumbar	O
DRG	O
of	O
Er81NLZ	O
/	O
+	O
(	O
A	O
-	O
D	O
and	O
I	O
-	O
L	O
)	O
and	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
(	O
E	O
-	O
H	O
and	O
M	O
-	O
P	O
)	O
embryos	O
.	O

Scale	O
bar	O
:	O
(	O
A	O
,	O
B	O
,	O
E	O
,	O
F	O
,	O
L	O
,	O
and	O
P	O
)	O
,	O
70	O
mu	O
m	O
;	O
(	O
C	O
,	O
D	O
,	O
G	O
,	O
H	O
,	O
I	O
-	O
K	O
,	O
and	O
M	O
-	O
O	O
)	O
,	O
75	O
mu	O
m	O
.	O

(	O
4	O
.	O
9	O
MB	O
CDR	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

Ia	O
Proprioceptive	O
Afferents	O
Make	O
Functional	O
Connections	O
with	O
Motor	O
Neurons	O
in	O
Er81EWS	O
-	O
Pea3	O
Mutants	O

(	O
A	O
and	O
B	O
)	O
Representative	O
traces	O
from	O
intracellular	O
recordings	O
measuring	O
Ia	O
afferent	O
monosynaptic	O
input	O
to	O
quadriceps	O
motor	O
neurons	O
evoked	O
by	O
suprathreshold	O
stimulation	O
of	O
the	O
quadriceps	O
nerve	O
in	O
wild	O
-	O
type	O
(	O
A	O
)	O
and	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
mutant	O
(	O
B	O
)	O
animals	O
.	O

(	O
C	O
)	O
Average	O
monosynaptic	O
amplitudes	O
(	O
+/-	O
standard	O
error	O
of	O
the	O
mean	O
)	O
from	O
all	O
recorded	O
cells	O
(	O
wild	O
-	O
type	O
,	O
n	O
=	O
11	O
;	O
mutant	O
,	O
n	O
=	O
8	O
)	O
.	O

(	O
20	O
KB	O
CDR	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

Generation	O
of	O
Mice	O
Expressing	O
EWS	O
-	O
Pea3	O
or	O
mGFP	O
in	O
Early	O
Post	O
-	O
Mitotic	O
DRG	O
Neurons	O

(	O
A	O
)	O
Top	O
panel	O
shows	O
organization	O
of	O
the	O
Tau	O
genomic	O
locus	O
in	O
the	O
region	O
targeted	O
by	O
homologous	O
recombination	O
in	O
analogy	O
to	O
Tucker	O
et	O
al	O
.	O

[	O
41	O
]	O
.	O

Exons	O
1	O
-	O
3	O
are	O
shown	O
as	O
light	O
blue	O
boxes	O
,	O
and	O
the	O
Tau	O
start	O
codon	O
in	O
exon	O
2	O
is	O
indicated	O
as	O
ATG	O
.	O

The	O
probe	O
used	O
to	O
detect	O
homologous	O
recombination	O
is	O
shown	O
as	O
a	O
grey	O
box	O
.	O

Middle	O
and	O
bottom	O
panels	O
show	O
Tau	O
locus	O
after	O
homologous	O
recombination	O
to	O
integrate	O
targeting	O
cassettes	O
(	O
green	O
)	O
into	O
exon	O
2	O
with	O
coincident	O
elimination	O
the	O
endogenous	O
Tau	O
start	O
codon	O
.	O

The	O
integrated	O
targeting	O
cassettes	O
allow	O
for	O
conditional	O
expression	O
of	O
EWS	O
-	O
Pea3	O
and	O
NLS	O
-	O
LacZ	O
(	O
NLZ	O
)	O
(	O
middle	O
)	O
or	O
mGFP	O
and	O
NLS	O
-	O
LacZ	O
(	O
bottom	O
)	O
upon	O
Cre	O
-	O
recombinase	O
-	O
mediated	O
activation	O
.	O

In	O
the	O
absence	O
of	O
Cre	O
recombinase	O
,	O
a	O
transcriptional	O
stop	O
sequence	O
flanked	O
by	O
loxP	O
sites	O
inhibits	O
expression	O
of	O
the	O
respective	O
transgenes	O
from	O
their	O
start	O
codons	O
(	O
ATG	O
in	O
grey	O
)	O
.	O

(	O
B	O
)	O
Southern	O
blot	O
analysis	O
of	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
and	O
TaumGFP	O
/	O
+	O
genomic	O
DNA	O
to	O
detect	O
the	O
mutant	O
allele	O
.	O

(	O
C	O
)	O
In	O
the	O
presence	O
of	O
Cre	O
recombinase	O
,	O
the	O
transcriptional	O
stop	O
sequence	O
in	O
the	O
cassettes	O
integrated	O
into	O
the	O
Tau	O
locus	O
is	O
removed	O
.	O

Expression	O
of	O
EWS	O
-	O
Pea3	O
and	O
NLS	O
-	O
LacZ	O
(	O
top	O
)	O
or	O
mGFP	O
and	O
NLS	O
-	O
LacZ	O
(	O
bottom	O
)	O
can	O
now	O
occur	O
in	O
neurons	O
coincidently	O
expressing	O
Cre	O
recombinase	O
and	O
Tau	O
(	O
indicated	O
as	O
ATG	O
in	O
green	O
)	O
.	O

(	O
D	O
-	O
L	O
)	O
Expression	O
of	O
Isl1	O
(	O
D	O
,	O
G	O
,	O
and	O
J	O
)	O
,	O
EWS	O
-	O
Pea3	O
(	O
E	O
and	O
H	O
)	O
,	O
GFP	O
(	O
K	O
)	O
,	O
or	O
LacZ	O
(	O
F	O
,	O
I	O
,	O
and	O
L	O
)	O
,	O
in	O
E12	O
(	O
D	O
-	O
I	O
)	O
or	O
E13	O
.	O
5	O
(	O
J	O
-	O
L	O
)	O
DRG	O
neurons	O
of	O
wild	O
-	O
type	O
(	O
D	O
-	O
F	O
)	O
,	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
(	O
G	O
-	O
I	O
)	O
,	O
and	O
TaumGFP	O
/	O
+	O
Isl1Cre	O
/	O
+	O
(	O
J	O
-	O
L	O
)	O
embryos	O
.	O

Scale	O
bar	O
:	O
(	O
D	O
-	O
F	O
)	O
,	O
40	O
mu	O
m	O
;	O
(	O
G	O
-	O
I	O
)	O
,	O
35	O
mu	O
m	O
;	O
(	O
J	O
-	O
K	O
)	O
,	O
50	O
mu	O
m	O
.	O

(	O
1	O
.	O
5	O
MB	O
CDR	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S4	O

Generation	O
of	O
PVCre	O
Mice	O

(	O
A	O
)	O
Above	O
is	O
the	O
organization	O
of	O
the	O
PV	O
genomic	O
locus	O
.	O

Exons	O
are	O
schematically	O
illustrated	O
as	O
light	O
blue	O
boxes	O
,	O
where	O
exon	O
2	O
contains	O
the	O
start	O
codon	O
(	O
ATG	O
)	O
and	O
exon	O
5	O
contains	O
the	O
stop	O
codon	O
(	O
STOP	O
)	O
.	O

Probe	O
to	O
screen	O
for	O
homologous	O
recombination	O
is	O
shown	O
as	O
grey	O
box	O
.	O

Below	O
is	O
a	O
schematic	O
diagram	O
to	O
show	O
the	O
PV	O
locus	O
after	O
the	O
integration	O
of	O
an	O
IRES	O
-	O
Cre	O
cassette	O
(	O
green	O
)	O
3	O
'	O
to	O
the	O
translational	O
stop	O
codon	O
of	O
PV	O
using	O
homologous	O
recombination	O
in	O
ES	O
cells	O
.	O

(	O
B	O
)	O
Southern	O
blot	O
analysis	O
of	O
PVCre	O
wild	O
-	O
type	O
(	O
+	O
/	O
+	O
)	O
and	O
heterozygous	O
(	O
+	O
/	O
-	O
)	O
genomic	O
DNA	O
using	O
the	O
probe	O
indicated	O
in	O
(	O
A	O
)	O
.	O

(	O
C	O
and	O
D	O
)	O
Expression	O
of	O
GFP	O
(	O
green	O
)	O
and	O
LacZ	O
(	O
red	O
;	O
C	O
)	O
or	O
PV	O
(	O
red	O
;	O
D	O
)	O
in	O
P0	O
TaumGFP	O
/	O
+	O
PVCre	O
/	O
+	O
mice	O
.	O

Note	O
that	O
more	O
than	O
90	O
%	O
of	O
PV	O
+	O
neurons	O
coexpress	O
GFP	O
(	O
D	O
;	O
data	O
not	O
shown	O
)	O
.	O

Scale	O
bar	O
:	O
(	O
C	O
and	O
D	O
)	O
,	O
50	O
mu	O
m	O
.	O

(	O
2	O
MB	O
CDR	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S5	O

Gene	O
Expression	O
Analysis	O
upon	O
Precocious	O
Induction	O
of	O
EWS	O
-	O
Pea3	O
in	O
DRG	O
Neurons	O

Immunohistochemical	O
analysis	O
of	O
PV	O
(	O
A	O
and	O
D	O
)	O
,	O
Calretinin	O
(	O
B	O
and	O
E	O
)	O
,	O
and	O
Calbindin	O
(	O
C	O
and	O
F	O
)	O
expression	O
on	O
E16	O
.	O
5	O
lumbar	O
DRG	O
of	O
wild	O
-	O
type	O
(	O
A	O
-	O
C	O
)	O
and	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
(	O
D	O
-	O
F	O
)	O
embryos	O
.	O

Scale	O
bar	O
:	O
80	O
mu	O
m	O
.	O

(	O
950	O
KB	O
CDR	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Acknowledgements	O

The	O
generation	O
and	O
initial	O
characterization	O
of	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
mice	O
was	O
performed	O
in	O
the	O
laboratory	O
of	O
Thomas	O
Jessell	O
at	O
Columbia	O
University	O
,	O
with	O
expert	O
assistance	O
from	O
Barbara	O
Hahn	O
and	O
Monica	O
Mendelsohn	O
.	O

We	O
thank	O
Thomas	O
Jessell	O
for	O
encouragement	O
and	O
many	O
stimulating	O
discussions	O
and	O
thank	O
him	O
and	O
Pico	O
Caroni	O
for	O
helpful	O
comments	O
on	O
the	O
manuscript	O
.	O

We	O
thank	O
Jean	O
-	O
Francois	O
Spetz	O
,	O
Patrick	O
Kopp	O
,	O
Bernard	O
Kuchemann	O
,	O
and	O
Monika	O
Mielich	O
for	O
excellent	O
technical	O
assistance	O
,	O
Ina	O
Kramer	O
for	O
providing	O
Runx3	O
antibodies	O
,	O
Pico	O
Caroni	O
for	O
providing	O
mGFP	O
cDNA	O
,	O
John	O
A	O
.	O
Hassell	O
for	O
providing	O
EWS	O
-	O
Pea3	O
cDNA	O
and	O
fruitful	O
discussions	O
on	O
ETS	O
gene	O
function	O
,	O
and	O
Y	O
.	O

A	O
.	O

Barde	O
and	O
K	O
.	O

Tucker	O
for	O
providing	O
the	O
Tau	O
targeting	O
construct	O
.	O

SH	O
,	O
EV	O
,	O
MS	O
,	O
TP	O
,	O
CL	O
,	O
DRL	O
,	O
and	O
SA	O
were	O
supported	O
by	O
a	O
grant	O
from	O
the	O
Swiss	O
National	O
Science	O
Foundation	O
,	O
by	O
the	O
Kanton	O
of	O
Basel	O
-	O
Stadt	O
,	O
and	O
by	O
the	O
Novartis	O
Research	O
Foundation	O
.	O

In	O
addition	O
,	O
DRL	O
was	O
supported	O
by	O
a	O
research	O
fellowship	O
from	O
the	O
Roche	O
Research	O
Foundation	O
.	O

Conflict	O
of	O
interest	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
conflicts	O
of	O
interests	O
exist	O
.	O

Abbreviations	O

DRG	O
-	O
dorsal	O
root	O
ganglion	O
/	O
ganglia	O

E	O
-	O
embryonic	O
day	O

EWS	O
-	O
Ewing	O
sarcoma	O

mGFP	O
-	O
membrane	O
-	O
targeted	O
green	O
fluorescent	O
protein	B-CHEBI

NT	O
-	O
3	O
-	O
neurotrophin	O
3	O

P	O
-	O
postnatal	O
day	O

PV	O
-	O
Parvalbumin	O

spGFP	O
-	O
synaptophysin	O
green	O
fluorescent	O
protein	B-CHEBI

Figures	O
and	O
Tables	O

Figure	O
1	O

Replacement	O
of	O
Er81	O
by	O
EWS	O
-	O
Pea3	O

(	O
A	O
)	O
Generation	O
of	O
Er81EWS	O
-	O
Pea3	O
mutant	O
mice	O
.	O

Above	O
is	O
the	O
organization	O
of	O
the	O
Er81	O
genomic	O
locus	O
in	O
the	O
region	O
targeted	O
by	O
homologous	O
recombination	O
in	O
analogy	O
to	O
[	O
14	O
]	O
.	O

Exons	O
1	O
-	O
4	O
are	O
shown	O
as	O
light	O
blue	O
boxes	O
,	O
and	O
the	O
Er81	O
start	O
codon	O
in	O
exon	O
2	O
is	O
indicated	O
as	O
ATG	O
.	O

The	O
probe	O
used	O
to	O
detect	O
homologous	O
recombination	O
is	O
shown	O
as	O
a	O
grey	O
box	O
.	O

Below	O
is	O
replacement	O
of	O
Er81	O
by	O
EWS	O
-	O
Pea3	O
through	O
the	O
integration	O
of	O
EWS	O
-	O
Pea3	O
in	O
frame	O
with	O
the	O
endogenous	O
start	O
codon	O
of	O
the	O
Er81	O
locus	O
in	O
exon	O
2	O
(	O
in	O
analogy	O
to	O
[	O
14	O
]	O
)	O
.	O

(	O
B	O
)	O
PCR	O
and	O
Southern	O
blot	O
analysis	O
of	O
Er81EWS	O
-	O
Pea3	O
wild	O
-	O
type	O
(	O
+	O
/	O
+	O
)	O
,	O
heterozygous	O
(	O
+	O
/	O
-	O
)	O
,	O
and	O
homozygous	O
(	O
-	O
/	O
-	O
)	O
genomic	O
DNA	O
to	O
detect	O
the	O
mutant	O
allele	O
.	O

PCR	O
primer	O
pairs	O
(	O
EWS	O
-	O
Pea3ki	O
)	O
were	O
used	O
to	O
detect	O
specifically	O
the	O
recombined	O
allele	O
,	O
and	O
a	O
primer	O
pair	O
in	O
exon2	O
was	O
used	O
to	O
detect	O
the	O
presence	O
of	O
the	O
wild	O
-	O
type	O
allele	O
[	O
14	O
]	O
.	O

(	O
C	O
-	O
E	O
)	O
Analysis	O
of	O
Er81	O
expression	O
in	O
lumbar	O
DRG	O
neurons	O
of	O
E16	O
.	O
5	O
wild	O
-	O
type	O
(	O
C	O
)	O
,	O
Er81	O
-	O
/	O
-	O
(	O
D	O
)	O
,	O
and	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
(	O
E	O
)	O
embryos	O
.	O

Inset	O
in	O
lower	O
right	O
corner	O
of	O
each	O
panel	O
shows	O
Isl1	O
expression	O
in	O
the	O
respective	O
DRG	O
.	O

(	O
F	O
-	O
H	O
)	O
PV	O
expression	O
in	O
lumbar	O
DRG	O
of	O
E16	O
.	O
5	O
wild	O
-	O
type	O
(	O
F	O
)	O
,	O
Er81	O
-	O
/	O
-	O
(	O
G	O
)	O
,	O
and	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
(	O
H	O
)	O
embryos	O
.	O

Confocal	O
scans	O
were	O
performed	O
with	O
equal	O
gain	O
intensity	O
.	O

(	O
J	O
)	O
Transcriptional	O
transactivation	O
of	O
luciferase	O
expression	O
from	O
a	O
minimal	O
reporter	O
construct	O
containing	O
five	O
consensus	O
ETS	O
DNA	O
-	O
binding	O
sites	O
(	O
GCCGGAAGC	O
;	O
[	O
18	O
,	O
19	O
]	O
)	O
and	O
a	O
minimal	O
TK	O
promoter	O
upon	O
transient	O
transfection	O
of	O
Er81	O
(	O
n	O
>=	O
7	O
;	O
3	O
.	O
03	O
+/-	O
0	O
.	O
66	O
)	O
or	O
EWS	O
-	O
Pea3	O
(	O
n	O
>=	O
7	O
;	O
20	O
.	O
3	O
+/-	O
2	O
.	O
7	O
)	O
.	O

Relative	O
luciferase	O
activity	O
normalized	O
to	O
control	O
(	O
Con	O
)	O
.	O

Scale	O
bar	O
:	O
80	O
mu	O
m	O
.	O

Figure	O
2	O

Rescue	O
of	O
Ia	O
Proprioceptive	O
Afferent	O
Projections	O
into	O
the	O
Ventral	O
Spinal	O
Cord	O
in	O
Er81EWS	O
-	O
Pea3	O
Mutants	O

(	O
A	O
-	O
F	O
)	O
Morphological	O
analysis	O
of	O
central	O
projections	O
at	O
lumbar	O
level	O
L3	O
of	O
PV	O
+	O
DRG	O
neurons	O
(	O
A	O
-	O
C	O
)	O
or	O
all	O
DRG	O
sensory	O
afferents	O
after	O
application	O
of	O
fluorescently	B-CHEBI
labeled	I-CHEBI
dextran	O
to	O
individual	O
dorsal	O
roots	O
(	O
D	O
-	O
F	O
)	O
in	O
P0	O
.	O
5	O
(	O
A	O
-	O
C	O
)	O
or	O
P5	O
(	O
D	O
-	O
F	O
)	O
wild	O
-	O
type	O
(	O
A	O
and	O
D	O
)	O
,	O
Er81	O
-	O
/	O
-	O
(	O
B	O
and	O
E	O
)	O
,	O
and	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
(	O
C	O
and	O
F	O
)	O
mice	O
.	O

Red	O
dotted	O
line	O
indicates	O
intermediate	O
level	O
of	O
spinal	O
cord	O
.	O

(	O
G	O
-	O
I	O
)	O
Analysis	O
of	O
vGlut1	O
immunocytochemistry	O
in	O
the	O
ventral	O
horn	O
of	O
P0	O
.	O
5	O
wild	O
-	O
type	O
(	O
G	O
)	O
,	O
Er81	O
-	O
/	O
-	O
(	O
H	O
)	O
,	O
and	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
(	O
I	O
)	O
mice	O
.	O

Yellow	O
dotted	O
box	O
in	O
(	O
A	O
)	O
indicates	O
size	O
of	O
images	O
shown	O
in	O
(	O
G	O
-	O
I	O
)	O
.	O

(	O
J	O
-	O
L	O
)	O
Schematic	O
summary	O
diagrams	O
of	O
the	O
morphological	O
rescue	O
of	O
Ia	O
proprioceptive	O
afferent	O
projections	O
(	O
blue	O
)	O
into	O
the	O
ventral	O
spinal	O
cord	O
observed	O
in	O
wild	O
-	O
type	O
(	O
J	O
)	O
,	O
Er81	O
-	O
/	O
-	O
(	O
K	O
)	O
,	O
and	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
(	O
L	O
)	O
mice	O
.	O

DRG	O
indicated	O
by	O
dotted	O
grey	O
line	O
;	O
motor	O
neurons	O
are	O
shown	O
in	O
black	O
.	O

Scale	O
bar	O
:	O
(	O
A	O
-	O
C	O
)	O
,	O
150	O
mu	O
m	O
;	O
(	O
D	O
-	O
F	O
)	O
,	O
160	O
mu	O
m	O
;	O
(	O
G	O
-	O
I	O
)	O
,	O
70	O
mu	O
m	O
.	O

Figure	O
3	O

Defects	O
in	O
the	O
Establishment	O
of	O
Sensory	O
Afferent	O
Projections	O
upon	O
Precocious	O
Expression	O
of	O
EWS	O
-	O
Pea3	O
in	O
DRG	O
Neurons	O

(	O
A	O
-	O
C	O
and	O
G	O
-	O
I	O
)	O
Visualization	O
of	O
sensory	O
afferent	O
projections	O
(	O
green	O
)	O
into	O
the	O
spinal	O
cord	O
of	O
wild	O
-	O
type	O
(	O
A	O
-	O
C	O
)	O
and	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
(	O
G	O
-	O
I	O
)	O
embryos	O
at	O
E13	O
.	O
5	O
(	O
A	O
,	O
C	O
,	O
G	O
,	O
and	O
I	O
)	O
and	O
E16	O
.	O
5	O
(	O
B	O
and	O
H	O
)	O
by	O
Cre	O
-	O
recombinase	O
-	O
mediated	O
activation	O
of	O
mGFP	O
expression	O
from	O
the	O
Tau	O
locus	O
(	O
A	O
,	O
B	O
,	O
G	O
,	O
and	O
H	O
)	O
or	O
by	O
a	O
Thy1spGFP	O
transgene	O
(	O
C	O
and	O
I	O
;	O
[	O
25	O
]	O
)	O
.	O

Grey	O
arrows	O
indicate	O
normal	O
pattern	O
of	O
afferent	O
projections	O
into	O
the	O
spinal	O
cord	O
,	O
whereas	O
red	O
arrows	O
show	O
aberrant	O
accumulation	O
of	O
sensory	O
afferents	O
at	O
the	O
lateral	O
edge	O
of	O
the	O
spinal	O
cord	O
in	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
embryos	O
.	O

(	O
D	O
-	O
F	O
and	O
J	O
-	O
L	O
)	O
Analysis	O
of	O
sensory	O
afferent	O
projections	O
(	O
green	O
)	O
into	O
the	O
skin	O
(	O
D	O
and	O
J	O
)	O
or	O
muscle	O
(	O
E	O
and	O
K	O
;	O
red	O
,	O
alpha	O
-	O
Bungarotoxin	O
,	O
BTX	O
)	O
of	O
wild	O
-	O
type	O
(	O
D	O
-	O
F	O
)	O
and	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
(	O
J	O
-	O
L	O
)	O
embryos	O
at	O
E16	O
.	O
5	O
by	O
Cre	O
-	O
recombinase	O
-	O
mediated	O
activation	O
of	O
mGFP	O
(	O
D	O
,	O
E	O
,	O
J	O
,	O
and	O
K	O
)	O
expression	O
from	O
the	O
Tau	O
locus	O
.	O

(	O
F	O
and	O
L	O
)	O
show	O
Egr3	O
expression	O
in	O
intrafusal	O
muscle	O
fibers	O
using	O
in	O
situ	O
hybridization	O
(	O
consecutive	O
sections	O
to	O
[	O
E	O
and	O
K	O
]	O
are	O
shown	O
)	O
.	O

(	O
M	O
-	O
Q	O
)	O
Analysis	O
of	O
bifurcation	O
of	O
sensory	O
afferent	O
projections	O
towards	O
the	O
spinal	O
cord	O
in	O
E13	O
.	O
5	O
wild	O
-	O
type	O
(	O
M	O
)	O
and	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
(	O
O	O
and	O
Q	O
)	O
embryos	O
after	O
injection	O
of	O
fluorescently	B-CHEBI
labeled	I-CHEBI
dextran	O
(	O
green	O
)	O
into	O
one	O
DRG	O
(	O
lumbar	O
level	O
L3	O
)	O
.	O

Confocal	O
scanning	O
plane	O
for	O
(	O
M	O
and	O
O	O
)	O
is	O
schematically	O
illustrated	O
in	O
(	O
N	O
)	O
.	O

Inset	O
in	O
(	O
O	O
)	O
is	O
also	O
shown	O
at	O
a	O
deeper	O
confocal	O
scanning	O
plane	O
(	O
P	O
and	O
Q	O
)	O
to	O
visualize	O
aberrant	O
axonal	O
projections	O
.	O

Scale	O
bar	O
:	O
(	O
A	O
and	O
G	O
)	O
,	O
60	O
mu	O
m	O
;	O
(	O
B	O
and	O
H	O
)	O
,	O
80	O
mu	O
m	O
;	O
(	O
C	O
and	O
I	O
)	O
,	O
100	O
mu	O
m	O
;	O
(	O
D	O
and	O
J	O
)	O
,	O
160	O
mu	O
m	O
;	O
(	O
E	O
,	O
F	O
,	O
K	O
,	O
and	O
L	O
)	O
,	O
70	O
mu	O
m	O
;	O
(	O
M	O
,	O
O	O
,	O
and	O
Q	O
)	O
,	O
240	O
mu	O
m	O
.	O

Figure	O
4	O

Neurotrophin	O
-	O
Independent	O
Neurite	O
Outgrowth	O
In	O
Vitro	O
of	O
DRG	O
Neurons	O
Expressing	O
EWS	O
-	O
Pea3	O
Precociously	O

E13	O
.	O
5	O
lumbar	O
DRG	O
from	O
wild	O
-	O
type	O
(	O
A	O
,	O
B	O
,	O
and	O
C	O
)	O
,	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
(	O
D	O
,	O
E	O
,	O
and	O
F	O
)	O
,	O
or	O
Bax	O
-	O
/	O
-	O
(	O
G	O
,	O
H	O
,	O
and	O
I	O
)	O
embryos	O
cultured	O
for	O
48	O
h	O
without	O
neurotrophic	O
support	O
(	O
A	O
,	O
D	O
,	O
and	O
G	O
)	O
or	O
in	O
the	O
presence	O
of	O
NGF	O
(	O
B	O
,	O
E	O
,	O
and	O
H	O
)	O
or	O
NT	O
-	O
3	O
(	O
C	O
,	O
F	O
,	O
and	O
I	O
)	O
were	O
stained	O
for	O
expression	O
of	O
neurofilament	O
to	O
visualize	O
axonal	O
extensions	O
.	O

Scale	O
bar	O
:	O
130	O
mu	O
m	O
.	O

Figure	O
5	O

DRG	O
Neurons	O
Expressing	O
EWS	O
-	O
Pea3	O
Isochronically	O
Depend	O
on	O
Neurotrophins	O
for	O
Survival	O

E14	O
.	O
5	O
lumbar	O
DRG	O
from	O
TaumGFP	O
/	O
+	O
PVCre	O
/	O
+	O
(	O
A	O
and	O
B	O
)	O
and	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
PVCre	O
/	O
+	O
(	O
C	O
and	O
D	O
)	O
embryos	O
cultured	O
for	O
48	O
h	O
without	O
neurotrophic	O
support	O
(	O
A	O
and	O
C	O
)	O
or	O
in	O
the	O
presence	O
of	O
NT	O
-	O
3	O
(	O
B	O
and	O
D	O
)	O
were	O
stained	O
for	O
expression	O
of	O
neurofilament	O
(	O
red	O
)	O
and	O
LacZ	O
(	O
green	O
)	O
to	O
visualize	O
axonal	O
extensions	O
and	O
survival	O
of	O
PV	O
-	O
expressing	O
proprioceptive	O
afferents	O
.	O

Scale	O
bar	O
:	O
150	O
mu	O
m	O
.	O

Figure	O
6	O

Loss	O
of	O
Trk	O
Receptor	O
Expression	O
and	O
Increased	O
Survival	O
in	O
DRG	O
Neurons	O
upon	O
Precocious	O
ETS	O
Signaling	O

(	O
A	O
-	O
C	O
and	O
G	O
-	O
I	O
)	O
In	O
situ	O
hybridization	O
analysis	O
of	O
TrkA	O
(	O
A	O
and	O
G	O
)	O
,	O
TrkB	O
(	O
B	O
and	O
H	O
)	O
,	O
and	O
TrkC	O
(	O
C	O
and	O
I	O
)	O
expression	O
in	O
E16	O
.	O
5	O
lumbar	O
DRG	O
of	O
wild	O
-	O
type	O
(	O
A	O
-	O
C	O
)	O
and	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
(	O
G	O
-	O
I	O
)	O
embryos	O
.	O

(	O
D	O
-	O
F	O
and	O
J	O
-	O
L	O
)	O
Analysis	O
of	O
lumbar	O
DRG	O
of	O
wild	O
-	O
type	O
(	O
D	O
)	O
,	O
TaumGFP	O
/	O
+	O
IslCre	O
/	O
+	O
(	O
E	O
and	O
F	O
)	O
,	O
and	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
(	O
J	O
,	O
K	O
,	O
and	O
L	O
)	O
embryos	O
for	O
(	O
1	O
)	O
neuronal	O
cell	O
death	O
at	O
E13	O
.	O
5	O
by	O
TUNEL	O
(	O
green	O
;	O
D	O
and	O
J	O
)	O
,	O
(	O
2	O
)	O
cell	O
survival	O
and	O
proliferation	O
at	O
E16	O
.	O
5	O
by	O
LacZ	O
(	O
blue	O
)	O
wholemount	O
staining	O
(	O
E	O
and	O
K	O
;	O
lumbar	O
levels	O
L1	O
and	O
L2	O
are	O
shown	O
)	O
,	O
and	O
(	O
3	O
)	O
BrdU	O
(	O
green	O
)	O
/	O
LacZ	O
(	O
red	O
)	O
double	O
labeling	O
(	O
F	O
and	O
L	O
)	O
.	O

(	O
M	O
and	O
N	O
)	O
Quantitative	O
analysis	O
(	O
n	O
>=	O
3	O
independent	O
experiments	O
)	O
of	O
the	O
mean	O
number	O
of	O
apoptotic	O
events	O
relative	O
to	O
wild	O
-	O
type	O
levels	O
is	O
shown	O
in	O
(	O
M	O
)	O
and	O
neuronal	O
survival	O
in	O
(	O
N	O
)	O
as	O
percent	O
of	O
wild	O
-	O
type	O
of	O
DRG	O
at	O
lumbar	O
levels	O
L1	O
to	O
L5	O
as	O
quantified	O
on	O
serial	O
sections	O
.	O

(	O
O	O
)	O
Western	O
blot	O
analysis	O
of	O
protein	B-CHEBI
extracts	O
isolated	O
from	O
lumbar	O
DRG	O
of	O
E16	O
.	O
5	O
wild	O
-	O
type	O
(	O
wt	O
)	O
and	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
(	O
mut	O
)	O
embryos	O
using	O
the	O
following	O
antibodies	O
:	O
Akt	O
,	O
p	O
-	O
Akt	O
(	O
Ser473	O
)	O
,	O
CREB	O
,	O
p	O
-	O
CREB	O
(	O
Ser133	O
)	O
,	O
Bax	O
,	O
Bcl2	O
,	O
and	O
Bcl	O
-	O
xl	O
.	O

(	O
P	O
)	O
Quantitative	O
analysis	O
of	O
protein	B-CHEBI
levels	O
relative	O
to	O
wild	O
-	O
type	O
in	O
percent	O
is	O
shown	O
on	O
the	O
right	O
(	O
n	O
=	O
3	O
independent	O
experiments	O
)	O
.	O

Scale	O
bar	O
:	O
(	O
A	O
-	O
C	O
and	O
G	O
-	O
I	O
)	O
,	O
35	O
mu	O
m	O
;	O
(	O
D	O
and	O
J	O
)	O
,	O
40	O
mu	O
m	O
;	O
(	O
E	O
and	O
K	O
)	O
,	O
200	O
mu	O
m	O
;	O
(	O
F	O
and	O
L	O
)	O
,	O
50	O
mu	O
m	O
.	O

Figure	O
7	O

Gene	O
Expression	O
Analysis	O
upon	O
Induction	O
of	O
Precocious	O
or	O
Isochronic	O
ETS	O
Signaling	O

(	O
A	O
-	O
H	O
)	O
Analysis	O
of	O
TrkC	O
expression	O
by	O
in	O
situ	O
hybridization	O
(	O
A	O
-	O
D	O
)	O
,	O
or	O
Calretinin	O
(	O
red	O
)	O
and	O
LacZ	O
(	O
green	O
)	O
expression	O
by	O
immunohistochemistry	O
(	O
E	O
-	O
H	O
)	O
,	O
on	O
E16	O
.	O
5	O
lumbar	O
DRG	O
of	O
wild	O
-	O
type	O
(	O
A	O
and	O
E	O
)	O
,	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Isl1Cre	O
/	O
+	O
(	O
B	O
and	O
F	O
)	O
,	O
Er81EWS	O
-	O
Pea3	O
/	O
-	O
(	O
C	O
and	O
G	O
)	O
,	O
and	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
PVCre	O
/	O
+	O
(	O
D	O
and	O
H	O
)	O
embryos	O
.	O

(	O
I	O
)	O
Summary	O
diagram	O
illustrating	O
deregulation	O
of	O
TrkC	O
(	O
red	O
arrows	O
,	O
downregulation	O
)	O
and	O
Calretinin	O
(	O
green	O
arrows	O
,	O
upregulation	O
)	O
expression	O
upon	O
precocious	O
(	O
B	O
and	O
F	O
)	O
induction	O
of	O
EWS	O
-	O
Pea3	O
expression	O
in	O
DRG	O
neurons	O
(	O
B	O
and	O
F	O
;	O
E10	O
-	O
E11	O
,	O
i	O
.	O
e	O
.	O
,	O
shortly	O
after	O
cell	O
cycle	O
exit	O
,	O
E9	O
.	O
5	O
-	O
E10	O
)	O
.	O

In	O
contrast	O
,	O
activation	O
of	O
EWS	O
-	O
Pea3	O
from	O
the	O
endogenous	O
Er81	O
locus	O
(	O
C	O
and	O
G	O
;	O
E12	O
.	O
5	O
-	O
E13	O
)	O
or	O
via	O
Cre	O
recombinase	O
expression	O
from	O
the	O
PV	O
locus	O
activating	O
late	O
expression	O
from	O
the	O
Tau	O
locus	O
(	O
D	O
and	O
H	O
;	O
E14	O
.	O
5	O
)	O
does	O
not	O
interfere	O
with	O
the	O
normal	O
expression	O
of	O
TrkC	O
and	O
Calretinin	O
(	O
shown	O
in	O
grey	O
)	O
.	O

Scale	O
bar	O
:	O
(	O
A	O
-	O
D	O
)	O
,	O
65	O
mu	O
m	O
;	O
(	O
E	O
-	O
H	O
)	O
,	O
80	O
mu	O
m	O
.	O

Figure	O
8	O

Precocious	O
ETS	O
Signaling	O
Induces	O
Gene	O
Expression	O
Changes	O
Cell	O
-	O
Autonomously	O

(	O
A	O
-	O
D	O
)	O
Expression	O
of	O
TrkA	O
(	O
A	O
and	O
C	O
;	O
green	O
)	O
or	O
TrkC	O
(	O
B	O
and	O
D	O
;	O
green	O
)	O
,	O
and	O
LacZ	O
(	O
red	O
)	O
,	O
in	O
E16	O
.	O
5	O
lumbar	O
DRG	O
of	O
TaumGFP	O
/	O
+	O
Hb9Cre	O
/	O
+	O
(	O
A	O
and	O
B	O
)	O
and	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Hb9Cre	O
/	O
+	O
(	O
C	O
and	O
D	O
)	O
embryos	O
.	O

(	O
E	O
-	O
L	O
)	O
Expression	O
of	O
Calretinin	O
(	O
green	O
)	O
,	O
LacZ	O
(	O
red	O
)	O
,	O
and	O
Isl1	O
(	O
F	O
,	O
J	O
,	O
H	O
,	O
and	O
L	O
;	O
blue	O
)	O
in	O
E16	O
.	O
5	O
brachial	O
(	O
E	O
-	O
H	O
)	O
and	O
lumbar	O
(	O
I	O
-	O
L	O
)	O
DRG	O
of	O
TaumGFP	O
/	O
+	O
Hb9Cre	O
/	O
+	O
(	O
E	O
,	O
F	O
,	O
I	O
,	O
and	O
J	O
)	O
and	O
TauEWS	O
-	O
Pea3	O
/	O
+	O
Hb9Cre	O
/	O
+	O
(	O
G	O
,	O
H	O
,	O
K	O
,	O
and	O
L	O
)	O
embryos	O
.	O

Scale	O
bar	O
:	O
(	O
A	O
-	O
D	O
)	O
,	O
80	O
mu	O
m	O
;	O
(	O
E	O
-	O
L	O
)	O
,	O
70	O
mu	O
m	O
.	O

Figure	O
9	O

Progressive	O
Neuronal	O
Specification	O
Is	O
Paralleled	O
by	O
a	O
Developmental	O
Shift	O
in	O
Response	O
to	O
ETS	O
Transcription	O
Factor	O
Signaling	O

Schematic	O
summary	O
diagram	O
illustrating	O
the	O
importance	O
of	O
temporally	O
appropriate	O
upregulation	O
of	O
transcription	O
factor	O
expression	O
during	O
specification	O
of	O
DRG	O
neurons	O
for	O
late	O
aspects	O
of	O
neuronal	O
differentiation	O
and	O
circuit	O
assembly	O
.	O

(	O
A	O
-	O
D	O
)	O
Expression	O
of	O
EWS	O
-	O
Pea3	O
from	O
the	O
endogenous	O
Er81	O
locus	O
can	O
rescue	O
anatomical	O
defects	O
observed	O
in	O
Er81	O
-	O
/	O
-	O
mice	O
,	O
and	O
no	O
change	O
in	O
expression	O
of	O
TrkC	O
(	O
green	O
)	O
or	O
Calretinin	O
(	O
CR	O
;	O
grey	O
)	O
is	O
observed	O
in	O
proprioceptive	O
afferents	O
(	O
A	O
,	O
B	O
,	O
and	O
D	O
)	O
.	O

In	O
contrast	O
,	O
precocious	O
ETS	O
signaling	O
leads	O
to	O
severe	O
defects	O
in	O
the	O
establishment	O
of	O
DRG	O
neuronal	O
projections	O
accompanied	O
by	O
inappropriate	O
gene	O
expression	O
changes	O
(	O
C	O
;	O
upregulation	O
of	O
CR	O
(	O
red	O
)	O
and	O
downregulation	O
of	O
TrkC	O
[	O
grey	O
]	O
)	O
.	O

(	O
E	O
)	O
Precocious	O
ETS	O
signaling	O
(	O
red	O
)	O
during	O
progressive	O
specification	O
of	O
proprioceptive	O
sensory	O
neurons	O
leads	O
to	O
aberrant	O
neuronal	O
differentiation	O
(	O
red	O
dashed	O
line	O
)	O
.	O

In	O
contrast	O
,	O
the	O
isochronic	O
,	O
target	O
-	O
induced	O
(	O
green	O
;	O
peripheral	O
signal	O
)	O
onset	O
of	O
ETS	O
transcription	O
factor	O
signaling	O
(	O
black	O
)	O
induces	O
appropriate	O
terminal	O
neuronal	O
differentiation	O
(	O
blue	O
)	O
.	O

Footnotes	O

Author	O
contributions	O
.	O

SH	O
and	O
SA	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

SH	O
,	O
EV	O
,	O
MS	O
,	O
TP	O
,	O
CL	O
,	O
DRL	O
,	O
and	O
SA	O
performed	O
the	O
experiments	O
.	O

SA	O
wrote	O
the	O
paper	O
.	O

Citation	O
:	O
Hippenmeyer	O
S	O
,	O
Vrieseling	O
E	O
,	O
Sigrist	O
M	O
,	O
Portmann	O
T	O
,	O
Laengle	O
C	O
,	O
et	O
al	O
.	O

(	O
2005	O
)	O
A	O
developmental	O
switch	O
in	O
the	O
response	O
of	O
DRG	O
neurons	O
to	O
ETS	O
transcription	O
factor	O
signaling	O
.	O

PLoS	O
Biol	O
3	O
(	O
5	O
)	O
:	O
e159	O
.	O

Ataxia	O
and	O
peripheral	O
nerve	O
hypomyelination	O
in	O
ADAM22	O
-	O
deficient	O
mice	O

Abstract	O

Background	O

ADAM22	O
is	O
a	O
member	O
of	O
the	O
ADAM	O
gene	O
family	O
,	O
but	O
the	O
fact	O
that	O
it	O
is	O
expressed	O
only	O
in	O
the	O
nervous	O
systems	O
makes	O
it	O
unique	O
.	O

ADAM22	O
'	O
s	O
sequence	O
similarity	O
to	O
other	O
ADAMs	O
suggests	O
it	O
to	O
be	O
an	O
integrin	O
binder	O
and	O
thus	O
to	O
have	O
a	O
role	O
in	O
cell	O
-	O
cell	O
or	O
cell	O
-	O
matrix	O
interactions	O
.	O

To	O
elucidate	O
the	O
physiological	O
functions	O
of	O
ADAM22	O
,	O
we	O
employed	O
gene	O
targeting	O
to	O
generate	O
ADAM22	O
knockout	O
mice	O
.	O

Results	O

ADAM22	O
-	O
deficient	O
mice	O
were	O
produced	O
in	O
a	O
good	O
accordance	O
with	O
the	O
Mendelian	O
ratio	O
and	O
appeared	O
normal	O
at	O
birth	O
.	O

After	O
one	O
week	O
,	O
severe	O
ataxia	O
was	O
observed	O
,	O
and	O
all	O
homozygotes	O
died	O
before	O
weaning	O
,	O
probably	O
due	O
to	O
convulsions	O
.	O

No	O
major	O
histological	O
abnormalities	O
were	O
detected	O
in	O
the	O
cerebral	O
cortex	O
or	O
cerebellum	O
of	O
the	O
homozygous	O
mutants	O
;	O
however	O
,	O
marked	O
hypomyelination	O
of	O
the	O
peripheral	O
nerves	O
was	O
observed	O
.	O

Conclusion	O

The	O
results	O
of	O
our	O
study	O
demonstrate	O
that	O
ADAM22	O
is	O
closely	O
involved	O
in	O
the	O
correct	O
functioning	O
of	O
the	O
nervous	O
system	O
.	O

Further	O
analysis	O
of	O
ADAM22	O
will	O
provide	O
clues	O
to	O
understanding	O
the	O
mechanisms	O
of	O
human	O
diseases	O
such	O
as	O
epileptic	O
seizures	O
and	O
peripheral	O
neuropathy	O
.	O

Background	O

ADAM	O
(	O
A	O
Disintegrin	O
And	O
Metalloprotease	O
)	O
is	O
a	O
family	O
of	O
membrane	O
-	O
spanning	O
multi	O
-	O
domain	O
proteins	B-CHEBI
containing	O
a	O
metalloproteinase	O
-	O
like	O
domain	O
and	O
a	O
disintegrin	O
-	O
like	O
domain	O
.	O

Currently	O
,	O
more	O
than	O
30	O
ADAMs	O
have	O
been	O
identified	O
in	O
mammals	O
.	O

Their	O
biological	O
activities	O
implicate	O
ADAMs	O
in	O
fertilization	O
,	O
myogenesis	O
and	O
neurogenesis	O
by	O
proteolysis	O
and	O
adhesion	O
.	O

Some	O
types	O
of	O
ADAM	O
are	O
catalytically	O
active	O
metalloproteases	O
and	O
shed	O
the	O
extracellular	O
domains	O
of	O
membrane	O
-	O
bound	O
growth	O
factors	O
or	O
receptors	O
[	O
1	O
,	O
2	O
]	O
.	O

For	O
example	O
,	O
ADAM17	O
(	O
TACE	O
)	O
has	O
been	O
shown	O
to	O
cleave	O
several	O
substrates	O
,	O
including	O
tumour	O
necrosis	O
factor	O
alpha	O
[	O
3	O
,	O
4	O
]	O
,	O
heparin	B-CHEBI
-	O
binding	O
epidermal	O
growth	O
factor	O
-	O
like	O
growth	O
factor	O
[	O
6	O
,	O
7	O
]	O
and	O
transforming	O
growth	O
factor	O
alpha	O
[	O
8	O
]	O
.	O

Studies	O
of	O
ADAM17	O
-	O
null	O
mice	O
have	O
revealed	O
that	O
ADAM17	O
is	O
critical	O
in	O
embryogenesis	O
and	O
plays	O
an	O
essential	O
role	O
in	O
the	O
supply	O
of	O
growth	O
factors	O
[	O
6	O
,	O
8	O
]	O
.	O

ADAMs	O
are	O
also	O
involved	O
in	O
cell	O
-	O
cell	O
or	O
cell	O
-	O
matrix	O
adhesion	O
through	O
their	O
interaction	O
with	O
integrins	O
or	O
syndecans	O
.	O

More	O
than	O
10	O
ADAMs	O
have	O
been	O
shown	O
to	O
support	O
integrin	O
-	O
mediated	O
cell	O
adhesion	O
in	O
vitro	O
[	O
9	O
]	O
.	O

It	O
has	O
been	O
reported	O
that	O
ADAM2	O
-	O
null	O
and	O
ADAM3	O
-	O
null	O
male	O
mutants	O
are	O
infertile	O
and	O
their	O
spermatozoa	O
lack	O
egg	O
-	O
binding	O
abilities	O
[	O
10	O
-	O
12	O
]	O
.	O

Both	O
ADAM2	O
and	O
ADAM3	O
are	O
not	O
metalloproteases	O
because	O
they	O
lack	O
catalytic	O
site	O
sequences	O
in	O
their	O
metalloprotease	O
domain	O
.	O

These	O
studies	O
clearly	O
showed	O
that	O
non	O
-	O
proteinase	O
members	O
of	O
ADAMs	O
also	O
have	O
significant	O
roles	O
in	O
vivo	O
.	O

We	O
have	O
reported	O
the	O
findings	O
of	O
ADAM11	O
,	O
ADAM22	O
and	O
ADAM23	O
genes	O
and	O
their	O
restricted	O
expression	O
in	O
the	O
human	O
and	O
murine	O
nervous	O
systems	O
[	O
13	O
-	O
15	O
]	O
.	O

Sequence	O
analysis	O
suggests	O
that	O
they	O
are	O
not	O
metalloproteases	O
,	O
since	O
they	O
all	O
lack	O
a	O
catalytic	O
motif	O
.	O

It	O
has	O
been	O
reported	O
that	O
ADAM23	O
protein	B-CHEBI
is	O
localised	O
to	O
the	O
cell	O
surface	O
[	O
16	O
]	O
,	O
interacts	O
with	O
alpha	O
-	O
v	O
beta	O
-	O
3	O
integrin	O
heterodimer	O
[	O
17	O
]	O
and	O
the	O
disruption	O
of	O
ADAM23	O
gene	O
in	O
the	O
mouse	O
results	O
in	O
premature	O
death	O
associated	O
with	O
ataxia	O
and	O
tremor	O
[	O
18	O
]	O
.	O

Although	O
the	O
cause	O
of	O
death	O
in	O
this	O
mouse	O
is	O
unknown	O
,	O
for	O
these	O
phenotypes	O
,	O
impaired	O
cell	O
-	O
cell	O
or	O
cell	O
-	O
matrix	O
interactions	O
in	O
the	O
nervous	O
system	O
caused	O
by	O
loss	O
of	O
ADAM23	O
may	O
be	O
responsible	O
.	O

ADAM22	O
and	O
ADAM23	O
share	O
highly	O
homologous	O
sequences	O
in	O
their	O
extracellular	O
domains	O
.	O

Especially	O
,	O
it	O
is	O
evident	O
in	O
their	O
putative	O
integrin	O
binding	O
loop	O
sequences	O
,	O
CR	O
(	O
E	O
/	O
D	O
)	O
AVN	O
(	O
E	O
/	O
D	O
)	O
CD	O
,	O
which	O
is	O
located	O
centre	O
of	O
the	O
disintegrin	O
domain	O
.	O

These	O
findings	O
led	O
us	O
to	O
hypothesize	O
that	O
ADAM22	O
is	O
an	O
integrin	O
binder	O
and	O
plays	O
an	O
important	O
role	O
in	O
the	O
nervous	O
system	O
,	O
as	O
does	O
ADAM23	O
.	O

To	O
determine	O
the	O
physiological	O
functions	O
of	O
ADAM22	O
,	O
we	O
generated	O
and	O
analysed	O
Adam22	O
gene	O
-	O
targeted	O
mice	O
.	O

Results	O

Generation	O
of	O
ADAM22	O
-	O
deficient	O
mice	O

Mice	O
carrying	O
a	O
targeted	O
mutation	O
in	O
their	O
Adam22	O
gene	O
were	O
generated	O
by	O
homologous	O
recombination	O
(	O
Fig	O
.	O
1A	O
)	O
.	O

Correct	O
targeting	O
events	O
were	O
confirmed	O
by	O
Southern	O
blot	O
analysis	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

Since	O
the	O
termination	O
codon	O
was	O
introduced	O
in	O
exon	O
8	O
in	O
the	O
pro	O
-	O
protein	B-CHEBI
domain	O
,	O
only	O
the	O
truncated	O
form	O
of	O
the	O
ADAM22	O
protein	B-CHEBI
would	O
be	O
synthesized	O
from	O
this	O
targeted	O
allele	O
.	O

Because	O
a	O
pro	O
-	O
protein	B-CHEBI
domain	O
is	O
always	O
removed	O
in	O
the	O
mature	O
functional	O
ADAM	O
-	O
proteins	B-CHEBI
by	O
the	O
Furin	O
-	O
like	O
proteases	O
and	O
is	O
thought	O
to	O
be	O
non	O
-	O
functional	O
itself	O
,	O
we	O
considered	O
that	O
this	O
truncated	O
form	O
of	O
ADAM22	O
protein	B-CHEBI
has	O
no	O
function	O
.	O

Absence	O
of	O
mature	O
ADAM22	O
protein	B-CHEBI
in	O
homozygous	O
mutants	O
was	O
confirmed	O
by	O
Western	O
blot	O
analysis	O
using	O
the	O
specific	O
antibody	O
,	O
which	O
recognizes	O
the	O
cytoplasmic	O
domain	O
of	O
the	O
ADAM22	O
protein	B-CHEBI
(	O
Fig	O
.	O
1C	O
)	O
.	O

Homozygous	O
mutants	O
showed	O
no	O
noticeable	O
defects	O
at	O
birth	O
and	O
were	O
indistinguishable	O
from	O
wild	O
-	O
type	O
or	O
heterozygous	O
littermates	O
during	O
the	O
first	O
week	O
.	O

At	O
postnatal	O
day	O
10	O
(	O
P10	O
)	O
,	O
most	O
of	O
the	O
homozygous	O
mutants	O
were	O
distinguishable	O
by	O
abnormalities	O
such	O
as	O
reduced	O
body	O
weight	O
and	O
uncoordinated	O
movements	O
of	O
their	O
limbs	O
.	O

After	O
P10	O
,	O
all	O
homozygotes	O
displayed	O
severe	O
ataxia	O
(	O
Fig	O
.	O
2	O
)	O
and	O
began	O
to	O
die	O
.	O

To	O
measure	O
the	O
survival	O
rate	O
and	O
body	O
weight	O
of	O
each	O
genotype	O
precisely	O
,	O
we	O
backcrossed	O
heterozygous	O
male	O
mutants	O
to	O
C57BL	O
/	O
6	O
females	O
more	O
than	O
6	O
times	O
.	O

The	O
resulting	O
(	O
N	O
6	O
)	O
heterozygous	O
males	O
and	O
females	O
were	O
intercrossed	O
and	O
the	O
produced	O
offspring	O
were	O
analysed	O
.	O

The	O
numbers	O
of	O
survivors	O
of	O
each	O
genotype	O
every	O
5	O
days	O
are	O
shown	O
in	O
Table	O
1	O
.	O

At	O
P10	O
,	O
the	O
ratio	O
of	O
each	O
genotype	O
was	O
in	O
close	O
accordance	O
with	O
the	O
Mendelian	O
ratio	O
(	O
20	O
.	O
5	O
%	O
+	O
/	O
+	O
,	O
55	O
.	O
1	O
%	O
+	O
/	O
-	O
,	O
24	O
.	O
4	O
%	O
-	O
/	O
-	O
;	O
n	O
=	O
78	O
)	O
.	O

This	O
result	O
shows	O
that	O
ADAM22	O
is	O
not	O
essential	O
for	O
embryogenesis	O
.	O

At	O
P10	O
,	O
the	O
average	O
body	O
weight	O
of	O
homozygous	O
mutants	O
was	O
approximately	O
half	O
that	O
of	O
wild	O
-	O
type	O
and	O
heterozygous	O
littermates	O
(	O
Table	O
2	O
)	O
.	O

Homozygous	O
mutants	O
died	O
one	O
by	O
one	O
after	O
P10	O
,	O
and	O
all	O
homozygotes	O
died	O
before	O
P20	O
.	O

Of	O
more	O
than	O
100	O
homozygotes	O
we	O
have	O
produced	O
,	O
none	O
have	O
survived	O
more	O
than	O
25	O
days	O
after	O
birth	O
.	O

Meanwhile	O
,	O
heterozygous	O
mutants	O
looked	O
normal	O
,	O
were	O
fertile	O
,	O
and	O
survived	O
for	O
more	O
than	O
one	O
year	O
without	O
obvious	O
defects	O
.	O

Histopathology	O
of	O
ADAM22	O
-	O
deficient	O
mice	O

We	O
have	O
reported	O
the	O
predominant	O
expression	O
of	O
ADAM22	O
mRNA	B-CHEBI
in	O
the	O
human	O
and	O
mouse	O
brain	O
by	O
Northern	O
blot	O
analysis	O
[	O
13	O
,	O
14	O
]	O
.	O

To	O
determine	O
the	O
distribution	O
of	O
ADAM22	O
transcript	O
in	O
the	O
adult	O
mouse	O
CNS	O
precisely	O
,	O
in	O
situ	O
hybridisation	O
analysis	O
was	O
performed	O
using	O
35S	B-CHEBI
-	O
labeled	O
RNA	O
probe	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

3	O
,	O
ADAM22	O
mRNA	B-CHEBI
was	O
expressed	O
throughout	O
the	O
adult	O
mouse	O
CNS	O
.	O

Strong	O
signal	O
was	O
detected	O
in	O
the	O
cerebellar	O
granule	O
cells	O
and	O
hippocampal	O
formation	O
.	O

In	O
the	O
spinal	O
cord	O
,	O
hybridisation	O
signal	O
was	O
restricted	O
to	O
the	O
grey	O
matter	O
.	O

The	O
distribution	O
of	O
ADAM22	O
transcripts	O
in	O
the	O
CNS	O
was	O
quite	O
similar	O
with	O
that	O
of	O
ADAM11	O
,	O
whose	O
neuronal	O
expression	O
has	O
been	O
reported	O
[	O
19	O
]	O
.	O

These	O
results	O
suggest	O
that	O
the	O
ADAM22	O
mRNA	B-CHEBI
expression	O
is	O
neuronal	O
in	O
the	O
mouse	O
CNS	O
.	O

Based	O
on	O
the	O
mRNA	B-CHEBI
distribution	O
pattern	O
,	O
we	O
performed	O
immunohistopathological	O
analysis	O
of	O
the	O
cerebellum	O
and	O
hippocampus	O
extensively	O
.	O

Despite	O
the	O
high	O
level	O
of	O
expression	O
of	O
ADAM22	O
mRNAs	B-CHEBI
in	O
the	O
cerebellar	O
granule	O
cells	O
,	O
granule	O
cell	O
layer	O
was	O
normally	O
formed	O
and	O
Purkinje	O
cell	O
morphology	O
(	O
calbindin	O
-	O
staining	O
)	O
of	O
the	O
mutant	O
mouse	O
looked	O
intact	O
(	O
Figs	O
.	O
4A	O
-	O
D	O
)	O
.	O

Hippocampal	O
formation	O
was	O
also	O
normally	O
formed	O
(	O
Figs	O
.	O
4I	O
-	O
J	O
)	O
.	O

These	O
results	O
suggest	O
that	O
neuronal	O
cell	O
migration	O
was	O
not	O
impaired	O
in	O
the	O
mutant	O
mouse	O
.	O

Myelin	O
-	O
formation	O
detected	O
by	O
MBP	O
(	O
myelin	O
basic	B-CHEBI
protein	B-CHEBI
)	O
staining	O
of	O
the	O
mutant	O
in	O
the	O
cerebellum	O
(	O
Fig	O
.	O
4H	O
)	O
and	O
spinal	O
cord	O
(	O
Fig	O
.	O
4L	O
)	O
was	O
also	O
indistinguishable	O
with	O
the	O
wild	O
-	O
type	O
littermate	O
(	O
Figs	O
.	O
4G	O
,	O
K	O
)	O
.	O

In	O
summary	O
,	O
we	O
could	O
not	O
find	O
any	O
signs	O
of	O
abnormalities	O
in	O
the	O
mutant	O
mouse	O
brain	O
by	O
the	O
light	O
microscopic	O
examination	O
.	O

Next	O
,	O
the	O
spinal	O
cord	O
and	O
peripheral	O
nerves	O
of	O
each	O
genotype	O
were	O
analysed	O
by	O
toluidine	O
blue	O
stain	O
,	O
which	O
reveals	O
myelin	O
formation	O
.	O

Surprisingly	O
,	O
lack	O
of	O
myelin	O
or	O
thin	O
myelin	O
was	O
observed	O
in	O
the	O
sciatic	O
nerves	O
(	O
Fig	O
.	O
5B	O
)	O
and	O
trigeminal	O
nerves	O
(	O
Fig	O
.	O
5D	O
)	O
in	O
homozygous	O
mutants	O
.	O

Because	O
no	O
lesions	O
were	O
observed	O
in	O
the	O
spinal	O
cord	O
(	O
Fig	O
.	O
5F	O
)	O
,	O
it	O
was	O
suggested	O
that	O
Schwann	O
cell	O
specific	O
myelination	O
defect	O
occurred	O
in	O
the	O
homozygous	O
mice	O
.	O

To	O
analyse	O
the	O
state	O
of	O
myelinating	O
Schwann	O
cells	O
and	O
axons	O
,	O
electron	B-CHEBI
microscopic	O
(	O
EM	O
)	O
analysis	O
of	O
the	O
sciatic	O
nerve	O
was	O
performed	O
(	O
Fig	O
.	O
6	O
)	O
.	O

Schwann	O
cells	O
formed	O
thin	O
or	O
no	O
myelin	O
in	O
the	O
homozygous	O
mutant	O
(	O
Fig	O
.	O
6B	O
)	O
.	O

In	O
contrast	O
,	O
heterozygous	O
mice	O
showed	O
complete	O
myelination	O
(	O
Fig	O
.	O
6A	O
)	O
.	O

Morphology	O
of	O
the	O
axons	O
looked	O
normal	O
in	O
each	O
genotype	O
.	O

Immunohistochemical	O
analysis	O
of	O
the	O
sciatic	O
nerve	O
showed	O
that	O
increased	O
number	O
of	O
nuclei	O
(	O
Fig	O
.	O
7B	O
)	O
and	O
reduced	O
staining	O
of	O
MBP	O
(	O
Fig	O
.	O
7D	O
)	O
were	O
remarkable	O
in	O
the	O
homozygous	O
mutant	O
.	O

The	O
Schwann	O
cell	O
marker	O
,	O
S100	O
staining	O
signal	O
was	O
intensely	O
observed	O
in	O
the	O
homozygote	O
as	O
well	O
as	O
wild	O
-	O
type	O
(	O
Figs	O
.	O
7E	O
,	O
F	O
)	O
.	O

These	O
results	O
suggest	O
that	O
proliferation	O
of	O
the	O
Schwann	O
cells	O
was	O
not	O
impaired	O
but	O
differentiation	O
is	O
severely	O
delayed	O
in	O
the	O
ADAM22	O
-	O
deficient	O
mice	O
.	O

Novel	O
ADAM22	O
transcript	O
variants	O
isolated	O
from	O
the	O
peripheral	O
nervous	O
system	O

In	O
the	O
case	O
of	O
human	O
ADAM22	O
,	O
isolation	O
of	O
five	O
splicing	O
variants	O
and	O
existence	O
of	O
two	O
terminating	O
exons	O
have	O
been	O
reported	O
[	O
13	O
,	O
20	O
,	O
21	O
]	O
.	O

However	O
,	O
the	O
latter	O
terminating	O
exon	O
(	O
exon	O
31	O
)	O
of	O
the	O
mouse	O
species	O
has	O
not	O
been	O
identified	O
yet	O
.	O

To	O
isolate	O
the	O
long	O
form	O
of	O
mouse	O
ADAM22	O
transcripts	O
,	O
at	O
first	O
,	O
we	O
sought	O
the	O
mouse	O
genome	O
by	O
BLAST	O
homology	O
search	O
.	O

Search	O
results	O
showed	O
that	O
the	O
mouse	O
genome	O
contig	O
NT	O
_	O
039297	O
contained	O
most	O
of	O
the	O
mouse	O
Adam22	O
gene	O
.	O

In	O
this	O
contig	O
sequence	O
,	O
we	O
found	O
putative	O
exons	O
30	O
and	O
31	O
,	O
those	O
sequences	O
were	O
quite	O
similar	O
to	O
human	O
ADAM22	O
isoform	O
1	O
(	O
GenBank	O
#	O
NM	O
_	O
021723	O
)	O
.	O

To	O
confirm	O
existence	O
of	O
transcripts	O
,	O
we	O
designed	O
primers	O
on	O
the	O
putative	O
exon	O
31	O
and	O
performed	O
RT	O
-	O
PCR	O
using	O
mouse	O
cerebellum	O
mRNA	B-CHEBI
as	O
a	O
template	O
.	O

TA	O
-	O
cloning	O
of	O
the	O
amplified	O
fragments	O
and	O
sequencing	O
analysis	O
showed	O
that	O
5	O
of	O
8	O
clones	O
were	O
type	O
1	O
isoform	O
(	O
G01	O
)	O
,	O
2	O
clones	O
were	O
type	O
3	O
isoform	O
(	O
G03	O
)	O
and	O
1	O
clone	O
(	O
G08	O
)	O
contained	O
a	O
novel	O
exon	O
between	O
exons	O
29	O
and	O
30	O
.	O

Next	O
,	O
we	O
performed	O
RT	O
-	O
PCR	O
analysis	O
of	O
mRNAs	B-CHEBI
purified	O
from	O
several	O
adult	O
mouse	O
tissues	O
,	O
such	O
as	O
the	O
spinal	O
cord	O
,	O
dorsal	O
root	O
ganglion	O
(	O
DRG	O
)	O
,	O
sciatic	O
nerve	O
and	O
cultured	O
primary	O
Schwann	O
cells	O
.	O

Interestingly	O
,	O
multiple	O
DNA	O
fragments	O
were	O
amplified	O
from	O
each	O
tissue	O
(	O
Fig	O
.	O
8	O
)	O
,	O
and	O
length	O
of	O
major	O
fragments	O
in	O
each	O
lane	O
was	O
different	O
.	O

For	O
example	O
,	O
length	O
of	O
major	O
amplified	O
PCR	O
fragments	O
from	O
the	O
sciatic	O
nerve	O
(	O
Fig	O
.	O
8A	O
,	O
lane	O
5	O
)	O
and	O
cultured	O
Schwann	O
cells	O
(	O
lane	O
6	O
)	O
were	O
almost	O
identical	O
,	O
and	O
were	O
shorter	O
than	O
those	O
from	O
other	O
tissues	O
.	O

In	O
contrast	O
,	O
major	O
fragments	O
from	O
the	O
DRG	O
(	O
lane	O
4	O
)	O
were	O
longer	O
than	O
others	O
.	O

We	O
performed	O
TA	O
-	O
cloning	O
and	O
sequencing	O
to	O
analyse	O
exon	O
organization	O
of	O
the	O
amplified	O
transcripts	O
(	O
Fig	O
.	O
8C	O
)	O
.	O

Forty	O
seven	O
clones	O
were	O
isolated	O
in	O
total	O
and	O
were	O
classified	O
in	O
16	O
independent	O
clones	O
(	O
G01	O
-	O
G23	O
)	O
.	O

Comparison	O
with	O
the	O
genomic	O
sequence	O
revealed	O
the	O
existence	O
of	O
8	O
novel	O
exons	O
(	O
exons	O
27S	O
,	O
27L	O
,	O
29	O
.	O
1	O
,	O
29	O
.	O
3	O
,	O
29	O
.	O
5	O
,	O
29	O
.	O
7	O
,	O
30	O
and	O
31	O
)	O
.	O

These	O
novel	O
exons	O
were	O
flanked	O
by	O
well	O
-	O
defined	O
introns	O
that	O
obey	O
the	O
GT	O
-	O
AG	O
rule	O
.	O

Exon	O
organization	O
of	O
each	O
clone	O
was	O
shown	O
in	O
Fig	O
.	O

8C	O
.	O

Characteristic	O
feature	O
of	O
ADAM22	O
transcripts	O
is	O
tissue	O
specific	O
insertion	O
or	O
skipping	O
of	O
exons	O
.	O

Because	O
the	O
number	O
of	O
nucleotides	B-CHEBI
of	O
exons	O
26	O
,	O
27	O
,	O
27L	O
,	O
29	O
.	O
3	O
,	O
29	O
.	O
5	O
and	O
29	O
.	O
7	O
is	O
a	O
multiple	O
of	O
3	O
,	O
insertion	O
or	O
skipping	O
of	O
these	O
exons	O
will	O
not	O
change	O
the	O
downstream	O
reading	O
frame	O
.	O

Known	O
peptide	O
motives	O
were	O
not	O
found	O
in	O
the	O
newly	O
isolated	O
sequences	O
.	O

This	O
RT	O
-	O
PCR	O
analysis	O
is	O
summarized	O
as	O
follows	O
:	O
ADAM22	O
transcripts	O
were	O
roughly	O
subdivided	O
in	O
3	O
groups	O
,	O
CNS	O
-	O
form	O
(	O
containing	O
exon	O
27	O
)	O
,	O
DRG	O
-	O
form	O
(	O
containing	O
exon	O
27L	O
)	O
and	O
Schwann	O
-	O
cell	O
-	O
form	O
(	O
skipping	O
exon	O
26	O
and	O
27	O
)	O
.	O

From	O
these	O
results	O
,	O
we	O
concluded	O
that	O
ADAM22	O
is	O
expressed	O
in	O
a	O
cell	O
-	O
type	O
specific	O
manner	O
,	O
and	O
plays	O
an	O
essential	O
role	O
in	O
myelinogenesis	O
in	O
the	O
PNS	O
.	O

Discussion	O

In	O
the	O
present	O
study	O
,	O
we	O
examined	O
the	O
function	O
of	O
ADAM22	O
by	O
generating	O
mice	O
that	O
lacked	O
the	O
Adam22	O
gene	O
.	O

ADAM22	O
-	O
deficient	O
mice	O
exhibited	O
severe	O
ataxia	O
and	O
premature	O
death	O
.	O

In	O
contrast	O
,	O
heterozygous	O
mutants	O
were	O
healthy	O
,	O
fertile	O
and	O
survived	O
more	O
than	O
1	O
year	O
without	O
obvious	O
abnormalities	O
.	O

The	O
cause	O
of	O
death	O
in	O
the	O
homozygous	O
mutants	O
is	O
not	O
clear	O
;	O
however	O
,	O
it	O
is	O
likely	O
to	O
be	O
due	O
to	O
multiple	O
seizures	O
.	O

This	O
is	O
because	O
convulsive	O
seizures	O
were	O
occasionally	O
observed	O
in	O
homozygotes	O
,	O
after	O
which	O
the	O
suffered	O
mice	O
appeared	O
exhausted	O
and	O
,	O
in	O
most	O
cases	O
,	O
died	O
on	O
the	O
next	O
day	O
.	O

It	O
is	O
known	O
that	O
cortical	O
dysplasia	O
resulting	O
from	O
aberrant	O
brain	O
development	O
causes	O
seizure	O
syndrome	O
[	O
22	O
]	O
.	O

For	O
example	O
,	O
mice	O
lacking	O
the	O
neuron	O
-	O
specific	O
activator	O
of	O
cyclin	O
5	O
,	O
p35	O
,	O
exhibit	O
seizures	O
and	O
a	O
severe	O
neuronal	O
migration	O
defect	O
[	O
23	O
]	O
.	O

Because	O
ADAM22	O
protein	B-CHEBI
is	O
expressed	O
on	O
the	O
cell	O
surface	O
and	O
is	O
likely	O
to	O
be	O
involved	O
in	O
cell	O
-	O
cell	O
or	O
cell	O
-	O
matrix	O
interactions	O
,	O
we	O
hypothesized	O
that	O
depletion	O
of	O
ADAM22	O
would	O
generate	O
aberrant	O
neuronal	O
migration	O
.	O

Histochemical	O
analysis	O
was	O
performed	O
to	O
verify	O
this	O
hypothesis	O
.	O

However	O
,	O
no	O
marked	O
abnormalities	O
were	O
observed	O
in	O
the	O
mutant	O
mouse	O
brain	O
,	O
ruling	O
out	O
a	O
critical	O
role	O
for	O
ADAM22	O
in	O
neuronal	O
migration	O
.	O

Another	O
possible	O
explanation	O
is	O
that	O
the	O
premature	O
death	O
in	O
first	O
2	O
weeks	O
of	O
life	O
is	O
caused	O
by	O
the	O
dysfunction	O
of	O
the	O
autonomic	O
nervous	O
system	O
.	O

Especially	O
,	O
nerves	O
which	O
control	O
the	O
breathing	O
would	O
be	O
very	O
important	O
,	O
because	O
the	O
respiration	O
system	O
undergoes	O
significant	O
maturation	O
in	O
the	O
first	O
2	O
-	O
3	O
weeks	O
after	O
birth	O
.	O

For	O
example	O
,	O
the	O
myelin	O
-	O
deficient	O
(	O
MD	O
)	O
rat	O
,	O
which	O
carries	O
a	O
point	O
mutation	O
in	O
the	O
proteolipid	O
protein	B-CHEBI
(	O
PLP	O
)	O
gene	O
,	O
exhibits	O
ataxia	O
,	O
tremor	O
,	O
dysmyelination	O
and	O
dies	O
at	O
approximately	O
postnatal	O
day	O
21	O
.	O

In	O
MD	O
rat	O
,	O
early	O
death	O
is	O
caused	O
by	O
the	O
dysfunction	O
of	O
the	O
brain	O
stem	O
which	O
is	O
essential	O
for	O
autonomic	O
control	O
of	O
respiration	O
during	O
hypoxia	O
[	O
24	O
]	O
.	O

Further	O
study	O
is	O
needed	O
to	O
verify	O
the	O
cause	O
of	O
death	O
in	O
ADAM22	O
-	O
deficient	O
mice	O
.	O

Another	O
interesting	O
phenotype	O
observed	O
in	O
ADAM22	O
-	O
deficient	O
mice	O
was	O
hypomyelinogenesis	O
.	O

Histopathological	O
analysis	O
revealed	O
marked	O
hypomyelination	O
in	O
the	O
sciatic	O
and	O
trigeminal	O
nerves	O
.	O

However	O
,	O
myelin	O
formation	O
in	O
the	O
spinal	O
cord	O
and	O
the	O
brain	O
was	O
normal	O
.	O

It	O
was	O
therefore	O
evident	O
that	O
hypomyelinogenesis	O
occurred	O
specifically	O
in	O
the	O
peripheral	O
nerves	O
in	O
the	O
knockout	O
mice	O
,	O
suggesting	O
Schwann	O
cell	O
dysfunction	O
.	O

In	O
the	O
mutant	O
sciatic	O
nerve	O
,	O
the	O
density	O
of	O
pro	O
-	O
myelinating	O
Schwann	O
cells	O
(	O
S100	O
-	O
positive	O
,	O
MBP	O
-	O
negative	O
)	O
was	O
markedly	O
higher	O
than	O
that	O
seen	O
in	O
heterozygotes	O
.	O

Higher	O
pro	O
-	O
myelinating	O
Schwann	O
cell	O
density	O
and	O
marked	O
delay	O
in	O
myelin	O
formation	O
indicate	O
that	O
ADAM22	O
plays	O
an	O
important	O
role	O
in	O
Schwann	O
cell	O
differentiation	O
,	O
but	O
not	O
in	O
proliferation	O
.	O

Investigations	O
on	O
why	O
hypomyelinogenesis	O
occurred	O
in	O
ADAM22	O
-	O
deficient	O
mice	O
centre	O
on	O
integrin	O
.	O

This	O
is	O
because	O
several	O
ADAMs	O
have	O
been	O
shown	O
to	O
interact	O
with	O
integrins	O
via	O
disintegrin	O
domains	O
[	O
9	O
]	O
,	O
and	O
it	O
has	O
been	O
suggested	O
that	O
alpha	O
-	O
6	O
beta	O
-	O
1	O
integrin	O
on	O
the	O
Schwann	O
cell	O
plays	O
an	O
important	O
role	O
in	O
myelin	O
formation	O
[	O
25	O
]	O
.	O

In	O
addition	O
,	O
laminin	O
-	O
2	O
is	O
a	O
key	O
player	O
in	O
peripheral	O
myelin	O
formation	O
,	O
because	O
laminin	O
-	O
2	O
deficiency	O
causes	O
dysmyelination	O
in	O
mice	O
and	O
humans	O
,	O
and	O
its	O
receptors	O
,	O
alpha	O
-	O
6	O
beta	O
-	O
1	O
integrin	O
and	O
dystroglycan	O
,	O
are	O
also	O
shown	O
to	O
be	O
deeply	O
involved	O
in	O
myelin	O
formation	O
[	O
26	O
,	O
27	O
]	O
.	O

The	O
conditional	O
knockout	O
studies	O
of	O
beta	O
-	O
1	O
integrin	O
and	O
laminin	O
gamma	O
-	O
1	O
in	O
Schwann	O
cell	O
suggested	O
that	O
both	O
laminin	O
-	O
2	O
and	O
integrins	O
are	O
essential	O
for	O
segregation	O
of	O
large	O
bundles	O
of	O
axons	O
in	O
the	O
early	O
stage	O
of	O
myelin	O
formation	O
[	O
25	O
,	O
28	O
]	O
.	O

In	O
contrast	O
,	O
the	O
phenotype	O
seen	O
in	O
the	O
ADAM22	O
-	O
deficient	O
mice	O
was	O
quite	O
different	O
:	O
for	O
example	O
,	O
unsorted	O
bundles	O
of	O
axons	O
were	O
not	O
seen	O
in	O
nerves	O
and	O
roots	O
.	O

We	O
assume	O
that	O
ADAM22	O
partially	O
modulates	O
integrin	O
-	O
mediated	O
signals	O
or	O
is	O
involved	O
at	O
a	O
later	O
stage	O
of	O
myelin	O
formation	O
.	O

Conclusion	O

In	O
summary	O
,	O
we	O
generated	O
ADAM22	O
-	O
deficient	O
mice	O
and	O
proved	O
that	O
ADAM22	O
plays	O
an	O
essential	O
role	O
in	O
both	O
the	O
CNS	O
and	O
the	O
PNS	O
.	O

The	O
results	O
of	O
this	O
study	O
suggest	O
that	O
ADAM22	O
is	O
involved	O
in	O
human	O
diseases	O
such	O
as	O
epilepsy	O
and	O
peripheral	O
neuropathy	O
.	O

The	O
human	O
ADAM22	O
gene	O
is	O
relatively	O
large	O
,	O
at	O
300	O
kb	O
in	O
length	O
,	O
and	O
is	O
comprised	O
of	O
more	O
than	O
30	O
exons	O
.	O

It	O
is	O
assigned	O
on	O
7q21	O
,	O
where	O
several	O
chromosomal	O
aberrations	O
that	O
are	O
accompanied	O
by	O
neurological	O
disorders	O
have	O
been	O
identified	O
[	O
29	O
,	O
30	O
]	O
.	O

Further	O
detailed	O
molecular	B-CHEBI
function	O
analysis	O
of	O
ADAM22	O
may	O
lead	O
to	O
progress	O
in	O
uncovering	O
the	O
mechanisms	O
that	O
underlie	O
certain	O
human	O
neurological	O
diseases	O
.	O

Methods	O

Construction	O
of	O
an	O
Adam22	O
gene	O
-	O
targeting	O
vector	O

The	O
18	O
-	O
kb	O
genomic	O
DNA	O
fragments	O
covering	O
exons	O
5	O
,	O
6	O
,	O
7	O
,	O
8	O
and	O
9	O
of	O
the	O
Adam22	O
gene	O
were	O
amplified	O
from	O
C57BL	O
/	O
6	O
genomic	O
DNA	O
by	O
PCR	O
using	O
Expand	O
Hi	O
-	O
Fidelity	O
enzyme	O
mix	O
(	O
Roche	O
Diagnostics	O
)	O
and	O
primers	O
designed	O
for	O
each	O
exon	O
.	O

To	O
generate	O
a	O
mutation	O
in	O
the	O
mouse	O
Adam22	O
gene	O
,	O
we	O
inserted	O
the	O
PGKneo	O
cassette	O
into	O
exon	O
8	O
of	O
the	O
Adam22	O
gene	O
.	O

The	O
final	O
targeting	O
construct	O
consisted	O
of	O
a	O
10	O
.	O
5	O
-	O
kb	O
genomic	O
DNA	O
fragment	O
that	O
was	O
interrupted	O
by	O
the	O
insertion	O
of	O
the	O
PGKneo	O
cassette	O
and	O
contained	O
a	O
MC1	O
/	O
TK	O
cassette	O
as	O
a	O
negative	O
selection	O
marker	O
against	O
random	O
integration	O
[	O
5	O
]	O
.	O

Generation	O
of	O
Adam22	O
deficient	O
mice	O

The	O
linearised	O
targeting	O
vector	O
was	O
electroporated	O
into	O
TT2	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
[	O
31	O
]	O
.	O

Homologous	O
recombinants	O
were	O
selected	O
by	O
PCR	O
.	O

The	O
extracted	O
genomic	O
DNA	O
from	O
each	O
clone	O
was	O
amplified	O
using	O
the	O
forward	O
primer	O
AGN2	O
:	O
5	O
'	O
-	O
GCCTGCTTGCCGAATATCATGGTGGAAAAT	O
-	O
3	O
'	O
in	O
the	O
PGKneo	O
cassette	O
,	O
and	O
the	O
reverse	O
primer	O
MFP065R	O
:	O
5	O
'	O
-	O
ACTATTTCTGTGATGAGGGCACAGCATC	O
-	O
3	O
'	O
outside	O
the	O
targeting	O
vector	O
.	O

Homologous	O
recombined	O
DNA	O
was	O
efficiently	O
amplified	O
by	O
35	O
cycles	O
of	O
the	O
following	O
amplification	O
steps	O
(	O
94	O
degrees	O
C	O
-	O
30	O
s	O
and	O
68	O
degrees	O
C	O
-	O
5	O
min	O
)	O
.	O

The	O
targeting	O
efficiency	O
of	O
this	O
construct	O
was	O
about	O
4	O
%	O
.	O

Correctly	O
targeted	O
ES	O
clones	O
were	O
injected	O
into	O
fertilized	O
ICR	O
mouse	O
eggs	O
at	O
the	O
eight	O
-	O
cell	O
stage	O
.	O

The	O
resulting	O
male	O
chimeras	O
were	O
mated	O
with	O
C57BL	O
/	O
6N	O
females	O
,	O
and	O
heterozygous	O
male	O
and	O
female	O
mice	O
were	O
interbred	O
to	O
generate	O
homozygous	O
mice	O
.	O

The	O
ataxic	O
phenotypes	O
of	O
homozygous	O
mice	O
were	O
observed	O
in	O
two	O
independent	O
lines	O
.	O

Southern	O
blot	O
analysis	O

Mouse	O
genomic	O
DNA	O
used	O
for	O
Southern	O
blot	O
analysis	O
was	O
extracted	O
from	O
the	O
liver	O
of	O
each	O
genotype	O
.	O

BamHI	O
-	O
digested	O
genomic	O
DNA	O
was	O
probed	O
with	O
the	O
[	O
32P	B-CHEBI
]	O
-	O
labelled	O
0	O
.	O
4	O
-	O
kb	O
SpeI	O
-	O
BamHI	O
genomic	O
fragment	O
,	O
which	O
is	O
located	O
between	O
exons	O
8	O
and	O
9	O
.	O

Antibody	O
production	O

His	B-CHEBI
-	O
tagged	O
and	O
MBP	O
-	O
fused	O
recombinant	O
protein	B-CHEBI
containing	O
cytoplasmic	O
domain	O
(	O
cp	O
)	O
of	O
human	O
ADAM22	O
isoform	O
1	O
(	O
position	O
:	O
756	O
-	O
906	O
,	O
151	O
amino	B-CHEBI
acids	I-CHEBI
in	O
length	O
)	O
were	O
produced	O
in	O
E	O
.	O
coli	O
.	O

His	B-CHEBI
-	O
tagged	O
ADAM22	O
-	O
cp	O
protein	B-CHEBI
was	O
purified	O
in	O
denatured	O
condition	O
using	O
Ni	B-CHEBI
-	O
NTA	B-CHEBI
resin	O
(	O
Qiagen	O
GmbH	O
)	O
and	O
dialysed	O
in	O
PBS	O
.	O

Precipitated	O
protein	B-CHEBI
was	O
recovered	O
and	O
was	O
mixed	O
with	O
Freund	O
'	O
s	O
complete	O
adjuvant	O
(	O
Invitrogen	O
)	O
,	O
then	O
,	O
the	O
mixture	O
was	O
used	O
for	O
immunization	O
of	O
rabbits	O
.	O

The	O
antiserum	O
raised	O
against	O
the	O
His	B-CHEBI
-	O
tagged	O
ADAM22	O
-	O
cp	O
protein	B-CHEBI
was	O
incubated	O
with	O
MBP	O
-	O
fused	O
ADAM22	O
-	O
cp	O
protein	B-CHEBI
coupled	O
to	O
Affi	O
-	O
Gel	O
10	O
beads	O
(	O
Bio	O
-	O
Rad	O
)	O
.	O

Beads	O
with	O
bound	O
antibodies	O
were	O
washed	O
in	O
PBS	O
,	O
and	O
the	O
bound	O
antibodies	O
were	O
eluted	O
with	O
100	O
mM	O
glycine	B-CHEBI
,	O
pH	O
3	O
.	O
0	O
,	O
and	O
neutralized	O
immediately	O
.	O

Using	O
the	O
affinity	O
purified	O
antibody	O
,	O
both	O
human	O
and	O
mouse	O
ADAM22	O
proteins	B-CHEBI
were	O
detected	O
by	O
Western	O
blot	O
analysis	O
.	O

However	O
,	O
unfortunately	O
the	O
antibody	O
was	O
not	O
suitable	O
for	O
immunohistochemical	O
analysis	O
of	O
mouse	O
tissues	O
.	O

Western	O
blot	O
analysis	O

The	O
absence	O
of	O
ADAM22	O
protein	B-CHEBI
in	O
the	O
Adam22	O
-	O
/	O
-	O
mice	O
was	O
confirmed	O
by	O
Western	O
blot	O
analysis	O
.	O

Briefly	O
,	O
the	O
cerebellum	O
was	O
isolated	O
from	O
a	O
P14	O
.	O
5	O
mouse	O
of	O
each	O
genotype	O
and	O
homogenized	O
with	O
a	O
Polytron	O
homogenizer	O
in	O
cell	O
lysis	O
buffer	O
(	O
50	O
mM	O
Tris	B-CHEBI
-	O
HCl	B-CHEBI
,	O
pH	O
7	O
.	O
5	O
,	O
100	O
mM	O
NaCl	B-CHEBI
,	O
1	O
%	O
NP	O
-	O
40	O
,	O
Complete	O
protease	B-CHEBI
inhibitors	I-CHEBI
[	O
Roche	O
Diagnostics	O
]	O
)	O
.	O

After	O
removal	O
of	O
cell	O
debris	O
by	O
centrifugation	O
,	O
the	O
supernatant	O
was	O
separated	O
on	O
10	O
%	O
SDS	B-CHEBI
-	O
PAGE	O
,	O
and	O
transferred	O
to	O
a	O
nitrocellulose	O
membrane	O
.	O

The	O
blot	O
was	O
then	O
incubated	O
with	O
polyclonal	O
antibody	O
against	O
the	O
cytoplasmic	O
domain	O
of	O
ADAM22	O
(	O
at	O
1	O
:	O
1	O
,	O
000	O
)	O
.	O

Bound	O
antibodies	O
were	O
visualized	O
with	O
horseradish	O
peroxidase	O
-	O
labelled	O
second	O
antibody	O
and	O
a	O
ECL	O
-	O
plus	O
chemiluminescence	O
detection	O
system	O
(	O
Amersham	O
Biosciences	O
Corp	O
.	O
)	O
.	O

Primary	O
Schwann	O
cell	O
culture	O

Primary	O
Schwann	O
cells	O
were	O
prepared	O
from	O
4	O
-	O
month	O
-	O
old	O
C57BL	O
/	O
6	O
mice	O
according	O
to	O
Manent	O
'	O
s	O
protocol	O
[	O
32	O
]	O
with	O
minor	O
modifications	O
.	O

Briefly	O
,	O
sciatic	O
nerves	O
were	O
removed	O
and	O
incubated	O
for	O
7	O
days	O
in	O
the	O
pre	O
-	O
treatment	O
medium	O
,	O
which	O
consisted	O
of	O
D	O
-	O
MEM	O
(	O
high	O
glucose	B-CHEBI
)	O
supplemented	O
with	O
10	O
%	O
FCS	O
,	O
50	O
mg	O
/	O
ml	O
gentamicin	O
(	O
Invitrogen	O
Corp	O
.	O
)	O
,	O
2	O
.	O
5	O
mu	O
g	O
/	O
ml	O
fungizone	O
(	O
Invitrogen	O
Corp	O
.	O
)	O
,	O
2	O
mu	O
M	O
forskolin	B-CHEBI
(	O
EMD	O
Biosciences	O
Inc	O
.	O
)	O
and	O
10	O
ng	O
/	O
ml	O
recombinant	O
heregulin	O
-	O
beta1	O
(	O
R	O
&	O
D	O
Systems	O
)	O
.	O

For	O
dissociation	O
,	O
cultured	O
sciatic	O
nerves	O
were	O
cut	O
into	O
pieces	O
and	O
incubated	O
at	O
37	O
degrees	O
C	O
for	O
3	O
hours	O
in	O
Opti	O
-	O
MEM	O
medium	O
(	O
Invitrogen	O
Corp	O
.	O
)	O
containing	O
130	O
U	O
/	O
ml	O
collagenase	O
type	O
I	O
(	O
Invitrogen	O
Corp	O
.	O
)	O
and	O
0	O
.	O
4	O
U	O
/	O
ml	O
dispase	O
II	O
(	O
Roche	O
Diagnostics	O
)	O
.	O

Dissociated	O
cells	O
were	O
resuspended	O
in	O
the	O
pre	O
-	O
treatment	O
medium	O
and	O
plated	O
on	O
Poly	O
-	O
D	B-CHEBI
-	I-CHEBI
Lysine	I-CHEBI
/	O
Laminin	O
coated	O
plate	O
(	O
BD	O
Biosciences	O
)	O
.	O

The	O
purity	O
of	O
the	O
cultured	O
Schwann	O
cells	O
,	O
as	O
determined	O
by	O
indirect	O
immunofluorescence	O
analysis	O
,	O
approached	O
90	O
%	O
.	O

RT	O
-	O
PCR	O
analysis	O

Adult	O
C57BL	O
/	O
6	O
male	O
mice	O
were	O
used	O
in	O
this	O
study	O
.	O

Total	O
RNAs	O
purified	O
from	O
the	O
cerebellum	O
,	O
spinal	O
cord	O
,	O
sciatic	O
nerve	O
,	O
DRG	O
and	O
cultured	O
Schwann	O
cells	O
using	O
TRIzol	O
(	O
Invitrogen	O
Corp	O
.	O
)	O
and	O
RNeasy	O
kit	O
(	O
Qiagen	O
GmbH	O
)	O
were	O
analysed	O
by	O
RT	O
-	O
PCR	O
using	O
SuperScript	O
II	O
and	O
random	O
primer	O
(	O
Invitrogen	O
Corp	O
.	O
)	O
,	O
and	O
PCR	O
amplification	O
(	O
40	O
cycles	O
;	O
94	O
degrees	O
C	O
-	O
30	O
s	O
,	O
60	O
degrees	O
C	O
-	O
30	O
s	O
and	O
68	O
degrees	O
C	O
-	O
5	O
min	O
)	O
with	O
Expand	O
Hi	O
-	O
Fidelity	O
DNA	O
polymerase	O
(	O
Roche	O
Diagnostics	O
)	O
and	O
ADAM22	O
-	O
specific	O
primers	O
.	O

To	O
detect	O
splicing	O
variants	O
in	O
the	O
cytoplasmic	O
domain	O
,	O
a	O
forward	O
primer	O
was	O
placed	O
just	O
upstream	O
of	O
the	O
transmembrane	O
domain	O
and	O
a	O
reverse	O
primer	O
was	O
set	O
on	O
the	O
terminating	O
exon	O
.	O

The	O
primers	O
used	O
in	O
this	O
study	O
were	O
as	O
follows	O
.	O

ISH04	O
-	O
forward	O
:	O
5	O
'	O
-	O
AACAGGCACTGGACAGGGGCTGAC	O
-	O
3	O
'	O
and	O
ISH04	O
-	O
reverse	O
:	O
5	O
'	O
-	O
AATGGATGTCTCCCATAGCCTGGC	O
-	O
3	O
'	O
.	O

Histopathology	O

Mice	O
were	O
anesthetized	O
with	O
ethyl	B-CHEBI
ether	I-CHEBI
.	O

Whole	O
-	O
body	O
perfusion	O
by	O
2	O
%	O
paraformaldehyde	O
-	O
glutaraldehyde	O
solution	O
followed	O
by	O
heparin	B-CHEBI
-	O
included	O
saline	O
was	O
performed	O
.	O

Sciatic	O
nerves	O
,	O
trigeminal	O
nerves	O
,	O
brain	O
and	O
spinal	O
cord	O
were	O
removed	O
and	O
fixed	O
in	O
10	O
%	O
neutral	O
-	O
buffered	O
formalin	O
.	O

The	O
spinal	O
cord	O
and	O
other	O
nerve	O
blocks	O
were	O
washed	O
and	O
postfixed	O
with	O
2	O
%	O
osmium	B-CHEBI
tetroxide	O
,	O
and	O
were	O
dehydrated	O
in	O
ethanol	B-CHEBI
and	O
equilibrated	O
in	O
Epon	O
.	O

Epon	O
embedded	O
semithin	O
sections	O
were	O
stained	O
with	O
toluidine	O
blue	O
and	O
were	O
subjected	O
to	O
light	O
microscopic	O
examination	O
.	O

For	O
electron	B-CHEBI
microscopic	O
analysis	O
,	O
thin	O
sections	O
were	O
cut	O
using	O
an	O
ultramicrotome	O
,	O
stained	O
with	O
1	O
.	O
5	O
%	O
uranylacetate	O
in	O
50	O
%	O
ethanol	B-CHEBI
and	O
0	O
.	O
8	O
%	O
lead	B-CHEBI
citrate	B-CHEBI
,	O
and	O
analysed	O
using	O
electron	B-CHEBI
microscope	O
.	O

All	O
procedures	O
were	O
conducted	O
according	O
to	O
the	O
Eisai	O
Animal	O
Care	O
Committee	O
'	O
s	O
guidelines	O
.	O

Immunohistochemistry	O

Frozen	O
sections	O
were	O
rinsed	O
in	O
0	O
.	O
1	O
%	O
Triton	O
X	O
-	O
100	O
/	O
PBS	O
at	O
room	O
temperature	O
for	O
1	O
hour	O
,	O
and	O
were	O
blocked	O
in	O
BLOCKACE	O
solution	O
(	O
Dai	O
-	O
nippon	O
)	O
.	O

The	O
following	O
antibodies	O
were	O
incubated	O
overnight	O
in	O
0	O
.	O
1	O
%	O
BLOCKACE	O
at	O
4	O
degrees	O
C	O
:	O

monoclonal	O
mouse	O
anti	O
-	O
calbindin	O
28	O
K	O
(	O
Sigma	O
,	O
1	O
:	O
200	O
)	O
;	O
monoclonal	O
mouse	O
anti	O
-	O
MBP	O
(	O
SMI	O
-	O
99	O
,	O
Sternberger	O
Monoclonals	O
Inc	O
.	O
,	O
1	O
:	O
50	O
)	O
;	O
monoclonal	O
mouse	O
anti	O
-	O
Neu	O
N	O
(	O
CHEMICON	O
,	O
1	O
:	O
100	O
)	O
;	O
rabbit	O
anti	O
-	O
S100	O
polyclonal	O
(	O
DAKO	O
,	O
1	O
:	O
200	O
)	O
.	O

Nuclei	O
were	O
counterstained	O
with	O
1	O
mu	O
g	O
/	O
ml	O
DAPI	O
(	O
Sigma	O
)	O
.	O

MBP	O
staining	O
was	O
performed	O
after	O
microwave	O
epitope	O
retrieval	O
in	O
10	O
mmol	O
/	O
L	O
citrate	B-CHEBI
buffer	O
(	O
pH	O
6	O
)	O
.	O

Sections	O
were	O
incubated	O
for	O
1	O
hour	O
with	O
secondary	O
antibodies	O
:	O
Cy3	O
-	O
labeled	O
donkey	O
anti	O
-	O
rabbit	O
IgG	O
(	O
Jackson	O
Immuno	O
Research	O
,	O
1	O
:	O
200	O
)	O
,	O
FITC	B-CHEBI
-	O
labelled	O
donkey	O
anti	O
-	O
mouse	O
IgG	O
(	O
Jackson	O
Immuno	O
Research	O
,	O
1	O
:	O
200	O
)	O
.	O

Sections	O
were	O
photographed	O
with	O
an	O
Olympus	O
microscope	O
(	O
Olympus	O
IX71	O
)	O
equipped	O
with	O
a	O
high	O
-	O
resolution	O
CCD	O
camera	O
.	O

RNA	O
in	O
situ	O
hybridisation	O

In	O
situ	O
hybridisation	O
on	O
frozen	O
sections	O
were	O
carried	O
out	O
using	O
35S	B-CHEBI
-	O
labelled	O
RNA	O
probes	O
.	O

Briefly	O
,	O
610	O
bp	O
of	O
mouse	O
ADAM22	O
cDNA	O
(	O
position	O
:	O
1351	O
-	O
1960	O
from	O
initiating	O
ATG	O
)	O
was	O
cloned	O
into	O
the	O
pBluescript	O
II	O
SK	O
(	O
+	O
)	O
or	O
the	O
pBluescript	O
II	O
KS	O
(	O
+	O
)	O
vector	O
.	O

Using	O
these	O
plasmids	O
as	O
templates	O
,	O
sense	O
and	O
antisense	O
labelled	O
RNA	O
probes	O
were	O
generated	O
by	O
T7	O
RNA	O
polymerase	O
and	O
[	O
alpha	O
35S	O
]	O
UTP	B-CHEBI
.	O

Frozen	O
brain	O
and	O
spinal	O
cord	O
from	O
2	O
month	O
-	O
old	O
C57BL	O
/	O
6	O
female	O
mice	O
were	O
used	O
in	O
this	O
analysis	O
.	O

Pretreatment	O
,	O
hybridisation	O
,	O
RNase	O
treatment	O
and	O
washing	O
was	O
carried	O
out	O
following	O
the	O
protocol	O
described	O
in	O
the	O
literature	O
[	O
33	O
]	O
.	O

Dehydrated	O
slides	O
were	O
attached	O
to	O
imaging	O
plates	O
for	O
48	O
hours	O
and	O
the	O
autoradiograms	O
were	O
analysed	O
using	O
a	O
Bio	O
-	O
Image	O
Analyser	O
(	O
BAS3000	O
,	O
Fuji	O
Photo	O
Film	O
)	O
.	O

Authors	O
'	O
contributions	O

KS	O
is	O
leading	O
this	O
project	O
,	O
and	O
performed	O
cDNA	O
cloning	O
,	O
plasmid	O
construction	O
,	O
antibody	O
production	O
,	O
immunohistochemical	O
study	O
,	O
and	O
wrote	O
the	O
manuscript	O
.	O

KH	O
and	O
JK	O
conducted	O
histopathological	O
experiments	O
.	O

TH	O
analysed	O
mRNA	B-CHEBI
distribution	O
by	O
in	O
situ	O
hybridisation	O
.	O

ET	O
,	O
NM	O
,	O
MI	O
,	O
TO	O
and	O
KY	O
contributed	O
to	O
the	O
generation	O
of	O
knockout	O
mice	O
.	O

TN	O
supervised	O
the	O
project	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
manuscript	O
.	O

Acknowledgements	O

We	O
are	O
grateful	O
to	O
Isao	O
Tanaka	O
,	O
Masayuki	O
Okada	O
,	O
Yoshiharu	O
Mizui	O
,	O
Kappei	O
Tsukahara	O
,	O
Hiroyuki	O
Kato	O
,	O
Hiroo	O
Ogura	O
and	O
Junro	O
Kuromitsu	O
(	O
Eisai	O
Co	O
.	O
,	O
Ltd	O
.	O
)	O
,	O
and	O
Shin	O
-	O
ichi	O
Murase	O
(	O
Virginia	O
University	O
)	O
for	O
the	O
fruitful	O
discussions	O
and	O
advice	O
.	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Targeted	O
mutation	O
of	O
Adam22	O
.	O

(	O
A	O
)	O
The	O
genomic	O
structure	O
of	O
the	O
wild	O
-	O
type	O
Adam22	O
allele	O
(	O
top	O
)	O
,	O
the	O
targeting	O
construct	O
(	O
middle	O
)	O
and	O
the	O
disrupted	O
allele	O
(	O
bottom	O
)	O
are	O
shown	O
.	O

ADAM22	O
expression	O
was	O
disrupted	O
by	O
the	O
insertion	O
of	O
a	O
termination	O
codon	O
and	O
a	O
PGKneo	O
cassette	O
into	O
exon	O
8	O
.	O

An	O
MC1	O
/	O
TK	O
cassette	O
at	O
the	O
end	O
of	O
the	O
targeting	O
vector	O
allows	O
for	O
negative	O
selection	O
.	O

The	O
3	O
'	O
probe	O
represents	O
the	O
position	O
of	O
the	O
external	O
probe	O
used	O
for	O
Southern	O
blot	O
analysis	O
,	O
and	O
expected	O
BamHI	O
[	O
B	O
]	O
fragments	O
are	O
indicated	O
by	O
arrows	O
.	O

(	O
B	O
)	O
Southern	O
blot	O
analysis	O
of	O
mouse	O
genomic	O
DNA	O
.	O

The	O
expected	O
DNA	O
fragments	O
for	O
the	O
wild	O
-	O
type	O
allele	O
and	O
disrupted	O
allele	O
are	O
7	O
.	O
5	O
-	O
kb	O
and	O
2	O
.	O
5	O
-	O
kb	O
,	O
respectively	O
.	O

+	O
/	O
+	O
,	O
wild	O
-	O
type	O
;	O
+	O
/	O
-	O
,	O
heterozygote	O
;	O
-	O
/	O
-	O
,	O
homozygote	O
.	O

(	O
C	O
)	O
Western	O
blot	O
analysis	O
of	O
ADAM22	O
expression	O
in	O
the	O
mouse	O
cerebellum	O
.	O

Absence	O
of	O
ADAM22	O
protein	B-CHEBI
in	O
the	O
Adam22	O
(	O
-	O
/	O
-	O
)	O
mutant	O
cerebellum	O
was	O
shown	O
using	O
anti	O
-	O
ADAM22	O
-	O
cp	O
(	O
cytoplasmic	O
domain	O
)	O
polyclonal	O
antibody	O
.	O

Figure	O
2	O

Uncoordinated	O
movements	O
in	O
the	O
Adam22	O
(	O
-	O
/	O
-	O
)	O
mice	O
at	O
postnatal	O
day	O
18	O
(	O
P18	O
)	O
.	O

(	O
A	O
)	O
Adam22	O
(	O
-	O
/	O
-	O
)	O
mice	O
were	O
smaller	O
than	O
their	O
wild	O
-	O
type	O
(	O
+	O
/	O
+	O
)	O
littermates	O
.	O

(	O
B	O
,	O
C	O
)	O
Adam22	O
(	O
-	O
/	O
-	O
)	O
mice	O
at	O
P18	O
were	O
unable	O
to	O
support	O
themselves	O
on	O
their	O
hindlimbs	O
.	O

Figure	O
3	O

Neuronal	O
ADAM22	O
mRNA	B-CHEBI
expression	O
in	O
the	O
CNS	O
.	O

To	O
determine	O
the	O
ADAM22	O
mRNA	B-CHEBI
distribution	O
,	O
in	O
situ	O
hybridisation	O
analysis	O
using	O
35S	B-CHEBI
-	O
labeled	O
probe	O
was	O
performed	O
.	O

Coronal	O
(	O
A	O
,	O
B	O
)	O
and	O
sagittal	O
(	O
C	O
,	O
D	O
)	O
sections	O
of	O
the	O
mouse	O
brain	O
and	O
spinal	O
cord	O
(	O
E	O
)	O
were	O
shown	O
.	O

Using	O
the	O
antisense	O
probe	O
(	O
A	O
,	O
C	O
)	O
,	O
strong	O
signals	O
were	O
obtained	O
,	O
especially	O
in	O
the	O
hippocampus	O
and	O
the	O
cerebellum	O
,	O
while	O
no	O
signals	O
was	O
detected	O
by	O
the	O
sense	O
probe	O
(	O
B	O
,	O
D	O
)	O
.	O

In	O
the	O
spinal	O
cord	O
,	O
autoradiograms	O
of	O
ADAM22	O
mRNA	B-CHEBI
was	O
detected	O
in	O
the	O
grey	O
matter	O
(	O
E	O
)	O
.	O

Figure	O
4	O

Normal	O
neurodevelopment	O
in	O
the	O
CNS	O
of	O
ADAM22	O
-	O
deficient	O
mice	O
.	O

Sagittal	O
sections	O
of	O
the	O
cerebellum	O
from	O
wild	O
-	O
type	O
mice	O
(	O
A	O
,	O
C	O
,	O
E	O
,	O
G	O
)	O
and	O
homozygous	O
mutants	O
(	O
B	O
,	O
D	O
,	O
F	O
,	O
H	O
)	O
at	O
postnatal	O
day	O
13	O
were	O
stained	O
for	O
calbindin	O
(	O
C	O
and	O
D	O
;	O
green	O
)	O
or	O
MBP	O
(	O
G	O
and	O
H	O
;	O
green	O
)	O
,	O
and	O
were	O
counterstained	O
with	O
DAPI	O
(	O
A	O
,	O
B	O
,	O
E	O
,	O
F	O
;	O
blue	O
)	O
.	O

Significant	O
abnormalities	O
were	O
not	O
observed	O
in	O
the	O
homozygotes	O
.	O

Hippocampal	O
neurons	O
were	O
stained	O
by	O
anti	O
-	O
Neu	O
N	O
antibody	O
(	O
I	O
and	O
J	O
)	O
.	O

Spinal	O
myelin	O
was	O
analysed	O
by	O
MBP	O
staining	O
(	O
K	O
and	O
L	O
)	O
.	O

These	O
analyses	O
showed	O
no	O
obvious	O
differences	O
between	O
homozygotes	O
(	O
J	O
,	O
L	O
)	O
and	O
wild	O
-	O
type	O
littermates	O
(	O
I	O
,	O
K	O
)	O
.	O

Bar	O
:	O
(	O
A	O
,	O
B	O
,	O
E	O
,	O
F	O
)	O
100	O
mu	O
m	O
,	O
(	O
K	O
,	O
L	O
)	O
250	O
mu	O
m	O
.	O

Figure	O
5	O

Hypomyelination	O
of	O
peripheral	O
nerves	O
in	O
ADAM22	O
-	O
deficient	O
mice	O
.	O

Epon	O
embedded	O
semithin	O
cross	O
-	O
sections	O
of	O
the	O
sciatic	O
nerves	O
(	O
A	O
,	O
B	O
)	O
,	O
the	O
trigeminal	O
nerves	O
(	O
C	O
,	O
D	O
)	O
and	O
the	O
spinal	O
cord	O
[	O
lateral	O
funiculus	O
]	O
(	O
E	O
,	O
F	O
)	O
of	O
the	O
indicated	O
genotypes	O
at	O
postnatal	O
day	O
10	O
were	O
stained	O
with	O
toluidine	O
blue	O
.	O

Note	O
that	O
the	O
ADAM22	O
-	O
deficient	O
mouse	O
shows	O
thin	O
myelin	O
or	O
lack	O
of	O
myelin	O
in	O
the	O
peripheral	O
nerve	O
fibres	O
(	O
B	O
,	O
D	O
)	O
,	O
but	O
the	O
spinal	O
myelinated	O
fibres	O
are	O
intact	O
(	O
F	O
)	O
.	O

Figure	O
6	O

Electron	B-CHEBI
microscopic	O
analysis	O
of	O
sciatic	O
nerves	O
.	O

Electron	B-CHEBI
micrographs	O
of	O
the	O
sciatic	O
nerves	O
from	O
Adam22	O
+	O
/	O
-	O
(	O
A	O
)	O
and	O
Adam22	O
-	O
/	O
-	O
(	O
B	O
)	O
mice	O
at	O
postnatal	O
day	O
10	O
are	O
shown	O
.	O

In	O
the	O
heterozygote	O
(	O
A	O
)	O
,	O
thick	O
myelin	O
was	O
formed	O
,	O
while	O
no	O
myelin	O
was	O
formed	O
in	O
the	O
ADAM22	O
-	O
deficient	O
mouse	O
(	O
B	O
)	O
.	O

The	O
axons	O
looked	O
normal	O
in	O
each	O
genotype	O
.	O

Figure	O
7	O

Marked	O
delay	O
in	O
differentiation	O
of	O
the	O
mutant	O
Schwann	O
cells	O
.	O

Transverse	O
sections	O
of	O
the	O
sciatic	O
nerves	O
of	O
the	O
indicated	O
genotypes	O
at	O
postnatal	O
day	O
13	O
were	O
stained	O
for	O
MBP	O
(	O
C	O
and	O
D	O
;	O
green	O
)	O
or	O
S100	O
(	O
E	O
and	O
F	O
;	O
red	O
)	O
,	O
and	O
were	O
counterstained	O
with	O
DAPI	O
(	O
A	O
,	O
B	O
;	O
blue	O
)	O
.	O

In	O
the	O
mutant	O
sciatic	O
nerve	O
,	O
density	O
of	O
DAPI	O
-	O
signals	O
were	O
greatly	O
increased	O
(	O
B	O
)	O
compared	O
with	O
those	O
of	O
the	O
wild	O
-	O
type	O
(	O
A	O
)	O
.	O

Bar	O
:	O
(	O
A	O
,	O
B	O
)	O
=	O
50	O
mu	O
m	O
.	O

Figure	O
8	O

Adam22	O
gene	O
structure	O
and	O
tissue	O
specific	O
transcripts	O
.	O

(	O
A	O
)	O
RT	O
-	O
PCR	O
analysis	O
.	O

Amplified	O
DNA	O
fragments	O
were	O
analysed	O
by	O
1	O
%	O
agarose	B-CHEBI
gel	O
electrophoresis	O
.	O

Lanes	O
1	O
.	O

100	O
bp	O
DNA	O
ladder	O
;	O
2	O
.	O
cerebellum	O
;	O
3	O
.	O
spinal	O
cord	O
;	O
4	O
.	O
dorsal	O
root	O
ganglion	O
;	O
5	O
.	O
sciatic	O
nerve	O
;	O
6	O
.	O
cultured	O
Schwann	O
cells	O
;	O
7	O
.	O
distilled	O
water	B-CHEBI
(	O
B	O
)	O
Exon	O
organization	O
of	O
the	O
mouse	O
Adam22	O
gene	O
is	O
illustrated	O
.	O

Boxes	O
indicate	O
exons	O
.	O

The	O
G01	O
transcript	O
(	O
orthologous	O
to	O
the	O
human	O
ADAM22	O
isoform	O
1	O
transcript	O
)	O
is	O
composed	O
of	O
grey	O
boxes	O
.	O

Boxes	O
in	O
black	O
indicate	O
non	O
-	O
coding	O
region	O
.	O

(	O
C	O
)	O
Summary	O
of	O
the	O
isolated	O
clones	O
.	O

The	O
nucleotide	B-CHEBI
sequence	O
data	O
have	O
been	O
deposited	O
with	O
the	O
DDBJ	O
/	O
EMBL	O
/	O
GenBank	O
Data	O
Libraries	O
under	O
the	O
accession	O
numbers	O
described	O
in	O
the	O
table	O
.	O

(	O
D	O
)	O
Number	O
of	O
clones	O
isolated	O
from	O
each	O
tissue	O
is	O
summarized	O
.	O

Cb	O
;	O
cerebellum	O
,	O
Sp	O
;	O
spinal	O
cord	O
,	O
DRG	O
;	O
dorsal	O
root	O
ganglion	O
,	O
SN	O
;	O
sciatic	O
nerve	O
,	O
cSC	O
;	O
cultured	O
Schwann	O
cells	O
.	O

Table	O
1	O

Genotyping	O
of	O
the	O
progeny	O
of	O
Adam22	O
heterozygous	O
intercrosses	O
.	O

From	O
heterozygous	O
intercrosses	O
,	O
78	O
mice	O
were	O
produced	O
.	O

Numbers	O
of	O
mice	O
in	O
each	O
genotype	O
were	O
counted	O
on	O
postnatal	O
day	O
10	O
,	O
15	O
and	O
20	O
.	O

No	O
homozygotes	O
were	O
survived	O
more	O
than	O
postnatal	O
day	O
20	O
.	O

+	O
/	O
+	O
,	O
wild	O
-	O
type	O
;	O
+	O
/	O
-	O
,	O
heterozygote	O
;	O
-	O
/	O
-	O
,	O
homozygote	O
.	O

Table	O
2	O

Body	O
weight	O
of	O
progeny	O
at	O
postnatal	O
day	O
10	O
.	O
5	O

+	O
/	O
+	O
,	O
wild	O
-	O
type	O
;	O
+	O
/	O
-	O
,	O
heterozygote	O
;	O
-	O
/	O
-	O
,	O
homozygote	O
.	O

Potential	O
genetic	O
modifiers	O
of	O
the	O
cystic	O
fibrosis	O
intestinal	O
inflammatory	O
phenotype	O
on	O
mouse	O
chromosomes	O
1	O
,	O
9	O
,	O
and	O
10	O

Abstract	O

Background	O

Although	O
cystic	O
fibrosis	O
is	O
caused	O
by	O
mutations	O
in	O
the	O
cystic	O
fibrosis	O
transmembrane	O
conductance	O
regulator	O
(	O
CFTR	O
)	O
gene	O
,	O
the	O
severity	O
of	O
disease	O
is	O
highly	O
variable	O
indicating	O
the	O
influence	O
of	O
modifier	O
genes	O
.	O

The	O
intestines	O
of	O
Cftr	O
deficient	O
mice	O
(	O
CF	O
mice	O
:	O
Cftrtm1Unc	O
)	O
are	O
prone	O
to	O
obstruction	O
by	O
excessive	O
mucus	O
accumulation	O
and	O
are	O
used	O
as	O
a	O
model	O
of	O
meconium	O
ileus	O
and	O
distal	O
intestinal	O
obstruction	O
syndrome	O
.	O

This	O
phenotype	O
is	O
strongly	O
dependent	O
on	O
the	O
genetic	O
background	O
of	O
the	O
mice	O
.	O

On	O
the	O
C57Bl	O
/	O
6	O
background	O
,	O
the	O
majority	O
of	O
CF	O
mice	O
cannot	O
survive	O
on	O
solid	O
mouse	O
chow	O
,	O
have	O
inflammation	O
of	O
the	O
small	O
intestine	O
,	O
and	O
are	O
about	O
30	O
%	O
smaller	O
than	O
wild	O
type	O
littermates	O
.	O

In	O
this	O
work	O
potential	O
modifier	O
loci	O
of	O
the	O
CF	O
intestinal	O
phenotype	O
were	O
identified	O
.	O

Results	O

CF	O
mice	O
on	O
a	O
mixed	O
genetic	O
background	O
(	O
95	O
%	O
C57Bl	O
/	O
6	O
and	O
5	O
%	O
129Sv	O
)	O
were	O
compared	O
to	O
CF	O
mice	O
congenic	O
on	O
the	O
C57Bl	O
/	O
6	O
background	O
for	O
several	O
parameters	O
of	O
the	O
intestinal	O
CF	O
phenotype	O
.	O

CF	O
mice	O
on	O
the	O
mixed	O
background	O
exhibit	O
significantly	O
greater	O
survival	O
when	O
fed	O
dry	O
mouse	O
chow	O
,	O
have	O
reduced	O
intestinal	O
inflammation	O
as	O
measured	O
by	O
quantitative	O
RT	O
-	O
PCR	O
for	O
marker	O
genes	O
,	O
have	O
near	O
normal	O
body	O
weight	O
gain	O
,	O
and	O
have	O
reduced	O
mucus	O
accumulation	O
in	O
the	O
intestinal	O
crypts	O
.	O

There	O
was	O
an	O
indication	O
of	O
a	O
gender	O
effect	O
for	O
body	O
weight	O
gain	O
:	O
males	O
did	O
not	O
show	O
a	O
significant	O
improvement	O
at	O
4	O
weeks	O
of	O
age	O
,	O
but	O
were	O
of	O
normal	O
weight	O
at	O
8	O
weeks	O
,	O
while	O
females	O
showed	O
improvement	O
at	O
both	O
4	O
and	O
8	O
weeks	O
.	O

By	O
a	O
preliminary	O
genome	O
-	O
wide	O
PCR	O
allele	O
scanning	O
,	O
three	O
regions	O
were	O
found	O
to	O
be	O
potentially	O
associated	O
with	O
the	O
milder	O
phenotype	O
.	O

One	O
on	O
chr	O
.	O
1	O
,	O
defined	O
by	O
marker	O
D1Mit36	O
,	O
one	O
on	O
chr	O
.	O

9	O
defined	O
by	O
marker	O
D9Mit90	O
,	O
and	O
one	O
on	O
chr	O
.	O

10	O
,	O
defined	O
by	O
marker	O
D10Mit14	O
.	O

Conclusion	O

Potential	O
modifier	O
regions	O
were	O
found	O
that	O
have	O
a	O
positive	O
impact	O
on	O
the	O
inflammatory	O
phenotype	O
of	O
the	O
CF	O
mouse	O
small	O
intestine	O
and	O
animal	O
survival	O
.	O

Identification	O
of	O
polymorphisms	O
in	O
specific	O
genes	O
in	O
these	O
regions	O
should	O
provide	O
important	O
new	O
information	O
about	O
genetic	O
modifiers	O
of	O
the	O
CF	O
intestinal	O
phenotype	O
.	O

Background	O

Cystic	O
fibrosis	O
(	O
CF	O
)	O
is	O
caused	O
by	O
mutations	O
in	O
the	O
cystic	O
fibrosis	O
transmembrane	O
conductance	O
regulator	O
(	O
CFTR	O
)	O
gene	O
[	O
1	O
]	O
.	O

Different	O
mutations	O
have	O
a	O
range	O
of	O
effects	O
on	O
the	O
levels	O
of	O
CFTR	O
protein	B-CHEBI
and	O
its	O
proper	O
functioning	O
in	O
epithelial	O
transport	O
of	O
Cl	B-CHEBI
-	I-CHEBI
and	O
HCO3	B-CHEBI
-	I-CHEBI
[	O
2	O
,	O
3	O
]	O
.	O

The	O
severity	O
of	O
the	O
pancreatic	O
phenotype	O
in	O
human	O
CF	O
is	O
well	O
correlated	O
with	O
the	O
extent	O
of	O
impaired	O
CFTR	O
function	O
caused	O
by	O
specific	O
mutations	O
.	O

Loss	O
of	O
CFTR	O
function	O
results	O
in	O
destruction	O
of	O
the	O
exocrine	O
tissue	O
and	O
eventual	O
pancreatic	O
insufficiency	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
effects	O
of	O
CF	O
on	O
organs	O
including	O
the	O
airways	O
and	O
intestines	O
is	O
less	O
well	O
correlated	O
with	O
specific	O
CFTR	O
mutations	O
and	O
their	O
effects	O
on	O
CFTR	O
protein	B-CHEBI
function	O
[	O
4	O
-	O
8	O
]	O
.	O

This	O
indicates	O
that	O
other	O
genes	O
are	O
likely	O
to	O
be	O
important	O
as	O
modifiers	O
of	O
the	O
CF	O
phenotype	O
.	O

With	O
the	O
exception	O
of	O
pancreatic	O
insufficiency	O
resulting	O
in	O
impaired	O
digestion	O
,	O
other	O
aspects	O
of	O
CF	O
are	O
less	O
readily	O
related	O
to	O
loss	O
of	O
CFTR	O
function	O
.	O

Nutritional	O
problems	O
can	O
persist	O
even	O
with	O
adequate	O
oral	O
enzyme	O
supplementation	O
[	O
9	O
]	O
and	O
neutralization	O
of	O
gastric	O
acid	B-CHEBI
to	O
improve	O
lipase	O
function	O
[	O
10	O
]	O
,	O
and	O
may	O
involve	O
both	O
impaired	O
digestion	O
and	O
absorption	O
of	O
nutrients	B-CHEBI
[	O
11	O
]	O
.	O

Inadequate	O
absorption	O
or	O
assimilation	O
of	O
nutrients	B-CHEBI
appears	O
to	O
be	O
of	O
greater	O
importance	O
because	O
even	O
with	O
adequate	O
oral	O
enzyme	O
supplementation	O
nutrition	O
is	O
rarely	O
fully	O
corrected	O
[	O
11	O
]	O
.	O

There	O
is	O
also	O
excessive	O
mucus	O
accumulation	O
in	O
the	O
CF	O
intestine	O
,	O
and	O
inappropriate	O
inflammation	O
is	O
common	O
[	O
12	O
]	O
.	O

Mucus	O
is	O
involved	O
in	O
obstruction	O
of	O
the	O
gut	O
which	O
occurs	O
frequently	O
in	O
CF	O
infants	O
(	O
called	O
meconium	O
ileus	O
,	O
MI	O
)	O
and	O
adults	O
(	O
called	O
distal	O
intestinal	O
obstruction	O
syndrome	O
,	O
DIOS	O
)	O
[	O
11	O
,	O
13	O
]	O
.	O

And	O
,	O
similar	O
to	O
CF	O
airways	O
,	O
there	O
is	O
also	O
an	O
inflammation	O
of	O
the	O
CF	O
intestines	O
[	O
14	O
,	O
15	O
]	O
.	O

These	O
changes	O
are	O
less	O
directly	O
related	O
to	O
specific	O
mutations	O
in	O
the	O
CFTR	O
gene	O
and	O
are	O
likely	O
related	O
to	O
other	O
differences	O
in	O
individual	O
genetic	O
makeup	O
.	O

Previous	O
work	O
using	O
human	O
patients	O
and	O
genetically	O
altered	O
mice	O
has	O
identified	O
some	O
modifier	O
genes	O
and	O
have	O
advanced	O
our	O
understanding	O
of	O
CF	O
pathophysiology	O
[	O
4	O
]	O
.	O

In	O
one	O
study	O
using	O
CF	O
mice	O
on	O
different	O
genetic	O
backgrounds	O
,	O
a	O
region	O
on	O
mouse	O
chromosome	O
7	O
was	O
shown	O
to	O
ameliorate	O
intestinal	O
blockage	O
and	O
the	O
effect	O
was	O
in	O
part	O
due	O
to	O
a	O
calcium	B-CHEBI
-	O
regulated	O
Cl	B-CHEBI
-	O
channel	O
which	O
compensated	O
for	O
loss	O
of	O
CFTR	O
function	O
[	O
16	O
,	O
17	O
]	O
.	O

Marker	O
haplotypes	O
of	O
the	O
syntenic	O
region	O
of	O
human	O
chromosome	O
19q13	O
were	O
also	O
shown	O
to	O
be	O
associated	O
with	O
the	O
risk	O
of	O
MI	O
in	O
CF	O
patients	O
[	O
18	O
]	O
.	O

In	O
other	O
work	O
,	O
a	O
region	O
on	O
mouse	O
chr	O
.	O

6	O
was	O
strongly	O
associated	O
with	O
lung	O
inflammation	O
,	O
consisting	O
of	O
mononuclear	O
cell	O
interstitial	O
infiltration	O
and	O
fibrosis	O
in	O
CF	O
mouse	O
airways	O
;	O
and	O
other	O
loci	O
on	O
chr	O
.	O

1	O
,	O
2	O
,	O
10	O
,	O
and	O
17	O
were	O
also	O
linked	O
to	O
the	O
airway	O
phenotype	O
[	O
19	O
]	O
.	O

In	O
this	O
work	O
,	O
CF	O
mice	O
on	O
a	O
mixed	O
strain	O
background	O
were	O
found	O
to	O
have	O
a	O
less	O
severe	O
CF	O
phenotype	O
compared	O
to	O
CF	O
mice	O
congenic	O
on	O
the	O
C57Bl	O
/	O
6	O
background	O
.	O

There	O
were	O
no	O
differences	O
in	O
the	O
pancreatic	O
phenotype	O
comparing	O
CF	O
mice	O
on	O
the	O
different	O
backgrounds	O
[	O
20	O
]	O
.	O

However	O
,	O
mice	O
on	O
the	O
mixed	O
background	O
seemed	O
more	O
robust	O
than	O
CF	O
mice	O
on	O
the	O
B6	O
background	O
which	O
prompted	O
us	O
to	O
characterize	O
them	O
in	O
greater	O
detail	O
.	O

Genome	O
wide	O
allele	O
scanning	O
was	O
used	O
to	O
begin	O
identification	O
of	O
regions	O
associated	O
with	O
the	O
less	O
severe	O
intestinal	O
phenotype	O
.	O

Future	O
identification	O
of	O
specific	O
genes	O
should	O
further	O
our	O
understanding	O
of	O
the	O
complex	O
intestinal	O
CF	O
phenotype	O
.	O

Results	O
and	O
discussion	O

CF	O
mice	O
on	O
the	O
mixed	O
background	O
have	O
improved	O
body	O
weight	O
gain	O

Body	O
mass	O
was	O
recorded	O
for	O
male	O
and	O
female	O
mice	O
at	O
4	O
and	O
8	O
weeks	O
of	O
age	O
.	O

On	O
the	O
B6	O
background	O
,	O
female	O
and	O
male	O
mice	O
are	O
about	O
30	O
%	O
smaller	O
than	O
wild	O
type	O
mice	O
at	O
both	O
4	O
and	O
8	O
weeks	O
of	O
age	O
(	O
Fig	O
.	O
1A	O
,	O
B	O
)	O
.	O

By	O
comparison	O
,	O
female	O
CF	O
mice	O
on	O
the	O
mixed	O
background	O
were	O
not	O
significantly	O
smaller	O
than	O
wild	O
type	O
mice	O
at	O
4	O
weeks	O
of	O
age	O
(	O
Fig	O
.	O
1A	O
)	O
.	O

The	O
improved	O
body	O
weight	O
of	O
female	O
CF	O
mice	O
on	O
the	O
mixed	O
background	O
was	O
maintained	O
at	O
8	O
weeks	O
of	O
age	O
.	O

Male	O
CF	O
mice	O
on	O
the	O
mixed	O
background	O
at	O
4	O
weeks	O
of	O
age	O
were	O
significantly	O
smaller	O
than	O
wild	O
type	O
and	O
not	O
significantly	O
larger	O
than	O
CF	O
mice	O
congenic	O
on	O
the	O
B6	O
background	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

By	O
8	O
weeks	O
of	O
age	O
,	O
CF	O
males	O
on	O
the	O
mixed	O
background	O
were	O
12	O
%	O
smaller	O
but	O
this	O
was	O
not	O
significantly	O
different	O
compared	O
to	O
wild	O
type	O
mice	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

Figure	O
1	O

Effect	O
of	O
genetic	O
background	O
on	O
body	O
weights	O
of	O
CF	O
mice	O
.	O

(	O
A	O
)	O
Female	O
and	O
(	O
B	O
)	O
male	O
mice	O
were	O
weighed	O
at	O
4	O
and	O
8	O
weeks	O
of	O
age	O
.	O

Data	O
are	O
means	O
+/-	O
SEM	O
.	O

(	O
*	O
)	O
P	O
<	O
0	O
.	O
001	O
vs	O
other	O
three	O
groups	O
by	O
ANOVA	O
with	O
a	O
post	O
-	O
hoc	O
Tukey	O
'	O
s	O
test	O
.	O

There	O
were	O
no	O
significant	O
differences	O
for	O
any	O
of	O
the	O
other	O
comparisons	O
.	O

Data	O
were	O
obtained	O
from	O
:	O
65	O
wild	O
type	O
and	O
26	O
CF	O
B6	O
females	O
,	O
36	O
wild	O
type	O
and	O
8	O
CF	O
mixed	O
background	O
females	O
,	O
68	O
wild	O
type	O
and	O
30	O
CF	O
B6	O
males	O
,	O
and	O
37	O
wild	O
type	O
and	O
6	O
CF	O
mixed	O
background	O
males	O
.	O

CF	O
mice	O
on	O
the	O
mixed	O
background	O
have	O
reduced	O
expression	O
of	O
inflammatory	O
markers	O

Previous	O
work	O
showed	O
that	O
CF	O
mice	O
on	O
the	O
B6	O
background	O
have	O
an	O
innate	O
-	O
type	O
inflammation	O
of	O
the	O
small	O
intestine	O
[	O
21	O
]	O
.	O

To	O
determine	O
whether	O
the	O
mixed	O
genetic	O
background	O
affected	O
expression	O
of	O
inflammatory	O
marker	O
genes	O
,	O
quantitative	O
,	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
was	O
used	O
to	O
measure	O
gene	O
expression	O
.	O

Expression	O
of	O
the	O
following	O
genes	O
was	O
compared	O
in	O
wild	O
type	O
and	O
CF	O
mice	O
on	O
the	O
different	O
genetic	O
backgrounds	O
.	O

Mast	O
cell	O
protease	O
2	O
(	O
Mcpt2	O
)	O
is	O
a	O
marker	O
of	O
differentiated	O
mast	O
cells	O
[	O
22	O
]	O
and	O
mast	O
cells	O
are	O
more	O
abundant	O
in	O
the	O
B6	O
CF	O
mouse	O
intestine	O
.	O

Leucine	B-CHEBI
-	O
rich	O
alpha	O
2	O
glycoprotein	O
(	O
Lrg1	O
,	O
[	O
23	O
]	O
)	O
is	O
a	O
marker	O
of	O
differentiating	O
neutrophils	O
,	O
which	O
are	O
more	O
numerous	O
in	O
the	O
B6	O
CF	O
mouse	O
intestine	O
.	O

The	O
same	O
gene	O
is	O
also	O
known	O
as	O
leucine	B-CHEBI
-	O
rich	O
high	O
endothelial	O
cell	O
glycoprotein	O
(	O
Lrhg	O
)	O
and	O
has	O
been	O
shown	O
to	O
be	O
a	O
marker	O
of	O
high	O
endothelial	O
venules	O
(	O
HEV	O
)	O
[	O
24	O
]	O
which	O
increase	O
in	O
tissues	O
during	O
inflammation	O
[	O
25	O
,	O
26	O
]	O
.	O

Hematopoietic	O
cell	O
transcript	O
1	O
(	O
HemT1	O
,	O
[	O
27	O
]	O
)	O
is	O
a	O
marker	O
of	O
blood	O
cell	O
proliferation	O
and	O
its	O
expression	O
is	O
strongly	O
elevated	O
in	O
the	O
B6	O
CF	O
mouse	O
small	O
intestine	O
.	O

Serum	O
amyloid	O
A3	O
(	O
SAA3	O
,	O
[	O
28	O
]	O
)	O
is	O
an	O
acute	O
phase	O
gene	O
and	O
its	O
expression	O
in	O
villus	O
epithelial	O
cells	O
is	O
increased	O
in	O
the	O
B6	O
CF	O
intestine	O
.	O

Suppressor	O
of	O
cytokine	O
signaling	O
3	O
(	O
SOCS3	O
,	O
[	O
29	O
]	O
)	O
is	O
an	O
anti	O
-	O
inflammatory	O
gene	O
that	O
interacts	O
with	O
the	O
JAK	O
-	O
STAT	O
pathway	O
and	O
its	O
expression	O
in	O
increased	O
in	O
the	O
B6	O
CF	O
intestine	O
.	O

Muclin	O
(	O
also	O
known	O
as	O
dmbt1	O
,	O
[	O
30	O
]	O
)	O
expression	O
is	O
upregulated	O
in	O
the	O
B6	O
CF	O
intestine	O
;	O
it	O
is	O
a	O
cell	O
surface	O
glycoprotein	O
postulated	O
to	O
be	O
an	O
epithelial	O
protective	O
molecule	B-CHEBI
[	O
21	O
,	O
31	O
]	O
.	O

Consistent	O
with	O
previous	O
results	O
,	O
Mcpt2	O
was	O
increased	O
in	O
CF	O
mice	O
on	O
the	O
B6	O
background	O
by	O
over	O
9	O
-	O
fold	O
compared	O
to	O
wild	O
type	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

By	O
contrast	O
,	O
there	O
was	O
not	O
a	O
significant	O
difference	O
in	O
Mcpt2	O
expression	O
between	O
CF	O
and	O
wild	O
type	O
on	O
the	O
mixed	O
background	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

Lrg1	O
/	O
Lrhg	O
expression	O
was	O
increased	O
more	O
than	O
20	O
-	O
fold	O
in	O
CF	O
mice	O
on	O
the	O
B6	O
background	O
compared	O
to	O
wild	O
type	O
,	O
but	O
there	O
was	O
no	O
significant	O
difference	O
between	O
CF	O
and	O
wild	O
type	O
on	O
the	O
mixed	O
background	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

SAA3	O
mRNA	B-CHEBI
was	O
about	O
3	O
.	O
5	O
-	O
fold	O
increased	O
in	O
CF	O
mice	O
on	O
the	O
B6	O
background	O
,	O
but	O
was	O
not	O
significantly	O
different	O
compared	O
to	O
wild	O
type	O
on	O
the	O
mixed	O
background	O
(	O
Fig	O
.	O
2C	O
)	O
.	O

SOCS3	O
was	O
more	O
than	O
2	O
-	O
fold	O
increased	O
in	O
CF	O
mice	O
on	O
the	O
B6	O
background	O
compared	O
to	O
wild	O
type	O
,	O
and	O
on	O
the	O
mixed	O
background	O
was	O
only	O
1	O
.	O
5	O
-	O
fold	O
greater	O
than	O
wild	O
type	O
,	O
and	O
the	O
difference	O
was	O
not	O
significant	O
(	O
Fig	O
.	O
2D	O
)	O
.	O

Muclin	O
is	O
overexpressed	O
almost	O
3	O
-	O
fold	O
in	O
the	O
CF	O
intestine	O
on	O
the	O
B6	O
background	O
,	O
but	O
on	O
the	O
mixed	O
background	O
the	O
expression	O
level	O
in	O
CF	O
mice	O
was	O
not	O
significantly	O
different	O
than	O
wild	O
type	O
(	O
Fig	O
.	O
2E	O
)	O
.	O

Finally	O
,	O
HemT1	O
was	O
overexpressed	O
almost	O
20	O
-	O
fold	O
in	O
B6	O
CF	O
mice	O
compared	O
to	O
wild	O
type	O
,	O
and	O
on	O
the	O
mixed	O
background	O
the	O
CF	O
expression	O
level	O
was	O
not	O
statistically	O
different	O
from	O
wild	O
type	O
(	O
Fig	O
.	O
2F	O
)	O
.	O

Figure	O
2	O

Effect	O
of	O
genetic	O
background	O
on	O
inflammatory	O
gene	O
expression	O
in	O
CF	O
mouse	O
small	O
intestine	O
.	O

RNA	O
expression	O
levels	O
were	O
determined	O
by	O
quantitative	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
using	O
gene	O
-	O
specific	O
primers	O
.	O

Data	O
are	O
expressed	O
relative	O
to	O
GAPDH	O
mRNA	B-CHEBI
,	O
which	O
does	O
not	O
vary	O
between	O
wild	O
type	O
and	O
CF	O
mice	O
.	O

Data	O
are	O
means	O
+/-	O
SEM	O
.	O

(	O
*	O
)	O
CF	O
vs	O
wild	O
type	O
on	O
the	O
B6	O
background	O
,	O
P	O
<	O
0	O
.	O
005	O
;	O
(	O
+	O
)	O
CF	O
on	O
the	O
mixed	O
background	O
vs	O
CF	O
on	O
the	O
B6	O
background	O
,	O
P	O
<	O
0	O
.	O
05	O
by	O
ANOVA	O
with	O
a	O
post	O
-	O
hoc	O
Tukey	O
'	O
s	O
test	O
.	O

There	O
were	O
no	O
significant	O
differences	O
for	O
any	O
of	O
the	O
6	O
genes	O
comparing	O
:	O
wild	O
type	O
B6	O
mice	O
vs	O
wild	O
type	O
mixed	O
background	O
;	O
or	O
CF	O
mice	O
on	O
the	O
mixed	O
background	O
vs	O
wild	O
type	O
on	O
either	O
background	O
.	O

There	O
were	O
8	O
-	O
11	O
samples	O
analyzed	O
per	O
group	O
for	O
each	O
gene	O
.	O

Because	O
of	O
the	O
gender	O
differences	O
in	O
body	O
weight	O
,	O
the	O
gene	O
expression	O
data	O
were	O
analyzed	O
by	O
gender	O
but	O
there	O
was	O
no	O
significant	O
difference	O
between	O
females	O
and	O
males	O
.	O

With	O
the	O
limited	O
number	O
of	O
animals	O
,	O
there	O
was	O
also	O
no	O
evidence	O
for	O
imprinting	O
.	O

CF	O
mice	O
on	O
the	O
mixed	O
background	O
have	O
less	O
intestinal	O
mucus	O
accumulation	O

The	O
most	O
striking	O
histological	O
difference	O
in	O
the	O
CF	O
mouse	O
small	O
intestine	O
is	O
the	O
accumulation	O
of	O
mucus	O
in	O
intestinal	O
crypts	O
which	O
is	O
associated	O
with	O
the	O
lethal	O
obstruction	O
that	O
results	O
in	O
death	O
of	O
these	O
mice	O
on	O
a	O
standard	O
solid	O
chow	O
diet	O
[	O
32	O
]	O
.	O

Using	O
periodic	B-CHEBI
acid	I-CHEBI
Schiff	O
'	O
s	O
staining	O
for	O
neutral	O
mucins	O
,	O
histological	O
analysis	O
of	O
small	O
intestine	O
tissues	O
was	O
performed	O
.	O

The	O
wild	O
type	O
small	O
intestine	O
on	O
both	O
the	O
B6	O
and	O
the	O
mixed	O
genetic	O
backgrounds	O
were	O
similar	O
.	O

The	O
intestinal	O
crypts	O
were	O
very	O
small	O
with	O
only	O
traces	O
of	O
PAS	O
-	O
reactivity	O
in	O
the	O
lumen	O
(	O
Fig	O
.	O
3A	O
and	O
3C	O
,	O
respectively	O
)	O
.	O

The	O
surfaces	O
of	O
the	O
villus	O
epithelium	O
were	O
moderately	O
stained	O
and	O
goblet	O
cells	O
were	O
strongly	O
stained	O
in	O
the	O
wild	O
type	O
tissues	O
.	O

In	O
contrast	O
,	O
the	O
intestine	O
of	O
CF	O
mice	O
on	O
the	O
B6	O
genetic	O
background	O
exhibited	O
greatly	O
dilated	O
crypts	O
filled	O
with	O
PAS	O
-	O
reactive	O
mucus	O
(	O
Fig	O
.	O
3B	O
)	O
.	O

CF	O
mice	O
on	O
the	O
mixed	O
background	O
had	O
less	O
mucus	O
accumulation	O
than	O
CF	O
mice	O
on	O
the	O
B6	O
background	O
(	O
Fig	O
.	O
3D	O
-	O
F	O
)	O
.	O

The	O
amount	O
of	O
mucus	O
in	O
CF	O
mice	O
on	O
the	O
mixed	O
background	O
was	O
variable	O
from	O
mouse	O
to	O
mouse	O
.	O

In	O
some	O
mice	O
(	O
Fig	O
.	O
3D	O
)	O
,	O
only	O
occasional	O
crypts	O
had	O
accumulated	O
mucus	O
and	O
the	O
crypt	O
lumina	O
were	O
not	O
very	O
dilated	O
.	O

In	O
some	O
mice	O
there	O
was	O
more	O
mucus	O
in	O
the	O
crypts	O
(	O
Fig	O
.	O
3E	O
)	O
,	O
while	O
others	O
had	O
moderate	O
mucus	O
accumulation	O
(	O
Fig	O
.	O
3F	O
)	O
.	O

A	O
total	O
of	O
six	O
CF	O
mice	O
on	O
the	O
mixed	O
background	O
were	O
examined	O
histologically	O
,	O
and	O
three	O
had	O
little	O
mucus	O
,	O
one	O
had	O
some	O
mucus	O
,	O
and	O
two	O
had	O
moderate	O
amounts	O
of	O
mucus	O
.	O

Despite	O
the	O
variability	O
,	O
all	O
the	O
CF	O
mice	O
on	O
the	O
mixed	O
background	O
had	O
less	O
crypt	O
dilation	O
and	O
less	O
mucus	O
accumulation	O
compared	O
to	O
CF	O
mice	O
on	O
the	O
B6	O
background	O
.	O

Figure	O
3	O

Histological	O
appearance	O
of	O
the	O
small	O
intestine	O
of	O
wild	O
type	O
and	O
CF	O
mice	O
on	O
the	O
different	O
genetic	O
backgrounds	O
.	O

Tissue	O
was	O
paraffin	O
embedded	O
and	O
stained	O
with	O
PAS	O
for	O
neutral	O
mucins	O
.	O

The	O
sections	O
are	O
from	O
the	O
middle	O
portion	O
of	O
the	O
small	O
intestine	O
(	O
A	O
)	O
Wild	O
type	O
on	O
the	O
B6	O
background	O
.	O

(	O
B	O
)	O
CF	O
on	O
the	O
B6	O
background	O
.	O

(	O
C	O
)	O
Wild	O
type	O
on	O
the	O
mixed	O
background	O
.	O

(	O
D	O
-	O
F	O
)	O
CF	O
on	O
the	O
mixed	O
background	O
.	O

(	O
A	O
,	O
C	O
)	O
In	O
the	O
wild	O
type	O
tissue	O
from	O
both	O
backgrounds	O
,	O
the	O
crypts	O
are	O
small	O
and	O
have	O
narrow	O
lumina	O
(	O
arrows	O
)	O
.	O

(	O
B	O
)	O
In	O
the	O
CF	O
tissue	O
on	O
the	O
B6	O
background	O
,	O
the	O
crypt	O
lumina	O
are	O
greatly	O
dilated	O
and	O
filled	O
with	O
PAS	O
-	O
reactive	O
mucus	O
(	O
arrows	O
)	O
.	O

In	O
some	O
CF	O
mice	O
on	O
the	O
mixed	O
background	O
,	O
the	O
crypts	O
are	O
not	O
apparently	O
different	O
than	O
wild	O
type	O
(	O
D	O
)	O
,	O
and	O
the	O
crypts	O
are	O
normal	O
appearing	O
(	O
arrows	O
)	O
.	O

Some	O
CF	O
mice	O
on	O
the	O
mixed	O
background	O
had	O
mildly	O
affected	O
crypts	O
(	O
E	O
)	O
,	O
while	O
others	O
had	O
greater	O
crypt	O
dilation	O
and	O
mucus	O
accumulation	O
(	O
F	O
)	O
.	O

Overall	O
,	O
the	O
CF	O
mice	O
on	O
the	O
mixed	O
background	O
were	O
less	O
severely	O
affected	O
compared	O
to	O
those	O
on	O
the	O
B6	O
background	O
.	O

Thus	O
,	O
it	O
appears	O
that	O
whatever	O
the	O
nature	O
of	O
the	O
genetic	O
differences	O
between	O
the	O
two	O
background	O
strains	O
,	O
they	O
affect	O
secretion	O
and	O
accumulation	O
of	O
mucus	O
in	O
the	O
CF	O
small	O
intestine	O
.	O

To	O
determine	O
if	O
the	O
difference	O
could	O
be	O
accounted	O
for	O
by	O
altered	O
mucin	O
gene	O
expression	O
,	O
quantitative	O
RT	O
-	O
PCR	O
was	O
used	O
to	O
measure	O
mRNA	B-CHEBI
expression	O
of	O
the	O
intestinal	O
goblet	O
cell	O
mucin	O
gene	O
,	O
Muc2	O
.	O

In	O
wild	O
type	O
intestine	O
,	O
B6	O
mice	O
had	O
0	O
.	O
079	O
+	O
/	O
-	O
0	O
.	O
024	O
copies	O
of	O
Muc2	O
/	O
GAPDH	O
(	O
n	O
=	O
8	O
)	O
,	O
and	O
on	O
the	O
mixed	O
background	O
the	O
level	O
was	O
0	O
.	O
077	O
+	O
/	O
-	O
0	O
.	O
012	O
(	O
n	O
=	O
11	O
)	O
.	O

CF	O
mice	O
on	O
the	O
B6	O
background	O
had	O
0	O
.	O
059	O
+	O
/	O
-	O
0	O
.	O
024	O
copies	O
of	O
Muc2	O
mRNA	B-CHEBI
per	O
GAPDH	O
(	O
n	O
=	O
11	O
)	O
,	O
and	O
on	O
the	O
mixed	O
background	O
the	O
level	O
was	O
0	O
.	O
056	O
+	O
/	O
-	O
0	O
.	O
010	O
(	O
n	O
=	O
11	O
)	O
.	O

Despite	O
the	O
increased	O
mucus	O
accumulation	O
in	O
CF	O
,	O
there	O
is	O
a	O
slight	O
decrease	O
in	O
Muc2	O
mRNA	B-CHEBI
in	O
the	O
CF	O
small	O
intestine	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
,	O
as	O
previously	O
reported	O
[	O
33	O
]	O
.	O

However	O
,	O
the	O
milder	O
CF	O
phenotype	O
on	O
the	O
mixed	O
background	O
,	O
which	O
includes	O
less	O
mucus	O
accumulation	O
,	O
does	O
not	O
involve	O
decreased	O
mucin	O
gene	O
expression	O
.	O

CF	O
mice	O
on	O
the	O
mixed	O
background	O
have	O
improved	O
survival	O

As	O
reported	O
by	O
others	O
[	O
34	O
]	O
,	O
the	O
expected	O
number	O
of	O
Cftr	O
null	O
mice	O
on	O
the	O
B6	O
background	O
that	O
survived	O
to	O
weaning	O
was	O
significantly	O
less	O
than	O
that	O
expected	O
from	O
Mendelian	O
genetics	O
(	O
Tables	O
1	O
and	O
2	O
)	O
.	O

The	O
degree	O
of	O
significance	O
was	O
greater	O
for	O
male	O
mice	O
(	O
Tables	O
1	O
and	O
2	O
)	O
.	O

In	O
contrast	O
,	O
on	O
the	O
mixed	O
background	O
,	O
the	O
distribution	O
of	O
genotypes	O
of	O
female	O
offspring	O
was	O
not	O
significantly	O
different	O
from	O
the	O
expected	O
(	O
Tables	O
1	O
)	O
.	O

For	O
male	O
mice	O
on	O
the	O
mixed	O
background	O
,	O
the	O
P	O
-	O
value	O
was	O
less	O
significant	O
but	O
still	O
different	O
compared	O
to	O
the	O
B6	O
males	O
(	O
Table	O
2	O
)	O
.	O

These	O
data	O
indicate	O
that	O
the	O
mixed	O
background	O
is	O
associated	O
with	O
increased	O
survival	O
of	O
CF	O
mice	O
.	O

Table	O
1	O

Distribution	O
of	O
Cftr	O
genotypes	O
in	O
female	O
offspring	O
from	O
breeding	O
Cftr	O
heterozygotes	O
on	O
the	O
B6	O
and	O
mixed	O
backgrounds	O
.	O

Statistical	O
analysis	O
was	O
by	O
Chi	O
-	O
square	O
.	O

(	O
*	O
)	O
P	O
-	O
value	O
if	O
the	O
sample	O
size	O
for	O
the	O
B6	O
mice	O
is	O
adjusted	O
to	O
be	O
equal	O
to	O
that	O
of	O
the	O
mixed	O
background	O
mice	O
,	O
assuming	O
the	O
same	O
distribution	O
of	O
genotypes	O
.	O

Table	O
2	O

Distribution	O
of	O
Cftr	O
genotypes	O
in	O
male	O
offspring	O
from	O
breeding	O
Cftr	O
heterozygotes	O
on	O
the	O
B6	O
and	O
mixed	O
backgrounds	O
.	O

Statistical	O
analysis	O
was	O
by	O
Chi	O
-	O
square	O
.	O

(	O
*	O
)	O
P	O
-	O
value	O
if	O
the	O
sample	O
size	O
for	O
the	O
B6	O
mice	O
is	O
adjusted	O
to	O
be	O
equal	O
to	O
that	O
of	O
the	O
mixed	O
background	O
mice	O
,	O
assuming	O
the	O
same	O
distribution	O
of	O
genotypes	O
.	O

The	O
major	O
cause	O
of	O
death	O
in	O
CF	O
mice	O
is	O
intestinal	O
obstruction	O
,	O
and	O
intestinal	O
obstruction	O
is	O
worsened	O
when	O
the	O
mice	O
are	O
fed	O
standard	O
solid	O
mouse	O
chow	O
[	O
35	O
]	O
.	O

Since	O
the	O
CF	O
mice	O
on	O
the	O
mixed	O
background	O
had	O
better	O
weight	O
gain	O
than	O
on	O
the	O
B6	O
background	O
and	O
less	O
mucus	O
accumulation	O
in	O
the	O
small	O
intestine	O
,	O
their	O
ability	O
to	O
survive	O
on	O
solid	O
chow	O
was	O
tested	O
.	O

Mice	O
were	O
maintained	O
on	O
the	O
liquid	O
diet	O
until	O
8	O
weeks	O
of	O
age	O
,	O
and	O
then	O
switched	O
to	O
solid	O
chow	O
for	O
up	O
to	O
eight	O
weeks	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

4	O
,	O
wild	O
type	O
mice	O
had	O
100	O
%	O
survival	O
on	O
chow	O
,	O
as	O
expected	O
.	O

The	O
majority	O
of	O
CF	O
mice	O
on	O
the	O
B6	O
background	O
died	O
within	O
2	O
-	O
3	O
weeks	O
on	O
solid	O
chow	O
,	O
with	O
about	O
60	O
%	O
mortality	O
over	O
the	O
8	O
week	O
period	O
.	O

In	O
contrast	O
,	O
only	O
22	O
%	O
of	O
the	O
CF	O
mice	O
on	O
the	O
mixed	O
background	O
died	O
(	O
Fig	O
.	O
4	O
)	O
.	O

Figure	O
4	O

Effect	O
of	O
genetic	O
background	O
on	O
CF	O
mouse	O
survival	O
on	O
solid	O
chow	O
.	O

Mice	O
were	O
maintained	O
on	O
the	O
liquid	O
diet	O
(	O
Peptamen	O
)	O
until	O
8	O
weeks	O
of	O
age	O
,	O
at	O
which	O
time	O
they	O
were	O
fed	O
standard	O
solid	O
mouse	O
chow	O
for	O
up	O
to	O
8	O
additional	O
weeks	O
.	O

Deaths	O
were	O
recorded	O
as	O
they	O
occurred	O
and	O
mice	O
in	O
obvious	O
distress	O
were	O
sacrificed	O
and	O
'	O
death	O
'	O
recorded	O
as	O
the	O
subsequent	O
day	O
.	O

By	O
log	O
-	O
rank	O
test	O
,	O
CF	O
mice	O
on	O
the	O
mixed	O
background	O
had	O
significantly	O
earlier	O
death	O
compared	O
to	O
wild	O
type	O
(	O
P	O
=	O
0	O
.	O
035	O
)	O
,	O
and	O
significantly	O
later	O
death	O
than	O
CF	O
mice	O
on	O
the	O
B6	O
background	O
(	O
P	O
=	O
0	O
.	O
025	O
)	O
.	O

CF	O
mice	O
on	O
the	O
B6	O
background	O
also	O
died	O
significantly	O
earlier	O
than	O
wild	O
type	O
(	O
P	O
<	O
0	O
.	O
0005	O
)	O
.	O

Identification	O
of	O
potential	O
modifier	O
loci	O

To	O
determine	O
the	O
contributions	O
of	O
B6	O
and	O
129	O
alleles	O
to	O
the	O
mixed	O
genetic	O
background	O
,	O
and	O
to	O
identify	O
potential	O
modifier	O
regions	O
,	O
tail	O
DNA	O
was	O
analyzed	O
by	O
PCR	O
for	O
markers	O
of	O
polymorphisms	O
between	O
these	O
two	O
mouse	O
strains	O
.	O

Mice	O
congenic	O
on	O
the	O
B6	O
background	O
,	O
which	O
were	O
derived	O
from	O
mice	O
originally	O
on	O
a	O
B6	O
/	O
129	O
mixed	O
background	O
,	O
were	O
also	O
analyzed	O
to	O
confirm	O
they	O
are	O
congenic	O
B6	O
.	O

Twelve	O
CF	O
mice	O
on	O
the	O
B6	O
background	O
averaged	O
99	O
.	O
5	O
%	O
B6	O
alleles	O
.	O

One	O
of	O
the	O
twelve	O
mice	O
had	O
alleles	O
from	O
both	O
strains	O
at	O
chr	O
.	O
9	O
,	O
40	O
cM	O
.	O

All	O
twelve	O
mice	O
had	O
both	O
B6	O
and	O
129	O
markers	O
on	O
chromosome	O
6	O
,	O
1	O
cM	O
which	O
is	O
probably	O
due	O
to	O
the	O
targeted	O
Cftr	O
gene	O
which	O
is	O
at	O
chr	O
.	O
6	O
,	O
3	O
.	O
1	O
cM	O
[	O
36	O
]	O
.	O

Three	O
CF	O
mice	O
on	O
the	O
mixed	O
background	O
were	O
initially	O
analyzed	O
and	O
were	O
found	O
to	O
be	O
95	O
%	O
B6	O
,	O
5	O
%	O
129	O
.	O

A	O
second	O
group	O
of	O
8	O
CF	O
mice	O
was	O
analyzed	O
and	O
the	O
markers	O
used	O
were	O
refined	O
to	O
focus	O
on	O
the	O
chromosomal	O
regions	O
showing	O
variations	O
from	O
the	O
B6	O
strain	O
.	O

The	O
differences	O
found	O
from	O
the	O
two	O
analyses	O
are	O
combined	O
in	O
Table	O
3	O
.	O

The	O
differences	O
in	O
the	O
mixed	O
strain	O
CF	O
mice	O
were	O
at	O
chr	O
.	O
1	O
,	O
92	O
cM	O
(	O
9	O
of	O
11	O
mice	O
had	O
both	O
B6	O
and	O
129	O
alleles	O
)	O
;	O
chr	O
.	O
9	O
,	O
9	O
cM	O
(	O
all	O
11	O
mice	O
had	O
two	O
129	O
alleles	O
)	O
;	O
and	O
chr	O
.	O
10	O
,	O
65	O
cM	O
(	O
10	O
mice	O
had	O
both	O
B6	O
and	O
129	O
alleles	O
)	O
.	O

Table	O
3	O

Genome	O
scanning	O
analysis	O
of	O
CF	O
mice	O
on	O
the	O
mixed	O
background	O
.	O

The	O
table	O
shows	O
the	O
distribution	O
of	O
B6	O
and	O
129	O
alleles	O
in	O
mice	O
from	O
the	O
two	O
genetic	O
backgrounds	O
.	O

An	O
initial	O
analysis	O
was	O
performed	O
on	O
3	O
samples	O
and	O
a	O
second	O
analysis	O
on	O
8	O
more	O
samples	O
.	O

Only	O
the	O
markers	O
that	O
were	O
not	O
uniformly	O
B6	O
alleles	O
are	O
shown	O
.	O

Some	O
of	O
the	O
markers	O
were	O
refined	O
based	O
on	O
the	O
initial	O
analysis	O
,	O
so	O
not	O
all	O
markers	O
were	O
used	O
for	O
all	O
11	O
mice	O
.	O

(	O
*	O
)	O
Eleven	O
samples	O
were	O
analyzed	O
but	O
one	O
sample	O
was	O
ambiguous	O
.	O

Because	O
the	O
spacing	O
of	O
markers	O
used	O
was	O
about	O
12	O
cM	O
,	O
genes	O
within	O
75	O
%	O
of	O
this	O
interval	O
on	O
either	O
side	O
of	O
the	O
markers	O
were	O
looked	O
at	O
for	O
potential	O
relevance	O
to	O
the	O
milder	O
CF	O
intestinal	O
phenotype	O
.	O

None	O
of	O
the	O
known	O
chloride	B-CHEBI
channels	O
that	O
might	O
substitute	O
for	O
the	O
missing	O
CFTR	O
are	O
in	O
the	O
regions	O
of	O
the	O
three	O
chromosomes	O
associated	O
with	O
the	O
milder	O
phenotype	O
.	O

There	O
are	O
several	O
potassium	B-CHEBI
channel	O
genes	O
in	O
the	O
identified	O
regions	O
that	O
potentially	O
could	O
affect	O
electrolyte	O
and	O
fluid	O
transport	O
:	O
Kcnj9	O
(	O
chr	O
.	O
1	O
,	O
94	O
.	O
2	O
cM	O
)	O
,	O
Kcnj10	O
(	O
chr	O
.	O
1	O
,	O
93	O
.	O
5	O
cM	O
)	O
,	O
Kcnj5	O
(	O
chr	O
.	O
9	O
,	O
11	O
cM	O
)	O
,	O
and	O
Kcnc2	O
(	O
chr	O
.	O
10	O
,	O
62	O
cM	O
)	O
.	O

All	O
gene	O
names	O
are	O
from	O
the	O
Mouse	O
Genome	O
Informatics	O
website	O
.	O

Inflammation	O
is	O
a	O
hallmark	O
of	O
CF	O
,	O
and	O
whether	O
there	O
is	O
an	O
inherent	O
defect	O
in	O
CF	O
that	O
predisposes	O
to	O
excessive	O
inflammation	O
is	O
controversial	O
.	O

Several	O
genes	O
involved	O
in	O
inflammation	O
and	O
the	O
immune	O
system	O
are	O
located	O
in	O
the	O
regions	O
of	O
the	O
markers	O
identified	O
:	O
TNF	O
superfamily	O
members	O
Tnfsf4	O
,	O
6	O
,	O
and	O
8	O
(	O
chr	O
.	O
1	O
,	O
84	O
.	O
9	O
-	O
85	O
cM	O
)	O
which	O
are	O
involved	O
in	O
T	O
cell	O
activation	O
[	O
37	O
,	O
38	O
]	O
;	O
three	O
selectin	O
genes	O
(	O
Sele	O
,	O
Sell	O
,	O
Selp	O
,	O
chr	O
.	O
1	O
,	O
86	O
.	O
6	O
cM	O
)	O
which	O
are	O
involved	O
in	O
immune	O
cell	O
infiltration	O
into	O
inflamed	O
tissues	O
[	O
39	O
]	O
;	O
several	O
members	O
of	O
immune	O
cell	O
surface	O
proteins	B-CHEBI
of	O
the	O
Slam	O
family	O
(	O
slamf1	O
,	O
2	O
,	O
5	O
,	O
6	O
,	O
and	O
9	O
;	O
chr	O
.	O
1	O
,	O
89	O
.	O
5	O
-	O
93	O
.	O
3	O
cM	O
)	O
[	O
40	O
]	O
;	O
the	O
chemokine	O
gene	O
Xcl1	O
(	O
chr	O
.	O
1	O
,	O
87	O
cM	O
)	O
which	O
is	O
expressed	O
by	O
mast	O
cells	O
and	O
recruits	O
lymphocytes	O
[	O
41	O
]	O
;	O
several	O
immunoglobulin	O
Fc	O
receptor	O
genes	O
(	O
Fcrl3	O
,	O
Fcgr2b	O
,	O
and	O
Fcgr3	O
at	O
chr	O
.	O
1	O
,	O
92	O
.	O
3	O
cM	O
;	O
Fcer1g	O
at	O
chr	O
.	O
1	O
,	O
93	O
.	O
3	O
cM	O
;	O
Fcer1a	O
at	O
chr	O
.	O
1	O
,	O
94	O
.	O
2	O
cM	O
)	O
;	O
the	O
flagellin	O
receptor	O
Tlr5	O
(	O
chr	O
.	O
1	O
,	O
98	O
cM	O
)	O
;	O
Mmp3	O
(	O
chr	O
.	O
9	O
,	O
1	O
cM	O
)	O
which	O
recruits	O
CD4	O
+	O
lymphocytes	O
[	O
42	O
]	O
;	O
Mmp7	O
(	O
chr	O
.	O
9	O
,	O
1	O
cM	O
)	O
which	O
activates	O
Paneth	O
cell	O
-	O
derived	O
cryptdins	O
(	O
alpha	O
-	O
defensins	O
)	O
[	O
43	O
]	O
;	O
Icam1	O
(	O
chr	O
.	O
9	O
,	O
7	O
cM	O
)	O
which	O
is	O
involved	O
in	O
lymphocyte	O
infiltration	O
into	O
inflamed	O
tissues	O
[	O
44	O
]	O
;	O
Kitl	O
(	O
chr	O
.	O
10	O
,	O
57	O
cM	O
)	O
which	O
is	O
also	O
known	O
as	O
stem	O
cell	O
factor	O
,	O
and	O
is	O
crucial	O
for	O
mast	O
cell	O
differentiation	O
[	O
45	O
]	O
;	O
Im5	O
(	O
chr	O
.	O
10	O
,	O
65	O
cM	O
)	O
which	O
is	O
involved	O
in	O
antibody	O
-	O
responsiveness	O
[	O
46	O
]	O
;	O
Lyzs	O
(	O
chr	O
.	O
10	O
,	O
66	O
cM	O
)	O
which	O
is	O
a	O
Paneth	O
cell	O
product	O
that	O
digests	O
cell	O
walls	O
of	O
bacteria	O
[	O
47	O
]	O
;	O
Ifng	O
(	O
chr	O
.	O
10	O
,	O
67	O
cM	O
)	O
which	O
is	O
an	O
important	O
inflammatory	O
signal	O
in	O
CF	O
as	O
well	O
as	O
other	O
conditions	O
[	O
48	O
]	O
;	O
Il22	O
(	O
chr	O
.	O
10	O
,	O
67	O
cM	O
)	O
,	O
a	O
member	O
of	O
the	O
anti	O
-	O
inflammatory	O
IL	O
-	O
10	O
interleukin	O
family	O
[	O
49	O
]	O
;	O
and	O
the	O
Stat2	O
and	O
6	O
genes	O
(	O
chr	O
.	O
10	O
,	O
70	O
cM	O
)	O
which	O
are	O
important	O
components	O
of	O
intracellular	O
signaling	O
pathways	O
[	O
50	O
]	O
.	O

Also	O
near	O
the	O
identified	O
markers	O
are	O
a	O
number	O
of	O
QTL	O
associated	O
with	O
body	O
weight	O
:	O
Cfbw1	O
,	O
CF	O
mouse	O
body	O
weight	O
at	O
chr	O
.	O
1	O
,	O
85	O
cM	O
;	O
Obq9	O
,	O
obesity	O
9	O
at	O
chr	O
.	O
1	O
,	O
88	O
cM	O
;	O
Bw8q1	O
,	O
body	O
weight	O
8	O
at	O
chr	O
.	O
1	O
,	O
100	O
cM	O
;	O
Lbm6	O
,	O
lean	O
body	O
mass	O
6	O
at	O
chr	O
.	O
9	O
,	O
7	O
.	O
7	O
cM	O
;	O
Bwtq4	O
,	O
body	O
weight	O
4	O
at	O
chr	O
.	O
9	O
,	O
8	O
cM	O
;	O
Bgeq8	O
,	O
body	O
growth	O
early	O
8	O
at	O
chr	O
.	O
10	O
,	O
57	O
cM	O
;	O
and	O
Pbwg5	O
,	O
postnatal	O
body	O
weight	O
growth	O
5	O
at	O
chr	O
.	O
10	O
,	O
68	O
cM	O
.	O

Clearly	O
,	O
there	O
are	O
numerous	O
genes	O
in	O
the	O
three	O
regions	O
identified	O
in	O
this	O
study	O
.	O

Because	O
the	O
CF	O
mouse	O
intestinal	O
phenotype	O
is	O
characterized	O
by	O
an	O
innate	O
type	O
immune	O
response	O
,	O
with	O
increases	O
in	O
mast	O
cells	O
and	O
neutrophils	O
,	O
the	O
genes	O
that	O
affect	O
these	O
cells	O
are	O
of	O
special	O
interest	O
.	O

The	O
Kitl	O
gene	O
is	O
crucial	O
for	O
differentiation	O
of	O
mast	O
cells	O
,	O
and	O
CF	O
mice	O
on	O
the	O
mixed	O
background	O
have	O
much	O
fewer	O
mature	O
mast	O
cells	O
than	O
on	O
the	O
B6	O
background	O
as	O
revealed	O
by	O
less	O
expression	O
of	O
Mcpt2	O
.	O

Similarly	O
,	O
for	O
neutrophils	O
the	O
selectins	O
and	O
Icam1	O
are	O
of	O
interest	O
,	O
as	O
these	O
proteins	B-CHEBI
are	O
required	O
for	O
extravasation	O
of	O
neutrophils	O
from	O
the	O
circulation	O
into	O
the	O
inflamed	O
tissue	O
.	O

Altered	O
immune	O
responses	O
may	O
also	O
relate	O
to	O
excessive	O
mucus	O
accumulation	O
in	O
the	O
CF	O
intestine	O
.	O

It	O
is	O
unclear	O
why	O
mucus	O
accumulates	O
to	O
high	O
levels	O
in	O
CF	O
tissues	O
.	O

In	O
part	O
it	O
may	O
be	O
due	O
to	O
reduced	O
fluid	O
secretion	O
and	O
a	O
more	O
acidic	B-CHEBI
environment	O
in	O
the	O
lumina	O
of	O
affected	O
organs	O
.	O

However	O
,	O
there	O
is	O
also	O
evidence	O
for	O
hypersecretion	O
of	O
mucus	O
in	O
CF	O
[	O
12	O
]	O
,	O
and	O
it	O
is	O
likely	O
that	O
effector	B-CHEBI
molecules	I-CHEBI
released	O
by	O
mast	O
cells	O
and	O
neutrophils	O
(	O
histamine	B-CHEBI
,	O
proteases	O
,	O
prostaglandins	B-CHEBI
)	O
have	O
an	O
important	O
role	O
in	O
stimulating	O
mucus	O
secretion	O
.	O

Conclusion	O

This	O
work	O
demonstrated	O
that	O
the	O
CF	O
inflammatory	O
phenotype	O
is	O
much	O
less	O
severe	O
in	O
mice	O
with	O
a	O
small	O
contribution	O
of	O
129	O
/	O
Sv	O
alleles	O
.	O

A	O
preliminary	O
analysis	O
identified	O
regions	O
on	O
chr	O
.	O
1	O
,	O
9	O
,	O
and	O
10	O
are	O
that	O
are	O
potentially	O
associated	O
with	O
the	O
milder	O
phenotype	O
.	O

Because	O
of	O
the	O
inflammation	O
of	O
the	O
CF	O
small	O
intestine	O
,	O
and	O
the	O
possible	O
effects	O
of	O
immune	O
cells	O
on	O
mucus	O
secretion	O
,	O
the	O
genes	O
in	O
the	O
identified	O
regions	O
which	O
are	O
involved	O
in	O
mast	O
cell	O
and	O
neutrophil	O
differentiation	O
and	O
behavior	O
are	O
of	O
special	O
interest	O
as	O
potential	O
CF	O
modifiers	O
.	O

Future	O
work	O
should	O
focus	O
on	O
narrowing	O
down	O
these	O
regions	O
and	O
determining	O
if	O
there	O
are	O
polymorphisms	O
that	O
affect	O
expression	O
of	O
specific	O
genes	O
that	O
make	O
the	O
CF	O
intestinal	O
phenotype	O
less	O
severe	O
.	O

Methods	O

Animals	O

Wild	O
type	O
and	O
Cftr	O
null	O
mice	O
on	O
two	O
different	O
genetic	O
backgrounds	O
were	O
used	O
in	O
this	O
study	O
.	O

One	O
group	O
was	O
congenic	O
on	O
the	O
C57Bl	O
/	O
6	O
(	O
B6	O
)	O
background	O
,	O
as	O
previously	O
described	O
[	O
21	O
]	O
.	O

The	O
other	O
group	O
was	O
on	O
a	O
mixed	O
background	O
of	O
about	O
95	O
%	O
B6	O
and	O
5	O
%	O
129	O
/	O
Sv	O
(	O
129	O
)	O
.	O

The	O
mice	O
on	O
the	O
mixed	O
background	O
originated	O
as	O
part	O
of	O
a	O
recently	O
published	O
study	O
[	O
20	O
]	O
as	O
follows	O
.	O

Mice	O
carrying	O
a	O
targeted	O
mutation	O
of	O
the	O
gastrin	O
gene	O
on	O
a	O
mixed	O
B6	O
/	O
129	O
background	O
[	O
51	O
]	O
were	O
bred	O
for	O
eight	O
generations	O
onto	O
the	O
B6	O
background	O
.	O

The	O
gastrin	O
(	O
+	O
/	O
-	O
)	O
mice	O
were	O
then	O
crossed	O
for	O
six	O
generations	O
with	O
Cftr	O
(	O
+	O
/	O
-	O
)	O
mice	O
congenic	O
on	O
the	O
B6	O
background	O
.	O

A	O
genome	O
scan	O
at	O
this	O
point	O
showed	O
that	O
the	O
mice	O
were	O
about	O
95	O
%	O
B6	O
and	O
5	O
%	O
129	O
(	O
see	O
below	O
)	O
.	O

These	O
mice	O
were	O
bred	O
to	O
obtain	O
mice	O
wild	O
type	O
for	O
both	O
gastrin	O
alleles	O
and	O
either	O
Cftr	O
homozygous	O
wild	O
type	O
[	O
Cftr	O
(	O
+	O
/	O
+	O
)	O
]	O
or	O
Cftr	O
homozygous	O
null	O
[	O
Cftr	O
(	O
-	O
/	O
-	O
)	O
]	O
.	O

Mice	O
were	O
genotyped	O
at	O
2	O
weeks	O
of	O
age	O
by	O
PCR	O
as	O
previously	O
described	O
[	O
21	O
]	O
.	O

Unless	O
otherwise	O
stated	O
,	O
mice	O
were	O
maintained	O
on	O
a	O
complete	O
elemental	O
liquid	O
diet	O
(	O
Peptamen	O
;	O
Nestle	O
Deerfield	O
,	O
IL	O
)	O
to	O
prevent	O
intestinal	O
obstruction	O
that	O
occurs	O
in	O
CF	O
mice	O
[	O
52	O
]	O
.	O

Wild	O
type	O
littermates	O
were	O
maintained	O
on	O
the	O
same	O
diet	O
.	O

In	O
some	O
experiments	O
,	O
8	O
week	O
old	O
mice	O
were	O
transferred	O
onto	O
solid	O
mouse	O
chow	O
instead	O
of	O
Peptamen	O
,	O
and	O
survival	O
was	O
recorded	O
.	O

Mice	O
with	O
apparent	O
distress	O
were	O
sacrificed	O
and	O
survival	O
on	O
chow	O
was	O
recorded	O
as	O
the	O
following	O
day	O
.	O

Male	O
and	O
female	O
mice	O
were	O
used	O
at	O
6	O
-	O
16	O
weeks	O
of	O
age	O
.	O

Mice	O
were	O
kept	O
in	O
a	O
specific	O
pathogen	O
-	O
free	O
facility	O
in	O
barrier	O
-	O
top	O
cages	O
.	O

All	O
procedures	O
were	O
approved	O
by	O
the	O
University	O
of	O
Kansas	O
Medical	O
Center	O
IACUC	O
.	O

Genetic	O
background	O
determination	O

The	O
Genome	O
Scanning	O
Service	O
of	O
The	O
Jackson	O
Laboratory	O
(	O
Bar	O
Harbor	O
,	O
ME	O
)	O
was	O
used	O
to	O
determine	O
the	O
contributions	O
of	O
C57Bl	O
/	O
6	O
and	O
129	O
/	O
Sv	O
strains	O
in	O
the	O
interbred	O
mice	O
.	O

Pieces	O
of	O
mouse	O
tail	O
were	O
sent	O
to	O
The	O
Jackson	O
Laboratory	O
for	O
simple	O
sequence	O
length	O
polymorphism	O
(	O
SSLP	O
)	O
PCR	O
analysis	O
with	O
the	O
DMit	O
primers	O
specific	O
for	O
B6	O
and	O
129	O
strain	O
alleles	O
.	O

The	O
SSLP	O
panel	O
consists	O
of	O
108	O
mapped	O
markers	O
designed	O
to	O
distinguish	O
between	O
B6	O
and	O
129	O
strains	O
.	O

The	O
markers	O
are	O
spaced	O
12	O
-	O
13	O
cM	O
apart	O
and	O
span	O
the	O
nineteen	O
autosomes	O
.	O

Measurement	O
of	O
gene	O
expression	O

Total	O
RNA	O
was	O
extracted	O
from	O
the	O
entire	O
small	O
intestine	O
as	O
previously	O
described	O
[	O
21	O
]	O
.	O

Quantitative	O
,	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
was	O
used	O
to	O
measure	O
expression	O
of	O
specific	O
genes	O
using	O
the	O
previously	O
described	O
primers	O
[	O
21	O
]	O
.	O

Values	O
were	O
normalized	O
to	O
GAPDH	O
mRNA	B-CHEBI
and	O
expression	O
of	O
this	O
housekeeping	O
gene	O
is	O
not	O
altered	O
in	O
the	O
CF	O
mouse	O
small	O
intestine	O
[	O
21	O
]	O
.	O

Expression	O
of	O
the	O
major	O
intestinal	O
mucin	O
,	O
Muc2	O
,	O
was	O
also	O
measured	O
using	O
the	O
forward	O
(	O
5	O
'	O
-	O
GAC	O
TTC	O
GAT	O
GGA	O
CAC	O
TGC	O
TC	O
-	O
3	O
'	O
)	O
and	O
reverse	O
(	O
5	O
'	O
-	O
CAC	O
GGT	O
GTT	O
TAT	O
CTA	O
CCA	O
AC	O
-	O
3	O
'	O
)	O
primers	O
.	O

Histology	O

The	O
small	O
intestine	O
was	O
flushed	O
with	O
phosphate	B-CHEBI
buffered	B-CHEBI
saline	O
and	O
immersion	O
fixed	O
overnight	O
in	O
4	O
%	O
paraformaldehyde	O
.	O

The	O
tissues	O
were	O
then	O
prepared	O
for	O
paraffin	O
embedding	O
and	O
sectioning	O
by	O
a	O
commercial	O
service	O
(	O
HSRL	O
,	O
Woodstock	O
,	O
VA	O
)	O
.	O

Sections	O
(	O
5	O
mu	O
m	O
)	O
were	O
stained	O
with	O
periodic	B-CHEBI
acid	I-CHEBI
Schiff	O
'	O
s	O
(	O
PAS	O
)	O
for	O
neutral	O
mucins	O
.	O

Statistics	O

Gene	O
expression	O
and	O
body	O
weight	O
data	O
were	O
compared	O
by	O
ANOVA	O
with	O
a	O
post	O
-	O
hoc	O
Tukey	O
'	O
s	O
analysis	O
(	O
Systat	O
software	O
,	O
Chicago	O
,	O
IL	O
)	O
.	O

Survival	O
data	O
were	O
analyzed	O
by	O
a	O
log	O
-	O
rank	O
test	O
for	O
P	O
values	O
(	O
PEPI	O
software	O
,	O
)	O
.	O

The	O
distributions	O
of	O
genotypes	O
of	O
pups	O
surviving	O
to	O
weaning	O
from	O
breeding	O
Cftr	O
(	O
+	O
/	O
-	O
)	O
mice	O
were	O
compared	O
to	O
that	O
expected	O
by	O
Mendelian	O
genetics	O
using	O
Chi	O
-	O
square	O
analysis	O
.	O

For	O
all	O
statistical	O
tests	O
,	O
P	O
<	O
0	O
.	O
05	O
was	O
considered	O
significant	O
.	O

Authors	O
'	O
contributions	O

RCD	O
oversaw	O
the	O
project	O
,	O
performed	O
the	O
histological	O
analysis	O
,	O
performed	O
statistical	O
analyses	O
,	O
and	O
contributed	O
to	O
writing	O
the	O
manuscript	O
.	O

ON	O
performed	O
the	O
quantitative	O
RT	O
-	O
PCR	O
analysis	O
,	O
and	O
contributed	O
to	O
writing	O
the	O
manuscript	O
.	O

Acknowledgements	O

We	O
thank	O
Larysa	O
Stroganova	O
for	O
maintenance	O
of	O
the	O
mouse	O
colonies	O
and	O
PCR	O
genotyping	O
.	O

Supported	O
by	O
National	O
Institutes	O
of	O
Health	O
grant	O
DK	O
56791	O
.	O

Haplotypes	O
at	O
the	O
Tas2r	O
locus	O
on	O
distal	O
chromosome	O
6	O
vary	O
with	O
quinine	B-CHEBI
taste	O
sensitivity	O
in	O
inbred	O
mice	O

Abstract	O

Background	O

The	O
detection	O
of	O
bitter	O
-	O
tasting	O
compounds	B-CHEBI
by	O
the	O
gustatory	O
system	O
is	O
thought	O
to	O
alert	O
animals	O
to	O
the	O
presence	O
of	O
potentially	O
toxic	B-CHEBI
food	B-CHEBI
.	O

Some	O
,	O
if	O
not	O
all	O
,	O
bitter	O
stimuli	O
activate	O
specific	O
taste	O
receptors	O
,	O
the	O
T2Rs	O
,	O
which	O
are	O
expressed	O
in	O
subsets	O
of	O
taste	O
receptor	O
cells	O
on	O
the	O
tongue	O
and	O
palate	O
.	O

However	O
,	O
there	O
is	O
evidence	O
for	O
both	O
receptor	O
-	O
dependent	O
and	O
-	O
independent	O
transduction	O
mechanisms	O
for	O
a	O
number	O
of	O
bitter	O
stimuli	O
,	O
including	O
quinine	B-CHEBI
hydrochloride	B-CHEBI
(	O
QHCl	O
)	O
and	O
denatonium	O
benzoate	B-CHEBI
(	O
DB	O
)	O
.	O

Results	O

We	O
used	O
brief	O
-	O
access	O
behavioral	O
taste	O
testing	O
of	O
BXD	O
/	O
Ty	O
recombinant	O
inbred	O
(	O
RI	O
)	O
mouse	O
strains	O
to	O
map	O
the	O
major	O
quantitative	O
trait	O
locus	O
(	O
QTL	O
)	O
for	O
taste	O
sensitivity	O
to	O
QHCl	O
.	O

This	O
QTL	O
is	O
restricted	O
to	O
a	O
~	O
5	O
Mb	O
interval	O
on	O
chromosome	O
6	O
that	O
includes	O
24	O
genes	O
encoding	O
T2Rs	O
(	O
Tas2rs	O
)	O
.	O

Tas2rs	O
at	O
this	O
locus	O
display	O
in	O
total	O
307	O
coding	O
region	O
single	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
between	O
the	O
two	O
BXD	O
/	O
Ty	O
RI	O
parental	O
strains	O
,	O
C57BL	O
/	O
6J	O
(	O
quinine	B-CHEBI
-	O
sensitive	O
)	O
and	O
DBA	O
/	O
2J	O
(	O
quinine	B-CHEBI
insensitive	O
)	O
;	O
approximately	O
50	O
%	O
of	O
these	O
mutations	O
are	O
silent	O
.	O

Individual	O
RI	O
lines	O
contain	O
exclusively	O
either	O
C57BL	O
/	O
6J	O
or	O
DBA	O
/	O
2J	O
Tas2r	O
alleles	O
at	O
this	O
locus	O
,	O
and	O
RI	O
lines	O
containing	O
C57BL	O
/	O
6J	O
Tas2r	O
alleles	O
are	O
more	O
sensitive	O
to	O
QHCl	O
than	O
are	O
lines	O
containing	O
DBA	O
/	O
2J	O
alleles	O
.	O

Thus	O
,	O
the	O
entire	O
Tas2r	O
cluster	O
comprises	O
a	O
large	O
haplotype	O
that	O
correlates	O
with	O
quinine	B-CHEBI
taster	O
status	O
.	O

Conclusion	O

These	O
studies	O
,	O
the	O
first	O
using	O
a	O
taste	O
-	O
salient	O
assay	O
to	O
map	O
the	O
major	O
QTL	O
for	O
quinine	B-CHEBI
taste	O
,	O
indicate	O
that	O
a	O
T2R	O
-	O
dependent	O
transduction	O
cascade	O
is	O
responsible	O
for	O
the	O
majority	O
of	O
strain	O
variance	O
in	O
quinine	B-CHEBI
taste	O
sensitivity	O
.	O

Furthermore	O
,	O
the	O
large	O
number	O
of	O
polymorphisms	O
within	O
coding	O
exons	O
of	O
the	O
Tas2r	O
cluster	O
,	O
coupled	O
with	O
evidence	O
that	O
inbred	O
strains	O
exhibit	O
largely	O
similar	O
bitter	O
taste	O
phenotypes	O
,	O
suggest	O
that	O
T2R	O
receptors	O
are	O
quite	O
tolerant	O
to	O
variation	O
.	O

Background	O

Animals	O
use	O
the	O
gustatory	O
system	O
to	O
provide	O
information	O
about	O
food	B-CHEBI
quality	O
.	O

For	O
example	O
,	O
sweet	O
-	O
tasting	O
foods	B-CHEBI
may	O
have	O
a	O
high	O
caloric	O
content	O
and	O
are	O
preferred	O
,	O
while	O
bitter	O
-	O
tasting	O
foods	B-CHEBI
often	O
contain	O
toxic	B-CHEBI
substances	I-CHEBI
,	O
and	O
are	O
generally	O
avoided	O
.	O

Two	O
families	O
of	O
G	O
protein	B-CHEBI
-	O
coupled	O
receptors	O
(	O
GPCRs	O
)	O
expressed	O
in	O
subpopulations	O
of	O
taste	O
receptor	O
cells	O
(	O
TRCs	O
)	O
of	O
the	O
gustatory	O
epithelium	O
have	O
been	O
implicated	O
in	O
the	O
detection	O
and	O
transduction	O
of	O
sweet	O
,	O
bitter	O
and	O
umami	O
(	O
i	O
.	O
e	O
.	O
,	O
glutamate	B-CHEBI
)	O
taste	O
:	O
T1Rs	O
for	O
sweet	O
-	O
and	O
umami	O
-	O
tasting	O
stimuli	O
[	O
1	O
-	O
8	O
]	O
,	O
and	O
T2Rs	O
for	O
bitter	O
-	O
tasting	O
compounds	B-CHEBI
[	O
9	O
-	O
11	O
]	O
.	O

The	O
genes	O
that	O
encode	O
T2Rs	O
,	O
the	O
Tas2rs	O
,	O
were	O
first	O
identified	O
by	O
database	O
mining	O
of	O
mammalian	O
genomes	O
near	O
chromosomal	O
markers	O
previously	O
linked	O
to	O
differences	O
in	O
bitter	O
taste	O
sensitivity	O
[	O
9	O
,	O
11	O
-	O
18	O
]	O
.	O

In	O
mice	O
,	O
the	O
majority	O
of	O
Tas2rs	O
lie	O
within	O
a	O
single	O
cluster	O
on	O
distal	O
chromosome	O
6	O
.	O

Thirty	O
-	O
three	O
human	O
Tas2rs	O
(	O
including	O
8	O
pseudogenes	O
)	O
and	O
thirty	O
-	O
six	O
mouse	O
Tas2rs	O
(	O
including	O
3	O
pseudogenes	O
in	O
C57BL	O
/	O
6J	O
mice	O
)	O
have	O
been	O
identified	O
[	O
9	O
,	O
11	O
,	O
19	O
]	O
,	O
and	O
several	O
of	O
these	O
respond	O
to	O
particular	O
bitter	O
stimuli	O
in	O
heterologous	O
expression	O
assays	O
[	O
10	O
,	O
20	O
-	O
23	O
]	O
,	O
or	O
represent	O
a	O
strong	O
candidate	O
gene	O
for	O
a	O
specific	O
bitter	O
taste	O
quantitative	O
trait	O
[	O
18	O
,	O
24	O
,	O
25	O
]	O
.	O

Several	O
quantitative	O
trait	O
loci	O
(	O
QTL	O
)	O
have	O
been	O
identified	O
that	O
influence	O
two	O
-	O
bottle	O
intake	O
of	O
bitter	O
stimuli	O
in	O
the	O
mouse	O
,	O
including	O
loci	O
for	O
quinine	B-CHEBI
(	O
Qui	B-CHEBI
)	O
[	O
12	O
,	O
16	O
,	O
26	O
]	O
,	O
cyclohexamide	B-CHEBI
(	O
Cyx	B-CHEBI
)	O
[	O
13	O
]	O
and	O
sucrose	B-CHEBI
octaacetate	O
(	O
Soa	O
)	O
[	O
14	O
,	O
15	O
,	O
17	O
]	O
sensitivity	O
.	O

Each	O
of	O
these	O
QTL	O
map	O
to	O
mouse	O
distal	O
chromosome	O
6	O
and	O
are	O
linked	O
to	O
the	O
marker	O
D6Mit13	O
,	O
which	O
lies	O
within	O
a	O
cluster	O
of	O
24	O
intact	O
Tas2rs	O
in	O
the	O
C57BL	O
/	O
6	O
genome	O
(	O
e	O
.	O
g	O
.	O
,	O
[	O
16	O
,	O
27	O
,	O
28	O
]	O
)	O
.	O

However	O
,	O
the	O
interpretation	O
of	O
these	O
studies	O
remains	O
problematic	O
for	O
two	O
reasons	O
.	O

First	O
,	O
the	O
density	O
of	O
chromosomal	O
markers	O
and	O
number	O
of	O
recombinant	O
inbred	O
(	O
RI	O
)	O
strains	O
used	O
in	O
these	O
earlier	O
studies	O
did	O
not	O
permit	O
the	O
physical	O
definition	O
of	O
the	O
intervals	O
containing	O
each	O
QTL	O
.	O

Second	O
,	O
these	O
previous	O
attempts	O
to	O
map	O
bitter	O
taste	O
QTLs	O
relied	O
on	O
behavioral	O
assays	O
that	O
measured	O
consumption	O
,	O
and	O
were	O
thus	O
susceptible	O
to	O
contributions	O
of	O
post	O
-	O
ingestive	O
effects	O
such	O
as	O
toxicity	O
.	O

As	O
we	O
have	O
shown	O
previously	O
,	O
such	O
effects	O
can	O
confound	O
the	O
quantification	O
of	O
bitter	O
taste	O
behaviors	O
[	O
29	O
]	O
.	O

Therefore	O
,	O
the	O
relevance	O
and	O
/	O
or	O
contribution	O
of	O
the	O
aforementioned	O
QTLs	O
to	O
bitter	O
taste	O
remain	O
unclear	O
.	O

Furthermore	O
,	O
a	O
number	O
of	O
physiological	O
studies	O
have	O
suggested	O
that	O
the	O
transduction	O
of	O
some	O
amphiphilic	O
bitter	O
compounds	B-CHEBI
,	O
such	O
as	O
quinine	B-CHEBI
and	O
denatonium	O
benzoate	B-CHEBI
,	O
may	O
stimulate	O
taste	O
receptor	O
cells	O
independently	O
of	O
GPCRs	O
(	O
e	O
.	O
g	O
.	O
[	O
30	O
]	O
)	O
.	O

Quinine	B-CHEBI
may	O
directly	O
activate	O
G	O
proteins	B-CHEBI
,	O
and	O
both	O
quinine	B-CHEBI
and	O
denatonium	O
can	O
block	O
K	B-CHEBI
+	I-CHEBI
channels	O
[	O
31	O
-	O
36	O
]	O
;	O
caffeine	B-CHEBI
,	O
another	O
bitter	O
-	O
tasting	O
substance	B-CHEBI
,	O
directly	O
inhibits	O
intracellular	O
phosphodiesterase	O
[	O
33	O
]	O
.	O

However	O
,	O
the	O
relative	O
contributions	O
of	O
T2R	O
-	O
dependent	O
and	O
T2R	O
-	O
independent	O
mechanisms	O
to	O
the	O
detection	O
of	O
these	O
bitter	O
stimuli	O
are	O
unknown	O
.	O

Here	O
we	O
use	O
a	O
taste	O
-	O
salient	O
brief	O
-	O
access	O
lick	O
test	O
[	O
29	O
,	O
37	O
]	O
to	O
measure	O
taste	O
sensitivities	O
in	O
C57BL	O
/	O
6J	O
(	O
B6	O
)	O
,	O
DBA	O
/	O
2J	O
(	O
D2	O
)	O
and	O
BXD	O
/	O
Ty	O
(	O
BXD	O
)	O
recombinant	O
inbred	O
(	O
RI	O
)	O
mice	O
to	O
two	O
bitter	O
stimuli	O
,	O
quinine	B-CHEBI
hydrochloride	B-CHEBI
(	O
QHCl	O
)	O
and	O
denatonium	O
benzoate	B-CHEBI
(	O
DB	O
)	O
.	O

Using	O
17	O
BXD	O
lines	O
that	O
were	O
genotyped	O
at	O
762	O
informative	O
chromosomal	O
markers	O
,	O
we	O
mapped	O
a	O
major	O
QTL	O
for	O
QHCl	O
taste	O
to	O
a	O
~	O
5	O
Mb	O
interval	O
on	O
distal	O
chromosome	O
6	O
that	O
contains	O
all	O
24	O
of	O
the	O
Tas2r	O
genes	O
in	O
the	O
distal	O
cluster	O
.	O

We	O
analyzed	O
the	O
sequence	O
of	O
each	O
Tas2r	O
allele	O
in	O
the	O
parental	O
strains	O
(	O
B6	O
and	O
D2	O
)	O
and	O
29	O
RI	O
lines	O
.	O

This	O
analysis	O
revealed	O
that	O
all	O
24	O
genes	O
are	O
polymorphic	O
between	O
the	O
two	O
strains	O
,	O
and	O
that	O
these	O
24	O
Tas2rs	O
comprise	O
a	O
single	O
haplotype	O
that	O
correlates	O
with	O
QHCl	O
taste	O
sensitivity	O
.	O

Results	O

Taste	O
testing	O

Previous	O
efforts	O
to	O
map	O
QTL	O
for	O
bitter	O
taste	O
have	O
utilized	O
consumption	O
tests	O
that	O
may	O
be	O
confounded	O
by	O
the	O
contributions	O
of	O
post	O
-	O
ingestive	O
effects	O
[	O
29	O
]	O
.	O

We	O
used	O
a	O
modified	O
brief	O
-	O
access	O
lick	O
test	O
,	O
which	O
minimizes	O
the	O
contribution	O
of	O
such	O
effects	O
[	O
29	O
,	O
37	O
]	O
to	O
determine	O
whether	O
B6	O
and	O
D2	O
mice	O
display	O
differences	O
in	O
taste	O
sensitivity	O
to	O
the	O
taste	O
stimuli	O
QHCl	O
and	O
DB	O
.	O

After	O
initially	O
screening	O
B6	O
and	O
D2	O
mice	O
to	O
determine	O
stimulus	O
concentrations	O
that	O
were	O
aversive	O
but	O
not	O
saturating	O
[	O
47	O
]	O
,	O
we	O
selected	O
two	O
ligand	O
concentrations	O
for	O
each	O
compound	B-CHEBI
that	O
best	O
differentiated	O
the	O
two	O
strains	O
.	O

Subsequent	O
taste	O
testing	O
of	O
BXD	O
RI	O
lines	O
was	O
restricted	O
to	O
these	O
two	O
concentrations	O
(	O
1	O
and	O
3	O
mM	O
for	O
both	O
QHCl	O
and	O
DB	O
)	O
.	O

Avoidance	O
by	O
male	O
and	O
female	O
B6	O
and	O
D2	O
mice	O
increased	O
(	O
as	O
indicated	O
by	O
the	O
decreased	O
lick	O
ratio	O
)	O
in	O
a	O
concentration	O
-	O
dependent	O
manner	O
for	O
both	O
compounds	B-CHEBI
(	O
Figure	O
1A	O
;	O
Table	O
1	O
)	O
.	O

There	O
was	O
a	O
significant	O
strain	O
difference	O
for	O
both	O
1	O
and	O
3	O
mM	O
QHCl	O
(	O
F	O
[	O
1	O
,	O
25	O
]	O
>	O
24	O
.	O
6	O
;	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O

D2	O
mice	O
displayed	O
decreased	O
aversion	O
relative	O
to	O
B6	O
mice	O
at	O
both	O
concentrations	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
strains	O
did	O
not	O
significantly	O
differ	O
in	O
taste	O
sensitivity	O
to	O
DB	O
(	O
Figure	O
1A	O
)	O
.	O

There	O
were	O
no	O
significant	O
effects	O
of	O
gender	O
.	O

Table	O
1	O

Mean	O
lick	O
ratios	O
for	O
B6	O
,	O
D2	O
and	O
BXD	O
mice	O
.	O

The	O
number	O
of	O
individual	O
mice	O
tested	O
for	O
each	O
strain	O
(	O
n	O
)	O
is	O
listed	O
in	O
the	O
second	O
column	O
.	O

Subsequent	O
columns	O
show	O
the	O
mean	O
lick	O
rate	O
to	O
water	B-CHEBI
during	O
testing	O
(	O
+/-	O
SEM	O
)	O
,	O
mean	O
lick	O
ratio	O
for	O
denatonium	O
benzoate	B-CHEBI
(	O
DB	O
)	O
,	O
PROP	B-CHEBI
(	O
6	B-CHEBI
-	I-CHEBI
n	I-CHEBI
-	I-CHEBI
propylthiouracil	I-CHEBI
;	O
PR	B-CHEBI
)	O
and	O
quinine	B-CHEBI
hydrochloride	B-CHEBI
(	O
QH	O
)	O
at	O
each	O
of	O
two	O
concentrations	O
(	O
see	O
Methods	O
for	O
details	O
)	O
.	O

Figure	O
1	O

Lick	O
ratios	O
(	O
mean	O
+/-	O
SE	O
)	O
for	O
B6	O
,	O
D2	O
and	O
BXD	O
strains	O
.	O

(	O
A	O
)	O
Mean	O
lick	O
ratios	O
for	O
B6	O
(	O
filled	O
circles	O
)	O
and	O
D2	O
(	O
open	O
circles	O
)	O
mice	O
at	O
two	O
concentrations	O
of	O
QHCl	O
and	O
DB	O
.	O

In	O
all	O
panels	O
,	O
a	O
lower	O
mean	O
lick	O
ratio	O
indicates	O
a	O
greater	O
aversion	O
,	O
and	O
therefore	O
greater	O
taste	O
sensitivity	O
,	O
to	O
the	O
stimulus	O
.	O

For	O
panels	O
B	O
,	O
C	O
,	O
and	O
D	O
,	O
each	O
BXD	O
strain	O
is	O
represented	O
by	O
a	O
different	O
color	O
,	O
and	O
listed	O
in	O
order	O
from	O
least	O
sensitive	O
to	O
most	O
sensitive	O
to	O
1	O
mM	O
QHCL	O
.	O

(	O
B	O
)	O
Mean	O
lick	O
ratios	O
for	O
the	O
six	O
BXD	O
strains	O
that	O
are	O
most	O
sensitive	O
to	O
QHCl	O
in	O
this	O
assay	O
.	O

(	O
C	O
)	O
Mean	O
lick	O
ratios	O
for	O
the	O
five	O
BXD	O
strains	O
that	O
are	O
least	O
sensitive	O
to	O
QHCl	O
in	O
this	O
assay	O
.	O

(	O
D	O
)	O
Mean	O
lick	O
ratios	O
for	O
the	O
six	O
BXD	O
strains	O
intermediate	O
in	O
QHCl	O
taste	O
sensitivity	O
to	O
those	O
in	O
(	O
B	O
)	O
and	O
(	O
C	O
)	O
.	O

Cutoffs	O
for	O
the	O
three	O
QHCl	O
taster	O
groups	O
were	O
arbitrarily	O
set	O
,	O
as	O
there	O
was	O
a	O
continuity	O
of	O
the	O
phenotype	O
at	O
1	O
mM	O
QHCl	O
:	O
sensitive	O
strains	O
exhibited	O
a	O
lick	O
ratio	O
for	O
1	O
mM	O
QHCl	O
of	O
<=	O
0	O
.	O
3	O
,	O
intermediate	O
strains	O
from	O
0	O
.	O
31	O
-	O
0	O
.	O
6	O
,	O
and	O
insensitive	O
strains	O
>	O
0	O
.	O
6	O
.	O

The	O
absence	O
of	O
two	O
distinct	O
phenotypic	O
classes	O
suggests	O
that	O
sensitivity	O
to	O
QHCL	O
is	O
under	O
polygenic	O
control	O
.	O

We	O
next	O
tested	O
mice	O
from	O
17	O
BXD	O
lines	O
in	O
the	O
same	O
manner	O
.	O

BXD	O
mice	O
also	O
typically	O
avoided	O
both	O
stimuli	O
in	O
a	O
concentration	O
dependent	O
manner	O
(	O
Figures	O
1B	O
-	O
1D	O
;	O
Table	O
1	O
)	O
.	O

However	O
,	O
QHCl	O
and	O
DB	O
taste	O
sensitivity	O
vary	O
independently	O
across	O
these	O
RI	O
strains	O
:	O
some	O
strains	O
highly	O
sensitive	O
to	O
QHCl	O
are	O
relatively	O
insensitive	O
to	O
DB	O
,	O
and	O
vice	O
versa	O
(	O
Figures	O
1B	O
-	O
1D	O
)	O
.	O

QTL	O
mapping	O

Linkage	O
analysis	O
was	O
conducted	O
using	O
Map	O
Manager	O
QTX	O
(	O
version	O
0	O
.	O
30	O
[	O
38	O
]	O
)	O
.	O

No	O
significant	O
QTLs	O
were	O
identified	O
for	O
DB	O
taste	O
sensitivity	O
,	O
although	O
several	O
associations	O
with	O
markers	O
on	O
chromosomes	O
2	O
,	O
8	O
and	O
12	O
were	O
"	O
suggestive	O
"	O
(	O
LRS	O
>	O
9	O
.	O
4	O
,	O
genome	O
-	O
wide	O
p	O
=	O
0	O
.	O
65	O
;	O
see	O
Additional	O
File	O
1	O
)	O
.	O

A	O
significant	O
(	O
LRS	O
>	O
20	O
.	O
5	O
;	O
genome	O
-	O
wide	O
p	O
=	O
0	O
.	O
05	O
)	O
QTL	O
for	O
sensitivity	O
to	O
1	O
mM	O
QHCl	O
was	O
indicated	O
on	O
chromosome	O
6	O
,	O
with	O
a	O
second	O
,	O
suggestive	O
(	O
LRS	O
>	O
11	O
.	O
4	O
;	O
genome	O
-	O
wide	O
p	O
=	O
0	O
.	O
65	O
)	O
QTL	O
on	O
chromosome	O
8	O
(	O
Figure	O
2A	O
)	O
;	O
at	O
3	O
mM	O
QHCl	O
,	O
both	O
of	O
these	O
QTL	O
were	O
suggestive	O
(	O
LRS	O
>	O
10	O
.	O
9	O
)	O
but	O
did	O
not	O
reach	O
genome	O
-	O
wide	O
significance	O
(	O
Figure	O
2B	O
)	O
.	O

Figure	O
2	O

A	O
major	O
QTL	O
for	O
QHCl	O
taste	O
on	O
mouse	O
chromosome	O
6	O
.	O

(	O
Top	O
panel	O
)	O
The	O
interval	O
map	O
(	O
see	O
Methods	O
)	O
shows	O
a	O
significant	O
QTL	O
on	O
chromosome	O
6	O
(	O
green	O
)	O
and	O
a	O
suggestive	O
QTL	O
on	O
chromosome	O
8	O
(	O
yellow	O
)	O
affecting	O
taste	O
responses	O
to	O
1	O
mM	O
QHCl	O
.	O

(	O
Bottom	O
panel	O
)	O
For	O
3	O
mM	O
QHCl	O
,	O
both	O
QTL	O
were	O
suggestive	O
(	O
yellow	O
)	O
.	O

The	O
dashed	O
line	O
indicates	O
genome	O
-	O
wide	O
significance	O
.	O

The	O
chromosome	O
6	O
QTL	O
was	O
linked	O
to	O
a	O
single	O
marker	O
,	O
D6Mit13	O
(	O
Table	O
2	O
,	O
Figure	O
3	O
)	O
.	O

Adjacent	O
proximal	O
markers	O
D6Mit254	O
and	O
D6Mit194	O
are	O
unlinked	O
to	O
the	O
QHCl	O
QTL	O
,	O
as	O
is	O
distal	O
marker	O
D6Mit374	O
.	O

Across	O
the	O
17	O
RI	O
lines	O
tested	O
there	O
is	O
at	O
least	O
one	O
recombination	O
event	O
between	O
D6Mit13	O
and	O
either	O
D6Mit254	O
(	O
and	O
D6Mit194	O
,	O
the	O
physical	O
position	O
of	O
which	O
is	O
not	O
well	O
defined	O
)	O
or	O
D6Mit374	O
.	O

An	O
additional	O
proximal	O
marker	O
,	O
D6Mit61	O
,	O
which	O
lies	O
between	O
D6Mit194	O
and	O
D6Mit13	O
,	O
was	O
identified	O
from	O
genotypes	O
of	O
the	O
BXD	O
lines	O
reported	O
by	O
the	O
Jackson	O
Laboratories	O
.	O

BXD	O
/	O
Ty	O
-	O
34	O
RI	O
mice	O
display	O
a	O
clear	O
D2	O
phenotype	O
for	O
QHCl	O
taste	O
(	O
Figure	O
1C	O
)	O
and	O
D2	O
genotype	O
for	O
D6Mit13	O
,	O
but	O
have	O
a	O
B6	O
genotype	O
for	O
D6Mit61	O
[	O
39	O
,	O
40	O
]	O
,	O
indicating	O
that	O
D6Mit61	O
is	O
unlinked	O
to	O
the	O
QHCl	O
QTL	O
.	O

Therefore	O
,	O
this	O
QTL	O
interval	O
can	O
be	O
conservatively	O
defined	O
as	O
that	O
portion	O
of	O
mouse	O
chromosome	O
6	O
that	O
lies	O
between	O
D6Mit254	O
and	O
D6Mit374	O
,	O
but	O
is	O
most	O
likely	O
restricted	O
to	O
the	O
region	O
between	O
D6Mit61	O
and	O
D6Mit374	O
.	O

Physical	O
mapping	O
of	O
the	O
single	O
linked	O
marker	O
,	O
D6Mit13	O
,	O
and	O
the	O
two	O
closest	O
unlinked	O
markers	O
,	O
D6Mit61and	O
D6Mit374	O
,	O
was	O
performed	O
in	O
silico	O
based	O
on	O
the	O
May	O
,	O
2004	O
build	O
of	O
the	O
public	O
B6	O
genome	O
.	O

Based	O
on	O
these	O
marker	O
positions	O
,	O
the	O
size	O
of	O
the	O
QHCl	O
chromosome	O
6	O
QTL	O
is	O
less	O
than	O
5	O
.	O
0	O
Mb	O
(	O
Figure	O
3	O
)	O
.	O

This	O
region	O
contains	O
a	O
number	O
of	O
known	O
genes	O
,	O
all	O
but	O
eleven	O
of	O
which	O
encode	O
members	O
of	O
two	O
large	O
receptor	O
families	O
:	O
natural	O
killer	O
cell	O
lectin	O
-	O
like	O
receptors	O
,	O
and	O
T2R	O
-	O
type	O
taste	O
receptors	O
.	O

The	O
Tas2r	O
genes	O
(	O
which	O
encode	O
the	O
T2Rs	O
)	O
are	O
found	O
clustered	O
within	O
a	O
1	O
.	O
2	O
Mb	O
interval	O
on	O
either	O
side	O
of	O
D6Mit13	O
(	O
Figure	O
3	O
,	O
Figure	O
4	O
)	O
.	O

Because	O
of	O
their	O
proximity	O
to	O
the	O
linked	O
marker	O
,	O
their	O
demonstrated	O
expression	O
in	O
taste	O
receptor	O
cells	O
,	O
and	O
their	O
role	O
in	O
the	O
detection	O
of	O
at	O
least	O
some	O
bitter	O
-	O
tasting	O
compounds	B-CHEBI
,	O
we	O
hypothesized	O
that	O
one	O
or	O
more	O
of	O
the	O
24	O
Tas2rs	O
at	O
this	O
locus	O
were	O
responsible	O
for	O
the	O
major	O
QHCl	O
taste	O
sensitivity	O
QTL	O
.	O

Figure	O
3	O

The	O
QHCl	O
QTL	O
is	O
linked	O
to	O
a	O
single	O
marker	O
on	O
chromosome	O
6	O
.	O

(	O
A	O
)	O
As	O
shown	O
in	O
the	O
interval	O
map	O
for	O
chromosome	O
6	O
,	O
the	O
trait	O
value	O
(	O
lick	O
ratio	O
for	O
1	O
mM	O
QHCl	O
)	O
correlates	O
strongly	O
across	O
BXD	O
RI	O
strains	O
with	O
the	O
polymorphic	O
marker	O
D6Mit13	O
(	O
bold	O
)	O
.	O

The	O
dashed	O
line	O
indicates	O
genome	O
-	O
wide	O
significance	O
.	O

(	O
B	O
)	O
The	O
QHCl	O
QTL	O
(	O
which	O
lies	O
between	O
unlinked	O
markers	O
D6Mit61	O
and	O
D6Mit	O
374	O
)	O
contains	O
a	O
cluster	O
of	O
putative	O
bitter	O
taste	O
receptor	O
genes	O
,	O
the	O
Tas2rs	O
(	O
gray	O
box	O
)	O
.	O

Physical	O
positions	O
of	O
the	O
polymorphic	O
markers	O
are	O
given	O
in	O
Mb	O
,	O
and	O
are	O
based	O
on	O
the	O
May	O
,	O
2004	O
build	O
of	O
the	O
B6	O
mouse	O
genome	O
.	O

The	O
physical	O
position	O
of	O
D6Mit194	O
(	O
*	O
)	O
is	O
tentative	O
.	O

Figure	O
4	O

A	O
map	O
of	O
the	O
distal	O
chromosome	O
6	O
Tas2r	O
cluster	O
.	O

Twenty	O
-	O
four	O
intact	O
Tas2r	O
genes	O
map	O
to	O
distal	O
chromosome	O
6	O
(	O
black	O
)	O
.	O

The	O
Tas2rs	O
are	O
found	O
in	O
two	O
subclusters	O
on	O
either	O
side	O
of	O
the	O
polymorphic	O
marker	O
D6Mit13	O
(	O
red	O
)	O
and	O
two	O
genes	O
encoding	O
proline	B-CHEBI
-	O
rich	O
salivary	O
proteins	B-CHEBI
(	O
Prp2	O
and	O
Prh1	O
;	O
red	O
)	O
.	O

Map	O
positions	O
,	O
in	O
Mb	O
,	O
represent	O
chromosome	O
6	O
positions	O
in	O
the	O
May	O
,	O
2004	O
assembly	O
of	O
the	O
B6	O
genome	O
.	O

T2R	O
alleles	O

If	O
one	O
(	O
or	O
more	O
)	O
Tas2rs	O
underlie	O
the	O
chromosome	O
6	O
QHCl	O
taste	O
sensitivity	O
QTL	O
,	O
we	O
would	O
predict	O
that	O
one	O
(	O
or	O
more	O
)	O
Tas2r	O
genes	O
would	O
exhibit	O
one	O
of	O
three	O
likely	O
characteristics	O
:	O
(	O
1	O
)	O
A	O
Tas2r	O
allele	O
is	O
a	O
pseudogene	O
,	O
or	O
is	O
deleted	O
,	O
in	O
D2	O
(	O
QHCL	O
-	O
insensitive	O
)	O
,	O
but	O
not	O
B6	O
(	O
QHCl	O
-	O
sensitive	O
)	O
,	O
mice	O
;	O
(	O
2	O
)	O
Missense	O
mutations	O
in	O
the	O
single	O
coding	O
exon	O
of	O
a	O
D2	O
Tas2r	O
allele	O
impact	O
protein	B-CHEBI
functions	O
such	O
as	O
ligand	O
binding	O
or	O
receptor	O
coupling	O
to	O
downstream	O
signaling	O
cascades	O
;	O
(	O
3	O
)	O
Mutations	O
in	O
noncoding	O
or	O
regulatory	O
regions	O
of	O
a	O
D2	O
Tas2r	O
allele	O
affects	O
expression	O
of	O
the	O
protein	B-CHEBI
product	I-CHEBI
.	O

Though	O
we	O
considered	O
all	O
three	O
of	O
these	O
to	O
be	O
valid	O
possibilities	O
,	O
we	O
initially	O
focused	O
on	O
the	O
likelihood	O
that	O
deletion	O
or	O
mutation	O
within	O
the	O
coding	O
sequence	O
of	O
a	O
single	O
D2	O
Tas2r	O
would	O
correlate	O
with	O
the	O
QHCl	O
taste	O
insensitivity	O
phenotype	O
.	O

Twenty	O
-	O
four	O
intact	O
Tas2rs	O
,	O
along	O
with	O
three	O
apparent	O
Tas2r	O
pseudogenes	O
,	O
have	O
been	O
identified	O
in	O
the	O
distal	O
chromosome	O
6	O
cluster	O
of	O
B6	O
mice	O
[	O
19	O
]	O
(	O
Figure	O
4	O
)	O
.	O

We	O
designed	O
oligonucleotides	O
to	O
non	O
-	O
coding	O
regions	O
flanking	O
the	O
coding	O
sequence	O
of	O
each	O
intact	O
Tas2r	O
[	O
see	O
Additional	O
file	O
2	O
]	O
.	O

Using	O
these	O
oligos	O
,	O
we	O
amplified	O
each	O
Tas2r	O
coding	O
sequence	O
from	O
D2	O
genomic	O
DNA	O
.	O

PCR	O
products	O
were	O
subcloned	O
into	O
cloning	O
vectors	O
and	O
sequenced	O
.	O

Comparisons	O
of	O
the	O
sequences	O
of	O
B6	O
and	O
D2	O
orthologues	O
revealed	O
that	O
only	O
two	O
of	O
the	O
twenty	O
-	O
four	O
Tas2r	O
alleles	O
examined	O
,	O
Tas2r106	O
and	O
Tas2r124	O
,	O
were	O
identical	O
across	O
strains	O
at	O
the	O
amino	B-CHEBI
acid	I-CHEBI
level	O
(	O
data	O
not	O
shown	O
)	O
.	O

A	O
third	O
,	O
Tas2r120	O
,	O
could	O
not	O
be	O
amplified	O
from	O
D2	O
genomic	O
DNA	O
(	O
Figure	O
5	O
)	O
using	O
either	O
of	O
two	O
pairs	O
of	O
oligonucleotides	O
(	O
Additional	O
file	O
2	O
)	O
,	O
suggesting	O
that	O
this	O
Tas2r	O
is	O
deleted	O
in	O
D2	O
mice	O
.	O

Two	O
D2	O
alleles	O
,	O
Tas2r103	O
and	O
Tas2r117	O
,	O
contained	O
numerous	O
missense	O
mutations	O
and	O
small	O
deletions	O
that	O
create	O
frame	O
shifts	O
and	O
premature	O
termination	O
;	O
these	O
two	O
genes	O
may	O
be	O
pseudogenes	O
in	O
this	O
strain	O
.	O

The	O
remaining	O
19	O
Tas2rs	O
contained	O
between	O
one	O
and	O
16	O
missense	O
mutations	O
.	O

All	O
24	O
Tas2rs	O
examined	O
have	O
different	O
alleles	O
in	O
B6	O
and	O
D2	O
mice	O
,	O
and	O
307	O
single	O
nucleotide	O
polymorphisms	O
are	O
present	O
within	O
coding	O
exons	O
(	O
data	O
not	O
shown	O
)	O
.	O

Although	O
polymorphic	O
residues	B-CHEBI
between	O
B6	O
and	O
D2	O
Tas2rs	O
are	O
found	O
in	O
all	O
regions	O
of	O
the	O
receptors	O
,	O
23	O
%	O
of	O
the	O
amino	B-CHEBI
acid	I-CHEBI
changes	O
seen	O
are	O
within	O
the	O
first	O
two	O
extracellular	O
loops	O
of	O
the	O
T2Rs	O
(	O
data	O
not	O
shown	O
)	O
.	O

Figure	O
5	O

Allelic	O
variation	O
across	O
strains	O
for	O
four	O
Tas2rs	O
.	O

B6	O
and	O
D2	O
alleles	O
of	O
four	O
Tas2rs	O
can	O
be	O
differentiated	O
based	O
on	O
diagnostic	O
restriction	O
digests	O
of	O
amplified	O
PCR	O
products	O
(	O
Tas2r105	O
,	O
Tas2r116	O
and	O
Tas2r131	O
)	O
or	O
on	O
the	O
presence	O
or	O
absence	O
of	O
a	O
PCR	O
product	O
(	O
Tas2r120	O
)	O
.	O

In	O
each	O
of	O
the	O
17	O
BXD	O
strains	O
tested	O
,	O
Tas2r	O
genotype	O
was	O
always	O
correlated	O
with	O
QHCl	O
taster	O
phenotype	O
(	O
blue	O
=	O
B6	O
taster	O
phenotype	O
,	O
red	O
=	O
D2	O
taster	O
phenotype	O
)	O
.	O

See	O
additional	O
file	O
1	O
:	O
Table	O
3	O
for	O
restriction	O
enzymes	O
and	O
oligonucleotides	O
.	O

The	O
variability	O
between	O
orthologous	O
receptors	O
in	O
these	O
two	O
inbred	O
strains	O
suggested	O
that	O
it	O
might	O
be	O
possible	O
to	O
narrow	O
the	O
physical	O
boundaries	O
of	O
the	O
QHCl	O
taste	O
QTL	O
by	O
determining	O
which	O
Tas2r	O
alleles	O
are	O
correlated	O
with	O
QHCl	O
taste	O
sensitivity	O
.	O

Therefore	O
,	O
we	O
proceeded	O
to	O
screen	O
genomic	O
DNA	O
from	O
29	O
available	O
BXD	O
RI	O
lines	O
,	O
including	O
the	O
17	O
that	O
we	O
had	O
used	O
in	O
taste	O
testing	O
,	O
for	O
the	O
Tas2r	O
alleles	O
they	O
contained	O
.	O

In	O
most	O
cases	O
,	O
we	O
were	O
able	O
to	O
identify	O
diagnostic	O
restriction	O
endonuclease	O
digests	O
that	O
would	O
allow	O
us	O
to	O
quickly	O
identify	O
whether	O
a	O
particular	O
Tas2r	O
PCR	O
product	O
was	O
amplified	O
from	O
a	O
B6	O
or	O
D2	O
allele	O
.	O

We	O
did	O
not	O
analyze	O
three	O
genes	O
(	O
Tas2r104	O
,	O
Tas2r114	O
and	O
Tas2r110	O
)	O
where	O
no	O
diagnostic	O
restriction	O
endonuclease	O
could	O
be	O
identified	O
.	O

For	O
Tas2r120	O
,	O
which	O
is	O
likely	O
deleted	O
in	O
D2	O
mice	O
,	O
the	O
absence	O
of	O
a	O
PCR	O
product	O
was	O
diagnostic	O
of	O
the	O
D2	O
genotype	O
for	O
this	O
gene	O
.	O

Surprisingly	O
,	O
we	O
discovered	O
that	O
there	O
have	O
been	O
no	O
apparent	O
recombination	O
events	O
within	O
the	O
distal	O
chromosome	O
6	O
cluster	O
during	O
the	O
generation	O
of	O
the	O
BXD	O
RI	O
lines	O
.	O

For	O
all	O
RI	O
lines	O
tested	O
,	O
every	O
Tas2r	O
within	O
an	O
individual	O
RI	O
line	O
originated	O
from	O
the	O
same	O
parental	O
strain	O
(	O
Figures	O
5	O
,	O
6	O
)	O
.	O

Furthermore	O
,	O
the	O
genotype	O
of	O
each	O
Tas2r	O
gene	O
always	O
correlated	O
with	O
the	O
QHCl	O
taste	O
phenotype	O
(	O
Figures	O
6	O
,	O
7	O
)	O
,	O
suggesting	O
that	O
the	O
entire	O
Tas2r	O
cluster	O
is	O
a	O
single	O
haplotype	O
that	O
varies	O
with	O
QHCl	O
taster	O
status	O
.	O

Figure	O
6	O

The	O
Tas2r	O
cluster	O
is	O
a	O
single	O
haplotype	O
in	O
BXD	O
/	O
Ty	O
RI	O
mice	O
.	O

The	O
coding	O
exon	O
of	O
each	O
of	O
21	O
Tas2rs	O
in	O
the	O
distal	O
chromosome	O
6	O
cluster	O
was	O
amplified	O
genomic	O
DNA	O
from	O
29	O
BXD	O
/	O
Ty	O
RI	O
strains	O
.	O

Each	O
Tas2r	O
within	O
an	O
individual	O
BXD	O
strain	O
originated	O
from	O
the	O
same	O
parental	O
strain	O
(	O
B6	O
allele	O
=	O
gray	O
,	O
D2	O
allele	O
=	O
white	O
)	O
.	O

The	O
17	O
BXD	O
strains	O
that	O
were	O
behaviorally	O
tested	O
in	O
this	O
study	O
are	O
indicated	O
(	O
*	O
)	O
.	O

Figure	O
7	O

Tas2r	O
genotype	O
correlates	O
with	O
QHCl	O
taste	O
phenotype	O
.	O

Mean	O
lick	O
ratios	O
of	O
B6	O
,	O
D2	O
and	O
BXD	O
strains	O
reported	O
in	O
Figure	O
1	O
are	O
grouped	O
based	O
on	O
Tas2r	O
haplotype	O
(	O
B6	O
haplotype	O
=	O
blue	O
,	O
D2	O
haplotype	O
=	O
red	O
)	O
.	O

B6	O
mice	O
(	O
blue	O
line	O
on	O
left	O
panel	O
)	O
are	O
more	O
sensitive	O
to	O
1	O
mM	O
and	O
3	O
mM	O
QHCl	O
than	O
are	O
D2	O
mice	O
(	O
red	O
line	O
on	O
left	O
panel	O
)	O
in	O
brief	O
access	O
taste	O
tests	O
.	O

Similarly	O
,	O
BXD	O
strains	O
with	O
the	O
B6	O
Tas2r	O
haplotype	O
(	O
blue	O
lines	O
,	O
right	O
panel	O
)	O
are	O
more	O
sensitive	O
to	O
QHCl	O
than	O
are	O
BXD	O
strains	O
with	O
the	O
D2	O
Tas2r	O
haplotype	O
(	O
red	O
lines	O
,	O
right	O
panel	O
)	O
.	O

The	O
BXD	O
strains	O
are	O
listed	O
in	O
order	O
from	O
least	O
to	O
most	O
sensitive	O
to	O
1	O
mM	O
QHCL	O
.	O

Discussion	O

The	O
gustatory	O
system	O
of	O
mammals	O
is	O
thought	O
to	O
detect	O
thousands	O
of	O
chemically	B-CHEBI
-	O
diverse	O
bitter	O
-	O
tasting	O
substances	B-CHEBI
[	O
41	O
]	O
.	O

Although	O
specific	O
receptors	O
,	O
enzymes	O
and	O
channels	O
have	O
been	O
implicated	O
in	O
the	O
transduction	O
of	O
bitter	O
stimuli	O
,	O
how	O
interactions	O
of	O
bitter	O
stimuli	O
with	O
taste	O
receptor	O
cells	O
lead	O
to	O
cellular	O
activation	O
and	O
signaling	O
to	O
the	O
central	O
nervous	O
system	O
is	O
still	O
poorly	O
understood	O
.	O

We	O
have	O
found	O
that	O
a	O
single	O
QTL	O
on	O
distal	O
chromosome	O
6	O
accounts	O
for	O
most	O
of	O
the	O
variation	O
in	O
QHCL	O
taste	O
sensitivity	O
between	O
B6	O
and	O
D2	O
mice	O
.	O

This	O
QTL	O
maps	O
to	O
the	O
same	O
chromosomal	O
position	O
as	O
a	O
previously	O
identified	O
QTL	O
for	O
quinine	B-CHEBI
intake	O
,	O
Qui	B-CHEBI
[	O
16	O
,	O
28	O
]	O
,	O
indicating	O
that	O
taste	O
is	O
the	O
major	O
factor	O
in	O
regulating	O
quinine	B-CHEBI
aversion	O
.	O

This	O
is	O
an	O
important	O
distinction	O
,	O
as	O
the	O
consumption	O
of	O
bitter	O
-	O
tasting	O
stimuli	O
can	O
be	O
dependent	O
on	O
factors	O
independent	O
of	O
taste	O
,	O
such	O
as	O
toxicity	O
[	O
29	O
]	O
.	O

Using	O
17	O
RI	O
lines	O
and	O
762	O
chromosomal	O
markers	O
,	O
we	O
have	O
restricted	O
the	O
quinine	B-CHEBI
taste	O
QTL	O
to	O
a	O
<	O
5	O
Mb	O
region	O
on	O
distal	O
chromosome	O
6	O
that	O
contains	O
24	O
Tas2r	O
genes	O
.	O

At	O
least	O
60	O
other	O
genes	O
also	O
lie	O
within	O
this	O
interval	O
,	O
including	O
two	O
genes	O
that	O
encode	O
proline	B-CHEBI
-	O
rich	O
salivary	O
proteins	B-CHEBI
,	O
Prp2	O
and	O
Prh1	O
;	O
these	O
proteins	B-CHEBI
appear	O
to	O
play	O
no	O
direct	O
role	O
in	O
bitter	O
taste	O
[	O
48	O
]	O
.	O

Tas2rs	O
are	O
the	O
most	O
likely	O
candidates	O
for	O
the	O
QHCl	O
quantitative	O
trait	O
gene	O
(	O
s	O
)	O
due	O
to	O
:	O
(	O
1	O
)	O
their	O
expression	O
in	O
taste	O
receptor	O
cells	O
and	O
(	O
2	O
)	O
genetic	O
and	O
functional	O
evidence	O
linking	O
them	O
to	O
the	O
detection	O
of	O
a	O
number	O
of	O
bitter	O
taste	O
stimuli	O
.	O

As	O
of	O
yet	O
there	O
is	O
no	O
evidence	O
for	O
quinine	B-CHEBI
activation	O
of	O
T2Rs	O
from	O
functional	O
assays	O
of	O
these	O
receptors	O
in	O
heterologous	O
cells	O
or	O
membrane	O
preparations	O
,	O
likely	O
due	O
to	O
the	O
lipophilic	O
nature	O
of	O
quinine	B-CHEBI
[	O
23	O
]	O
.	O

However	O
,	O
several	O
physiological	O
studies	O
have	O
suggested	O
that	O
quinine	B-CHEBI
can	O
directly	O
activate	O
G	O
proteins	B-CHEBI
or	O
cationic	B-CHEBI
conductances	O
,	O
or	O
can	O
block	O
K	B-CHEBI
+	I-CHEBI
channels	O
in	O
taste	O
receptor	O
cells	O
[	O
34	O
-	O
36	O
]	O
.	O

While	O
our	O
data	O
indicates	O
that	O
quinine	B-CHEBI
taste	O
is	O
largely	O
T2R	O
-	O
dependent	O
,	O
it	O
is	O
not	O
exclusively	O
so	O
.	O

For	O
example	O
,	O
the	O
BXD	O
RI	O
lines	O
exhibited	O
a	O
range	O
of	O
quinine	B-CHEBI
sensitivity	O
,	O
with	O
several	O
strains	O
having	O
similar	O
sensitivities	O
to	O
that	O
of	O
B6	O
,	O
some	O
strains	O
with	O
sensitivities	O
similar	O
to	O
that	O
of	O
D2	O
,	O
and	O
a	O
third	O
group	O
with	O
a	O
more	O
intermediate	O
phenotype	O
(	O
Figures	O
1	O
,	O
7	O
)	O
.	O

This	O
observation	O
is	O
consistent	O
with	O
a	O
polygenic	O
basis	O
for	O
quinine	B-CHEBI
taste	O
[	O
16	O
,	O
26	O
]	O
.	O

Also	O
,	O
a	O
suggestive	O
QTL	O
on	O
chromosome	O
8	O
does	O
not	O
contain	O
any	O
Tas2r	O
genes	O
,	O
but	O
does	O
contain	O
a	O
number	O
of	O
genes	O
encoding	O
ion	B-CHEBI
channels	O
,	O
enzymes	O
and	O
members	O
of	O
other	O
receptor	O
families	O
(	O
our	O
unpublished	O
data	O
)	O
.	O

It	O
will	O
be	O
interesting	O
to	O
determine	O
whether	O
this	O
suggestive	O
QTL	O
is	O
linked	O
to	O
quinine	B-CHEBI
taste	O
and	O
,	O
if	O
so	O
,	O
whether	O
it	O
is	O
specific	O
for	O
this	O
single	O
bitter	O
stimulus	O
or	O
more	O
broadly	O
related	O
to	O
all	O
bitter	O
taste	O
.	O

Of	O
the	O
29	O
BXD	O
RI	O
lines	O
examined	O
,	O
there	O
was	O
no	O
apparent	O
recombination	O
event	O
within	O
the	O
chromosome	O
6	O
Tas2r	O
cluster	O
.	O

While	O
increasing	O
the	O
number	O
of	O
BXD	O
RI	O
lines	O
or	O
the	O
number	O
of	O
markers	O
used	O
for	O
genotyping	O
them	O
would	O
facilitate	O
the	O
definition	O
of	O
smaller	O
QTL	O
intervals	O
,	O
in	O
this	O
case	O
such	O
an	O
effort	O
is	O
unlikely	O
to	O
permit	O
the	O
identification	O
of	O
one	O
or	O
a	O
few	O
Tas2rs	O
involved	O
in	O
quinine	B-CHEBI
taste	O
.	O

For	O
example	O
,	O
we	O
examined	O
six	O
lines	O
of	O
AXB	O
and	O
BXA	O
RIs	O
with	O
reported	O
recombinations	O
around	O
D6Mit13	O
;	O
a	O
small	O
sampling	O
of	O
the	O
Tas2rs	O
in	O
these	O
RI	O
lines	O
again	O
indicated	O
no	O
recombinations	O
within	O
the	O
Tas2r	O
cluster	O
(	O
data	O
not	O
shown	O
)	O
.	O

Behavioral	O
genetic	O
approaches	O
have	O
been	O
invaluable	O
for	O
identifying	O
genes	O
involved	O
in	O
taste	O
function	O
,	O
such	O
as	O
the	O
Tas1r3	O
gene	O
that	O
encodes	O
a	O
receptor	O
important	O
for	O
sweet	O
and	O
umami	O
taste	O
[	O
42	O
]	O
.	O

Positional	O
cloning	O
also	O
permitted	O
the	O
identification	O
of	O
the	O
Tas2r	O
responsible	O
for	O
the	O
majority	O
of	O
variance	O
of	O
phenylthiocarbamide	O
(	O
PTC	O
)	O
taste	O
sensitivity	O
in	O
humans	O
[	O
18	O
]	O
.	O

In	O
both	O
of	O
these	O
cases	O
,	O
however	O
,	O
the	O
genes	O
linked	O
to	O
saccharin	O
or	O
PTC	O
taste	O
were	O
not	O
tightly	O
clustered	O
with	O
paralogues	O
.	O

For	O
bitter	O
taste	O
,	O
behavioral	O
genetic	O
approaches	O
may	O
be	O
more	O
useful	O
for	O
identifying	O
genes	O
encoding	O
downstream	O
signaling	O
molecules	B-CHEBI
or	O
components	O
of	O
T2R	O
-	O
independent	O
transduction	O
mechanisms	O
.	O

For	O
example	O
,	O
a	O
QTL	O
for	O
PROP	B-CHEBI
avoidance	O
has	O
been	O
suggested	O
on	O
chromosome	O
7	O
[	O
16	O
]	O
,	O
and	O
we	O
observe	O
a	O
suggestive	O
QTL	O
for	O
quinine	B-CHEBI
taste	O
on	O
chromosome	O
8	O
(	O
Figure	O
2	O
)	O
;	O
in	O
neither	O
case	O
are	O
Tas2rs	O
found	O
at	O
these	O
loci	O
(	O
data	O
not	O
shown	O
)	O
.	O

It	O
is	O
somewhat	O
puzzling	O
that	O
22	O
of	O
the	O
24	O
Tas2rs	O
examined	O
encode	O
variant	O
proteins	B-CHEBI
in	O
B6	O
and	O
D2	O
mice	O
even	O
though	O
these	O
strains	O
exhibit	O
similar	O
taste	O
responses	O
to	O
bitter	O
compounds	B-CHEBI
such	O
as	O
DB	O
or	O
cyclohexamide	B-CHEBI
[	O
47	O
]	O
.	O

Taken	O
together	O
,	O
these	O
observations	O
suggest	O
that	O
Tas2rs	O
are	O
quite	O
tolerant	O
of	O
variation	O
,	O
and	O
that	O
perhaps	O
most	O
of	O
the	O
differences	O
observed	O
do	O
not	O
affect	O
domains	O
important	O
for	O
ligand	O
interactions	O
or	O
receptor	O
-	O
mediated	O
signaling	O
mechanisms	O
.	O

Interestingly	O
,	O
23	O
%	O
of	O
missense	O
mutations	O
in	O
D2	O
Tas2rs	O
affect	O
the	O
first	O
two	O
extracellular	O
loops	O
of	O
the	O
receptors	O
.	O

These	O
two	O
loops	O
have	O
been	O
recently	O
shown	O
to	O
affect	O
the	O
ligand	O
response	O
profiles	O
of	O
some	O
T2Rs	O
[	O
23	O
]	O
.	O

More	O
systematic	O
analyses	O
of	O
structure	O
-	O
function	O
relationships	O
between	O
these	O
T2R	O
variants	O
and	O
an	O
array	O
of	O
bitter	O
stimuli	O
are	O
necessary	O
to	O
determine	O
which	O
changes	O
may	O
impact	O
ligand	O
binding	O
,	O
interactions	O
with	O
other	O
proteins	B-CHEBI
,	O
or	O
overall	O
receptor	O
structure	O
.	O

Such	O
large	O
numbers	O
of	O
nonsynonymous	O
substitutions	O
between	O
orthologues	O
is	O
suggestive	O
of	O
adaptive	O
selection	O
.	O

Analysis	O
of	O
sequence	O
diversity	O
of	O
Tas2rs	O
in	O
humans	O
,	O
great	O
apes	O
and	O
old	O
world	O
monkeys	O
suggest	O
that	O
Tas2rs	O
are	O
subject	O
to	O
some	O
degree	O
of	O
positive	O
selection	O
[	O
43	O
,	O
44	O
]	O
.	O

However	O
,	O
the	O
fact	O
that	O
these	O
two	O
mouse	O
strains	O
,	O
members	O
of	O
the	O
same	O
species	O
,	O
are	O
so	O
closely	O
related	O
makes	O
this	O
explanation	O
problematic	O
.	O

It	O
is	O
possible	O
that	O
B6	O
and	O
D2	O
mice	O
,	O
which	O
have	O
a	O
similar	O
origin	O
in	O
the	O
early	O
20th	O
century	O
,	O
inherited	O
different	O
Tas2r	O
haplotypes	O
present	O
in	O
wild	O
mouse	O
populations	O
prior	O
to	O
inbreeding	O
.	O

Characterization	O
of	O
Tas2r	O
sequences	O
of	O
several	O
wild	O
mouse	O
species	O
or	O
subspecies	O
,	O
or	O
in	O
other	O
inbred	O
lines	O
,	O
would	O
shed	O
light	O
on	O
this	O
issue	O
.	O

Conclusion	O

In	O
conclusion	O
,	O
we	O
have	O
found	O
that	O
sensitivity	O
to	O
the	O
bitter	O
-	O
tasting	O
substance	B-CHEBI
quinine	B-CHEBI
,	O
as	O
assayed	O
by	O
a	O
taste	O
specific	O
brief	O
-	O
access	O
test	O
,	O
is	O
a	O
polygenic	O
trait	O
in	O
mice	O
.	O

However	O
,	O
the	O
major	O
mechanism	O
for	O
quinine	B-CHEBI
taste	O
transduction	O
is	O
likely	O
dependent	O
on	O
one	O
or	O
more	O
T2R	O
receptors	O
.	O

Most	O
Tas2r	O
genes	O
in	O
the	O
distal	O
chromosome	O
6	O
cluster	O
are	O
polymorphic	O
across	O
inbred	O
strains	O
of	O
mice	O
,	O
and	O
this	O
cluster	O
forms	O
a	O
single	O
haplotype	O
that	O
correlates	O
with	O
quinine	B-CHEBI
taste	O
sensitivity	O
.	O

The	O
numerous	O
differences	O
in	O
T2R	O
protein	B-CHEBI
sequence	O
between	O
these	O
two	O
mouse	O
strains	O
suggests	O
that	O
T2Rs	O
are	O
broadly	O
tuned	O
receptors	O
quite	O
tolerant	O
to	O
sequence	O
variation	O
.	O

This	O
tolerance	O
may	O
help	O
to	O
preserve	O
the	O
ability	O
of	O
T2R	O
-	O
expressing	O
,	O
bitter	O
-	O
sensitive	O
taste	O
cells	O
to	O
respond	O
to	O
a	O
wide	O
array	O
of	O
potentially	O
toxic	B-CHEBI
stimuli	O
.	O

Methods	O

Mice	O
and	O
solutions	O

A	O
total	O
of	O
188	O
adult	O
male	O
and	O
female	O
mice	O
were	O
behaviorally	O
tested	O
in	O
these	O
experiments	O
:	O
16	O
C57BL	O
/	O
6J	O
(	O
B6	O
;	O
9	O
males	O
,	O
7	O
females	O
)	O
,	O
12	O
DBA	O
/	O
2J	O
(	O
6	O
females	O
,	O
6	O
males	O
)	O
,	O
and	O
90	O
BXD	O
/	O
Ty	O
recombinant	O
inbred	O
mice	O
(	O
average	O
=	O
5	O
/	O
line	O
;	O
64	O
males	O
,	O
26	O
females	O
)	O
from	O
17	O
unique	O
lines	O
(	O
1	O
,	O
2	O
,	O
5	O
,	O
6	O
,	O
11	O
,	O
13	O
,	O
14	O
,	O
15	O
,	O
20	O
,	O
21	O
,	O
24	O
,	O
27	O
,	O
29	O
,	O
31	O
,	O
32	O
,	O
33	O
,	O
34	O
)	O
.	O

All	O
mice	O
were	O
either	O
obtained	O
from	O
Jackson	O
Laboratories	O
(	O
Bar	O
Harbor	O
,	O
ME	O
)	O
,	O
or	O
were	O
bred	O
from	O
mating	O
pairs	O
at	O
UTHSC	O
.	O

At	O
time	O
of	O
testing	O
,	O
mice	O
were	O
individually	O
housed	O
in	O
standard	O
shoebox	O
cages	O
with	O
woodchip	O
bedding	O
and	O
ad	O
libitum	O
food	B-CHEBI
(	O
Teklad	O
8640	O
rodent	O
diet	O
)	O
.	O

Taste	O
stimuli	O
used	O
in	O
this	O
experiment	O
were	O
made	O
from	O
reagent	B-CHEBI
-	O
grade	O
chemicals	B-CHEBI
:	O
Sucrose	B-CHEBI
,	O
denatonium	O
benzoate	B-CHEBI
,	O
6	B-CHEBI
-	I-CHEBI
n	I-CHEBI
-	I-CHEBI
propylthiouracil	I-CHEBI
and	O
quinine	B-CHEBI
hydrochloride	B-CHEBI
(	O
Sigma	O
Aldrich	O
Corp	O
.	O
;	O
St	O
.	O
Louis	O
,	O
MO	O
)	O
.	O

Concentrations	O
of	O
each	O
solution	O
were	O
made	O
fresh	O
daily	O
using	O
distilled	O
water	B-CHEBI
,	O
and	O
all	O
taste	O
stimuli	O
were	O
presented	O
at	O
room	O
temperature	O
.	O

All	O
animal	O
protocols	O
were	O
approved	O
by	O
the	O
UTHSC	O
Institutional	O
Animal	O
care	O
and	O
Use	O
Committee	O
.	O

Brief	O
-	O
access	O
tests	O

All	O
behavioral	O
tests	O
were	O
conducted	O
in	O
the	O
commercially	O
available	O
Davis	O
MS	O
-	O
160	O
gustometer	O
(	O
DiLog	O
Instruments	O
,	O
Inc	O
.	O
,	O
Tallahassee	O
FL	O
)	O
.	O

Testing	O
procedures	O
were	O
similar	O
to	O
those	O
described	O
earlier	O
[	O
29	O
,	O
37	O
]	O
.	O

Briefly	O
,	O
after	O
24	O
hours	O
of	O
water	B-CHEBI
deprivation	O
,	O
na	O
i	O
ve	O
mice	O
are	O
given	O
a	O
single	O
20	O
-	O
minute	O
trial	O
consisting	O
of	O
access	O
to	O
a	O
single	O
bottle	O
of	O
distilled	O
water	B-CHEBI
(	O
sipper	O
tube	O
training	O
)	O
.	O

On	O
day	O
2	O
,	O
mice	O
could	O
initiate	O
up	O
to	O
sixteen	O
5	O
s	O
trials	O
with	O
a	O
single	O
lick	O
to	O
one	O
of	O
four	O
bottles	O
containing	O
distilled	O
water	B-CHEBI
(	O
trial	O
training	O
)	O
.	O

Testing	O
occurred	O
in	O
sessions	O
3	O
and	O
4	O
,	O
with	O
one	O
test	O
session	O
per	O
day	O
per	O
mouse	O
.	O

Trials	O
were	O
5	O
s	O
in	O
length	O
with	O
an	O
inter	O
-	O
trial	O
interval	O
of	O
10	O
s	O
,	O
and	O
mice	O
had	O
up	O
to	O
120	O
s	O
to	O
initiate	O
a	O
trial	O
;	O
if	O
a	O
trial	O
was	O
not	O
initiated	O
during	O
this	O
interval	O
,	O
the	O
shutter	O
closed	O
for	O
10	O
s	O
and	O
the	O
next	O
trial	O
was	O
presented	O
.	O

Mice	O
were	O
tested	O
with	O
2	O
concentrations	O
each	O
of	O
4	O
different	O
taste	O
stimuli	O
[	O
1	O
and	O
3	O
mM	O
QHCl	O
,	O
1	O
and	O
3	O
mM	O
DB	O
,	O
3	O
and	O
10	O
mM	O
PROP	B-CHEBI
(	O
unpublished	O
data	O
)	O
,	O
and	O
0	O
.	O
01	O
and	O
0	O
.	O
1	O
M	O
sucrose	B-CHEBI
]	O
.	O

Stimulus	O
trials	O
were	O
presented	O
in	O
3	O
blocks	O
of	O
8	O
trials	O
,	O
for	O
a	O
total	O
of	O
24	O
possible	O
trials	O
per	O
test	O
session	O
.	O

Each	O
block	O
consisted	O
of	O
each	O
concentration	O
of	O
stimulus	O
plus	O
four	O
presentations	O
of	O
distilled	O
water	B-CHEBI
in	O
random	O
order	O
.	O

Individual	O
mice	O
were	O
also	O
tested	O
in	O
random	O
order	O
.	O

The	O
dependent	O
measure	O
for	O
each	O
computed	O
for	O
each	O
mouse	O
was	O
the	O
lick	O
ratio	O
(	O
average	O
number	O
of	O
licks	O
to	O
stimulusx	O
/	O
average	O
number	O
of	O
licks	O
to	O
water	B-CHEBI
)	O
where	O
x	O
is	O
a	O
given	O
concentration	O
of	O
stimulus	O
and	O
the	O
average	O
number	O
of	O
licks	O
to	O
water	B-CHEBI
is	O
derived	O
from	O
the	O
water	B-CHEBI
trials	O
during	O
both	O
test	O
sessions	O
.	O

Lick	O
ratio	O
data	O
for	O
each	O
stimulus	O
were	O
compiled	O
for	O
all	O
individual	O
mice	O
,	O
and	O
means	O
were	O
prepared	O
for	O
each	O
strain	O
.	O

B6	O
vs	O
.	O
D2	O
comparisons	O
(	O
Fig	O
.	O
1A	O
)	O
were	O
made	O
using	O
main	O
effects	O
ANOVA	O
.	O

Lick	O
ratios	O
for	O
individual	O
mice	O
to	O
sucrose	B-CHEBI
were	O
generally	O
~	O
1	O
.	O
0	O
(	O
data	O
not	O
shown	O
)	O
,	O
indicating	O
that	O
either	O
concentration	O
of	O
this	O
compound	B-CHEBI
was	O
licked	O
at	O
a	O
similar	O
rate	O
to	O
water	B-CHEBI
by	O
these	O
thirsty	O
animals	O
.	O

This	O
stimulus	O
was	O
intended	O
as	O
a	O
"	O
neutral	O
"	O
stimulus	O
,	O
albeit	O
one	O
that	O
has	O
different	O
sensory	O
properties	O
than	O
water	B-CHEBI
,	O
and	O
therefore	O
not	O
analyzed	O
further	O
.	O

This	O
was	O
done	O
to	O
encourage	O
sampling	O
on	O
"	O
non	O
-	O
water	B-CHEBI
"	O
trials	O
,	O
as	O
there	O
is	O
some	O
evidence	O
that	O
mice	O
detect	O
distilled	O
vs	O
.	O
adulterated	O
water	B-CHEBI
in	O
brief	O
-	O
access	O
taste	O
tests	O
based	O
on	O
olfactory	O
clues	O
;	O
there	O
is	O
no	O
evidence	O
that	O
mice	O
can	O
detect	O
or	O
distinguish	O
among	O
concentrations	O
of	O
a	O
particular	O
stimulus	O
[	O
37	O
]	O
.	O

QTL	O
mapping	O

Linkage	O
analysis	O
was	O
conducted	O
on	O
BXD	O
mice	O
using	O
freely	O
available	O
software	O
(	O
Map	O
Manager	O
QTX	O
[	O
38	O
]	O
)	O
,	O
and	O
BXD	O
genotype	O
data	O
shared	O
by	O
Robert	O
W	O
.	O
Williams	O
,	O
University	O
of	O
Tennessee	O
Health	O
Science	O
Center	O
[	O
45	O
]	O
.	O

Simple	O
interval	O
mapping	O
was	O
conducted	O
.	O

This	O
method	O
evaluates	O
the	O
association	O
between	O
trait	O
values	O
(	O
lick	O
ratios	O
)	O
and	O
expected	O
genotype	O
of	O
a	O
hypothetical	O
quantitative	O
trait	O
locus	O
(	O
QTL	O
)	O
at	O
multiple	O
analysis	O
points	O
between	O
each	O
pair	O
of	O
adjacent	O
marker	O
loci	O
.	O

The	O
significance	O
of	O
each	O
potential	O
association	O
is	O
measured	O
by	O
the	O
likelihood	O
ratio	O
statistic	O
(	O
LRS	O
;	O
e	O
.	O
g	O
.	O
[	O
46	O
]	O
)	O
.	O

Permutation	O
analysis	O
(	O
x2000	O
)	O
was	O
used	O
to	O
determine	O
genome	O
-	O
wide	O
significance	O
criteria	O
for	O
LRS	O
scores	O
.	O

Significance	O
was	O
set	O
at	O
p	O
<	O
0	O
.	O
05	O
and	O
suggestive	O
refers	O
to	O
p	O
<	O
0	O
.	O
63	O
.	O

Additional	O
markers	O
used	O
to	O
refine	O
the	O
QTL	O
on	O
chromosome	O
6	O
were	O
identified	O
from	O
the	O
Jackson	O
Laboratories	O
online	O
resources	O
for	O
the	O
BXD	O
RI	O
strains	O
[	O
40	O
]	O
.	O

Identification	O
of	O
T2R	O
alleles	O

Oligonucleotides	O
were	O
based	O
on	O
published	O
mTas2r	O
B6	O
or	O
129	O
/	O
SvJ	O
cDNA	O
sequences	O
or	O
on	O
the	O
public	O
B6	O
genome	O
.	O

Entire	O
coding	O
regions	O
plus	O
~	O
50	O
kb	O
of	O
flanking	O
sequence	O
of	O
each	O
single	O
-	O
exon	O
Tas2r	O
was	O
amplified	O
from	O
D2	O
or	O
BXD	O
RI	O
genomic	O
DNA	O
(	O
Jackson	O
Laboratories	O
,	O
Bar	O
Harbor	O
,	O
ME	O
)	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
using	O
a	O
high	O
-	O
fidelity	O
polymerase	O
TaqPro	O
Complete	O
(	O
Denville	O
Scientific	O
,	O
South	O
Plainfield	O
,	O
NJ	O
)	O
.	O

PCR	O
products	O
were	O
subcloned	O
into	O
pGemT	O
-	O
Easy	O
(	O
Promega	O
,	O
Madison	O
,	O
WI	O
)	O
and	O
sequenced	O
at	O
the	O
University	O
of	O
Maryland	O
School	O
of	O
Medicine	O
Biopolymer	O
Core	O
.	O

The	O
sequences	O
of	O
D2	O
products	O
were	O
compared	O
to	O
B6	O
sequences	O
available	O
in	O
Genbank	O
(	O
see	O
Additional	O
file	O
2	O
)	O
,	O
and	O
polymorphisms	O
identified	O
.	O

When	O
possible	O
,	O
unique	O
restriction	O
sites	O
were	O
identified	O
that	O
differentiated	O
B6	O
and	O
D2	O
alleles	O
,	O
and	O
the	O
corresponding	O
restriction	O
endonucleases	O
were	O
used	O
in	O
diagnostic	O
digests	O
of	O
Tas2r	O
cDNAs	O
amplified	O
from	O
genomic	O
DNA	O
of	O
each	O
BXD	O
/	O
Ty	O
RI	O
strain	O
.	O

For	O
Tas2r120	O
,	O
the	O
absence	O
of	O
a	O
PCR	O
product	O
was	O
considered	O
diagnostic	O
of	O
the	O
D2	O
allele	O
.	O

Authors	O
'	O
Contributions	O

TN	O
conducted	O
the	O
in	O
silico	O
analysis	O
of	O
the	O
quinine	B-CHEBI
taste	O
QTL	O
,	O
analyzed	O
the	O
Tas2r	O
genes	O
,	O
participated	O
in	O
the	O
design	O
of	O
the	O
study	O
and	O
drafted	O
the	O
manuscript	O
.	O

JB	O
conducted	O
the	O
behavioral	O
studies	O
and	O
QTL	O
analysis	O
.	O

SM	O
assisted	O
with	O
the	O
in	O
silico	O
analysis	O
of	O
the	O
quinine	B-CHEBI
taste	O
QTL	O
and	O
the	O
Tas2rs	O
,	O
and	O
with	O
the	O
QTL	O
analysis	O
.	O

JB	O
and	O
SM	O
conceived	O
of	O
the	O
study	O
,	O
participated	O
in	O
its	O
design	O
,	O
and	O
edited	O
the	O
manuscript	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Comments	O
and	O
requests	O
should	O
be	O
addressed	O
to	O
JB	O
or	O
SM	O
.	O

Table	O
2	O

Linkage	O
of	O
a	O
QHCl	O
QTL	O
to	O
D6Mit13	O
on	O
chromosome	O
6	O
.	O

Markers	O
are	O
listed	O
from	O
proximal	O
(	O
D6Mit150	O
)	O
to	O
distal	O
(	O
SO8Gnf046	O
.	O
785	O
)	O
,	O
with	O
physical	O
position	O
indicated	O
in	O
Mb	O
.	O

The	O
physical	O
position	O
of	O
D6Mit194	O
(	O
italics	O
)	O
should	O
be	O
considered	O
tentative	O
.	O

The	O
LRS	O
(	O
likelihood	O
ratio	O
statistic	O
)	O
is	O
listed	O
for	O
each	O
locus	O
,	O
signifying	O
the	O
level	O
of	O
association	O
of	O
the	O
trait	O
(	O
QHCl	O
taste	O
sensitivity	O
)	O
with	O
each	O
locus	O
.	O

Variance	O
(	O
Var	O
)	O
refers	O
to	O
the	O
amount	O
of	O
the	O
total	O
trait	O
variance	O
explained	O
by	O
a	O
QTL	O
at	O
this	O
locus	O
,	O
as	O
a	O
percentage	O
.	O

Additive	O
regression	O
coefficients	O
(	O
Add	O
)	O
are	O
listed	O
for	O
each	O
association	O
;	O
in	O
each	O
case	O
the	O
coefficient	O
is	O
positive	O
,	O
indicating	O
that	O
D2	O
alleles	O
increase	O
the	O
trait	O
value	O
(	O
i	O
.	O
e	O
.	O
higher	O
lick	O
ratios	O
)	O
.	O

In	O
simple	O
marker	O
regression	O
analysis	O
,	O
all	O
of	O
these	O
loci	O
are	O
associated	O
with	O
QHCl	O
sensitivity	O
at	O
p	O
<	O
0	O
.	O
001	O
;	O
only	O
the	O
association	O
of	O
sensitivity	O
to	O
1	O
mM	O
QHCl	O
with	O
D6Mit13	O
reaches	O
genome	O
-	O
wide	O
significance	O
(	O
asterisk	O
)	O
.	O

Supplementary	O
Material	O

Additional	O
File	O
2	O

Table	O
4	O
:	O
Molecular	B-CHEBI
biological	O
methods	O
for	O
the	O
analysis	O
of	O
Tas2rs	O
.	O

Click	O
here	O
for	O
file	O

Additional	O
File	O
1	O

Table	O
3	O
:	O
Marker	O
regression	O
results	O
for	O
DB	O
taste	O
sensitivity	O
.	O

Click	O
here	O
for	O
file	O

Acknowledgements	O

The	O
authors	O
thank	O
Sandeep	O
Raghow	O
and	O
Aldan	O
Shank	O
for	O
technical	O
assistance	O
with	O
the	O
behavioral	O
studies	O
and	O
Robert	O
Lane	O
for	O
useful	O
discussions	O
.	O

This	O
study	O
was	O
supported	O
by	O
grants	O
from	O
the	O
National	O
Institute	O
on	O
Deafness	O
and	O
Other	O
Communication	O
Disorders	O
(	O
DC05786	O
to	O
SM	O
,	O
DC04935	O
to	O
JB	O
)	O
,	O
a	O
Program	O
Enrichment	O
Fellowship	O
from	O
the	O
University	O
of	O
Maryland	O
,	O
Baltimore	O
(	O
TN	O
)	O
and	O
by	O
the	O
University	O
of	O
Tennessee	O
Health	O
Sciences	O
Center	O
(	O
JB	O
)	O
.	O

A	O
screen	O
for	O
proteins	B-CHEBI
that	O
interact	O
with	O
PAX6	O
:	O
C	B-CHEBI
-	O
terminal	O
mutations	O
disrupt	O
interaction	O
with	O
HOMER3	O
,	O
DNCL1	O
and	O
TRIM11	O

Abstract	O

Background	O

The	O
PAX6	O
protein	B-CHEBI
is	O
a	O
transcriptional	O
regulator	O
with	O
a	O
key	O
role	O
in	O
ocular	O
and	O
neurological	O
development	O
.	O

Individuals	O
with	O
heterozygous	O
loss	O
-	O
of	O
-	O
function	O
mutations	O
in	O
the	O
PAX6	O
gene	O
have	O
malformations	O
of	O
the	O
eye	O
and	O
brain	O
.	O

Little	O
is	O
known	O
about	O
the	O
interactions	O
of	O
PAX6	O
with	O
other	O
proteins	B-CHEBI
,	O
so	O
we	O
carried	O
out	O
a	O
systematic	O
screen	O
for	O
proteins	B-CHEBI
that	O
interact	O
with	O
PAX6	O
.	O

Results	O

We	O
used	O
bioinformatics	O
techniques	O
to	O
characterise	O
a	O
highly	O
conserved	O
peptide	O
at	O
the	O
C	B-CHEBI
-	O
terminus	O
of	O
the	O
PAX6	O
protein	B-CHEBI
.	O

Yeast	O
two	O
-	O
hybrid	O
library	O
screens	O
were	O
then	O
carried	O
out	O
to	O
identify	O
brain	O
-	O
expressed	O
proteins	B-CHEBI
that	O
interact	O
with	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
and	O
with	O
the	O
entire	O
PAX6	O
proline	B-CHEBI
-	O
serine	B-CHEBI
-	O
threonine	B-CHEBI
-	O
rich	O
domain	O
.	O

Three	O
novel	O
PAX6	O
-	O
interacting	O
proteins	B-CHEBI
were	O
identified	O
:	O
the	O
post	O
-	O
synaptic	O
density	O
(	O
PSD	O
)	O
protein	B-CHEBI
HOMER3	O
,	O
the	O
dynein	O
subunit	O
DNCL1	O
,	O
and	O
the	O
tripartite	O
motif	O
protein	B-CHEBI
TRIM11	O
.	O

Three	O
C	B-CHEBI
-	O
terminal	O
PAX6	O
mutations	O
,	O
previously	O
identified	O
in	O
patients	O
with	O
eye	O
malformations	O
,	O
all	O
reduced	O
or	O
abolished	O
the	O
interactions	O
.	O

Conclusion	O

Our	O
preliminary	O
data	O
suggest	O
that	O
PAX6	O
interacts	O
with	O
HOMER3	O
,	O
DNCL1	O
and	O
TRIM11	O
.	O

We	O
propose	O
that	O
the	O
interaction	O
of	O
PAX6	O
with	O
HOMER3	O
and	O
DNCL1	O
is	O
a	O
mechanism	O
by	O
which	O
synaptic	O
activation	O
could	O
lead	O
to	O
changes	O
in	O
neuronal	O
transcriptional	O
activity	O
,	O
and	O
that	O
some	O
of	O
the	O
neural	O
anomalies	O
in	O
patients	O
with	O
PAX6	O
mutations	O
could	O
be	O
explained	O
by	O
impaired	O
protein	B-CHEBI
-	O
protein	B-CHEBI
interactions	O
.	O

Background	O

The	O
PAX6	O
protein	B-CHEBI
is	O
a	O
member	O
of	O
the	O
PAX	O
(	O
paired	O
-	O
box	O
)	O
family	O
of	O
transcriptional	O
regulators	O
and	O
is	O
essential	O
for	O
normal	O
ocular	O
and	O
neural	O
development	O
[	O
1	O
]	O
.	O

Heterozygous	O
mutations	O
of	O
the	O
human	O
PAX6	O
gene	O
cause	O
aniridia	O
(	O
absence	O
of	O
the	O
iris	O
)	O
and	O
a	O
range	O
of	O
other	O
congenital	O
eye	O
malformations	O
[	O
2	O
]	O
.	O

Neural	O
defects	O
such	O
as	O
foveal	O
hypoplasia	O
and	O
optic	O
nerve	O
hypoplasia	O
are	O
common	O
in	O
PAX6	O
-	O
associated	O
eye	O
disease	O
[	O
3	O
-	O
5	O
]	O
.	O

Homozygous	O
mutations	O
in	O
man	O
and	O
mouse	O
are	O
lethal	O
and	O
result	O
in	O
severe	O
developmental	O
abnormalities	O
including	O
anophthalmia	O
,	O
severe	O
reduction	O
of	O
the	O
olfactory	O
structures	O
and	O
gross	O
brain	O
malformations	O
[	O
2	O
,	O
6	O
]	O
.	O

The	O
roles	O
of	O
PAX6	O
in	O
brain	O
development	O
have	O
mainly	O
been	O
studied	O
in	O
homozygous	O
mutant	O
mice	O
or	O
rats	O
and	O
include	O
arealisation	O
of	O
the	O
cerebral	O
cortex	O
[	O
7	O
]	O
,	O
formation	O
of	O
the	O
prosencephalon	O
-	O
mesencephalon	O
boundary	O
[	O
8	O
]	O
,	O
axon	O
guidance	O
[	O
8	O
]	O
,	O
differentiation	O
of	O
neurons	O
from	O
glia	O
[	O
9	O
]	O
and	O
neuronal	O
migration	O
in	O
the	O
cerebellum	O
[	O
10	O
]	O
.	O

The	O
discovery	O
of	O
multiple	O
and	O
diverse	O
roles	O
for	O
PAX6	O
in	O
brain	O
development	O
prompted	O
MRI	O
analyses	O
of	O
aniridia	O
patients	O
,	O
and	O
a	O
range	O
of	O
distinctive	O
brain	O
anomalies	O
were	O
uncovered	O
.	O

The	O
most	O
common	O
and	O
striking	O
of	O
these	O
was	O
absence	O
or	O
hypoplasia	O
of	O
the	O
anterior	O
commissure	O
[	O
11	O
]	O
.	O

Other	O
defects	O
included	O
absence	O
or	O
hypoplasia	O
of	O
the	O
pineal	O
gland	O
,	O
cortical	O
polymicrogyria	O
,	O
white	O
matter	O
changes	O
in	O
the	O
corpus	O
callosum	O
and	O
grey	O
matter	O
changes	O
in	O
the	O
cerebellum	O
[	O
11	O
-	O
13	O
]	O
.	O

Functional	O
changes	O
included	O
hyposmia	O
and	O
abnormal	O
inter	O
-	O
hemispheric	O
auditory	O
transfer	O
[	O
11	O
,	O
14	O
]	O
.	O

The	O
defining	O
feature	O
of	O
all	O
PAX	O
proteins	B-CHEBI
is	O
the	O
presence	O
of	O
a	O
128	O
amino	B-CHEBI
acid	I-CHEBI
DNA	O
-	O
binding	O
paired	O
domain	O
that	O
has	O
been	O
highly	O
conserved	O
over	O
evolution	O
[	O
1	O
]	O
.	O

In	O
addition	O
to	O
the	O
paired	O
domain	O
,	O
PAX6	O
also	O
contains	O
a	O
DNA	O
-	O
binding	O
homeodomain	O
and	O
a	O
proline	B-CHEBI
,	O
serine	B-CHEBI
and	O
threonine	B-CHEBI
-	O
rich	O
(	O
PST	O
)	O
domain	O
at	O
the	O
C	B-CHEBI
-	O
terminus	O
[	O
1	O
,	O
6	O
]	O
.	O

The	O
PST	O
domain	O
,	O
which	O
encompasses	O
the	O
C	B-CHEBI
-	O
terminal	O
145	O
amino	B-CHEBI
acids	I-CHEBI
of	O
PAX6	O
,	O
has	O
been	O
shown	O
to	O
act	O
as	O
a	O
transcriptional	O
activator	O
[	O
6	O
]	O
.	O

The	O
PAX6	O
protein	B-CHEBI
directly	O
regulates	O
a	O
wide	O
range	O
of	O
target	O
genes	O
[	O
1	O
,	O
2	O
]	O
including	O
Pax2	O
[	O
15	O
]	O
,	O
Ngn2	O
[	O
16	O
]	O
and	O
glucagon	O
[	O
17	O
]	O
.	O

The	O
Pax6	O
gene	O
has	O
a	O
spatially	O
and	O
temporally	O
complex	O
expression	O
pattern	O
in	O
the	O
eye	O
,	O
brain	O
,	O
nasal	O
structures	O
,	O
spinal	O
cord	O
and	O
pancreas	O
[	O
1	O
]	O
.	O

Although	O
PAX6	O
is	O
clearly	O
involved	O
in	O
multiple	O
developmental	O
processes	O
,	O
common	O
themes	O
are	O
now	O
emerging	O
concerning	O
the	O
role	O
of	O
PAX6	O
in	O
neural	O
tissues	O
.	O

Gradients	O
of	O
Pax6	O
expression	O
are	O
important	O
for	O
determining	O
positional	O
characteristics	O
in	O
the	O
retina	O
[	O
18	O
]	O
and	O
the	O
neocortex	O
[	O
7	O
]	O
.	O

PAX6	O
plays	O
a	O
role	O
in	O
development	O
of	O
specific	O
axonal	O
connections	O
between	O
the	O
retina	O
and	O
the	O
brain	O
[	O
18	O
]	O
and	O
within	O
the	O
forebrain	O
[	O
8	O
,	O
19	O
]	O
.	O

It	O
is	O
also	O
involved	O
in	O
the	O
differentiation	O
of	O
neural	O
cell	O
types	O
from	O
multipotent	O
precursors	O
in	O
the	O
retina	O
[	O
16	O
]	O
and	O
the	O
cerebral	O
cortex	O
[	O
9	O
]	O
through	O
activation	O
of	O
bHLH	O
genes	O
such	O
as	O
Ngn2	O
and	O
Mash1	O
.	O

These	O
studies	O
provide	O
a	O
clear	O
link	O
between	O
PAX6	O
function	O
in	O
the	O
retina	O
and	O
the	O
brain	O
,	O
and	O
are	O
of	O
particular	O
relevance	O
to	O
the	O
neurological	O
phenotypes	O
of	O
individuals	O
with	O
PAX6	O
mutations	O
.	O

It	O
is	O
becoming	O
apparent	O
that	O
transcription	O
factors	O
do	O
not	O
act	O
in	O
isolation	O
but	O
are	O
dependent	O
on	O
interactions	O
with	O
other	O
proteins	B-CHEBI
to	O
carry	O
out	O
their	O
function	O
[	O
20	O
,	O
21	O
]	O
.	O

These	O
interactions	O
introduce	O
more	O
specificity	O
into	O
the	O
regulatory	O
function	O
of	O
a	O
given	O
transcription	O
factor	O
.	O

To	O
date	O
only	O
three	O
PAX6	O
protein	B-CHEBI
-	O
protein	B-CHEBI
interactions	O
have	O
been	O
described	O
:	O
with	O
SOX2	O
on	O
the	O
lens	O
-	O
specific	O
enhancer	O
element	O
of	O
the	O
delta	O
-	O
crystallin	O
gene	O
[	O
22	O
]	O
;	O
with	O
MDIA	O
,	O
which	O
modulates	O
PAX6	O
activity	O
in	O
early	O
neuronal	O
development	O
[	O
23	O
]	O
,	O
and	O
with	O
MAF	O
proteins	B-CHEBI
on	O
the	O
glucagon	O
promoter	O
,	O
which	O
causes	O
increased	O
expression	O
of	O
this	O
pancreatic	O
hormone	B-CHEBI
gene	O
[	O
17	O
]	O
.	O

Here	O
we	O
report	O
the	O
preliminary	O
results	O
of	O
the	O
first	O
systematic	O
screen	O
for	O
proteins	B-CHEBI
that	O
interact	O
with	O
PAX6	O
.	O

We	O
used	O
sequence	O
alignment	O
algorithms	O
and	O
secondary	O
structure	O
prediction	O
programs	O
to	O
define	O
a	O
new	O
domain	O
of	O
32	O
amino	B-CHEBI
acids	I-CHEBI
at	O
the	O
C	B-CHEBI
-	O
terminal	O
end	O
of	O
the	O
PAX6	O
protein	B-CHEBI
.	O

We	O
then	O
screened	O
a	O
brain	O
library	O
with	O
this	O
peptide	O
using	O
the	O
yeast	O
two	O
-	O
hybrid	O
technique	O
and	O
identified	O
three	O
novel	O
interacting	O
proteins	B-CHEBI
,	O
HOMER3	O
,	O
DNCL1	O
and	O
TRIM11	O
.	O

The	O
interaction	O
between	O
PAX6	O
and	O
these	O
proteins	B-CHEBI
was	O
disrupted	O
by	O
naturally	O
occurring	O
C	B-CHEBI
-	O
terminal	O
PAX6	O
mutations	O
.	O

Results	O

A	O
highly	O
conserved	O
C	B-CHEBI
-	O
terminal	O
PAX6	O
peptide	O

We	O
and	O
others	O
[	O
31	O
-	O
33	O
]	O
noted	O
that	O
there	O
is	O
significant	O
sequence	O
conservation	O
at	O
the	O
C	B-CHEBI
-	O
terminal	O
end	O
of	O
the	O
PAX6	O
protein	B-CHEBI
.	O

BLAST	O
analysis	O
of	O
the	O
amino	B-CHEBI
acid	I-CHEBI
sequence	O
of	O
the	O
PAX6	O
PST	O
domain	O
(	O
aa	B-CHEBI
278	O
-	O
422	O
)	O
revealed	O
a	O
highly	O
conserved	O
motif	O
within	O
the	O
last	O
28	O
amino	B-CHEBI
acids	I-CHEBI
(	O
beginning	O
at	O
the	O
'	O
GLISP	O
'	O
motif	O
,	O
Figure	O
1a	O
)	O
.	O

Strong	O
conservation	O
was	O
seen	O
in	O
distantly	O
related	O
species	O
such	O
as	O
axolotl	O
(	O
Ambystoma	O
mexicanum	O
)	O
and	O
sea	O
urchin	O
(	O
Paracentrotus	O
lividus	O
)	O
(	O
Figure	O
1a	O
)	O
.	O

Figure	O
1	O

Characterisation	O
of	O
the	O
PAX6	O
C	B-CHEBI
-	O
terminal	O
peptide	O
.	O

(	O
a	O
)	O
CLUSTAL	O
alignment	O
of	O
the	O
terminal	O
42	O
amino	B-CHEBI
acids	I-CHEBI
of	O
PAX6	O
from	O
diverse	O
species	O
.	O

(	O
*	O
)	O
indicates	O
invariant	O
residues	B-CHEBI
,	O
(	O
:	O
)	O
indicates	O
highly	O
similar	O
substitutions	O
and	O
(	O
.	O
)	O
indicates	O
moderately	O
similar	O
substitutions	O
.	O

(	O
b	O
)	O
Secondary	O
structure	O
analysis	O
of	O
the	O
highly	O
conserved	O
terminal	O
28	O
amino	B-CHEBI
acids	I-CHEBI
predicts	O
a	O
single	O
beta	O
sheet	O
(	O
arrow	O
)	O
in	O
the	O
SVPVQ	O
peptide	O
.	O

(	O
c	O
)	O
When	O
4	O
residues	B-CHEBI
are	O
added	O
in	O
the	O
N	B-CHEBI
-	O
terminal	O
direction	O
,	O
2	O
beta	O
sheets	O
are	O
now	O
predicted	O
.	O

We	O
subjected	O
the	O
whole	O
PAX6	O
PST	O
domain	O
to	O
secondary	O
structure	O
analysis	O
using	O
JPRED	O
,	O
a	O
program	O
that	O
uses	O
a	O
number	O
of	O
different	O
protein	B-CHEBI
structure	O
prediction	O
algorithms	O
to	O
generate	O
a	O
consensus	O
secondary	O
structure	O
(	O
Figure	O
1	O
)	O
[	O
25	O
,	O
26	O
]	O
.	O

The	O
PST	O
domain	O
was	O
largely	O
devoid	O
of	O
predicted	O
secondary	O
structure	O
except	O
for	O
the	O
C	B-CHEBI
-	O
terminal	O
region	O
,	O
which	O
contained	O
two	O
predicted	O
beta	O
sheets	O
within	O
the	O
highly	O
conserved	O
domain	O
,	O
one	O
in	O
the	O
'	O
GLISP	O
'	O
motif	O
and	O
one	O
in	O
the	O
'	O
SPVPQ	O
'	O
motif	O
(	O
identical	O
to	O
the	O
pattern	O
shown	O
in	O
Figure	O
1c	O
)	O
.	O

Initially	O
we	O
defined	O
the	O
C	B-CHEBI
-	O
terminal	O
domain	O
as	O
running	O
from	O
the	O
'	O
GLISP	O
'	O
motif	O
up	O
to	O
the	O
stop	O
codon	O
,	O
since	O
this	O
region	O
was	O
most	O
highly	O
conserved	O
and	O
contained	O
strongly	O
predicted	O
secondary	O
structure	O
elements	O
.	O

However	O
when	O
we	O
performed	O
secondary	O
structure	O
prediction	O
analysis	O
on	O
this	O
28	O
amino	B-CHEBI
acid	I-CHEBI
peptide	O
,	O
the	O
first	O
beta	O
sheet	O
was	O
lost	O
(	O
Figure	O
1b	O
)	O
.	O

Addition	O
of	O
another	O
4	O
amino	B-CHEBI
acids	I-CHEBI
(	O
TTST	O
)	O
immediately	O
before	O
'	O
GLISP	O
'	O
caused	O
recovery	O
of	O
the	O
first	O
beta	O
sheet	O
(	O
Figure	O
1c	O
)	O
.	O

Although	O
these	O
4	O
residues	B-CHEBI
are	O
not	O
highly	O
conserved	O
(	O
Figure	O
1a	O
)	O
,	O
they	O
appear	O
to	O
be	O
important	O
for	O
seeding	O
the	O
first	O
beta	O
sheet	O
and	O
therefore	O
for	O
secondary	O
structure	O
.	O

Thus	O
we	O
define	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
as	O
being	O
the	O
final	O
32	O
amino	B-CHEBI
acids	I-CHEBI
of	O
PAX6	O
,	O
running	O
from	O
threonine	B-CHEBI
391	O
to	O
the	O
stop	O
codon	O
(	O
top	O
line	O
of	O
Figure	O
1c	O
)	O
.	O

Yeast	O
two	O
-	O
hybrid	O
screening	O

We	O
hypothesised	O
that	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
might	O
be	O
involved	O
in	O
protein	B-CHEBI
-	O
protein	B-CHEBI
interactions	O
,	O
and	O
we	O
tested	O
this	O
by	O
screening	O
a	O
cDNA	O
library	O
using	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
with	O
a	O
construct	O
(	O
PAX6CTP	O
)	O
in	O
which	O
the	O
32	O
amino	B-CHEBI
acid	I-CHEBI
C	B-CHEBI
-	O
terminal	O
peptide	O
was	O
fused	O
to	O
the	O
yeast	O
GAL4	O
DNA	O
binding	O
domain	O
.	O

We	O
chose	O
to	O
screen	O
a	O
mouse	O
brain	O
cDNA	O
library	O
as	O
no	O
human	O
libraries	O
were	O
available	O
.	O

Given	O
the	O
fact	O
that	O
the	O
amino	B-CHEBI
acid	I-CHEBI
sequence	O
of	O
the	O
PAX6	O
protein	B-CHEBI
is	O
identical	O
in	O
man	O
and	O
mouse	O
,	O
we	O
reasoned	O
that	O
a	O
mouse	O
brain	O
library	O
would	O
yield	O
relevant	O
interactors	O
.	O

For	O
comparison	O
we	O
also	O
carried	O
out	O
the	O
screen	O
using	O
a	O
construct	O
containing	O
the	O
whole	O
PST	O
domain	O
(	O
PAX6PST	O
)	O
.	O

The	O
C	B-CHEBI
-	O
terminal	O
peptide	O
screen	O
gave	O
15	O
colonies	O
that	O
were	O
positive	O
with	O
all	O
three	O
reporters	O
and	O
the	O
PST	O
domain	O
screen	O
gave	O
62	O
colonies	O
.	O

The	O
interacting	O
plasmids	O
were	O
isolated	O
and	O
the	O
cDNA	O
inserts	O
sequenced	O
.	O

Three	O
cDNAs	O
were	O
identified	O
3	O
or	O
more	O
times	O
,	O
Homer3	O
(	O
NM	O
_	O
011984	O
)	O
,	O
Dncl1	O
(	O
Dynein	O
cytoplasmic	O
light	O
chain	O
1	O
,	O
NM	O
_	O
019682	O
,	O
also	O
known	O
as	O
Pin	O
or	O
Dlc8	O
)	O
and	O
Trim11	O
(	O
Tripartite	O
motif	O
protein	B-CHEBI
family	O
member	O
11	O
,	O
NM	O
_	O
053168	O
)	O
.	O

Homer3	O
(	O
6	O
clones	O
)	O
and	O
Dncl1	O
(	O
2	O
clones	O
)	O
were	O
identified	O
in	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
screen	O
.	O

Homer3	O
(	O
7	O
clones	O
)	O
,	O
Dncl1	O
(	O
2	O
clones	O
)	O
and	O
Trim11	O
(	O
6	O
clones	O
)	O
were	O
identified	O
in	O
the	O
PST	O
domain	O
screen	O
.	O

All	O
cDNA	O
inserts	O
were	O
in	O
-	O
frame	O
with	O
the	O
coding	O
region	O
of	O
the	O
pPC86	O
GAL4	O
activation	O
domain	O
.	O

None	O
of	O
the	O
cDNAs	O
was	O
present	O
in	O
a	O
list	O
of	O
known	O
false	O
positives	O
[	O
34	O
]	O
.	O

HOMER3	O
is	O
a	O
member	O
of	O
the	O
HOMER	O
family	O
of	O
neuronal	O
post	O
-	O
synaptic	O
density	O
(	O
PSD	O
)	O
proteins	B-CHEBI
[	O
35	O
]	O
.	O

DNCL1	O
is	O
a	O
subunit	O
of	O
two	O
motor	O
protein	B-CHEBI
complexes	O
,	O
dynein	O
and	O
myosin	O
-	O
Va	O
,	O
both	O
of	O
which	O
are	O
involved	O
in	O
intracellular	O
trafficking	O
of	O
proteins	B-CHEBI
and	O
organelles	O
in	O
neurons	O
[	O
36	O
,	O
37	O
]	O
.	O

TRIM11	O
is	O
a	O
member	O
of	O
the	O
tripartite	O
motif	O
protein	B-CHEBI
family	O
and	O
contains	O
a	O
RING	O
finger	O
,	O
a	O
B	O
-	O
box	O
zinc	B-CHEBI
finger	O
,	O
a	O
coiled	O
coil	O
domain	O
and	O
a	O
B30	O
.	O
2	O
domain	O
[	O
38	O
]	O
.	O

The	O
possible	O
significance	O
of	O
the	O
interactions	O
between	O
these	O
proteins	B-CHEBI
and	O
PAX6	O
is	O
discussed	O
below	O
.	O

Semi	O
-	O
quantitative	O
PCR	O

To	O
check	O
that	O
the	O
Homer3	O
,	O
Dncl1	O
and	O
Trim11	O
clones	O
were	O
not	O
identified	O
multiple	O
times	O
solely	O
because	O
they	O
are	O
highly	O
abundant	O
in	O
the	O
library	O
,	O
we	O
performed	O
a	O
semi	O
-	O
quantitative	O
PCR	O
assay	O
.	O

We	O
compared	O
the	O
relative	O
abundance	O
of	O
Homer3	O
,	O
Dncl1	O
,	O
Trim11	O
and	O
Pax6	O
with	O
Gapdh	O
and	O
Atp5a1	O
.	O

Gapdh	O
and	O
Atp5a1	O
both	O
show	O
strong	O
constitutive	O
expression	O
in	O
a	O
variety	O
of	O
tissues	O
including	O
the	O
brain	O
[	O
29	O
,	O
30	O
]	O
.	O

Homer3	O
,	O
Dncl1	O
,	O
Trim11	O
and	O
Pax6	O
were	O
only	O
amplified	O
strongly	O
after	O
35	O
cycles	O
of	O
PCR	O
(	O
Figure	O
2	O
)	O
and	O
were	O
therefore	O
present	O
at	O
relatively	O
low	O
levels	O
compared	O
to	O
Gapdh	O
(	O
amplified	O
strongly	O
after	O
25	O
cycles	O
)	O
and	O
Atp5a1	O
(	O
amplified	O
strongly	O
after	O
30	O
cycles	O
;	O
Figure	O
2	O
)	O
.	O

Figure	O
2	O

Semi	O
-	O
quantitative	O
PCR	O
analysis	O
of	O
Homer3	O
,	O
Dncl1	O
,	O
Trim11	O
and	O
Pax6	O
in	O
the	O
mouse	O
brain	O
cDNA	O
library	O
.	O

Library	O
cDNA	O
was	O
amplified	O
with	O
primers	O
specific	O
for	O
Pax6	O
(	O
600	O
bp	O
)	O
,	O
Homer3	O
(	O
485	O
bp	O
band	O
)	O
,	O
Dncl1	O
(	O
485	O
bp	O
)	O
and	O
Trim11	O
(	O
609	O
bp	O
)	O
for	O
20	O
,	O
25	O
,	O
30	O
or	O
35	O
cycles	O
.	O

Atp5a1	O
(	O
415	O
bp	O
)	O
and	O
Gapdh	O
(	O
450	O
bp	O
)	O
,	O
which	O
are	O
highly	O
expressed	O
in	O
the	O
brain	O
,	O
are	O
included	O
for	O
comparison	O
.	O

M	O
indicates	O
the	O
Phi	O
x	O
174	O
HaeIII	O
DNA	O
size	O
marker	O
;	O
the	O
positions	O
of	O
the	O
603	O
bp	O
and	O
310	O
bp	O
marker	O
bands	O
are	O
indicated	O
.	O

We	O
concluded	O
that	O
Homer3	O
,	O
Dncl1	O
and	O
Trim11	O
clones	O
were	O
not	O
highly	O
abundant	O
in	O
the	O
library	O
.	O

This	O
is	O
consistent	O
with	O
the	O
idea	O
that	O
they	O
were	O
pulled	O
out	O
because	O
the	O
encoded	O
proteins	B-CHEBI
interact	O
specifically	O
with	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
or	O
PST	O
domain	O
of	O
PAX6	O
.	O

Yeast	O
two	O
-	O
hybrid	O
pairwise	O
interactions	O

By	O
library	O
screening	O
we	O
identified	O
two	O
proteins	B-CHEBI
(	O
HOMER3	O
and	O
DNCL1	O
)	O
that	O
interact	O
with	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
and	O
three	O
proteins	B-CHEBI
(	O
HOMER3	O
,	O
DNCL1	O
and	O
TRIM11	O
)	O
that	O
interact	O
with	O
the	O
whole	O
PST	O
domain	O
.	O

This	O
suggests	O
that	O
HOMER3	O
and	O
DNCL1	O
interact	O
specifically	O
with	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
while	O
TRIM11	O
interacts	O
with	O
a	O
more	O
N	B-CHEBI
-	O
terminal	O
part	O
of	O
the	O
PST	O
domain	O
.	O

We	O
conducted	O
pairwise	O
tests	O
between	O
specific	O
constructs	O
to	O
confirm	O
the	O
interactions	O
identified	O
in	O
the	O
library	O
screen	O
and	O
to	O
further	O
investigate	O
the	O
interaction	O
between	O
PAX6	O
and	O
HOMER3	O
,	O
DNCL1	O
and	O
TRIM11	O
.	O

The	O
Dncl1	O
and	O
Trim11	O
clones	O
that	O
were	O
pulled	O
out	O
of	O
the	O
library	O
were	O
full	O
-	O
length	O
,	O
but	O
the	O
Homer3	O
cDNAs	O
lacked	O
the	O
N	B-CHEBI
-	O
terminal	O
70	O
amino	B-CHEBI
acids	I-CHEBI
.	O

The	O
missing	O
coding	O
region	O
was	O
inserted	O
into	O
the	O
truncated	O
Homer3	O
cDNA	O
to	O
give	O
a	O
full	O
-	O
length	O
expression	O
construct	O
(	O
see	O
Methods	O
)	O
.	O

Pairwise	O
interactions	O
were	O
carried	O
out	O
with	O
both	O
the	O
full	O
-	O
length	O
and	O
truncated	O
Homer3	O
clones	O
.	O

We	O
confirmed	O
that	O
the	O
whole	O
PAX6	O
PST	O
domain	O
interacts	O
with	O
HOMER3	O
(	O
full	O
-	O
length	O
and	O
truncated	O
constructs	O
)	O
,	O
TRIM11	O
and	O
DNCL1	O
,	O
as	O
all	O
three	O
reporter	O
genes	O
were	O
strongly	O
activated	O
in	O
pairwise	O
tests	O
(	O
Figure	O
3	O
;	O
Table	O
1	O
)	O
.	O

In	O
contrast	O
the	O
interaction	O
between	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
and	O
HOMER3	O
or	O
DNCL1	O
could	O
not	O
be	O
confirmed	O
with	O
pairwise	O
tests	O
(	O
Table	O
1	O
)	O
.	O

Occasionally	O
,	O
partial	O
suppression	O
of	O
growth	O
on	O
plates	O
containing	O
5	O
-	O
fluoro	B-CHEBI
-	O
orotic	B-CHEBI
acid	I-CHEBI
was	O
observed	O
,	O
indicating	O
low	O
-	O
level	O
activation	O
of	O
the	O
URA3	O
reporter	O
;	O
however	O
HIS3	O
and	O
LacZ	O
activation	O
were	O
not	O
observed	O
.	O

The	O
reasons	O
for	O
this	O
are	O
not	O
clear	O
,	O
although	O
it	O
may	O
be	O
that	O
the	O
pairwise	O
tests	O
were	O
of	O
sub	O
-	O
optimal	O
sensitivity	O
compared	O
to	O
the	O
library	O
screen	O
.	O

However	O
we	O
were	O
able	O
to	O
confirm	O
that	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
is	O
important	O
for	O
the	O
interaction	O
with	O
HOMER3	O
and	O
DNCL1	O
because	O
interaction	O
with	O
the	O
PAX6PST	O
-	O
CT	O
construct	O
,	O
which	O
lacks	O
the	O
final	O
32	O
amino	B-CHEBI
acids	I-CHEBI
,	O
was	O
completely	O
abolished	O
(	O
Figure	O
3	O
,	O
Table	O
1	O
)	O
.	O

TRIM11	O
interacted	O
equally	O
well	O
with	O
PAX6PST	O
and	O
PAX6PST	O
-	O
CT	O
(	O
Figure	O
3	O
,	O
Table	O
1	O
)	O
.	O

This	O
is	O
consistent	O
with	O
the	O
library	O
screens	O
in	O
which	O
TRIM11	O
was	O
isolated	O
with	O
the	O
PST	O
domain	O
but	O
not	O
with	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
and	O
supports	O
the	O
idea	O
that	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
is	O
not	O
important	O
for	O
the	O
interaction	O
between	O
PAX6	O
and	O
TRIM11	O
.	O

Figure	O
3	O

LacZ	O
reporter	O
gene	O
activation	O
in	O
pairwise	O
tests	O
.	O

pPC86	O
constructs	O
are	O
shown	O
across	O
the	O
top	O
,	O
and	O
pDBLeu	O
constructs	O
are	O
shown	O
down	O
the	O
right	O
hand	O
side	O
.	O

PAX6PST	O
,	O
PAX6	O
PST	O
domain	O
;	O
PAX6PST	O
/	O
Q422R	O
,	O
PAX6	O
PST	O
domain	O
with	O
the	O
Q422R	O
mutation	O
;	O
PAX6PST	O
/	O
X423L	O
,	O
PAX6	O
PST	O
domain	O
with	O
the	O
X423L	O
mutation	O
,	O
PAX6PST	O
/	O
1615del10	O
,	O
PAX6	O
PST	O
domain	O
with	O
the	O
1615	O
del10	O
mutation	O
;	O
PAX6PST	O
-	O
CT	O
,	O
PAX6	O
PST	O
domain	O
minus	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
.	O

'	O
Truncated	O
HOMER3	O
'	O
is	O
HOMER3	O
lacking	O
the	O
N	B-CHEBI
-	O
terminal	O
70	O
amino	B-CHEBI
acids	I-CHEBI
.	O

Five	O
control	O
strains	O
are	O
shown	O
for	O
comparison	O
(	O
left	O
)	O
.	O

These	O
range	O
from	O
non	O
-	O
interactor	O
(	O
A	O
)	O
to	O
strong	O
interactor	O
(	O
E	O
)	O
.	O

Table	O
1	O

Pairwise	O
interaction	O
tests	O
between	O
normal	O
and	O
mutant	O
PAX6	O
constructs	O
and	O
HOMER3	O
,	O
DNCL1	O
and	O
TRIM11	O
.	O

+	O
+	O
+	O
:	O
strong	O
interaction	O
;	O
+	O
+	O
:	O
moderate	O
interaction	O
;	O
+	O
:	O
weak	O
interaction	O
;	O
(	O
+	O
)	O
borderline	O
interaction	O
with	O
one	O
or	O
two	O
reporters	O
activated	O
at	O
very	O
low	O
levels	O
;	O
0	O
:	O
no	O
interaction	O
.	O

PAX6PST	O
,	O
PAX6	O
PST	O
domain	O
;	O
PAX6CTP	O
,	O
PAX6	O
C	B-CHEBI
-	O
terminal	O
peptide	O
;	O
PAX6PST	O
-	O
CT	O
,	O
PAX6	O
PST	O
domain	O
minus	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
;	O
PAX6PST	O
/	O
Q422R	O
,	O
PAX6	O
PST	O
domain	O
with	O
the	O
Q422R	O
mutation	O
;	O
PAX6PST	O
/	O
X423L	O
,	O
PAX6	O
PST	O
domain	O
with	O
the	O
X423L	O
mutation	O
,	O
PAX6PST	O
/	O
1615del	O
,	O
PAX6	O
PST	O
domain	O
with	O
the	O
1615	O
del10	O
mutation	O
.	O

HOMER3	O
-	O
FL	O
,	O
HOMER3	O
full	O
-	O
length	O
clone	O
;	O
HOMER3	O
-	O
Tr	O
,	O
truncated	O
HOMER3	O
clone	O
lacking	O
the	O
N	B-CHEBI
-	O
terminal	O
70	O
amino	B-CHEBI
acids	I-CHEBI
.	O

Having	O
confirmed	O
that	O
HOMER3	O
,	O
DNCL1	O
and	O
TRIM11	O
interact	O
with	O
the	O
PAX6	O
PST	O
domain	O
,	O
we	O
next	O
investigated	O
how	O
the	O
interactions	O
were	O
affected	O
by	O
three	O
C	B-CHEBI
-	O
terminal	O
PAX6	O
mutations	O
that	O
have	O
been	O
previously	O
described	O
in	O
patients	O
with	O
ocular	O
anomalies	O
.	O

The	O
first	O
mutation	O
is	O
a	O
single	O
nucleotide	O
substitution	O
1627A	O
>	O
G	B-CHEBI
that	O
causes	O
a	O
glutamine	B-CHEBI
to	I-CHEBI
arginine	I-CHEBI
amino	I-CHEBI
acid	I-CHEBI
substitution	O
in	O
the	O
last	O
codon	O
of	O
PAX6	O
.	O

This	O
missense	O
mutation	O
(	O
Q422R	O
)	O
has	O
been	O
reported	O
in	O
two	O
patients	O
,	O
one	O
affected	O
by	O
anterior	O
segment	O
dysgenesis	O
with	O
uveal	O
ectropion	O
and	O
one	O
with	O
typical	O
aniridia	O
and	O
foveal	O
hypoplasia	O
[	O
27	O
,	O
33	O
]	O
.	O

The	O
second	O
mutation	O
(	O
1615del10	O
)	O
was	O
found	O
in	O
an	O
aniridia	O
family	O
[	O
28	O
]	O
.	O

This	O
frame	O
-	O
shifting	O
deletion	O
occurs	O
just	O
before	O
the	O
PAX6	O
stop	O
codon	O
and	O
is	O
predicted	O
to	O
cause	O
translational	O
read	O
-	O
through	O
into	O
the	O
3	O
'	O
untranslated	O
region	O
,	O
generating	O
a	O
protein	B-CHEBI
in	O
which	O
the	O
last	O
5	O
amino	B-CHEBI
acids	I-CHEBI
of	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
are	O
replaced	O
by	O
a	O
103	O
amino	B-CHEBI
acid	I-CHEBI
-	O
extension	O
.	O

Affected	O
individuals	O
in	O
this	O
family	O
showed	O
unusual	O
neurobehavioural	O
traits	O
including	O
impaired	O
social	O
cognition	O
and	O
poor	O
verbal	O
inhibition	O
[	O
28	O
]	O
.	O

MRI	O
analysis	O
revealed	O
grey	O
matter	O
abnormalities	O
in	O
the	O
frontal	O
lobe	O
,	O
temporal	O
lobe	O
and	O
cerebellum	O
,	O
and	O
white	O
matter	O
deficits	O
in	O
the	O
corpus	O
callosum	O
[	O
13	O
]	O
.	O

The	O
third	O
mutation	O
1629insT	O
(	O
X423L	O
)	O
has	O
been	O
reported	O
in	O
several	O
aniridia	O
patients	O
[	O
11	O
,	O
12	O
,	O
27	O
,	O
33	O
]	O
.	O

Insertion	O
of	O
a	O
single	O
T	B-CHEBI
nucleotide	O
at	O
position	O
1629	O
changes	O
the	O
stop	O
codon	O
(	O
TAA	O
)	O
to	O
a	O
leucine	B-CHEBI
codon	O
(	O
TTA	O
)	O
and	O
generates	O
a	O
full	O
length	O
PAX6	O
protein	B-CHEBI
with	O
a	O
C	B-CHEBI
-	O
terminal	O
extension	O
that	O
extends	O
for	O
a	O
further	O
35	O
amino	B-CHEBI
acids	I-CHEBI
into	O
the	O
3	O
'	O
untranslated	O
region	O
.	O

MRI	O
analysis	O
of	O
six	O
patients	O
with	O
this	O
mutation	O
revealed	O
variable	O
brain	O
defects	O
including	O
absence	O
or	O
hypoplasia	O
of	O
the	O
anterior	O
commissure	O
,	O
pineal	O
gland	O
and	O
olfactory	O
bulbs	O
[	O
12	O
]	O
.	O

Two	O
patients	O
had	O
temporal	O
polymicrogyria	O
,	O
one	O
in	O
association	O
with	O
epilepsy	O
[	O
12	O
]	O
.	O

The	O
three	O
mutations	O
were	O
introduced	O
into	O
the	O
PAX6PST	O
construct	O
,	O
and	O
pairwise	O
tests	O
were	O
carried	O
out	O
to	O
investigate	O
the	O
interaction	O
of	O
each	O
mutant	O
protein	B-CHEBI
with	O
HOMER3	O
,	O
DNCL1	O
and	O
TRIM11	O
.	O

All	O
three	O
mutations	O
had	O
a	O
clear	O
effect	O
on	O
the	O
interactions	O
.	O

The	O
most	O
subtle	O
mutation	O
(	O
Q422R	O
)	O
caused	O
a	O
reduction	O
in	O
the	O
interaction	O
with	O
HOMER3	O
and	O
DNCL1	O
(	O
Figure	O
3	O
,	O
Table	O
1	O
)	O
.	O

The	O
C	B-CHEBI
-	O
terminal	O
extension	O
mutations	O
X423L	O
and1615del10	O
mutations	O
both	O
dramatically	O
reduced	O
or	O
abolished	O
the	O
interaction	O
with	O
HOMER3	O
and	O
DNCL1	O
(	O
Figure	O
3	O
,	O
Table	O
1	O
)	O
.	O

None	O
of	O
the	O
three	O
mutations	O
affected	O
the	O
interaction	O
with	O
TRIM11	O
which	O
again	O
is	O
consistent	O
with	O
the	O
hypothesis	O
that	O
TRIM11	O
interacts	O
with	O
a	O
more	O
N	B-CHEBI
-	O
terminal	O
part	O
of	O
the	O
PST	O
domain	O
.	O

Discussion	O

On	O
the	O
basis	O
of	O
secondary	O
structure	O
predictions	O
and	O
amino	B-CHEBI
acid	I-CHEBI
sequence	O
conservation	O
,	O
we	O
defined	O
a	O
novel	O
PAX6	O
protein	B-CHEBI
domain	O
,	O
which	O
we	O
have	O
called	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
.	O

We	O
performed	O
yeast	O
two	O
-	O
hybrid	O
library	O
screens	O
with	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
and	O
the	O
whole	O
PST	O
domain	O
and	O
we	O
identified	O
three	O
novel	O
interacting	O
proteins	B-CHEBI
,	O
HOMER3	O
,	O
DNCL1	O
and	O
TRIM11	O
.	O

In	O
library	O
screens	O
,	O
HOMER3	O
and	O
DNCL1	O
interacted	O
with	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
and	O
the	O
PST	O
domain	O
while	O
TRIM11	O
interacted	O
only	O
with	O
the	O
PST	O
domain	O
,	O
suggesting	O
that	O
HOMER3	O
and	O
DNCL1	O
specifically	O
interact	O
with	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
while	O
TRIM11	O
interacts	O
with	O
a	O
more	O
N	B-CHEBI
-	O
terminal	O
part	O
of	O
the	O
PST	O
domain	O
.	O

The	O
interactions	O
between	O
the	O
PST	O
domain	O
and	O
HOMER3	O
,	O
DNCL1	O
and	O
TRIM11	O
were	O
confirmed	O
in	O
pairwise	O
tests	O
.	O

We	O
were	O
not	O
able	O
to	O
confirm	O
the	O
interaction	O
between	O
HOMER3	O
or	O
DNCL1	O
with	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
construct	O
in	O
pairwise	O
tests	O
,	O
but	O
we	O
showed	O
that	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
was	O
important	O
for	O
PAX6	O
/	O
HOMER3	O
or	O
PAX6	O
/	O
DNCL1	O
interaction	O
because	O
HOMER3	O
and	O
DNCL1	O
did	O
not	O
interact	O
with	O
a	O
PST	O
domain	O
construct	O
lacking	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
.	O

HOMER3	O
is	O
found	O
in	O
the	O
PSD	O
of	O
neurons	O
and	O
directly	O
binds	O
to	O
type	O
I	O
metabotropic	O
glutamate	B-CHEBI
receptors	O
,	O
which	O
act	O
via	O
phospholipase	O
C	O
to	O
stimulate	O
IP3	O
-	O
mediated	O
release	O
of	O
Ca2	B-CHEBI
+	I-CHEBI
from	O
intracellular	O
vesicles	O
[	O
35	O
,	O
39	O
]	O
.	O

HOMER3	O
is	O
a	O
member	O
of	O
the	O
HOMER	O
family	O
of	O
proteins	B-CHEBI
that	O
are	O
constitutively	O
expressed	O
in	O
the	O
brain	O
and	O
play	O
a	O
role	O
in	O
post	O
-	O
synaptic	O
signalling	O
and	O
receptor	O
trafficking	O
by	O
forming	O
multivalent	O
links	O
with	O
various	O
receptors	O
and	O
PSD	O
scaffolding	O
proteins	B-CHEBI
[	O
35	O
,	O
39	O
-	O
41	O
]	O
.	O

HOMER	O
proteins	B-CHEBI
have	O
also	O
been	O
implicated	O
in	O
axon	O
guidance	O
during	O
brain	O
development	O
[	O
42	O
]	O
.	O

DNCL1	O
is	O
a	O
subunit	O
of	O
two	O
intracellular	O
transport	O
protein	B-CHEBI
complexes	O
,	O
dynein	O
and	O
myosin	O
Va	O
[	O
36	O
]	O
.	O

Dynein	O
and	O
myosin	O
Va	O
are	O
involved	O
in	O
the	O
microtubule	O
-	O
based	O
and	O
actin	O
-	O
based	O
movement	O
respectively	O
of	O
proteins	B-CHEBI
,	O
organelles	O
and	O
vesicles	O
in	O
neurons	O
[	O
36	O
,	O
37	O
]	O
.	O

Myosin	O
Va	O
is	O
enriched	O
in	O
the	O
PSD	O
[	O
43	O
]	O
,	O
and	O
DNCL1	O
binds	O
to	O
a	O
variety	O
of	O
PSD	O
proteins	B-CHEBI
including	O
guanylate	B-CHEBI
kinase	O
domain	O
-	O
associated	O
protein	B-CHEBI
[	O
44	O
]	O
and	O
neuronal	O
nitric	B-CHEBI
oxide	I-CHEBI
synthase	O
[	O
45	O
]	O
.	O

TRIM11	O
is	O
a	O
member	O
of	O
the	O
mouse	O
tripartite	O
motif	O
protein	B-CHEBI
family	O
(	O
also	O
known	O
as	O
the	O
RBCC	O
family	O
)	O
,	O
and	O
contains	O
the	O
three	O
characteristic	O
structural	O
motifs	O
of	O
this	O
protein	B-CHEBI
family	O
,	O
a	O
RING	O
finger	O
,	O
a	O
B	O
-	O
box	O
zinc	B-CHEBI
finger	O
,	O
and	O
a	O
coiled	O
coil	O
domain	O
,	O
as	O
well	O
as	O
a	O
B30	O
.	O
2	O
domain	O
that	O
is	O
found	O
in	O
many	O
but	O
not	O
all	O
TRIM	O
proteins	B-CHEBI
[	O
38	O
]	O
.	O

TRIM11	O
interacts	O
with	O
Humanin	O
,	O
a	O
protein	B-CHEBI
that	O
suppresses	O
the	O
neurotoxicity	O
associated	O
with	O
Alzheimer	O
'	O
s	O
disease	O
[	O
46	O
]	O
.	O

TRIM11	O
lowers	O
Humanin	O
levels	O
by	O
a	O
mechanism	O
that	O
appears	O
to	O
involve	O
ubiqutin	O
-	O
mediated	O
proteasomal	O
degradation	O
[	O
46	O
]	O
.	O

At	O
present	O
our	O
data	O
must	O
be	O
considered	O
preliminary	O
because	O
the	O
interactions	O
have	O
not	O
been	O
confirmed	O
by	O
any	O
other	O
approach	O
.	O

However	O
it	O
is	O
interesting	O
to	O
speculate	O
that	O
the	O
interaction	O
of	O
PAX6	O
with	O
HOMER3	O
and	O
DNCL1	O
may	O
be	O
the	O
basis	O
of	O
a	O
mechanism	O
by	O
which	O
synaptic	O
signalling	O
causes	O
changes	O
in	O
gene	O
expression	O
.	O

We	O
propose	O
that	O
PAX6	O
is	O
sequestered	O
in	O
the	O
PSD	O
by	O
binding	O
to	O
HOMER3	O
.	O

Since	O
receptor	O
activation	O
causes	O
dissociation	O
of	O
HOMER	O
proteins	B-CHEBI
[	O
35	O
]	O
,	O
PAX6	O
may	O
be	O
released	O
as	O
a	O
result	O
of	O
synaptic	O
activity	O
,	O
allowing	O
it	O
to	O
interact	O
with	O
DNCL1	O
.	O

The	O
PAX6	O
/	O
DNCL1	O
complex	O
could	O
then	O
participate	O
in	O
myosin	O
Va	O
-	O
mediated	O
transport	O
along	O
the	O
PSD	O
-	O
associated	O
actin	O
cytoskeleton	O
followed	O
by	O
dynein	O
-	O
mediated	O
transport	O
along	O
the	O
microtubule	O
network	O
,	O
eventually	O
reaching	O
the	O
nucleus	O
[	O
36	O
]	O
.	O

Since	O
TRIM11	O
is	O
implicated	O
in	O
protein	B-CHEBI
degradation	O
[	O
46	O
]	O
,	O
it	O
may	O
play	O
a	O
role	O
in	O
PAX6	O
protein	B-CHEBI
turnover	O
.	O

Precedents	O
for	O
association	O
of	O
transcription	O
factors	O
with	O
the	O
post	O
-	O
synaptic	O
density	O
include	O
STAT3	O
and	O
CREB	O
,	O
which	O
act	O
as	O
messengers	B-CHEBI
between	O
the	O
synapse	O
and	O
the	O
nucleus	O
[	O
47	O
,	O
48	O
]	O
.	O

Although	O
the	O
full	O
-	O
length	O
PAX6	O
protein	B-CHEBI
is	O
predominantly	O
nuclear	O
,	O
there	O
is	O
good	O
evidence	O
in	O
mouse	O
,	O
quail	O
and	O
nematode	O
for	O
an	O
isoform	O
that	O
lacks	O
the	O
paired	O
domain	O
,	O
is	O
both	O
nuclear	O
and	O
cytoplasmic	O
,	O
and	O
binds	O
DNA	O
through	O
the	O
homeodomain	O
alone	O
[	O
49	O
-	O
51	O
]	O
.	O

In	O
mice	O
the	O
paired	O
-	O
less	O
isoform	O
is	O
relatively	O
abundant	O
in	O
brain	O
[	O
49	O
]	O
;	O
however	O
its	O
subcellular	O
localisation	O
in	O
neurones	O
,	O
and	O
the	O
possibility	O
of	O
an	O
association	O
with	O
the	O
PSD	O
,	O
remains	O
to	O
be	O
investigated	O
.	O

Regarding	O
the	O
subcellular	O
localisation	O
of	O
the	O
putative	O
interacting	O
proteins	B-CHEBI
,	O
HOMER3	O
is	O
predominantly	O
found	O
at	O
the	O
interface	O
between	O
the	O
PSD	O
and	O
the	O
cytoplasm	O
[	O
39	O
]	O
,	O
DNCL1	O
is	O
chiefly	O
cytoplasmic	O
,	O
although	O
nuclear	O
localisation	O
has	O
been	O
reported	O
[	O
51	O
]	O
,	O
and	O
TRIM11	O
is	O
both	O
nuclear	O
and	O
cytoplasmic	O
[	O
38	O
]	O
.	O

Therefore	O
cytoplasmic	O
PAX6	O
could	O
potentially	O
interact	O
with	O
all	O
three	O
proteins	B-CHEBI
,	O
while	O
nuclear	O
PAX6	O
could	O
interact	O
with	O
TRIM11	O
and	O
DNCL1	O
.	O

At	O
the	O
tissue	O
level	O
,	O
HOMER3	O
expression	O
has	O
been	O
detected	O
in	O
thymus	O
and	O
lung	O
but	O
it	O
has	O
mainly	O
been	O
studied	O
in	O
brain	O
where	O
it	O
is	O
found	O
in	O
the	O
forebrain	O
,	O
hippocampus	O
and	O
cerebellum	O
[	O
39	O
]	O
.	O

DNCL1	O
and	O
TRIM11	O
both	O
have	O
wide	O
expression	O
domains	O
that	O
include	O
the	O
brain	O
[	O
44	O
,	O
38	O
]	O
.	O

Thus	O
the	O
expression	O
of	O
all	O
three	O
interactors	O
overlaps	O
with	O
PAX6	O
at	O
the	O
tissue	O
level	O
[	O
2	O
,	O
7	O
,	O
8	O
,	O
10	O
]	O
.	O

We	O
detected	O
co	O
-	O
expression	O
of	O
PAX6	O
,	O
HOMER3	O
,	O
DNCL1	O
and	O
TRIM11	O
by	O
RT	O
-	O
PCR	O
in	O
human	O
adult	O
brain	O
RNA	O
(	O
IH	O
,	O
L	O
Harrison	O
and	O
A	O
Brown	O
,	O
data	O
not	O
shown	O
)	O
.	O

We	O
demonstrated	O
that	O
the	O
interaction	O
between	O
the	O
PST	O
domain	O
and	O
HOMER3	O
or	O
DNCL1	O
was	O
impaired	O
by	O
three	O
naturally	O
occurring	O
mutations	O
that	O
are	O
located	O
in	O
the	O
PAX6	O
C	B-CHEBI
-	O
terminal	O
peptide	O
.	O

The	O
Q422R	O
mutation	O
,	O
which	O
involves	O
a	O
glutamine	B-CHEBI
to	O
arginine	B-CHEBI
substitution	O
at	O
the	O
last	B-CHEBI
amino	I-CHEBI
acid	I-CHEBI
position	O
of	O
PAX6	O
,	O
caused	O
a	O
reduction	O
in	O
the	O
interaction	O
with	O
HOMER3	O
and	O
DNCL1	O
.	O

The	O
X423L	O
and	O
1615del10	O
mutations	O
severely	O
reduced	O
or	O
completely	O
abolished	O
the	O
interaction	O
with	O
HOMER3	O
and	O
DNCL1	O
.	O

The	O
predicted	O
effect	O
of	O
the	O
X423L	O
and	O
1615del10	O
mutations	O
is	O
to	O
cause	O
translation	O
into	O
the	O
3	O
'	O
untranslated	O
region	O
,	O
thus	O
generating	O
proteins	B-CHEBI
with	O
abnormal	O
extensions	O
that	O
might	O
be	O
expected	O
to	O
disrupt	O
the	O
conformation	O
of	O
the	O
C	B-CHEBI
-	O
terminal	O
end	O
of	O
the	O
protein	B-CHEBI
.	O

The	O
1615del10	O
mutation	O
also	O
removes	O
the	O
last	O
5	O
amino	B-CHEBI
acids	I-CHEBI
of	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
[	O
28	O
]	O
.	O

None	O
of	O
the	O
mutations	O
affected	O
the	O
interaction	O
with	O
TRIM11	O
,	O
suggesting	O
that	O
they	O
do	O
not	O
alter	O
the	O
conformation	O
of	O
the	O
more	O
N	B-CHEBI
-	O
terminal	O
part	O
of	O
the	O
PST	O
domain	O
.	O

All	O
our	O
data	O
are	O
consistent	O
with	O
the	O
hypothesis	O
that	O
TRIM11	O
does	O
not	O
interact	O
with	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
,	O
but	O
interacts	O
with	O
the	O
PST	O
domain	O
between	O
the	O
homeodomain	O
and	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
.	O

Most	O
aniridia	O
patients	O
are	O
heterozygous	O
for	O
mutations	O
that	O
introduce	O
a	O
premature	O
termination	O
codon	O
into	O
the	O
PAX6	O
open	O
reading	O
frame	O
[	O
2	O
,	O
52	O
]	O
.	O

These	O
alleles	O
would	O
be	O
expected	O
to	O
encode	O
truncated	O
proteins	B-CHEBI
or	O
no	O
protein	B-CHEBI
at	O
all	O
if	O
the	O
mutant	O
RNA	O
is	O
degraded	O
by	O
nonsense	O
-	O
mediated	O
decay	O
[	O
52	O
]	O
.	O

We	O
propose	O
that	O
the	O
brain	O
anomalies	O
that	O
have	O
been	O
observed	O
in	O
aniridia	O
patients	O
may	O
be	O
partly	O
explained	O
by	O
impaired	O
interaction	O
between	O
PAX6	O
and	O
HOMER3	O
,	O
DNCL1	O
and	O
TRIM11	O
.	O

The	O
neurobehavioural	O
phenotype	O
associated	O
with	O
1615del10	O
and	O
the	O
polymicrogyria	O
associated	O
with	O
X423L	O
may	O
result	O
from	O
a	O
specific	O
effect	O
of	O
these	O
unusual	O
C	B-CHEBI
-	O
terminal	O
extension	O
mutations	O
.	O

There	O
is	O
evidence	O
that	O
signalling	O
and	O
transport	O
mechanisms	O
that	O
were	O
initially	O
characterized	O
in	O
the	O
brain	O
may	O
also	O
be	O
conserved	O
in	O
the	O
retina	O
,	O
suggesting	O
that	O
impaired	O
PAX6	O
protein	B-CHEBI
-	O
protein	B-CHEBI
interactions	O
may	O
also	O
have	O
implications	O
for	O
the	O
retinal	O
defects	O
observed	O
in	O
individuals	O
with	O
PAX6	O
mutations	O
[	O
53	O
,	O
54	O
]	O
.	O

Conclusion	O

We	O
have	O
presented	O
preliminary	O
evidence	O
that	O
the	O
neurodevelopmental	O
transcriptional	O
regulator	O
PAX6	O
interacts	O
with	O
HOMER3	O
,	O
DNCL1	O
and	O
TRIM11	O
.	O

We	O
suggest	O
that	O
the	O
interaction	O
of	O
PAX6	O
with	O
HOMER3	O
and	O
DNCL1	O
is	O
a	O
mechanism	O
by	O
which	O
synaptic	O
signalling	O
could	O
lead	O
to	O
regulated	O
changes	O
in	O
gene	O
expression	O
in	O
neurons	O
.	O

We	O
also	O
propose	O
that	O
some	O
of	O
the	O
neural	O
anomalies	O
in	O
patients	O
with	O
PAX6	O
mutations	O
may	O
be	O
explained	O
by	O
impaired	O
protein	B-CHEBI
-	O
protein	B-CHEBI
interactions	O
.	O

Methods	O

Bioinformatics	O
techniques	O

Sequence	O
database	O
searches	O
were	O
carried	O
out	O
using	O
the	O
BLAST	O
program	O
available	O
through	O
the	O
Bioinformatics	O
Applications	O
at	O
the	O
Rosalind	O
Franklin	O
Centre	O
for	O
Genomics	O
Research	O
[	O
24	O
]	O
.	O

Protein	B-CHEBI
sequences	O
that	O
were	O
highly	O
homologous	O
to	O
the	O
C	B-CHEBI
-	O
terminus	O
of	O
human	O
PAX6	O
were	O
aligned	O
using	O
CLUSTAL	O
[	O
24	O
]	O
.	O

Secondary	O
structure	O
prediction	O
was	O
performed	O
using	O
the	O
JPRED	O
consensus	O
method	O
[	O
25	O
,	O
26	O
]	O
.	O

Yeast	O
two	O
-	O
hybrid	O
constructs	O

All	O
cDNA	O
and	O
amino	B-CHEBI
acid	I-CHEBI
numbering	O
is	O
based	O
on	O
the	O
human	O
PAX6	O
cDNA	O
and	O
protein	B-CHEBI
reference	O
sequences	O
available	O
from	O
the	O
Human	O
PAX6	O
Allelic	O
Variant	O
Database	O
web	O
site	O
[	O
27	O
]	O
.	O

Standard	O
PCR	O
and	O
subcloning	O
techniques	O
were	O
used	O
to	O
make	O
three	O
PAX6	O
cDNA	O
constructs	O
in	O
the	O
pDBLeu	O
expression	O
vector	O
(	O
ProQuest	O
Two	O
-	O
Hybrid	O
System	O
,	O
Invitrogen	O
)	O
,	O
which	O
generates	O
a	O
protein	B-CHEBI
fused	O
to	O
the	O
yeast	O
GAL4	O
DNA	O
binding	O
domain	O
.	O

PAX6PST	O
contains	O
the	O
whole	O
PST	O
domain	O
(	O
amino	B-CHEBI
acids	I-CHEBI
278	O
-	O
422	O
of	O
the	O
full	O
-	O
length	O
PAX6	O
protein	B-CHEBI
)	O
.	O

Primers	O
were	O
ST001	O
(	O
forward	O
)	O
5	O
'	O
-	O
AAA	O
AGT	O
TCG	O
ACT	O
GCC	O
AGC	O
AAC	O
ACA	O
CCT	O
AGT	O
C	B-CHEBI
-	O
3	O
'	O
and	O
ST005	O
(	O
R	O
)	O
5	O
'	O
-	O
TTT	O
TGC	O
GGC	O
TTT	O
TTA	O
CTG	O
TAA	O
TCT	O
TGG	O
CCA	O
GTA	O
TTG	O
-	O
3	O
'	O
.	O

PAX6CTP	O
contains	O
the	O
newly	O
defined	O
C	B-CHEBI
-	O
terminal	O
peptide	O
alone	O
(	O
391	O
-	O
422	O
)	O
.	O

Primers	O
were	O
ST004	O
(	O
F	O
)	O
5	O
'	O
-	O
AAA	O
AGT	O
CGA	O
CTA	O
CCA	O
CTT	O
CAA	O
CAG	O
GAC	O
TCA	O
TT	O
-	O
3	O
'	O
and	O
ST005	O
(	O
R	O
)	O
.	O

PAX6PST	O
-	O
CT	O
contains	O
the	O
PST	O
domain	O
minus	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
(	O
278	O
-	O
390	O
)	O
.	O

This	O
was	O
made	O
by	O
cutting	O
PAX6PST	O
with	O
NdeI	O
and	O
NotI	O
to	O
drop	O
out	O
the	O
C	B-CHEBI
-	O
terminal	O
peptide	O
,	O
and	O
inserting	O
a	O
synthetic	O
linker	O
between	O
the	O
two	O
restriction	O
sites	O
.	O

All	O
fragments	O
generated	O
by	O
PCR	O
or	O
with	O
linkers	O
were	O
sequenced	O
to	O
check	O
that	O
no	O
errors	O
had	O
been	O
introduced	O
.	O

A	O
PAX6	O
PST	O
domain	O
construct	O
containing	O
the	O
mutation	O
1627A	O
>	O
G	B-CHEBI
(	O
Q422R	O
)	O
was	O
generated	O
in	O
the	O
same	O
way	O
as	O
the	O
PAX6PST	O
construct	O
,	O
but	O
using	O
the	O
reverse	O
PCR	O
primer	O
ST006	O
5	O
'	O
-	O
TTT	O
TGC	O
GGC	O
CGC	O
TTT	O
TTA	O
CCG	O
TAA	O
TCT	O
TGG	O
CCA	O
GTA	O
TTG	O
AG	O
-	O
3	O
'	O
,	O
which	O
contains	O
the	O
mutant	O
nucleotide	O
substitution	O
(	O
underlined	O
)	O
.	O

cDNA	O
sequences	O
containing	O
the	O
mutations	O
1615del10	O
[	O
28	O
]	O
and	O
1629insT	O
(	O
X423L	O
)	O
[	O
12	O
]	O
were	O
generated	O
by	O
PCR	O
from	O
reverse	O
transcribed	O
RNA	O
(	O
a	O
gift	O
from	O
Dr	O
K	O
Williamson	O
and	O
Prof	O
V	O
van	O
Heyningen	O
)	O
.	O

Primers	O
were	O
ST015	O
(	O
F	O
)	O
5	O
'	O
-	O
CCC	O
ACA	O
TAT	O
GCA	O
GAC	O
ACA	O
C	B-CHEBI
-	O
3	O
'	O
and	O
ST031	O
(	O
R	O
)	O
5	O
'	O
-	O
TTG	O
CGG	O
CCG	O
CAT	O
CCA	O
TCC	O
AGT	O
CTA	O
CAT	O
TGT	O
TC	O
-	O
3	O
'	O
.	O

The	O
PAX6PST	O
construct	O
was	O
cut	O
with	O
NdeI	O
and	O
NotI	O
to	O
release	O
the	O
normal	O
C	B-CHEBI
-	O
terminal	O
peptide	O
,	O
and	O
the	O
mutant	O
sequence	O
was	O
inserted	O
.	O

Yeast	O
two	O
-	O
hybrid	O
library	O
screens	O

A	O
mouse	O
brain	O
cDNA	O
library	O
(	O
ProQuest	O
,	O
Invitrogen	O
)	O
was	O
screened	O
with	O
the	O
PAX6PST	O
and	O
PAX6CTP	O
pDBLeu	O
constructs	O
.	O

The	O
library	O
was	O
constructed	O
in	O
the	O
pPC86	O
vector	O
,	O
which	O
produces	O
proteins	B-CHEBI
fused	O
to	O
the	O
yeast	O
GAL4	O
activation	O
domain	O
.	O

The	O
system	O
uses	O
three	O
GAL4	O
-	O
activated	O
reporter	O
genes	O
,	O
HIS3	O
,	O
URA3	O
and	O
lacZ	O
,	O
to	O
identify	O
positive	O
interactions	O
.	O

Reporters	O
are	O
activated	O
when	O
the	O
bait	O
protein	B-CHEBI
fused	O
to	O
the	O
GAL4	O
DNA	O
binding	O
domain	O
(	O
pDBLeu	O
)	O
interacts	O
with	O
the	O
prey	O
protein	B-CHEBI
fused	O
to	O
the	O
GAL4	O
activation	O
domain	O
(	O
pPC86	O
)	O
,	O
thus	O
reconstituting	O
GAL4	O
function	O
.	O

HIS3	O
activation	O
allows	O
growth	O
on	O
plates	O
lacking	O
histidine	B-CHEBI
.	O

Weak	O
URA3	O
activation	O
suppresses	O
growth	O
on	O
plates	O
containing	O
5	O
-	O
fluro	B-CHEBI
-	O
orotic	B-CHEBI
acid	I-CHEBI
while	O
strong	O
URA3	O
activation	O
permits	O
growth	O
on	O
plates	O
lacking	O
uracil	B-CHEBI
.	O

LacZ	O
activation	O
causes	O
X	O
-	O
gal	O
to	O
turn	O
blue	O
in	O
a	O
beta	O
-	O
galactosidase	O
assay	O
.	O

All	O
assays	O
were	O
carried	O
out	O
in	O
parallel	O
with	O
the	O
five	O
ProQuest	O
control	O
yeast	O
strains	O
A	O
-	O
E	O
,	O
which	O
range	O
from	O
non	O
-	O
interactor	O
(	O
A	O
)	O
to	O
strong	O
interactor	O
(	O
E	O
)	O
.	O

All	O
procedures	O
were	O
carried	O
out	O
according	O
to	O
the	O
supplier	O
'	O
s	O
protocols	O
.	O

Briefly	O
,	O
chemically	B-CHEBI
competent	O
MaV203	O
yeast	O
cells	O
were	O
co	O
-	O
transformed	O
with	O
the	O
cDNA	O
library	O
and	O
the	O
bait	O
plasmid	O
pDBLeu	O
PAX6CTP	O
or	O
pDBLeu	O
PAX6PST	O
.	O

Transformants	O
(	O
5	O
x	O
107	O
)	O
were	O
plated	O
on	O
medium	O
lacking	O
histidine	B-CHEBI
to	O
check	O
for	O
HIS3	O
activation	O
.	O

HIS3	O
positives	O
were	O
then	O
assayed	O
for	O
all	O
3	O
reporters	O
.	O

The	O
pPC86	O
prey	O
plasmid	O
was	O
isolated	O
from	O
all	O
HIS3	O
/	O
URA3	O
/	O
LacZ	O
positives	O
and	O
the	O
cDNA	O
insert	O
sequenced	O
.	O

BLAST	O
searches	O
were	O
performed	O
to	O
identify	O
the	O
cDNA	O
insert	O
[	O
24	O
]	O
.	O

Pairwise	O
interactions	O

Specific	O
interactions	O
were	O
tested	O
by	O
transforming	O
competent	O
MaV203	O
yeast	O
cells	O
with	O
one	O
bait	O
construct	O
(	O
in	O
pDBLeu	O
)	O
and	O
one	O
prey	O
construct	O
(	O
in	O
pPC86	O
)	O
and	O
testing	O
the	O
resulting	O
colonies	O
for	O
activation	O
of	O
the	O
HIS3	O
,	O
URA3	O
and	O
LacZ	O
reporters	O
as	O
before	O
.	O

To	O
create	O
a	O
full	O
-	O
length	O
Homer3	O
clone	O
for	O
pairwise	O
tests	O
,	O
a	O
cDNA	O
clone	O
(	O
IMAGE	O
clone	O
3602414	O
,	O
accession	O
number	O
BE569374	O
)	O
containing	O
the	O
missing	O
N	B-CHEBI
-	O
terminal	O
70	O
amino	B-CHEBI
acids	I-CHEBI
was	O
identified	O
by	O
a	O
BLAST	O
search	O
of	O
the	O
EST	O
nucleotide	O
sequence	O
database	O
and	O
obtained	O
from	O
the	O
Rosalind	O
Franklin	O
Centre	O
for	O
Genomics	O
Research	O
.	O

The	O
missing	O
fragment	O
was	O
amplified	O
from	O
the	O
IMAGE	O
clone	O
by	O
PCR	O
and	O
inserted	O
into	O
the	O
pPC86	O
-	O
Homer3	O
plasmid	O
to	O
create	O
a	O
full	O
-	O
length	O
expression	O
construct	O
.	O

Semi	O
-	O
quantitative	O
PCR	O

To	O
check	O
the	O
relative	O
representation	O
of	O
clones	O
in	O
the	O
cDNA	O
library	O
,	O
semi	O
-	O
quantitative	O
PCR	O
was	O
performed	O
on	O
Pax6	O
,	O
Homer3	O
,	O
Dncl1	O
,	O
Trim11	O
and	O
the	O
constitutively	O
expressed	O
genes	O
Gapdh	O
and	O
Atp5a1	O
[	O
29	O
,	O
30	O
]	O
.	O

Primers	O
were	O
designed	O
to	O
cross	O
at	O
least	O
one	O
intron	O
,	O
so	O
that	O
only	O
correctly	O
spliced	O
clones	O
were	O
amplified	O
.	O

Primer	O
sequences	O
were	O
:	O
Pax6	O
-	O
F	O
CAG	O
CCA	O
AAA	O
TAG	O
ATC	O
TAC	O
CTG	O
;	O
Pax6	O
-	O
R	O
CGA	O
TCA	O
CAT	O
GCT	O
CTC	O
TCC	O
TT	O
;	O
Homer3	O
-	O
F	O
CCC	O
AGG	O
TGG	O
CTG	O
TAG	O
AGC	O
;	O
Homer3	O
-	O
R	O
CTC	O
TAC	O
ACA	O
GTG	O
CAA	O
AGC	O
TCA	O
G	B-CHEBI
;	O
Trim11	O
-	O
F	O
GTG	O
CAG	O
GAT	O
GTG	O
AAG	O
CTG	O
;	O
Trim11	O
-	O
R	O
GCC	O
TGC	O
AGA	O
TAG	O
TCA	O
TAG	O
GG	O
;	O
Dncl1	O
-	O
F	O
CAA	O
AAA	O
TGC	O
AGA	O
CAT	O
GTC	O
G	B-CHEBI
;	O
Dncl1	O
-	O
R	O
CTA	O
AGG	O
GAG	O
AAA	O
AAA	O
ATG	O
GGG	O
;	O
Gapdh	O
-	O
F	O
:	O
CAT	O
CAC	O
CAT	O
CTT	O
CCA	O
GGA	O
GC	O
;	O
Gapdh	O
-	O
R	O
:	O
ATG	O
ACC	O
TTG	O
CCC	O
ACA	O
GCC	O
TT	O
;	O
Atp5a1	O
-	O
F	O
:	O
CAC	O
ACG	O
TGA	O
GAT	O
GTC	O
CTC	O
CA	O
;	O
Atp5a1	O
-	O
R	O
:	O
CAC	O
AGA	O
GAT	O
TCG	O
GGG	O
ATA	O
A	B-CHEBI
.	O

10	O
ng	O
library	O
cDNA	O
were	O
amplified	O
in	O
a	O
reaction	O
containing	O
1xAmpliTaq	O
polymerase	O
buffer	O
(	O
Perkin	O
Elmer	O
)	O
,	O
1	O
.	O
5	O
mM	O
MgCl2	B-CHEBI
,	O
200	O
mu	O
M	O
each	O
primer	O
and	O
2	O
.	O
5	O
units	O
of	O
AmpliTaq	O
polymerase	O
(	O
Perkin	O
Elmer	O
)	O
.	O

PCR	O
conditions	O
were	O
(	O
95	O
degrees	O
C	O
for	O
30	O
sec	O
)	O
x	O
1	O
,	O
(	O
94	O
degrees	O
C	O
for	O
30	O
sec	O
,	O
55	O
degrees	O
C	O
for	O
30	O
sec	O
,	O
72	O
degrees	O
C	O
for	O
30	O
sec	O
)	O
x	O
32	O
and	O
(	O
72	O
degrees	O
C	O
for	O
2	O
min	O
)	O
x	O
1	O
.	O

Products	O
were	O
resolved	O
on	O
a	O
2	O
.	O
5	O
%	O
agarose	B-CHEBI
gel	O
with	O
Phi	O
X174	O
/	O
HaeIII	O
size	O
markers	O
(	O
Promega	O
)	O
.	O

Abbreviations	O

PST	O
domain	O
,	O
proline	B-CHEBI
-	O
,	O
serine	B-CHEBI
-	O
and	O
threonine	B-CHEBI
-	O
rich	O
domain	O
;	O
PSD	O
,	O
post	O
-	O
synaptic	O
density	O
;	O
PCR	O
,	O
polymerase	O
chain	O
reaction	O
.	O

Authors	O
'	O
contributions	O

STC	O
carried	O
out	O
the	O
bioinformatic	O
analyses	O
and	O
all	O
experimental	O
work	O
.	O

IMH	O
conceived	O
,	O
designed	O
and	O
supervised	O
the	O
study	O
,	O
and	O
obtained	O
funding	O
.	O

The	O
manuscript	O
was	O
prepared	O
jointly	O
by	O
STC	O
and	O
IMH	O
,	O
who	O
have	O
both	O
read	O
and	O
approved	O
the	O
final	O
version	O
.	O

Acknowledgements	O

We	O
gratefully	O
acknowledge	O
Dr	O
A	O
Brown	O
for	O
technical	O
advice	O
on	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
and	O
the	O
Rosalind	O
Franklin	O
Centre	O
for	O
Genomics	O
Research	O
for	O
supplying	O
the	O
Homer3	O
IMAGE	O
clone	O
.	O

STC	O
was	O
supported	O
by	O
Fight	O
for	O
Sight	O
and	O
IMH	O
was	O
supported	O
by	O
a	O
Career	O
Development	O
Award	O
from	O
the	O
UK	O
Medical	O
Research	O
Council	O
.	O

Medium	O
-	O
Chain	O
Acyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
Dehydrogenase	O
Deficiency	O
in	O
Gene	O
-	O
Targeted	O
Mice	O

Abstract	O

Medium	O
-	O
chain	O
acyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
dehydrogenase	O
(	O
MCAD	O
)	O
deficiency	O
is	O
the	O
most	O
common	O
inherited	O
disorder	O
of	O
mitochondrial	O
fatty	B-CHEBI
acid	I-CHEBI
beta	O
-	O
oxidation	O
in	O
humans	O
.	O

To	O
better	O
understand	O
the	O
pathogenesis	O
of	O
this	O
disease	O
,	O
we	O
developed	O
a	O
mouse	O
model	O
for	O
MCAD	O
deficiency	O
(	O
MCAD	O
-	O
/	O
-	O
)	O
by	O
gene	O
targeting	O
in	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
.	O

The	O
MCAD	O
-	O
/	O
-	O
mice	O
developed	O
an	O
organic	O
aciduria	O
and	O
fatty	O
liver	O
,	O
and	O
showed	O
profound	O
cold	O
intolerance	O
at	O
4	O
degrees	O
C	O
with	O
prior	O
fasting	O
.	O

The	O
sporadic	O
cardiac	O
lesions	O
seen	O
in	O
MCAD	O
-	O
/	O
-	O
mice	O
have	O
not	O
been	O
reported	O
in	O
human	O
MCAD	O
patients	O
.	O

There	O
was	O
significant	O
neonatal	O
mortality	O
of	O
MCAD	O
-	O
/	O
-	O
pups	O
demonstrating	O
similarities	O
to	O
patterns	O
of	O
clinical	O
episodes	O
and	O
mortality	O
in	O
MCAD	O
-	O
deficient	O
patients	O
.	O

The	O
MCAD	O
-	O
deficient	O
mouse	O
reproduced	O
important	O
aspects	O
of	O
human	O
MCAD	O
deficiency	O
and	O
is	O
a	O
valuable	O
model	O
for	O
further	O
analysis	O
of	O
the	O
roles	O
of	O
fatty	B-CHEBI
acid	I-CHEBI
oxidation	O
and	O
pathogenesis	O
of	O
human	O
diseases	O
involving	O
fatty	B-CHEBI
acid	I-CHEBI
oxidation	O
.	O

Synopsis	O

Medium	O
-	O
chain	O
acyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
dehydrogenase	O
(	O
MCAD	O
)	O
deficiency	O
is	O
one	O
of	O
the	O
most	O
common	O
inherited	O
disorders	O
of	O
metabolism	O
.	O

This	O
defect	O
in	O
fatty	B-CHEBI
acid	I-CHEBI
oxidation	O
can	O
lead	O
to	O
severe	O
and	O
sometimes	O
fatal	O
disease	O
,	O
especially	O
in	O
young	O
children	O
because	O
they	O
are	O
unable	O
to	O
tolerate	O
a	O
fasting	O
episode	O
.	O

Metabolic	O
complications	O
include	O
very	O
low	O
blood	O
glucose	B-CHEBI
concentrations	O
and	O
generation	O
of	O
toxic	B-CHEBI
by	B-CHEBI
-	I-CHEBI
products	I-CHEBI
.	O

This	O
disorder	O
can	O
result	O
in	O
sudden	O
infant	O
death	O
.	O

Using	O
a	O
process	O
known	O
as	O
gene	O
targeting	O
in	O
mouse	O
embryonic	O
stem	O
cells	O
,	O
the	O
authors	O
have	O
developed	O
a	O
mouse	O
model	O
with	O
the	O
same	O
enzyme	O
deficiency	O
.	O

This	O
mouse	O
model	O
of	O
MCAD	O
deficiency	O
develops	O
many	O
of	O
the	O
same	O
disease	O
characteristics	O
found	O
in	O
affected	O
children	O
.	O

The	O
MCAD	O
-	O
deficient	O
mouse	O
model	O
shows	O
a	O
high	O
rate	O
of	O
newborn	O
loss	O
,	O
intolerance	O
to	O
cold	O
,	O
and	O
the	O
characteristic	O
biochemical	O
changes	O
in	O
the	O
blood	O
,	O
tissues	O
,	O
and	O
urine	O
that	O
are	O
very	O
similar	O
to	O
those	O
found	O
in	O
the	O
human	O
disease	O
counterpart	O
.	O

The	O
MCAD	O
-	O
deficient	O
mouse	O
model	O
will	O
allow	O
researchers	O
to	O
better	O
understand	O
disease	O
mechanisms	O
so	O
that	O
new	O
preventive	O
measures	O
or	O
therapies	O
can	O
be	O
developed	O
.	O

Introduction	O

Mitochondrial	O
beta	O
-	O
oxidation	O
of	O
fatty	B-CHEBI
acids	I-CHEBI
provides	O
energy	O
,	O
especially	O
during	O
fasting	O
conditions	O
.	O

Fatty	B-CHEBI
acid	I-CHEBI
oxidation	O
occurs	O
in	O
mitochondria	O
and	O
consists	O
of	O
a	O
repeating	O
circuit	O
of	O
four	O
sequential	O
steps	O
.	O

There	O
are	O
four	O
straight	O
-	O
chain	O
acyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
dehydrogenases	O
involved	O
in	O
the	O
initial	O
step	O
.	O

Medium	O
-	O
chain	O
acyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
dehydrogenase	O
(	O
MCAD	O
)	O
(	O
the	O
mouse	O
gene	O
is	O
Acadm	O
,	O
whereas	O
the	O
protein	B-CHEBI
is	O
MCAD	O
)	O
,	O
specifically	O
,	O
is	O
responsible	O
for	O
catalyzing	O
the	O
dehydrogenation	O
of	O
medium	O
-	O
chain	O
length	O
(	O
C6	O
-	O
C12	O
)	O
fatty	B-CHEBI
acid	I-CHEBI
thioesters	B-CHEBI
[	O
1	O
]	O
.	O

Acadm	O
is	O
transcribed	O
in	O
the	O
nucleus	O
,	O
translated	O
in	O
the	O
cytosol	O
,	O
and	O
translocated	O
into	O
the	O
mitochondrial	O
matrix	O
[	O
2	O
-	O
4	O
]	O
.	O

Once	O
inside	O
the	O
mitochondrial	O
matrix	O
,	O
the	O
MCAD	O
monomers	O
are	O
assembled	O
into	O
homotetramers	O
to	O
gain	O
enzymatic	O
activity	O
[	O
4	O
]	O
.	O

MCAD	O
activity	O
is	O
essential	O
for	O
complete	O
fatty	B-CHEBI
acid	I-CHEBI
oxidation	O
.	O

Inherited	O
MCAD	O
deficiency	O
exists	O
in	O
humans	O
as	O
an	O
autosomal	O
recessive	O
disorder	O
.	O

MCAD	O
deficiency	O
was	O
first	O
described	O
in	O
1982	O
--	O
1983	O
[	O
5	O
-	O
7	O
]	O
and	O
has	O
been	O
described	O
in	O
numerous	O
patients	O
[	O
1	O
,	O
8	O
-	O
11	O
]	O
.	O

The	O
carrier	O
frequency	O
in	O
the	O
Caucasian	O
population	O
has	O
been	O
estimated	O
to	O
be	O
between	O
1	O
in	O
50	O
to	O
80	O
with	O
an	O
incidence	O
of	O
clinical	O
disease	O
expected	O
at	O
around	O
1	O
in	O
15	O
,	O
000	O
[	O
1	O
,	O
9	O
,	O
12	O
]	O
.	O

MCAD	O
-	O
deficient	O
patients	O
exhibit	O
clinical	O
episodes	O
often	O
associated	O
with	O
fasting	O
.	O

Patients	O
manifest	O
disease	O
usually	O
during	O
the	O
first	O
two	O
years	O
of	O
life	O
.	O

Symptoms	O
include	O
hypoketotic	O
hypoglycemia	O
and	O
Reye	O
-	O
like	O
episodes	O
[	O
1	O
]	O
.	O

It	O
is	O
estimated	O
that	O
approximately	O
59	O
%	O
of	O
patients	O
presenting	O
clinically	O
between	O
15	O
to	O
26	O
mo	O
of	O
age	O
die	O
during	O
their	O
first	O
clinical	O
episode	O
[	O
1	O
]	O
.	O

The	O
pathogenesis	O
of	O
the	O
wide	O
range	O
of	O
metabolic	O
disturbances	O
in	O
MCAD	O
deficiency	O
is	O
poorly	O
understood	O
and	O
certain	O
aspects	O
of	O
patient	O
management	O
are	O
controversial	O
.	O

An	O
animal	O
model	O
for	O
MCAD	O
deficiency	O
is	O
essential	O
to	O
better	O
understand	O
the	O
pathogenesis	O
of	O
MCAD	O
deficiency	O
and	O
to	O
develop	O
better	O
management	O
regimens	O
for	O
human	O
patients	O
.	O

To	O
gain	O
further	O
insight	O
into	O
the	O
mechanisms	O
of	O
this	O
disease	O
,	O
we	O
developed	O
a	O
mouse	O
model	O
of	O
MCAD	O
deficiency	O
by	O
gene	O
targeting	O
in	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
(	O
for	O
reviews	O
[	O
13	O
,	O
14	O
]	O
)	O
.	O

The	O
mutant	O
mice	O
had	O
many	O
relevant	O
features	O
characteristic	O
of	O
the	O
disease	O
found	O
in	O
human	O
MCAD	O
-	O
deficient	O
patients	O
,	O
along	O
with	O
some	O
unexpected	O
findings	O
.	O

Results	O

Gene	O
Targeting	O
and	O
Generation	O
of	O
MCAD	O
-	O
Deficient	O
Mice	O

MCAD	O
insertion	O
vector	O
(	O
MCAD	O
IV2	O
)	O
was	O
designed	O
to	O
undergo	O
gap	O
repair	O
of	O
the	O
1	O
.	O
3	O
-	O
kb	O
deleted	O
region	O
upon	O
homologous	O
recombination	O
in	O
129P2	O
(	O
129P2	O
/	O
OlaHsd	O
)	O
ES	O
cells	O
E14	O
-	O
1	O
.	O

Correct	O
targeting	O
of	O
the	O
MCAD	O
locus	O
resulted	O
in	O
a	O
duplication	O
of	O
exons	O
8	O
,	O
9	O
,	O
and	O
10	O
and	O
integration	O
of	O
flanking	O
plasmid	O
and	O
Neo	O
sequences	O
(	O
Figure	O
1A	O
)	O
.	O

The	O
insertion	O
vector	O
was	O
designed	O
to	O
duplicate	O
exon	O
8	O
,	O
9	O
,	O
and	O
10	O
at	O
the	O
MCAD	O
locus	O
.	O

Translation	O
of	O
the	O
duplicated	O
exon	O
8	O
region	O
results	O
in	O
the	O
formation	O
of	O
premature	O
stop	O
codons	O
resulting	O
in	O
truncation	O
of	O
the	O
MCAD	O
monomer	O
.	O

Specifically	O
,	O
the	O
first	O
premature	O
stop	O
codon	O
arises	O
after	O
translation	O
of	O
only	O
seven	O
amino	B-CHEBI
acids	I-CHEBI
from	O
the	O
duplicated	O
exon	O
8	O
.	O

The	O
resulting	O
MCAD	O
monomer	O
is	O
missing	O
the	O
C	B-CHEBI
-	O
terminal	O
domain	O
alpha	O
-	O
helixes	O
that	O
are	O
responsible	O
for	O
making	O
intersubunit	O
contacts	O
to	O
generate	O
the	O
functional	O
MCAD	O
homotetramer	O
.	O

Figure	O
1	O

Strategy	O
for	O
Disruption	O
of	O
the	O
Mouse	O
Acadm	O
Gene	O

(	O
A	O
)	O
The	O
MCAD	O
IV2	O
insertion	O
targeting	O
vector	O
with	O
a	O
deleted	O
1	O
.	O
3	O
-	O
kb	O
region	O
encompassing	O
exon	O
10	O
and	O
flanking	O
sequences	O
.	O

MCAD	O
IV2	O
undergoes	O
gap	O
repair	O
upon	O
homologous	O
recombination	O
at	O
the	O
endogenous	O
Acadm	O
locus	O
resulting	O
in	O
a	O
duplication	O
of	O
exons	O
8	O
,	O
9	O
,	O
and	O
10	O
at	O
the	O
disrupted	O
allele	O
.	O

(	O
B	O
)	O
Southern	O
blot	O
analysis	O
of	O
EcoRI	O
-	O
digested	O
genomic	O
DNA	O
from	O
ES	O
cells	O
screened	O
by	O
PCR	O
.	O

Probe	O
A	O
,	O
a	O
DNA	O
fragment	O
consisting	O
of	O
a	O
portion	O
of	O
exon	O
10	O
that	O
is	O
not	O
present	O
in	O
the	O
targeting	O
vector	O
,	O
hybridizes	O
to	O
an	O
endogenous	O
3	O
.	O
1	O
-	O
kb	O
fragment	O
and	O
,	O
upon	O
homologous	O
recombination	O
,	O
to	O
a	O
13	O
.	O
2	O
-	O
kb	O
fragment	O
.	O

Lane	O
1	O
represents	O
a	O
wild	O
-	O
type	O
ES	O
cell	O
line	O
,	O
and	O
Lane	O
2	O
and	O
3	O
represent	O
targeted	O
ES	O
cell	O
lines	O
.	O

ES	O
cell	O
clones	O
were	O
screened	O
by	O
PCR	O
(	O
data	O
not	O
shown	O
)	O
and	O
confirmed	O
by	O
Southern	O
blot	O
analysis	O
.	O

Southern	O
blot	O
analysis	O
used	O
an	O
exon	O
10	O
probe	O
(	O
probe	O
A	O
)	O
,	O
not	O
present	O
in	O
the	O
targeting	O
vector	O
,	O
hybridized	O
to	O
a	O
13	O
.	O
2	O
-	O
kb	O
band	O
in	O
addition	O
to	O
the	O
3	O
.	O
1	O
-	O
kb	O
endogenous	O
band	O
indicating	O
targeted	O
insertion	O
of	O
the	O
vector	O
at	O
the	O
Acadm	O
locus	O
(	O
Figure	O
1B	O
)	O
.	O

Correctly	O
targeted	O
ES	O
cell	O
clones	O
were	O
microinjected	O
into	O
B6	O
(	O
C57BL	O
/	O
6NTac	O
)	O
blastocysts	O
to	O
generate	O
chimeric	O
mice	O
.	O

Chimeric	O
mice	O
were	O
backcrossed	O
to	O
both	O
129P2	O
and	O
B6	O
inbred	O
mice	O
to	O
produce	O
MCAD	O
+	O
/	O
-	O
and	O
eventually	O
MCAD	O
-	O
/	O
-	O
mice	O
on	O
a	O
B6	O
/	O
129	O
mixed	O
background	O
.	O

The	O
studies	O
described	O
here	O
were	O
conducted	O
exclusively	O
on	O
the	O
B6	O
/	O
129	O
mixed	O
background	O
compared	O
with	O
littermate	O
controls	O
or	O
B6	O
/	O
129	O
control	O
groups	O
maintained	O
by	O
intercrosses	O
as	O
were	O
the	O
mutants	O
.	O

Perpetuating	O
this	O
mutation	O
as	O
a	O
congenic	O
mutant	O
line	O
on	O
the	O
129P2	O
background	O
proved	O
impractical	O
.	O

The	O
129P2	O
mice	O
were	O
poor	O
breeders	O
as	O
wild	O
-	O
types	O
,	O
and	O
when	O
introduced	O
,	O
the	O
Acadm	O
mutation	O
was	O
nearly	O
lost	O
on	O
this	O
background	O
because	O
of	O
the	O
high	O
rate	O
of	O
neonatal	O
death	O
.	O

Because	O
of	O
the	O
molecular	B-CHEBI
structure	O
of	O
the	O
targeted	O
allele	O
,	O
it	O
proved	O
virtually	O
impossible	O
to	O
distinguish	O
all	O
three	O
potential	O
genotypes	O
.	O

We	O
could	O
clearly	O
detect	O
the	O
presence	O
or	O
absence	O
of	O
the	O
targeted	O
allele	O
,	O
however	O
,	O
whether	O
a	O
particular	O
mouse	O
was	O
MCAD	O
-	O
/	O
-	O
or	O
MCAD	O
+	O
/	O
-	O
could	O
not	O
be	O
determined	O
by	O
Southern	O
blot	O
or	O
PCR	O
of	O
genomic	O
DNA	O
.	O

Ultimately	O
MCAD	O
-	O
/	O
-	O
mice	O
were	O
ascertained	O
by	O
immunoblot	O
analysis	O
of	O
offspring	O
with	O
subsequent	O
perpetuation	O
of	O
MCAD	O
-	O
/	O
-	O
and	O
MCAD	O
+	O
/	O
+	O
mice	O
as	O
separate	O
groups	O
.	O

RNA	O
Analysis	O

RT	O
-	O
PCR	O
amplification	O
from	O
exon	O
7	O
to	O
11	O
from	O
total	O
heart	O
RNA	O
amplified	O
the	O
expected	O
600	O
-	O
base	O
pair	O
(	O
bp	O
)	O
fragment	O
in	O
MCAD	O
+	O
/	O
+	O
and	O
MCAD	O
+	O
/	O
-	O
mice	O
,	O
and	O
a	O
1	O
.	O
5	O
-	O
kb	O
fragment	O
in	O
MCAD	O
-	O
/	O
-	O
mice	O
(	O
data	O
not	O
shown	O
)	O
.	O

Sequence	O
analysis	O
of	O
the	O
1	O
.	O
5	O
-	O
kb	O
fragment	O
revealed	O
that	O
the	O
amplified	O
fragment	O
consisted	O
of	O
exon	O
7	O
to	O
exon	O
10	O
with	O
280	O
bp	O
of	O
pGEM	O
plasmid	O
sequence	O
followed	O
by	O
exons	O
8	O
-	O
11	O
.	O

Some	O
of	O
the	O
plasmid	O
sequences	O
,	O
along	O
with	O
the	O
pPGKNEOpA	O
sequence	O
,	O
were	O
deleted	O
from	O
this	O
spliced	O
mRNA	B-CHEBI
.	O

Northern	O
blot	O
analysis	O
revealed	O
Acadm	O
was	O
normally	O
expressed	O
in	O
all	O
tissues	O
analyzed	O
from	O
MCAD	O
+	O
/	O
+	O
mice	O
with	O
the	O
most	O
robust	O
expression	O
occurring	O
in	O
brown	O
fat	O
,	O
kidney	O
,	O
heart	O
,	O
skeletal	O
muscle	O
,	O
and	O
liver	O
with	O
minimal	O
expression	O
in	O
the	O
brain	O
,	O
white	O
fat	O
,	O
and	O
testes	O
(	O
Figure	O
2	O
)	O
.	O

Interestingly	O
,	O
although	O
RT	O
-	O
PCR	O
amplified	O
an	O
incorrectly	O
spliced	O
Acadm	O
transcript	O
,	O
no	O
Acadm	O
transcripts	O
were	O
detected	O
by	O
northern	O
blot	O
analysis	O
from	O
MCAD	O
-	O
/	O
-	O
mice	O
.	O

These	O
results	O
strongly	O
suggest	O
that	O
the	O
mutant	O
RNA	O
is	O
unstable	O
and	O
degraded	O
rapidly	O
or	O
,	O
alternatively	O
,	O
undergoes	O
nonsense	O
mediated	O
RNA	O
decay	O
.	O

Figure	O
2	O

Northern	O
Blot	O
Analysis	O
from	O
MCAD	O
-	O
/	O
-	O
(	O
n	O
=	O
2	O
)	O
and	O
MCAD	O
+	O
/	O
+	O
(	O
n	O
=	O
2	O
)	O
Mice	O

Acadm	O
message	O
was	O
detected	O
from	O
the	O
heart	O
,	O
liver	O
,	O
brown	O
fat	O
,	O
brain	O
,	O
kidney	O
,	O
and	O
muscle	O
(	O
and	O
white	O
fat	O
and	O
testes	O
,	O
data	O
not	O
shown	O
)	O
of	O
only	O
MCAD	O
+	O
/	O
+	O
mice	O
.	O

Most	O
robust	O
expression	O
occurred	O
in	O
brown	O
fat	O
,	O
kidney	O
,	O
heart	O
,	O
and	O
skeletal	O
muscle	O
.	O

MCAD	O
-	O
/	O
-	O
mice	O
had	O
no	O
detectable	O
message	O
in	O
all	O
tissues	O
examined	O
.	O

Liver	O
Enzyme	O
Analyses	O

Immunoblot	O
analyses	O
of	O
liver	O
homogenates	O
with	O
anti	O
-	O
MCAD	O
antisera	O
demonstrated	O
that	O
the	O
42	O
kDa	O
MCAD	O
monomer	O
was	O
present	O
in	O
MCAD	O
+	O
/	O
+	O
mice	O
,	O
but	O
not	O
in	O
MCAD	O
-	O
/	O
-	O
mice	O
(	O
Figure	O
3	O
)	O
.	O

As	O
a	O
control	O
analysis	O
,	O
anti	O
-	O
short	O
-	O
chain	O
acyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
dehydrogenase	O
(	O
SCAD	O
)	O
antisera	O
revealed	O
no	O
differences	O
in	O
levels	O
of	O
expression	O
of	O
SCAD	O
protein	B-CHEBI
between	O
MCAD	O
+	O
/	O
+	O
and	O
MCAD	O
-	O
/	O
-	O
mice	O
(	O
Figure	O
3	O
)	O
.	O

Figure	O
3	O

Immunoblots	O
of	O
Liver	O
Homogenates	O
from	O
MCAD	O
+	O
/	O
+	O
and	O
MCAD	O
-	O
/	O
-	O
Mice	O

These	O
were	O
probed	O
with	O
anti	O
-	O
MCAD	O
antibody	O
or	O
anti	O
-	O
SCAD	O
antibody	O
.	O

Homozygous	O
MCAD	O
-	O
/	O
-	O
mice	O
had	O
no	O
detectable	O
MCAD	O
protein	B-CHEBI
.	O

MCAD	O
protein	B-CHEBI
is	O
only	O
detectable	O
under	O
the	O
MCAD	O
protein	B-CHEBI
-	O
spiked	O
(	O
positive	O
control	O
)	O
lane	O
.	O

As	O
a	O
control	O
analysis	O
,	O
liver	O
homogenates	O
probed	O
with	O
anti	O
-	O
SCAD	O
antibody	O
revealed	O
that	O
SCAD	O
protein	B-CHEBI
was	O
present	O
in	O
both	O
MCAD	O
+	O
/	O
+	O
and	O
MCAD	O
-	O
/	O
-	O
mice	O
.	O

No	O
MCAD	O
positive	O
-	O
control	O
protein	B-CHEBI
is	O
detected	O
by	O
anti	O
-	O
SCAD	O
antibodies	O
(	O
MCAD	O
lane	O
)	O
.	O

mw	O
,	O
molecular	B-CHEBI
weight	O
standards	O
.	O

Enzyme	O
activity	O
was	O
analyzed	O
in	O
mouse	O
liver	O
homogenates	O
using	O
the	O
electron	B-CHEBI
transport	O
flavoprotein	B-CHEBI
(	O
ETF	O
)	O
reduction	O
assay	O
with	O
octanoyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
(	O
C8	O
:	O
0	O
)	O
and	O
palmitoyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
(	O
C16	O
:	O
0	O
)	O
as	O
substrates	O
.	O

MCAD	O
-	O
/	O
-	O
mice	O
had	O
a	O
significant	O
reduction	O
in	O
ability	O
to	O
dehydrogenate	O
octanoyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
and	O
a	O
modest	O
reduction	O
in	O
activity	O
toward	O
palmitoyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
compared	O
to	O
MCAD	O
+	O
/	O
+	O
mice	O
(	O
Table	O
1	O
)	O
.	O

Specifically	O
,	O
the	O
dehydrogenation	O
of	O
octanoyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
and	O
palmitoyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
substrates	O
were	O
reduced	O
by	O
75	O
%	O
and	O
by	O
30	O
%	O
,	O
respectively	O
,	O
in	O
MCAD	O
-	O
/	O
-	O
mice	O
as	O
compared	O
to	O
MCAD	O
+	O
/	O
+	O
controls	O
.	O

Table	O
1	O

Characteristics	O
of	O
MCAD	O
-	O
Deficient	O
Mice	O

Values	O
given	O
are	O
mean	O
+/-	O
SD	O
.	O

aMCAD	O
+	O
/	O
+	O
n	O
=	O
5	O
and	O
MCAD	O
-	O
/	O
-	O
n	O
=	O
5	O
.	O

bMCAD	O
+	O
/	O
+	O
n	O
=	O
8	O
litters	O
and	O
MCAD	O
-	O
/	O
-	O
n	O
=	O
10	O
litters	O
.	O

cMCAD	O
+	O
/	O
+	O
n	O
=	O
5	O
and	O
MCAD	O
-	O
/	O
-	O
n	O
=	O
6	O
.	O

dMCAD	O
+	O
/	O
+	O
n	O
=	O
4	O
and	O
MCAD	O
-	O
/	O
-	O
n	O
=	O
5	O
.	O

eExpressed	O
as	O
a	O
ratio	O
relative	O
to	O
the	O
internal	O
standard	O
.	O

Neonatal	O
Deaths	O

Significant	O
neonatal	O
mortality	O
was	O
noted	O
in	O
MCAD	O
-	O
/	O
-	O
pups	O
.	O

Although	O
equal	O
numbers	O
of	O
pups	O
were	O
born	O
from	O
MCAD	O
+	O
/	O
+	O
and	O
MCAD	O
-	O
/	O
-	O
mice	O
,	O
only	O
41	O
%	O
of	O
MCAD	O
-	O
/	O
-	O
mice	O
survived	O
to	O
weaning	O
as	O
compared	O
to	O
98	O
%	O
of	O
MCAD	O
+	O
/	O
+	O
mice	O
(	O
Table	O
1	O
)	O
.	O

The	O
mechanism	O
of	O
neonatal	O
loss	O
remains	O
undetermined	O
.	O

The	O
MCAD	O
-	O
/	O
-	O
pups	O
are	O
abandoned	O
more	O
frequently	O
than	O
MCAD	O
+	O
/	O
+	O
pups	O
for	O
unknown	O
reasons	O
.	O

They	O
are	O
likely	O
more	O
prone	O
to	O
hypothermia	O
than	O
MCAD	O
+	O
/	O
+	O
.	O

Because	O
of	O
the	O
difficulty	O
of	O
distinguishing	O
the	O
MCAD	O
-	O
/	O
-	O
mutants	O
from	O
the	O
MCAD	O
+	O
/	O
-	O
heterozygous	O
pups	O
by	O
molecular	B-CHEBI
analysis	O
due	O
to	O
the	O
insertion	O
mutation	O
,	O
we	O
could	O
only	O
compare	O
MCAD	O
+	O
/	O
+	O
x	O
MCAD	O
+	O
/	O
+	O
matings	O
with	O
MCAD	O
-	O
/	O
-	O
x	O
MCAD	O
-	O
/	O
-	O
matings	O
.	O

Thus	O
,	O
we	O
were	O
unable	O
to	O
evaluate	O
the	O
pedigrees	O
from	O
heterozygous	O
matings	O
.	O

Fasting	O
and	O
Cold	O
Intolerance	O

In	O
order	O
to	O
examine	O
the	O
stress	O
effects	O
of	O
fasting	O
on	O
MCAD	O
-	O
deficient	O
mice	O
,	O
they	O
were	O
fasted	O
for	O
24	O
h	O
prior	O
to	O
analysis	O
.	O

MCAD	O
-	O
/	O
-	O
mice	O
displayed	O
lower	O
serum	O
glucose	B-CHEBI
and	O
elevated	O
serum	O
free	O
fatty	B-CHEBI
acid	I-CHEBI
levels	O
although	O
neither	O
result	O
was	O
significant	O
,	O
as	O
compared	O
to	O
MCAD	O
+	O
/	O
+	O
mice	O
(	O
Table	O
1	O
)	O
.	O

To	O
determine	O
the	O
effects	O
of	O
cold	O
stress	O
,	O
mice	O
were	O
fasted	O
for	O
18	O
h	O
and	O
placed	O
in	O
4	O
degrees	O
C	O
environment	O
for	O
a	O
3	O
-	O
h	O
period	O
.	O

The	O
MCAD	O
-	O
/	O
-	O
mice	O
were	O
significantly	O
compromised	O
within	O
this	O
short	O
period	O
of	O
cold	O
stress	O
,	O
some	O
severe	O
enough	O
to	O
result	O
in	O
fatalities	O
.	O

After	O
1	O
h	O
of	O
the	O
cold	O
challenge	O
,	O
the	O
average	O
rectal	O
temperature	O
of	O
MCAD	O
-	O
/	O
-	O
mice	O
(	O
n	O
=	O
5	O
)	O
was	O
23	O
.	O
4	O
degrees	O
C	O
as	O
compared	O
with	O
35	O
degrees	O
C	O
for	O
MCAD	O
+	O
/	O
+	O
mice	O
(	O
n	O
=	O
4	O
)	O
.	O

Rectal	O
temperatures	O
declined	O
to	O
unrecoverable	O
temperatures	O
of	O
16	O
.	O
7	O
-	O
19	O
.	O
2	O
degrees	O
C	O
in	O
three	O
of	O
the	O
five	O
MCAD	O
-	O
/	O
-	O
mice	O
.	O

By	O
the	O
end	O
of	O
the	O
1	O
.	O
5	O
-	O
h	O
mark	O
,	O
the	O
two	O
surviving	O
MCAD	O
-	O
/	O
-	O
mice	O
averaged	O
22	O
.	O
7	O
degrees	O
C	O
.	O

In	O
contrast	O
,	O
all	O
four	O
MCAD	O
+	O
/	O
+	O
mice	O
survived	O
the	O
3	O
-	O
h	O
cold	O
stress	O
,	O
ending	O
with	O
an	O
average	O
rectal	O
temperature	O
of	O
33	O
.	O
6	O
degrees	O
C	O
.	O

Organic	O
Acid	B-CHEBI
and	O
Acylcarnitine	B-CHEBI
Analysis	O

Urine	O
organic	O
acid	B-CHEBI
analysis	O
revealed	O
that	O
MCAD	O
-	O
/	O
-	O
mice	O
developed	O
an	O
organic	O
acid	B-CHEBI
profile	O
similar	O
to	O
MCAD	O
-	O
deficient	O
human	O
patients	O
.	O

Specifically	O
,	O
when	O
fasted	O
for	O
18	O
h	O
,	O
MCAD	O
-	O
/	O
-	O
mice	O
developed	O
significantly	O
elevated	O
concentrations	O
of	O
adipic	B-CHEBI
,	I-CHEBI
suberic	I-CHEBI
,	I-CHEBI
and	I-CHEBI
sebacic	I-CHEBI
acids	I-CHEBI
and	O
hexanoylglycine	O
as	O
compared	O
to	O
MCAD	O
+	O
/	O
+	O
controls	O
,	O
which	O
showed	O
trace	O
to	O
no	O
detectable	O
amounts	O
of	O
the	O
same	O
organic	O
acids	B-CHEBI
(	O
Table	O
1	O
)	O
.	O

Adipic	B-CHEBI
acid	I-CHEBI
is	O
not	O
specific	O
to	O
MCAD	O
deficiency	O
.	O

We	O
also	O
evaluated	O
beta	B-CHEBI
-	I-CHEBI
hydroxybutyric	I-CHEBI
and	O
acetoacetic	B-CHEBI
concentrations	O
and	O
found	O
no	O
significant	O
differences	O
between	O
MCAD	O
genotypes	O
(	O
data	O
not	O
shown	O
)	O
.	O

Comparison	O
of	O
MCAD	O
+	O
/	O
+	O
and	O
MCAD	O
-	O
/	O
-	O
mice	O
revealed	O
no	O
significant	O
differences	O
in	O
total	O
serum	O
carnitine	O
concentrations	O
between	O
MCAD	O
+	O
/	O
+	O
and	O
MCAD	O
-	O
/	O
-	O
mice	O
,	O
but	O
MCAD	O
-	O
/	O
-	O
mice	O
had	O
a	O
5	O
-	O
to	O
6	O
-	O
fold	O
elevation	O
of	O
serum	O
decenoylcarnitine	O
evident	O
in	O
the	O
acylcarnitine	B-CHEBI
profile	O
(	O
Figure	O
4A	O
)	O
.	O

Bile	O
acylcarnitine	B-CHEBI
analysis	O
revealed	O
a	O
similar	O
acylcarnitine	B-CHEBI
pattern	O
as	O
in	O
serum	O
(	O
Figure	O
4B	O
)	O
.	O

However	O
,	O
the	O
acylcarnitine	B-CHEBI
profiles	O
of	O
the	O
MCAD	O
-	O
/	O
-	O
mice	O
are	O
different	O
from	O
those	O
of	O
human	O
MCAD	O
-	O
deficient	O
patients	O
(	O
Figure	O
4C	O
)	O
.	O

Human	O
patients	O
present	O
with	O
elevated	O
levels	O
of	O
C6	O
,	O
C8	O
,	O
and	O
C10	O
:	O
1	O
acylcarnitines	B-CHEBI
,	O
as	O
did	O
the	O
mutant	O
mice	O
;	O
however	O
,	O
the	O
predominant	O
peak	O
was	O
C8	O
acylcarnitine	B-CHEBI
in	O
humans	O
,	O
whereas	O
in	O
the	O
mouse	O
it	O
was	O
C10	O
:	O
1	O
acylcarnitine	B-CHEBI
.	O

Figure	O
4	O

Acylcarnitine	B-CHEBI
Analyses	O

(	O
A	O
)	O
Serum	O
acylcarnitine	B-CHEBI
analysis	O
of	O
MCAD	O
+	O
/	O
+	O
(	O
n	O
=	O
4	O
)	O
and	O
MCAD	O
-	O
/	O
-	O
mice	O
(	O
n	O
=	O
4	O
)	O

There	O
are	O
significant	O
elevations	O
in	O
acylcarnitine	B-CHEBI
species	O
as	O
indicated	O
in	O
MCAD	O
-	O
/	O
-	O
mice	O
.	O

Values	O
shown	O
are	O
mean	O
values	O
+/-	O
standard	O
deviation	O
(	O
SD	O
)	O
.	O

Asterisk	O
indicates	O
p	O
<	O
0	O
.	O
002	O
and	O
++	O
indicates	O
p	O
<	O
0	O
.	O
01	O
.	O

(	O
B	O
)	O
There	O
are	O
significant	O
elevations	O
in	O
bile	O
acylcarnitines	B-CHEBI
of	O
the	O
same	O
mice	O
shown	O
in	O
(	O
A	O
)	O
as	O
indicated	O
.	O

Values	O
shown	O
are	O
mean	O
values	O
+/-	O
SD	O
.	O

Asterisk	O
indicates	O
p	O
<	O
0	O
.	O
001	O
.	O

(	O
C	O
)	O
Bile	O
acylcarnitine	B-CHEBI
profile	O
of	O
an	O
MCAD	O
-	O
/	O
-	O
mouse	O
compared	O
to	O
a	O
human	O
patient	O
with	O
MCAD	O
deficiency	O
.	O

Internal	O
standards	O
are	O
indicated	O
by	O
an	O
asterisk	O
.	O

Histopathology	O

Complete	O
histopathologic	O
examination	O
of	O
one	O
group	O
of	O
mutant	O
and	O
MCAD	O
+	O
/	O
+	O
control	O
mice	O
after	O
a	O
24	O
-	O
h	O
fast	O
demonstrated	O
diffuse	O
microvesicular	O
and	O
macrovesicular	O
hepatic	O
steatosis	O
in	O
6	O
-	O
8	O
-	O
wk	O
-	O
old	O
MCAD	O
-	O
/	O
-	O
mice	O
whereas	O
MCAD	O
+	O
/	O
+	O
mice	O
had	O
no	O
histologic	O
changes	O
(	O
Figure	O
5A	O
and	O
5B	O
)	O
.	O

In	O
another	O
group	O
of	O
4	O
-	O
wk	O
-	O
old	O
MCAD	O
+	O
/	O
+	O
and	O
MCAD	O
-	O
/	O
-	O
mice	O
fasted	O
for	O
24	O
-	O
h	O
,	O
there	O
were	O
minimal	O
to	O
no	O
abnormalities	O
in	O
all	O
organs	O
evaluated	O
.	O

Only	O
the	O
older	O
MCAD	O
-	O
/	O
-	O
mice	O
,	O
therefore	O
,	O
demonstrated	O
hepatic	O
steatosis	O
.	O

In	O
addition	O
,	O
we	O
found	O
sporadic	O
cardiac	O
lesions	O
in	O
multiple	O
MCAD	O
-	O
/	O
-	O
mice	O
.	O

Figure	O
5	O

Histopathology	O
of	O
MCAD	O
+	O
/	O
+	O
and	O
MCAD	O
-	O
/	O
-	O
Mice	O

(	O
A	O
)	O
MCAD	O
+	O
/	O
+	O
mice	O
had	O
no	O
evidence	O
of	O
hepatic	O
steatosis	O
following	O
a	O
24	O
-	O
h	O
fast	O
.	O

Liver	O
section	O
with	O
Oil	O
-	O
Red	O
O	O
stain	O
.	O

(	O
B	O
)	O
Hepatosteatosis	O
in	O
MCAD	O
-	O
/	O
-	O
mouse	O
following	O
a	O
24	O
-	O
h	O
fast	O
.	O

Oil	O
-	O
Red	O
O	O
stained	O
liver	O
sections	O
revealed	O
severe	O
and	O
diffuse	O
microvesicular	O
and	O
macrovesicular	O
hepatic	O
steatosis	O
in	O
MCAD	O
-	O
/	O
-	O
mice	O
.	O

(	O
C	O
and	O
D	O
)	O
Diffuse	O
cardiomyopathy	O
with	O
chronic	O
active	O
multifocal	O
myocyte	O
degeneration	O
and	O
necrosis	O
in	O
MCAD	O
-	O
/	O
-	O
mice	O
.	O

In	O
one	O
example	O
,	O
an	O
MCAD	O
-	O
/	O
-	O
mouse	O
had	O
diffuse	O
cardiomyopathy	O
with	O
chronic	O
active	O
multifocal	O
myocyte	O
degeneration	O
and	O
necrosis	O
(	O
Figure	O
5C	O
and	O
5D	O
)	O
.	O

Changes	O
in	O
degenerating	O
myocytes	O
included	O
swelling	O
,	O
pale	O
staining	O
,	O
and	O
,	O
in	O
portions	O
of	O
the	O
sarcoplasm	O
,	O
replacement	O
of	O
myofibrils	O
with	O
finely	O
granular	O
eosinophilic	O
material	O
.	O

Nuclei	O
of	O
affected	O
myocytes	O
were	O
large	O
,	O
pale	O
,	O
and	O
vesicular	O
and	O
had	O
prominent	O
nucleoli	O
.	O

In	O
the	O
most	O
severely	O
affected	O
areas	O
,	O
there	O
was	O
loss	O
of	O
myocytes	O
accompanied	O
by	O
fibrosis	O
.	O

In	O
the	O
wall	O
of	O
the	O
aorta	O
at	O
the	O
base	O
of	O
the	O
heart	O
there	O
was	O
multifocal	O
degeneration	O
of	O
the	O
elastic	O
tissue	O
,	O
accompanied	O
by	O
multifocal	O
collections	O
of	O
globular	O
translucent	O
yellow	O
-	O
brown	O
pigment	B-CHEBI
interpreted	O
to	O
be	O
ceroid	O
/	O
lipofuscin	O
.	O

Similar	O
deposits	O
were	O
scattered	O
within	O
adjacent	O
adipose	O
tissue	O
.	O

Discussion	O

Successfully	O
targeting	O
Acadm	O
produced	O
a	O
mouse	O
model	O
for	O
MCAD	O
deficiency	O
with	O
features	O
that	O
mimic	O
the	O
clinical	O
,	O
biochemical	O
,	O
and	O
pathologic	O
phenotype	O
found	O
in	O
human	O
patients	O
.	O

MCAD	O
-	O
deficient	O
patients	O
have	O
abnormal	O
plasma	O
and	O
urine	O
metabolites	B-CHEBI
associated	O
with	O
the	O
medium	O
chain	O
-	O
length	O
enzyme	O
specificity	O
.	O

MCAD	O
-	O
deficient	O
patients	O
[	O
15	O
]	O
often	O
display	O
a	O
characteristic	O
urinary	O
hexanoylglycine	O
peak	O
,	O
as	O
was	O
seen	O
in	O
MCAD	O
-	O
/	O
-	O
mice	O
.	O

Acylcarnitine	B-CHEBI
analysis	O
indicated	O
,	O
however	O
,	O
mouse	O
MCAD	O
is	O
more	O
active	O
toward	O
longer	O
chain	O
substrates	O
than	O
the	O
human	O
MCAD	O
enzyme	O
.	O

This	O
finding	O
is	O
similar	O
to	O
that	O
seen	O
with	O
very	O
long	B-CHEBI
-	I-CHEBI
chain	I-CHEBI
acyl	I-CHEBI
-	I-CHEBI
CoA	I-CHEBI
dehydrogenase	O
(	O
VLCAD	O
)	O
where	O
mouse	O
VLCAD	O
is	O
most	O
active	O
toward	O
C16	O
acyl	B-CHEBI
-	O
substrates	O
as	O
compared	O
to	O
human	O
VLCAD	O
with	O
the	O
most	O
enzymatic	O
activity	O
toward	O
C14	O
acyl	B-CHEBI
-	O
substrates	O
[	O
16	O
]	O
.	O

ETF	O
reduction	O
assays	O
of	O
liver	O
homogenates	O
were	O
performed	O
to	O
characterize	O
the	O
MCAD	O
-	O
/	O
-	O
mice	O
at	O
the	O
enzymatic	O
level	O
.	O

MCAD	O
-	O
/	O
-	O
mice	O
had	O
a	O
significantly	O
reduced	O
ability	O
to	O
dehydrogenate	O
C8	O
-	O
CoA	B-CHEBI
,	O
as	O
is	O
the	O
case	O
in	O
human	O
patients	O
where	O
MCAD	O
activity	O
is	O
reduced	O
to	O
near	O
zero	O
with	O
C8	O
-	O
CoA	B-CHEBI
.	O

This	O
was	O
less	O
so	O
with	O
palmitoyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
(	O
C16	O
:	O
0	O
)	O
.	O

Because	O
there	O
was	O
clearly	O
no	O
MCAD	O
antigen	O
detected	O
in	O
MCAD	O
-	O
/	O
-	O
mice	O
,	O
the	O
residual	O
dehydrogenase	O
activity	O
measured	O
with	O
these	O
two	O
substrates	O
must	O
represent	O
the	O
activity	O
of	O
other	O
chain	O
length	O
-	O
specific	O
acyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
dehydrogenases	O
.	O

A	O
high	O
degree	O
of	O
neonatal	O
mortality	O
in	O
MCAD	O
-	O
/	O
-	O
mice	O
was	O
a	O
striking	O
observation	O
and	O
appears	O
to	O
be	O
analogous	O
to	O
the	O
patterns	O
of	O
clinical	O
episodes	O
and	O
mortality	O
in	O
MCAD	O
-	O
deficient	O
patients	O
.	O

MCAD	O
-	O
/	O
-	O
mice	O
exhibited	O
significant	O
neonatal	O
mortality	O
with	O
approximately	O
60	O
%	O
of	O
the	O
MCAD	O
-	O
/	O
-	O
pups	O
dying	O
prior	O
to	O
weaning	O
at	O
3	O
wk	O
of	O
age	O
.	O

Human	O
patients	O
present	O
with	O
hypoglycemia	O
,	O
hypoketonemia	O
,	O
and	O
nonketotic	O
organic	O
aciduria	O
precipitated	O
by	O
fasting	O
,	O
most	O
frequently	O
during	O
the	O
first	O
24	O
mo	O
in	O
life	O
[	O
1	O
]	O
.	O

It	O
is	O
likely	O
that	O
neonatal	O
MCAD	O
-	O
/	O
-	O
pups	O
are	O
manifesting	O
sensitivity	O
to	O
fasting	O
with	O
decompensation	O
in	O
a	O
short	O
period	O
of	O
time	O
if	O
maternal	O
milk	O
is	O
not	O
ingested	O
.	O

In	O
contrast	O
,	O
no	O
mortality	O
was	O
noted	O
in	O
adult	O
MCAD	O
-	O
/	O
-	O
mice	O
unless	O
challenged	O
with	O
cold	O
stress	O
and	O
fasting	O
.	O

Under	O
cold	O
challenge	O
conditions	O
,	O
however	O
,	O
MCAD	O
-	O
/	O
-	O
mice	O
were	O
unable	O
to	O
maintain	O
body	O
temperature	O
.	O

Brown	O
fat	O
is	O
predominantly	O
responsible	O
for	O
thermogenesis	O
and	O
normally	O
expresses	O
high	O
levels	O
of	O
Acadm	O
mRNA	B-CHEBI
.	O

The	O
microvesicular	O
and	O
macrovesicular	O
hepatic	O
steatosis	O
seen	O
in	O
fasted	O
MCAD	O
-	O
/	O
-	O
mice	O
is	O
consistent	O
with	O
the	O
primary	O
pathological	O
finding	O
seen	O
in	O
human	O
MCAD	O
patients	O
with	O
fasting	O
stress	O
.	O

Sporadic	O
cardiac	O
lesions	O
in	O
MCAD	O
-	O
/	O
-	O
mice	O
,	O
however	O
,	O
were	O
an	O
interesting	O
and	O
unexpected	O
finding	O
.	O

The	O
diffuse	O
cardiomyopathy	O
with	O
multifocal	O
myocyte	O
degeneration	O
and	O
necrosis	O
observed	O
in	O
MCAD	O
-	O
/	O
-	O
mice	O
has	O
not	O
been	O
reported	O
in	O
human	O
MCAD	O
patients	O
,	O
however	O
,	O
cardiac	O
arrhythmias	O
and	O
dysfunction	O
have	O
been	O
reported	O
in	O
MCAD	O
-	O
deficient	O
patients	O
[	O
17	O
,	O
18	O
]	O
.	O

Interestingly	O
,	O
cardiomyopathy	O
has	O
been	O
observed	O
in	O
VLCAD	O
deficiency	O
[	O
19	O
]	O
and	O
other	O
disorders	O
of	O
long	B-CHEBI
chain	I-CHEBI
fat	I-CHEBI
metabolism	O
such	O
as	O
severe	O
CPT	O
-	O
1	O
and	O
-	O
2	O
deficiencies	O
[	O
1	O
]	O
.	O

Thus	O
it	O
is	O
tempting	O
to	O
relate	O
the	O
cardiac	O
problems	O
in	O
the	O
mouse	O
to	O
the	O
apparent	O
broader	O
range	O
of	O
substrate	O
utilization	O
of	O
mouse	O
MCAD	O
.	O

The	O
inconsistent	O
liver	O
and	O
cardiac	O
lesions	O
in	O
these	O
mice	O
is	O
analogous	O
with	O
the	O
significant	O
inter	O
-	O
and	O
intrafamilial	O
phenotypic	O
heterogeneity	O
seen	O
in	O
MCAD	O
deficiency	O
in	O
humans	O
[	O
1	O
,	O
20	O
]	O
.	O

In	O
comparisons	O
with	O
our	O
experiences	O
with	O
the	O
other	O
mouse	O
models	O
for	O
acyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
dehydrogenase	O
deficiencies	O
,	O
the	O
overall	O
phenotype	O
of	O
MCAD	O
-	O
/	O
-	O
mice	O
is	O
less	O
severe	O
than	O
that	O
found	O
in	O
LCAD	O
-	O
/	O
-	O
mice	O
,	O
yet	O
more	O
pronounced	O
than	O
the	O
VLCAD	O
-	O
/	O
-	O
or	O
SCAD	O
-	O
/	O
-	O
mouse	O
models	O
[	O
16	O
,	O
21	O
,	O
22	O
]	O
.	O

All	O
of	O
these	O
mutants	O
are	O
cold	O
intolerant	O
and	O
display	O
varying	O
degrees	O
of	O
fatty	O
changes	O
in	O
liver	O
,	O
heart	O
,	O
and	O
kidney	O
.	O

LCAD	O
-	O
/	O
-	O
mice	O
show	O
more	O
spontaneous	O
deaths	O
and	O
gestational	O
losses	O
than	O
the	O
other	O
deficiencies	O
[	O
21	O
]	O
.	O

The	O
significant	O
neonatal	O
mortality	O
in	O
MCAD	O
-	O
/	O
-	O
mice	O
is	O
distinctive	O
from	O
these	O
other	O
mouse	O
models	O
suggesting	O
a	O
greater	O
degree	O
of	O
sensitivity	O
to	O
fasting	O
intolerance	O
.	O

The	O
phenotypes	O
of	O
both	O
the	O
VLCAD	O
-	O
/	O
-	O
and	O
SCAD	O
-	O
/	O
-	O
mice	O
are	O
relatively	O
mild	O
if	O
the	O
animals	O
are	O
not	O
cold	O
stressed	O
[	O
16	O
,	O
22	O
]	O
.	O

The	O
MCAD	O
-	O
deficient	O
mouse	O
offers	O
new	O
insights	O
into	O
the	O
pathogenesis	O
of	O
mitochondrial	O
beta	O
-	O
oxidation	O
deficiencies	O
and	O
will	O
provide	O
a	O
robust	O
tool	O
to	O
better	O
understand	O
the	O
role	O
of	O
fatty	B-CHEBI
acids	I-CHEBI
in	O
other	O
relevant	O
diseases	O
.	O

Materials	O
and	O
Methods	O

Construction	O
of	O
MCAD	O
targeting	O
vector	O
.	O

A	O
neomycin	B-CHEBI
resistance	O
gene	O
cassette	O
[	O
23	O
]	O
was	O
subcloned	O
into	O
the	O
SalI	O
site	O
of	O
pGEM11Zf	O
(	O
+	O
)	O
.	O

The	O
plasmid	O
was	O
digested	O
with	O
EcoRI	O
and	O
the	O
overhangs	O
were	O
filled	O
with	O
Klenow	O
enzyme	O
.	O

Subsequent	O
ligation	O
of	O
the	O
blunt	O
ends	O
recircularized	O
the	O
vector	O
and	O
destroyed	O
the	O
EcoRI	O
site	O
within	O
the	O
polylinker	O
of	O
the	O
pGEMl1Zf	O
(	O
+	O
)	O
plasmid	O
.	O

Next	O
,	O
an	O
8	O
-	O
kb	O
Acadm	O
genomic	O
fragment	O
spanning	O
exons	O
8	O
,	O
9	O
,	O
and	O
10	O
and	O
flanking	O
intron	O
sequences	O
,	O
originally	O
obtained	O
from	O
a	O
Lambda	O
FIXII	O
129Sv	O
mouse	O
genomic	O
library	O
[	O
24	O
,	O
25	O
]	O
,	O
was	O
directionally	O
cloned	O
into	O
the	O
NotI	O
and	O
XhoI	O
sites	O
of	O
pGEM11Zf	O
(	O
+	O
)	O
.	O

The	O
vector	O
was	O
digested	O
with	O
BamHI	O
and	O
EcoRI	O
to	O
remove	O
a	O
1	O
.	O
3	O
-	O
kb	O
BamHI	O
/	O
EcoRI	O
genomic	O
fragment	O
containing	O
exon	O
10	O
and	O
flanking	O
intron	O
sequences	O
.	O

The	O
digested	O
vector	O
,	O
without	O
the	O
1	O
.	O
3	O
-	O
kb	O
BamHI	O
/	O
EcoRI	O
genomic	O
fragment	O
,	O
was	O
purified	O
by	O
gel	O
purification	O
and	O
recircularized	O
by	O
ligation	O
using	O
three	O
oligonucleotides	O
:	O
5	O
'	O
-	O
AATTGTCGACA	O
-	O
3	O
'	O
;	O
5	O
'	O
GATCGTCGACA	O
-	O
3	O
'	O
;	O
and	O
5	O
'	O
-	O
TCGATGTCGAC	O
-	O
3	O
'	O
.	O

The	O
recircularized	O
vector	O
,	O
resulting	O
from	O
the	O
ligation	O
of	O
the	O
long	O
arm	O
to	O
the	O
short	O
arm	O
of	O
homology	O
,	O
contained	O
a	O
unique	O
SalI	O
site	O
where	O
the	O
1	O
.	O
3	O
-	O
kb	O
exon	O
10	O
region	O
was	O
deleted	O
.	O

Generation	O
of	O
MCAD	O
-	O
deficient	O
mice	O
.	O

The	O
Acadm	O
insertion	O
vector	O
was	O
linearized	O
by	O
SalI	O
digestion	O
,	O
the	O
site	O
of	O
the	O
1	O
.	O
3	O
-	O
kb	O
genomic	O
fragment	O
deletion	O
,	O
and	O
electroporated	O
into	O
E14	O
-	O
1	O
ES	O
cells	O
(	O
a	O
kind	O
gift	O
from	O
R	O
.	O
Kuhn	O
)	O
,	O
derived	O
from	O
129P2	O
mice	O
.	O

Correctly	O
targeted	O
Acadm	O
insertion	O
vector	O
was	O
designed	O
to	O
undergo	O
gap	O
repair	O
of	O
the	O
1	O
.	O
3	O
-	O
kb	O
deletion	O
upon	O
double	O
stranded	O
-	O
break	O
repair	O
[	O
26	O
]	O
during	O
homologous	O
recombination	O
.	O

Southern	O
blot	O
analysis	O
was	O
conducted	O
to	O
confirm	O
homologous	O
recombination	O
.	O

Genomic	O
DNA	O
from	O
G418	O
resistant	O
ES	O
colonies	O
was	O
digested	O
with	O
EcoRI	O
,	O
electrophoresed	O
,	O
blotted	O
,	O
and	O
probed	O
with	O
an	O
850	O
-	O
bp	O
probe	O
(	O
probe	O
A	O
)	O
generated	O
by	O
PCR	O
from	O
Acadm	O
exon	O
10	O
to	O
intron	O
10	O
.	O

This	O
DNA	O
fragment	O
is	O
not	O
present	O
within	O
Acadm	O
insertion	O
vector	O
and	O
was	O
expected	O
to	O
hybridize	O
to	O
a	O
13	O
.	O
2	O
-	O
kb	O
genomic	O
DNA	O
fragment	O
upon	O
homologous	O
recombination	O
.	O

Correctly	O
targeted	O
ES	O
cell	O
clones	O
were	O
microinjected	O
into	O
B6	O
blastocysts	O
to	O
generate	O
chimeric	O
mice	O
.	O

Chimeric	O
mice	O
were	O
subsequently	O
backcrossed	O
to	O
B6	O
and	O
129P2	O
mice	O
to	O
produce	O
gene	O
-	O
targeted	O
mice	O
AcadmtmUab1	O
/	O
+	O
(	O
MCAD	O
+	O
/	O
-	O
)	O
and	O
eventually	O
AcadmtmUab1	O
/	O
tm1Uab	O
MCAD	O
-	O
/	O
-	O
(	O
B6	O
;	O
129	O
)	O
mice	O
.	O

Mice	O
were	O
negative	O
for	O
mouse	O
pathogens	O
based	O
on	O
serological	O
assays	O
for	O
ten	O
different	O
viruses	O
,	O
aerobic	O
bacterial	O
cultures	O
of	O
nasopharynx	O
and	O
cecum	O
,	O
examinations	O
for	O
endo	O
-	O
and	O
ectoparasites	O
,	O
and	O
histopathology	O
of	O
all	O
major	O
organs	O
.	O

RNA	O
analysis	O
.	O

Total	O
RNA	O
was	O
isolated	O
from	O
the	O
heart	O
of	O
30	O
day	O
old	O
MCAD	O
+	O
/	O
+	O
,	O
MCAD	O
+	O
/	O
-	O
,	O
and	O
MCAD	O
-	O
/	O
-	O
mice	O
by	O
standard	O
techniques	O
using	O
guanidinium	B-CHEBI
thiocyanate	B-CHEBI
method	O
[	O
27	O
]	O
.	O

Reverse	O
transcription	O
was	O
performed	O
using	O
random	O
oligonucleotides	O
as	O
recommended	O
by	O
the	O
manufacturer	O
(	O
Clontech	O
,	O
Mountain	O
View	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

PCR	O
was	O
subsequently	O
performed	O
using	O
oligonucleotides	O
specific	O
to	O
exon	O
7	O
and	O
exon	O
11	O
of	O
Acadm	O
.	O

PCR	O
amplifications	O
were	O
performed	O
as	O
described	O
above	O
.	O

PCR	O
fragments	O
were	O
subsequently	O
sequenced	O
after	O
subcloning	O
into	O
pGEM	O
-	O
T	O
Easy	O
vector	O
(	O
Promega	O
,	O
Madison	O
,	O
Wisconsin	O
,	O
United	O
States	O
)	O
.	O

In	O
order	O
to	O
determine	O
the	O
extent	O
of	O
Acadm	O
mRNA	B-CHEBI
expressed	O
from	O
the	O
MCAD	O
-	O
/	O
-	O
mice	O
,	O
northern	O
blot	O
analysis	O
was	O
performed	O
.	O

Total	O
RNA	O
was	O
isolated	O
from	O
heart	O
,	O
liver	O
,	O
brown	O
fat	O
,	O
brain	O
,	O
kidney	O
,	O
skeletal	O
muscle	O
,	O
white	O
fat	O
,	O
and	O
testes	O
of	O
3	O
-	O
mo	O
-	O
old	O
MCAD	O
+	O
/	O
+	O
and	O
MCAD	O
-	O
/	O
-	O
mice	O
using	O
the	O
Ultraspec	O
RNA	O
Isolation	O
Kit	O
(	O
BIOTEX	O
Laboratories	O
,	O
Inc	O
.	O
,	O
Houston	O
,	O
Texas	O
,	O
United	O
States	O
)	O
as	O
per	O
manufacturer	O
'	O
s	O
protocol	O
.	O

Ten	O
mu	O
g	O
of	O
total	O
RNA	O
from	O
each	O
sample	O
was	O
loaded	O
onto	O
a	O
0	O
.	O
8	O
%	O
agarose	B-CHEBI
-	O
formaldehyde	B-CHEBI
gel	O
,	O
transferred	O
to	O
nitrocellulose	O
filter	O
(	O
Hybond	O
N	O
;	O
GE	O
Healthcare	O
Amersham	O
Biosciences	O
Corp	O
.	O
,	O
Piscataway	O
,	O
New	O
Jersey	O
,	O
United	O
States	O
)	O
,	O
and	O
hybridized	O
with	O
32P	B-CHEBI
-	O
radiolabeled	B-CHEBI
full	O
-	O
length	O
mouse	O
Acadm	O
cDNA	O
probe	O
using	O
standard	O
procedures	O
[	O
28	O
]	O
.	O

Hybridizations	O
were	O
performed	O
under	O
highly	O
stringent	O
conditions	O
(	O
42	O
degrees	O
C	O
in	O
2	O
x	O
SSC	O
,	O
50	O
%	O
formamide	B-CHEBI
,	O
10	O
%	O
dextran	B-CHEBI
sulfate	I-CHEBI
,	O
5	O
x	O
Denhardt	O
'	O
s	O
reagent	B-CHEBI
,	O
1	O
%	O
SDS	B-CHEBI
,	O
and	O
salmon	O
sperm	O
DNA	O
)	O
for	O
18	O
h	O
.	O

The	O
hybridized	O
filter	O
was	O
washed	O
two	O
times	O
in	O
4	O
x	O
SSC	O
,	O
0	O
.	O
1	O
%	O
SDS	B-CHEBI
and	O
two	O
times	O
in	O
2	O
x	O
SSC	O
;	O
0	O
.	O
1	O
%	O
SDS	B-CHEBI
at	O
55	O
degrees	O
C	O
for	O
1	O
h	O
.	O

The	O
filter	O
was	O
exposed	O
to	O
autoradiographic	O
film	O
(	O
Hyperfilm	O
MP	O
;	O
GE	O
Healthcare	O
Amersham	O
Biosciences	O
,	O
Piscataway	O
,	O
New	O
Jersey	O
,	O
United	O
States	O
)	O
.	O

Replicate	O
agarose	B-CHEBI
-	O
formaldehyde	B-CHEBI
gels	O
were	O
stained	O
by	O
ethidium	B-CHEBI
bromide	I-CHEBI
to	O
verify	O
equal	O
RNA	O
loading	O
.	O

Immunoblot	O
analysis	O
of	O
MCAD	O
protein	B-CHEBI
.	O

To	O
evaluate	O
the	O
quantity	O
of	O
MCAD	O
protein	B-CHEBI
in	O
mouse	O
tissue	O
,	O
liver	O
samples	O
from	O
6	O
-	O
8	O
-	O
wk	O
-	O
old	O
MCAD	O
+	O
/	O
+	O
(	O
n	O
=	O
1	O
)	O
and	O
MCAD	O
-	O
/	O
-	O
(	O
n	O
=	O
3	O
)	O
mice	O
were	O
immediately	O
frozen	O
in	O
liquid	O
nitrogen	B-CHEBI
and	O
stored	O
at	O
-	O
80	O
degrees	O
C	O
.	O

For	O
analysis	O
,	O
tissue	O
was	O
homogenized	O
and	O
lysed	O
in	O
RIPA	O
buffer	O
(	O
1	O
x	O
PBS	O
,	O
1	O
%	O
Nonidet	O
P	O
-	O
40	O
,	O
0	O
.	O
5	O
%	O
sodium	B-CHEBI
deoxycholate	I-CHEBI
,	O
and	O
1	O
%	O
SDS	B-CHEBI
)	O
with	O
10	O
%	O
glycerol	B-CHEBI
and	O
Complete	O
Protease	B-CHEBI
Inhibitor	I-CHEBI
,	O
(	O
Roche	O
Diagnostics	O
Corporation	O
,	O
Indianapolis	O
,	O
Indiana	O
,	O
United	O
States	O
)	O
,	O
1	O
mM	O
of	O
phenylmethylsulfonylfluoride	B-CHEBI
,	O
and	O
1	O
mM	O
of	O
sodium	B-CHEBI
orthovanadate	I-CHEBI
.	O

Lysates	O
were	O
quantified	O
by	O
Bradford	O
BCA	O
protein	B-CHEBI
assay	O
(	O
Bio	O
-	O
Rad	O
,	O
Hercules	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Protein	B-CHEBI
lysates	O
were	O
denatured	O
,	O
separated	O
in	O
8	O
%	O
SDS	B-CHEBI
-	O
PAGE	O
,	O
and	O
transferred	O
overnight	O
onto	O
a	O
0	O
.	O
45	O
mu	O
m	O
nitrocellulose	O
membrane	O
(	O
Schleicher	O
and	O
Schuell	O
,	O
Keene	O
,	O
New	O
Hampshire	O
,	O
United	O
States	O
)	O
.	O

After	O
blocking	O
with	O
5	O
%	O
nonfat	O
milk	O
in	O
phosphate	B-CHEBI
-	O
buffered	B-CHEBI
saline	O
with	O
0	O
.	O
1	O
%	O
Tween	O
-	O
20	O
,	O
the	O
membrane	O
was	O
immunoblotted	O
overnight	O
at	O
4	O
degrees	O
C	O
with	O
1	O
:	O
500	O
dilution	O
of	O
an	O
anti	O
-	O
MCAD	O
antibody	O
.	O

Blots	O
were	O
incubated	O
in	O
anti	O
-	O
mouse	O
IgG	O
HRP	O
-	O
conjugated	O
secondary	O
antibody	O
for	O
2	O
-	O
4	O
h	O
at	O
room	O
temperature	O
using	O
standard	O
procedures	O
and	O
developed	O
by	O
chemiluminiscence	O
(	O
Renaissance	O
,	O
NEN	O
Lifesciences	O
Products	O
,	O
Boston	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
.	O

Liver	O
enzyme	O
activity	O
.	O

In	O
order	O
to	O
evaluate	O
MCAD	O
activity	O
in	O
mice	O
,	O
liver	O
homogenates	O
were	O
prepared	O
from	O
MCAD	O
+	O
/	O
+	O
(	O
n	O
=	O
5	O
)	O
and	O
MCAD	O
-	O
/	O
-	O
mice	O
(	O
n	O
=	O
5	O
)	O
.	O

The	O
sensitive	O
and	O
highly	O
specific	O
anaerobic	O
ETF	O
reduction	O
assay	O
was	O
used	O
on	O
tissue	O
extracts	O
with	O
octanoyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
(	O
C8	O
)	O
and	O
palmitoyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
(	O
C16	O
)	O
as	O
substrate	O
as	O
previously	O
described	O
[	O
29	O
]	O
.	O

Fasting	O
and	O
cold	O
challenge	O
.	O

Eight	O
-	O
wk	O
-	O
old	O
MCAD	O
+	O
/	O
+	O
and	O
MCAD	O
-	O
/	O
-	O
mice	O
were	O
fasted	O
for	O
18	O
h	O
(	O
cold	O
tolerance	O
experiments	O
)	O
or	O
24	O
h	O
(	O
serum	O
glucose	B-CHEBI
,	O
free	O
fatty	B-CHEBI
acid	I-CHEBI
,	O
organic	O
acid	B-CHEBI
,	O
and	O
carnitine	B-CHEBI
experiments	O
)	O
prior	O
to	O
analysis	O
.	O

Glucose	B-CHEBI
concentration	O
was	O
measured	O
in	O
10	O
mu	O
l	O
sera	O
using	O
an	O
Ektachem	O
DT	O
II	O
system	O
(	O
Johnson	O
and	O
Johnson	O
Clinical	O
Diagnostics	O
,	O
Rochester	O
,	O
New	O
York	O
,	O
United	O
States	O
)	O
.	O

Total	O
non	O
-	O
esterified	O
fatty	B-CHEBI
acids	I-CHEBI
(	O
NEFA	O
)	O
were	O
measured	O
by	O
an	O
enzymatic	O
,	O
colorimetric	O
method	O
(	O
"	O
NEFA	O
-	O
C	O
"	O
reagents	B-CHEBI
,	O
Wako	O
Diagnostics	O
,	O
Richmond	O
,	O
Virginia	O
,	O
United	O
States	O
)	O
.	O

The	O
assay	O
was	O
modified	O
to	O
accommodate	O
a	O
reduced	O
sample	O
size	O
(	O
10	O
mu	O
l	O
)	O
and	O
use	O
of	O
a	O
microplate	O
reader	O
for	O
measurement	O
of	O
optical	O
density	O
at	O
550	O
nm	O
.	O

Urine	O
organic	O
acid	B-CHEBI
analyses	O
were	O
performed	O
using	O
gas	O
chromatography	O
-	O
mass	O
spectroscopy	O
as	O
previously	O
described	O
[	O
22	O
,	O
30	O
]	O
,	O
except	O
tetracosane	B-CHEBI
(	O
C24	O
;	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
was	O
used	O
as	O
the	O
internal	O
standard	O
,	O
and	O
quantitative	O
determinations	O
were	O
made	O
based	O
on	O
comparison	O
with	O
synthetic	O
calibration	O
standards	O
.	O

Acylcarnitine	B-CHEBI
analyses	O
in	O
serum	O
and	O
bile	O
were	O
conducted	O
using	O
electrospray	O
tandem	O
mass	O
spectrometry	O
[	O
31	O
,	O
32	O
]	O
.	O

Histopathology	O
.	O

Twelve	O
mice	O
were	O
examined	O
for	O
gross	O
and	O
histologic	O
abnormalities	O
,	O
including	O
one	O
male	O
and	O
one	O
female	O
MCAD	O
-	O
/	O
-	O
mouse	O
18	O
-	O
mo	O
-	O
old	O
,	O
one	O
male	O
and	O
one	O
female	O
MCAD	O
+	O
/	O
+	O
mouse	O
6	O
-	O
mo	O
-	O
old	O
,	O
two	O
male	O
and	O
two	O
female	O
MCAD	O
-	O
/	O
-	O
mice	O
4	O
-	O
wk	O
-	O
old	O
,	O
and	O
two	O
male	O
and	O
two	O
female	O
MCAD	O
+	O
/	O
+	O
mice	O
4	O
-	O
wk	O
-	O
old	O
.	O

Kidney	O
,	O
spleen	O
,	O
pancreas	O
,	O
liver	O
,	O
brain	O
,	O
heart	O
,	O
testicles	O
,	O
ovaries	O
,	O
and	O
skeletal	O
muscle	O
were	O
fixed	O
by	O
immersion	O
in	O
buffered	O
10	O
%	O
formalin	O
,	O
processed	O
routinely	O
for	O
paraffin	O
sectioning	O
,	O
sectioned	O
at	O
5	O
mu	O
m	O
,	O
and	O
stained	O
with	O
hematoxylin	O
and	O
eosin	O
.	O

Frozen	O
liver	O
sections	O
were	O
prepared	O
using	O
standard	O
methods	O
and	O
sections	O
were	O
stained	O
with	O
Oil	O
-	O
red	O
-	O
O	O
.	O

Slides	O
were	O
examined	O
without	O
knowledge	O
of	O
genotype	O
or	O
age	O
.	O

Other	O
mice	O
were	O
examined	O
because	O
of	O
sporadic	O
clinical	O
disease	O
.	O

Those	O
with	O
visible	O
cardiac	O
enlargement	O
were	O
evaluated	O
for	O
cardiac	O
lesions	O
.	O

Statistical	O
analyses	O
.	O

Results	O
between	O
groups	O
were	O
tested	O
for	O
statistical	O
significance	O
using	O
Student	O
'	O
s	O
t	O
-	O
test	O
.	O

A	O
p	O
<	O
0	O
.	O
05	O
was	O
set	O
as	O
significant	O
.	O

Supporting	O
Information	O

Accession	O
Number	O

The	O
GenBank	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
Genbank	O
)	O
accession	O
number	O
for	O
the	O
mouse	O
gene	O
Acadm	O
is	O
U07159	O
.	O

Acknowledgements	O

We	O
thank	O
Sushama	O
Varma	O
for	O
technical	O
assistance	O
.	O

This	O
research	O
was	O
supported	O
by	O
the	O
University	O
of	O
Alabama	O
at	O
Birmingham	O
(	O
UAB	O
)	O
Comprehensive	O
Cancer	O
Center	O
(	O
Oligonucleotide	O
and	O
Transgenic	O
Animal	O
Shared	O
Facilities	O
)	O
grant	O
P30	O
-	O
CA13148	O
,	O
UAB	O
Musculoskeletal	O
Disease	O
and	O
Arthritis	O
Center	O
(	O
Gene	O
Targeting	O
Core	O
Facility	O
)	O
grant	O
P60	O
-	O
AR20614	O
,	O
UAB	O
Clinical	O
Nutrition	O
Research	O
Center	O
grant	O
P30	O
-	O
DK	O
-	O
56336	O
,	O
and	O
by	O
National	O
Institutes	O
of	O
Health	O
grants	O
R01	O
-	O
RR02599	O
(	O
PAW	O
)	O
,	O
T32	O
-	O
RR	O
-	O
07003	O
(	O
RJT	O
)	O
,	O
K01	O
-	O
RR00129	O
(	O
RJT	O
)	O
,	O
RO1	O
-	O
DK45482	O
(	O
JV	O
)	O
,	O
and	O
DK54936	O
(	O
JV	O
)	O
.	O

Abbreviations	O

bp	O
-	O
base	O
pair	O

ES	O
-	O
embryonic	O
stem	O

ETF	O
-	O
electron	B-CHEBI
transport	O
flavoprotein	B-CHEBI

MCAD	O
-	O
medium	O
-	O
chain	O
acyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
dehydrogenase	O

SCAD	O
-	O
short	O
-	O
chain	O
acyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
dehydrogenase	O

SD	O
-	O
standard	O
deviation	O

VLCAD	O
-	O
very	O
long	B-CHEBI
-	I-CHEBI
chain	I-CHEBI
acyl	I-CHEBI
-	I-CHEBI
CoA	I-CHEBI
dehydrogenase	O

Footnotes	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Author	O
contributions	O
.	O

RJT	O
,	O
JV	O
,	O
PR	O
,	O
DM	O
,	O
and	O
PAW	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

RJT	O
,	O
DAH	O
,	O
LT	O
,	O
JV	O
,	O
PR	O
,	O
DM	O
,	O
JDS	O
,	O
and	O
PAW	O
performed	O
the	O
experiments	O
.	O

RJT	O
,	O
DAH	O
,	O
LT	O
,	O
JV	O
,	O
JDS	O
,	O
PR	O
,	O
DM	O
,	O
TRS	O
,	O
and	O
PAW	O
analyzed	O
the	O
data	O
and	O
contributed	O
reagents	B-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

RJT	O
,	O
JV	O
,	O
PR	O
,	O
DM	O
,	O
TRS	O
,	O
JDS	O
,	O
and	O
PAW	O
wrote	O
the	O
paper	O
.	O

Citation	O
:	O
Tolwani	O
RJ	O
,	O
Hamm	O
DA	O
,	O
Tian	O
L	O
,	O
Sharer	O
JD	O
,	O
Vockley	O
J	O
,	O
et	O
al	O
.	O

(	O
2005	O
)	O
Medium	O
-	O
chain	O
acyl	B-CHEBI
-	I-CHEBI
CoA	I-CHEBI
dehydrogenase	O
deficiency	O
in	O
gene	O
-	O
targeted	O
mice	O
.	O

PLoS	O
Genet	O
1	O
(	O
2	O
)	O
:	O
e23	O
.	O

Ablation	O
of	O
the	O
Sam68	O
RNA	O
Binding	O
Protein	B-CHEBI
Protects	O
Mice	O
from	O
Age	O
-	O
Related	O
Bone	O
Loss	O

Abstract	O

The	O
Src	O
substrate	O
associated	O
in	O
mitosis	O
of	O
68	O
kDa	O
(	O
Sam68	O
)	O
is	O
a	O
KH	O
-	O
type	O
RNA	O
binding	O
protein	B-CHEBI
that	O
has	O
been	O
shown	O
to	O
regulate	O
several	O
aspects	O
of	O
RNA	O
metabolism	O
;	O
however	O
,	O
its	O
physiologic	O
role	O
has	O
remained	O
elusive	O
.	O

Herein	O
we	O
report	O
the	O
generation	O
of	O
Sam68	O
-	O
null	O
mice	O
by	O
homologous	O
recombination	O
.	O

Aged	O
Sam68	O
-	O
/	O
-	O
mice	O
preserved	O
their	O
bone	O
mass	O
,	O
in	O
sharp	O
contrast	O
with	O
12	O
-	O
month	O
-	O
old	O
wild	O
-	O
type	O
littermates	O
in	O
which	O
bone	O
mass	O
was	O
decreased	O
up	O
to	O
approximately	O
75	O
%	O
.	O

In	O
fact	O
,	O
the	O
bone	O
volume	O
of	O
the	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
mice	O
was	O
virtually	O
indistinguishable	O
from	O
that	O
of	O
4	O
-	O
month	O
-	O
old	O
wild	O
-	O
type	O
or	O
Sam68	O
-	O
/	O
-	O
mice	O
.	O

Sam68	O
-	O
/	O
-	O
bone	O
marrow	O
stromal	O
cells	O
had	O
a	O
differentiation	O
advantage	O
for	O
the	O
osteogenic	O
pathway	O
.	O

Moreover	O
,	O
the	O
knockdown	O
of	O
Sam68	O
using	O
short	O
hairpin	O
RNA	O
in	O
the	O
embryonic	O
mesenchymal	O
multipotential	O
progenitor	O
C3H10T1	O
/	O
2	O
cells	O
resulted	O
in	O
more	O
pronounced	O
expression	O
of	O
the	O
mature	O
osteoblast	O
marker	O
osteocalcin	O
when	O
differentiation	O
was	O
induced	O
with	O
bone	O
morphogenetic	O
protein	B-CHEBI
-	O
2	O
.	O

Cultures	O
of	O
mouse	O
embryo	O
fibroblasts	O
generated	O
from	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
littermates	O
were	O
induced	O
to	O
differentiate	O
into	O
adipocytes	O
with	O
culture	O
medium	O
containing	O
pioglitazone	O
and	O
the	O
Sam68	O
-	O
/	O
-	O
mouse	O
embryo	O
fibroblasts	O
shown	O
to	O
have	O
impaired	O
adipocyte	O
differentiation	O
.	O

Furthermore	O
,	O
in	O
vivo	O
it	O
was	O
shown	O
that	O
sections	O
of	O
bone	O
from	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
mice	O
had	O
few	O
marrow	O
adipocytes	O
compared	O
with	O
their	O
age	O
-	O
matched	O
wild	O
-	O
type	O
littermate	O
controls	O
,	O
which	O
exhibited	O
fatty	O
bone	O
marrow	O
.	O

Our	O
findings	O
identify	O
endogenous	O
Sam68	O
as	O
a	O
positive	O
regulator	O
of	O
adipocyte	O
differentiation	O
and	O
a	O
negative	O
regulator	O
of	O
osteoblast	O
differentiation	O
,	O
which	O
is	O
consistent	O
with	O
Sam68	O
being	O
a	O
modulator	O
of	O
bone	O
marrow	O
mesenchymal	O
cell	O
differentiation	O
,	O
and	O
hence	O
bone	O
metabolism	O
,	O
in	O
aged	O
mice	O
.	O

Synopsis	O

Osteoporosis	O
is	O
a	O
debilitating	O
bone	O
disease	O
that	O
is	O
characterized	O
by	O
reduced	O
bone	O
mass	O
and	O
microarchitectural	O
damage	O
,	O
which	O
result	O
in	O
increased	O
bone	O
fragility	O
and	O
susceptibility	O
to	O
fracture	O
.	O

Peak	O
bone	O
mass	O
,	O
which	O
is	O
achieved	O
by	O
the	O
age	O
of	O
30	O
in	O
humans	O
,	O
has	O
been	O
identified	O
as	O
a	O
major	O
determinant	O
of	O
resistance	O
or	O
susceptibility	O
to	O
osteoporosis	O
.	O

The	O
authors	O
generated	O
mice	O
deficient	O
for	O
the	O
Sam68	O
RNA	O
binding	O
protein	B-CHEBI
,	O
a	O
protein	B-CHEBI
of	O
unknown	O
physiologic	O
function	O
.	O

The	O
mice	O
develop	O
normally	O
and	O
are	O
protected	O
against	O
bone	O
loss	O
during	O
aging	O
.	O

Age	O
-	O
related	O
bone	O
loss	O
has	O
long	O
been	O
associated	O
with	O
an	O
increase	O
in	O
marrow	O
adipocytes	O
,	O
which	O
are	O
derived	O
from	O
the	O
same	O
mesenchymal	O
lineage	O
as	O
osteoblasts	O
in	O
bone	O
marrow	O
.	O

The	O
authors	O
showed	O
that	O
Sam68	O
regulates	O
the	O
differentiation	O
of	O
this	O
mesenchymal	O
lineage	O
,	O
such	O
that	O
in	O
its	O
absence	O
,	O
osteoblasts	O
continued	O
to	O
be	O
generated	O
in	O
aging	O
bone	O
,	O
leading	O
to	O
preservation	O
of	O
bone	O
mass	O
.	O

This	O
study	O
identifies	O
a	O
physiologic	O
role	O
for	O
Sam68	O
as	O
a	O
modulator	O
of	O
the	O
bone	O
marrow	O
stem	O
cell	O
niche	O
and	O
hence	O
of	O
bone	O
metabolism	O
.	O

The	O
data	O
identify	O
Sam68	O
as	O
a	O
potential	O
therapeutic	O
target	O
for	O
the	O
prevention	O
and	O
treatment	O
of	O
age	O
-	O
related	O
bone	O
loss	O
.	O

Introduction	O

During	O
skeletal	O
development	O
,	O
the	O
anabolic	O
activity	O
of	O
osteoblasts	O
[	O
1	O
]	O
is	O
favored	O
over	O
the	O
catabolic	O
activity	O
of	O
osteoclasts	O
[	O
2	O
]	O
,	O
which	O
results	O
in	O
a	O
net	O
gain	O
in	O
bone	O
mass	O
.	O

At	O
skeletal	O
maturity	O
,	O
bone	O
mass	O
is	O
maintained	O
through	O
the	O
balanced	O
activity	O
of	O
osteoblasts	O
and	O
osteoclasts	O
during	O
the	O
remodeling	O
cycle	O
.	O

During	O
skeletal	O
aging	O
,	O
there	O
is	O
a	O
shift	O
in	O
the	O
balance	O
that	O
favors	O
osteoclast	O
over	O
osteoblast	O
activity	O
,	O
which	O
results	O
in	O
net	O
bone	O
loss	O
[	O
3	O
]	O
.	O

The	O
amount	O
and	O
rate	O
at	O
which	O
bone	O
is	O
gained	O
during	O
development	O
and	O
lost	O
during	O
aging	O
are	O
determined	O
in	O
large	O
part	O
by	O
genetics	O
[	O
4	O
-	O
6	O
]	O
but	O
also	O
by	O
physical	O
activity	O
and	O
by	O
alterations	O
in	O
the	O
availability	O
and	O
response	O
of	O
bone	O
cells	O
to	O
circulating	O
hormones	B-CHEBI
[	O
7	O
-	O
9	O
]	O
and	O
locally	O
derived	O
growth	O
factors	O
[	O
10	O
,	O
11	O
]	O
.	O

Whereas	O
genetic	O
-	O
based	O
studies	O
have	O
provided	O
novel	O
insights	O
into	O
the	O
pathways	O
that	O
regulate	O
bone	O
development	O
[	O
12	O
-	O
14	O
]	O
,	O
relatively	O
little	O
is	O
known	O
about	O
the	O
etiology	O
of	O
age	O
-	O
related	O
bone	O
loss	O
.	O

Increased	O
bone	O
resorption	O
in	O
elderly	O
men	O
and	O
women	O
is	O
associated	O
with	O
a	O
reduction	O
in	O
bone	O
mass	O
and	O
an	O
increase	O
in	O
circulating	O
levels	O
of	O
bone	O
biomarkers	O
[	O
15	O
]	O
.	O

These	O
changes	O
have	O
been	O
attributed	O
primarily	O
to	O
nutritional	O
deficits	O
resulting	O
in	O
alterations	O
in	O
the	O
parathyroid	O
hormone	B-CHEBI
-	O
vitamin	B-CHEBI
D	I-CHEBI
axis	O
[	O
16	O
]	O
,	O
to	O
gonadal	O
hormone	B-CHEBI
deficiency	O
[	O
17	O
]	O
,	O
to	O
leptin	O
levels	O
and	O
the	O
sympathetic	O
nervous	O
system	O
[	O
8	O
,	O
18	O
-	O
20	O
]	O
,	O
and	O
to	O
alterations	O
in	O
bone	O
cell	O
apoptosis	O
[	O
21	O
]	O
.	O

Bone	O
loss	O
in	O
the	O
elderly	O
has	O
also	O
been	O
attributed	O
to	O
alterations	O
in	O
the	O
response	O
of	O
bone	O
marrow	O
stromal	O
cells	O
to	O
their	O
microenvironment	O
that	O
favors	O
differentiation	O
down	O
the	O
adipocyte	O
lineage	O
rather	O
than	O
the	O
osteoblast	O
lineage	O
[	O
22	O
]	O
.	O

Aging	O
has	O
long	O
been	O
associated	O
with	O
an	O
increase	O
in	O
marrow	O
fat	O
,	O
where	O
the	O
generation	O
of	O
adipocytes	O
is	O
favored	O
over	O
osteoblasts	O
[	O
23	O
]	O
.	O

Osteoblasts	O
and	O
adipocytes	O
are	O
derived	O
from	O
a	O
common	O
mesenchymal	O
precursor	O
cell	O
present	O
in	O
bone	O
marrow	O
,	O
and	O
the	O
factors	O
that	O
control	O
this	O
age	O
-	O
induced	O
switch	O
toward	O
adipogenic	O
differentiation	O
is	O
not	O
well	O
understood	O
[	O
24	O
]	O
.	O

While	O
several	O
transcriptional	O
regulatory	O
proteins	B-CHEBI
have	O
been	O
associated	O
with	O
cell	O
fate	O
determination	O
of	O
bone	O
marrow	O
mesenchymal	O
cells	O
,	O
including	O
peroxisome	O
proliferator	O
-	O
activated	O
receptor	O
gamma	O
(	O
PPAR	O
gamma	O
)	O
and	O
KLF5	O
[	O
25	O
-	O
30	O
]	O
,	O
the	O
role	O
of	O
RNA	O
binding	O
proteins	B-CHEBI
in	O
this	O
process	O
remains	O
unknown	O
.	O

RNA	O
binding	O
proteins	B-CHEBI
of	O
the	O
KH	O
type	O
are	O
known	O
regulators	O
of	O
cellular	O
differentiation	O
.	O

For	O
example	O
,	O
expression	O
defects	O
in	O
the	O
KH	O
domain	O
proteins	B-CHEBI
NOVA	O
and	O
FMRP	O
are	O
known	O
to	O
cause	O
paraneoplastic	O
neurologic	O
disorders	O
[	O
31	O
]	O
and	O
the	O
fragile	O
X	O
syndrome	O
,	O
respectively	O
,	O
in	O
humans	O
[	O
32	O
]	O
.	O

The	O
phenotype	O
of	O
the	O
quaking	O
viable	O
mice	O
suggests	O
a	O
role	O
for	O
the	O
QUAKING	O
RNA	O
binding	O
protein	B-CHEBI
in	O
oligodendrocytes	O
and	O
myelination	O
[	O
33	O
]	O
.	O

Indeed	O
,	O
the	O
ectopic	O
expression	O
of	O
the	O
QKI	O
-	O
6	O
/	O
7	O
isoforms	O
in	O
vivo	O
led	O
to	O
the	O
formation	O
of	O
glial	O
cells	O
rather	O
than	O
neurons	O
from	O
neural	O
progenitor	O
,	O
demonstrating	O
its	O
role	O
in	O
cell	O
fate	O
determination	O
[	O
34	O
]	O
.	O

The	O
loss	O
of	O
GLD	O
-	O
1	O
protein	B-CHEBI
in	O
Caenorhabditis	O
elegans	O
prevents	O
the	O
appearance	O
of	O
stem	O
cells	O
[	O
35	O
]	O
,	O
and	O
the	O
absence	O
of	O
the	O
KH	O
domain	O
protein	B-CHEBI
HOW	O
in	O
Drosophila	O
prevents	O
muscle	O
differentiation	O
and	O
results	O
in	O
flies	O
with	O
held	O
-	O
out	O
-	O
wings	O
[	O
36	O
,	O
37	O
]	O
.	O

The	O
Src	O
substrate	O
associated	O
in	O
mitosis	O
of	O
68	O
kDa	O
(	O
Sam68	O
)	O
is	O
also	O
a	O
member	O
of	O
the	O
family	O
of	O
KH	O
domain	O
RNA	O
binding	O
proteins	B-CHEBI
[	O
38	O
]	O
;	O
however	O
,	O
its	O
physiologic	O
role	O
has	O
remained	O
undefined	O
.	O

Sam68	O
was	O
identified	O
as	O
an	O
SH3	O
and	O
SH2	O
domain	O
interacting	O
protein	B-CHEBI
for	O
Src	O
family	O
kinases	O
and	O
is	O
also	O
a	O
known	O
substrate	O
of	O
Src	O
kinases	O
[	O
39	O
-	O
42	O
]	O
and	O
of	O
the	O
breast	O
tumor	O
kinase	O
[	O
43	O
]	O
.	O

Sam68	O
has	O
been	O
shown	O
to	O
facilitate	O
the	O
export	O
of	O
unspliced	O
HIV	O
RNA	O
[	O
44	O
]	O
and	O
to	O
regulate	O
pre	O
-	O
mRNA	B-CHEBI
processing	O
[	O
45	O
]	O
.	O

In	O
the	O
present	O
paper	O
,	O
we	O
report	O
the	O
generation	O
of	O
Sam68	O
-	O
/	O
-	O
mice	O
and	O
analysis	O
of	O
their	O
skeletal	O
phenotype	O
.	O

Our	O
data	O
indicate	O
that	O
the	O
absence	O
of	O
Sam68	O
confers	O
resistance	O
to	O
age	O
-	O
related	O
bone	O
loss	O
in	O
mice	O
such	O
that	O
old	O
Sam68	O
have	O
a	O
higher	O
bone	O
mass	O
than	O
their	O
wild	O
-	O
type	O
littermates	O
.	O

We	O
provide	O
evidence	O
that	O
Sam68	O
regulates	O
the	O
differentiation	O
of	O
bone	O
marrow	O
stromal	O
cells	O
by	O
showing	O
that	O
cells	O
isolated	O
from	O
Sam68	O
-	O
/	O
-	O
animals	O
had	O
enhanced	O
osteogenic	O
activity	O
and	O
decreased	O
adipogenic	O
activity	O
than	O
those	O
harvested	O
from	O
wild	O
-	O
type	O
littermates	O
.	O

Furthermore	O
,	O
Sam68	O
-	O
/	O
-	O
mouse	O
embryo	O
fibroblasts	O
(	O
MEFs	O
)	O
were	O
impaired	O
in	O
their	O
capacity	O
to	O
differentiate	O
into	O
adipocytes	O
,	O
consistent	O
with	O
Sam68	O
being	O
a	O
regulator	O
of	O
bone	O
marrow	O
mesenchymal	O
cell	O
differentiation	O
.	O

These	O
results	O
also	O
characterize	O
a	O
new	O
animal	O
model	O
to	O
study	O
bone	O
metabolism	O
,	O
regeneration	O
,	O
and	O
repair	O
during	O
aging	O
.	O

Results	O

Sam68	O
Is	O
Expressed	O
in	O
the	O
Developing	O
Skeleton	O
of	O
Embryonic	O
Mice	O

The	O
Sam68	O
mRNA	B-CHEBI
is	O
known	O
to	O
be	O
widely	O
expressed	O
[	O
38	O
]	O
,	O
whereas	O
its	O
pattern	O
of	O
protein	B-CHEBI
expression	O
in	O
vivo	O
remains	O
to	O
be	O
defined	O
.	O

Sections	O
of	O
paraffin	O
-	O
embedded	O
wild	O
-	O
type	O
E14	O
.	O
5	O
and	O
E16	O
.	O
5	O
embryonic	O
mice	O
were	O
immunostained	O
with	O
the	O
well	O
-	O
characterized	O
AD1	O
anti	O
-	O
Sam68	O
antibody	O
,	O
raised	O
in	O
rabbits	O
against	O
an	O
immunizing	O
peptide	O
that	O
corresponds	O
to	O
amino	B-CHEBI
acids	I-CHEBI
330	O
to	O
348	O
of	O
the	O
mouse	O
Sam68	O
protein	B-CHEBI
[	O
46	O
]	O
.	O

Sam68	O
immunoreactivity	O
was	O
observed	O
in	O
the	O
skeleton	O
and	O
soft	O
tissues	O
of	O
developing	O
wild	O
-	O
type	O
mice	O
at	O
E14	O
.	O
5	O
and	O
E16	O
.	O
5	O
(	O
Figure	O
1	O
)	O
.	O

Intense	O
staining	O
was	O
seen	O
in	O
the	O
nucleus	O
of	O
cells	O
in	O
the	O
developing	O
brain	O
,	O
heart	O
,	O
and	O
small	O
intestine	O
(	O
Figure	O
1B	O
)	O
,	O
as	O
well	O
as	O
in	O
chondrocytes	O
in	O
the	O
nasal	O
septum	O
and	O
the	O
glandular	O
tissue	O
adjacent	O
to	O
the	O
nasal	O
cartilage	O
(	O
Figure	O
1C	O
,	O
panels	O
A	O
-	O
D	O
)	O
,	O
in	O
the	O
vertebra	O
and	O
intervertebral	O
discs	O
(	O
panels	O
E	O
-	O
H	O
)	O
and	O
in	O
the	O
epiphysis	O
(	O
panels	O
I	O
-	O
K	O
)	O
and	O
metaphysis	O
(	O
panel	O
L	O
)	O
of	O
long	O
bones	O
.	O

Nuclear	O
staining	O
was	O
observed	O
in	O
proliferating	O
chondrocytes	O
and	O
hypertrophic	O
chondrocytes	O
(	O
Figure	O
1C	O
,	O
panel	O
H	O
)	O
,	O
in	O
osteoblasts	O
(	O
panel	O
L	O
;	O
Dataset	O
S1	O
)	O
,	O
and	O
in	O
osteoclasts	O
(	O
Dataset	O
S1	O
)	O
.	O

No	O
staining	O
was	O
observed	O
with	O
preimmune	O
serum	O
or	O
when	O
the	O
antiserum	O
was	O
preadsorbed	O
with	O
the	O
immunizing	O
peptide	O
(	O
Figure	O
1C	O
,	O
panels	O
B	O
,	O
F	O
,	O
and	O
J	O
)	O
.	O

Taken	O
together	O
,	O
these	O
data	O
demonstrate	O
that	O
Sam68	O
protein	B-CHEBI
is	O
selectively	O
expressed	O
in	O
the	O
developing	O
mouse	O
embryo	O
,	O
with	O
particularly	O
elevated	O
expression	O
in	O
cartilage	O
and	O
bone	O
.	O

Sam68	O
is	O
Not	O
Essential	O
for	O
Mouse	O
Development	O

To	O
define	O
the	O
physiologic	O
role	O
of	O
Sam68	O
,	O
we	O
generated	O
Sam68	O
-	O
deficient	O
mice	O
by	O
targeted	O
disruption	O
of	O
exons	O
4	O
and	O
5	O
of	O
the	O
sam68	O
gene	O
,	O
which	O
encode	O
the	O
functional	O
region	O
of	O
the	O
KH	O
-	O
type	O
RNA	O
binding	O
domain	O
(	O
Figure	O
2A	O
)	O
.	O

The	O
integrity	O
of	O
the	O
targeted	O
allele	O
was	O
verified	O
by	O
Southern	O
blot	O
analysis	O
(	O
Figure	O
2B	O
)	O
and	O
by	O
PCR	O
of	O
genomic	O
DNA	O
(	O
unpublished	O
data	O
)	O
.	O

Sam68	O
transcripts	O
encoded	O
by	O
exons	O
1	O
to	O
5	O
were	O
absent	O
as	O
evidenced	O
by	O
RT	O
-	O
PCR	O
(	O
Dataset	O
S2	O
)	O
,	O
and	O
Sam68	O
-	O
/	O
-	O
mice	O
were	O
devoid	O
of	O
Sam68	O
protein	B-CHEBI
,	O
as	O
visualized	O
by	O
immunoblotting	O
with	O
anti	O
-	O
Sam68	O
AD1	O
and	O
SC	O
-	O
333	O
antibodies	O
or	O
control	O
normal	O
rabbit	O
serum	O
or	O
anti	O
-	O
Sam68	O
AD1	O
preabsorbed	O
with	O
peptide	O
(	O
Figure	O
2C	O
)	O
.	O

SC	O
-	O
333	O
is	O
a	O
rabbit	O
anti	O
-	O
Sam68	O
antibody	O
that	O
was	O
raised	O
against	O
the	O
C	B-CHEBI
-	O
terminal	O
20	O
amino	B-CHEBI
acids	I-CHEBI
of	O
Sam68	O
[	O
47	O
]	O
.	O

These	O
data	O
confirmed	O
the	O
generation	O
of	O
a	O
mouse	O
deficient	O
in	O
Sam68	O
.	O

The	O
genotypes	O
of	O
offspring	O
from	O
heterozygote	O
intercrosses	O
exhibited	O
a	O
Mendelian	O
segregation	O
at	O
E18	O
.	O
5	O
(	O
Table	O
1	O
)	O
.	O

Despite	O
the	O
lack	O
of	O
visible	O
deformity	O
,	O
many	O
of	O
the	O
Sam68	O
-	O
/	O
-	O
pups	O
died	O
at	O
birth	O
of	O
unknown	O
causes	O
.	O

Sam68	O
+	O
/	O
-	O
mice	O
were	O
phenotypically	O
normal	O
and	O
Sam68	O
-	O
/	O
-	O
pups	O
that	O
survived	O
the	O
perinatal	O
period	O
invariably	O
lived	O
to	O
old	O
age	O
.	O

Despite	O
evidence	O
that	O
Sam68	O
mRNA	B-CHEBI
is	O
widely	O
expressed	O
and	O
phosphorylated	O
in	O
mitosis	O
[	O
41	O
,	O
42	O
]	O
,	O
the	O
Sam68	O
-	O
/	O
-	O
mice	O
did	O
not	O
develop	O
tumors	O
and	O
showed	O
no	O
immunologic	O
or	O
other	O
major	O
illnesses	O
.	O

Sam68	O
-	O
/	O
-	O
mice	O
did	O
,	O
however	O
,	O
have	O
difficulty	O
breeding	O
due	O
to	O
male	O
infertility	O
and	O
the	O
females	O
rarely	O
provided	O
adequate	O
care	O
to	O
their	O
young	O
.	O

Sam68	O
Deficiency	O
Protects	O
Mice	O
from	O
Age	O
-	O
Related	O
Bone	O
Loss	O

Src	O
null	O
animals	O
are	O
known	O
to	O
have	O
bone	O
metabolism	O
defects	O
[	O
48	O
]	O
,	O
and	O
since	O
Sam68	O
is	O
a	O
substrate	O
of	O
Src	O
,	O
we	O
decided	O
to	O
analyze	O
the	O
Sam68	O
mice	O
for	O
skeletal	O
abnormalities	O
.	O

Cohorts	O
of	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
mice	O
were	O
euthanized	O
at	O
4	O
and	O
12	O
months	O
of	O
age	O
for	O
skeletal	O
phenotyping	O
.	O

To	O
minimize	O
differences	O
in	O
the	O
bone	O
phenotype	O
that	O
might	O
arise	O
secondary	O
to	O
gender	O
or	O
weight	O
differences	O
,	O
we	O
selected	O
age	O
-	O
matched	O
female	O
mice	O
for	O
these	O
analyses	O
.	O

The	O
female	O
mice	O
demonstrated	O
similar	O
increases	O
in	O
body	O
weight	O
,	O
although	O
4	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
mice	O
weighed	O
less	O
than	O
Sam68	O
+	O
/	O
+	O
mice	O
,	O
and	O
similar	O
changes	O
in	O
bone	O
lengths	O
in	O
the	O
axial	O
and	O
appendicular	O
skeleton	O
between	O
4	O
and	O
12	O
months	O
of	O
age	O
(	O
Table	O
2	O
)	O
.	O

Faxitron	O
radiography	O
(	O
Faxitron	O
X	O
-	O
ray	O
Corporation	O
,	O
Wheeling	O
,	O
Illinois	O
,	O
United	O
States	O
)	O
(	O
Figure	O
3A	O
)	O
and	O
micro	O
-	O
computed	O
tomography	O
(	O
CT	O
)	O
(	O
Figure	O
3B	O
)	O
revealed	O
significant	O
cortical	O
thinning	O
(	O
arrow	O
)	O
and	O
a	O
reduction	O
in	O
metaphyseal	O
bone	O
(	O
asterisk	O
)	O
in	O
the	O
distal	O
femora	O
of	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
mice	O
compared	O
with	O
4	O
-	O
month	O
-	O
old	O
mice	O
of	O
either	O
genotype	O
and	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
mice	O
.	O

Similar	O
reductions	O
in	O
trabecular	O
bone	O
were	O
shown	O
by	O
Faxitron	O
and	O
micro	O
-	O
CT	O
in	O
the	O
fifth	O
lumbar	O
vertebrae	O
of	O
the	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
mice	O
but	O
not	O
in	O
the	O
Sam68	O
-	O
/	O
-	O
mice	O
(	O
unpublished	O
data	O
)	O
.	O

Total	O
body	O
bone	O
mineral	B-CHEBI
content	O
(	O
BMC	O
)	O
,	O
quantified	O
with	O
a	O
Lunar	O
PIXImus	O
mouse	O
densitometer	O
(	O
GE	O
-	O
Lunar	O
,	O
Madison	O
,	O
Wisconsin	O
,	O
United	O
States	O
)	O
,	O
increased	O
in	O
both	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
mice	O
between	O
4	O
months	O
and	O
12	O
months	O
of	O
age	O
,	O
but	O
only	O
reached	O
significance	O
in	O
the	O
Sam68	O
-	O
/	O
-	O
mice	O
(	O
Table	O
2	O
)	O
.	O

Similarly	O
,	O
a	O
greater	O
increase	O
in	O
BMC	O
was	O
seen	O
in	O
the	O
femur	O
and	O
vertebra	O
in	O
the	O
Sam68	O
-	O
/	O
-	O
mice	O
.	O

Bone	O
mineral	B-CHEBI
density	O
(	O
BMD	O
)	O
remained	O
constant	O
or	O
decreased	O
in	O
the	O
wild	O
type	O
mice	O
but	O
increased	O
significantly	O
in	O
the	O
total	O
body	O
and	O
in	O
the	O
femoral	O
and	O
vertebral	O
regions	O
of	O
interest	O
in	O
the	O
Sam68	O
-	O
/	O
-	O
(	O
Table	O
2	O
)	O
.	O

These	O
data	O
showed	O
that	O
Sam68	O
-	O
/	O
-	O
mice	O
continued	O
to	O
thrive	O
and	O
accrue	O
bone	O
in	O
the	O
axial	O
and	O
appendicular	O
skeleton	O
for	O
longer	O
than	O
12	O
months	O
.	O

This	O
was	O
in	O
contrast	O
to	O
the	O
situation	O
in	O
age	O
-	O
matched	O
,	O
littermate	O
controls	O
in	O
which	O
a	O
significant	O
amount	O
of	O
bone	O
was	O
lost	O
over	O
the	O
same	O
timeframe	O
.	O

Three	O
-	O
Dimensional	O
Architecture	O
of	O
Bone	O
Is	O
Preserved	O
in	O
Aged	O
Sam68	O
-	O
/	O
-	O
Mice	O

Bone	O
loss	O
and	O
compromised	O
architecture	O
are	O
characteristic	O
features	O
of	O
the	O
skeletons	O
of	O
aged	O
C57BL	O
/	O
6	O
mice	O
and	O
resemble	O
the	O
clinical	O
features	O
of	O
age	O
-	O
related	O
bone	O
loss	O
in	O
humans	O
that	O
can	O
predispose	O
an	O
individual	O
to	O
fracture	O
.	O

Quantification	O
of	O
the	O
micro	O
-	O
CT	O
data	O
shown	O
in	O
Figure	O
3B	O
confirmed	O
the	O
reduction	O
in	O
bone	O
volume	O
compared	O
with	O
tissue	O
volume	O
(	O
BV	O
/	O
TV	O
;	O
Figure	O
4A	O
,	O
left	O
)	O
in	O
the	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
mice	O
(	O
hatched	O
bars	O
)	O
compared	O
with	O
4	O
-	O
month	O
-	O
old	O
mice	O
of	O
both	O
genotypes	O
(	O
solid	O
bars	O
)	O
and	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
mice	O
(	O
stippled	O
bars	O
)	O
.	O

This	O
was	O
associated	O
with	O
a	O
significant	O
increase	O
(	O
p	O
<	O
0	O
.	O
01	O
;	O
denoted	O
by	O
the	O
asterisks	O
)	O
in	O
the	O
structure	O
model	O
index	O
,	O
which	O
measures	O
the	O
ratio	O
of	O
plate	O
-	O
like	O
to	O
rod	O
-	O
like	O
structures	O
(	O
Figure	O
4A	O
,	O
right	O
)	O
.	O

A	O
quantifiable	O
increase	O
in	O
the	O
mean	O
trabecular	O
separation	O
(	O
Tb	O
.	O
Sp	O
)	O
(	O
unpublished	O
data	O
)	O
in	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
mice	O
was	O
due	O
to	O
an	O
increase	O
in	O
the	O
percentage	O
of	O
spaces	O
falling	O
in	O
the	O
range	O
of	O
350	O
to	O
700	O
mu	O
m	O
(	O
Figure	O
4B	O
,	O
red	O
hatched	O
line	O
)	O
.	O

Trabecular	O
thickness	O
remained	O
constant	O
among	O
the	O
different	O
groups	O
of	O
mice	O
(	O
unpublished	O
data	O
)	O
.	O

In	O
effect	O
,	O
this	O
meant	O
that	O
there	O
were	O
fewer	O
trabeculae	O
,	O
rather	O
than	O
equivalent	O
numbers	O
of	O
thin	O
trabeculae	O
,	O
in	O
the	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
mice	O
compared	O
with	O
any	O
of	O
the	O
other	O
groups	O
of	O
mice	O
.	O

Bone	O
Remodeling	O
Is	O
Preserved	O
in	O
Aged	O
Sam68	O
-	O
/	O
-	O
Mice	O

To	O
further	O
define	O
the	O
mechanisms	O
involved	O
in	O
the	O
preservation	O
of	O
bone	O
mass	O
in	O
aged	O
Sam68	O
-	O
/	O
-	O
mice	O
,	O
we	O
prepared	O
sections	O
from	O
plastic	O
-	O
embedded	O
femora	O
and	O
tibia	O
to	O
evaluate	O
osteoblast	O
and	O
osteoclast	O
activity	O
(	O
Figure	O
5	O
)	O
.	O

In	O
situ	O
enzyme	O
histochemical	O
staining	O
for	O
alkaline	B-CHEBI
phosphatase	O
(	O
ALP	O
;	O
brown	O
stain	O
)	O
activity	O
was	O
used	O
as	O
a	O
biomarker	O
for	O
osteoblasts	O
and	O
tartrate	B-CHEBI
-	O
resistant	O
ALP	O
(	O
tartrate	B-CHEBI
-	O
resistant	O
acid	B-CHEBI
phosphatase	O
[	O
TRAP	O
]	O
;	O
red	O
stain	O
)	O
activity	O
as	O
a	O
marker	O
for	O
osteoclasts	O
.	O

Little	O
difference	O
was	O
seen	O
between	O
Sam68	O
+	O
/	O
+	O
(	O
Figure	O
5A	O
and	O
5B	O
)	O
and	O
Sam68	O
-	O
/	O
-	O
(	O
Figure	O
5C	O
and	O
5D	O
)	O
mice	O
at	O
4	O
months	O
of	O
age	O
.	O

ALP	O
-	O
and	O
TRAP	O
-	O
positive	O
cells	O
were	O
reduced	O
in	O
the	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
mice	O
(	O
Figure	O
5E	O
and	O
5F	O
)	O
and	O
remained	O
unchanged	O
in	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
mice	O
(	O
Figure	O
5G	O
and	O
5H	O
)	O
.	O

The	O
reduction	O
in	O
both	O
osteoblast	O
and	O
osteoclast	O
activity	O
in	O
the	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
mice	O
argued	O
against	O
bone	O
being	O
lost	O
primarily	O
due	O
to	O
a	O
relative	O
increase	O
in	O
osteoclast	O
over	O
osteoblast	O
activity	O
,	O
as	O
seen	O
in	O
high	O
turnover	O
disease	O
[	O
49	O
]	O
.	O

Histomorphometric	O
analyses	O
[	O
50	O
]	O
of	O
the	O
long	O
bones	O
(	O
Table	O
3	O
)	O
corroborated	O
the	O
radiologic	O
evidence	O
of	O
age	O
-	O
related	O
bone	O
loss	O
.	O

Bone	O
volume	O
(	O
BV	O
/	O
TV	O
)	O
,	O
newly	O
formed	O
osteoid	O
(	O
OV	O
/	O
TV	O
)	O
,	O
and	O
mineral	B-CHEBI
apposition	O
rate	O
(	O
MAR	O
)	O
were	O
all	O
significantly	O
reduced	O
in	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
mice	O
compared	O
with	O
4	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
mice	O
.	O

These	O
reductions	O
were	O
associated	O
with	O
a	O
significant	O
increase	O
in	O
marrow	O
fat	O
(	O
FV	O
/	O
TV	O
)	O
and	O
decreased	O
numbers	O
of	O
osteoblasts	O
(	O
nOB	O
/	O
TV	O
)	O
and	O
osteoclasts	O
(	O
nOC	O
/	O
TV	O
)	O
per	O
tissue	O
volume	O
(	O
Table	O
3	O
)	O
.	O

These	O
results	O
were	O
in	O
contrast	O
to	O
those	O
of	O
the	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
mice	O
in	O
which	O
all	O
histomorphometric	O
parameters	O
,	O
including	O
marrow	O
fat	O
,	O
resembled	O
those	O
of	O
young	O
mice	O
of	O
either	O
genotype	O
(	O
Table	O
3	O
)	O
.	O

When	O
cells	O
were	O
expressed	O
as	O
a	O
function	O
of	O
the	O
bone	O
perimeter	O
(	O
nOB	O
/	O
BP	O
,	O
nOC	O
/	O
BP	O
)	O
,	O
there	O
were	O
no	O
statistical	O
differences	O
and	O
the	O
ratio	O
of	O
osteoblasts	O
to	O
osteoclasts	O
was	O
similar	O
in	O
all	O
groups	O
of	O
mice	O
(	O
Table	O
3	O
)	O
.	O

Circulating	O
levels	O
of	O
serum	O
C	B-CHEBI
-	O
telopeptide	O
(	O
sCTX	O
;	O
Roche	O
Diagnostics	O
,	O
Mannheim	O
,	O
Germany	O
)	O
and	O
ALP	O
showed	O
little	O
difference	O
among	O
the	O
groups	O
,	O
except	O
for	O
a	O
small	O
decrease	O
in	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
mice	O
and	O
(	O
Dataset	O
S3	O
)	O
.	O

Serum	O
estrogen	O
was	O
significantly	O
decreased	O
in	O
all	O
12	O
-	O
month	O
-	O
old	O
mice	O
regardless	O
of	O
genotype	O
with	O
a	O
reciprocal	O
increase	O
in	O
interleukin	O
-	O
6	O
levels	O
(	O
Dataset	O
S3	O
)	O
.	O

Given	O
the	O
involvement	O
of	O
leptin	O
in	O
regulating	O
body	O
and	O
bone	O
mass	O
,	O
serum	O
leptin	O
was	O
measured	O
in	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
mice	O
.	O

Twelve	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
mice	O
had	O
significantly	O
lower	O
levels	O
than	O
young	O
and	O
old	O
Sam68	O
+	O
/	O
+	O
mice	O
and	O
young	O
Sam68	O
-	O
/	O
-	O
mice	O
(	O
Dataset	O
S3	O
)	O
.	O

Taken	O
together	O
,	O
these	O
observations	O
suggested	O
that	O
preservation	O
of	O
bone	O
mass	O
in	O
the	O
Sam68	O
-	O
/	O
-	O
mice	O
was	O
not	O
due	O
primarily	O
to	O
altered	O
estrogen	O
status	O
but	O
could	O
have	O
been	O
influenced	O
by	O
differences	O
in	O
circulating	O
leptin	O
levels	O
.	O

Osteoblast	O
,	O
but	O
Not	O
Osteoclast	O
,	O
Activity	O
Is	O
Altered	O
in	O
Sam68	O
-	O
/	O
-	O
Mice	O
Ex	O
Vivo	O

Maintenance	O
of	O
bone	O
mass	O
during	O
the	O
adult	O
remodeling	O
cycle	O
is	O
dependent	O
on	O
the	O
coupling	O
of	O
osteoblast	O
to	O
osteoclast	O
activity	O
,	O
such	O
that	O
there	O
is	O
no	O
net	O
gain	O
or	O
loss	O
of	O
bone	O
[	O
49	O
]	O
.	O

To	O
further	O
explore	O
the	O
age	O
-	O
related	O
advantage	O
of	O
Sam68	O
-	O
/	O
-	O
mice	O
with	O
respect	O
to	O
bone	O
preservation	O
,	O
we	O
examined	O
the	O
functional	O
activity	O
of	O
Sam68	O
-	O
/	O
-	O
osteoblasts	O
and	O
osteoclasts	O
ex	O
vivo	O
(	O
Figure	O
6A	O
and	O
6B	O
)	O
.	O

Cultures	O
of	O
bone	O
marrow	O
stromal	O
cells	O
harvested	O
from	O
4	O
-	O
week	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
mice	O
and	O
maintained	O
for	O
18	O
days	O
in	O
osteoblast	O
differentiation	O
medium	O
demonstrated	O
more	O
intense	O
staining	O
for	O
ALP	O
at	O
6	O
days	O
(	O
unpublished	O
data	O
)	O
and	O
18	O
days	O
(	O
Figure	O
6A	O
)	O
,	O
and	O
more	O
mineralized	O
nodules	O
at	O
18	O
days	O
,	O
than	O
the	O
Sam68	O
+	O
/	O
+	O
mice	O
,	O
even	O
though	O
similar	O
amounts	O
of	O
fibroblast	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
-	O
F	O
)	O
were	O
observed	O
(	O
Figure	O
6A	O
and	O
unpublished	O
data	O
)	O
.	O

RT	O
-	O
PCR	O
analysis	O
of	O
molecular	B-CHEBI
markers	O
of	O
osteoblast	O
differentiation	O
(	O
Dataset	O
S2	O
)	O
revealed	O
similar	O
increases	O
over	O
time	O
in	O
RNA	O
from	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
mice	O
,	O
although	O
type	O
I	O
collagen	O
appeared	O
to	O
be	O
up	O
-	O
regulated	O
at	O
both	O
timepoints	O
in	O
the	O
Sam68	O
-	O
/	O
-	O
mice	O
.	O

Short	O
-	O
term	O
cultures	O
of	O
mature	O
osteoclasts	O
released	O
from	O
the	O
crushed	O
long	O
bones	O
of	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
mice	O
stained	O
equally	O
well	O
for	O
TRAP	O
and	O
excavated	O
approximately	O
equal	O
numbers	O
of	O
pits	O
of	O
equal	O
size	O
in	O
dentin	O
slices	O
,	O
as	O
visualized	O
by	O
scanning	O
electron	B-CHEBI
microscopy	O
(	O
Figure	O
6B	O
)	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
osteoclasts	O
may	O
not	O
be	O
the	O
primary	O
defect	O
in	O
Sam68	O
-	O
/	O
-	O
mice	O
,	O
as	O
they	O
are	O
in	O
Src	O
null	O
mice	O
[	O
48	O
]	O
.	O

The	O
Absence	O
of	O
Sam68	O
Prevents	O
Adipocyte	O
Differentiation	O
and	O
Promotes	O
Osteoblast	O
Differentiation	O

It	O
is	O
well	O
recognized	O
that	O
bone	O
marrow	O
stromal	O
cells	O
give	O
rise	O
to	O
both	O
osteoblasts	O
and	O
adipocytes	O
and	O
that	O
age	O
-	O
related	O
bone	O
loss	O
is	O
accompanied	O
by	O
an	O
increase	O
in	O
differentiation	O
down	O
the	O
adipocyte	O
lineage	O
[	O
22	O
]	O
.	O

Therefore	O
,	O
the	O
loss	O
of	O
Sam68	O
could	O
influence	O
the	O
bone	O
marrow	O
stromal	O
cells	O
to	O
differentiate	O
along	O
the	O
osteogenic	O
versus	O
the	O
adipogenic	O
pathway	O
.	O

Alternatively	O
,	O
the	O
loss	O
of	O
Sam68	O
could	O
indirectly	O
regulate	O
bone	O
mass	O
as	O
a	O
general	O
disturbance	O
of	O
neuroendocrine	O
control	O
as	O
was	O
shown	O
when	O
leptin	O
and	O
the	O
sympathetic	O
nervous	O
system	O
axis	O
were	O
shown	O
to	O
negatively	O
regulate	O
bone	O
mass	O
[	O
8	O
]	O
.	O

To	O
confirm	O
a	O
role	O
for	O
Sam68	O
in	O
the	O
regulation	O
of	O
adipocyte	O
differentiation	O
,	O
we	O
isolated	O
primary	O
MEFs	O
from	O
14	O
.	O
5	O
-	O
day	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
embryos	O
.	O

The	O
primary	O
Sam68	O
-	O
/	O
-	O
MEFs	O
were	O
differentiated	O
into	O
adipocytes	O
in	O
vitro	O
in	O
culture	O
medium	O
containing	O
5	O
mu	O
M	O
pioglitazone	O
to	O
induce	O
adipogenesis	O
.	O

Cells	O
at	O
days	O
0	O
,	O
4	O
,	O
6	O
,	O
and	O
12	O
were	O
stained	O
with	O
Oil	O
red	O
O	O
to	O
monitor	O
adipogenesis	O
.	O

Adipogenesis	O
was	O
more	O
pronounced	O
in	O
the	O
wild	O
-	O
type	O
MEFs	O
cultures	O
than	O
in	O
the	O
Sam68	O
-	O
/	O
-	O
MEFs	O
,	O
consistent	O
with	O
the	O
positive	O
role	O
of	O
endogenous	O
Sam68	O
in	O
adipocyte	O
differentiation	O
(	O
Figure	O
7	O
)	O
.	O

The	O
expression	O
of	O
key	O
transcription	O
factors	O
including	O
the	O
PPAR	O
gamma	O
and	O
KLF5	O
was	O
impaired	O
in	O
Sam68	O
-	O
/	O
-	O
differentiated	O
MEFs	O
compared	O
with	O
Sam68	O
+	O
/	O
+	O
MEFs	O
,	O
consistent	O
with	O
impaired	O
adipogenesis	O
in	O
the	O
absence	O
of	O
Sam68	O
(	O
Figure	O
7	O
)	O
.	O

These	O
data	O
,	O
together	O
with	O
data	O
confirming	O
a	O
lean	O
phenotype	O
in	O
Sam68	O
-	O
/	O
-	O
mice	O
(	O
N	O
.	O
Torabi	O
and	O
S	O
.	O
Richard	O
,	O
unpublished	O
data	O
)	O
,	O
support	O
the	O
hypothesis	O
that	O
Sam68	O
modulates	O
the	O
differentiation	O
of	O
mesenchymal	O
cells	O
.	O

To	O
further	O
examine	O
this	O
phenotype	O
in	O
a	O
cell	O
autonomous	O
system	O
,	O
we	O
chose	O
the	O
embryonic	O
mesenchymal	O
multipotential	O
progenitor	O
cells	O
C3H10T1	O
/	O
2	O
.	O

The	O
addition	O
of	O
BMP	O
-	O
2	O
induced	O
osteoblast	O
differentiation	O
,	O
as	O
evidenced	O
by	O
an	O
approximately	O
400	O
-	O
fold	O
increase	O
in	O
expression	O
of	O
the	O
osteocalcin	O
(	O
OCN	O
)	O
gene	O
[	O
51	O
]	O
.	O

Populations	O
of	O
C3H10T1	O
/	O
2	O
cells	O
stably	O
transfected	O
with	O
either	O
pSuper	O
-	O
retro	O
(	O
control	O
)	O
and	O
pSuper	O
-	O
retro	O
harboring	O
a	O
short	O
hairpin	O
against	O
Sam68	O
(	O
Sam68sh	O
)	O
were	O
selected	O
with	O
puromycin	B-CHEBI
.	O

The	O
expression	O
of	O
Sam68	O
was	O
reduced	O
by	O
approximately	O
80	O
%	O
as	O
evidenced	O
by	O
immunoblot	O
analyses	O
using	O
beta	O
-	O
actin	O
as	O
a	O
loading	O
control	O
(	O
Figure	O
8A	O
)	O
.	O

Osteoblast	O
differentiation	O
was	O
induced	O
in	O
cultures	O
expressing	O
pSuper	O
-	O
retro	O
or	O
pSuper	O
-	O
retro	O
Sam68sh	O
by	O
addition	O
of	O
BMP	O
-	O
2	O
to	O
the	O
culture	O
medium	O
.	O

.	O
The	O
expression	O
of	O
OCN	O
and	O
beta	O
-	O
actin	O
mRNAs	B-CHEBI
was	O
examined	O
by	O
semiquantitative	O
RT	O
-	O
PCR	O
and	O
the	O
Sam68sh	O
-	O
expressing	O
cells	O
displayed	O
a	O
more	O
pronounced	O
osteoblast	O
phenotype	O
compared	O
with	O
control	O
cells	O
,	O
as	O
assessed	O
by	O
the	O
expression	O
of	O
OCN	O
(	O
Figure	O
8B	O
)	O
.	O

Given	O
the	O
apparent	O
enhancement	O
of	O
mineralized	O
nodule	O
formation	O
by	O
Sam68	O
-	O
/	O
-	O
bone	O
marrow	O
stromal	O
cells	O
ex	O
vivo	O
and	O
the	O
phenotype	O
observed	O
with	O
short	O
hairpin	O
RNA	O
(	O
shRNA	O
)	O
-	O
treated	O
C3H10T1	O
/	O
2	O
,	O
we	O
stained	O
sections	O
of	O
bone	O
from	O
4	O
-	O
and	O
12	O
-	O
month	O
-	O
old	O
mice	O
for	O
evidence	O
of	O
changes	O
in	O
marrow	O
adiposity	O
.	O

Figure	O
9	O
shows	O
sections	O
of	O
undecalcified	O
bone	O
from	O
4	O
-	O
and	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
mice	O
stained	O
with	O
von	O
Kossa	O
and	O
toluidine	O
blue	O
to	O
show	O
mineralized	O
tissue	O
(	O
Figure	O
9A	O
,	O
black	O
)	O
and	O
marrow	O
adipocytes	O
(	O
Figure	O
9B	O
,	O
white	O
)	O
and	O
left	O
unstained	O
to	O
show	O
fluorochrome	O
labeling	O
of	O
the	O
mineralization	O
fronts	O
(	O
Figure	O
9C	O
)	O
.	O

Twelve	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
mice	O
showed	O
a	O
noticeable	O
decrease	O
in	O
trabecular	O
bone	O
(	O
Figure	O
9A	O
)	O
,	O
which	O
was	O
associated	O
with	O
a	O
significant	O
increase	O
in	O
marrow	O
adiposity	O
(	O
Figure	O
9B	O
)	O
and	O
with	O
the	O
two	O
fluorochrome	B-CHEBI
labels	I-CHEBI
superimposed	O
upon	O
one	O
another	O
(	O
Figure	O
9C	O
)	O
.	O

In	O
contrast	O
,	O
the	O
bones	O
of	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
mice	O
appeared	O
similar	O
to	O
those	O
of	O
the	O
4	O
-	O
month	O
-	O
old	O
mice	O
of	O
either	O
genotype	O
.	O

These	O
data	O
demonstrate	O
that	O
Sam68	O
regulates	O
the	O
differentiation	O
of	O
bone	O
marrow	O
mesenchymal	O
cells	O
to	O
promote	O
adipocyte	O
differentiation	O
and	O
inhibit	O
osteoblast	O
differentiation	O
in	O
aging	O
bone	O
.	O

Discussion	O

The	O
present	O
study	O
provides	O
evidence	O
that	O
a	O
physiologic	O
role	O
of	O
Sam68	O
is	O
to	O
modulate	O
bone	O
marrow	O
mesenchymal	O
stem	O
cells	O
.	O

Young	O
Sam68	O
-	O
/	O
-	O
mice	O
developed	O
normally	O
and	O
contained	O
similar	O
bone	O
mass	O
compared	O
with	O
wild	O
-	O
type	O
littermates	O
.	O

Aged	O
(	O
12	O
months	O
)	O
Sam68	O
-	O
/	O
-	O
mice	O
displayed	O
a	O
high	O
bone	O
mass	O
phenotype	O
compared	O
with	O
Sam68	O
+	O
/	O
+	O
littermates	O
.	O

The	O
wild	O
-	O
type	O
littermates	O
underwent	O
age	O
-	O
related	O
bone	O
loss	O
that	O
occurs	O
naturally	O
in	O
mammals	O
,	O
while	O
the	O
Sam68	O
-	O
/	O
-	O
animals	O
preserved	O
their	O
bone	O
mass	O
with	O
aging	O
.	O

The	O
differentiation	O
of	O
bone	O
marrow	O
stem	O
cells	O
isolated	O
from	O
Sam68	O
-	O
/	O
-	O
mice	O
and	O
embryonic	O
mesenchymal	O
multipotential	O
progenitor	O
cells	O
C3H10T1	O
/	O
2	O
treated	O
with	O
Sam68	O
shRNA	O
resulted	O
in	O
a	O
more	O
pronounced	O
osteoblast	O
differentiation	O
.	O

These	O
findings	O
demonstrate	O
that	O
the	O
loss	O
of	O
Sam68	O
enhances	O
osteoblast	O
differentiation	O
.	O

The	O
converse	O
was	O
also	O
true	O
,	O
as	O
MEFs	O
isolated	O
from	O
Sam68	O
-	O
/	O
-	O
animals	O
were	O
impaired	O
in	O
their	O
ability	O
to	O
undergo	O
adipocyte	O
differentiation	O
compared	O
with	O
Sam68	O
+	O
/	O
+	O
MEFs	O
.	O

These	O
findings	O
suggest	O
that	O
a	O
physiologic	O
role	O
for	O
Sam68	O
is	O
to	O
regulate	O
the	O
balance	O
between	O
adipogenic	O
and	O
osteogenic	O
differentiation	O
of	O
the	O
bone	O
marrow	O
mesenchymal	O
.	O

Sam68	O
protein	B-CHEBI
expression	O
was	O
observed	O
throughout	O
the	O
developing	O
mouse	O
embryo	O
,	O
in	O
keeping	O
with	O
previous	O
reports	O
that	O
identified	O
the	O
Sam68	O
mRNA	B-CHEBI
to	O
be	O
widely	O
expressed	O
[	O
38	O
]	O
.	O

We	O
observe	O
Sam68	O
staining	O
in	O
the	O
brain	O
,	O
heart	O
,	O
and	O
intestine	O
(	O
see	O
Figure	O
1	O
)	O
as	O
well	O
as	O
liver	O
,	O
skin	O
,	O
and	O
kidney	O
(	O
unpublished	O
data	O
)	O
of	O
late	O
-	O
stage	O
embryos	O
.	O

This	O
expression	O
pattern	O
is	O
consistent	O
with	O
previous	O
work	O
that	O
has	O
observed	O
Sam68	O
in	O
neurons	O
[	O
52	O
]	O
and	O
as	O
a	O
substrate	O
of	O
the	O
intestinal	O
SIK	O
/	O
breast	O
tumor	O
kinase	O
[	O
43	O
]	O
.	O

The	O
expression	O
of	O
Sam68	O
was	O
not	O
altered	O
in	O
aging	O
bone	O
marrow	O
stromal	O
cells	O
or	O
in	O
senescencing	O
WI	O
-	O
38	O
cells	O
(	O
unpublished	O
data	O
)	O
.	O

The	O
presence	O
of	O
Sam68	O
in	O
chondrocytes	O
,	O
osteoblasts	O
and	O
osteoclasts	O
in	O
developing	O
cartilage	O
and	O
bone	O
predicted	O
a	O
pivotal	O
role	O
for	O
the	O
protein	B-CHEBI
in	O
skeletal	O
development	O
.	O

The	O
Sam68	O
-	O
/	O
-	O
mice	O
were	O
generated	O
using	O
a	O
traditional	O
targeting	O
approach	O
where	O
the	O
functional	O
KH	O
domain	O
was	O
deleted	O
and	O
approximately	O
one	O
third	O
of	O
the	O
Sam68	O
-	O
/	O
-	O
mice	O
survived	O
to	O
adulthood	O
with	O
no	O
apparent	O
defects	O
.	O

One	O
explanation	O
for	O
this	O
phenomenon	O
is	O
that	O
Sam68	O
function	O
is	O
sub	O
-	O
served	O
by	O
one	O
or	O
more	O
of	O
its	O
family	O
members	O
during	O
development	O
such	O
as	O
SLM	O
-	O
1	O
and	O
SLM	O
-	O
2	O
[	O
47	O
]	O
.	O

Alternatively	O
,	O
Sam68	O
is	O
not	O
required	O
during	O
embryonic	O
development	O
.	O

However	O
,	O
two	O
thirds	O
of	O
the	O
Sam68	O
-	O
/	O
-	O
,	O
but	O
not	O
the	O
Sam68	O
+	O
/	O
-	O
pups	O
,	O
were	O
killed	O
by	O
their	O
Sam68	O
+	O
/	O
-	O
mothers	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
mothers	O
are	O
able	O
to	O
detect	O
a	O
subtle	O
defect	O
/	O
difference	O
that	O
we	O
cannot	O
.	O

Adult	O
Sam68	O
-	O
/	O
-	O
mice	O
live	O
a	O
normal	O
life	O
span	O
of	O
approximately	O
two	O
years	O
.	O

The	O
Sam68	O
-	O
/	O
-	O
males	O
were	O
sterile	O
and	O
the	O
Sam68	O
-	O
/	O
-	O
females	O
provided	O
inadequate	O
care	O
to	O
their	O
young	O
,	O
but	O
the	O
pups	O
were	O
not	O
scattered	O
and	O
neglected	O
as	O
observed	O
with	O
FosB	O
-	O
/	O
-	O
mice	O
[	O
53	O
]	O
.	O

Serum	O
levels	O
of	O
estrogen	O
decreased	O
in	O
aging	O
Sam68	O
-	O
/	O
-	O
females	O
as	O
expected	O
;	O
however	O
,	O
the	O
leptin	O
levels	O
decreased	O
in	O
aged	O
Sam68	O
-	O
/	O
-	O
females	O
.	O

The	O
aged	O
Sam68	O
-	O
/	O
-	O
females	O
were	O
not	O
obese	O
and	O
actually	O
weighed	O
less	O
than	O
the	O
littermate	O
controls	O
(	O
see	O
Table	O
2	O
)	O
.	O

Moreover	O
,	O
their	O
appetite	O
was	O
not	O
altered	O
with	O
aging	O
(	O
N	O
.	O
Torabi	O
and	O
S	O
.	O
Richard	O
,	O
unpublished	O
data	O
)	O
,	O
suggesting	O
that	O
the	O
observed	O
leptin	O
reduction	O
was	O
not	O
recreating	O
ob	O
/	O
ob	O
-	O
like	O
phenotypes	O
related	O
to	O
weight	O
,	O
appetite	O
and	O
female	O
sterility	O
[	O
54	O
]	O
.	O

The	O
skeletal	O
phenotyping	O
of	O
cohorts	O
of	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
mice	O
showed	O
that	O
bone	O
mass	O
was	O
preserved	O
in	O
aged	O
Sam68	O
-	O
/	O
-	O
mice	O
.	O

Traditional	O
histology	O
and	O
histomorphometry	O
suggested	O
that	O
the	O
mechanism	O
involved	O
preservation	O
of	O
osteoblast	O
and	O
osteoclast	O
activity	O
.	O

The	O
documented	O
role	O
of	O
the	O
Sam68	O
regulatory	O
protein	B-CHEBI
,	O
Src	O
,	O
in	O
osteopetrosis	O
led	O
us	O
to	O
investigate	O
the	O
morphology	O
and	O
activity	O
of	O
Sam68	O
-	O
/	O
-	O
osteoclasts	O
ex	O
vivo	O
.	O

The	O
Src	O
tyrosine	B-CHEBI
kinase	O
was	O
shown	O
to	O
play	O
a	O
role	O
in	O
bone	O
remodeling	O
when	O
Src	O
-	O
/	O
-	O
mice	O
died	O
at	O
6	O
months	O
of	O
age	O
with	O
an	O
osteopetrotic	O
phenotype	O
[	O
48	O
]	O
and	O
the	O
defect	O
was	O
attributed	O
to	O
defective	O
osteoclast	O
function	O
[	O
55	O
-	O
59	O
]	O
.	O

We	O
therefore	O
cultured	O
mature	O
osteoclasts	O
harvested	O
from	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
mice	O
ex	O
vivo	O
on	O
dentin	O
slices	O
to	O
quantify	O
their	O
resorptive	O
capacity	O
.	O

The	O
fact	O
that	O
Sam68	O
-	O
/	O
-	O
osteoclasts	O
looked	O
and	O
acted	O
like	O
Sam68	O
+	O
/	O
+	O
osteoclasts	O
ex	O
vivo	O
and	O
in	O
vivo	O
made	O
it	O
unlikely	O
that	O
this	O
was	O
the	O
primary	O
source	O
of	O
the	O
difference	O
in	O
bone	O
metabolism	O
in	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
mice	O
.	O

The	O
fact	O
that	O
the	O
CTX	O
levels	O
were	O
lower	O
in	O
young	O
and	O
old	O
Sam68	O
-	O
/	O
-	O
mice	O
suggested	O
that	O
there	O
is	O
reduced	O
bone	O
resorption	O
compared	O
with	O
wild	O
-	O
type	O
littermate	O
controls	O
.	O

However	O
,	O
this	O
reduction	O
in	O
bone	O
resorption	O
occurred	O
with	O
normal	O
osteoclast	O
activity	O
,	O
as	O
assessed	O
by	O
in	O
vitro	O
culturing	O
.	O

These	O
observations	O
are	O
consistent	O
with	O
the	O
Sam68	O
-	O
/	O
-	O
mice	O
having	O
a	O
youth	O
-	O
like	O
bone	O
phenotype	O
.	O

However	O
,	O
it	O
is	O
still	O
possible	O
,	O
that	O
a	O
mild	O
impairment	O
in	O
Sam68	O
-	O
/	O
-	O
mice	O
osteoclast	O
function	O
may	O
manifest	O
itself	O
later	O
in	O
life	O
in	O
overall	O
accumulation	O
of	O
bone	O
and	O
this	O
will	O
require	O
further	O
detailed	O
studies	O
.	O

Ex	O
vivo	O
differentiation	O
of	O
primary	O
bone	O
marrow	O
stromal	O
cells	O
,	O
harvested	O
from	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
mice	O
,	O
down	O
the	O
osteoblast	O
lineage	O
revealed	O
an	O
osteogenic	O
advantage	O
in	O
the	O
cultures	O
of	O
cells	O
derived	O
from	O
the	O
Sam68	O
-	O
/	O
-	O
mice	O
.	O

It	O
will	O
be	O
important	O
to	O
demonstrate	O
that	O
a	O
similar	O
effect	O
is	O
observed	O
using	O
primary	O
bone	O
marrow	O
stromal	O
cells	O
from	O
aged	O
Sam68	O
-	O
/	O
-	O
mice	O
.	O

Similar	O
findings	O
were	O
observed	O
when	O
embryonic	O
mesenchymal	O
multipotential	O
progenitor	O
cells	O
C3H10T1	O
/	O
2	O
treated	O
with	O
Sam68	O
shRNA	O
,	O
were	O
differentiated	O
into	O
osteoblasts	O
with	O
BMP2	O
.	O

Our	O
findings	O
that	O
aged	O
Sam68	O
-	O
/	O
-	O
mice	O
do	O
not	O
develop	O
fatty	O
bone	O
marrow	O
and	O
that	O
MEFs	O
derived	O
from	O
Sam68	O
-	O
/	O
-	O
mice	O
have	O
impaired	O
adipocyte	O
differentiation	O
,	O
indicate	O
that	O
Sam68	O
regulates	O
both	O
adipocyte	O
and	O
osteoblast	O
differentiation	O
.	O

These	O
findings	O
identify	O
Sam68	O
as	O
the	O
first	O
RNA	O
binding	O
protein	B-CHEBI
to	O
regulate	O
mesenchymal	O
cell	O
differentiation	O
and	O
the	O
challenge	O
will	O
be	O
to	O
identify	O
the	O
specific	O
RNA	O
targets	O
that	O
it	O
regulates	O
during	O
this	O
process	O
.	O

The	O
fact	O
that	O
osteoblast	O
function	O
is	O
altered	O
in	O
Src	O
-	O
/	O
-	O
mice	O
[	O
60	O
,	O
61	O
]	O
raises	O
the	O
possibility	O
that	O
preservation	O
of	O
bone	O
mass	O
in	O
the	O
Sam68	O
-	O
/	O
-	O
mice	O
could	O
be	O
linked	O
with	O
and	O
regulated	O
by	O
Src	O
.	O

The	O
pathway	O
by	O
which	O
leptin	O
regulates	O
bone	O
resorption	O
was	O
identified	O
to	O
involve	O
the	O
sympathetic	O
nervous	O
system	O
relaying	O
to	O
the	O
osteoblasts	O
via	O
the	O
beta	O
-	O
adrenergic	O
pathway	O
leading	O
to	O
the	O
release	O
of	O
growth	O
factors	O
including	O
RANKL	O
that	O
causes	O
the	O
osteoclasts	O
to	O
thrive	O
[	O
8	O
,	O
18	O
-	O
20	O
]	O
.	O

The	O
lowering	O
of	O
leptin	O
levels	O
in	O
aged	O
Sam68	O
-	O
/	O
-	O
mice	O
is	O
consistent	O
with	O
these	O
mice	O
having	O
a	O
high	O
bone	O
mass	O
compared	O
with	O
their	O
aged	O
littermates	O
.	O

These	O
data	O
would	O
suggest	O
that	O
the	O
leptin	O
-	O
sympathetic	O
pathway	O
is	O
unaltered	O
in	O
Sam68	O
-	O
/	O
-	O
mice	O
and	O
that	O
the	O
lowering	O
of	O
leptin	O
may	O
explain	O
the	O
lower	O
levels	O
of	O
CTX	O
in	O
the	O
serum	O
of	O
Sam68	O
-	O
/	O
-	O
mice	O
.	O

These	O
findings	O
suggest	O
that	O
Sam68	O
may	O
be	O
regulating	O
bone	O
metabolism	O
at	O
two	O
different	O
levels	O
:	O
(	O
1	O
)	O
the	O
absence	O
of	O
Sam68	O
results	O
in	O
lower	O
leptin	O
levels	O
that	O
may	O
reduce	O
bone	O
resorption	O
via	O
the	O
sympathetic	O
nervous	O
system	O
and	O
(	O
2	O
)	O
the	O
absence	O
of	O
Sam68	O
favors	O
osteoblast	O
,	O
rather	O
than	O
adipocyte	O
,	O
differentiation	O
.	O

In	O
conclusion	O
,	O
our	O
data	O
define	O
a	O
physiologic	O
role	O
for	O
Sam68	O
in	O
bone	O
metabolism	O
and	O
bone	O
marrow	O
mesenchymal	O
stem	O
cell	O
differentiation	O
.	O

The	O
bone	O
phenotype	O
observed	O
in	O
Sam68	O
-	O
/	O
-	O
mice	O
imply	O
that	O
inhibitors	B-CHEBI
of	O
Sam68	O
could	O
prevent	O
age	O
-	O
related	O
bone	O
loss	O
.	O

Furthermore	O
,	O
the	O
results	O
also	O
suggest	O
that	O
Sam68	O
expression	O
levels	O
,	O
hypomorphism	O
,	O
and	O
mutations	O
in	O
humans	O
may	O
influence	O
susceptibility	O
to	O
marrow	O
adipocyte	O
accumulation	O
and	O
osteoporosis	O
.	O

Our	O
findings	O
also	O
identify	O
a	O
new	O
animal	O
model	O
to	O
study	O
aging	O
bone	O
loss	O
.	O

Materials	O
and	O
Methods	O

Histologic	O
,	O
immunohistochemical	O
,	O
and	O
histomorphometric	O
analyses	O
.	O

All	O
analyses	O
were	O
performed	O
essentially	O
as	O
described	O
previously	O
[	O
62	O
,	O
63	O
]	O
.	O

Briefly	O
,	O
embryonic	O
mice	O
were	O
removed	O
from	O
timed	O
pregnant	O
dams	O
at	O
E14	O
.	O
5	O
and	O
E16	O
.	O
5	O
and	O
fixed	O
intact	O
for	O
36	O
h	O
in	O
4	O
%	O
paraformaldehyde	O
,	O
rinsed	O
thoroughly	O
in	O
PBS	O
,	O
and	O
processed	O
for	O
paraffin	O
embedding	O
.	O

Serial	O
4	O
-	O
mu	O
m	O
sections	O
were	O
cut	O
on	O
a	O
modified	O
Leica	O
RM	O
2155	O
rotary	O
microtome	O
(	O
Leica	O
Microsystems	O
,	O
Richmond	O
Hill	O
,	O
Ontario	O
,	O
Canada	O
)	O
,	O
stained	O
with	O
a	O
1	O
:	O
600	O
dilution	O
of	O
the	O
AD1	O
anti	O
-	O
Sam68	O
antibody	O
[	O
46	O
]	O
and	O
counterstained	O
with	O
either	O
methyl	B-CHEBI
green	O
or	O
hematoxylin	O
.	O

Adult	O
mice	O
were	O
given	O
an	O
intraperitoneal	O
injection	O
of	O
30	O
mg	O
/	O
kg	O
calcein	O
at	O
7	O
days	O
and	O
30	O
mg	O
/	O
kg	O
tetracycline	B-CHEBI
at	O
2	O
days	O
prior	O
to	O
sacrifice	O
to	O
label	O
actively	O
mineralizing	O
surfaces	O
.	O

After	O
overnight	O
fixation	O
in	O
4	O
%	O
paraformaldehyde	O
and	O
rinsing	O
in	O
PBS	O
,	O
the	O
left	O
femur	O
and	O
tibia	O
were	O
embedded	O
in	O
polymethylmethacrylate	O
(	O
MMA	O
)	O
or	O
a	O
mixture	O
of	O
50	O
%	O
MMA	O
and	O
50	O
%	O
glycolmethacrylate	O
(	O
GMA	O
)	O
.	O

Serial	O
4	O
-	O
to	O
6	O
-	O
mu	O
m	O
sections	O
of	O
MMA	O
-	O
embedded	O
tissues	O
were	O
left	O
unstained	O
or	O
stained	O
with	O
von	O
Kossa	O
and	O
toluidine	O
blue	O
or	O
with	O
toluidine	O
blue	O
alone	O
,	O
while	O
4	O
-	O
mu	O
m	O
MMA	O
-	O
GMA	O
sections	O
were	O
stained	O
for	O
TRAP	O
and	O
ALP	O
activity	O
.	O

Images	O
were	O
captured	O
using	O
a	O
Leica	O
DMR	O
microscope	O
(	O
Leica	O
Microsystems	O
)	O
equipped	O
with	O
a	O
Retiga	O
1300	O
camera	O
(	O
Qimaging	O
,	O
Burnaby	O
,	O
British	O
Columbia	O
,	O
Canada	O
)	O
and	O
the	O
primary	O
histomorphometric	O
data	O
obtained	O
using	O
Bioquant	O
Nova	O
Prime	O
image	O
analysis	O
software	O
(	O
Bioquant	O
Image	O
Analysis	O
Corp	O
,	O
Nashville	O
,	O
Tennessee	O
,	O
United	O
States	O
)	O
.	O

Nomenclature	O
and	O
abbreviations	O
conform	O
to	O
those	O
recommended	O
by	O
the	O
American	O
Society	O
for	O
Bone	O
and	O
Mineral	B-CHEBI
Research	O
[	O
50	O
]	O
.	O

Generation	O
of	O
mice	O
with	O
targeted	O
disruption	O
of	O
the	O
sam68	O
gene	O
.	O

A	O
lambda	O
bacteriophage	O
clone	O
encompassing	O
Sam68	O
exons	O
3	O
to	O
9	O
was	O
isolated	O
from	O
a	O
129	O
/	O
SvJ	O
genomic	O
library	O
using	O
full	O
-	O
length	O
Sam68	O
cDNA	O
as	O
a	O
probe	O
.	O

XbaI	O
-	O
digested	O
Sam68	O
genomic	O
DNA	O
fragments	O
of	O
4	O
kb	O
(	O
encompassing	O
exon	O
4	O
and	O
part	O
of	O
exon	O
5	O
)	O
and	O
3kb	O
(	O
spanning	O
part	O
of	O
exon	O
5	O
and	O
exon	O
6	O
)	O
were	O
subcloned	O
in	O
Bluescript	O
SK	O
resulting	O
in	O
pBS4	O
and	O
pBS3	O
,	O
respectively	O
.	O

A	O
DNA	O
fragment	O
was	O
amplified	O
from	O
pBS4	O
with	O
the	O
following	O
oligonucleotides	O
(	O
5	O
'	O
-	O
AAT	O
GTC	O
TAG	O
AAA	O
CAA	O
CTC	O
ATA	O
TAC	O
AGA	O
C	B-CHEBI
-	O
3	O
'	O
)	O
and	O
the	O
universal	O
primer	O
.	O

The	O
XbaI	O
-	O
digested	O
1	O
-	O
kb	O
DNA	O
fragment	O
was	O
subcloned	O
in	O
the	O
XbaI	O
site	O
of	O
pPNT	O
(	O
a	O
gift	O
from	O
Andrew	O
Karaplis	O
,	O
McGill	O
University	O
,	O
Montr	O
e	O
al	O
,	O
Quebec	O
,	O
Canada	O
)	O
.	O

The	O
3	O
-	O
kb	O
fragment	O
from	O
pBS3	O
was	O
amplified	O
by	O
PCR	O
with	O
(	O
5	O
'	O
-	O
GGG	O
ATG	O
CGG	O
CCG	O
CTC	O
TAG	O
AAT	O
TGT	O
CCT	O
ACT	O
TGA	O
ACG	O
G	B-CHEBI
-	O
3	O
'	O
)	O
and	O
(	O
5	O
'	O
-	O
CGG	O
TGG	O
CGG	O
CCG	O
CTG	O
TCG	O
ACC	O
TGA	O
GTA	O
ACA	O
TTT	O
CTT	O
A	O
-	O
3	O
'	O
)	O
and	O
subcloned	O
in	O
the	O
NotI	O
site	O
of	O
pPNT	O
.	O

The	O
targeting	O
vector	O
pPNT	O
-	O
Sam68	O
replaces	O
exon	O
4	O
and	O
part	O
of	O
exon	O
5	O
with	O
a	O
neomycin	B-CHEBI
-	O
resistant	O
gene	O
cassette	O
.	O

An	O
SalI	O
site	O
was	O
introduced	O
at	O
the	O
3	O
'	O
end	O
of	O
the	O
3	O
-	O
kb	O
DNA	O
fragment	O
and	O
was	O
used	O
to	O
linearize	O
the	O
plasmid	O
for	O
electroporation	O
into	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
.	O

Approximately	O
1	O
,	O
000	O
ES	O
colonies	O
were	O
screened	O
and	O
two	O
clones	O
were	O
identified	O
that	O
contained	O
the	O
Sam68	O
mutant	O
allele	O
,	O
as	O
determined	O
by	O
Southern	O
blotting	O
.	O

Targeted	O
ES	O
cells	O
were	O
injected	O
into	O
3	O
.	O
5	O
-	O
day	O
-	O
old	O
BALB	O
/	O
c	O
blastocysts	O
and	O
were	O
transferred	O
into	O
CD	O
-	O
1	O
foster	O
mothers	O
,	O
and	O
animals	O
classified	O
as	O
chimeras	O
by	O
coat	O
color	O
were	O
mated	O
with	O
BALB	O
/	O
c	O
mice	O
.	O

Germ	O
line	O
transmission	O
was	O
achieved	O
and	O
the	O
mice	O
were	O
maintained	O
in	O
C57BL	O
/	O
6	O
background	O
.	O

The	O
mice	O
used	O
for	O
this	O
study	O
represent	O
mice	O
that	O
were	O
backcrossed	O
in	O
C57BL	O
/	O
6	O
between	O
three	O
and	O
eight	O
generations	O
;	O
in	O
addition	O
,	O
we	O
maintained	O
the	O
mice	O
in	O
the	O
129	O
/	O
SvJ	O
strain	O
and	O
observed	O
a	O
similar	O
phenotype	O
.	O

Genotyping	O
and	O
immunoblot	O
analyses	O
.	O

All	O
mouse	O
procedures	O
were	O
performed	O
in	O
accordance	O
with	O
McGill	O
University	O
guidelines	O
,	O
which	O
are	O
set	O
by	O
the	O
Canadian	O
Council	O
on	O
Animal	O
Care	O
.	O

Genomic	O
DNA	O
was	O
isolated	O
from	O
tail	O
biopsies	O
and	O
analyzed	O
by	O
Southern	O
blotting	O
and	O
genomic	O
PCR	O
analysis	O
.	O

The	O
DNA	O
fragment	O
utilized	O
as	O
the	O
probe	O
for	O
the	O
Southern	O
blotting	O
analysis	O
was	O
amplified	O
with	O
the	O
following	O
two	O
oligonucleotides	O
(	O
5	O
'	O
-	O
AAG	O
CCT	O
TTA	O
CTG	O
GTT	O
GTG	O
T	B-CHEBI
-	O
3	O
'	O
)	O
and	O
(	O
5	O
'	O
-	O
CTT	O
GAA	O
ACG	O
CAC	O
CGT	O
AGG	O
CT	O
-	O
3	O
'	O
)	O
.	O

The	O
wild	O
-	O
type	O
sam68	O
allele	O
was	O
identified	O
by	O
genomic	O
PCR	O
using	O
the	O
following	O
oligonucleotides	O
5	O
'	O
-	O
AAA	O
TCC	O
TAA	O
CCC	O
TCC	O
TCA	O
GTC	O
AG	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
GAT	O
ATG	O
ATG	O
GAT	O
GAT	O
ATC	O
TGT	O
CAG	O
-	O
3	O
'	O
.	O

The	O
sam68	O
-	O
targeted	O
allele	O
was	O
identified	O
by	O
genomic	O
PCR	O
using	O
the	O
following	O
oligonucleotides	O
5	O
'	O
-	O
CTT	O
GGG	O
TGG	O
AGA	O
GGC	O
TAT	O
TCG	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
GTC	O
GGG	O
CAT	O
GCG	O
CGC	O
CTT	O
GAG	O
C	O
-	O
3	O
'	O
.	O

Radiology	O
and	O
serum	O
biochemistry	O
on	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
mice	O
.	O

Radiography	O
,	O
BMD	O
,	O
and	O
micro	O
-	O
CT	O
were	O
performed	O
essentially	O
as	O
described	O
previously	O
[	O
63	O
]	O
.	O

Mice	O
were	O
administered	O
a	O
lethal	O
dose	O
of	O
anesthetic	B-CHEBI
at	O
the	O
indicated	O
times	O
,	O
exsanguinated	O
,	O
and	O
imaged	O
using	O
a	O
Faxitron	O
MX20	O
equipped	O
with	O
an	O
FPX	O
-	O
2	O
Imaging	O
system	O
(	O
Dalsa	O
Medoptics	O
,	O
Waterloo	O
,	O
Ontario	O
,	O
Canada	O
)	O
.	O

Body	O
fat	O
,	O
BMC	O
,	O
and	O
BMD	O
were	O
evaluated	O
using	O
a	O
Lunar	O
PixiMUS	O
1	O
.	O
46	O
(	O
GE	O
-	O
Lunar	O
,	O
Madison	O
,	O
Wisconsin	O
,	O
United	O
States	O
)	O
.	O

Morphometric	O
parameters	O
were	O
determined	O
on	O
anesthetized	O
mice	O
at	O
the	O
time	O
of	O
sacrifice	O
by	O
direct	O
measurement	O
or	O
from	O
the	O
Faxitron	O
radiograph	O
.	O

Micro	O
-	O
CT	O
was	O
performed	O
on	O
the	O
left	O
femur	O
and	O
fourth	O
lumbar	O
vertebra	O
after	O
removal	O
of	O
soft	O
tissues	O
and	O
overnight	O
fixation	O
in	O
4	O
%	O
paraformaldehyde	O
.	O

The	O
distal	O
metaphysis	O
was	O
scanned	O
with	O
a	O
Skyscan	O
1072	O
micro	O
-	O
CT	O
instrument	O
(	O
Skyscan	O
,	O
Antwerp	O
,	O
Belgium	O
)	O
.	O

Image	O
acquisition	O
was	O
performed	O
at	O
100	O
kV	O
and	O
98	O
mu	O
A	O
,	O
with	O
a	O
0	O
.	O
9	O
degrees	O
rotation	O
between	O
frames	O
.	O

The	O
two	O
-	O
dimensional	O
images	O
were	O
used	O
to	O
generate	O
three	O
-	O
dimensional	O
reconstructions	O
to	O
obtain	O
quantitative	O
data	O
with	O
the	O
3D	O
Creator	O
software	O
supplied	O
with	O
the	O
instrument	O
.	O

Serum	O
biochemistry	O
(	O
ALP	O
,	O
Ca	O
,	O
PO4	O
,	O
Mg	O
)	O
was	O
determined	O
at	O
the	O
Rodent	O
Diagnostics	O
Lab	O
(	O
McGill	O
University	O
,	O
Montr	O
e	O
al	O
,	O
Quebec	O
,	O
Canada	O
)	O
using	O
routine	O
automated	O
techniques	O
.	O

Commercial	O
assays	O
were	O
used	O
to	O
determine	O
serum	O
levels	O
of	O
CTX	O
(	O
RatLaps	O
ELISA	O
,	O
Nordic	O
Bioscience	O
)	O
,	O
17	B-CHEBI
beta	I-CHEBI
estradiol	I-CHEBI
(	O
IBL	O
Immuno	O
-	O
Biological	O
,	O
Hamburg	O
,	O
Germany	O
)	O
,	O
leptin	O
(	O
R	O
&	O
D	O
Systems	O
,	O
Minneapolis	O
,	O
Minnesota	O
,	O
United	O
States	O
)	O
,	O
and	O
interleukin	O
-	O
6	O
(	O
R	O
&	O
D	O
Systems	O
)	O
.	O

Ex	O
vivo	O
assessment	O
of	O
osteoblast	O
and	O
osteoclast	O
activity	O
.	O

Bone	O
marrow	O
was	O
flushed	O
from	O
the	O
tibia	O
and	O
femora	O
of	O
juvenile	O
4	O
-	O
week	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
mice	O
to	O
obtain	O
stromal	O
cells	O
that	O
were	O
maintained	O
in	O
differentiation	O
medium	O
for	O
6	O
or	O
18	O
days	O
as	O
described	O
[	O
63	O
]	O
.	O

Cultures	O
were	O
stained	O
in	O
situ	O
for	O
ALP	O
activity	O
and	O
with	O
von	O
Kossa	O
stain	O
to	O
detect	O
mineralized	O
nodules	O
.	O

Total	O
RNA	O
was	O
harvested	O
from	O
parallel	O
cultures	O
for	O
RT	O
-	O
PCR	O
analysis	O
of	O
osteoblast	O
-	O
related	O
gene	O
expression	O
over	O
time	O
as	O
described	O
previously	O
[	O
63	O
]	O
.	O

Osteoclasts	O
were	O
isolated	O
from	O
the	O
crushed	O
long	O
bones	O
of	O
juvenile	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
mice	O
and	O
used	O
for	O
quantitative	O
studies	O
as	O
described	O
[	O
64	O
]	O
.	O

Briefly	O
,	O
cells	O
were	O
plated	O
on	O
glass	O
coverslips	O
or	O
on	O
dentin	O
slices	O
in	O
24	O
-	O
well	O
cluster	O
plates	O
for	O
assessment	O
of	O
cell	O
number	O
and	O
pit	O
number	O
,	O
respectively	O
.	O

Cover	O
slips	O
were	O
immersed	O
in	O
4	O
%	O
paraformaldehyde	O
and	O
stained	O
for	O
TRAP	O
activity	O
after	O
2	O
h	O
.	O

Dentin	O
slices	O
were	O
left	O
for	O
28	O
h	O
before	O
removing	O
the	O
cells	O
with	O
1	O
M	O
ammonium	B-CHEBI
hydroxide	I-CHEBI
and	O
air	O
drying	O
before	O
coating	O
with	O
sputter	O
Au	B-CHEBI
-	O
Pd	B-CHEBI
and	O
examination	O
with	O
scanning	O
electron	B-CHEBI
microscopy	O
(	O
McGill	O
Electron	B-CHEBI
Microscopy	O
Centre	O
)	O
.	O

Light	O
microscope	O
images	O
were	O
captured	O
using	O
a	O
Leica	O
DMR	O
microscope	O
equipped	O
with	O
a	O
Retiga	O
1300	O
camera	O
.	O

Quantitative	O
analyses	O
were	O
performed	O
using	O
Adobe	O
Photoshop	O
and	O
the	O
data	O
presented	O
as	O
the	O
mean	O
+/-	O
SD	O
of	O
two	O
or	O
three	O
independent	O
experiments	O
.	O

Statistical	O
comparisons	O
were	O
made	O
using	O
the	O
Student	O
'	O
s	O
t	O
test	O
.	O

Preparation	O
of	O
mouse	O
embryonic	O
fibroblast	O
and	O
induction	O
of	O
adipocyte	O
differentiation	O
.	O

MEFs	O
were	O
prepared	O
from	O
14	O
.	O
5	O
-	O
day	O
-	O
old	O
embryos	O
.	O

Only	O
early	O
-	O
passage	O
MEFs	O
were	O
used	O
for	O
the	O
experimental	O
studies	O
,	O
and	O
induction	O
of	O
adipocyte	O
differentiation	O
was	O
carried	O
out	O
according	O
to	O
the	O
methods	O
previously	O
described	O
[	O
30	O
]	O
.	O

Cultured	O
cells	O
were	O
stained	O
with	O
Oil	O
Red	O
O	O
as	O
described	O
[	O
29	O
]	O
.	O

RNA	O
preparation	O
and	O
RT	O
-	O
PCR	O
to	O
assess	O
adipogenesis	O
in	O
Sam68	O
-	O
/	O
-	O
MEFs	O
.	O

Total	O
cellular	O
RNA	O
was	O
prepared	O
by	O
TRIzol	O
reagent	B-CHEBI
according	O
to	O
the	O
manufacturer	O
'	O
s	O
protocol	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Total	O
RNA	O
(	O
1	O
mu	O
g	O
)	O
was	O
reverse	O
-	O
transcribed	O
,	O
and	O
cDNA	O
samples	O
were	O
subjected	O
to	O
PCR	O
.	O

RT	O
-	O
PCR	O
was	O
normalized	O
by	O
the	O
transcriptional	O
level	O
of	O
GAPDH	O
.	O

The	O
following	O
5	O
'	O
and	O
3	O
'	O
primers	O
were	O
used	O
to	O
evaluate	O
adipogenic	O
differentiation	O
:	O
KLF5	O
:	O
5	O
'	O
-	O
AGA	O
CAA	O
GCT	O
GAG	O
ATG	O
CTG	O
C	B-CHEBI
-	O
3	O
'	O
,	O
5	O
'	O
-	O
GGC	O
AAA	O
CCT	O
CCA	O
GTC	O
GC	O
-	O
3	O
'	O
;	O
PPAR	O
gamma	O
:	O
5	O
'	O
-	O
GTG	O
CGA	O
TCA	O
AAG	O
TAG	O
AAC	O
CTG	O
C	B-CHEBI
-	O
3	O
'	O
,	O
5	O
'	O
-	O
CCT	O
ATC	O
ATA	O
AAT	O
AAG	O
CTT	O
CAA	O
TCG	O
-	O
3	O
'	O
;	O
beta	O
-	O
Actin	O
:	O
5	O
'	O
-	O
TAG	O
GCG	O
GAC	O
TGT	O
TAC	O
TGA	O
GC	O
-	O
3	O
'	O
,	O
5	O
'	O
-	O
AGC	O
CTT	O
CAT	O
ACA	O
TCA	O
AGT	O
TGG	O
-	O
3	O
'	O
;	O
and	O
Sam68	O
:	O
5	O
'	O
-	O
GTG	O
GAG	O
ACC	O
CCA	O
AAT	O
ATG	O
CCC	O
A	B-CHEBI
-	O
3	O
'	O
and	O
5	O
'	O
-	O
AAA	O
CTG	O
CTC	O
CTG	O
ACA	O
GAT	O
ATC	O
A	B-CHEBI
-	O
3	O
'	O
.	O

Sam68	O
down	O
-	O
regulation	O
using	O
Sam68sh	O
.	O

To	O
generate	O
an	O
shRNA	O
,	O
64	O
-	O
base	O
duplex	O
DNA	B-CHEBI
nucleotides	I-CHEBI
were	O
purchased	O
from	O
Invitrogen	O
.	O

This	O
fragment	O
comprised	O
19	O
base	B-CHEBI
residues	I-CHEBI
specific	O
to	O
mouse	O
Sam68	O
(	O
GATCCCC	O
AAGATGACGAGGAGAATTATTCAAGAGA	O
TAATTCTCCTCGTCATCTT	O
TTTTTGGAAA	O
)	O
.	O

This	O
fragment	O
was	O
cloned	O
into	O
pSUPER	O
retro	O
(	O
OligoEngine	O
,	O
Seattle	O
,	O
Washington	O
,	O
United	O
States	O
)	O
.	O

Transfections	O
were	O
performed	O
using	O
LipofectAMINE	O
Plus	O
(	O
Invitrogen	O
)	O
with	O
cloned	O
DNA	O
fragment	O
or	O
empty	O
vector	O
.	O

At	O
48	O
h	O
after	O
transfection	O
,	O
populations	O
were	O
selected	O
for	O
2	O
.	O
5	O
mu	O
g	O
/	O
ml	O
puromycin	B-CHEBI
and	O
the	O
knockdown	O
observed	O
by	O
immunoblotting	O
with	O
anti	O
-	O
Sam68	O
(	O
AD1	O
)	O
antibody	O
.	O

Osteogenic	O
differentiation	O
analysis	O
of	O
C3HT101	O
/	O
2	O
cells	O
.	O

For	O
osteogenic	O
differentiation	O
,	O
C3HT101	O
/	O
2	O
(	O
ATCC	O
)	O
cells	O
were	O
incubated	O
in	O
48	O
-	O
well	O
tissue	O
culture	O
plates	O
at	O
1	O
.	O
25	O
x	O
104	O
cells	O
/	O
cm2	O
.	O

After	O
24	O
-	O
h	O
incubation	O
,	O
the	O
culture	O
media	O
were	O
changed	O
to	O
fresh	O
media	O
containing	O
300	O
ng	O
/	O
ml	O
BMP	O
-	O
2	O
(	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
.	O

Total	O
cellular	O
RNA	O
was	O
prepared	O
as	O
described	O
above	O
,	O
and	O
osteocalcin	O
,	O
beta	O
-	O
actin	O
,	O
and	O
GAPDH	O
gene	O
expression	O
at	O
indicated	O
times	O
after	O
BMP	O
-	O
2	O
treatment	O
was	O
quantified	O
by	O
RT	O
-	O
PCR	O
.	O

Supporting	O
Information	O

Dataset	O
S1	O

Localization	O
of	O
Sam68	O
in	O
Primary	O
Mouse	O
Osteoblasts	O
and	O
Osteoclasts	O

(	O
124	O
KB	O
PPT	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Dataset	O
S2	O

Gene	O
Expression	O
Profile	O
of	O
Cultured	O
Stromal	O
Cells	O
at	O
Days	O
6	O
and	O
18	O
of	O
Culture	O
Isolated	O
from	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
Mice	O

(	O
204	O
KB	O
PPT	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Dataset	O
S3	O

Serum	O
Biochemistry	O
and	O
Bone	O
Biomarkers	O
in	O
4	O
-	O
and	O
12	O
-	O
Month	O
-	O
Old	O
Mice	O

(	O
46	O
KB	O
DOC	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Acknowledgements	O

We	O
acknowledge	O
Jean	O
-	O
Sebastien	O
Binette	O
(	O
Centre	O
for	O
Bone	O
and	O
Periodontal	O
Research	O
)	O
and	O
Jacinthe	O
Sirois	O
(	O
Qu	O
e	O
bec	O
Transgenic	O
Research	O
Network	O
)	O
for	O
excellent	O
technical	O
assistance	O
.	O

We	O
are	O
grateful	O
to	O
Erique	O
Lukong	O
,	O
Daniel	O
Larocque	O
,	O
and	O
Mark	O
Bedford	O
for	O
helpful	O
discussions	O
.	O

This	O
work	O
was	O
supported	O
by	O
grant	O
MT13377	O
to	O
SR	O
and	O
grant	O
MOP	O
-	O
13419	O
to	O
JEH	O
from	O
the	O
Canadian	O
Institutes	O
of	O
Health	O
Research	O
(	O
CIHR	O
)	O
.	O

SR	O
holds	O
an	O
Investigator	O
Award	O
from	O
the	O
CIHR	O
and	O
JEH	O
is	O
a	O
Chercheur	O
Boursier	O
,	O
Senior	O
of	O
the	O
FRSQ	O
.	O

Abbreviations	O

ALP	O
-	O
alkaline	B-CHEBI
phosphatase	O

BMC	O
-	O
bone	O
mineral	B-CHEBI
content	O

BMD	O
-	O
bone	O
mineral	B-CHEBI
density	O

BMP	O
-	O
2	O
-	O
bone	O
morphogenetic	O
protein	B-CHEBI
-	O
2	O

CT	O
-	O
computed	O
tomography	O

CTX	O
-	O
C	B-CHEBI
-	O
telopeptide	O

MEF	O
-	O
mouse	O
embryo	O
fibroblast	O

PPAR	O
gamma	O
-	O
peroxisome	O
proliferator	O
-	O
activated	O
receptor	O
gamma	O

shRNA	O
-	O
short	O
hairpin	O
RNA	O

TRAP	O
-	O
tartrate	B-CHEBI
-	O
resistant	O
acid	B-CHEBI
phosphatase	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Immunohistochemical	O
Localization	O
of	O
Sam68	O
in	O
Embryonic	O
Mice	O

(	O
A	O
)	O
Embryonic	O
mice	O
were	O
removed	O
from	O
pregnant	O
dams	O
at	O
E14	O
.	O
5	O
and	O
E16	O
.	O
5	O
,	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
,	O
and	O
embedded	O
in	O
paraffin	O
.	O

The	O
entire	O
embryo	O
was	O
immunostained	O
with	O
the	O
AD1	O
anti	O
-	O
Sam68	O
antibody	O
and	O
counterstained	O
with	O
methyl	B-CHEBI
green	O
,	O
and	O
the	O
image	O
was	O
captured	O
at	O
x	O
1	O
.	O
2	O
magnification	O
.	O

(	O
B	O
)	O
Embryonic	O
soft	O
tissues	O
from	O
the	O
brain	O
,	O
heart	O
and	O
gut	O
were	O
stained	O
with	O
hematoxylin	O
(	O
left	O
)	O
and	O
immunostained	O
with	O
anti	O
-	O
Sam68	O
antibody	O
(	O
right	O
)	O
,	O
and	O
images	O
were	O
captured	O
at	O
x	O
20	O
magnification	O
.	O

(	O
C	O
)	O
Intense	O
anti	O
-	O
Sam68	O
immunoreactivity	O
was	O
seen	O
in	O
chondrocytes	O
in	O
the	O
nasal	O
septum	O
(	O
panels	O
A	O
-	O
D	O
)	O
,	O
in	O
developing	O
vertebra	O
(	O
panels	O
E	O
-	O
H	O
)	O
,	O
and	O
in	O
the	O
femoral	O
epiphysis	O
(	O
panels	O
I	O
-	O
K	O
)	O
,	O
as	O
well	O
as	O
in	O
diaphyseal	O
osteoblasts	O
(	O
panel	O
L	O
)	O
.	O

Adjacent	O
sections	O
were	O
stained	O
with	O
hematoxylin	O
and	O
eosin	O
(	O
panels	O
A	O
,	O
E	O
,	O
and	O
I	O
)	O
or	O
with	O
antibody	O
preadsorbed	O
with	O
the	O
immunizing	O
peptide	O
(	O
panels	O
B	O
,	O
F	O
,	O
and	O
J	O
)	O
.	O

Sam68	O
was	O
localized	O
primarily	O
in	O
the	O
nucleus	O
of	O
cells	O
in	O
a	O
variety	O
of	O
tissues	O
but	O
was	O
also	O
found	O
occasionally	O
in	O
the	O
cytoplasm	O
.	O

Magnification	O
at	O
source	O
x	O
20	O
,	O
except	O
for	O
panels	O
D	O
,	O
H	O
,	O
and	O
L	O
,	O
which	O
were	O
x	O
40	O
.	O

Staining	O
patterns	O
are	O
representative	O
of	O
three	O
to	O
five	O
embryos	O
.	O

Figure	O
2	O

Generation	O
of	O
Sam68	O
-	O
Deficient	O
Mice	O

(	O
A	O
)	O
The	O
genomic	O
organizations	O
of	O
the	O
wild	O
-	O
type	O
and	O
targeted	O
sam68	O
alleles	O
after	O
homologous	O
recombination	O
are	O
depicted	O
.	O

The	O
location	O
of	O
the	O
DNA	O
fragment	O
used	O
as	O
a	O
probe	O
for	O
the	O
Southern	O
blot	O
analysis	O
is	O
shown	O
,	O
as	O
well	O
as	O
the	O
sizes	O
of	O
the	O
two	O
BglII	O
fragments	O
detected	O
for	O
wild	O
-	O
type	O
and	O
targeted	O
sam68	O
alleles	O
.	O

The	O
targeted	O
allele	O
replaces	O
exon	O
4	O
and	O
part	O
of	O
exon	O
5	O
of	O
sam68	O
with	O
a	O
PGK	O
-	O
neomycin	O
cassette	O
.	O

(	O
B	O
)	O
Southern	O
-	O
blot	O
analysis	O
of	O
genomic	O
DNA	O
from	O
wild	O
-	O
type	O
(	O
+	O
/	O
+	O
)	O
,	O
heterozygous	O
(	O
+	O
/	O
-	O
)	O
,	O
and	O
homozygous	O
(	O
-	O
/	O
-	O
)	O
mice	O
.	O

DNA	O
fragments	O
corresponding	O
to	O
wild	O
-	O
type	O
(	O
4	O
.	O
5	O
kb	O
)	O
and	O
the	O
targeted	O
(	O
5	O
.	O
5	O
kb	O
)	O
alleles	O
are	O
illustrated	O
.	O

(	O
C	O
)	O
Western	O
blot	O
analysis	O
of	O
Sam68	O
expression	O
.	O

Protein	B-CHEBI
extracts	O
from	O
wild	O
-	O
type	O
,	O
heterozygous	O
,	O
and	O
homozygous	O
cells	O
subjected	O
to	O
immunoblot	O
analyses	O
using	O
normal	O
rabbit	O
serum	O
,	O
anti	O
-	O
Sam68	O
AD1	O
antibody	O
,	O
the	O
peptide	O
antibody	O
AD1	O
preabsorbed	O
with	O
the	O
immunogenic	O
peptide	O
corresponding	O
to	O
amino	B-CHEBI
acids	I-CHEBI
330	O
-	O
348	O
of	O
mouse	O
Sam68	O
,	O
anti	O
-	O
Sam68	O
Sc333	O
antibody	O
that	O
recognizes	O
the	O
C	B-CHEBI
-	O
terminal	O
20	O
amino	B-CHEBI
acids	I-CHEBI
of	O
Sam68	O
,	O
and	O
anti	O
-	O
actin	O
antibodies	O
as	O
loading	O
control	O
.	O

The	O
migration	O
of	O
the	O
molecular	B-CHEBI
mass	O
markers	O
is	O
known	O
on	O
the	O
left	O
in	O
kDa	O
.	O

Figure	O
3	O

Radiologic	O
Assessment	O
of	O
the	O
Femur	O
of	O
Young	O
and	O
Old	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
Mice	O

(	O
A	O
)	O
Mice	O
were	O
given	O
a	O
lethal	O
dose	O
of	O
anesthetic	B-CHEBI
at	O
the	O
indicated	O
times	O
,	O
and	O
contact	O
radiographs	O
of	O
the	O
distal	O
femora	O
were	O
obtained	O
on	O
a	O
Faxitron	O
MX20	O
equipped	O
with	O
an	O
FPX	O
-	O
2	O
Imaging	O
system	O
.	O

Representative	O
radiographs	O
of	O
the	O
distal	O
femur	O
of	O
Sam68	O
+	O
/	O
+	O
(	O
+	O
/	O
+	O
)	O
and	O
Sam68	O
-	O
/	O
-	O
(	O
-	O
/	O
-	O
)	O
mice	O
revealed	O
comparable	O
radiopacity	O
at	O
4	O
months	O
(	O
left	O
)	O
.	O

At	O
12	O
months	O
(	O
right	O
)	O
,	O
cortical	O
thinning	O
(	O
arrow	O
)	O
and	O
radiolucency	O
(	O
asterisk	O
)	O
were	O
apparent	O
in	O
the	O
distal	O
femur	O
of	O
+	O
/	O
+	O
mice	O
but	O
not	O
-	O
/	O
-	O
mice	O
.	O

(	O
B	O
)	O
Bones	O
were	O
dissected	O
free	O
of	O
soft	O
tissue	O
and	O
fixed	O
overnight	O
in	O
4	O
%	O
paraformaldehyde	O
before	O
scanning	O
on	O
a	O
Skyscan	O
1072	O
static	O
instrument	O
equipped	O
with	O
3D	O
Creator	O
analytical	O
software	O
.	O

Representative	O
three	O
-	O
dimensional	O
re	O
-	O
constructions	O
and	O
two	O
-	O
dimensional	O
cross	O
-	O
sectional	O
scans	O
demonstrated	O
similar	O
architecture	O
in	O
the	O
distal	O
femur	O
of	O
Sam68	O
+	O
/	O
+	O
(	O
+	O
/	O
+	O
)	O
and	O
Sam68	O
-	O
/	O
-	O
(	O
-	O
/	O
-	O
)	O
mice	O
.	O

In	O
keeping	O
with	O
the	O
results	O
from	O
Faxitron	O
x	O
-	O
ray	O
,	O
trabecular	O
bone	O
(	O
asterisk	O
)	O
and	O
cortical	O
thickness	O
(	O
arrow	O
)	O
were	O
reduced	O
in	O
the	O
femur	O
of	O
12	O
-	O
month	O
-	O
old	O
+	O
/	O
+	O
mice	O
compared	O
with	O
all	O
other	O
groups	O
.	O

The	O
images	O
are	O
representative	O
of	O
those	O
from	O
five	O
to	O
seven	O
animals	O
in	O
each	O
group	O
.	O

Figure	O
4	O

Quantitative	O
Micro	O
-	O
CT	O
of	O
Trabecular	O
Bone	O
Composition	O
and	O
Architecture	O

(	O
A	O
)	O
Bone	O
volume	O
/	O
tissue	O
volume	O
(	O
BV	O
/	O
TV	O
)	O
and	O
structure	O
model	O
index	O
(	O
SMI	O
)	O
were	O
calculated	O
on	O
the	O
femur	O
and	O
fourth	O
lumbar	O
vertebra	O
of	O
six	O
or	O
seven	O
mice	O
in	O
each	O
group	O
using	O
3D	O
Creator	O
software	O
supplied	O
with	O
the	O
Skyscan	O
instrument	O
.	O

Results	O
expressed	O
as	O
the	O
mean	O
+/-	O
SD	O
showed	O
significant	O
differences	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
between	O
4	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
mice	O
(	O
solid	O
black	O
)	O
and	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
mice	O
(	O
hatched	O
black	O
)	O
but	O
not	O
between	O
4	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
mice	O
(	O
solid	O
white	O
)	O
and	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
mice	O
(	O
stippled	O
white	O
)	O
.	O

(	O
B	O
)	O
The	O
distance	O
between	O
trabeculae	O
was	O
reflected	O
in	O
a	O
shift	O
to	O
the	O
right	O
of	O
the	O
distribution	O
curves	O
for	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
.	O

Solid	O
black	O
=	O
4	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
;	O
hatched	O
black	O
=	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
;	O
solid	O
red	O
=	O
4	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
;	O
stippled	O
red	O
=	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
.	O

The	O
asterisks	O
denote	O
p	O
<	O
0	O
.	O
01	O
.	O

Figure	O
5	O

Histologic	O
Analysis	O
of	O
Undecalcified	O
Bone	O
from	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
Mice	O

Sections	O
of	O
tibia	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
and	O
embedded	O
in	O
plastic	O
were	O
stained	O
for	O
ALP	O
(	O
A	O
-	O
C	O
,	O
E	O
-	O
G	O
)	O
activity	O
to	O
identify	O
osteoblasts	O
or	O
for	O
TRAP	O
(	O
B	O
-	O
D	O
,	O
F	O
-	O
H	O
)	O
activity	O
to	O
identify	O
osteoclasts	O
.	O

Staining	O
patterns	O
were	O
similar	O
in	O
4	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
(	O
A	O
and	O
B	O
)	O
,	O
4	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
(	O
C	O
and	O
D	O
)	O
,	O
and	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
-	O
/	O
-	O
(	O
G	O
and	O
H	O
)	O
mice	O
compared	O
with	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
mice	O
(	O
E	O
and	O
F	O
)	O
.	O

Magnification	O
at	O
source	O
,	O
left	O
panels	O
x	O
10	O
and	O
right	O
panels	O
x	O
40	O
.	O

Micrographs	O
are	O
representative	O
of	O
those	O
taken	O
from	O
five	O
to	O
seven	O
sections	O
in	O
each	O
group	O
of	O
animals	O
.	O

Figure	O
6	O

Ex	O
Vivo	O
Activity	O
of	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
Osteoblasts	O
and	O
Osteoclasts	O

Marrow	O
stromal	O
cells	O
were	O
isolated	O
from	O
the	O
long	O
bones	O
of	O
juvenile	O
mice	O
and	O
maintained	O
under	O
conditions	O
that	O
promote	O
osteoblast	O
differentiation	O
.	O

(	O
A	O
)	O
Cultures	O
were	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
after	O
6	O
or	O
18	O
days	O
and	O
stained	O
in	O
situ	O
for	O
ALP	O
activity	O
and	O
with	O
silver	B-CHEBI
nitrate	I-CHEBI
(	O
von	O
Kossa	O
)	O
to	O
detect	O
mineralized	O
nodules	O
.	O

Sam68	O
-	O
/	O
-	O
cultures	O
stained	O
more	O
intensely	O
for	O
ALP	O
at	O
early	O
and	O
late	O
time	O
points	O
and	O
produced	O
significantly	O
more	O
mineralized	O
nodules	O
after	O
18	O
days	O
.	O

Asterisks	O
represent	O
p	O
<	O
0	O
.	O
01	O
.	O

(	O
B	O
)	O
Primary	O
osteoclasts	O
were	O
isolated	O
from	O
the	O
crushed	O
long	O
bones	O
of	O
the	O
same	O
mice	O
and	O
plated	O
on	O
glass	O
coverslips	O
or	O
on	O
dentin	O
slices	O
to	O
quantify	O
numbers	O
and	O
activity	O
,	O
respectively	O
.	O

Osteoclasts	O
were	O
identified	O
as	O
cells	O
with	O
three	O
or	O
more	O
nuclei	O
that	O
stained	O
positive	O
for	O
TRAP	O
activity	O
(	O
upper	O
)	O
and	O
excavated	O
pits	O
in	O
dentin	O
slices	O
,	O
as	O
demonstrated	O
by	O
SEM	O
(	O
lower	O
,	O
bar	O
=	O
20	O
mu	O
m	O
)	O
.	O

No	O
statistical	O
differences	O
were	O
observed	O
either	O
in	O
the	O
number	O
of	O
TRAP	O
-	O
positive	O
cells	O
or	O
in	O
their	O
resorptive	O
activity	O
.	O

Figure	O
7	O

Ex	O
Vivo	O
Adipogenesis	O
Analysis	O
of	O
Sam68	O
-	O
/	O
-	O
Mouse	O
Embryonic	O
Fibroblasts	O

MEFs	O
were	O
isolated	O
from	O
mouse	O
embryos	O
at	O
embryonic	O
day	O
14	O
.	O
5	O
.	O

Equal	O
number	O
of	O
MEFs	O
from	O
Sam68	O
+	O
/	O
+	O
and	O
Sam68	O
-	O
/	O
-	O
was	O
plated	O
on	O
glass	O
cover	O
slips	O
in	O
24	O
well	O
-	O
plates	O
.	O

Adipocyte	O
differentiation	O
was	O
carried	O
out	O
at	O
indicated	O
times	O
by	O
the	O
addition	O
of	O
complete	O
media	O
containing	O
the	O
pioglitazone	O
.	O

(	O
A	O
)	O
Cultures	O
were	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
and	O
stained	O
with	O
Oil	O
Red	O
O	O
to	O
detect	O
the	O
fat	O
droplets	O
stored	O
in	O
adipocytes	O
and	O
photographed	O
(	O
top	O
)	O
.	O

The	O
cell	O
images	O
were	O
magnified	O
x	O
10	O
and	O
x	O
20	O
as	O
indicated	O
.	O

(	O
B	O
)	O
RT	O
-	O
PCR	O
was	O
carried	O
out	O
on	O
total	O
cellular	O
RNA	O
isolated	O
after	O
differentiation	O
of	O
the	O
MEFs	O
for	O
day	O
0	O
,	O
2	O
,	O
4	O
,	O
6	O
,	O
and	O
12	O
.	O

The	O
DNA	O
fragments	O
were	O
visualized	O
on	O
agarose	B-CHEBI
gels	O
stained	O
with	O
ethidium	B-CHEBI
bromide	I-CHEBI
.	O

The	O
expression	O
of	O
adipogenic	O
markers	O
C	O
/	O
EBP	O
beta	O
,	O
C	O
/	O
EBP	O
delta	O
,	O
PPAR	O
alpha	O
,	O
and	O
KLF5	O
was	O
examined	O
as	O
well	O
as	O
the	O
expression	O
of	O
controls	O
including	O
Sam68	O
,	O
beta	O
-	O
actin	O
,	O
and	O
GAPDH	O
.	O

Figure	O
8	O

Enhanced	O
Osteogenic	O
Differentiation	O
of	O
the	O
C3HT101	O
/	O
2	O
Embryonic	O
Cell	O
Line	O
Depleted	O
of	O
Endogenous	O
Sam68	O

(	O
A	O
)	O
C3HT101	O
/	O
2	O
cells	O
transfected	O
with	O
an	O
empty	O
vector	O
(	O
pSuper	O
-	O
retro	O
)	O
or	O
a	O
vector	O
containing	O
an	O
shRNA	O
(	O
Sam68	O
shRNA	O
)	O
were	O
selected	O
with	O
puromycin	B-CHEBI
,	O
and	O
knockdown	O
populations	O
depleted	O
of	O
Sam68	O
were	O
identified	O
.	O

The	O
reduction	O
in	O
Sam68	O
protein	B-CHEBI
was	O
analyzed	O
by	O
immunoblotting	O
with	O
anti	O
-	O
Sam68	O
(	O
AD1	O
)	O
antibody	O
and	O
anti	O
-	O
beta	O
-	O
actin	O
antibodies	O
as	O
loading	O
controls	O
.	O

(	O
B	O
)	O
Osteogenic	O
differentiation	O
was	O
carried	O
out	O
with	O
conditioned	O
medium	O
containing	O
BMP	O
-	O
2	O
for	O
the	O
indicated	O
times	O
.	O

To	O
assess	O
the	O
level	O
of	O
osteogenic	O
differentiation	O
in	O
these	O
cells	O
,	O
expression	O
of	O
late	O
osteoblast	O
marker	O
,	O
osteocalcin	O
(	O
OCN	O
)	O
,	O
was	O
analyzed	O
by	O
RT	O
-	O
PCR	O
and	O
compared	O
with	O
beta	O
-	O
actin	O
and	O
GAPDH	O
controls	O
.	O

The	O
DNA	O
fragments	O
were	O
visualized	O
by	O
agarose	B-CHEBI
gel	O
stained	O
with	O
ethidium	B-CHEBI
bromide	I-CHEBI
.	O

Figure	O
9	O

Old	O
Sam68	O
-	O
/	O
-	O
Mice	O
Are	O
Protected	O
from	O
the	O
Development	O
of	O
Fatty	O
Bone	O
Marrow	O

Sections	O
of	O
undecalcified	O
bone	O
were	O
stained	O
with	O
von	O
Kossa	O
and	O
toluidine	O
blue	O
and	O
images	O
captured	O
at	O
original	O
magnifications	O
of	O
x	O
2	O
(	O
A	O
)	O
,	O
x	O
40	O
(	O
B	O
and	O
C	O
)	O
to	O
evaluate	O
mineralized	O
tissue	O
(	O
A	O
,	O
black	O
)	O
,	O
marrow	O
adipocytes	O
(	O
B	O
,	O
white	O
)	O
,	O
and	O
the	O
mineralization	O
fronts	O
(	O
C	O
,	O
yellow	O
and	O
green	O
)	O
.	O

The	O
12	O
-	O
month	O
-	O
old	O
Sam68	O
+	O
/	O
+	O
bone	O
demonstrated	O
a	O
significant	O
reduction	O
in	O
bone	O
(	O
A	O
)	O
and	O
increase	O
in	O
marrow	O
adipocytes	O
(	O
B	O
)	O
and	O
a	O
decrease	O
in	O
the	O
distance	O
between	O
two	O
consecutive	O
fluorochrome	B-CHEBI
labels	I-CHEBI
(	O
C	O
)	O
.	O

Magnification	O
at	O
source	O
was	O
x	O
40	O
.	O

Micrographs	O
are	O
representative	O
of	O
four	O
to	O
six	O
screened	O
in	O
each	O
group	O
of	O
animals	O
.	O

Table	O
1	O

Progeny	O
of	O
Sam68	O
Heterozygote	O
Breeding	O

Table	O
2	O

Morphology	O
and	O
Bone	O
Mineral	B-CHEBI
Density	O
in	O
4	O
-	O
and	O
12	O
-	O
Month	O
-	O
Old	O
Female	O
Mice	O

Table	O
3	O

Histomorphometric	O
Analysis	O
of	O
Long	O
Bones	O
from	O
4	O
-	O
and	O
12	O
-	O
Month	O
-	O
Old	O
Mice	O

Footnotes	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Author	O
contributions	O
.	O

SR	O
and	O
JEH	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

SR	O
,	O
NT	O
,	O
GVF	O
,	O
GAT	O
,	O
TC	O
,	O
GV	O
,	O
MM	O
,	O
PC	O
,	O
AFR	O
,	O
SK	O
,	O
WL	O
,	O
AL	O
,	O
and	O
YJG	O
performed	O
the	O
experiments	O
.	O

SR	O
and	O
JEH	O
analyzed	O
the	O
data	O
.	O

MLT	O
generated	O
the	O
mice	O
.	O

SR	O
and	O
JEH	O
wrote	O
the	O
paper	O
.	O

A	O
previous	O
version	O
of	O
this	O
article	O
appeared	O
as	O
an	O
Early	O
Online	O
Release	O
on	O
November	O
11	O
,	O
2005	O
(	O
DOI	O
:	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pgen	O
.	O
0010074	O
.	O
eor	O
)	O
.	O

Citation	O
:	O
Richard	O
S	O
,	O
Torabi	O
N	O
,	O
Franco	O
GV	O
,	O
Tremblay	O
GA	O
,	O
Chen	O
T	O
,	O
et	O
al	O
.	O

(	O
2005	O
)	O
Ablation	O
of	O
the	O
Sam68	O
RNA	O
binding	O
protein	B-CHEBI
protects	O
mice	O
from	O
age	O
-	O
related	O
bone	O
loss	O
.	O

PLoS	O
Genet	O
1	O
(	O
6	O
)	O
:	O
e74	O
.	O

m	O
-	O
Calpain	O
is	O
required	O
for	O
preimplantation	O
embryonic	O
development	O
in	O
mice	O

Abstract	O

Background	O

mu	O
-	O
calpain	O
and	O
m	O
-	O
calpain	O
are	O
ubiquitously	O
expressed	O
proteases	O
implicated	O
in	O
cellular	O
migration	O
,	O
cell	O
cycle	O
progression	O
,	O
degenerative	O
processes	O
and	O
cell	O
death	O
.	O

These	O
heterodimeric	O
enzymes	O
are	O
composed	O
of	O
distinct	O
catalytic	O
subunits	O
,	O
encoded	O
by	O
Capn1	O
(	O
mu	O
-	O
calpain	O
)	O
or	O
Capn2	O
(	O
m	O
-	O
calpain	O
)	O
,	O
and	O
a	O
common	O
regulatory	O
subunit	O
encoded	O
by	O
Capn4	O
.	O

Disruption	O
of	O
the	O
mouse	O
Capn4	O
gene	O
abolished	O
both	O
mu	O
-	O
calpain	O
and	O
m	O
-	O
calpain	O
activity	O
,	O
and	O
resulted	O
in	O
embryonic	O
lethality	O
,	O
thereby	O
suggesting	O
essential	O
roles	O
for	O
one	O
or	O
both	O
of	O
these	O
enzymes	O
during	O
mammalian	O
embryogenesis	O
.	O

Disruption	O
of	O
the	O
Capn1	O
gene	O
produced	O
viable	O
,	O
fertile	O
mice	O
implying	O
that	O
either	O
m	O
-	O
calpain	O
could	O
compensate	O
for	O
the	O
loss	O
of	O
mu	O
-	O
calpain	O
,	O
or	O
that	O
the	O
loss	O
of	O
m	O
-	O
calpain	O
was	O
responsible	O
for	O
death	O
of	O
Capn4	O
-	O
/	O
-	O
mice	O
.	O

Results	O

To	O
distinguish	O
between	O
the	O
alternatives	O
described	O
above	O
,	O
we	O
deleted	O
an	O
essential	O
coding	O
region	O
in	O
the	O
mouse	O
Capn2	O
gene	O
in	O
embryonic	O
stems	O
cells	O
and	O
transmitted	O
this	O
mutant	O
allele	O
through	O
the	O
mouse	O
germline	O
.	O

Breeding	O
of	O
heterozygous	O
animals	O
failed	O
to	O
produce	O
homozygous	O
mutant	O
live	O
offspring	O
or	O
implanted	O
embryos	O
.	O

A	O
nested	O
PCR	O
genotyping	O
protocol	O
was	O
established	O
,	O
and	O
homozygous	O
preimplantation	O
mutant	O
embryos	O
were	O
detected	O
at	O
the	O
morula	O
but	O
not	O
at	O
the	O
blastocyts	O
stage	O
.	O

Conclusion	O

We	O
conclude	O
that	O
homozygous	O
disruption	O
of	O
the	O
Capn2	O
gene	O
results	O
in	O
pre	O
-	O
implantation	O
embryonic	O
lethality	O
between	O
the	O
morula	O
and	O
blastocyst	O
stage	O
.	O

This	O
establishes	O
that	O
mu	O
-	O
calpain	O
and	O
m	O
-	O
calpain	O
have	O
distinct	O
functions	O
,	O
and	O
that	O
m	O
-	O
calpain	O
is	O
vital	O
for	O
development	O
of	O
the	O
preimplantation	O
murine	O
embryo	O
.	O

Background	O

The	O
two	O
ubiquitous	O
Ca2	B-CHEBI
+	I-CHEBI
-	O
dependent	O
,	O
cysteine	B-CHEBI
proteases	O
known	O
as	O
mu	O
-	O
calpain	O
(	O
calpain	O
-	O
1	O
)	O
and	O
m	O
-	O
calpain	O
(	O
capain	O
-	O
2	O
)	O
,	O
are	O
the	O
founding	O
members	O
of	O
a	O
gene	O
family	O
comprising	O
13	O
genes	O
in	O
mammals	O
[	O
1	O
-	O
3	O
]	O
.	O

Both	O
are	O
heterodimeric	O
enzymes	O
consisting	O
of	O
distinct	O
80	O
kDa	O
catalytic	O
subunits	O
,	O
encoded	O
by	O
the	O
Capn1	O
(	O
mu	O
-	O
80	O
k	O
)	O
and	O
Capn2	O
(	O
m	O
-	O
80	O
k	O
)	O
genes	O
,	O
respectively	O
,	O
that	O
associate	O
with	O
a	O
common	O
28	O
kDa	O
regulatory	O
subunit	O
encoded	O
by	O
the	O
Capn4	O
gene	O
.	O

The	O
mu	O
-	O
80	O
k	O
and	O
m	O
-	O
80	O
k	O
subunits	O
share	O
62	O
%	O
amino	B-CHEBI
acid	I-CHEBI
sequence	O
identity	O
,	O
and	O
are	O
very	O
similar	O
in	O
terms	O
of	O
structure	O
,	O
protein	B-CHEBI
chemistry	O
,	O
and	O
in	O
vitro	O
substrate	O
specificity	O
.	O

Despite	O
these	O
similarities	O
,	O
the	O
differential	O
expression	O
patterns	O
of	O
mu	O
-	O
and	O
m	O
-	O
calpain	O
in	O
mammalian	O
tissues	O
suggest	O
they	O
have	O
some	O
isoform	O
specific	O
and	O
distinct	O
functions	O
.	O

The	O
mu	O
and	O
m	O
designations	O
derive	O
from	O
the	O
levels	O
of	O
Ca2	B-CHEBI
+	I-CHEBI
required	O
in	O
vitro	O
for	O
optimal	O
activation	O
;	O
10	O
-	O
50	O
mu	O
M	O
Ca2	B-CHEBI
+	I-CHEBI
for	O
mu	O
-	O
calpain	O
and	O
0	O
.	O
3	O
-	O
0	O
.	O
35	O
mM	O
Ca2	B-CHEBI
+	I-CHEBI
for	O
m	O
-	O
calpain	O
.	O

It	O
is	O
generally	O
assumed	O
that	O
mu	O
-	O
and	O
m	O
-	O
calpain	O
maintain	O
their	O
differential	O
sensitivities	O
to	O
calcium	B-CHEBI
in	O
vivo	O
,	O
although	O
this	O
has	O
not	O
yet	O
been	O
strictly	O
demonstrated	O
.	O

Furthermore	O
,	O
since	O
the	O
cytoplasmic	O
free	O
Ca2	B-CHEBI
+	I-CHEBI
concentration	O
is	O
typically	O
less	O
than	O
1	O
mu	O
M	O
,	O
it	O
is	O
also	O
assumed	O
that	O
other	O
in	O
vivo	O
factors	O
must	O
contribute	O
to	O
regulation	O
of	O
these	O
enzymes	O
[	O
3	O
]	O
.	O

Without	O
apriori	O
knowledge	O
of	O
the	O
factors	O
regulating	O
calpain	O
activity	O
or	O
their	O
relevant	O
substrates	O
,	O
elucidation	O
of	O
biological	O
functions	O
for	O
calpains	O
presents	O
a	O
challenge	O
.	O

Research	O
on	O
calpains	O
has	O
linked	O
them	O
with	O
a	O
wide	O
variety	O
of	O
functions	O
including	O
muscle	O
growth	O
,	O
development	O
,	O
degeneration	O
(	O
3	O
)	O
,	O
neuronal	O
growth	O
and	O
neurodegeneration	O
[	O
4	O
]	O
,	O
cell	O
cycle	O
progression	O
[	O
5	O
,	O
6	O
]	O
,	O
signal	O
cascades	O
triggered	O
by	O
integrins	O
and	O
growth	O
factors	O
[	O
7	O
]	O
,	O
membrane	O
protrusion	O
[	O
8	O
]	O
,	O
remodeling	O
of	O
the	O
cytoskeleton	O
and	O
cell	O
migration	O
[	O
9	O
-	O
15	O
]	O
,	O
and	O
regulation	O
of	O
cell	O
death	O
via	O
both	O
necrosis	O
and	O
apoptosis	O
[	O
16	O
-	O
22	O
]	O
.	O

To	O
date	O
,	O
the	O
literature	O
suggests	O
a	O
complex	O
interplay	O
between	O
caspases	O
and	O
calpains	O
[	O
23	O
,	O
24	O
]	O
and	O
impact	O
of	O
calpain	O
on	O
cell	O
death	O
pathway	O
components	O
[	O
25	O
]	O
.	O

The	O
lack	O
of	O
highly	O
specific	O
cell	O
-	O
permeable	O
inhibitors	B-CHEBI
of	O
calpains	O
contributes	O
to	O
the	O
challenge	O
of	O
investigating	O
and	O
defining	O
calpain	O
functions	O
in	O
these	O
processes	O
.	O

Although	O
over	O
-	O
expression	O
of	O
calpastatin	O
,	O
the	O
endogenous	O
protein	B-CHEBI
inhibitor	B-CHEBI
of	O
mu	O
-	O
and	O
m	O
-	O
calpain	O
provides	O
an	O
important	O
approach	O
for	O
these	O
efforts	O
,	O
it	O
will	O
not	O
distinguish	O
isoform	O
specific	O
functions	O
[	O
24	O
,	O
26	O
,	O
27	O
]	O
.	O

Some	O
work	O
has	O
suggested	O
isoform	O
specific	O
roles	O
,	O
such	O
as	O
a	O
role	O
for	O
m	O
-	O
calpain	O
in	O
epidermal	O
growth	O
factor	O
(	O
EGF	O
)	O
-	O
induced	O
cell	O
motility	O
[	O
28	O
,	O
29	O
]	O
and	O
a	O
role	O
for	O
mu	O
-	O
calpain	O
in	O
interferon	O
-	O
inducible	O
protein	B-CHEBI
9	O
-	O
induced	O
migration	O
of	O
keratinocytes	O
[	O
28	O
]	O
.	O

A	O
cell	O
permeable	O
calpain	O
inhibitor	B-CHEBI
(	O
which	O
likely	O
inhibits	O
other	O
thiol	B-CHEBI
-	O
proteases	O
as	O
well	O
)	O
has	O
been	O
used	O
to	O
select	O
cells	O
lacking	O
mu	O
-	O
calpain	O
which	O
display	O
reduced	O
proliferation	O
rates	O
[	O
30	O
]	O
.	O

Interestingly	O
,	O
m	O
-	O
calpain	O
expression	O
persisted	O
in	O
these	O
cells	O
,	O
suggesting	O
a	O
possible	O
requirement	O
of	O
m	O
-	O
calpain	O
for	O
cell	O
survival	O
[	O
30	O
]	O
.	O

Targeted	O
gene	O
deletion	O
in	O
mice	O
provides	O
a	O
powerful	O
approach	O
to	O
determining	O
the	O
physiological	O
roles	O
of	O
mu	O
-	O
and	O
m	O
-	O
calpain	O
and	O
the	O
opportunity	O
to	O
approach	O
their	O
isoform	O
specific	O
functions	O
.	O

Initial	O
studies	O
targeted	O
Capn4	O
based	O
on	O
the	O
prediction	O
that	O
loss	O
of	O
this	O
calpain	O
subunit	O
would	O
abolish	O
activity	O
of	O
both	O
mu	O
-	O
and	O
m	O
-	O
calpain	O
.	O

Capn4	O
-	O
/	O
-	O
murine	O
embryos	O
died	O
between	O
days	O
10	O
and	O
11	O
of	O
gestation	O
,	O
and	O
there	O
was	O
no	O
detectable	O
mu	O
-	O
or	O
m	O
-	O
calpain	O
activity	O
in	O
these	O
or	O
younger	O
embryos	O
[	O
31	O
]	O
.	O

Capn4	O
-	O
/	O
-	O
murine	O
embryonic	O
fibroblasts	O
(	O
MEFs	O
)	O
could	O
be	O
cultured	O
from	O
these	O
embryos	O
,	O
although	O
they	O
also	O
lacked	O
calpain	O
activity	O
as	O
assessed	O
by	O
casein	O
zymography	O
or	O
by	O
the	O
formation	O
of	O
characteristic	O
spectrin	O
breakdown	O
products	O
,	O
and	O
they	O
displayed	O
migration	O
defects	O
consistent	O
with	O
a	O
role	O
for	O
calpain	O
in	O
release	O
of	O
focal	O
adhesions	O
[	O
9	O
]	O
.	O

An	O
independently	O
derived	O
Capn4	O
knockout	O
,	O
involving	O
a	O
more	O
extensive	O
deletion	O
of	O
the	O
gene	O
,	O
resulted	O
in	O
an	O
earlier	O
embryonic	O
lethality	O
,	O
apparently	O
at	O
a	O
pre	O
-	O
implantation	O
stage	O
[	O
32	O
]	O
.	O

The	O
different	O
times	O
of	O
embryonic	O
lethality	O
suggested	O
that	O
the	O
first	O
reported	O
Capn4	O
-	O
/	O
-	O
mice	O
[	O
31	O
]	O
were	O
targeted	O
with	O
a	O
hypomorphic	O
mutation	O
,	O
which	O
retained	O
some	O
small	O
level	O
of	O
calpain	O
activity	O
,	O
allowing	O
for	O
their	O
survival	O
to	O
mid	O
-	O
gestation	O
,	O
while	O
the	O
second	O
reported	O
Capn4	O
-	O
/	O
-	O
mice	O
[	O
32	O
]	O
represented	O
a	O
true	O
null	O
mutation	O
.	O

Disruption	O
of	O
Capn1	O
,	O
encoding	O
the	O
mu	O
-	O
calpain	O
catalytic	O
subunit	O
,	O
was	O
subsequently	O
reported	O
to	O
result	O
in	O
fertile	O
,	O
viable	O
mice	O
with	O
some	O
mild	O
defects	O
in	O
the	O
mu	O
-	O
calpain	O
rich	O
platelets	O
relating	O
to	O
their	O
aggregation	O
and	O
clot	O
retraction	O
[	O
33	O
]	O
.	O

The	O
fact	O
that	O
Capn4	O
null	O
mice	O
die	O
during	O
embryogenesis	O
indicates	O
that	O
at	O
least	O
one	O
of	O
the	O
ubiquitous	O
calpains	O
is	O
essential	O
for	O
development	O
to	O
term	O
.	O

The	O
viability	O
of	O
Capn1	O
-	O
deficient	O
mice	O
does	O
not	O
however	O
distinguish	O
between	O
two	O
possibilities	O
:	O
either	O
that	O
m	O
-	O
calpain	O
is	O
specifically	O
required	O
during	O
embryogenesis	O
,	O
or	O
that	O
either	O
form	O
of	O
calpain	O
alone	O
is	O
sufficient	O
and	O
can	O
compensate	O
for	O
the	O
absence	O
of	O
the	O
other	O
.	O

To	O
resolve	O
this	O
question	O
,	O
we	O
have	O
now	O
knocked	O
out	O
the	O
Capn2	O
gene	O
encoding	O
the	O
m	O
-	O
80	O
k	O
subunit	O
in	O
mice	O
.	O

We	O
report	O
here	O
that	O
Capn2	O
null	O
embryos	O
died	O
prior	O
to	O
the	O
implantation	O
stage	O
,	O
indicating	O
that	O
m	O
-	O
calpain	O
is	O
indispensable	O
for	O
early	O
embryogenesis	O
.	O

This	O
role	O
cannot	O
be	O
fulfilled	O
by	O
mu	O
-	O
calpain	O
,	O
which	O
is	O
expressed	O
in	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
[	O
31	O
]	O
and	O
is	O
assumed	O
to	O
be	O
present	O
at	O
this	O
stage	O
of	O
gestation	O
.	O

This	O
demonstrates	O
unequivocally	O
that	O
m	O
-	O
calpain	O
and	O
mu	O
-	O
calpain	O
have	O
distinct	O
physiological	O
roles	O
during	O
early	O
embryogenesis	O
.	O

Results	O

Isolation	O
and	O
characterization	O
of	O
Capn2	O
targeted	O
ES	O
cell	O
clones	O

Two	O
independent	O
Capn2	O
+	O
/	O
-	O
ES	O
cell	O
lines	O
,	O
designated	O
ES27	O
and	O
ES36	O
,	O
were	O
isolated	O
from	O
a	O
screen	O
of	O
305	O
drug	B-CHEBI
-	O
resistant	O
clones	O
.	O

Correct	O
targeting	O
of	O
the	O
Capn2	O
locus	O
was	O
established	O
both	O
by	O
Southern	O
blot	O
hybridization	O
and	O
PCR	O
analysis	O
.	O

A	O
probe	O
located	O
outside	O
the	O
short	O
(	O
upstream	O
)	O
arm	O
of	O
homology	O
hybridized	O
to	O
a	O
3	O
.	O
5	O
-	O
kb	O
BamHI	O
fragment	O
of	O
the	O
wild	O
-	O
type	O
allele	O
and	O
5	O
.	O
3	O
-	O
kb	O
BamHI	O
fragment	O
of	O
the	O
mutant	O
allele	O
as	O
predicted	O
from	O
genomic	O
maps	O
(	O
Figure	O
2A	O
)	O
.	O

The	O
same	O
probe	O
also	O
detected	O
the	O
expected	O
7	O
.	O
2	O
-	O
kb	O
wild	O
-	O
type	O
and	O
6	O
.	O
4	O
-	O
kb	O
mutant	O
BglII	O
fragments	O
,	O
4	O
.	O
9	O
-	O
kb	O
wild	O
-	O
type	O
and	O
5	O
.	O
7	O
-	O
kb	O
mutant	O
NcoI	O
fragments	O
,	O
as	O
well	O
as	O
7	O
.	O
2	O
-	O
kb	O
wild	O
-	O
type	O
and	O
4	O
.	O
9	O
-	O
kb	O
mutant	O
BglII	O
/	O
AgeI	O
fragments	O
(	O
not	O
shown	O
)	O
.	O

A	O
probe	O
derived	O
from	O
the	O
PGK	O
-	O
Neo	O
cassette	O
recognized	O
only	O
the	O
5	O
.	O
3	O
-	O
kb	O
BamHI	O
fragment	O
in	O
Capn2	O
+	O
/	O
-	O
ES	O
cells	O
,	O
suggesting	O
that	O
the	O
targeting	O
vector	O
had	O
integrated	O
solely	O
at	O
the	O
Capn2	O
locus	O
(	O
not	O
shown	O
)	O
.	O

A	O
PCR	O
screening	O
method	O
was	O
also	O
established	O
that	O
generated	O
a	O
wild	O
-	O
type	O
product	O
of	O
2	O
,	O
749	O
bp	O
and	O
a	O
2	O
,	O
711	O
bp	O
product	O
from	O
the	O
mutant	O
allele	O
.	O

The	O
2	O
,	O
711	O
bp	O
product	O
was	O
only	O
evident	O
in	O
the	O
two	O
targeted	O
cell	O
lines	O
(	O
Figure	O
2B	O
)	O
.	O

Figure	O
2	O

Characterization	O
of	O
targeted	O
ES	O
cell	O
lines	O
.	O

(	O
A	O
)	O
Targeted	O
disruption	O
of	O
the	O
Capn2	O
locus	O
was	O
detected	O
initially	O
by	O
Southern	O
blotting	O
.	O

Membranes	O
were	O
blotted	O
with	O
BamHI	O
-	O
digested	O
genomic	O
DNA	O
extracted	O
from	O
ES	O
cells	O
and	O
hybridized	O
with	O
a	O
DIG	B-CHEBI
-	O
labeled	O
823	O
bp	O
BamHI	O
/	O
HindIII	O
fragment	O
located	O
immediately	O
upstream	O
of	O
the	O
short	O
arm	O
of	O
the	O
targeting	O
vector	O
(	O
Figure	O
1	O
)	O
.	O

A	O
3	O
.	O
5	O
-	O
kb	O
BamHI	O
fragment	O
corresponding	O
to	O
the	O
wild	O
-	O
type	O
allele	O
was	O
present	O
in	O
all	O
cells	O
,	O
whereas	O
a	O
5	O
.	O
3	O
-	O
kb	O
fragment	O
from	O
the	O
mutant	O
allele	O
was	O
detected	O
in	O
two	O
targeted	O
cell	O
lines	O
,	O
designated	O
ES27	O
and	O
ES36	O
.	O

(	O
B	O
)	O
PCR	O
genotyping	O
was	O
carried	O
out	O
with	O
two	O
separate	O
reactions	O
designed	O
to	O
amplify	O
either	O
a	O
2	O
,	O
748	O
bp	O
segment	O
from	O
the	O
wild	O
-	O
type	O
allele	O
or	O
a	O
2	O
,	O
711	O
bp	O
segment	O
from	O
the	O
mutant	O
allele	O
.	O

Both	O
reactions	O
used	O
a	O
common	O
sense	O
primer	O
located	O
in	O
intron	O
4	O
,	O
outside	O
the	O
short	O
arm	O
of	O
the	O
targeting	O
vector	O
,	O
and	O
distinct	O
allele	O
-	O
specific	O
antisense	O
primers	O
.	O

The	O
reaction	O
to	O
detect	O
the	O
wild	O
-	O
type	O
allele	O
used	O
an	O
antisense	O
primer	O
located	O
in	O
exon	O
7	O
while	O
the	O
amplification	O
of	O
the	O
mutant	O
sequence	O
was	O
done	O
with	O
an	O
antisense	O
primer	O
in	O
the	O
PGK	O
-	O
Neo	O
cassette	O
.	O

The	O
results	O
confirm	O
the	O
presence	O
of	O
the	O
wild	O
-	O
type	O
allele	O
in	O
all	O
cells	O
,	O
whereas	O
the	O
mutant	O
allele	O
signal	O
was	O
observed	O
only	O
in	O
the	O
two	O
targeted	O
clones	O
.	O

(	O
M	O
)	O
denotes	O
the	O
molecular	B-CHEBI
weight	O
marker	O
.	O

Generation	O
of	O
chimeric	O
mice	O
and	O
germline	O
transmission	O
of	O
the	O
mutant	O
Capn2	O
allele	O

Eight	O
chimeric	O
male	O
mice	O
were	O
produced	O
in	O
morula	O
aggregation	O
experiments	O
using	O
the	O
Capn2	O
+	O
/	O
-	O
ES27	O
cell	O
line	O
.	O

Two	O
of	O
these	O
males	O
transmitted	O
the	O
Capn2	O
+	O
/	O
-	O
ES27	O
genotype	O
through	O
the	O
germline	O
into	O
the	O
F1	O
generation	O
.	O

Heterozygous	O
Capn2	O
+	O
/	O
-	O
animals	O
appeared	O
normal	O
,	O
with	O
no	O
obvious	O
defects	O
in	O
gross	O
anatomy	O
,	O
reproduction	O
,	O
or	O
life	O
span	O
.	O

Out	O
of	O
199	O
weanlings	O
from	O
heterozygous	O
intercrosses	O
,	O
no	O
Capn2	O
-	O
/	O
-	O
progeny	O
were	O
detected	O
(	O
Table	O
2	O
)	O
.	O

We	O
did	O
not	O
observe	O
high	O
rates	O
of	O
perinatal	O
death	O
,	O
and	O
no	O
Capn2	O
-	O
/	O
-	O
stillborns	O
were	O
observed	O
.	O

This	O
suggested	O
that	O
Capn2	O
-	O
/	O
-	O
animals	O
perished	O
at	O
some	O
stage	O
during	O
embryonic	O
development	O
.	O

In	O
an	O
attempt	O
to	O
determine	O
if	O
embryonic	O
death	O
occurred	O
at	O
a	O
post	O
-	O
implantation	O
stage	O
,	O
embryos	O
were	O
harvested	O
for	O
genotyping	O
at	O
different	O
times	O
between	O
E10	O
.	O
5	O
and	O
E18	O
.	O
5	O
.	O

No	O
Capn2	O
-	O
/	O
-	O
embryos	O
were	O
observed	O
and	O
no	O
signs	O
of	O
embryo	O
resorption	O
were	O
detected	O
(	O
Table	O
2	O
)	O
.	O

This	O
indicated	O
that	O
the	O
Capn2	O
-	O
/	O
-	O
embryos	O
might	O
be	O
dying	O
prior	O
to	O
implantation	O
.	O

Embryos	O
were	O
then	O
flushed	O
from	O
the	O
oviducts	O
of	O
pregnant	O
females	O
at	O
E2	O
.	O
5	O
or	O
E3	O
.	O
5	O
,	O
and	O
genotyped	O
by	O
means	O
of	O
a	O
nested	O
PCR	O
strategy	O
(	O
Figure	O
4	O
)	O
.	O

Two	O
of	O
90	O
successfully	O
genotyped	O
pre	O
-	O
implantation	O
embryos	O
were	O
Capn2	O
-	O
/	O
-	O
,	O
(	O
Table	O
2	O
;	O
Figure	O
5	O
)	O
.	O

Both	O
of	O
these	O
Capn2	O
-	O
/	O
-	O
embryos	O
were	O
isolated	O
at	O
the	O
8	O
-	O
cell	O
stage	O
and	O
did	O
not	O
display	O
any	O
obvious	O
morphological	O
defects	O
.	O

None	O
of	O
the	O
46	O
successfully	O
genotyped	O
blastocyst	O
-	O
staged	O
embryos	O
were	O
Capn2	O
-	O
/	O
-	O
.	O

The	O
scarcity	O
of	O
Capn2	O
-	O
deficient	O
embryos	O
surviving	O
to	O
the	O
8	O
-	O
cell	O
stage	O
suggested	O
that	O
the	O
loss	O
of	O
m	O
-	O
calpain	O
activity	O
must	O
fatally	O
compromise	O
the	O
viability	O
of	O
early	O
embryos	O
.	O

Furthermore	O
,	O
it	O
is	O
possible	O
that	O
persistence	O
of	O
some	O
maternally	O
derived	O
mRNA	B-CHEBI
transcript	I-CHEBI
or	O
protein	B-CHEBI
might	O
have	O
allowed	O
a	O
small	O
number	O
of	O
Capn2	O
-	O
/	O
-	O
embryos	O
to	O
survive	O
to	O
the	O
morula	O
-	O
stage	O
.	O

Table	O
2	O

Genotype	O
distribution	O
of	O
offspring	O
derived	O
from	O
Capn2	O
transgenic	O
mice	O
.	O

*	O
ND	O
,	O
not	O
determined	O

Figure	O
4	O

Nested	O
PCR	O
strategy	O
for	O
genotyping	O
of	O
pre	O
-	O
implantation	O
embryos	O
.	O

Due	O
to	O
the	O
scarcity	O
of	O
extractable	O
genetic	O
material	O
,	O
a	O
nested	O
PCR	O
strategy	O
was	O
developed	O
in	O
order	O
to	O
genotype	O
pre	O
-	O
implantation	O
embryos	O
.	O

Separate	O
reactions	O
were	O
used	O
to	O
amplify	O
a	O
429	O
bp	O
fragment	O
from	O
the	O
wild	O
-	O
type	O
allele	O
and	O
a	O
389	O
bp	O
segment	O
from	O
the	O
mutant	O
allele	O
,	O
both	O
spanning	O
the	O
3	O
'	O
end	O
of	O
the	O
short	O
(	O
upstream	O
)	O
arm	O
of	O
the	O
targeting	O
vector	O
.	O

In	O
both	O
reactions	O
,	O
a	O
213	O
bp	O
sequence	O
located	O
within	O
the	O
short	O
arm	O
was	O
co	O
-	O
amplified	O
with	O
the	O
'	O
diagnostic	O
'	O
products	O
as	O
an	O
internal	O
control	O
.	O

The	O
same	O
sense	O
primers	O
were	O
used	O
to	O
amplify	O
'	O
diagnostic	O
'	O
sequences	O
in	O
both	O
reactions	O
,	O
whereas	O
the	O
antisense	O
primers	O
were	O
allele	O
-	O
specific	O
.	O

The	O
primers	O
,	O
represented	O
by	O
triangles	O
,	O
are	O
depicted	O
in	O
two	O
(	O
nested	O
)	O
sets	O
for	O
each	O
of	O
the	O
three	O
reactions	O
.	O

Exons	O
are	O
represented	O
by	O
open	O
,	O
vertical	O
rectangles	O
,	O
the	O
PGK	O
-	O
Neo	O
cassette	O
by	O
an	O
open	O
,	O
horizontal	O
rectangle	O
,	O
while	O
thin	O
vertical	O
lines	O
denote	O
the	O
boundaries	O
of	O
the	O
short	O
arm	O
and	O
the	O
5	O
'	O
end	O
of	O
the	O
long	O
(	O
downstream	O
)	O
arm	O
.	O

A	O
grey	O
,	O
horizontal	O
rectangle	O
delineates	O
the	O
segment	O
of	O
the	O
wild	O
-	O
type	O
allele	O
that	O
is	O
replaced	O
by	O
the	O
PGK	O
-	O
Neo	O
cassette	O
in	O
the	O
mutant	O
allele	O
.	O

Figure	O
5	O

Genotyping	O
of	O
pre	O
-	O
implantation	O
embryos	O
.	O

A	O
nested	O
PCR	O
strategy	O
was	O
used	O
to	O
genotype	O
embryos	O
prior	O
to	O
implantation	O
as	O
described	O
in	O
Figure	O
4	O
.	O

Capn2	O
+	O
/	O
-	O
mice	O
were	O
mated	O
and	O
the	O
date	O
of	O
fertilization	O
established	O
by	O
the	O
appearance	O
of	O
vaginal	O
plugs	O
.	O

Blastocyst	O
(	O
E3	O
.	O
5	O
)	O
or	O
8	O
-	O
cell	O
embryos	O
(	O
E2	O
.	O
5	O
)	O
were	O
flushed	O
from	O
the	O
oviducts	O
and	O
then	O
digested	O
with	O
proteinase	O
K	O
.	O

In	O
separate	O
reactions	O
segments	O
found	O
exclusively	O
in	O
either	O
the	O
wild	O
-	O
type	O
or	O
mutant	O
alleles	O
were	O
co	O
-	O
amplified	O
with	O
an	O
internal	O
control	O
sequence	O
,	O
located	O
in	O
the	O
short	O
(	O
upstream	O
)	O
arm	O
of	O
the	O
targeting	O
vector	O
,	O
which	O
is	O
found	O
in	O
both	O
alleles	O
.	O

The	O
final	O
products	O
were	O
429	O
bp	O
for	O
the	O
wild	O
-	O
type	O
allele	O
,	O
389	O
bp	O
for	O
the	O
mutant	O
allele	O
,	O
and	O
213	O
bp	O
for	O
the	O
internal	O
control	O
.	O

(	O
A	O
)	O
A	O
representative	O
example	O
of	O
the	O
genotyping	O
of	O
blastocyst	O
stage	O
embryos	O
.	O

Embryos	O
#	O
1	O
,	O
2	O
,	O
4	O
,	O
5	O
,	O
and	O
6	O
were	O
Capn2	O
+	O
/	O
-	O
whereas	O
embryos	O
#	O
3	O
and	O
#	O
7	O
were	O
Capn2	O
+	O
/	O
+	O
,	O
denoted	O
by	O
the	O
absence	O
of	O
the	O
389	O
bp	O
mutant	O
signal	O
.	O

(	O
B	O
)	O
An	O
example	O
of	O
the	O
genotyping	O
of	O
8	O
-	O
cell	O
embryos	O
is	O
shown	O
.	O

Embryos	O
#	O
1	O
,	O
2	O
,	O
3	O
,	O
5	O
,	O
and	O
6	O
were	O
Capn2	O
+	O
/	O
-	O
while	O
embryo	O
#	O
4	O
was	O
Capn2	O
-	O
/	O
-	O
,	O
marked	O
by	O
the	O
absence	O
of	O
the	O
429	O
bp	O
wild	O
-	O
type	O
signal	O
.	O

(	O
M	O
)	O
denotes	O
the	O
molecular	B-CHEBI
weight	O
marker	O
.	O

The	O
genotyping	O
results	O
for	O
weanlings	O
,	O
post	O
-	O
implantation	O
,	O
and	O
pre	O
-	O
implantation	O
embryos	O
are	O
shown	O
in	O
Table	O
2	O
.	O

Curiously	O
,	O
the	O
ratio	O
of	O
Capn2	O
+	O
/	O
+	O
to	O
Capn2	O
+	O
/	O
-	O
animals	O
from	O
inbred	O
heterozygous	O
intercrosses	O
was	O
substantially	O
less	O
than	O
the	O
predicted	O
1	O
:	O
2	O
Mendelian	O
ratio	O
.	O

In	O
a	O
group	O
of	O
199	O
animals	O
derived	O
from	O
heterozygote	O
breeding	O
(	O
33	O
litters	O
)	O
,	O
23	O
Capn2	O
+	O
/	O
+	O
(	O
11	O
.	O
6	O
%	O
)	O
and	O
176	O
(	O
88	O
.	O
4	O
%	O
)	O
Capn2	O
+	O
/	O
-	O
animals	O
were	O
observed	O
.	O

The	O
ratio	O
of	O
Capn2	O
+	O
/	O
+	O
to	O
Capn2	O
+	O
/	O
-	O
animals	O
among	O
males	O
(	O
14	O
%	O
to	O
82	O
%	O
)	O
or	O
females	O
(	O
13	O
%	O
to	O
90	O
%	O
)	O
was	O
essentially	O
the	O
same	O
is	O
it	O
was	O
for	O
the	O
combined	O
population	O
,	O
and	O
there	O
were	O
an	O
average	O
of	O
six	O
pups	O
per	O
litter	O
,	O
which	O
is	O
normal	O
for	O
this	O
background	O
strain	O
.	O

A	O
larger	O
than	O
expected	O
proportion	O
Capn2	O
+	O
/	O
-	O
animals	O
was	O
also	O
evident	O
in	O
both	O
post	O
-	O
implantation	O
and	O
pre	O
-	O
implantation	O
embryos	O
(	O
Table	O
2	O
)	O
.	O

Interestingly	O
,	O
a	O
similar	O
over	O
-	O
representation	O
of	O
heterozygous	O
animals	O
was	O
also	O
reported	O
in	O
one	O
of	O
the	O
Capn4	O
transgenic	O
lines	O
,	O
though	O
the	O
genotype	O
skewing	O
was	O
not	O
as	O
extreme	O
[	O
32	O
]	O
.	O

Crosses	O
between	O
Capn2	O
+	O
/	O
+	O
and	O
Capn2	O
+	O
/	O
-	O
animals	O
also	O
resulted	O
in	O
a	O
greater	O
than	O
expected	O
proportion	O
of	O
Capn2	O
+	O
/	O
-	O
animals	O
(	O
Table	O
2	O
)	O
.	O

An	O
even	O
higher	O
degree	O
of	O
Capn2	O
+	O
/	O
-	O
over	O
-	O
representation	O
was	O
seen	O
when	O
the	O
mutant	O
allele	O
came	O
the	O
mother	O
(	O
73	O
%	O
)	O
compared	O
to	O
when	O
it	O
came	O
from	O
the	O
father	O
(	O
59	O
%	O
)	O
.	O

In	O
these	O
crosses	O
the	O
ratios	O
of	O
Capn2	O
+	O
/	O
+	O
to	O
Capn2	O
+	O
/	O
-	O
animals	O
among	O
males	O
or	O
females	O
compared	O
well	O
with	O
the	O
ratio	O
in	O
the	O
combined	O
populations	O
;	O
77	O
%	O
of	O
males	O
and	O
69	O
%	O
of	O
females	O
were	O
Capn2	O
+	O
/	O
-	O
when	O
the	O
mutant	O
allele	O
came	O
from	O
the	O
mother	O
,	O
and	O
62	O
%	O
of	O
males	O
and	O
55	O
%	O
of	O
females	O
were	O
Capn2	O
+	O
/	O
-	O
when	O
the	O
mutant	O
allele	O
came	O
from	O
the	O
father	O
.	O

Attempted	O
generation	O
of	O
Capn2	O
-	O
/	O
-	O
ES	O
cells	O

Capn2	O
+	O
/	O
-	O
ES	O
cells	O
were	O
subjected	O
to	O
clonal	O
selection	O
in	O
the	O
presence	O
of	O
2	O
mg	O
/	O
mL	O
G418	O
in	O
attempts	O
to	O
generate	O
homozygous	O
mutant	O
cells	O
by	O
gene	O
conversion	O
.	O

This	O
procedure	O
has	O
been	O
extensively	O
applied	O
to	O
targeted	O
ES	O
cells	O
and	O
was	O
readily	O
achieved	O
in	O
the	O
case	O
of	O
Capn4	O
+	O
/	O
-	O
ES	O
cells	O
[	O
31	O
]	O
.	O

In	O
this	O
case	O
,	O
however	O
,	O
no	O
Capn2	O
-	O
/	O
-	O
ES	O
cells	O
were	O
isolated	O
in	O
screens	O
of	O
126	O
drug	B-CHEBI
-	O
resistant	O
clones	O
.	O

The	O
inability	O
to	O
isolate	O
Capn2	O
-	O
/	O
-	O
ES	O
cells	O
,	O
in	O
concert	O
with	O
the	O
absence	O
of	O
Capn2	O
-	O
/	O
-	O
embryos	O
beyond	O
the	O
8	O
-	O
cell	O
stage	O
,	O
suggested	O
that	O
m	O
-	O
calpain	O
activity	O
might	O
be	O
essential	O
for	O
cell	O
viability	O
or	O
the	O
establishment	O
of	O
viable	O
ES	O
cell	O
clones	O
.	O

Discussion	O

Although	O
calpain	O
activity	O
was	O
first	O
identified	O
four	O
decades	O
ago	O
,	O
a	O
clear	O
understanding	O
of	O
the	O
substrates	O
and	O
functions	O
of	O
the	O
enzymes	O
has	O
remained	O
elusive	O
.	O

In	O
large	O
part	O
,	O
this	O
has	O
been	O
due	O
to	O
the	O
lack	O
of	O
inhibitors	B-CHEBI
capable	O
of	O
specifically	O
down	O
-	O
regulating	O
the	O
calpains	O
without	O
affecting	O
other	O
proteases	O
.	O

In	O
the	O
past	O
decade	O
,	O
the	O
story	O
has	O
been	O
further	O
complicated	O
by	O
the	O
discovery	O
of	O
a	O
number	O
of	O
previously	O
unknown	O
isoforms	O
which	O
may	O
be	O
differently	O
regulated	O
and	O
have	O
different	O
substrate	O
specificity	O
.	O

Gene	O
targeting	O
in	O
mice	O
has	O
provided	O
a	O
powerful	O
approach	O
to	O
examine	O
the	O
physiologic	O
roles	O
of	O
individual	O
calpain	O
isoforms	O
.	O

This	O
was	O
first	O
used	O
to	O
disrupt	O
the	O
Capn4	O
gene	O
,	O
encoding	O
the	O
small	O
regulatory	O
subunit	O
common	O
to	O
both	O
mu	O
-	O
and	O
m	O
-	O
calpain	O
.	O

Two	O
independent	O
laboratories	O
observed	O
embryonic	O
lethality	O
in	O
Capn4	O
knockout	O
mice	O
,	O
albeit	O
at	O
different	O
stages	O
of	O
development	O
[	O
31	O
,	O
32	O
]	O
.	O

These	O
observations	O
supported	O
the	O
hypothesis	O
that	O
the	O
small	O
subunit	O
is	O
required	O
for	O
both	O
mu	O
-	O
and	O
m	O
-	O
calpain	O
,	O
and	O
furthermore	O
suggested	O
four	O
possibilities	O
regarding	O
their	O
requirement	O
for	O
embryonic	O
development	O
:	O
1	O
)	O
both	O
isoforms	O
were	O
required	O
;	O
2	O
)	O
mu	O
-	O
calpain	O
was	O
required	O
;	O
3	O
)	O
m	O
-	O
calpain	O
was	O
required	O
,	O
or	O
4	O
)	O
mu	O
-	O
and	O
m	O
-	O
calpain	O
are	O
redundant	O
,	O
and	O
one	O
or	O
the	O
other	O
isoform	O
was	O
required	O
.	O

These	O
options	O
were	O
narrowed	O
down	O
by	O
the	O
subsequent	O
observation	O
that	O
Capn1	O
-	O
/	O
-	O
mice	O
,	O
which	O
lack	O
the	O
mu	O
-	O
calpain	O
catalytic	O
subunit	O
,	O
were	O
healthy	O
and	O
fertile	O
,	O
although	O
platelet	O
aggregation	O
and	O
clot	O
retraction	O
defects	O
were	O
observed	O
[	O
33	O
]	O
.	O

At	O
that	O
point	O
,	O
we	O
were	O
left	O
with	O
the	O
last	O
two	O
possibilities	O
that	O
either	O
m	O
-	O
calpain	O
was	O
specifically	O
required	O
during	O
embryogenesis	O
,	O
or	O
that	O
either	O
isoform	O
alone	O
was	O
sufficient	O
for	O
sustaining	O
embryonic	O
viability	O
.	O

We	O
report	O
here	O
that	O
Capn2	O
-	O
/	O
-	O
mice	O
,	O
which	O
lack	O
the	O
m	O
-	O
calpain	O
catalytic	O
subunit	O
,	O
die	O
at	O
the	O
preimplantation	O
stage	O
of	O
development	O
.	O

This	O
observation	O
allows	O
us	O
to	O
now	O
conclude	O
that	O
m	O
-	O
calpain	O
is	O
specifically	O
required	O
during	O
embryogenesis	O
.	O

Since	O
homozygous	O
disruption	O
of	O
the	O
Capn4	O
gene	O
was	O
also	O
expected	O
to	O
abolish	O
m	O
-	O
calpain	O
activity	O
,	O
this	O
result	O
is	O
in	O
agreement	O
with	O
the	O
phenotype	O
presented	O
by	O
one	O
of	O
the	O
two	O
Capn4	O
targeted	O
lines	O
in	O
which	O
preimplantation	O
lethality	O
of	O
null	O
embryos	O
was	O
also	O
observed	O
[	O
32	O
]	O
.	O

The	O
survival	O
of	O
Capn4	O
-	O
/	O
-	O
embryos	O
from	O
the	O
original	O
targeted	O
line	O
reported	O
by	O
Arthur	O
and	O
colleagues	O
to	O
mid	O
-	O
gestation	O
is	O
more	O
difficult	O
to	O
reconcile	O
[	O
31	O
]	O
.	O

In	O
retrospect	O
,	O
it	O
seems	O
likely	O
that	O
the	O
latter	O
line	O
represents	O
a	O
hypomorphic	O
state	O
,	O
rather	O
than	O
a	O
true	O
null	O
.	O

The	O
Capn4	O
targeting	O
strategy	O
employed	O
by	O
Arthur	O
and	O
colleagues	O
involved	O
disrupting	O
the	O
C	B-CHEBI
-	O
terminus	O
of	O
the	O
calpain	O
small	O
subunit	O
by	O
insertion	O
of	O
the	O
PGK	O
-	O
Neo	O
cassette	O
into	O
the	O
middle	O
of	O
exon	O
9	O
,	O
which	O
caused	O
truncation	O
of	O
the	O
protein	B-CHEBI
[	O
31	O
]	O
.	O

This	O
strategy	O
was	O
based	O
upon	O
previous	O
structure	O
/	O
function	O
studies	O
showing	O
that	O
excision	O
of	O
the	O
C	B-CHEBI
-	O
terminal	O
25	O
amino	B-CHEBI
acid	I-CHEBI
residues	I-CHEBI
of	O
the	O
small	O
subunit	O
abolished	O
calpain	O
activity	O
when	O
co	O
-	O
expressed	O
with	O
the	O
m	O
-	O
calpain	O
large	O
subunit	O
in	O
E	O
.	O
coli	O
[	O
34	O
]	O
.	O

In	O
contrast	O
,	O
the	O
Capn4	O
targeting	O
strategy	O
employed	O
by	O
Zimmerman	O
and	O
colleagues	O
involved	O
a	O
much	O
more	O
extensive	O
deletion	O
of	O
exons	O
4	O
through	O
8	O
[	O
32	O
]	O
.	O

It	O
now	O
seems	O
probable	O
that	O
the	O
difference	O
in	O
the	O
time	O
of	O
lethality	O
of	O
these	O
two	O
targeted	O
Capn4	O
lines	O
can	O
be	O
explained	O
by	O
different	O
extents	O
of	O
disruption	O
.	O

The	O
Zimmerman	O
allele	O
probably	O
represents	O
a	O
true	O
null	O
genotype	O
while	O
the	O
Arthur	O
allele	O
is	O
likely	O
a	O
hypomorphic	O
mutation	O
.	O

Alternate	O
targeting	O
strategies	O
have	O
been	O
shown	O
to	O
yield	O
different	O
phenotypes	O
in	O
gene	O
disruption	O
studies	O
.	O

For	O
example	O
,	O
three	O
different	O
targeting	O
strategies	O
were	O
independently	O
used	O
to	O
disrupt	O
the	O
mixed	O
lineage	O
leukemia	O
(	O
Mll	O
)	O
gene	O
.	O

In	O
all	O
three	O
studies	O
,	O
homozygous	O
null	O
embryos	O
perished	O
during	O
embryogenesis	O
,	O
but	O
at	O
different	O
stages	O
(	O
E0	O
.	O
5	O
,	O
E10	O
.	O
5	O
,	O
E14	O
.	O
5	O
)	O
[	O
35	O
]	O
.	O

The	O
variation	O
in	O
phenotype	O
was	O
attributed	O
to	O
the	O
differences	O
in	O
degree	O
of	O
function	O
of	O
the	O
truncated	O
proteins	B-CHEBI
produced	O
from	O
the	O
mutant	O
alleles	O
.	O

A	O
similar	O
effect	O
might	O
be	O
at	O
work	O
in	O
the	O
two	O
Capn4	O
transgenic	O
lines	O
.	O

Efforts	O
were	O
made	O
to	O
detect	O
transcripts	O
or	O
calpain	O
activities	O
derived	O
from	O
the	O
Arthur	O
Capn4	O
allele	O
.	O

This	O
allele	O
gave	O
rise	O
to	O
multiple	O
mRNA	B-CHEBI
species	O
,	O
detectable	O
by	O
RT	O
-	O
PCR	O
,	O
reading	O
through	O
from	O
the	O
first	O
half	O
of	O
exon	O
9	O
to	O
at	O
least	O
two	O
different	O
cryptic	O
splice	O
sites	O
in	O
the	O
PGK	O
promoter	O
sequence	O
[	O
31	O
]	O
.	O

These	O
transcripts	O
could	O
give	O
rise	O
to	O
defective	O
calpain	O
small	O
subunits	O
with	O
10	O
-	O
30	O
inappropriate	O
C	B-CHEBI
-	O
terminal	O
acids	B-CHEBI
,	O
which	O
might	O
be	O
sufficient	O
to	O
support	O
a	O
low	O
level	O
of	O
calpain	O
activity	O
.	O

However	O
,	O
expression	O
of	O
calpains	O
with	O
these	O
modified	O
small	O
subunits	O
did	O
not	O
give	O
rise	O
to	O
any	O
detectable	O
calpain	O
activity	O
when	O
expressed	O
in	O
E	O
.	O
coli	O
,	O
although	O
their	O
functionality	O
in	O
mammalian	O
cells	O
has	O
yet	O
to	O
be	O
determined	O
(	O
J	O
.	O
S	O
.	O
Elce	O
,	O
unpublished	O
work	O
)	O
It	O
has	O
also	O
been	O
suggested	O
that	O
calpain	O
large	O
subunits	O
alone	O
might	O
provide	O
some	O
activity	O
in	O
eukaryotic	O
cells	O
,	O
although	O
the	O
Zimmerman	O
et	O
al	O
.	O
knockout	O
appears	O
to	O
exclude	O
that	O
possibility	O
,	O
and	O
no	O
calpain	O
activity	O
was	O
observed	O
in	O
our	O
hands	O
when	O
calpain	O
large	O
subunits	O
were	O
expressed	O
alone	O
either	O
in	O
E	O
.	O
coli	O
or	O
in	O
mammalian	O
cells	O
[	O
36	O
]	O
.	O

The	O
different	O
timing	O
of	O
lethality	O
in	O
the	O
Capn4	O
knockouts	O
might	O
also	O
be	O
a	O
consequence	O
of	O
the	O
different	O
genetic	O
backgrounds	O
of	O
the	O
two	O
transgenic	O
lines	O
,	O
which	O
has	O
been	O
observed	O
to	O
influence	O
the	O
phenotype	O
of	O
transgenic	O
mice	O
on	O
a	O
number	O
of	O
occasions	O
[	O
37	O
]	O
.	O

One	O
of	O
the	O
enduring	O
questions	O
in	O
calpain	O
research	O
has	O
been	O
whether	O
the	O
two	O
ubiquitous	O
isoforms	O
,	O
mu	O
-	O
and	O
m	O
-	O
calpain	O
,	O
possess	O
distinct	O
in	O
vivo	O
roles	O
.	O

The	O
two	O
enzymes	O
share	O
62	O
%	O
sequence	O
identity	O
and	O
are	O
very	O
similar	O
in	O
their	O
structure	O
and	O
biochemistry	O
.	O

Notably	O
,	O
they	O
cleave	O
essentially	O
the	O
same	O
set	O
of	O
substrates	O
in	O
vitro	O
,	O
suggesting	O
that	O
they	O
have	O
the	O
potential	O
to	O
carry	O
out	O
the	O
same	O
functions	O
in	O
vivo	O
.	O

On	O
the	O
other	O
hand	O
,	O
since	O
they	O
require	O
different	O
amounts	O
of	O
Ca2	B-CHEBI
+	I-CHEBI
for	O
in	O
vitro	O
activation	O
,	O
it	O
is	O
possible	O
that	O
the	O
two	O
isoforms	O
are	O
differentially	O
regulated	O
inside	O
cells	O
.	O

It	O
is	O
now	O
clear	O
,	O
from	O
the	O
gene	O
targeting	O
work	O
done	O
in	O
mice	O
,	O
that	O
mu	O
-	O
and	O
m	O
-	O
calpain	O
have	O
some	O
distinct	O
physiological	O
roles	O
,	O
at	O
least	O
during	O
embryogenesis	O
.	O

As	O
noted	O
,	O
whereas	O
Capn2	O
null	O
murine	O
embryos	O
die	O
prior	O
to	O
implantation	O
,	O
homozygous	O
disruption	O
of	O
the	O
mu	O
-	O
calpain	O
large	O
subunit	O
gene	O
,	O
Capn1	O
,	O
did	O
not	O
affect	O
the	O
viability	O
of	O
mice	O
[	O
33	O
]	O
.	O

The	O
principal	O
phenotype	O
observed	O
as	O
a	O
result	O
of	O
Capn1	O
deficiency	O
involved	O
a	O
disturbance	O
in	O
platelet	O
function	O
,	O
possibly	O
at	O
the	O
level	O
of	O
the	O
tyrosine	B-CHEBI
phosphorylation	O
of	O
certain	O
proteins	B-CHEBI
involved	O
in	O
platelet	O
activation	O
.	O

Both	O
mu	O
-	O
and	O
m	O
-	O
calpain	O
activities	O
are	O
present	O
in	O
most	O
mammalian	O
cells	O
,	O
although	O
the	O
published	O
data	O
,	O
owing	O
to	O
weaknesses	O
in	O
the	O
available	O
methodology	O
,	O
do	O
not	O
provide	O
reliable	O
estimates	O
of	O
their	O
relative	O
amounts	O
.	O

Platelets	O
and	O
erythrocytes	O
contain	O
abundant	O
mu	O
-	O
calpain	O
activity	O
,	O
while	O
m	O
-	O
calpain	O
activity	O
is	O
barely	O
detectable	O
.	O

Compensation	O
for	O
mu	O
-	O
calpain	O
deficiency	O
by	O
m	O
-	O
calpain	O
is	O
therefore	O
less	O
likely	O
in	O
platelets	O
and	O
erythrocytes	O
than	O
in	O
other	O
cell	O
types	O
.	O

As	O
a	O
result	O
,	O
it	O
is	O
not	O
possible	O
to	O
determine	O
whether	O
the	O
absence	O
of	O
marked	O
phenotype	O
in	O
Capn1	O
-	O
/	O
-	O
animals	O
is	O
due	O
to	O
a	O
compensatory	O
affect	O
by	O
the	O
remaining	O
m	O
-	O
calpain	O
activity	O
,	O
or	O
whether	O
the	O
functions	O
of	O
mu	O
-	O
calpain	O
are	O
simply	O
not	O
essential	O
.	O

In	O
contrast	O
,	O
lethality	O
in	O
Capn2	O
-	O
/	O
-	O
embryos	O
demonstrates	O
that	O
m	O
-	O
calpain	O
activity	O
is	O
essential	O
for	O
embryonic	O
development	O
beyond	O
the	O
8	O
-	O
cell	O
stage	O
.	O

It	O
follows	O
that	O
at	O
least	O
some	O
functions	O
of	O
mu	O
-	O
calpain	O
and	O
m	O
-	O
calpain	O
are	O
distinct	O
.	O

The	O
underlying	O
cause	O
of	O
the	O
preimplantation	O
lethality	O
in	O
Capn2	O
-	O
/	O
-	O
embryos	O
has	O
not	O
yet	O
been	O
clarified	O
.	O

The	O
two	O
homozygous	O
null	O
embryos	O
identified	O
at	O
the	O
8	O
-	O
cell	O
stage	O
did	O
not	O
present	O
any	O
obvious	O
morphological	O
defects	O
.	O

However	O
,	O
the	O
fact	O
that	O
only	O
two	O
out	O
of	O
90	O
successfully	O
genotyped	O
pre	O
-	O
implantation	O
embryos	O
proved	O
to	O
be	O
Capn2	O
-	O
/	O
-	O
is	O
in	O
itself	O
revealing	O
.	O

Preimplantation	O
lethality	O
resulting	O
from	O
gene	O
knockouts	O
can	O
typically	O
be	O
attributed	O
to	O
two	O
general	O
causes	O
.	O

In	O
some	O
cases	O
,	O
defects	O
are	O
incurred	O
in	O
the	O
embryonic	O
differentiation	O
program	O
which	O
can	O
often	O
be	O
observed	O
morphologically	O
[	O
38	O
]	O
.	O

Null	O
embryos	O
of	O
this	O
type	O
often	O
survive	O
beyond	O
the	O
morula	O
stage	O
,	O
and	O
a	O
Mendelian	O
distribution	O
of	O
embryonic	O
genotypes	O
is	O
usually	O
noted	O
.	O

In	O
other	O
cases	O
,	O
however	O
,	O
the	O
gene	O
disruption	O
is	O
thought	O
to	O
compromise	O
fatally	O
the	O
viability	O
of	O
cells	O
in	O
the	O
early	O
embryo	O
[	O
3	O
,	O
39	O
-	O
43	O
]	O
.	O

In	O
these	O
instances	O
,	O
only	O
a	O
few	O
null	O
embryos	O
are	O
ever	O
observed	O
and	O
homozygous	O
mutant	O
ES	O
cells	O
could	O
not	O
be	O
isolated	O
.	O

The	O
Capn2	O
knockout	O
fits	O
into	O
the	O
latter	O
category	O
.	O

If	O
it	O
is	O
true	O
that	O
m	O
-	O
calpain	O
is	O
essential	O
for	O
some	O
aspect	O
of	O
cell	O
viability	O
,	O
the	O
survival	O
of	O
a	O
few	O
Capn2	O
-	O
/	O
-	O
embryos	O
to	O
the	O
8	O
-	O
cell	O
stage	O
is	O
most	O
likely	O
due	O
to	O
the	O
persistence	O
of	O
some	O
maternal	O
m	O
-	O
calpain	O
mRNA	B-CHEBI
and	O
/	O
or	O
protein	B-CHEBI
through	O
2	O
-	O
3	O
cell	O
divisions	O
.	O

The	O
mechanistic	O
reasons	O
for	O
lethality	O
in	O
the	O
absence	O
of	O
m	O
-	O
calpain	O
are	O
still	O
unclear	O
.	O

There	O
have	O
been	O
several	O
reports	O
of	O
m	O
-	O
calpain	O
involvement	O
in	O
cell	O
proliferation	O
in	O
certain	O
circumstances	O
,	O
including	O
reports	O
of	O
its	O
involvement	O
in	O
chromosome	O
segregation	O
during	O
mitosis	O
[	O
44	O
]	O
as	O
well	O
as	O
during	O
meiosis	O
[	O
45	O
]	O
.	O

Defects	O
in	O
migration	O
,	O
reported	O
in	O
Capn4	O
-	O
/	O
-	O
cells	O
[	O
9	O
]	O
,	O
could	O
contribute	O
to	O
failed	O
embryonic	O
development	O
.	O

The	O
association	O
between	O
calpain	O
and	O
cell	O
viability	O
has	O
been	O
noted	O
in	O
Capn4	O
-	O
/	O
-	O
MEFs	O
and	O
other	O
cell	O
lines	O
,	O
although	O
the	O
reported	O
work	O
frequently	O
did	O
not	O
distinguish	O
between	O
mu	O
-	O
and	O
m	O
-	O
calpain	O
,	O
and	O
did	O
not	O
show	O
that	O
calpain	O
was	O
strictly	O
essential	O
[	O
5	O
,	O
6	O
]	O
.	O

In	O
both	O
CHO	O
cells	O
and	O
Capn4	O
-	O
/	O
-	O
MEFs	O
,	O
calpain	O
was	O
shown	O
to	O
influence	O
cell	O
proliferation	O
,	O
but	O
only	O
at	O
very	O
low	O
cell	O
densities	O
[	O
5	O
]	O
.	O

Calpain	O
has	O
also	O
been	O
associated	O
with	O
progression	O
through	O
the	O
G1	O
stage	O
of	O
the	O
cell	O
cycle	O
[	O
6	O
]	O
.	O

Furthermore	O
,	O
some	O
of	O
the	O
proteins	B-CHEBI
known	O
to	O
be	O
involved	O
in	O
cell	O
cycle	O
progression	O
,	O
such	O
as	O
p53	O
,	O
p107	O
,	O
cyclin	O
D1	O
,	O
and	O
p27kip1	O
are	O
reputed	O
to	O
be	O
calpain	O
substrates	O
[	O
3	O
]	O
.	O

Sperm	O
binding	O
to	O
the	O
oocyte	O
leads	O
to	O
increased	O
cytoplasmic	O
calcium	B-CHEBI
which	O
triggers	O
the	O
acrosome	O
reaction	O
[	O
46	O
]	O
.	O

Both	O
mu	O
-	O
and	O
m	O
-	O
calpain	O
have	O
recently	O
been	O
detected	O
in	O
rodent	O
sperm	O
[	O
47	O
]	O
and	O
oocytes	O
[	O
45	O
]	O
.	O

m	O
-	O
calpain	O
was	O
implicated	O
in	O
the	O
acrosome	O
reaction	O
[	O
47	O
]	O
which	O
correlated	O
with	O
a	O
translocation	O
of	O
m	O
-	O
calpain	O
to	O
the	O
cortical	O
membrane	O
in	O
oocytes	O
where	O
it	O
might	O
participate	O
in	O
the	O
release	O
of	O
cortical	O
granule	O
contents	O
required	O
to	O
prevent	O
polyspermy	O
[	O
45	O
]	O
.	O

m	O
-	O
calpain	O
also	O
relocalized	O
to	O
the	O
oocyte	O
meiotic	O
spindle	O
after	O
fertilization	O
,	O
were	O
it	O
could	O
be	O
involved	O
in	O
chromosome	O
segregation	O
[	O
45	O
]	O
.	O

Polyspermy	O
or	O
defective	O
chromosome	O
segregation	O
would	O
both	O
have	O
lethal	O
effects	O
on	O
early	O
embryonic	O
development	O
.	O

It	O
should	O
also	O
be	O
stressed	O
that	O
Capn4	O
-	O
/	O
-	O
ES	O
and	O
MEF	O
cells	O
from	O
the	O
presumptive	O
hypomorphic	O
allele	O
can	O
be	O
maintained	O
in	O
culture	O
despite	O
an	O
apparent	O
lack	O
of	O
calpain	O
activity	O
,	O
as	O
assessed	O
by	O
casein	O
zymography	O
or	O
by	O
the	O
appearance	O
of	O
characteristic	O
spectrin	O
breakdown	O
products	O
.	O

It	O
is	O
conceivable	O
,	O
as	O
discussed	O
earlier	O
,	O
that	O
a	O
trace	O
amount	O
of	O
calpain	O
activity	O
,	O
beneath	O
levels	O
detectable	O
by	O
these	O
methods	O
,	O
is	O
retained	O
from	O
this	O
mutant	O
Capn4	O
allele	O
,	O
and	O
it	O
is	O
sufficient	O
for	O
maintaining	O
the	O
viability	O
of	O
the	O
cells	O
.	O

Furthermore	O
,	O
calpain	O
-	O
independent	O
mechanisms	O
for	O
protecting	O
cell	O
viability	O
might	O
exist	O
in	O
these	O
cell	O
lines	O
that	O
are	O
absent	O
in	O
early	O
embryonic	O
cells	O
.	O

The	O
repeated	O
failure	O
to	O
achieve	O
gene	O
conversion	O
of	O
Capn2	O
+	O
/	O
-	O
to	O
Capn2	O
-	O
/	O
-	O
ES	O
cells	O
by	O
selection	O
of	O
clones	O
in	O
high	O
concentrations	O
of	O
G418	O
suggests	O
that	O
the	O
homozygous	O
mutant	O
state	O
somehow	O
compromises	O
cell	O
viability	O
or	O
clonal	O
selection	O
of	O
ES	O
cells	O
.	O

Efforts	O
are	O
under	O
way	O
to	O
express	O
the	O
m	O
-	O
80	O
k	O
subunit	O
from	O
a	O
Capn2	O
cDNA	O
rescue	O
transgene	O
prior	O
to	O
gene	O
conversion	O
in	O
order	O
to	O
preemptively	O
rescue	O
m	O
-	O
calpain	O
activity	O
before	O
the	O
remaining	O
endogenous	O
wild	O
-	O
type	O
allele	O
is	O
lost	O
.	O

However	O
,	O
difficulty	O
in	O
achieving	O
stable	O
expression	O
of	O
the	O
rescue	O
transgene	O
has	O
thus	O
far	O
hampered	O
these	O
attempts	O
.	O

One	O
curiosity	O
which	O
arose	O
during	O
the	O
genotyping	O
of	O
progeny	O
from	O
heterozygous	O
interbreeding	O
was	O
the	O
highly	O
non	O
-	O
Mendelian	O
ratio	O
of	O
Capn2	O
+	O
/	O
+	O
(	O
11	O
.	O
6	O
%	O
)	O
to	O
Capn2	O
+	O
/	O
-	O
(	O
88	O
.	O
4	O
%	O
)	O
of	O
weanlings	O
.	O

At	O
present	O
,	O
there	O
is	O
no	O
obvious	O
explanation	O
for	O
this	O
result	O
.	O

Crosses	O
between	O
wild	O
-	O
type	O
and	O
heterozygous	O
mice	O
also	O
produced	O
progeny	O
with	O
a	O
greater	O
than	O
expected	O
proportion	O
of	O
heterozygous	O
offspring	O
.	O

Interestingly	O
,	O
heterozygous	O
crosses	O
involving	O
the	O
Capn4	O
transgenic	O
line	O
generated	O
by	O
Zimmerman	O
and	O
colleagues	O
yielded	O
progeny	O
with	O
a	O
similar	O
,	O
if	O
less	O
extreme	O
,	O
skewing	O
in	O
favor	O
of	O
the	O
heterozygous	O
genotype	O
.	O

Out	O
of	O
a	O
total	O
of	O
80	O
genotyped	O
animals	O
,	O
22	O
.	O
5	O
%	O
were	O
wild	O
-	O
type	O
and	O
77	O
.	O
5	O
%	O
were	O
heterozygous	O
,	O
with	O
no	O
homozygous	O
null	O
progeny	O
observed	O
[	O
32	O
]	O
.	O

These	O
observations	O
suggest	O
a	O
developmental	O
advantage	O
associated	O
with	O
reduced	O
calpain	O
expression	O
.	O

Perhaps	O
future	O
studies	O
will	O
reveal	O
a	O
mechanistic	O
basis	O
for	O
this	O
.	O

Conclusion	O

The	O
work	O
presented	O
here	O
has	O
clarified	O
two	O
important	O
questions	O
regarding	O
the	O
physiological	O
roles	O
of	O
the	O
two	O
ubiquitous	O
calpain	O
isoforms	O
,	O
mu	O
-	O
and	O
m	O
-	O
calpain	O
.	O

Firstly	O
,	O
it	O
was	O
determined	O
that	O
m	O
-	O
calpain	O
plays	O
an	O
indispensable	O
role	O
in	O
murine	O
embryogenesis	O
,	O
possibly	O
related	O
to	O
pre	O
-	O
implantation	O
development	O
.	O

Furthermore	O
,	O
this	O
function	O
cannot	O
be	O
carried	O
out	O
by	O
mu	O
-	O
calpain	O
despite	O
the	O
apparent	O
in	O
vitro	O
similarities	O
of	O
mu	O
-	O
and	O
m	O
-	O
calpain	O
,	O
demonstrating	O
that	O
the	O
two	O
isoforms	O
clearly	O
have	O
some	O
distinct	O
roles	O
in	O
vivo	O
.	O

The	O
functions	O
of	O
m	O
-	O
calpain	O
during	O
post	O
-	O
implantation	O
embryogenesis	O
and	O
in	O
adult	O
mice	O
remain	O
to	O
be	O
elucidated	O
and	O
will	O
have	O
to	O
be	O
addressed	O
using	O
a	O
conditional	O
gene	O
targeting	O
strategy	O
.	O

Methods	O

Cloning	O
and	O
sequencing	O
of	O
the	O
mouse	O
Capn2	O
locus	O

The	O
mouse	O
Capn2	O
gene	O
encodes	O
the	O
700	O
amino	B-CHEBI
acids	I-CHEBI
of	O
the	O
m	O
-	O
calpain	O
large	O
subunit	O
(	O
m	O
-	O
80	O
k	O
)	O
and	O
consists	O
of	O
21	O
exons	O
extending	O
over	O
50	O
-	O
kb	O
on	O
chromosome	O
1	O
.	O

A	O
cDNA	O
clone	O
encoding	O
a	O
portion	O
of	O
the	O
mouse	O
m	O
-	O
80	O
k	O
subunit	O
was	O
purchased	O
(	O
dbEST	O
Id	O
,	O
807416	O
,	O
Image	O
:	O
606689	O
,	O
Image	O
Consortium	O
,	O
LLNL	O
)	O
.	O

It	O
was	O
found	O
to	O
contain	O
2	O
.	O
8	O
-	O
kb	O
of	O
sequence	O
from	O
position	O
247	O
of	O
the	O
coding	O
sequence	O
to	O
the	O
stop	O
codon	O
at	O
position	O
2	O
,	O
101	O
,	O
including	O
the	O
3	O
'	O
-	O
UTR	O
to	O
the	O
polyA	O
signal	O
.	O

A	O
fragment	O
of	O
this	O
cDNA	O
was	O
subcloned	O
and	O
used	O
to	O
screen	O
a	O
129Sv	O
mouse	O
genomic	O
library	O
in	O
lambda	O
-	O
Dash	O
II	O
.	O

Overlapping	O
genomic	O
clones	O
were	O
obtained	O
covering	O
15	O
,	O
354	O
bp	O
,	O
extending	O
from	O
a	O
BamHI	O
site	O
in	O
intron	O
3	O
to	O
a	O
BamHI	O
site	O
in	O
intron	O
15	O
.	O

These	O
clones	O
were	O
sequenced	O
completely	O
on	O
both	O
strands	O
and	O
the	O
data	O
were	O
submitted	O
to	O
GenBank	O
(	O
accession	O
no	O
.	O
AF497625	O
)	O
.	O

The	O
submitted	O
sequences	O
agreed	O
precisely	O
with	O
the	O
public	O
databases	O
,	O
and	O
also	O
filled	O
in	O
several	O
small	O
gaps	O
corresponding	O
to	O
short	O
repetitive	O
sequences	O
which	O
could	O
only	O
be	O
firmly	O
established	O
by	O
repeated	O
sequencing	O
in	O
non	O
-	O
standard	O
conditions	O
.	O

Construction	O
of	O
the	O
Capn2	O
targeting	O
vector	O

A	O
targeting	O
construct	O
was	O
designed	O
to	O
replace	O
a	O
785	O
bp	O
BamHI	O
-	O
HindIII	O
fragment	O
,	O
containing	O
exon	O
7	O
of	O
the	O
Capn2	O
gene	O
,	O
with	O
the	O
PGK	O
-	O
Neo	O
cassette	O
(	O
Figure	O
1	O
)	O
.	O

Exon	O
7	O
encodes	O
24	O
amino	B-CHEBI
acids	I-CHEBI
in	O
the	O
active	O
-	O
site	O
region	O
,	O
including	O
Asn286	O
,	O
one	O
of	O
the	O
catalytic	O
triad	O
residues	B-CHEBI
.	O

The	O
short	O
(	O
upstream	O
)	O
arm	O
of	O
the	O
targeting	O
construct	O
was	O
provided	O
by	O
a	O
2	O
.	O
7	O
-	O
kb	O
HindIII	O
-	O
BamHI	O
fragment	O
,	O
containing	O
exons	O
5	O
and	O
6	O
,	O
which	O
was	O
inserted	O
into	O
the	O
pPNT	O
vector	O
upstream	O
of	O
the	O
PGK	O
-	O
Neo	O
cassette	O
[	O
48	O
]	O
.	O

During	O
cloning	O
,	O
the	O
BamHI	O
site	O
at	O
the	O
3	O
'	O
end	O
of	O
the	O
short	O
arm	O
was	O
abolished	O
.	O

The	O
loss	O
of	O
this	O
BamHI	O
site	O
in	O
the	O
mutant	O
allele	O
,	O
coupled	O
with	O
the	O
introduction	O
of	O
a	O
new	O
BamHI	O
site	O
at	O
the	O
3	O
'	O
end	O
of	O
the	O
PGK	O
-	O
Neo	O
cassette	O
,	O
provided	O
a	O
basis	O
for	O
distinguishing	O
the	O
wild	O
-	O
type	O
and	O
mutant	O
alleles	O
by	O
Southern	O
blotting	O
.	O

The	O
long	O
(	O
downstream	O
)	O
arm	O
of	O
homology	O
was	O
provided	O
by	O
a	O
7	O
-	O
kb	O
HindIII	O
-	O
KpnI	O
fragment	O
,	O
extending	O
from	O
intron	O
7	O
to	O
intron	O
12	O
,	O
inserted	O
between	O
the	O
PGK	O
-	O
Neo	O
and	O
thymidine	B-CHEBI
kinase	O
(	O
tk	O
)	O
cassettes	O
.	O

Figure	O
1	O

Targeting	O
strategy	O
for	O
disruption	O
of	O
the	O
murine	O
Capn2	O
gene	O
.	O

The	O
murine	O
Capn2	O
gene	O
,	O
encoding	O
the	O
m	O
-	O
80	O
k	O
subunit	O
,	O
was	O
disrupted	O
in	O
ES	O
cells	O
by	O
homologous	O
recombination	O
.	O

The	O
structures	O
of	O
the	O
wild	O
-	O
type	O
allele	O
(	O
top	O
)	O
,	O
the	O
targeting	O
vector	O
(	O
middle	O
)	O
,	O
and	O
the	O
mutant	O
allele	O
(	O
bottom	O
)	O
are	O
depicted	O
.	O

In	O
the	O
mutant	O
allele	O
,	O
a	O
PGK	O
-	O
Neo	O
cassette	O
replaces	O
a	O
0	O
.	O
8	O
-	O
kb	O
genomic	O
fragment	O
containing	O
exon	O
7	O
(	O
grey	O
rectangle	O
)	O
which	O
encodes	O
the	O
active	O
site	O
asparagine	B-CHEBI
residue	I-CHEBI
(	O
Asn286	O
)	O
In	O
the	O
targeting	O
vector	O
,	O
the	O
PGK	O
-	O
Neo	O
cassette	O
is	O
flanked	O
by	O
2	O
.	O
7	O
-	O
kb	O
of	O
Capn2	O
homologous	O
sequence	O
in	O
the	O
upstream	O
(	O
short	O
)	O
arm	O
and	O
7	O
.	O
9	O
-	O
kb	O
of	O
homology	O
in	O
the	O
downstream	O
(	O
long	O
)	O
arm	O
.	O

A	O
probe	O
located	O
immediately	O
outside	O
of	O
the	O
short	O
arm	O
detects	O
a	O
3	O
.	O
5	O
-	O
kb	O
BamHI	O
fragment	O
from	O
the	O
wild	O
-	O
type	O
allele	O
and	O
a	O
5	O
.	O
3	O
-	O
kb	O
BamHI	O
fragment	O
from	O
the	O
mutant	O
allele	O
.	O

Exons	O
are	O
depicted	O
as	O
open	O
vertical	O
rectangles	O
except	O
for	O
exon	O
7	O
which	O
is	O
represented	O
by	O
a	O
solid	O
vertical	O
rectangle	O
.	O

The	O
probe	O
used	O
in	O
most	O
Southern	O
blot	O
analyses	O
is	O
shown	O
as	O
a	O
solid	O
,	O
horizontal	O
rectangle	O
,	O
while	O
triangles	O
mark	O
the	O
positions	O
of	O
PCR	O
primers	O
also	O
used	O
for	O
genotyping	O
purposes	O
.	O

ES	O
cell	O
culture	O
,	O
transfection	O
and	O
selection	O
of	O
targeted	O
clones	O

Mouse	O
R1	O
ES	O
cells	O
[	O
49	O
]	O
were	O
maintained	O
on	O
gelatin	O
-	O
coated	O
plates	O
with	O
feeder	O
layers	O
of	O
mouse	O
embryonic	O
fibroblasts	O
at	O
37	O
degrees	O
C	O
under	O
5	O
%	O
CO2	B-CHEBI
in	O
ES	O
cell	O
medium	O
(	O
DMEM	O
[	O
high	O
glucose	B-CHEBI
]	O
supplemented	O
with	O
15	O
%	O
fetal	O
bovine	O
serum	O
,	O
0	O
.	O
1	O
mM	O
non	O
-	O
essential	O
amino	B-CHEBI
acids	I-CHEBI
,	O
2	O
mM	O
glutamine	B-CHEBI
,	O
1	O
mM	O
sodium	B-CHEBI
pyruvate	B-CHEBI
,	O
0	O
.	O
1	O
mM	O
2	B-CHEBI
-	I-CHEBI
mercaptoethanol	I-CHEBI
,	O
100	O
U	O
/	O
ml	O
penicillin	B-CHEBI
,	O
100	O
mu	O
g	O
/	O
ml	O
streptomycin	B-CHEBI
,	O
25	O
mu	O
g	O
/	O
ml	O
amphotericin	O
,	O
and	O
1	O
,	O
000	O
U	O
/	O
ml	O
of	O
ESGro	O
[	O
Chemicon	O
]	O
)	O
.	O

Fetal	O
bovine	O
serum	O
from	O
HyClone	O
Laboratories	O
Inc	O
(	O
Logan	O
,	O
Utah	O
)	O
was	O
tested	O
for	O
its	O
ability	O
to	O
support	O
ES	O
cell	O
growth	O
.	O

Gelatin	O
was	O
from	O
Sigma	O
-	O
Aldrich	O
Canada	O
(	O
Oakville	O
,	O
Ontario	O
)	O
.	O

Unless	O
otherwise	O
specified	O
,	O
all	O
other	O
tissue	O
culture	O
reagents	B-CHEBI
were	O
from	O
Gibco	O
-	O
BRL	O
.	O

The	O
targeting	O
construct	O
was	O
linearized	O
by	O
NotI	O
digestion	O
and	O
electroporated	O
into	O
R1	O
ES	O
cells	O
.	O

Cells	O
were	O
plated	O
without	O
feeder	O
layers	O
on	O
gelatin	O
-	O
coated	O
plates	O
and	O
transformed	O
clones	O
were	O
selected	O
in	O
the	O
presence	O
of	O
200	O
mu	O
g	O
/	O
ml	O
G418	O
(	O
Gibco	O
-	O
BRL	O
)	O
and	O
2	O
mu	O
M	O
ganciclovir	O
(	O
Syntex	O
,	O
Inc	O
.	O
)	O
for	O
eight	O
days	O
.	O

Drug	B-CHEBI
-	O
resistant	O
clones	O
were	O
picked	O
,	O
expanded	O
on	O
gelatin	O
-	O
coated	O
plates	O
,	O
and	O
genotyped	O
by	O
Southern	O
blotting	O
and	O
PCR	O
analysis	O
(	O
see	O
below	O
)	O
.	O

Generation	O
of	O
targeted	O
mice	O

Capn2	O
+	O
/	O
-	O
ES	O
cells	O
were	O
aggregated	O
overnight	O
with	O
8	O
-	O
cell	O
embryos	O
recovered	O
from	O
CD1	O
matings	O
,	O
as	O
previously	O
described	O
[	O
31	O
]	O
.	O

On	O
the	O
next	O
day	O
,	O
blastocysts	O
were	O
transferred	O
to	O
pseudopregnant	O
CD1	O
females	O
.	O

Chimeric	O
animals	O
were	O
identifiable	O
at	O
birth	O
by	O
black	O
eye	O
pigmentation	O
and	O
subsequently	O
by	O
patches	O
of	O
agouti	O
coat	O
colour	O
.	O

Chimeric	O
males	O
were	O
bred	O
with	O
CD1	O
females	O
to	O
identify	O
those	O
males	O
capable	O
of	O
germline	O
transmission	O
.	O

These	O
were	O
then	O
bred	O
with	O
129SvJ	O
females	O
to	O
establish	O
the	O
mutation	O
in	O
an	O
inbred	O
genetic	O
background	O
.	O

Mouse	O
protocols	O
were	O
approved	O
by	O
the	O
Queen	O
'	O
s	O
University	O
Animal	O
Care	O
Committee	O
according	O
to	O
the	O
guidelines	O
of	O
the	O
Canadian	O
Council	O
on	O
Animal	O
Care	O
.	O

Genotyping	O
methods	O

Several	O
Southern	O
blot	O
and	O
PCR	O
strategies	O
were	O
exploited	O
in	O
order	O
to	O
determine	O
the	O
genotype	O
of	O
the	O
Capn2	O
locus	O
.	O

Southern	O
blotting	O
was	O
carried	O
out	O
using	O
the	O
digoxigenin	B-CHEBI
(	O
DIG	B-CHEBI
)	O
non	O
-	O
radioactive	O
system	O
(	O
Roche	O
)	O
.	O

In	O
most	O
cases	O
,	O
membranes	O
were	O
blotted	O
with	O
BamHI	O
-	O
digested	O
genomic	O
DNA	O
and	O
hybridized	O
with	O
a	O
DIG	B-CHEBI
-	O
labeled	O
823	O
bp	O
exon	O
4	O
-	O
containing	O
BamHI	O
-	O
HindIII	O
fragment	O
located	O
immediately	O
upstream	O
of	O
the	O
short	O
arm	O
of	O
homology	O
(	O
Figure	O
1	O
)	O
.	O

A	O
681	O
bp	O
PstI	O
-	O
XbaI	O
fragment	O
from	O
the	O
PGK	O
-	O
Neo	O
cassette	O
was	O
also	O
used	O
to	O
probe	O
Southern	O
blots	O
in	O
order	O
to	O
verify	O
a	O
single	O
integration	O
event	O
in	O
targeted	O
clones	O
.	O

Genotyping	O
was	O
also	O
carried	O
out	O
by	O
PCR	O
analysis	O
of	O
genomic	O
DNA	O
.	O

The	O
sequences	O
of	O
all	O
oligonucleotide	O
primers	O
are	O
listed	O
in	O
Table	O
1	O
.	O

A	O
single	O
-	O
step	O
PCR	O
strategy	O
was	O
sufficient	O
for	O
genotyping	O
ES	O
cells	O
or	O
biopsies	O
from	O
post	O
-	O
implantation	O
embryos	O
and	O
weanlings	O
(	O
Figure	O
1	O
)	O
.	O

A	O
2	O
,	O
748	O
bp	O
segment	O
of	O
the	O
wild	O
-	O
type	O
allele	O
and	O
a	O
2	O
,	O
711	O
bp	O
segment	O
of	O
the	O
mutant	O
allele	O
were	O
amplified	O
in	O
separate	O
reactions	O
using	O
a	O
common	O
(	O
intron	O
4	O
)	O
sense	O
primer	O
,	O
located	O
outside	O
the	O
short	O
arm	O
of	O
homology	O
,	O
and	O
distinct	O
antisense	O
primers	O
which	O
hybridized	O
to	O
either	O
wild	O
-	O
type	O
(	O
exon	O
7	O
)	O
or	O
mutant	O
(	O
PGK	O
-	O
Neo	O
)	O
sequence	O
(	O
Table	O
I	O
)	O
.	O

The	O
thermocycling	O
parameters	O
included	O
a	O
five	O
minute	O
initial	O
denaturation	O
step	O
at	O
95	O
degrees	O
C	O
,	O
30	O
cycles	O
of	O
one	O
minute	O
denaturation	O
at	O
95	O
degrees	O
C	O
,	O
one	O
minute	O
annealing	O
at	O
56	O
degrees	O
C	O
,	O
and	O
one	O
minute	O
extension	O
at	O
72	O
degrees	O
C	O
,	O
with	O
a	O
ten	O
minute	O
final	O
extension	O
step	O
.	O

Table	O
1	O

Oligonucleotide	O
primers	O
used	O
to	O
genotype	O
the	O
Capn2	O
locus	O

Due	O
to	O
the	O
limited	O
amount	O
of	O
genetic	O
material	O
available	O
in	O
pre	O
-	O
implantation	O
embryos	O
,	O
a	O
nested	O
PCR	O
strategy	O
was	O
developed	O
to	O
yield	O
reliable	O
genotyping	O
information	O
(	O
Figure	O
4	O
)	O
.	O

Whole	O
embryos	O
were	O
first	O
digested	O
in	O
20	O
mu	O
L	O
of	O
proteinase	O
K	O
buffer	O
(	O
see	O
below	O
)	O
.	O

The	O
lysate	O
was	O
then	O
divided	O
in	O
two	O
,	O
with	O
half	O
(	O
10	O
mu	O
L	O
)	O
being	O
used	O
in	O
the	O
amplification	O
of	O
the	O
wild	O
-	O
type	O
allele	O
and	O
the	O
remaining	O
10	O
mu	O
L	O
in	O
the	O
amplification	O
of	O
the	O
mutant	O
allele	O
.	O

The	O
first	O
reaction	O
in	O
the	O
nested	O
PCR	O
amplification	O
of	O
the	O
wild	O
-	O
type	O
allele	O
was	O
carried	O
out	O
in	O
a	O
final	O
reaction	O
volume	O
of	O
50	O
mu	O
L	O
,	O
using	O
an	O
intron	O
6	O
sense	O
primer	O
and	O
an	O
antisense	O
primer	O
located	O
in	O
intron	O
7	O
.	O

Two	O
mu	O
L	O
of	O
the	O
first	O
reaction	O
were	O
used	O
as	O
template	O
in	O
the	O
second	O
PCR	O
amplification	O
using	O
another	O
intron	O
6	O
sense	O
primer	O
and	O
an	O
antisense	O
primer	O
in	O
exon	O
7	O
.	O

The	O
nested	O
amplification	O
of	O
the	O
mutant	O
allele	O
was	O
carried	O
out	O
similarly	O
.	O

The	O
first	O
primer	O
pair	O
consisted	O
of	O
the	O
intron	O
6	O
sense	O
primer	O
and	O
an	O
antisense	O
primer	O
in	O
the	O
PGK	O
-	O
Neo	O
cassette	O
.	O

The	O
nested	O
primer	O
pair	O
was	O
comprised	O
of	O
the	O
second	O
intron	O
6	O
sense	O
primer	O
and	O
an	O
antisense	O
primer	O
also	O
located	O
within	O
the	O
PGK	O
-	O
Neo	O
sequence	O
.	O

It	O
should	O
be	O
noted	O
that	O
amplification	O
of	O
both	O
sequences	O
involved	O
the	O
same	O
sense	O
primers	O
in	O
both	O
steps	O
of	O
the	O
nested	O
PCR	O
strategy	O
.	O

In	O
addition	O
,	O
the	O
two	O
sets	O
of	O
reactions	O
included	O
a	O
common	O
internal	O
control	O
designed	O
to	O
amplify	O
a	O
genomic	O
region	O
within	O
the	O
short	O
arm	O
of	O
the	O
targeting	O
vector	O
that	O
is	O
preserved	O
in	O
both	O
the	O
wild	O
-	O
type	O
and	O
mutant	O
alleles	O
.	O

The	O
first	O
primer	O
pair	O
of	O
the	O
control	O
PCR	O
was	O
made	O
up	O
of	O
an	O
intron	O
4	O
sense	O
primer	O
and	O
an	O
intron	O
5	O
antisense	O
primer	O
.	O

The	O
second	O
primer	O
pair	O
comprised	O
an	O
exon	O
5	O
sense	O
primer	O
and	O
a	O
nested	O
intron	O
5	O
antisense	O
primer	O
.	O

The	O
final	O
products	O
were	O
213	O
bp	O
for	O
the	O
control	O
PCR	O
,	O
429	O
bp	O
for	O
the	O
wild	O
-	O
type	O
PCR	O
,	O
and	O
389	O
bp	O
for	O
the	O
mutant	O
PCR	O
.	O

All	O
reactions	O
were	O
carried	O
out	O
using	O
identical	O
PCR	O
conditions	O
entailing	O
an	O
initial	O
five	O
minute	O
denaturation	O
at	O
95	O
degrees	O
C	O
,	O
35	O
cycles	O
of	O
one	O
minute	O
denaturation	O
at	O
95	O
degrees	O
C	O
,	O
one	O
minute	O
annealing	O
at	O
56	O
degrees	O
C	O
,	O
and	O
one	O
minute	O
extension	O
at	O
72	O
degrees	O
C	O
,	O
with	O
a	O
final	O
extension	O
step	O
of	O
ten	O
minutes	O
.	O

Isolation	O
of	O
pre	O
-	O
implantation	O
embryos	O

Time	O
of	O
fertilization	O
was	O
determined	O
by	O
observation	O
of	O
copulation	O
plugs	O
,	O
and	O
noon	O
of	O
that	O
day	O
was	O
defined	O
as	O
E0	O
.	O
5	O
.	O

Pre	O
-	O
implantation	O
embryos	O
were	O
obtained	O
by	O
dissecting	O
the	O
uteri	O
out	O
of	O
pregnant	O
females	O
at	O
E2	O
.	O
5	O
or	O
E3	O
.	O
5	O
and	O
flushing	O
the	O
oviducts	O
with	O
ES	O
cell	O
medium	O
.	O

Isolated	O
embryos	O
were	O
then	O
digested	O
for	O
five	O
hours	O
at	O
55	O
degrees	O
C	O
in	O
20	O
mu	O
L	O
of	O
lysis	O
buffer	O
(	O
50	O
mM	O
Tris	B-CHEBI
-	O
HCl	B-CHEBI
,	O
0	O
.	O
5	O
%	O
Triton	O
X	O
-	O
100	O
,	O
200	O
mu	O
L	O
/	O
mL	O
proteinase	O
K	O
,	O
pH	O
8	O
.	O
0	O
)	O
,	O
followed	O
by	O
ten	O
minutes	O
at	O
95	O
degrees	O
C	O
to	O
inactivate	O
the	O
proteinase	O
K	O
.	O

Lysates	O
were	O
then	O
used	O
for	O
PCR	O
genotyping	O
.	O

List	O
of	O
abbreviations	O

EGF	O
:	O
Epidermal	O
growth	O
factor	O

ES	O
:	O
Embryonic	O
stem	O

MEF	O
:	O
Mouse	O
embryonic	O
fibroblast	O

kDa	O
:	O
kilodalton	O

kb	O
:	O
kilobase	O

bp	O
:	O
base	O
pair	O

Authors	O
'	O
contributions	O

DEC	O
generated	O
the	O
Capn2	O
targeting	O
construct	O
.	O

PD	O
and	O
PAG	O
carried	O
out	O
the	O
ES	O
electroporation	O
and	O
selection	O
of	O
targeted	O
clones	O
.	O

KW	O
performed	O
aggregation	O
chimeras	O
to	O
establish	O
germline	O
chimeric	O
animals	O
.	O

TDV	O
established	O
and	O
maintained	O
the	O
knockout	O
mouse	O
colony	O
and	O
performed	O
genotyping	O
analysis	O
.	O

PD	O
,	O
JSCA	O
,	O
JSE	O
,	O
DEC	O
and	O
PAG	O
conceived	O
the	O
study	O
and	O
helped	O
draft	O
the	O
manuscript	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Figure	O
3	O

Genotyping	O
of	O
weanlings	O
from	O
heterozygote	O
intercrosses	O
.	O

A	O
representative	O
example	O
of	O
the	O
Southern	O
blot	O
genotyping	O
of	O
progeny	O
from	O
a	O
Capn2	O
+	O
/	O
-	O
intercross	O
is	O
shown	O
.	O

Genomic	O
DNA	O
was	O
extracted	O
from	O
mouse	O
tail	O
biopsies	O
taken	O
from	O
three	O
-	O
week	O
old	O
weanlings	O
and	O
genotyped	O
by	O
Southern	O
blotting	O
as	O
described	O
in	O
Figure	O
1	O
.	O

A	O
3	O
.	O
5	O
-	O
kb	O
BamHI	O
fragment	O
from	O
the	O
wild	O
-	O
type	O
allele	O
was	O
detected	O
in	O
all	O
animals	O
while	O
a	O
5	O
.	O
3	O
-	O
kb	O
BamHI	O
fragment	O
from	O
the	O
mutant	O
allele	O
was	O
observed	O
in	O
a	O
subset	O
of	O
progeny	O
.	O

No	O
Capn2	O
-	O
/	O
-	O
offspring	O
were	O
detected	O
among	O
weanlings	O
or	O
post	O
-	O
implantation	O
embryos	O
,	O
nor	O
were	O
embryo	O
resorption	O
sites	O
observed	O
.	O

These	O
results	O
indicate	O
that	O
Capn2	O
-	O
/	O
-	O
embryos	O
perished	O
at	O
a	O
pre	O
-	O
implantation	O
stage	O
.	O

Acknowledgements	O

We	O
would	O
like	O
to	O
thank	O
Andras	O
Nagy	O
for	O
providing	O
the	O
R1	O
ES	O
cell	O
line	O
,	O
Janet	O
Rossant	O
for	O
the	O
129SvJ	O
mouse	O
genomic	O
DNA	O
library	O
,	O
and	O
Ralph	O
Zirngibl	O
for	O
modification	O
of	O
the	O
pPNT	O
vector	O
.	O

Initial	O
cloning	O
of	O
Capn2	O
and	O
vector	O
construction	O
was	O
undertaken	O
by	O
DEC	O
as	O
a	O
sabbatical	O
visitor	O
at	O
Queen	O
'	O
s	O
University	O
with	O
support	O
from	O
the	O
National	O
Science	O
Foundation	O
(	O
MCB9723636	O
)	O
and	O
the	O
University	O
of	O
Maine	O
.	O

This	O
work	O
was	O
supported	O
by	O
grants	O
from	O
the	O
Canadian	O
Institutes	O
of	O
Health	O
Research	O
and	O
The	O
Heart	O
and	O
Stroke	O
Foundation	O
of	O
Canada	O
.	O

P	O
.	O
D	O
.	O
was	O
an	O
Ontario	O
Graduate	O
Scholar	O
.	O

Deficits	O
in	O
spatial	O
learning	O
and	O
motor	O
coordination	O
in	O
ADAM11	O
-	O
deficient	O
mice	O

Abstract	O

Background	O

ADAM11	O
is	O
a	O
member	O
of	O
the	O
ADAM	O
gene	O
family	O
and	O
is	O
mainly	O
expressed	O
in	O
the	O
nervous	O
system	O
.	O

It	O
is	O
thought	O
to	O
be	O
an	O
adhesion	O
molecule	B-CHEBI
,	O
since	O
it	O
has	O
a	O
disintegrin	O
-	O
like	O
domain	O
related	O
to	O
cell	O
-	O
cell	O
or	O
cell	O
-	O
matrix	O
interactions	O
.	O

To	O
elucidate	O
the	O
physiological	O
functions	O
of	O
ADAM11	O
,	O
we	O
generated	O
ADAM11	O
-	O
deficient	O
mice	O
by	O
means	O
of	O
gene	O
targeting	O
.	O

Results	O

ADAM11	O
-	O
deficient	O
mice	O
were	O
apparently	O
normal	O
,	O
and	O
survived	O
more	O
than	O
one	O
year	O
with	O
no	O
major	O
histological	O
abnormalities	O
in	O
the	O
brain	O
or	O
spinal	O
cord	O
.	O

Because	O
ADAM11	O
is	O
highly	O
expressed	O
in	O
the	O
hippocampus	O
and	O
cerebellum	O
,	O
we	O
have	O
examined	O
ADAM11	O
mutant	O
mice	O
for	O
learning	O
using	O
visual	O
and	O
hidden	O
water	B-CHEBI
maze	O
tasks	O
,	O
and	O
their	O
motor	O
coordination	O
using	O
a	O
rotating	O
rod	O
task	O
.	O

Our	O
results	O
showed	O
that	O
their	O
visual	O
water	B-CHEBI
maze	O
task	O
results	O
are	O
normal	O
,	O
but	O
the	O
hidden	O
water	B-CHEBI
maze	O
and	O
rotating	O
rod	O
task	O
skills	O
are	O
impaired	O
in	O
ADAM11	O
-	O
deficient	O
mice	O
.	O

Conclusion	O

Our	O
results	O
indicate	O
that	O
ADAM11	O
mutation	O
does	O
not	O
affect	O
cell	O
migration	O
and	O
differentiation	O
during	O
development	O
,	O
but	O
affects	O
learning	O
and	O
motor	O
coordination	O
.	O

Thus	O
,	O
ADAM11	O
might	O
play	O
an	O
important	O
signalling	O
or	O
structural	O
role	O
as	O
a	O
cell	O
adhesion	O
molecule	B-CHEBI
at	O
the	O
synapse	O
,	O
and	O
may	O
thus	O
participate	O
in	O
synaptic	O
regulation	O
underlying	O
behavioural	O
changes	O
.	O

Background	O

The	O
ADAM	O
(	O
A	O
Disintegrin	O
And	O
Metalloprotease	O
)	O
family	O
comprises	O
membrane	O
-	O
spanning	O
multi	O
-	O
domain	O
proteins	B-CHEBI
containing	O
a	O
metalloproteinase	O
-	O
like	O
domain	O
and	O
a	O
disintegrin	O
-	O
like	O
domain	O
.	O

Approximately	O
half	O
of	O
the	O
ADAMs	O
are	O
catalytically	O
active	O
metalloproteases	O
that	O
shed	O
a	O
broad	O
range	O
of	O
substrates	O
,	O
such	O
as	O
cytokines	O
,	O
growth	O
factors	O
,	O
receptors	O
,	O
adhesion	O
molecules	B-CHEBI
[	O
1	O
,	O
2	O
]	O
.	O

Recent	O
gene	O
-	O
disruption	O
studies	O
in	O
mice	O
have	O
disclosed	O
a	O
physiological	O
role	O
of	O
each	O
ADAM	O
.	O

For	O
example	O
,	O
ADAM10	O
,	O
ADAM17	O
and	O
ADAM19	O
are	O
critical	O
for	O
normal	O
development	O
by	O
providing	O
growth	O
signals	O
at	O
the	O
correct	O
times	O
and	O
places	O
[	O
3	O
-	O
6	O
]	O
.	O

In	O
contrast	O
,	O
the	O
functions	O
of	O
ADAM8	O
,	O
ADAM9	O
,	O
ADAM12	O
and	O
ADAM15	O
are	O
not	O
essential	O
for	O
embryogenesis	O
,	O
suggesting	O
a	O
possible	O
functional	O
redundancy	O
with	O
other	O
protease	O
[	O
7	O
-	O
10	O
]	O
.	O

The	O
remaining	O
half	O
,	O
which	O
are	O
non	O
-	O
protease	O
-	O
ADAMs	O
,	O
are	O
thought	O
to	O
be	O
adhesion	O
molecules	B-CHEBI
.	O

More	O
than	O
ten	O
ADAMs	O
have	O
been	O
shown	O
to	O
support	O
integrin	O
-	O
mediated	O
cell	O
adhesion	O
in	O
vitro	O
[	O
11	O
]	O
.	O

More	O
recently	O
,	O
the	O
finding	O
has	O
been	O
reported	O
that	O
integrin	O
-	O
mediated	O
cell	O
migration	O
of	O
tissue	O
culture	O
cells	O
can	O
be	O
controlled	O
by	O
distinct	O
ADAMs	O
[	O
12	O
]	O
.	O

In	O
C	O
.	O
elegans	O
,	O
unc	O
-	O
71	O
gene	O
coding	O
a	O
non	O
-	O
protease	O
-	O
ADAM	O
protein	B-CHEBI
have	O
been	O
shown	O
to	O
be	O
involved	O
in	O
cell	O
migration	O
events	O
in	O
vivo	O
[	O
13	O
]	O
.	O

However	O
,	O
the	O
physiological	O
roles	O
of	O
mammalian	O
non	O
-	O
protease	O
-	O
ADAMs	O
are	O
poorly	O
understood	O
in	O
vivo	O
.	O

Genetic	O
deletion	O
studies	O
in	O
mice	O
have	O
shown	O
that	O
both	O
Adam2	O
-	O
null	O
and	O
Adam3	O
-	O
null	O
male	O
mutants	O
are	O
infertile	O
and	O
their	O
spermatozoa	O
lack	O
egg	O
-	O
binding	O
abilities	O
[	O
14	O
-	O
16	O
]	O
.	O

The	O
precise	O
mechanism	O
is	O
under	O
investigation	O
[	O
17	O
]	O
.	O

We	O
have	O
reported	O
the	O
findings	O
of	O
ADAM11	O
,	O
ADAM22	O
and	O
ADAM23	O
genes	O
and	O
their	O
restricted	O
expression	O
in	O
the	O
human	O
and	O
murine	O
nervous	O
systems	O
[	O
18	O
,	O
19	O
]	O
.	O

These	O
ADAMs	O
lack	O
a	O
catalytic	O
motif	O
critical	O
for	O
the	O
metalloproteinase	O
activity	O
,	O
suggesting	O
that	O
they	O
are	O
not	O
proteases	O
.	O

We	O
assume	O
that	O
these	O
ADAMs	O
might	O
contribute	O
to	O
cell	O
migration	O
,	O
differentiation	O
and	O
survival	O
or	O
synaptic	O
regulation	O
by	O
binding	O
to	O
integrins	O
,	O
cell	O
-	O
surface	O
proteins	B-CHEBI
or	O
intracellular	O
signalling	O
molecules	B-CHEBI
[	O
20	O
,	O
21	O
]	O
.	O

We	O
have	O
reported	O
severe	O
ataxia	O
,	O
seizures	O
,	O
and	O
death	O
before	O
weaning	O
,	O
accompanied	O
with	O
hypomyelination	O
of	O
the	O
peripheral	O
nervous	O
system	O
in	O
Adam22	O
-	O
null	O
mutant	O
mice	O
[	O
22	O
]	O
.	O

It	O
has	O
been	O
reported	O
that	O
the	O
disruption	O
of	O
Adam23	O
gene	O
in	O
the	O
mouse	O
results	O
in	O
premature	O
death	O
associated	O
with	O
ataxia	O
and	O
tremor	O
[	O
23	O
]	O
.	O

Is	O
spite	O
of	O
such	O
extreme	O
phenotypes	O
,	O
no	O
histological	O
defects	O
in	O
the	O
brain	O
has	O
been	O
observed	O
in	O
either	O
Adam22	O
-	O
null	O
nor	O
Adam23	O
-	O
null	O
mice	O
.	O

ADAM11	O
is	O
the	O
closest	O
paralog	O
of	O
ADAM22	O
and	O
ADAM23	O
,	O
and	O
its	O
orthologs	O
have	O
been	O
found	O
in	O
vertebrates	O
,	O
but	O
not	O
in	O
invertebrates	O
.	O

It	O
has	O
been	O
reported	O
that	O
the	O
Xenopus	O
ADAM11	O
ortholog	O
,	O
xMDC11a	O
,	O
has	O
an	O
expression	O
pattern	O
associated	O
with	O
neural	O
development	O
,	O
with	O
a	O
proposed	O
role	O
in	O
cell	O
migration	O
[	O
24	O
]	O
;	O
and	O
it	O
has	O
been	O
reported	O
in	O
analyses	O
using	O
Northern	O
blot	O
and	O
in	O
situ	O
hybridisation	O
methods	O
that	O
the	O
murine	O
Adam11	O
gene	O
is	O
expressed	O
in	O
both	O
the	O
developing	O
and	O
adult	O
nervous	O
system	O
[	O
19	O
,	O
25	O
]	O
.	O

These	O
findings	O
led	O
us	O
to	O
hypothesise	O
that	O
ADAM11	O
is	O
an	O
integrin	O
binder	O
that	O
plays	O
an	O
important	O
role	O
in	O
the	O
nervous	O
system	O
,	O
as	O
do	O
ADAM22	O
and	O
ADAM23	O
.	O

To	O
determine	O
the	O
physiological	O
functions	O
of	O
ADAM11	O
,	O
we	O
generated	O
and	O
analysed	O
Adam11	O
gene	O
-	O
targeted	O
mice	O
.	O

Results	O

Generation	O
of	O
ADAM11	O
-	O
deficient	O
mice	O

Mice	O
carrying	O
a	O
targeted	O
mutation	O
in	O
their	O
Adam11	O
gene	O
were	O
generated	O
by	O
homologous	O
recombination	O
(	O
Fig	O
.	O
1A	O
)	O
.	O

Correct	O
targeting	O
events	O
were	O
confirmed	O
by	O
Southern	O
blot	O
analysis	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

As	O
a	O
result	O
of	O
this	O
procedure	O
,	O
since	O
a	O
termination	O
codon	O
was	O
introduced	O
in	O
exon	O
5	O
in	O
the	O
pro	O
-	O
protein	B-CHEBI
domain	O
,	O
only	O
the	O
truncated	O
form	O
of	O
the	O
ADAM11	O
protein	B-CHEBI
would	O
be	O
synthesised	O
from	O
this	O
targeted	O
allele	O
.	O

Because	O
pro	O
-	O
protein	B-CHEBI
domains	O
are	O
always	O
removed	O
in	O
mature	O
functional	O
ADAM	O
-	O
proteins	B-CHEBI
by	O
furin	O
-	O
like	O
proteases	O
and	O
are	O
thus	O
thought	O
to	O
be	O
non	O
-	O
functional	O
,	O
we	O
concluded	O
that	O
this	O
truncated	O
form	O
of	O
ADAM11	O
protein	B-CHEBI
would	O
have	O
no	O
function	O
[	O
26	O
]	O
.	O

Absence	O
of	O
mature	O
ADAM11	O
protein	B-CHEBI
in	O
homozygous	O
mutants	O
was	O
confirmed	O
by	O
Western	O
blot	O
analysis	O
using	O
a	O
specific	O
antibody	O
that	O
recognises	O
the	O
ADAM11	O
protein	B-CHEBI
(	O
Fig	O
.	O
1C	O
)	O
.	O

Analysis	O
by	O
Western	O
blot	O
showed	O
that	O
heterozygous	O
mutants	O
produced	O
approximately	O
half	O
of	O
the	O
wild	O
-	O
type	O
levels	O
of	O
ADAM11	O
protein	B-CHEBI
.	O

ADAM11	O
-	O
deficient	O
mice	O
are	O
viable	O
and	O
appear	O
normal	O

Mating	O
of	O
mice	O
heterozygous	O
for	O
the	O
ADAM11	O
mutation	O
yielded	O
a	O
near	O
-	O
Mendelian	O
distribution	O
of	O
genotypes	O
in	O
the	O
offspring	O
and	O
the	O
ratio	O
of	O
females	O
and	O
males	O
was	O
the	O
same	O
in	O
all	O
groups	O
(	O
data	O
not	O
shown	O
)	O
.	O

For	O
the	O
present	O
experiments	O
,	O
ADAM11	O
-	O
deficient	O
male	O
mice	O
(	O
backcrossed	O
generations	O
into	O
C57BL	O
/	O
6NCrj	O
,	O
n	O
=	O
14	O
)	O
were	O
used	O
in	O
all	O
behavioural	O
analyses	O
and	O
anatomical	O
-	O
histological	O
studies	O
.	O

Homozygous	O
ADAM11	O
-	O
deficient	O
mice	O
were	O
viable	O
and	O
appeared	O
normal	O
,	O
indicating	O
that	O
the	O
Adam11	O
gene	O
is	O
not	O
essential	O
to	O
development	O
and	O
survival	O
.	O

The	O
gain	O
in	O
body	O
weight	O
of	O
(	O
-	O
/	O
-	O
)	O
mice	O
was	O
comparable	O
to	O
that	O
of	O
(	O
+	O
/	O
+	O
)	O
and	O
(	O
+	O
/	O
-	O
)	O
mice	O
at	O
least	O
until	O
24	O
weeks	O
of	O
age	O
(	O
data	O
not	O
shown	O
)	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
locomotor	O
activity	O
among	O
(	O
+	O
/	O
+	O
)	O
,	O
(	O
+	O
/	O
-	O
)	O
and	O
(	O
-	O
/	O
-	O
)	O
genotypes	O
(	O
data	O
not	O
shown	O
)	O
.	O

No	O
apparent	O
anatomical	O
-	O
histological	O
change	O
was	O
observed	O
in	O
the	O
spinal	O
cord	O
,	O
heart	O
,	O
lung	O
,	O
liver	O
,	O
kidney	O
,	O
spleen	O
,	O
testis	O
or	O
ovary	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
brain	O
of	O
(	O
-	O
/	O
-	O
)	O
mice	O
,	O
including	O
the	O
hippocampus	O
(	O
Fig	O
.	O
1D	O
)	O
and	O
cerebellum	O
(	O
Fig	O
.	O
1E	O
)	O
appeared	O
normal	O
after	O
HE	O
staining	O
when	O
(	O
+	O
/	O
+	O
)	O
,	O
(	O
+	O
/	O
-	O
)	O
and	O
(	O
-	O
/	O
-	O
)	O
mice	O
were	O
compared	O
.	O

Since	O
Adam11	O
is	O
predominantly	O
expressed	O
in	O
the	O
hippocampus	O
and	O
cerebellum	O
,	O
we	O
applied	O
hippocampus	O
-	O
or	O
cerebellum	O
-	O
dependent	O
behavioural	O
analyses	O
.	O

Spatial	O
learning	O
in	O
ADAM11	O
-	O
deficient	O
mice	O

To	O
study	O
the	O
functions	O
of	O
ADAM11	O
in	O
the	O
hippocampus	O
,	O
we	O
examined	O
the	O
spatial	O
learning	O
ability	O
of	O
ADAM11	O
-	O
deficient	O
mice	O
using	O
the	O
Morris	O
Water	B-CHEBI
Maze	O
task	O
[	O
27	O
]	O
.	O

First	O
,	O
mice	O
were	O
trained	O
in	O
a	O
hidden	O
platform	O
task	O
,	O
in	O
which	O
mice	O
searched	O
for	O
a	O
submerged	O
platform	O
to	O
escape	O
from	O
the	O
water	B-CHEBI
.	O

Adam11	O
(	O
-	O
/	O
-	O
)	O
mice	O
were	O
found	O
to	O
take	O
a	O
significantly	O
longer	O
time	O
to	O
locate	O
the	O
hidden	O
platform	O
than	O
(	O
+	O
/	O
+	O
)	O
and	O
(	O
+	O
/	O
-	O
)	O
mice	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

Nonetheless	O
,	O
the	O
ability	O
of	O
(	O
+	O
/	O
+	O
)	O
,	O
(	O
+	O
/	O
-	O
)	O
and	O
(	O
-	O
/	O
-	O
)	O
mice	O
to	O
find	O
the	O
hidden	O
platform	O
improved	O
over	O
test	O
sessions	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

Thus	O
,	O
(	O
+	O
/	O
+	O
)	O
,	O
(	O
+	O
/	O
-	O
)	O
and	O
(	O
-	O
/	O
-	O
)	O
mice	O
were	O
able	O
to	O
learn	O
the	O
location	O
of	O
the	O
hidden	O
platform	O
during	O
the	O
course	O
of	O
the	O
trials	O
,	O
although	O
the	O
capacity	O
of	O
(	O
-	O
/	O
-	O
)	O
mice	O
to	O
find	O
the	O
platform	O
was	O
lower	O
than	O
that	O
of	O
(	O
+	O
/	O
+	O
)	O
and	O
(	O
+	O
/	O
-	O
)	O
mice	O
.	O

We	O
further	O
performed	O
a	O
probe	O
test	O
,	O
in	O
which	O
the	O
platform	O
was	O
removed	O
from	O
the	O
pool	O
after	O
completion	O
of	O
the	O
hidden	O
platform	O
task	O
,	O
and	O
the	O
trained	O
mice	O
were	O
allowed	O
to	O
swim	O
freely	O
for	O
60	O
sec	O
.	O

The	O
time	O
spent	O
in	O
the	O
target	O
quadrant	O
of	O
(	O
-	O
/	O
-	O
)	O
is	O
significantly	O
lower	O
than	O
that	O
of	O
(	O
+	O
/	O
+	O
)	O
mice	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

Adam11	O
(	O
+	O
/	O
-	O
)	O
mice	O
appeared	O
to	O
spend	O
a	O
shorter	O
time	O
in	O
the	O
target	O
quadrant	O
,	O
but	O
there	O
was	O
no	O
significant	O
difference	O
between	O
(	O
+	O
/	O
+	O
)	O
and	O
(	O
+	O
/	O
-	O
)	O
mice	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

These	O
results	O
indicate	O
a	O
spatial	O
learning	O
impairment	O
in	O
(	O
-	O
/	O
-	O
)	O
mice	O
.	O

The	O
swimming	O
distance	O
of	O
(	O
+	O
/	O
+	O
)	O
,	O
(	O
+	O
/	O
-	O
)	O
and	O
(	O
-	O
/	O
-	O
)	O
mice	O
,	O
however	O
,	O
was	O
similar	O
during	O
the	O
probe	O
trial	O
(	O
Fig	O
.	O
2C	O
)	O
.	O

In	O
the	O
visible	O
platform	O
task	O
,	O
the	O
performance	O
of	O
mice	O
with	O
(	O
+	O
/	O
+	O
)	O
,	O
(	O
+	O
/	O
-	O
)	O
and	O
(	O
-	O
/	O
-	O
)	O
genotypes	O
improved	O
during	O
the	O
course	O
of	O
the	O
test	O
sessions	O
,	O
as	O
indicated	O
by	O
a	O
progressive	O
decrease	O
in	O
the	O
latency	O
for	O
locating	O
the	O
platform	O
(	O
Fig	O
.	O
2D	O
)	O
,	O
suggesting	O
that	O
(	O
-	O
/	O
-	O
)	O
mice	O
learn	O
this	O
visible	O
platform	O
task	O
just	O
as	O
well	O
as	O
(	O
+	O
/	O
+	O
)	O
and	O
(	O
+	O
/	O
-	O
)	O
mice	O
.	O

These	O
results	O
also	O
indicated	O
that	O
(	O
-	O
/	O
-	O
)	O
mice	O
have	O
normal	O
visible	O
and	O
motor	O
function	O
and	O
the	O
motivation	O
needed	O
in	O
the	O
water	B-CHEBI
maze	O
task	O
.	O

Motor	O
function	O
of	O
ADAM11	O
-	O
deficient	O
mice	O

To	O
study	O
the	O
functions	O
of	O
ADAM11	O
in	O
the	O
cerebellum	O
,	O
we	O
examined	O
the	O
motor	O
function	O
of	O
ADAM11	O
-	O
deficient	O
mice	O
using	O
a	O
rotating	O
rod	O
task	O
[	O
28	O
]	O
.	O

In	O
the	O
rotating	O
rod	O
test	O
,	O
the	O
retention	O
time	O
of	O
(	O
+	O
/	O
-	O
)	O
and	O
(	O
-	O
/	O
-	O
)	O
mice	O
on	O
the	O
rod	O
was	O
not	O
significantly	O
different	O
from	O
that	O
of	O
(	O
+	O
/	O
+	O
)	O
mice	O
at	O
0	O
rpm	O
(	O
stationary	O
)	O
[	O
+	O
/	O
-	O
:	O
F	O
(	O
1	O
,	O
80	O
)	O
=	O
1	O
.	O
67	O
,	O
p	O
=	O
0	O
.	O
21	O
;	O
-	O
/	O
-	O
:	O
F	O
(	O
1	O
,	O
88	O
)	O
=	O
0	O
.	O
002	O
,	O
p	O
=	O
0	O
.	O
96	O
]	O
(	O
Fig	O
.	O
3A	O
)	O
.	O

In	O
(	O
+	O
/	O
-	O
)	O
mice	O
,	O
the	O
tendency	O
of	O
decreased	O
retention	O
times	O
was	O
seen	O
at	O
5	O
,	O
10	O
and	O
15	O
rpm	O
,	O
but	O
there	O
was	O
no	O
significant	O
difference	O
between	O
(	O
+	O
/	O
+	O
)	O
and	O
(	O
+	O
/	O
-	O
)	O
mice	O
[	O
5	O
rpm	O
:	O
F	O
(	O
1	O
,	O
20	O
)	O
=	O
1	O
.	O
27	O
,	O
p	O
=	O
0	O
.	O
27	O
;	O
10	O
rpm	O
:	O
F	O
(	O
1	O
,	O
20	O
)	O
=	O
1	O
.	O
07	O
,	O
p	O
=	O
0	O
.	O
31	O
;	O
15	O
rpm	O
:	O
F	O
(	O
1	O
,	O
20	O
)	O
=	O
2	O
.	O
716	O
,	O
p	O
=	O
0	O
.	O
11	O
]	O
(	O
Figs	O
.	O
3B	O
,	O
3C	O
and	O
3D	O
)	O
.	O

However	O
,	O
(	O
-	O
/	O
-	O
)	O
mice	O
fell	O
more	O
quickly	O
from	O
the	O
rod	O
than	O
(	O
+	O
/	O
+	O
)	O
mice	O
at	O
5	O
,	O
10	O
and	O
15	O
rpm	O
[	O
5	O
rpm	O
:	O
F	O
(	O
1	O
,	O
27	O
.	O
3	O
)	O
=	O
17	O
.	O
51	O
,	O
p	O
=	O
0	O
.	O
0002	O
;	O
10	O
rpm	O
:	O
F	O
(	O
1	O
,	O
22	O
)	O
=	O
11	O
.	O
05	O
,	O
p	O
=	O
0	O
.	O
003	O
;	O
15	O
rpm	O
:	O
F	O
(	O
1	O
,	O
22	O
)	O
=	O
19	O
.	O
22	O
,	O
p	O
=	O
0	O
.	O
0002	O
]	O
(	O
Figs	O
.	O
3B	O
,	O
3C	O
and	O
3D	O
)	O
.	O

The	O
retention	O
time	O
was	O
not	O
significantly	O
improved	O
in	O
(	O
-	O
/	O
-	O
)	O
mice	O
across	O
trials	O
of	O
training	O
at	O
5	O
,	O
10	O
and	O
15	O
rpm	O
[	O
5	O
rpm	O
:	O
F	O
(	O
3	O
,	O
15	O
.	O
3	O
)	O
=	O
2	O
.	O
05	O
,	O
p	O
=	O
0	O
.	O
15	O
;	O
10	O
rpm	O
:	O
F	O
(	O
7	O
,	O
11	O
)	O
=	O
2	O
.	O
61	O
,	O
p	O
=	O
0	O
.	O
07	O
;	O
15	O
rpm	O
:	O
F	O
(	O
19	O
,	O
26	O
.	O
6	O
)	O
=	O
1	O
.	O
57	O
,	O
p	O
=	O
0	O
.	O
14	O
]	O
(	O
Figs	O
.	O
3B	O
,	O
3C	O
and	O
3D	O
)	O
.	O

In	O
a	O
traction	O
test	O
,	O
(	O
-	O
/	O
-	O
)	O
mice	O
showed	O
a	O
high	O
grip	O
strength	O
similar	O
to	O
that	O
of	O
(	O
+	O
/	O
+	O
)	O
and	O
(	O
+	O
/	O
-	O
)	O
mice	O
(	O
Fig	O
.	O
4	O
)	O
.	O

The	O
hanging	O
score	O
and	O
time	O
of	O
(	O
-	O
/	O
-	O
)	O
mice	O
were	O
also	O
similar	O
to	O
those	O
of	O
(	O
+	O
/	O
+	O
)	O
and	O
(	O
+	O
/	O
-	O
)	O
mice	O
(	O
Figs	O
.	O
5A	O
and	O
5B	O
)	O
.	O

A	O
footprint	O
test	O
did	O
not	O
reveal	O
any	O
abnormalities	O
in	O
walking	O
patterns	O
,	O
including	O
stride	O
length	O
and	O
step	O
width	O
,	O
as	O
a	O
function	O
of	O
genotypes	O
(	O
Figs	O
.	O
6A	O
and	O
6B	O
)	O
.	O

Discussion	O

In	O
the	O
present	O
study	O
,	O
we	O
examined	O
the	O
function	O
of	O
ADAM11	O
by	O
generating	O
mice	O
that	O
lacked	O
the	O
Adam11	O
gene	O
.	O

It	O
has	O
been	O
reported	O
that	O
the	O
Adam11	O
gene	O
is	O
expressed	O
in	O
the	O
brain	O
,	O
heart	O
,	O
liver	O
and	O
testis	O
,	O
as	O
manifested	O
in	O
Northern	O
blot	O
analysis	O
[	O
19	O
]	O
.	O

Interestingly	O
,	O
ADAM11	O
-	O
deficient	O
mice	O
appeared	O
normal	O
and	O
survived	O
more	O
than	O
one	O
year	O
without	O
apparent	O
histological	O
abnormality	O
,	O
including	O
the	O
brain	O
,	O
heart	O
,	O
liver	O
and	O
testis	O
.	O

The	O
expression	O
patterns	O
of	O
the	O
Adam11	O
gene	O
in	O
the	O
brain	O
have	O
been	O
studied	O
using	O
in	O
situ	O
hybridisation	O
[	O
25	O
]	O
.	O

This	O
study	O
has	O
shown	O
high	O
expression	O
of	O
ADAM11	O
mRNA	B-CHEBI
in	O
the	O
hippocampus	O
and	O
cerebellum	O
.	O

We	O
therefore	O
focused	O
on	O
examining	O
the	O
hippocampus	O
-	O
and	O
cerebellum	O
-	O
dependent	O
behavioural	O
tests	O
to	O
study	O
the	O
functions	O
of	O
ADAM11	O
in	O
the	O
nervous	O
system	O
.	O

It	O
is	O
widely	O
accepted	O
that	O
the	O
hippocampus	O
is	O
involved	O
in	O
the	O
performance	O
of	O
the	O
hidden	O
platform	O
version	O
of	O
the	O
water	B-CHEBI
maze	O
test	O
,	O
since	O
lesions	O
of	O
the	O
hippocampal	O
pathways	O
lead	O
to	O
a	O
severe	O
impairment	O
of	O
learning	O
in	O
this	O
task	O
[	O
29	O
]	O
.	O

In	O
the	O
hidden	O
platform	O
task	O
,	O
ADAM11	O
-	O
deficient	O
mice	O
needed	O
more	O
time	O
to	O
reach	O
the	O
platform	O
than	O
wild	O
-	O
type	O
mice	O
.	O

Spatial	O
learning	O
was	O
also	O
assessed	O
using	O
a	O
probe	O
trial	O
,	O
in	O
which	O
the	O
platform	O
was	O
removed	O
from	O
the	O
pool	O
on	O
the	O
day	O
following	O
nine	O
days	O
of	O
training	O
.	O

The	O
wild	O
-	O
type	O
mice	O
spent	O
significantly	O
more	O
time	O
searching	O
for	O
the	O
platform	O
in	O
the	O
target	O
quadrant	O
than	O
the	O
other	O
quadrants	O
.	O

However	O
,	O
ADAM11	O
-	O
deficient	O
mice	O
did	O
not	O
search	O
selectively	O
in	O
the	O
target	O
quadrant	O
.	O

On	O
the	O
other	O
hand	O
,	O
in	O
the	O
visible	O
platform	O
version	O
,	O
in	O
which	O
the	O
motor	O
ability	O
and	O
visual	O
acuity	O
of	O
the	O
mouse	O
are	O
tested	O
,	O
ADAM11	O
-	O
defieient	O
mice	O
were	O
normal	O
.	O

These	O
results	O
indicated	O
that	O
ADAM11	O
-	O
deficient	O
mice	O
showed	O
a	O
spatial	O
learning	O
impairment	O
.	O

The	O
cerebellum	O
is	O
in	O
charge	O
of	O
the	O
smooth	O
coordination	O
of	O
somatic	O
motor	O
activity	O
,	O
regulation	O
of	O
muscle	O
tone	O
,	O
and	O
mechanisms	O
that	O
influence	O
and	O
maintain	O
equilibrium	O
[	O
30	O
]	O
.	O

It	O
is	O
widely	O
accepted	O
that	O
the	O
cerebellum	O
is	O
involved	O
in	O
the	O
performance	O
of	O
the	O
rotating	O
rod	O
task	O
,	O
since	O
mice	O
with	O
structural	O
abnormalities	O
in	O
the	O
cerebellum	O
[	O
31	O
]	O
or	O
with	O
disruptions	O
in	O
genes	O
enriched	O
in	O
the	O
cerebellum	O
[	O
32	O
]	O
exhibit	O
performance	O
deficits	O
in	O
this	O
task	O
.	O

In	O
the	O
rotating	O
rod	O
test	O
in	O
this	O
study	O
,	O
although	O
the	O
retention	O
time	O
of	O
ADAM11	O
-	O
deficient	O
mice	O
on	O
the	O
rod	O
was	O
not	O
different	O
from	O
wild	O
-	O
type	O
mice	O
at	O
0	O
rpm	O
(	O
stationary	O
)	O
,	O
ADAM11	O
-	O
deficient	O
mice	O
fell	O
more	O
quickly	O
from	O
the	O
rod	O
than	O
wild	O
-	O
type	O
mice	O
at	O
5	O
,	O
10	O
and	O
15	O
rpm	O
.	O

These	O
results	O
indicate	O
that	O
ADAM11	O
-	O
deficient	O
mice	O
have	O
a	O
deficit	O
in	O
motor	O
coordination	O
.	O

On	O
the	O
other	O
hand	O
,	O
in	O
the	O
visual	O
platform	O
version	O
of	O
the	O
water	B-CHEBI
maze	O
task	O
,	O
motor	O
ability	O
for	O
swimming	O
in	O
ADAM11	O
-	O
deficient	O
mice	O
was	O
normal	O
.	O

These	O
results	O
suggested	O
that	O
there	O
might	O
be	O
a	O
different	O
mechanism	O
of	O
motor	O
function	O
between	O
swimming	O
and	O
the	O
rotating	O
rod	O
task	O
.	O

It	O
has	O
been	O
also	O
reported	O
that	O
the	O
cerebellum	O
is	O
involved	O
in	O
another	O
important	O
distinct	O
function	O
:	O
learning	O
associated	O
with	O
component	O
movement	O
(	O
motor	O
learning	O
)	O
[	O
33	O
]	O
.	O

The	O
retention	O
time	O
of	O
synaptotagmin	O
(	O
Syt	O
)	O
IV	O
-	O
deficient	O
mice	O
on	O
the	O
rod	O
was	O
significantly	O
shorter	O
than	O
wild	O
-	O
type	O
mice	O
,	O
and	O
they	O
improved	O
it	O
approximately	O
to	O
the	O
same	O
rates	O
as	O
did	O
wild	O
-	O
type	O
mice	O
during	O
rotating	O
rod	O
performance	O
[	O
34	O
]	O
.	O

These	O
data	O
suggest	O
the	O
basis	O
for	O
the	O
performance	O
deficit	O
on	O
the	O
rotating	O
rod	O
task	O
in	O
the	O
Syt	O
IV	O
mutants	O
is	O
in	O
motor	O
coordination	O
rather	O
than	O
in	O
motor	O
learning	O
.	O

The	O
results	O
in	O
the	O
present	O
study	O
showed	O
that	O
ADAM11	O
-	O
deficient	O
mice	O
slightly	O
,	O
though	O
not	O
significantly	O
,	O
improved	O
motor	O
learning	O
ability	O
during	O
rotating	O
rod	O
performance	O
.	O

However	O
,	O
the	O
deficit	O
of	O
motor	O
learning	O
in	O
ADAM11	O
-	O
deficient	O
mice	O
was	O
not	O
clear	O
in	O
this	O
study	O
.	O

Because	O
they	O
could	O
not	O
ride	O
on	O
the	O
rotating	O
rod	O
,	O
they	O
might	O
not	O
learn	O
this	O
task	O
.	O

To	O
examine	O
motor	O
learning	O
ability	O
in	O
ADAM11	O
-	O
deficient	O
mice	O
in	O
detail	O
,	O
we	O
will	O
need	O
to	O
use	O
other	O
cerebellar	O
-	O
dependent	O
learning	O
tasks	O
,	O
such	O
as	O
a	O
classical	O
eyelid	O
conditioning	O
test	O
.	O

There	O
was	O
no	O
impairment	O
in	O
the	O
grip	O
strength	O
and	O
wire	O
suspension	O
test	O
in	O
ADAM11	O
-	O
deficient	O
mice	O
.	O

Spontaneous	O
motor	O
activity	O
and	O
walking	O
patterns	O
of	O
ADAM11	O
-	O
deficient	O
mice	O
were	O
also	O
found	O
to	O
be	O
normal	O
,	O
suggesting	O
that	O
the	O
dysfunction	O
found	O
in	O
the	O
rotating	O
rod	O
test	O
was	O
not	O
derived	O
from	O
muscle	O
weakness	O
or	O
other	O
peripheral	O
disturbances	O
.	O

These	O
results	O
suggest	O
that	O
limited	O
brain	O
sites	O
,	O
mainly	O
the	O
hippocampus	O
and	O
cerebellum	O
,	O
might	O
contribute	O
to	O
the	O
dominant	O
phenotype	O
,	O
spatial	O
learning	O
impairment	O
and	O
motor	O
discoordination	O
in	O
ADAM11	O
-	O
deficient	O
mice	O
.	O

In	O
situ	O
hybridisation	O
analysis	O
has	O
detected	O
Adam11	O
gene	O
expression	O
in	O
the	O
pyramidal	O
cells	O
of	O
CA1	O
-	O
CA3	O
fields	O
and	O
granule	O
cells	O
of	O
the	O
dentate	O
gyrus	O
in	O
the	O
hippocampus	O
and	O
in	O
granular	O
cells	O
in	O
the	O
cerebellum	O
[	O
25	O
]	O
.	O

It	O
is	O
unlikely	O
that	O
morphological	O
changes	O
during	O
development	O
led	O
to	O
impairment	O
of	O
spatial	O
learning	O
and	O
motor	O
coordination	O
,	O
and	O
morphological	O
alterations	O
in	O
the	O
cytoarchitecture	O
of	O
the	O
hippocampus	O
and	O
cerebellum	O
were	O
not	O
observed	O
in	O
ADAM11	O
-	O
deficient	O
mice	O
after	O
histological	O
investigation	O
using	O
HE	O
staining	O
.	O

However	O
,	O
because	O
it	O
is	O
thought	O
that	O
ADAM11	O
plays	O
a	O
role	O
in	O
neuron	O
-	O
neuron	O
or	O
neuron	O
-	O
glial	O
cell	O
interactions	O
,	O
a	O
more	O
precise	O
morphological	O
investigation	O
will	O
be	O
needed	O
.	O

It	O
has	O
been	O
reported	O
that	O
adhesion	O
molecules	B-CHEBI
,	O
such	O
as	O
neural	O
cell	O
adhesion	O
molecule	B-CHEBI
(	O
NCAM	O
)	O
,	O
are	O
not	O
only	O
implicated	O
in	O
cell	O
interactions	O
during	O
nervous	O
system	O
development	O
,	O
but	O
are	O
also	O
recognised	O
as	O
important	O
mediators	O
of	O
synaptic	O
plasticity	O
in	O
the	O
adult	O
nervous	O
system	O
[	O
35	O
]	O
.	O

Changes	O
in	O
neuron	O
excitability	O
in	O
the	O
hippocampus	O
,	O
such	O
as	O
decreases	O
in	O
the	O
post	O
-	O
burst	O
after	O
hyperpolarization	O
(	O
AHP	O
)	O
,	O
have	O
been	O
thought	O
to	O
affect	O
long	O
-	O
term	O
potentiation	O
(	O
LTP	O
)	O
[	O
36	O
]	O
,	O
an	O
experimental	O
model	O
of	O
the	O
synaptic	O
changes	O
thought	O
to	O
underlie	O
learning	O
and	O
memory	O
[	O
37	O
]	O
.	O

It	O
has	O
also	O
been	O
reported	O
that	O
mice	O
lacking	O
NMDA	O
receptor	O
for	O
both	O
NR2A	O
and	O
NR2C	O
subunits	O
showed	O
motor	O
dysfunction	O
and	O
complete	O
loss	O
of	O
both	O
spontaneous	O
and	O
evoked	O
excitatory	O
postsynaptic	O
currents	O
(	O
EPSCs	O
)	O
in	O
cerebellar	O
granule	O
cells	O
[	O
38	O
]	O
.	O

Therefore	O
,	O
electrophyological	O
studies	O
to	O
enable	O
analysis	O
of	O
synaptic	O
transmission	O
and	O
plasticity	O
in	O
the	O
hippocampus	O
and	O
cerebellum	O
of	O
ADAM11	O
-	O
deficient	O
mice	O
will	O
be	O
needed	O
.	O

These	O
studies	O
might	O
clarify	O
whether	O
ADAM11	O
plays	O
an	O
important	O
signalling	O
or	O
structural	O
role	O
at	O
the	O
synaptic	O
level	O
and	O
whether	O
it	O
participates	O
in	O
synaptic	O
regulation	O
.	O

ADAM11	O
-	O
deficient	O
mice	O
remained	O
alive	O
for	O
more	O
than	O
one	O
year	O
without	O
ataxia	O
or	O
tremor	O
,	O
but	O
showed	O
a	O
deficit	O
in	O
spatial	O
learning	O
and	O
motor	O
dysfunction	O
.	O

On	O
the	O
other	O
hand	O
,	O
mice	O
lacking	O
the	O
Adam22	O
gene	O
showed	O
severe	O
ataxia	O
,	O
exhibited	O
marked	O
hypomyelination	O
of	O
the	O
peripheral	O
nerves	O
,	O
and	O
died	O
before	O
weaning	O
[	O
22	O
]	O
.	O

Mice	O
lacking	O
the	O
Adam23	O
gene	O
showed	O
severe	O
ataxia	O
and	O
tremor	O
and	O
died	O
before	O
weaning	O
[	O
23	O
]	O
.	O

These	O
findings	O
suggest	O
that	O
ADAM11	O
,	O
ADAM22	O
and	O
ADAM23	O
have	O
separate	O
and	O
important	O
roles	O
in	O
the	O
nervous	O
system	O
.	O

A	O
genome	O
database	O
search	O
revealed	O
orthologs	O
of	O
ADAM11	O
,	O
ADAM22	O
and	O
ADAM23	O
genes	O
to	O
exist	O
in	O
vertebrates	O
such	O
as	O
mammals	O
,	O
fish	O
,	O
and	O
amphibians	O
,	O
but	O
not	O
in	O
invertebrates	O
.	O

Although	O
the	O
precise	O
molecular	B-CHEBI
functions	O
of	O
these	O
ADAMs	O
are	O
still	O
unclear	O
,	O
further	O
investigations	O
will	O
provide	O
clues	O
to	O
understanding	O
the	O
nervous	O
system	O
of	O
higher	O
organisms	O
.	O

Conclusion	O

ADAM11	O
-	O
deficient	O
mice	O
survived	O
more	O
than	O
one	O
year	O
without	O
ataxia	O
or	O
tremor	O
,	O
showed	O
no	O
abnormalities	O
in	O
body	O
weight	O
gain	O
,	O
spontaneous	O
motor	O
activity	O
,	O
muscle	O
strength	O
,	O
or	O
walking	O
patterns	O
,	O
and	O
exhibited	O
no	O
apparent	O
anatomical	O
-	O
histological	O
changes	O
.	O

However	O
,	O
hippocampus	O
-	O
dependent	O
spatial	O
learning	O
and	O
cerebellum	O
-	O
dependent	O
motor	O
coordination	O
in	O
ADAM11	O
-	O
deficient	O
mice	O
were	O
impaired	O
when	O
tested	O
using	O
water	B-CHEBI
maze	O
and	O
rotating	O
rod	O
tasks	O
.	O

Our	O
genetically	O
modified	O
mouse	O
strain	O
has	O
the	O
potential	O
to	O
be	O
a	O
useful	O
and	O
sensitive	O
tools	O
for	O
detailed	O
investigation	O
of	O
ADAM	O
proteins	B-CHEBI
'	O
functions	O
in	O
the	O
nervous	O
system	O
.	O

Methods	O

Construction	O
of	O
an	O
Adam11	O
gene	O
-	O
targeting	O
vector	O

The	O
13	O
.	O
7	O
-	O
kb	O
BamHI	O
DNA	O
fragment	O
covering	O
exons	O
2	O
-	O
20	O
of	O
the	O
Adam11	O
gene	O
was	O
amplified	O
from	O
C57BL	O
/	O
6	O
genomic	O
DNA	O
by	O
the	O
PCR	O
using	O
Expand	O
Hi	O
-	O
Fidelity	O
polymerase	O
mix	O
(	O
Roche	O
Diagnostics	O
KK	O
,	O
Tokyo	O
,	O
Japan	O
)	O
.	O

To	O
generate	O
a	O
mutation	O
in	O
the	O
mouse	O
Adam11	O
gene	O
,	O
we	O
inserted	O
a	O
PGKneo	O
cassette	O
into	O
exons	O
5	O
-	O
7	O
of	O
the	O
Adam11	O
gene	O
.	O

The	O
final	O
targeting	O
construct	O
consisted	O
of	O
a	O
10	O
.	O
1	O
-	O
kb	O
genomic	O
DNA	O
fragment	O
that	O
was	O
interrupted	O
by	O
the	O
insertion	O
of	O
the	O
PGKneo	O
cassette	O
and	O
contained	O
a	O
MC1	O
/	O
TK	O
cassette	O
as	O
a	O
negative	O
selection	O
marker	O
against	O
random	O
integration	O
[	O
39	O
]	O
.	O

Generation	O
of	O
Adam11	O
deficient	O
mice	O

The	O
linearised	O
targeting	O
vector	O
was	O
electroporated	O
into	O
TT2	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
[	O
40	O
]	O
.	O

Homologous	O
recombinants	O
were	O
selected	O
by	O
PCR	O
using	O
the	O
following	O
primers	O
,	O
AGN1	O
:	O
5	O
'	O
-	O
TCGTGCTTTACGGTATCGCCGCTCCCGATT	O
-	O
3	O
'	O
in	O
the	O
PGKneo	O
cassette	O
,	O
and	O
SGN033	O
:	O
5	O
'	O
-	O
GGACCCGGAAGACATTTGCACGGT	O
-	O
3	O
'	O
outside	O
the	O
targeting	O
vector	O
.	O

Homologous	O
recombined	O
DNA	O
was	O
efficiently	O
amplified	O
by	O
35	O
cycles	O
of	O
the	O
following	O
amplification	O
steps	O
(	O
94	O
degrees	O
C	O
-	O
30	O
sec	O
and	O
68	O
degrees	O
C	O
-	O
5	O
min	O
)	O
.	O

Correctly	O
targeted	O
ES	O
clones	O
were	O
injected	O
into	O
fertilised	O
ICR	O
mouse	O
eggs	O
at	O
the	O
eight	O
-	O
cell	O
stage	O
.	O

The	O
resulting	O
male	O
chimeras	O
were	O
mated	O
with	O
C57BL	O
/	O
6NCrj	O
females	O
(	O
Charles	O
River	O
Japan	O
,	O
Tokyo	O
,	O
Japan	O
)	O
,	O
and	O
resulting	O
heterozygous	O
(	O
+	O
/	O
-	O
)	O
male	O
and	O
female	O
mice	O
were	O
interbred	O
to	O
generate	O
homozygous	O
(	O
-	O
/	O
-	O
)	O
mice	O
.	O

Southern	O
blot	O
analysis	O

Mouse	O
genomic	O
DNA	O
used	O
for	O
Southern	O
blot	O
analysis	O
was	O
extracted	O
from	O
the	O
liver	O
of	O
each	O
genotype	O
.	O

BamHI	O
-	O
digested	O
genomic	O
DNA	O
was	O
probed	O
with	O
the	O
[	O
32P	B-CHEBI
]	O
-	O
labelled	O
BE2K	O
probe	O
,	O
which	O
was	O
a	O
2	O
.	O
0	O
-	O
kb	O
BamHI	O
-	O
EcoRI	O
genomic	O
fragment	O
located	O
in	O
intron	O
2	O
.	O

Western	O
blot	O
analysis	O

The	O
absence	O
of	O
ADAM11	O
protein	B-CHEBI
in	O
the	O
(	O
-	O
/	O
-	O
)	O
mice	O
was	O
confirmed	O
by	O
Western	O
blot	O
analysis	O
.	O

To	O
be	O
brief	O
,	O
the	O
cerebellum	O
was	O
isolated	O
from	O
a	O
six	O
month	O
-	O
old	O
mouse	O
of	O
each	O
genotype	O
and	O
homogenised	O
in	O
cell	O
lysis	O
buffer	O
(	O
50	O
mM	O
Tris	B-CHEBI
-	O
HCl	B-CHEBI
,	O
pH	O
7	O
.	O
5	O
,	O
100	O
mM	O
NaCl	B-CHEBI
,	O
1	O
%	O
NP	O
-	O
40	O
,	O
protease	B-CHEBI
inhibitor	I-CHEBI
cocktail	O
[	O
Roche	O
Diagnostics	O
]	O
)	O
.	O

After	O
removal	O
of	O
cell	O
debris	O
by	O
centrifugation	O
,	O
the	O
glycosylated	O
proteins	B-CHEBI
in	O
the	O
supernatant	O
were	O
concentrated	O
by	O
the	O
affinity	O
chromatography	O
using	O
Con	O
A	O
Sepharose	O
4B	O
(	O
Amersham	O
Biosciences	O
Corp	O
.	O
)	O
.	O

Each	O
sample	O
was	O
separated	O
on	O
10	O
%	O
SDS	B-CHEBI
-	O
PAGE	O
,	O
and	O
transferred	O
to	O
a	O
PVDF	O
membrane	O
.	O

The	O
blot	O
was	O
then	O
incubated	O
with	O
monoclonal	O
antibody	O
against	O
the	O
ADAM11	O
(	O
U	O
.	O
S	O
.	O
Patent	O
5	O
,	O
631	O
,	O
351	O
)	O
at	O
1	O
mu	O
g	O
/	O
ml	O
.	O

Bound	O
antibodies	O
were	O
visualised	O
with	O
horseradish	O
peroxidase	O
-	O
labelled	O
second	O
antibody	O
and	O
an	O
ECL	O
-	O
plus	O
chemiluminescence	O
detection	O
system	O
(	O
Amersham	O
Biosciences	O
Corp	O
.	O
)	O
.	O

Behavioural	O
analysis	O

All	O
animal	O
procedures	O
conformed	O
to	O
the	O
Japanese	O
regulations	O
on	O
animal	O
care	O
and	O
use	O
,	O
following	O
the	O
Guideline	O
for	O
Animal	O
Experimentation	O
of	O
the	O
Japanese	O
Association	O
for	O
Laboratory	O
of	O
Animal	O
Science	O
,	O
and	O
were	O
approved	O
by	O
the	O
Animal	O
Care	O
and	O
Use	O
Committee	O
of	O
Eisai	O
Co	O
.	O
,	O
Ltd	O
.	O

For	O
the	O
present	O
experiments	O
,	O
ADAM11	O
-	O
deficient	O
male	O
mice	O
(	O
backcrossed	O
generations	O
into	O
C57BL	O
/	O
6NCrj	O
,	O
n	O
=	O
14	O
)	O
were	O
used	O
in	O
all	O
behavioural	O
analyses	O
(	O
22	O
-	O
24	O
weeks	O
of	O
age	O
)	O
.	O

All	O
of	O
the	O
behavioural	O
studies	O
were	O
conducted	O
between	O
10	O
:	O
00	O
and	O
16	O
:	O
00	O
by	O
a	O
well	O
-	O
trained	O
experimenter	O
blind	O
to	O
the	O
mouse	O
genotypes	O
.	O

Spontaneous	O
motor	O
activity	O

Locomotor	O
activity	O
in	O
a	O
novel	O
environment	O
was	O
measured	O
by	O
introducing	O
mice	O
(	O
+	O
/	O
+	O
,	O
+	O
/	O
-	O
and	O
-	O
/	O
-	O
;	O
n	O
=	O
8	O
,	O
8	O
and	O
8	O
,	O
respectively	O
)	O
for	O
90	O
min	O
in	O
a	O
Plexiglas	O
box	O
(	O
30	O
x	O
20	O
x	O
13	O
cm	O
)	O
using	O
a	O
VERSAMAX	O
equipment	O
and	O
software	O
(	O
Accuscan	O
,	O
Columbus	O
,	O
OH	O
,	O
USA	O
)	O
.	O

Water	B-CHEBI
maze	O
task	O

Spatial	O
learning	O
was	O
assessed	O
by	O
three	O
variants	O
of	O
the	O
Morris	O
water	B-CHEBI
maze	O
task	O
[	O
27	O
]	O
adapted	O
for	O
mice	O
.	O

Hidden	O
platform	O
task	O
:	O
The	O
pool	O
was	O
divided	O
into	O
four	O
quadrants	O
with	O
four	O
starting	O
locations	O
,	O
called	O
north	O
,	O
east	O
,	O
south	O
and	O
west	O
,	O
at	O
equal	O
distances	O
to	O
the	O
rim	O
.	O

A	O
circular	O
,	O
transparent	O
acrylic	O
platform	O
(	O
diameter	O
8	O
cm	O
)	O
was	O
submerged	O
1	O
cm	O
below	O
the	O
surface	O
of	O
the	O
water	B-CHEBI
in	O
the	O
centre	O
of	O
the	O
southeast	O
quadrant	O
for	O
each	O
trial	O
of	O
this	O
task	O
.	O

Each	O
mouse	O
was	O
allowed	O
to	O
swim	O
for	O
60	O
sec	O
and	O
the	O
time	O
required	O
to	O
reach	O
the	O
platform	O
(	O
escape	O
latency	O
)	O
was	O
recorded	O
in	O
each	O
trial	O
.	O

In	O
total	O
this	O
task	O
consisted	O
of	O
four	O
trials	O
per	O
day	O
over	O
9	O
days	O
(	O
1	O
min	O
inter	O
-	O
trial	O
intervals	O
)	O
.	O

Each	O
trial	O
was	O
initiated	O
by	O
randomly	O
placing	O
an	O
animal	O
in	O
one	O
of	O
the	O
four	O
starting	O
locations	O
.	O

Probe	O
trial	O
:	O
A	O
single	O
probe	O
trial	O
was	O
carried	O
out	O
after	O
the	O
hidden	O
platform	O
task	O
had	O
been	O
completed	O
.	O

In	O
this	O
trial	O
,	O
the	O
platform	O
was	O
removed	O
and	O
the	O
movement	O
of	O
each	O
mouse	O
was	O
monitored	O
using	O
a	O
computer	O
-	O
based	O
video	O
tracking	O
system	O
(	O
BTA	O
-	O
2	O
;	O
Muromachi	O
Kikai	O
Co	O
.	O
,	O
Ltd	O
.	O
,	O
Tokyo	O
,	O
Japan	O
)	O
.	O

Each	O
mouse	O
was	O
placed	O
into	O
the	O
northwest	O
quadrant	O
of	O
the	O
pool	O
and	O
allowed	O
to	O
swim	O
for	O
60	O
sec	O
.	O

Swim	O
path	O
length	O
and	O
the	O
time	O
spent	O
in	O
the	O
trained	O
(	O
southeast	O
)	O
quadrant	O
were	O
calculated	O
.	O

Visible	O
platform	O
task	O
:	O
In	O
this	O
task	O
,	O
the	O
circular	O
platform	O
was	O
made	O
visible	O
by	O
attaching	O
a	O
black	O
board	O
to	O
it	O
and	O
the	O
mouse	O
was	O
required	O
to	O
locate	O
the	O
visible	O
platform	O
.	O

The	O
mouse	O
was	O
allowed	O
to	O
swim	O
for	O
60	O
sec	O
and	O
this	O
task	O
consisted	O
of	O
four	O
trials	O
per	O
day	O
for	O
three	O
consecutive	O
days	O
(	O
1	O
min	O
inter	O
-	O
trial	O
intervals	O
)	O
.	O

Each	O
trial	O
was	O
initiated	O
by	O
randomly	O
placing	O
an	O
animal	O
in	O
one	O
of	O
the	O
four	O
starting	O
locations	O
.	O

Rotating	O
rod	O
test	O

Motor	O
coordination	O
was	O
assessed	O
with	O
a	O
rotating	O
rod	O
apparatus	O
(	O
KN	O
-	O
75	O
,	O
Natsume	O
Seisakujo	O
,	O
Tokyo	O
,	O
Japan	O
)	O
,	O
which	O
consisted	O
of	O
a	O
plastic	O
rod	O
(	O
3	O
cm	O
diameter	O
,	O
8	O
cm	O
long	O
)	O
with	O
a	O
gritted	O
surface	O
flanked	O
by	O
two	O
large	O
discs	O
(	O
40	O
cm	O
diameter	O
)	O
.	O

The	O
mice	O
were	O
first	O
placed	O
on	O
the	O
stationary	O
rod	O
for	O
4	O
successive	O
trials	O
,	O
followed	O
by	O
4	O
trials	O
at	O
a	O
rotation	O
speed	O
of	O
5	O
rpm	O
,	O
8	O
trials	O
at	O
10	O
rpm	O
,	O
and	O
20	O
trials	O
at	O
15	O
rpm	O
in	O
that	O
order	O
.	O

Latency	O
until	O
a	O
fall	O
occurred	O
was	O
monitored	O
for	O
120	O
sec	O
.	O

Intra	O
-	O
trial	O
intervals	O
for	O
each	O
animal	O
were	O
more	O
than	O
20	O
min	O
.	O

Traction	O
test	O

The	O
grip	O
strength	O
of	O
each	O
mouse	O
was	O
measured	O
with	O
a	O
traction	O
apparatus	O
(	O
FU	O
-	O
1	O
,	O
Muromachi	O
Kikai	O
Co	O
.	O
,	O
Ltd	O
.	O
)	O
.	O

Each	O
mouse	O
was	O
made	O
to	O
grasp	O
the	O
attached	O
bar	O
(	O
2	O
mm	O
diameter	O
)	O
with	O
the	O
forepaws	O
and	O
was	O
slowly	O
pulled	O
back	O
by	O
the	O
tail	O
.	O

The	O
maximum	O
tension	O
before	O
release	O
was	O
recorded	O
.	O

Wire	O
suspension	O
test	O

A	O
mouse	O
was	O
placed	O
on	O
a	O
stainless	O
bar	O
(	O
50	O
cm	O
length	O
,	O
2	O
mm	O
diameter	O
,	O
elevated	O
up	O
to	O
37	O
cm	O
from	O
a	O
surface	O
)	O
at	O
a	O
point	O
midway	O
between	O
the	O
supports	O
and	O
observed	O
for	O
30	O
sec	O
in	O
four	O
separate	O
trials	O
.	O

The	O
amount	O
of	O
time	O
spent	O
hanging	O
was	O
recorded	O
and	O
scored	O
according	O
to	O
the	O
following	O
system	O
[	O
41	O
]	O
:	O
0	O
,	O
fell	O
off	O
;	O
1	O
,	O
hung	O
onto	O
the	O
bar	O
with	O
two	O
forepaws	O
;	O
2	O
,	O
in	O
addition	O
to	O
1	O
,	O
attempted	O
to	O
climb	O
onto	O
the	O
bar	O
;	O
3	O
,	O
hung	O
onto	O
the	O
bar	O
with	O
two	O
forepaws	O
and	O
one	O
or	O
both	O
hind	O
paws	O
;	O
4	O
,	O
hung	O
onto	O
the	O
bar	O
with	O
all	O
four	O
paws	O
with	O
tail	O
wrapped	O
around	O
the	O
bar	O
;	O
5	O
,	O
escaped	O
to	O
one	O
of	O
the	O
supports	O
.	O

Footprint	O
test	O

Black	O
ink	O
was	O
applied	O
to	O
the	O
hind	O
paws	O
of	O
each	O
mouse	O
and	O
the	O
mice	O
were	O
placed	O
in	O
a	O
narrow	O
alley	O
(	O
9	O
x	O
25	O
x	O
10	O
cm	O
)	O
on	O
white	O
paper	O
.	O

Stride	O
length	O
and	O
step	O
width	O
were	O
calculated	O
.	O

Statistics	O

Data	O
are	O
expressed	O
as	O
the	O
means	O
+/-	O
SEM	O
.	O

Statistical	O
analysis	O
was	O
conducted	O
using	O
the	O
software	O
package	O
SAS	O
8	O
.	O
1	O
(	O
SAS	O
Institute	O
Japan	O
Ltd	O
.	O
,	O
Tokyo	O
,	O
Japan	O
)	O
.	O

Statistical	O
significance	O
was	O
determined	O
by	O
analysis	O
of	O
variance	O
(	O
ANOVA	O
)	O
followed	O
by	O
the	O
Dunnett	O
-	O
type	O
multiple	O
comparison	O
test	O
,	O
and	O
p	O
values	O
of	O
less	O
than	O
0	O
.	O
05	O
were	O
considered	O
to	O
be	O
significant	O
in	O
the	O
water	B-CHEBI
maze	O
task	O
.	O

Behavioural	O
data	O
in	O
the	O
rotating	O
rod	O
test	O
were	O
analysed	O
by	O
one	O
-	O
or	O
two	O
-	O
way	O
ANOVA	O
with	O
repeated	O
measures	O
,	O
and	O
p	O
values	O
of	O
less	O
than	O
0	O
.	O
05	O
were	O
considered	O
to	O
be	O
significant	O
.	O

Histopathology	O

Sections	O
of	O
tissues	O
including	O
the	O
brain	O
,	O
spinal	O
cord	O
,	O
heart	O
,	O
lung	O
,	O
liver	O
,	O
kidney	O
,	O
spleen	O
and	O
testis	O
from	O
mice	O
(	O
+	O
/	O
+	O
,	O
+	O
/	O
-	O
and	O
-	O
/	O
-	O
;	O
n	O
=	O
7	O
,	O
7	O
and	O
7	O
,	O
respectively	O
)	O
were	O
fixed	O
in	O
10	O
%	O
buffered	B-CHEBI
formalin	O
and	O
embedded	O
in	O
paraffin	O
.	O

Each	O
paraffin	O
section	O
of	O
thick	O
4	O
mu	O
m	O
was	O
stained	O
with	O
hematoxylin	O
and	O
eosin	O
(	O
HE	O
)	O
.	O

Authors	O
'	O
contributions	O

KS	O
is	O
leading	O
this	O
project	O
,	O
and	O
performed	O
cDNA	O
cloning	O
,	O
plasmid	O
construction	O
,	O
antibody	O
production	O
,	O
biochemical	O
study	O
,	O
and	O
wrote	O
the	O
manuscript	O
.	O

ET	O
is	O
also	O
leading	O
this	O
project	O
,	O
performed	O
the	O
generation	O
of	O
knockout	O
mice	O
and	O
behavioural	O
analyses	O
,	O
and	O
wrote	O
the	O
manuscript	O
.	O

TO	O
and	O
KY	O
contributed	O
to	O
the	O
generation	O
of	O
knockout	O
mice	O
.	O

TN	O
and	O
JK	O
supervised	O
the	O
project	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
manuscript	O
.	O

Acknowledgements	O

We	O
are	O
grateful	O
to	O
Isao	O
Tanaka	O
,	O
Masayuki	O
Okada	O
,	O
Mitsuhiro	O
Ino	O
,	O
Norimasa	O
Miyamoto	O
,	O
Kappei	O
Tsukahara	O
,	O
Hiroyuki	O
Kato	O
,	O
Hiroo	O
Ogura	O
,	O
Tatsuto	O
Fukushima	O
,	O
Yoshiaki	O
Furuya	O
,	O
Jiro	O
Sonoda	O
(	O
Eisai	O
Co	O
.	O
,	O
Ltd	O
.	O
)	O
,	O
Paul	O
Frankland	O
(	O
University	O
of	O
Toronto	O
)	O
,	O
and	O
Hachiro	O
Sugimoto	O
(	O
Kyoto	O
University	O
)	O
for	O
fruitful	O
discussions	O
and	O
advice	O
.	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Targeted	O
mutation	O
of	O
Adam11	O
.	O

(	O
A	O
)	O
Top	O
;	O
Domain	O
structure	O
of	O
ADAM11	O
protein	B-CHEBI
.	O

PRO	O
,	O
proprotein	O
;	O
MP	O
,	O
metalloprotease	O
-	O
like	O
;	O
DIS	O
,	O
disintegrin	O
-	O
like	O
;	O
CR	O
/	O
EGF	O
,	O
Cysteine	B-CHEBI
-	O
rich	O
and	O
EGF	O
-	O
like	O
repeat	O
;	O
TM	O
,	O
transmembrane	O
;	O
Cyto	O
,	O
cytoplasmic	O
domain	O
.	O

Adam11	O
gene	O
was	O
disrupted	O
by	O
the	O
insertion	O
of	O
a	O
termination	O
codon	O
and	O
a	O
PGKneo	O
cassette	O
into	O
exons	O
5	O
-	O
7	O
.	O

An	O
MC1	O
/	O
TK	O
cassette	O
at	O
the	O
end	O
of	O
the	O
targeting	O
vector	O
allowed	O
for	O
negative	O
selection	O
.	O

The	O
BE2K	O
-	O
probe	O
used	O
for	O
Southern	O
blot	O
analysis	O
,	O
and	O
the	O
expected	O
BamHI	O
"	O
B	O
"	O
fragments	O
of	O
the	O
targeted	O
allele	O
(	O
TG	O
)	O
and	O
wild	O
-	O
type	O
allele	O
(	O
WT	O
)	O
are	O
indicated	O
by	O
arrows	O
.	O

The	O
primers	O
,	O
AGN1	O
and	O
033	O
were	O
used	O
for	O
the	O
selection	O
of	O
the	O
recombinant	O
ES	O
clones	O
.	O

(	O
B	O
)	O
Southern	O
blot	O
analysis	O
of	O
mouse	O
genomic	O
DNA	O
.	O

The	O
expected	O
DNA	O
fragments	O
for	O
the	O
wild	O
-	O
type	O
allele	O
(	O
WT	O
)	O
and	O
targeted	O
allele	O
(	O
TG	O
)	O
are	O
13	O
.	O
7	O
-	O
kb	O
and	O
10	O
.	O
3	O
-	O
kb	O
,	O
respectively	O
.	O

+	O
/	O
+	O
,	O
wild	O
-	O
type	O
;	O
+	O
/	O
-	O
,	O
heterozygote	O
;	O
-	O
/	O
-	O
,	O
homozygote	O
.	O

(	O
C	O
)	O
Western	O
blot	O
analysis	O
of	O
ADAM11	O
expression	O
in	O
the	O
mouse	O
cerebellum	O
.	O

Absence	O
of	O
ADAM11	O
protein	B-CHEBI
in	O
the	O
(	O
-	O
/	O
-	O
)	O
mutant	O
cerebellum	O
was	O
shown	O
using	O
anti	O
-	O
ADAM11	O
monoclonal	O
antibody	O
.	O

"	O
P	O
"	O
indicates	O
the	O
positive	O
control	O
,	O
HA	O
-	O
tagged	O
mouse	O
ADAM11	O
protein	B-CHEBI
expressed	O
in	O
HeLa	O
cells	O
.	O

White	O
circle	O
indicates	O
mature	O
-	O
form	O
of	O
ADAM11	O
protein	B-CHEBI
and	O
black	O
circle	O
shows	O
immature	O
-	O
form	O
,	O
which	O
was	O
not	O
processed	O
.	O

(	O
D	O
)	O
Hippocampus	O
sections	O
with	O
HE	O
stain	O
.	O

Scar	O
=	O
30	O
mu	O
m	O
.	O

(	O
E	O
)	O
Cerebellum	O
sections	O
with	O
HE	O
stain	O
.	O

Scar	O
=	O
200	O
mu	O
m	O
.	O

Figure	O
2	O

Morris	O
water	B-CHEBI
maze	O
task	O
of	O
ADAM11	O
-	O
deficient	O
mice	O
.	O

(	O
A	O
)	O
Escape	O
latencies	O
(	O
sec	O
)	O
in	O
the	O
hidden	O
platform	O
task	O
over	O
nine	O
testing	O
days	O
.	O

Asterisk	O
:	O
significant	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
difference	O
from	O
(	O
+	O
/	O
+	O
)	O
mice	O
.	O

(	O
B	O
)	O
The	O
probe	O
test	O
after	O
the	O
acquisition	O
trials	O
of	O
the	O
hidden	O
platform	O
task	O
.	O

Times	O
spent	O
in	O
each	O
quadrant	O
of	O
the	O
water	B-CHEBI
pool	O
are	O
shown	O
.	O

Asterisk	O
:	O
significant	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
difference	O
from	O
(	O
+	O
/	O
+	O
)	O
mice	O
.	O

TQ	O
,	O
training	O
quadrant	O
;	O
AR	O
,	O
adjacent	O
right	O
quadrant	O
;	O
AL	O
,	O
adjacent	O
left	O
quadrant	O
;	O
OP	O
,	O
opposite	O
quadrant	O
.	O

(	O
C	O
)	O
Swimming	O
distances	O
(	O
cm	O
)	O
during	O
the	O
probe	O
test	O
.	O

(	O
D	O
)	O
Escape	O
latencies	O
(	O
sec	O
)	O
in	O
the	O
visible	O
platform	O
task	O
over	O
three	O
testing	O
days	O
.	O

+	O
/	O
+	O
,	O
+	O
/	O
-	O
and	O
-	O
/	O
-	O
;	O
n	O
=	O
11	O
,	O
14	O
and	O
12	O
,	O
respectively	O
.	O

Figure	O
3	O

Retention	O
time	O
of	O
ADAM11	O
-	O
deficient	O
mice	O
on	O
the	O
rotating	O
rod	O
at	O
speeds	O
of	O
0	O
rpm	O
(	O
stationary	O
)	O
,	O
5	O
,	O
10	O
and	O
15	O
rpm	O
.	O

Asterisk	O
:	O
significant	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
difference	O
from	O
(	O
+	O
/	O
+	O
)	O
mice	O
.	O

+	O
/	O
+	O
,	O
+	O
/	O
-	O
and	O
-	O
/	O
-	O
;	O
n	O
=	O
11	O
,	O
14	O
and	O
12	O
,	O
respectively	O
.	O

Figure	O
4	O

Traction	O
test	O
(	O
g	O
)	O
of	O
ADAM11	O
-	O
deficient	O
mice	O
.	O

+	O
/	O
+	O
,	O
+	O
/	O
-	O
and	O
-	O
/	O
-	O
;	O
n	O
=	O
12	O
,	O
10	O
and	O
12	O
,	O
respectively	O
.	O

Figure	O
5	O

Wire	O
suspension	O
test	O
of	O
ADAM11	O
-	O
deficient	O
mice	O
.	O

(	O
A	O
)	O
Score	O
in	O
the	O
wire	O
suspension	O
test	O
.	O

(	O
B	O
)	O
Retention	O
time	O
(	O
sec	O
)	O
in	O
the	O
wire	O
suspension	O
test	O
.	O

+	O
/	O
+	O
,	O
+	O
/	O
-	O
and	O
-	O
/	O
-	O
;	O
n	O
=	O
12	O
,	O
10	O
and	O
12	O
,	O
respectively	O
.	O

Figure	O
6	O

Footprint	O
test	O
of	O
ADAM11	O
-	O
deficient	O
mice	O
.	O

(	O
A	O
)	O
Stride	O
length	O
(	O
cm	O
)	O
in	O
the	O
footprint	O
test	O
.	O

(	O
B	O
)	O
Step	O
width	O
(	O
cm	O
)	O
in	O
the	O
footprint	O
test	O
.	O

+	O
/	O
+	O
,	O
+	O
/	O
-	O
and	O
-	O
/	O
-	O
;	O
n	O
=	O
12	O
,	O
10	O
and	O
12	O
,	O
respectively	O
.	O

Genome	O
-	O
wide	O
isolation	O
of	O
growth	O
and	O
obesity	O
QTL	O
using	O
mouse	O
speed	O
congenic	O
strains	O

Abstract	O

Background	O

High	O
growth	O
(	O
hg	O
)	O
modifier	O
and	O
background	O
independent	O
quantitative	O
trait	O
loci	O
(	O
QTL	O
)	O
affecting	O
growth	O
,	O
adiposity	O
and	O
carcass	O
composition	O
were	O
previously	O
identified	O
on	O
mouse	O
chromosomes	O
(	O
MMU	O
)	O
1	O
,	O
2	O
,	O
5	O
,	O
8	O
,	O
9	O
,	O
11	O
and	O
17	O
.	O

To	O
confirm	O
and	O
further	O
characterize	O
each	O
QTL	O
,	O
two	O
panels	O
of	O
speed	O
congenic	O
strains	O
were	O
developed	O
by	O
introgressing	O
CAST	O
/	O
EiJ	O
(	O
CAST	O
)	O
QTL	O
alleles	O
onto	O
either	O
mutant	O
C57Bl	O
/	O
6J	O
-	O
hg	O
/	O
hg	O
(	O
HG	O
)	O
or	O
wild	O
type	O
C57Bl	O
/	O
6J	O
(	O
B6	O
)	O
genetic	O
backgrounds	O
.	O

Results	O

The	O
first	O
speed	O
congenic	O
panel	O
was	O
developed	O
by	O
introgressing	O
four	O
overlapping	O
donor	O
regions	O
spanning	O
MMU2	O
in	O
its	O
entirety	O
onto	O
both	O
HG	O
and	O
B6	O
backgrounds	O
,	O
for	O
a	O
total	O
of	O
eight	O
strains	O
.	O

Phenotypic	O
characterization	O
of	O
the	O
MMU2	O
panel	O
confirmed	O
the	O
segregation	O
of	O
multiple	O
growth	O
and	O
obesity	O
QTL	O
and	O
strongly	O
suggested	O
that	O
a	O
subset	O
of	O
these	O
loci	O
modify	O
the	O
effects	O
of	O
the	O
hg	O
deletion	O
.	O

The	O
second	O
panel	O
consisted	O
of	O
individual	O
donor	O
regions	O
on	O
an	O
HG	O
background	O
for	O
each	O
QTL	O
on	O
MMU1	O
,	O
5	O
,	O
8	O
,	O
9	O
,	O
11	O
and	O
17	O
.	O

Of	O
the	O
six	O
developed	O
strains	O
,	O
five	O
were	O
successfully	O
characterized	O
and	O
displayed	O
significant	O
differences	O
in	O
growth	O
and	O
/	O
or	O
obesity	O
as	O
compared	O
to	O
controls	O
.	O

All	O
five	O
displayed	O
phenotypes	O
similar	O
to	O
those	O
originally	O
attributed	O
to	O
each	O
QTL	O
,	O
however	O
,	O
novel	O
phenotypes	O
were	O
unmasked	O
in	O
several	O
of	O
the	O
strains	O
including	O
sex	O
-	O
specific	O
effects	O
.	O

Conclusion	O

The	O
speed	O
congenic	O
strains	O
developed	O
herein	O
constitute	O
an	O
invaluable	O
genomic	O
resource	O
and	O
provide	O
the	O
foundation	O
to	O
identify	O
the	O
specific	O
nature	O
of	O
genetic	O
variation	O
influencing	O
growth	O
and	O
obesity	O
.	O

Background	O

The	O
use	O
of	O
mouse	O
models	O
has	O
provided	O
valuable	O
insight	O
into	O
the	O
etiology	O
of	O
monogenic	O
syndromes	O
caused	O
by	O
single	O
gene	O
mutations	O
.	O

However	O
,	O
such	O
models	O
do	O
not	O
mimic	O
the	O
genetic	O
complexity	O
of	O
disease	O
traits	O
commonly	O
seen	O
in	O
the	O
human	O
population	O
.	O

Complex	O
traits	O
,	O
such	O
as	O
polygenic	O
growth	O
and	O
obesity	O
are	O
influenced	O
by	O
the	O
small	O
to	O
moderate	O
direct	O
effects	O
of	O
quantitative	O
trait	O
loci	O
(	O
QTL	O
)	O
,	O
epistasis	O
between	O
QTL	O
alleles	O
,	O
environmental	O
perturbations	O
and	O
QTL	O
-	O
environment	O
interactions	O
.	O

To	O
date	O
numerous	O
mouse	O
growth	O
and	O
obesity	O
QTL	O
have	O
been	O
localized	O
[	O
1	O
,	O
2	O
]	O
,	O
however	O
,	O
little	O
progress	O
has	O
been	O
made	O
in	O
determining	O
the	O
specific	O
nature	O
of	O
the	O
underlying	O
genetic	O
variants	O
.	O

One	O
resource	O
used	O
to	O
fine	O
map	O
QTL	O
are	O
congenic	O
strains	O
which	O
are	O
designed	O
to	O
convert	O
a	O
complex	O
polygenic	O
trait	O
into	O
one	O
that	O
is	O
mono	O
-	O
or	O
oligogenic	O
.	O

This	O
is	O
accomplished	O
by	O
eliminating	O
segregating	O
genetic	O
variation	O
outside	O
the	O
locus	O
of	O
interest	O
and	O
reducing	O
the	O
environmental	O
variation	O
influencing	O
a	O
trait	O
by	O
characterizing	O
large	O
numbers	O
of	O
genetically	O
identical	O
mice	O
.	O

The	O
Complex	O
Trait	O
Consortium	O
(	O
CTC	O
)	O
considers	O
congenic	O
analysis	O
an	O
excellent	O
method	O
to	O
confirm	O
and	O
subsequently	O
fine	O
map	O
QTL	O
[	O
3	O
]	O
.	O

Traditionally	O
,	O
congenic	O
strains	O
are	O
developed	O
by	O
introgressing	O
QTL	O
alleles	O
from	O
a	O
donor	O
strain	O
,	O
whose	O
boundaries	O
are	O
defined	O
by	O
genetic	O
markers	O
,	O
on	O
the	O
genetic	O
background	O
of	O
a	O
recipient	O
strain	O
via	O
10	O
backcrosses	O
[	O
4	O
]	O
.	O

While	O
technically	O
straightforward	O
this	O
is	O
a	O
time	O
consuming	O
endeavor	O
taking	O
over	O
three	O
years	O
to	O
construct	O
a	O
single	O
strain	O
.	O

The	O
speed	O
congenic	O
approach	O
is	O
an	O
alternative	O
to	O
this	O
lengthy	O
process	O
and	O
can	O
reduce	O
the	O
number	O
of	O
required	O
backcrosses	O
from	O
10	O
to	O
five	O
[	O
5	O
,	O
6	O
]	O
.	O

This	O
strategy	O
uses	O
marker	O
-	O
assisted	O
selection	O
to	O
identify	O
male	O
mice	O
inheriting	O
fewer	O
donor	O
alleles	O
,	O
than	O
expected	O
on	O
average	O
,	O
during	O
each	O
backcross	O
.	O

Numerous	O
traditionally	O
developed	O
and	O
speed	O
congenics	O
have	O
been	O
used	O
to	O
successfully	O
isolate	O
mouse	O
QTL	O
for	O
a	O
wide	O
array	O
of	O
traits	O
,	O
including	O
growth	O
and	O
obesity	O
[	O
7	O
-	O
13	O
]	O
.	O

The	O
C57Bl	O
/	O
6J	O
-	O
hg	O
/	O
hg	O
(	O
HG	O
)	O
mouse	O
is	O
a	O
model	O
of	O
systemic	O
overgrowth	O
resulting	O
from	O
a	O
spontaneous	O
deletion	O
on	O
MMU10	O
,	O
which	O
eliminates	O
expression	O
of	O
the	O
Socs2	O
(	O
suppressor	O
of	O
cytokine	O
signaling	O
2	O
)	O
gene	O
[	O
14	O
-	O
16	O
]	O
.	O

The	O
role	O
of	O
Socs2	O
in	O
the	O
HG	O
phenotype	O
was	O
confirmed	O
by	O
an	O
independently	O
engineered	O
Socs2	O
-	O
/	O
-	O
knockout	O
mouse	O
which	O
shared	O
a	O
number	O
of	O
phenotypes	O
in	O
common	O
with	O
HG	O
,	O
including	O
gigantism	O
[	O
17	O
]	O
.	O

QTL	O
which	O
alter	O
the	O
phenotypic	O
effects	O
of	O
another	O
locus	O
are	O
referred	O
to	O
as	O
modifier	O
QTL	O
[	O
18	O
]	O
.	O

Modifier	O
QTL	O
have	O
been	O
mapped	O
for	O
numerous	O
traits	O
and	O
in	O
these	O
studies	O
the	O
modified	O
locus	O
is	O
typically	O
a	O
known	O
gene	O
containing	O
a	O
spontaneously	O
arisen	O
or	O
engineered	O
mutation	O
with	O
major	O
phenotypic	O
effects	O
,	O
such	O
as	O
hg	O
[	O
11	O
,	O
19	O
-	O
21	O
]	O
.	O

Epistasis	O
forms	O
the	O
basis	O
of	O
these	O
interactions	O
,	O
implying	O
that	O
the	O
known	O
gene	O
and	O
its	O
modifiers	O
are	O
members	O
of	O
the	O
same	O
biochemical	O
or	O
metabolic	O
pathway	O
.	O

Different	O
genetic	O
backgrounds	O
have	O
been	O
shown	O
to	O
modify	O
the	O
growth	O
-	O
enhancing	O
effects	O
of	O
hg	O
[	O
15	O
,	O
22	O
]	O
.	O

Since	O
the	O
primary	O
function	O
of	O
Socs2	O
is	O
to	O
negatively	O
regulate	O
growth	B-CHEBI
hormone	I-CHEBI
(	O
Gh	B-CHEBI
)	O
[	O
23	O
]	O
,	O
it	O
is	O
likely	O
these	O
background	O
effects	O
are	O
the	O
result	O
of	O
polymorphism	O
influencing	O
interactions	O
between	O
members	O
of	O
the	O
Gh	B-CHEBI
signaling	O
pathway	O
.	O

Thus	O
,	O
identification	O
of	O
hg	O
modifiers	O
has	O
the	O
potential	O
to	O
uncover	O
novel	O
members	O
of	O
metabolically	O
important	O
pathways	O
or	O
previously	O
unknown	O
convergences	O
between	O
pathways	O
.	O

As	O
an	O
initial	O
step	O
,	O
growth	O
and	O
carcass	O
composition	O
QTL	O
were	O
identified	O
in	O
a	O
cross	O
between	O
CAST	O
/	O
EiJ	O
(	O
CAST	O
)	O
and	O
HG	O
[	O
24	O
]	O
.	O

In	O
the	O
F2	O
,	O
mice	O
homozygous	O
for	O
the	O
hg	O
deletion	O
(	O
hg	O
/	O
hg	O
)	O
and	O
wild	O
type	O
(	O
+	O
/	O
+	O
)	O
were	O
assayed	O
and	O
hg	O
modifier	O
QTL	O
were	O
defined	O
as	O
those	O
either	O
absent	O
in	O
+	O
/	O
+	O
mice	O
and	O
segregating	O
in	O
hg	O
/	O
hg	O
or	O
loci	O
with	O
altered	O
gene	O
action	O
dependent	O
on	O
background	O
.	O

Four	O
hg	O
modifier	O
QTL	O
(	O
Wg2	O
on	O
MMU2	O
,	O
Carfhg2	O
on	O
MMU9	O
,	O
Carp2	O
on	O
MMU11	O
and	O
Feml3	O
on	O
MMU17	O
)	O
were	O
identified	O
,	O
along	O
with	O
12	O
additional	O
QTL	O
(	O
Q1Ucd1	O
on	O
MMU1	O
(	O
which	O
only	O
reached	O
a	O
suggestive	O
level	O
of	O
statistical	O
significance	O
)	O
,	O
Wg1	O
,	O
Carp1	O
,	O
Cara1	O
and	O
Feml1	O
on	O
MMU2	O
,	O
Carfhg1	O
on	O
MMU5	O
,	O
Wg3	O
on	O
MMU8	O
,	O
Feml2	O
on	O
MMU9	O
,	O
Wg4	O
and	O
Cara2	O
on	O
MMU11	O
and	O
Carp3	O
and	O
Cara3	O
on	O
MMU17	O
)	O
whose	O
expression	O
was	O
independent	O
of	O
the	O
hg	O
locus	O
.	O

In	O
the	O
current	O
study	O
we	O
have	O
developed	O
speed	O
congenic	O
strains	O
to	O
isolate	O
all	O
the	O
aforementioned	O
QTL	O
.	O

Single	O
strains	O
on	O
an	O
HG	O
background	O
were	O
created	O
for	O
each	O
chromosomal	O
region	O
outside	O
of	O
MMU2	O
,	O
while	O
a	O
comprehensive	O
panel	O
of	O
overlapping	O
strains	O
with	O
identical	O
donor	O
regions	O
on	O
both	O
B6	O
and	O
HG	O
backgrounds	O
were	O
developed	O
for	O
MMU2	O
.	O

The	O
MMU2	O
panel	O
was	O
developed	O
to	O
confirm	O
the	O
presence	O
of	O
multiple	O
QTL	O
and	O
test	O
for	O
QTL	O
-	O
hg	O
interactions	O
.	O

Additionally	O
,	O
based	O
on	O
the	O
knowledge	O
of	O
potential	O
QTL	O
-	O
hg	O
interactions	O
,	O
genes	O
involved	O
in	O
Gh	B-CHEBI
signaling	O
,	O
whose	O
genomic	O
location	O
overlapped	O
hg	O
modifier	O
QTL	O
on	O
MMU2	O
,	O
9	O
,	O
11	O
and	O
17	O
,	O
were	O
sequenced	O
.	O

Results	O

Speed	O
congenic	O
strain	O
development	O

Two	O
speed	O
congenic	O
panels	O
were	O
created	O
,	O
the	O
first	O
comprehensively	O
dissected	O
MMU2	O
while	O
the	O
second	O
isolated	O
QTL	O
on	O
MMU1	O
,	O
5	O
,	O
8	O
,	O
9	O
,	O
11	O
and	O
17	O
(	O
Table	O
1	O
)	O
.	O

The	O
MMU2	O
panel	O
consisted	O
of	O
eight	O
congenic	O
strains	O
developed	O
by	O
introgressing	O
four	O
overlapping	O
donor	O
regions	O
onto	O
both	O
B6	O
and	O
HG	O
genetic	O
backgrounds	O
(	O
Table	O
1	O
)	O
.	O

Single	O
donor	O
regions	O
bred	O
onto	O
an	O
HG	O
background	O
were	O
created	O
to	O
isolate	O
the	O
remaining	O
QTL	O
on	O
MMU1	O
,	O
5	O
,	O
8	O
,	O
9	O
,	O
11	O
and	O
17	O
.	O

Implementation	O
of	O
a	O
speed	O
congenic	O
approach	O
using	O
marker	O
-	O
assisted	O
breeding	O
with	O
79	O
genome	O
-	O
wide	O
microsatellite	O
markers	O
accelerated	O
production	O
of	O
all	O
strains	O
[	O
5	O
,	O
6	O
]	O
(	O
Additional	O
File	O
1	O
and	O
Figure	O
1	O
)	O
.	O

Strain	O
abbreviations	O
and	O
genomic	O
region	O
isolated	O
by	O
each	O
strain	O
are	O
listed	O
in	O
Table	O
1	O
.	O

In	O
addition	O
to	O
both	O
congenic	O
panels	O
,	O
two	O
control	O
strains	O
homozygous	O
B6	O
(	O
B6	O
.	O
CASTC	O
;	O
B6C	O
)	O
or	O
HG	O
(	O
HG	O
.	O
CASTC	O
;	O
HGC	O
)	O
for	O
all	O
genome	O
-	O
wide	O
markers	O
genotyped	O
were	O
developed	O
from	O
the	O
same	O
cross	O
(	O
see	O
Methods	O
)	O
and	O
served	O
as	O
the	O
basis	O
for	O
strain	O
comparisons	O
.	O

After	O
stabilizing	O
each	O
congenic	O
,	O
12	O
of	O
14	O
were	O
phenotypically	O
characterized	O
for	O
growth	O
and	O
adiposity	O
.	O

The	O
HG2D	O
and	O
HG5	O
strains	O
were	O
not	O
characterized	O
due	O
to	O
reproductive	O
problems	O
.	O

The	O
recombinant	O
end	O
points	O
for	O
all	O
strains	O
were	O
refined	O
using	O
microsatellite	O
markers	O
flanking	O
each	O
donor	O
region	O
(	O
Additional	O
File	O
2	O
)	O
.	O

MMU2	O
speed	O
congenic	O
strain	O
characterization	O

Due	O
to	O
the	O
overlapping	O
nature	O
of	O
the	O
MMU2	O
congenics	O
,	O
five	O
distinct	O
chromosomal	O
regions	O
(	O
Regions	O
I	O
-	O
V	O
)	O
were	O
queried	O
for	O
the	O
presence	O
of	O
QTL	O
(	O
Figure	O
2	O
)	O
.	O

As	O
a	O
separate	O
analysis	O
we	O
also	O
tested	O
for	O
interactions	O
between	O
each	O
donor	O
region	O
and	O
the	O
two	O
distinct	O
genetic	O
backgrounds	O
.	O

The	O
following	O
sections	O
describe	O
the	O
phenotypes	O
for	O
each	O
B6	O
.	O
CAST	O
and	O
HG	O
.	O
CAST	O
speed	O
congenic	O
strain	O
as	O
well	O
as	O
the	O
results	O
of	O
the	O
interaction	O
analysis	O
.	O

B6	O
.	O
CAST	O
MMU2	O
speed	O
congenic	O
strains	O

The	O
B62D	O
strain	O
exhibited	O
the	O
largest	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
decreases	O
in	O
body	O
weight	O
of	O
any	O
B6	O
.	O
CAST	O
congenic	O
(	O
Additional	O
File	O
3	O
)	O
.	O

Both	O
sexes	O
had	O
reductions	O
in	O
weight	O
at	O
2	O
(	O
2WK	O
)	O
,	O
3	O
(	O
3WK	O
)	O
,	O
6	O
(	O
6WK	O
)	O
and	O
9	O
(	O
9WK	O
)	O
weeks	O
of	O
age	O
compared	O
to	O
control	O
B6C	O
mice	O
(	O
Figure	O
3	O
)	O
.	O

Despite	O
large	O
decreases	O
in	O
body	O
weight	O
,	O
no	O
differences	O
in	O
growth	O
rates	O
(	O
G26	O
,	O
weight	O
gain	O
from	O
2	O
to	O
6	O
weeks	O
and	O
G29	O
,	O
weight	O
gain	O
from	O
2	O
to	O
9	O
weeks	O
)	O
were	O
observed	O
(	O
Additional	O
File	O
3	O
)	O
.	O

Therefore	O
,	O
the	O
B62D	O
unique	O
region	O
(	O
Region	O
V	O
)	O
harbors	O
either	O
an	O
early	O
-	O
growth	O
QTL	O
or	O
maternal	O
genotype	O
effect	O
which	O
produces	O
a	O
distinct	O
decrease	O
in	O
body	O
weight	O
prior	O
to	O
2WK	O
.	O

These	O
effects	O
are	O
evident	O
in	O
the	O
growth	O
curves	O
for	O
both	O
sexes	O
of	O
each	O
strain	O
(	O
Figure	O
3	O
)	O
.	O

Additionally	O
,	O
B62D	O
mice	O
displayed	O
significantly	O
shorter	O
tail	O
lengths	O
despite	O
no	O
difference	O
in	O
naso	O
-	O
anal	O
length	O
(	O
NA	O
)	O
(	O
Table	O
2	O
)	O
.	O

In	O
contrast	O
,	O
B62M	O
mice	O
displayed	O
small	O
decreases	O
in	O
body	O
weights	O
and	O
growth	O
(	O
male	O
9WK	O
was	O
significant	O
,	O
female	O
6WK	O
and	O
9WK	O
were	O
suggestive	O
at	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
significant	O
decreases	O
in	O
NA	O
(	O
male	O
P	O
=	O
0	O
.	O
0152	O
)	O
and	O
tail	O
length	O
(	O
Additional	O
File	O
3	O
and	O
Table	O
2	O
)	O
.	O

The	O
decrease	O
in	O
NA	O
in	O
B62M	O
mice	O
is	O
surprising	O
since	O
the	O
2M	O
donor	O
region	O
is	O
entirely	O
nested	O
within	O
the	O
2D	O
donor	O
region	O
and	O
B62D	O
mice	O
showed	O
no	O
difference	O
in	O
NA	O
(	O
Figure	O
2	O
)	O
.	O

These	O
data	O
indicate	O
the	O
presence	O
of	O
three	O
QTL	O
with	O
the	O
2D	O
unique	O
region	O
.	O

Two	O
of	O
which	O
are	O
disjoined	O
by	O
the	O
B62M	O
and	O
B62D	O
strains	O
and	O
additively	O
decrease	O
body	O
weight	O
and	O
tail	O
length	O
,	O
but	O
not	O
NA	O
.	O

The	O
third	O
QTL	O
,	O
located	O
within	O
the	O
B62D	O
unique	O
region	O
(	O
Region	O
V	O
)	O
,	O
increases	O
NA	O
canceling	O
the	O
effects	O
of	O
the	O
B62M	O
QTL	O
(	O
Region	O
IV	O
)	O
decreasing	O
NA	O
.	O

B62PM	O
females	O
had	O
decreases	O
in	O
all	O
growth	O
-	O
related	O
traits	O
except	O
2WK	O
and	O
3WK	O
,	O
while	O
no	O
differences	O
were	O
seen	O
in	O
males	O
(	O
Additional	O
File	O
3	O
)	O
.	O

Similarly	O
,	O
only	O
B62P	O
females	O
and	O
not	O
males	O
showed	O
significant	O
decreases	O
in	O
9WK	O
,	O
G26	O
and	O
G29	O
(	O
Additional	O
File	O
3	O
)	O
,	O
indicating	O
these	O
two	O
strains	O
share	O
a	O
female	O
specific	O
growth	O
QTL	O
(	O
Region	O
II	O
)	O
.	O

In	O
the	O
original	O
genome	O
scan	O
body	O
fat	O
percentage	O
as	O
determined	O
by	O
chemical	B-CHEBI
compositional	O
analysis	O
was	O
not	O
linked	O
to	O
markers	O
on	O
MMU2	O
[	O
24	O
]	O
.	O

However	O
,	O
since	O
numerous	O
obesity	O
QTL	O
have	O
been	O
found	O
on	O
MMU2	O
[	O
2	O
]	O
,	O
some	O
of	O
which	O
were	O
discovered	O
in	O
B6	O
by	O
CAST	O
crosses	O
[	O
9	O
,	O
25	O
]	O
,	O
we	O
chose	O
to	O
measure	O
dissected	O
fat	O
pad	O
weights	O
as	O
a	O
more	O
sensitive	O
measure	O
of	O
adiposity	O
.	O

Table	O
2	O
lists	O
the	O
weights	O
of	O
gonadal	O
(	O
GFP	O
)	O
,	O
femoral	O
(	O
FFP	O
)	O
,	O
mesenteric	O
(	O
MFP	O
)	O
and	O
retroperitoneal	O
(	O
RFP	O
)	O
fat	O
pads	O
,	O
along	O
with	O
total	O
fat	O
pad	O
weight	O
(	O
sum	O
of	O
the	O
four	O
fat	O
pads	O
)	O
,	O
adiposity	O
index	O
(	O
AI	O
=	O
TF	O
/	O
weight	O
at	O
sacrifice	O
(	O
WSAC	O
)	O
)	O
and	O
body	O
mass	O
index	O
(	O
BMI	O
=	O
WSAC	O
/	O
NA2	O
*	O
100	O
)	O
for	O
each	O
MMU2	O
congenic	O
strain	O
.	O

Similar	O
to	O
large	O
differences	O
in	O
body	O
weight	O
the	O
B62D	O
strain	O
displayed	O
highly	O
significant	O
decreases	O
in	O
adiposity	O
.	O

B62D	O
was	O
the	O
only	O
strain	O
where	O
both	O
sexes	O
had	O
significant	O
decreases	O
in	O
TF	O
,	O
AI	O
and	O
BMI	O
.	O

Interestingly	O
,	O
no	O
difference	O
in	O
adiposity	O
was	O
seen	O
in	O
B62M	O
mice	O
.	O

This	O
discordance	O
indicates	O
the	O
leanness	O
promoting	O
QTL	O
is	O
located	O
in	O
the	O
B62D	O
unique	O
region	O
(	O
Region	O
V	O
)	O
.	O

Only	O
minor	O
differences	O
in	O
various	O
fat	O
pad	O
weights	O
were	O
observed	O
for	O
the	O
B62P	O
and	O
B62PM	O
strains	O
(	O
Table	O
2	O
)	O
.	O

HG	O
.	O
CAST	O
MMU2	O
speed	O
congenic	O
panel	O

HG2P	O
and	O
HG2PM	O
mice	O
of	O
both	O
sexes	O
displayed	O
significant	O
decreases	O
in	O
post	O
-	O
weaning	O
body	O
weights	O
and	O
growth	O
rates	O
(	O
Additional	O
Table	O
3	O
)	O
.	O

In	O
addition	O
,	O
the	O
HG2M	O
strain	O
displayed	O
highly	O
significant	O
decreases	O
in	O
length	O
,	O
similar	O
to	O
B62M	O
mice	O
(	O
Table	O
2	O
)	O
.	O

These	O
results	O
indicate	O
QTL	O
within	O
Region	O
II	O
shared	O
between	O
the	O
HG2P	O
and	O
HG2PM	O
strains	O
decrease	O
body	O
size	O
,	O
weight	O
gain	O
and	O
NA	O
(	O
only	O
in	O
females	O
)	O
,	O
while	O
a	O
QTL	O
in	O
the	O
HG2M	O
region	O
significantly	O
decreases	O
tail	O
length	O
.	O

Similar	O
to	O
growth	O
traits	O
a	O
general	O
decrease	O
in	O
GFP	O
,	O
MFP	O
,	O
RFP	O
,	O
TF	O
and	O
AI	O
were	O
seen	O
in	O
HG2P	O
and	O
HG2PM	O
mice	O
(	O
Region	O
II	O
)	O
(	O
Table	O
2	O
)	O
.	O

These	O
differences	O
in	O
adiposity	O
are	O
likely	O
pleiotropic	O
effects	O
of	O
the	O
growth	O
QTL	O
shared	O
between	O
these	O
two	O
strains	O
.	O

Surprisingly	O
,	O
HG2M	O
mice	O
displayed	O
striking	O
sex	O
differences	O
in	O
adiposity	O
.	O

Males	O
exhibited	O
an	O
increase	O
in	O
AI	O
(	O
P	O
=	O
0	O
.	O
0256	O
)	O
with	O
a	O
decrease	O
in	O
BMI	O
(	O
P	O
=	O
0	O
.	O
0462	O
)	O
and	O
the	O
exact	O
opposite	O
was	O
seen	O
in	O
females	O
(	O
AI	O
,	O
P	O
<	O
0	O
.	O
0001	O
;	O
BMI	O
,	O
P	O
=	O
0	O
.	O
0425	O
)	O
(	O
Table	O
2	O
)	O
.	O

Therefore	O
,	O
the	O
obesity	O
QTL	O
in	O
the	O
HG2M	O
unique	O
region	O
(	O
Region	O
IV	O
)	O
is	O
profoundly	O
impacted	O
by	O
the	O
presence	O
of	O
hg	O
.	O

Confirmation	O
of	O
QTL	O
-	O
hg	O
interactions	O

An	O
important	O
feature	O
of	O
our	O
experimental	O
design	O
was	O
the	O
ability	O
to	O
test	O
for	O
interactions	O
between	O
QTL	O
in	O
each	O
MMU2	O
donor	O
region	O
and	O
genotype	O
at	O
the	O
HG	O
locus	O
,	O
since	O
identical	O
donor	O
regions	O
were	O
introgressed	O
on	O
two	O
genetic	O
backgrounds	O
,	O
B6	O
(	O
+	O
/	O
+	O
)	O
and	O
HG	O
(	O
hg	O
/	O
hg	O
)	O
.	O

Significant	O
interactions	O
between	O
donor	O
region	O
and	O
HG	O
genotype	O
were	O
viewed	O
as	O
strong	O
evidence	O
that	O
hg	O
modifier	O
QTL	O
reside	O
within	O
that	O
unique	O
genomic	O
region	O
.	O

In	O
the	O
original	O
linkage	O
analysis	O
the	O
mode	O
of	O
gene	O
action	O
and	O
peak	O
location	O
of	O
Wg2	O
were	O
dependent	O
on	O
the	O
presence	O
of	O
hg	O
[	O
24	O
]	O
(	O
Table	O
1	O
)	O
.	O

In	O
the	O
present	O
study	O
,	O
only	O
homozygous	O
congenic	O
mice	O
were	O
characterized	O
,	O
thus	O
,	O
the	O
overdominant	O
effects	O
of	O
Wg2	O
were	O
not	O
tested	O
.	O

However	O
,	O
since	O
its	O
original	O
peak	O
location	O
differed	O
dependent	O
on	O
background	O
we	O
hypothesized	O
that	O
Wg2	O
represents	O
a	O
set	O
of	O
linked	O
QTL	O
between	O
74	O
.	O
9	O
and	O
181	O
.	O
8	O
Mbp	O
within	O
the	O
2M	O
and	O
2D	O
donor	O
regions	O
(	O
Region	O
III	O
-	O
V	O
)	O
,	O
some	O
of	O
which	O
interact	O
with	O
hg	O
.	O

Following	O
this	O
logic	O
we	O
expected	O
one	O
or	O
both	O
of	O
these	O
strains	O
would	O
exhibit	O
donor	O
region	O
by	O
HG	O
genotype	O
interactions	O
.	O

Unfortunately	O
,	O
we	O
were	O
unable	O
to	O
characterize	O
HG2D	O
mice	O
.	O

However	O
,	O
as	O
noted	O
above	O
,	O
strong	O
sex	O
-	O
specific	O
effects	O
were	O
seen	O
in	O
HG2M	O
mice	O
.	O

Significant	O
2M	O
donor	O
region	O
by	O
HG	O
genotype	O
by	O
sex	O
three	O
-	O
way	O
interactions	O
for	O
AI	O
(	O
P	O
=	O
0	O
.	O
0004	O
;	O
Figure	O
4	O
)	O
and	O
TF	O
were	O
identified	O
(	O
Table	O
3	O
)	O
.	O

The	O
basis	O
of	O
these	O
interactions	O
was	O
a	O
decrease	O
in	O
HG2M	O
female	O
and	O
an	O
increase	O
in	O
HG2M	O
male	O
adiposity	O
,	O
with	O
no	O
differences	O
in	O
fat	O
accumulation	O
across	O
B62M	O
sexes	O
.	O

Significant	O
2PM	O
donor	O
region	O
by	O
HG	O
genotype	O
two	O
-	O
way	O
and	O
2PM	O
donor	O
region	O
by	O
HG	O
genotype	O
by	O
sex	O
three	O
-	O
way	O
interactions	O
were	O
also	O
seen	O
for	O
TF	O
and	O
AI	O
(	O
Table	O
3	O
)	O
.	O

In	O
addition	O
,	O
significant	O
2P	O
donor	O
region	O
x	O
HG	O
genotype	O
interactions	O
were	O
observed	O
for	O
all	O
traits	O
listed	O
,	O
although	O
some	O
traits	O
did	O
reached	O
significance	O
at	O
the	O
critical	O
P	O
<	O
0	O
.	O
0071	O
(	O
Table	O
3	O
)	O
.	O

The	O
basis	O
for	O
each	O
interaction	O
was	O
a	O
decrease	O
in	O
phenotype	O
in	O
HG2P	O
compared	O
to	O
HGC	O
and	O
no	O
difference	O
between	O
B62P	O
and	O
B6C	O
.	O

Together	O
these	O
data	O
confirm	O
that	O
MMU2	O
QTL	O
modify	O
the	O
effects	O
of	O
the	O
hg	O
deletion	O
.	O

Speed	O
congenic	O
strains	O
for	O
QTL	O
on	O
MMU1	O
,	O
8	O
,	O
9	O
,	O
11	O
and	O
17	O

HG1	O

Q1Ucd1	O
affecting	O
G26	O
was	O
the	O
least	O
significant	O
of	O
any	O
QTL	O
identified	O
in	O
the	O
original	O
intercross	O
and	O
only	O
reached	O
a	O
suggestive	O
level	O
of	O
significance	O
(	O
LOD	O
=	O
2	O
.	O
46	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
[	O
26	O
]	O
.	O

In	O
accordance	O
,	O
HG1	O
mice	O
had	O
small	O
differences	O
in	O
all	O
growth	O
and	O
length	O
traits	O
.	O

NA	O
in	O
both	O
sexes	O
and	O
2WK	O
,	O
3WK	O
,	O
6WK	O
and	O
tail	O
length	O
in	O
females	O
was	O
significant	O
at	O
a	O
critical	O
P	O
<	O
0	O
.	O
005	O
(	O
Table	O
4	O
)	O
.	O

The	O
only	O
difference	O
in	O
adiposity	O
was	O
a	O
significant	O
decrease	O
in	O
male	O
MFP	O
(	O
Table	O
5	O
)	O
.	O

The	O
successful	O
capture	O
and	O
confirmation	O
of	O
the	O
small	O
effect	O
Q1Ucd1	O
-	O
w26	O
QTL	O
adds	O
support	O
to	O
pursuing	O
QTL	O
identified	O
at	O
suggestive	O
levels	O
of	O
statistical	O
confidence	O
from	O
genome	O
scans	O
.	O

HG8	O

Markers	O
on	O
MMU8	O
were	O
linked	O
with	O
G29	O
in	O
the	O
original	O
intercross	O
[	O
24	O
]	O
.	O

This	O
QTL	O
was	O
small	O
,	O
only	O
accounting	O
for	O
4	O
.	O
3	O
%	O
of	O
the	O
phenotypic	O
variance	O
.	O

Interestingly	O
,	O
in	O
HG8	O
mice	O
no	O
differences	O
in	O
growth	O
were	O
detected	O
;	O
however	O
,	O
they	O
were	O
significantly	O
leaner	O
than	O
controls	O
(	O
Table	O
5	O
)	O
.	O

In	O
males	O
a	O
general	O
decrease	O
in	O
fat	O
pad	O
mass	O
,	O
TF	O
and	O
AI	O
was	O
detected	O
;	O
however	O
,	O
only	O
MFP	O
was	O
significant	O
at	O
a	O
critical	O
P	O
<	O
0	O
.	O
005	O
.	O

Male	O
AI	O
was	O
nearly	O
significant	O
at	O
a	O
nominal	O
P	O
=	O
0	O
.	O
0082	O
.	O

Larger	O
decreases	O
in	O
fat	O
mass	O
were	O
seen	O
in	O
HG8	O
females	O
,	O
with	O
significant	O
decreases	O
detected	O
for	O
GFP	O
,	O
MFP	O
and	O
AI	O
.	O

Additionally	O
,	O
RFP	O
and	O
TF	O
were	O
nearly	O
significant	O
with	O
nominal	O
P	O
values	O
of	O
0	O
.	O
0208	O
and	O
0	O
.	O
0153	O
,	O
respectively	O
.	O

HG8	O
mice	O
represent	O
a	O
lean	O
congenic	O
model	O
in	O
which	O
CAST	O
alleles	O
protect	O
against	O
fat	O
accumulation	O
.	O

HG9	O

CAST	O
alleles	O
in	O
the	O
proximal	O
region	O
of	O
MMU9	O
were	O
previously	O
found	O
to	O
be	O
linked	O
with	O
an	O
increase	O
in	O
body	O
fat	O
percentage	O
and	O
a	O
decrease	O
in	O
femur	O
length	O
[	O
24	O
]	O
.	O

The	O
effects	O
appeared	O
to	O
be	O
the	O
result	O
of	O
two	O
linked	O
QTL	O
,	O
Carfhg2	O
at	O
10	O
cM	O
and	O
Feml2	O
at	O
20	O
cM	O
,	O
instead	O
of	O
one	O
pleiotropically	O
impacting	O
both	O
traits	O
(	O
Table	O
1	O
)	O
.	O

In	O
support	O
of	O
this	O
,	O
the	O
increase	O
in	O
fat	O
was	O
dependent	O
on	O
hg	O
;	O
however	O
,	O
differences	O
in	O
femur	O
length	O
were	O
not	O
[	O
24	O
]	O
.	O

In	O
confirmation	O
of	O
Carfhg2	O
all	O
measures	O
of	O
adiposity	O
in	O
HG9	O
mice	O
were	O
increased	O
relative	O
to	O
control	O
mice	O
;	O
except	O
MFP	O
in	O
both	O
sexes	O
and	O
BMI	O
in	O
males	O
(	O
Table	O
5	O
)	O
.	O

In	O
males	O
,	O
GFP	O
,	O
RFP	O
,	O
FFP	O
and	O
AI	O
were	O
increased	O
by	O
29	O
.	O
0	O
%	O
,	O
51	O
.	O
2	O
%	O
,	O
42	O
.	O
9	O
%	O
and	O
30	O
.	O
0	O
%	O
,	O
respectively	O
.	O

In	O
females	O
these	O
increases	O
were	O
much	O
larger	O
.	O

The	O
same	O
measurements	O
were	O
increased	O
by	O
68	O
.	O
8	O
%	O
,	O
99	O
.	O
4	O
%	O
,	O
69	O
.	O
7	O
%	O
and	O
57	O
.	O
3	O
%	O
,	O
relative	O
to	O
HGC	O
females	O
.	O

A	O
2	O
.	O
9	O
%	O
and	O
3	O
.	O
6	O
%	O
reduction	O
in	O
male	O
and	O
female	O
NA	O
,	O
respectively	O
,	O
was	O
also	O
detected	O
.	O

This	O
was	O
expected	O
since	O
NA	O
was	O
previously	O
found	O
to	O
be	O
an	O
excellent	O
indicator	O
of	O
femur	O
length	O
(	O
R2	O
=	O
0	O
.	O
88	O
)	O
in	O
HG	O
mice	O
[	O
27	O
]	O
and	O
as	O
noted	O
above	O
this	O
region	O
contains	O
the	O
Feml2	O
QTL	O
[	O
24	O
]	O
.	O

These	O
data	O
confirm	O
the	O
effects	O
of	O
Carfhg2	O
on	O
adiposity	O
and	O
Feml2	O
on	O
length	O
and	O
indicate	O
the	O
isolated	O
effects	O
of	O
Carfhg2	O
are	O
more	O
significant	O
than	O
originally	O
observed	O
.	O

HG11	O

In	O
the	O
original	O
intercross	O
CAST	O
alleles	O
near	O
50	O
cM	O
on	O
MMU11	O
were	O
linked	O
with	O
a	O
reduction	O
in	O
G29	O
,	O
carcass	O
ash	O
(	O
ASH	O
)	O
and	O
carcass	O
protein	B-CHEBI
(	O
PROT	B-CHEBI
)	O
[	O
24	O
]	O
.	O

Therefore	O
,	O
we	O
measured	O
each	O
carcass	O
component	O
using	O
chemical	B-CHEBI
compositional	O
analysis	O
in	O
the	O
HGC	O
,	O
HG11	O
and	O
HG17	O
strains	O
.	O

Originally	O
,	O
Carp2	O
was	O
dependent	O
on	O
the	O
presence	O
of	O
hg	O
and	O
no	O
significant	O
sex	O
effects	O
were	O
detected	O
[	O
24	O
]	O
.	O

In	O
contrast	O
to	O
those	O
results	O
,	O
HG11	O
mice	O
displayed	O
significant	O
differences	O
in	O
growth	O
and	O
obesity	O
between	O
the	O
sexes	O
.	O

In	O
general	O
,	O
males	O
demonstrated	O
a	O
5	O
%	O
increase	O
and	O
females	O
a	O
5	O
%	O
decrease	O
in	O
all	O
growth	O
-	O
related	O
traits	O
(	O
Table	O
4	O
)	O
.	O

Most	O
of	O
these	O
differences	O
,	O
however	O
,	O
were	O
not	O
significant	O
at	O
a	O
critical	O
P	O
<	O
0	O
.	O
005	O
,	O
although	O
almost	O
all	O
were	O
at	O
a	O
nominal	O
P	O
<	O
0	O
.	O
05	O
.	O

Following	O
the	O
same	O
trend	O
,	O
males	O
displayed	O
an	O
increase	O
in	O
tail	O
length	O
and	O
a	O
small	O
suggestive	O
increase	O
in	O
NA	O
(	O
P	O
=	O
0	O
.	O
06	O
)	O
,	O
while	O
females	O
displayed	O
significant	O
decreases	O
in	O
NA	O
.	O

In	O
support	O
of	O
the	O
sex	O
-	O
specific	O
QTL	O
effects	O
strain	O
by	O
sex	O
interactions	O
(	O
P	O
<	O
0	O
.	O
04	O
)	O
were	O
seen	O
for	O
the	O
following	O
growth	O
traits	O
:	O
3WK	O
,	O
6WK	O
,	O
9WK	O
,	O
G26	O
,	O
G29	O
and	O
NA	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
basis	O
of	O
each	O
interaction	O
was	O
an	O
increase	O
in	O
the	O
males	O
and	O
a	O
decrease	O
in	O
females	O
.	O

In	O
our	O
analysis	O
of	O
the	O
HGC	O
,	O
HG11	O
and	O
HG17	O
strains	O
,	O
concordant	O
results	O
were	O
observed	O
measuring	O
adiposity	O
using	O
chemical	B-CHEBI
lipid	B-CHEBI
extraction	O
and	O
weighing	O
fat	O
pad	O
mass	O
.	O

The	O
phenotypic	O
correlation	O
between	O
carcass	O
fat	O
(	O
FAT	O
)	O
as	O
a	O
percent	O
of	O
the	O
empty	O
carcass	O
weight	O
(	O
ECW	O
;	O
weight	O
of	O
total	O
body	O
(	O
including	O
organs	O
)	O
minus	O
the	O
head	O
and	O
gastrointestinal	O
tract	O
)	O
(	O
%	O
FAT	O
)	O
determined	O
by	O
chemical	B-CHEBI
analysis	O
and	O
AI	O
,	O
using	O
data	O
from	O
all	O
three	O
lines	O
(	O
HGC	O
,	O
HG11	O
and	O
HG17	O
)	O
,	O
was	O
0	O
.	O
92	O
.	O

These	O
data	O
suggest	O
that	O
individual	O
fat	O
pad	O
dissection	O
is	O
an	O
excellent	O
proxy	O
for	O
measuring	O
whole	O
body	O
adiposity	O
and	O
provides	O
a	O
much	O
more	O
sensitive	O
technique	O
to	O
measure	O
fat	O
accumulation	O
in	O
specific	O
body	O
regions	O
.	O

HG11	O
females	O
displayed	O
slight	O
increases	O
in	O
all	O
fat	O
pads	O
(	O
except	O
MFP	O
)	O
and	O
AI	O
,	O
although	O
,	O
only	O
the	O
16	O
.	O
5	O
%	O
increase	O
in	O
AI	O
was	O
significant	O
(	O
Table	O
5	O
)	O
.	O

In	O
contrast	O
,	O
HG11	O
males	O
did	O
not	O
show	O
a	O
difference	O
in	O
fat	O
mass	O
leading	O
to	O
a	O
significant	O
strain	O
by	O
sex	O
interaction	O
(	O
P	O
=	O
0	O
.	O
008	O
)	O
for	O
AI	O
(	O
data	O
not	O
shown	O
)	O
.	O

Identical	O
to	O
the	O
results	O
obtained	O
using	O
fat	O
pad	O
weights	O
;	O
female	O
HG11	O
carcasses	O
displayed	O
an	O
increase	O
in	O
%	O
FAT	O
(	O
Table	O
6	O
)	O
.	O

HG11	O
male	O
carcasses	O
had	O
higher	O
levels	O
carcass	O
ash	O
(	O
ASH	O
)	O
as	O
a	O
percent	O
of	O
ECW	O
(	O
%	O
ASH	O
)	O
and	O
female	O
carcasses	O
displayed	O
lower	O
levels	O
of	O
H2O	O
and	O
ASH	O
(	O
Table	O
6	O
)	O
.	O

Strains	O
by	O
sex	O
interactions	O
(	O
P	O
<	O
0	O
.	O
005	O
)	O
were	O
identified	O
for	O
H2O	O
,	O
%	O
H2O	O
,	O
%	O
FAT	O
,	O
ASH	O
and	O
PROT	O
(	O
data	O
not	O
shown	O
)	O
.	O

If	O
the	O
aggregate	O
phenotype	O
in	O
HG11	O
is	O
due	O
to	O
a	O
single	O
locus	O
,	O
its	O
function	O
may	O
be	O
to	O
disrupt	O
energy	O
partitioning	O
by	O
decreasing	O
the	O
deposition	O
of	O
lean	O
tissue	O
and	O
increasing	O
lipid	B-CHEBI
accumulation	O
in	O
females	O
,	O
while	O
having	O
the	O
opposite	O
action	O
in	O
males	O
.	O

However	O
,	O
it	O
may	O
also	O
be	O
due	O
to	O
distinct	O
sex	O
-	O
specific	O
QTL	O
with	O
opposing	O
action	O
.	O

HG17	O

In	O
the	O
original	O
intercross	O
CAST	O
alleles	O
at	O
MMU17	O
markers	O
were	O
associated	O
with	O
decreases	O
in	O
femur	O
length	O
,	O
ASH	O
and	O
PROT	O
[	O
24	O
]	O
and	O
similar	O
results	O
were	O
seen	O
in	O
HG17	O
mice	O
.	O

Interestingly	O
,	O
both	O
sexes	O
were	O
heavier	O
at	O
2WK	O
(	O
males	O
,	O
P	O
=	O
0	O
.	O
0045	O
;	O
females	O
,	O
P	O
=	O
0	O
.	O
0342	O
)	O
,	O
but	O
lighter	O
at	O
9WK	O
,	O
leading	O
to	O
substantially	O
lower	O
G26	O
and	O
G29	O
(	O
Table	O
4	O
)	O
.	O

In	O
general	O
growth	O
differences	O
ranged	O
between	O
5	O
%	O
and	O
15	O
%	O
lower	O
in	O
congenic	O
mice	O
.	O

Both	O
sexes	O
had	O
significant	O
reductions	O
in	O
length	O
traits	O
relative	O
to	O
control	O
mice	O
.	O

NA	O
was	O
reduced	O
by	O
2	O
.	O
7	O
%	O
(	O
P	O
=	O
0	O
.	O
0186	O
)	O
and	O
3	O
.	O
4	O
%	O
in	O
males	O
and	O
females	O
,	O
respectively	O
(	O
Table	O
4	O
)	O
.	O

In	O
addition	O
,	O
tail	O
was	O
reduced	O
by	O
approximately	O
6	O
%	O
in	O
both	O
sexes	O
(	O
Table	O
4	O
)	O
.	O

In	O
general	O
,	O
HG17	O
mice	O
displayed	O
increases	O
in	O
all	O
fat	O
pads	O
(	O
except	O
MFP	O
)	O
,	O
TF	O
and	O
AI	O
(	O
Table	O
5	O
)	O
.	O

However	O
,	O
none	O
of	O
these	O
differences	O
were	O
significant	O
at	O
critical	O
P	O
<	O
0	O
.	O
005	O
.	O

In	O
addition	O
,	O
HG17	O
male	O
carcasses	O
possessed	O
lower	O
levels	O
of	O
H2O	O
and	O
ASH	O
,	O
while	O
female	O
carcasses	O
contained	O
lower	O
levels	O
of	O
%	O
H2O	O
,	O
ASH	O
,	O
%	O
ASH	O
and	O
%	O
PROT	O
(	O
Table	O
6	O
)	O
.	O

MMU2	O
,	O
9	O
,	O
11	O
and	O
17	O
hg	O
modifier	O
candidate	O
gene	O
sequencing	O

The	O
HG	O
phenotype	O
is	O
due	O
to	O
the	O
deletion	O
of	O
Socs2	O
,	O
therefore	O
we	O
reasoned	O
that	O
QTL	O
on	O
MMU2	O
,	O
9	O
,	O
11	O
and	O
17	O
interacting	O
with	O
hg	O
possibly	O
represent	O
variation	O
within	O
genes	O
participating	O
in	O
various	O
aspects	O
of	O
Gh	B-CHEBI
function	O
.	O

To	O
select	O
candidate	O
genes	O
for	O
sequencing	O
we	O
identified	O
genes	O
known	O
to	O
be	O
or	O
potentially	O
involved	O
in	O
Gh	B-CHEBI
signaling	O
,	O
are	O
responsive	O
to	O
Gh	B-CHEBI
or	O
that	O
propagate	O
downstream	O
Gh	B-CHEBI
functions	O
.	O

Forty	O
-	O
four	O
hg	O
modifier	O
candidate	O
genes	O
were	O
identified	O
from	O
primary	O
literature	O
,	O
reviews	O
and	O
book	O
chapters	O
and	O
coordinated	O
using	O
the	O
GenMAPP	O
(	O
Gene	O
MicroArray	O
Pathway	O
Profiler	O
)	O
pathway	O
building	O
software	O
(	O
Figure	O
5	O
)	O
.	O

The	O
coding	O
region	O
of	O
each	O
gene	O
was	O
sequenced	O
from	O
the	O
CAST	O
strain	O
and	O
compared	O
to	O
the	O
publicly	O
available	O
B6	O
sequence	O
to	O
identify	O
polymorphisms	O
(	O
Additional	O
File	O
4	O
)	O
.	O

A	O
total	O
of	O
94	O
.	O
492	O
kbp	O
was	O
sequenced	O
(	O
75	O
.	O
378	O
kbp	O
CDS	O
and	O
19	O
.	O
114	O
Kbp	O
5	O
'	O
and	O
3	O
'	O
untranslated	O
region	O
(	O
UTR	O
)	O
)	O
,	O
representing	O
25	O
,	O
083	O
amino	B-CHEBI
acids	I-CHEBI
.	O

Comparison	O
with	O
the	O
public	O
B6	O
assembly	O
(	O
May	O
2004	O
University	O
of	O
California	O
,	O
Santa	O
Cruz	O
(	O
UCSC	O
[	O
28	O
]	O
)	O
mm5	O
genome	O
assembly	O
,	O
National	O
Center	O
for	O
Biotechnology	O
Information	O
(	O
NCBI	O
)	O
Build	O
33	O
)	O
identified	O
307	O
polymorphisms	O
between	O
CAST	O
and	O
B6	O
.	O

Of	O
these	O
,	O
295	O
were	O
single	O
nucleotide	B-CHEBI
polymorphisms	O
(	O
SNP	O
)	O
and	O
12	O
were	O
insertions	O
or	O
deletions	O
in	O
CAST	O
(	O
Additional	O
File	O
4	O
)	O
.	O

All	O
12	O
insertions	O
or	O
deletions	O
were	O
located	O
within	O
5	O
'	O
and	O
3	O
'	O
UTRs	O
.	O

Fifty	O
-	O
six	O
nonsynonomous	O
SNP	O
(	O
nsSNP	O
)	O
were	O
identified	O
in	O
14	O
different	O
genes	O
(	O
Additional	O
File	O
4	O
)	O
.	O

PolyPhen	O
[	O
29	O
]	O
and	O
SIFT	O
[	O
30	O
]	O
are	O
software	O
programs	O
designed	O
to	O
identify	O
nsSNP	O
which	O
potentially	O
alter	O
protein	B-CHEBI
function	O
by	O
evaluating	O
evolutionary	O
conservation	O
at	O
specific	O
amino	B-CHEBI
acid	I-CHEBI
residues	I-CHEBI
using	O
a	O
multiple	O
sequence	O
alignment	O
of	O
protein	B-CHEBI
sequences	O
homologous	O
to	O
the	O
query	O
.	O

When	O
applied	O
to	O
our	O
data	O
set	O
PolyPhen	O
,	O
SIFT	O
or	O
both	O
programs	O
predicted	O
that	O
15	O
of	O
the	O
56	O
nsSNP	O
in	O
9	O
different	O
genes	O
would	O
possibly	O
alter	O
protein	B-CHEBI
function	O
(	O
Table	O
7	O
)	O
.	O

Discussion	O

Speed	O
congenic	O
strains	O
provide	O
a	O
powerful	O
approach	O
to	O
confirm	O
and	O
physically	O
confine	O
QTL	O
within	O
intervals	O
defined	O
by	O
molecular	B-CHEBI
markers	O
.	O

In	O
the	O
current	O
study	O
,	O
approximately	O
20	O
%	O
of	O
the	O
CAST	O
genome	O
harboring	O
all	O
previously	O
detected	O
growth	O
and	O
carcass	O
composition	O
QTL	O
was	O
isolated	O
on	O
an	O
HG	O
or	O
B6	O
background	O
through	O
the	O
development	O
of	O
14	O
speed	O
congenic	O
strains	O
.	O

Two	O
distinct	O
speed	O
congenic	O
panels	O
were	O
developed	O
,	O
the	O
first	O
provided	O
a	O
comprehensive	O
isolation	O
of	O
all	O
MMU2	O
QTL	O
between	O
the	O
B6	O
,	O
HG	O
and	O
CAST	O
strains	O
and	O
the	O
second	O
targeted	O
all	O
QTL	O
outside	O
of	O
MMU2	O
.	O

Each	O
successfully	O
characterized	O
strain	O
exhibited	O
phenotypic	O
differences	O
relative	O
to	O
control	O
mice	O
.	O

These	O
strains	O
represent	O
important	O
resources	O
and	O
provide	O
the	O
genetic	O
resource	O
to	O
positionally	O
clone	O
numerous	O
quantitative	O
trait	O
genes	O
.	O

One	O
criticism	O
of	O
the	O
speed	O
congenic	O
approach	O
is	O
the	O
potential	O
for	O
QTL	O
to	O
reside	O
among	O
unwanted	O
donor	O
alleles	O
not	O
eliminated	O
during	O
backcrossing	O
.	O

In	O
this	O
case	O
differences	O
between	O
the	O
congenic	O
and	O
control	O
strains	O
would	O
be	O
due	O
in	O
part	O
or	O
whole	O
to	O
these	O
contaminating	O
alleles	O
.	O

We	O
took	O
several	O
precautions	O
to	O
reduce	O
the	O
probability	O
of	O
this	O
occurrence	O
.	O

First	O
,	O
our	O
control	O
strains	O
were	O
developed	O
from	O
mice	O
undergoing	O
the	O
same	O
selection	O
as	O
all	O
of	O
the	O
other	O
congenics	O
.	O

Therefore	O
,	O
it	O
is	O
possible	O
that	O
any	O
unwanted	O
QTL	O
or	O
mutations	O
arising	O
during	O
congenic	O
construction	O
are	O
shared	O
between	O
all	O
strains	O
.	O

More	O
importantly	O
,	O
we	O
have	O
knowledge	O
of	O
all	O
large	O
previously	O
detected	O
growth	O
and	O
obesity	O
QTL	O
in	O
the	O
current	O
cross	O
[	O
24	O
]	O
.	O

Using	O
this	O
information	O
we	O
increased	O
the	O
density	O
of	O
markers	O
in	O
each	O
QTL	O
region	O
(	O
MMU1	O
,	O
2	O
,	O
5	O
,	O
8	O
,	O
9	O
,	O
11	O
and	O
17	O
;	O
Table	O
1	O
and	O
Additional	O
File	O
1	O
)	O
,	O
ensuring	O
the	O
absence	O
of	O
CAST	O
alleles	O
at	O
each	O
of	O
these	O
QTL	O
.	O

This	O
approach	O
,	O
termed	O
"	O
QTL	O
-	O
Marker	O
-	O
Assisted	O
Counter	O
Selection	O
"	O
or	O
QMACS	O
,	O
has	O
been	O
previously	O
used	O
to	O
characterize	O
QTL	O
for	O
hypnotic	O
sensitivity	O
to	O
ethanol	B-CHEBI
[	O
31	O
]	O
.	O

In	O
that	O
study	O
,	O
only	O
markers	O
flanking	O
QTL	O
were	O
typed	O
,	O
not	O
genome	O
-	O
wide	O
markers	O
.	O

In	O
contrast	O
,	O
we	O
selected	O
not	O
only	O
against	O
known	O
QTL	O
,	O
we	O
also	O
screened	O
for	O
genome	O
wide	O
heterozygosity	O
increasing	O
the	O
probability	O
that	O
effects	O
observed	O
are	O
due	O
to	O
genetic	O
variation	O
within	O
each	O
donor	O
region	O
.	O

Although	O
great	O
effort	O
was	O
put	O
forth	O
to	O
eliminate	O
non	O
-	O
donor	O
region	O
direct	O
genetic	O
effects	O
,	O
other	O
factors	O
such	O
as	O
maternal	O
genotype	O
(	O
maternal	O
genotype	O
for	O
each	O
congenic	O
versus	O
control	O
dams	O
differed	O
)	O
and	O
environmental	O
effects	O
could	O
confound	O
our	O
results	O
.	O

Maternal	O
genotype	O
effects	O
on	O
growth	O
and	O
obesity	O
have	O
been	O
observed	O
in	O
a	O
number	O
of	O
mouse	O
crosses	O
[	O
8	O
,	O
32	O
-	O
35	O
]	O
and	O
their	O
existence	O
in	O
the	O
current	O
cross	O
cannot	O
be	O
discounted	O
.	O

However	O
,	O
our	O
congenics	O
provide	O
the	O
ideal	O
foundation	O
genomic	O
resource	O
to	O
test	O
for	O
the	O
influence	O
of	O
any	O
of	O
these	O
possible	O
effects	O
.	O

Future	O
fine	O
mapping	O
experiments	O
can	O
be	O
designed	O
to	O
randomize	O
the	O
influences	O
of	O
any	O
contaminating	O
donor	O
alleles	O
and	O
environmental	O
differences	O
,	O
as	O
well	O
as	O
test	O
for	O
maternal	O
genotype	O
effects	O
.	O

MMU2	O
is	O
a	O
hotspot	O
for	O
growth	O
and	O
obesity	O
QTL	O
.	O

Over	O
30	O
QTL	O
have	O
been	O
identified	O
in	O
various	O
experiments	O
[	O
1	O
,	O
2	O
]	O
.	O

Several	O
previously	O
reported	O
or	O
novel	O
MMU2	O
QTL	O
have	O
been	O
isolated	O
and	O
characterized	O
using	O
congenic	O
strains	O
[	O
7	O
,	O
9	O
-	O
11	O
,	O
36	O
]	O
.	O

Our	O
findings	O
are	O
no	O
different	O
and	O
indicate	O
that	O
MMU2	O
is	O
highly	O
complex	O
with	O
regards	O
to	O
genes	O
affecting	O
growth	O
and	O
obesity	O
.	O

The	O
overlapping	O
nature	O
of	O
our	O
MMU2	O
strains	O
allowed	O
us	O
to	O
parse	O
the	O
chromosome	O
into	O
five	O
regions	O
(	O
Regions	O
I	O
-	O
V	O
)	O
(	O
Figure	O
2	O
)	O
.	O

The	O
data	O
support	O
the	O
presence	O
of	O
at	O
least	O
one	O
QTL	O
in	O
each	O
of	O
the	O
five	O
regions	O
(	O
Figure	O
2	O
)	O
.	O

Each	O
of	O
the	O
five	O
pleiotropically	O
impact	O
both	O
growth	O
and	O
obesity	O
,	O
although	O
to	O
varying	O
degrees	O
.	O

In	O
addition	O
to	O
the	O
large	O
number	O
of	O
MMU2	O
QTL	O
,	O
the	O
presence	O
of	O
hg	O
adds	O
complexity	O
by	O
either	O
eliciting	O
interactions	O
with	O
the	O
same	O
QTL	O
or	O
by	O
inducing	O
the	O
expression	O
of	O
novel	O
QTL	O
.	O

The	O
2P	O
unique	O
region	O
(	O
Region	O
I	O
)	O
contains	O
an	O
hg	O
modifier	O
with	O
large	O
effects	O
on	O
growth	O
and	O
smaller	O
effects	O
on	O
obesity	O
(	O
Table	O
3	O
)	O
.	O

In	O
contrast	O
,	O
interactions	O
between	O
2PM	O
/	O
2M	O
QTL	O
and	O
hg	O
primarily	O
affect	O
fat	O
deposition	O
(	O
Table	O
3	O
)	O
.	O

As	O
illustrated	O
in	O
Figure	O
4	O
the	O
2M	O
donor	O
region	O
exhibits	O
strong	O
sex	O
effects	O
on	O
the	O
rate	O
of	O
lipid	B-CHEBI
storage	O
,	O
dependent	O
on	O
background	O
.	O

In	O
control	O
mice	O
,	O
HGC	O
females	O
have	O
a	O
higher	O
AI	O
than	O
males	O
,	O
while	O
the	O
opposite	O
is	O
seen	O
in	O
B6C	O
mice	O
.	O

Interestingly	O
,	O
the	O
2M	O
hg	O
modifier	O
QTL	O
abolished	O
the	O
hg	O
induced	O
sexual	O
dimorphism	O
in	O
adiposity	O
(	O
Figure	O
4	O
)	O
.	O

Although	O
these	O
results	O
provide	O
insight	O
into	O
the	O
nature	O
of	O
hg	O
modifier	O
QTL	O
,	O
it	O
should	O
be	O
noted	O
,	O
that	O
the	O
actual	O
number	O
and	O
precise	O
location	O
of	O
loci	O
is	O
still	O
unclear	O
.	O

In	O
addition	O
to	O
MMU2	O
,	O
three	O
other	O
congenics	O
(	O
HG9	O
,	O
HG11	O
and	O
HG17	O
)	O
captured	O
hg	O
modifier	O
QTL	O
.	O

In	O
classical	O
terms	O
,	O
they	O
are	O
QTL	O
which	O
modify	O
the	O
expressivity	O
of	O
growth	O
and	O
obesity	O
in	O
HG	O
mice	O
[	O
18	O
]	O
.	O

These	O
QTL	O
are	O
novel	O
since	O
they	O
represent	O
epistasis	O
between	O
hg	O
and	O
the	O
modifier	O
gene	O
.	O

QTL	O
-	O
hg	O
epistasis	O
implies	O
that	O
Socs2	O
and	O
the	O
hg	O
modifiers	O
are	O
in	O
the	O
same	O
biological	O
pathway	O
.	O

Therefore	O
,	O
these	O
QTL	O
are	O
likely	O
due	O
to	O
polymorphism	O
in	O
genes	O
interacting	O
with	O
Gh	B-CHEBI
,	O
responsive	O
to	O
Gh	B-CHEBI
or	O
which	O
in	O
some	O
way	O
modulate	O
Gh	B-CHEBI
function	O
.	O

This	O
information	O
will	O
significantly	O
aid	O
QTL	O
cloning	O
by	O
providing	O
another	O
filter	O
to	O
screen	O
candidates	O
.	O

Cloning	O
these	O
QTL	O
has	O
major	O
implications	O
to	O
improve	O
our	O
understanding	O
of	O
Gh	B-CHEBI
and	O
its	O
regulation	O
of	O
growth	O
and	O
adiposity	O
and	O
in	O
the	O
administration	O
of	O
human	O
Gh	B-CHEBI
therapeutics	O
.	O

HG1	O
mice	O
displayed	O
differences	O
only	O
in	O
growth	O
traits	O
.	O

Originally	O
,	O
Q1Ucd1	O
had	O
small	O
effects	O
and	O
these	O
results	O
illustrate	O
the	O
power	O
of	O
congenic	O
strain	O
analysis	O
to	O
isolate	O
small	O
effect	O
QTL	O
,	O
although	O
it	O
is	O
likely	O
this	O
QTL	O
represents	O
the	O
lower	O
boundary	O
of	O
detection	O
using	O
only	O
20	O
-	O
30	O
congenic	O
mice	O
.	O

The	O
most	O
notable	O
candidate	O
genes	O
located	O
within	O
the	O
HG1	O
interval	O
are	O
the	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
1	O
(	O
Stat1	O
)	O
and	O
Stat4	O
.	O

Two	O
of	O
the	O
congenics	O
had	O
major	O
alterations	O
in	O
the	O
deposition	O
of	O
adipose	O
tissue	O
,	O
HG8	O
and	O
HG9	O
.	O

The	O
HG8	O
donor	O
region	O
promotes	O
leanness	O
.	O

Congenic	O
females	O
displayed	O
a	O
reduction	O
of	O
over	O
25	O
%	O
in	O
AI	O
.	O

In	O
contrast	O
,	O
the	O
HG9	O
strain	O
is	O
an	O
obese	O
mouse	O
model	O
.	O

The	O
strain	O
is	O
quite	O
novel	O
for	O
two	O
reasons	O
.	O

First	O
,	O
the	O
effect	O
size	O
is	O
large	O
;	O
AI	O
was	O
57	O
%	O
higher	O
in	O
HG9	O
females	O
and	O
30	O
%	O
higher	O
in	O
males	O
.	O

Secondly	O
,	O
it	O
is	O
dependent	O
on	O
hg	O
for	O
its	O
expression	O
.	O

The	O
HG9	O
strain	O
represents	O
a	O
major	O
epistasis	O
-	O
based	O
obese	O
mouse	O
model	O
and	O
promises	O
to	O
aid	O
in	O
the	O
understanding	O
of	O
obesity	O
and	O
specifically	O
the	O
modulation	O
of	O
adipose	O
tissue	O
deposition	O
by	O
Gh	B-CHEBI
.	O

Studies	O
are	O
currently	O
underway	O
to	O
identify	O
the	O
causative	O
mutation	O
and	O
to	O
characterize	O
the	O
effects	O
of	O
age	O
and	O
diet	O
on	O
obesity	O
in	O
this	O
strain	O
as	O
well	O
as	O
testing	O
for	O
other	O
physiological	O
consequences	O
such	O
as	O
alterations	O
in	O
food	O
intake	O
and	O
insulin	O
sensitivity	O
.	O

The	O
HG11	O
strain	O
is	O
of	O
particular	O
interest	O
for	O
a	O
number	O
of	O
reasons	O
.	O

First	O
,	O
HG11	O
congenic	O
mice	O
demonstrated	O
significant	O
strain	O
by	O
sex	O
interactions	O
for	O
a	O
number	O
of	O
traits	O
.	O

Males	O
were	O
generally	O
larger	O
,	O
faster	O
growing	O
and	O
longer	O
and	O
the	O
converse	O
was	O
seen	O
in	O
females	O
.	O

The	O
confounding	O
effects	O
of	O
sex	O
are	O
likely	O
the	O
reason	O
for	O
the	O
discrepancies	O
between	O
the	O
congenic	O
and	O
genome	O
scan	O
results	O
,	O
where	O
both	O
sexes	O
were	O
analyzed	O
together	O
.	O

Secondly	O
,	O
Carp2	O
was	O
found	O
to	O
interact	O
with	O
hg	O
and	O
MMU11	O
is	O
saturated	O
with	O
genes	O
involved	O
in	O
the	O
central	O
Gh	B-CHEBI
intracellular	O
signaling	O
pathway	O
,	O
such	O
as	O
Gh	B-CHEBI
,	O
Stat5b	O
and	O
Stat5a	O
.	O

Thirdly	O
,	O
MMU11	O
growth	O
QTL	O
overlapping	O
HG11	O
have	O
been	O
identified	O
in	O
a	O
number	O
of	O
crosses	O
using	O
different	O
mouse	O
strains	O
[	O
37	O
-	O
41	O
]	O
.	O

Given	O
the	O
well	O
documented	O
sexually	O
dimorphic	O
nature	O
of	O
Gh	B-CHEBI
secretion	O
and	O
Gh	B-CHEBI
induced	O
gene	O
expression	O
[	O
42	O
,	O
43	O
]	O
,	O
it	O
is	O
probable	O
that	O
the	O
underlying	O
mutation	O
in	O
the	O
HG11	O
congenic	O
may	O
reside	O
in	O
a	O
gene	O
enhancing	O
Gh	B-CHEBI
induced	O
sex	O
-	O
specific	O
effects	O
.	O

The	O
structural	O
Gh	B-CHEBI
gene	O
itself	O
and	O
Stat5b	O
are	O
excellent	O
candidates	O
.	O

The	O
potential	O
role	O
of	O
Gh	B-CHEBI
would	O
include	O
polymorphism	O
that	O
alters	O
protein	B-CHEBI
function	O
in	O
the	O
absence	O
of	O
Socs2	O
or	O
that	O
causes	O
transcriptional	O
deregulation	O
of	O
Gh	B-CHEBI
.	O

Additionally	O
,	O
functional	O
variation	O
in	O
Stat5b	O
may	O
explain	O
the	O
sex	O
-	O
specific	O
phenotypes	O
in	O
HG11	O
mice	O
since	O
it	O
is	O
the	O
primary	O
transcription	O
factor	O
responsible	O
for	O
Gh	B-CHEBI
induced	O
sex	O
-	O
specific	O
liver	O
gene	O
expression	O
[	O
44	O
]	O
.	O

Future	O
studies	O
aimed	O
at	O
identifying	O
the	O
HG11	O
QTG	O
,	O
will	O
certainly	O
include	O
a	O
thorough	O
characterization	O
of	O
Gh	B-CHEBI
and	O
Stat5b	O
sequence	O
and	O
expression	O
patterns	O
in	O
congenic	O
mice	O
.	O

The	O
hg	O
modifier	O
QTL	O
located	O
within	O
the	O
HG17	O
strain	O
had	O
large	O
effects	O
on	O
growth	O
,	O
body	O
length	O
and	O
carcass	O
components	O
.	O

The	O
most	O
intriguing	O
candidate	O
gene	O
located	O
in	O
the	O
congenic	O
is	O
Sstr5	O
.	O

Somatostatin	O
is	O
a	O
potent	O
inhibitor	B-CHEBI
of	O
Gh	B-CHEBI
and	O
Sstr5	O
is	O
one	O
of	O
five	O
receptors	O
which	O
mediate	O
these	O
effects	O
[	O
45	O
,	O
46	O
]	O
.	O

Ubiquitous	O
and	O
pancreatic	O
beta	O
cell	O
specific	O
knockout	O
of	O
Sstr5	O
leads	O
to	O
alterations	O
in	O
insulin	B-CHEBI
secretion	O
and	O
glucose	B-CHEBI
homeostasis	O
[	O
47	O
,	O
48	O
]	O
.	O

We	O
sequenced	O
candidate	O
hg	O
modifier	O
genes	O
to	O
complement	O
the	O
characterization	O
of	O
the	O
speed	O
congenics	O
on	O
MMU2	O
,	O
9	O
,	O
11	O
and	O
17	O
.	O

A	O
limited	O
number	O
of	O
studies	O
have	O
identified	O
variation	O
within	O
CAST	O
coding	O
sequence	O
;	O
so	O
sequencing	O
candidates	O
gave	O
us	O
the	O
opportunity	O
to	O
estimate	O
the	O
SNP	O
frequency	O
in	O
coding	O
sequence	O
relative	O
to	O
B6	O
.	O

This	O
information	O
will	O
be	O
vital	O
to	O
future	O
fine	O
mapping	O
studies	O
,	O
which	O
will	O
include	O
gene	O
expression	O
analysis	O
.	O

The	O
high	O
SNP	O
frequency	O
(	O
0	O
.	O
312	O
%	O
;	O
295	O
SNP	O
in	O
94	O
.	O
492	O
kbp	O
)	O
in	O
CAST	O
genes	O
may	O
lead	O
to	O
a	O
higher	O
rate	O
of	O
false	O
positives	O
using	O
DNA	O
microarrays	O
or	O
quantitative	O
real	O
-	O
time	O
PCR	O
assays	O
,	O
most	O
of	O
which	O
are	O
based	O
on	O
B6	O
sequence	O
.	O

Therefore	O
,	O
these	O
sequence	O
data	O
can	O
be	O
used	O
to	O
guide	O
the	O
development	O
of	O
gene	O
expression	O
assays	O
to	O
confirm	O
differential	O
expression	O
for	O
candidates	O
and	O
suggests	O
that	O
genes	O
identified	O
by	O
downstream	O
experiments	O
should	O
also	O
be	O
sequenced	O
.	O

More	O
importantly	O
,	O
sequencing	O
hg	O
modifier	O
candidates	O
allowed	O
us	O
to	O
identify	O
nonsynonomous	O
polymorphism	O
,	O
which	O
may	O
underlie	O
QTL	O
.	O

SIFT	O
and	O
/	O
or	O
PolyPhen	O
predicted	O
alterations	O
in	O
protein	B-CHEBI
function	O
for	O
15	O
of	O
the	O
56	O
total	O
nsSNP	O
(	O
27	O
%	O
)	O
in	O
nine	O
of	O
the	O
44	O
total	O
genes	O
(	O
20	O
%	O
)	O
(	O
Table	O
7	O
)	O
.	O

It	O
has	O
been	O
shown	O
that	O
predicting	O
function	O
based	O
on	O
evolutionary	O
conservation	O
using	O
programs	O
such	O
as	O
SIFT	O
and	O
PolyPhen	O
is	O
very	O
accurate	O
[	O
49	O
]	O
.	O

Four	O
of	O
the	O
nine	O
genes	O
(	O
Ubr1	O
,	O
Ptpns1	O
,	O
Ubce7ip5	O
and	O
Mmp9	O
;	O
all	O
of	O
which	O
are	O
on	O
MMU2	O
)	O
are	O
of	O
particular	O
interest	O
.	O

It	O
has	O
been	O
suggested	O
the	O
Socs2	O
may	O
rely	O
on	O
ubiquitination	O
dependent	O
proteasomal	O
degradation	O
to	O
inhibit	O
Gh	B-CHEBI
signaling	O
[	O
23	O
]	O
.	O

Ubr1	O
and	O
Ubce7ip5	O
are	O
both	O
involved	O
in	O
protein	B-CHEBI
ubiquitination	O
and	O
Ubr1	O
knockout	O
mice	O
show	O
an	O
20	O
%	O
decrease	O
in	O
body	O
weight	O
partly	O
due	O
to	O
a	O
reduction	O
in	O
adipose	O
tissue	O
[	O
50	O
,	O
51	O
]	O
.	O

Ptpns1	O
knockout	O
mice	O
displayed	O
a	O
10	O
%	O
reduction	O
in	O
body	O
weight	O
[	O
52	O
]	O
and	O
Mmp9	O
knockout	O
mice	O
show	O
a	O
reduction	O
in	O
size	O
and	O
drastically	O
reduced	O
bone	O
length	O
[	O
53	O
]	O
.	O

All	O
of	O
these	O
genes	O
are	O
excellent	O
functional	O
and	O
positional	O
hg	O
modifier	O
candidate	O
genes	O
and	O
this	O
information	O
can	O
be	O
incorporated	O
into	O
future	O
fine	O
mapping	O
studies	O
.	O

Conclusion	O

The	O
speed	O
congenic	O
strains	O
developed	O
herein	O
confirm	O
previously	O
identified	O
genome	O
-	O
wide	O
QTL	O
affecting	O
growth	O
,	O
obesity	O
and	O
carcass	O
composition	O
.	O

Our	O
novel	O
congenic	O
development	O
approach	O
on	O
MMU2	O
provided	O
confirmation	O
of	O
QTL	O
-	O
hg	O
interactions	O
,	O
which	O
will	O
significantly	O
aid	O
in	O
future	O
fine	O
mapping	O
experiments	O
.	O

The	O
identification	O
of	O
the	O
molecular	B-CHEBI
mediators	O
of	O
QTL	O
-	O
hg	O
epistasis	O
as	O
well	O
as	O
the	O
QTG	O
for	O
the	O
remaining	O
congenics	O
will	O
provide	O
essential	O
information	O
on	O
the	O
molecular	B-CHEBI
genetic	O
architecture	O
of	O
growth	O
and	O
obesity	O
.	O

Methods	O

Mouse	O
strains	O
and	O
husbandry	O

CAST	O
/	O
EiJ	O
(	O
stock	O
#	O
000928	O
)	O
mice	O
were	O
purchased	O
from	O
the	O
Jackson	O
Laboratory	O
.	O

The	O
hg	O
mutation	O
was	O
originally	O
identified	O
in	O
a	O
selected	O
outcross	O
line	O
[	O
22	O
]	O
and	O
has	O
been	O
introgressed	O
onto	O
a	O
B6	O
background	O
via	O
nine	O
backcrosses	O
to	O
create	O
the	O
HG	O
strain	O
.	O

HG	O
mice	O
used	O
in	O
this	O
experiment	O
were	O
from	O
the	O
17th	O
or	O
later	O
generation	O
of	O
inbreeding	O
.	O

Mice	O
were	O
housed	O
in	O
polycarbonate	O
cages	O
under	O
controlled	O
conditions	O
of	O
temperature	O
(	O
21	O
degrees	O
C	O
+/-	O
2	O
degrees	O
C	O
)	O
,	O
humidity	O
(	O
40	O
-	O
70	O
%	O
)	O
and	O
lighting	O
(	O
14	O
h	O
light	O
,	O
10	O
h	O
dark	O
,	O
lights	O
on	O
at	O
7	O
AM	O
)	O
,	O
and	O
managed	O
according	O
to	O
the	O
guidelines	O
of	O
the	O
American	O
Association	O
for	O
Accreditation	O
of	O
Laboratory	O
Animal	O
Care	O
(	O
AAALAC	O
)	O
.	O

Genotyping	O

DNA	O
for	O
genotyping	O
was	O
isolated	O
from	O
1	O
.	O
0	O
-	O
2	O
.	O
0	O
mm	O
tail	O
clips	O
by	O
digesting	O
with	O
Proteinase	O
K	O
(	O
Fisher	O
)	O
at	O
55	O
degrees	O
C	O
in	O
a	O
buffer	O
composed	O
of	O
0	O
.	O
45	O
%	O
NP40	O
(	O
Sigma	O
)	O
,	O
0	O
.	O
45	O
%	O
Tween	O
20	O
(	O
Fisher	O
)	O
and	O
1X	O
PCR	O
buffer	O
(	O
Promega	O
)	O
.	O

The	O
product	O
of	O
this	O
digestion	O
was	O
diluted	O
(	O
1	O
:	O
10	O
)	O
in	O
sterile	O
H2O	B-CHEBI
and	O
used	O
for	O
genotyping	O
without	O
further	O
purification	O
.	O

Microsatellite	O
genotyping	O
was	O
performed	O
using	O
standard	O
PCR	O
and	O
gel	O
electrophoresis	O
protocols	O
.	O

Reaction	O
conditions	O
for	O
each	O
marker	O
are	O
listed	O
in	O
Additional	O
File	O
1	O
and	O
2	O
.	O

MMU2	O
congenic	O
mice	O
were	O
genotyped	O
for	O
hg	O
using	O
a	O
two	O
primer	O
genotyping	O
assay	O
.	O

One	O
primer	O
set	O
(	O
HG	O
-	O
F	O
,	O
ctcctgtctgggctgtgag	O
and	O
HG	O
-	O
R	O
,	O
caaaggcagaagtggggtaa	O
)	O
spanned	O
the	O
hg	O
deletion	O
producing	O
a	O
447	O
bp	O
product	O
in	O
hg	O
/	O
hg	O
and	O
+	O
/	O
hg	O
mice	O
.	O

The	O
other	O
set	O
(	O
CRADD3a	O
.	O
F	O
,	O
gtccatcagcattcctgaaa	O
and	O
CRADD3	O
.	O
R	O
,	O
tgtccagcaacagcattgtc	O
)	O
amplified	O
a	O
232	O
bp	O
Cradd	O
amplicon	O
(	O
located	O
within	O
the	O
hg	O
deletion	O
)	O
in	O
+	O
/	O
+	O
and	O
+	O
/	O
hg	O
mice	O
[	O
54	O
]	O
.	O

The	O
PCR	O
annealing	O
temperature	O
was	O
55	O
degrees	O
C	O
and	O
the	O
MgCl2	O
concentration	O
was	O
1	O
.	O
5	O
mM	O
.	O

Development	O
of	O
B6	O
.	O
CAST	O
and	O
HG	O
.	O
CAST	O
MMU2	O
speed	O
congenic	O
strains	O

All	O
speed	O
congenic	O
strains	O
were	O
developed	O
starting	O
with	O
an	O
initial	O
cross	O
between	O
a	O
CAST	O
male	O
and	O
HG	O
females	O
(	O
Figure	O
1	O
)	O
[	O
5	O
,	O
6	O
]	O
.	O

Male	O
F1	O
mice	O
were	O
then	O
backcrossed	O
to	O
HG	O
females	O
.	O

All	O
agouti	O
(	O
the	O
dominant	O
nonagouti	O
(	O
a	O
)	O
locus	O
is	O
located	O
at	O
154	O
.	O
8	O
Mbp	O
on	O
MMU2	O
)	O
N2	O
males	O
were	O
genotyped	O
for	O
79	O
microsatellite	O
markers	O
(	O
Additional	O
File	O
1	O
)	O
.	O

These	O
markers	O
were	O
evenly	O
spaced	O
across	O
the	O
genome	O
,	O
except	O
in	O
regions	O
previously	O
identified	O
as	O
harboring	O
QTL	O
[	O
1	O
]	O
,	O
which	O
were	O
more	O
densely	O
screened	O
.	O

The	O
"	O
best	O
"	O
N2	O
agouti	O
male	O
with	O
the	O
lowest	O
level	O
of	O
genome	O
-	O
wide	O
unwanted	O
heterozygosity	O
while	O
maintaining	O
CAST	O
alleles	O
for	O
all	O
MMU2	O
markers	O
was	O
selected	O
for	O
breeding	O
.	O

This	O
selection	O
scheme	O
was	O
used	O
at	O
each	O
generation	O
until	O
a	O
N4	O
male	O
was	O
identified	O
as	O
homozygous	O
HG	O
for	O
all	O
markers	O
typed	O
outside	O
MMU2	O
.	O

After	O
an	O
additional	O
backcross	O
to	O
HG	O
females	O
,	O
recombinant	O
males	O
were	O
identified	O
providing	O
the	O
foundation	O
for	O
the	O
four	O
overlapping	O
donor	O
regions	O
.	O

Selected	O
recombinant	O
males	O
were	O
then	O
backcrossed	O
to	O
both	O
B6	O
and	O
HG	O
females	O
to	O
create	O
strains	O
,	O
which	O
were	O
B6	O
(	O
+	O
/	O
+	O
)	O
or	O
HG	O
(	O
hg	O
/	O
hg	O
)	O
and	O
heterozygous	O
congenic	O
.	O

These	O
mice	O
were	O
intermated	O
to	O
produce	O
homozygous	O
founders	O
for	O
each	O
strain	O
.	O

This	O
novel	O
breeding	O
scheme	O
created	O
four	O
identical	O
founder	O
congenics	O
on	O
two	O
backgrounds	O
B6	O
(	O
+	O
/	O
+	O
)	O
and	O
HG	O
(	O
hg	O
/	O
hg	O
)	O
,	O
which	O
formed	O
the	O
basis	O
for	O
our	O
examination	O
of	O
interactions	O
caused	O
by	O
the	O
presence	O
of	O
the	O
hg	O
deletion	O
.	O

MMU2	O
speed	O
congenic	O
strains	O
were	O
maintained	O
through	O
brother	O
-	O
sister	O
mating	O
.	O

Once	O
each	O
congenic	O
was	O
stabilized	O
,	O
20	O
additional	O
microsatellite	O
markers	O
were	O
used	O
to	O
refine	O
the	O
position	O
of	O
each	O
congenic	O
recombinant	O
end	O
point	O
(	O
Additional	O
File	O
2	O
)	O
.	O

Development	O
of	O
HG	O
.	O
CAST	O
speed	O
congenic	O
strains	O
for	O
MMU1	O
,	O
5	O
,	O
8	O
,	O
9	O
,	O
11	O
and	O
17	O

All	O
black	O
N2	O
males	O
from	O
the	O
first	O
two	O
crosses	O
described	O
above	O
were	O
genotyped	O
for	O
12	O
markers	O
(	O
D1Mit432	O
,	O
-	O
480	O
,	O
D5Mit353	O
,	O
-	O
311	O
,	O
D9Mit60	O
,	O
-	O
262	O
,	O
D11Mit5	O
,	O
-	O
67	O
,	O
D8Mit234	O
,	O
-	O
211	O
and	O
D17Mit28	O
and	O
-	O
142	O
)	O
,	O
two	O
spanning	O
each	O
of	O
the	O
six	O
QTL	O
harboring	O
regions	O
(	O
MMU1	O
,	O
5	O
,	O
8	O
,	O
9	O
,	O
11	O
and	O
17	O
;	O
Table	O
1	O
and	O
Additional	O
File	O
1	O
)	O
.	O

Markers	O
were	O
selected	O
to	O
capture	O
,	O
at	O
a	O
minimum	O
,	O
the	O
2	O
-	O
LOD	O
support	O
interval	O
.	O

Two	O
N2	O
males	O
were	O
selected	O
to	O
propagate	O
the	O
N3	O
generation	O
;	O
one	O
heterozygous	O
for	O
QTL	O
on	O
MMU1	O
and	O
9	O
and	O
the	O
other	O
heterozygous	O
for	O
QTL	O
on	O
MMU5	O
,	O
8	O
,	O
11	O
and	O
17	O
(	O
Figure	O
1	O
)	O
.	O

Both	O
males	O
were	O
homozygous	O
for	O
HG	O
alleles	O
at	O
all	O
other	O
known	O
QTL	O
.	O

These	O
males	O
were	O
backcrossed	O
to	O
HG	O
females	O
and	O
two	O
of	O
the	O
resulting	O
N3	O
males	O
inheriting	O
the	O
same	O
sets	O
of	O
QTL	O
as	O
their	O
sire	O
were	O
selected	O
for	O
breeding	O
.	O

These	O
males	O
were	O
subsequently	O
backcrossed	O
to	O
HG	O
females	O
and	O
three	O
N4	O
males	O
were	O
identified	O
heterozygous	O
for	O
the	O
following	O
regions	O
:	O
1	O
)	O
MMU1	O
and	O
9	O
;	O
2	O
)	O
MMU5	O
and	O
11	O
;	O
3	O
)	O
MMU8	O
,	O
11	O
and	O
17	O
(	O
Figure	O
1	O
)	O
.	O

Starting	O
at	O
N4	O
and	O
continuing	O
through	O
N6	O
,	O
the	O
"	O
best	O
"	O
male	O
with	O
the	O
lowest	O
percent	O
of	O
unwanted	O
donor	O
alleles	O
was	O
selected	O
after	O
performing	O
a	O
genome	O
scan	O
using	O
the	O
remaining	O
67	O
genome	O
-	O
wide	O
markers	O
(	O
79	O
total	O
markers	O
minus	O
the	O
12	O
markers	O
genotyped	O
in	O
the	O
first	O
two	O
backcrosses	O
spanning	O
the	O
know	O
QTL	O
intervals	O
)	O
.	O

At	O
N5	O
a	O
distinct	O
strain	O
was	O
created	O
for	O
each	O
of	O
the	O
six	O
individual	O
donor	O
regions	O
and	O
heterozygous	O
mice	O
were	O
intermated	O
(	O
Figure	O
1	O
)	O
.	O

Homozygous	O
HG	O
.	O
CAST	O
speed	O
congenic	O
strains	O
were	O
maintained	O
through	O
brother	O
-	O
sister	O
mating	O
.	O

Once	O
each	O
congenic	O
was	O
stabilized	O
,	O
19	O
additional	O
microsatellite	O
markers	O
were	O
used	O
to	O
refine	O
the	O
position	O
of	O
each	O
congenic	O
recombinant	O
end	O
point	O
(	O
Additional	O
File	O
2	O
)	O
.	O

Development	O
of	O
B6	O
.	O
CASTC	O
and	O
HG	O
.	O
CASTC	O
control	O
strains	O

HG	O
is	O
a	O
strain	O
in	O
which	O
the	O
hg	O
deletion	O
has	O
been	O
introgressed	O
onto	O
a	O
B6	O
background	O
,	O
therefore	O
the	O
only	O
genetic	O
differences	O
between	O
the	O
strains	O
would	O
be	O
the	O
hg	O
locus	O
,	O
tightly	O
linked	O
alleles	O
from	O
the	O
outbred	O
strain	O
on	O
which	O
hg	O
arose	O
and	O
contaminating	O
alleles	O
remaining	O
after	O
the	O
nine	O
backcrosses	O
and	O
fixed	O
during	O
inbreeding	O
.	O

Instead	O
of	O
using	O
parental	O
B6	O
and	O
HG	O
strains	O
as	O
controls	O
for	O
phenotypic	O
comparisons	O
with	O
each	O
speed	O
congenic	O
,	O
we	O
choose	O
to	O
develop	O
independent	O
control	O
strains	O
originating	O
from	O
the	O
same	O
cross	O
as	O
the	O
congenic	O
panels	O
.	O

Separate	O
B6	O
.	O
CAST	O
control	O
(	O
B6C	O
)	O
and	O
HG	O
.	O
CAST	O
control	O
(	O
HGC	O
)	O
strains	O
were	O
developed	O
using	O
mice	O
from	O
the	O
MMU2	O
experiment	O
.	O

Mice	O
from	O
the	O
last	O
backcross	O
inheriting	O
only	O
B6	O
or	O
HG	O
MMU2	O
alleles	O
at	O
markers	O
spanning	O
MMU2	O
were	O
intermated	O
to	O
serve	O
as	O
the	O
basis	O
for	O
each	O
control	O
.	O

Both	O
control	O
strains	O
were	O
subsequently	O
maintained	O
through	O
brother	O
-	O
sister	O
mating	O
.	O

The	O
control	O
strains	O
were	O
coisogenic	O
with	O
the	O
parental	O
B6	O
or	O
HG	O
strain	O
with	O
the	O
exception	O
of	O
mutations	O
that	O
arose	O
during	O
congenic	O
construction	O
and	O
a	O
small	O
percentage	O
of	O
contaminating	O
donor	O
alleles	O
missed	O
after	O
6	O
backcrosses	O
.	O

Therefore	O
,	O
since	O
the	O
congenics	O
and	O
controls	O
were	O
developed	O
through	O
the	O
same	O
selection	O
scheme	O
and	O
possibly	O
share	O
common	O
contaminating	O
regions	O
,	O
the	O
B6C	O
and	O
HGC	O
strains	O
are	O
the	O
most	O
ideal	O
control	O
to	O
compare	O
each	O
congenic	O
.	O

Phenotypic	O
characterization	O

Trait	O
data	O
were	O
collected	O
on	O
approximately	O
40	O
mice	O
(	O
20	O
of	O
each	O
sex	O
)	O
from	O
each	O
congenic	O
and	O
control	O
strain	O
.	O

To	O
eliminate	O
parity	O
and	O
reduce	O
litter	O
size	O
effects	O
only	O
progeny	O
from	O
uniparous	O
dams	O
were	O
characterized	O
and	O
all	O
litters	O
were	O
standardized	O
to	O
5	O
-	O
7	O
pups	O
/	O
litter	O
.	O

Mice	O
were	O
weaned	O
at	O
3	O
weeks	O
of	O
age	O
.	O

Feed	B-CHEBI
(	O
Purina	O
5008	O
;	O
23	O
.	O
5	O
%	O
protein	B-CHEBI
,	O
6	O
.	O
5	O
%	O
fat	O
,	O
3	O
.	O
3	O
Kcal	O
/	O
g	O
)	O
and	O
water	B-CHEBI
were	O
offered	O
ad	O
libitum	O
.	O

Mice	O
were	O
weighed	O
to	O
the	O
nearest	O
0	O
.	O
1	O
g	O
at	O
2WK	O
,	O
3WK	O
,	O
6WK	O
,	O
and	O
9WK	O
of	O
age	O
.	O

At	O
9WK	O
(	O
+/-	O
5	O
days	O
)	O
mice	O
were	O
anesthetized	O
under	O
isoflurane	O
and	O
nasal	O
-	O
anal	O
length	O
(	O
NA	O
)	O
and	O
nasal	O
-	O
tail	O
(	O
NT	O
)	O
were	O
measured	O
to	O
the	O
nearest	O
mm	O
.	O

Tail	O
length	O
was	O
calculated	O
as	O
NA	O
minus	O
NT	O
.	O

Anesthetized	O
mice	O
were	O
then	O
sacrificed	O
by	O
decapitation	O
and	O
exsanguinated	O
.	O

Femoral	O
fat	O
pad	O
(	O
FFP	O
)	O
,	O
gonadal	O
fat	O
pad	O
(	O
GFP	O
)	O
,	O
mesenteric	O
fat	O
pad	O
(	O
MFP	O
)	O
and	O
retroperitoneal	O
fat	O
pad	O
(	O
RFP	O
)	O
were	O
removed	O
and	O
weighed	O
to	O
the	O
nearest	O
mg	O
.	O

Chemical	B-CHEBI
compositional	O
analysis	O
was	O
performed	O
for	O
HGC	O
,	O
HG11	O
and	O
HG17	O
carcasses	O
as	O
previously	O
described	O
with	O
slight	O
modifications	O
[	O
24	O
]	O
.	O

Briefly	O
,	O
after	O
weighing	O
each	O
fat	O
pad	O
was	O
returned	O
to	O
the	O
carcass	O
.	O

The	O
entire	O
gastrointestinal	O
(	O
GI	O
)	O
tract	O
was	O
subsequently	O
removed	O
and	O
carcasses	O
were	O
again	O
weighed	O
.	O

This	O
represented	O
the	O
empty	O
carcass	O
weight	O
(	O
ECW	O
)	O
.	O

Carcasses	O
were	O
labeled	O
and	O
secured	O
in	O
two	O
layers	O
of	O
cheesecloth	O
(	O
Fisher	O
)	O
and	O
frozen	O
at	O
-	O
20	O
degrees	O
C	O
until	O
analysis	O
.	O

At	O
this	O
time	O
,	O
carcasses	O
were	O
freeze	O
-	O
dried	O
for	O
seven	O
days	O
and	O
water	B-CHEBI
content	O
was	O
determined	O
by	O
subtracting	O
the	O
freeze	O
-	O
dried	O
weight	O
from	O
ECW	O
.	O

FAT	O
was	O
then	O
extracted	O
with	O
ether	O
for	O
7	O
days	O
,	O
followed	O
by	O
acetone	B-CHEBI
for	O
an	O
additional	O
7	O
days	O
in	O
a	O
Soxhlet	O
apparatus	O
.	O

Carcass	O
ash	O
(	O
ASH	O
)	O
was	O
determined	O
measuring	O
the	O
remains	O
after	O
a	O
16	O
hour	O
incineration	O
at	O
575	O
degrees	O
C	O
.	O

Carcass	O
protein	B-CHEBI
(	O
PROT	B-CHEBI
)	O
was	O
calculated	O
as	O
the	O
remaining	O
portion	O
after	O
carcass	O
fat	O
(	O
FAT	O
)	O
and	O
ASH	O
were	O
subtracted	O
from	O
ECW	O
.	O

Statistical	O
analysis	O

The	O
MEANS	O
and	O
UNIVARIATE	O
procedures	O
of	O
SAS	O
were	O
used	O
to	O
generate	O
descriptive	O
statistics	O
and	O
test	O
normality	O
assumptions	O
for	O
each	O
trait	O
[	O
55	O
]	O
.	O

All	O
data	O
were	O
then	O
analyzed	O
using	O
the	O
GLM	O
procedure	O
of	O
SAS	O
[	O
55	O
]	O
with	O
a	O
linear	O
model	O
that	O
included	O
the	O
fixed	O
effects	O
of	O
strain	O
,	O
sex	O
and	O
strain	O
by	O
sex	O
interaction	O
;	O
dam	O
'	O
s	O
weight	O
at	O
breeding	O
by	O
strain	O
was	O
used	O
as	O
a	O
covariate	O
.	O

A	O
second	O
linear	O
model	O
was	O
used	O
to	O
test	O
for	O
strain	O
by	O
hg	O
genotype	O
(	O
+	O
/	O
+	O
or	O
hg	O
/	O
hg	O
)	O
interactions	O
.	O

This	O
model	O
included	O
the	O
fixed	O
effects	O
of	O
donor	O
region	O
,	O
sex	O
and	O
HG	O
genotype	O
and	O
all	O
possible	O
two	O
and	O
three	O
-	O
way	O
interactions	O
.	O

Choosing	O
a	O
nominal	O
P	O
value	O
of	O
0	O
.	O
05	O
and	O
applying	O
the	O
Bonferroni	O
correction	O
for	O
multiple	O
comparisons	O
established	O
significant	O
differences	O
in	O
the	O
ANOVA	O
'	O
s	O
.	O

The	O
critical	O
P	O
values	O
used	O
are	O
indicated	O
in	O
each	O
table	O
.	O

Identification	O
of	O
candidate	O
genes	O

Genes	O
were	O
identified	O
by	O
manual	O
data	O
mining	O
of	O
primary	O
literature	O
,	O
reviews	O
and	O
book	O
chapters	O
.	O

To	O
organize	O
and	O
collate	O
genomic	O
and	O
functional	O
information	O
for	O
each	O
gene	O
we	O
created	O
a	O
custom	O
Gh	B-CHEBI
signaling	O
Gene	O
Map	O
Annotator	O
and	O
Pathway	O
Profiler	O
(	O
GenMAPP	O
)	O
pathway	O
[	O
56	O
]	O
(	O
Figure	O
5	O
)	O
.	O

Visualization	O
and	O
color	O
-	O
coding	O
of	O
genes	O
using	O
GenMAPP	O
aided	O
the	O
selection	O
of	O
candidate	O
genes	O
mapping	O
within	O
QTL	O
regions	O
on	O
MMU2	O
,	O
9	O
,	O
11	O
and	O
17	O
.	O

Candidate	O
gene	O
sequencing	O

PCR	O
amplicons	O
covering	O
the	O
coding	O
sequence	O
and	O
partial	O
5	O
'	O
and	O
3	O
'	O
untranslated	O
regions	O
for	O
each	O
selected	O
candidate	O
gene	O
were	O
amplified	O
,	O
purified	O
and	O
sequenced	O
from	O
the	O
CAST	O
strain	O
using	O
protocols	O
outlined	O
in	O
[	O
57	O
]	O
with	O
slight	O
modifications	O
.	O

Total	O
RNA	O
from	O
brain	O
,	O
liver	O
,	O
spleen	O
,	O
lung	O
and	O
testis	O
was	O
isolated	O
from	O
an	O
adult	O
CAST	O
male	O
mouse	O
using	O
Trizol	O
(	O
Ambion	O
)	O
.	O

cDNA	O
was	O
produced	O
from	O
total	O
RNA	O
using	O
standard	O
procedures	O
.	O

PCR	O
primer	O
sets	O
for	O
each	O
gene	O
were	O
designed	O
using	O
Primer3	O
[	O
58	O
]	O
(	O
Additional	O
File	O
5	O
)	O
.	O

The	O
initial	O
amplification	O
was	O
performed	O
in	O
10	O
mu	O
l	O
PCR	O
reactions	O
using	O
the	O
Invitrogen	O
Platinum	O
TaqPCRx	O
amplification	O
system	O
(	O
Invitrogen	O
)	O
.	O

The	O
reactions	O
contained	O
1X	O
PCR	O
buffer	O
,	O
1X	O
Enhancer	O
solution	O
,	O
1	O
.	O
5	O
mM	O
MgSO4	B-CHEBI
,	O
0	O
.	O
17	O
mM	O
dNTPs	B-CHEBI
,	O
1	O
mu	O
M	O
each	O
primer	O
,	O
0	O
.	O
1	O
unit	O
of	O
Platinum	O
Taq	O
(	O
Invitrogen	O
)	O
and	O
approximately	O
25	O
ng	O
of	O
cDNA	O
.	O

Reactions	O
were	O
incubated	O
for	O
5	O
min	O
at	O
95	O
degrees	O
C	O
,	O
then	O
cycled	O
for	O
45	O
s	O
at	O
95	O
degrees	O
C	O
,	O
45	O
s	O
at	O
55	O
degrees	O
C	O
,	O
1	O
min	O
at	O
72	O
degrees	O
C	O
for	O
35	O
cycles	O
with	O
a	O
final	O
72	O
degrees	O
C	O
extension	O
for	O
10	O
min	O
on	O
a	O
MJ	O
Research	O
PTC	O
-	O
200	O
.	O

The	O
products	O
were	O
visualized	O
on	O
1	O
.	O
5	O
%	O
agarose	B-CHEBI
gels	O
containing	O
0	O
.	O
06	O
mu	O
g	O
/	O
ml	O
EtBr	B-CHEBI
.	O

Bands	O
of	O
the	O
correct	O
size	O
were	O
excised	O
and	O
incubated	O
in	O
100	O
mu	O
l	O
of	O
sterile	O
H2O	B-CHEBI
at	O
80	O
degrees	O
C	O
for	O
10	O
min	O
to	O
elute	O
DNA	O
.	O

Reamplification	O
reactions	O
consisted	O
of	O
1X	O
PCR	O
buffer	O
,	O
1	O
.	O
5	O
mM	O
MgCl2	B-CHEBI
,	O
0	O
.	O
17	O
mM	O
dNTPs	B-CHEBI
,	O
1	O
mu	O
M	O
each	O
primer	O
,	O
0	O
.	O
1	O
unit	O
of	O
Taq	O
(	O
Promega	O
)	O
and	O
10	O
mu	O
l	O
of	O
eluate	O
in	O
a	O
total	O
volume	O
of	O
50	O
mu	O
l	O
.	O

The	O
same	O
cycling	O
parameters	O
were	O
used	O
for	O
reamplification	O
reactions	O
.	O

Products	O
were	O
visualized	O
on	O
1	O
%	O
0	O
.	O
5X	O
TBE	O
agarose	B-CHEBI
gels	O
containing	O
0	O
.	O
06	O
mu	O
g	O
/	O
ml	O
EtBr	B-CHEBI
,	O
excised	O
and	O
purfied	O
using	O
PCR	O
purification	O
columns	O
(	O
Promega	O
)	O
.	O

To	O
quantity	O
each	O
fragment	O
1	O
mu	O
l	O
of	O
each	O
purified	O
product	O
was	O
run	O
on	O
a	O
1	O
.	O
0	O
%	O
agarose	B-CHEBI
gel	O
containing	O
0	O
.	O
06	O
mu	O
g	O
/	O
ml	O
EtBr	B-CHEBI
,	O
along	O
with	O
a	O
DNA	O
mass	O
ladder	O
(	O
Invitrogen	O
)	O
.	O

In	O
a	O
96	O
well	O
plate	O
,	O
15	O
ng	O
of	O
each	O
PCR	O
product	O
was	O
added	O
to	O
5	O
pM	O
of	O
primer	O
for	O
sequencing	O
.	O

The	O
College	O
of	O
Agriculture	O
and	O
Environmental	O
Sciences	O
(	O
CAES	O
)	O
Genomics	O
Facility	O
at	O
the	O
University	O
of	O
California	O
,	O
Davis	O
,	O
performed	O
bidirectional	O
sequencing	O
of	O
each	O
amplicon	O
.	O

Sequence	O
analysis	O

B6	O
mRNA	B-CHEBI
sequences	I-CHEBI
for	O
each	O
gene	O
were	O
downloaded	O
from	O
the	O
May	O
2004	O
(	O
mm5	O
)	O
UCSC	O
(	O
NCBI	O
Build	O
33	O
)	O
genome	O
assembly	O
[	O
28	O
]	O
.	O

These	O
sequences	O
were	O
imported	O
along	O
with	O
all	O
CAST	O
sequence	O
traces	O
into	O
the	O
SeqMan	O
sequence	O
assembly	O
program	O
(	O
DNASTAR	O
)	O
and	O
manually	O
curated	O
for	O
quality	O
.	O

Poor	O
quality	O
reads	O
were	O
resequenced	O
.	O

Individual	O
contigs	O
were	O
created	O
for	O
each	O
gene	O
and	O
polymorphisms	O
were	O
detected	O
and	O
curated	O
by	O
manual	O
inspection	O
.	O

Authors	O
'	O
contributions	O

CRF	O
and	O
JFM	O
conceived	O
the	O
study	O
.	O

CRF	O
developed	O
and	O
characterized	O
each	O
speed	O
congenic	O
strain	O
,	O
assisted	O
with	O
phenotypic	O
data	O
analysis	O
and	O
drafted	O
the	O
manuscript	O
.	O

PMC	O
assisted	O
with	O
experimental	O
design	O
and	O
phenotypic	O
data	O
analysis	O
.	O

JFM	O
assisted	O
in	O
the	O
evaluation	O
of	O
experimental	O
results	O
and	O
the	O
manuscript	O
and	O
provided	O
coordination	O
of	O
the	O
project	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Supplementary	O
Material	O

Additional	O
File	O
1	O

Table	O
of	O
microsatellite	O
markers	O
used	O
in	O
the	O
construction	O
of	O
B6	O
.	O
CAST	O
and	O
HG	O
.	O
CAST	O
speed	O
congenic	O
strains	O

Click	O
here	O
for	O
file	O

Additional	O
File	O
2	O

Table	O
of	O
microsatellite	O
markers	O
used	O
to	O
position	O
the	O
recombinant	O
ends	O
of	O
each	O
speed	O
congenic	O
strain	O

Click	O
here	O
for	O
file	O

Additional	O
File	O
3	O

Table	O
of	O
body	O
weight	O
and	O
growth	O
rate	O
phenotypes	O
of	O
B6	O
.	O
CAST	O
and	O
HG	O
.	O
CAST	O
MMU2	O
speed	O
congenic	O
strains	O

Click	O
here	O
for	O
file	O

Additional	O
File	O
4	O

Table	O
of	O
results	O
of	O
sequence	O
comparisons	O
between	O
CAST	O
and	O
B6	O
for	O
MMU2	O
hg	O
modifier	O
candidate	O
genes	O

Click	O
here	O
for	O
file	O

Additional	O
File	O
5	O

Table	O
of	O
PCR	O
primers	O
used	O
to	O
sequence	O
MMU2	O
,	O
9	O
,	O
11	O
and	O
17	O
hg	O
modifier	O
candidate	O
genes	O

Click	O
here	O
for	O
file	O

Acknowledgements	O

We	O
thank	O
Vince	O
De	O
Vera	O
for	O
mouse	O
care	O
and	O
Alma	O
Islas	O
-	O
Trejo	O
,	O
Kerri	O
Morimoto	O
,	O
Gonzalo	O
Rincon	O
,	O
Ricardo	O
Verdugo	O
,	O
Karina	O
Guevara	O
,	O
James	O
Chitwood	O
,	O
Lee	O
Nguyen	O
,	O
Galen	O
Williams	O
and	O
Emily	O
Farber	O
for	O
assistance	O
with	O
mouse	O
phenotyping	O
.	O

We	O
also	O
thank	O
Scott	O
Taylor	O
and	O
Dr	O
.	O
Ed	O
DePeters	O
for	O
assistance	O
and	O
use	O
of	O
the	O
UCD	O
Animal	O
Science	O
Nutrition	O
Laboratory	O
for	O
carcass	O
composition	O
analysis	O
.	O

This	O
work	O
was	O
supported	O
by	O
the	O
National	O
Research	O
Initiative	O
of	O
the	O
USDA	O
Cooperative	O
State	O
Research	O
,	O
Education	O
and	O
Extension	O
Service	O
,	O
grant	O
number	O
2005	O
-	O
35205	O
-	O
15453	O
.	O

CRF	O
was	O
supported	O
by	O
the	O
Austin	O
Eugene	O
Lyons	O
fellowship	O
.	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Outline	O
of	O
the	O
speed	O
congenic	O
approach	O
used	O
to	O
capture	O
genome	O
-	O
wide	O
growth	O
and	O
obesity	O
QTL	O
.	O

Details	O
of	O
the	O
congenic	O
matings	O
are	O
outlined	O
in	O
"	O
Methods	O
"	O
.	O

The	O
matings	O
used	O
to	O
construct	O
the	O
MMU2	O
speed	O
congenic	O
panel	O
are	O
listed	O
on	O
the	O
left	O
of	O
the	O
figure	O
,	O
along	O
with	O
the	O
expected	O
and	O
observed	O
%	O
heterozygosity	O
at	O
each	O
generation	O
.	O

%	O
heterozygosity	O
is	O
defined	O
as	O
the	O
number	O
of	O
markers	O
heterozygous	O
B6	O
(	O
or	O
HG	O
)	O
/	O
CAST	O
as	O
a	O
percent	O
of	O
the	O
total	O
number	O
of	O
markers	O
typed	O
(	O
N	O
=	O
79	O
)	O
.	O

The	O
right	O
side	O
of	O
the	O
illustration	O
lists	O
the	O
matings	O
used	O
to	O
construct	O
the	O
MMU1	O
,	O
5	O
,	O
8	O
,	O
9	O
,	O
11	O
and	O
17	O
speed	O
congenic	O
strains	O
,	O
along	O
with	O
the	O
expected	O
and	O
observed	O
%	O
heterozygosity	O
at	O
each	O
generation	O
.	O

Figure	O
2	O

Genome	O
-	O
wide	O
speed	O
congenic	O
strains	O
and	O
summary	O
of	O
QTL	O
effects	O
.	O

White	O
bars	O
indicate	O
the	O
boundaries	O
of	O
CAST	O
donor	O
regions	O
and	O
hatched	O
bars	O
indicate	O
intervals	O
of	O
unknown	O
genotype	O
.	O

The	O
minimum	O
physical	O
intervals	O
(	O
Mbp	O
)	O
of	O
each	O
donor	O
region	O
are	O
listed	O
in	O
Table	O
1	O
.	O

To	O
provide	O
a	O
general	O
summary	O
of	O
the	O
results	O
,	O
MMU2	O
is	O
divided	O
into	O
five	O
chromosomal	O
regions	O
(	O
I	O
,	O
II	O
,	O
III	O
,	O
IV	O
and	O
V	O
)	O
.	O

Phenotypic	O
differences	O
for	O
male	O
and	O
female	O
(	O
+	O
/	O
+	O
and	O
hg	O
/	O
hg	O
)	O
mice	O
relative	O
to	O
the	O
appropriate	O
controls	O
are	O
listed	O
.	O

For	O
congenics	O
outside	O
of	O
MMU2	O
,	O
a	O
general	O
summary	O
of	O
QTL	O
effects	O
is	O
listed	O
to	O
the	O
right	O
of	O
each	O
donor	O
region	O
.	O

Abbreviations	O
:	O
WT	O
,	O
body	O
weight	O
;	O
GR	O
,	O
growth	O
rate	O
;	O
T	O
,	O
tail	O
length	O
;	O
NA	O
,	O
nasal	O
-	O
anal	O
body	O
length	O
;	O
TF	O
,	O
total	O
weight	O
of	O
four	O
fat	O
pads	O
;	O
AI	O
,	O
adiposity	O
index	O
and	O
BMI	O
,	O
body	O
mass	O
index	O
.	O

Figure	O
3	O

Growth	O
curves	O
for	O
MMU2	O
B6	O
.	O
CAST	O
and	O
HG	O
.	O
CAST	O
speed	O
congenic	O
strains	O
.	O

Body	O
weight	O
LSMEANS	O
+/-	O
SEM	O
are	O
plotted	O
as	O
a	O
function	O
of	O
time	O
(	O
weeks	O
)	O
.	O

Top	O
plot	O
,	O
growth	O
curves	O
in	O
male	O
B6	O
(	O
+	O
/	O
+	O
)	O
and	O
HG	O
(	O
hg	O
/	O
hg	O
)	O
speed	O
congenic	O
strains	O
;	O
bottom	O
plot	O
,	O
growth	O
curves	O
in	O
female	O
B6	O
(	O
+	O
/	O
+	O
)	O
and	O
HG	O
(	O
hg	O
/	O
hg	O
)	O
speed	O
congenic	O
strains	O
.	O

Figure	O
4	O

Significant	O
three	O
-	O
way	O
donor	O
region	O
by	O
HG	O
genotype	O
by	O
sex	O
interaction	O
for	O
AI	O
in	O
the	O
2M	O
donor	O
region	O
.	O

AI	O
plot	O
illustrates	O
the	O
effect	O
of	O
the	O
hg	O
deletion	O
on	O
altering	O
fat	O
deposition	O
between	O
the	O
sexes	O
.	O

The	O
interaction	O
is	O
significant	O
at	O
P	O
=	O
0	O
.	O
0004	O
.	O

Figure	O
5	O

GenMAPP	O
growth	B-CHEBI
hormone	I-CHEBI
(	O
Gh	B-CHEBI
)	O
signaling	O
pathway	O
.	O

Genes	O
known	O
to	O
be	O
or	O
potentially	O
involved	O
in	O
Gh	B-CHEBI
signaling	O
were	O
mined	O
from	O
primary	O
literature	O
,	O
reviews	O
and	O
book	O
chapters	O
.	O

Genes	O
are	O
organized	O
broadly	O
based	O
on	O
functionality	O
.	O

MMU	O
genomic	O
position	O
for	O
each	O
gene	O
is	O
to	O
the	O
right	O
of	O
each	O
symbol	O
and	O
genes	O
located	O
on	O
MMU2	O
,	O
9	O
,	O
11	O
and	O
17	O
are	O
highlighted	O
in	O
yellow	O
,	O
purple	O
,	O
orange	O
and	O
green	O
,	O
respectively	O
.	O

Genes	O
located	O
on	O
MMUX	O
are	O
labeled	O
in	O
white	O
.	O

Forty	O
-	O
four	O
of	O
the	O
genes	O
overlapping	O
QTL	O
intervals	O
were	O
selected	O
for	O
sequencing	O
in	O
the	O
CAST	O
strain	O
.	O

Table	O
1	O

B6	O
.	O
CAST	O
and	O
HG	O
.	O
CAST	O
speed	O
congenic	O
strains	O
developed	O
to	O
isolate	O
and	O
characterize	O
genome	O
-	O
wide	O
QTL	O
affecting	O
growth	O
and	O
obesity	O

QTL	O
,	O
quantitative	O
trait	O
locus	O
;	O
MMU	O
,	O
mouse	O
chromosome	O
;	O
LOD	O
,	O
log	O
of	O
the	O
odds	O

a	O
QTL	O
MGI	O
[	O
59	O
]	O
nomenclature	O
.	O

Q1Ucd1	O
-	O
w26	O
never	O
received	O
an	O
official	O
MGI	O
name	O
,	O
because	O
it	O
only	O
reached	O
a	O
suggestive	O
level	O
of	O
significance	O
;	O
hg	O
modifier	O
QTL	O
are	O
in	O
bold	O
[	O
24	O
]	O
.	O

b	O
Mbp	O
position	O
according	O
to	O
the	O
August	O
2005	O
mm7	O
UCSC	O
[	O
28	O
]	O
genome	O
assembly	O
(	O
NCBI	O
Build	O
35	O
)	O
,	O
peak	O
LOD	O
from	O
[	O
24	O
]	O
.	O

c	O
In	O
the	O
linkage	O
analysis	O
performed	O
in	O
[	O
24	O
]	O
,	O
the	O
peak	O
location	O
for	O
Wg2	O
,	O
Carp1	O
,	O
Cara1	O
and	O
Feml1	O
was	O
59	O
-	O
63	O
cM	O
(	O
115	O
-	O
120	O
Mbp	O
)	O
in	O
hg	O
/	O
hg	O
F2	O
mice	O
and	O
78	O
-	O
83	O
cM	O
(	O
135	O
-	O
150	O
Mbp	O
)	O
in	O
+	O
/	O
+	O
F2	O
mice	O
.	O

d	O
Full	O
congenic	O
name	O
consists	O
of	O
three	O
parts	O
:	O
1	O
.	O

B6	O
.	O
CAST	O
,	O
indicates	O
the	O
recipient	O
strain	O
is	O
B6	O
and	O
the	O
donor	O
strain	O
is	O
CAST	O
;	O
HG	O
.	O
CAST	O
,	O
indicates	O
the	O
recipient	O
strain	O
is	O
HG	O
and	O
the	O
donor	O
strain	O
is	O
CAST	O
;	O
2	O
.	O
markers	O
defining	O
the	O
minimal	O
congenic	O
interval	O
;	O
3	O
.	O
the	O
number	O
of	O
backcrosses	O
used	O
for	O
speed	O
congenic	O
development	O
.	O

e	O
Represents	O
the	O
minimum	O
genomic	O
region	O
spanned	O
by	O
CAST	O
donor	O
alleles	O
.	O

Table	O
2	O

Body	O
length	O
and	O
adiposity	O
phenotypes	O
of	O
B6	O
.	O
CAST	O
and	O
HG	O
.	O
CAST	O
MMU2	O
speed	O
congenic	O
strains	O

NA	O
,	O
nasal	O
-	O
anal	O
body	O
length	O
;	O
Tail	O
,	O
tail	O
length	O
;	O
GFP	O
,	O
gonadal	O
fat	O
pad	O
;	O
FFP	O
,	O
femoral	O
fat	O
pad	O
;	O
MFP	O
,	O
mesenteric	O
fat	O
pad	O
;	O
RFP	O
,	O
retroperitoneal	O
fat	O
pad	O
;	O
TF	O
,	O
summed	O
weight	O
of	O
four	O
fat	O
pads	O
;	O
AI	O
,	O
adiposity	O
index	O
(	O
TF	O
/	O
body	O
weight	O
*	O
100	O
)	O
and	O
BMI	O
,	O
body	O
mass	O
index	O
(	O
body	O
weight	O
at	O
sacrifice	O
/	O
NA2	O
*	O
100	O
)	O
.	O

Values	O
are	O
expressed	O
as	O
LSMEANS	O
+/-	O
SEM	O
.	O

LSMEANS	O
in	O
bold	O
are	O
significantly	O
different	O
than	O
the	O
respective	O
control	O
after	O
Bonferroni	O
correction	O
(	O
B6	O
(	O
critical	O
P	O
<	O
0	O
.	O
00625	O
)	O
or	O
HG	O
(	O
P	O
<	O
0	O
.	O
00833	O
)	O
)	O
within	O
each	O
sex	O
.	O

Table	O
3	O

Significance	O
levels	O
for	O
the	O
main	O
effects	O
,	O
two	O
-	O
way	O
and	O
three	O
way	O
interactions	O
of	O
MMU2	O
speed	O
congenic	O
donor	O
region	O
(	O
DR	O
)	O
,	O
HG	O
genotype	O
(	O
HG	O
)	O
(	O
+	O
/	O
+	O
or	O
hg	O
/	O
hg	O
)	O
and	O
sex	O
for	O
selected	O
traits	O

6WK	O
,	O
weight	O
at	O
6	O
weeks	O
of	O
age	O
;	O
9WK	O
,	O
weight	O
at	O
9	O
weeks	O
of	O
age	O
;	O
G26	O
,	O
weight	O
gain	O
from	O
2	O
to	O
6	O
weeks	O
of	O
age	O
;	O
G29	O
,	O
weight	O
gain	O
from	O
2	O
to	O
9	O
weeks	O
of	O
age	O
;	O
NA	O
,	O
nasal	O
-	O
anal	O
body	O
length	O
;	O
TF	O
,	O
total	O
fat	O
pad	O
weight	O
and	O
AI	O
,	O
adiposity	O
index	O
.	O

Significant	O
effects	O
after	O
a	O
Bonferroni	O
correction	O
(	O
critical	O
P	O
<	O
0	O
.	O
0071	O
)	O
are	O
in	O
bold	O
.	O

a	O
The	O
distal	O
(	O
2D	O
)	O
donor	O
region	O
was	O
not	O
analyzed	O
.	O

Table	O
4	O

Body	O
size	O
,	O
growth	O
rate	O
and	O
length	O
phenotypes	O
of	O
HG	O
.	O
CAST	O
speed	O
congenic	O
strains	O

2WK	O
,	O
weight	O
at	O
2	O
weeks	O
of	O
age	O
;	O
3WK	O
,	O
weight	O
at	O
3	O
weeks	O
of	O
age	O
;	O
6WK	O
,	O
weight	O
at	O
6	O
weeks	O
of	O
age	O
;	O
9WK	O
,	O
weight	O
at	O
9	O
weeks	O
of	O
age	O
;	O
G26	O
,	O
weight	O
gain	O
from	O
2	O
to	O
6	O
weeks	O
of	O
age	O
;	O
G29	O
,	O
weight	O
gain	O
from	O
2	O
to	O
9	O
weeks	O
of	O
age	O
;	O
NA	O
,	O
nasal	O
-	O
anal	O
body	O
length	O
;	O
Tail	O
,	O
tail	O
length	O
.	O

Values	O
are	O
expressed	O
as	O
least	O
square	O
means	O
(	O
LSMEANS	O
)	O
+/-	O
SEM	O
.	O

LSMEANS	O
in	O
bold	O
are	O
significantly	O
different	O
than	O
the	O
control	O
(	O
HGC	O
)	O
(	O
critical	O
P	O
<	O
0	O
.	O
005	O
)	O
after	O
Bonferroni	O
correction	O
within	O
each	O
sex	O
.	O

Table	O
5	O

Adiposity	O
phenotypes	O
of	O
HG	O
.	O
CAST	O
speed	O
congenic	O
strains	O

GFP	O
,	O
gonadal	O
fat	O
pad	O
;	O
FFP	O
,	O
femoral	O
fat	O
pad	O
;	O
MFP	O
,	O
mesenteric	O
fat	O
pad	O
;	O
RFP	O
,	O
retroperitoneal	O
fat	O
pad	O
;	O
TF	O
,	O
summed	O
weight	O
of	O
four	O
fat	O
pads	O
;	O
AI	O
,	O
adiposity	O
index	O
(	O
TF	O
/	O
body	O
weight	O
*	O
100	O
)	O
and	O
BMI	O
,	O
body	O
mass	O
index	O
(	O
body	O
weight	O
at	O
sacrifice	O
/	O
NA2	O
*	O
100	O
)	O
.	O

Values	O
are	O
expressed	O
as	O
least	O
square	O
means	O
(	O
LSMEANS	O
)	O
+/-	O
SEM	O
.	O

LSMEANS	O
in	O
bold	O
are	O
significantly	O
different	O
than	O
the	O
control	O
(	O
HGC	O
)	O
(	O
critical	O
P	O
<	O
0	O
.	O
005	O
)	O
after	O
Bonferroni	O
correction	O
within	O
each	O
sex	O
.	O

Table	O
6	O

Carcass	O
composition	O
phenotypes	O
of	O
HG	O
.	O
CAST	O
speed	O
congenic	O
strains	O

H2O	B-CHEBI
,	O
carcass	O
water	B-CHEBI
;	O
%	O
H2O	B-CHEBI
,	O
water	B-CHEBI
as	O
a	O
percent	O
of	O
carcass	O
weight	O
;	O
FAT	O
,	O
carcass	O
fat	O
;	O
%	O
FAT	O
,	O
fat	O
as	O
a	O
percent	O
of	O
carcass	O
weight	O
;	O
ASH	O
,	O
carcass	O
ash	O
;	O
%	O
ASH	O
,	O
ash	O
as	O
a	O
percent	O
of	O
carcass	O
weight	O
;	O
PROT	B-CHEBI
,	O
carcass	O
protein	B-CHEBI
,	O
%	O
PROT	B-CHEBI
,	O
protein	B-CHEBI
as	O
a	O
percent	O
of	O
carcass	O
weight	O
.	O

Values	O
are	O
expressed	O
as	O
least	O
square	O
means	O
(	O
LSMEANS	O
)	O
+/-	O
SEM	O
.	O

LSMEANS	O
in	O
bold	O
are	O
significantly	O
different	O
than	O
the	O
control	O
(	O
HGC	O
)	O
(	O
critical	O
P	O
<	O
0	O
.	O
0125	O
)	O
after	O
Bonferroni	O
correction	O
within	O
each	O
sex	O
.	O

Table	O
7	O

Nonsynonymous	O
SNP	O
in	O
MMU2	O
,	O
9	O
and	O
17	O
hg	O
modifier	O
candidate	O
genes	O
predicted	O
by	O
SIFT	O
and	O
Polyphen	O
to	O
alter	O
protein	B-CHEBI
function	O

MMU	O
,	O
mouse	O
chromosome	O
;	O
AA	O
,	O
amino	O
acid	O
;	O
PBD	O
,	O
probably	O
damaging	O
,	O
PSD	O
,	O
possibly	O
damaging	O
;	O
B	O
,	O
Benign	O
;	O
T	O
,	O
tolerated	O
and	O
D	O
,	O
deleterious	O
.	O

a	O
Amino	O
acid	O
change	O
,	O
first	O
residue	O
listed	O
corresponds	O
to	O
the	O
CAST	O
allele	O
and	O
second	O
corresponds	O
to	O
the	O
B6	O
allele	O
.	O

b	O
Indicates	O
which	O
allele	O
was	O
designated	O
as	O
"	O
mutant	O
"	O
,	O
i	O
.	O
e	O
.	O
B6	O
/	O
CAST	O
,	O
B6	O
allele	O
is	O
mutant	O
and	O
CAST	O
is	O
wild	O
type	O
.	O

Fgf9	O
and	O
Wnt4	O
Act	O
as	O
Antagonistic	B-CHEBI
Signals	O
to	O
Regulate	O
Mammalian	O
Sex	O
Determination	O

Abstract	O

The	O
genes	O
encoding	O
members	O
of	O
the	O
wingless	O
-	O
related	O
MMTV	O
integration	O
site	O
(	O
WNT	O
)	O
and	O
fibroblast	O
growth	O
factor	O
(	O
FGF	O
)	O
families	O
coordinate	O
growth	O
,	O
morphogenesis	O
,	O
and	O
differentiation	O
in	O
many	O
fields	O
of	O
cells	O
during	O
development	O
.	O

In	O
the	O
mouse	O
,	O
Fgf9	O
and	O
Wnt4	O
are	O
expressed	O
in	O
gonads	O
of	O
both	O
sexes	O
prior	O
to	O
sex	O
determination	O
.	O

Loss	O
of	O
Fgf9	O
leads	O
to	O
XY	O
sex	O
reversal	O
,	O
whereas	O
loss	O
of	O
Wnt4	O
results	O
in	O
partial	O
testis	O
development	O
in	O
XX	O
gonads	O
.	O

However	O
,	O
the	O
relationship	O
between	O
these	O
signals	O
and	O
the	O
male	O
sex	O
-	O
determining	O
gene	O
,	O
Sry	O
,	O
was	O
unknown	O
.	O

We	O
show	O
through	O
gain	O
-	O
and	O
loss	O
-	O
of	O
-	O
function	O
experiments	O
that	O
fibroblast	O
growth	O
factor	O
9	O
(	O
FGF9	O
)	O
and	O
WNT4	O
act	O
as	O
opposing	O
signals	O
to	O
regulate	O
sex	O
determination	O
.	O

In	O
the	O
mouse	O
XY	O
gonad	O
,	O
Sry	O
normally	O
initiates	O
a	O
feed	O
-	O
forward	O
loop	O
between	O
Sox9	O
and	O
Fgf9	O
,	O
which	O
up	O
-	O
regulates	O
Fgf9	O
and	O
represses	O
Wnt4	O
to	O
establish	O
the	O
testis	O
pathway	O
.	O

Surprisingly	O
,	O
loss	O
of	O
Wnt4	O
in	O
XX	O
gonads	O
is	O
sufficient	O
to	O
up	O
-	O
regulate	O
Fgf9	O
and	O
Sox9	O
in	O
the	O
absence	O
of	O
Sry	O
.	O

These	O
data	O
suggest	O
that	O
the	O
fate	O
of	O
the	O
gonad	O
is	O
controlled	O
by	O
antagonism	O
between	O
Fgf9	O
and	O
Wnt4	O
.	O

The	O
role	O
of	O
the	O
male	O
sex	O
-	O
determining	O
switch	O
--	O
Sry	O
in	O
the	O
case	O
of	O
mammals	O
--	O
is	O
to	O
tip	O
the	O
balance	O
between	O
these	O
underlying	O
patterning	O
signals	O
.	O

In	O
principle	O
,	O
sex	O
determination	O
in	O
other	O
vertebrates	O
may	O
operate	O
through	O
any	O
switch	O
that	O
introduces	O
an	O
imbalance	O
between	O
these	O
two	O
signaling	O
pathways	O
.	O

Introduction	O

The	O
development	O
of	O
sexually	O
dimorphic	O
reproductive	O
organs	O
is	O
a	O
common	O
feature	O
among	O
animal	O
species	O
.	O

The	O
testis	O
and	O
ovary	O
represent	O
two	O
divergent	O
pathways	O
of	O
development	O
from	O
the	O
bipotential	O
embryonic	O
gonad	O
.	O

The	O
switch	O
that	O
initiates	O
divergent	O
development	O
of	O
the	O
gonad	O
is	O
highly	O
diverse	O
among	O
species	O
;	O
however	O
,	O
the	O
underlying	O
mechanisms	O
that	O
lead	O
to	O
the	O
establishment	O
of	O
ovary	O
or	O
testis	O
pathways	O
are	O
likely	O
to	O
be	O
conserved	O
.	O

In	O
all	O
species	O
,	O
the	O
embryonic	O
gonad	O
is	O
made	O
up	O
of	O
a	O
mixed	O
population	O
of	O
germ	O
cells	O
and	O
somatic	O
cells	O
.	O

This	O
tissue	O
is	O
remarkable	O
in	O
that	O
all	O
of	O
its	O
cells	O
are	O
believed	O
to	O
be	O
bipotential	O
,	O
and	O
can	O
differentiate	O
into	O
ovarian	O
or	O
testicular	O
lineages	O
[	O
1	O
,	O
2	O
]	O
.	O

Consistent	O
with	O
the	O
idea	O
that	O
cells	O
in	O
this	O
primordium	O
are	O
poised	O
between	O
two	O
developmental	O
pathways	O
,	O
some	O
of	O
the	O
genes	O
that	O
are	O
involved	O
in	O
establishing	O
sexual	O
dimorphism	O
,	O
including	O
Dax1	O
(	O
dosage	O
-	O
sensitive	O
sex	O
reversal	O
-	O
congenital	O
adrenal	O
hypoplasia	O
critical	O
region	O
on	O
the	O
X	O
chromosome	O
protein	B-CHEBI
1	O
)	O
,	O
Sox9	O
(	O
Sry	O
-	O
like	O
HMG	O
box	O
9	O
)	O
,	O
Fgf9	O
(	O
fibroblast	O
growth	O
factor	O
9	O
)	O
,	O
and	O
Wnt4	O
(	O
wingless	O
-	O
related	O
MMTV	O
integration	O
site	O
4	O
)	O
,	O
are	O
initially	O
expressed	O
in	O
similar	O
patterns	O
in	O
XX	O
and	O
XY	O
gonads	O
[	O
3	O
-	O
8	O
]	O
.	O

The	O
conventional	O
view	O
of	O
mammalian	O
sex	O
determination	O
is	O
that	O
the	O
basic	O
pathway	O
of	O
organ	O
development	O
is	O
ovarian	O
,	O
and	O
that	O
the	O
testis	O
-	O
determining	O
gene	O
operates	O
by	O
diverting	O
this	O
program	O
toward	O
testis	O
development	O
by	O
simultaneously	O
influencing	O
the	O
fate	O
of	O
the	O
key	O
supporting	O
cell	O
lineage	O
and	O
initiating	O
a	O
male	O
-	O
specific	O
morphogenetic	O
program	O
.	O

All	O
of	O
the	O
experimental	O
evidence	O
suggests	O
that	O
these	O
two	O
processes	O
are	O
closely	O
interwoven	O
.	O

For	O
example	O
,	O
both	O
proliferation	O
[	O
9	O
]	O
and	O
migration	O
of	O
cells	O
to	O
trigger	O
testis	O
cord	O
formation	O
[	O
10	O
,	O
11	O
]	O
appear	O
to	O
be	O
closely	O
integrated	O
with	O
Sertoli	O
cell	O
differentiation	O
.	O

Sry	O
,	O
a	O
Y	O
chromosome	O
-	O
linked	O
gene	O
,	O
is	O
the	O
primary	O
sex	O
-	O
determining	O
gene	O
in	O
mammals	O
[	O
12	O
-	O
14	O
]	O
.	O

In	O
the	O
absence	O
of	O
Sry	O
expression	O
--	O
in	O
XX	O
embryos	O
,	O
or	O
in	O
XY	O
embryos	O
carrying	O
a	O
deletion	O
of	O
Sry	O
--	O
cells	O
in	O
the	O
gonad	O
follow	O
an	O
ovarian	O
differentiation	O
pathway	O
.	O

Genetic	O
evidence	O
from	O
chimeric	O
mice	O
[	O
15	O
]	O
,	O
and	O
expression	O
studies	O
using	O
reporter	O
transgenes	O
[	O
2	O
,	O
16	O
]	O
,	O
indicate	O
that	O
Sry	O
expression	O
is	O
required	O
only	O
in	O
precursors	O
of	O
the	O
somatic	O
supporting	O
cell	O
lineage	O
.	O

Expression	O
of	O
Sry	O
in	O
these	O
bipotential	O
cells	O
leads	O
to	O
their	O
differentiation	O
as	O
testis	O
-	O
specific	O
Sertoli	O
cells	O
rather	O
than	O
as	O
follicle	O
cells	O
,	O
the	O
parallel	O
cell	O
type	O
of	O
the	O
ovary	O
[	O
2	O
]	O
.	O

It	O
is	O
believed	O
that	O
the	O
Sertoli	O
cell	O
is	O
the	O
first	O
cell	O
type	O
to	O
differentiate	O
in	O
the	O
gonad	O
[	O
17	O
]	O
.	O

There	O
is	O
substantial	O
evidence	O
that	O
a	O
critical	O
threshold	O
number	O
of	O
Sertoli	O
cells	O
is	O
required	O
to	O
establish	O
testis	O
differentiation	O
[	O
9	O
,	O
15	O
,	O
18	O
-	O
20	O
]	O
.	O

In	O
cases	O
where	O
this	O
threshold	O
is	O
not	O
reached	O
,	O
ovary	O
differentiation	O
ensues	O
.	O

Once	O
Sry	O
expression	O
begins	O
,	O
expression	O
patterns	O
of	O
other	O
genes	O
in	O
the	O
gonad	O
begin	O
to	O
diverge	O
.	O

The	O
first	O
gene	O
downstream	O
of	O
Sry	O
known	O
to	O
show	O
male	O
-	O
specific	O
up	O
-	O
regulation	O
in	O
Sertoli	O
cell	O
precursors	O
is	O
a	O
related	O
gene	O
expressed	O
in	O
many	O
tissues	O
in	O
the	O
developing	O
embryo	O
,	O
Sox9	O
.	O

Disruption	O
of	O
Sox9	O
expression	O
in	O
the	O
XY	O
gonad	O
causes	O
male	O
-	O
to	O
-	O
female	O
sex	O
reversal	O
[	O
21	O
,	O
22	O
]	O
,	O
whereas	O
increasing	O
the	O
dose	O
of	O
Sox9	O
in	O
the	O
XX	O
gonad	O
leads	O
to	O
testis	O
development	O
[	O
23	O
-	O
25	O
]	O
.	O

These	O
studies	O
indicate	O
that	O
Sox9	O
plays	O
a	O
central	O
role	O
in	O
sex	O
determination	O
.	O

Unlike	O
Sry	O
,	O
which	O
is	O
specific	O
to	O
mammals	O
,	O
expression	O
of	O
Sox9	O
is	O
known	O
to	O
be	O
conserved	O
in	O
the	O
gonad	O
of	O
many	O
species	O
.	O

In	O
mammals	O
,	O
Sox9	O
is	O
up	O
-	O
regulated	O
immediately	O
after	O
Sry	O
expression	O
initiates	O
.	O

Experiments	O
tracing	O
Sry	O
-	O
expressing	O
cells	O
using	O
a	O
stable	O
reporter	O
demonstrated	O
that	O
once	O
testis	O
differentiation	O
is	O
established	O
,	O
all	O
Sertoli	O
cells	O
that	O
express	O
Sox9	O
are	O
descendants	O
of	O
cells	O
that	O
have	O
expressed	O
Sry	O
[	O
16	O
]	O
,	O
suggesting	O
that	O
activation	O
of	O
Sox9	O
is	O
a	O
cell	O
-	O
autonomous	O
effect	O
of	O
Sry	O
.	O

However	O
,	O
mutations	O
in	O
several	O
signaling	O
pathways	O
including	O
Fgf9	O
and	O
Igf1r	O
/	O
Irr	O
/	O
Ir	O
(	O
insulin	B-CHEBI
-	O
like	O
growth	O
factor	O
1	O
receptor	O
/	O
insulin	B-CHEBI
receptor	O
-	O
related	O
receptor	O
/	O
insulin	B-CHEBI
receptor	O
)	O
resulted	O
in	O
loss	O
of	O
Sox9	O
expression	O
and	O
partial	O
or	O
complete	O
sex	O
reversal	O
[	O
26	O
,	O
27	O
]	O
,	O
suggesting	O
that	O
extracellular	O
signaling	O
pathways	O
play	O
a	O
significant	O
role	O
during	O
primary	O
sex	O
determination	O
.	O

Mice	O
homozygous	O
for	O
a	O
null	O
mutation	O
in	O
Fgf9	O
display	O
male	O
-	O
to	O
-	O
female	O
sex	O
reversal	O
caused	O
by	O
disruption	O
of	O
all	O
testis	O
-	O
specific	O
cellular	O
events	O
,	O
including	O
cell	O
proliferation	O
,	O
mesonephric	O
cell	O
migration	O
,	O
testis	O
cord	O
formation	O
,	O
and	O
the	O
differentiation	O
of	O
Sertoli	O
cells	O
[	O
26	O
,	O
27	O
]	O
.	O

Fgf9	O
,	O
like	O
many	O
of	O
the	O
founding	O
signals	O
in	O
the	O
gonads	O
,	O
is	O
initially	O
expressed	O
in	O
gonads	O
of	O
both	O
sexes	O
,	O
but	O
becomes	O
male	O
-	O
specific	O
after	O
Sry	O
is	O
expressed	O
.	O

In	O
a	O
reciprocal	O
manner	O
,	O
expression	O
of	O
Wnt4	O
,	O
which	O
is	O
also	O
initially	O
common	O
to	O
gonads	O
of	O
both	O
sexes	O
,	O
becomes	O
female	O
-	O
specific	O
[	O
8	O
]	O
.	O

XX	O
gonads	O
with	O
a	O
null	O
mutation	O
in	O
Wnt4	O
display	O
some	O
obvious	O
aspects	O
of	O
testicular	O
differentiation	O
[	O
28	O
]	O
.	O

Based	O
on	O
the	O
theory	O
that	O
Sertoli	O
cells	O
initiate	O
all	O
downstream	O
testicular	O
differentiation	O
,	O
this	O
might	O
imply	O
that	O
Sertoli	O
differentiation	O
had	O
been	O
initiated	O
in	O
Wnt4	O
-	O
/	O
-	O
XX	O
gonads	O
.	O

However	O
,	O
expression	O
of	O
Sertoli	O
cell	O
markers	O
was	O
not	O
previously	O
detected	O
in	O
these	O
mutants	O
during	O
fetal	O
stages	O
[	O
8	O
,	O
29	O
]	O
,	O
leading	O
to	O
the	O
conclusion	O
that	O
Wnt4	O
was	O
not	O
involved	O
in	O
primary	O
sex	O
determination	O
in	O
the	O
gonad	O
.	O

To	O
integrate	O
these	O
findings	O
,	O
we	O
investigated	O
the	O
genetic	O
relationship	O
of	O
Sry	O
,	O
Sox9	O
,	O
Fgf9	O
,	O
and	O
Wnt4	O
in	O
the	O
regulatory	O
network	O
that	O
governs	O
the	O
gonadal	O
field	O
.	O

We	O
show	O
that	O
the	O
loss	O
of	O
Fgf9	O
in	O
homozygous	O
mutant	O
XY	O
gonads	O
does	O
not	O
affect	O
the	O
expression	O
of	O
SRY	O
or	O
the	O
initial	O
up	O
-	O
regulation	O
of	O
SOX9	O
;	O
however	O
,	O
SOX9	O
expression	O
is	O
not	O
maintained	O
in	O
the	O
Fgf9	O
-	O
/	O
-	O
mutant	O
gonads	O
,	O
and	O
testis	O
differentiation	O
is	O
aborted	O
.	O

We	O
also	O
demonstrate	O
that	O
FGF9	O
represses	O
the	O
ovary	O
-	O
promoting	O
gene	O
,	O
Wnt4	O
.	O

We	O
hypothesize	O
that	O
FGF9	O
functions	O
in	O
a	O
feed	O
-	O
forward	O
loop	O
to	O
expand	O
Sertoli	O
precursor	O
cells	O
,	O
which	O
secrete	O
FGF9	O
,	O
to	O
a	O
critical	O
threshold	O
number	O
sufficient	O
to	O
suppress	O
Wnt4	O
.	O

This	O
directly	O
or	O
indirectly	O
stabilizes	O
SOX9	O
expression	O
and	O
secures	O
the	O
male	O
fate	O
of	O
the	O
gonad	O
.	O

WNT4	O
seems	O
to	O
oppose	O
the	O
male	O
pathway	O
by	O
repressing	O
expression	O
of	O
SOX9	O
and	O
FGF9	O
.	O

Surprisingly	O
,	O
both	O
male	O
pathway	O
genes	O
are	O
transiently	O
activated	O
in	O
Wnt4	O
-	O
/	O
-	O
XX	O
gonads	O
in	O
the	O
absence	O
of	O
the	O
Y	O
-	O
linked	O
gene	O
Sry	O
.	O

Based	O
on	O
this	O
genetic	O
and	O
in	O
vitro	O
data	O
,	O
we	O
suggest	O
that	O
the	O
plasticity	O
of	O
the	O
bipotential	O
gonad	O
is	O
controlled	O
by	O
mutually	O
antagonistic	B-CHEBI
signals	O
between	O
FGF9	O
and	O
WNT4	O
in	O
the	O
gonadal	O
field	O
.	O

These	O
signals	O
coordinate	O
sexually	O
dimorphic	O
patterns	O
of	O
growth	O
,	O
morphogenesis	O
,	O
and	O
cellular	O
differentiation	O
.	O

Results	O

Early	O
Bipotential	O
Expression	O
of	O
FGF9	O
Resolves	O
to	O
an	O
XY	O
-	O
Specific	O
Pattern	O
by	O
12	O
.	O
5	O
dpc	O

Using	O
an	O
antibody	O
specific	O
to	O
FGF9	O
,	O
we	O
examined	O
expression	O
during	O
normal	O
gonad	O
development	O
.	O

FGF9	O
protein	B-CHEBI
was	O
distributed	O
throughout	O
the	O
11	O
.	O
5	O
dpc	O
gonad	O
in	O
both	O
sexes	O
(	O
Figure	O
1A	O
and	O
1B	O
)	O
.	O

However	O
,	O
by	O
12	O
.	O
5	O
dpc	O
,	O
FGF9	O
was	O
detected	O
only	O
in	O
XY	O
gonads	O
in	O
two	O
domains	O
:	O
in	O
cells	O
near	O
the	O
surface	O
of	O
gonads	O
and	O
in	O
cells	O
located	O
within	O
testis	O
cords	O
.	O

This	O
sex	O
-	O
specific	O
expression	O
pattern	O
was	O
maintained	O
in	O
gonads	O
at	O
13	O
.	O
5	O
dpc	O
(	O
Figure	O
1C	O
-	O
1F	O
)	O
.	O

FGF9	O
expression	O
within	O
testis	O
cords	O
was	O
localized	O
to	O
Sertoli	O
cells	O
and	O
excluded	O
from	O
germ	O
cells	O
based	O
on	O
the	O
germ	O
cell	O
membrane	O
marker	O
platelet	O
/	O
endothelial	O
cell	O
adhesion	O
molecule	B-CHEBI
(	O
PECAM	O
)	O
(	O
Figure	O
1D	O
and	O
1F	O
)	O
.	O

To	O
confirm	O
this	O
result	O
,	O
we	O
examined	O
agametic	O
gonads	O
from	O
KitW	O
/	O
Wv	O
compound	O
heterozygous	O
embryos	O
,	O
which	O
develop	O
testis	O
cords	O
containing	O
Sertoli	O
cells	O
only	O
.	O

FGF9	O
was	O
detectable	O
at	O
normal	O
levels	O
in	O
testis	O
cords	O
in	O
XY	O
KitW	O
/	O
Wv	O
gonads	O
,	O
where	O
alkaline	B-CHEBI
phosphatase	O
staining	O
verified	O
the	O
absence	O
of	O
germ	O
cells	O
(	O
Figure	O
1G	O
-	O
1J	O
)	O
,	O
indicating	O
that	O
FGF9	O
is	O
expressed	O
by	O
Sertoli	O
cells	O
,	O
and	O
that	O
its	O
expression	O
is	O
not	O
dependent	O
on	O
the	O
presence	O
of	O
germ	O
cells	O
.	O

In	O
summary	O
,	O
FGF9	O
expression	O
was	O
present	O
in	O
both	O
XX	O
and	O
XY	O
gonads	O
at	O
bipotential	O
stages	O
,	O
and	O
became	O
restricted	O
to	O
XY	O
gonads	O
as	O
testis	O
differentiation	O
proceeded	O
.	O

Sry	O
Expression	O
Is	O
Normal	O
in	O
Homozygous	O
Null	O
Fgf9	O
XY	O
Gonads	O

The	O
early	O
expression	O
of	O
Fgf9	O
in	O
bipotential	O
gonads	O
raised	O
the	O
question	O
of	O
whether	O
Fgf9	O
is	O
an	O
upstream	O
regulator	O
of	O
Sry	O
.	O

To	O
investigate	O
this	O
possibility	O
,	O
we	O
mated	O
Fgf9	O
+	O
/	O
-	O
mice	O
with	O
a	O
transgenic	O
reporter	O
line	O
that	O
carries	O
an	O
enhanced	O
green	O
fluorescent	O
protein	B-CHEBI
(	O
EGFP	O
)	O
transgene	O
driven	O
by	O
the	O
Sry	O
promoter	O
Sry	O
-	O
EGFP	O
.	O

At	O
early	O
stages	O
,	O
this	O
transgene	O
represents	O
the	O
pattern	O
of	O
endogenous	O
Sry	O
expression	O
[	O
2	O
]	O
.	O

The	O
expression	O
of	O
the	O
EGFP	O
reporter	O
was	O
detected	O
in	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
comparable	O
to	O
Fgf9	O
+	O
/	O
-	O
littermate	O
controls	O
(	O
Figure	O
2A	O
and	O
2B	O
)	O
,	O
suggesting	O
that	O
transcriptional	O
regulation	O
of	O
Sry	O
is	O
independent	O
of	O
Fgf9	O
.	O

Sex	O
reversal	O
is	O
caused	O
not	O
only	O
by	O
the	O
loss	O
of	O
normal	O
levels	O
of	O
Sry	O
expression	O
[	O
30	O
,	O
31	O
]	O
,	O
but	O
also	O
by	O
mutations	O
disrupting	O
SRY	O
import	O
into	O
the	O
nucleus	O
[	O
32	O
]	O
.	O

The	O
transgene	O
,	O
Sry	O
-	O
EGFP	O
,	O
does	O
not	O
reflect	O
the	O
intracellular	O
distribution	O
of	O
the	O
SRY	O
protein	B-CHEBI
.	O

To	O
investigate	O
this	O
aspect	O
of	O
SRY	O
regulation	O
,	O
we	O
bred	O
Fgf9	O
+	O
/	O
-	O
mice	O
with	O
another	O
Sry	O
reporter	O
mouse	O
line	O
carrying	O
a	O
Myc	O
-	O
tagged	O
Sry	O
transgene	O
,	O
SryMyc	O
,	O
which	O
recapitulates	O
the	O
endogenous	O
intracellular	O
SRY	O
expression	O
pattern	O
[	O
16	O
]	O
.	O

Using	O
an	O
antibody	O
against	O
c	O
-	O
MYC	O
,	O
the	O
expression	O
and	O
nuclear	O
localization	O
of	O
SRYMYC	O
in	O
SryMyc	O
;	O
Fgf9	O
-	O
/	O
-	O
gonads	O
was	O
indistinguishable	O
from	O
littermate	O
controls	O
(	O
Figure	O
2C	O
and	O
2D	O
)	O
.	O

These	O
data	O
using	O
two	O
different	O
Sry	O
transgenic	O
reporter	O
lines	O
provide	O
evidence	O
that	O
Sry	O
expression	O
is	O
not	O
dependent	O
on	O
Fgf9	O
.	O

Therefore	O
,	O
Fgf9	O
signaling	O
must	O
act	O
in	O
parallel	O
and	O
/	O
or	O
downstream	O
of	O
Sry	O
to	O
regulate	O
testis	O
development	O
.	O

FGF9	O
Can	O
Up	O
-	O
Regulate	O
SOX9	O
Expression	O

In	O
our	O
previous	O
study	O
we	O
did	O
not	O
observe	O
SOX9	O
expression	O
at	O
12	O
.	O
5	O
dpc	O
in	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
that	O
fail	O
to	O
develop	O
into	O
normal	O
testes	O
[	O
26	O
]	O
.	O

However	O
,	O
the	O
loss	O
of	O
SOX9	O
expression	O
at	O
12	O
.	O
5	O
dpc	O
could	O
be	O
a	O
consequence	O
of	O
the	O
loss	O
of	O
Sertoli	O
differentiation	O
rather	O
than	O
a	O
reflection	O
of	O
the	O
genetic	O
interaction	O
between	O
FGF9	O
and	O
SOX9	O
.	O

Normally	O
,	O
Sox9	O
is	O
weakly	O
expressed	O
in	O
wild	O
-	O
type	O
genital	O
ridges	O
of	O
both	O
XX	O
and	O
XY	O
embryos	O
at	O
10	O
.	O
5	O
dpc	O
and	O
,	O
after	O
the	O
onset	O
of	O
Sry	O
expression	O
,	O
is	O
up	O
-	O
regulated	O
in	O
XY	O
gonads	O
[	O
5	O
,	O
33	O
,	O
16	O
]	O
.	O

As	O
results	O
indicated	O
that	O
Fgf9	O
functioned	O
downstream	O
of	O
,	O
or	O
in	O
parallel	O
with	O
Sry	O
,	O
we	O
investigated	O
whether	O
Fgf9	O
was	O
involved	O
in	O
the	O
up	O
-	O
regulation	O
of	O
Sox9	O
expression	O
.	O

Primary	O
cell	O
culture	O
and	O
gonad	O
culture	O
systems	O
were	O
used	O
to	O
assess	O
Sox9	O
activation	O
by	O
exogenous	O
FGF9	O
.	O

For	O
in	O
vitro	O
cell	O
culture	O
,	O
cells	O
were	O
isolated	O
from	O
11	O
.	O
5	O
dpc	O
gonads	O
free	O
of	O
mesonephroi	O
,	O
and	O
cultured	O
on	O
extracellular	O
matrix	O
-	O
coated	O
coverslips	O
with	O
or	O
without	O
addition	O
of	O
purified	O
FGF9	O
in	O
culture	O
media	O
.	O

After	O
culture	O
for	O
24	O
h	O
,	O
SOX9	O
expression	O
was	O
monitored	O
by	O
an	O
antibody	O
specific	O
to	O
SOX9	O
in	O
XX	O
cells	O
and	O
control	O
XY	O
cells	O
.	O

Exogenous	O
FGF9	O
increased	O
cell	O
number	O
in	O
XX	O
and	O
XY	O
cell	O
cultures	O
compared	O
with	O
cells	O
in	O
a	O
duplicate	O
culture	O
without	O
FGF9	O
treatment	O
(	O
unpublished	O
data	O
)	O
,	O
and	O
caused	O
the	O
up	O
-	O
regulation	O
of	O
SOX9	O
in	O
XX	O
cells	O
(	O
Figure	O
2E	O
-	O
2H	O
)	O
.	O

Up	O
-	O
regulation	O
of	O
SOX9	O
had	O
not	O
previously	O
been	O
seen	O
in	O
whole	O
XX	O
gonads	O
cultured	O
with	O
exogenous	O
FGF9	O
[	O
9	O
]	O
.	O

To	O
explain	O
the	O
difference	O
between	O
experimental	O
results	O
from	O
dissociated	O
XX	O
gonadal	O
cells	O
and	O
XX	O
gonads	O
,	O
we	O
reasoned	O
that	O
the	O
local	O
concentrations	O
of	O
FGF9	O
might	O
not	O
be	O
high	O
enough	O
to	O
override	O
blocking	O
signals	O
in	O
the	O
intact	O
XX	O
gonad	O
,	O
or	O
that	O
active	O
FGF9	O
was	O
not	O
efficiently	O
localized	O
or	O
presented	O
in	O
the	O
extracellular	O
matrix	O
of	O
the	O
XX	O
gonad	O
.	O

To	O
test	O
the	O
local	O
effect	O
of	O
FGF9	O
,	O
we	O
modified	O
the	O
XX	O
gonad	O
culture	O
by	O
stably	O
immobilizing	O
FGF9	O
,	O
or	O
BSA	O
as	O
a	O
control	O
,	O
on	O
beads	O
(	O
Figure	O
2I	O
-	O
2K	O
)	O
.	O

Under	O
these	O
conditions	O
,	O
SOX9	O
expression	O
was	O
up	O
-	O
regulated	O
locally	O
in	O
cells	O
near	O
the	O
surface	O
of	O
the	O
XX	O
gonad	O
in	O
contact	O
with	O
the	O
FGF9	O
bead	O
(	O
Figure	O
2K	O
)	O
.	O

Taken	O
together	O
,	O
these	O
in	O
vitro	O
data	O
demonstrate	O
that	O
ectopic	O
FGF9	O
signaling	O
can	O
induce	O
SOX9	O
expression	O
in	O
XX	O
gonadal	O
cells	O
,	O
suggesting	O
a	O
positive	O
interaction	O
between	O
Fgf9	O
and	O
Sox9	O
.	O

Fgf9	O
Is	O
Required	O
for	O
Maintaining	O
SOX9	O
Expression	O
in	O
XY	O
Gonads	O

To	O
investigate	O
whether	O
Fgf9	O
is	O
essential	O
for	O
the	O
up	O
-	O
regulation	O
of	O
Sox9	O
in	O
vivo	O
,	O
we	O
assessed	O
SOX9	O
expression	O
in	O
loss	O
-	O
of	O
-	O
function	O
Fgf9	O
+	O
/	O
-	O
and	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
at	O
11	O
.	O
5	O
-	O
12	O
.	O
5	O
dpc	O
(	O
Figure	O
3A	O
-	O
3F	O
)	O
.	O

In	O
wild	O
-	O
type	O
and	O
heterozygous	O
mutant	O
XY	O
gonads	O
at	O
11	O
.	O
5	O
dpc	O
,	O
SOX9	O
was	O
detected	O
in	O
a	O
small	O
number	O
of	O
cells	O
in	O
the	O
gonad	O
(	O
Figure	O
3A	O
)	O
.	O

Over	O
the	O
next	O
6	O
h	O
of	O
development	O
,	O
nuclear	O
SOX9	O
accumulated	O
rapidly	O
in	O
cells	O
toward	O
the	O
cortex	O
and	O
the	O
anterior	O
and	O
posterior	O
poles	O
of	O
the	O
gonad	O
,	O
replicating	O
patterns	O
previously	O
reported	O
for	O
both	O
Sry	O
and	O
Sox9	O
expression	O
[	O
2	O
,	O
16	O
,	O
34	O
-	O
36	O
]	O
.	O

This	O
unique	O
pattern	O
was	O
also	O
observed	O
in	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
(	O
Figure	O
3D	O
and	O
3E	O
)	O
.	O

Somatic	O
cells	O
within	O
Fgf9	O
-	O
/	O
-	O
gonads	O
were	O
positive	O
for	O
SOX9	O
at	O
11	O
.	O
5	O
dpc	O
,	O
the	O
earliest	O
stages	O
examined	O
,	O
demonstrating	O
that	O
initial	O
expression	O
and	O
up	O
-	O
regulation	O
of	O
SOX9	O
were	O
not	O
disrupted	O
in	O
Fgf9	O
-	O
/	O
-	O
mutant	O
XY	O
gonads	O
prior	O
to	O
12	O
.	O
0	O
dpc	O
.	O

Notably	O
,	O
in	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
,	O
SOX9	O
was	O
no	O
longer	O
detectable	O
by	O
12	O
.	O
5	O
dpc	O
,	O
and	O
Sertoli	O
precursor	O
cells	O
never	O
began	O
to	O
organize	O
into	O
normal	O
testis	O
cord	O
structures	O
(	O
Figure	O
3F	O
)	O
.	O

These	O
data	O
indicate	O
that	O
although	O
Fgf9	O
is	O
not	O
required	O
for	O
the	O
up	O
-	O
regulation	O
of	O
Sox9	O
in	O
vivo	O
,	O
it	O
is	O
indispensable	O
to	O
maintain	O
Sox9	O
expression	O
in	O
Sertoli	O
precursor	O
cells	O
.	O

Sox9	O
Is	O
Required	O
for	O
Fgf9	O
Up	O
-	O
Regulation	O
in	O
XY	O
Gonads	O

We	O
hypothesized	O
that	O
if	O
the	O
linear	O
relationship	O
among	O
the	O
three	O
genes	O
were	O
Sry	O
-->	O
Fgf9	O
-->	O
Sox9	O
,	O
expression	O
of	O
Fgf9	O
would	O
be	O
normal	O
in	O
XY	O
gonads	O
in	O
the	O
absence	O
of	O
Sox9	O
.	O

Alternatively	O
,	O
if	O
the	O
relationship	O
were	O
Sry	O
-->	O
Sox9	O
-->	O
Fgf9	O
,	O
expression	O
of	O
Fgf9	O
should	O
be	O
reduced	O
or	O
absent	O
in	O
XY	O
gonads	O
in	O
the	O
absence	O
of	O
Sox9	O
.	O

We	O
examined	O
Fgf9	O
expression	O
in	O
Sox9	O
homozygous	O
mutant	O
(	O
Sox9	O
Delta	O
/	O
Delta	O
)	O
XY	O
gonads	O
generated	O
by	O
crossing	O
mice	O
homozygous	O
for	O
a	O
conditional	O
null	O
(	O
flox	O
)	O
allele	O
of	O
Sox9	O
(	O
Sox9flox	O
/	O
flox	O
)	O
with	O
mice	O
carrying	O
germline	O
-	O
specific	O
Cre	O
transgenes	O
,	O
Prm1	O
-	O
Cre	O
in	O
male	O
and	O
Zp3	O
-	O
Cre	O
in	O
female	O
[	O
22	O
,	O
37	O
]	O
.	O

The	O
Sox9	O
null	O
mutant	O
embryos	O
die	O
after	O
11	O
.	O
5	O
dpc	O
because	O
of	O
cardiovascular	O
defects	O
[	O
37	O
]	O
.	O

Chaboissier	O
et	O
al	O
.	O

[	O
22	O
]	O
successfully	O
cultured	O
11	O
.	O
5	O
dpc	O
Sox9	O
null	O
mutant	O
gonads	O
in	O
vitro	O
and	O
detected	O
male	O
and	O
female	O
markers	O
after	O
2	O
-	O
3	O
d	O
of	O
culture	O
,	O
suggesting	O
that	O
Sox9	O
mutant	O
gonads	O
are	O
viable	O
and	O
developmentally	O
competent	O
at	O
11	O
.	O
5	O
dpc	O
--	O
the	O
time	O
point	O
at	O
which	O
we	O
collected	O
samples	O
to	O
perform	O
mRNA	B-CHEBI
in	O
situ	O
hybridization	O
(	O
Figure	O
3G	O
-	O
3J	O
)	O
.	O

The	O
expression	O
of	O
Fgf9	O
was	O
significantly	O
decreased	O
or	O
absent	O
in	O
XY	O
Sox9	O
Delta	O
/	O
Delta	O
gonads	O
at	O
11	O
.	O
5	O
dpc	O
(	O
Figure	O
3J	O
)	O
,	O
while	O
Sry	O
expression	O
was	O
similar	O
to	O
wild	O
-	O
type	O
(	O
Figure	O
3G	O
and	O
3H	O
)	O
,	O
as	O
previously	O
reported	O
[	O
20	O
]	O
,	O
suggesting	O
that	O
Fgf9	O
expression	O
in	O
wild	O
-	O
type	O
XY	O
gonads	O
is	O
dependent	O
on	O
the	O
expression	O
of	O
Sox9	O
.	O

These	O
findings	O
also	O
indicate	O
that	O
expression	O
of	O
Sry	O
is	O
not	O
sufficient	O
to	O
regulate	O
Fgf9	O
in	O
the	O
absence	O
of	O
Sox9	O
.	O

Therefore	O
,	O
we	O
conclude	O
that	O
Sox9	O
is	O
essential	O
for	O
Fgf9	O
expression	O
,	O
and	O
Fgf9	O
,	O
in	O
return	O
,	O
maintains	O
Sox9	O
expression	O
,	O
generating	O
a	O
positive	O
feed	O
-	O
forward	O
loop	O
between	O
these	O
two	O
genes	O
in	O
XY	O
gonads	O
.	O

Like	O
Fgf9	O
Mutant	O
Gonads	O
,	O
Sox9	O
Delta	O
/	O
Delta	O
XY	O
Gonads	O
Show	O
Defects	O
in	O
Cell	O
Proliferation	O

We	O
previously	O
reported	O
that	O
XY	O
-	O
specific	O
cell	O
proliferation	O
is	O
defective	O
in	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
[	O
7	O
]	O
.	O

Because	O
Sox9	O
acts	O
as	O
a	O
positive	O
regulator	O
of	O
Fgf9	O
expression	O
,	O
we	O
questioned	O
whether	O
cell	O
proliferation	O
in	O
XY	O
gonads	O
was	O
also	O
compromised	O
by	O
the	O
loss	O
of	O
Sox9	O
.	O

We	O
examined	O
proliferation	O
in	O
Sox9	O
Delta	O
/	O
Delta	O
gonads	O
at	O
11	O
.	O
5	O
dpc	O
using	O
a	O
mitotic	O
cell	O
marker	O
,	O
phosphorylated	O
histone	B-CHEBI
H3	O
.	O

Proliferating	O
cells	O
were	O
more	O
abundant	O
and	O
concentrated	O
in	O
a	O
domain	O
near	O
the	O
surface	O
of	O
wild	O
-	O
type	O
XY	O
gonads	O
,	O
and	O
this	O
XY	O
-	O
specific	O
cell	O
proliferation	O
was	O
evident	O
in	O
XY	O
Sox9flox	O
/	O
Delta	O
littermate	O
controls	O
(	O
Figure	O
3K	O
)	O
.	O

However	O
,	O
in	O
Sox9	O
Delta	O
/	O
Delta	O
XY	O
gonads	O
proliferation	O
was	O
reduced	O
and	O
similar	O
to	O
XX	O
gonads	O
(	O
Figure	O
3L	O
-	O
3O	O
)	O
.	O

This	O
result	O
supports	O
the	O
idea	O
that	O
there	O
is	O
a	O
mutual	O
interdependence	O
between	O
Sox9	O
and	O
Fgf9	O
generating	O
a	O
positive	O
feed	O
-	O
forward	O
loop	O
,	O
and	O
that	O
both	O
genes	O
are	O
required	O
for	O
the	O
expansion	O
of	O
somatic	O
cells	O
,	O
including	O
Sertoli	O
cell	O
precursors	O
,	O
in	O
XY	O
gonads	O
.	O

The	O
Male	O
Pathway	O
Is	O
Aborted	O
in	O
Fgf9	O
-	O
/	O
-	O
Sertoli	O
Precursors	O

Based	O
on	O
the	O
fact	O
that	O
Sox9	O
is	O
initially	O
expressed	O
in	O
Fgf9	O
-	O
/	O
-	O
gonads	O
,	O
we	O
investigated	O
whether	O
other	O
genes	O
in	O
the	O
male	O
pathway	O
are	O
activated	O
.	O

We	O
examined	O
two	O
markers	O
for	O
Sertoli	O
cell	O
differentiation	O
,	O
anti	O
-	O
Mullerian	O
hormone	B-CHEBI
(	O
Amh	O
)	O
[	O
38	O
]	O
and	O
Desert	O
hedgehog	O
(	O
Dhh	O
)	O
[	O
39	O
]	O
in	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
using	O
whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
.	O

Dhh	O
,	O
which	O
is	O
expressed	O
in	O
XY	O
wild	O
-	O
type	O
and	O
heterozygous	O
gonads	O
beginning	O
at	O
11	O
.	O
5	O
dpc	O
,	O
was	O
absent	O
from	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
,	O
although	O
mesonephric	O
expression	O
was	O
still	O
detected	O
(	O
Figure	O
4A	O
and	O
4B	O
)	O
.	O

Amh	O
,	O
which	O
is	O
a	O
direct	O
transcriptional	O
target	O
of	O
SOX9	O
activated	O
after	O
11	O
.	O
5	O
dpc	O
[	O
38	O
,	O
40	O
]	O
,	O
was	O
detected	O
at	O
reduced	O
levels	O
in	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
at	O
12	O
.	O
5	O
dpc	O
(	O
Figure	O
4C	O
-	O
4F	O
)	O
.	O

The	O
residual	O
level	O
of	O
Amh	O
suggested	O
that	O
the	O
transient	O
expression	O
of	O
SOX9	O
in	O
Fgf9	O
-	O
/	O
-	O
gonads	O
at	O
11	O
.	O
5	O
dpc	O
was	O
sufficient	O
to	O
activate	O
Amh	O
,	O
a	O
direct	O
downstream	O
target	O
.	O

However	O
,	O
the	O
absence	O
of	O
Dhh	O
indicated	O
that	O
not	O
all	O
Sertoli	O
pathways	O
are	O
initiated	O
.	O

The	O
initial	O
specification	O
of	O
Sertoli	O
cell	O
precursors	O
was	O
not	O
affected	O
by	O
the	O
loss	O
of	O
Fgf9	O
,	O
as	O
evidenced	O
by	O
normal	O
Sry	O
and	O
Sox9	O
expression	O
in	O
Fgf9	O
-	O
/	O
-	O
gonads	O
at	O
11	O
.	O
5	O
dpc	O
(	O
Figures	O
2	O
and	O
3D	O
)	O
.	O

However	O
,	O
SOX9	O
expression	O
in	O
XY	O
Fgf9	O
-	O
/	O
-	O
gonads	O
rapidly	O
disappeared	O
(	O
Figure	O
3E	O
and	O
3F	O
)	O
,	O
and	O
other	O
Sertoli	O
markers	O
were	O
absent	O
or	O
severely	O
reduced	O
(	O
Figure	O
4A	O
-	O
4F	O
)	O
.	O

To	O
investigate	O
the	O
possibility	O
that	O
this	O
loss	O
was	O
due	O
to	O
cell	O
death	O
,	O
we	O
immunostained	O
XY	O
Fgf9	O
-	O
/	O
-	O
gonads	O
at	O
12	O
.	O
0	O
dpc	O
--	O
a	O
time	O
point	O
at	O
which	O
SOX9	O
-	O
expressing	O
cells	O
were	O
declining	O
in	O
numbers	O
(	O
Figure	O
3E	O
)	O
--	O
for	O
active	O
caspase	O
-	O
3	O
,	O
an	O
apoptotic	O
cell	O
marker	O
.	O

Apoptotic	O
cells	O
were	O
not	O
observed	O
in	O
Fgf9	O
-	O
/	O
-	O
gonads	O
or	O
in	O
littermate	O
controls	O
at	O
12	O
.	O
0	O
dpc	O
,	O
although	O
Fgf9	O
-	O
/	O
-	O
samples	O
showed	O
somewhat	O
increased	O
cell	O
death	O
in	O
mesonephric	O
tubules	O
and	O
ducts	O
,	O
another	O
site	O
of	O
Fgf9	O
expression	O
(	O
Figure	O
4G	O
and	O
4H	O
)	O
.	O

These	O
data	O
suggested	O
that	O
the	O
loss	O
of	O
SOX9	O
expression	O
in	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
was	O
not	O
caused	O
by	O
cell	O
death	O
but	O
by	O
the	O
disruption	O
of	O
FGF9	O
/	O
SOX9	O
feed	O
-	O
forward	O
regulation	O
.	O

To	O
determine	O
whether	O
the	O
aborting	O
of	O
the	O
male	O
pathway	O
in	O
Fgf9	O
-	O
/	O
-	O
Sertoli	O
precursors	O
was	O
associated	O
with	O
the	O
transition	O
of	O
supporting	O
cells	O
from	O
male	O
to	O
female	O
differentiation	O
,	O
we	O
investigated	O
expression	O
of	O
Wnt4	O
,	O
an	O
ovary	O
-	O
promoting	O
gene	O
.	O

At	O
12	O
.	O
5	O
dpc	O
Wnt4	O
was	O
up	O
-	O
regulated	O
in	O
XY	O
Fgf9	O
-	O
/	O
-	O
but	O
not	O
in	O
XY	O
Fgf9	O
+	O
/	O
-	O
gonad	O
controls	O
(	O
Figure	O
4I	O
-	O
4K	O
)	O
.	O

This	O
result	O
suggests	O
that	O
Fgf9	O
is	O
necessary	O
for	O
the	O
down	O
-	O
regulation	O
of	O
Wnt4	O
in	O
differentiating	O
XY	O
gonads	O
at	O
/	O
after	O
bipotential	O
stages	O
.	O

Fgf9	O
and	O
Wnt4	O
Antagonize	O
Each	O
Other	O

Our	O
finding	O
that	O
high	O
levels	O
of	O
Wnt4	O
persist	O
in	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
implies	O
a	O
genetic	O
antagonism	O
specifically	O
between	O
Fgf9	O
and	O
Wnt4	O
,	O
as	O
both	O
SRY	O
and	O
SOX9	O
are	O
initially	O
expressed	O
in	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
at	O
11	O
.	O
5	O
dpc	O
,	O
yet	O
this	O
is	O
not	O
sufficient	O
to	O
down	O
-	O
regulate	O
Wnt4	O
.	O

To	O
test	O
whether	O
exogenous	O
FGF9	O
could	O
down	O
-	O
regulate	O
expression	O
of	O
Wnt4	O
,	O
we	O
cultured	O
the	O
XX	O
gonad	O
/	O
mesonephros	O
complex	O
with	O
or	O
without	O
FGF9	O
protein	B-CHEBI
,	O
and	O
examined	O
Wnt4	O
expression	O
by	O
whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
.	O

Treatment	O
of	O
XX	O
gonads	O
with	O
exogenous	O
FGF9	O
suppressed	O
the	O
normal	O
expression	O
of	O
Wnt4	O
(	O
Figure	O
5A	O
-	O
5C	O
)	O
,	O
supporting	O
the	O
hypothesis	O
that	O
Fgf9	O
,	O
rather	O
than	O
Sry	O
or	O
Sox9	O
,	O
functions	O
to	O
down	O
-	O
regulate	O
Wnt4	O
in	O
wild	O
-	O
type	O
XY	O
gonads	O
.	O

We	O
reasoned	O
that	O
if	O
FGF9	O
and	O
WNT4	O
do	O
act	O
as	O
opposing	O
signals	O
,	O
then	O
reduction	O
in	O
the	O
dose	O
of	O
Wnt4	O
might	O
render	O
the	O
XX	O
gonad	O
more	O
susceptible	O
to	O
the	O
male	O
-	O
promoting	O
effects	O
of	O
exogenous	O
FGF9	O
.	O

To	O
test	O
this	O
possibility	O
,	O
XX	O
Wnt4	O
+	O
/	O
-	O
and	O
Wnt4	O
+	O
/	O
+	O
gonads	O
were	O
cultured	O
in	O
medium	O
with	O
or	O
without	O
FGF9	O
,	O
and	O
were	O
examined	O
for	O
SOX9	O
expression	O
(	O
Figure	O
5D	O
-	O
5G	O
)	O
.	O

We	O
found	O
that	O
FGF9	O
induced	O
SOX9	O
up	O
-	O
regulation	O
in	O
XX	O
Wnt4	O
+	O
/	O
-	O
gonads	O
,	O
but	O
not	O
in	O
Wnt4	O
+	O
/	O
+	O
XX	O
gonads	O
(	O
Figure	O
5F	O
and	O
5G	O
)	O
.	O

These	O
results	O
demonstrate	O
antagonism	O
between	O
WNT4	O
and	O
FGF9	O
under	O
in	O
vitro	O
gain	O
-	O
of	O
-	O
function	O
conditions	O
.	O

To	O
test	O
antagonism	O
between	O
these	O
factors	O
under	O
loss	O
-	O
of	O
-	O
function	O
conditions	O
in	O
vivo	O
,	O
we	O
investigated	O
whether	O
Fgf9	O
is	O
derepressed	O
in	O
the	O
absence	O
of	O
Wnt4	O
(	O
Figure	O
6A	O
-	O
6C	O
)	O
.	O

Using	O
an	O
antibody	O
against	O
FGF9	O
,	O
we	O
found	O
that	O
FGF9	O
was	O
expressed	O
in	O
Wnt4	O
-	O
/	O
-	O
XX	O
gonads	O
but	O
not	O
in	O
Wnt4	O
+	O
/	O
-	O
XX	O
controls	O
(	O
Figure	O
6B	O
and	O
6C	O
)	O
.	O

This	O
result	O
suggested	O
that	O
FGF9	O
is	O
normally	O
down	O
-	O
regulated	O
by	O
WNT4	O
in	O
XX	O
gonads	O
.	O

Given	O
our	O
finding	O
that	O
FGF9	O
,	O
a	O
positive	O
regulator	O
of	O
Sox9	O
,	O
is	O
derepressed	O
in	O
XX	O
Wnt4	O
-	O
/	O
-	O
gonads	O
,	O
we	O
asked	O
whether	O
expression	O
of	O
SOX9	O
might	O
also	O
occur	O
in	O
XX	O
Wnt4	O
-	O
/	O
-	O
gonads	O
(	O
Figure	O
6D	O
-	O
6L	O
)	O
.	O

An	O
antibody	O
against	O
SOX9	O
revealed	O
that	O
expression	O
was	O
initially	O
up	O
-	O
regulated	O
in	O
Wnt4	O
-	O
/	O
-	O
XX	O
gonads	O
at	O
11	O
.	O
5	O
dpc	O
(	O
Figure	O
6F	O
and	O
6I	O
)	O
,	O
although	O
it	O
was	O
rapidly	O
down	O
-	O
regulated	O
by	O
12	O
.	O
0	O
dpc	O
and	O
absent	O
at	O
12	O
.	O
5	O
dpc	O
(	O
Figure	O
6I	O
and	O
6L	O
)	O
.	O

This	O
finding	O
was	O
confirmed	O
by	O
mRNA	B-CHEBI
in	O
situ	O
hybridization	O
,	O
which	O
also	O
detected	O
Sox9	O
transcripts	O
in	O
11	O
.	O
5	O
dpc	O
Wnt4	O
-	O
/	O
-	O
XX	O
gonads	O
(	O
Figure	O
S1	O
)	O
.	O

Wnt4	O
-	O
/	O
-	O
XX	O
gonads	O
do	O
not	O
increase	O
in	O
size	O
comparable	O
to	O
normal	O
XY	O
gonads	O
(	O
Figure	O
6C	O
,	O
6F	O
,	O
6I	O
,	O
and	O
6L	O
)	O
,	O
and	O
Sertoli	O
cell	O
differentiation	O
and	O
testis	O
cord	O
formation	O
do	O
not	O
occur	O
.	O

Nevertheless	O
,	O
it	O
is	O
noteworthy	O
that	O
up	O
-	O
regulation	O
of	O
SOX9	O
occurs	O
in	O
this	O
case	O
in	O
the	O
absence	O
of	O
Sry	O
,	O
by	O
eliminating	O
the	O
antagonistic	B-CHEBI
effect	O
of	O
Wnt4	O
and	O
up	O
-	O
regulating	O
FGF9	O
,	O
supporting	O
our	O
hypothesis	O
that	O
sex	O
determination	O
occurs	O
by	O
tipping	O
the	O
balance	O
between	O
these	O
two	O
opposing	O
signals	O
.	O

Discussion	O

Many	O
studies	O
support	O
the	O
view	O
that	O
cells	O
in	O
the	O
undifferentiated	O
gonad	O
are	O
bipotential	O
;	O
the	O
supporting	O
cell	O
precursor	O
lineage	O
can	O
develop	O
into	O
follicle	O
cells	O
or	O
Sertoli	O
cells	O
.	O

In	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
,	O
cells	O
initially	O
embark	O
on	O
the	O
Sertoli	O
pathway	O
,	O
but	O
in	O
the	O
absence	O
of	O
Fgf9	O
can	O
neither	O
maintain	O
Sox9	O
expression	O
nor	O
establish	O
downstream	O
male	O
pathways	O
.	O

The	O
loss	O
of	O
Sertoli	O
cells	O
in	O
XY	O
Fgf9	O
-	O
/	O
-	O
gonads	O
is	O
not	O
due	O
to	O
cell	O
death	O
,	O
but	O
instead	O
to	O
a	O
transition	O
of	O
supporting	O
cell	O
fate	O
as	O
SOX9	O
expression	O
is	O
lost	O
.	O

We	O
suggest	O
that	O
in	O
the	O
absence	O
of	O
the	O
antagonizing	O
activity	O
of	O
FGF9	O
,	O
WNT4	O
signals	O
predominate	O
and	O
govern	O
somatic	O
cell	O
fate	O
in	O
the	O
gonadal	O
field	O
.	O

The	O
Drosophila	O
genital	O
disk	O
is	O
also	O
a	O
field	O
of	O
cells	O
that	O
normally	O
follows	O
one	O
of	O
two	O
sexually	O
dimorphic	O
fates	O
.	O

For	O
many	O
years	O
it	O
was	O
believed	O
that	O
the	O
fate	O
of	O
each	O
cell	O
in	O
the	O
genital	O
disk	O
was	O
under	O
the	O
cell	O
-	O
autonomous	O
control	O
of	O
double	O
sex	O
(	O
dsx	O
)	O
,	O
the	O
key	O
regulator	O
of	O
the	O
sex	O
determination	O
pathway	O
.	O

However	O
,	O
mosaic	O
studies	O
have	O
shown	O
that	O
the	O
genetic	O
sex	O
of	O
the	O
cells	O
in	O
the	O
anterior	O
/	O
posterior	O
organizers	O
of	O
the	O
disk	O
,	O
not	O
the	O
sex	O
of	O
the	O
majority	O
of	O
cells	O
in	O
the	O
disk	O
,	O
regulate	O
the	O
sexually	O
dimorphic	O
fate	O
of	O
the	O
disk	O
.	O

This	O
occurs	O
through	O
the	O
sex	O
-	O
specific	O
regulation	O
of	O
WNT	O
,	O
FGF	O
,	O
and	O
transforming	O
growth	O
factor	O
beta	O
signaling	O
,	O
which	O
in	O
turn	O
regulate	O
the	O
growth	O
,	O
cell	O
differentiation	O
,	O
and	O
morphogenesis	O
of	O
the	O
disk	O
[	O
41	O
,	O
42	O
]	O
.	O

Sex	O
-	O
specific	O
regulation	O
of	O
gonad	O
organogenesis	O
in	O
vertebrates	O
may	O
occur	O
in	O
a	O
similar	O
manner	O
,	O
where	O
some	O
cells	O
are	O
cell	O
-	O
autonomously	O
responsive	O
to	O
the	O
sex	O
-	O
determining	O
switch	O
;	O
however	O
,	O
the	O
establishment	O
of	O
the	O
male	O
or	O
female	O
program	O
occurs	O
through	O
the	O
non	O
-	O
cell	O
-	O
autonomous	O
activity	O
of	O
classic	O
signaling	O
pathways	O
that	O
act	O
in	O
an	O
antagonistic	B-CHEBI
manner	O
and	O
coordinate	O
growth	O
,	O
cell	O
differentiation	O
and	O
morphogenesis	O
in	O
the	O
gonad	O
.	O

The	O
interplay	O
between	O
cell	O
-	O
autonomous	O
and	O
non	O
-	O
cell	O
-	O
autonomous	O
pathways	O
in	O
the	O
mammalian	O
gonad	O
is	O
not	O
well	O
understood	O
.	O

In	O
XX	O
<-->	O
XY	O
chimera	O
experiments	O
,	O
XX	O
cells	O
can	O
be	O
recruited	O
to	O
the	O
Sertoli	O
lineage	O
,	O
indicating	O
that	O
non	O
-	O
cell	O
-	O
autonomous	O
signaling	O
mechanisms	O
operate	O
under	O
these	O
conditions	O
[	O
15	O
]	O
.	O

Other	O
more	O
recent	O
studies	O
have	O
suggested	O
that	O
paracrine	O
signals	O
could	O
be	O
involved	O
in	O
the	O
establishment	O
of	O
Sertoli	O
cells	O
[	O
43	O
-	O
46	O
]	O
.	O

The	O
current	O
study	O
reveals	O
that	O
ectopic	O
FGF9	O
can	O
induce	O
SOX9	O
under	O
conditions	O
in	O
which	O
XX	O
cells	O
are	O
dissociated	O
(	O
Figure	O
2F	O
)	O
,	O
when	O
an	O
FGF9	O
-	O
coated	O
bead	O
is	O
directly	O
applied	O
to	O
the	O
XX	O
gonad	O
(	O
Figure	O
2K	O
)	O
,	O
or	O
when	O
the	O
dose	O
of	O
Wnt4	O
is	O
reduced	O
(	O
Figure	O
5G	O
)	O
.	O

Whether	O
FGF9	O
normally	O
acts	O
non	O
-	O
cell	O
-	O
autonomously	O
in	O
vivo	O
to	O
recruit	O
XY	O
cells	O
to	O
the	O
Sertoli	O
lineage	O
by	O
up	O
-	O
regulating	O
SOX9	O
is	O
not	O
clear	O
.	O

We	O
show	O
that	O
Sry	O
can	O
initially	O
up	O
-	O
regulate	O
SOX9	O
in	O
the	O
absence	O
of	O
Fgf9	O
,	O
suggesting	O
that	O
FGF9	O
is	O
not	O
necessary	O
for	O
this	O
step	O
.	O

However	O
,	O
FGF9	O
may	O
act	O
to	O
trigger	O
cell	O
proliferation	O
,	O
increasing	O
the	O
number	O
of	O
Sertoli	O
precursors	O
above	O
a	O
threshold	O
needed	O
to	O
stabilize	O
the	O
male	O
pathway	O
,	O
consistent	O
with	O
threshold	O
requirements	O
deduced	O
from	O
earlier	O
studies	O
using	O
XX	O
<-->	O
XY	O
chimeric	O
gonads	O
[	O
15	O
]	O
.	O

Since	O
Sertoli	O
cells	O
produce	O
FGF9	O
,	O
loss	O
of	O
proliferation	O
of	O
Sertoli	O
precursors	O
may	O
result	O
in	O
a	O
reduction	O
of	O
the	O
overall	O
level	O
of	O
FGF9	O
,	O
and	O
/	O
or	O
other	O
male	O
paracrine	O
signals	O
,	O
below	O
a	O
critical	O
threshold	O
level	O
required	O
to	O
antagonize	O
the	O
influence	O
of	O
WNT4	O
.	O

This	O
model	O
is	O
appealing	O
,	O
because	O
it	O
links	O
cell	O
proliferation	O
,	O
believed	O
to	O
be	O
required	O
for	O
establishment	O
of	O
the	O
male	O
pathway	O
[	O
9	O
]	O
,	O
with	O
Sertoli	O
fate	O
determination	O
.	O

A	O
recent	O
study	O
by	O
Yoshioka	O
et	O
al	O
.	O

[	O
47	O
]	O
showed	O
that	O
misexpression	O
of	O
Fgf9	O
in	O
chick	O
nephrogenous	O
mesenchyme	O
led	O
to	O
the	O
expansion	O
of	O
gonadal	O
marker	O
gene	O
expression	O
,	O
implicating	O
Fgf9	O
in	O
gonadal	O
cell	O
proliferation	O
across	O
species	O
.	O

It	O
has	O
been	O
suggested	O
that	O
SOX9	O
represses	O
WNT4	O
based	O
on	O
misexpression	O
studies	O
[	O
48	O
]	O
.	O

Here	O
we	O
show	O
that	O
the	O
addition	O
of	O
FGF9	O
protein	B-CHEBI
to	O
XX	O
gonad	O
explant	O
cultures	O
repressed	O
the	O
expression	O
of	O
Wnt4	O
.	O

Down	O
-	O
regulation	O
of	O
Wnt4	O
is	O
unlikely	O
to	O
occur	O
through	O
SOX9	O
,	O
as	O
SOX9	O
is	O
not	O
up	O
-	O
regulated	O
in	O
this	O
situation	O
[	O
7	O
]	O
.	O

Furthermore	O
,	O
although	O
both	O
SRY	O
and	O
SOX9	O
are	O
initially	O
expressed	O
in	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
,	O
Wnt4	O
is	O
not	O
down	O
-	O
regulated	O
in	O
the	O
absence	O
of	O
Fgf9	O
(	O
Figure	O
4K	O
)	O
.	O

These	O
findings	O
support	O
the	O
idea	O
that	O
FGF9	O
acts	O
as	O
the	O
antagonist	B-CHEBI
of	O
Wnt4	O
.	O

Antagonism	O
of	O
WNT	O
signals	O
may	O
be	O
a	O
multistep	O
process	O
involving	O
both	O
the	O
transcriptional	O
down	O
-	O
regulation	O
of	O
Wnt4	O
observed	O
in	O
this	O
study	O
and	O
the	O
destabilization	O
of	O
downstream	O
Wnt	O
intracellular	O
pathways	O
that	O
antagonize	O
SOX9	O
expression	O
,	O
as	O
shown	O
in	O
chondrocyte	O
differentiation	O
[	O
49	O
]	O
,	O
or	O
that	O
compete	O
for	O
intracellular	O
signal	O
transducers	O
as	O
has	O
been	O
reported	O
in	O
other	O
systems	O
[	O
50	O
,	O
51	O
]	O
.	O

Future	O
work	O
will	O
address	O
these	O
possibilities	O
.	O

In	O
support	O
of	O
the	O
idea	O
that	O
Wnt4	O
antagonizes	O
the	O
male	O
pathway	O
,	O
we	O
found	O
that	O
the	O
loss	O
of	O
Wnt4	O
caused	O
the	O
up	O
-	O
regulation	O
of	O
both	O
SOX9	O
and	O
FGF9	O
in	O
XX	O
gonads	O
where	O
Sry	O
is	O
absent	O
.	O

It	O
appears	O
that	O
the	O
male	O
pathway	O
can	O
be	O
initiated	O
by	O
disrupting	O
the	O
balance	O
between	O
Wnt4	O
and	O
Fgf9	O
,	O
a	O
finding	O
that	O
has	O
strong	O
implications	O
for	O
other	O
vertebrate	O
sex	O
-	O
determination	O
systems	O
in	O
which	O
Sry	O
is	O
not	O
the	O
sex	O
determining	O
factor	O
.	O

However	O
,	O
up	O
-	O
regulation	O
of	O
Sox9	O
is	O
not	O
sufficient	O
to	O
establish	O
testis	O
development	O
in	O
this	O
mutant	O
,	O
as	O
occurs	O
in	O
Odsex	O
and	O
other	O
gain	O
-	O
of	O
-	O
function	O
mutants	O
where	O
Sox9	O
is	O
misexpressed	O
in	O
the	O
XX	O
gonad	O
[	O
24	O
,	O
25	O
]	O
.	O

In	O
those	O
two	O
misexpression	O
cases	O
,	O
Sox9	O
expression	O
may	O
have	O
been	O
artificially	O
sustained	O
by	O
exogenous	O
regulatory	O
sequences	O
that	O
bypass	O
the	O
fine	O
dosage	O
balance	O
in	O
this	O
signaling	O
network	O
.	O

In	O
Wnt4	O
mutants	O
,	O
SOX9	O
expression	O
is	O
not	O
maintained	O
.	O

In	O
light	O
of	O
the	O
observation	O
that	O
the	O
Wnt4	O
-	O
/	O
-	O
XX	O
gonad	O
does	O
not	O
increase	O
significantly	O
in	O
size	O
(	O
Figure	O
6	O
)	O
,	O
it	O
is	O
possible	O
that	O
the	O
FGF9	O
/	O
SOX9	O
-	O
expressing	O
population	O
did	O
not	O
reach	O
a	O
critical	O
threshold	O
.	O

Alternatively	O
(	O
or	O
in	O
addition	O
)	O
,	O
another	O
male	O
-	O
specific	O
factor	O
normally	O
dependent	O
on	O
Sry	O
may	O
be	O
required	O
to	O
sustain	O
SOX9	O
expression	O
,	O
possibly	O
FGF	O
-	O
binding	O
proteins	B-CHEBI
in	O
the	O
extracellular	O
matrix	O
or	O
FGF	O
receptors	O
.	O

It	O
is	O
equally	O
plausible	O
that	O
there	O
are	O
other	O
female	O
-	O
specific	O
factors	O
that	O
antagonize	O
the	O
establishment	O
of	O
SOX9	O
expression	O
.	O

It	O
has	O
been	O
observed	O
that	O
several	O
other	O
WNTs	O
are	O
expressed	O
in	O
the	O
XX	O
gonad	O
[	O
52	O
]	O
,	O
and	O
these	O
or	O
other	O
factors	O
may	O
partially	O
compensate	O
for	O
the	O
loss	O
of	O
Wnt4	O
.	O

These	O
findings	O
suggest	O
that	O
WNT4	O
signaling	O
normally	O
acts	O
as	O
a	O
repressor	O
of	O
the	O
male	O
pathway	O
by	O
interfering	O
with	O
the	O
up	O
-	O
regulation	O
of	O
SOX9	O
expression	O
.	O

One	O
report	O
of	O
a	O
duplication	O
of	O
the	O
region	O
of	O
human	O
Chromosome	O
1	O
,	O
which	O
includes	O
WNT4	O
,	O
led	O
to	O
an	O
intersex	O
phenotype	O
[	O
53	O
]	O
.	O

However	O
,	O
the	O
report	O
constitutes	O
only	O
circumstantial	O
evidence	O
.	O

Such	O
a	O
role	O
is	O
not	O
supported	O
by	O
efforts	O
to	O
misexpress	O
Wnt4	O
in	O
XY	O
gonads	O
,	O
which	O
have	O
led	O
to	O
very	O
mild	O
phenotypes	O
with	O
no	O
evidence	O
for	O
defects	O
in	O
Sertoli	O
cell	O
differentiation	O
[	O
54	O
]	O
.	O

It	O
is	O
possible	O
that	O
WNT4	O
protein	B-CHEBI
did	O
not	O
function	O
as	O
an	O
active	O
signal	O
in	O
these	O
transgenic	O
mice	O
,	O
either	O
because	O
it	O
was	O
not	O
expressed	O
in	O
the	O
right	O
cells	O
,	O
at	O
the	O
right	O
time	O
,	O
or	O
at	O
the	O
right	O
level	O
.	O

Consistent	O
with	O
our	O
data	O
and	O
the	O
partially	O
sex	O
-	O
reversed	O
phenotype	O
of	O
Wnt4	O
-	O
/	O
-	O
XX	O
mutants	O
,	O
other	O
WNTs	O
or	O
additional	O
female	O
factors	O
may	O
be	O
required	O
.	O

The	O
switch	O
that	O
controls	O
sex	O
determination	O
is	O
biologically	O
diverse	O
.	O

Sry	O
is	O
not	O
present	O
in	O
nonmammalian	O
systems	O
;	O
however	O
,	O
antagonistic	B-CHEBI
signaling	O
between	O
FGFs	O
and	O
WNTs	O
may	O
be	O
the	O
conserved	O
mechanism	O
that	O
balances	O
the	O
gonad	O
between	O
testicular	O
and	O
ovarian	O
fates	O
in	O
vertebrates	O
.	O

In	O
theory	O
,	O
any	O
genetic	O
or	O
environmental	O
switch	O
may	O
tip	O
the	O
balance	O
toward	O
the	O
male	O
pathway	O
.	O

Based	O
on	O
our	O
findings	O
we	O
propose	O
that	O
cells	O
in	O
the	O
mammalian	O
gonad	O
are	O
balanced	O
between	O
two	O
competing	O
cell	O
fates	O
by	O
counterbalanced	O
signaling	O
pathways	O
,	O
Fgf9	O
,	O
expressed	O
near	O
the	O
coelomic	O
surface	O
,	O
and	O
Wnt4	O
,	O
expressed	O
near	O
the	O
mesonephric	O
border	O
(	O
Figure	O
7	O
)	O
.	O

In	O
mammalian	O
XY	O
gonads	O
,	O
the	O
onset	O
of	O
Sry	O
expression	O
initiates	O
the	O
male	O
pathway	O
by	O
up	O
-	O
regulating	O
Sox9	O
.	O

SOX9	O
up	O
-	O
regulates	O
Fgf9	O
,	O
which	O
initiates	O
a	O
Sox9	O
/	O
Fgf9	O
feed	O
-	O
forward	O
loop	O
that	O
accelerates	O
commitment	O
to	O
the	O
male	O
pathway	O
.	O

In	O
XX	O
gonads	O
or	O
XY	O
mutant	O
gonads	O
lacking	O
Sry	O
,	O
Sox9	O
,	O
or	O
Fgf9	O
,	O
the	O
SOX9	O
/	O
FGF9	O
feed	O
-	O
forward	O
loop	O
is	O
not	O
established	O
,	O
and	O
WNT4	O
gains	O
control	O
of	O
the	O
gonadal	O
field	O
.	O

This	O
results	O
in	O
the	O
down	O
-	O
regulation	O
of	O
Sox9	O
and	O
Fgf9	O
,	O
tilting	O
the	O
balance	O
toward	O
commitment	O
to	O
the	O
female	O
pathway	O
.	O

Further	O
experiments	O
will	O
be	O
required	O
to	O
define	O
the	O
molecular	B-CHEBI
mechanism	O
of	O
FGF9	O
and	O
WNT4	O
action	O
.	O

However	O
,	O
our	O
in	O
vivo	O
and	O
in	O
vitro	O
data	O
strongly	O
support	O
the	O
antagonistic	B-CHEBI
relationship	O
of	O
these	O
two	O
signaling	O
pathways	O
in	O
regulating	O
expression	O
of	O
the	O
testis	O
-	O
determining	O
factor	O
SOX9	O
.	O

Materials	O
and	O
Methods	O

Animals	O
and	O
genotyping	O
.	O

The	O
Fgf9	O
mutation	O
was	O
maintained	O
on	O
a	O
C57BL	O
/	O
6	O
(	O
B6	O
)	O
background	O
that	O
leads	O
to	O
sex	O
reversal	O
in	O
100	O
%	O
of	O
XY	O
Fgf9	O
-	O
/	O
-	O
offspring	O
.	O

Sry	O
-	O
EGFP	O
mice	O
,	O
a	O
kind	O
gift	O
from	O
K	O
.	O

Albrecht	O
and	O
E	O
.	O

Eicher	O
,	O
were	O
initially	O
on	O
a	O
mixed	O
B6	O
/	O
129	O
and	O
were	O
backcrossed	O
to	O
B6	O
for	O
five	O
generations	O
.	O

Offspring	O
were	O
then	O
crossed	O
to	O
Fgf9	O
+	O
/	O
-	O
and	O
intercrossed	O
and	O
backcrossed	O
to	O
B6	O
in	O
alternating	O
generations	O
.	O

All	O
XY	O
Fgf9	O
-	O
/	O
-	O
offspring	O
showed	O
complete	O
sex	O
reversal	O
.	O

SryMyc	O
mice	O
were	O
maintained	O
on	O
a	O
CBA	O
background	O
,	O
and	O
Wnt4	O
on	O
a	O
mixed	O
129	O
/	O
SVJ	O
background	O
.	O

Mutant	O
embryos	O
were	O
sexed	O
by	O
PCR	O
using	O
Y	O
chromosome	O
-	O
specific	O
primers	O
and	O
were	O
genotyped	O
as	O
described	O
[	O
2	O
,	O
16	O
,	O
26	O
,	O
55	O
]	O
.	O

Mice	O
homozygous	O
for	O
the	O
Sox9	O
deletion	O
were	O
generated	O
using	O
a	O
germline	O
-	O
specific	O
gene	O
deletion	O
system	O
as	O
described	O
[	O
20	O
]	O
.	O

In	O
situ	O
hybridization	O
and	O
immunocytochemistry	O
.	O

In	O
situ	O
hybridization	O
was	O
performed	O
on	O
paraformaldehyde	O
-	O
fixed	O
/	O
OCT	O
embedded	O
cryosections	O
,	O
as	O
described	O
[	O
56	O
]	O
.	O

Whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
was	O
performed	O
as	O
previously	O
described	O
[	O
57	O
]	O
.	O

Probes	O
used	O
for	O
in	O
situ	O
hybridization	O
were	O
:	O
Amh	O
[	O
58	O
]	O
,	O
Dhh	O
[	O
20	O
]	O
,	O
Wnt4	O
[	O
8	O
]	O
,	O
and	O
Fgf9	O
[	O
59	O
]	O
.	O

Digoxigenin	B-CHEBI
-	O
labeled	O
probes	O
were	O
prepared	O
according	O
to	O
the	O
Boehringer	O
-	O
Mannheim	O
-	O
Roche	O
protocol	O
.	O

Antibodies	O
used	O
in	O
whole	O
-	O
mount	O
immunocytochemistry	O
were	O
:	O
mouse	O
monoclonal	O
anti	O
-	O
N	O
-	O
MYC	O
(	O
Cell	O
Signaling	O
Technology	O
,	O
Beverly	O
,	O
Massachusetts	O
,	O
United	O
States	O
;	O
1	O
:	O
100	O
)	O
,	O
rabbit	O
anti	O
-	O
SOX9	O
(	O
gift	O
of	O
F	O
.	O
Poulat	O
;	O
1	O
:	O
1	O
,	O
000	O
)	O
,	O
rat	O
anti	O
-	O
PECAM	O
(	O
Pharmingen	O
,	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
;	O
1	O
:	O
500	O
)	O
,	O
rabbit	O
anti	O
-	O
caspase	O
-	O
3	O
fragment	O
(	O
BD	O
Bioscience	O
,	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
;	O
1	O
:	O
100	O
)	O
,	O
and	O
rabbit	O
anti	O
-	O
phosphorylated	O
histone	B-CHEBI
H3	O
(	O
Cell	O
Signaling	O
;	O
1	O
:	O
250	O
)	O
.	O

Antibody	O
binding	O
was	O
detected	O
using	O
fluorophore	O
-	O
conjugated	O
secondary	O
antibodies	O
(	O
Jackson	O
ImmunoResearch	O
,	O
West	O
Grove	O
,	O
Pennsylvania	O
,	O
United	O
States	O
)	O
as	O
recommended	O
.	O

For	O
FGF9	O
immunostaining	O
,	O
gonads	O
were	O
prepared	O
as	O
frozen	O
sections	O
,	O
and	O
rabbit	O
anti	O
-	O
mouse	O
FGF9	O
(	O
Cell	O
Science	O
;	O
1	O
:	O
50	O
)	O
and	O
anti	O
-	O
rabbit	O
IgG	O
conjugated	O
with	O
peroxidase	O
secondary	O
antibody	O
were	O
used	O
,	O
followed	O
by	O
amplification	O
with	O
tyramide	O
-	O
Cy3	O
fluorophore	O
(	O
Molecular	B-CHEBI
Probes	O
,	O
Eugene	O
,	O
Oregon	O
,	O
United	O
States	O
)	O
.	O

This	O
antibody	O
did	O
not	O
detect	O
FGF9	O
in	O
12	O
.	O
5	O
dpc	O
ovary	O
or	O
Fgf9	O
-	O
/	O
-	O
null	O
mutant	O
gonads	O
.	O

Immunostained	O
samples	O
were	O
mounted	O
in	O
DABCO	O
and	O
imaged	O
on	O
a	O
Zeiss	O
LSM420	O
confocal	O
microscope	O
.	O

Primary	O
gonadal	O
cell	O
culture	O
.	O

11	O
.	O
5	O
dpc	O
embryos	O
were	O
collected	O
from	O
CD1	O
mice	O
,	O
and	O
sex	O
was	O
determined	O
by	O
staining	O
amnions	O
as	O
described	O
[	O
15	O
]	O
.	O

Whole	O
genital	O
ridges	O
were	O
dissected	O
and	O
gonads	O
were	O
separated	O
from	O
mesonephroi	O
.	O

The	O
gonads	O
were	O
treated	O
with	O
collagenase	O
(	O
0	O
.	O
025	O
%	O
)	O
and	O
trypsin	O
(	O
0	O
.	O
025	O
%	O
)	O
in	O
HAT	O
buffer	O
at	O
37	O
degrees	O
C	O
for	O
10	O
min	O
.	O

After	O
the	O
digestion	O
,	O
cells	O
were	O
mechanically	O
dissociated	O
by	O
pipetting	O
,	O
washed	O
in	O
DMEM	O
,	O
plated	O
on	O
10	O
-	O
mm	O
diameter	O
coverslips	O
coated	O
with	O
extracellular	O
matrix	O
(	O
Sigma	O
)	O
,	O
and	O
were	O
cultured	O
in	O
DMEM	O
containing	O
5	O
%	O
fetal	O
bovine	O
serum	O
and	O
1	O
x	O
antibiotics	B-CHEBI
/	O
antimycotics	B-CHEBI
at	O
37	O
degrees	O
C	O
,	O
5	O
%	O
CO2	B-CHEBI
.	O

In	O
one	O
of	O
duplicate	O
cultures	O
,	O
FGF9	O
(	O
R	O
&	O
D	O
Systems	O
,	O
Minneapolis	O
,	O
Minnesota	O
,	O
United	O
States	O
)	O
was	O
added	O
to	O
the	O
final	O
concentration	O
of	O
50	O
ng	O
/	O
ml	O
in	O
the	O
culture	O
medium	O
.	O

After	O
36	O
h	O
of	O
culture	O
,	O
cells	O
were	O
fixed	O
and	O
immunostained	O
for	O
SOX9	O
.	O

Syto13	O
(	O
Molecular	B-CHEBI
Probes	O
)	O
was	O
used	O
for	O
nuclear	O
counterstaining	O
,	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instruction	O
.	O

Gonad	O
explant	O
culture	O
.	O

Gonad	O
/	O
mesonephros	O
complexes	O
were	O
dissected	O
at	O
11	O
.	O
5	O
dpc	O
and	O
cultured	O
on	O
agar	O
blocks	O
for	O
36	O
h	O
at	O
37	O
degrees	O
C	O
,	O
5	O
%	O
CO2	B-CHEBI
as	O
described	O
[	O
60	O
]	O
.	O

For	O
FGF9	O
treatment	O
,	O
50	O
ng	O
/	O
ml	O
FGF9	O
(	O
R	O
&	O
D	O
Systems	O
)	O
was	O
added	O
directly	O
to	O
the	O
culture	O
medium	O
,	O
or	O
an	O
FGF9	O
-	O
loaded	O
bead	O
was	O
placed	O
on	O
the	O
surface	O
of	O
gonad	O
.	O

To	O
coat	O
beads	O
,	O
heparin	B-CHEBI
-	O
agarose	B-CHEBI
beads	O
(	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
were	O
incubated	O
in	O
50	O
mu	O
g	O
/	O
ml	O
FGF9	O
for	O
2	O
h	O
,	O
and	O
washed	O
five	O
times	O
in	O
culture	O
medium	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Confirmation	O
that	O
Transcription	O
of	O
Sox9	O
Is	O
Up	O
-	O
Regulated	O
in	O
Wnt4	O
-	O
/	O
-	O
XX	O
Gonads	O

Whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
for	O
Sox9	O
detected	O
Sox9	O
expression	O
in	O
11	O
.	O
5	O
dpc	O
Wnt4	O
+	O
/	O
-	O
XY	O
controls	O
and	O
Wnt4	O
-	O
/	O
-	O
XX	O
gonads	O
.	O

(	O
428	O
KB	O
PPT	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Acknowledgements	O

The	O
Sry	O
-	O
EGFP	O
transgenics	O
were	O
a	O
kind	O
gift	O
from	O
Eva	O
M	O
.	O

Eicher	O
.	O

We	O
thank	O
Serge	O
Nef	O
for	O
freely	O
providing	O
information	O
from	O
his	O
microarray	O
screen	O
,	O
Hao	O
Chang	O
for	O
generating	O
some	O
of	O
the	O
Sox9	O
mutant	O
and	O
control	O
urogenital	O
ridges	O
,	O
members	O
of	O
the	O
Capel	O
lab	O
for	O
discussion	O
,	O
and	O
Iordan	O
Batchvarov	O
for	O
help	O
with	O
animals	O
.	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Abbreviations	O

dpc	O
-	O
day	O
post	O
coitum	O

EGFP	O
-	O
enhanced	O
green	O
fluorescent	O
protein	B-CHEBI

FGF	O
-	O
fibroblast	O
growth	O
factor	O

PECAM	O
-	O
platelet	O
/	O
endothelial	O
cell	O
adhesion	O
molecule	B-CHEBI

SOX	O
-	O
SRY	O
-	O
like	O
HMG	O
box	O

SRY	O
-	O
sex	O
-	O
determining	O
region	O
of	O
the	O
Y	O

WNT	O
-	O
wingless	O
-	O
related	O
MMTV	O
integration	O
site	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Stage	O
-	O
and	O
Cell	O
-	O
Specific	O
Expression	O
of	O
FGF9	O
in	O
Embryonic	O
Gonads	O

(	O
A	O
-	O
F	O
)	O
Detection	O
of	O
FGF9	O
protein	B-CHEBI
(	O
red	O
)	O
at	O
different	O
stages	O
of	O
gonad	O
development	O
.	O

FGF9	O
is	O
up	O
-	O
regulated	O
in	O
XY	O
gonads	O
at	O
11	O
.	O
5	O
(	O
B	O
)	O
,	O
12	O
.	O
5	O
(	O
D	O
)	O
,	O
and	O
13	O
.	O
5	O
dpc	O
(	O
F	O
)	O
while	O
it	O
is	O
down	O
-	O
regulated	O
in	O
XX	O
after	O
11	O
.	O
5	O
dpc	O
(	O
A	O
,	O
C	O
,	O
and	O
E	O
)	O
.	O

No	O
signal	O
was	O
detected	O
in	O
XY	O
Fgf9	O
-	O
/	O
-	O
gonads	O
(	O
unpublished	O
data	O
)	O
.	O

(	O
G	O
-	O
J	O
)	O
Serial	O
sections	O
of	O
wild	O
-	O
type	O
XX	O
and	O
compound	O
heterozygous	O
KitW	O
/	O
Wv	O
XY	O
gonads	O
stained	O
for	O
alkaline	B-CHEBI
phosphatase	O
(	O
purple	O
;	O
G	O
and	O
I	O
)	O
and	O
FGF9	O
(	O
red	O
;	O
H	O
and	O
J	O
)	O
.	O

Testis	O
cords	O
are	O
formed	O
in	O
the	O
absence	O
of	O
germ	O
cells	O
in	O
XY	O
KitW	O
/	O
Wv	O
mutant	O
gonads	O
at	O
12	O
.	O
5	O
dpc	O
(	O
arrowhead	O
in	O
J	O
)	O
.	O

Expression	O
of	O
FGF9	O
is	O
present	O
in	O
the	O
mutant	O
gonads	O
where	O
Sertoli	O
cells	O
are	O
the	O
only	O
remaining	O
cell	O
type	O
in	O
the	O
cords	O
(	O
J	O
)	O
.	O

Semitransparent	O
dotted	O
line	O
indicates	O
the	O
boundary	O
between	O
gonad	O
and	O
mesonephroi	O
.	O

PECAM	O
(	O
green	O
)	O
marks	O
germ	O
cells	O
and	O
vascular	O
endothelial	O
cells	O
(	O
C	O
-	O
F	O
,	O
H	O
,	O
and	O
J	O
)	O
.	O

The	O
scale	O
bars	O
represent	O
25	O
mu	O
m	O
.	O

g	O
,	O
gonad	O
;	O
m	O
,	O
mesonephroi	O
.	O

Figure	O
2	O

Epistatic	O
Relationship	O
of	O
Sry	O
,	O
Fgf9	O
,	O
and	O
Sox9	O

(	O
A	O
-	O
D	O
)	O
Sry	O
expression	O
is	O
not	O
dependent	O
on	O
Fgf9	O
.	O

Fgf9	O
+	O
/	O
-	O
(	O
A	O
)	O
and	O
Fgf9	O
-	O
/	O
-	O
(	O
B	O
)	O
XY	O
gonads	O
at	O
11	O
.	O
5	O
dpc	O
expressing	O
GFP	O
(	O
green	O
)	O
from	O
the	O
Sry	O
promoter	O
(	O
polygonal	O
cells	O
,	O
arrows	O
)	O
.	O

Blood	O
cells	O
show	O
background	O
fluorescence	O
(	O
doughnut	O
-	O
shaped	O
cells	O
)	O
.	O

Fgf9	O
+	O
/	O
-	O
(	O
C	O
)	O
and	O
Fgf9	O
-	O
/	O
-	O
(	O
D	O
)	O
XY	O
gonads	O
at	O
11	O
.	O
5	O
dpc	O
expressing	O
SRYMYC	O
protein	B-CHEBI
(	O
red	O
,	O
arrowheads	O
)	O
.	O

Inset	O
shows	O
nuclear	O
counterstain	O
(	O
green	O
,	O
Syto13	O
)	O
colocalizing	O
with	O
SRYMYC	O
.	O

PECAM	O
(	O
blue	O
)	O
marks	O
endothelial	O
and	O
germ	O
cells	O
.	O

Scale	O
bars	O
represent	O
25	O
mu	O
m	O
.	O

(	O
E	O
-	O
K	O
)	O
Exogenous	O
FGF9	O
can	O
up	O
-	O
regulate	O
SOX9	O
expression	O
in	O
XX	O
gonads	O
.	O

Immunostaining	O
of	O
SOX9	O
(	O
green	O
)	O
in	O
primary	O
cultures	O
of	O
gonadal	O
cells	O
.	O

XX	O
cells	O
(	O
E	O
)	O
and	O
XY	O
cells	O
(	O
G	O
)	O
cultured	O
with	O
exogenous	O
FGF9	O
show	O
induction	O
of	O
SOX9	O
expression	O
(	O
F	O
and	O
H	O
,	O
respectively	O
)	O
.	O

Cells	O
were	O
counterstained	O
using	O
the	O
nuclear	O
marker	O
,	O
Syto13	O
(	O
red	O
)	O
.	O

Immunostaining	O
of	O
SOX9	O
(	O
red	O
)	O
in	O
gonad	O
explants	O
cultured	O
with	O
BSA	O
-	O
or	O
FGF9	O
-	O
coated	O
beads	O
.	O

SOX9	O
is	O
expressed	O
in	O
XY	O
gonads	O
and	O
cells	O
contacting	O
FGF9	O
-	O
coated	O
beads	O
(	O
dotted	O
circle	O
labeled	O
"	O
F	O
"	O
)	O
in	O
XX	O
gonads	O
(	O
I	O
and	O
K	O
)	O
but	O
not	O
in	O
XX	O
cells	O
contacting	O
BSA	O
-	O
coated	O
control	O
beads	O
(	O
"	O
B	O
"	O
)	O
(	O
J	O
)	O
.	O

PECAM	O
(	O
blue	O
)	O
marks	O
endothelial	O
and	O
germ	O
cells	O
.	O

Scale	O
bars	O
(	O
I	O
-	O
K	O
)	O
represent	O
50	O
mu	O
m	O
.	O

Figure	O
3	O

Interdependent	O
Relationship	O
between	O
Fgf9	O
and	O
Sox9	O

(	O
A	O
-	O
F	O
)	O
Immunostaining	O
of	O
SOX9	O
(	O
red	O
)	O
in	O
Fgf9	O
+	O
/	O
-	O
and	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
shows	O
that	O
Fgf9	O
is	O
required	O
for	O
maintenance	O
of	O
SOX9	O
.	O

The	O
up	O
-	O
regulation	O
of	O
SOX9	O
in	O
Sertoli	O
precursor	O
cells	O
appears	O
normal	O
in	O
Fgf9	O
-	O
/	O
-	O
gonads	O
at	O
11	O
.	O
5	O
dpc	O
(	O
D	O
)	O
compared	O
with	O
heterozygous	O
littermate	O
controls	O
(	O
A	O
)	O
.	O

However	O
,	O
SOX9	O
is	O
detected	O
in	O
fewer	O
cells	O
in	O
mutant	O
gonads	O
at	O
12	O
.	O
0	O
dpc	O
(	O
B	O
and	O
E	O
)	O
,	O
and	O
is	O
lost	O
by	O
12	O
.	O
5	O
dpc	O
(	O
C	O
and	O
F	O
)	O
.	O

(	O
G	O
-	O
J	O
)	O
mRNA	B-CHEBI
whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
for	O
Sry	O
and	O
Fgf9	O
in	O
Sox9flox	O
/	O
Delta	O
and	O
Sox9	O
Delta	O
/	O
Delta	O
XY	O
gonads	O
shows	O
that	O
Sox9	O
is	O
required	O
for	O
Fgf9	O
expression	O
.	O

Sry	O
expression	O
is	O
detected	O
in	O
both	O
Sox9flox	O
/	O
Delta	O
and	O
Sox9	O
Delta	O
/	O
Delta	O
gonads	O
at	O
11	O
.	O
5	O
dpc	O
(	O
G	O
and	O
H	O
)	O
,	O
whereas	O
Fgf9	O
expression	O
is	O
markedly	O
decreased	O
or	O
absent	O
in	O
Sox9	O
Delta	O
/	O
Delta	O
gonads	O
at	O
11	O
.	O
5	O
dpc	O
(	O
I	O
and	O
J	O
)	O
.	O

(	O
K	O
-	O
O	O
)	O
Comparison	O
of	O
cell	O
proliferation	O
in	O
Sox9	O
Delta	O
/	O
Delta	O
versus	O
Sox9flox	O
/	O
Delta	O
gonads	O
at	O
11	O
.	O
5	O
dpc	O
using	O
immunostaining	O
for	O
phosphorylated	O
histone	B-CHEBI
H3	O
.	O

XY	O
-	O
specific	O
proliferation	O
at	O
the	O
gonad	O
surface	O
(	O
K	O
)	O
is	O
reduced	O
in	O
the	O
absence	O
of	O
Sox9	O
(	O
L	O
)	O
.	O

Bar	O
graph	O
(	O
O	O
)	O
shows	O
quantitation	O
of	O
proliferation	O
obtained	O
by	O
counting	O
positive	O
cells	O
in	O
the	O
cortical	O
region	O
of	O
each	O
gonad	O
(	O
right	O
brace	O
)	O
and	O
normalizing	O
to	O
the	O
number	O
obtained	O
from	O
XY	O
Sox9flox	O
/	O
Delta	O
gonads	O
.	O

n	O
=	O
30	O
,	O
with	O
five	O
sections	O
of	O
each	O
gonad	O
and	O
three	O
pairs	O
of	O
gonads	O
for	O
each	O
genotype	O
.	O

PECAM	O
,	O
green	O
(	O
A	O
-	O
F	O
and	O
K	O
-	O
N	O
)	O
.	O

The	O
scale	O
bars	O
represent	O
25	O
mu	O
m	O
.	O

Figure	O
4	O

Sertoli	O
Cell	O
Precursors	O
Switch	O
from	O
Expression	O
of	O
Male	O
to	O
Female	O
Pathway	O
Genes	O

(	O
A	O
-	O
F	O
)	O
Whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
for	O
genes	O
in	O
the	O
male	O
pathway	O
downstream	O
of	O
Sox9	O
,	O
Dhh	O
,	O
and	O
Amh	O
.	O

Dhh	O
expression	O
is	O
disrupted	O
in	O
XY	O
Fgf9	O
-	O
/	O
-	O
gonads	O
(	O
g	O
)	O
at	O
11	O
.	O
5	O
dpc	O
(	O
A	O
and	O
B	O
)	O
.	O

Amh	O
expression	O
is	O
severely	O
reduced	O
in	O
XY	O
Fgf9	O
-	O
/	O
-	O
gonads	O
at	O
12	O
.	O
5	O
dpc	O
(	O
E	O
and	O
F	O
)	O
.	O

(	O
G	O
and	O
H	O
)	O
Analysis	O
of	O
cell	O
death	O
in	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
using	O
an	O
apoptotic	O
marker	O
,	O
active	O
caspase	O
-	O
3	O
(	O
red	O
)	O
.	O

No	O
increased	O
apoptosis	O
is	O
observed	O
in	O
XY	O
Fgf9	O
-	O
/	O
-	O
gonads	O
(	O
g	O
)	O
compared	O
with	O
control	O
XY	O
gonads	O
,	O
although	O
apoptotic	O
cells	O
are	O
increased	O
around	O
mesonephric	O
tubules	O
(	O
m	O
)	O
of	O
the	O
mutant	O
gonads	O
(	O
arrow	O
in	O
H	O
)	O
.	O

Semitransparent	O
dotted	O
line	O
indicates	O
boundary	O
between	O
mesonephros	O
and	O
gonad	O
.	O

(	O
PECAM	O
,	O
green	O
)	O
.	O

(	O
I	O
-	O
K	O
)	O
Whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
for	O
Wnt4	O
,	O
an	O
ovary	O
marker	O
.	O

Wnt4	O
is	O
expressed	O
in	O
Fgf9	O
-	O
/	O
-	O
XY	O
gonads	O
at	O
12	O
.	O
5	O
dpc	O
(	O
K	O
)	O
similar	O
to	O
the	O
level	O
in	O
XX	O
Fgf9	O
+	O
/	O
-	O
controls	O
(	O
I	O
)	O
but	O
not	O
in	O
XY	O
controls	O
(	O
J	O
)	O
.	O

The	O
scale	O
bars	O
represent	O
50	O
mu	O
m	O
.	O

g	O
,	O
gonad	O
;	O
m	O
,	O
mesonephros	O
.	O

Figure	O
5	O

Mutual	O
Antagonism	O
between	O
Fgf9	O
and	O
Wnt4	O

(	O
A	O
-	O
C	O
)	O
Wnt4	O
whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
on	O
gonad	O
cultures	O
.	O

Adding	O
exogenous	O
FGF9	O
in	O
gonad	O
cultures	O
results	O
in	O
the	O
down	O
-	O
regulation	O
of	O
Wnt4	O
expression	O
in	O
cultured	O
XX	O
gonads	O
(	O
C	O
)	O
.	O

Controls	O
(	O
A	O
and	O
B	O
)	O
were	O
cultured	O
without	O
FGF9	O
peptide	O
.	O

(	O
D	O
-	O
G	O
)	O
Reduction	O
in	O
the	O
dose	O
of	O
Wnt4	O
allows	O
FGF9	O
to	O
induce	O
SOX9	O
in	O
XX	O
gonads	O
.	O

Immunostaining	O
of	O
SOX9	O
(	O
red	O
)	O
shows	O
that	O
addition	O
of	O
FGF9	O
up	O
-	O
regulates	O
SOX9	O
expression	O
in	O
heterozygous	O
Wnt4	O
+	O
/	O
-	O
XX	O
gonads	O
(	O
G	O
)	O
,	O
but	O
not	O
in	O
Wnt4	O
+	O
/	O
+	O
XX	O
gonads	O
(	O
F	O
)	O
.	O

PECAM	O
,	O
green	O
.	O

The	O
scale	O
bars	O
represent	O
50	O
mu	O
m	O
.	O

Figure	O
6	O

Ectopic	O
Expression	O
of	O
Male	O
Factors	O
,	O
SOX9	O
and	O
FGF9	O
,	O
in	O
XX	O
Wnt4	O
-	O
/	O
-	O
Gonads	O

(	O
A	O
-	O
C	O
)	O
FGF9	O
(	O
red	O
)	O
immunostaining	O
shows	O
that	O
FGF9	O
is	O
expressed	O
in	O
XX	O
Wnt4	O
-	O
/	O
-	O
gonads	O
at	O
12	O
.	O
5	O
dpc	O
(	O
C	O
)	O
relative	O
to	O
littermate	O
controls	O
(	O
A	O
and	O
B	O
)	O
.	O

(	O
D	O
-	O
L	O
)	O
SOX9	O
(	O
red	O
)	O
immunostaining	O
shows	O
that	O
SOX9	O
is	O
transiently	O
up	O
-	O
regulated	O
in	O
XX	O
Wnt4	O
-	O
/	O
-	O
gonads	O
.	O

SOX9	O
expression	O
is	O
detected	O
in	O
Wnt4	O
-	O
/	O
-	O
XX	O
gonads	O
at	O
11	O
.	O
5	O
-	O
12	O
.	O
0	O
dpc	O
(	O
F	O
and	O
I	O
)	O
,	O
albeit	O
at	O
reduced	O
levels	O
compared	O
with	O
XY	O
gonad	O
controls	O
(	O
E	O
-	O
H	O
)	O
.	O

SOX9	O
is	O
not	O
detected	O
in	O
control	O
XX	O
Wnt4	O
+	O
/	O
-	O
gonads	O
(	O
D	O
-	O
J	O
)	O
or	O
Wnt4	O
-	O
/	O
-	O
XX	O
gonads	O
at	O
12	O
.	O
5	O
dpc	O
(	O
L	O
)	O
.	O

The	O
ectopic	O
coelomic	O
vessel	O
in	O
XX	O
Wnt4	O
-	O
/	O
-	O
gonads	O
[	O
28	O
]	O
is	O
indicated	O
by	O
arrowheads	O
.	O

PECAM	O
,	O
green	O
.	O

The	O
scale	O
bars	O
represent	O
50	O
mu	O
m	O
.	O

Figure	O
7	O

Opposing	O
Signals	O
Regulate	O
Sex	O
Determination	O
in	O
the	O
Bipotential	O
Gonad	O

In	O
both	O
XX	O
and	O
XY	O
gonads	O
at	O
11	O
.	O
25	O
dpc	O
(	O
15	O
tail	O
-	O
somite	O
stage	O
)	O
,	O
Fgf9	O
transcripts	O
(	O
white	O
arrows	O
)	O
are	O
detected	O
near	O
the	O
gonad	O
surface	O
(	O
A	O
and	O
B	O
)	O
,	O
whereas	O
Wnt4	O
transcripts	O
are	O
detected	O
near	O
the	O
gonad	O
mesonephric	O
boundary	O
(	O
C	O
and	O
D	O
)	O
.	O

We	O
propose	O
a	O
model	O
in	O
which	O
the	O
fate	O
of	O
the	O
gonad	O
is	O
balanced	O
between	O
these	O
competing	O
signals	O
.	O

A	O
genetic	O
or	O
environmental	O
switch	O
initiates	O
the	O
male	O
pathway	O
by	O
creating	O
an	O
imbalance	O
between	O
these	O
signals	O
.	O

In	O
mammals	O
,	O
this	O
imbalance	O
occurs	O
through	O
the	O
up	O
-	O
regulation	O
of	O
Sox9	O
.	O

Sox9	O
up	O
-	O
regulates	O
Fgf9	O
,	O
and	O
Fgf9	O
maintains	O
Sox9	O
,	O
forming	O
a	O
positive	O
feed	O
-	O
forward	O
loop	O
in	O
XY	O
gonads	O
.	O

In	O
this	O
situation	O
,	O
the	O
balance	O
between	O
FGF9	O
and	O
WNT4	O
signals	O
is	O
shifted	O
in	O
favor	O
of	O
FGF9	O
,	O
and	O
the	O
dominance	O
of	O
the	O
male	O
pathway	O
is	O
established	O
.	O

In	O
the	O
absence	O
of	O
a	O
feed	O
-	O
forward	O
loop	O
between	O
SOX9	O
and	O
FGF9	O
(	O
e	O
.	O
g	O
.	O
,	O
in	O
XX	O
gonads	O
)	O
,	O
WNT4	O
blocks	O
Fgf9	O
,	O
initiating	O
the	O
female	O
pathway	O
.	O

Footnotes	O

Author	O
contributions	O
.	O

YK	O
,	O
AK	O
,	O
and	O
BC	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

YK	O
,	O
AK	O
,	O
LD	O
,	O
and	O
JB	O
performed	O
the	O
experiments	O
.	O

YK	O
,	O
RLB	O
,	O
and	O
BC	O
analyzed	O
the	O
data	O
.	O

YK	O
,	O
RS	O
,	O
MCC	O
,	O
FP	O
,	O
RRB	O
,	O
RLB	O
,	O
and	O
BC	O
contributed	O
reagents	B-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

YK	O
and	O
BC	O
wrote	O
the	O
paper	O
with	O
significant	O
input	O
from	O
RLB	O
.	O

Citation	O
:	O
Kim	O
Y	O
,	O
Kobayashi	O
A	O
,	O
Sekido	O
R	O
,	O
DiNapoli	O
L	O
,	O
Brennan	O
J	O
,	O
et	O
al	O
.	O

(	O
2006	O
)	O
Fgf9	O
and	O
Wnt4	O
act	O
as	O
antagonistic	B-CHEBI
signals	O
to	O
regulate	O
mammalian	O
sex	O
determination	O
.	O

PLoS	O
Biol	O
4	O
(	O
6	O
)	O
:	O
e187	O
.	O

DOI	O
:	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pbio	O
.	O
0040187	O

Funding	O
.	O

This	O
work	O
was	O
funded	O
by	O
grants	O
from	O
the	O
National	O
Institutes	O
of	O
Health	O
to	O
BC	O
(	O
HD39963	O
)	O
,	O
and	O
to	O
RRB	O
(	O
HD30284	O
)	O
.	O

RMCE	O
-	O
ASAP	O
:	O
a	O
gene	O
targeting	O
method	O
for	O
ES	O
and	O
somatic	O
cells	O
to	O
accelerate	O
phenotype	O
analyses	O

Abstract	O

In	O
recent	O
years	O
,	O
tremendous	O
insight	O
has	O
been	O
gained	O
on	O
p53	O
regulation	O
by	O
targeting	O
mutations	O
at	O
the	O
p53	O
locus	O
using	O
homologous	O
recombination	O
in	O
ES	O
cells	O
to	O
generate	O
mutant	O
mice	O
.	O

Although	O
informative	O
,	O
this	O
approach	O
is	O
inefficient	O
,	O
slow	O
and	O
expensive	O
.	O

To	O
facilitate	O
targeting	O
at	O
the	O
p53	O
locus	O
,	O
we	O
developed	O
an	O
improved	O
Recombinase	O
-	O
Mediated	O
Cassette	O
Exchange	O
(	O
RMCE	O
)	O
method	O
.	O

Our	O
approach	O
enables	O
efficient	O
targeting	O
in	O
ES	O
cells	O
to	O
facilitate	O
the	O
production	O
of	O
mutant	O
mice	O
.	O

But	O
more	O
importantly	O
,	O
the	O
approach	O
was	O
Adapted	O
for	O
targeting	O
in	O
Somatic	O
cells	O
to	O
Accelerate	O
Phenotyping	O
(	O
RMCE	O
-	O
ASAP	O
)	O
.	O

We	O
provide	O
proof	O
-	O
of	O
-	O
concept	O
for	O
this	O
at	O
the	O
p53	O
locus	O
,	O
by	O
showing	O
efficient	O
targeting	O
in	O
fibroblasts	O
,	O
and	O
rapid	O
phenotypic	O
read	O
-	O
out	O
of	O
a	O
recessive	O
mutation	O
after	O
a	O
single	O
exchange	O
.	O

RMCE	O
-	O
ASAP	O
combines	O
inverted	O
heterologous	O
recombinase	O
target	O
sites	O
,	O
a	O
positive	O
/	O
negative	O
selection	O
marker	O
that	O
preserves	O
the	O
germline	O
capacity	O
of	O
ES	O
cells	O
,	O
and	O
the	O
power	O
of	O
mouse	O
genetics	O
.	O

These	O
general	O
principles	O
should	O
make	O
RMCE	O
-	O
ASAP	O
applicable	O
to	O
any	O
locus	O
.	O

INTRODUCTION	O

p53	O
is	O
one	O
of	O
the	O
most	O
highly	O
analyzed	O
proteins	B-CHEBI
for	O
the	O
past	O
25	O
years	O
.	O

Studies	O
in	O
cultured	O
cells	O
,	O
often	O
relying	O
on	O
the	O
transfection	O
of	O
plasmids	O
expressing	O
various	O
p53	O
mutants	O
,	O
have	O
established	O
models	O
to	O
explain	O
how	O
p53	O
is	O
regulated	O
.	O

In	O
recent	O
years	O
,	O
some	O
of	O
these	O
models	O
were	O
tested	O
in	O
vivo	O
by	O
targeting	O
subtle	O
mutations	O
at	O
the	O
p53	O
locus	O
using	O
homologous	O
recombination	O
in	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
to	O
generate	O
mutant	O
mice	O
.	O

The	O
strength	O
of	O
this	O
approach	O
is	O
that	O
mutations	O
are	O
tested	O
in	O
a	O
genomic	O
setting	O
and	O
expressed	O
from	O
the	O
endogenous	O
promoter	O
,	O
ensuring	O
physiological	O
expression	O
levels	O
and	O
correct	O
spatio	O
-	O
temporal	O
profiles	O
.	O

As	O
significant	O
differences	O
between	O
phenotypes	O
from	O
targeted	O
p53	O
mutants	O
in	O
vivo	O
and	O
transfection	O
data	O
were	O
observed	O
[	O
e	O
.	O
g	O
.	O
Refs	O
(	O
1	O
-	O
5	O
)	O
]	O
,	O
more	O
targeted	O
mutations	O
need	O
to	O
be	O
generated	O
and	O
analyzed	O
in	O
multiple	O
tissues	O
to	O
formulate	O
more	O
accurate	O
models	O
of	O
p53	O
regulation	O
.	O

However	O
,	O
using	O
homologous	O
recombination	O
in	O
ES	O
cells	O
to	O
generate	O
mutant	O
mice	O
is	O
an	O
inefficient	O
,	O
slow	O
and	O
expensive	O
method	O
because	O
(	O
i	O
)	O
homologous	O
recombination	O
typically	O
occurs	O
at	O
low	O
frequency	O
in	O
ES	O
cells	O
,	O
requiring	O
sophisticated	O
selection	O
schemes	O
and	O
screening	O
of	O
hundreds	O
of	O
clones	O
to	O
identify	O
the	O
desired	O
mutant	O
;	O
(	O
ii	O
)	O
large	O
(	O
15	O
-	O
20	O
kb	O
)	O
plasmids	O
,	O
often	O
difficult	O
to	O
clone	O
,	O
are	O
required	O
to	O
increase	O
targeting	O
efficiency	O
and	O
(	O
iii	O
)	O
breeding	O
mice	O
to	O
homozygosity	O
and	O
housing	O
a	O
mouse	O
colony	O
generate	O
further	O
delays	O
and	O
costs	O
.	O

Such	O
limitations	O
make	O
the	O
repeated	O
targeting	O
of	O
a	O
locus	O
a	O
technically	O
daunting	O
and	O
economically	O
impractical	O
task	O
.	O

Improvements	O
in	O
current	O
technologies	O
are	O
needed	O
to	O
enable	O
such	O
analyses	O
to	O
be	O
applied	O
to	O
the	O
p53	O
or	O
other	O
genes	O
.	O

Developing	O
methods	O
to	O
increase	O
targeting	O
efficiency	O
in	O
ES	O
cells	O
is	O
clearly	O
an	O
important	O
goal	O
.	O

In	O
addition	O
,	O
efficient	O
methods	O
for	O
gene	O
targeting	O
in	O
fibroblasts	O
could	O
expedite	O
phenotypic	O
analyses	O
.	O

Indeed	O
,	O
siRNAs	O
in	O
fibroblasts	O
often	O
provide	O
a	O
faster	O
read	O
-	O
out	O
than	O
equivalent	O
gene	O
knock	O
-	O
outs	O
in	O
animals	O
(	O
6	O
)	O
.	O

However	O
,	O
modeling	O
most	O
disease	O
-	O
associated	O
mutations	O
requires	O
generating	O
subtle	O
mutations	O
,	O
not	O
knock	O
-	O
outs	O
or	O
reduced	O
expression	O
alleles	O
.	O

Targeting	O
point	O
mutations	O
in	O
fibroblasts	O
by	O
homologous	O
recombination	O
is	O
extremely	O
inefficient	O
,	O
and	O
targeting	O
both	O
alleles	O
is	O
required	O
to	O
reveal	O
the	O
phenotype	O
of	O
recessive	O
autosomal	O
mutations	O
.	O

Here	O
we	O
report	O
an	O
approach	O
that	O
enables	O
highly	O
efficient	O
targeting	O
at	O
the	O
p53	O
locus	O
in	O
both	O
ES	O
cells	O
and	O
fibroblasts	O
.	O

Recombinase	O
-	O
Mediated	O
Cassette	O
Exchange	O
(	O
RMCE	O
)	O
approaches	O
were	O
developed	O
to	O
improve	O
targeting	O
efficiency	O
using	O
a	O
two	O
-	O
step	O
process	O
:	O
the	O
gene	O
of	O
interest	O
is	O
first	O
replaced	O
by	O
a	O
selection	O
cassette	O
flanked	O
by	O
recombinase	O
target	O
sites	O
(	O
e	O
.	O
g	O
.	O
loxP	O
sites	O
for	O
Cre	O
recombinase	O
,	O
to	O
create	O
a	O
'	O
floxed	O
'	O
locus	O
)	O
.	O

Then	O
,	O
Cre	O
-	O
mediated	O
recombination	O
in	O
the	O
presence	O
of	O
a	O
cassette	O
containing	O
a	O
floxed	O
mutant	O
allele	O
removes	O
the	O
resident	O
sequence	O
and	O
inserts	O
the	O
mutant	O
gene	O
(	O
7	O
)	O
.	O

Previously	O
,	O
technical	O
difficulties	O
have	O
prevented	O
RMCE	O
from	O
being	O
applied	O
routinely	O
to	O
generate	O
mutant	O
mice	O
.	O

For	O
example	O
,	O
exchanges	O
using	O
cassettes	O
with	O
directly	O
repeated	O
loxP	O
sites	O
were	O
inefficient	O
because	O
excisions	O
dominated	O
the	O
intended	O
exchanges	O
(	O
8	O
)	O
.	O

loxP	O
sites	O
with	O
different	O
sequences	O
were	O
generated	O
to	O
overcome	O
this	O
problem	O
,	O
but	O
these	O
sites	O
also	O
underwent	O
intramolecular	O
recombination	O
,	O
making	O
RMCE	O
efficient	O
only	O
if	O
the	O
replacement	O
cassette	O
contained	O
a	O
marker	O
enabling	O
selection	O
of	O
the	O
desired	O
recombinant	O
(	O
7	O
,	O
9	O
-	O
12	O
)	O
.	O

However	O
,	O
interference	O
resulting	O
from	O
expression	O
of	O
the	O
selection	O
marker	O
and	O
the	O
endogenous	O
gene	O
(	O
13	O
)	O
necessitates	O
strategies	O
to	O
remove	O
the	O
selectable	O
gene	O
.	O

Together	O
,	O
previous	O
studies	O
indicate	O
that	O
an	O
optimal	O
RMCE	O
requires	O
(	O
i	O
)	O
inverted	O
heterologous	O
loxP	O
sites	O
diverging	O
by	O
at	O
least	O
2	O
nt	O
to	O
maximize	O
the	O
efficiency	O
of	O
exchange	O
and	O
(	O
ii	O
)	O
an	O
expression	O
cassette	O
enabling	O
both	O
positive	O
selection	O
to	O
identify	O
the	O
initial	O
recombinant	O
and	O
then	O
negative	O
selection	O
to	O
obtain	O
a	O
'	O
marker	O
-	O
free	O
'	O
mutant	O
allele	O
(	O
14	O
)	O
.	O

Most	O
RMCE	O
experiments	O
have	O
been	O
performed	O
at	O
random	O
sites	O
in	O
somatic	O
cell	O
lines	O
.	O

Only	O
a	O
few	O
mutant	O
mice	O
generated	O
by	O
RMCE	O
in	O
ES	O
cells	O
have	O
been	O
reported	O
,	O
but	O
the	O
RMCE	O
systematically	O
introduced	O
a	O
selectable	O
marker	O
(	O
15	O
-	O
17	O
)	O
,	O
or	O
,	O
when	O
tested	O
without	O
an	O
incoming	O
marker	O
,	O
proved	O
inefficient	O
(	O
12	O
)	O
.	O

A	O
recent	O
report	O
disclosed	O
an	O
additional	O
problem	O
:	O
the	O
Hygromycin	O
-	O
Thymidine	B-CHEBI
Kinase	O
fusion	O
gene	O
used	O
most	O
frequently	O
for	O
positive	O
/	O
negative	O
selection	O
in	O
RMCE	O
,	O
leads	O
to	O
mouse	O
sterility	O
,	O
so	O
that	O
exchanges	O
can	O
only	O
be	O
performed	O
in	O
ES	O
cells	O
(	O
16	O
)	O
.	O

The	O
RMCE	O
strategy	O
presented	O
here	O
relies	O
on	O
the	O
integrated	O
use	O
of	O
inverted	O
heterologous	O
loxP	O
sites	O
,	O
a	O
positive	O
/	O
negative	O
selection	O
marker	O
that	O
preserves	O
the	O
germline	O
capacity	O
of	O
ES	O
cells	O
,	O
and	O
the	O
power	O
of	O
mouse	O
genetics	O
to	O
expedite	O
phenotypic	O
analyses	O
.	O

We	O
show	O
that	O
our	O
approach	O
enables	O
efficient	O
targeting	O
of	O
marker	O
-	O
free	O
mutations	O
at	O
the	O
p53	O
locus	O
in	O
ES	O
cells	O
to	O
generate	O
mutant	O
mice	O
,	O
but	O
more	O
importantly	O
,	O
it	O
is	O
Adapted	O
for	O
targeting	O
in	O
Somatic	O
cells	O
to	O
Accelerate	O
Phenotyping	O
(	O
ASAP	O
)	O
.	O

Because	O
it	O
relies	O
on	O
very	O
general	O
principles	O
,	O
RMCE	O
-	O
ASAP	O
could	O
be	O
applied	O
to	O
any	O
locus	O
of	O
interest	O
.	O

MATERIALS	O
AND	O
METHODS	O

Targeting	O
construct	O
for	O
a	O
p53	O
RMCE	O
-	O
ready	O
locus	O

Details	O
for	O
plasmid	O
construction	O
are	O
available	O
upon	O
request	O
owing	O
to	O
space	O
limitations	O
mandating	O
a	O
brief	O
outline	O
.	O

We	O
started	O
from	O
a	O
plasmid	O
L3	O
-	O
1L	O
containing	O
heterologous	O
loxP	O
sites	O
(	O
L3	O
is	O
the	O
mutant	O
loxP257	O
recently	O
described	O
(	O
14	O
)	O
,	O
1L	O
is	O
an	O
inverted	O
WT	O
loxP	O
)	O
.	O

The	O
WT	O
loxP	O
and	O
loxP257	O
differ	O
in	O
their	O
spacer	O
sequences	O
:	O
the	O
spacer	O
sequence	O
is	O
5	O
'	O
-	O
ATGTATGC	O
-	O
3	O
'	O
for	O
WT	O
loxP	O
and	O
5	O
'	O
-	O
AAGTCTCC	O
-	O
3	O
'	O
for	O
loxP257	O
.	O

The	O
three	O
mutations	O
in	O
the	O
loxP257	O
spacer	O
sequence	O
prevent	O
it	O
to	O
recombine	O
with	O
WT	O
loxP	O
,	O
ensuring	O
efficient	O
RMCE	O
in	O
several	O
cell	O
lines	O
:	O
accurate	O
RMCE	O
with	O
these	O
loxP	O
sites	O
occurred	O
with	O
an	O
average	O
frequency	O
of	O
81	O
%	O
at	O
two	O
loci	O
in	O
CHO	O
cells	O
and	O
an	O
average	O
frequency	O
of	O
69	O
%	O
at	O
four	O
loci	O
in	O
Hela	O
cells	O
(	O
14	O
)	O
.	O

The	O
L3	O
-	O
1L	O
plasmid	O
was	O
first	O
modified	O
to	O
include	O
a	O
ClaI	O
and	O
a	O
FseI	O
site	O
between	O
the	O
LoxP	O
sites	O
,	O
leading	O
to	O
plasmid	O
L3	O
-	O
CF	O
-	O
1L	O
.	O

We	O
next	O
modified	O
a	O
puro	O
Delta	O
TK	O
plasmid	O
(	O
YTC37	O
,	O
a	O
kind	O
gift	O
from	O
A	O
.	O
Bradley	O
)	O
by	O
using	O
oligonucleotides	O
to	O
destroy	O
a	O
NotI	O
site	O
downstream	O
of	O
the	O
puro	O
Delta	O
TK	O
gene	O
and	O
introduce	O
a	O
NotI	O
site	O
upstream	O
,	O
and	O
a	O
FseI	O
site	O
downstream	O
of	O
the	O
gene	O
(	O
leading	O
to	O
plasmid	O
CN	O
-	O
Puro	O
Delta	O
TK	O
-	O
F	O
)	O
.	O

Next	O
,	O
a	O
PmlI	O
-	O
MfeI	O
6	O
.	O
3	O
kb	O
fragment	O
from	O
Trp53	O
was	O
subcloned	O
in	O
a	O
modified	O
pBluescript	O
KSII	O
+	O
(	O
pBS	O
,	O
Stratagene	O
)	O
,	O
and	O
the	O
resulting	O
plasmid	O
was	O
digested	O
with	O
SwaI	O
to	O
introduce	O
an	O
EagI	O
site	O
,	O
leading	O
to	O
p53PmlEag	O
,	O
a	O
plasmid	O
containing	O
exons	O
2	O
-	O
11	O
of	O
p53	O
.	O

We	O
then	O
inserted	O
a	O
5	O
.	O
5	O
kb	O
ClaI	O
-	O
EagI	O
fragment	O
from	O
p53PmlEag	O
in	O
plasmid	O
CN	O
-	O
Puro	O
Delta	O
TK	O
-	O
F	O
digested	O
by	O
ClaI	O
and	O
NotI	O
,	O
and	O
inserted	O
the	O
resulting	O
fragment	O
between	O
the	O
loxP	O
sites	O
of	O
L3	O
-	O
CF	O
-	O
1L	O
by	O
ClaI	O
and	O
FseI	O
digestion	O
,	O
leading	O
to	O
L3	O
-	O
p53PmlEagPuro	O
Delta	O
TK	O
-	O
1L	O
.	O

We	O
next	O
engineered	O
a	O
plasmid	O
containing	O
the	O
region	O
for	O
3	O
'	O
-	O
homology	O
downstream	O
of	O
the	O
p53	O
gene	O
and	O
the	O
DTA	O
gene	O
in	O
two	O
steps	O
:	O
(	O
i	O
)	O
we	O
performed	O
a	O
three	O
-	O
way	O
ligation	O
between	O
a	O
modified	O
pBS	O
digested	O
by	O
HindIII	O
and	O
NotI	O
,	O
a	O
HindIII	O
-	O
EcoRI	O
fragment	O
from	O
Trp53	O
for	O
3	O
'	O
homology	O
and	O
an	O
EcoRI	O
-	O
NotI	O
fragment	O
containing	O
the	O
DTA	O
gene	O
,	O
from	O
plasmid	O
pgkdtabpa	O
(	O
kind	O
gift	O
of	O
P	O
.	O
Soriano	O
)	O
,	O
leading	O
to	O
plasmid	O
3	O
'	O
+	O
DTA	O
and	O
(	O
ii	O
)	O
because	O
the	O
Bsu36I	O
-	O
EcoRI	O
region	O
downstream	O
of	O
p53	O
contains	O
repetitive	O
sequences	O
(	O
F	O
.	O
Toledo	O
and	O
G	O
.	O
M	O
.	O
Wahl	O
,	O
unpublished	O
data	O
)	O
,	O
we	O
later	O
deleted	O
this	O
region	O
,	O
to	O
obtain	O
plasmid	O
3	O
'	O
+	O
DTA	O
.	O

The	O
5	O
'	O
homology	O
consists	O
of	O
a	O
3	O
.	O
4	O
kb	O
-	O
long	O
BamHI	O
-	O
PmlI	O
fragment	O
from	O
intron	O
1	O
of	O
p53	O
cloned	O
in	O
a	O
modified	O
pBS	O
(	O
plasmid	O
p5	O
'	O
)	O
.	O

Finally	O
,	O
appropriate	O
fragments	O
from	O
plasmids	O
p5	O
'	O
,	O
L3	O
-	O
p53PmlEagPuro	O
Delta	O
TK	O
-	O
1L	O
,	O
and	O
3	O
'	O
+	O
DTA	O
were	O
assembled	O
in	O
a	O
modified	O
pSP72	O
plasmid	O
(	O
Promega	O
)	O
.	O

Plasmid	O
Flox	O
,	O
the	O
resulting	O
targeting	O
construct	O
,	O
was	O
verified	O
by	O
restriction	O
analysis	O
,	O
then	O
sequenced	O
using	O
30	O
primers	O
chosen	O
to	O
precisely	O
verify	O
all	O
p53	O
coding	O
sequences	O
,	O
all	O
exon	O
-	O
intron	O
junctions	O
and	O
the	O
sequences	O
at	O
and	O
around	O
the	O
loxP	O
sites	O
.	O

Exchange	O
constructs	O
:	O
making	O
the	O
p53GFP	O
and	O
p53	O
Delta	O
PGFP	O
plasmids	O

To	O
make	O
a	O
p53	O
-	O
GFP	O
fusion	O
protein	B-CHEBI
,	O
we	O
first	O
subcloned	O
a	O
SacII	O
-	O
HindIII	O
fragment	O
of	O
the	O
p53	O
locus	O
(	O
corresponding	O
to	O
part	O
of	O
exon	O
10	O
to	O
sequences	O
downstream	O
of	O
the	O
gene	O
)	O
into	O
pBS	O
,	O
then	O
mutated	O
the	O
HindIII	O
site	O
into	O
a	O
FseI	O
site	O
.	O

We	O
next	O
mutated	O
the	O
C	B-CHEBI
-	O
terminal	O
part	O
of	O
the	O
p53	O
gene	O
in	O
two	O
rounds	O
of	O
PCR	O
mutagenesis	O
,	O
first	O
with	O
primers	O
5	O
'	O
-	O
GGGCCTGACTCAGACGGATCCCCTCTGCATCCCGTC	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
GACGGGATGCAGAGGGGATCCGTCTGAGTCAGGCCC	O
-	O
3	O
'	O
,	O
which	O
removed	O
the	O
stop	O
codon	O
and	O
introduced	O
a	O
BamHI	O
site	O
,	O
then	O
with	O
primers	O
5	O
'	O
-	O
GACGGATCCCCTCTGAATTCCGTCCCCATCACCA	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
TGGTGATGGGGACGGAATACAGAGGGGATCCGTC	O
-	O
3	O
'	O
,	O
which	O
introduced	O
an	O
EcoRI	O
site	O
.	O

We	O
verified	O
the	O
sequence	O
from	O
the	O
mutated	O
plasmid	O
,	O
then	O
digested	O
it	O
with	O
BamHI	O
and	O
EcoRI	O
,	O
to	O
insert	O
in	O
frame	O
GFP	O
sequences	O
from	O
a	O
Bam	O
HI	O
-	O
EcoRI	O
fragment	O
of	O
plasmid	O
phr	O
-	O
GFP	O
-	O
1	O
(	O
Stratagene	O
)	O
.	O

We	O
verified	O
the	O
sequence	O
of	O
this	O
p53	O
-	O
GFP	O
fusion	O
fragment	O
,	O
then	O
swapped	O
it	O
in	O
the	O
L3	O
-	O
p53PmlEagPuro	O
Delta	O
TK	O
-	O
1L	O
plasmid	O
(	O
see	O
above	O
)	O
by	O
HindIII	O
and	O
FseI	O
digestion	O
,	O
resulting	O
in	O
the	O
p53GFP	O
exchange	O
construct	O
,	O
the	O
sequence	O
which	O
was	O
verified	O
before	O
use	O
.	O

The	O
p53	O
Delta	O
PGFP	O
exchange	O
construct	O
was	O
engineered	O
by	O
combining	O
sequences	O
from	O
the	O
p53GFP	O
exchange	O
plasmid	O
and	O
sequences	O
from	O
the	O
p53	O
Delta	O
P	O
targeting	O
construct	O
described	O
recently	O
(	O
5	O
)	O
.	O

Its	O
sequence	O
was	O
also	O
verified	O
before	O
use	O
.	O

Sequences	O
and	O
use	O
of	O
PCR	O
primers	O

a	O
:	O
5	O
'	O
-	O
CCCCGGCCCTCACCCTCATCTTCG	O
-	O
3	O
'	O
,	O
from	O
the	O
Pu	O
Delta	O
TK	O
gene	O
,	O
assays	O
targeting	O
of	O
Flox	O
plasmid	O
;	O
b	O
:	O
5	O
'	O
-	O
AACAAAACAAAACAGCAGCAACAA	O
-	O
3	O
'	O
,	O
from	O
sequences	O
downstream	O
of	O
the	O
p53	O
gene	O
and	O
outside	O
Flox	O
sequences	O
,	O
assays	O
targeting	O
of	O
Flox	O
and	O
RMCE	O
with	O
p53GFP	O
or	O
p53	O
Delta	O
PGFP	O
plasmids	O
;	O
c	O
:	O
5	O
'	O
-	O
TGAAGAGCAAGGGCGTGGTGAAGGA	O
-	O
3	O
'	O
,	O
from	O
GFP	O
sequences	O
,	O
assays	O
RMCE	O
with	O
p53GFP	O
orp53	O
Delta	O
PGFP	O
plasmids	O
;	O
d	O
:	O
5	O
'	O
-	O
CAAAAAATGGAAGGAAATCAGGAACTAA	O
-	O
3	O
'	O
,	O
from	O
p53	O
intron	O
3	O
,	O
and	O
e	O
:	O
5	O
'	O
-	O
TCTAGACAGAGAAAAAAGAGGCATT	O
-	O
3	O
'	O
,	O
from	O
p53	O
intron	O
4	O
,	O
assay	O
RMCE	O
with	O
p53	O
Delta	O
PGFP	O
plasmid	O
;	O
f	O
:	O
5	O
'	O
-	O
ATGGGAGGCTGCCAGTCCTAACCC	O
and	O
g	O
:	O
5	O
'	O
-	O
GTGTTTCATTAGTTCCCCACCTTGAC	O
-	O
3	O
'	O
amplify	O
the	O
WT	O
p53	O
allele	O
according	O
to	O
Taconic	O
'	O
s	O
procedures	O
,	O
h	O
:	O
5	O
'	O
-	O
TTTACGGAGCCCTGGCGCTCGATGT	O
-	O
3	O
'	O
and	O
i	O
:	O
5	O
'	O
-	O
GTGGGAGGGACAAAAGTTCGAGGCC	O
-	O
3	O
'	O
amplify	O
the	O
Neo	O
marker	O
in	O
the	O
p53	O
KO	O
allele	O
according	O
to	O
Taconic	O
'	O
s	O
procedures	O
.	O

Cell	O
culture	O
conditions	O

Primary	O
MEFs	O
,	O
isolated	O
from	O
13	O
.	O
5	O
day	O
embryos	O
,	O
were	O
cultured	O
in	O
DMEM	O
with	O
15	O
%	O
FBS	O
,	O
100	O
mM	O
BME	O
,	O
2	O
mM	O
l	B-CHEBI
-	I-CHEBI
glutamine	I-CHEBI
and	O
antibiotics	B-CHEBI
.	O

129	O
/	O
SvJae	O
ES	O
cells	O
were	O
grown	O
in	O
the	O
same	O
medium	O
supplemented	O
with	O
1000	O
U	O
/	O
ml	O
ESGRO	O
(	O
Chemicon	O
)	O
,	O
on	O
a	O
layer	O
of	O
mitomycin	B-CHEBI
C	I-CHEBI
-	O
treated	O
SNLPuro	O
-	O
7	O
/	O
4	O
feeders	O
(	O
kind	O
gift	O
of	O
A	O
.	O
Bradley	O
)	O
.	O

Selections	O
were	O
performed	O
with	O
2	O
mu	O
g	O
/	O
ml	O
puromycin	B-CHEBI
,	O
0	O
.	O
2	O
mu	O
M	O
FIAU	O
or	O
2	O
mu	O
M	O
ganciclovir	O
.	O

Targeting	O
/	O
genotyping	O
of	O
the	O
RMCE	O
-	O
ready	O
locus	O

29	O
/	O
SvJae	O
ES	O
cells	O
were	O
electroporated	O
with	O
the	O
Flox	O
construct	O
linearized	O
with	O
PmeI	O
,	O
and	O
puromycin	B-CHEBI
resistant	O
clones	O
were	O
analyzed	O
as	O
described	O
(	O
Figure	O
2	O
)	O
.	O

Two	O
clones	O
were	O
injected	O
into	O
blastocysts	O
and	O
transmitted	O
through	O
the	O
germline	O
.	O

Performing	O
RMCE	O
in	O
ES	O
cells	O

A	O
total	O
of	O
8	O
x	O
105	O
p53RMCE	O
/	O
+	O
ES	O
cells	O
were	O
grown	O
without	O
puromycin	B-CHEBI
for	O
12	O
h	O
,	O
electroporated	O
with	O
15	O
mu	O
g	O
CMV	O
-	O
Cre	O
plasmid	O
(	O
pOG231	O
)	O
and	O
200	O
mu	O
g	O
of	O
the	O
exchange	O
construct	O
,	O
and	O
plated	O
in	O
T25	O
flasks	O
at	O
105	O
cells	O
per	O
flask	O
.	O

FIAU	O
was	O
added	O
to	O
the	O
medium	O
3	O
-	O
4	O
days	O
after	O
electroporation	O
.	O

Individual	O
clones	O
,	O
picked	O
10	O
days	O
after	O
electroporation	O
,	O
were	O
grown	O
in	O
96	O
-	O
well	O
plates	O
and	O
expanded	O
to	O
generate	O
duplicate	O
plates	O
for	O
freezing	O
and	O
DNA	O
analysis	O
by	O
PCR	O
and	O
Southern	O
.	O

Performing	O
RMCE	O
in	O
MEFs	O

A	O
total	O
of	O
106	O
p53RMCE	O
/	O
-	O
MEFs	O
cells	O
were	O
grown	O
without	O
puromycin	B-CHEBI
for	O
12	O
h	O
,	O
electroporated	O
with	O
3	O
mu	O
g	O
pOG231	O
and	O
30	O
mu	O
g	O
exchange	O
construct	O
,	O
and	O
plated	O
in	O
a	O
single	O
10	O
cm	O
-	O
dish	O
,	O
grown	O
for	O
3	O
days	O
then	O
split	O
in	O
several	O
dishes	O
at	O
105	O
cells	O
per	O
dish	O
.	O

FIAU	O
or	O
ganciclovir	O
was	O
added	O
to	O
the	O
medium	O
4	O
days	O
after	O
electroporation	O
,	O
for	O
3	O
-	O
4	O
days	O
.	O

Clones	O
,	O
picked	O
10	O
days	O
after	O
electroporation	O
,	O
were	O
grown	O
in	O
24	O
-	O
well	O
plates	O
and	O
expanded	O
for	O
freezing	O
and	O
DNA	O
analysis	O
.	O

Western	O
-	O
blots	O

Cells	O
,	O
untreated	O
or	O
treated	O
for	O
24	O
h	O
with	O
0	O
.	O
5	O
mu	O
g	O
/	O
ml	O
adriamycin	B-CHEBI
,	O
were	O
lysed	O
on	O
the	O
dish	O
in	O
a	O
buffer	O
consisting	O
of	O
50	O
mM	O
Tris	B-CHEBI
(	O
pH	O
8	O
.	O
0	O
)	O
,	O
5	O
mM	O
EDTA	B-CHEBI
,	O
150	O
mM	O
NaCl	B-CHEBI
,	O
0	O
.	O
5	O
%	O
Nonidet	O
P	O
-	O
40	O
,	O
1	O
mM	O
PMSF	B-CHEBI
,	O
1	O
mM	O
sodium	B-CHEBI
vanadate	I-CHEBI
,	O
10	O
mM	O
NaF	B-CHEBI
and	O
Complete	O
Mini	O
Protease	B-CHEBI
Inhibitors	I-CHEBI
(	O
Roche	O
Diagnostics	O
)	O
at	O
4	O
degrees	O
C	O
for	O
30	O
min	O
.	O

Lysates	O
were	O
scraped	O
,	O
then	O
spun	O
at	O
6000	O
x	O
g	O
at	O
4	O
degrees	O
C	O
for	O
10	O
min	O
.	O

Protein	B-CHEBI
concentration	O
in	O
the	O
supernatant	O
was	O
determined	O
using	O
the	O
Bio	O
-	O
Rad	O
DC	O
protein	B-CHEBI
assay	O
.	O

Lysates	O
were	O
separated	O
on	O
single	O
percentage	O
SDS	B-CHEBI
/	O
PAGE	O
gels	O
,	O
then	O
electrophoretically	O
transferred	O
to	O
poly	O
(	O
vinylidene	O
difluoride	O
)	O
,	O
using	O
standard	O
procedures	O
.	O
Blots	O
were	O
incubated	O
in	O
5	O
%	O
non	O
-	O
fat	O
dried	O
milk	O
in	O
TBST	O
(	O
0	O
.	O
02	O
M	O
Tris	B-CHEBI
,	O
pH	O
7	O
.	O
6	O
/	O
0	O
.	O
35	O
M	O
NaCl	B-CHEBI
/	O
0	O
.	O
1	O
%	O
Tween	O
-	O
20	O
)	O
for	O
1	O
h	O
at	O
room	O
temperature	O
before	O
probing	O
with	O
primary	O
antibodies	O
against	O
p53	O
(	O
CM	O
-	O
5	O
,	O
Novacastra	O
)	O
and	O
-	O
actin	O
(	O
Sigma	O
)	O
.	O

Secondary	O
antibodies	O
used	O
include	O
peroxidase	O
-	O
conjugated	O
goat	O
anti	O
-	O
mouse	O
IgG	O
and	O
anti	O
-	O
rabbit	O
IgG	O
(	O
Pierce	O
)	O
.	O

Probed	O
blots	O
were	O
incubated	O
with	O
Pierce	O
Supersignal	O
West	O
Pico	O
chemiluminescent	O
substrate	O
and	O
exposed	O
to	O
X	O
-	O
ray	O
films	O
.	O

Flow	O
cytometry	O

Log	O
phase	O
cells	O
were	O
irradiated	O
at	O
RT	O
with	O
a	O
60	O
Co	O
gamma	O
-	O
irradiator	O
at	O
doses	O
of	O
6	O
or	O
12	O
Gy	O
and	O
incubated	O
for	O
24	O
h	O
.	O

Cells	O
were	O
then	O
pulse	O
-	O
labeled	O
for	O
1	O
h	O
with	O
BrdU	O
(	O
10	O
mu	O
M	O
)	O
,	O
fixed	O
in	O
70	O
%	O
ethanol	B-CHEBI
,	O
double	O
-	O
stained	O
with	O
FITC	B-CHEBI
anti	O
-	O
BrdU	O
and	O
propidium	O
iodide	B-CHEBI
,	O
then	O
sorted	O
by	O
using	O
a	O
Becton	O
Dickinson	O
FACScan	O
machine	O
.	O

Data	O
were	O
analyzed	O
using	O
Becton	O
Dickinson	O
Cellquest	O
Pro	O
.	O

RESULTS	O
AND	O
DISCUSSION	O

The	O
rationale	O
for	O
RMCE	O
-	O
ASAP	O
is	O
detailed	O
in	O
Figure	O
1	O
.	O

The	O
first	O
step	O
requires	O
generating	O
a	O
floxed	O
allele	O
in	O
ES	O
cells	O
that	O
will	O
serve	O
as	O
the	O
substrate	O
for	O
subsequent	O
exchanges	O
(	O
RMCE	O
-	O
ready	O
ES	O
cell	O
,	O
Figure	O
1	O
)	O
.	O

The	O
targeting	O
strategy	O
is	O
detailed	O
in	O
Figure	O
2	O
.	O

The	O
frequency	O
of	O
targeting	O
was	O
4	O
%	O
(	O
12	O
/	O
300	O
puromycin	B-CHEBI
-	O
resistant	O
clones	O
,	O
analyzed	O
by	O
Southern	O
blot	O
and	O
long	O
-	O
range	O
PCR	O
,	O
Figure	O
2	O
)	O
.	O

We	O
next	O
tested	O
the	O
efficiency	O
of	O
RMCE	O
in	O
ES	O
cells	O
,	O
using	O
a	O
replacement	O
construct	O
encoding	O
p53	O
fused	O
to	O
GFP	O
(	O
p53GFP	O
)	O
to	O
enable	O
tracking	O
p53	O
in	O
individual	O
live	O
cells	O
.	O

Importantly	O
however	O
,	O
GFP	O
fluorescence	O
was	O
not	O
used	O
to	O
screen	O
cells	O
with	O
targeted	O
events	O
,	O
as	O
we	O
wanted	O
to	O
develop	O
a	O
general	O
method	O
to	O
isolate	O
marker	O
-	O
free	O
recombinants	O
.	O

The	O
exchange	O
strategy	O
is	O
detailed	O
in	O
Figure	O
3A	O
.	O

We	O
picked	O
65	O
ES	O
cell	O
clones	O
resistant	O
to	O
1	O
-	O
(	O
-	O
2	O
-	O
deoxy	O
-	O
2	O
-	O
fluoro	B-CHEBI
-	O
1	O
-	O
b	O
-	O
d	O
-	O
arabino	O
-	O
furanosyl	O
)	O
-	O
5	B-CHEBI
-	I-CHEBI
iodouracil	I-CHEBI
(	O
FIAU	O
)	O
due	O
to	O
TK	O
loss	O
and	O
analyzed	O
their	O
DNA	O
by	O
PCR	O
and	O
Southern	O
blot	O
.	O

Strikingly	O
,	O
54	O
proper	O
recombinants	O
were	O
identified	O
,	O
indicating	O
very	O
high	O
RMCE	O
efficiency	O
(	O
83	O
%	O
)	O
.	O

RMCE	O
also	O
proved	O
to	O
be	O
precise	O
,	O
as	O
no	O
aberrant	O
bands	O
were	O
detected	O
in	O
PCR	O
and	O
Southern	O
blots	O
(	O
Figure	O
3A	O
)	O
.	O

p53	O
+	O
/	O
GFP	O
ES	O
clones	O
were	O
analyzed	O
by	O
western	O
blot	O
with	O
an	O
antibody	O
against	O
p53	O
,	O
and	O
found	O
to	O
express	O
an	O
additional	O
band	O
at	O
the	O
expected	O
size	O
(	O
ca	O
.	O
80	O
kDa	O
)	O
.	O

Surprisingly	O
,	O
the	O
fusion	O
of	O
GFP	O
to	O
p53	O
apparently	O
altered	O
p53	O
stability	O
:	O
steady	O
-	O
state	O
levels	O
of	O
p53GFP	O
were	O
much	O
higher	O
than	O
those	O
of	O
wild	O
-	O
type	O
p53	O
(	O
p53WT	O
)	O
in	O
unstressed	O
cells	O
,	O
and	O
did	O
not	O
vary	O
significantly	O
after	O
DNA	O
damage	O
,	O
so	O
that	O
the	O
levels	O
for	O
both	O
p53WT	O
and	O
p53GFP	O
were	O
similar	O
after	O
adriamycin	B-CHEBI
treatment	O
(	O
Figure	O
3A	O
)	O
.	O

Six	O
independent	O
p53	O
+	O
/	O
GFP	O
clones	O
were	O
injected	O
into	O
blastocysts	O
and	O
transferred	O
to	O
pseudo	O
-	O
pregnant	O
females	O
using	O
standard	O
procedures	O
.	O

Strikingly	O
,	O
no	O
pregnancies	O
were	O
obtained	O
.	O

It	O
has	O
been	O
shown	O
that	O
the	O
p53	O
pathway	O
is	O
regulated	O
very	O
differently	O
in	O
ES	O
and	O
somatic	O
cells	O
:	O
ES	O
cells	O
contain	O
relatively	O
high	O
p53	O
levels	O
and	O
lack	O
the	O
p53	O
-	O
mediated	O
DNA	O
damage	O
responses	O
found	O
in	O
somatic	O
cells	O
(	O
18	O
)	O
.	O

This	O
,	O
together	O
with	O
the	O
observation	O
that	O
p53	O
levels	O
decrease	O
during	O
mouse	O
embryogenesis	O
(	O
19	O
)	O
,	O
suggested	O
an	O
explanation	O
for	O
the	O
observed	O
lack	O
of	O
pregnancies	O
:	O
we	O
speculate	O
that	O
the	O
high	O
levels	O
of	O
p53GFP	O
in	O
the	O
ES	O
cells	O
injected	O
into	O
blastocysts	O
might	O
have	O
prevented	O
normal	O
embryonic	O
development	O
once	O
these	O
cells	O
began	O
to	O
differentiate	O
and	O
the	O
p53	O
pathway	O
became	O
functional	O
.	O

To	O
test	O
this	O
possibility	O
,	O
we	O
performed	O
RMCE	O
with	O
a	O
p53	O
fusion	O
gene	O
in	O
which	O
the	O
p53	O
proline	B-CHEBI
-	O
rich	O
domain	O
(	O
PRD	O
)	O
was	O
deleted	O
(	O
p53	O
Delta	O
P	O
)	O
,	O
and	O
the	O
p53	O
Delta	O
P	O
was	O
fused	O
to	O
GFP	O
.	O

We	O
used	O
this	O
mutant	O
because	O
deleting	O
the	O
proline	B-CHEBI
-	O
rich	O
domain	O
decreases	O
stability	O
and	O
compromises	O
DNA	O
-	O
damage	O
responses	O
in	O
vivo	O
(	O
5	O
)	O
.	O

According	O
to	O
our	O
hypothesis	O
,	O
this	O
hypomorphic	O
mutant	O
should	O
not	O
prevent	O
embryonic	O
development	O
.	O

RMCE	O
with	O
a	O
p53	O
Delta	O
PGFP	O
replacement	O
plasmid	O
was	O
again	O
very	O
efficient	O
and	O
western	O
blots	O
revealed	O
an	O
additional	O
band	O
of	O
the	O
predicted	O
molecular	B-CHEBI
weight	O
only	O
in	O
p53	O
+	O
/	O
Delta	O
PGFP	O
ES	O
cells	O
(	O
Figure	O
3B	O
)	O
.	O

As	O
expected	O
,	O
the	O
PRD	O
deletion	O
correlated	O
with	O
lower	O
expression	O
levels	O
:	O
p53	O
Delta	O
PGFP	O
was	O
much	O
less	O
abundant	O
than	O
p53WT	O
in	O
all	O
p53	O
+	O
/	O
Delta	O
PGFP	O
clones	O
(	O
Figure	O
3B	O
)	O
.	O

We	O
next	O
determined	O
whether	O
p53	O
+	O
/	O
Delta	O
PGFP	O
ES	O
cells	O
could	O
generate	O
chimeric	O
mice	O
and	O
transmit	O
the	O
modified	O
allele	O
through	O
the	O
germline	O
.	O

Two	O
p53	O
+	O
/	O
Delta	O
PGFP	O
ES	O
cell	O
clones	O
were	O
injected	O
into	O
blastocysts	O
and	O
highly	O
chimeric	O
(	O
>	O
80	O
%	O
)	O
mice	O
were	O
obtained	O
.	O

Heterozygote	O
pups	O
were	O
recovered	O
from	O
the	O
mating	O
the	O
chimeras	O
with	O
WT	O
mice	O
(	O
Figure	O
3C	O
)	O
.	O

These	O
data	O
demonstrate	O
that	O
marker	O
-	O
free	O
RMCE	O
is	O
very	O
efficient	O
in	O
ES	O
cells	O
and	O
allows	O
germline	O
transmission	O
of	O
a	O
targeted	O
mutation	O
(	O
see	O
Figure	O
1	O
,	O
path	O
A	O
)	O
.	O

We	O
next	O
determined	O
whether	O
the	O
RMCE	O
approach	O
could	O
be	O
used	O
to	O
target	O
mutations	O
at	O
the	O
p53	O
allele	O
in	O
somatic	O
cells	O
(	O
Figure	O
1	O
,	O
path	O
B	O
)	O
.	O

We	O
first	O
verified	O
that	O
the	O
RMCE	O
-	O
ready	O
p53	O
locus	O
(	O
p53RMCE	O
)	O
could	O
be	O
transmitted	O
through	O
the	O
germline	O
by	O
mating	O
p53RMCE	O
/	O
+	O
chimeras	O
with	O
p53	O
+	O
/	O
-	O
mice	O
(	O
20	O
)	O
(	O
Figure	O
4	O
)	O
.	O

Importantly	O
,	O
this	O
allowed	O
us	O
to	O
generate	O
p53RMCE	O
/	O
-	O
MEFs	O
,	O
which	O
were	O
used	O
to	O
test	O
RMCE	O
at	O
the	O
p53	O
locus	O
in	O
somatic	O
cells	O
.	O

We	O
first	O
attempted	O
RMCE	O
in	O
MEFs	O
by	O
electroporating	O
p53RMCE	O
/	O
-	O
MEFs	O
with	O
a	O
Cre	O
-	O
expression	O
plasmid	O
and	O
the	O
p53GFP	O
plasmid	O
,	O
followed	O
by	O
selection	O
with	O
FIAU	O
or	O
ganciclovir	O
.	O

Strikingly	O
,	O
no	O
clones	O
with	O
an	O
exchanged	O
allele	O
were	O
identified	O
(	O
data	O
not	O
shown	O
)	O
.	O

RMCE	O
with	O
p53GFP	O
in	O
ES	O
cells	O
showed	O
that	O
p53GFP	O
is	O
expressed	O
at	O
high	O
levels	O
(	O
Figure	O
3A	O
)	O
,	O
and	O
as	O
mentioned	O
before	O
,	O
the	O
p53	O
pathway	O
that	O
can	O
be	O
activated	O
in	O
MEFs	O
is	O
not	O
readily	O
activated	O
in	O
ES	O
cells	O
(	O
18	O
)	O
.	O

The	O
results	O
above	O
suggest	O
that	O
high	O
levels	O
of	O
p53GFP	O
could	O
be	O
tolerated	O
by	O
ES	O
cells	O
but	O
toxic	B-CHEBI
to	O
MEFs	O
,	O
so	O
that	O
MEFs	O
in	O
which	O
an	O
RMCE	O
had	O
occurred	O
failed	O
to	O
proliferate	O
.	O

To	O
test	O
this	O
possibility	O
,	O
p53RMCE	O
/	O
-	O
MEFs	O
were	O
electroporated	O
with	O
the	O
p53GFP	O
replacement	O
construct	O
with	O
or	O
without	O
a	O
Cre	O
-	O
expression	O
plasmid	O
,	O
then	O
analyzed	O
by	O
fluorescence	O
microscopy	O
48	O
h	O
after	O
electroporation	O
.	O

The	O
experiment	O
was	O
done	O
without	O
selection	O
to	O
enable	O
observation	O
of	O
cells	O
under	O
conditions	O
where	O
a	O
failure	O
to	O
proliferate	O
would	O
not	O
derive	O
from	O
FIAU	O
or	O
ganciclovir	O
toxicity	O
but	O
rather	O
solely	O
from	O
the	O
effects	O
of	O
p53GFP	O
.	O

We	O
observed	O
a	O
few	O
fluorescent	O
cells	O
only	O
when	O
the	O
Cre	O
expression	O
plasmid	O
was	O
co	O
-	O
electroporated	O
,	O
suggesting	O
that	O
such	O
cells	O
resulted	O
from	O
RMCE	O
.	O

Importantly	O
,	O
the	O
rare	O
fluorescent	O
cells	O
had	O
a	O
flat	O
,	O
'	O
fried	O
-	O
egg	O
'	O
appearance	O
typical	O
of	O
senescent	O
cells	O
(	O
Figure	O
5A	O
)	O
,	O
and	O
when	O
plates	O
were	O
observed	O
5	O
days	O
later	O
,	O
the	O
cells	O
had	O
detached	O
.	O

Altogether	O
,	O
the	O
results	O
suggest	O
that	O
RMCE	O
can	O
give	O
rise	O
to	O
p53GFP	O
-	O
expressing	O
MEFs	O
,	O
but	O
they	O
die	O
rapidly	O
owing	O
to	O
p53GFP	O
toxicity	O
.	O

We	O
also	O
performed	O
RMCE	O
in	O
p53RMCE	O
/	O
-	O
MEFs	O
with	O
the	O
p53	O
Delta	O
PGFP	O
construct	O
.	O

p53	O
Delta	O
PGFP	O
-	O
expressing	O
MEFs	O
were	O
viable	O
,	O
recovered	O
with	O
an	O
efficiency	O
of	O
~	O
40	O
%	O
,	O
and	O
,	O
as	O
expected	O
from	O
ES	O
cell	O
experiments	O
,	O
expressed	O
a	O
p53	O
Delta	O
PGFP	O
protein	B-CHEBI
at	O
much	O
lower	O
levels	O
than	O
p53WT	O
(	O
Figure	O
5B	O
)	O
.	O

Unlike	O
WT	O
MEFs	O
,	O
p53	O
Delta	O
P	O
/	O
Delta	O
P	O
MEFs	O
are	O
unable	O
to	O
arrest	O
cycling	O
after	O
irradiation	O
(	O
5	O
)	O
.	O

Likewise	O
,	O
we	O
found	O
that	O
irradiation	O
doses	O
that	O
arrested	O
p53RMCE	O
/	O
-	O
MEFs	O
(	O
which	O
express	O
a	O
wild	O
-	O
type	O
p53	O
from	O
the	O
RMCE	O
-	O
ready	O
locus	O
,	O
see	O
Figure	O
2	O
)	O
did	O
not	O
arrest	O
p53	O
Delta	O
PGFP	O
/	O
-	O
MEFs	O
(	O
Figure	O
5C	O
)	O
.	O

These	O
data	O
show	O
that	O
a	O
single	O
RMCE	O
-	O
ASAP	O
reaction	O
in	O
heterozygous	O
MEFs	O
enables	O
detection	O
of	O
a	O
recessive	O
phenotype	O
.	O

The	O
results	O
confirm	O
that	O
deleting	O
the	O
proline	B-CHEBI
rich	O
domain	O
leads	O
to	O
less	O
active	O
p53	O
with	O
impaired	O
cell	O
cycle	O
control	O
,	O
and	O
also	O
indicate	O
that	O
a	O
GFP	O
C	B-CHEBI
-	O
terminal	O
fusion	O
can	O
dramatically	O
alter	O
p53	O
regulation	O
.	O

A	O
summary	O
of	O
our	O
results	O
is	O
presented	O
in	O
Table	O
1	O
.	O

These	O
data	O
report	O
the	O
development	O
and	O
implementation	O
of	O
an	O
improved	O
RMCE	O
approach	O
that	O
enables	O
efficient	O
allele	O
modification	O
in	O
ES	O
cells	O
to	O
generate	O
mice	O
and	O
in	O
heterozygous	O
MEFs	O
to	O
accelerate	O
phenotypic	O
analyses	O
.	O

The	O
success	O
of	O
RMCE	O
-	O
ASAP	O
relied	O
on	O
the	O
integrated	O
use	O
of	O
inverted	O
heterologous	O
loxP	O
sites	O
,	O
a	O
positive	O
/	O
negative	O
selection	O
marker	O
that	O
preserves	O
the	O
germline	O
capacity	O
of	O
ES	O
cells	O
,	O
and	O
,	O
for	O
somatic	O
cells	O
,	O
the	O
existence	O
of	O
a	O
knock	O
-	O
out	O
allele	O
of	O
the	O
gene	O
of	O
interest	O
.	O

These	O
characteristics	O
should	O
make	O
RMCE	O
-	O
ASAP	O
a	O
robust	O
and	O
general	O
technology	O
for	O
analysis	O
of	O
mammalian	O
genes	O
under	O
conditions	O
that	O
preserve	O
normal	O
control	O
mechanisms	O
in	O
different	O
tissues	O
.	O

In	O
addition	O
,	O
RMCE	O
-	O
ASAP	O
could	O
be	O
used	O
to	O
generate	O
fibroblastic	O
cell	O
lines	O
tailored	O
for	O
the	O
repeated	O
targeting	O
of	O
widely	O
studied	O
genes	O
(	O
p53	O
,	O
c	O
-	O
myc	O
,	O
NF	O
-	O
KB	O
,	O
etc	O
.	O
)	O
.	O

Acknowledgements	O

The	O
authors	O
thank	O
A	O
.	O

Bradley	O
for	O
the	O
Puro	O
Delta	O
TK	O
gene	O
and	O
SNLPuro	O
-	O
7	O
/	O
4	O
cells	O
,	O
P	O
Soriano	O
for	O
the	O
DTA	O
gene	O
,	O
G	O
.	O

Campbell	O
for	O
technical	O
assistance	O
and	O
E	O
.	O

T	O
.	O

Wong	O
for	O
helpful	O
discussions	O
.	O

The	O
work	O
was	O
supported	O
by	O
NIH	O
grants	O
CA100845	O
and	O
CA061449	O
to	O
G	O
.	O
M	O
.	O
W	O
.	O

F	O
.	O
T	O
.	O
was	O
supported	O
in	O
part	O
by	O
the	O
Institut	O
Pasteur	O
and	O
a	O
fellowship	O
from	O
Association	O
pour	O
la	O
Recherche	O
sur	O
le	O
Cancer	O
.	O

Funding	O
to	O
pay	O
the	O
Open	O
Access	O
publication	O
charges	O
for	O
this	O
article	O
was	O
provided	O
by	O
the	O
Institut	O
Pasteur	O
.	O

Conflict	O
of	O
interest	O
statement	O
.	O

None	O
declared	O
.	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Rationale	O
for	O
a	O
RMCE	O
-	O
ASAP	O
.	O

Using	O
homologous	O
recombination	O
,	O
the	O
gene	O
of	O
interest	O
(	O
GOI	O
,	O
open	O
boxes	O
:	O
exons	O
)	O
,	O
is	O
targeted	O
with	O
a	O
construct	O
introducing	O
upstream	O
of	O
coding	O
regions	O
one	O
loxP	O
(	O
blue	O
arrowhead	O
)	O
and	O
downstream	O
,	O
a	O
positive	O
/	O
negative	O
selection	O
cassette	O
(	O
red	O
box	O
)	O
and	O
a	O
second	O
inverted	O
heterologous	O
loxP	O
(	O
purple	O
arrowhead	O
)	O
to	O
create	O
RMCE	O
-	O
ready	O
ES	O
cells	O
.	O

An	O
exchange	O
is	O
performed	O
in	O
these	O
cells	O
by	O
co	O
-	O
transfecting	O
a	O
Cre	O
expression	O
plasmid	O
and	O
a	O
marker	O
-	O
free	O
plasmid	O
with	O
a	O
floxed	O
mutant	O
GOI	O
(	O
green	O
box	O
:	O
mutated	O
exon	O
)	O
,	O
to	O
produce	O
a	O
mutant	O
mouse	O
(	O
path	O
A	O
)	O
.	O

Importantly	O
RMCE	O
-	O
ASAP	O
incorporates	O
two	O
major	O
improvements	O
over	O
classical	O
RMCE	O
(	O
path	O
B	O
)	O
:	O
(	O
i	O
)	O
the	O
positive	O
/	O
negative	O
selection	O
cassette	O
does	O
not	O
prevent	O
germline	O
transmission	O
,	O
so	O
that	O
RMCE	O
-	O
ready	O
mice	O
can	O
be	O
obtained	O
;	O
(	O
ii	O
)	O
the	O
selection	O
cassette	O
does	O
not	O
replace	O
,	O
but	O
rather	O
lies	O
downstream	O
of	O
the	O
GOI	O
.	O

This	O
is	O
a	O
crucial	O
requirement	O
for	O
accelerated	O
phenotyping	O
in	O
somatic	O
cells	O
,	O
as	O
maintaining	O
a	O
functional	O
GOI	O
ensures	O
that	O
the	O
RMCE	O
-	O
ready	O
locus	O
still	O
behaves	O
like	O
a	O
WT	O
locus	O
.	O

Hence	O
,	O
after	O
breeding	O
the	O
RMCE	O
-	O
ready	O
mouse	O
with	O
mice	O
heterozygotes	O
for	O
the	O
GOI	O
,	O
somatic	O
cells	O
with	O
an	O
RMCE	O
-	O
ready	O
locus	O
and	O
a	O
WT	O
or	O
KO	O
allele	O
can	O
be	O
recovered	O
[	O
e	O
.	O
g	O
.	O
RMCE	O
/	O
+	O
and	O
RMCE	O
/	O
-	O
mouse	O
embryonic	O
fibroblasts	O
(	O
MEFs	O
)	O
]	O
.	O

Such	O
cells	O
,	O
phenotypically	O
similar	O
to	O
+	O
/	O
+	O
and	O
+	O
/	O
-	O
cells	O
,	O
can	O
then	O
be	O
used	O
for	O
phenotypic	O
analyses	O
of	O
dominant	O
or	O
recessive	O
mutations	O
after	O
a	O
single	O
exchange	O
.	O

Figure	O
2	O

Generating	O
ES	O
cells	O
with	O
a	O
p53	O
RMCE	O
-	O
ready	O
locus	O
.	O

The	O
p53	O
gene	O
is	O
contained	O
in	O
a	O
17	O
kb	O
-	O
long	O
EcoRI	O
(	O
RI	O
)	O
fragment	O
(	O
black	O
boxes	O
:	O
coding	O
sequences	O
,	O
white	O
boxes	O
:	O
UTRs	O
)	O
.	O

The	O
Flox	O
targeting	O
construct	O
(	O
below	O
)	O
,	O
the	O
sequence	O
which	O
was	O
verified	O
before	O
use	O
(	O
Materials	O
and	O
Methods	O
)	O
,	O
contains	O
(	O
i	O
)	O
a	O
3	O
.	O
4	O
kb	O
-	O
long	O
5	O
'	O
homology	O
region	O
;	O
(	O
ii	O
)	O
0	O
.	O
2	O
kb	O
upstream	O
of	O
coding	O
sequences	O
,	O
an	O
EcoRI	O
site	O
and	O
L3	O
,	O
a	O
mutant	O
loxP	O
[	O
loxP257	O
,	O
(	O
14	O
)	O
]	O
;	O
(	O
iii	O
)	O
p53	O
exons	O
;	O
(	O
iv	O
)	O
0	O
.	O
4	O
kb	O
downstream	O
,	O
a	O
puro	O
Delta	O
TK	O
fusion	O
gene	O
(	O
puDTK	O
)	O
for	O
positive	O
/	O
negative	O
selection	O
(	O
21	O
)	O
and	O
an	O
inverted	O
WT	O
loxP	O
(	O
1L	O
)	O
;	O
(	O
v	O
)	O
a	O
1	O
.	O
2	O
kb	O
-	O
long	O
3	O
'	O
homology	O
region	O
and	O
(	O
vi	O
)	O
the	O
diphteria	O
alpha	O
-	O
toxin	B-CHEBI
(	O
DTA	O
)	O
gene	O
for	O
targeting	O
enrichment	O
.	O

The	O
recombinants	O
resulting	O
from	O
the	O
depicted	O
crossing	O
-	O
overs	O
are	O
identified	O
by	O
a	O
6	O
.	O
5	O
kb	O
band	O
in	O
Southern	O
blot	O
with	O
probe	O
A	O
and	O
a	O
3	O
kb	O
band	O
by	O
PCR	O
with	O
primers	O
a	O
and	O
b	O
.	O

A	O
representative	O
Southern	O
,	O
and	O
PCR	O
of	O
one	O
positive	O
(	O
beta	O
)	O
and	O
two	O
negative	O
clones	O
,	O
are	O
shown	O
.	O

Figure	O
3	O

Performing	O
RMCE	O
in	O
ES	O
cells	O
.	O

(	O
A	O
)	O
RMCE	O
with	O
a	O
p53GFP	O
plasmid	O
.	O

The	O
exchange	O
plasmid	O
,	O
the	O
sequence	O
which	O
was	O
verified	O
before	O
use	O
,	O
contains	O
p53GFP	O
coding	O
sequences	O
flanked	O
by	O
L3	O
and	O
1L	O
sites	O
.	O

It	O
was	O
electroporated	O
with	O
a	O
Cre	O
expression	O
plasmid	O
.	O

FIAU	O
-	O
resistant	O
clones	O
were	O
analyzed	O
by	O
PCR	O
with	O
primers	O
b	O
and	O
c	O
and	O
Southern	O
blot	O
with	O
probe	O
B	O
.	O

Both	O
approaches	O
led	O
to	O
identical	O
results	O
and	O
identified	O
54	O
/	O
65	O
RMCE	O
recombinants	O
.	O

Representative	O
clones	O
(	O
P	O
-	O
Z	O
)	O
are	O
shown	O
(	O
left	O
)	O
,	O
analyzed	O
by	O
PCR	O
(	O
top	O
)	O
and	O
Southern	O
(	O
bottom	O
)	O
:	O
all	O
clones	O
but	O
Q	O
and	O
T	O
are	O
positive	O
with	O
both	O
assays	O
.	O

All	O
positive	O
clones	O
produced	O
a	O
band	O
of	O
the	O
expected	O
size	O
by	O
PCR	O
,	O
indicating	O
correct	O
recombination	O
at	O
1L	O
,	O
and	O
displayed	O
only	O
the	O
expected	O
12	O
and	O
5	O
kb	O
bands	O
by	O
Southern	O
,	O
indicating	O
correct	O
recombination	O
at	O
L3	O
.	O

The	O
absence	O
of	O
bands	O
of	O
aberrant	O
size	O
in	O
Southerns	O
also	O
indicated	O
that	O
the	O
exchange	O
plasmid	O
was	O
neither	O
rearranged	O
nor	O
inserted	O
at	O
ectopic	O
sites	O
.	O

Thus	O
RMCE	O
was	O
efficient	O
and	O
accurate	O
.	O

Recombinant	O
clones	O
were	O
analyzed	O
by	O
western	O
blot	O
with	O
an	O
antibody	O
to	O
p53	O
.	O

In	O
the	O
representative	O
western	O
(	O
right	O
)	O
,	O
cells	O
from	O
two	O
independent	O
p53	O
+	O
/	O
GFP	O
ES	O
clones	O
were	O
left	O
untreated	O
or	O
treated	O
with	O
adriamycin	B-CHEBI
(	O
ADR	B-CHEBI
)	O
at	O
0	O
.	O
5	O
mu	O
g	O
/	O
ml	O
for	O
24	O
h	O
,	O
and	O
protein	B-CHEBI
extracts	O
were	O
prepared	O
.	O

p53GFP	O
migrated	O
at	O
the	O
expected	O
size	O
of	O
80	O
kDa	O
and	O
was	O
expressed	O
at	O
unexpectedly	O
high	O
levels	O
regardless	O
of	O
stress	O
.	O

(	O
B	O
)	O
RMCE	O
with	O
a	O
p53	O
Delta	O
PGFP	O
plasmid	O
.	O

The	O
p53	O
Delta	O
PGFP	O
exchange	O
construct	O
(	O
which	O
sequence	O
was	O
verified	O
before	O
use	O
)	O
differed	O
from	O
the	O
p53GFP	O
construct	O
only	O
in	O
that	O
it	O
contains	O
a	O
mutated	O
exon	O
4	O
(	O
4	O
*	O
)	O
encoding	O
a	O
PRD	O
deletion	O
.	O

RMCE	O
was	O
again	O
very	O
efficient	O
,	O
with	O
10	O
/	O
12	O
FIAU	O
-	O
resistant	O
clones	O
producing	O
a	O
3	O
kb	O
band	O
by	O
PCR	O
with	O
primers	O
b	O
and	O
c	O
.	O

A	O
western	O
analysis	O
of	O
four	O
FIAU	O
-	O
resistant	O
clones	O
is	O
shown	O
below	O
(	O
with	O
low	O
/	O
high	O
exposures	O
:	O
Lo	O
X	O
/	O
Hi	O
X	O
)	O
.	O

As	O
expected	O
,	O
all	O
except	O
clone	O
x	O
expressed	O
p53	O
Delta	O
PGFP	O
.	O

p53	O
Delta	O
PGFP	O
migrated	O
at	O
the	O
expected	O
size	O
of	O
75	O
kDa	O
and	O
accumulated	O
after	O
stress	O
,	O
but	O
at	O
lower	O
levels	O
than	O
p53WT	O
.	O

(	O
C	O
)	O
Germline	O
transmission	O
of	O
the	O
p53	O
Delta	O
PGFP	O
mutation	O
.	O

DNA	O
of	O
seven	O
littermates	O
(	O
U42	O
-	O
U48	O
)	O
,	O
obtained	O
from	O
mating	O
a	O
p53	O
Delta	O
PGFP	O
chimera	O
with	O
a	O
WT	O
mouse	O
,	O
was	O
analyzed	O
by	O
PCR	O
with	O
primers	O
d	O
and	O
e	O
(	O
see	O
B	O
)	O
,	O
with	O
DNA	O
from	O
WT	O
,	O
p53	O
+	O
/	O
Delta	O
P	O
and	O
p53	O
Delta	O
P	O
/	O
Delta	O
P	O
MEFs	O
(	O
5	O
)	O
as	O
controls	O
.	O

U45	O
,	O
a	O
p53	O
+	O
/	O
Delta	O
PGFP	O
mouse	O
,	O
demonstrated	O
transmission	O
of	O
the	O
mutation	O
.	O

Figure	O
4	O

Germline	O
transmission	O
of	O
the	O
p53	O
RMCE	O
-	O
ready	O
locus	O
.	O

p53RMCE	O
/	O
+	O
ES	O
cells	O
were	O
injected	O
into	O
blastocysts	O
to	O
generate	O
chimeric	O
mice	O
.	O

Chimeras	O
(	O
>	O
80	O
%	O
)	O
were	O
then	O
mated	O
with	O
p53	O
+	O
/	O
-	O
mice	O
(	O
Taconic	O
)	O
and	O
MEFs	O
were	O
prepared	O
.	O

MEFs	O
were	O
first	O
genotyped	O
by	O
PCR	O
with	O
primers	O
a	O
and	O
b	O
(	O
see	O
Figure	O
2	O
)	O
to	O
detect	O
the	O
Puro	O
Delta	O
TK	O
marker	O
of	O
the	O
RMCE	O
allele	O
(	O
top	O
)	O
.	O

This	O
revealed	O
germline	O
transmission	O
of	O
the	O
p53	O
RMCE	O
-	O
ready	O
locus	O
in	O
MEFs	O
1	O
,	O
2	O
and	O
6	O
.	O

Each	O
of	O
these	O
three	O
MEF	O
clones	O
was	O
further	O
analyzed	O
(	O
bottom	O
)	O
with	O
primers	O
f	O
and	O
g	O
(	O
left	O
lanes	O
)	O
and	O
h	O
and	O
i	O
(	O
right	O
lanes	O
)	O
,	O
routinely	O
used	O
to	O
genotype	O
p53	O
+	O
/	O
-	O
mice	O
(	O
sequences	O
in	O
Materials	O
and	O
Methods	O
)	O
.	O

Primers	O
f	O
and	O
g	O
amplify	O
a	O
320	O
bp	O
product	O
from	O
a	O
WT	O
or	O
RMCE	O
allele	O
,	O
while	O
primers	O
h	O
and	O
i	O
specifically	O
amplify	O
a	O
150	O
bp	O
product	O
from	O
the	O
Neo	O
marker	O
in	O
the	O
KO	O
allele	O
.	O

MEF	O
1	O
are	O
p53RMCE	O
/	O
+	O
and	O
MEFs	O
2	O
and	O
6	O
are	O
p53RMCE	O
/	O
-	O
cells	O
.	O

Figure	O
5	O

Performing	O
RMCE	O
in	O
MEFs	O
.	O

(	O
A	O
)	O
RMCE	O
with	O
the	O
p53GFP	O
plasmid	O
leads	O
to	O
the	O
transient	O
observation	O
of	O
cells	O
with	O
intense	O
nuclear	O
fluorescence	O
.	O

p53RMCE	O
/	O
-	O
MEFs	O
,	O
electroporated	O
with	O
a	O
Cre	O
expression	O
plasmid	O
and	O
the	O
p53GFP	O
exchange	O
plasmid	O
,	O
were	O
analyzed	O
48	O
h	O
later	O
by	O
fluorescence	O
microscopy	O
.	O

A	O
typical	O
field	O
(	O
left	O
to	O
right	O
:	O
fluorescence	O
,	O
phase	O
contrast	O
,	O
merged	O
)	O
with	O
a	O
fluorescent	O
cell	O
(	O
arrow	O
)	O
is	O
shown	O
.	O

The	O
fluorescent	O
cell	O
is	O
enlarged	O
(	O
extreme	O
right	O
)	O
.	O

(	O
B	O
)	O
RMCE	O
with	O
the	O
p53	O
Delta	O
PGFP	O
plasmid	O
.	O

p53RMCE	O
/	O
-	O
MEFs	O
,	O
electroporated	O
with	O
a	O
Cre	O
expression	O
plasmid	O
and	O
the	O
p53	O
Delta	O
PGFP	O
plasmid	O
,	O
were	O
selected	O
with	O
ganciclovir	O
.	O

PCR	O
with	O
primers	O
d	O
and	O
e	O
(	O
Figure	O
3B	O
)	O
indicated	O
that	O
9	O
/	O
22	O
ganciclovir	O
-	O
resistant	O
clones	O
integrated	O
the	O
Delta	O
P	O
mutation	O
[	O
top	O
row	O
,	O
a	O
representative	O
analysis	O
of	O
10	O
clones	O
(	O
Q	O
-	O
Z	O
)	O
is	O
shown	O
]	O
.	O

PCR	O
with	O
primers	O
b	O
and	O
c	O
next	O
verified	O
that	O
the	O
detected	O
PRD	O
deletions	O
resulted	O
from	O
RMCE	O
at	O
the	O
p53	O
locus	O
,	O
not	O
random	O
integration	O
(	O
middle	O
row	O
,	O
as	O
expected	O
clones	O
R	O
,	O
S	O
,	O
T	O
and	O
W	O
are	O
positive	O
,	O
but	O
not	O
Q	O
)	O
.	O

Western	O
analysis	O
of	O
positive	O
clones	O
(	O
bottom	O
row	O
)	O
showed	O
that	O
p53	O
Delta	O
PGFP	O
accumulated	O
after	O
ADR	B-CHEBI
,	O
but	O
at	O
lower	O
levels	O
than	O
p53WT	O
.	O

(	O
C	O
)	O
Phenotypic	O
assay	O
of	O
p53	O
Delta	O
PGFP	O
:	O
loss	O
of	O
cell	O
cycle	O
control	O
.	O

Asynchronous	O
p53RMCE	O
/	O
-	O
and	O
p53	O
Delta	O
PGFP	O
/	O
-	O
MEFs	O
left	O
untreated	O
,	O
or	O
irradiated	O
with	O
doses	O
of	O
6	O
or	O
12	O
Gy	O
,	O
were	O
analyzed	O
(	O
top	O
shows	O
a	O
typical	O
experiment	O
;	O
bottom	O
plots	O
results	O
from	O
>=	O
4	O
independent	O
experiments	O
and	O
>=	O
3	O
independent	O
MEFs	O
)	O
.	O

Note	O
that	O
the	O
p53RMCE	O
locus	O
encodes	O
a	O
WT	O
p53	O
.	O

Table	O
1	O

Summary	O
of	O
targeting	O
experiments	O

In	O
ES	O
cells	O
,	O
targeting	O
p53	O
Delta	O
PGFP	O
or	O
p53GFP	O
by	O
RMCE	O
was	O
~	O
20	O
times	O
more	O
efficient	O
than	O
targeting	O
Flox	O
by	O
homologous	O
recombination	O
.	O

In	O
MEFs	O
,	O
due	O
to	O
p53GFP	O
toxicity	O
,	O
only	O
the	O
targeting	O
efficiency	O
of	O
RMCE	O
with	O
p53	O
Delta	O
PGFP	O
could	O
be	O
evaluated	O
.	O

Importantly	O
,	O
a	O
phenotypic	O
read	O
-	O
out	O
of	O
the	O
p53	O
Delta	O
PGFP	O
mutation	O
in	O
MEFs	O
,	O
if	O
it	O
had	O
been	O
performed	O
after	O
targeting	O
in	O
fibroblasts	O
by	O
homologous	O
recombination	O
,	O
would	O
have	O
required	O
two	O
rounds	O
of	O
inefficient	O
targeting	O
to	O
target	O
both	O
p53	O
alleles	O
.	O

RanBP2	O
Modulates	O
Cox11	O
and	O
Hexokinase	O
I	O
Activities	O
and	O
Haploinsufficiency	O
of	O
RanBP2	O
Causes	O
Deficits	O
in	O
Glucose	B-CHEBI
Metabolism	O

Abstract	O

The	O
Ran	O
-	O
binding	O
protein	B-CHEBI
2	O
(	O
RanBP2	O
)	O
is	O
a	O
large	O
multimodular	O
and	O
pleiotropic	O
protein	B-CHEBI
.	O

Several	O
molecular	B-CHEBI
partners	O
with	O
distinct	O
functions	O
interacting	O
specifically	O
with	O
selective	O
modules	O
of	O
RanBP2	O
have	O
been	O
identified	O
.	O

Yet	O
,	O
the	O
significance	O
of	O
these	O
interactions	O
with	O
RanBP2	O
and	O
the	O
genetic	O
and	O
physiological	O
role	O
(	O
s	O
)	O
of	O
RanBP2	O
in	O
a	O
whole	O
-	O
animal	O
model	O
remain	O
elusive	O
.	O

Here	O
,	O
we	O
report	O
the	O
identification	O
of	O
two	O
novel	O
partners	O
of	O
RanBP2	O
and	O
a	O
novel	O
physiological	O
role	O
of	O
RanBP2	O
in	O
a	O
mouse	O
model	O
.	O

RanBP2	O
associates	O
in	O
vitro	O
and	O
in	O
vivo	O
and	O
colocalizes	O
with	O
the	O
mitochondrial	O
metallochaperone	O
,	O
Cox11	O
,	O
and	O
the	O
pacemaker	O
of	O
glycolysis	O
,	O
hexokinase	O
type	O
I	O
(	O
HKI	O
)	O
via	O
its	O
leucine	B-CHEBI
-	O
rich	O
domain	O
.	O

The	O
leucine	B-CHEBI
-	O
rich	O
domain	O
of	O
RanBP2	O
also	O
exhibits	O
strong	O
chaperone	O
activity	O
toward	O
intermediate	O
and	O
mature	O
folding	O
species	O
of	O
Cox11	O
supporting	O
a	O
chaperone	O
role	O
of	O
RanBP2	O
in	O
the	O
cytosol	O
during	O
Cox11	O
biogenesis	O
.	O

Cox11	O
partially	O
colocalizes	O
with	O
HKI	O
,	O
thus	O
supporting	O
additional	O
and	O
distinct	O
roles	O
in	O
cell	O
function	O
.	O

Cox11	O
is	O
a	O
strong	O
inhibitor	O
of	O
HKI	O
,	O
and	O
RanBP2	O
suppresses	O
the	O
inhibitory	O
activity	O
of	O
Cox11	O
over	O
HKI	O
.	O

To	O
probe	O
the	O
physiological	O
role	O
of	O
RanBP2	O
and	O
its	O
role	O
in	O
HKI	O
function	O
,	O
a	O
mouse	O
model	O
harboring	O
a	O
genetically	O
disrupted	O
RanBP2	O
locus	O
was	O
generated	O
.	O

RanBP2	O
-	O
/	O
-	O
are	O
embryonically	O
lethal	O
,	O
and	O
haploinsufficiency	O
of	O
RanBP2	O
in	O
an	O
inbred	O
strain	O
causes	O
a	O
pronounced	O
decrease	O
of	O
HKI	O
and	O
ATP	B-CHEBI
levels	O
selectively	O
in	O
the	O
central	O
nervous	O
system	O
.	O

Inbred	O
RanBP2	O
+	O
/	O
-	O
mice	O
also	O
exhibit	O
deficits	O
in	O
growth	O
rates	O
and	O
glucose	B-CHEBI
catabolism	O
without	O
impairment	O
of	O
glucose	B-CHEBI
uptake	O
and	O
gluconeogenesis	O
.	O

These	O
phenotypes	O
are	O
accompanied	O
by	O
a	O
decrease	O
in	O
the	O
electrophysiological	O
responses	O
of	O
photosensory	O
and	O
postreceptoral	O
neurons	O
.	O

Hence	O
,	O
RanBP2	O
and	O
its	O
partners	O
emerge	O
as	O
critical	O
modulators	O
of	O
neuronal	O
HKI	O
,	O
glucose	B-CHEBI
catabolism	O
,	O
energy	O
homeostasis	O
,	O
and	O
targets	O
for	O
metabolic	O
,	O
aging	O
disorders	O
and	O
allied	O
neuropathies	O
.	O

Synopsis	O

The	O
Ran	O
-	O
binding	O
protein	B-CHEBI
2	O
(	O
RanBP2	O
)	O
is	O
a	O
large	O
protein	B-CHEBI
with	O
several	O
domains	O
.	O

Although	O
several	O
protein	B-CHEBI
partners	O
were	O
found	O
to	O
interact	O
with	O
selective	O
domains	O
of	O
RanBP2	O
,	O
none	O
to	O
this	O
date	O
were	O
found	O
toward	O
its	O
large	O
leucine	B-CHEBI
-	O
rich	O
domain	O
(	O
LD	O
)	O
.	O

Cell	O
-	O
based	O
experiments	O
support	O
several	O
roles	O
of	O
RanBP2	O
in	O
cell	O
function	O
,	O
such	O
as	O
the	O
production	O
of	O
functional	O
proteins	B-CHEBI
,	O
control	O
of	O
protein	B-CHEBI
trafficking	O
between	O
the	O
nuclear	O
and	O
cytosol	O
compartments	O
,	O
and	O
control	O
of	O
multiple	O
facets	O
underlying	O
cell	O
division	O
.	O

Still	O
,	O
the	O
genetic	O
and	O
physiological	O
implications	O
of	O
the	O
interactions	O
between	O
RanBP2	O
and	O
its	O
partners	O
and	O
of	O
the	O
function	O
of	O
RanBP2	O
in	O
a	O
whole	O
-	O
animal	O
model	O
remain	O
elusive	O
.	O

The	O
authors	O
report	O
the	O
identification	O
of	O
two	O
novel	O
mitochondrial	O
partners	O
of	O
the	O
LD	O
of	O
RanBP2	O
,	O
Cox11	O
and	O
hexokinase	O
type	O
I	O
(	O
HKI	O
)	O
;	O
and	O
with	O
multidisciplinary	O
approaches	O
probe	O
the	O
role	O
of	O
RanBP2	O
and	O
its	O
LD	O
on	O
Cox11	O
,	O
HKI	O
,	O
and	O
functions	O
allied	O
to	O
these	O
.	O

The	O
authors	O
found	O
that	O
RanBP2	O
exhibits	O
chaperone	O
activity	O
toward	O
HKI	O
and	O
Cox11	O
.	O

RanBP2	O
and	O
Cox11	O
profoundly	O
modulate	O
HKI	O
activity	O
.	O

Moreover	O
,	O
partial	O
loss	O
-	O
of	O
-	O
function	O
of	O
RanBP2	O
in	O
a	O
mouse	O
model	O
induces	O
deficits	O
in	O
growth	O
rates	O
and	O
breakdown	O
of	O
glucose	B-CHEBI
,	O
promotes	O
the	O
down	O
-	O
regulation	O
of	O
HKI	O
and	O
ATP	B-CHEBI
levels	O
selectively	O
in	O
the	O
central	O
nervous	O
system	O
,	O
and	O
impairs	O
visual	O
function	O
.	O

These	O
findings	O
support	O
a	O
critical	O
role	O
of	O
RanBP2	O
and	O
its	O
partners	O
in	O
metabolic	O
processes	O
and	O
allied	O
disease	O
states	O
.	O

Introduction	O

The	O
RanBP2	O
/	O
Nup358	O
is	O
a	O
unique	O
vertebrate	O
and	O
large	O
scaffold	O
protein	B-CHEBI
comprised	O
of	O
multiple	O
structural	O
and	O
functional	O
domains	O
[	O
1	O
-	O
4	O
]	O
.	O

Several	O
roles	O
of	O
RanBP2	O
have	O
emerged	O
that	O
implicate	O
RanBP2	O
in	O
nucleocytoplasmic	O
trafficking	O
[	O
3	O
,	O
5	O
]	O
,	O
protein	B-CHEBI
biogenesis	O
[	O
6	O
,	O
7	O
]	O
,	O
the	O
formation	O
of	O
the	O
mitotic	O
spindle	O
,	O
assembly	O
of	O
the	O
nuclear	O
envelope	O
[	O
8	O
]	O
,	O
and	O
the	O
integration	O
of	O
the	O
nuclear	O
envelope	O
breakdown	O
with	O
kinetochore	O
formation	O
and	O
maturation	O
during	O
early	O
mitotic	O
progression	O
[	O
9	O
]	O
.	O

The	O
specific	O
interaction	O
of	O
RanBP2	O
with	O
a	O
diverse	O
set	O
of	O
partners	O
likely	O
reflects	O
a	O
pleiotropic	O
role	O
of	O
RanBP2	O
in	O
cell	O
function	O
,	O
possibly	O
through	O
the	O
integration	O
of	O
multiple	O
pathways	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
cell	O
(	O
tissue	O
)	O
-	O
selective	O
interaction	O
of	O
RanBP2	O
with	O
some	O
of	O
its	O
partners	O
may	O
also	O
impart	O
cell	O
-	O
restricted	O
roles	O
to	O
RanBP2	O
.	O

For	O
example	O
,	O
the	O
Ran	O
-	O
binding	O
domains	O
RBDn	O
=	O
1	O
-	O
4	O
of	O
RanBP2	O
associate	O
with	O
the	O
nuclear	O
import	O
co	O
-	O
receptor	O
,	O
importin	O
-	O
beta	O
[	O
10	O
,	O
11	O
]	O
,	O
and	O
antibodies	O
against	O
RanBP2	O
inhibit	O
the	O
nuclear	O
import	O
pathway	O
in	O
HeLa	O
cells	O
[	O
3	O
]	O
;	O
but	O
such	O
a	O
role	O
seems	O
dispensable	O
in	O
Xenopus	O
oocytes	O
[	O
12	O
]	O
.	O

In	O
addition	O
,	O
the	O
combination	O
of	O
the	O
C	B-CHEBI
-	O
terminal	O
domains	O
,	O
RBD4	O
and	O
CY	O
(	O
of	O
RanBP2	O
)	O
,	O
associates	O
with	O
a	O
subset	O
of	O
G	O
protein	B-CHEBI
-	O
coupled	O
receptors	O
,	O
the	O
red	O
/	O
green	O
opsin	O
,	O
expressed	O
in	O
photosensory	O
neurons	O
and	O
enhances	O
opsin	O
functional	O
production	O
[	O
6	O
,	O
7	O
]	O
,	O
while	O
the	O
interaction	O
of	O
the	O
KBD	O
of	O
RanBP2	O
with	O
a	O
subset	O
of	O
the	O
conventional	O
microtubule	O
-	O
based	O
motor	O
proteins	B-CHEBI
,	O
the	O
kinesins	O
,	O
KIF5B	O
and	O
KIF5C	O
,	O
occurs	O
selectively	O
in	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
[	O
13	O
]	O
.	O

A	O
diverse	O
set	O
of	O
additional	O
molecular	B-CHEBI
partners	O
,	O
each	O
associating	O
specifically	O
with	O
a	O
selective	O
domain	O
of	O
RanBP2	O
,	O
are	O
likely	O
to	O
impart	O
and	O
integrate	O
additional	O
roles	O
to	O
RanBP2	O
.	O

For	O
example	O
,	O
the	O
cyclophilin	O
-	O
like	O
domain	O
(	O
CLD	O
)	O
,	O
the	O
internal	O
repeat	O
(	O
W1W2	O
/	O
IR	O
)	O
,	O
and	O
zinc	B-CHEBI
-	O
finger	O
rich	O
(	O
ZnF	O
)	O
domains	O
of	O
RanBP2	O
associate	O
specifically	O
with	O
components	O
of	O
the	O
19S	O
cap	O
of	O
the	O
proteasome	O
[	O
14	O
]	O
,	O
the	O
E2	O
SUMO	O
-	O
1	O
-	O
conjugating	O
enzyme	O
(	O
Ubc9	O
)	O
[	O
15	O
]	O
,	O
and	O
the	O
nuclear	O
export	O
receptor	O
,	O
CRM1	O
/	O
exportin	O
-	O
1	O
[	O
16	O
]	O
,	O
respectively	O
.	O

RanBP2	O
itself	O
was	O
also	O
found	O
to	O
exhibit	O
SUMO1	O
E3	O
ligase	O
activity	O
[	O
17	O
]	O
,	O
supporting	O
a	O
direct	O
link	O
between	O
RanBP2	O
-	O
mediated	O
SUMO	O
-	O
1	O
substrate	O
modification	O
and	O
relocation	O
of	O
SUMO	O
-	O
1	O
modified	O
cytosolic	O
substrates	O
(	O
e	O
.	O
g	O
.	O
,	O
RanGAP	O
)	O
to	O
the	O
cytosolic	O
face	O
of	O
the	O
nuclear	O
pore	O
complex	O
(	O
NPC	O
)	O
[	O
18	O
]	O
.	O

Finally	O
,	O
RanBP2	O
was	O
also	O
found	O
to	O
localize	O
prominently	O
to	O
the	O
mitochondria	O
-	O
rich	O
ellipsoid	O
subcellular	O
compartment	O
of	O
photosensory	O
neurons	O
[	O
19	O
]	O
and	O
to	O
RanGTPase	O
-	O
restricted	O
foci	O
along	O
cytoplasmic	O
tracks	O
[	O
19	O
]	O
,	O
in	O
addition	O
to	O
its	O
localization	O
at	O
cytoplasmic	O
fibrils	O
emanating	O
from	O
nuclear	O
pores	O
[	O
2	O
,	O
3	O
,	O
10	O
,	O
12	O
,	O
19	O
]	O
.	O

Emerging	O
evidence	O
supports	O
that	O
the	O
CNS	O
-	O
selective	O
effects	O
of	O
RanBP2	O
may	O
also	O
underlie	O
the	O
pathogenesis	O
of	O
certain	O
neuropathies	O
.	O

Parkin	O
is	O
ubiquitously	O
expressed	O
and	O
interacts	O
with	O
the	O
Ubc9	O
-	O
interacting	O
domain	O
of	O
RanBP2	O
[	O
20	O
]	O
.	O

This	O
promotes	O
the	O
ubiquitination	O
and	O
degradation	O
of	O
RanBP2	O
[	O
20	O
]	O
,	O
possibly	O
via	O
the	O
interaction	O
of	O
the	O
CLD	O
domain	O
of	O
RanBP2	O
with	O
the	O
19S	O
cap	O
subunits	O
of	O
the	O
proteasome	O
[	O
14	O
]	O
.	O

Interestingly	O
,	O
the	O
small	O
yeast	O
Ran	O
-	O
binding	O
protein	B-CHEBI
1	O
(	O
RanBP1	O
)	O
,	O
Yrb1p	O
,	O
with	O
strong	O
homology	O
to	O
the	O
Ran	O
-	O
binding	O
domains	O
of	O
RanBP2	O
,	O
is	O
also	O
required	O
for	O
cell	O
-	O
cycle	O
regulated	O
protein	B-CHEBI
degradation	O
[	O
21	O
]	O
.	O

Parkin	O
,	O
like	O
RanBP2	O
[	O
17	O
]	O
,	O
has	O
E3	O
-	O
ligase	O
activity	O
[	O
22	O
-	O
24	O
]	O
;	O
and	O
loss	O
-	O
of	O
-	O
function	O
of	O
parkin	O
leads	O
to	O
early	O
onset	O
autosomal	O
recessive	O
juvenile	O
Parkinsonism	O
[	O
25	O
]	O
.	O

While	O
the	O
dopaminergic	B-CHEBI
neuronal	O
-	O
restricted	O
effects	O
of	O
mutations	O
in	O
parkin	O
are	O
not	O
understood	O
[	O
25	O
]	O
,	O
parkin	O
-	O
/	O
-	O
mice	O
exhibit	O
mitochondrial	O
dysfunction	O
and	O
energy	O
and	O
growth	O
deficits	O
,	O
and	O
a	O
fraction	O
of	O
parkin	O
localizes	O
to	O
the	O
cytoplasmic	O
face	O
of	O
the	O
mitochondria	O
,	O
where	O
together	O
with	O
other	O
partners	O
is	O
thought	O
to	O
promote	O
the	O
degradation	O
of	O
selective	O
mitochondrial	O
substrates	O
and	O
to	O
exert	O
a	O
neuroprotective	O
function	O
[	O
26	O
-	O
29	O
]	O
.	O

These	O
data	O
suggest	O
that	O
deficits	O
in	O
RanBP2	O
and	O
parkin	O
may	O
share	O
(	O
patho	O
)	O
physiological	O
pathways	O
and	O
support	O
a	O
multifaceted	O
role	O
of	O
RanBP2	O
.	O

Yet	O
clear	O
functions	O
of	O
RanBP2	O
in	O
animal	O
and	O
cell	O
physiology	O
remain	O
elusive	O
.	O

Here	O
,	O
we	O
report	O
on	O
the	O
identification	O
and	O
function	O
of	O
two	O
novel	O
partners	O
of	O
RanBP2	O
,	O
Cox11	O
and	O
hexokinase	O
type	O
I	O
(	O
HKI	O
)	O
,	O
which	O
interact	O
with	O
a	O
large	O
and	O
orphan	O
domain	O
of	O
RanBP2	O
,	O
the	O
leucine	B-CHEBI
-	O
rich	O
domain	O
(	O
LD	O
)	O
;	O
and	O
on	O
the	O
outcome	O
of	O
partial	O
loss	O
-	O
of	O
-	O
function	O
of	O
RanBP2	O
on	O
HKI	O
,	O
animal	O
physiology	O
,	O
and	O
glucose	B-CHEBI
/	O
energy	O
metabolism	O
.	O

Results	O

The	O
LD	O
of	O
RanBP2	O
Interacts	O
with	O
Cox11	O
and	O
HKI	O

The	O
LD	O
of	O
RanBP2	O
(	O
Figure	O
1A	O
)	O
is	O
a	O
large	O
and	O
orphan	O
domain	O
of	O
~	O
700	O
residues	B-CHEBI
(	O
~	O
80	O
kDa	O
)	O
,	O
for	O
which	O
no	O
molecular	B-CHEBI
partners	O
have	O
been	O
identified	O
until	O
this	O
date	O
.	O

Brain	O
and	O
retina	O
yeast	O
two	O
-	O
hybrid	O
libraries	O
were	O
screened	O
with	O
LD	O
.	O

Cox11	O
was	O
identified	O
as	O
a	O
partner	O
to	O
this	O
domain	O
(	O
Figure	O
1B	O
and	O
1C	O
)	O
.	O

Cox11	O
is	O
a	O
metallochaperone	O
implicated	O
in	O
cytochrome	B-CHEBI
c	I-CHEBI
oxidase	O
assembly	O
[	O
30	O
,	O
31	O
]	O
.	O

Structure	O
-	O
function	O
analysis	O
of	O
the	O
interaction	O
between	O
mCox11	O
,	O
LD	O
of	O
RanBP2	O
,	O
and	O
subdomains	O
thereof	O
,	O
with	O
quantitative	O
yeast	O
two	O
-	O
hybrid	O
assays	O
[	O
32	O
]	O
,	O
showed	O
optimal	O
interaction	O
between	O
the	O
intact	O
LD	O
and	O
Cox11	O
proteins	B-CHEBI
(	O
Figure	O
1C	O
)	O
.	O

Pull	O
-	O
down	O
assays	O
of	O
retinal	O
extracts	O
with	O
glutathione	B-CHEBI
S	B-CHEBI
-	O
transferase	O
(	O
GST	O
)	O
-	O
LD	O
precipitates	O
a	O
sodium	B-CHEBI
dodecyl	I-CHEBI
sulfate	I-CHEBI
-	O
resistant	O
dimer	O
isoform	O
of	O
Cox11	O
(	O
Figure	O
1D	O
,	O
top	O
panel	O
)	O
,	O
which	O
does	O
not	O
bind	O
to	O
GST	O
-	O
LDZIP	O
alone	O
.	O

In	O
addition	O
to	O
Cox11	O
,	O
we	O
also	O
found	O
that	O
other	O
mitochondrial	O
components	O
such	O
as	O
the	O
outer	O
membrane	O
-	O
associated	O
protein	B-CHEBI
,	O
HKI	O
[	O
33	O
]	O
(	O
Figure	O
1D	O
,	O
bottom	O
panel	O
)	O
and	O
mHsp70	O
(	O
unpublished	O
data	O
)	O
,	O
associated	O
with	O
LD	O
of	O
RanBP2	O
.	O

This	O
association	O
was	O
highly	O
specific	O
toward	O
the	O
HKI	O
isoform	O
,	O
because	O
HKII	O
,	O
HKIII	O
,	O
and	O
glucokinase	O
did	O
not	O
interact	O
with	O
the	O
LD	O
of	O
RanBP2	O
(	O
unpublished	O
data	O
)	O
.	O

The	O
interaction	O
of	O
Cox11	O
,	O
HKI	O
,	O
and	O
mHsp70	O
with	O
RanBP2	O
occurred	O
in	O
vivo	O
in	O
retinal	O
extracts	O
,	O
since	O
antibodies	O
against	O
these	O
and	O
RanBP2	O
coimmunoprecipitated	O
RanBP2	O
(	O
Figure	O
1E	O
)	O
and	O
HKI	O
(	O
Figure	O
1F	O
)	O
,	O
respectively	O
,	O
and	O
these	O
interactions	O
were	O
observed	O
across	O
different	O
tissues	O
(	O
Figure	O
S1	O
)	O
.	O

Since	O
RanBP2	O
exhibits	O
chaperone	O
activity	O
,	O
we	O
assessed	O
whether	O
the	O
interaction	O
between	O
the	O
LD	O
of	O
RanBP2	O
and	O
Cox11	O
was	O
direct	O
and	O
the	O
chaperone	O
activity	O
of	O
LD	O
toward	O
folding	O
species	O
of	O
Cox11	O
.	O

Reconstitution	O
binding	O
assays	O
were	O
carried	O
out	O
between	O
purified	O
LD	O
and	O
Cox11	O
,	O
fully	O
and	O
partially	O
denatured	O
with	O
GnHCl	O
and	O
urea	O
,	O
respectively	O
,	O
and	O
native	O
Cox11	O
(	O
Figure	O
1G	O
and	O
1H	O
)	O
.	O

Partial	O
denatured	O
Cox11	O
exhibits	O
significantly	O
higher	O
and	O
concentration	O
-	O
dependent	O
binding	O
affinity	O
toward	O
LD	O
compared	O
with	O
the	O
native	O
and	O
fully	O
denatured	O
Cox11	O
(	O
Figure	O
1G	O
)	O
.	O

In	O
addition	O
,	O
native	O
Cox11	O
purified	O
upon	O
expression	O
in	O
the	O
presence	O
of	O
CuSO4	B-CHEBI
(	O
a	O
prosthetic	O
group	O
tightly	O
bound	O
to	O
Cox11	O
)	O
[	O
31	O
]	O
,	O
shows	O
significantly	O
higher	O
binding	O
activity	O
toward	O
the	O
LD	O
of	O
RanBP2	O
,	O
than	O
in	O
the	O
absence	O
of	O
CuSO4	B-CHEBI
(	O
Figure	O
1H	O
)	O
.	O

Figure	O
1	O

The	O
LD	O
of	O
RanBP2	O
Interacts	O
with	O
Cox11	O
and	O
HKI	O

(	O
A	O
)	O
Primary	O
structure	O
of	O
RanBP2	O
and	O
its	O
structural	O
/	O
functional	O
domains	O
.	O

The	O
N	B-CHEBI
-	O
terminal	O
LD	O
of	O
RanBP2	O
is	O
underlined	O
.	O

(	O
B	O
)	O
Sequence	O
alignment	O
of	O
murine	O
and	O
yeast	O
Cox11	O
.	O

The	O
yeast	O
Cox11	O
C	B-CHEBI
-	O
and	O
N	B-CHEBI
-	O
terminal	O
domains	O
are	O
poorly	O
conserved	O
.	O

Arrow	O
and	O
solid	O
line	O
denote	O
the	O
predicted	O
mitochondrial	O
cleavage	O
site	O
and	O
membrane	O
-	O
spanning	O
domain	O
.	O

The	O
dotted	O
and	O
dashed	O
lines	O
above	O
the	O
aligned	O
sequences	O
represent	O
,	O
respectively	O
,	O
Cox11	O
-	O
N	B-CHEBI
and	O
Cox11	O
-	O
C	B-CHEBI
constructs	O
shown	O
in	O
Figure	O
1C	O
.	O

(	O
C	O
)	O
Structure	O
-	O
function	O
analysis	O
of	O
the	O
interaction	O
between	O
the	O
LD	O
of	O
RanBP2	O
and	O
Cox11	O
.	O

Optimal	O
interaction	O
between	O
the	O
LD	O
and	O
Cox11	O
occurred	O
in	O
the	O
presence	O
of	O
constructs	O
comprising	O
both	O
the	O
complete	O
LD	O
and	O
Cox11	O
.	O

Although	O
removal	O
of	O
the	O
cytosolic	O
N	B-CHEBI
-	O
terminal	O
(	O
Cox11	O
-	O
C	B-CHEBI
)	O
significantly	O
decreased	O
the	O
interaction	O
with	O
LD	O
,	O
the	O
mitochondrial	O
intermembrane	O
domain	O
of	O
Cox11	O
(	O
Cox11	O
-	O
C	B-CHEBI
)	O
together	O
with	O
the	O
C	B-CHEBI
-	O
terminal	O
half	O
of	O
LD	O
(	O
LD	O
-	O
C	B-CHEBI
)	O
retained	O
most	O
of	O
the	O
interaction	O
activity	O
.	O

LD	O
-	O
N	B-CHEBI
and	O
LD	O
-	O
C	B-CHEBI
ended	O
and	O
began	O
with	O
the	O
leucine	B-CHEBI
zipper	O
domain	O
of	O
RanBP2	O
.	O

White	O
and	O
black	O
bars	O
denote	O
beta	O
-	O
galactosidase	O
activity	O
and	O
growth	O
rates	O
in	O
selective	O
growth	O
medium	O
,	O
respectively	O
.	O

Results	O
shown	O
represent	O
the	O
mean	O
+/-	O
SD	O
,	O
n	O
=	O
3	O
.	O

(	O
D	O
)	O
GST	O
pull	O
-	O
down	O
assays	O
with	O
the	O
LD	O
of	O
RanBP2	O
and	O
its	O
leucine	B-CHEBI
zipper	O
domain	O
and	O
retinal	O
extracts	O
.	O

The	O
LD	O
,	O
but	O
not	O
the	O
leucine	B-CHEBI
zipper	O
domain	O
of	O
RanBP2	O
,	O
associate	O
with	O
Cox11	O
(	O
top	O
panel	O
,	O
lane	O
1	O
)	O
and	O
HKI	O
(	O
bottom	O
panel	O
,	O
lane	O
1	O
)	O
.	O

(	O
E	O
)	O
Coimmunoprecipitation	O
of	O
RanBP2	O
with	O
antibodies	O
against	O
its	O
molecular	B-CHEBI
partners	O
shows	O
that	O
RanBP2	O
forms	O
a	O
complex	O
in	O
vivo	O
with	O
HKI	O
(	O
lanes	O
1	O
and	O
2	O
)	O
,	O
mHsp70	O
(	O
lane	O
3	O
)	O
,	O
and	O
Cox11	O
(	O
lane	O
4	O
)	O
.	O

Lanes	O
5	O
,	O
6	O
,	O
and	O
7	O
are	O
control	O
immunoprecipitation	O
reactions	O
with	O
different	O
antibodies	O
against	O
the	O
RanBP2	O
domains	O
,	O
KBD	O
,	O
ZnF	O
,	O
and	O
XAFXFG	O
of	O
nucleoporins	O
.	O

(	O
F	O
)	O
Reciprocal	O
coimmunoprecipitation	O
of	O
HKI	O
with	O
antibodies	O
against	O
RanBP2	O
(	O
used	O
and	O
shown	O
in	O
(	O
E	O
)	O
)	O
.	O

(	O
G	O
)	O
Reconstitution	O
pull	O
-	O
down	O
assays	O
with	O
purified	O
LD	O
and	O
increasing	O
concentrations	O
of	O
native	O
(	O
top	O
panel	O
)	O
,	O
denatured	O
(	O
middle	O
panel	O
)	O
,	O
and	O
partially	O
denatured	O
(	O
bottom	O
panel	O
)	O
Cox11	O
,	O
respectively	O
,	O
in	O
the	O
absence	O
and	O
presence	O
of	O
denaturating	O
agent	O
,	O
GnHCl	O
and	O
chaotropic	O
agent	O
,	O
urea	B-CHEBI
.	O

Folding	O
intermediates	O
(	O
lower	O
panel	O
)	O
of	O
Cox11	O
exhibit	O
the	O
highest	O
binding	O
activity	O
toward	O
the	O
LD	O
of	O
RanBP2	O
.	O

(	O
H	O
)	O
Similar	O
experiments	O
as	O
in	O
(	O
G	O
)	O
but	O
in	O
the	O
presence	O
of	O
native	O
Cox11	O
expressed	O
in	O
the	O
absence	O
(	O
top	O
panel	O
)	O
or	O
presence	O
(	O
bottom	O
panel	O
)	O
of	O
CuSO4	O
.	O

The	O
mature	O
isoform	O
of	O
the	O
metallochaperone	O
has	O
an	O
increased	O
affinity	O
toward	O
the	O
LD	O
of	O
RanBP2	O
.	O

LD	O
,	O
leucine	B-CHEBI
-	O
rich	O
domain	O
;	O
LZ	O
,	O
leucine	B-CHEBI
zipper	O
domain	O
;	O
RBD1	O
-	O
4	O
,	O
Ran	O
-	O
binding	O
domains	O
1	O
-	O
4	O
;	O
ZnF	O
,	O
zinc	B-CHEBI
finger	O
cluster	O
domain	O
;	O
KBD	O
,	O
kinesin	O
(	O
KIF5B	O
/	O
KIF5C	O
)	O
-	O
binding	O
domain	O
;	O
CLD	O
,	O
cyclophilin	O
-	O
like	O
domain	O
;	O
IR	O
,	O
internal	O
repeat	O
domain	O
;	O
CY	O
,	O
cyclophilin	O
domain	O
.	O

Cox	O
11	O
Inhibits	O
HKI	O
Activity	O
and	O
the	O
LD	O
of	O
RanBP2	O
Reverses	O
the	O
Inhibition	O
of	O
Cox11	O
over	O
HKI	O

To	O
probe	O
whether	O
the	O
interaction	O
of	O
Cox11	O
and	O
HKI	O
with	O
the	O
LD	O
of	O
RanBP2	O
modulates	O
the	O
enzymatic	O
activity	O
of	O
HKI	O
,	O
we	O
first	O
examined	O
the	O
effect	O
of	O
increasing	O
concentrations	O
of	O
Cox11	O
on	O
the	O
initial	O
rates	O
of	O
HKI	O
enzymatic	O
activity	O
(	O
Figure	O
2A	O
)	O
.	O

Cox11	O
strongly	O
inhibits	O
HKI	O
activity	O
in	O
a	O
concentration	O
-	O
dependent	O
fashion	O
,	O
and	O
at	O
~	O
15	O
nM	O
of	O
Cox11	O
,	O
HKI	O
activity	O
could	O
not	O
be	O
recorded	O
(	O
Figure	O
2A	O
)	O
.	O

Cox11	O
behaves	O
as	O
a	O
partial	O
noncompetitive	O
inhibitor	B-CHEBI
of	O
HKI	O
by	O
affecting	O
the	O
Vmax	O
of	O
HKI	O
for	O
glucose	B-CHEBI
(	O
Figure	O
2B	O
)	O
.	O

Then	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
the	O
LD	O
of	O
RanBP2	O
on	O
the	O
HK	O
activity	O
in	O
the	O
presence	O
of	O
a	O
fixed	O
inhibitory	O
concentration	O
of	O
Cox11	O
,	O
saturating	O
concentration	O
of	O
glucose	B-CHEBI
substrate	O
,	O
and	O
increasing	O
concentrations	O
of	O
LD	O
.	O

As	O
shown	O
in	O
Figure	O
2C	O
,	O
the	O
LD	O
domain	O
sharply	O
reversed	O
the	O
inhibitory	O
effect	O
of	O
Cox11	O
on	O
HKI	O
activity	O
in	O
a	O
concentration	O
-	O
dependent	O
manner	O
,	O
but	O
under	O
saturating	O
(	O
and	O
stochiometric	O
)	O
amounts	O
of	O
LD	O
,	O
the	O
velocity	O
of	O
the	O
reaction	O
did	O
not	O
reach	O
that	O
observed	O
for	O
HKI	O
activity	O
in	O
the	O
absence	O
of	O
Cox11	O
(	O
Figure	O
2A	O
)	O
,	O
suggesting	O
the	O
LD	O
by	O
itself	O
may	O
also	O
have	O
an	O
effect	O
on	O
HKI	O
activity	O
.	O

Indeed	O
,	O
a	O
saturating	O
concentration	O
of	O
LD	O
reduced	O
the	O
Vmax	O
but	O
not	O
the	O
Km	O
of	O
HKI	O
(	O
Figure	O
2D	O
)	O
by	O
~	O
20	O
%	O
under	O
similar	O
conditions	O
.	O

Figure	O
2	O

Effect	O
of	O
Cox11	O
and	O
RanBP2	O
on	O
HKI	O
Activity	O

(	O
A	O
)	O
Saturation	O
kinetics	O
,	O
rate	O
versus	O
glucose	B-CHEBI
of	O
HKI	O
(	O
0	O
.	O
24	O
mu	O
g	O
)	O
in	O
the	O
absence	O
(	O
solid	O
circles	O
)	O
and	O
presence	O
of	O
Cox11	O
(	O
open	O
circles	O
,	O
0	O
.	O
25	O
nM	O
;	O
solid	O
triangles	O
,	O
7	O
.	O
5	O
nM	O
)	O
.	O

The	O
activity	O
of	O
HKI	O
decreases	O
with	O
increasing	O
concentrations	O
of	O
Cox11	O
.	O

No	O
measurable	O
HKI	O
activity	O
was	O
recorded	O
in	O
the	O
presence	O
of	O
15	O
nM	O
of	O
Cox11	O
(	O
unpublished	O
data	O
)	O
.	O

(	O
B	O
)	O
Hanes	O
-	O
Wolf	O
plot	O
of	O
(	O
A	O
)	O
(	O
1	O
/	O
rate	O
versus	O
glucose	B-CHEBI
)	O
in	O
the	O
absence	O
and	O
presence	O
of	O
fixed	O
concentrations	O
of	O
Cox11	O
.	O

Linearity	O
of	O
reciprocal	O
plots	O
also	O
supported	O
the	O
hyperbolic	O
behavior	O
of	O
the	O
reactions	O
(	O
unpublished	O
data	O
)	O
.	O

Cox11	O
behaves	O
as	O
a	O
noncompetitive	O
inhibitor	B-CHEBI
of	O
HKI	O
by	O
reducing	O
the	O
Vmax	O
of	O
HKI	O
but	O
not	O
its	O
Km	O
toward	O
glucose	B-CHEBI
.	O

(	O
C	O
)	O
HKI	O
rate	O
is	O
plotted	O
as	O
a	O
function	O
of	O
LD	O
concentration	O
at	O
saturating	O
glucose	B-CHEBI
and	O
fixed	O
Cox11	O
(	O
7	O
.	O
5	O
nM	O
)	O
concentrations	O
.	O

Note	O
that	O
increasing	O
concentrations	O
of	O
the	O
LD	O
of	O
RanBP2	O
reverse	O
the	O
inhibition	O
of	O
HKI	O
activity	O
by	O
Cox11	O
.	O

A	O
half	O
-	O
maximal	O
effect	O
of	O
the	O
LD	O
of	O
RanBP2	O
on	O
HKI	O
activity	O
in	O
the	O
presence	O
of	O
7	O
.	O
5	O
nM	O
of	O
Cox11	O
was	O
observed	O
at	O
a	O
concentration	O
of	O
~	O
0	O
.	O
05	O
nM	O
of	O
LD	O
.	O

(	O
D	O
)	O
Rate	O
versus	O
glucose	B-CHEBI
plot	O
in	O
the	O
absence	O
and	O
presence	O
of	O
the	O
LD	O
of	O
RanBP2	O
.	O

At	O
a	O
saturating	O
concentration	O
of	O
the	O
LD	O
of	O
RanBP2	O
(	O
3	O
.	O
75	O
nM	O
)	O
,	O
the	O
HKI	O
activity	O
was	O
reduced	O
by	O
about	O
20	O
%	O
.	O

v	O
,	O
rate	O
;	O
S	O
,	O
glucose	B-CHEBI
.	O

RanBP2	O
Colocalizes	O
with	O
HK1	O
,	O
Cox11	O
,	O
and	O
mHsp70	O
in	O
the	O
Retina	O
and	O
Cultured	O
Neurons	O

In	O
addition	O
to	O
its	O
presence	O
at	O
the	O
vicinity	O
of	O
NPCs	O
,	O
we	O
have	O
shown	O
previously	O
that	O
RanBP2	O
is	O
localized	O
to	O
and	O
abundant	O
in	O
the	O
mitochondria	O
-	O
rich	O
ellipsoid	O
subcellular	O
compartment	O
of	O
photosensory	O
(	O
photoreceptor	O
)	O
neurons	O
of	O
the	O
retina	O
[	O
19	O
]	O
.	O

We	O
extended	O
the	O
subcellular	O
colocalization	O
studies	O
on	O
RanBP2	O
and	O
its	O
novel	O
partners	O
by	O
immunocytochemistry	O
to	O
determine	O
if	O
RanBP2	O
,	O
Cox11	O
,	O
HKI	O
,	O
and	O
mHsp70	O
colocalize	O
in	O
hippocampal	O
neurons	O
(	O
Figure	O
3A	O
-	O
3C	O
)	O
,	O
cerebral	O
cortex	O
neurons	O
(	O
Figure	O
3D	O
-	O
3F	O
)	O
,	O
ellipsoid	O
(	O
mitochondria	O
-	O
rich	O
)	O
subcellular	O
compartments	O
of	O
photosensory	O
neurons	O
of	O
the	O
retina	O
(	O
Figure	O
3G	O
-	O
3O	O
)	O
,	O
and	O
dissociated	O
primary	O
glia	O
and	O
neuron	O
cultures	O
from	O
the	O
brain	O
(	O
Figure	O
3P	O
-	O
3Z	O
)	O
.	O

Double	O
immunostaining	O
with	O
antibodies	O
against	O
these	O
proteins	B-CHEBI
showed	O
that	O
they	O
colocalize	O
to	O
the	O
mitochondria	O
(	O
Figure	O
3A	O
-	O
3Z	O
)	O
.	O

Figure	O
3	O

Localization	O
of	O
RanBP2	O
and	O
Its	O
LD	O
Molecular	B-CHEBI
Partners	O

(	O
A	O
-	O
F	O
)	O
are	O
thin	O
cryosections	O
of	O
an	O
area	O
of	O
the	O
hipocampus	O
(	O
CA1	O
neurons	O
)	O
and	O
cerebral	O
cortex	O
,	O
respectively	O
,	O
immunostained	O
against	O
HKI	O
(	O
A	O
and	O
D	O
)	O
,	O
RanBP2	O
(	O
B	O
and	O
E	O
)	O
,	O
and	O
merged	O
images	O
thereof	O
(	O
C	O
and	O
F	O
)	O
.	O

Note	O
that	O
while	O
RanBP2	O
and	O
HKI	O
are	O
widely	O
expressed	O
among	O
and	O
colocalize	O
to	O
hippocampal	O
neurons	O
(	O
C	O
)	O
,	O
HKI	O
expression	O
and	O
localization	O
with	O
RanBP2	O
is	O
restricted	O
to	O
a	O
subset	O
of	O
cortical	O
neurons	O
(	O
likely	O
interneurons	O
)	O
(	O
F	O
)	O
.	O

Images	O
of	O
the	O
distal	O
region	O
of	O
bovine	O
retinal	O
cryosections	O
comprising	O
part	O
of	O
the	O
nuclear	O
layer	O
of	O
photoreceptor	O
neurons	O
and	O
their	O
inner	O
(	O
myoid	O
and	O
ellipsoid	O
)	O
segment	O
compartment	O
(	O
G	O
-	O
O	O
)	O
are	O
immunostained	O
against	O
mHsp70	O
(	O
G	O
)	O
and	O
RanBP2	O
(	O
H	O
)	O
,	O
mHsp70	O
(	O
J	O
)	O
and	O
Cox11	O
(	O
K	O
)	O
,	O
HKI	O
(	O
M	O
)	O
and	O
Cox11	O
(	O
N	O
)	O
,	O
and	O
merged	O
images	O
thereof	O
(	O
I	O
-	O
O	O
)	O
.	O

Note	O
the	O
prominent	O
localization	O
of	O
RanBP2	O
,	O
mHsp70	O
,	O
and	O
Cox11	O
at	O
the	O
mitochondria	O
-	O
rich	O
ellipsoid	O
compartment	O
of	O
photoreceptors	O
and	O
the	O
colocalization	O
of	O
RanBP2	O
and	O
Cox11	O
with	O
mHsp70	O
(	O
I	O
and	O
L	O
)	O
,	O
while	O
HKI	O
colocalization	O
with	O
Cox11	O
was	O
limited	O
to	O
restricted	O
foci	O
(	O
R	O
,	O
arrowheads	O
)	O
.	O

High	O
-	O
resolution	O
images	O
of	O
dissociated	O
primary	O
cerebral	O
neurons	O
and	O
glial	O
cells	O
confirmed	O
that	O
the	O
colocalization	O
of	O
HKI	O
and	O
Cox11	O
was	O
highly	O
restricted	O
(	O
P	O
-	O
R	O
)	O
,	O
while	O
RanBP2	O
extensively	O
colocalized	O
with	O
HKI	O
(	O
S	O
-	O
U	O
)	O
and	O
mHsp70	O
(	O
V	O
-	O
Z	O
)	O
.	O

Scale	O
bars	O
in	O
A	O
-	O
O	O
and	O
P	O
-	O
Z	O
are	O
40	O
and	O
10	O
mu	O
m	O
,	O
respectively	O
.	O

ONL	O
,	O
outer	O
nuclear	O
layer	O
.	O

Haploinsufficiency	O
of	O
RanBP2	O
Causes	O
Decreased	O
Levels	O
of	O
HKI	O
and	O
Partial	O
Mislocalization	O
of	O
HKI	O

To	O
determine	O
the	O
physiological	O
implications	O
of	O
the	O
interaction	O
between	O
RanBP2	O
and	O
HKI	O
(	O
and	O
other	O
partners	O
)	O
,	O
we	O
employed	O
a	O
murine	O
embryonic	O
stem	O
129Ola	O
cell	O
line	O
with	O
a	O
targeted	O
RanBP2	O
locus	O
produced	O
by	O
gene	O
-	O
trapping	O
to	O
produce	O
stable	O
inbred	O
(	O
coisogenic	O
)	O
and	O
mixed	O
background	O
lines	O
,	O
respectively	O
(	O
Figure	O
4A	O
and	O
4B	O
)	O
.	O

Genotyping	O
of	O
299	O
F2	O
offspring	O
revealed	O
a	O
RanBP2	O
+	O
/	O
+	O
:	O
RanBP2	O
+	O
/	O
-	O
:	O
RanBP2	O
-	O
/	O
-	O
distribution	O
(	O
89	O
:	O
210	O
:	O
0	O
)	O
that	O
deviated	O
from	O
the	O
expected	O
Mendelian	O
ratio	O
and	O
supports	O
that	O
the	O
RanBP2	O
-	O
/	O
-	O
mice	O
were	O
embryonically	O
lethal	O
.	O

E12	O
.	O
5	O
embryos	O
show	O
strong	O
expression	O
of	O
RanBP2	O
in	O
the	O
optic	O
vesicle	O
and	O
throughout	O
much	O
of	O
the	O
embryo	O
,	O
which	O
had	O
no	O
apparent	O
developmental	O
abnormalities	O
(	O
Figure	O
4C	O
)	O
.	O

In	O
agreement	O
with	O
previous	O
immunocytochemistry	O
analysis	O
[	O
19	O
]	O
,	O
the	O
RanBP2	O
gene	O
is	O
expressed	O
across	O
mature	O
retinal	O
neurons	O
,	O
but	O
expression	O
in	O
ganglion	O
cells	O
of	O
the	O
adult	O
retina	O
was	O
extremely	O
strong	O
(	O
Figure	O
4D	O
and	O
4E	O
)	O
.	O

Figure	O
4	O

Insertion	O
Mutagenesis	O
of	O
the	O
Murine	O
RanBP2	O
Gene	O

(	O
A	O
)	O
Diagram	O
of	O
the	O
genomic	O
region	O
of	O
RanBP2	O
disrupted	O
by	O
insertion	O
trap	O
mutagenesis	O
with	O
a	O
bicistronic	O
reporter	O
vector	O
between	O
exon	O
1	O
and	O
2	O
.	O

The	O
bicistronic	O
transcript	O
produces	O
two	O
proteins	B-CHEBI
under	O
regulation	O
of	O
RanBP2	O
.	O

Upon	O
splicing	O
of	O
RanBP2	O
,	O
a	O
fusion	O
between	O
exon	O
1	O
and	O
beta	O
-	O
geo	O
(	O
a	O
fusion	O
between	O
the	O
beta	O
-	O
gal	O
and	O
neo	O
genes	O
)	O
is	O
generated	O
,	O
while	O
human	O
placental	O
alkaline	B-CHEBI
phophatase	O
(	O
PLAP	O
)	O
is	O
independently	O
translated	O
using	O
the	O
internal	O
ribosome	O
entry	O
site	O
.	O

Consistent	O
with	O
previous	O
studies	O
,	O
the	O
expression	O
of	O
the	O
former	O
is	O
directed	O
to	O
cell	O
bodies	O
,	O
while	O
expression	O
of	O
the	O
latter	O
is	O
targeted	O
to	O
the	O
axonal	O
processes	O
[	O
67	O
,	O
68	O
]	O
.	O

Transcriptional	O
5	O
'	O
RACE	O
analysis	O
detects	O
a	O
fusion	O
between	O
exon	O
1	O
and	O
beta	O
-	O
geo	O
.	O

(	O
B	O
)	O
Southern	O
analysis	O
of	O
the	O
RanBP2	O
locus	O
of	O
wild	O
-	O
type	O
and	O
heterozygous	O
genomic	O
DNA	O
of	O
tails	O
of	O
F1	O
mice	O
digested	O
with	O
PpuMI	O
(	O
left	O
panel	O
)	O
and	O
HindIII	O
(	O
right	O
panel	O
)	O
with	O
probes	O
at	O
the	O
3	O
'	O
(	O
left	O
panel	O
)	O
and	O
5	O
'	O
(	O
right	O
panel	O
)	O
flanking	O
regions	O
of	O
the	O
insertion	O
breakpoint	O
.	O

Q1	O
is	O
a	O
cosmid	O
containing	O
the	O
RanBP2	O
gene	O
up	O
to	O
exon	O
20	O
[	O
4	O
]	O
.	O

(	O
C	O
)	O
Lateroventral	O
view	O
of	O
a	O
whole	O
-	O
mount	O
stain	O
of	O
a	O
~	O
12	O
.	O
5	O
dpc	O
heterozygous	O
embryo	O
for	O
PLAP	O
and	O
beta	O
-	O
gal	O
(	O
inset	O
picture	O
)	O
activities	O
.	O

Although	O
PLAP	O
was	O
broadly	O
expressed	O
(	O
e	O
.	O
g	O
.	O
,	O
somites	O
,	O
limbs	O
,	O
and	O
CNS	O
)	O
,	O
the	O
PLAP	O
and	O
beta	O
-	O
Gal	O
(	O
inset	O
picture	O
)	O
expression	O
was	O
particularly	O
high	O
in	O
the	O
optic	O
vesicle	O
(	O
arrow	O
)	O
.	O

X	O
-	O
gal	O
single	O
(	O
D	O
)	O
and	O
combined	O
staining	O
with	O
PLAP	O
(	O
E	O
)	O
of	O
a	O
retinal	O
section	O
of	O
a	O
3	O
-	O
mo	O
-	O
old	O
RanBP2	O
+	O
/	O
-	O
mouse	O
.	O

Consistent	O
with	O
previous	O
immunocytochemistry	O
studies	O
,	O
beta	O
-	O
Gal	O
activity	O
is	O
detected	O
in	O
the	O
neuroretinal	O
bodies	O
and	O
inner	O
segment	O
compartment	O
of	O
photoreceptors	O
with	O
conspicuously	O
strong	O
expression	O
in	O
ganglion	O
cells	O
.	O

PLAP	O
expression	O
is	O
found	O
throughout	O
the	O
plexiform	O
/	O
synaptic	O
layers	O
and	O
outer	O
segment	O
of	O
photoreceptors	O
(	O
E	O
)	O
.	O

GC	O
,	O
ganglion	O
cell	O
;	O
PLAP	O
,	O
human	O
placental	O
alkaline	B-CHEBI
phophatase	O
;	O
ROS	O
,	O
rod	O
outer	O
segment	O
;	O
RIS	O
,	O
rod	O
inner	O
segment	O
;	O
ONL	O
,	O
outer	O
nuclear	O
layer	O
;	O
OPL	O
,	O
outer	O
plexiform	O
(	O
synaptic	O
)	O
layer	O
;	O
INL	O
,	O
inner	O
nuclear	O
layer	O
;	O
IPL	O
,	O
inner	O
plexiform	O
(	O
synaptic	O
)	O
layer	O
;	O
GC	O
,	O
ganglion	O
cell	O
layer	O
.	O

In	O
light	O
of	O
the	O
association	O
in	O
vivo	O
of	O
RanBP2	O
with	O
Cox11	O
and	O
HKI	O
(	O
Figures	O
1	O
and	O
3	O
)	O
,	O
profound	O
in	O
vitro	O
modulation	O
of	O
HKI	O
enzymatic	O
activity	O
by	O
RanBP2	O
and	O
Cox11	O
(	O
Figure	O
2	O
)	O
,	O
and	O
the	O
critical	O
role	O
of	O
HKI	O
in	O
catalyzing	O
a	O
rate	O
-	O
limiting	O
step	O
of	O
glycolysis	O
,	O
we	O
probed	O
whether	O
RanBP2	O
+	O
/	O
-	O
mice	O
presented	O
disturbances	O
in	O
HKI	O
,	O
Cox11	O
,	O
and	O
energy	O
homeostasis	O
.	O

Monoallelic	O
expression	O
of	O
RanBP2	O
does	O
not	O
affect	O
the	O
number	O
of	O
NPCs	O
and	O
their	O
distribution	O
in	O
hippocampal	O
neurons	O
(	O
Figure	O
5A	O
,	O
unpublished	O
data	O
)	O
,	O
but	O
it	O
led	O
to	O
consistent	O
lower	O
expression	O
of	O
RanBP2	O
by	O
more	O
than	O
50	O
%	O
in	O
the	O
CNS	O
(	O
brain	O
and	O
retina	O
)	O
in	O
129Ola	O
(	O
Figure	O
5B	O
-	O
5D	O
)	O
,	O
but	O
not	O
in	O
C57BL	O
/	O
6J	O
/	O
129Ola	O
backgrounds	O
(	O
unpublished	O
data	O
)	O
.	O

Hence	O
,	O
we	O
focused	O
our	O
analysis	O
on	O
the	O
inbred	O
RanBP2	O
+	O
/	O
-	O
129Ola	O
mouse	O
line	O
.	O

Although	O
the	O
levels	O
of	O
RanBP2	O
were	O
decreased	O
in	O
the	O
retina	O
,	O
brain	O
,	O
and	O
hippocampus	O
of	O
RanBP2	O
+	O
/	O
-	O
mice	O
by	O
~	O
50	O
%	O
-	O
60	O
%	O
(	O
Figure	O
5B	O
and	O
5C	O
)	O
,	O
the	O
levels	O
of	O
others	O
nucleoporins	O
,	O
Nup153	O
and	O
Nup62	O
,	O
and	O
mHsp70	O
and	O
Cox11	O
,	O
remained	O
unchanged	O
(	O
Figure	O
5B	O
,	O
unpublished	O
data	O
)	O
.	O

In	O
addition	O
,	O
we	O
observed	O
a	O
strong	O
decrease	O
of	O
the	O
levels	O
of	O
HKI	O
(	O
3	O
-	O
to	O
4	O
-	O
fold	O
)	O
(	O
Figure	O
5B	O
and	O
5C	O
)	O
.	O

This	O
decrease	O
was	O
selective	O
to	O
the	O
CNS	O
,	O
since	O
HKI	O
levels	O
remained	O
largely	O
unaffected	O
in	O
the	O
skeletal	O
muscle	O
,	O
spleen	O
,	O
and	O
liver	O
(	O
Figure	O
5D	O
)	O
.	O

Because	O
HKI	O
plays	O
a	O
key	O
role	O
in	O
the	O
production	O
of	O
energy	O
intermediate	O
substrates	O
and	O
HKI	O
is	O
virtually	O
the	O
sole	O
HK	O
isoform	O
expressed	O
in	O
the	O
CNS	O
[	O
33	O
,	O
34	O
]	O
,	O
we	O
probed	O
the	O
impact	O
of	O
HKI	O
and	O
RanBP2	O
reduction	O
in	O
the	O
levels	O
of	O
ATP	B-CHEBI
.	O

As	O
shown	O
in	O
Figure	O
5E	O
,	O
there	O
was	O
significant	O
and	O
concordant	O
reduction	O
in	O
levels	O
of	O
ATP	B-CHEBI
in	O
the	O
CNS	O
(	O
brain	O
and	O
retina	O
)	O
,	O
but	O
not	O
in	O
non	O
-	O
neuronal	O
tissues	O
.	O

Finally	O
,	O
we	O
also	O
observed	O
partial	O
and	O
selective	O
delocalization	O
of	O
HKI	O
,	O
but	O
not	O
of	O
Cox11	O
,	O
from	O
the	O
ellipsoid	O
(	O
mitochondria	O
-	O
rich	O
)	O
to	O
the	O
adjacent	O
myoid	O
subcellular	O
compartment	O
of	O
rod	O
photosensory	O
neurons	O
(	O
Figure	O
S2A	O
-	O
S2E	O
)	O
.	O

This	O
was	O
also	O
accompanied	O
by	O
reduced	O
HKI	O
levels	O
in	O
the	O
inner	O
retina	O
,	O
in	O
particular	O
in	O
the	O
inner	O
plexiform	O
(	O
synaptic	O
)	O
layer	O
(	O
Figure	O
S2A	O
-	O
S2E	O
)	O
.	O

Figure	O
5	O

Haploinsufficiency	O
of	O
RanBP2	O
Causes	O
a	O
Decrease	O
in	O
HKI	O
Protein	B-CHEBI
and	O
ATP	B-CHEBI
Levels	O

(	O
A	O
)	O
Quantitative	O
analysis	O
of	O
NPCs	O
in	O
dissociated	O
hippocampal	O
neurons	O
of	O
wild	O
-	O
type	O
(	O
+	O
/	O
+	O
)	O
and	O
heterozygote	O
(	O
+	O
/	O
-	O
)	O
mice	O
upon	O
immunostaining	O
with	O
mAb414	O
.	O

No	O
difference	O
in	O
the	O
density	O
of	O
NPCs	O
(	O
3	O
-	O
4	O
NPC	O
/	O
mu	O
m2	O
)	O
at	O
the	O
nuclear	O
envelope	O
was	O
found	O
between	O
RanBP2	O
+	O
/	O
+	O
and	O
RanBP2	O
+	O
/	O
-	O
mice	O
.	O

(	O
B	O
)	O
Immunoblots	O
with	O
anti	O
-	O
RanBP2	O
/	O
Nup153	O
/	O
Nup62	O
(	O
mAb414	O
)	O
,	O
-	O
HKI	O
,	O
-	O
mHsp70	O
,	O
and	O
-	O
Cox11	O
antibodies	O
of	O
retinal	O
(	O
top	O
panel	O
)	O
and	O
hippocampal	O
homogenates	O
of	O
+	O
/	O
+	O
and	O
+	O
/	O
-	O
mice	O
.	O

In	O
comparison	O
to	O
RanBP2	O
+	O
/	O
+	O
,	O
RanBP2	O
+	O
/	O
-	O
mice	O
exhibit	O
a	O
reduction	O
in	O
the	O
expression	O
levels	O
of	O
RanBP2	O
and	O
HKI	O
but	O
not	O
of	O
other	O
proteins	B-CHEBI
.	O

(	O
C	O
)	O
Quantitative	O
analysis	O
of	O
relative	O
protein	B-CHEBI
expression	O
levels	O
of	O
RanBP2	O
,	O
Cox11	O
,	O
HKI	O
,	O
and	O
mHsp70	O
in	O
the	O
hippocampus	O
of	O
RanBP2	O
+	O
/	O
+	O
and	O
RanBP2	O
+	O
/	O
-	O
mice	O
.	O

There	O
is	O
~	O
2	O
-	O
and	O
4	O
-	O
fold	O
reduction	O
of	O
RanBP2	O
and	O
HKI	O
in	O
heterozygote	O
mice	O
.	O

(	O
D	O
)	O
The	O
level	O
of	O
HKI	O
is	O
reduced	O
in	O
the	O
brain	O
but	O
not	O
in	O
other	O
non	O
-	O
neuronal	O
tissues	O
tested	O
(	O
muscle	O
,	O
spleen	O
,	O
and	O
liver	O
)	O
.	O

(	O
E	O
)	O
The	O
total	O
ATP	B-CHEBI
level	O
is	O
reduced	O
in	O
the	O
CNS	O
tissues	O
(	O
brain	O
and	O
retina	O
)	O
but	O
not	O
in	O
non	O
-	O
neuronal	O
tissues	O
tested	O
(	O
e	O
.	O
g	O
.	O
,	O
spleen	O
)	O
.	O

Metabolic	O
Disturbances	O
Caused	O
by	O
Haploinsufficiency	O
of	O
RanBP2	O

The	O
growth	O
rates	O
of	O
inbred	O
RanBP2	O
+	O
/	O
-	O
mice	O
on	O
high	O
-	O
fat	O
(	O
~	O
10	O
%	O
fat	O
)	O
diet	O
were	O
significantly	O
slower	O
than	O
RanBP2	O
+	O
/	O
+	O
mice	O
(	O
Figure	O
6A	O
)	O
.	O

Beginning	O
at	O
around	O
4	O
mo	O
of	O
age	O
,	O
RanBP2	O
+	O
/	O
-	O
mice	O
exhibit	O
a	O
significant	O
slower	O
gain	O
in	O
body	O
mass	O
than	O
wild	O
-	O
type	O
mice	O
(	O
Figure	O
6A	O
)	O
.	O

In	O
addition	O
,	O
RanBP2	O
+	O
/	O
-	O
inbred	O
mice	O
presented	O
deficits	O
in	O
body	O
mass	O
that	O
were	O
erased	O
by	O
changing	O
the	O
genetic	O
background	O
to	O
a	O
mixed	O
C57BL	O
/	O
6J	O
/	O
129Ola	O
(	O
Figure	O
6B	O
)	O
.	O

Food	B-CHEBI
consumption	O
did	O
not	O
account	O
for	O
the	O
body	O
weight	O
differences	O
observed	O
(	O
Figure	O
6C	O
)	O
.	O

Figure	O
6	O

RanBP2	O
+	O
/	O
-	O
Mice	O
on	O
High	O
-	O
Fat	O
Diet	O
Exhibit	O
Deficits	O
in	O
Growth	O

(	O
A	O
)	O
In	O
comparison	O
to	O
wild	O
-	O
type	O
mice	O
,	O
RanBP2	O
+	O
/	O
-	O
mice	O
show	O
slower	O
growth	O
rates	O
beginning	O
at	O
4	O
mo	O
of	O
age	O
(	O
arrow	O
)	O
,	O
and	O
the	O
difference	O
in	O
body	O
weight	O
between	O
these	O
is	O
maintained	O
afterward	O
.	O

Note	O
that	O
RanBP2	O
+	O
/	O
-	O
mice	O
lack	O
the	O
growth	O
spur	O
observed	O
in	O
wild	O
-	O
type	O
mice	O
between	O
3	O
and	O
4	O
mo	O
of	O
age	O
.	O

(	O
B	O
)	O
In	O
comparison	O
to	O
inbred	O
RanBP2	O
+	O
/	O
-	O
mice	O
(	O
129Ola	O
genetic	O
background	O
)	O
,	O
the	O
difference	O
in	O
body	O
weight	O
between	O
RanBP2	O
+	O
/	O
+	O
and	O
RanBP2	O
+	O
/	O
-	O
mice	O
is	O
masked	O
upon	O
placing	O
these	O
on	O
a	O
mixed	O
129Ola	O
/	O
C57Bl6	O
genetic	O
background	O
.	O

(	O
C	O
)	O
RanBP2	O
+	O
/	O
+	O
and	O
RanBP2	O
+	O
/	O
-	O
inbred	O
mice	O
exhibit	O
similar	O
rates	O
of	O
food	B-CHEBI
consumption	O
.	O

Mice	O
in	O
(	O
A	O
)	O
,	O
(	O
B	O
)	O
,	O
and	O
(	O
C	O
)	O
were	O
placed	O
on	O
a	O
high	O
-	O
fat	O
diet	O
since	O
birth	O
(	O
n	O
=	O
5	O
)	O
.	O

HKI	O
in	O
the	O
CNS	O
(	O
brain	O
and	O
retina	O
)	O
accounts	O
virtually	O
for	O
all	O
expression	O
of	O
HK	O
isozymes	O
and	O
glucose	B-CHEBI
utilization	O
in	O
the	O
CNS	O
[	O
33	O
,	O
34	O
]	O
.	O

Moreover	O
,	O
glucose	B-CHEBI
is	O
the	O
sole	O
reliance	O
source	O
of	O
energy	O
in	O
the	O
CNS	O
under	O
normal	O
conditions	O
,	O
the	O
CNS	O
lacks	O
glucose	B-CHEBI
storage	O
sources	O
,	O
and	O
despite	O
the	O
disproportionate	O
mass	O
of	O
the	O
CNS	O
to	O
the	O
rest	O
of	O
the	O
body	O
,	O
the	O
CNS	O
consumes	O
daily	O
about	O
60	O
%	O
of	O
the	O
body	O
'	O
s	O
glucose	B-CHEBI
and	O
25	O
%	O
of	O
the	O
total	O
oxygen	B-CHEBI
[	O
35	O
,	O
36	O
]	O
.	O

To	O
determine	O
the	O
impact	O
of	O
RanBP2	O
haploinsufficiency	O
on	O
the	O
utilization	O
,	O
formation	O
,	O
and	O
uptake	O
of	O
glucose	B-CHEBI
,	O
we	O
carried	O
out	O
several	O
physiological	O
assays	O
.	O

In	O
contrast	O
to	O
mice	O
placed	O
on	O
a	O
normal	O
chow	B-CHEBI
diet	O
(	O
~	O
5	O
%	O
fat	O
;	O
unpublished	O
data	O
)	O
,	O
RanBP2	O
+	O
/	O
-	O
mice	O
on	O
a	O
higher	O
fat	O
diet	O
(	O
~	O
10	O
%	O
fat	O
)	O
performed	O
significantly	O
worse	O
in	O
the	O
glucose	B-CHEBI
tolerance	O
test	O
beginning	O
at	O
6	O
mo	O
of	O
age	O
(	O
Figure	O
7A	O
and	O
7B	O
)	O
,	O
thus	O
supporting	O
that	O
the	O
RanBP2	O
+	O
/	O
-	O
mice	O
exhibited	O
a	O
deficit	O
in	O
glucose	B-CHEBI
clearance	O
.	O

This	O
deficit	O
was	O
rescued	O
in	O
RanBP2	O
+	O
/	O
-	O
mice	O
of	O
mixed	O
C57BL	O
/	O
6J	O
/	O
129Ola	O
background	O
(	O
Figure	O
S3	O
)	O
.	O

Glucose	B-CHEBI
clearance	O
was	O
not	O
affected	O
due	O
to	O
a	O
disturbance	O
in	O
insulin	B-CHEBI
-	O
mediated	O
glucose	B-CHEBI
uptake	O
(	O
Figure	O
7C	O
)	O
.	O

Then	O
,	O
we	O
probed	O
whether	O
RanBP2	O
induces	O
impairment	O
of	O
gluconeogenesis	O
,	O
which	O
could	O
contribute	O
to	O
the	O
pathophysiological	O
production	O
and	O
clearance	O
of	O
glucose	B-CHEBI
.	O

To	O
this	O
end	O
,	O
the	O
administration	O
of	O
the	O
gluconeogenic	O
substrate	O
precursor	O
,	O
pyruvate	B-CHEBI
(	O
pyruvate	B-CHEBI
tolerance	O
test	O
)	O
,	O
showed	O
that	O
there	O
was	O
no	O
difference	O
in	O
glucose	B-CHEBI
production	O
in	O
RanBP2	O
+	O
/	O
-	O
mice	O
(	O
Figure	O
7D	O
)	O
.	O

Hence	O
,	O
partial	O
loss	O
-	O
of	O
-	O
function	O
of	O
RanBP2	O
had	O
no	O
impact	O
on	O
the	O
gluconeogenesis	O
pathway	O
.	O

However	O
,	O
upon	O
glucose	B-CHEBI
production	O
(	O
15	O
min	O
)	O
,	O
the	O
clearance	O
rates	O
of	O
glucose	B-CHEBI
were	O
again	O
significantly	O
slower	O
in	O
RanBP2	O
+	O
/	O
-	O
than	O
in	O
RanBP2	O
+	O
/	O
+	O
mice	O
(	O
Figure	O
7D	O
)	O
,	O
confirming	O
an	O
impairment	O
in	O
glucose	B-CHEBI
breakdown	O
.	O

Figure	O
7	O

Metabolic	O
Phenotypes	O
of	O
RanBP2	O
+	O
/	O
-	O
Inbred	O
Mice	O
on	O
High	O
-	O
Fat	O
Diet	O

(	O
A	O
)	O
3	O
-	O
mo	O
-	O
old	O
inbred	O
RanBP2	O
+	O
/	O
-	O
mice	O
(	O
n	O
=	O
5	O
)	O
have	O
normal	O
glucose	B-CHEBI
clearance	O
rates	O
upon	O
glucose	B-CHEBI
challenge	O
and	O
overnight	O
fasting	O
.	O

(	O
B	O
)	O
In	O
contrast	O
,	O
6	O
-	O
mo	O
-	O
old	O
inbred	O
RanBP2	O
+	O
/	O
-	O
mice	O
(	O
n	O
=	O
5	O
)	O
have	O
significantly	O
decreased	O
glucose	B-CHEBI
clearance	O
rates	O
upon	O
glucose	B-CHEBI
challenge	O
and	O
overnight	O
fasting	O
.	O

(	O
C	O
)	O
Fasted	O
6	O
-	O
to	O
8	O
-	O
mo	O
-	O
old	O
RanBP2	O
+	O
/	O
+	O
and	O
RanBP2	O
+	O
/	O
-	O
mice	O
have	O
no	O
difference	O
in	O
insulin	B-CHEBI
-	O
mediated	O
glucose	B-CHEBI
uptake	O
as	O
assayed	O
by	O
insulin	B-CHEBI
tolerance	O
test	O
(	O
n	O
=	O
5	O
)	O
.	O

(	O
D	O
)	O
Pyruvate	B-CHEBI
tolerance	O
test	O
shows	O
normal	O
rise	O
in	O
glucose	B-CHEBI
but	O
decreased	O
glucose	B-CHEBI
clearance	O
between	O
inbred	O
RanBP2	O
+	O
/	O
+	O
and	O
RanBP2	O
+	O
/	O
-	O
mice	O
(	O
n	O
=	O
5	O
)	O
.	O

Haploinsufficiency	O
of	O
RanBP2	O
Causes	O
Deficits	O
in	O
the	O
Electrophysiological	O
Output	O
of	O
Receptoral	O
and	O
Postreceptoral	O
Retinal	O
Neurons	O

In	O
light	O
of	O
the	O
prominent	O
expression	O
of	O
RanBP2	O
and	O
HKI	O
in	O
retinal	O
neurons	O
[	O
1	O
,	O
19	O
]	O
,	O
the	O
vital	O
dependence	O
of	O
the	O
neuronal	O
retina	O
(	O
and	O
brain	O
)	O
on	O
glucose	B-CHEBI
as	O
the	O
main	O
substrate	O
source	O
for	O
energy	O
production	O
,	O
and	O
the	O
determinant	O
impact	O
of	O
metabolic	O
disorders	O
,	O
such	O
as	O
diabetes	O
,	O
in	O
retinal	O
function	O
(	O
e	O
.	O
g	O
.	O
,	O
diabetic	O
retinopathy	O
)	O
[	O
37	O
]	O
,	O
we	O
probed	O
the	O
impact	O
of	O
deficits	O
in	O
RanBP2	O
,	O
HKI	O
,	O
and	O
ATP	B-CHEBI
,	O
on	O
the	O
electrophysiological	O
responses	O
of	O
subclasses	O
(	O
rod	O
and	O
cone	O
)	O
photoreceptor	O
and	O
postreceptor	O
retinal	O
neurons	O
of	O
RanBP2	O
+	O
/	O
-	O
and	O
in	O
RanBP2	O
+	O
/	O
+	O
mice	O
.	O

The	O
scotopic	O
(	O
dark	O
-	O
adapted	O
)	O
responses	O
mediated	O
by	O
the	O
rod	O
photoreceptor	O
pathway	O
at	O
low	O
-	O
stimulus	O
intensities	O
and	O
mixed	O
rod	O
and	O
cone	O
pathways	O
at	O
high	O
-	O
stimulus	O
intensities	O
were	O
substantially	O
reduced	O
in	O
RanBP2	O
+	O
/	O
-	O
mice	O
(	O
Figure	O
8A	O
)	O
.	O

The	O
differences	O
in	O
the	O
photopic	O
(	O
light	O
-	O
adapted	O
)	O
responses	O
,	O
initiated	O
by	O
cone	O
photoreceptors	O
,	O
which	O
make	O
up	O
3	O
%	O
of	O
the	O
photosensory	O
neurons	O
in	O
the	O
mouse	O
retina	O
[	O
38	O
]	O
,	O
were	O
less	O
obvious	O
but	O
still	O
exhibited	O
a	O
trend	O
toward	O
reduced	O
amplitudes	O
across	O
a	O
range	O
of	O
increasing	O
light	O
stimulus	O
intensities	O
(	O
Figure	O
8B	O
)	O
.	O

The	O
reduction	O
in	O
the	O
scotopic	O
responses	O
included	O
decreases	O
in	O
both	O
b	O
-	O
wave	O
(	O
Figure	O
8C	O
)	O
and	O
a	O
-	O
wave	O
(	O
Figure	O
8D	O
)	O
amplitudes	O
mediated	O
by	O
postreceptoral	O
and	O
receptoral	O
neurons	O
,	O
respectively	O
.	O

Postreceptoral	O
second	O
-	O
order	O
neuron	O
responses	O
,	O
represented	O
by	O
the	O
b	O
-	O
wave	O
,	O
tended	O
to	O
be	O
more	O
consistently	O
and	O
substantially	O
reduced	O
than	O
the	O
a	O
-	O
waves	O
,	O
which	O
directly	O
reflect	O
photoreceptor	O
activity	O
.	O

Since	O
second	O
-	O
order	O
neuron	O
responses	O
depend	O
on	O
input	O
from	O
photoreceptors	O
,	O
this	O
suggests	O
that	O
reduced	O
b	O
-	O
wave	O
amplitudes	O
are	O
the	O
result	O
of	O
the	O
accumulation	O
of	O
decreases	O
in	O
the	O
light	O
response	O
of	O
both	O
photoreceptors	O
and	O
postreceptoral	O
neurons	O
.	O

Anesthetics	B-CHEBI
,	O
particularly	O
ketamine	O
,	O
can	O
cause	O
sustained	O
elevation	O
of	O
glucose	B-CHEBI
in	O
mice	O
,	O
which	O
in	O
turn	O
affects	O
electroretinogram	O
responses	O
[	O
39	O
]	O
.	O

Thus	O
,	O
we	O
were	O
concerned	O
that	O
differences	O
in	O
electroretinogram	O
amplitudes	O
between	O
RanBP2	O
+	O
/	O
-	O
and	O
RanBP2	O
+	O
/	O
+	O
may	O
reflect	O
differences	O
in	O
glucose	B-CHEBI
level	O
changes	O
in	O
response	O
to	O
anesthesia	O
.	O

However	O
,	O
we	O
found	O
no	O
significant	O
differences	O
in	O
glucose	B-CHEBI
levels	O
measured	O
before	O
and	O
every	O
15	O
min	O
during	O
75	O
min	O
of	O
anesthesia	O
(	O
n	O
=	O
4	O
-	O
5	O
)	O
.	O

Glucose	B-CHEBI
rose	O
at	O
the	O
same	O
rate	O
and	O
reached	O
a	O
maximum	O
of	O
approximately	O
3	O
.	O
3	O
times	O
the	O
pre	O
-	O
anesthesia	O
level	O
in	O
both	O
genotypes	O
(	O
unpublished	O
data	O
)	O
.	O

Figure	O
8	O

Electroretinograms	O
from	O
6	O
-	O
Mo	O
-	O
Old	O
RanBP2	O
+	O
/	O
-	O
and	O
RanBP2	O
+	O
/	O
+	O
Inbred	O
Mice	O
Showing	O
Photoreceptor	O
and	O
Postreceptor	O
Neuron	O
Electrophysiological	O
Response	O
Phenotypes	O

(	O
A	O
)	O
Scotopic	O
(	O
dark	O
-	O
adapted	O
)	O
responses	O
from	O
RanBP2	O
+	O
/	O
-	O
mice	O
to	O
light	O
stimuli	O
of	O
increasing	O
intensity	O
,	O
beginning	O
at	O
threshold	O
,	O
have	O
reduced	O
amplitudes	O
compared	O
to	O
those	O
observed	O
in	O
RanBP2	O
+	O
/	O
+	O
mice	O
.	O

The	O
three	O
lower	O
intensities	O
represent	O
responses	O
generated	O
in	O
the	O
rod	O
photoreceptor	O
neuronal	O
pathway	O
.	O

The	O
upper	O
intensities	O
are	O
comprised	O
of	O
responses	O
generated	O
in	O
both	O
the	O
rod	O
and	O
cone	O
pathways	O
.	O

(	O
B	O
)	O
Photopic	O
(	O
light	O
-	O
adapted	O
,	O
cone	O
photoreceptor	O
pathway	O
)	O
responses	O
of	O
RanBP2	O
+	O
/	O
-	O
mice	O
to	O
increasing	O
light	O
stimulus	O
intensities	O
also	O
exhibited	O
reduced	O
amplitudes	O
compared	O
to	O
those	O
observed	O
in	O
RanBP2	O
+	O
/	O
+	O
mice	O
.	O

(	O
C	O
)	O
Average	O
+/-	O
SE	O
(	O
n	O
=	O
9	O
)	O
scotopic	O
b	O
-	O
wave	O
amplitudes	O
from	O
RanBP2	O
+	O
/	O
-	O
(	O
open	O
circles	O
)	O
and	O
RanBP2	O
+	O
/	O
+	O
(	O
filled	O
squares	O
)	O
mice	O
representing	O
postreceptoral	O
neuron	O
function	O
.	O

(	O
Note	O
:	O
log	O
amplitude	O
scale	O
.	O
)	O

(	O
D	O
)	O
Average	O
+/-	O
SE	O
(	O
n	O
=	O
5	O
)	O
scotopic	O
a	O
-	O
wave	O
amplitudes	O
,	O
representing	O
photoreceptor	O
function	O
,	O
for	O
RanBP2	O
+	O
/	O
-	O
and	O
RanBP2	O
+	O
/	O
+	O
mice	O
in	O
response	O
to	O
bright	O
flashes	O
.	O

Amplitudes	O
of	O
responses	O
from	O
RanBP2	O
+	O
/	O
-	O
mice	O
were	O
lower	O
over	O
the	O
entire	O
range	O
of	O
stimulus	O
intensities	O
for	O
both	O
b	O
-	O
and	O
a	O
-	O
waves	O
.	O

Asterisks	O
represent	O
significant	O
differences	O
between	O
the	O
groups	O
(	O
Student	O
'	O
s	O
t	O
test	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Statistical	O
significance	O
was	O
found	O
across	O
all	O
intensities	O
for	O
b	O
-	O
wave	O
amplitudes	O
(	O
2	O
-	O
way	O
ANOVA	O
,	O
p	O
<	O
0	O
.	O
0001	O
)	O
,	O
but	O
not	O
for	O
the	O
a	O
-	O
wave	O
.	O

Discussion	O

Our	O
findings	O
support	O
that	O
RanBP2	O
plays	O
a	O
determinant	O
role	O
in	O
modulating	O
glucose	B-CHEBI
and	O
energy	O
homeostasis	O
.	O

The	O
data	O
support	O
that	O
Cox1	O
and	O
HKI	O
are	O
novel	O
partners	O
in	O
vivo	O
for	O
the	O
large	O
LD	O
of	O
RanBP2	O
(	O
Figures	O
1	O
and	O
2	O
)	O
.	O

The	O
LD	O
of	O
RanBP2	O
exhibits	O
chaperone	O
activity	O
toward	O
folding	O
intermediates	O
of	O
Cox11	O
,	O
and	O
possibly	O
,	O
the	O
mature	O
HKI	O
(	O
Figure	O
1	O
)	O
.	O

Cox11	O
inhibits	O
noncompetitively	O
the	O
activity	O
of	O
HKI	O
with	O
~	O
2	O
-	O
3	O
molecules	B-CHEBI
of	O
Cox11	O
(	O
assuming	O
formation	O
of	O
Cox11	O
dimer	O
)	O
required	O
to	O
inhibit	O
completely	O
the	O
activity	O
of	O
a	O
molecule	B-CHEBI
of	O
HKI	O
(	O
Figure	O
2A	O
and	O
2B	O
)	O
.	O

Cox11	O
sequesters	O
HKI	O
by	O
binding	O
to	O
HKI	O
at	O
a	O
site	O
that	O
is	O
distinct	O
from	O
the	O
active	O
site	O
and	O
effectively	O
reduces	O
the	O
availability	O
of	O
[	O
HKI	O
]	O
tot	O
for	O
catalysis	O
.	O

This	O
is	O
reflected	O
by	O
a	O
reduction	O
of	O
the	O
Vmax	O
of	O
HKI	O
without	O
significantly	O
affecting	O
the	O
Km	O
of	O
the	O
active	O
site	O
of	O
HKI	O
toward	O
glucose	B-CHEBI
(	O
Figure	O
2A	O
and	O
2B	O
)	O
.	O

The	O
inhibitory	O
property	O
of	O
Cox11	O
over	O
HKI	O
is	O
suppressed	O
by	O
RanBP2	O
(	O
Figure	O
2C	O
)	O
,	O
which	O
by	O
itself	O
has	O
a	O
weak	O
but	O
significant	O
inhibitory	O
activity	O
over	O
HKI	O
(	O
Figure	O
2D	O
)	O
.	O

The	O
sub	O
-	O
stochiometry	O
effect	O
of	O
the	O
LD	O
of	O
RanBP2	O
over	O
the	O
inhibition	O
of	O
HKI	O
by	O
Cox11	O
supports	O
that	O
a	O
LD	O
-	O
dependent	O
chaperonin	O
-	O
like	O
mechanism	O
underlies	O
the	O
suppression	O
of	O
Cox11	O
-	O
dependent	O
inhibition	O
of	O
HKI	O
by	O
RanBP2	O
,	O
and	O
that	O
RanBP2	O
acts	O
as	O
a	O
molecular	B-CHEBI
"	O
buffer	O
"	O
over	O
HK1	O
and	O
Cox11	O
activities	O
.	O

The	O
partial	O
loss	O
of	O
the	O
RanBP2	O
chaperone	O
activity	O
in	O
RanBP2	O
+	O
/	O
-	O
mice	O
also	O
leads	O
to	O
deficits	O
in	O
the	O
sequestration	O
of	O
HKI	O
in	O
the	O
ellipsoid	O
compartment	O
of	O
photosensory	O
neurons	O
.	O

This	O
possibly	O
underlies	O
the	O
mistargeting	O
of	O
HKI	O
to	O
the	O
myoid	O
compartment	O
of	O
these	O
neurons	O
(	O
Figure	O
S2	O
)	O
.	O

The	O
data	O
support	O
that	O
the	O
ultimate	O
pathophysiological	O
outcome	O
in	O
HKI	O
,	O
caused	O
by	O
a	O
reduction	O
in	O
RanBP2	O
levels	O
and	O
its	O
chaperone	O
activity	O
,	O
is	O
the	O
selective	O
degradation	O
of	O
HKI	O
as	O
reflected	O
by	O
the	O
reduced	O
levels	O
of	O
HKI	O
(	O
and	O
ATP	B-CHEBI
)	O
but	O
not	O
of	O
other	O
mitochondrial	O
and	O
NPC	O
components	O
(	O
Figure	O
5	O
)	O
.	O

Through	O
this	O
process	O
,	O
it	O
is	O
also	O
possible	O
that	O
deficits	O
in	O
RanBP2	O
cause	O
a	O
disturbance	O
in	O
the	O
equilibrium	O
between	O
Cox11	O
,	O
HK1	O
,	O
and	O
RanBP2	O
by	O
leading	O
to	O
an	O
increase	O
of	O
the	O
inhibitory	O
activity	O
of	O
Cox11	O
over	O
HKI	O
that	O
promotes	O
the	O
uncoupling	O
of	O
the	O
interaction	O
of	O
HKI	O
from	O
RanBP2	O
,	O
ultimately	O
causing	O
HKI	O
degradation	O
.	O

Regardless	O
,	O
lower	O
levels	O
of	O
HKI	O
likely	O
contribute	O
to	O
the	O
decreased	O
levels	O
in	O
ATP	B-CHEBI
,	O
slower	O
growth	O
rates	O
,	O
and	O
diminished	O
ability	O
to	O
metabolize	O
glucose	B-CHEBI
of	O
RanBP2	O
+	O
/	O
-	O
mice	O
(	O
Figures	O
5	O
-	O
7	O
)	O
.	O

As	O
discussed	O
subsequently	O
,	O
the	O
ATP	B-CHEBI
deficits	O
in	O
the	O
retina	O
likely	O
account	O
for	O
the	O
reduced	O
electrophysiological	O
responses	O
of	O
retinal	O
neurons	O
(	O
Figure	O
8	O
)	O
.	O

Various	O
domains	O
of	O
RanBP2	O
have	O
been	O
previously	O
implicated	O
with	O
a	O
chaperone	O
role	O
in	O
the	O
cell	O
.	O

These	O
include	O
the	O
enhancement	O
of	O
the	O
biogenesis	O
of	O
red	O
/	O
green	O
opsin	O
by	O
the	O
combination	O
of	O
the	O
RBD4	O
-	O
CY	O
domains	O
[	O
6	O
,	O
7	O
]	O
and	O
the	O
stabilization	O
by	O
the	O
Ran	O
-	O
binding	O
domains	O
of	O
RanBP2	O
of	O
the	O
guanosine	B-CHEBI
triphosphate	I-CHEBI
-	O
bound	O
conformational	O
state	O
of	O
RanGTPase	O
and	O
interaction	O
of	O
Ran	O
with	O
importin	O
-	O
beta	O
[	O
11	O
,	O
40	O
,	O
41	O
]	O
.	O

The	O
data	O
herein	O
show	O
that	O
the	O
multi	O
-	O
chaperone	O
role	O
of	O
RanBP2	O
extends	O
also	O
to	O
its	O
LD	O
in	O
light	O
of	O
its	O
ability	O
to	O
associate	O
to	O
distinct	O
folding	O
species	O
of	O
Cox11	O
and	O
to	O
prevent	O
HKI	O
from	O
being	O
degraded	O
.	O

This	O
chaperone	O
function	O
is	O
likely	O
to	O
be	O
complemented	O
by	O
other	O
partners	O
of	O
RanBP2	O
with	O
similar	O
and	O
pleiotropic	O
functions	O
.	O

For	O
example	O
,	O
the	O
combination	O
of	O
the	O
CLD	O
of	O
RanBP2	O
with	O
several	O
subunits	O
of	O
the	O
19S	O
cap	O
of	O
the	O
proteasome	O
[	O
14	O
]	O
,	O
and	O
of	O
its	O
neighboring	O
internal	O
repeat	O
,	O
W1W2	O
/	O
IR	O
with	O
the	O
E3	O
-	O
ubiquitin	O
ligase	O
,	O
parkin	O
[	O
20	O
]	O
,	O
and	O
the	O
E2	O
SUMO	O
-	O
1	O
-	O
conjugating	O
protein	B-CHEBI
,	O
Ubc9	O
[	O
15	O
]	O
may	O
contribute	O
to	O
the	O
down	O
-	O
regulation	O
of	O
HKI	O
by	O
26S	O
proteasome	O
-	O
mediated	O
proteolysis	O
and	O
modulation	O
of	O
the	O
molecular	B-CHEBI
and	O
subcellular	O
partitioning	O
of	O
these	O
partners	O
.	O

In	O
this	O
regard	O
,	O
it	O
will	O
be	O
interesting	O
to	O
probe	O
whether	O
parkin	O
also	O
causes	O
deficits	O
in	O
HKI	O
in	O
dopaminergic	B-CHEBI
neurons	O
,	O
since	O
parkin	O
was	O
reported	O
to	O
modulate	O
RanBP2	O
turnover	O
[	O
20	O
]	O
,	O
and	O
parkin	O
loss	O
-	O
of	O
-	O
function	O
also	O
causes	O
energy	O
and	O
growth	O
deficits	O
[	O
26	O
-	O
29	O
,	O
42	O
]	O
.	O

These	O
data	O
add	O
a	O
new	O
dimension	O
to	O
the	O
complexity	O
of	O
the	O
regulation	O
of	O
the	O
glycolytic	O
pathway	O
,	O
in	O
particular	O
in	O
the	O
CNS	O
,	O
where	O
glycolysis	O
plays	O
a	O
major	O
role	O
in	O
supplying	O
energy	O
and	O
where	O
the	O
proteasome	O
machinery	O
may	O
play	O
a	O
critical	O
role	O
in	O
modulating	O
components	O
of	O
the	O
energy	O
supply	O
machinery	O
[	O
43	O
]	O
.	O

This	O
is	O
further	O
evidenced	O
by	O
the	O
presence	O
of	O
genetic	O
modifiers	O
in	O
RanBP2	O
+	O
/	O
-	O
mice	O
on	O
a	O
mixed	O
genetic	O
background	O
that	O
compensates	O
for	O
deficits	O
in	O
RanBP2	O
and	O
deregulation	O
of	O
its	O
partners	O
in	O
glucose	B-CHEBI
/	O
energy	O
homeostasis	O
as	O
observed	O
in	O
the	O
coisogenic	O
line	O
.	O

The	O
presence	O
of	O
such	O
compensatory	O
mechanisms	O
is	O
also	O
supported	O
by	O
the	O
identification	O
of	O
a	O
quantitative	O
trait	O
locus	O
,	O
which	O
encompasses	O
RanBP2	O
,	O
and	O
modifies	O
the	O
expression	O
of	O
diabetes	O
-	O
related	O
phenotypes	O
[	O
44	O
]	O
.	O

The	O
data	O
herein	O
show	O
tissues	O
with	O
a	O
decrease	O
of	O
RanBP2	O
and	O
HKI	O
levels	O
mirror	O
a	O
reduction	O
in	O
the	O
ATP	B-CHEBI
levels	O
.	O

Since	O
the	O
constitutive	O
Na	B-CHEBI
+	I-CHEBI
/	O
K	B-CHEBI
+	I-CHEBI
ATPase	O
pump	O
and	O
the	O
ATP	B-CHEBI
-	O
dependent	O
conversion	O
of	O
glutamine	B-CHEBI
to	O
glutamate	B-CHEBI
(	O
both	O
fundamental	O
to	O
maintain	O
the	O
electrical	O
activity	O
in	O
the	O
CNS	O
)	O
consumes	O
the	O
vast	O
majority	O
of	O
the	O
energy	O
produced	O
by	O
the	O
CNS	O
[	O
45	O
-	O
47	O
]	O
,	O
this	O
likely	O
underlies	O
the	O
suppression	O
of	O
the	O
electrophysiological	O
output	O
responses	O
of	O
retinal	O
neurons	O
(	O
Figure	O
8	O
)	O
.	O

Moreover	O
,	O
deficits	O
in	O
HKI	O
may	O
lead	O
to	O
intracellular	O
hyperglycemia	O
in	O
the	O
CNS	O
,	O
promote	O
sorbitol	B-CHEBI
-	O
induced	O
osmotic	O
stress	O
,	O
and	O
compromise	O
further	O
the	O
ATPase	O
-	O
dependent	O
Na	B-CHEBI
+	I-CHEBI
/	O
K	B-CHEBI
+	I-CHEBI
pump	O
activity	O
[	O
48	O
-	O
50	O
]	O
.	O

This	O
may	O
be	O
exacerbated	O
by	O
a	O
decrease	O
of	O
ATP	B-CHEBI
,	O
since	O
the	O
activity	O
of	O
HKI	O
is	O
also	O
stimulated	O
by	O
ATP	B-CHEBI
[	O
51	O
]	O
.	O

The	O
cumulative	O
effects	O
of	O
a	O
reduction	O
in	O
ATP	B-CHEBI
and	O
intracellular	O
hyperglycemia	O
are	O
known	O
to	O
act	O
synergistically	O
and	O
modulate	O
the	O
electrophysiological	O
properties	O
of	O
neuronal	O
activity	O
.	O

Figure	O
9	O
integrates	O
in	O
a	O
model	O
these	O
variables	O
and	O
implications	O
of	O
the	O
data	O
presented	O
herein	O
.	O

Still	O
,	O
other	O
bona	O
fide	O
RanBP2	O
partners	O
previously	O
identified	O
and	O
described	O
in	O
the	O
Introduction	O
also	O
become	O
strong	O
candidates	O
to	O
play	O
a	O
role	O
in	O
energy	O
homeostasis	O
.	O

For	O
example	O
,	O
the	O
unfolding	O
and	O
chaperone	O
activity	O
of	O
components	O
of	O
the	O
19S	O
cap	O
of	O
the	O
proteasome	O
may	O
be	O
modulated	O
by	O
the	O
CLD	O
of	O
RanBP2	O
[	O
14	O
]	O
and	O
contribute	O
to	O
the	O
selective	O
HKI	O
(	O
and	O
other	O
substrates	O
)	O
degradation	O
[	O
43	O
]	O
,	O
while	O
association	O
of	O
nuclear	O
import	O
receptor	O
,	O
importin	O
-	O
beta	O
with	O
the	O
Ran	O
-	O
binding	O
domains	O
of	O
RanBP2	O
[	O
10	O
,	O
11	O
]	O
,	O
may	O
mediate	O
the	O
nuclear	O
translocation	O
of	O
multifunctional	O
substrates	O
,	O
such	O
as	O
glyceraldehyde	B-CHEBI
-	I-CHEBI
3	I-CHEBI
-	I-CHEBI
phosphate	I-CHEBI
dehydrogenase	O
.	O

This	O
trafficking	O
process	O
is	O
selectively	O
inhibited	O
by	O
the	O
neuroprotective	O
drug	B-CHEBI
,	O
R	O
-	O
(	O
-	O
)	O
-	O
deprenyl	O
and	O
derivates	O
thereof	O
,	O
and	O
are	O
often	O
employed	O
to	O
treat	O
Parkinson	O
disease	O
[	O
52	O
-	O
57	O
]	O
.	O

Hence	O
,	O
RanBP2	O
and	O
its	O
partners	O
emerge	O
as	O
key	O
players	O
and	O
target	O
genes	O
in	O
mediating	O
neuropathophysiological	O
mechanisms	O
implicated	O
in	O
various	O
genetic	O
and	O
environmental	O
lesions	O
to	O
the	O
CNS	O
,	O
as	O
in	O
patients	O
with	O
Parkinson	O
,	O
diabetes	O
with	O
insulin	B-CHEBI
-	O
resistance	O
,	O
and	O
other	O
neuropathies	O
and	O
neurodegenerative	O
diseases	O
,	O
often	O
linked	O
to	O
aging	O
manifestations	O
.	O

To	O
this	O
effect	O
,	O
the	O
RanBP2	O
mouse	O
model	O
will	O
serve	O
as	O
a	O
unique	O
genetic	O
tool	O
to	O
probe	O
selective	O
,	O
multiple	O
and	O
novel	O
pathways	O
,	O
which	O
may	O
have	O
not	O
been	O
anticipated	O
to	O
be	O
linked	O
to	O
metabolic	O
processes	O
and	O
allied	O
pathophysiological	O
states	O
.	O

Figure	O
9	O

Model	O
Depicting	O
a	O
Role	O
of	O
RanBP2	O
and	O
Some	O
of	O
Its	O
Partners	O
in	O
Metabolic	O
and	O
Neuronal	O
Function	O

RanBP2	O
interacts	O
with	O
Cox11	O
and	O
HKI	O
and	O
the	O
triad	O
is	O
in	O
equilibrium	O
under	O
normal	O
physiological	O
conditions	O
.	O

RanBP2	O
prevents	O
the	O
inhibition	O
of	O
HKI	O
by	O
Cox11	O
and	O
its	O
degradation	O
.	O

The	O
ultimate	O
effect	O
of	O
RanBP2	O
on	O
its	O
partners	O
is	O
the	O
stimulation	O
of	O
the	O
glycolytic	O
pathway	O
and	O
production	O
of	O
ATP	B-CHEBI
.	O

The	O
glycolytic	O
pathway	O
is	O
critical	O
to	O
fuel	O
the	O
constitutive	O
Na	B-CHEBI
+	I-CHEBI
/	O
K	B-CHEBI
+	I-CHEBI
-	O
ATPase	O
pump	O
to	O
maintain	O
the	O
dark	O
current	O
between	O
the	O
inner	O
and	O
outer	O
segment	O
compartments	O
of	O
photosensory	O
neurons	O
.	O

A	O
deficit	O
(	O
haploinsufficiency	O
)	O
in	O
RanBP2	O
disturbs	O
the	O
equilibrium	O
between	O
RanBP2	O
,	O
HKI	O
,	O
and	O
Cox11	O
.	O

This	O
pathophysiological	O
event	O
promotes	O
the	O
destabilization	O
and	O
degradation	O
of	O
HKI	O
and	O
a	O
decrease	O
in	O
ATP	B-CHEBI
production	O
required	O
to	O
maintain	O
the	O
depolarization	O
state	O
neurons	O
,	O
and	O
,	O
hence	O
,	O
a	O
reduction	O
in	O
the	O
response	O
of	O
receptoral	O
and	O
postreceptoral	O
neurons	O
.	O

A	O
reduction	O
in	O
ATP	B-CHEBI
levels	O
also	O
negatively	O
modulates	O
HKI	O
activity	O
/	O
level	O
.	O

Decreased	O
levels	O
of	O
HKI	O
promote	O
intracellular	O
hyperglycemia	O
and	O
activate	O
stress	O
kinases	O
,	O
which	O
modulate	O
negatively	O
the	O
Na	B-CHEBI
+	I-CHEBI
/	O
K	B-CHEBI
+	I-CHEBI
-	O
ATPase	O
pump	O
by	O
phosphorylation	O
.	O

Pathophysiological	O
pathways	O
promoted	O
by	O
RanBP2	O
haploinsufficiency	O
are	O
represented	O
by	O
dash	O
lines	O
.	O

RIS	O
,	O
rod	O
inner	O
segment	O
;	O
ROS	O
,	O
rod	O
outer	O
segment	O
.	O

Finally	O
,	O
RanBP2	O
appears	O
to	O
join	O
other	O
nucleoporins	O
,	O
such	O
as	O
Nup96	O
[	O
58	O
]	O
,	O
in	O
novel	O
physiological	O
functions	O
that	O
are	O
vital	O
for	O
complex	O
organisms	O
and	O
that	O
were	O
not	O
anticipated	O
from	O
cell	O
-	O
based	O
studies	O
.	O

The	O
reduced	O
expression	O
of	O
these	O
proteins	B-CHEBI
in	O
whole	O
-	O
animal	O
models	O
generates	O
phenotypes	O
that	O
are	O
tissue	O
-	O
restricted	O
and	O
more	O
importantly	O
,	O
do	O
not	O
seem	O
to	O
recapitulate	O
phenotypes	O
observed	O
with	O
knockdown	O
experiments	O
in	O
cell	O
-	O
based	O
culture	O
assays	O
.	O

For	O
example	O
,	O
short	O
interfering	O
RNA	O
-	O
mediated	O
knockdown	O
of	O
RanBP2	O
[	O
9	O
]	O
and	O
members	O
of	O
the	O
Nup107	O
-	O
Nup160	O
complex	O
[	O
59	O
-	O
61	O
]	O
have	O
shown	O
,	O
respectively	O
,	O
to	O
cause	O
mitotic	O
arrest	O
and	O
disruption	O
of	O
nuclear	O
pore	O
assembly	O
and	O
deficits	O
in	O
mRNA	B-CHEBI
export	O
in	O
cell	O
culture	O
.	O

Yet	O
,	O
haploinsufficiency	O
of	O
RanBP2	O
(	O
this	O
work	O
)	O
and	O
Nup96	O
[	O
58	O
]	O
predominantly	O
produce	O
,	O
instead	O
,	O
CNS	O
-	O
restricted	O
deficits	O
in	O
energy	O
metabolism	O
and	O
alterations	O
in	O
the	O
immune	O
system	O
linked	O
to	O
the	O
down	O
-	O
regulation	O
of	O
interferon	O
-	O
beta	O
-	O
regulated	O
proteins	B-CHEBI
and	O
increased	O
susceptibility	O
of	O
viral	O
infection	O
,	O
respectively	O
.	O

While	O
these	O
apparent	O
outcome	O
disparities	O
among	O
experimental	O
systems	O
remain	O
unclear	O
,	O
they	O
could	O
potentially	O
result	O
from	O
variations	O
in	O
redundancies	O
and	O
compensatory	O
mechanisms	O
inherent	O
to	O
each	O
experimental	O
system	O
.	O

Regardless	O
,	O
these	O
genetic	O
and	O
whole	O
-	O
animal	O
models	O
set	O
the	O
stage	O
to	O
probe	O
novel	O
molecular	B-CHEBI
pathways	O
in	O
various	O
physiological	O
and	O
genetic	O
contexts	O
,	O
and	O
provide	O
also	O
a	O
link	O
to	O
pathophysiological	O
processes	O
underlying	O
several	O
human	O
diseases	O
.	O

Materials	O
and	O
Methods	O

Yeast	O
two	O
-	O
hybrid	O
screening	O
and	O
assays	O
.	O

The	O
LD	O
of	O
human	O
RanBP2	O
(	O
residues	O
62	O
-	O
711	O
)	O
was	O
subcloned	O
in	O
-	O
frame	O
into	O
the	O
GAL4	O
DNA	O
-	O
binding	O
domain	O
of	O
bait	O
vector	O
,	O
pBUTE	O
(	O
a	O
kanamycin	B-CHEBI
-	O
resistant	O
version	O
of	O
GAL4	O
bait	O
vector	O
pGBDUC1	O
)	O
[	O
62	O
]	O
and	O
HybriZAP	O
pBD	O
-	O
GAL4	O
vector	O
(	O
Stratagene	O
,	O
La	O
Jolla	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

The	O
former	O
was	O
used	O
to	O
screen	O
~	O
18	O
million	O
clones	O
via	O
mating	O
from	O
murine	O
9	O
-	O
to	O
10	O
-	O
d	O
-	O
old	O
embryo	O
and	O
brain	O
cDNA	O
libraries	O
at	O
the	O
Molecular	B-CHEBI
Interaction	O
Facility	O
(	O
MIF	O
)	O
,	O
University	O
of	O
Wisconsin	O
,	O
Madison	O
,	O
Wisconsin	O
.	O

The	O
latter	O
was	O
used	O
to	O
screen	O
via	O
transformation	O
of	O
~	O
5	O
million	O
clones	O
from	O
bovine	O
retinal	O
cDNA	O
libraries	O
[	O
32	O
]	O
.	O

The	O
screens	O
generated	O
six	O
clones	O
.	O

One	O
and	O
two	O
in	O
-	O
frame	O
clones	O
were	O
independently	O
isolated	O
from	O
the	O
embryonic	O
and	O
adult	O
brain	O
libraries	O
,	O
respectively	O
,	O
and	O
the	O
interactions	O
were	O
validated	O
.	O

The	O
three	O
clones	O
encoded	O
Cox11	O
.	O

Interactions	O
between	O
Cox11	O
,	O
LD	O
,	O
and	O
subdomains	O
thereof	O
were	O
quantified	O
by	O
liquid	O
beta	O
-	O
galactosidase	O
(	O
Applied	O
Biosystems	O
,	O
Foster	O
City	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
growth	O
assays	O
[	O
63	O
]	O
.	O

The	O
maximum	O
specific	O
growth	O
speed	O
(	O
mu	O
max	O
)	O
was	O
determined	O
by	O
calculating	O
mu	O
max	O
=	O
(	O
ln	O
(	O
xt	O
)	O
-	O
ln	O
(	O
x0	O
)	O
)	O
/	O
t	O
,	O
where	O
xt	O
is	O
the	O
OD600	O
of	O
the	O
culture	O
at	O
t	O
=	O
t	O
,	O
x0	O
is	O
the	O
OD600	O
at	O
t	O
=	O
0	O
and	O
t	O
is	O
the	O
time	O
between	O
x0	O
and	O
xt	O
.	O

Assays	O
were	O
performed	O
with	O
three	O
independent	O
clones	O
and	O
three	O
samples	O
of	O
each	O
clone	O
,	O
the	O
results	O
were	O
averaged	O
,	O
and	O
the	O
standard	O
deviations	O
calculated	O
.	O

Site	O
-	O
directed	O
and	O
deletion	O
mutagenesis	O
and	O
plasmid	O
construction	O
.	O

Deletion	O
mutagenesis	O
was	O
carried	O
out	O
with	O
pairs	O
of	O
primers	O
against	O
domains	O
of	O
interest	O
described	O
in	O
the	O
figure	O
legends	O
.	O

PCR	O
products	O
were	O
subcloned	O
into	O
pGEX	O
-	O
KG	O
[	O
64	O
]	O
,	O
HybriZAP	O
pBD	O
-	O
GAL4	O
vector	O
(	O
Stratagene	O
)	O
,	O
and	O
pBUTE	O
[	O
62	O
]	O
vectors	O
.	O

GST	O
-	O
LDZIP	O
alone	O
comprised	O
residues	B-CHEBI
447	O
-	O
483	O
of	O
human	O
RanBP2	O
.	O

GST	O
pull	O
-	O
down	O
and	O
immunoprecipitation	O
assays	O
.	O

CHAPS	O
-	O
solubilized	O
retinal	O
extracts	O
,	O
expression	O
,	O
and	O
purification	O
of	O
GST	O
-	O
fused	O
constructs	O
were	O
prepared	O
as	O
previously	O
described	O
[	O
65	O
]	O
.	O

GST	O
pull	O
-	O
down	O
assays	O
were	O
carried	O
out	O
with	O
0	O
.	O
5	O
-	O
2	O
.	O
2	O
mu	O
M	O
of	O
GST	O
-	O
fused	O
proteins	B-CHEBI
[	O
65	O
]	O
.	O

Co	O
-	O
precipitates	O
were	O
resolved	O
on	O
SDS	B-CHEBI
-	O
PAGE	O
and	O
analyzed	O
by	O
Western	O
blot	O
with	O
antibodies	O
described	O
in	O
the	O
Results	O
section	O
.	O

Unfolded	O
and	O
partially	O
denatured	O
Cox11	O
were	O
generated	O
by	O
incubating	O
recombinant	O
and	O
native	O
Cox11	O
overnight	O
with	O
5	O
.	O
6	O
and	O
7	O
M	O
guanidine	B-CHEBI
hydrochloride	I-CHEBI
and	O
urea	B-CHEBI
,	O
respectively	O
.	O

The	O
Cox11	O
conformers	O
were	O
then	O
diluted	O
~	O
20	O
-	O
fold	O
in	O
CHAPS	O
-	O
binding	O
buffer	O
containing	O
GST	O
-	O
LD	O
.	O

Immunoprecipitation	O
assays	O
with	O
5	O
mu	O
g	O
of	O
antibody	O
and	O
Western	O
blots	O
(	O
~	O
200	O
-	O
400	O
ng	O
/	O
ml	O
of	O
antibody	O
)	O
were	O
performed	O
exactly	O
as	O
described	O
previously	O
[	O
13	O
]	O
.	O

Hexokinase	O
I	O
assay	O
.	O

Hexokinase	O
I	O
activity	O
was	O
determined	O
spectrophotometrically	O
at	O
25	O
degrees	O
C	O
by	O
the	O
method	O
of	O
coupling	O
the	O
glucose	B-CHEBI
-	I-CHEBI
6	I-CHEBI
-	I-CHEBI
phosphate	I-CHEBI
production	O
via	O
glucose	B-CHEBI
-	I-CHEBI
6	I-CHEBI
-	I-CHEBI
phosphate	I-CHEBI
dehydrogenase	O
with	O
the	O
change	O
in	O
the	O
absorbance	O
of	O
NADPH	B-CHEBI
at	O
340	O
nm	O
and	O
as	O
described	O
by	O
[	O
66	O
]	O
.	O

The	O
reaction	O
was	O
started	O
by	O
the	O
addition	O
of	O
purified	O
brain	O
hexokinase	O
I	O
(	O
0	O
.	O
24	O
mu	O
g	O
)	O
(	O
gift	O
from	O
J	O
.	O
Wilson	O
)	O
to	O
1	O
.	O
0	O
ml	O
of	O
reaction	O
mixture	O
containing	O
0	O
.	O
05	O
M	O
Tris	B-CHEBI
-	O
HCl	B-CHEBI
(	O
pH	O
8	O
.	O
5	O
)	O
,	O
7	O
.	O
4	O
mM	O
MgCl2	B-CHEBI
,	O
6	O
.	O
6	O
mM	O
ATP	B-CHEBI
,	O
0	O
.	O
65	O
mM	O
NADP	B-CHEBI
,	O
11	O
.	O
1	O
mM	O
monothioglycerol	O
,	O
and	O
1	O
unit	O
of	O
glucose	B-CHEBI
6	I-CHEBI
-	I-CHEBI
phosphate	I-CHEBI
dehydrogenase	O
.	O

In	O
the	O
case	O
of	O
hexokinase	O
activity	O
measured	O
in	O
the	O
presence	O
of	O
Cox11	O
and	O
LD	O
,	O
the	O
purified	O
HKI	O
was	O
incubated	O
with	O
the	O
recombinant	O
proteins	B-CHEBI
for	O
15	O
min	O
at	O
4	O
degrees	O
C	O
before	O
measurement	O
of	O
the	O
activity	O
.	O

The	O
data	O
were	O
fitted	O
directly	O
into	O
the	O
Michaelis	O
-	O
Menten	O
equation	O
using	O
SIGMAPLOT	O
(	O
SPSS	O
Science	O
)	O
.	O

Antibodies	O
.	O

Rabbit	O
antisera	O
were	O
raised	O
against	O
the	O
recombinant	O
murine	O
Cox11	O
(	O
residues	O
40	O
-	O
275	O
)	O
and	O
affinity	O
-	O
purified	O
under	O
non	O
-	O
denaturing	O
conditions	O
(	O
Stereogene	O
)	O
as	O
previously	O
described	O
[	O
13	O
]	O
.	O

Cox11	O
antibodies	O
were	O
used	O
at	O
200	O
ng	O
/	O
ml	O
for	O
Western	O
analysis	O
.	O

The	O
monoclonal	O
antibody	O
Hsp70	O
was	O
from	O
Affinity	O
Bioreagents	O
(	O
Golden	O
,	O
Colorado	O
,	O
United	O
States	O
)	O
and	O
antibodies	O
against	O
the	O
KBD	O
(	O
JX2	O
)	O
and	O
ZnF	O
domains	O
of	O
RanBP2	O
have	O
been	O
described	O
[	O
13	O
,	O
16	O
]	O
.	O

Polyclonal	O
and	O
monoclonal	O
antibodies	O
against	O
Hexokinase	O
I	O
were	O
provided	O
by	O
J	O
.	O

Wilson	O
.	O

The	O
mAb414	O
was	O
purchased	O
from	O
Abcam	O
(	O
Cambridge	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
.	O

Immunocytochemistry	O
and	O
microscopy	O
.	O

Retina	O
dissections	O
,	O
radial	O
cryosections	O
(	O
~	O
6	O
mu	O
m	O
)	O
,	O
and	O
immunohistochemistry	O
procedures	O
were	O
carried	O
out	O
as	O
described	O
elsewhere	O
[	O
19	O
]	O
.	O

Brains	O
from	O
3	O
-	O
to	O
5	O
-	O
mo	O
-	O
old	O
C57Bl	O
/	O
6	O
mice	O
were	O
fixed	O
overnight	O
in	O
2	O
%	O
paraformaldehyde	O
,	O
infused	O
with	O
30	O
%	O
sucrose	B-CHEBI
,	O
and	O
processed	O
for	O
cryosectioning	O
.	O

Primary	O
brain	O
neurons	O
and	O
glial	O
cells	O
were	O
prepared	O
from	O
the	O
cerebral	O
cortex	O
.	O

This	O
was	O
macerated	O
in	O
the	O
Hank	O
'	O
s	O
Balanced	O
Salt	B-CHEBI
solution	O
and	O
triturated	O
.	O

Primary	O
cells	O
were	O
cultured	O
in	O
DMEM	O
(	O
GIBCO	O
,	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
collagen	O
-	O
coated	O
35	O
-	O
mm	O
glass	O
bottom	O
culture	O
dishes	O
(	O
MatTek	O
Corporation	O
,	O
Ashland	O
,	O
Maine	O
)	O
at	O
5	O
%	O
CO2	B-CHEBI
/	O
37	O
degrees	O
C	O
for	O
~	O
2	O
d	O
and	O
processed	O
for	O
immunocytochemistry	O
.	O

Primary	O
antibodies	O
were	O
used	O
at	O
concentrations	O
~	O
2	O
.	O
5	O
-	O
10	O
mu	O
g	O
/	O
ml	O
.	O

Alexa	O
488	O
-	O
and	O
Alexa	O
594	O
-	O
conjugated	O
secondary	O
antibodies	O
(	O
2	O
.	O
5	O
mu	O
g	O
/	O
ml	O
)	O
(	O
Molecular	B-CHEBI
Probes	O
)	O
were	O
used	O
for	O
visualization	O
of	O
proteins	B-CHEBI
.	O

Crossover	O
of	O
fluorescent	B-CHEBI
probes	I-CHEBI
,	O
background	O
,	O
and	O
autofluorescence	O
were	O
found	O
to	O
be	O
negligible	O
.	O

Visualization	O
of	O
specimens	O
and	O
localization	O
of	O
proteins	B-CHEBI
were	O
carried	O
out	O
by	O
wide	O
-	O
field	O
epifluorescence	O
microscopy	O
on	O
Nikon	O
(	O
Tokyo	O
,	O
Japan	O
)	O
E600	O
upright	O
and	O
TE2000U	O
inverted	O
research	O
microscopes	O
equipped	O
with	O
similar	O
Apochromat	O
objectives	O
.	O

Images	O
with	O
the	O
Nikon	O
E600	O
were	O
acquired	O
with	O
a	O
SPOT	O
-	O
RT	O
digital	O
camera	O
coupled	O
to	O
the	O
microscope	O
and	O
driven	O
by	O
SPOT	O
Imaging	O
v4	O
.	O
0	O
software	O
(	O
Diagnostic	O
Instruments	O
,	O
Sterling	O
Heights	O
,	O
Michigan	O
,	O
United	O
States	O
)	O
.	O

All	O
images	O
were	O
captured	O
at	O
nonsaturating	O
integration	O
levels	O
,	O
12	O
-	O
bit	O
mono	O
black	O
/	O
white	O
,	O
and	O
then	O
pseudo	O
-	O
colored	O
.	O

Protein	B-CHEBI
colocalization	O
analysis	O
was	O
carried	O
out	O
on	O
the	O
Nikon	O
TE2000U	O
microscope	O
equipped	O
with	O
appropriate	O
excitation	O
and	O
emission	O
filter	O
wheels	O
,	O
cube	O
filters	O
,	O
100	O
W	O
mercury	B-CHEBI
light	O
source	O
,	O
Nomarski	O
/	O
DIC	O
,	O
and	O
Plan	O
Apochromat	O
optics	O
(	O
100	O
x	O
,	O
60	O
x	O
,	O
and	O
40	O
x	O
oil	O
objectives	O
with	O
NA	O
of	O
1	O
.	O
4	O
,	O
40	O
x	O
LWD	O
,	O
and	O
20	O
x	O
LWD	O
objectives	O
and	O
encoded	O
motorized	O
Z	O
-	O
Stage	O
(	O
Prior	O
Scientific	O
,	O
Rockland	O
,	O
Maryland	O
,	O
United	O
States	O
)	O
.	O

Images	O
with	O
the	O
inverted	O
Nikon	O
TE2000U	O
microscope	O
were	O
obtained	O
using	O
a	O
CCD	O
camera	O
(	O
CoolSNAP	O
HQ	O
;	O
Roper	O
Scientific	O
,	O
Trenton	O
,	O
New	O
Jersey	O
,	O
United	O
States	O
)	O
.	O

Images	O
acquired	O
under	O
identical	O
acquisition	O
parameters	O
were	O
analyzed	O
using	O
Metamorph	O
Software	O
v6	O
.	O
2	O
(	O
Universal	O
Imaging	O
,	O
Glendale	O
,	O
Wisconsin	O
,	O
United	O
States	O
)	O
.	O

Whenever	O
applicable	O
,	O
serial	O
optical	O
Z	O
-	O
stacks	O
(	O
20	O
-	O
30	O
focal	O
planes	O
at	O
100	O
-	O
nm	O
intervals	O
)	O
were	O
captured	O
and	O
computationally	O
processed	O
by	O
3	O
-	O
D	O
blind	O
deconvolution	O
methods	O
with	O
the	O
same	O
software	O
.	O

Generation	O
of	O
a	O
mouse	O
line	O
with	O
a	O
disrupted	O
RanBP2	O
locus	O
and	O
histological	O
analysis	O
of	O
trapped	O
RanBP2	O
mice	O
.	O

A	O
feeder	O
-	O
independent	O
mouse	O
ES	O
cell	O
line	O
derived	O
from	O
the	O
129P2	O
/	O
OlaHsd	O
strain	O
and	O
harboring	O
a	O
disrupted	O
RanBP2	O
locus	O
by	O
insertion	O
mutagenesis	O
with	O
the	O
gene	O
trap	O
vector	O
,	O
pGT0pfs	O
[	O
67	O
,	O
68	O
]	O
(	O
generated	O
by	O
W	O
.	O
Skarnes	O
)	O
,	O
was	O
obtained	O
from	O
the	O
Mutant	O
Mouse	O
Regional	O
Resource	O
Center	O
(	O
University	O
of	O
California	O
Davis	O
,	O
Davis	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

The	O
gene	O
trap	O
vector	O
contains	O
a	O
promoterless	O
neo	O
-	O
lacZ	O
fusion	O
gene	O
with	O
a	O
splice	O
acceptor	O
site	O
at	O
the	O
5	O
'	O
end	O
followed	O
by	O
an	O
internal	O
ribosome	O
entry	O
site	O
(	O
IRES	O
)	O
and	O
the	O
human	O
placental	O
alkaline	B-CHEBI
phosphatase	O
(	O
PLAP	O
)	O
reporter	O
cassette	O
.	O

The	O
RanBP2	O
129Ola	O
ES	O
line	O
was	O
injected	O
into	O
C57BL	O
/	O
6J	O
blastocysts	O
and	O
four	O
male	O
chimeras	O
were	O
generated	O
.	O

These	O
were	O
bred	O
into	O
129P2	O
/	O
OlaHsd	O
(	O
Harlan	O
,	O
Indianapolis	O
,	O
Indiana	O
,	O
United	O
States	O
)	O
and	O
C57BL	O
/	O
6J	O
(	O
Jackson	O
Laboratory	O
,	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
United	O
States	O
)	O
females	O
.	O

The	O
two	O
resulting	O
and	O
independent	O
F1s	O
lines	O
,	O
with	O
129P2	O
/	O
OlaHsd	O
inbred	O
and	O
129P2	O
/	O
OlaHsd	O
/	O
C57BL	O
/	O
6J	O
mixed	O
genetic	O
backgrounds	O
,	O
were	O
tested	O
for	O
germline	O
transmission	O
by	O
PCR	O
and	O
Southern	O
blot	O
analysis	O
of	O
tail	O
genomic	O
DNA	O
.	O

beta	O
-	O
gal	O
and	O
PLAP	O
activities	O
in	O
whole	O
mount	O
embryos	O
and	O
retinal	O
sections	O
were	O
detected	O
,	O
respectively	O
,	O
by	O
incubation	O
with	O
5	O
-	O
bromo	B-CHEBI
-	O
4	O
-	O
chloro	B-CHEBI
-	O
3	O
-	O
indolyl	O
beta	O
-	O
D	O
-	O
galactopyranoside	O
and	O
AP	O
staining	O
buffer	O
(	O
0	O
.	O
1	O
mg	O
/	O
ml	O
5	O
-	O
bromo	B-CHEBI
-	O
4	O
-	O
chloro	B-CHEBI
-	O
3	O
-	O
indolyl	O
phosphate	B-CHEBI
,	O
1	O
mg	O
/	O
ml	O
nitroblue	B-CHEBI
tetrazolium	I-CHEBI
in	O
100	O
mM	O
Tris	B-CHEBI
-	O
HCl	B-CHEBI
(	O
pH	O
9	O
.	O
5	O
)	O
,	O
100	O
mM	O
NaCl	B-CHEBI
,	O
5	O
mM	O
MgCl2	B-CHEBI
)	O
as	O
described	O
elsewhere	O
[	O
67	O
,	O
68	O
]	O
.	O

Western	O
blot	O
and	O
quantitation	O
analysis	O
of	O
protein	B-CHEBI
expression	O
and	O
ATP	B-CHEBI
levels	O
.	O

Homogenates	O
and	O
detergent	B-CHEBI
solubilized	O
extracts	O
of	O
tissues	O
and	O
immunoblots	O
were	O
prepared	O
as	O
described	O
elsewhere	O
[	O
69	O
]	O
.	O

Quantitation	O
of	O
immunoblot	O
bands	O
calibrated	O
against	O
internal	O
marker	O
bands	O
,	O
such	O
as	O
mHsp70	O
and	O
Nup153	O
,	O
was	O
carried	O
out	O
with	O
Gel	O
Pro	O
Analyzer	O
(	O
MediaCybernetics	O
,	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

For	O
determination	O
of	O
ATP	B-CHEBI
levels	O
,	O
freshly	O
dissected	O
and	O
flash	O
-	O
frozen	O
tissues	O
were	O
homogenized	O
in	O
2	O
.	O
5	O
%	O
trichloroacetic	B-CHEBI
acid	I-CHEBI
(	O
TCA	B-CHEBI
)	O
,	O
neutralized	O
,	O
and	O
diluted	O
to	O
a	O
final	O
concentration	O
of	O
0	O
.	O
1	O
%	O
with	O
Tris	B-CHEBI
-	O
Acetate	B-CHEBI
(	O
pH	O
7	O
.	O
75	O
)	O
.	O

ATP	B-CHEBI
measurements	O
were	O
carried	O
out	O
with	O
the	O
ENLITEN	O
ATP	B-CHEBI
Assay	O
System	O
Bioluminescence	O
Detection	O
Kit	O
for	O
ATP	B-CHEBI
(	O
Promega	O
,	O
Madison	O
,	O
Wisconsin	O
,	O
United	O
States	O
)	O
as	O
per	O
the	O
manufacturer	O
'	O
s	O
instruction	O
in	O
SpectraMax	O
-	O
M5	O
(	O
Molecular	B-CHEBI
Devices	O
,	O
Sunnyvale	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Protein	B-CHEBI
concentration	O
was	O
measured	O
by	O
the	O
BCA	O
method	O
(	O
BioRad	O
,	O
Hercules	O
,	O
California	O
,	O
United	O
States	O
)	O
using	O
BSA	O
as	O
a	O
standard	O
.	O

Metabolic	O
assays	O
.	O

Two	O
groups	O
of	O
male	O
mice	O
were	O
kept	O
under	O
separate	O
diet	O
since	O
gestation	O
or	O
birth	O
.	O

One	O
group	O
was	O
fed	O
with	O
a	O
normal	O
chow	B-CHEBI
diet	O
(	O
PicoLab	O
Rodent	O
Diet	O
20	O
-	O
5053	O
;	O
LabDiet	O
,	O
Richmond	O
,	O
Indiana	O
,	O
United	O
States	O
)	O
,	O
while	O
the	O
other	O
was	O
placed	O
on	O
a	O
higher	O
energy	O
and	O
fat	O
diet	O
(	O
PicoLab	O
Mouse	O
Diet	O
20	O
-	O
5058	O
;	O
LabDiet	O
)	O
.	O

Glucose	B-CHEBI
tolerance	O
test	O
was	O
performed	O
on	O
overnight	O
-	O
fasted	O
mice	O
injected	O
intraperitoneally	O
with	O
2	O
g	O
of	O
glucose	B-CHEBI
per	O
kg	O
of	O
body	O
weight	O
.	O

Venous	O
blood	O
glucose	B-CHEBI
values	O
were	O
determined	O
at	O
immediately	O
before	O
(	O
0	O
min	O
)	O
,	O
and	O
15	O
,	O
30	O
,	O
60	O
,	O
and	O
120	O
min	O
after	O
the	O
injection	O
with	O
an	O
automatic	O
glucose	B-CHEBI
monitor	O
instrument	O
(	O
One	O
Touch	O
Ultra	O
,	O
Lifescan	O
)	O
.	O

Insulin	B-CHEBI
tolerance	O
test	O
was	O
performed	O
the	O
same	O
way	O
as	O
that	O
described	O
for	O
the	O
glucose	B-CHEBI
tolerance	O
test	O
with	O
the	O
exception	O
that	O
human	O
insulin	B-CHEBI
(	O
0	O
.	O
75	O
U	O
/	O
kg	O
of	O
body	O
mass	O
)	O
was	O
injected	O
intraperitoneally	O
in	O
non	O
-	O
fasted	O
mice	O
.	O

Pyruvate	B-CHEBI
challenge	O
test	O
was	O
performed	O
the	O
same	O
way	O
as	O
that	O
described	O
for	O
the	O
glucose	B-CHEBI
tolerance	O
test	O
with	O
the	O
exception	O
that	O
pyruvate	B-CHEBI
dissolved	O
in	O
saline	O
(	O
2	O
g	O
/	O
kg	O
of	O
body	O
mass	O
)	O
was	O
injected	O
intraperitoneally	O
in	O
overnight	O
-	O
fasted	O
mice	O
.	O

Electroretinography	O
.	O

Five	O
~	O
6	O
-	O
mo	O
-	O
old	O
male	O
RanBP2	O
+	O
/	O
+	O
and	O
RanBP2	O
+	O
/	O
-	O
mice	O
in	O
129ola	O
background	O
were	O
kept	O
in	O
dim	O
cyclic	O
light	O
(	O
10	O
lux	O
)	O
for	O
2	O
wk	O
before	O
electroretinographic	O
responses	O
were	O
recorded	O
.	O

The	O
mice	O
were	O
anesthetized	O
intraperitoneally	O
with	O
ketamine	O
(	O
80	O
mg	O
/	O
kg	O
)	O
and	O
xylazine	O
(	O
4	O
mg	O
/	O
kg	O
)	O
.	O

Body	O
temperature	O
was	O
maintained	O
with	O
a	O
heating	O
pad	O
at	O
37	O
.	O
5	O
+/-	O
1	O
degrees	O
C	O
throughout	O
the	O
recording	O
.	O

The	O
pupils	O
were	O
fully	O
dilated	O
with	O
0	O
.	O
5	O
%	O
tropicamide	O
and	O
2	O
.	O
5	O
%	O
phenylephrine	B-CHEBI
HCl	B-CHEBI
,	O
and	O
both	O
eyes	O
were	O
recorded	O
simultaneously	O
.	O

Corneal	O
gold	B-CHEBI
-	O
wire	O
loops	O
were	O
used	O
as	O
the	O
active	O
electrodes	O
under	O
0	O
.	O
5	O
%	O
proparacaine	O
hydrochloride	B-CHEBI
topical	O
anesthesia	O
.	O

Gold	B-CHEBI
-	O
wire	O
electrodes	O
placed	O
on	O
the	O
sclera	O
near	O
the	O
limbus	O
served	O
as	O
reference	O
electrodes	O
.	O

A	O
ground	O
wire	O
was	O
attached	O
to	O
the	O
ear	O
.	O

Scotopic	O
responses	O
were	O
recorded	O
from	O
threshold	O
to	O
9	O
log	O
units	O
of	O
intensity	O
above	O
threshold	O
,	O
amplified	O
,	O
and	O
filtered	O
(	O
5	O
,	O
000	O
gain	O
,	O
0	O
.	O
1	O
-	O
1	O
,	O
000	O
Hz	O
)	O
.	O

For	O
photopic	O
recordings	O
background	O
light	O
at	O
34	O
cd	O
/	O
m2	O
was	O
used	O
to	O
suppress	O
rod	O
function	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Western	O
Blot	O
Analysis	O
of	O
the	O
Association	O
of	O
LD	O
of	O
RanBP2	O
with	O
HKI	O
and	O
Cox11	O
across	O
Tissues	O

GST	O
-	O
JX2	O
(	O
2	O
.	O
2	O
mu	O
M	O
)	O
was	O
incubated	O
with	O
different	O
tissue	O
extracts	O
(	O
~	O
2	O
.	O
0	O
mg	O
)	O
and	O
the	O
GST	O
-	O
JX2	O
coprecipitates	O
from	O
seven	O
different	O
tissues	O
were	O
analyzed	O
by	O
Western	O
blot	O
with	O
the	O
antibodies	O
against	O
HKI	O
and	O
Cox11	O
.	O

The	O
LD	O
of	O
RanBP2	O
associated	O
with	O
the	O
HKI	O
and	O
Cox11	O
in	O
all	O
seven	O
tissues	O
tested	O
.	O

(	O
59	O
KB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

Immunostaining	O
of	O
Radial	O
Cryosections	O
of	O
Wild	O
-	O
Type	O
(	O
+	O
/	O
+	O
)	O
and	O
Heterozygote	O
(	O
+	O
/	O
-	O
)	O
RanBP2	O
Mice	O
Retinas	O
with	O
Anti	O
-	O
HKI	O
and	O
-	O
Cox11	O
Antibodies	O

A1	O
and	O
B1	O
represent	O
magnifications	O
of	O
just	O
the	O
distal	O
section	O
of	O
the	O
retina	O
(	O
inner	O
segment	O
subcellular	O
compartment	O
of	O
the	O
photosensory	O
neuron	O
layer	O
)	O
.	O

Note	O
the	O
partial	O
delocalization	O
of	O
HKI	O
to	O
the	O
myoid	O
subcompartment	O
of	O
the	O
inner	O
segment	O
of	O
photoreceptor	O
neurons	O
in	O
+	O
/	O
-	O
mice	O
(	O
B1	O
)	O
and	O
decreased	O
levels	O
of	O
HKI	O
in	O
the	O
inner	O
plexiform	O
(	O
synaptic	O
)	O
layer	O
of	O
the	O
retina	O
(	O
A	O
and	O
B	O
)	O
.	O

This	O
is	O
reflected	O
by	O
a	O
significant	O
increase	O
and	O
decrease	O
of	O
the	O
mean	O
fluorescence	O
intensity	O
(	O
in	O
arbitrary	O
units	O
)	O
of	O
HKI	O
in	O
the	O
myoid	O
and	O
inner	O
plexiform	O
(	O
synaptic	O
)	O
layers	O
,	O
respectively	O
(	O
E	O
)	O
.	O

AU	O
,	O
arbitrary	O
unit	O
;	O
ROS	O
,	O
rod	O
outer	O
segment	O
;	O
RIS	O
,	O
rod	O
inner	O
segment	O
;	O
ONL	O
,	O
outer	O
nuclear	O
layer	O
;	O
OPL	O
,	O
outer	O
plexiform	O
layer	O
,	O
INL	O
,	O
inner	O
nuclear	O
layer	O
;	O
IPL	O
,	O
inner	O
plexiform	O
layer	O
;	O
GCL	O
,	O
ganglion	O
cell	O
layer	O
;	O
E	O
and	O
M	O
are	O
,	O
respectively	O
,	O
the	O
ellipsoid	O
(	O
mitochondria	O
-	O
rich	O
)	O
and	O
myoid	O
compartments	O
of	O
photosensory	O
neurons	O
.	O

(	O
476	O
KB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

Metabolic	O
Phenotype	O
of	O
RanBP2	O
+	O
/	O
-	O
Mice	O
in	O
a	O
Mixed	O
Background	O
and	O
High	O
-	O
Fat	O
Diet	O

There	O
was	O
no	O
difference	O
in	O
the	O
glucose	B-CHEBI
tolerance	O
test	O
between	O
RanBP2	O
+	O
/	O
+	O
and	O
RanBP2	O
+	O
/	O
-	O
mice	O
on	O
a	O
mixed	O
129Ola	O
/	O
C57Bl6	O
genetic	O
background	O
(	O
C	O
)	O
.	O

(	O
38	O
KB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Acknowledgements	O

We	O
thank	O
John	O
Wilson	O
for	O
purified	O
HKI	O
,	O
antibodies	O
against	O
HKI	O
,	O
HKII	O
,	O
HKIII	O
,	O
and	O
glucokinase	O
,	O
and	O
support	O
;	O
Arthur	O
Haas	O
for	O
help	O
with	O
kinetic	O
analysis	O
of	O
HKI	O
;	O
and	O
William	O
Skarnes	O
for	O
helpful	O
suggestions	O
with	O
the	O
analysis	O
of	O
ES	O
insertion	O
trap	O
lines	O
.	O

Abbreviations	O

CLD	O
-	O
cyclophilin	O
-	O
like	O
domain	O

CNS	O
-	O
central	O
nervous	O
system	O

GST	O
-	O
glutathione	B-CHEBI
-	O
S	B-CHEBI
-	O
transferase	O

HKI	O
-	O
hexokinase	O
type	O
I	O

LD	O
-	O
leucine	B-CHEBI
-	O
rich	O
domain	O

NPC	O
-	O
nuclear	O
pore	O
complex	O

RanBP2	O
-	O
Ran	O
-	O
binding	O
protein	B-CHEBI
2	O

Footnotes	O

currency	O
Current	O
address	O
:	O
Fugent	O
LLC	O
,	O
Madison	O
,	O
Wisconsin	O
,	O
United	O
States	O
of	O
America	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

A	O
previous	O
version	O
of	O
this	O
article	O
appeared	O
as	O
an	O
Early	O
Online	O
Release	O
on	O
September	O
1	O
,	O
2006	O
(	O
DOI	O
:	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pgen	O
.	O
0020177	O
.	O
eor	O
)	O
.	O

Author	O
contributions	O
.	O

AA	O
,	O
RB	O
,	O
MG	O
,	O
DR	O
,	O
RAB	O
,	O
and	O
PAF	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

AA	O
,	O
RB	O
,	O
MG	O
,	O
JO	O
,	O
DR	O
,	O
XL	O
,	O
and	O
CBB	O
performed	O
the	O
experiments	O
.	O

AA	O
,	O
RB	O
,	O
MG	O
,	O
JO	O
,	O
DR	O
,	O
RAB	O
,	O
PAS	O
,	O
and	O
PAF	O
analyzed	O
the	O
data	O
.	O

PAF	O
contributed	O
reagents	B-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

PAF	O
wrote	O
the	O
paper	O
.	O

Funding	O
.	O

Work	O
supported	O
by	O
The	O
National	O
Institutes	O
of	O
Health	O
EY11993	O
/	O
EY012665	O
to	O
PAF	O
and	O
The	O
National	O
Institutes	O
of	O
Health	O
2P30	O
-	O
EY005722	O
-	O
21	O
.	O

PAF	O
is	O
the	O
Jules	O
and	O
Doris	O
Stein	O
Research	O
to	O
Prevent	O
Blindness	O
Professor	O
.	O

Defective	O
ALK5	O
signaling	O
in	O
the	O
neural	O
crest	O
leads	O
to	O
increased	O
postmigratory	O
neural	O
crest	O
cell	O
apoptosis	O
and	O
severe	O
outflow	O
tract	O
defects	O

Abstract	O

Background	O

Congenital	O
cardiovascular	O
diseases	O
are	O
the	O
most	O
common	O
form	O
of	O
birth	O
defects	O
in	O
humans	O
.	O

A	O
substantial	O
portion	O
of	O
these	O
defects	O
has	O
been	O
associated	O
with	O
inappropriate	O
induction	O
,	O
migration	O
,	O
differentiation	O
and	O
patterning	O
of	O
pluripotent	O
cardiac	O
neural	O
crest	O
stem	O
cells	O
.	O

While	O
TGF	O
-	O
beta	O
-	O
superfamily	O
signaling	O
has	O
been	O
strongly	O
implicated	O
in	O
neural	O
crest	O
cell	O
development	O
,	O
the	O
detailed	O
molecular	B-CHEBI
signaling	O
mechanisms	O
in	O
vivo	O
are	O
still	O
poorly	O
understood	O
.	O

Results	O

We	O
deleted	O
the	O
TGF	O
-	O
beta	O
type	O
I	O
receptor	O
Alk5	O
specifically	O
in	O
the	O
mouse	O
neural	O
crest	O
cell	O
lineage	O
.	O

Failure	O
in	O
signaling	O
via	O
ALK5	O
leads	O
to	O
severe	O
cardiovascular	O
and	O
pharyngeal	O
defects	O
,	O
including	O
inappropriate	O
remodeling	O
of	O
pharyngeal	O
arch	O
arteries	O
,	O
abnormal	O
aortic	O
sac	O
development	O
,	O
failure	O
in	O
pharyngeal	O
organ	O
migration	O
and	O
persistent	O
truncus	O
arteriosus	O
.	O

While	O
ALK5	O
is	O
not	O
required	O
for	O
neural	O
crest	O
cell	O
migration	O
,	O
our	O
results	O
demonstrate	O
that	O
it	O
plays	O
an	O
important	O
role	O
in	O
the	O
survival	O
of	O
post	O
-	O
migratory	O
cardiac	O
neural	O
crest	O
cells	O
.	O

Conclusion	O

Our	O
results	O
demonstrate	O
that	O
ALK5	O
-	O
mediated	O
signaling	O
in	O
neural	O
crest	O
cells	O
plays	O
an	O
essential	O
cell	O
-	O
autonomous	O
role	O
in	O
the	O
pharyngeal	O
and	O
cardiac	O
outflow	O
tract	O
development	O
.	O

Background	O

A	O
considerable	O
percentage	O
of	O
cardiac	O
birth	O
defects	O
is	O
caused	O
by	O
a	O
failure	O
in	O
normal	O
migration	O
,	O
differentiation	O
or	O
patterning	O
of	O
the	O
cardiac	O
neural	O
crest	O
(	O
CNC	O
)	O
.	O

This	O
subset	O
of	O
pluripotent	O
neural	O
crest	O
stem	O
cells	O
forms	O
in	O
the	O
dorsal	O
aspect	O
of	O
the	O
neural	O
tube	O
at	O
the	O
level	O
of	O
the	O
mid	O
-	O
otic	O
placode	O
to	O
the	O
third	O
somite	O
[	O
1	O
]	O
.	O

Subsequently	O
cardiac	O
neural	O
crest	O
cells	O
(	O
CNCCs	O
)	O
delaminate	O
,	O
undergo	O
a	O
phenotypic	O
transformation	O
from	O
an	O
epithelial	O
to	O
mesenchymal	O
cell	O
type	O
,	O
and	O
migrate	O
latero	O
-	O
ventrally	O
into	O
the	O
3rd	O
,	O
4th	O
and	O
6th	O
pharyngeal	O
arch	O
arteries	O
(	O
PAAs	O
)	O
,	O
where	O
they	O
contribute	O
to	O
the	O
formation	O
of	O
the	O
smooth	O
muscle	O
cell	O
layer	O
of	O
endothelial	O
structures	O
derived	O
from	O
the	O
aortic	O
arch	O
arteries	O
[	O
1	O
-	O
3	O
]	O
.	O

A	O
subset	O
of	O
CNCCs	O
continues	O
to	O
migrate	O
deeper	O
into	O
the	O
aortic	O
sac	O
to	O
form	O
the	O
aortico	O
-	O
pulmonary	O
septum	O
;	O
a	O
vital	O
structure	O
,	O
which	O
separates	O
the	O
pulmonary	O
trunk	O
from	O
the	O
aorta	O
[	O
4	O
]	O
.	O

An	O
indispensable	O
role	O
of	O
CNCCs	O
in	O
the	O
development	O
of	O
the	O
cardiac	O
outflow	O
tract	O
was	O
originally	O
demonstrated	O
by	O
pioneering	O
studies	O
of	O
Kirby	O
and	O
coworkers	O
[	O
1	O
]	O
,	O
who	O
showed	O
that	O
ablation	O
of	O
the	O
CNC	O
in	O
the	O
chick	O
led	O
to	O
severe	O
outflow	O
tract	O
(	O
OFT	O
)	O
defects	O
including	O
persistent	O
truncus	O
arteriosus	O
(	O
PTA	O
)	O
,	O
mispatterning	O
of	O
the	O
great	O
vessels	O
and	O
outflow	O
tract	O
mal	O
-	O
alignments	O
[	O
5	O
]	O
.	O

Early	O
migratory	O
CNCCs	O
have	O
been	O
shown	O
to	O
retain	O
a	O
considerable	O
degree	O
of	O
plasticity	O
and	O
their	O
fate	O
is	O
largely	O
controlled	O
by	O
instructional	O
signals	O
from	O
local	O
environments	O
into	O
which	O
NCCs	O
migrate	O
[	O
6	O
]	O
.	O

Several	O
recent	O
studies	O
have	O
indicated	O
that	O
members	O
of	O
the	O
TGF	O
-	O
beta	O
superfamily	O
,	O
i	O
.	O
e	O
.	O
,	O
TGF	O
-	O
beta	O
s	O
and	O
BMPs	O
are	O
likely	O
candidates	O
to	O
provide	O
some	O
of	O
these	O
signals	O
.	O

Mice	O
deficient	O
in	O
TGF	O
-	O
beta	O
2	O
display	O
fourth	O
aortic	O
arch	O
artery	O
defects	O
[	O
7	O
]	O
,	O
while	O
neural	O
crest	O
cell	O
specific	O
abrogation	O
of	O
TGF	O
-	O
beta	O
type	O
II	O
receptor	O
(	O
Tgfbr2	O
)	O
results	O
in	O
interruption	O
of	O
the	O
aortic	O
arch	O
and	O
PTA	O
[	O
8	O
,	O
9	O
]	O
.	O

BMPs	O
6	O
and	O
-	O
7	O
are	O
required	O
for	O
proper	O
formation	O
of	O
the	O
outflow	O
tract	O
cushions	O
[	O
10	O
]	O
,	O
while	O
BMP	O
type	O
II	O
receptor	O
is	O
needed	O
for	O
proper	O
development	O
of	O
the	O
conotruncal	O
ridges	O
[	O
11	O
]	O
.	O

Moreover	O
,	O
neural	O
crest	O
-	O
specific	O
deletion	O
of	O
the	O
BMP	O
type	O
I	O
receptors	O
Alk2	O
and	O
Alk3	O
has	O
been	O
shown	O
to	O
lead	O
to	O
defective	O
aortico	O
-	O
pulmonary	O
septation	O
,	O
among	O
other	O
cardiac	O
defects	O
[	O
12	O
,	O
13	O
]	O
.	O

TGF	O
-	O
beta	O
subfamily	O
ligands	O
signal	O
via	O
a	O
receptor	O
complex	O
composed	O
of	O
two	O
type	O
II	O
receptors	O
and	O
two	O
type	O
I	O
receptors	O
[	O
14	O
,	O
15	O
]	O
.	O

Ligand	O
binding	O
leads	O
to	O
phosphorylation	O
and	O
activation	O
of	O
type	O
I	O
receptors	O
,	O
which	O
,	O
in	O
turn	O
,	O
phosphorylate	O
and	O
activate	O
a	O
specific	O
set	O
of	O
downstream	O
signaling	O
molecules	B-CHEBI
called	O
Smads	O
.	O

In	O
general	O
terms	O
,	O
TGF	O
-	O
beta	O
s	O
bind	O
to	O
the	O
TGF	O
-	O
beta	O
type	O
II	O
receptor	O
(	O
TGF	O
beta	O
RII	O
)	O
and	O
TGF	O
-	O
beta	O
type	O
I	O
receptor	O
(	O
ALK5	O
)	O
activating	O
TGF	O
-	O
beta	O
Smads	O
(	O
2	O
and	O
3	O
)	O
,	O
while	O
BMPs	O
bind	O
to	O
the	O
BMP	O
type	O
II	O
receptor	O
and	O
type	O
I	O
receptors	O
ALK2	O
,	O
-	O
3	O
,	O
or	O
6	O
,	O
activating	O
BMP	O
Smads	O
(	O
1	O
,	O
5	O
and	O
8	O
)	O
.	O

However	O
,	O
it	O
is	O
likely	O
that	O
these	O
signaling	O
interactions	O
are	O
more	O
complex	O
in	O
vivo	O
,	O
possibly	O
allowing	O
formation	O
of	O
heterotetrameric	O
complexes	O
composed	O
of	O
different	O
type	O
II	O
and	O
type	O
I	O
receptors	O
[	O
16	O
]	O
.	O

In	O
addition	O
,	O
recent	O
studies	O
have	O
identified	O
novel	O
TGF	O
-	O
beta	O
-	O
related	O
ligands	O
,	O
which	O
can	O
bind	O
to	O
entire	O
different	O
combinations	O
of	O
receptors	O
.	O

For	O
instance	O
,	O
growth	O
and	O
differentiation	O
factors	O
(	O
GDFs	O
)	O
8	O
and	O
9	O
can	O
bind	O
to	O
Activin	O
type	O
II	O
receptor	O
and	O
ALK5	O
to	O
activate	O
TGF	O
-	O
beta	O
Smads	O
[	O
17	O
,	O
18	O
]	O
.	O

Therefore	O
,	O
we	O
hypothesized	O
that	O
deletion	O
of	O
Alk5	O
in	O
a	O
specific	O
cell	O
lineage	O
should	O
reveal	O
phenotypes	O
which	O
cannot	O
be	O
seen	O
in	O
comparable	O
mutants	O
lacking	O
Tgfbr2	O
.	O

Indeed	O
,	O
we	O
recently	O
showed	O
that	O
neural	O
crest	O
cell	O
specific	O
Alk5	O
mutants	O
display	O
a	O
unique	O
spectrum	O
of	O
craniofacial	O
developmental	O
defects	O
,	O
e	O
.	O
g	O
.	O
,	O
cleft	O
snout	O
and	O
severe	O
mandibular	O
hypoplasia	O
[	O
19	O
]	O
;	O
these	O
phenotypes	O
were	O
not	O
seen	O
in	O
corresponding	O
Tgfbr2	O
mutants	O
[	O
20	O
]	O
.	O

To	O
determine	O
,	O
whether	O
ALK5	O
would	O
also	O
mediate	O
unique	O
non	O
-	O
redundant	O
signaling	O
events	O
in	O
cardiac	O
neural	O
crest	O
cells	O
,	O
we	O
focused	O
on	O
cardiac	O
and	O
pharyngeal	O
phenotypes	O
of	O
mouse	O
embryos	O
lacking	O
Alk5	O
specifically	O
in	O
neural	O
crest	O
cells	O
.	O

We	O
discovered	O
that	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
,	O
pharyngeal	O
organs	O
(	O
thymus	O
and	O
parathyroid	O
)	O
fail	O
to	O
migrate	O
appropriately	O
.	O

Moreover	O
,	O
the	O
mutant	O
embryos	O
display	O
severe	O
aortic	O
sac	O
and	O
pharyngeal	O
arch	O
artery	O
defects	O
,	O
and	O
failed	O
aortico	O
-	O
pulmonary	O
septation	O
leading	O
to	O
PTA	O
.	O

Our	O
data	O
further	O
suggest	O
that	O
at	O
least	O
some	O
of	O
these	O
abnormal	O
detected	O
phenotypes	O
result	O
from	O
a	O
dramatic	O
increase	O
in	O
apoptosis	O
of	O
postmigratory	O
cardiac	O
neural	O
crest	O
cells	O
.	O

These	O
phenotypes	O
differ	O
remarkably	O
from	O
those	O
seen	O
in	O
corresponding	O
Tgfbr2	O
mutants	O
,	O
suggesting	O
that	O
ALK5	O
mediates	O
a	O
wider	O
spectrum	O
of	O
signaling	O
events	O
than	O
its	O
classical	O
binding	O
partner	O
TGF	O
beta	O
RII	O
in	O
cardiac	O
neural	O
crest	O
cells	O
during	O
cardiac	O
and	O
pharyngeal	O
development	O
.	O

Results	O

Persistent	O
truncus	O
arteriosus	O
and	O
abnormal	O
large	O
vessels	O
in	O
mice	O
lacking	O
Alk5	O
in	O
cardiac	O
NCCs	O

To	O
inactivate	O
Alk5	O
in	O
cardiac	O
NCCs	O
,	O
mice	O
homozygous	O
for	O
the	O
floxed	O
Alk5	O
allele	O
(	O
Alk5Flox	O
/	O
Flox	O
)	O
[	O
21	O
]	O
were	O
crossed	O
with	O
transgenic	O
Wnt1	O
-	O
Cre	O
mice	O
[	O
22	O
]	O
,	O
which	O
were	O
also	O
heterozygous	O
for	O
the	O
Alk5	O
knockout	O
allele	O
(	O
Alk5KO	O
)	O
allele	O
.	O

The	O
resulting	O
mice	O
heterozygous	O
for	O
the	O
Alk5Flox	O
and	O
Alk5KO	O
alleles	O
,	O
which	O
also	O
carried	O
the	O
Wnt1	O
-	O
Cre	O
transgene	O
,	O
had	O
the	O
Alk5	O
gene	O
specifically	O
inactivated	O
in	O
NCCs	O
(	O
herein	O
termed	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
)	O
,	O
while	O
the	O
littermates	O
with	O
remaining	O
allelic	O
combinations	O
were	O
phenotypically	O
normal	O
and	O
served	O
as	O
controls	O
(	O
Alk5Flox	O
/	O
+	O
,	O
Alk5KO	O
/	O
+	O
;	O
Wnt1	O
-	O
Cre	O
)	O
.	O

When	O
embryos	O
were	O
harvested	O
during	O
the	O
last	O
day	O
of	O
gestation	O
,	O
an	O
expected	O
number	O
(	O
25	O
%	O
)	O
of	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
were	O
recovered	O
.	O

However	O
,	O
all	O
mutant	O
offspring	O
died	O
either	O
during	O
the	O
birth	O
or	O
during	O
the	O
first	O
post	O
-	O
natal	O
hours	O
.	O

To	O
determine	O
,	O
if	O
ALK5	O
-	O
mediated	O
TGF	O
-	O
beta	O
-	O
signaling	O
had	O
a	O
role	O
in	O
development	O
of	O
the	O
OFT	O
and	O
large	O
vessels	O
of	O
the	O
aortic	O
arch	O
,	O
we	O
performed	O
casting	O
dye	B-CHEBI
experiments	O
on	O
E17	O
embryos	O
(	O
Fig	O
.	O
1A	O
-	O
D	O
)	O
.	O

In	O
wild	O
-	O
type	O
embryos	O
(	O
Fig	O
.	O
1A	O
)	O
,	O
the	O
aorta	O
was	O
clearly	O
separated	O
from	O
the	O
pulmonary	O
trunk	O
,	O
and	O
the	O
right	O
brachiocephalic	O
,	O
left	O
carotid	O
and	O
left	O
subclavian	O
arteries	O
branched	O
directly	O
off	O
the	O
aortic	O
arch	O
.	O

In	O
contrast	O
,	O
Alk5	O
/	O
Wnt1Cre	O
mutant	O
embryos	O
consistently	O
displayed	O
a	O
single	O
prominent	O
arterial	O
trunk	O
(	O
Fig	O
.	O
1C	O
-	O
D	O
)	O
,	O
while	O
corresponding	O
Tgfbr2	O
mutant	O
embryos	O
(	O
Fig	O
.	O
1B	O
)	O
displayed	O
interrupted	O
aortic	O
arch	O
,	O
as	O
reported	O
earlier	O
[	O
8	O
]	O
.	O

Approximately	O
40	O
%	O
of	O
the	O
Alk5	O
mutants	O
had	O
a	O
right	O
-	O
sided	O
outflow	O
tract	O
,	O
with	O
the	O
retroesophageal	O
arch	O
connecting	O
to	O
the	O
descending	O
aorta	O
and	O
to	O
the	O
left	O
subclavian	O
artery	O
.	O

The	O
carotid	O
arteries	O
originated	O
either	O
from	O
a	O
common	O
bud	O
located	O
in	O
the	O
ventral	O
side	O
of	O
the	O
ascending	O
arch	O
,	O
or	O
from	O
separate	O
adjacent	O
sites	O
,	O
as	O
verified	O
by	O
serial	O
sectioning	O
(	O
Fig	O
.	O
1M	O
-	O
P	O
)	O
.	O

The	O
remaining	O
mutants	O
displayed	O
a	O
left	O
-	O
sided	O
aortic	O
arch	O
,	O
where	O
the	O
right	O
carotid	O
arteries	O
originated	O
from	O
the	O
right	O
lateral	O
aspect	O
of	O
the	O
ascending	O
trunk	O
,	O
while	O
the	O
left	O
carotid	O
arteries	O
budded	O
from	O
the	O
ventral	O
or	O
right	O
ventral	O
aspects	O
of	O
the	O
trunk	O
(	O
Fig	O
.	O
1I	O
-	O
L	O
)	O
.	O

Both	O
right	O
and	O
left	O
subclavian	O
arteries	O
consistently	O
originated	O
from	O
the	O
descending	O
part	O
of	O
the	O
aortic	O
arch	O
.	O

Similarly	O
,	O
in	O
all	O
mutants	O
both	O
left	O
and	O
right	O
pulmonary	O
arteries	O
always	O
branched	O
out	O
from	O
the	O
common	O
arterial	O
trunk	O
.	O

To	O
conclude	O
,	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
consistently	O
displayed	O
PTA	O
,	O
which	O
differed	O
significantly	O
from	O
the	O
characteristic	O
interrupted	O
aortic	O
arch	O
phenotype	O
seen	O
in	O
Tgfbr2	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
[	O
8	O
,	O
9	O
]	O
.	O

Figure	O
1	O

Abrogation	O
of	O
Alk5	O
in	O
neural	O
crest	O
cells	O
leads	O
to	O
persistent	O
truncus	O
arteriosus	O
type	O
A2	O
.	O

A	O
-	O
D	O
,	O
Casting	O
-	O
dye	B-CHEBI
analysis	O
of	O
OFT	O
morphogenesis	O
at	O
E17	O
.	O
0	O
.	O

Control	O
(	O
A	O
)	O
,	O
Tgfbr2	O
/	O
Wnt1	O
-	O
Cre	O
mutant	O
[	O
8	O
]	O
(	O
B	O
)	O
demonstrating	O
the	O
PTA	O
type	O
A4	O
(	O
=	O
truncus	O
arteriosus	O
with	O
interrupted	O
aortic	O
arch	O
[	O
30	O
]	O
)	O
and	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
demonstrating	O
the	O
right	O
-	O
sided	O
(	O
C	O
)	O
and	O
left	O
-	O
sided	O
(	O
D	O
)	O
arches	O
of	O
the	O
truncus	O
.	O

E	O
-	O
P	O
,	O
Histological	O
cross	O
-	O
sections	O
on	O
four	O
different	O
levels	O
(	O
rostral	O
to	O
caudal	O
)	O
at	O
E17	O
.	O
0	O
.	O

In	O
a	O
control	O
(	O
E	O
-	O
H	O
)	O
,	O
the	O
ascending	O
aorta	O
(	O
Ao	O
)	O
and	O
pulmonary	O
trunk	O
(	O
PT	O
)	O
are	O
separated	O
by	O
the	O
conotruncal	O
septum	O
.	O

In	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
(	O
I	O
-	O
P	O
)	O
the	O
conotruncal	O
septum	O
fails	O
to	O
form	O
,	O
and	O
either	O
left	O
-	O
sided	O
(	O
I	O
-	O
L	O
)	O
or	O
right	O
-	O
sided	O
(	O
M	O
-	O
P	O
)	O
aortic	O
arch	O
can	O
be	O
seen	O
.	O

Aberrant	O
branching	O
of	O
carotid	O
arteries	O
from	O
the	O
truncus	O
has	O
been	O
illustrated	O
by	O
black	O
arrows	O
(	O
J	O
and	O
M	O
)	O
.	O

Ao	O
,	O
aorta	O
;	O
PT	O
,	O
pulmonary	O
trunk	O
;	O
RSA	O
,	O
right	O
subclavian	O
artery	O
;	O
RCA	O
,	O
right	O
carotid	O
artery	O
;	O
LCA	O
;	O
left	O
carotid	O
artery	O
;	O
LSA	O
,	O
left	O
subclavian	O
artery	O
;	O
IAA	O
,	O
interrupted	O
aortic	O
arch	O
;	O
PTA	O
,	O
persistent	O
truncus	O
arteriosus	O
.	O

Abnormal	O
patterning	O
of	O
the	O
pharyngeal	O
arch	O
arteries	O
and	O
aortic	O
sac	O
in	O
Alk5	O
/	O
Wnt1Cre	O
mutants	O

During	O
cardiovascular	O
development	O
,	O
the	O
PAAs	O
undergo	O
a	O
complex	O
set	O
of	O
sequential	O
asymmetric	O
remodeling	O
steps	O
resulting	O
in	O
the	O
left	O
-	O
sided	O
aortic	O
arch	O
.	O

To	O
determine	O
,	O
whether	O
ALK5	O
-	O
mediated	O
signaling	O
was	O
involved	O
in	O
remodeling	O
of	O
PAAs	O
,	O
we	O
performed	O
intracardiac	O
India	O
ink	O
injections	O
at	O
different	O
developmental	O
stages	O
.	O

While	O
at	O
E10	O
,	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
did	O
not	O
show	O
obvious	O
differences	O
in	O
the	O
PAAs	O
,	O
abnormal	O
remodeling	O
became	O
obvious	O
in	O
mutants	O
a	O
day	O
later	O
at	O
E11	O
(	O
Fig	O
.	O
2	O
)	O
.	O

The	O
controls	O
displayed	O
the	O
well	O
-	O
formed	O
3rd	O
,	O
4th	O
and	O
6th	O
PAAs	O
.	O

Moreover	O
,	O
the	O
carotid	O
duct	O
(	O
the	O
dorsal	O
aorta	O
between	O
the	O
3rd	O
and	O
4th	O
PAAs	O
)	O
was	O
already	O
regressing	O
as	O
demonstrated	O
by	O
the	O
reduced	O
size	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

In	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
,	O
the	O
3rd	O
and	O
4th	O
pairs	O
of	O
PAAs	O
were	O
bilaterally	O
hypoplastic	O
,	O
whereas	O
the	O
6th	O
pair	O
of	O
PAAs	O
was	O
notably	O
hyperplastic	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

Furthermore	O
,	O
the	O
carotid	O
duct	O
was	O
remarkably	O
large	O
,	O
when	O
compared	O
to	O
controls	O
.	O

While	O
the	O
controls	O
displayed	O
an	O
interruption	O
of	O
the	O
carotid	O
duct	O
at	O
E12	O
and	O
E13	O
as	O
expected	O
(	O
Fig	O
.	O
2C	O
)	O
,	O
the	O
mutants	O
demonstrated	O
an	O
uncharacteristic	O
break	O
of	O
the	O
dorsal	O
aorta	O
between	O
the	O
4th	O
and	O
6th	O
pairs	O
of	O
PAAs	O
(	O
Fig	O
.	O
2D	O
)	O
.	O

Figure	O
2	O

Abnormal	O
patterning	O
of	O
the	O
PAAs	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
.	O

Left	O
lateral	O
view	O
after	O
intracardiac	O
ink	O
injections	O
to	O
visualize	O
the	O
developing	O
PAAs	O
at	O
E11	O
.	O
0	O
(	O
A	O
,	O
B	O
)	O
,	O
E12	O
.	O
0	O
(	O
C	O
,	O
D	O
)	O
and	O
E13	O
.	O
0	O
(	O
E	O
,	O
F	O
)	O
in	O
controls	O
(	O
A	O
,	O
C	O
,	O
E	O
)	O
and	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
(	O
B	O
,	O
D	O
,	O
F	O
)	O
.	O

Arrow	O
in	O
A	O
points	O
to	O
the	O
regressing	O
carotid	O
duct	O
.	O

Asterisk	O
in	O
B	O
depicts	O
the	O
corresponding	O
structure	O
in	O
the	O
mutant	O
with	O
no	O
signs	O
of	O
regression	O
.	O

Asterisk	O
in	O
D	O
illustrates	O
the	O
aberrant	O
regression	O
of	O
the	O
dorsal	O
aorta	O
between	O
the	O
4th	O
and	O
6th	O
PAAs	O
.	O

PT	O
,	O
pulmonary	O
trunk	O
;	O
Ao	O
,	O
Aorta	O
;	O
TA	O
,	O
truncus	O
arteriosus	O
.	O

Around	O
E11	O
.	O
5	O
,	O
the	O
aortic	O
sac	O
normally	O
forms	O
a	O
distinctive	O
T	O
-	O
shaped	O
structure	O
,	O
as	O
seen	O
in	O
frontal	O
sections	O
of	O
the	O
control	O
sample	O
in	O
Fig	O
.	O

3	O
(	O
A	O
,	O
C	O
)	O
.	O

Subsequently	O
,	O
the	O
right	O
horn	O
of	O
this	O
structure	O
transforms	O
into	O
the	O
prospective	O
brachiocephalic	O
artery	O
,	O
while	O
the	O
left	O
horn	O
together	O
with	O
the	O
left	O
4th	O
PAA	O
gives	O
rise	O
to	O
the	O
definitive	O
aortic	O
arch	O
[	O
23	O
]	O
.	O

In	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
,	O
the	O
T	O
-	O
shaped	O
aortic	O
sac	O
failed	O
to	O
form	O
(	O
Fig	O
.	O
3B	O
,	O
D	O
)	O
.	O

Instead	O
,	O
the	O
truncus	O
bifurcated	O
to	O
a	O
left	O
and	O
right	O
arm	O
,	O
which	O
further	O
branched	O
to	O
the	O
PAAs	O
,	O
particularly	O
to	O
the	O
predominant	O
pair	O
of	O
6th	O
PAAs	O
(	O
Fig	O
.	O
3B	O
,	O
D	O
)	O
.	O

The	O
observed	O
phenotype	O
is	O
consistent	O
with	O
the	O
absence	O
or	O
severe	O
hypoplasia	O
of	O
structures	O
derived	O
from	O
the	O
aortic	O
sac	O
in	O
late	O
stage	O
embryos	O
(	O
E17	O
)	O
,	O
e	O
.	O
g	O
.	O
,	O
the	O
missing	O
brachiocephalic	O
artery	O
and	O
severe	O
shortening	O
of	O
the	O
ascending	O
truncus	O
as	O
shown	O
in	O
the	O
Figure	O
1	O
.	O

Figure	O
3	O

Abnormal	O
Aortic	O
Sac	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
.	O

Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
(	O
B	O
,	O
D	O
)	O
fail	O
to	O
form	O
the	O
typical	O
T	O
-	O
shaped	O
structure	O
of	O
the	O
aortic	O
sac	O
seen	O
in	O
controls	O
at	O
E11	O
.	O
5	O
.	O

(	O
A	O
,	O
C	O
)	O
.	O

A	O
-	O
B	O
,	O
frontal	O
image	O
of	O
ink	O
-	O
injected	O
embryos	O
;	O
C	O
-	O
D	O
,	O
frontal	O
sections	O
(	O
H	O
&	O
E	O
staining	O
)	O
.	O

Arrows	O
in	O
A	O
and	O
B	O
point	O
to	O
the	O
level	O
of	O
section	O
shown	O
in	O
C	O
and	O
D	O
(	O
red	O
arrows	O
in	O
C	O
and	O
D	O
point	O
to	O
the	O
aortic	O
sac	O
of	O
the	O
control	O
and	O
mutant	O
,	O
respectively	O
)	O
.	O

Cardiac	O
NCCs	O
deficient	O
in	O
Alk5	O
can	O
populate	O
the	O
outflow	O
tract	O

Next	O
we	O
used	O
the	O
R26R	O
lineage	O
-	O
tracing	O
assay	O
to	O
determine	O
whether	O
CNCCs	O
could	O
appropriately	O
populate	O
the	O
outflow	O
tract	O
region	O
.	O

Briefly	O
,	O
Alk5Flox	O
/	O
Flox	O
mice	O
were	O
crossed	O
with	O
the	O
ROSA26	O
Cre	O
reporter	O
mice	O
,	O
and	O
subsequently	O
Alk5Flox	O
/	O
Flox	O
;	O
R26R	O
(	O
+	O
/	O
+	O
)	O
females	O
were	O
crossed	O
with	O
Alk5KO	O
/	O
WT	O
;	O
Wnt1	O
-	O
Cre	O
males	O
.	O

The	O
resulting	O
embryos	O
had	O
the	O
NC	O
-	O
lineage	O
permanently	O
labeled	O
with	O
beta	O
-	O
galactosidase	O
expression	O
,	O
and	O
displayed	O
identical	O
phenotypes	O
to	O
those	O
obtained	O
without	O
the	O
R26R	O
reporter	O
.	O

Staining	O
of	O
embryos	O
for	O
beta	O
-	O
galactosidase	O
at	O
E8	O
-	O
E11	O
did	O
not	O
reveal	O
detectable	O
differences	O
in	O
NCC	O
migration	O
between	O
mutants	O
and	O
controls	O
(	O
data	O
not	O
shown	O
)	O
.	O

Similarly	O
,	O
serial	O
transverse	O
sectioning	O
of	O
whole	O
mount	O
embryos	O
(	O
E10	O
-	O
E12	O
)	O
and	O
subsequent	O
analysis	O
of	O
positively	O
stained	O
cells	O
in	O
the	O
OFT	O
region	O
demonstrated	O
that	O
CNCCs	O
deficient	O
in	O
Alk5	O
were	O
capable	O
of	O
populating	O
the	O
PAAs	O
,	O
aortic	O
sac	O
and	O
conotruncal	O
ridges	O
at	O
a	O
level	O
comparable	O
to	O
that	O
of	O
controls	O
(	O
Fig	O
4	O
)	O
.	O

To	O
conclude	O
,	O
the	O
observed	O
phenotypes	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
were	O
certainly	O
not	O
due	O
to	O
defective	O
migration	O
of	O
CNCCs	O
to	O
the	O
pharyngeal	O
and	O
outflow	O
tract	O
regions	O
.	O

Figure	O
4	O

Normal	O
cardiac	O
NCC	O
migration	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
.	O

The	O
OFT	O
of	O
controls	O
(	O
A	O
,	O
C	O
,	O
E	O
)	O
and	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
(	O
B	O
,	O
D	O
,	O
F	O
)	O
display	O
similar	O
staining	O
patterns	O
when	O
analyzed	O
using	O
the	O
R26R	O
lineage	O
tracing	O
assay	O
at	O
E11	O
.	O
0	O
.	O

A	O
-	O
B	O
,	O
whole	O
mount	O
staining	O
(	O
left	O
lateral	O
image	O
)	O
;	O
C	O
-	O
F	O
,	O
transverse	O
sections	O
on	O
the	O
level	O
of	O
the	O
4th	O
(	O
C	O
,	O
D	O
)	O
and	O
6th	O
(	O
E	O
,	O
F	O
)	O
PAAs	O
.	O

Arrows	O
(	O
A	O
-	O
F	O
)	O
point	O
to	O
the	O
most	O
proximal	O
location	O
staining	O
positive	O
for	O
the	O
beta	O
-	O
galactosidase	O
activity	O
.	O

Aortic	O
sac	O
and	O
aortico	O
-	O
pulmonary	O
septal	O
defects	O
in	O
Alk5	O
/	O
Wnt1Cre	O
mutant	O
embryos	O

Septation	O
of	O
the	O
outflow	O
tract	O
lumen	O
begins	O
in	O
a	O
cranial	O
-	O
to	O
-	O
caudal	O
direction	O
,	O
starting	O
distally	O
in	O
the	O
aortic	O
sac	O
and	O
proceeding	O
toward	O
the	O
heart	O
[	O
24	O
]	O
.	O

Initially	O
,	O
the	O
condensed	O
mesenchyme	O
derived	O
from	O
the	O
NC	O
forms	O
in	O
the	O
base	O
of	O
the	O
aortic	O
sac	O
between	O
the	O
origins	O
of	O
4th	O
and	O
6th	O
PAAs	O
.	O

Subsequently	O
,	O
two	O
prongs	O
of	O
the	O
developing	O
aortico	O
-	O
pulmonary	O
(	O
AP	O
)	O
septum	O
extend	O
into	O
the	O
truncal	O
cushions	O
and	O
the	O
aortico	O
-	O
pulmonary	O
septation	O
complex	O
crosses	O
the	O
aortic	O
sac	O
cranially	O
.	O

In	O
ink	O
-	O
injected	O
control	O
embryos	O
at	O
E11	O
.	O
5	O
,	O
a	O
characteristic	O
conotruncal	O
transition	O
separating	O
the	O
truncus	O
and	O
conus	O
could	O
be	O
seen	O
as	O
a	O
twisted	O
configuration	O
,	O
resulting	O
from	O
a	O
change	O
in	O
orientation	O
of	O
the	O
truncal	O
and	O
conal	O
cushions	O
(	O
Fig	O
.	O
5	O
)	O
.	O

In	O
contrast	O
,	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
the	O
outflow	O
tract	O
appeared	O
unusually	O
straight	O
,	O
failing	O
to	O
demonstrate	O
the	O
distinct	O
conotruncal	O
transition	O
(	O
Fig	O
.	O
5B	O
,	O
D	O
)	O
.	O

This	O
assay	O
also	O
clearly	O
showed	O
a	O
dramatic	O
reduction	O
in	O
the	O
size	O
of	O
the	O
aortic	O
sac	O
.	O

Histological	O
analysis	O
of	O
control	O
samples	O
displayed	O
the	O
characteristic	O
rotation	O
of	O
the	O
aortic	O
sac	O
and	O
truncal	O
OFT	O
at	O
the	O
level	O
where	O
the	O
AP	O
septation	O
takes	O
place	O
and	O
verified	O
the	O
presence	O
of	O
the	O
distinctive	O
condensed	O
AP	O
-	O
septal	O
mesenchyme	O
,	O
which	O
gradually	O
divided	O
the	O
OFT	O
to	O
the	O
aorta	O
and	O
the	O
pulmonary	O
trunk	O
(	O
asterisks	O
in	O
Fig	O
.	O
6A	O
)	O
.	O

R26R	O
lineage	O
tracing	O
showed	O
that	O
this	O
tissue	O
is	O
derived	O
from	O
the	O
NC	O
,	O
while	O
immunostaining	O
for	O
alpha	O
-	O
SMA	O
showed	O
differentiation	O
into	O
smooth	O
muscle	O
(	O
Fig	O
6B	O
)	O
.	O

In	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
the	O
characteristic	O
rotation	O
of	O
the	O
aortic	O
sac	O
and	O
truncal	O
OFT	O
fails	O
to	O
take	O
place	O
(	O
Fig	O
.	O
6G	O
-	O
L	O
)	O
,	O
and	O
a	O
properly	O
formed	O
AP	O
-	O
septum	O
was	O
not	O
detectable	O
(	O
Fig	O
.	O
6G	O
,	O
H	O
)	O
.	O

R26R	O
lineage	O
tracing	O
demonstrated	O
that	O
the	O
defects	O
were	O
not	O
due	O
to	O
failure	O
of	O
NCCs	O
to	O
reach	O
the	O
OFT	O
region	O
.	O

NC	O
-	O
derived	O
cells	O
around	O
the	O
abnomally	O
bifurcated	O
aortic	O
sac	O
,	O
the	O
abnormally	O
large	O
sixth	O
PAAs	O
and	O
the	O
truncus	O
demonstrated	O
strong	O
alpha	O
SMA	O
staining	O
(	O
Fig	O
.	O
6H	O
,	O
J	O
,	O
L	O
)	O
.	O

Recently	O
,	O
we	O
showed	O
that	O
the	O
NC	O
-	O
specific	O
mutants	O
of	O
the	O
related	O
type	O
I	O
receptor	O
,	O
Alk2	O
,	O
display	O
PTA	O
as	O
well	O
[	O
12	O
]	O
.	O

In	O
Alk2	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
,	O
the	O
rotation	O
of	O
the	O
aortic	O
sac	O
and	O
truncal	O
OFT	O
failed	O
to	O
occur	O
(	O
Fig	O
.	O
6M	O
-	O
R	O
)	O
as	O
seen	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
.	O

However	O
,	O
in	O
Alk2	O
mutants	O
the	O
6th	O
pair	O
of	O
the	O
PAAs	O
was	O
grossly	O
hypoplastic	O
,	O
and	O
while	O
the	O
Alk2	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
displayed	O
a	O
noticeable	O
amount	O
of	O
septal	O
tissue	O
between	O
the	O
4th	O
and	O
6th	O
PAAs	O
(	O
Fig	O
.	O
6M	O
,	O
N	O
)	O
,	O
the	O
condensed	O
septal	O
mesenchyme	O
lacking	O
Alk2	O
failed	O
to	O
extend	O
the	O
prongs	O
into	O
the	O
truncal	O
cushions	O
and	O
to	O
form	O
the	O
AP	O
septum	O
.	O

Concurrently	O
,	O
the	O
6th	O
PAAs	O
were	O
losing	O
their	O
patency	O
,	O
which	O
may	O
have	O
further	O
contributed	O
to	O
the	O
failed	O
AP	O
septation	O
(	O
Fig	O
.	O
6M	O
,	O
O	O
,	O
Q	O
)	O
.	O

While	O
CNCCs	O
managed	O
to	O
migrate	O
to	O
the	O
aortic	O
sac	O
and	O
the	O
truncal	O
cushion	O
level	O
(	O
Fig	O
.	O
6N	O
,	O
P	O
,	O
R	O
)	O
,	O
immunostaining	O
for	O
alpha	O
SMA	O
appeared	O
much	O
weaker	O
when	O
compared	O
to	O
controls	O
and	O
Alk5	O
mutants	O
,	O
implying	O
that	O
ALK2	O
-	O
mediated	O
signaling	O
is	O
involved	O
in	O
smooth	O
muscle	O
cell	O
differentiation	O
as	O
previously	O
suggested	O
[	O
12	O
]	O
.	O

To	O
conclude	O
,	O
while	O
both	O
Alk2	O
and	O
Alk5	O
mutants	O
demonstrate	O
a	O
failure	O
in	O
both	O
the	O
rotation	O
of	O
the	O
aortic	O
sac	O
and	O
the	O
truncal	O
OFT	O
,	O
and	O
in	O
the	O
formation	O
of	O
the	O
AP	O
septum	O
,	O
the	O
pathogenetic	O
mechanisms	O
behind	O
these	O
defects	O
appear	O
remarkably	O
different	O
.	O

Figure	O
5	O

The	O
truncal	O
OFT	O
fails	O
to	O
rotate	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
.	O

Left	O
(	O
A	O
,	O
C	O
)	O
and	O
right	O
(	O
B	O
,	O
D	O
)	O
lateral	O
images	O
of	O
ink	O
-	O
injected	O
control	O
(	O
A	O
-	O
B	O
)	O
and	O
mutant	O
(	O
C	O
-	O
D	O
)	O
embryos	O
at	O
E11	O
.	O
5	O
demonstrate	O
the	O
abnormally	O
straight	O
OFT	O
in	O
mutants	O
lacking	O
the	O
typical	O
conotruncal	O
transition	O
(	O
black	O
arrow	O
in	O
A	O
vs	O
.	O
black	O
arrowhead	O
in	O
C	O
)	O
seen	O
in	O
control	O
.	O

Red	O
arrowhead	O
(	O
C	O
)	O
points	O
to	O
the	O
abnormally	O
shaped	O
aortic	O
sac	O
.	O

Red	O
"	O
s	O
"	O
,	O
aortic	O
sac	O
;	O
t	O
,	O
truncus	O
;	O
c	O
,	O
conus	O
.	O

Figure	O
6	O

Signaling	O
via	O
ALK5	O
and	O
ALK2	O
controls	O
different	O
aspects	O
of	O
aortico	O
-	O
pulmonary	O
septation	O
.	O

Frontal	O
sections	O
from	O
distal	O
(	O
top	O
row	O
)	O
to	O
proximal	O
(	O
bottom	O
row	O
)	O
of	O
the	O
control	O
(	O
A	O
-	O
F	O
)	O
,	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutant	O
(	O
G	O
-	O
L	O
)	O
and	O
Alk2	O
/	O
Wnt1	O
-	O
Cre	O
mutant	O
(	O
M	O
-	O
R	O
)	O
samples	O
(	O
E11	O
.	O
5	O
)	O
.	O

A	O
,	O
C	O
,	O
E	O
,	O
G	O
,	O
I	O
,	O
K	O
,	O
M	O
,	O
O	O
,	O
Q	O
,	O
H	O
&	O
E	O
staining	O
;	O
B	O
,	O
D	O
,	O
F	O
,	O
H	O
,	O
J	O
,	O
L	O
,	O
N	O
,	O
P	O
,	O
R	O
,	O
double	O
staining	O
for	O
alpha	O
SMA	O
(	O
brown	O
)	O
and	O
beta	O
-	O
galactosidase	O
(	O
green	O
;	O
R26R	O
reporter	O
assay	O
)	O
.	O

6	O
,	O
the	O
6th	O
PAA	O
;	O
AS	O
,	O
aortic	O
sac	O
;	O
TA	O
,	O
truncus	O
arteriosus	O
;	O
Ao	O
,	O
Aorta	O
;	O
PT	O
,	O
pulmonary	O
trunk	O
;	O
Asterisks	O
in	O
A	O
,	O
B	O
,	O
M	O
and	O
N	O
depict	O
the	O
AP	O
septal	O
mesenchyme	O
.	O

Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
display	O
increased	O
apoptosis	O
of	O
post	O
-	O
migratory	O
neural	O
crest	O
cells	O

As	O
described	O
above	O
,	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
displayed	O
an	O
inadequate	O
amount	O
of	O
AP	O
-	O
septal	O
tissue	O
in	O
the	O
base	O
of	O
the	O
aortic	O
sac	O
between	O
the	O
origins	O
of	O
4th	O
and	O
6th	O
PAAs	O
.	O

To	O
analyze	O
whether	O
this	O
phenotype	O
resulted	O
either	O
from	O
defective	O
CNCC	O
proliferation	O
or	O
inappropriate	O
apoptosis	O
,	O
we	O
used	O
BrdU	O
and	O
TUNEL	O
staining	O
,	O
respectively	O
.	O

While	O
CNCC	O
proliferation	O
was	O
not	O
affected	O
in	O
Alk5	O
mutants	O
(	O
data	O
not	O
shown	O
)	O
,	O
we	O
could	O
detect	O
a	O
dramatic	O
increase	O
in	O
the	O
number	O
of	O
TUNEL	O
positive	O
cells	O
in	O
tissues	O
surrounding	O
the	O
aortic	O
sac	O
including	O
the	O
site	O
where	O
the	O
AP	O
-	O
septum	O
forms	O
(	O
Fig	O
.	O
7A	O
-	O
C	O
)	O
.	O

Dual	O
staining	O
for	O
lacZ	O
and	O
TUNEL	O
positive	O
cells	O
demonstrated	O
that	O
these	O
cells	O
were	O
postmigratory	O
CNCCs	O
;	O
this	O
phenotype	O
was	O
already	O
clearly	O
detectable	O
at	O
E10	O
.	O
5	O
.	O

These	O
results	O
were	O
confirmed	O
by	O
using	O
immunostaining	O
for	O
cleaved	O
caspase	O
-	O
3	O
,	O
another	O
marker	O
for	O
apoptosis	O
(	O
Fig	O
.	O
7I	O
,	O
J	O
)	O
.	O

In	O
the	O
chick	O
,	O
apoptotic	O
neural	O
crest	O
-	O
derived	O
cells	O
have	O
also	O
been	O
found	O
at	O
the	O
sites	O
,	O
where	O
the	O
prongs	O
of	O
the	O
AP	O
septum	O
penetrate	O
into	O
the	O
OFT	O
cushion	O
mesenchyme	O
[	O
25	O
,	O
26	O
]	O
.	O

Thus	O
,	O
we	O
compared	O
apoptosis	O
patterns	O
also	O
on	O
the	O
more	O
proximal	O
level	O
,	O
but	O
found	O
no	O
detectable	O
differences	O
at	O
E11	O
.	O
0	O
between	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
and	O
controls	O
(	O
Fig	O
.	O
7D	O
,	O
E	O
)	O
.	O

Unlike	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutant	O
embryos	O
,	O
increased	O
apoptosis	O
of	O
NC	O
-	O
derived	O
cells	O
is	O
not	O
responsible	O
for	O
the	O
observed	O
defects	O
in	O
the	O
OFT	O
septation	O
in	O
corresponding	O
Alk2	O
mutants	O
(	O
Fig	O
.	O
7C	O
,	O
E	O
)	O
.	O

Figure	O
7	O

Aberrant	O
apoptosis	O
of	O
NCCs	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
.	O

TUNEL	O
(	O
A	O
-	O
H	O
)	O
and	O
Cleaved	O
Caspase	O
-	O
3	O
(	O
I	O
,	O
J	O
)	O
staining	O
at	O
E11	O
.	O
0	O
demonstrates	O
a	O
notable	O
increase	O
in	O
apoptosis	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
(	O
B	O
,	O
H	O
,	O
J	O
)	O
on	O
the	O
aortic	O
sac	O
level	O
when	O
compared	O
to	O
controls	O
(	O
A	O
,	O
G	O
,	O
I	O
)	O
or	O
Alk2	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
(	O
C	O
)	O
(	O
frontal	O
sections	O
)	O
,	O
while	O
sections	O
on	O
the	O
OFT	O
level	O
do	O
not	O
demonstrate	O
differences	O
between	O
controls	O
(	O
D	O
)	O
and	O
Alk5	O
(	O
E	O
)	O
or	O
Alk2	O
(	O
F	O
)	O
mutants	O
.	O

G	O
,	O
H	O
,	O
TUNEL	O
staining	O
of	O
lacZ	O
-	O
stained	O
embryos	O
demonstrates	O
that	O
apoptotic	O
cells	O
are	O
of	O
neural	O
crest	O
origin	O
.	O

G	O
,	O
control	O
;	O
H	O
,	O
mutant	O
.	O

AS	O
,	O
aortic	O
sac	O
,	O
arrows	O
point	O
to	O
clusters	O
of	O
apoptotic	O
cells	O
surrounding	O
the	O
aortic	O
sac	O
.	O

To	O
conclude	O
,	O
our	O
results	O
suggest	O
that	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
a	O
noticeable	O
increase	O
in	O
apoptosis	O
coincides	O
with	O
the	O
abnormal	O
patterning	O
of	O
the	O
PAAs	O
and	O
the	O
aortic	O
sac	O
,	O
and	O
with	O
the	O
failed	O
AP	O
-	O
septation	O
.	O

These	O
data	O
support	O
a	O
specific	O
role	O
for	O
ALK5	O
signaling	O
,	O
either	O
directly	O
or	O
indirectly	O
,	O
in	O
CNCC	O
survival	O
,	O
since	O
a	O
similar	O
apoptosis	O
of	O
NC	O
-	O
derived	O
cells	O
is	O
not	O
seen	O
in	O
Tgfbr2	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
[	O
8	O
,	O
9	O
]	O
.	O

Pharyngeal	O
organs	O
fail	O
to	O
migrate	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O

In	O
addition	O
to	O
the	O
cardiac	O
OFT	O
,	O
development	O
of	O
pharyngeal	O
organs	O
,	O
i	O
.	O
e	O
.	O
,	O
the	O
parathyroid	O
glands	O
and	O
the	O
thymus	O
was	O
also	O
abnormal	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
(	O
see	O
Figs	O
.	O
1	O
and	O
8	O
)	O
.	O

Normally	O
the	O
thymus	O
develops	O
from	O
the	O
third	O
pharyngeal	O
pouch	O
endoderm	O
and	O
migrates	O
caudally	O
to	O
its	O
final	O
location	O
in	O
the	O
superior	O
mediastinum	O
as	O
seen	O
in	O
controls	O
at	O
E14	O
(	O
Fig	O
.	O
8A	O
,	O
B	O
)	O
.	O

In	O
contrast	O
,	O
the	O
thymic	O
primordia	O
of	O
the	O
Alk5	O
mutant	O
littermates	O
failed	O
to	O
descend	O
caudally	O
,	O
and	O
were	O
located	O
bilaterally	O
in	O
the	O
neck	O
region	O
,	O
where	O
they	O
were	O
surrounded	O
by	O
neural	O
crest	O
-	O
derived	O
mesenchyme	O
(	O
Fig	O
.	O
8D	O
,	O
E	O
)	O
.	O

The	O
fate	O
determination	O
assay	O
demonstrated	O
that	O
the	O
thymic	O
primordia	O
were	O
equally	O
populated	O
by	O
NCCs	O
both	O
in	O
controls	O
and	O
Alk5	O
mutants	O
(	O
Fig	O
.	O
8B	O
,	O
E	O
)	O
.	O

Likewise	O
the	O
parathyroid	O
glands	O
failed	O
to	O
migrate	O
normally	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
.	O

During	O
normal	O
development	O
,	O
the	O
parathyroids	O
first	O
migrate	O
in	O
association	O
with	O
the	O
thymic	O
primordia	O
,	O
until	O
they	O
reach	O
the	O
thyroids	O
in	O
the	O
neck	O
region	O
as	O
seen	O
in	O
Fig	O
8C	O
.	O

In	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
,	O
the	O
parathyroids	O
remained	O
associated	O
with	O
the	O
thymic	O
primordia	O
,	O
and	O
despite	O
this	O
abnormal	O
rostral	O
location	O
,	O
expression	O
of	O
parathyroid	O
hormone	O
was	O
indistinguishable	O
between	O
Alk5	O
mutants	O
and	O
controls	O
at	O
E14	O
(	O
Fig	O
.	O
8C	O
,	O
F	O
)	O
.	O

To	O
conclude	O
,	O
the	O
observed	O
pharyngeal	O
organ	O
phenotypes	O
were	O
also	O
in	O
striking	O
contrast	O
to	O
those	O
seen	O
in	O
Tgfbr2	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
[	O
8	O
,	O
9	O
]	O
.	O

Figure	O
8	O

Pharyngeal	O
organs	O
fail	O
to	O
migrate	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
.	O

At	O
E14	O
.	O
0	O
,	O
the	O
thymus	O
was	O
not	O
detectable	O
in	O
the	O
superior	O
mediastinum	O
(	O
asterisks	O
)	O
in	O
Alk5	O
mutants	O
(	O
D	O
)	O
,	O
when	O
compared	O
to	O
controls	O
(	O
A	O
)	O
.	O

Serial	O
sectioning	O
revealed	O
that	O
the	O
thymic	O
primordia	O
had	O
failed	O
to	O
descend	O
and	O
were	O
seen	O
bilaterally	O
in	O
the	O
upper	O
pharyngeal	O
region	O
(	O
E	O
,	O
F	O
)	O
surrounded	O
by	O
neural	O
crest	O
derived	O
mesenchyme	O
(	O
blue	O
staining	O
cells	O
in	O
E	O
)	O
.	O

In	O
controls	O
,	O
the	O
parathyroid	O
glands	O
were	O
properly	O
associated	O
with	O
the	O
thyroid	O
glands	O
(	O
arrows	O
in	O
C	O
)	O
,	O
while	O
in	O
Alk5	O
mutants	O
the	O
parathyroid	O
glands	O
were	O
associated	O
with	O
the	O
thymic	O
primordia	O
(	O
arrows	O
in	O
F	O
)	O
.	O

However	O
,	O
both	O
controls	O
and	O
mutants	O
expressed	O
parathyroid	O
hormone	B-CHEBI
(	O
PTH	O
)	O
at	O
comparable	O
levels	O
(	O
blue	O
staining	O
in	O
C	O
and	O
F	O
)	O
.	O

A	O
and	O
D	O
,	O
hematoxyllin	O
and	O
eosin	O
staining	O
;	O
B	O
and	O
E	O
,	O
R26	O
R	O
lineage	O
tracing	O
assay	O
-	O
counterstaining	O
with	O
eosin	O
;	O
C	O
and	O
F	O
,	O
section	O
in	O
situ	O
hybridization	O
for	O
PTH	O
-	O
counterstaining	O
with	O
eosin	O
.	O

T	O
,	O
thymus	O
;	O
Th	O
,	O
thyroid	O
;	O
asterisks	O
in	O
D	O
depict	O
the	O
absence	O
of	O
the	O
thymic	O
primordia	O
;	O
asterisks	O
in	O
E	O
and	O
F	O
depict	O
the	O
tongue	O
.	O

Discussion	O

During	O
the	O
last	O
few	O
years	O
the	O
Wnt1	O
-	O
Cre	O
transgenic	O
driver	O
line	O
has	O
proven	O
to	O
be	O
a	O
powerful	O
tool	O
for	O
tissue	O
-	O
specific	O
gene	O
deletion	O
in	O
NCCs	O
[	O
12	O
,	O
13	O
,	O
27	O
,	O
28	O
]	O
.	O

Using	O
this	O
approach	O
,	O
several	O
studies	O
have	O
independently	O
shown	O
that	O
the	O
NC	O
-	O
specific	O
deletion	O
of	O
the	O
Tgfbr2	O
gene	O
leads	O
to	O
a	O
distinct	O
set	O
of	O
calvarial	O
,	O
facial	O
and	O
cardiac	O
defects	O
[	O
8	O
,	O
9	O
,	O
20	O
,	O
29	O
]	O
.	O

Interestingly	O
,	O
these	O
defects	O
appear	O
quite	O
different	O
both	O
in	O
the	O
craniofacial	O
and	O
pharyngeal	O
regions	O
,	O
including	O
the	O
heart	O
,	O
when	O
compared	O
to	O
the	O
corresponding	O
mutants	O
of	O
Alk5	O
,	O
which	O
encodes	O
the	O
TGF	O
-	O
beta	O
type	O
I	O
receptor	O
,	O
a	O
prototypical	O
binding	O
partner	O
of	O
TGF	O
-	O
beta	O
RII	O
[	O
19	O
]	O
and	O
the	O
present	O
study	O
)	O
.	O

While	O
Tgfbr2	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
as	O
well	O
as	O
mice	O
deficient	O
in	O
Tgf	O
-	O
beta	O
2	O
display	O
the	O
PTA	O
type	O
A4	O
(	O
truncus	O
arteriosus	O
with	O
interrupted	O
aortic	O
arch	O
[	O
30	O
]	O
)	O
,	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
reported	O
here	O
demonstrate	O
earlier	O
patterning	O
defects	O
of	O
the	O
PAAs	O
,	O
which	O
is	O
particularly	O
obvious	O
in	O
the	O
3rd	O
pair	O
of	O
the	O
PAAs	O
.	O

Moreover	O
,	O
the	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
display	O
an	O
abnormal	O
patterning	O
of	O
the	O
aortic	O
sac	O
and	O
defective	O
AP	O
septation	O
leading	O
to	O
PTA	O
,	O
reminiscent	O
of	O
type	O
A2	O
(	O
=	O
truncus	O
artriosus	O
with	O
no	O
main	O
pulmonary	O
artery	O
segment	O
present	O
[	O
30	O
]	O
)	O
.	O

However	O
,	O
our	O
results	O
also	O
demonstrate	O
that	O
significant	O
hypoplasia	O
of	O
the	O
aortic	O
sac	O
leads	O
to	O
a	O
severe	O
shortening	O
of	O
the	O
ascending	O
truncal	O
arch	O
,	O
which	O
masks	O
possible	O
defects	O
in	O
derivatives	O
of	O
the	O
4th	O
PAAs	O
,	O
i	O
.	O
e	O
.	O
,	O
interruption	O
of	O
the	O
aortic	O
arch	O
.	O

These	O
observed	O
differences	O
are	O
likely	O
due	O
to	O
substantial	O
apoptosis	O
of	O
Alk5	O
-	O
deficient	O
post	O
-	O
migratory	O
neural	O
crest	O
cells	O
,	O
which	O
is	O
clearly	O
detectable	O
at	O
E10	O
.	O
5	O
,	O
whereas	O
similar	O
intense	O
cell	O
death	O
has	O
not	O
been	O
reported	O
in	O
Tgfbr2	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
[	O
9	O
]	O
.	O

Our	O
present	O
results	O
suggest	O
that	O
while	O
TGF	O
-	O
beta	O
signaling	O
in	O
cardiac	O
NCCs	O
is	O
predominantly	O
mediated	O
via	O
the	O
ALK5	O
/	O
TGF	O
-	O
beta	O
RII	O
receptor	O
complex	O
,	O
ALK5	O
also	O
mediates	O
signaling	O
of	O
other	O
related	O
ligands	O
,	O
which	O
are	O
either	O
directly	O
or	O
indirectly	O
required	O
for	O
appropriate	O
NCC	O
survival	O
.	O

In	O
fact	O
,	O
it	O
has	O
been	O
shown	O
that	O
,	O
besides	O
TGF	O
-	O
beta	O
RII	O
,	O
ALK5	O
can	O
also	O
form	O
a	O
complex	O
with	O
the	O
Activin	O
type	O
IIB	O
receptor	O
to	O
activate	O
downstream	O
Smads	O
2	O
/	O
3	O
[	O
18	O
,	O
31	O
]	O
.	O

Furthermore	O
,	O
a	O
subset	O
of	O
TGF	O
-	O
beta	O
-	O
related	O
growth	O
and	O
differentiation	O
factors	O
(	O
GDFs	O
)	O
,	O
e	O
.	O
g	O
.	O
,	O
GDF8	O
,	O
GDF9	O
,	O
GDF11	O
and	O
GDF15	O
could	O
induce	O
these	O
events	O
[	O
17	O
,	O
18	O
,	O
32	O
,	O
33	O
]	O
.	O

Although	O
relevant	O
Gdfs	O
8	O
,	O
9	O
11	O
and	O
15	O
are	O
not	O
expressed	O
in	O
the	O
developing	O
heart	O
,	O
nor	O
do	O
the	O
mice	O
deficient	O
in	O
these	O
Gdfs	O
display	O
developmental	O
cardiac	O
defects	O
,	O
we	O
cannot	O
exclude	O
the	O
possibility	O
that	O
circulating	O
GDFs	O
,	O
perhaps	O
in	O
concert	O
with	O
TGF	O
-	O
beta	O
s	O
may	O
contribute	O
to	O
NCC	O
survival	O
during	O
cardiac	O
and	O
pharyngeal	O
morphogenesis	O
.	O

We	O
specifically	O
studied	O
apoptosis	O
at	O
the	O
level	O
of	O
the	O
aortic	O
sac	O
,	O
where	O
the	O
AP	O
-	O
septum	O
forms	O
between	O
the	O
origins	O
of	O
4th	O
and	O
6th	O
PAAs	O
.	O

Already	O
at	O
E10	O
.	O
5	O
,	O
we	O
could	O
see	O
intense	O
apoptosis	O
among	O
the	O
postmigratory	O
NCCs	O
in	O
the	O
mesenchyme	O
surrounding	O
the	O
aortic	O
sac	O
at	O
the	O
site	O
where	O
the	O
prospective	O
AP	O
septum	O
forms	O
,	O
i	O
.	O
e	O
.	O
,	O
this	O
cell	O
death	O
precedes	O
the	O
AP	O
septal	O
defect	O
seen	O
in	O
mutants	O
.	O

Although	O
some	O
NC	O
-	O
derived	O
cells	O
appeared	O
to	O
be	O
differentiating	O
to	O
smooth	O
muscle	O
cells	O
in	O
the	O
OFT	O
(	O
Fig	O
.	O
6	O
)	O
,	O
we	O
could	O
never	O
detect	O
the	O
AP	O
septum	O
forming	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
between	O
E10	O
.	O
5	O
and	O
E11	O
.	O
5	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
pool	O
of	O
cells	O
forming	O
the	O
AP	O
septum	O
is	O
severely	O
affected	O
by	O
the	O
cell	O
death	O
.	O

Moreover	O
,	O
it	O
is	O
likely	O
that	O
these	O
cells	O
forming	O
the	O
AP	O
-	O
septum	O
die	O
the	O
before	O
majority	O
of	O
them	O
can	O
differentiate	O
to	O
smooth	O
muscle	O
cells	O
.	O

Several	O
in	O
vitro	O
studies	O
have	O
suggested	O
an	O
indispensable	O
role	O
for	O
TGF	O
-	O
beta	O
-	O
signaling	O
in	O
differentiation	O
of	O
NCCs	O
into	O
smooth	O
muscle	O
cells	O
.	O

Moreover	O
,	O
a	O
recent	O
in	O
vivo	O
study	O
suggested	O
that	O
mice	O
lacking	O
Tgfbr2	O
in	O
CNCCs	O
display	O
defective	O
NCC	O
differentiation	O
into	O
alpha	O
SMA	O
-	O
positive	O
cells	O
in	O
the	O
AP	O
septum	O
[	O
9	O
]	O
,	O
although	O
this	O
result	O
was	O
later	O
disputed	O
by	O
another	O
study	O
[	O
8	O
]	O
.	O

Our	O
immunohistochemical	O
staining	O
of	O
alpha	O
SMA	O
in	O
the	O
OFT	O
unequivocally	O
demonstrated	O
that	O
signaling	O
via	O
ALK5	O
is	O
not	O
required	O
for	O
smooth	O
muscle	O
differentiation	O
in	O
vivo	O
.	O

Moreover	O
,	O
it	O
has	O
been	O
suggested	O
that	O
deletion	O
of	O
Tgfbr2	O
in	O
NCCs	O
leads	O
to	O
other	O
phenotypic	O
features	O
reminiscent	O
of	O
those	O
seen	O
in	O
the	O
velocardiofacial	O
/	O
DiGeorge	O
syndrome	O
(	O
VCF	O
/	O
DGS	O
)	O
[	O
9	O
]	O
caused	O
by	O
a	O
deletion	O
of	O
the	O
so	O
called	O
DiGeorge	O
critical	O
region	O
(	O
DGCR	O
)	O
on	O
chromosome	O
22q11	O
[	O
34	O
,	O
35	O
]	O
.	O

Our	O
present	O
results	O
suggest	O
that	O
although	O
many	O
of	O
the	O
observed	O
phenotypes	O
seen	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
superficially	O
resemble	O
those	O
seen	O
in	O
VCF	O
/	O
DGS	O
,	O
a	O
detailed	O
examination	O
shows	O
that	O
the	O
NC	O
-	O
specific	O
abrogation	O
of	O
Alk5	O
does	O
not	O
lead	O
to	O
VCF	O
/	O
DGS	O
-	O
like	O
phenotypes	O
.	O

Firstly	O
,	O
while	O
the	O
pharyngeal	O
organ	O
migration	O
fails	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
,	O
perhaps	O
as	O
a	O
result	O
of	O
increased	O
mesenchymal	O
cell	O
death	O
in	O
the	O
pharyngeal	O
region	O
,	O
both	O
the	O
thymus	O
,	O
thyroid	O
and	O
parathyroid	O
seem	O
to	O
develop	O
relatively	O
normally	O
on	O
the	O
histological	O
level	O
in	O
these	O
mutants	O
.	O

Secondly	O
,	O
the	O
NCC	O
death	O
seen	O
in	O
Alk5	O
mutants	O
affects	O
a	O
predominantly	O
postmigratory	O
population	O
of	O
NCCs	O
,	O
while	O
genes	O
located	O
in	O
the	O
DGCR	O
,	O
i	O
.	O
e	O
.	O
,	O
Tbx1	O
and	O
CrkL	O
,	O
control	O
NCC	O
survival	O
earlier	O
at	O
E8	O
.	O
5	O
-	O
E10	O
by	O
regulating	O
proliferation	O
of	O
the	O
secondary	O
heart	O
field	O
(	O
SHF	O
)	O
,	O
and	O
endoderm	O
expansion	O
,	O
which	O
in	O
turn	O
provides	O
survival	O
signal	O
for	O
NCCs	O
allowing	O
them	O
to	O
populate	O
the	O
pharyngeal	O
region	O
[	O
36	O
-	O
39	O
]	O
.	O

NCC	O
ablation	O
in	O
the	O
chick	O
has	O
been	O
shown	O
to	O
lead	O
to	O
PTA	O
and	O
to	O
a	O
failure	O
of	O
addition	O
of	O
myocardium	O
from	O
the	O
secondary	O
heart	O
field	O
[	O
40	O
]	O
.	O

It	O
was	O
suggested	O
that	O
the	O
defective	O
migration	O
of	O
cells	O
from	O
the	O
secondary	O
heart	O
field	O
to	O
the	O
OFT	O
in	O
turn	O
resulted	O
in	O
shortening	O
and	O
inappropriate	O
rotation	O
of	O
the	O
OFT	O
,	O
leading	O
to	O
mal	O
-	O
alignment	O
of	O
the	O
arterial	O
pole	O
with	O
the	O
ventricles	O
[	O
41	O
]	O
.	O

While	O
the	O
detected	O
OFT	O
phenotype	O
in	O
Alk5	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
shared	O
many	O
similarities	O
with	O
that	O
seen	O
in	O
the	O
chick	O
NC	O
ablation	O
models	O
,	O
e	O
.	O
g	O
.	O
,	O
PTA	O
and	O
the	O
hypoplastic	O
aortic	O
sac	O
,	O
our	O
current	O
results	O
suggest	O
that	O
the	O
secondary	O
heart	O
field	O
is	O
not	O
severely	O
affected	O
in	O
Alk5	O
mutants	O
(	O
data	O
not	O
shown	O
)	O
.	O

Since	O
we	O
could	O
not	O
detect	O
appropriate	O
rotation	O
of	O
the	O
OFT	O
in	O
neural	O
crest	O
-	O
specific	O
mutants	O
of	O
Alk5	O
or	O
Alk2	O
,	O
it	O
appears	O
that	O
cells	O
derived	O
from	O
the	O
NC	O
,	O
as	O
well	O
as	O
those	O
from	O
the	O
SHF	O
,	O
are	O
mutually	O
required	O
for	O
proper	O
OFT	O
rotation	O
in	O
mice	O
.	O

However	O
,	O
it	O
appears	O
that	O
these	O
two	O
TGF	O
-	O
beta	O
/	O
BMP	O
type	O
I	O
receptors	O
contribute	O
to	O
OFT	O
rotation	O
through	O
different	O
mechanisms	O
.	O

In	O
Alk5	O
mutants	O
there	O
is	O
very	O
little	O
,	O
if	O
any	O
,	O
detectable	O
septal	O
mesenchyme	O
present	O
,	O
and	O
thus	O
it	O
could	O
be	O
argued	O
that	O
in	O
these	O
mutants	O
OFT	O
rotation	O
fails	O
due	O
to	O
a	O
lack	O
of	O
penetration	O
of	O
septal	O
prongs	O
into	O
the	O
cushion	O
mesenchyme	O
.	O

In	O
contrast	O
,	O
in	O
Alk2	O
/	O
Wnt1	O
-	O
Cre	O
mutants	O
a	O
sizeable	O
septal	O
mesenchyme	O
could	O
be	O
seen	O
,	O
still	O
without	O
any	O
obvious	O
looping	O
of	O
the	O
aortic	O
sac	O
and	O
truncal	O
OFT	O
,	O
suggesting	O
that	O
the	O
mere	O
presence	O
of	O
the	O
septal	O
mesenchyme	O
,	O
without	O
correct	O
smooth	O
muscle	O
cell	O
differentiation	O
,	O
is	O
not	O
sufficient	O
for	O
OFT	O
rotation	O
.	O

Conclusion	O

In	O
this	O
study	O
,	O
we	O
have	O
deleted	O
the	O
TGF	O
-	O
beta	O
type	O
I	O
receptor	O
(	O
Alk5	O
)	O
gene	O
specifically	O
in	O
the	O
mouse	O
neural	O
crest	O
(	O
NC	O
)	O
cell	O
lineage	O
.	O

Our	O
data	O
suggest	O
that	O
ALK5	O
is	O
required	O
cell	O
autonomously	O
in	O
the	O
NC	O
to	O
mediate	O
non	O
-	O
redundant	O
signaling	O
events	O
that	O
are	O
essential	O
for	O
appropriate	O
patterning	O
of	O
the	O
pharyngeal	O
organs	O
and	O
cardiac	O
OFT	O
.	O

The	O
cardiac	O
and	O
pharyngeal	O
defects	O
observed	O
in	O
the	O
NC	O
-	O
specific	O
Alk5	O
mutants	O
differ	O
significantly	O
from	O
those	O
seen	O
in	O
corresponding	O
mutants	O
lacking	O
the	O
TGF	O
-	O
beta	O
type	O
II	O
receptor	O
,	O
suggesting	O
that	O
signaling	O
mediated	O
by	O
ALK5	O
is	O
not	O
limited	O
to	O
the	O
classical	O
TGF	O
-	O
beta	O
ligands	O
during	O
cardiac	O
/	O
pharyngeal	O
development	O
.	O

Methods	O

Alk5	O
/	O
Wnt1Cre	O
mice	O

Alk5	O
(	O
and	O
Alk2	O
)	O
mutant	O
and	O
control	O
embryos	O
were	O
generated	O
by	O
mating	O
Alk5ko	O
/	O
+	O
(	O
Alk2ko	O
/	O
+	O
)	O
/	O
Wnt1	O
-	O
Cre	O
male	O
mice	O
with	O
females	O
homozygous	O
for	O
the	O
Alk5flox	O
(	O
Alk2flox	O
)	O
allele	O
and	O
the	O
R26R	O
reporter	O
[	O
12	O
,	O
19	O
]	O
.	O

Genotyping	O
was	O
performed	O
by	O
PCR	O
as	O
described	O
earlier	O
[	O
21	O
,	O
42	O
]	O
.	O

Wnt1	O
-	O
Cre	O
mice	O
were	O
kindly	O
provided	O
by	O
A	O
.	O

McMahon	O
(	O
Harvard	O
University	O
)	O
and	O
R26R	O
reporter	O
mice	O
were	O
obtained	O
from	O
the	O
Jackson	O
laboratories	O
.	O

All	O
studies	O
were	O
carried	O
out	O
at	O
the	O
Animal	O
Care	O
Facility	O
of	O
the	O
Saban	O
Research	O
Institute	O
of	O
Childrens	O
Hospital	O
Los	O
Angeles	O
in	O
accordance	O
with	O
institutional	O
guidelines	O
.	O

Timed	O
mataings	O

Mice	O
were	O
mated	O
during	O
the	O
dark	O
period	O
of	O
the	O
controlled	O
light	O
cycle	O
;	O
presence	O
of	O
vaginal	O
plugs	O
was	O
designated	O
as	O
day	O
0	O
hour	O
0	O
.	O

Females	O
were	O
euthanized	O
by	O
CO2	B-CHEBI
,	O
and	O
embryos	O
were	O
collected	O
in	O
Hanks	O
'	O
balanced	O
salt	B-CHEBI
solution	O
on	O
ice	O
.	O

Histological	O
analyses	O

Embryos	O
(	O
E17	O
)	O
were	O
fixed	O
with	O
4	O
%	O
paraformaldehyhe	O
for	O
14	O
hours	O
,	O
dehydrated	O
and	O
embedded	O
in	O
paraffin	O
wax	O
.	O

Sections	O
(	O
7	O
-	O
8	O
um	O
)	O
were	O
stained	O
with	O
Hematoxylin	O
and	O
Eosin	O
(	O
n	O
>=	O
3	O
for	O
each	O
genotype	O
)	O
.	O

For	O
lineage	O
tracing	O
analyses	O
,	O
embryos	O
were	O
stained	O
for	O
beta	O
-	O
galactosidase	O
activity	O
as	O
described	O
[	O
43	O
]	O
.	O

Briefly	O
,	O
the	O
specimens	O
(	O
E11	O
.	O
0	O
-	O
E11	O
.	O
5	O
)	O
were	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
for	O
30	O
minutes	O
at	O
room	O
temperature	O
,	O
washed	O
3	O
times	O
for	O
10	O
minutes	O
in	O
the	O
detergent	B-CHEBI
wash	O
and	O
developed	O
for	O
2	O
-	O
12	O
hours	O
in	O
X	O
-	O
gal	O
solution	O
(	O
n	O
>=	O
3	O
for	O
each	O
genotype	O
)	O
.	O

For	O
immunohistochemistry	O
,	O
fixed	O
sections	O
from	O
tissues	O
harvested	O
at	O
E10	O
.	O
5	O
-	O
E11	O
.	O
5	O
were	O
stained	O
with	O
monoclonal	O
alpha	O
-	O
smooth	O
muscle	O
actin	O
(	O
DAKO	O
)	O
,	O
cleaved	O
caspase	O
-	O
3	O
(	O
Cell	O
Signaling	O
)	O
or	O
phophohistone	O
-	O
H3	O
(	O
Cell	O
Signaling	O
)	O
antibodies	O
.	O

TUNEL	O
assays	O
were	O
performed	O
using	O
the	O
DeadEnd	O
fluorometric	O
TUNEL	O
system	O
(	O
Promega	O
)	O
.	O

In	O
each	O
assay	O
3	O
or	O
more	O
embryos	O
were	O
analyzed	O
for	O
each	O
genotype	O
.	O

Ink	O
and	O
casting	O
dye	B-CHEBI
injections	O

Embryos	O
(	O
E10	O
.	O
0	O
-	O
E13	O
.	O
0	O
)	O
were	O
dissected	O
and	O
placed	O
in	O
ice	O
cold	O
PBS	O
(	O
n	O
>=	O
3	O
per	O
genotype	O
in	O
each	O
time	O
point	O
)	O
.	O

Using	O
a	O
pulled	O
glass	O
pipette	O
,	O
India	O
ink	O
or	O
Yellow	O
casting	O
dye	B-CHEBI
(	O
Connecticut	O
Valley	O
Biological	O
Supply	O
)	O
was	O
injected	O
into	O
the	O
ventricles	O
until	O
ink	O
/	O
dye	B-CHEBI
penetrated	O
small	O
vessels	O
.	O

Embryos	O
were	O
postfixed	O
in	O
10	O
%	O
buffered	B-CHEBI
formalin	O
for	O
12	O
hours	O
,	O
dehydrated	O
and	O
cleared	O
in	O
benzylbenzoate	B-CHEBI
:	O
benzyl	B-CHEBI
alcohol	I-CHEBI
(	O
2	O
:	O
1v	O
/	O
v	O
)	O
.	O

Expression	O
analyses	O

To	O
visualize	O
parathyroid	O
hormone	B-CHEBI
expression	O
we	O
used	O
in	O
situ	O
hybridization	O
and	O
an	O
antisense	O
probe	O
corresponding	O
to	O
nucleotides	B-CHEBI
97	O
-	O
534	O
(	O
kindly	O
provided	O
by	O
Nancy	O
Manley	O
)	O
as	O
described	O
[	O
44	O
]	O
.	O

Authors	O
'	O
contributions	O

J	O
.	O
W	O
.	O
did	O
most	O
of	O
the	O
mouse	O
dissections	O
and	O
analyses	O
,	O
A	O
.	O
N	O
.	O
did	O
some	O
of	O
the	O
histological	O
analyses	O
,	O
J	O
.	O
L	O
.	O
generated	O
the	O
Alk5FXFXmice	O
,	O
M	O
.	O
D	O
.	O
did	O
some	O
of	O
the	O
expression	O
analyses	O
,	O
H	O
.	O
M	O
.	O
S	O
.	O
participated	O
in	O
design	O
and	O
provided	O
the	O
Tgfbr2	O
mutant	O
embryos	O
and	O
V	O
.	O
K	O
.	O
generated	O
the	O
Alk2FXFX	O
mice	O
,	O
designed	O
and	O
supervised	O
the	O
experiments	O
and	O
wrote	O
the	O
manuscript	O
.	O

All	O
authors	O
have	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Acknowledgements	O

We	O
thank	O
A	O
.	O

McMahon	O
for	O
providing	O
the	O
Wnt1	O
-	O
Cre	O
mouse	O
line	O
,	O
N	O
.	O

Manley	O
for	O
the	O
PTH	O
probe	O
and	O
B	O
.	O

Choudhary	O
for	O
Tgfbr2	O
/	O
Wnt1	O
-	O
Cre	O
embryos	O
.	O

H	O
.	O
M	O
.	O
S	O
.	O
was	O
supported	O
by	O
grants	O
from	O
the	O
NIH	O
,	O
and	O
V	O
.	O
K	O
.	O
by	O
grants	O
from	O
the	O
Robert	O
E	O
.	O
Schneider	O
Foundation	O
and	O
the	O
NIH	O
(	O
HL074862	O
and	O
DE013085	O
)	O
.	O

Genetic	O
Analysis	O
of	O
the	O
Roles	O
of	O
BMP2	O
,	O
BMP4	O
,	O
and	O
BMP7	O
in	O
Limb	O
Patterning	O
and	O
Skeletogenesis	O

Abstract	O

Bone	O
morphogenetic	O
protein	B-CHEBI
(	O
BMP	O
)	O
family	O
members	O
,	O
including	O
BMP2	O
,	O
BMP4	O
,	O
and	O
BMP7	O
,	O
are	O
expressed	O
throughout	O
limb	O
development	O
.	O

BMPs	O
have	O
been	O
implicated	O
in	O
early	O
limb	O
patterning	O
as	O
well	O
as	O
in	O
the	O
process	O
of	O
skeletogenesis	O
.	O

However	O
,	O
due	O
to	O
complications	O
associated	O
with	O
early	O
embryonic	O
lethality	O
,	O
particularly	O
for	O
Bmp2	O
and	O
Bmp4	O
,	O
and	O
with	O
functional	O
redundancy	O
among	O
BMP	O
molecules	B-CHEBI
,	O
it	O
has	O
been	O
difficult	O
to	O
decipher	O
the	O
specific	O
roles	O
of	O
these	O
BMP	O
molecules	B-CHEBI
during	O
different	O
stages	O
of	O
limb	O
development	O
.	O

To	O
circumvent	O
these	O
issues	O
,	O
we	O
have	O
constructed	O
a	O
series	O
of	O
mouse	O
strains	O
lacking	O
one	O
or	O
more	O
of	O
these	O
BMPs	O
,	O
using	O
conditional	O
alleles	O
in	O
the	O
case	O
of	O
Bmp2	O
and	O
Bmp4	O
to	O
remove	O
them	O
specifically	O
from	O
the	O
limb	O
bud	O
mesenchyme	O
.	O

Contrary	O
to	O
earlier	O
suggestions	O
,	O
our	O
results	O
indicate	O
that	O
BMPs	O
neither	O
act	O
as	O
secondary	O
signals	O
downstream	O
of	O
Sonic	O
Hedghog	O
(	O
SHH	O
)	O
in	O
patterning	O
the	O
anteroposterior	O
axis	O
nor	O
as	O
signals	O
from	O
the	O
interdigital	O
mesenchyme	O
in	O
specifying	O
digit	O
identity	O
.	O

We	O
do	O
find	O
that	O
a	O
threshold	O
level	O
of	O
BMP	O
signaling	O
is	O
required	O
for	O
the	O
onset	O
of	O
chondrogenesis	O
,	O
and	O
hence	O
some	O
chondrogenic	O
condensations	O
fail	O
to	O
form	O
in	O
limbs	O
deficient	O
in	O
both	O
BMP2	O
and	O
BMP4	O
.	O

However	O
,	O
in	O
the	O
condensations	O
that	O
do	O
form	O
,	O
subsequent	O
chondrogenic	O
differentiation	O
proceeds	O
normally	O
even	O
in	O
the	O
absence	O
of	O
BMP2	O
and	O
BMP7	O
or	O
BMP2	O
and	O
BMP4	O
.	O

In	O
contrast	O
,	O
we	O
find	O
that	O
the	O
loss	O
of	O
both	O
BMP2	O
and	O
BMP4	O
results	O
in	O
a	O
severe	O
impairment	O
of	O
osteogenesis	O
.	O

Synopsis	O

A	O
group	O
of	O
related	O
signaling	O
molecules	B-CHEBI
called	O
bone	O
morphogenetic	O
proteins	B-CHEBI
(	O
BMPs	O
)	O
are	O
known	O
to	O
play	O
important	O
roles	O
in	O
the	O
formation	O
of	O
the	O
structures	O
such	O
as	O
the	O
limbs	O
.	O

However	O
,	O
because	O
different	O
members	O
of	O
this	O
group	O
often	O
have	O
similar	O
effects	O
on	O
target	O
cells	O
and	O
are	O
produced	O
in	O
overlapping	O
regions	O
of	O
the	O
embryo	O
and	O
hence	O
can	O
be	O
redundant	O
with	O
one	O
another	O
,	O
removal	O
of	O
any	O
single	O
member	O
of	O
the	O
BMP	O
family	O
may	O
not	O
reveal	O
the	O
full	O
extent	O
of	O
the	O
roles	O
they	O
play	O
during	O
development	O
.	O

We	O
have	O
therefore	O
improved	O
on	O
this	O
type	O
of	O
analysis	O
by	O
removing	O
pairs	O
of	O
these	O
factors	O
(	O
BMP2	O
and	O
BMP4	O
or	O
BMP2	O
and	O
BMP7	O
)	O
specifically	O
from	O
the	O
developing	O
limb	O
.	O

Although	O
some	O
have	O
speculated	O
that	O
these	O
signals	O
play	O
an	O
early	O
role	O
in	O
organizing	O
or	O
"	O
patterning	O
"	O
the	O
different	O
tissues	O
of	O
the	O
limb	O
,	O
we	O
find	O
no	O
evidence	O
for	O
such	O
a	O
role	O
.	O

We	O
do	O
find	O
,	O
however	O
,	O
that	O
a	O
minimal	O
amount	O
of	O
BMP	O
signal	O
is	O
required	O
to	O
form	O
cartilage	O
,	O
and	O
hence	O
some	O
cartilaginous	O
elements	O
fail	O
to	O
form	O
in	O
limbs	O
deficient	O
in	O
both	O
BMP2	O
and	O
BMP4	O
.	O

Moreover	O
,	O
in	O
the	O
absence	O
of	O
these	O
two	O
BMP	O
family	O
members	O
,	O
there	O
is	O
a	O
severe	O
impairment	O
in	O
the	O
development	O
of	O
bone	O
tissue	O
,	O
resulting	O
in	O
severely	O
deformed	O
limbs	O
.	O

This	O
study	O
gives	O
important	O
new	O
insight	O
into	O
the	O
roles	O
of	O
these	O
BMP	O
signals	O
in	O
making	O
skeletal	O
tissues	O
in	O
the	O
embryo	O
.	O

Introduction	O

Bone	O
morphogenetic	O
proteins	B-CHEBI
(	O
BMPs	O
)	O
are	O
secreted	O
signaling	O
molecules	B-CHEBI
belonging	O
to	O
the	O
transforming	O
growth	O
factor	O
beta	O
superfamily	O
,	O
originally	O
identified	O
on	O
the	O
basis	O
of	O
their	O
ability	O
to	O
induce	O
ectopic	O
bone	O
formation	O
when	O
implanted	O
within	O
soft	O
tissue	O
in	O
vivo	O
[	O
1	O
-	O
3	O
]	O
.	O

BMP	O
family	O
members	O
are	O
now	O
known	O
to	O
play	O
an	O
extremely	O
diverse	O
set	O
of	O
roles	O
in	O
a	O
wide	O
variety	O
of	O
developmental	O
processes	O
[	O
4	O
]	O
.	O

Even	O
in	O
the	O
context	O
of	O
the	O
morphogenesis	O
of	O
a	O
single	O
structure	O
,	O
these	O
molecules	B-CHEBI
can	O
play	O
a	O
series	O
of	O
quite	O
divergent	O
roles	O
.	O

For	O
example	O
,	O
during	O
limb	O
development	O
,	O
BMPs	O
have	O
been	O
postulated	O
to	O
act	O
sequentially	O
in	O
multiple	O
distinct	O
aspects	O
of	O
patterning	O
,	O
cell	O
type	O
specification	O
,	O
and	O
differentiation	O
of	O
various	O
tissues	O
,	O
particularly	O
of	O
the	O
skeleton	O
.	O

The	O
earliest	O
step	O
of	O
limb	O
development	O
in	O
which	O
BMP	O
signaling	O
has	O
been	O
implicated	O
is	O
the	O
establishment	O
of	O
the	O
anterior	O
-	O
posterior	O
limb	O
axis	O
.	O

Differences	O
in	O
anterior	O
-	O
posterior	O
pattern	O
are	O
instructed	O
as	O
a	O
graded	O
response	O
to	O
Sonic	O
Hedghog	O
(	O
SHH	O
)	O
signaling	O
emanating	O
from	O
the	O
posterior	O
margin	O
of	O
the	O
limb	O
bud	O
[	O
5	O
]	O
.	O

It	O
has	O
remained	O
controversial	O
,	O
however	O
,	O
whether	O
this	O
response	O
is	O
direct	O
or	O
indirect	O
.	O

If	O
indeed	O
the	O
long	O
-	O
range	O
effects	O
of	O
SHH	O
are	O
indirectly	O
mediated	O
by	O
local	O
production	O
of	O
secondary	O
signals	O
,	O
the	O
leading	O
candidates	O
have	O
been	O
two	O
members	O
of	O
the	O
BMP	O
family	O
,	O
BMP2	O
and	O
BMP7	O
.	O

Both	O
are	O
expressed	O
in	O
a	O
broader	O
domain	O
than	O
SHH	O
in	O
the	O
early	O
posterior	O
limb	O
bud	O
mesenchyme	O
[	O
6	O
,	O
7	O
]	O
,	O
although	O
BMP7	O
also	O
has	O
a	O
second	O
,	O
weaker	O
domain	O
of	O
expression	O
in	O
the	O
anterior	O
limb	O
bud	O
mesenchyme	O
.	O

BMP2	O
[	O
8	O
]	O
and	O
BMP7	O
[	O
7	O
]	O
can	O
be	O
induced	O
by	O
ectopic	O
SHH	O
and	O
their	O
expression	O
is	O
greatly	O
diminished	O
in	O
the	O
absence	O
of	O
SHH	O
activity	O
[	O
9	O
]	O
.	O

BMP2	O
and	O
BMP7	O
are	O
thus	O
secondary	O
signals	O
produced	O
in	O
response	O
to	O
SHH	O
activity	O
.	O

Moreover	O
,	O
BMP	O
signaling	O
has	O
a	O
weak	O
ability	O
to	O
posteriorly	O
polarize	O
the	O
limb	O
in	O
ectopic	O
grafting	O
experiments	O
[	O
10	O
]	O
,	O
an	O
activity	O
enhanced	O
by	O
prior	O
low	O
-	O
level	O
exposure	O
to	O
SHH	O
[	O
11	O
]	O
.	O

It	O
remains	O
unclear	O
,	O
however	O
,	O
whether	O
BMP2	O
and	O
BMP7	O
activity	O
is	O
required	O
endogenously	O
for	O
anterior	O
-	O
posterior	O
limb	O
patterning	O
by	O
SHH	O
.	O

Bmp2	O
mutant	O
embryos	O
die	O
too	O
early	O
to	O
assess	O
their	O
limb	O
phenotypes	O
.	O

A	O
targeted	O
deletion	O
of	O
Bmp7	O
has	O
been	O
made	O
,	O
and	O
Bmp7	O
-	O
deficient	O
embryos	O
display	O
hindlimb	O
polydactyly	O
with	O
incomplete	O
penetrance	O
but	O
otherwise	O
phenotypically	O
normal	O
limbs	O
[	O
12	O
,	O
13	O
]	O
.	O

Nonetheless	O
,	O
Bmp7	O
knockout	O
mice	O
do	O
not	O
show	O
any	O
defect	O
in	O
limb	O
polarity	O
.	O

However	O
,	O
a	O
redundant	O
function	O
in	O
anterior	O
-	O
posterior	O
patterning	O
with	O
BMP2	O
remains	O
a	O
possibility	O
.	O

In	O
addition	O
to	O
BMP2	O
and	O
BMP7	O
,	O
a	O
third	O
member	O
of	O
this	O
family	O
that	O
is	O
closely	O
related	O
to	O
BMP2	O
,	O
BMP4	O
,	O
is	O
also	O
expressed	O
in	O
the	O
early	O
limb	O
bud	O
.	O

Like	O
BMP7	O
,	O
it	O
is	O
expressed	O
in	O
both	O
the	O
anterior	O
and	O
posterior	O
margins	O
of	O
the	O
limb	O
bud	O
mesenchyme	O
[	O
4	O
,	O
14	O
]	O
;	O
however	O
,	O
it	O
does	O
not	O
appear	O
to	O
be	O
induced	O
by	O
SHH	O
signaling	O
,	O
nor	O
does	O
its	O
expression	O
change	O
in	O
SHH	O
-	O
deficient	O
limb	O
buds	O
.	O

Thus	O
,	O
BMP4	O
is	O
not	O
a	O
candidate	O
for	O
a	O
secondary	O
signal	O
downstream	O
of	O
SHH	O
in	O
early	O
patterning	O
.	O

However	O
,	O
all	O
three	O
of	O
these	O
molecules	B-CHEBI
,	O
BMP2	O
,	O
BMP4	O
,	O
and	O
BMP7	O
,	O
have	O
been	O
suggested	O
to	O
act	O
in	O
a	O
second	O
distinct	O
phase	O
of	O
limb	O
patterning	O
,	O
when	O
digit	O
identities	O
are	O
established	O
downstream	O
of	O
earlier	O
patterning	O
events	O
.	O

In	O
the	O
vertebrate	O
limb	O
,	O
each	O
digit	O
can	O
be	O
uniquely	O
identified	O
based	O
on	O
its	O
size	O
,	O
length	O
,	O
number	O
of	O
phalanges	O
,	O
and	O
location	O
within	O
the	O
autopod	O
.	O

As	O
a	O
consequence	O
of	O
the	O
initial	O
establishment	O
of	O
anterior	O
-	O
posterior	O
positioned	O
information	O
within	O
the	O
limb	O
by	O
SHH	O
and	O
/	O
or	O
BMP	O
signaling	O
,	O
the	O
interdigital	O
mesenchyme	O
of	O
the	O
hand	O
plate	O
becomes	O
specified	O
in	O
a	O
graded	O
manner	O
.	O

Grafting	O
and	O
extirpation	O
experiments	O
have	O
shown	O
that	O
it	O
is	O
this	O
polarized	O
interdigital	O
tissue	O
which	O
directs	O
digit	O
morphology	O
[	O
15	O
]	O
.	O

BMP2	O
,	O
BMP4	O
,	O
and	O
BMP7	O
are	O
all	O
expressed	O
in	O
the	O
interdigital	O
mesenchyme	O
[	O
4	O
,	O
14	O
]	O
,	O
and	O
experiments	O
inhibiting	O
BMP	O
signaling	O
in	O
this	O
tissue	O
suggested	O
that	O
differential	O
levels	O
of	O
BMPs	O
in	O
the	O
interdigital	O
mesenchyme	O
might	O
be	O
the	O
relevant	O
factor	O
directing	O
digit	O
morphology	O
[	O
15	O
]	O
.	O

As	O
noted	O
above	O
,	O
BMP7	O
-	O
deficient	O
embryos	O
produce	O
mostly	O
normal	O
limbs	O
,	O
and	O
mice	O
harboring	O
a	O
conditional	O
deletion	O
of	O
Bmp4	O
in	O
the	O
limb	O
bud	O
mesenchyme	O
also	O
do	O
not	O
show	O
evidence	O
of	O
anterior	O
digit	O
transformation	O
[	O
16	O
]	O
,	O
as	O
would	O
have	O
been	O
predicted	O
if	O
BMP4	O
acted	O
as	O
an	O
interdigital	O
regulator	O
of	O
digit	O
morphology	O
.	O

In	O
the	O
light	O
of	O
these	O
observations	O
,	O
it	O
would	O
seem	O
unlikely	O
that	O
quantitative	O
differences	O
in	O
levels	O
of	O
interdigital	O
BMP	O
signal	O
are	O
responsible	O
for	O
establishing	O
digit	O
identity	O
,	O
although	O
redundancy	O
between	O
BMP2	O
,	O
BMP4	O
,	O
and	O
BMP7	O
in	O
this	O
role	O
remains	O
a	O
possibility	O
.	O

A	O
third	O
aspect	O
of	O
limb	O
patterning	O
in	O
which	O
BMP2	O
,	O
BMP4	O
,	O
and	O
BMP7	O
have	O
been	O
implicated	O
is	O
in	O
the	O
apoptotic	O
death	O
of	O
the	O
interdigital	O
tissue	O
.	O

For	O
example	O
,	O
ectopic	O
application	O
of	O
BMP	O
antagonists	O
demonstrates	O
that	O
BMP	O
signaling	O
is	O
necessary	O
for	O
this	O
process	O
,	O
and	O
in	O
its	O
absence	O
,	O
webbing	O
occurs	O
[	O
17	O
-	O
19	O
]	O
)	O
.	O

BMP	O
activity	O
also	O
plays	O
an	O
indirect	O
role	O
in	O
limb	O
patterning	O
as	O
a	O
key	O
component	O
of	O
a	O
feedback	O
loop	O
between	O
SHH	O
production	O
in	O
the	O
posterior	O
limb	O
bud	O
and	O
fibroblast	O
growth	O
factor	O
production	O
in	O
the	O
overlying	O
apical	O
ectodermal	O
ridge	O
(	O
AER	O
)	O
.	O

SHH	O
activity	O
leads	O
to	O
the	O
upregulation	O
of	O
the	O
BMP	O
antagonist	O
Gremlin	O
in	O
the	O
mesenchyme	O
[	O
20	O
,	O
21	O
]	O
.	O

This	O
,	O
in	O
turn	O
,	O
prevents	O
BMPs	O
from	O
downregulating	O
fibroblast	O
growth	O
factor	O
(	O
FGF	O
)	O
production	O
in	O
the	O
AER	O
[	O
17	O
,	O
22	O
]	O
and	O
maintains	O
the	O
integrity	O
of	O
the	O
AER	O
itself	O
[	O
23	O
]	O
.	O

FGF	O
signaling	O
feeds	O
back	O
to	O
maintain	O
SHH	O
production	O
in	O
the	O
posterior	O
mesenchyme	O
[	O
8	O
,	O
24	O
]	O
.	O

Thus	O
,	O
conditional	O
removal	O
of	O
BMP4	O
activity	O
from	O
the	O
posterior	O
limb	O
mesenchyme	O
results	O
in	O
a	O
persistence	O
of	O
the	O
AER	O
,	O
expanded	O
SHH	O
signaling	O
,	O
and	O
consequent	O
preaxial	O
and	O
postaxial	O
polydactyly	O
[	O
16	O
]	O
.	O

At	O
later	O
stages	O
of	O
limb	O
development	O
,	O
BMP	O
activity	O
is	O
also	O
believed	O
to	O
play	O
critical	O
roles	O
in	O
skeletogenesis	O
.	O

Activation	O
and	O
dominant	O
-	O
negative	O
experiments	O
in	O
the	O
chick	O
have	O
shown	O
that	O
signaling	O
through	O
the	O
BMPR	O
-	O
IB	O
receptor	O
is	O
necessary	O
and	O
sufficient	O
for	O
cartilage	O
condensation	O
in	O
chick	O
[	O
25	O
]	O
.	O

Likewise	O
,	O
conditional	O
knockout	O
of	O
BmpR1A	O
and	O
BmpR1B	O
blocks	O
all	O
chondrogenic	O
differentiation	O
in	O
the	O
mouse	O
limb	O
bud	O
[	O
26	O
]	O
.	O

Similarly	O
,	O
when	O
noggin	O
,	O
a	O
potent	O
BMP	O
inhibitor	O
,	O
is	O
introduced	O
in	O
early	O
stage	O
chick	O
limb	O
buds	O
prior	O
to	O
skeletogenesis	O
,	O
mesenchymal	O
condensation	O
does	O
not	O
take	O
place	O
[	O
27	O
,	O
28	O
]	O
.	O

Taken	O
together	O
,	O
these	O
studies	O
strongly	O
implicate	O
BMP	O
signaling	O
as	O
necessary	O
for	O
mesenchymal	O
condensations	O
and	O
the	O
initiation	O
of	O
chondrogenesis	O
.	O

However	O
,	O
the	O
phenotypes	O
in	O
these	O
experiments	O
are	O
severe	O
,	O
causing	O
either	O
global	O
chondrogenesis	O
or	O
absence	O
of	O
chondrogenesis	O
,	O
in	O
the	O
gain	O
-	O
and	O
loss	O
-	O
of	O
-	O
function	O
experiments	O
,	O
respectively	O
.	O

These	O
severe	O
defects	O
during	O
the	O
early	O
stages	O
of	O
skeletogenesis	O
preclude	O
investigation	O
of	O
any	O
specific	O
roles	O
for	O
BMPs	O
in	O
later	O
events	O
in	O
cartilage	O
differentiation	O
,	O
bone	O
formation	O
,	O
and	O
bone	O
metabolism	O
[	O
29	O
]	O
.	O

Conversely	O
,	O
removal	O
of	O
individual	O
ligands	O
such	O
as	O
BMP4	O
[	O
16	O
]	O
or	O
BMP7	O
[	O
12	O
,	O
13	O
]	O
has	O
not	O
displayed	O
defects	O
in	O
skeletal	O
differentiation	O
,	O
presumably	O
due	O
to	O
functional	O
redundancy	O
.	O

To	O
gain	O
further	O
insights	O
into	O
the	O
potential	O
roles	O
of	O
BMP	O
signaling	O
in	O
vertebrate	O
limb	O
patterning	O
and	O
skeletogenesis	O
,	O
we	O
have	O
produced	O
mice	O
simultaneously	O
lacking	O
BMP2	O
and	O
BMP4	O
activity	O
or	O
BMP2	O
and	O
BMP7	O
activity	O
in	O
the	O
limb	O
mesechyme	O
during	O
limb	O
development	O
.	O

Since	O
Bmp2	O
and	O
Bmp4	O
mutants	O
are	O
both	O
lethal	O
early	O
in	O
embryogenesis	O
[	O
30	O
,	O
31	O
]	O
,	O
we	O
used	O
conditional	O
alleles	O
of	O
both	O
these	O
genes	O
.	O

The	O
conditional	O
alleles	O
were	O
deleted	O
early	O
in	O
limb	O
development	O
through	O
the	O
action	O
of	O
a	O
cre	O
-	O
recombinase	O
transgene	O
expressed	O
under	O
the	O
control	O
of	O
the	O
Prx1	O
enhancer	O
[	O
32	O
]	O
.	O

Neither	O
limbs	O
deficient	O
in	O
BMP2	O
and	O
BMP7	O
nor	O
those	O
deficient	O
in	O
BMP2	O
and	O
BMP4	O
had	O
defects	O
suggestive	O
of	O
loss	O
of	O
anterior	O
-	O
posterior	O
patterning	O
information	O
,	O
arguing	O
against	O
these	O
factors	O
acting	O
as	O
secondary	O
signals	O
downstream	O
of	O
SHH	O
or	O
acting	O
as	O
interdigital	O
determinants	O
of	O
digit	O
identity	O
.	O

The	O
Bmp2	O
/	O
Bmp4	O
double	O
mutants	O
did	O
display	O
a	O
loss	O
of	O
posterior	O
digits	O
with	O
a	O
broad	O
posterior	O
hand	O
plate	O
,	O
suggestive	O
of	O
a	O
block	O
in	O
the	O
chondrogenic	O
condensation	O
of	O
the	O
posterior	O
digit	O
rays	O
,	O
rather	O
than	O
a	O
change	O
in	O
anterior	O
-	O
posterior	O
digit	O
identity	O
.	O

At	O
later	O
stages	O
,	O
the	O
combined	O
activity	O
of	O
neither	O
BMP2	O
and	O
BMP4	O
nor	O
of	O
BMP2	O
and	O
BMP7	O
is	O
required	O
for	O
chondrogenesis	O
.	O

Osteogenesis	O
is	O
also	O
initiated	O
properly	O
in	O
the	O
absence	O
of	O
these	O
pairs	O
of	O
factors	O
.	O

However	O
,	O
at	O
later	O
stages	O
,	O
the	O
combined	O
loss	O
of	O
BMP2	O
and	O
BMP4	O
evidently	O
becomes	O
limiting	O
,	O
and	O
osteogenesis	O
ceases	O
.	O

As	O
all	O
prior	O
reported	O
manipulations	O
of	O
the	O
BMP	O
pathway	O
during	O
skeletal	O
development	O
either	O
result	O
in	O
a	O
block	O
at	O
the	O
first	O
stage	O
of	O
chondrogenesis	O
or	O
allow	O
complete	O
skeletal	O
formation	O
,	O
this	O
is	O
the	O
first	O
demonstration	O
of	O
a	O
requirement	O
for	O
BMP	O
activity	O
in	O
osteogenic	O
differentiation	O
.	O

Results	O

To	O
investigate	O
the	O
roles	O
of	O
BMP	O
signaling	O
at	O
various	O
stages	O
of	O
limb	O
patterning	O
and	O
skeletogenesis	O
,	O
we	O
constructed	O
a	O
series	O
of	O
mice	O
deficient	O
singly	O
or	O
in	O
combination	O
in	O
the	O
ability	O
to	O
produce	O
BMP2	O
,	O
BMP4	O
,	O
and	O
BMP7	O
.	O

BMP7	O
-	O
deficient	O
mice	O
(	O
kindly	O
provided	O
by	O
Dr	O
.	O
Liz	O
Robertson	O
)	O
survive	O
until	O
birth	O
.	O

However	O
,	O
BMP2	O
and	O
BMP4	O
are	O
both	O
required	O
for	O
viability	O
early	O
in	O
embryonic	O
development	O
[	O
30	O
,	O
31	O
]	O
.	O

We	O
therefore	O
constructed	O
a	O
conditional	O
allele	O
of	O
Bmp2	O
,	O
introducing	O
loxP	O
sites	O
flanking	O
exon	O
3	O
.	O

We	O
obtained	O
a	O
conditional	O
allele	O
of	O
Bmp4	O
,	O
in	O
which	O
exon	O
4	O
is	O
flanked	O
by	O
loxP	O
sites	O
,	O
from	O
Dr	O
.	O
Holger	O
Kulessa	O
and	O
Dr	O
.	O
Brigid	O
Hogan	O
[	O
16	O
]	O
.	O

Both	O
of	O
these	O
alleles	O
would	O
be	O
expected	O
to	O
result	O
in	O
null	O
alleles	O
following	O
recombination	O
(	O
see	O
Materials	O
and	O
Methods	O
for	O
details	O
)	O
.	O

To	O
conditionally	O
inactivate	O
Bmp2	O
and	O
Bmp4	O
in	O
the	O
limb	O
,	O
we	O
used	O
a	O
well	O
-	O
characterized	O
transgene	O
in	O
which	O
cre	O
-	O
recombinase	O
is	O
expressed	O
under	O
the	O
control	O
of	O
the	O
Prx1	O
limb	O
enhancer	O
[	O
32	O
]	O
.	O

This	O
transgene	O
expresses	O
cre	O
very	O
early	O
in	O
limb	O
development	O
,	O
resulting	O
in	O
complete	O
recombination	O
of	O
floxed	O
alleles	O
at	O
early	O
limb	O
bud	O
stages	O
.	O

We	O
verified	O
the	O
ability	O
of	O
Prx1	O
:	O
:	O
cre	O
to	O
recombine	O
the	O
conditional	O
Bmp2	O
and	O
Bmp4	O
alleles	O
at	O
earliest	O
limb	O
bud	O
stages	O
using	O
in	O
situ	O
hybridization	O
.	O

Bmp2	O
is	O
first	O
expressed	O
in	O
the	O
limb	O
mesenchyme	O
at	O
embryonic	O
day	O
(	O
E	O
)	O
10	O
.	O
5	O
in	O
the	O
mouse	O
(	O
Figure	O
1A	O
,	O
asterisk	O
)	O
.	O

By	O
the	O
time	O
its	O
expression	O
is	O
first	O
detectable	O
,	O
the	O
floxed	O
Bmp2	O
allele	O
appears	O
to	O
be	O
completely	O
recombined	O
in	O
the	O
limb	O
mesenchyme	O
,	O
as	O
whole	O
mount	O
in	O
situ	O
hybridization	O
does	O
not	O
detect	O
any	O
mesenchymal	O
Bmp2	O
transcription	O
(	O
Figure	O
1B	O
)	O
.	O

At	O
E10	O
.	O
5	O
Bmp4	O
is	O
expressed	O
in	O
the	O
mouse	O
limb	O
mesenchyme	O
in	O
two	O
stripes	O
at	O
the	O
anterior	O
and	O
posterior	O
margins	O
(	O
Figure	O
1C	O
,	O
red	O
arrows	O
)	O
.	O

These	O
expression	O
domains	O
are	O
completely	O
lost	O
by	O
E10	O
.	O
5	O
in	O
the	O
presence	O
of	O
the	O
Prx1	O
:	O
:	O
cre	O
transgene	O
(	O
Figure	O
1D	O
)	O
.	O

Bmp2	O
and	O
Bmp4	O
are	O
also	O
expressed	O
in	O
the	O
AER	O
,	O
where	O
Prx1	O
:	O
:	O
cre	O
is	O
inactive	O
,	O
and	O
these	O
domains	O
of	O
expression	O
are	O
not	O
affected	O
(	O
Figure	O
1A	O
-	O
1D	O
,	O
black	O
arrows	O
)	O
.	O

An	O
Allelic	O
/	O
Nonallelic	O
Series	O
of	O
BMP	O
-	O
Deficient	O
Limbs	O

Mice	O
were	O
generated	O
with	O
limbs	O
deficient	O
in	O
BMP2	O
,	O
BMP4	O
,	O
or	O
BMP7	O
,	O
both	O
BMP2	O
and	O
BMP4	O
,	O
or	O
both	O
BMP2	O
and	O
BMP7	O
.	O

To	O
obtain	O
an	O
initial	O
indication	O
of	O
the	O
range	O
of	O
phenotypes	O
produced	O
in	O
these	O
animals	O
,	O
we	O
first	O
examined	O
the	O
limb	O
skeletons	O
of	O
newborn	O
animals	O
.	O

BMP2	O
-	O
deficient	O
limbs	O
appeared	O
remarkably	O
normal	O
,	O
both	O
in	O
skeletal	O
pattern	O
and	O
in	O
gross	O
aspects	O
of	O
chondrogenesis	O
and	O
osteogenesis	O
indicated	O
by	O
Alcian	O
blue	O
/	O
Alizarin	B-CHEBI
red	I-CHEBI
staining	O
.	O

The	O
one	O
notable	O
defect	O
in	O
the	O
appendicular	O
skeleton	O
of	O
these	O
animals	O
is	O
a	O
characteristic	O
malformation	O
of	O
the	O
scapula	O
(	O
Figure	O
1	O
,	O
red	O
arrow	O
)	O
.	O

BMP2	O
-	O
deficient	O
limbs	O
also	O
exhibit	O
3	O
/	O
4	O
soft	O
-	O
tissue	O
syndactyly	O
with	O
variable	O
penetrance	O
(	O
Figure	O
2	O
)	O
.	O

Mice	O
with	O
limbs	O
deficient	O
in	O
BMP4	O
activity	O
and	O
the	O
limbs	O
of	O
Bmp7	O
mutant	O
mice	O
have	O
both	O
been	O
previously	O
described	O
.	O

As	O
reported	O
[	O
16	O
]	O
,	O
in	O
the	O
absence	O
of	O
BMP4	O
activity	O
,	O
limbs	O
display	O
a	O
variable	O
penetrance	O
of	O
preaxial	O
and	O
postaxial	O
polydactyly	O
,	O
but	O
otherwise	O
,	O
normal	O
digit	O
patterns	O
and	O
apparently	O
normal	O
skeletal	O
differentiation	O
(	O
Figure	O
1G	O
and	O
1O	O
)	O
take	O
place	O
.	O

As	O
previously	O
described	O
,	O
mice	O
homozygous	O
for	O
a	O
null	O
mutation	O
in	O
Bmp7	O
[	O
12	O
]	O
have	O
no	O
defects	O
in	O
the	O
formation	O
of	O
the	O
normal	O
appendicular	O
skeletal	O
elements	O
(	O
Figure	O
1H	O
and	O
1P	O
)	O
.	O

We	O
do	O
occasionally	O
observe	O
preaxial	O
polydactyly	O
in	O
these	O
mutants	O
.	O

Compound	O
heterozygous	O
mice	O
,	O
with	O
one	O
functional	O
copy	O
each	O
of	O
Bmp2	O
and	O
Bmp4	O
in	O
the	O
limb	O
(	O
Bmp2	O
+	O
/	O
C	O
;	O
Bmp4	O
+	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
)	O
,	O
show	O
no	O
effect	O
on	O
either	O
limb	O
patterning	O
or	O
skeletogenesis	O
(	O
unpublished	O
data	O
)	O
.	O

Similarly	O
,	O
limb	O
skeletons	O
of	O
mice	O
in	O
which	O
both	O
copies	O
of	O
the	O
Bmp4	O
gene	O
and	O
one	O
copy	O
of	O
the	O
Bmp2	O
gene	O
have	O
been	O
conditionally	O
removed	O
in	O
the	O
limb	O
(	O
Bmp2	O
+	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
)	O
are	O
phenotypically	O
normal	O
other	O
than	O
exhibiting	O
the	O
variable	O
penetrance	O
preaxial	O
and	O
postaxial	O
polydactyly	O
seen	O
in	O
mice	O
deficient	O
in	O
BMP4	O
activity	O
alone	O
(	O
Figure	O
1J	O
and	O
1R	O
)	O
.	O

In	O
contrast	O
,	O
mice	O
in	O
which	O
both	O
copies	O
of	O
Bmp2	O
and	O
one	O
copy	O
of	O
Bmp4	O
had	O
been	O
removed	O
(	O
Bmp2C	O
/	O
C	O
;	O
Bmp4	O
+	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
)	O
showed	O
more	O
severe	O
skeletal	O
defects	O
,	O
including	O
significantly	O
thinner	O
skeletal	O
elements	O
.	O

However	O
,	O
the	O
digit	O
patterns	O
of	O
those	O
animals	O
are	O
completely	O
normal	O
(	O
Figure	O
1I	O
and	O
1Q	O
)	O
.	O

Animals	O
in	O
which	O
both	O
copies	O
of	O
Bmp2	O
and	O
Bmp4	O
were	O
removed	O
(	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
)	O
had	O
extremely	O
malformed	O
limbs	O
(	O
Figure	O
1K	O
and	O
1S	O
)	O
.	O

They	O
displayed	O
severely	O
short	O
and	O
malformed	O
stylopods	O
;	O
one	O
of	O
the	O
zeugopod	O
elements	O
was	O
almost	O
always	O
missing	O
,	O
and	O
the	O
remaining	O
one	O
was	O
so	O
deformed	O
that	O
it	O
was	O
difficult	O
to	O
identify	O
the	O
element	O
correctly	O
.	O

Moreover	O
,	O
the	O
joint	O
articulations	O
are	O
defective	O
such	O
that	O
zeugopod	O
and	O
stylopod	O
elements	O
are	O
fused	O
(	O
see	O
below	O
and	O
Figure	O
S1A	O
-	O
S1C	O
)	O
.	O

Interestingly	O
,	O
the	O
autopods	O
are	O
less	O
affected	O
than	O
the	O
proximal	O
elements	O
.	O

Nonetheless	O
,	O
the	O
autopod	O
elements	O
are	O
significantly	O
reduced	O
in	O
size	O
,	O
and	O
strikingly	O
the	O
two	O
posterior	O
-	O
most	O
digits	O
are	O
missing	O
in	O
the	O
forelimbs	O
of	O
these	O
animals	O
.	O

Simultaneous	O
removal	O
of	O
BMP2	O
and	O
BMP7	O
had	O
far	O
less	O
of	O
an	O
effect	O
than	O
did	O
removal	O
of	O
BMP2	O
and	O
BMP4	O
activity	O
.	O

Compound	O
heterozygous	O
removal	O
of	O
BMP2	O
and	O
BMP7	O
(	O
Bmp2	O
+	O
/	O
C	O
,	O
Bmp7	O
+	O
/	O
-	O
;	O
Prx1	O
:	O
:	O
cre	O
)	O
and	O
heterozygous	O
removal	O
of	O
BMP2	O
with	O
complete	O
removal	O
of	O
BMP7	O
(	O
Bmp2	O
+	O
/	O
C	O
,	O
Bmp7	O
-	O
/	O
-	O
;	O
Prx1	O
:	O
:	O
cre	O
)	O
were	O
both	O
completely	O
wild	O
-	O
type	O
in	O
skeletal	O
pattern	O
and	O
differentiation	O
(	O
unpublished	O
data	O
)	O
.	O

Mice	O
homozygous	O
for	O
removal	O
of	O
Bmp2	O
and	O
heterozygous	O
for	O
Bmp7	O
(	O
Bmp2C	O
/	O
C	O
,	O
Bmp7	O
+	O
/	O
-	O
;	O
Prx1	O
:	O
:	O
cre	O
)	O
displayed	O
the	O
same	O
subtle	O
scapular	O
defect	O
seen	O
in	O
Bmp2C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mutants	O
alone	O
(	O
unpublished	O
data	O
)	O
.	O

In	O
limbs	O
developing	O
in	O
the	O
complete	O
absence	O
of	O
both	O
BMP7	O
and	O
BMP2	O
activity	O
(	O
Bmp2C	O
/	O
C	O
,	O
Bmp7	O
-	O
/	O
-	O
;	O
Prx1	O
:	O
:	O
cre	O
)	O
,	O
the	O
last	O
phalanx	O
was	O
missing	O
from	O
digit	O
III	O
in	O
the	O
forelimb	O
,	O
and	O
these	O
limbs	O
displayed	O
the	O
same	O
phenotype	O
in	O
the	O
hindlimb	O
with	O
variable	O
penetrance	O
(	O
Figure	O
1L	O
and	O
1T	O
,	O
black	O
arrow	O
)	O
.	O

Additionally	O
,	O
the	O
fibulae	O
of	O
these	O
hindlimbs	O
are	O
malformed	O
and	O
do	O
not	O
articulate	O
with	O
the	O
femur	O
at	O
the	O
knee	O
(	O
Figure	O
1T	O
,	O
thick	O
red	O
arrow	O
)	O
.	O

They	O
also	O
display	O
the	O
same	O
scapular	O
defects	O
seen	O
in	O
Bmp2C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mice	O
,	O
and	O
the	O
overall	O
size	O
of	O
the	O
appendicular	O
skeleton	O
is	O
slightly	O
diminished	O
.	O

However	O
,	O
skeletal	O
differentiation	O
appears	O
normal	O
in	O
the	O
limbs	O
of	O
these	O
animals	O
.	O

Soft	O
Tissue	O
Syndactyly	O
Observed	O
in	O
Limbs	O
of	O
Mice	O
Devoid	O
of	O
BMP2	O
and	O
BMP4	O
Activity	O

As	O
noted	O
above	O
,	O
Bmp2	O
-	O
deficient	O
animals	O
display	O
a	O
variably	O
penetrant	O
3	O
/	O
4	O
soft	O
tissue	O
syndactyly	O
phenotype	O
(	O
Figure	O
2B	O
)	O
.	O

In	O
contrast	O
,	O
Bmp4	O
-	O
deficient	O
mice	O
show	O
no	O
evidence	O
of	O
syndactyly	O
(	O
unpublished	O
data	O
)	O
.	O

However	O
,	O
one	O
of	O
the	O
striking	O
defects	O
observed	O
in	O
the	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mice	O
is	O
that	O
in	O
the	O
newborn	O
animals	O
,	O
the	O
digits	O
of	O
both	O
forelimb	O
(	O
unpublished	O
data	O
)	O
and	O
hindlimb	O
show	O
complete	O
syndactyly	O
(	O
Figure	O
2D	O
;	O
compare	O
to	O
wild	O
-	O
type	O
,	O
Figure	O
2C	O
)	O
.	O

To	O
determine	O
the	O
origin	O
of	O
this	O
defect	O
,	O
we	O
examined	O
embryonic	O
limbs	O
at	O
E15	O
.	O
5	O
,	O
the	O
stage	O
when	O
interdigital	O
separation	O
is	O
normally	O
taking	O
place	O
(	O
Figure	O
2E	O
)	O
.	O

In	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
limbs	O
,	O
only	O
the	O
very	O
distal	O
tips	O
of	O
each	O
digit	O
were	O
separated	O
,	O
with	O
the	O
autopod	O
adopting	O
the	O
shape	O
of	O
a	O
notched	O
pallet	O
(	O
Figure	O
2F	O
)	O
.	O

In	O
wild	O
-	O
type	O
development	O
,	O
the	O
individual	O
digits	O
become	O
free	O
from	O
one	O
another	O
through	O
a	O
process	O
of	O
interdigital	O
apoptosis	O
,	O
observable	O
by	O
staining	O
with	O
acridine	B-CHEBI
orange	O
(	O
Figure	O
2E	O
and	O
2G	O
,	O
arrow	O
)	O
.	O

Interdigital	O
apoptosis	O
is	O
dramatically	O
reduced	O
in	O
the	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
limbs	O
(	O
Figure	O
2F	O
and	O
2H	O
,	O
arrow	O
)	O
.	O

(	O
Note	O
that	O
the	O
strong	O
acridine	B-CHEBI
orange	O
staining	O
in	O
Figure	O
2H	O
is	O
not	O
in	O
the	O
interdigital	O
mesenchyme	O
but	O
rather	O
is	O
in	O
the	O
remnant	O
of	O
the	O
cells	O
of	O
the	O
AER	O
[	O
red	O
asterisk	O
]	O
.	O
)	O

Another	O
region	O
of	O
very	O
prominent	O
apoptosis	O
in	O
the	O
wild	O
-	O
type	O
limb	O
bud	O
is	O
within	O
the	O
AER	O
.	O

The	O
AER	O
is	O
a	O
specialized	O
ridge	O
of	O
ectoderm	O
running	O
along	O
the	O
anterior	O
-	O
posterior	O
axis	O
at	O
the	O
distal	O
margin	O
of	O
the	O
early	O
limb	O
bud	O
.	O

One	O
of	O
the	O
phenotypes	O
characterizing	O
the	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mutant	O
is	O
expansion	O
of	O
the	O
AER	O
(	O
see	O
below	O
)	O
.	O

Moreover	O
,	O
in	O
the	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
animals	O
,	O
the	O
AER	O
is	O
maintained	O
as	O
late	O
as	O
E15	O
.	O
5	O
,	O
long	O
after	O
it	O
has	O
started	O
to	O
degrade	O
in	O
wild	O
-	O
type	O
limbs	O
.	O

This	O
can	O
be	O
seen	O
morphologically	O
(	O
unpublished	O
data	O
)	O
or	O
by	O
staining	O
for	O
expression	O
of	O
AER	O
-	O
specific	O
marker	O
such	O
as	O
Fgf8	O
(	O
Figure	O
2I	O
and	O
2J	O
)	O
.	O

The	O
AER	O
displays	O
intense	O
staining	O
with	O
acridine	B-CHEBI
orange	O
,	O
TUNEL	O
,	O
or	O
other	O
markers	O
for	O
apoptosis	O
at	O
every	O
stage	O
when	O
it	O
is	O
present	O
,	O
reflecting	O
the	O
rapid	O
turnover	O
of	O
cells	O
in	O
this	O
structure	O
[	O
33	O
-	O
35	O
]	O
.	O

The	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mutant	O
limbs	O
at	O
E15	O
.	O
5	O
show	O
strong	O
acridine	B-CHEBI
orange	O
staining	O
in	O
the	O
remnants	O
of	O
AER	O
(	O
Figure	O
2H	O
,	O
asterisk	O
)	O
,	O
in	O
domains	O
of	O
the	O
distal	O
tip	O
where	O
the	O
AER	O
remains	O
the	O
longest	O
(	O
compare	O
staining	O
in	O
Figure	O
2F	O
and	O
2J	O
)	O
.	O

No	O
significant	O
difference	O
was	O
observed	O
in	O
the	O
extent	O
of	O
apoptosis	O
in	O
the	O
cells	O
of	O
the	O
AER	O
in	O
earlier	O
stage	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mutant	O
embryonic	O
limbs	O
(	O
Figure	O
S1D	O
-	O
S1G	O
)	O
.	O

Patterning	O
Defects	O
in	O
Limb	O
Developing	O
with	O
Reduced	O
Levels	O
of	O
BMP	O
Signaling	O

BMP	O
signaling	O
has	O
been	O
proposed	O
to	O
play	O
several	O
distinct	O
roles	O
in	O
limb	O
patterning	O
.	O

The	O
first	O
of	O
these	O
is	O
in	O
establishing	O
differences	O
along	O
the	O
anterior	O
-	O
posterior	O
axis	O
of	O
the	O
limb	O
downstream	O
of	O
sonic	O
hedgehog	O
(	O
Shh	O
)	O
.	O

SHH	O
signaling	O
itself	O
extends	O
over	O
a	O
long	O
range	O
in	O
the	O
developing	O
limb	O
bud	O
,	O
based	O
on	O
both	O
activation	O
of	O
target	O
genes	O
[	O
36	O
]	O
and	O
protein	B-CHEBI
distribution	O
[	O
37	O
]	O
.	O

Nonetheless	O
,	O
some	O
models	O
have	O
suggested	O
that	O
the	O
patterning	O
effect	O
of	O
this	O
morphogenic	O
signal	O
is	O
mediated	O
entirely	O
[	O
10	O
]	O
or	O
in	O
part	O
[	O
11	O
]	O
by	O
BMP2	O
and	O
BMP7	O
produced	O
as	O
secondary	O
signals	O
in	O
response	O
to	O
SHH	O
.	O

We	O
have	O
removed	O
both	O
BMP2	O
and	O
BMP7	O
activities	O
in	O
the	O
early	O
limb	O
bud	O
(	O
Figure	O
1	O
)	O
,	O
and	O
moreover	O
,	O
there	O
is	O
no	O
apparent	O
upregulation	O
of	O
BMP4	O
expression	O
in	O
the	O
posterior	O
of	O
these	O
limbs	O
(	O
Figure	O
3A	O
-	O
3D	O
)	O
.	O

The	O
skeletal	O
phenotypes	O
of	O
mouse	O
limbs	O
formed	O
in	O
the	O
absence	O
of	O
BMP2	O
,	O
BMP7	O
,	O
and	O
both	O
BMP2	O
and	O
BMP7	O
are	O
illuminating	O
,	O
as	O
none	O
of	O
these	O
exhibit	O
significant	O
digit	O
pattern	O
defects	O
(	O
Figure	O
1	O
)	O
.	O

While	O
a	O
distal	O
phalanx	O
is	O
missing	O
in	O
the	O
middle	O
digits	O
of	O
the	O
double	O
mutants	O
(	O
Bmp2C	O
/	O
C	O
,	O
Bmp7	O
-	O
/	O
-	O
;	O
Prx1	O
:	O
:	O
cre	O
)	O
,	O
this	O
is	O
not	O
a	O
phenotype	O
consistent	O
with	O
a	O
decrease	O
or	O
loss	O
of	O
a	O
posteriorly	O
derived	O
polarizing	O
activity	O
.	O

Indeed	O
,	O
the	O
terminal	O
phalanx	O
forms	O
at	O
the	O
distal	O
tip	O
of	O
each	O
digit	O
by	O
a	O
distinct	O
mechanism	O
,	O
not	O
dependent	O
upon	O
anterior	O
-	O
posterior	O
patterning	O
[	O
38	O
]	O
.	O

These	O
data	O
strongly	O
indicate	O
that	O
BMP2	O
and	O
BMP7	O
are	O
not	O
required	O
secondary	O
signals	O
for	O
SHH	O
-	O
mediated	O
polarization	O
of	O
the	O
digits	O
along	O
the	O
anterior	O
-	O
posterior	O
axis	O
.	O

The	O
lack	O
of	O
transformations	O
in	O
digit	O
identity	O
in	O
the	O
limb	O
skeletons	O
formed	O
in	O
the	O
absence	O
of	O
BMP2	O
and	O
BMP7	O
activity	O
also	O
argues	O
against	O
BMP	O
signaling	O
being	O
the	O
critical	O
instructive	O
signal	O
from	O
the	O
interdigital	O
mesenchyme	O
to	O
the	O
forming	O
digits	O
.	O

While	O
a	O
distal	O
phalanx	O
was	O
lost	O
from	O
the	O
middle	O
digit	O
of	O
the	O
forelimbs	O
of	O
these	O
animals	O
,	O
these	O
digits	O
do	O
not	O
otherwise	O
have	O
a	O
morphology	O
consistent	O
with	O
their	O
being	O
transformed	O
anteriorly	O
into	O
digit	O
1	O
(	O
thumb	O
)	O
.	O

Indeed	O
,	O
in	O
the	O
hindlimbs	O
,	O
where	O
the	O
penetrance	O
of	O
the	O
phenotype	O
is	O
variable	O
,	O
the	O
mutant	O
middle	O
digits	O
are	O
otherwise	O
indistinguishable	O
from	O
wild	O
-	O
type	O
,	O
other	O
than	O
the	O
presence	O
or	O
absence	O
of	O
this	O
variable	O
skeletal	O
element	O
.	O

In	O
contrast	O
to	O
the	O
proposed	O
roles	O
for	O
BMPs	O
in	O
anterior	O
-	O
posterior	O
digit	O
patterning	O
,	O
we	O
obtained	O
further	O
support	O
for	O
the	O
well	O
-	O
accepted	O
idea	O
that	O
a	O
threshold	O
level	O
of	O
BMP	O
signaling	O
is	O
necessary	O
interdigitally	O
for	O
programmed	O
cell	O
death	O
to	O
occur	O
.	O

We	O
observed	O
syndactyly	O
with	O
variable	O
penetrance	O
in	O
limbs	O
developing	O
without	O
BMP2	O
activity	O
(	O
Figure	O
2B	O
)	O
,	O
and	O
nearly	O
complete	O
soft	O
tissue	O
syndactyly	O
of	O
all	O
digits	O
in	O
limbs	O
deficient	O
in	O
both	O
BMP2	O
and	O
BMP4	O
(	O
compare	O
Figure	O
2C	O
and	O
Figure	O
2D	O
)	O
.	O

The	O
one	O
dramatic	O
patterning	O
defect	O
we	O
observed	O
in	O
our	O
BMP	O
deficiency	O
series	O
was	O
the	O
loss	O
of	O
posterior	O
digits	O
in	O
forelimbs	O
deficient	O
in	O
both	O
BMP2	O
and	O
BMP4	O
(	O
Figure	O
1K	O
)	O
,	O
also	O
observed	O
in	O
earlier	O
limb	O
buds	O
stained	O
to	O
show	O
no	O
expression	O
of	O
the	O
condensation	O
marker	O
Sox9	O
(	O
Figure	O
3	O
)	O
.	O

To	O
understand	O
this	O
phenotype	O
,	O
we	O
analyzed	O
limb	O
buds	O
at	O
various	O
stages	O
using	O
a	O
series	O
of	O
molecular	B-CHEBI
markers	O
.	O

By	O
E11	O
.	O
5	O
,	O
the	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
limb	O
buds	O
are	O
noticeably	O
broader	O
,	O
expanded	O
in	O
the	O
posterior	O
relative	O
to	O
wild	O
-	O
type	O
.	O

This	O
correlates	O
with	O
an	O
anterior	O
expansion	O
in	O
Shh	O
expression	O
(	O
Figure	O
3E	O
and	O
3F	O
,	O
red	O
bracket	O
)	O
and	O
a	O
concomitant	O
expansion	O
of	O
the	O
AER	O
as	O
visualized	O
by	O
Fgf8	O
expression	O
(	O
Figure	O
3G	O
and	O
3H	O
,	O
red	O
bracket	O
)	O
.	O

The	O
expansion	O
in	O
Shh	O
expression	O
can	O
first	O
be	O
detected	O
at	O
E10	O
.	O
5	O
and	O
persists	O
at	O
least	O
until	O
E12	O
.	O
5	O
,	O
well	O
after	O
the	O
time	O
normal	O
Shh	O
expression	O
disappears	O
at	O
E11	O
.	O
75	O
(	O
Figure	O
3L	O
and	O
3P	O
)	O
.	O

The	O
expansion	O
of	O
the	O
AER	O
in	O
the	O
absence	O
of	O
BMP	O
signaling	O
may	O
be	O
understood	O
on	O
the	O
basis	O
of	O
the	O
feedback	O
loop	O
between	O
the	O
zone	O
of	O
polarizing	O
activity	O
(	O
ZPA	O
)	O
and	O
the	O
AER	O
.	O

Expression	O
of	O
several	O
Fgf	O
genes	O
[	O
20	O
,	O
21	O
]	O
and	O
maintenance	O
of	O
the	O
AER	O
itself	O
[	O
23	O
]	O
normally	O
depend	O
on	O
BMP	O
antagonism	O
induced	O
by	O
SHH	O
.	O

Thus	O
,	O
a	O
decrease	O
in	O
BMP	O
signaling	O
expands	O
and	O
maintains	O
the	O
AER	O
.	O

Because	O
Shh	O
expression	O
is	O
,	O
reciprocally	O
,	O
supported	O
by	O
FGF	O
signaling	O
from	O
the	O
AER	O
[	O
8	O
,	O
24	O
]	O
,	O
this	O
,	O
in	O
turn	O
,	O
feeds	O
back	O
on	O
the	O
ZPA	O
,	O
expanding	O
Shh	O
expression	O
.	O

While	O
this	O
explains	O
the	O
broader	O
hand	O
plate	O
of	O
the	O
BMP2	O
,	O
BMP4	O
-	O
deficient	O
limb	O
buds	O
,	O
it	O
is	O
somewhat	O
paradoxical	O
in	O
terms	O
of	O
the	O
skeletal	O
phenotype	O
,	O
as	O
a	O
broadened	O
autopod	O
would	O
normally	O
be	O
expected	O
to	O
result	O
in	O
the	O
formation	O
of	O
extra	O
digits	O
(	O
polydactyly	O
)	O
(	O
e	O
.	O
g	O
.	O
,	O
Figure	O
1G	O
and	O
1O	O
of	O
this	O
paper	O
and	O
[	O
16	O
]	O
)	O
,	O
not	O
the	O
loss	O
of	O
digits	O
,	O
as	O
observed	O
in	O
the	O
double	O
mutant	O
forelimbs	O
.	O

To	O
examine	O
the	O
loss	O
of	O
digits	O
more	O
closely	O
,	O
BMP2	O
,	O
BMP4	O
-	O
deficient	O
limb	O
buds	O
were	O
examined	O
during	O
cartilage	O
condensation	O
phase	O
of	O
the	O
digit	O
rays	O
at	O
E12	O
.	O
5	O
.	O

In	O
wild	O
-	O
type	O
limb	O
buds	O
the	O
condensation	O
of	O
all	O
five	O
digits	O
can	O
be	O
visualized	O
at	O
this	O
stage	O
by	O
in	O
situ	O
hybridization	O
with	O
a	O
probe	O
directed	O
against	O
Sox9	O
,	O
the	O
earliest	O
known	O
chondrogenic	O
marker	O
(	O
Figure	O
3I	O
)	O
.	O

However	O
,	O
in	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
limb	O
buds	O
at	O
E12	O
.	O
5	O
,	O
Sox9	O
only	O
detects	O
primordia	O
of	O
the	O
anterior	O
three	O
digits	O
of	O
the	O
forelimb	O
,	O
indicating	O
a	O
failure	O
in	O
the	O
formation	O
of	O
posterior	O
digits	O
at	O
this	O
earliest	O
stage	O
(	O
Figure	O
3J	O
)	O
.	O

Genes	O
such	O
as	O
Msx2	O
(	O
Figure	O
3N	O
)	O
continue	O
to	O
be	O
expressed	O
throughout	O
the	O
posterior	O
forelimb	O
mesenchyme	O
,	O
indicating	O
that	O
the	O
posterior	O
forelimb	O
tissue	O
is	O
viable	O
at	O
E12	O
.	O
5	O
in	O
the	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
animals	O
.	O

Msx2	O
is	O
normally	O
expressed	O
in	O
the	O
non	O
-	O
chondrogenic	O
interdigital	O
mesenchyme	O
at	O
this	O
stage	O
(	O
Figure	O
3M	O
)	O
,	O
a	O
continuation	O
of	O
an	O
earlier	O
expression	O
domain	O
throughout	O
the	O
distal	O
mesenchyme	O
.	O

This	O
expression	O
of	O
Msx2	O
in	O
the	O
posterior	O
of	O
the	O
BMP2	O
,	O
BMP4	O
-	O
deficient	O
forelimbs	O
reflects	O
a	O
failure	O
of	O
chondrogenesis	O
in	O
this	O
region	O
.	O

The	O
loss	O
of	O
the	O
posterior	O
forelimb	O
digits	O
in	O
these	O
mice	O
thus	O
does	O
not	O
appear	O
to	O
represent	O
a	O
decrease	O
in	O
polarizing	O
activity	O
leading	O
to	O
a	O
change	O
in	O
digit	O
identity	O
rather	O
a	O
consequence	O
of	O
the	O
overall	O
level	O
of	O
BMP	O
signaling	O
falling	O
below	O
a	O
threshold	O
for	O
initiating	O
chondrogenesis	O
in	O
the	O
posterior	O
of	O
these	O
forelimbs	O
.	O

The	O
posterior	O
of	O
the	O
hindlimb	O
in	O
the	O
mutant	O
,	O
in	O
contrast	O
,	O
appears	O
to	O
remain	O
above	O
this	O
threshold	O
,	O
and	O
more	O
than	O
five	O
digit	O
condensations	O
form	O
in	O
the	O
hindlimb	O
bud	O
(	O
Figures	O
3K	O
and	O
1S	O
)	O
and	O
no	O
ectopic	O
expression	O
of	O
Msx2	O
is	O
observed	O
in	O
the	O
posterior	O
(	O
Figure	O
3O	O
)	O
.	O

Skeletal	O
Differentiation	O
in	O
Limbs	O
Developing	O
with	O
Reduced	O
Levels	O
of	O
BMP	O
Signaling	O

BMPs	O
were	O
first	O
discovered	O
in	O
the	O
context	O
of	O
their	O
skeletogenic	O
activity	O
.	O

We	O
therefore	O
wanted	O
to	O
determine	O
whether	O
the	O
loss	O
of	O
the	O
specific	O
BMP	O
molecules	B-CHEBI
under	O
investigation	O
here	O
would	O
perturb	O
the	O
skeletal	O
differentiation	O
pathways	O
.	O

Accordingly	O
,	O
skeletal	O
preparations	O
from	O
each	O
of	O
the	O
various	O
mutant	O
alleles	O
were	O
subjected	O
to	O
histological	O
and	O
molecular	B-CHEBI
analyses	O
.	O

The	O
skeletal	O
elements	O
that	O
formed	O
in	O
the	O
absence	O
of	O
BMP2	O
,	O
BMP4	O
,	O
or	O
BMP7	O
or	O
BMP2	O
and	O
BMP7	O
all	O
underwent	O
normal	O
chondrogenesis	O
and	O
osteogenesis	O
by	O
a	O
series	O
of	O
criteria	O
.	O

All	O
showed	O
normal	O
staining	O
with	O
Alcian	O
blue	O
(	O
for	O
cartilage	O
)	O
and	O
Alizarin	B-CHEBI
red	I-CHEBI
(	O
for	O
mineralized	O
tissue	O
,	O
see	O
Figure	O
1	O
)	O
.	O

Most	O
were	O
also	O
analyzed	O
in	O
histological	O
sections	O
stained	O
with	O
toluidine	O
blue	O
and	O
showed	O
osteoid	O
formation	O
and	O
bone	O
matrix	O
deposition	O
(	O
compare	O
Figure	O
S2A	O
and	O
S2E	O
;	O
and	O
unpublished	O
data	O
)	O
.	O

The	O
skeletal	O
elements	O
in	O
these	O
various	O
BMP	O
-	O
deficient	O
animals	O
contained	O
normal	O
prehypertrophic	O
chondrocytes	O
expressing	O
type	O
II	O
collagen	O
,	O
hypertrophic	O
chondrocytes	O
expressing	O
type	O
X	O
collagen	O
,	O
as	O
well	O
as	O
the	O
osteoblasts	O
expressing	O
type	O
I	O
collagen	O
,	O
like	O
their	O
wild	O
-	O
type	O
counterparts	O
(	O
Figure	O
S2	O
;	O
compare	O
Figure	O
S2F	O
-	O
S2H	O
with	O
Figure	O
S2B	O
-	O
S2D	O
;	O
and	O
unpublished	O
data	O
)	O
.	O

In	O
contrast	O
,	O
however	O
,	O
limbs	O
completely	O
deficient	O
in	O
both	O
BMP2	O
and	O
BMP4	O
activity	O
showed	O
severe	O
defects	O
in	O
skeletal	O
differentiation	O
.	O

BMP2	O
and	O
BMP4	O
Are	O
Not	O
Critical	O
for	O
Chondrogenic	O
Differentiation	O

As	O
noted	O
above	O
,	O
at	O
E12	O
.	O
5	O
,	O
chondrogenic	O
condensation	O
of	O
the	O
digits	O
could	O
be	O
visualized	O
in	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
limb	O
buds	O
by	O
in	O
situ	O
hybridization	O
with	O
a	O
Sox9	O
probe	O
.	O

Similar	O
analysis	O
at	O
E10	O
.	O
5	O
and	O
E11	O
.	O
5	O
demonstrated	O
a	O
relatively	O
normal	O
process	O
of	O
condensation	O
of	O
the	O
proximal	O
skeletal	O
elements	O
(	O
Figure	O
S1H	O
-	O
S1M	O
)	O
,	O
despite	O
the	O
absence	O
of	O
detectable	O
Bmp2	O
and	O
Bmp4	O
transcripts	O
.	O

As	O
shown	O
in	O
Figure	O
S1N	O
and	O
S1O	O
,	O
expression	O
of	O
Col	O
II	O
,	O
a	O
chondrocyte	O
marker	O
,	O
is	O
observed	O
in	O
the	O
BMP2	O
,	O
BMP4	O
-	O
deficient	O
cartilage	O
(	O
Figure	O
S1O	O
)	O
as	O
early	O
as	O
E12	O
.	O
5	O
,	O
similar	O
to	O
a	O
wild	O
-	O
type	O
control	O
(	O
Figure	O
S1N	O
)	O
.	O

Similarly	O
,	O
at	O
E13	O
.	O
5	O
,	O
the	O
entire	O
limb	O
skeleton	O
could	O
be	O
visualized	O
undergoing	O
chondrogenesis	O
by	O
Alcian	O
blue	O
staining	O
,	O
albeit	O
in	O
a	O
defective	O
pattern	O
,	O
in	O
the	O
BMP2	O
,	O
BMP4	O
-	O
deficient	O
limb	O
buds	O
(	O
Figure	O
4A	O
and	O
4B	O
and	O
unpublished	O
data	O
)	O
.	O

As	O
the	O
cartilage	O
elements	O
grow	O
,	O
a	O
wave	O
of	O
hypertrophic	O
differentiation	O
occurs	O
from	O
the	O
center	O
toward	O
the	O
distal	O
ends	O
(	O
reviewed	O
in	O
[	O
39	O
-	O
41	O
]	O
)	O
.	O

Histological	O
examination	O
of	O
the	O
humeri	O
at	O
E13	O
.	O
5	O
showed	O
that	O
while	O
chondrogenic	O
differentiation	O
had	O
taken	O
place	O
in	O
the	O
BMP2	O
,	O
BMP4	O
-	O
deficient	O
humerus	O
,	O
hypertrophic	O
differentiation	O
was	O
delayed	O
(	O
Figure	O
4C	O
and	O
4D	O
)	O
.	O

However	O
,	O
by	O
E15	O
.	O
5	O
,	O
hypertrophy	O
was	O
evident	O
in	O
these	O
elements	O
as	O
seen	O
by	O
type	O
X	O
collagen	O
expression	O
(	O
Figure	O
4E	O
and	O
4F	O
)	O
.	O

The	O
hypertrophic	O
cells	O
in	O
BMP2	O
,	O
BMP4	O
-	O
deficient	O
limb	O
also	O
express	O
late	O
hypertrophic	O
markers	O
,	O
such	O
as	O
osteopontin	O
[	O
42	O
]	O
(	O
unpublished	O
data	O
)	O
.	O

To	O
examine	O
whether	O
the	O
successful	O
execution	O
of	O
chondrogenesis	O
in	O
the	O
BMP2	O
,	O
BMP4	O
-	O
deficient	O
limbs	O
is	O
a	O
result	O
of	O
compensatory	O
upregulation	O
of	O
other	O
ostegenic	O
BMPs	O
,	O
we	O
carried	O
out	O
in	O
situ	O
hybridization	O
for	O
Bmp6	O
and	O
Bmp7	O
in	O
these	O
limbs	O
.	O

At	O
E13	O
.	O
5	O
,	O
we	O
observed	O
no	O
increase	O
in	O
expression	O
of	O
Bmp6	O
(	O
Figure	O
S1P	O
-	O
S1S	O
)	O
or	O
Bmp7	O
(	O
compare	O
Figure	O
4H	O
with	O
Figure	O
4G	O
)	O
mRNA	B-CHEBI
in	O
the	O
mutant	O
tissues	O
compared	O
to	O
their	O
wild	O
-	O
type	O
counterparts	O

Osteogenesis	O
Is	O
Initiated	O
Normally	O
in	O
BMP2	O
,	O
BMP4	O
-	O
Deficient	O
Limb	O
Buds	O

Bone	O
formation	O
first	O
occurs	O
at	O
the	O
interface	O
between	O
the	O
late	O
hypertrophic	O
chondrocytes	O
and	O
the	O
surrounding	O
perichondrium	O
,	O
a	O
region	O
identified	O
as	O
the	O
bone	O
collar	O
.	O

We	O
examined	O
whether	O
the	O
osteogenesis	O
program	O
is	O
initiated	O
in	O
the	O
BMP2	O
,	O
BMP4	O
-	O
deficient	O
limbs	O
using	O
several	O
histological	O
and	O
molecular	B-CHEBI
criteria	O
,	O
as	O
described	O
below	O
(	O
Figure	O
5	O
)	O
.	O

Adjacent	O
to	O
the	O
hypertrophic	O
cells	O
,	O
a	O
bone	O
collar	O
is	O
laid	O
down	O
normally	O
in	O
the	O
absence	O
of	O
BMP2	O
and	O
BMP4	O
(	O
Figure	O
5A	O
and	O
5B	O
,	O
red	O
star	O
)	O
.	O

As	O
can	O
be	O
seen	O
in	O
sagittal	O
sections	O
through	O
an	O
E15	O
.	O
5	O
humerus	O
,	O
the	O
cells	O
embedded	O
in	O
the	O
mineralized	O
matrix	O
express	O
the	O
osteoblast	O
marker	O
Col	O
I	O
as	O
normal	O
(	O
Figure	O
5C	O
and	O
5D	O
)	O
.	O

By	O
E17	O
.	O
5	O
,	O
the	O
mineralized	O
cartilage	O
that	O
makes	O
up	O
the	O
late	O
hypertrophic	O
zone	O
of	O
the	O
growth	O
plate	O
normally	O
undergoes	O
removal	O
by	O
osteoclasts	O
(	O
Figure	O
5G	O
,	O
brown	O
-	O
stained	O
cells	O
,	O
red	O
arrows	O
)	O
,	O
resulting	O
in	O
the	O
formation	O
of	O
a	O
bone	O
marrow	O
cavity	O
(	O
red	O
arrow	O
in	O
Figure	O
5E	O
and	O
5I	O
,	O
see	O
also	O
Figure	O
6	O
)	O
.	O

Osteoprogenitor	O
cells	O
from	O
bone	O
collar	O
region	O
now	O
populate	O
this	O
site	O
and	O
deposit	O
osteoid	O
,	O
forming	O
the	O
trabecular	O
bone	O
in	O
the	O
bone	O
marrow	O
cavity	O
(	O
Figure	O
6E	O
,	O
red	O
arrow	O
)	O
and	O
cortical	O
bone	O
at	O
birth	O
(	O
Figure	O
5I	O
,	O
asterisk	O
)	O
.	O

In	O
contrast	O
,	O
in	O
E17	O
.	O
5	O
limbs	O
deficient	O
in	O
BMP2	O
and	O
BMP4	O
,	O
there	O
is	O
an	O
overall	O
delay	O
in	O
the	O
normal	O
endochondral	O
process	O
(	O
Figure	O
5F	O
)	O
.	O

While	O
vascularization	O
occurs	O
in	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
forelimbs	O
,	O
few	O
osteoclasts	O
are	O
recruited	O
to	O
the	O
mineralized	O
cartilage	O
(	O
compare	O
Figure	O
5G	O
and	O
Figure	O
5H	O
,	O
red	O
arrows	O
)	O
,	O
resulting	O
in	O
a	O
delay	O
in	O
bone	O
marrow	O
cavity	O
formation	O
in	O
the	O
absence	O
of	O
BMP2	O
and	O
BMP4	O
.	O

In	O
fact	O
,	O
bone	O
marrow	O
formation	O
and	O
trabecular	O
bone	O
formation	O
have	O
not	O
yet	O
started	O
at	O
birth	O
in	O
the	O
absence	O
of	O
BMP2	O
and	O
BMP4	O
(	O
Figure	O
5J	O
)	O
,	O
and	O
the	O
morphology	O
of	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
bones	O
at	O
birth	O
is	O
most	O
similar	O
to	O
control	O
embryos	O
at	O
E17	O
.	O
5	O
(	O
Figure	O
5E	O
)	O
.	O

To	O
differentiate	O
between	O
a	O
simple	O
delay	O
in	O
bone	O
formation	O
in	O
the	O
absence	O
of	O
BMP2	O
and	O
BMP4	O
and	O
the	O
inability	O
to	O
form	O
bone	O
without	O
these	O
BMPs	O
,	O
we	O
performed	O
histological	O
analyses	O
in	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mice	O
up	O
to	O
3	O
wks	O
of	O
age	O
.	O

As	O
shown	O
in	O
Figure	O
6A	O
through	O
6E	O
,	O
in	O
the	O
control	O
mice	O
,	O
a	O
bone	O
collar	O
is	O
found	O
adjacent	O
to	O
the	O
zone	O
of	O
late	O
hypertrophic	O
chondrocytes	O
at	O
1	O
wk	O
(	O
Figure	O
6A	O
and	O
6B	O
)	O
.	O

Many	O
osteoblasts	O
line	O
the	O
newly	O
formed	O
cortical	O
bone	O
in	O
the	O
diaphyseal	O
region	O
(	O
Figure	O
6C	O
,	O
blue	O
arrow	O
)	O
,	O
and	O
formation	O
of	O
a	O
secondary	O
ossification	O
center	O
has	O
begun	O
(	O
Figure	O
6A	O
,	O
red	O
star	O
)	O
.	O

At	O
3	O
wks	O
of	O
age	O
,	O
formation	O
of	O
the	O
secondary	O
ossification	O
center	O
is	O
complete	O
(	O
Figure	O
6D	O
,	O
red	O
star	O
)	O
,	O
along	O
with	O
robust	O
bone	O
marrow	O
formation	O
(	O
Figure	O
6D	O
,	O
bm	O
)	O
and	O
deposition	O
of	O
trabecular	O
bone	O
(	O
Figure	O
6E	O
,	O
pale	O
blue	O
tissue	O
marked	O
by	O
red	O
arrow	O
)	O
.	O

In	O
stark	O
contrast	O
,	O
bone	O
formation	O
is	O
not	O
observed	O
in	O
the	O
absence	O
of	O
BMP2	O
and	O
BMP4	O
at	O
1	O
or	O
3	O
wks	O
after	O
birth	O
(	O
Figure	O
6F	O
-	O
6J	O
)	O
.	O

The	O
appearance	O
of	O
the	O
skeletal	O
elements	O
in	O
the	O
double	O
mutants	O
remains	O
similar	O
to	O
E17	O
.	O
5	O
structures	O
seen	O
in	O
wild	O
-	O
type	O
limbs	O
(	O
Figure	O
5E	O
)	O
,	O
and	O
although	O
there	O
is	O
a	O
bone	O
collar	O
at	O
the	O
site	O
of	O
hypertrophic	O
cartilage	O
(	O
Figure	O
6G	O
)	O
,	O
no	O
bone	O
marrow	O
cavity	O
,	O
trabecular	O
bone	O
,	O
or	O
cortical	O
bone	O
is	O
present	O
(	O
Figure	O
6F	O
)	O
.	O

Many	O
osteoclasts	O
have	O
been	O
recruited	O
to	O
the	O
remaining	O
mineralized	O
cartilage	O
and	O
are	O
actively	O
resorbing	O
this	O
tissue	O
(	O
red	O
asterisks	O
,	O
Figure	O
6I	O
)	O
,	O
so	O
that	O
by	O
3	O
wks	O
,	O
all	O
the	O
mineralized	O
cartilage	O
in	O
the	O
diaphyseal	O
region	O
has	O
disappeared	O
,	O
leaving	O
a	O
void	O
where	O
bone	O
formation	O
should	O
have	O
occurred	O
(	O
Figure	O
6J	O
,	O
also	O
see	O
Figures	O
6L	O
and	O
S3	O
)	O
.	O

This	O
void	O
is	O
eventually	O
invaded	O
by	O
soft	O
tissues	O
and	O
the	O
adjacent	O
muscle	O
(	O
marked	O
s	O
and	O
m	O
,	O
respectively	O
,	O
in	O
Figure	O
6J	O
)	O
.	O

The	O
resorption	O
of	O
bone	O
at	O
3	O
wks	O
of	O
age	O
is	O
clearly	O
visible	O
in	O
the	O
proximal	O
femur	O
of	O
mutant	O
animals	O
where	O
a	O
portion	O
of	O
that	O
bone	O
is	O
missing	O
(	O
Figure	O
6L	O
,	O
black	O
arrow	O
)	O
.	O

The	O
inability	O
to	O
complete	O
osteoblast	O
differentiation	O
in	O
the	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mice	O
results	O
in	O
strikingly	O
defective	O
limb	O
morphology	O
at	O
1	O
wk	O
of	O
age	O
(	O
compare	O
Figure	O
S3G	O
and	O
S3H	O
)	O
.	O

To	O
determine	O
if	O
any	O
osteoblast	O
differentiation	O
occurs	O
in	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
forelimbs	O
,	O
we	O
examined	O
osteoblast	O
-	O
related	O
gene	O
expression	O
(	O
Figure	O
7	O
)	O
.	O

In	O
the	O
control	O
mice	O
,	O
osteoblasts	O
lining	O
the	O
surface	O
of	O
trabecular	O
and	O
cortical	O
bone	O
express	O
type	O
I	O
collagen	O
,	O
runx2	O
,	O
and	O
osterix	O
genes	O
at	O
both	O
1	O
wk	O
and	O
3	O
wks	O
after	O
birth	O
(	O
Figure	O
7A	O
-	O
7D	O
and	O
7I	O
-	O
7L	O
)	O
.	O

In	O
the	O
absence	O
of	O
BMP2	O
and	O
BMP4	O
,	O
cells	O
which	O
are	O
fibroblastic	O
in	O
appearance	O
(	O
Figure	O
6H	O
)	O
are	O
found	O
adjacent	O
to	O
the	O
mineralized	O
cartilage	O
surfaces	O
.	O

These	O
cells	O
express	O
amounts	O
of	O
type	O
I	O
collagen	O
and	O
runx2	O
comparable	O
to	O
control	O
osteoblasts	O
,	O
but	O
their	O
expression	O
of	O
osterix	O
,	O
while	O
noticeable	O
at	O
1	O
wk	O
,	O
becomes	O
almost	O
undetectable	O
at	O
3	O
wks	O
(	O
Figure	O
7E	O
-	O
7H	O
and	O
7M	O
-	O
7P	O
)	O
.	O

These	O
results	O
allow	O
us	O
to	O
conclude	O
that	O
the	O
fibroblast	O
-	O
like	O
cells	O
resident	O
in	O
the	O
bone	O
shaft	O
(	O
Figure	O
6H	O
)	O
may	O
be	O
osteoprogenitor	O
cells	O
unable	O
to	O
differentiate	O
into	O
mature	O
osteoblasts	O
in	O
the	O
absence	O
of	O
BMP2	O
and	O
BMP4	O
.	O

Discussion	O

Using	O
a	O
genetic	O
approach	O
to	O
remove	O
activity	O
of	O
different	O
Bmp	O
genes	O
during	O
limb	O
development	O
,	O
we	O
have	O
found	O
that	O
BMP2	O
,	O
BMP4	O
,	O
and	O
BMP7	O
either	O
individually	O
or	O
in	O
combination	O
are	O
not	O
required	O
for	O
specification	O
of	O
normal	O
digit	O
identities	O
.	O

However	O
,	O
BMP2	O
and	O
BMP4	O
are	O
required	O
in	O
concert	O
to	O
promote	O
condensation	O
of	O
the	O
posterior	O
digit	O
anlagen	O
.	O

We	O
have	O
also	O
shown	O
that	O
chondrogenesis	O
can	O
be	O
initiated	O
and	O
chondrogenic	O
differentiation	O
will	O
take	O
place	O
even	O
in	O
the	O
absence	O
of	O
both	O
BMP2	O
and	O
BMP4	O
or	O
BMP2	O
and	O
BMP7	O
.	O

On	O
the	O
other	O
hand	O
,	O
BMP2	O
and	O
BMP4	O
together	O
are	O
required	O
for	O
completion	O
of	O
osteogenesis	O
.	O

BMP	O
Signaling	O
and	O
Pattern	O
Formation	O

It	O
has	O
been	O
proposed	O
that	O
BMP	O
signaling	O
may	O
be	O
involved	O
in	O
digit	O
patterning	O
as	O
a	O
secondary	O
signal	O
originating	O
in	O
the	O
ZPA	O
[	O
7	O
,	O
11	O
,	O
43	O
]	O
or	O
as	O
a	O
later	O
mediator	O
of	O
interdigital	O
patterning	O
information	O
[	O
15	O
]	O
.	O

In	O
particular	O
,	O
BMP2	O
,	O
a	O
secreted	O
factor	O
that	O
is	O
induced	O
by	O
SHH	O
[	O
8	O
]	O
in	O
the	O
posterior	O
limb	O
bud	O
,	O
has	O
been	O
suggested	O
to	O
act	O
as	O
a	O
true	O
morphogen	O
secondary	O
to	O
SHH	O
signaling	O
to	O
properly	O
pattern	O
the	O
limb	O
digits	O
.	O

However	O
,	O
inactivation	O
of	O
Bmp2	O
during	O
early	O
limb	O
bud	O
development	O
clearly	O
does	O
not	O
cause	O
any	O
digit	O
patterning	O
defects	O
.	O

BMPs	O
are	O
known	O
,	O
in	O
many	O
cases	O
,	O
to	O
function	O
redundantly	O
[	O
44	O
]	O
.	O

In	O
considering	O
potential	O
secondary	O
signals	O
mediating	O
ZPA	O
activity	O
,	O
the	O
most	O
relevant	O
family	O
member	O
to	O
consider	O
is	O
BMP7	O
as	O
,	O
like	O
BMP2	O
(	O
and	O
unlike	O
BMP4	O
)	O
,	O
it	O
is	O
positively	O
regulated	O
by	O
SHH	O
signaling	O
[	O
7	O
]	O
.	O

However	O
,	O
Bmp7	O
expression	O
does	O
not	O
overlap	O
with	O
Bmp2	O
in	O
the	O
early	O
mouse	O
limb	O
bud	O
[	O
45	O
]	O
,	O
and	O
in	O
any	O
case	O
,	O
mice	O
in	O
which	O
we	O
conditionally	O
knocked	O
out	O
Bmp2	O
in	O
the	O
Bmp7	O
-	O
/	O
-	O
background	O
do	O
not	O
show	O
any	O
obvious	O
digit	O
patterning	O
defect	O
other	O
than	O
the	O
missing	O
final	O
phalanx	O
in	O
digit	O
III	O
.	O

Although	O
still	O
poorly	O
understood	O
,	O
the	O
final	O
phalanges	O
form	O
at	O
the	O
tip	O
of	O
every	O
digit	O
through	O
a	O
process	O
distinct	O
from	O
the	O
more	O
proximal	O
phalanges	O
[	O
38	O
]	O
.	O

Our	O
data	O
implicate	O
BMP	O
signaling	O
in	O
this	O
process	O
.	O

At	O
later	O
stages	O
,	O
BMP	O
signaling	O
has	O
been	O
suggested	O
to	O
play	O
a	O
role	O
in	O
mediating	O
the	O
transfer	O
of	O
positional	O
information	O
from	O
the	O
interdigital	O
mesenchyme	O
to	O
specify	O
the	O
identity	O
of	O
the	O
adjacent	O
digits	O
[	O
15	O
]	O
.	O

Application	O
of	O
the	O
BMP	O
antagonist	O
noggin	O
to	O
the	O
interdigital	O
tissue	O
at	O
the	O
time	O
of	O
digit	O
condensation	O
results	O
in	O
loss	O
of	O
phalanges	O
and	O
a	O
resultant	O
pattern	O
that	O
can	O
be	O
interpreted	O
as	O
an	O
anterior	O
homeotic	O
transformation	O
in	O
digit	O
identity	O
.	O

However	O
,	O
increasing	O
BMP	O
concentrations	O
interdigitally	O
with	O
exogenous	O
protein	B-CHEBI
does	O
not	O
result	O
in	O
the	O
reciprocal	O
posterior	O
transformations	O
,	O
and	O
the	O
noggin	O
experiments	O
can	O
also	O
be	O
interpreted	O
simply	O
as	O
a	O
block	O
in	O
the	O
condensation	O
of	O
the	O
primordia	O
of	O
distal	O
phalanges	O
when	O
BMP	O
activity	O
is	O
completely	O
abolished	O
[	O
38	O
]	O
.	O

Decreasing	O
the	O
level	O
of	O
interdigital	O
BMP	O
signaling	O
,	O
without	O
abolishing	O
it	O
,	O
provides	O
an	O
opportunity	O
for	O
differentiating	O
between	O
these	O
models	O
.	O

If	O
BMP	O
signaling	O
were	O
only	O
required	O
as	O
a	O
permissive	O
factor	O
for	O
chondrogenesis	O
,	O
partial	O
reduction	O
in	O
the	O
level	O
of	O
signaling	O
might	O
have	O
no	O
effect	O
.	O

However	O
,	O
if	O
levels	O
of	O
BMP	O
signaling	O
were	O
instructive	O
in	O
terms	O
of	O
digit	O
identities	O
,	O
then	O
a	O
substantial	O
decrease	O
in	O
the	O
amount	O
of	O
BMP	O
ligand	O
present	O
should	O
cause	O
transformations	O
in	O
digit	O
identity	O
.	O

This	O
is	O
not	O
what	O
is	O
observed	O
,	O
either	O
in	O
limbs	O
deficient	O
in	O
both	O
BMP2	O
and	O
BMP4	O
or	O
in	O
those	O
deficient	O
in	O
BMP2	O
and	O
BMP7	O
.	O

It	O
should	O
be	O
noted	O
that	O
the	O
interdigital	O
expression	O
domains	O
form	O
several	O
days	O
after	O
recombination	O
of	O
the	O
floxed	O
BMP	O
alleles	O
is	O
complete	O
.	O

Moreover	O
,	O
there	O
is	O
no	O
detectable	O
compensatory	O
upregulation	O
of	O
BMP7	O
in	O
the	O
interdigital	O
mesenchyme	O
of	O
the	O
BMP2	O
,	O
BMP4	O
-	O
deficient	O
limbs	O
(	O
compare	O
Figure	O
4G	O
and	O
Figure	O
4H	O
)	O
.	O

Thus	O
,	O
we	O
conclude	O
that	O
BMP	O
signaling	O
is	O
not	O
likely	O
to	O
be	O
responsible	O
in	O
a	O
quantitative	O
fashion	O
for	O
the	O
instructive	O
role	O
of	O
interdigital	O
mesenchyme	O
in	O
establishing	O
digit	O
identities	O
.	O

However	O
,	O
in	O
the	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
forelimbs	O
,	O
there	O
is	O
a	O
complete	O
loss	O
of	O
posterior	O
digit	O
ray	O
condensations	O
,	O
presumably	O
because	O
the	O
total	O
level	O
of	O
BMP	O
signaling	O
falls	O
below	O
the	O
threshold	O
for	O
initiation	O
of	O
condensation	O
,	O
as	O
previously	O
seen	O
in	O
cases	O
where	O
BMP	O
antagonists	O
have	O
been	O
used	O
[	O
27	O
,	O
28	O
]	O
.	O

It	O
is	O
worth	O
noting	O
that	O
the	O
defects	O
in	O
chondrogenesis	O
seen	O
in	O
the	O
BMP2	O
,	O
BMP4	O
-	O
deficient	O
limbs	O
are	O
much	O
more	O
severe	O
proximally	O
than	O
distally	O
.	O

This	O
is	O
particularly	O
significant	O
because	O
proximal	O
elements	O
condense	O
and	O
differentiate	O
before	O
distal	O
ones	O
.	O

Thus	O
,	O
if	O
the	O
conditional	O
alleles	O
were	O
partially	O
recombined	O
at	O
early	O
stages	O
and	O
only	O
completely	O
recombined	O
at	O
later	O
stages	O
,	O
it	O
is	O
the	O
distal	O
elements	O
,	O
formed	O
after	O
greater	O
recombination	O
has	O
taken	O
place	O
,	O
that	O
should	O
be	O
more	O
severely	O
affected	O
.	O

Since	O
it	O
is	O
the	O
proximal	O
elements	O
which	O
are	O
more	O
severely	O
affected	O
,	O
the	O
explanation	O
for	O
the	O
difference	O
in	O
severity	O
must	O
lie	O
elsewhere	O
.	O

This	O
is	O
most	O
likely	O
explained	O
by	O
compensation	O
in	O
the	O
distal	O
limb	O
bud	O
by	O
BMP2	O
,	O
BMP4	O
,	O
and	O
BMP7	O
produced	O
in	O
the	O
AER	O
.	O

Compensation	O
by	O
BMPs	O
in	O
the	O
AER	O
also	O
likely	O
explains	O
a	O
difference	O
seen	O
between	O
the	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mice	O
in	O
our	O
experiments	O
and	O
a	O
recently	O
published	O
analysis	O
[	O
16	O
]	O
,	O
which	O
used	O
the	O
identical	O
Bmp4	O
conditional	O
allele	O
and	O
Prx1	O
:	O
:	O
cre	O
driver	O
.	O

The	O
earlier	O
report	O
,	O
like	O
ours	O
,	O
described	O
preaxial	O
and	O
postaxial	O
polydactyly	O
.	O

However	O
,	O
they	O
observed	O
these	O
phenotypes	O
with	O
less	O
variability	O
and	O
,	O
moreover	O
,	O
described	O
multiple	O
preaxial	O
and	O
postaxial	O
ectopic	O
digits	O
,	O
while	O
we	O
saw	O
,	O
at	O
most	O
,	O
a	O
single	O
preaxial	O
and	O
postaxial	O
digit	O
.	O

The	O
difference	O
is	O
that	O
the	O
mice	O
analyzed	O
in	O
the	O
previous	O
report	O
had	O
one	O
null	O
allele	O
and	O
one	O
conditional	O
allele	O
,	O
while	O
ours	O
had	O
two	O
conditional	O
alleles	O
.	O

Their	O
mice	O
,	O
therefore	O
,	O
lost	O
a	O
half	O
-	O
dose	O
of	O
BMP4	O
from	O
the	O
AER	O
in	O
addition	O
to	O
complete	O
loss	O
in	O
the	O
mesenchyme	O
,	O
while	O
our	O
conditional	O
alleles	O
were	O
only	O
recombined	O
in	O
the	O
mesenchyme	O
by	O
the	O
Prx1	O
:	O
:	O
cre	O
driver	O
.	O

It	O
is	O
also	O
possible	O
that	O
the	O
difference	O
in	O
severity	O
relates	O
to	O
the	O
time	O
required	O
to	O
recombine	O
one	O
as	O
opposed	O
to	O
two	O
floxed	O
alleles	O
;	O
however	O
,	O
we	O
do	O
not	O
favor	O
this	O
explanation	O
as	O
all	O
detectable	O
BMP4	O
expression	O
is	O
lost	O
prior	O
to	O
any	O
morphological	O
differences	O
between	O
the	O
mutant	O
and	O
wild	O
-	O
type	O
limb	O
buds	O
.	O

Finally	O
,	O
differences	O
in	O
genetic	O
background	O
could	O
contribute	O
to	O
the	O
differences	O
as	O
the	O
Prx1	O
:	O
:	O
cre	O
line	O
is	O
outbred	O
.	O

A	O
final	O
aspect	O
of	O
patterning	O
previously	O
associated	O
with	O
BMP	O
signaling	O
is	O
interdigital	O
apoptosis	O
.	O

Consistent	O
with	O
this	O
,	O
we	O
see	O
some	O
syndactyly	O
in	O
the	O
BMP2	O
-	O
deficient	O
limbs	O
.	O

The	O
fact	O
that	O
this	O
is	O
variable	O
,	O
and	O
limited	O
to	O
the	O
3	O
/	O
4	O
interdigit	O
,	O
implies	O
that	O
the	O
threshold	O
for	O
induction	O
of	O
apoptosis	O
is	O
low	O
enough	O
that	O
loss	O
of	O
BMP2	O
,	O
BMP4	O
or	O
BMP7	O
or	O
BMP2	O
and	O
BMP7	O
still	O
leaves	O
sufficient	O
BMP	O
signaling	O
for	O
most	O
interdigital	O
cell	O
death	O
to	O
occur	O
normally	O
.	O

However	O
,	O
loss	O
of	O
both	O
BMP2	O
and	O
BMP4	O
results	O
in	O
complete	O
soft	O
tissue	O
syndactyly	O
,	O
i	O
.	O
e	O
.	O
,	O
webbing	O
between	O
all	O
the	O
digits	O
.	O

Although	O
BMP	O
activity	O
has	O
been	O
previously	O
implicated	O
in	O
regulating	O
interdigital	O
apoptosis	O
,	O
this	O
is	O
the	O
first	O
genetic	O
verification	O
of	O
their	O
requirement	O
for	O
this	O
process	O
.	O

BMP	O
Signaling	O
and	O
Skeletal	O
Development	O

As	O
discussed	O
above	O
,	O
our	O
data	O
indicate	O
that	O
threshold	O
levels	O
of	O
BMP	O
signaling	O
are	O
required	O
for	O
initiating	O
chondrogenic	O
condensation	O
,	O
consistent	O
with	O
prior	O
results	O
[	O
26	O
-	O
28	O
]	O
.	O

However	O
,	O
once	O
chondrogenesis	O
begins	O
,	O
cartilage	O
differentiation	O
can	O
be	O
sustained	O
,	O
albeit	O
with	O
some	O
detectable	O
delay	O
,	O
in	O
the	O
absence	O
of	O
BMP2	O
and	O
BMP4	O
or	O
in	O
the	O
absence	O
of	O
BMP2	O
and	O
BMP7	O
.	O

Thus	O
,	O
the	O
expression	O
of	O
either	O
BMP5	O
,	O
BMP6	O
,	O
and	O
BMP7	O
(	O
in	O
the	O
absence	O
of	O
BMP2	O
and	O
BMP4	O
)	O
or	O
the	O
expression	O
of	O
BMP4	O
,	O
BMP5	O
,	O
and	O
BMP6	O
(	O
in	O
the	O
absence	O
of	O
BMP2	O
and	O
BMP7	O
)	O
is	O
sufficient	O
to	O
support	O
mesenchymal	O
condensation	O
and	O
chondrocyte	O
differentiation	O
in	O
the	O
developing	O
limb	O
.	O

In	O
one	O
set	O
of	O
previous	O
studies	O
implicating	O
BMP	O
signaling	O
in	O
chondrogenesis	O
,	O
Yoon	O
et	O
al	O
.	O

[	O
26	O
]	O
showed	O
that	O
if	O
mice	O
lose	O
both	O
Alk3	O
(	O
BmprIa	O
)	O
and	O
Alk6	O
(	O
BmpIb	O
)	O
,	O
two	O
of	O
the	O
three	O
type	O
I	O
receptors	O
used	O
in	O
BMP	O
signal	O
transduction	O
,	O
there	O
is	O
a	O
dramatic	O
decrease	O
in	O
the	O
size	O
of	O
skeletal	O
primordial	O
due	O
to	O
a	O
reduction	O
of	O
proliferation	O
and	O
increase	O
in	O
apoptosis	O
.	O

The	O
size	O
of	O
the	O
skeletal	O
elements	O
in	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
limbs	O
are	O
also	O
decreased	O
compared	O
to	O
those	O
of	O
control	O
mice	O
,	O
although	O
not	O
to	O
the	O
extent	O
seen	O
in	O
the	O
double	O
receptor	O
mutant	O
.	O

We	O
do	O
not	O
know	O
if	O
reduced	O
size	O
of	O
the	O
skeletal	O
elements	O
in	O
our	O
study	O
is	O
similarly	O
due	O
to	O
reduced	O
proliferation	O
and	O
increase	O
in	O
apoptosis	O
,	O
lack	O
of	O
replacement	O
by	O
bone	O
,	O
or	O
a	O
combination	O
of	O
these	O
.	O

It	O
is	O
possible	O
that	O
a	O
triple	O
mutant	O
removing	O
BMP2	O
,	O
BMP4	O
,	O
and	O
BMP7	O
activities	O
would	O
have	O
a	O
similar	O
phenotype	O
as	O
the	O
BmprIa	O
,	O
BmprIb	O
double	O
mutant	O
,	O
although	O
these	O
could	O
also	O
be	O
compensated	O
from	O
other	O
BMPs	O
.	O

We	O
do	O
know	O
,	O
however	O
,	O
that	O
osteogenesis	O
is	O
defective	O
in	O
these	O
mice	O
,	O
although	O
bone	O
formation	O
proceeds	O
normally	O
in	O
siblings	O
retaining	O
one	O
functional	O
copy	O
of	O
either	O
the	O
Bmp2	O
or	O
Bmp4	O
gene	O
(	O
Figure	O
S4	O
)	O
,	O
as	O
it	O
does	O
in	O
mice	O
completely	O
deficient	O
in	O
BMP2	O
and	O
BMP7	O
(	O
Figures	O
1	O
and	O
S2	O
)	O
.	O

The	O
phenotype	O
we	O
observe	O
in	O
limbs	O
of	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mice	O
is	O
similar	O
to	O
the	O
phenotype	O
reported	O
for	O
osterix	O
knockout	O
mice	O
[	O
46	O
]	O
,	O
which	O
exhibited	O
severe	O
defects	O
in	O
osteoblastic	O
differentiation	O
.	O

Since	O
we	O
observe	O
fibroblastic	O
cells	O
adjacent	O
to	O
mineralized	O
cartilage	O
that	O
have	O
characteristics	O
of	O
osteoprogenitor	O
cells	O
but	O
fail	O
to	O
express	O
osterix	O
in	O
the	O
absence	O
of	O
both	O
BMP2	O
and	O
BMP4	O
,	O
one	O
important	O
role	O
of	O
BMP2	O
and	O
BMP4	O
during	O
endochondral	O
ossification	O
may	O
be	O
to	O
induce	O
osterix	O
gene	O
expression	O
in	O
osteoprogenitors	O
.	O

Strikingly	O
,	O
however	O
,	O
we	O
do	O
observe	O
osterix	O
expression	O
in	O
the	O
bone	O
collar	O
of	O
E16	O
.	O
5	O
mice	O
missing	O
functional	O
copies	O
of	O
both	O
the	O
Bmp2	O
and	O
Bmp4	O
genes	O
(	O
K	O
.	O
Tsuji	O
and	O
A	O
.	O
Bandyopadhyay	O
,	O
unpublished	O
data	O
)	O
.	O

This	O
suggests	O
that	O
varying	O
levels	O
of	O
expression	O
from	O
different	O
BMP	O
genes	O
during	O
preaxial	O
and	O
postaxial	O
development	O
result	O
in	O
fluctuations	O
in	O
total	O
levels	O
of	O
BMP	O
signaling	O
,	O
which	O
at	O
distinct	O
times	O
are	O
above	O
or	O
below	O
the	O
threshold	O
for	O
supporting	O
osteogenesis	O
.	O

While	O
many	O
osteogenic	O
BMP	O
molecules	B-CHEBI
,	O
apart	O
from	O
BMP2	O
and	O
BMP4	O
,	O
such	O
as	O
BMP5	O
,	O
BMP6	O
,	O
and	O
BMP7	O
,	O
are	O
expressed	O
during	O
the	O
endochondral	O
process	O
,	O
our	O
data	O
suggest	O
that	O
these	O
BMP	O
molecules	B-CHEBI
cannot	O
compensate	O
for	O
the	O
combined	O
loss	O
of	O
BMP2	O
and	O
BMP4	O
in	O
bone	O
formation	O
.	O

Recent	O
biochemical	O
and	O
genetic	O
experiments	O
have	O
suggested	O
that	O
individual	O
BMPs	O
have	O
identical	O
functions	O
.	O

BMP2	O
,	O
BMP4	O
,	O
BMP5	O
,	O
BMP6	O
,	O
and	O
BMP7	O
can	O
utilize	O
the	O
same	O
type	O
I	O
(	O
Alk2	O
,	O
Alk3	O
,	O
and	O
Alk6	O
)	O
and	O
type	O
II	O
receptors	O
(	O
BMP	O
RII	O
,	O
ActRII	O
,	O
and	O
ActRIIb	O
)	O
[	O
47	O
]	O
.	O

Once	O
the	O
complex	O
between	O
ligand	O
and	O
receptors	O
is	O
formed	O
,	O
BMP2	O
,	O
BMP4	O
,	O
BMP5	O
,	O
BMP6	O
,	O
and	O
BMP7	O
direct	O
the	O
phosphorylation	O
of	O
the	O
same	O
set	O
of	O
BMP	O
receptor	O
-	O
specific	O
Smads	O
(	O
1	O
,	O
5	O
,	O
or	O
8	O
)	O
,	O
and	O
the	O
signal	O
that	O
is	O
transduced	O
by	O
each	O
BMP	O
appears	O
to	O
be	O
identical	O
in	O
the	O
skeletal	O
target	O
cells	O
[	O
48	O
-	O
51	O
]	O
.	O

BMPs	O
have	O
also	O
been	O
shown	O
to	O
activate	O
MAPK	O
and	O
AKT	O
pathways	O
and	O
,	O
based	O
on	O
current	O
published	O
information	O
,	O
each	O
of	O
the	O
osteogenic	O
BMPs	O
appears	O
to	O
have	O
the	O
same	O
capacity	O
to	O
activate	O
these	O
signaling	O
pathways	O
[	O
52	O
-	O
54	O
]	O
.	O

When	O
this	O
information	O
is	O
considered	O
along	O
with	O
our	O
observation	O
that	O
one	O
allele	O
of	O
either	O
Bmp2	O
or	O
Bmp4	O
can	O
rescue	O
the	O
osteoblast	O
differentiation	O
phenotype	O
observed	O
in	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mice	O
(	O
see	O
Figures	O
1I	O
,	O
1J	O
,	O
1Q	O
,	O
and	O
1R	O
and	O
S4	O
)	O
,	O
we	O
favor	O
the	O
hypothesis	O
that	O
bone	O
formation	O
requires	O
a	O
threshold	O
amount	O
of	O
BMP	O
signaling	O
which	O
is	O
not	O
met	O
when	O
both	O
BMP2	O
and	O
BMP4	O
are	O
completely	O
absent	O
.	O

We	O
cannot	O
,	O
however	O
,	O
exclude	O
the	O
possibility	O
that	O
BMP2	O
and	O
BMP4	O
have	O
distinct	O
functions	O
in	O
osteoblastogenesis	O
.	O

Our	O
analysis	O
of	O
skeletogenesis	O
indicates	O
that	O
BMP2	O
and	O
BMP4	O
are	O
prerequisite	O
for	O
osteoblastogenesis	O
while	O
less	O
important	O
for	O
chondrogenesis	O
.	O

These	O
studies	O
provide	O
the	O
first	O
evidence	O
linking	O
BMP2	O
and	O
BMP4	O
with	O
bone	O
formation	O
in	O
an	O
in	O
vivo	O
setting	O
where	O
the	O
preceding	O
events	O
of	O
chondrogenesis	O
are	O
not	O
compromised	O
.	O

Materials	O
and	O
Methods	O

Reagents	B-CHEBI
.	O

Xylene	B-CHEBI
,	O
formamide	B-CHEBI
,	O
and	O
acetic	B-CHEBI
anhydride	I-CHEBI
were	O
purchased	O
from	O
Fisher	O
Scientific	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
fishersci	O
.	O
com	O
)	O
.	O

Alizarin	B-CHEBI
red	I-CHEBI
S	O
,	O
toluidine	O
blue	O
,	O
paraformaldehyde	O
,	O
polyvinylpyrrolidone	O
,	O
proteinase	O
K	O
,	O
RNase	O
A	O
,	O
tRNA	B-CHEBI
,	O
and	O
dithiothreitol	B-CHEBI
were	O
purchased	O
from	O
Sigma	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
sigmaaldrich	O
.	O
com	O
)	O
.	O

Alcian	O
blue	O
8GX	O
was	O
purchased	O
from	O
Electron	B-CHEBI
Microscopy	O
Science	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
emsdiasum	O
.	O
com	O
)	O
.	O

Dextran	B-CHEBI
sulfate	I-CHEBI
was	O
purchased	O
from	O
Pharmacia	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
pharmacia	O
.	O
com	O
)	O
.	O

Generation	O
of	O
Bmp2	O
and	O
Bmp4	O
conditional	O
null	O
allele	O
.	O

Mice	O
carrying	O
floxed	O
Bmp2	O
allele	O
were	O
available	O
through	O
a	O
material	O
transfer	O
agreement	O
between	O
Harvard	O
University	O
and	O
Wyeth	O
Pharmaceuticals	B-CHEBI
.	O

In	O
these	O
mice	O
,	O
LoxP	O
sites	O
were	O
integrated	O
to	O
excise	O
the	O
entire	O
protein	B-CHEBI
-	O
coding	O
region	O
in	O
exon	O
3	O
of	O
the	O
Bmp2	O
gene	O
.	O

Generation	O
of	O
Bmp4	O
conditional	O
allele	O
has	O
been	O
described	O
[	O
16	O
,	O
55	O
]	O
.	O

The	O
Prx1	O
:	O
:	O
cre	O
transgene	O
has	O
been	O
described	O
[	O
32	O
]	O
.	O

Generation	O
of	O
Bmp2	O
,	O
Bmp4	O
double	O
conditional	O
mice	O
and	O
Bmp2	O
conditional	O
,	O
Bmp7	O
mutant	O
mice	O
.	O

Bmp2C	O
/	O
C	O
animals	O
were	O
crossed	O
with	O
Bmp4C	O
/	O
C	O
animals	O
to	O
generate	O
Bmp2C	O
/	O
+	O
;	O
Bmp4C	O
/	O
+	O
animals	O
.	O

These	O
animals	O
were	O
crossed	O
with	O
Bmp2C	O
/	O
C	O
or	O
Bmp4C	O
/	O
C	O
animals	O
to	O
generate	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
+	O
or	O
Bmp2C	O
/	O
+	O
;	O
Bmp4C	O
/	O
C	O
animals	O
,	O
respectively	O
.	O

Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
+	O
or	O
Bmp2C	O
/	O
+	O
;	O
Bmp4C	O
/	O
C	O
animals	O
were	O
crossed	O
with	O
each	O
other	O
to	O
generate	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
animals	O
.	O

Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
females	O
were	O
crossed	O
with	O
males	O
bearing	O
Prx1	O
:	O
:	O
cre	O
transgene	O
to	O
generate	O
Bmp2C	O
/	O
+	O
;	O
Bmp4C	O
/	O
+	O
;	O
Prx1	O
:	O
:	O
cre	O
animals	O
.	O

Bmp2C	O
/	O
+	O
;	O
Bmp4C	O
/	O
+	O
;	O
Prx1	O
:	O
:	O
cre	O
males	O
were	O
crossed	O
with	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
females	O
to	O
generate	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
animals	O
.	O

Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
mice	O
carrying	O
floxed	O
alleles	O
of	O
the	O
Bmp	O
genes	O
without	O
Prx1	O
:	O
:	O
cre	O
are	O
wild	O
-	O
type	O
(	O
WT	O
)	O
.	O

Genotyping	O
of	O
animals	O
were	O
done	O
by	O
PCR	O
analyses	O
with	O
the	O
primers	O
(	O
5	O
'	O
-	O
3	O
'	O
)	O
GTGTGGTCCACCGCATCAC	O
(	O
AHP2	O
-	O
9	O
)	O
and	O
GGCAGACATTGTATCTCTAGG	O
(	O
AHP2	O
-	O
35	O
)	O
for	O
Bmp2	O
and	O
AGACTCTTTAGTGAGCATTTTCAAC	O
(	O
No	O
.	O
79	O
[	O
order	O
of	O
primers	O
tried	O
]	O
)	O
and	O
AGCCCAATTTCCACAACTTC	O
(	O
No	O
.	O
80	O
)	O
for	O
Bmp4	O
following	O
extraction	O
of	O
genomic	O
DNA	O
from	O
embryonic	O
or	O
adult	O
tail	O
.	O

For	O
Bmp2	O
,	O
the	O
floxed	O
allele	O
amplifies	O
as	O
a	O
545	O
-	O
bp	O
product	O
,	O
while	O
the	O
wild	O
-	O
type	O
allele	O
amplifies	O
as	O
a	O
474	O
-	O
bp	O
product	O
.	O

For	O
Bmp4	O
,	O
the	O
floxed	O
allele	O
amplifies	O
as	O
a	O
220	O
-	O
bp	O
product	O
,	O
while	O
the	O
wild	O
-	O
type	O
allele	O
amplifies	O
as	O
a	O
180	O
-	O
bp	O
product	O
.	O

Protocols	O
utilized	O
for	O
mouse	O
experiments	O
were	O
approved	O
by	O
the	O
Harvard	O
University	O
Institutional	O
Animal	O
Care	O
and	O
Use	O
Committee	O
(	O
Cliff	O
Tabin	O
#	O
02735	O
)	O
.	O

The	O
strategy	O
for	O
generating	O
a	O
Bmp2	O
conditional	O
null	O
in	O
the	O
BMP7	O
-	O
/	O
-	O
background	O
is	O
similar	O
to	O
the	O
strategy	O
used	O
for	O
generating	O
the	O
Bmp2	O
,	O
Bmp4	O
double	O
conditional	O
allele	O
with	O
three	O
important	O
differences	O
.	O

First	O
,	O
the	O
Bmp7	O
-	O
/	O
-	O
(	O
strain	O
kindly	O
donated	O
by	O
Dr	O
.	O
Liz	O
Robertson	O
[	O
12	O
]	O
)	O
is	O
not	O
a	O
conditional	O
allele	O
but	O
a	O
null	O
mutation	O
.	O

Second	O
,	O
Bmp7	O
-	O
/	O
-	O
mice	O
do	O
not	O
survive	O
past	O
birth	O
due	O
to	O
kidney	O
failure	O
[	O
12	O
]	O
and	O
hence	O
cannot	O
be	O
maintained	O
as	O
homozygous	O
for	O
the	O
null	O
allele	O
.	O

Third	O
,	O
Bmp2	O
and	O
Bmp7	O
are	O
on	O
the	O
same	O
chromosome	O
(	O
Chromosome	O
2	O
)	O
.	O

To	O
obtain	O
Bmp2C	O
/	O
C	O
,	O
Bmp7	O
-	O
/	O
-	O
;	O
Prx1	O
:	O
:	O
cre	O
we	O
crossed	O
Bmp2C	O
/	O
C	O
,	O
Bmp7	O
-	O
/	O
+	O
females	O
with	O
Bmp2C	O
/	O
+	O
,	O
Bmp7	O
-	O
/	O
+	O
;	O
Prx1	O
:	O
:	O
cre	O
males	O
.	O

Bmp2C	O
/	O
C	O
,	O
Bmp7	O
-	O
/	O
-	O
;	O
Prx1	O
:	O
:	O
cre	O
progeny	O
were	O
obtained	O
at	O
a	O
rate	O
slightly	O
higher	O
than	O
1	O
in	O
16	O
.	O

For	O
genotyping	O
of	O
Bmp7	O
locus	O
we	O
used	O
the	O
following	O
set	O
of	O
primers	O
:	O
Bmp7	O
_	O
ExI	O
_	O
5	O
'	O
(	O
5	O
'	O
-	O
3	O
'	O
)	O
TCGCCTGCAGCAAGTGACCTCGGGTC	O
;	O
Bmp7	O
_	O
ExI	O
_	O
3	O
'	O
(	O
5	O
'	O
-	O
3	O
'	O
)	O
TAGGGGTAGGAGAAGCCCTGTCCGTCC	O
and	O
Beta	O
-	O
geo	O
5	O
'	O
of	O
3	O
'	O
(	O
5	O
'	O
-	O
3	O
'	O
)	O
CTGCATACGCTTGATCCGGCTACCTGC	O
.	O

From	O
a	O
wild	O
-	O
type	O
chromosome	O
Bmp7	O
_	O
ExI	O
_	O
5	O
'	O
and	O
Bmp7	O
_	O
ExI	O
_	O
3	O
'	O
amplifies	O
an	O
approximately	O
423	O
-	O
bp	O
PCR	O
product	O
,	O
while	O
from	O
the	O
lacZ	O
insertion	O
mutant	O
this	O
pair	O
fails	O
to	O
amplify	O
any	O
product	O
.	O

Bmp7	O
_	O
ExI	O
_	O
5	O
'	O
and	O
Beta	O
-	O
geo	O
5	O
'	O
of	O
3	O
'	O
(	O
this	O
primer	O
is	O
designed	O
from	O
the	O
Beta	O
-	O
geo	O
cassette	O
)	O
amplifies	O
an	O
approximately	O
1	O
-	O
kb	O
PCR	O
product	O
from	O
the	O
lacZ	O
inserted	O
chromosome	O
.	O

Skeletal	O
analysis	O
.	O

Our	O
protocol	O
is	O
an	O
adaptation	O
of	O
the	O
procedure	O
described	O
[	O
56	O
]	O
previously	O
.	O

Newborn	O
and	O
older	O
animals	O
were	O
killed	O
using	O
carbon	B-CHEBI
dioxide	I-CHEBI
.	O

Skin	O
,	O
viscera	O
,	O
and	O
adipose	O
tissues	O
were	O
removed	O
within	O
2	O
h	O
after	O
death	O
,	O
and	O
samples	O
were	O
fixed	O
in	O
95	O
%	O
ethanol	B-CHEBI
for	O
5	O
d	O
.	O

Samples	O
were	O
then	O
placed	O
in	O
acetone	B-CHEBI
to	O
remove	O
residual	O
fat	O
for	O
2	O
d	O
.	O

For	O
E13	O
.	O
5	O
embryos	O
,	O
skin	O
was	O
not	O
removed	O
.	O

The	O
dehydrated	O
animals	O
were	O
stained	O
with	O
0	O
.	O
015	O
%	O
w	O
/	O
v	O
Alcian	O
blue	O
and	O
0	O
.	O
005	O
%	O
w	O
/	O
v	O
Alizarin	B-CHEBI
red	I-CHEBI
in	O
a	O
1	O
:	O
19	O
mixture	O
of	O
glacial	O
acetic	B-CHEBI
acid	I-CHEBI
and	O
70	O
%	O
ethanol	B-CHEBI
.	O

The	O
younger	O
animals	O
were	O
stained	O
for	O
5	O
h	O
at	O
37	O
degrees	O
C	O
and	O
then	O
overnight	O
at	O
room	O
temperature	O
,	O
while	O
the	O
newborns	O
were	O
stained	O
overnight	O
at	O
37	O
degrees	O
C	O
followed	O
by	O
2	O
d	O
at	O
room	O
temperature	O
.	O

The	O
stained	O
skeletons	O
were	O
kept	O
in	O
1	O
%	O
KOH	B-CHEBI
,	O
with	O
occasional	O
change	O
of	O
solution	O
,	O
until	O
cleared	O
.	O

The	O
cleared	O
skeletons	O
were	O
transferred	O
into	O
100	O
%	O
glycerol	B-CHEBI
and	O
photographed	O
.	O

Acridine	B-CHEBI
orange	O
staining	O
for	O
apoptotic	O
cells	O
.	O

A	O
working	O
stock	O
of	O
5	O
mg	O
/	O
ml	O
acridine	B-CHEBI
orange	O
was	O
diluted	O
1	O
:	O
10	O
,	O
000	O
in	O
PBS	O
.	O

Dissected	O
fresh	O
embryos	O
were	O
transferred	O
to	O
the	O
working	O
solution	O
of	O
acridine	B-CHEBI
orange	O
and	O
incubated	O
for	O
30	O
min	O
at	O
37	O
degrees	O
C	O
in	O
the	O
dark	O
.	O

Embryos	O
were	O
then	O
washed	O
twice	O
in	O
PBS	O
for	O
5	O
min	O
and	O
viewed	O
with	O
a	O
fluorescence	O
microscope	O
.	O

Whole	O
mount	O
in	O
situ	O
hybridization	O
.	O

In	O
situ	O
hybridization	O
staining	O
on	O
whole	O
embryos	O
was	O
performed	O
as	O
described	O
[	O
57	O
]	O
.	O

For	O
section	O
in	O
situ	O
hybridizations	O
,	O
please	O
see	O
below	O
.	O

Histology	O
,	O
section	O
in	O
situ	O
hybridizations	O
,	O
and	O
immunohistochemistry	O
.	O

For	O
histology	O
and	O
section	O
in	O
situ	O
hybridization	O
,	O
samples	O
were	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
in	O
PBS	O
at	O
4	O
degrees	O
C	O
overnight	O
.	O

Newborn	O
and	O
older	O
animals	O
were	O
then	O
decalcified	O
in	O
Tris	B-CHEBI
buffer	O
containing	O
10	O
%	O
EDTA	B-CHEBI
and	O
7	O
.	O
5	O
%	O
polyvinylpyrrolidone	O
(	O
pH	O
7	O
.	O
5	O
)	O
at	O
4	O
degrees	O
C	O
for	O
3	O
wks	O
.	O

Samples	O
were	O
then	O
dehydrated	O
through	O
a	O
graded	O
ethanol	B-CHEBI
series	O
,	O
cleared	O
in	O
xylene	B-CHEBI
,	O
and	O
embedded	O
in	O
paraffin	O
.	O

8	O
mu	O
m	O
sections	O
were	O
collected	O
and	O
stained	O
with	O
hematoxylin	O
and	O
eosin	O
(	O
H	O
&	O
E	O
)	O
or	O
toluidine	O
blue	O
following	O
standard	O
procedure	O
.	O

Section	O
in	O
situ	O
hybridization	O
with	O
digoxigenin	B-CHEBI
labeled	O
probes	O
was	O
performed	O
as	O
described	O
[	O
57	O
]	O
.	O

Section	O
in	O
situ	O
hybridization	O
with	O
radiolabeled	B-CHEBI
probes	O
was	O
performed	O
as	O
described	O
[	O
58	O
]	O
with	O
a	O
small	O
modification	O
.	O

Briefly	O
,	O
sections	O
were	O
deparaffinized	O
in	O
xylene	B-CHEBI
and	O
rehydrated	O
through	O
a	O
graded	O
ethanol	B-CHEBI
series	O
.	O

Sections	O
were	O
postfixed	O
in	O
4	O
%	O
paraformaldehyde	O
in	O
PBS	O
at	O
room	O
temperature	O
for	O
15	O
min	O
,	O
digested	O
with	O
10	O
mu	O
g	O
/	O
ml	O
proteinase	O
K	O
at	O
room	O
temperature	O
for	O
10	O
min	O
,	O
and	O
again	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
at	O
room	O
temperature	O
for	O
10	O
min	O
and	O
acetylated	O
in	O
the	O
solution	O
containing	O
0	O
.	O
2	O
%	O
hydrochloric	B-CHEBI
acid	I-CHEBI
,	O
0	O
.	O
1	O
M	O
triethanol	B-CHEBI
amine	I-CHEBI
,	O
and	O
0	O
.	O
25	O
%	O
acetic	B-CHEBI
anhydride	I-CHEBI
at	O
room	O
temperature	O
for	O
10	O
min	O
.	O

Sections	O
were	O
then	O
dehydrated	O
in	O
increasing	O
concentrations	O
of	O
ethanol	B-CHEBI
and	O
air	O
-	O
dried	O
.	O

Hybridization	O
was	O
performed	O
in	O
a	O
humidified	O
chamber	O
in	O
a	O
solution	O
containing	O
50	O
%	O
formamide	B-CHEBI
,	O
10	O
%	O
dextran	B-CHEBI
sulfate	I-CHEBI
,	O
1	O
x	O
Denhardt	O
'	O
s	O
solution	O
,	O
0	O
.	O
6	O
M	O
sodium	B-CHEBI
chloride	I-CHEBI
,	O
0	O
.	O
01	O
M	O
Tris	B-CHEBI
buffer	O
(	O
pH	O
7	O
.	O
5	O
)	O
,	O
0	O
.	O
001	O
M	O
EDTA	B-CHEBI
,	O
0	O
.	O
05	O
M	O
dithiothreitol	B-CHEBI
,	O
0	O
.	O
25	O
%	O
SDS	B-CHEBI
,	O
200	O
mu	O
g	O
tRNA	B-CHEBI
,	O
and	O
35S	B-CHEBI
-	O
labeled	O
cRNA	O
probe	O
at	O
the	O
final	O
concentration	O
of	O
5	O
x	O
106	O
cpm	O
/	O
ml	O
at	O
55	O
degrees	O
C	O
for	O
16	O
h	O
.	O

After	O
hybridization	O
,	O
sections	O
were	O
washed	O
with	O
a	O
solution	O
containing	O
5	O
x	O
SSC	O
and	O
10	O
mM	O
dithiothreitol	B-CHEBI
at	O
50	O
degrees	O
C	O
for	O
30	O
min	O
,	O
incubated	O
in	O
a	O
solution	O
containing	O
50	O
%	O
formamide	B-CHEBI
,	O
2	O
x	O
SSC	O
,	O
and	O
10	O
mM	O
dithiothreitol	B-CHEBI
at	O
65	O
degrees	O
C	O
for	O
30	O
min	O
,	O
treated	O
in	O
a	O
solution	O
containing	O
10	O
mu	O
g	O
/	O
ml	O
RNase	O
A	O
in	O
TNE	O
[	O
0	O
.	O
01	O
M	O
Tris	B-CHEBI
buffer	O
(	O
pH	O
7	O
.	O
6	O
)	O
,	O
0	O
.	O
5	O
M	O
sodium	B-CHEBI
chloride	I-CHEBI
,	O
and	O
0	O
.	O
001	O
M	O
EDTA	B-CHEBI
]	O
at	O
37	O
degrees	O
C	O
for	O
30	O
min	O
and	O
then	O
washed	O
with	O
50	O
%	O
formamide	B-CHEBI
,	O
2	O
x	O
SSC	O
,	O
and	O
10	O
mM	O
dithiothreitol	B-CHEBI
at	O
65	O
degrees	O
C	O
for	O
an	O
additional	O
30	O
min	O
followed	O
by	O
two	O
washes	O
with	O
2	O
x	O
SSC	O
/	O
10	O
mM	O
dithiothreitol	B-CHEBI
at	O
65	O
degrees	O
C	O
for	O
30	O
min	O
,	O
and	O
0	O
.	O
1	O
x	O
SSC	O
/	O
10	O
mM	O
dithiothreitol	B-CHEBI
at	O
65	O
degrees	O
C	O
for	O
30	O
min	O
.	O

To	O
visualize	O
the	O
signal	O
,	O
sections	O
were	O
dipped	O
into	O
NTB	O
-	O
2	O
emulsion	O
(	O
Kodak	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
Kodak	O
.	O
com	O
)	O
and	O
placed	O
at	O
4	O
degrees	O
C	O
.	O

After	O
developing	O
,	O
sections	O
were	O
counterstained	O
with	O
H	O
&	O
E	O
.	O

The	O
35S	B-CHEBI
-	O
labeled	O
cRNA	O
probes	O
were	O
transcribed	O
from	O
plasmids	O
encoding	O
type	O
I	O
collagen	O
[	O
59	O
]	O
,	O
runx2	O
[	O
60	O
]	O
,	O
osteopontin	O
[	O
61	O
]	O
,	O
and	O
osterix	O
[	O
46	O
]	O
.	O

Sense	O
and	O
antisense	O
probes	O
were	O
synthesized	O
from	O
linearized	O
plasmids	O
using	O
a	O
Riboprobe	O
Combination	O
System	O
(	O
Promega	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
promega	O
.	O
com	O
)	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Chondrogenic	O
Differentiation	O
in	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
Animals	O

(	O
A	O
-	O
C	O
)	O
In	O
BMP2	O
,	O
BMP4	O
-	O
deficient	O
limbs	O
,	O
there	O
is	O
only	O
one	O
zeugopod	O
present	O
,	O
and	O
it	O
is	O
often	O
fused	O
with	O
the	O
stylopod	O
.	O

All	O
panels	O
are	O
from	O
E17	O
.	O
5	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
embryos	O
.	O

(	O
A	O
)	O
Hematoxylin	O
and	O
eosin	O
-	O
stained	O
section	O
of	O
the	O
forelimb	O
.	O

Alcian	O
blue	O
-	O
and	O
Alizarin	B-CHEBI
red	I-CHEBI
-	O
stained	O
skeletons	O
shown	O
in	O
(	O
B	O
)	O
(	O
forelimb	O
)	O
and	O
(	O
C	O
)	O
(	O
hindlimb	O
)	O
.	O

Black	O
arrow	O
shows	O
the	O
fusion	O
of	O
the	O
zeugopod	O
and	O
stylopod	O
in	O
BMP2	O
,	O
BMP4	O
-	O
deficient	O
limbs	O
.	O

(	O
D	O
and	O
E	O
)	O
Acridine	B-CHEBI
orange	O
-	O
stained	O
limbs	O
from	O
E11	O
.	O
5	O
wild	O
-	O
type	O
(	O
D	O
)	O
and	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
embryos	O
(	O
E	O
)	O
.	O

(	O
F	O
and	O
G	O
)	O
Acridine	B-CHEBI
orange	O
-	O
stained	O
hindlimbs	O
from	O
E13	O
.	O
5	O
wild	O
-	O
type	O
(	O
F	O
)	O
and	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
(	O
G	O
)	O
embryos	O
.	O

(	O
H	O
-	O
M	O
)	O
In	O
the	O
absence	O
of	O
BMP2	O
and	O
BMP4	O
,	O
condensation	O
begins	O
in	O
the	O
limb	O
normally	O
.	O

Whole	O
mount	O
in	O
situ	O
staining	O
of	O
Sox9	O
mRNA	B-CHEBI
in	O
embryonic	O
limb	O
buds	O
from	O
E10	O
.	O
5	O
(	O
H	O
and	O
I	O
)	O
and	O
E11	O
.	O
5	O
(	O
J	O
-	O
M	O
)	O
embryos	O
.	O

(	O
H	O
,	O
J	O
,	O
and	O
L	O
)	O
From	O
wild	O
-	O
type	O
embryos	O
,	O
(	O
I	O
,	O
K	O
,	O
and	O
M	O
)	O
from	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
embryos	O
.	O

(	O
H	O
,	O
I	O
,	O
J	O
,	O
and	O
K	O
)	O
Forelimbs	O
,	O
(	O
L	O
and	O
M	O
)	O
hindlimbs	O
.	O

(	O
N	O
and	O
O	O
)	O
In	O
situ	O
hybridizations	O
with	O
Col	O
II	O
mRNA	B-CHEBI
probes	O
of	O
sections	O
derived	O
from	O
E12	O
.	O
5	O
wild	O
-	O
type	O
(	O
N	O
)	O
and	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
(	O
O	O
)	O
embryos	O
.	O

(	O
P	O
-	O
S	O
)	O
Bmp6	O
mRNA	B-CHEBI
expression	O
is	O
not	O
increased	O
in	O
E13	O
.	O
5	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
cartilage	O
.	O

Bmp6	O
in	O
situ	O
on	O
sagittal	O
sections	O
from	O
wild	O
-	O
type	O
(	O
Q	O
)	O
and	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
(	O
S	O
)	O
embryonic	O
forelimbs	O
.	O

(	O
P	O
and	O
R	O
)	O
Bright	O
field	O
images	O
of	O
(	O
Q	O
)	O
and	O
(	O
S	O
)	O
,	O
respectively	O
.	O

(	O
23	O
MB	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

Skeletal	O
Differentiation	O
Occurs	O
Normally	O
in	O
Absence	O
of	O
BMP2	O

(	O
A	O
)	O
Toluidine	O
blue	O
-	O
stained	O
section	O
of	O
newborn	O
femurs	O
from	O
Bmp2C	O
/	O
C	O
animals	O
.	O

(	O
B	O
-	O
D	O
)	O
Marker	O
analyses	O
.	O

Sections	O
of	O
femurs	O
from	O
Bmp2C	O
/	O
C	O
animals	O
hybridized	O
with	O
Col	O
II	O
(	O
B	O
)	O
,	O
Col	O
X	O
(	O
C	O
)	O
,	O
and	O
Col	O
I	O
(	O
D	O
)	O
mRNA	B-CHEBI
probes	O
.	O

(	O
E	O
)	O
Toluidine	O
blue	O
-	O
stained	O
section	O
of	O
newborn	O
femurs	O
from	O
Bmp2C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
animals	O
.	O

(	O
F	O
-	O
H	O
)	O
Marker	O
analyses	O
.	O

Sections	O
of	O
femurs	O
from	O
Bmp2C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
animals	O
hybridized	O
with	O
Col	O
II	O
(	O
F	O
)	O
,	O
Col	O
X	O
(	O
G	O
)	O
,	O
and	O
Col	O
I	O
(	O
H	O
)	O
mRNA	B-CHEBI
probes	O
.	O

(	O
15	O
MB	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

BMP2	O
,	O
BMP4	O
-	O
Deficient	O
Limb	O
Skeleton	O
Is	O
Resorbed	O

Alcian	O
blue	O
-	O
and	O
Alizarin	B-CHEBI
red	I-CHEBI
-	O
stained	O
skeletons	O
of	O
forelimbs	O
(	O
A	O
-	O
D	O
)	O
and	O
hindlimbs	O
(	O
E	O
-	O
F	O
)	O
from	O
1	O
-	O
wk	O
-	O
old	O
(	O
A	O
,	O
B	O
,	O
E	O
,	O
and	O
F	O
)	O
and	O
3	O
-	O
wk	O
-	O
old	O
(	O
C	O
and	O
D	O
)	O
animals	O
.	O

(	O
A	O
,	O
C	O
,	O
and	O
E	O
)	O
Wild	O
-	O
type	O
animals	O
,	O
(	O
B	O
,	O
D	O
,	O
and	O
F	O
)	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
animals	O
.	O

The	O
limbs	O
of	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
(	O
H	O
)	O
animals	O
are	O
severely	O
defective	O
compared	O
to	O
a	O
wild	O
-	O
type	O
(	O
G	O
)	O
animal	O
at	O
1	O
wk	O
of	O
age	O
.	O

Please	O
note	O
that	O
the	O
proximal	O
part	O
of	O
the	O
femur	O
is	O
present	O
at	O
1	O
wk	O
of	O
age	O
but	O
missing	O
at	O
3	O
wks	O
(	O
refer	O
to	O
Figure	O
6L	O
)	O
.	O

(	O
12	O
MB	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S4	O

Osteogenesis	O
Occurs	O
in	O
Mice	O
Lacking	O
Three	O
of	O
Four	O
Alleles	O
of	O
Bmp2	O
and	O
Bmp4	O
Combined	O

Toluidine	O
blue	O
-	O
stained	O
sections	O
of	O
femurs	O
from	O
adult	O
control	O
,	O
Bmp2C	O
/	O
+	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
,	O
and	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
+	O
;	O
Prx1	O
:	O
:	O
cre	O
animals	O
.	O

(	O
11	O
MB	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Acknowledgements	O

We	O
thank	O
Dr	O
.	O
Andy	O
Dudley	O
for	O
his	O
help	O
in	O
designing	O
mouse	O
genotyping	O
strategies	O
.	O

We	O
also	O
thank	O
Jose	O
Rivera	O
-	O
Feliciano	O
and	O
Dr	O
.	O
Douglas	O
Kim	O
for	O
helpful	O
discussions	O
.	O

We	O
are	O
immensely	O
grateful	O
to	O
Drs	O
.	O

Brigid	O
Hogan	O
and	O
Holger	O
Kulessa	O
for	O
their	O
kind	O
gift	O
of	O
the	O
Bmp4	O
conditional	O
allele	O
and	O
Drs	O
.	O

Liz	O
Robertson	O
and	O
Andy	O
Dudley	O
for	O
the	O
Bmp7	O
knockout	O
allele	O
.	O

We	O
would	O
like	O
to	O
acknowledge	O
the	O
help	O
of	O
Dr	O
.	O
Ernestina	O
Schipani	O
and	O
Jan	O
Saxton	O
for	O
help	O
with	O
histology	O
.	O

This	O
manuscript	O
is	O
dedicated	O
to	O
the	O
memory	O
of	O
Dr	O
.	O
Holger	O
Kulessa	O
,	O
whose	O
efforts	O
contributed	O
to	O
the	O
groundwork	O
for	O
this	O
study	O
and	O
whose	O
dedication	O
and	O
intense	O
commitment	O
to	O
excellence	O
in	O
science	O
are	O
greatly	O
missed	O
.	O

Abbreviations	O

AER	O
-	O
apical	O
ectodermal	O
ridge	O

BMP	O
-	O
bone	O
morphogenetic	O
protein	B-CHEBI

E	O
-	O
embryonic	O
day	O

FGF	O
-	O
fibroblast	O
growth	O
factor	O

SHH	O
-	O
Sonic	O
Hedgehog	O

Shh	O
-	O
sonic	O
hedgehog	O

ZPA	O
-	O
zone	O
of	O
polarizing	O
activity	O

Figures	O
and	O
Tables	O

Figure	O
1	O

An	O
Allelic	O
/	O
Nonallelic	O
Series	O
of	O
BMP	O
-	O
Deficient	O
Limbs	O

(	O
A	O
-	O
D	O
)	O
Prx1	O
:	O
:	O
cre	O
efficiently	O
recombines	O
Bmp2	O
and	O
Bmp4	O
conditional	O
alleles	O
in	O
the	O
limbs	O
.	O

Bmp2	O
(	O
A	O
and	O
B	O
)	O
and	O
Bmp4	O
(	O
C	O
and	O
D	O
)	O
whole	O
mount	O
mRNA	B-CHEBI
in	O
situ	O
hybridization	O
in	O
the	O
limb	O
.	O

Wild	O
-	O
type	O
(	O
A	O
)	O
and	O
Bmp2C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
(	O
B	O
)	O
are	O
forelimbs	O
from	O
E10	O
.	O
5	O
mouse	O
embryos	O
.	O

Mesenchymal	O
expression	O
[	O
asterisk	O
(	O
A	O
)	O
]	O
of	O
Bmp2	O
is	O
abolished	O
in	O
Bmp2C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
embryo	O
while	O
the	O
AER	O
expression	O
[	O
black	O
arrow	O
(	O
A	O
and	O
B	O
)	O
]	O
of	O
Bmp2	O
persists	O
.	O

Note	O
that	O
pink	O
staining	O
in	O
the	O
central	O
region	O
of	O
the	O
limb	O
bud	O
in	O
(	O
B	O
)	O
is	O
nonspecific	O
background	O
.	O

Wild	O
-	O
type	O
(	O
C	O
)	O
and	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
(	O
D	O
)	O
are	O
forelimbs	O
from	O
E10	O
.	O
5	O
mouse	O
embryos	O
.	O

Mesenchymal	O
expression	O
[	O
red	O
arrow	O
(	O
C	O
)	O
]	O
of	O
Bmp4	O
is	O
abolished	O
in	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
embryo	O
while	O
the	O
AER	O
expression	O
[	O
black	O
arrow	O
(	O
C	O
and	O
D	O
)	O
]	O
of	O
Bmp4	O
persists	O
.	O

(	O
E	O
-	O
T	O
)	O
Depletion	O
of	O
BMP2	O
and	O
BMP4	O
together	O
causes	O
severe	O
limb	O
skeletal	O
defects	O
.	O

(	O
E	O
-	O
T	O
)	O
Whole	O
mount	O
skeletons	O
from	O
newborn	O
animals	O
stained	O
with	O
Alcian	O
blue	O
and	O
Alizarin	B-CHEBI
red	I-CHEBI
.	O

(	O
E	O
-	O
L	O
)	O
Forelimbs	O
,	O
(	O
M	O
-	O
T	O
)	O
hindlimbs	O
.	O

(	O
E	O
and	O
M	O
)	O
Wild	O
-	O
type	O
,	O
(	O
F	O
and	O
N	O
)	O
Bmp2C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
,	O
(	O
G	O
and	O
O	O
)	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
,	O
(	O
H	O
and	O
P	O
)	O
Bmp7	O
-	O
/	O
-	O
,	O
(	O
I	O
and	O
Q	O
)	O
Bmp2C	O
/	O
C	O
;	O
Bmp4	O
+	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
,	O
(	O
J	O
and	O
R	O
)	O
Bmp2	O
+	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
,	O
(	O
K	O
and	O
S	O
)	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
,	O
(	O
L	O
and	O
T	O
)	O
Bmp2C	O
/	O
C	O
,	O
Bmp7	O
-	O
/	O
-	O
;	O
Prx1	O
:	O
:	O
cre	O
.	O

Thin	O
red	O
arrow	O
in	O
(	O
F	O
)	O
,	O
(	O
I	O
)	O
,	O
and	O
(	O
L	O
)	O
,	O
defective	O
scapula	O
;	O
thick	O
red	O
arrow	O
in	O
(	O
T	O
)	O
,	O
failure	O
of	O
fibula	O
to	O
articulate	O
with	O
knee	O
,	O
and	O
thick	O
black	O
arrow	O
in	O
(	O
L	O
)	O
and	O
(	O
T	O
)	O
,	O
missing	O
phalanx	O
in	O
digit	O
III	O
.	O

Figure	O
2	O

Depletion	O
of	O
BMP	O
Signaling	O
Causes	O
Interdigital	O
Syndactyly	O

(	O
A	O
-	O
D	O
)	O
Forelimb	O
of	O
adult	O
wild	O
-	O
type	O
(	O
A	O
)	O
and	O
Bmp2C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mouse	O
(	O
B	O
)	O
and	O
hindlimbs	O
of	O
newborn	O
wild	O
-	O
type	O
(	O
C	O
)	O
mouse	O
and	O
newborn	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
(	O
D	O
)	O
mouse	O
.	O

The	O
black	O
arrow	O
in	O
(	O
B	O
)	O
shows	O
soft	O
tissue	O
syndactyly	O
in	O
Bmp2C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mouse	O
.	O

(	O
E	O
and	O
F	O
)	O
Wild	O
-	O
type	O
and	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
,	O
respectively	O
,	O
showing	O
acridine	B-CHEBI
orange	O
-	O
stained	O
hindlimbs	O
of	O
E15	O
.	O
5	O
mouse	O
embryos	O
.	O

Acridine	B-CHEBI
orange	O
stain	O
is	O
in	O
yellow	O
.	O

(	O
G	O
and	O
H	O
)	O
Enlarged	O
views	O
of	O
selected	O
regions	O
from	O
(	O
E	O
)	O
and	O
(	O
F	O
)	O
,	O
respectively	O
.	O

Black	O
arrow	O
in	O
(	O
G	O
)	O
and	O
(	O
H	O
)	O
show	O
acridine	B-CHEBI
orange	O
-	O
stained	O
apoptotic	O
cells	O
in	O
the	O
interdigital	O
mesenchyme	O
,	O
and	O
asterisk	O
in	O
(	O
H	O
)	O
shows	O
the	O
remnant	O
of	O
the	O
AER	O
.	O

(	O
I	O
and	O
J	O
)	O
Fgf8	O
mRNA	B-CHEBI
expression	O
in	O
the	O
hindlimbs	O
of	O
E13	O
.	O
5	O
wild	O
-	O
type	O
(	O
I	O
)	O
and	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
(	O
J	O
)	O
embryos	O
.	O

The	O
thick	O
black	O
arrows	O
in	O
(	O
J	O
)	O
show	O
Fgf8	O
mRNA	B-CHEBI
expression	O
.	O

Figure	O
3	O

Patterning	O
Defects	O
in	O
Limbs	O
Deficient	O
of	O
Different	O
Combinations	O
of	O
BMP	O
Molecules	B-CHEBI

(	O
A	O
-	O
D	O
)	O
Bmp4	O
expression	O
in	O
limb	O
buds	O
from	O
E11	O
.	O
5	O
wild	O
-	O
type	O
(	O
A	O
and	O
C	O
)	O
and	O
Bmp2C	O
/	O
C	O
,	O
Bmp7	O
-	O
/	O
-	O
;	O
Prx1	O
:	O
:	O
cre	O
(	O
B	O
and	O
D	O
)	O
mouse	O
embryos	O
.	O

(	O
A	O
and	O
B	O
)	O
Forelimbs	O
,	O
(	O
C	O
and	O
D	O
)	O
hindlimbs	O
.	O

(	O
E	O
-	O
H	O
)	O
Shh	O
(	O
E	O
and	O
F	O
)	O
and	O
Fgf8	O
(	O
G	O
and	O
H	O
)	O
expression	O
in	O
E11	O
.	O
5	O
forelimbs	O
and	O
hindlimbs	O
,	O
respectively	O
.	O

(	O
E	O
and	O
G	O
)	O
Wild	O
-	O
type	O
embryos	O
,	O
(	O
F	O
and	O
H	O
)	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
embryos	O
.	O

(	O
I	O
-	O
P	O
)	O
Sox9	O
(	O
I	O
-	O
K	O
)	O
and	O
Msx2	O
(	O
M	O
-	O
O	O
)	O
expression	O
in	O
E12	O
.	O
5	O
wild	O
-	O
type	O
(	O
I	O
and	O
M	O
)	O
and	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mouse	O
embryonic	O
forelimbs	O
(	O
J	O
and	O
N	O
)	O
and	O
hindlimbs	O
(	O
K	O
and	O
O	O
)	O
.	O

(	O
L	O
and	O
P	O
)	O
Shh	O
expression	O
in	O
E12	O
.	O
5	O
wild	O
-	O
type	O
(	O
L	O
)	O
and	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
(	O
P	O
)	O
embryonic	O
hindlimbs	O
.	O

The	O
red	O
brackets	O
in	O
(	O
F	O
)	O
and	O
(	O
H	O
)	O
show	O
the	O
broadened	O
domains	O
of	O
expressions	O
of	O
Shh	O
and	O
Fgf8	O
,	O
respectively	O
.	O

Figure	O
4	O

Chondrogenesis	O
Starts	O
and	O
Proceeds	O
Normally	O
Even	O
in	O
the	O
Absence	O
of	O
BMP2	O
and	O
BMP4	O

(	O
A	O
and	O
B	O
)	O
Whole	O
mount	O
skeletons	O
from	O
E13	O
.	O
5	O
embryos	O
that	O
are	O
stained	O
with	O
alcian	O
blue	O
.	O

(	O
A	O
)	O
Wild	O
-	O
type	O
embryo	O
,	O
(	O
B	O
)	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
embryo	O
.	O

Black	O
arrow	O
in	O
(	O
B	O
)	O
shows	O
the	O
fusion	O
of	O
the	O
zeugopod	O
and	O
stylopod	O
.	O

(	O
C	O
and	O
D	O
)	O
Hematoxylin	O
and	O
eosin	O
-	O
stained	O
sagittal	O
sections	O
of	O
humeri	O
from	O
E13	O
.	O
5	O
wild	O
-	O
type	O
(	O
C	O
)	O
and	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
(	O
D	O
)	O
embryos	O
.	O

Thick	O
red	O
arrow	O
in	O
(	O
C	O
)	O
shows	O
the	O
hypertrophic	O
region	O
.	O

(	O
E	O
and	O
F	O
)	O
Sagittal	O
sections	O
of	O
wild	O
-	O
type	O
(	O
E	O
)	O
and	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
(	O
F	O
)	O
humeri	O
from	O
E15	O
.	O
5	O
embryos	O
were	O
hybridized	O
with	O
digoxigenin	B-CHEBI
-	O
labeled	O
antisense	O
rioprobes	O
for	O
ColX	O
.	O

(	O
G	O
and	O
H	O
)	O
Sagittal	O
sections	O
of	O
forelimbs	O
from	O
E13	O
.	O
5	O
wild	O
-	O
type	O
and	O
BMP2	O
,	O
BMP4	O
-	O
deficient	O
embryos	O
,	O
respectively	O
,	O
stained	O
with	O
radioactive	O
riboprobes	O
for	O
Bmp7	O
mRNA	B-CHEBI
.	O

(	O
G	O
'	O
)	O
and	O
(	O
H	O
'	O
)	O
show	O
the	O
bright	O
field	O
views	O
of	O
(	O
G	O
)	O
and	O
(	O
H	O
)	O
,	O
respectively	O
.	O

Figure	O
5	O

In	O
the	O
Absence	O
of	O
BMP2	O
and	O
BMP4	O
,	O
Osteogenesis	O
Begins	O
During	O
Early	O
Embryonic	O
Development	O

(	O
A	O
-	O
D	O
)	O
Sagittal	O
sections	O
of	O
forelimb	O
from	O
E15	O
.	O
5	O
embryos	O
.	O

(	O
A	O
and	O
B	O
)	O
Stained	O
with	O
toluidine	O
blue	O
.	O

(	O
A	O
)	O
Distal	O
ulna	O
from	O
wild	O
-	O
type	O
embryo	O
,	O
(	O
B	O
)	O
distal	O
ulna	O
/	O
radius	O
from	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
embryo	O
.	O

Mineralized	O
cartilage	O
is	O
shown	O
by	O
dark	O
purple	O
and	O
osteoid	O
is	O
shown	O
by	O
light	O
blue	O
(	O
red	O
asterisk	O
)	O
.	O

(	O
C	O
and	O
D	O
)	O
Humeri	O
sections	O
were	O
hybridized	O
with	O
digoxigenin	B-CHEBI
labeled	O
riboprobe	O
for	O
ColI	O
.	O

(	O
C	O
)	O
Section	O
of	O
wild	O
-	O
type	O
humerus	O
from	O
E15	O
.	O
5	O
embryo	O
,	O
(	O
D	O
)	O
from	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
E15	O
.	O
5	O
embryo	O
.	O

(	O
E	O
-	O
H	O
)	O
Sagittal	O
sections	O
of	O
zeugopod	O
from	O
E17	O
.	O
5	O
embryos	O
.	O

(	O
E	O
and	O
F	O
)	O
Stained	O
with	O
toluidine	O
blue	O
while	O
G	O
and	O
H	O
are	O
stained	O
for	O
TRAP	O
(	O
brown	O
stain	O
,	O
red	O
arrow	O
)	O
.	O

(	O
E	O
and	O
G	O
)	O
E17	O
.	O
5	O
proximal	O
radius	O
from	O
wild	O
-	O
type	O
embryo	O
,	O
(	O
F	O
and	O
H	O
)	O
E17	O
.	O
5	O
proximal	O
ulna	O
/	O
radius	O
from	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
embryo	O
.	O

Although	O
vascularization	O
occurs	O
in	O
the	O
absence	O
of	O
BMP2	O
and	O
BMP4	O
,	O
few	O
osteoclasts	O
are	O
observed	O
in	O
the	O
mineralized	O
cartilage	O
in	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mice	O
.	O

Please	O
note	O
all	O
the	O
panels	O
other	O
than	O
(	O
G	O
)	O
and	O
(	O
H	O
)	O
are	O
photographed	O
at	O
x	O
20	O
,	O
while	O
(	O
G	O
)	O
and	O
(	O
H	O
)	O
were	O
photographed	O
at	O
x	O
40	O
.	O

(	O
I	O
and	O
J	O
)	O
Sections	O
of	O
newborn	O
proximal	O
radius	O
(	O
I	O
)	O
from	O
control	O
animal	O
and	O
newborn	O
proximal	O
ulna	O
/	O
radius	O
(	O
J	O
)	O
from	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
animal	O
were	O
stained	O
with	O
toluidine	O
blue	O
.	O

Red	O
arrow	O
shows	O
the	O
bone	O
marrow	O
cavity	O
in	O
(	O
E	O
)	O
and	O
(	O
I	O
)	O
.	O

Note	O
that	O
bone	O
collar	O
(	O
red	O
*	O
)	O
forms	O
at	O
the	O
right	O
time	O
and	O
place	O
in	O
the	O
absence	O
of	O
BMP2	O
and	O
BMP4	O
.	O

Also	O
note	O
that	O
since	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mice	O
occasionally	O
have	O
only	O
one	O
bone	O
in	O
zeugopod	O
and	O
the	O
elbow	O
joint	O
is	O
occasionally	O
fused	O
,	O
it	O
is	O
difficult	O
to	O
distinguish	O
between	O
the	O
ulna	O
and	O
the	O
radius	O
.	O

Figure	O
6	O

Defects	O
in	O
Bone	O
Formation	O
in	O
the	O
Absence	O
of	O
BMP2	O
and	O
BMP4	O

Toluidine	O
blue	O
staining	O
of	O
sagittal	O
sections	O
of	O
distal	O
femurs	O
.	O

(	O
A	O
-	O
E	O
)	O
Control	O
femurs	O
at	O
1	O
wk	O
(	O
A	O
)	O
and	O
3	O
wks	O
(	O
D	O
)	O
of	O
age	O
.	O

Boxed	O
areas	O
in	O
(	O
A	O
)	O
are	O
enlarged	O
in	O
(	O
B	O
)	O
and	O
(	O
C	O
)	O
.	O

Boxed	O
area	O
in	O
(	O
D	O
)	O
is	O
enlarged	O
in	O
(	O
E	O
)	O
.	O

Blue	O
arrows	O
in	O
(	O
C	O
)	O
point	O
to	O
osteoblast	O
cells	O
lining	O
the	O
surface	O
of	O
cortical	O
bone	O
.	O

Pink	O
arrows	O
in	O
(	O
G	O
)	O
show	O
similar	O
cells	O
to	O
those	O
in	O
(	O
C	O
)	O
in	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
femurs	O
.	O

Red	O
star	O
in	O
(	O
A	O
)	O
and	O
(	O
D	O
)	O
marks	O
the	O
secondary	O
ossification	O
center	O
.	O

Pale	O
blue	O
-	O
stained	O
tissue	O
in	O
(	O
E	O
)	O
,	O
marked	O
by	O
red	O
arrows	O
,	O
is	O
trabecular	O
bone	O
.	O

bm	O
,	O
marks	O
the	O
bone	O
marrow	O
cavity	O
in	O
(	O
D	O
)	O
.	O

(	O
F	O
-	O
J	O
)	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
femurs	O
at	O
1	O
wk	O
(	O
F	O
)	O
and	O
3	O
wks	O
(	O
J	O
)	O
of	O
age	O
.	O

Boxed	O
areas	O
in	O
(	O
F	O
)	O
are	O
enlarged	O
in	O
(	O
G	O
)	O
,	O
(	O
H	O
)	O
,	O
and	O
(	O
I	O
)	O
.	O

(	O
A	O
)	O
,	O
(	O
D	O
)	O
,	O
(	O
F	O
)	O
,	O
and	O
(	O
J	O
)	O
are	O
shown	O
with	O
the	O
same	O
magnification	O
.	O

Note	O
that	O
there	O
are	O
defects	O
in	O
bone	O
formation	O
but	O
no	O
defect	O
in	O
osteoclast	O
mediated	O
bone	O
resorption	O
.	O

Mineralized	O
tissue	O
in	O
the	O
mid	O
shaft	O
of	O
femur	O
is	O
almost	O
resorbed	O
at	O
3	O
wks	O
.	O

(	O
H	O
)	O
Fibroblast	O
-	O
like	O
cells	O
present	O
in	O
the	O
bone	O
shaft	O
of	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mouse	O
.	O

Red	O
star	O
in	O
(	O
I	O
)	O
shows	O
the	O
osteoclasts	O
invading	O
the	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
femurs	O
at	O
1	O
wk	O
of	O
age	O
.	O

s	O
and	O
m	O
mark	O
soft	O
tissues	O
and	O
muscle	O
in	O
(	O
J	O
)	O
,	O
respectively	O
.	O

(	O
K	O
and	O
L	O
)	O
Three	O
-	O
wk	O
-	O
old	O
wild	O
-	O
type	O
(	O
K	O
)	O
and	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
(	O
L	O
)	O
hindlimb	O
skeletons	O
stained	O
with	O
Alcian	O
blue	O
and	O
Alizarin	B-CHEBI
red	I-CHEBI
.	O

The	O
black	O
arrow	O
shows	O
the	O
missing	O
part	O
of	O
proximal	O
femur	O
.	O

Figure	O
7	O

Osteoblast	O
Maturation	O
Is	O
Inhibited	O
in	O
the	O
Absence	O
of	O
BMP2	O
and	O
BMP4	O

(	O
A	O
-	O
D	O
)	O
Distal	O
femurs	O
from	O
control	O
mice	O
at	O
1	O
wk	O
of	O
age	O
.	O

(	O
E	O
-	O
H	O
)	O
Distal	O
femurs	O
from	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mice	O
at	O
1	O
wk	O
of	O
age	O
.	O

(	O
I	O
-	O
L	O
)	O
Distal	O
femurs	O
from	O
control	O
mice	O
at	O
3	O
wks	O
of	O
age	O
.	O

(	O
M	O
-	O
P	O
)	O
Distal	O
femurs	O
from	O
Bmp2C	O
/	O
C	O
;	O
Bmp4C	O
/	O
C	O
;	O
Prx1	O
:	O
:	O
cre	O
mice	O
at	O
3	O
wks	O
of	O
age	O
.	O

In	O
situ	O
hybridization	O
of	O
early	O
osteoblast	O
differentiation	O
-	O
related	O
marker	O
genes	O
Col	O
I	O
(	O
B	O
,	O
F	O
,	O
J	O
,	O
and	O
N	O
)	O
,	O
runx2	O
(	O
C	O
,	O
G	O
,	O
K	O
,	O
and	O
O	O
)	O
and	O
osterix	O
(	O
D	O
,	O
H	O
,	O
L	O
,	O
and	O
P	O
)	O
.	O

Footnotes	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

A	O
previous	O
version	O
of	O
this	O
article	O
appeared	O
as	O
an	O
Early	O
Online	O
Release	O
on	O
November	O
6	O
,	O
2006	O
(	O
doi	O
:	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pgen	O
.	O
0020216	O
.	O
eor	O
)	O
.	O

Author	O
contributions	O
.	O

AB	O
,	O
KT	O
,	O
BDH	O
,	O
VR	O
,	O
and	O
CJT	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

AB	O
,	O
KT	O
,	O
KC	O
,	O
and	O
BDH	O
performed	O
the	O
experiments	O
.	O

AB	O
,	O
KT	O
,	O
VR	O
,	O
and	O
CJT	O
analyzed	O
the	O
data	O
.	O

AB	O
and	O
KT	O
wrote	O
the	O
paper	O
.	O

Funding	O
.	O

This	O
work	O
was	O
supported	O
by	O
a	O
grant	O
from	O
the	O
National	O
Institutes	O
of	O
Health	O
(	O
P01	O
DK56246	O
to	O
CJT	O
)	O
and	O
by	O
funds	O
from	O
the	O
Forsyth	O
Institute	O
and	O
Harvard	O
School	O
of	O
Dental	O
Medicine	O
(	O
to	O
VR	O
)	O
.	O

Combining	O
global	O
genome	O
and	O
transcriptome	O
approaches	O
to	O
identify	O
the	O
candidate	O
genes	O
of	O
small	O
-	O
effect	O
quantitative	O
trait	O
loci	O
in	O
collagen	O
-	O
induced	O
arthritis	O

Abstract	O

Quantitative	O
traits	O
such	O
as	O
complex	O
diseases	O
are	O
controlled	O
by	O
many	O
small	O
-	O
effect	O
genes	O
that	O
are	O
difficult	O
to	O
identify	O
.	O

Here	O
we	O
present	O
a	O
novel	O
strategy	O
to	O
identify	O
the	O
candidate	O
genes	O
for	O
small	O
-	O
effect	O
quantitative	O
trait	O
loci	O
(	O
QTL	O
)	O
in	O
collagen	O
induced	O
arthritis	O
(	O
CIA	O
)	O
using	O
global	O
genome	O
and	O
transcriptome	O
approaches	O
.	O

First	O
,	O
we	O
performed	O
genome	O
linkage	O
analysis	O
in	O
F2	O
progeny	O
of	O
the	O
CIA	O
susceptible	O
and	O
resistant	O
strains	O
to	O
search	O
for	O
small	O
-	O
effect	O
QTL	O
.	O

Second	O
,	O
we	O
detected	O
gene	O
expression	O
patterns	O
of	O
both	O
strains	O
during	O
CIA	O
.	O

The	O
candidate	O
genes	O
were	O
identified	O
using	O
three	O
criteria	O
:	O
they	O
are	O
located	O
in	O
a	O
genomic	O
region	O
linked	O
to	O
CIA	O
;	O
they	O
are	O
disease	O
-	O
specific	O
differentially	O
expressed	O
during	O
CIA	O
;	O
and	O
they	O
are	O
strain	O
-	O
specific	O
differentially	O
expressed	O
regarding	O
the	O
two	O
parental	O
strains	O
.	O

Eight	O
small	O
-	O
effect	O
QTL	O
controlling	O
CIA	O
severity	O
were	O
identified	O
.	O

Of	O
22	O
,	O
000	O
screened	O
genes	O
,	O
117	O
were	O
both	O
strain	O
-	O
specific	O
and	O
disease	O
-	O
specific	O
differentially	O
expressed	O
during	O
CIA	O
.	O

Of	O
these	O
117	O
genes	O
,	O
21	O
were	O
located	O
inside	O
the	O
support	O
intervals	O
of	O
the	O
8	O
small	O
-	O
effect	O
QTL	O
and	O
thus	O
were	O
considered	O
as	O
candidate	O
genes	O
.	O

Introduction	O

Susceptibility	O
to	O
most	O
complex	O
diseases	O
is	O
controlled	O
by	O
many	O
genes	O
,	O
each	O
having	O
a	O
small	O
effect	O
on	O
the	O
disease	O
.	O

One	O
example	O
is	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
,	O
a	O
common	O
complex	O
multifactorial	O
autoimmune	O
disease	O
.	O

Several	O
studies	O
have	O
been	O
carried	O
out	O
to	O
detect	O
the	O
genetic	O
basis	O
of	O
RA	O
,	O
and	O
more	O
than	O
30	O
genomic	O
regions	O
have	O
shown	O
evidence	O
of	O
linkage	O
to	O
the	O
disease	O
.	O

Most	O
of	O
these	O
genomic	O
regions	O
did	O
not	O
reach	O
a	O
genome	O
-	O
wide	O
significant	O
threshold	O
value	O
of	O
linkage	O
,	O
with	O
P	O
values	O
between	O
0	O
.	O
05	O
and	O
0	O
.	O
001	O
[	O
1	O
-	O
5	O
]	O
.	O

Thus	O
,	O
these	O
loci	O
only	O
have	O
a	O
small	O
effect	O
on	O
RA	O
.	O

Small	O
genetic	O
contributions	O
could	O
also	O
be	O
seen	O
from	O
the	O
susceptibility	O
genes	O
of	O
RA	O
identified	O
so	O
far	O
,	O
including	O
HLA	O
-	O
DR4	O
,	O
PADI4	O
,	O
PTPN22	O
and	O
FCRL3	O
[	O
6	O
-	O
9	O
]	O
.	O

Except	O
for	O
HLA	O
-	O
DR4	O
,	O
which	O
is	O
strongly	O
associated	O
with	O
RA	O
,	O
all	O
the	O
other	O
susceptibility	O
genes	O
have	O
only	O
a	O
small	O
effect	O
on	O
the	O
disease	O
.	O

In	O
the	O
mouse	O
model	O
of	O
RA	O
,	O
small	O
genetic	O
contributions	O
are	O
also	O
often	O
observed	O
.	O

For	O
example	O
,	O
in	O
a	O
previous	O
study	O
,	O
we	O
carried	O
out	O
a	O
genome	O
screen	O
to	O
identify	O
the	O
quantitative	O
trait	O
loci	O
(	O
QTL	O
)	O
in	O
collagen	O
-	O
induced	O
arthritis	O
(	O
CIA	O
)	O
,	O
which	O
is	O
a	O
widely	O
used	O
animal	O
model	O
of	O
RA	O
.	O

Only	O
one	O
QTL	O
,	O
Cia2	O
,	O
was	O
identified	O
for	O
the	O
phenotype	O
of	O
CIA	O
severity	O
,	O
but	O
this	O
QTL	O
contributes	O
to	O
only	O
16	O
%	O
of	O
the	O
phenotype	O
variations	O
for	O
CIA	O
susceptibility	O
in	O
F2	O
progeny	O
[	O
10	O
]	O
.	O

This	O
suggests	O
that	O
there	O
must	O
be	O
other	O
susceptibility	O
genes	O
whose	O
contributions	O
were	O
not	O
big	O
enough	O
to	O
reach	O
the	O
stringent	O
significance	O
threshold	O
value	O
of	O
linkage	O
analysis	O
.	O

One	O
aim	O
of	O
using	O
animal	O
models	O
for	O
complex	O
diseases	O
is	O
to	O
detect	O
the	O
genetic	O
basis	O
of	O
these	O
diseases	O
.	O

With	O
controllable	O
environmental	O
factors	O
as	O
well	O
as	O
the	O
known	O
genetic	O
background	O
,	O
animal	O
models	O
are	O
powerful	O
tools	O
to	O
search	O
for	O
susceptibility	O
genes	O
for	O
complex	O
diseases	O
,	O
and	O
have	O
been	O
intensively	O
employed	O
for	O
that	O
purpose	O
.	O

More	O
than	O
27	O
,	O
000	O
QTL	O
have	O
been	O
identified	O
in	O
the	O
mouse	O
genome	O
since	O
the	O
first	O
QTL	O
was	O
identified	O
at	O
the	O
beginning	O
of	O
the	O
1990s	O
[	O
11	O
]	O
.	O

By	O
2005	O
,	O
approximately	O
20	O
quantitative	O
trait	O
genes	O
(	O
QTGs	O
)	O
in	O
the	O
mouse	O
genome	O
had	O
been	O
identified	O
[	O
12	O
,	O
13	O
]	O
.	O

Interestingly	O
,	O
most	O
QTGs	O
identified	O
in	O
animal	O
models	O
have	O
the	O
causal	O
polymorphisms	O
in	O
the	O
protein	B-CHEBI
-	O
coding	O
region	O
[	O
14	O
]	O
,	O
which	O
provoke	O
protein	B-CHEBI
structure	O
changes	O
or	O
protein	B-CHEBI
deficiency	O
.	O

This	O
suggests	O
,	O
on	O
the	O
one	O
hand	O
,	O
that	O
small	O
-	O
effect	O
QTL	O
are	O
difficult	O
to	O
identify	O
with	O
traditional	O
strategies	O
and	O
,	O
on	O
the	O
other	O
hand	O
,	O
that	O
the	O
polymorphisms	O
regulating	O
gene	O
expression	O
might	O
only	O
slightly	O
affect	O
the	O
quantitative	O
traits	O
,	O
and	O
thus	O
are	O
more	O
difficult	O
to	O
identify	O
.	O

Microarray	O
-	O
based	O
global	O
gene	O
expression	O
is	O
a	O
powerful	O
technique	O
for	O
investigating	O
complex	O
diseases	O
.	O

During	O
disease	O
development	O
,	O
genes	O
involved	O
in	O
the	O
disease	O
are	O
likely	O
to	O
be	O
differentially	O
regulated	O
.	O

Therefore	O
,	O
signature	O
genes	O
of	O
the	O
diseases	O
could	O
be	O
identified	O
by	O
detecting	O
the	O
expression	O
patterns	O
of	O
the	O
disease	O
-	O
related	O
cells	O
/	O
tissues	O
and	O
their	O
ideal	O
controls	O
.	O

In	O
the	O
past	O
decade	O
,	O
many	O
studies	O
applied	O
this	O
technique	O
to	O
study	O
both	O
RA	O
and	O
its	O
animal	O
models	O
[	O
15	O
-	O
22	O
]	O
.	O

Indeed	O
,	O
genes	O
involved	O
in	O
arthritis	O
show	O
distinct	O
expression	O
patterns	O
in	O
certain	O
tissues	O
and	O
pathological	O
stages	O
of	O
the	O
disease	O
.	O

Genes	O
involved	O
in	O
immunoinflammatory	O
responses	O
were	O
differentially	O
expressed	O
in	O
the	O
blood	O
cells	O
in	O
RA	O
patients	O
[	O
18	O
]	O
.	O

Chemokines	O
and	O
adhesion	O
molecules	B-CHEBI
were	O
upregulated	O
in	O
the	O
joint	O
at	O
the	O
initiation	O
phase	O
of	O
arthritis	O
in	O
animal	O
models	O
[	O
21	O
,	O
22	O
]	O
,	O
while	O
genes	O
involved	O
in	O
cartilage	O
destruction	O
and	O
bone	O
erosion	O
were	O
differentially	O
expressed	O
at	O
the	O
late	O
phase	O
of	O
arthritis	O
in	O
animal	O
models	O
of	O
RA	O
[	O
15	O
,	O
16	O
]	O
.	O

Besides	O
detecting	O
genes	O
involved	O
in	O
complex	O
diseases	O
,	O
microarrays	O
could	O
also	O
be	O
used	O
to	O
detect	O
the	O
genetic	O
polymorphisms	O
regulating	O
gene	O
expression	O
because	O
differential	O
expressions	O
between	O
two	O
strains	O
might	O
be	O
the	O
result	O
of	O
a	O
polymorphism	O
located	O
in	O
regulatory	O
elements	O
.	O

To	O
identify	O
the	O
small	O
-	O
effect	O
QTL	O
of	O
CIA	O
as	O
well	O
as	O
the	O
potential	O
candidate	O
genes	O
inside	O
them	O
,	O
we	O
investigated	O
CIA	O
genetically	O
susceptible	O
and	O
resistant	O
strains	O
at	O
both	O
the	O
genome	O
and	O
transcriptome	O
levels	O
.	O

At	O
the	O
genome	O
level	O
,	O
F2	O
progeny	O
of	O
the	O
CIA	O
susceptible	O
(	O
DBA	O
/	O
1	O
)	O
and	O
resistant	O
(	O
FVB	O
/	O
N	O
)	O
strains	O
were	O
generated	O
and	O
a	O
genome	O
-	O
wide	O
linkage	O
analysis	O
was	O
performed	O
to	O
identify	O
small	O
-	O
effect	O
QTL	O
.	O

At	O
the	O
transcriptome	O
level	O
,	O
we	O
detected	O
the	O
gene	O
expression	O
patterns	O
of	O
both	O
the	O
DBA	O
/	O
1	O
and	O
FVB	O
/	O
N	O
strains	O
at	O
four	O
different	O
phases	O
of	O
CIA	O
.	O

The	O
potential	O
candidate	O
genes	O
were	O
identified	O
based	O
on	O
three	O
criteria	O
:	O
they	O
are	O
located	O
within	O
the	O
genomic	O
region	O
linked	O
to	O
CIA	O
;	O
they	O
are	O
disease	O
-	O
specific	O
differentially	O
expressed	O
during	O
CIA	O
;	O
and	O
they	O
are	O
strain	O
-	O
specific	O
differentially	O
expressed	O
between	O
the	O
two	O
parental	O
strains	O
during	O
CIA	O
.	O

Materials	O
and	O
methods	O

Animals	O
,	O
immunisation	O
and	O
assessment	O
of	O
arthritis	O

Both	O
DBA	O
/	O
1	O
and	O
FVB	O
/	O
N	O
mice	O
used	O
in	O
this	O
study	O
were	O
obtained	O
from	O
the	O
Jackson	O
Laboratory	O
and	O
kept	O
in	O
a	O
climate	O
-	O
controlled	O
environment	O
with	O
12	O
hour	O
light	O
/	O
dark	O
cycles	O
in	O
the	O
animal	O
facility	O
at	O
the	O
University	O
of	O
Rostock	O
.	O

All	O
animal	O
experiments	O
were	O
pre	O
-	O
approved	O
by	O
the	O
State	O
Animal	O
Care	O
Committee	O
.	O

CIA	O
was	O
induced	O
in	O
control	O
and	O
experimental	O
animals	O
according	O
to	O
established	O
protocols	O
described	O
previously	O
[	O
10	O
]	O
.	O

In	O
brief	O
,	O
DBA	O
/	O
1J	O
,	O
FVB	O
/	O
N	O
and	O
(	O
DBA	O
/	O
1J	O
x	O
FVB	O
/	O
N	O
)	O
F2	O
progeny	O
were	O
immunised	O
at	O
8	O
to	O
12	O
weeks	O
at	O
the	O
base	O
of	O
the	O
tail	O
with	O
125	O
mu	O
g	O
of	O
bovine	O
Collagen	O
II	O
(	O
Chondrex	O
,	O
Redmond	O
,	O
WA	O
,	O
USA	O
)	O
emulsified	O
in	O
CFA	O
(	O
DIFCO	O
,	O
Detroit	O
,	O
MI	O
,	O
USA	O
)	O
.	O

The	O
clinical	O
scoring	O
of	O
arthritis	O
commenced	O
18	O
days	O
after	O
immunisation	O
,	O
and	O
animals	O
were	O
monitored	O
three	O
times	O
weekly	O
for	O
signs	O
of	O
CIA	O
.	O

Arthritis	O
development	O
was	O
monitored	O
in	O
all	O
four	O
limbs	O
using	O
a	O
three	O
-	O
score	O
system	O
per	O
limb	O
as	O
described	O
previously	O
[	O
10	O
]	O
.	O

Eight	O
-	O
week	O
old	O
FVB	O
/	O
N	O
and	O
DBA	O
/	O
1J	O
mice	O
were	O
used	O
for	O
the	O
detection	O
of	O
gene	O
expression	O
.	O

They	O
were	O
divided	O
into	O
four	O
experimental	O
groups	O
according	O
to	O
the	O
different	O
phases	O
of	O
CIA	O
,	O
namely	O
naive	O
control	O
(	O
NC	O
)	O
,	O
post	O
-	O
immunisation	O
(	O
PI	O
)	O
,	O
onset	O
of	O
arthritis	O
(	O
OA	O
)	O
and	O
chronic	O
arthritis	O
(	O
CA	O
)	O
(	O
Table	O
1	O
)	O
.	O

The	O
NC	O
group	O
contained	O
non	O
-	O
immunised	O
mice	O
that	O
were	O
sacrificed	O
at	O
the	O
age	O
of	O
8	O
weeks	O
.	O

The	O
mice	O
in	O
the	O
PI	O
group	O
were	O
sacrificed	O
on	O
day	O
10	O
after	O
immunisation	O
.	O

The	O
mice	O
in	O
the	O
OA	O
group	O
were	O
sacrificed	O
on	O
day	O
35	O
after	O
immunisation	O
.	O

Three	O
FVB	O
/	O
N	O
non	O
-	O
arthritic	O
mice	O
and	O
three	O
DBA	O
/	O
1	O
mice	O
that	O
showed	O
signs	O
of	O
arthritis	O
on	O
day	O
33	O
or	O
34	O
after	O
immunisation	O
were	O
sacrificed	O
on	O
day	O
35	O
after	O
immunisation	O
.	O

The	O
mice	O
in	O
the	O
CA	O
group	O
were	O
sacrificed	O
on	O
day	O
95	O
after	O
immunisation	O
.	O

Three	O
non	O
-	O
arthritic	O
FVB	O
/	O
N	O
mice	O
and	O
three	O
DBA	O
/	O
1	O
mice	O
that	O
had	O
developed	O
arthritis	O
for	O
at	O
least	O
two	O
months	O
were	O
sacrificed	O
on	O
day	O
95	O
after	O
immunisation	O
.	O

Linkage	O
analysis	O

Detailed	O
information	O
on	O
genotyping	O
of	O
the	O
genome	O
screen	O
has	O
been	O
described	O
previously	O
[	O
10	O
]	O
.	O

In	O
short	O
,	O
we	O
genotyped	O
290	O
F2	O
mice	O
using	O
126	O
informative	O
microsatellite	O
markers	O
covering	O
the	O
genome	O
with	O
an	O
average	O
inter	O
-	O
marker	O
distance	O
of	O
11	O
.	O
5	O
cM	O
for	O
290	O
F2	O
progeny	O
.	O

All	O
linkage	O
analyses	O
were	O
performed	O
with	O
QTX	O
Map	O
manager	O
software	O
[	O
23	O
]	O
.	O

The	O
main	O
clinical	O
phenotype	O
of	O
CIA	O
,	O
arthritis	O
severity	O
,	O
was	O
taken	O
as	O
phenotype	O
.	O

To	O
detect	O
the	O
small	O
-	O
effect	O
QTL	O
,	O
the	O
threshold	O
value	O
of	O
linkage	O
was	O
set	O
as	O
P	O
=	O
0	O
.	O
05	O
(	O
Chi	O
-	O
square	O
test	O
)	O
.	O

Sample	O
preparation	O
and	O
microarray	O
hybridisation	O

Lymph	O
nodes	O
(	O
LNs	O
)	O
draining	O
the	O
immunisation	O
site	O
were	O
used	O
for	O
total	O
RNA	O
preparation	O
.	O

The	O
total	O
RNA	O
was	O
extracted	O
from	O
the	O
tissue	O
homogenates	O
using	O
a	O
commercial	O
kit	O
in	O
accordance	O
with	O
the	O
provided	O
protocol	O
(	O
QIGEN	O
,	O
Hilden	O
,	O
Germany	O
)	O
.	O

Analysis	O
of	O
gene	O
expression	O
was	O
conducted	O
using	O
a	O
U430A	O
array	O
(	O
Affymetrix	O
,	O
Santa	O
Clara	O
,	O
CA	O
,	O
USA	O
)	O
interrogating	O
more	O
than	O
22	O
,	O
000	O
genes	O
.	O

RNA	O
probes	O
were	O
labelled	O
in	O
accordance	O
with	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Samples	O
from	O
individual	O
mice	O
were	O
hybridised	O
onto	O
individual	O
arrays	O
.	O

Hybridisation	O
and	O
washing	O
of	O
gene	O
chips	O
were	O
done	O
as	O
previously	O
described	O
[	O
16	O
]	O
.	O

Fluorescent	O
signals	O
were	O
collected	O
by	O
laser	O
scan	O
(	O
Hewlett	O
-	O
Packard	O
Gene	O
Scanner	O
)	O
.	O

Microarray	O
analysis	O

Normalisation	O
of	O
the	O
expression	O
level	O
was	O
done	O
using	O
Affymetrix	O
software	O
MAS	O
5	O
,	O
which	O
is	O
based	O
on	O
global	O
scaling	O
of	O
total	O
gene	O
expression	O
level	O
per	O
microarray	O
.	O

The	O
normalised	O
expression	O
values	O
were	O
imported	O
to	O
and	O
analysed	O
by	O
dCHIP	O
[	O
24	O
]	O
.	O

Differentially	O
expressed	O
genes	O
were	O
identified	O
by	O
defining	O
the	O
appropriate	O
filtering	O
criteria	O
in	O
the	O
dCHIP	O
software	O
as	O
:	O
lower	O
90	O
%	O
confidence	O
boundary	O
of	O
fold	O
change	O
between	O
the	O
group	O
means	O
exceeded	O
twofold	O
;	O
the	O
absolute	O
difference	O
between	O
the	O
two	O
groups	O
exceeded	O
100	O
;	O
the	O
P	O
value	O
threshold	O
of	O
the	O
unpaired	O
t	O
-	O
test	O
was	O
0	O
.	O
05	O
.	O

The	O
false	O
discovery	O
rate	O
was	O
established	O
with	O
a	O
permutation	O
test	O
for	O
each	O
pairwise	O
comparison	O
to	O
estimate	O
the	O
proportion	O
of	O
false	O
-	O
positive	O
genes	O
.	O

Hierarchical	O
gene	O
clustering	O
was	O
performed	O
with	O
dCHIP	O
to	O
characterise	O
the	O
gene	O
expression	O
patterns	O
during	O
CIA	O
.	O

The	O
default	O
clustering	O
algorithm	O
of	O
genes	O
was	O
as	O
follows	O
:	O
the	O
distance	O
between	O
two	O
genes	O
is	O
defined	O
as	O
1	O
-	O
r	O
,	O
where	O
r	O
is	O
the	O
Pearson	O
correlation	O
coefficient	O
between	O
the	O
standardised	O
expression	O
values	O
of	O
the	O
two	O
genes	O
across	O
the	O
samples	O
used	O
.	O

To	O
characterise	O
the	O
functional	O
relationship	O
between	O
differentially	O
expressed	O
genes	O
,	O
Gene	O
Ontology	O
(	O
GO	O
)	O
term	O
classification	O
incorporated	O
in	O
DNA	O
-	O
Chip	O
Analyzer	O
was	O
performed	O
.	O

The	O
significant	O
level	O
for	O
a	O
function	O
cluster	O
was	O
set	O
at	O
P	O
<	O
0	O
.	O
005	O
,	O
and	O
the	O
minimum	O
size	O
of	O
a	O
cluster	O
was	O
three	O
genes	O
.	O

Results	O

Small	O
-	O
effect	O
QTL	O
of	O
CIA	O
in	O
(	O
DBA	O
/	O
1	O
x	O
FVB	O
/	O
N	O
)	O
F2	O
progeny	O

In	O
a	O
previous	O
study	O
,	O
we	O
carried	O
out	O
a	O
genome	O
screen	O
to	O
identify	O
QTL	O
controlling	O
CIA	O
susceptibility	O
in	O
(	O
DBA	O
/	O
1	O
x	O
FVB	O
/	O
N	O
)	O
F2	O
progeny	O
.	O

For	O
the	O
phenotype	O
of	O
arthritis	O
severity	O
,	O
only	O
one	O
QTL	O
,	O
Cia2	O
,	O
was	O
identified	O
,	O
with	O
a	O
highly	O
significant	O
logarithm	O
of	O
the	O
odds	O
(	O
LOD	O
)	O
score	O
of	O
12	O
[	O
10	O
]	O
.	O

However	O
,	O
Cia2	O
contributed	O
to	O
only	O
16	O
%	O
of	O
the	O
phenotype	O
variations	O
,	O
indicating	O
that	O
there	O
should	O
be	O
some	O
small	O
-	O
effect	O
QTL	O
whose	O
contributions	O
to	O
CIA	O
were	O
not	O
big	O
enough	O
to	O
reach	O
the	O
significant	O
threshold	O
value	O
of	O
linkage	O
.	O

To	O
identify	O
these	O
potential	O
small	O
-	O
effect	O
QTL	O
,	O
we	O
reanalyzed	O
the	O
data	O
using	O
a	O
lower	O
threshold	O
value	O
of	O
linkage	O
(	O
P	O
=	O
0	O
.	O
05	O
)	O
.	O

We	O
reasoned	O
that	O
since	O
the	O
main	O
candidate	O
gene	O
of	O
Cia2	O
,	O
complement	O
component	O
C5	O
(	O
Hc	O
)	O
,	O
was	O
proven	O
to	O
be	O
essential	O
for	O
CIA	O
development	O
and	O
because	O
the	O
FVB	O
/	O
N	O
strain	O
is	O
C5	O
deficient	O
[	O
10	O
,	O
25	O
]	O
,	O
some	O
small	O
-	O
effect	O
QTL	O
might	O
be	O
masked	O
by	O
Cia2	O
.	O

To	O
exclude	O
the	O
masking	O
effect	O
of	O
C5	O
,	O
we	O
performed	O
linkage	O
analysis	O
with	O
3	O
datasets	O
,	O
the	O
first	O
containing	O
all	O
290	O
F2	O
progeny	O
,	O
the	O
second	O
77	O
C5	O
+	O
/	O
+	O
F2	O
progeny	O
and	O
the	O
third	O
133	O
C5	O
+	O
/	O
-	O
F2	O
progeny	O
.	O

Eight	O
genomic	O
regions	O
were	O
linked	O
to	O
the	O
phenotype	O
of	O
CIA	O
severity	O
(	O
loci	O
1	O
to	O
8	O
,	O
Table	O
2	O
)	O
,	O
with	O
P	O
values	O
varying	O
between	O
0	O
.	O
043	O
and	O
0	O
.	O
003	O
.	O

These	O
eight	O
small	O
-	O
effect	O
QTL	O
were	O
located	O
on	O
chromosomes	O
5	O
,	O
6	O
,	O
7	O
,	O
10	O
,	O
11	O
,	O
16	O
,	O
and	O
17	O
.	O

Five	O
loci	O
were	O
identified	O
in	O
at	O
least	O
two	O
datasets	O
.	O

Of	O
the	O
eight	O
loci	O
,	O
five	O
had	O
DBA	O
/	O
1	O
as	O
the	O
susceptibility	O
allele	O
,	O
and	O
three	O
had	O
FVB	O
/	O
N	O
as	O
the	O
susceptibility	O
allele	O
.	O

Lander	O
and	O
Botstein	O
[	O
26	O
]	O
suggested	O
a	O
LOD	O
score	O
of	O
between	O
2	O
and	O
3	O
to	O
ensure	O
an	O
overall	O
false	O
positive	O
rate	O
of	O
5	O
%	O
,	O
which	O
means	O
that	O
using	O
a	O
lower	O
threshold	O
value	O
will	O
prevent	O
false	O
negative	O
QTL	O
at	O
the	O
expense	O
of	O
increasing	O
false	O
positive	O
QTL	O
.	O

Being	O
aware	O
of	O
this	O
,	O
we	O
examined	O
these	O
genomic	O
regions	O
to	O
search	O
whether	O
they	O
,	O
or	O
their	O
syntenic	O
genomic	O
regions	O
on	O
the	O
human	O
genome	O
,	O
have	O
been	O
previously	O
linked	O
to	O
arthritis	O
.	O

Four	O
small	O
-	O
effect	O
QTL	O
overlapped	O
with	O
arthritis	O
QTL	O
on	O
the	O
mouse	O
genome	O
identified	O
previously	O
.	O

Locus	O
1	O
and	O
2	O
overlap	O
with	O
Cia13	O
and	O
Cia14	O
,	O
which	O
control	O
severity	O
of	O
CIA	O
in	O
(	O
DBA	O
/	O
1	O
x	O
BALB	O
/	O
C	O
)	O
F2	O
progeny	O
[	O
27	O
]	O
.	O

Locus	O
5	O
located	O
on	O
chromosome	O
10	O
overlaps	O
with	O
Cia8	O
,	O
which	O
was	O
identified	O
in	O
(	O
DBA	O
/	O
1	O
x	O
B10	O
.	O
Q	O
)	O
F2	O
progeny	O
[	O
28	O
]	O
.	O

Locus	O
6	O
overlaps	O
with	O
Pgia7	O
,	O
which	O
controls	O
susceptibility	O
to	O
proteoglycan	B-CHEBI
-	O
induced	O
arthritis	O
(	O
PGIA	O
)	O
and	O
was	O
identified	O
in	O
(	O
BALB	O
/	O
C	O
x	O
DBA	O
/	O
2	O
)	O
F2	O
progeny	O
[	O
29	O
]	O
.	O

The	O
syntenic	O
genomic	O
regions	O
of	O
five	O
small	O
-	O
effect	O
QTL	O
on	O
the	O
human	O
genome	O
have	O
been	O
reported	O
to	O
be	O
linked	O
to	O
RA	O
.	O

These	O
are	O
genomic	O
regions	O
22q11	O
and	O
12p13	O
-	O
q24	O
on	O
chromosome	O
22	O
and	O
12	O
(	O
the	O
counterparts	O
of	O
locus	O
2	O
)	O
,	O
12p13	O
-	O
pter	O
on	O
chromosome	O
12	O
(	O
the	O
counterpart	O
of	O
locus	O
3	O
)	O
,	O
21q22	O
-	O
qter	O
and	O
10q22	O
-	O
23	O
on	O
chromosome	O
21	O
and	O
10	O
(	O
the	O
counterparts	O
of	O
locus	O
5	O
)	O
,	O
17q21	O
-	O
25	O
on	O
chromosome	O
17	O
(	O
the	O
counterpart	O
of	O
locus	O
6	O
)	O
and	O
3q29	O
-	O
qter	O
on	O
chromosome	O
3	O
(	O
the	O
counterpart	O
of	O
locus	O
7	O
)	O
[	O
2	O
,	O
4	O
]	O
.	O

Strain	O
-	O
specific	O
differentially	O
expressed	O
genes	O

We	O
detected	O
the	O
gene	O
expression	O
profiles	O
using	O
three	O
mice	O
per	O
group	O
,	O
which	O
is	O
a	O
small	O
number	O
.	O

Being	O
aware	O
of	O
the	O
importance	O
of	O
data	O
reproducibility	O
,	O
we	O
determined	O
the	O
coefficient	O
of	O
variation	O
(	O
CV	O
)	O
to	O
measure	O
data	O
variability	O
.	O

The	O
CV	O
for	O
each	O
gene	O
on	O
the	O
chip	O
and	O
the	O
mean	O
CV	O
for	O
the	O
entire	O
probe	O
set	O
were	O
calculated	O
.	O

The	O
mean	O
CV	O
ranged	O
between	O
18	O
.	O
4	O
%	O
and	O
25	O
.	O
8	O
%	O
for	O
all	O
experimental	O
groups	O
,	O
and	O
this	O
relatively	O
low	O
CV	O
indicated	O
that	O
these	O
data	O
could	O
be	O
used	O
for	O
further	O
analysis	O
(	O
Table	O
1	O
)	O
.	O

To	O
search	O
for	O
strain	O
-	O
specific	O
differentially	O
expressed	O
genes	O
,	O
we	O
performed	O
comparisons	O
of	O
gene	O
expression	O
between	O
the	O
DBA	O
/	O
1	O
and	O
FVB	O
/	O
N	O
strains	O
at	O
all	O
four	O
phases	O
of	O
CIA	O
,	O
including	O
NC	O
,	O
PI	O
,	O
OA	O
and	O
CA	O
.	O

For	O
the	O
naive	O
mice	O
without	O
immunisation	O
,	O
361	O
genes	O
were	O
differentially	O
expressed	O
between	O
the	O
two	O
strains	O
.	O

On	O
day	O
10	O
after	O
immunisation	O
,	O
when	O
both	O
strains	O
did	O
not	O
show	O
any	O
sign	O
of	O
the	O
disease	O
,	O
141	O
genes	O
were	O
differentially	O
expressed	O
.	O

After	O
DBA	O
/	O
1	O
mice	O
developed	O
CIA	O
,	O
184	O
and	O
85	O
differentially	O
expressed	O
genes	O
were	O
identified	O
between	O
these	O
two	O
strains	O
at	O
the	O
onset	O
and	O
chronic	O
phases	O
,	O
respectively	O
.	O

When	O
the	O
lists	O
of	O
the	O
differentially	O
expressed	O
genes	O
at	O
the	O
four	O
phases	O
were	O
merged	O
and	O
overlapping	O
genes	O
were	O
excluded	O
,	O
509	O
genes	O
were	O
identified	O
(	O
Additional	O
file	O
1	O
)	O
.	O

Twenty	O
-	O
one	O
genes	O
consistently	O
showed	O
differential	O
expression	O
between	O
the	O
two	O
strains	O
at	O
all	O
phases	O
.	O

Besides	O
these	O
21	O
genes	O
,	O
only	O
3	O
additional	O
genes	O
were	O
strain	O
-	O
specific	O
differentially	O
expressed	O
during	O
the	O
3	O
phases	O
after	O
CIA	O
induction	O
(	O
PI	O
,	O
OA	O
and	O
CA	O
;	O
Figure	O
1	O
)	O
.	O

Disease	O
-	O
specific	O
differentially	O
expressed	O
genes	O

To	O
identify	O
the	O
disease	O
-	O
specific	O
differentially	O
expressed	O
genes	O
in	O
CIA	O
,	O
we	O
detected	O
the	O
genes	O
that	O
were	O
differentially	O
expressed	O
in	O
LNs	O
during	O
CIA	O
in	O
the	O
susceptible	O
strain	O
.	O

Three	O
experimental	O
conditions	O
,	O
PI	O
,	O
OA	O
and	O
CA	O
,	O
were	O
compared	O
with	O
the	O
NC	O
group	O
.	O

On	O
day	O
10	O
after	O
immunisation	O
,	O
102	O
genes	O
were	O
differentially	O
expressed	O
-	O
most	O
of	O
them	O
were	O
upregulated	O
(	O
78	O
out	O
of	O
102	O
)	O
-	O
while	O
at	O
the	O
onset	O
phase	O
of	O
the	O
disease	O
,	O
only	O
26	O
genes	O
were	O
differentially	O
expressed	O
.	O

At	O
the	O
chronic	O
phase	O
of	O
the	O
disease	O
,	O
184	O
differentially	O
expressed	O
genes	O
were	O
identified	O
,	O
with	O
156	O
downregulated	O
genes	O
.	O

Only	O
one	O
gene	O
was	O
differentially	O
expressed	O
at	O
all	O
three	O
phases	O
of	O
CIA	O
.	O

Besides	O
this	O
gene	O
,	O
five	O
,	O
one	O
and	O
six	O
differentially	O
expressed	O
genes	O
were	O
shared	O
by	O
PI	O
with	O
OA	O
,	O
PI	O
with	O
CA	O
and	O
OA	O
with	O
CA	O
,	O
respectively	O
(	O
Figure	O
2a	O
)	O
.	O

Taken	O
together	O
,	O
310	O
disease	O
-	O
specific	O
differentially	O
expressed	O
genes	O
were	O
differentially	O
regulated	O
during	O
CIA	O
in	O
DBA	O
/	O
1	O
mice	O
(	O
Additional	O
file	O
2	O
)	O
.	O

To	O
further	O
characterise	O
the	O
gene	O
expression	O
pattern	O
during	O
CIA	O
,	O
we	O
performed	O
hierarchical	O
cluster	O
analysis	O
for	O
these	O
310	O
genes	O
.	O

Six	O
gene	O
clusters	O
were	O
identified	O
(	O
clusters	O
I	O
to	O
VI	O
,	O
Figure	O
2b	O
)	O
,	O
each	O
with	O
a	O
distinct	O
gene	O
expression	O
pattern	O
during	O
CIA	O
.	O

Cluster	O
I	O
contains	O
16	O
genes	O
,	O
representing	O
genes	O
that	O
were	O
upregulated	O
after	O
induction	O
of	O
CIA	O
.	O

The	O
expression	O
of	O
these	O
genes	O
reached	O
a	O
peak	O
at	O
the	O
onset	O
phase	O
of	O
the	O
disease	O
and	O
functional	O
clustering	O
results	O
revealed	O
that	O
they	O
are	O
related	O
to	O
the	O
immune	O
response	O
.	O

Cluster	O
II	O
contains	O
12	O
genes	O
whose	O
expression	O
was	O
gradually	O
upregulated	O
and	O
reached	O
a	O
peak	O
at	O
the	O
chronic	O
phase	O
of	O
CIA	O
.	O

These	O
genes	O
are	O
mainly	O
related	O
to	O
the	O
immune	O
response	O
,	O
organelle	O
membrane	O
and	O
extracellular	O
region	O
and	O
space	O
.	O

Cluster	O
III	O
contains	O
78	O
genes	O
that	O
were	O
only	O
upregulated	O
at	O
the	O
PI	O
phase	O
.	O

These	O
genes	O
are	O
related	O
to	O
the	O
intercellular	O
junction	O
.	O

More	O
than	O
half	O
of	O
the	O
genes	O
(	O
156	O
of	O
310	O
)	O
belong	O
to	O
cluster	O
IV	O
and	O
represent	O
genes	O
specifically	O
downregultaed	O
at	O
the	O
chronic	O
phase	O
.	O

These	O
genes	O
are	O
functionally	O
related	O
to	O
lymphocyte	O
proliferation	O
,	O
T	O
cell	O
activation	O
,	O
protein	B-CHEBI
binding	O
as	O
well	O
as	O
the	O
notch	O
signal	O
pathway	O
.	O

Cluster	O
V	O
contains	O
eight	O
genes	O
downregulated	O
at	O
the	O
PI	O
phase	O
.	O

Cluster	O
VI	O
contains	O
18	O
genes	O
downregulated	O
at	O
the	O
OA	O
phase	O
.	O

The	O
GO	O
term	O
classification	O
showed	O
no	O
functional	O
cluster	O
that	O
was	O
significantly	O
enriched	O
in	O
these	O
two	O
gene	O
clusters	O
.	O

Candidate	O
genes	O
for	O
the	O
small	O
-	O
effect	O
QTL	O
of	O
CIA	O

To	O
identify	O
candidate	O
susceptibility	O
genes	O
for	O
the	O
CIA	O
small	O
-	O
effect	O
QTL	O
,	O
we	O
compared	O
the	O
list	O
of	O
strain	O
-	O
specific	O
differentially	O
expressed	O
genes	O
with	O
the	O
list	O
of	O
disease	O
-	O
specific	O
differentially	O
expressed	O
genes	O
;	O
117	O
genes	O
were	O
shared	O
by	O
both	O
lists	O
(	O
Additional	O
file	O
3	O
)	O
.	O

Figure	O
3	O
visualises	O
positions	O
of	O
the	O
117	O
genes	O
retrieved	O
from	O
Ensembl	O
[	O
30	O
]	O
in	O
relation	O
to	O
the	O
8	O
small	O
-	O
effect	O
QTL	O
.	O

The	O
eight	O
loci	O
were	O
located	O
on	O
7	O
chromosomes	O
,	O
5	O
,	O
6	O
,	O
7	O
,	O
10	O
,	O
11	O
,	O
16	O
and	O
17	O
.	O

Since	O
the	O
confidence	O
intervals	O
of	O
QTL	O
in	O
F2	O
progeny	O
are	O
around	O
20	O
cM	O
[	O
26	O
]	O
,	O
we	O
used	O
40	O
Mb	O
as	O
the	O
confidence	O
intervals	O
for	O
all	O
loci	O
.	O

Twenty	O
-	O
one	O
genes	O
were	O
located	O
in	O
the	O
confidence	O
intervals	O
of	O
six	O
of	O
the	O
eight	O
QTL	O
.	O

We	O
located	O
5	O
,	O
4	O
,	O
2	O
,	O
1	O
,	O
3	O
and	O
6	O
potential	O
candidate	O
genes	O
within	O
the	O
confidence	O
intervals	O
of	O
loci	O
1	O
,	O
2	O
,	O
3	O
,	O
5	O
,	O
6	O
and	O
8	O
,	O
respectively	O
,	O
while	O
no	O
candidate	O
gene	O
was	O
identified	O
for	O
loci	O
4	O
and	O
7	O
.	O

Table	O
3	O
summarises	O
the	O
21	O
candidate	O
genes	O
identified	O
in	O
this	O
study	O
.	O

Two	O
genes	O
,	O
hspa1a	O
and	O
Oas1a	O
,	O
were	O
upregulated	O
at	O
the	O
OA	O
phase	O
of	O
CIA	O
and	O
Oas1a	O
was	O
also	O
upregulated	O
at	O
the	O
PI	O
phase	O
.	O

Except	O
for	O
these	O
two	O
genes	O
,	O
all	O
other	O
19	O
genes	O
were	O
downregulated	O
at	O
the	O
chronic	O
phase	O
of	O
CIA	O
.	O

All	O
genes	O
,	O
except	O
hspa1a	O
,	O
showed	O
expression	O
differences	O
between	O
the	O
two	O
strains	O
at	O
the	O
NC	O
phase	O
.	O

Five	O
genes	O
were	O
differentially	O
expressed	O
at	O
all	O
phases	O
of	O
CIA	O
,	O
including	O
H2	O
-	O
Q10	O
,	O
Mapk14	O
,	O
Pscd1	O
,	O
Kpnb1	O
and	O
Wdr1	O
.	O

Among	O
these	O
five	O
genes	O
,	O
H2	O
-	O
Q10	O
had	O
a	O
consistently	O
higher	O
expression	O
in	O
the	O
DBA	O
/	O
1	O
than	O
the	O
FVB	O
/	O
N	O
strain	O
in	O
all	O
CIA	O
phases	O
,	O
while	O
the	O
other	O
four	O
genes	O
had	O
a	O
higher	O
expression	O
in	O
the	O
DBA	O
/	O
1	O
strain	O
at	O
the	O
early	O
stages	O
,	O
including	O
NC	O
,	O
PI	O
and	O
OA	O
,	O
but	O
a	O
lower	O
expression	O
at	O
the	O
chronic	O
phase	O
.	O

GO	O
term	O
classification	O
analysis	O
revealed	O
that	O
the	O
functional	O
cluster	O
of	O
protein	B-CHEBI
kinase	O
cascade	O
was	O
significantly	O
enriched	O
in	O
the	O
21	O
candidate	O
genes	O
.	O

This	O
functional	O
cluster	O
contained	O
four	O
genes	O
,	O
including	O
Mapk14	O
,	O
Mapk8ip3	O
,	O
Stat5a	O
and	O
Gna12	O
.	O

Discussion	O

In	O
this	O
study	O
,	O
we	O
attempted	O
for	O
the	O
first	O
time	O
to	O
identify	O
small	O
-	O
effect	O
QTL	O
in	O
an	O
F2	O
progeny	O
.	O

Small	O
-	O
effect	O
QTL	O
are	O
defined	O
as	O
those	O
reaching	O
the	O
threshold	O
value	O
of	O
P	O
=	O
0	O
.	O
05	O
but	O
that	O
did	O
not	O
reach	O
the	O
significant	O
threshold	O
value	O
suggested	O
by	O
Lander	O
and	O
Botstein	O
[	O
26	O
]	O
.	O

Although	O
not	O
significant	O
,	O
there	O
is	O
evidence	O
that	O
most	O
of	O
the	O
eight	O
small	O
-	O
effect	O
QTL	O
likely	O
contain	O
susceptibility	O
genes	O
for	O
CIA	O
.	O

First	O
,	O
we	O
performed	O
the	O
linkage	O
analysis	O
in	O
three	O
datasets	O
,	O
including	O
all	O
290	O
F	O
progeny	O
,	O
76	O
C5	O
+	O
/	O
+	O
F2	O
progeny	O
and	O
133	O
C5	O
+	O
/	O
-	O
F2	O
progeny	O
.	O

Five	O
of	O
the	O
eight	O
small	O
-	O
effect	O
QTL	O
were	O
identified	O
in	O
at	O
least	O
two	O
datasets	O
,	O
suggesting	O
that	O
these	O
QTL	O
are	O
reproducible	O
.	O

Second	O
,	O
many	O
QTL	O
identified	O
in	O
the	O
present	O
study	O
overlap	O
with	O
arthritis	O
QTL	O
previously	O
identified	O
,	O
including	O
loci	O
1	O
,	O
2	O
,	O
5	O
and	O
6	O
.	O

In	O
addition	O
,	O
syntenic	O
analysis	O
revealed	O
that	O
the	O
counterpart	O
genomic	O
regions	O
on	O
the	O
human	O
genome	O
of	O
many	O
of	O
these	O
eight	O
QTL	O
are	O
linked	O
to	O
RA	O
.	O

For	O
five	O
of	O
the	O
eight	O
small	O
-	O
effect	O
QTL	O
the	O
DBA	O
/	O
1	O
alleles	O
are	O
the	O
arthritis	O
-	O
enhancing	O
alleles	O
,	O
while	O
the	O
FVBN	O
alleles	O
are	O
the	O
arthritis	O
-	O
enhancing	O
alleles	O
in	O
the	O
other	O
three	O
QTL	O
,	O
indicating	O
that	O
some	O
susceptibility	O
genes	O
could	O
come	O
from	O
the	O
resistant	O
strain	O
.	O

Interestingly	O
,	O
loci	O
2	O
and	O
7	O
partially	O
overlap	O
with	O
two	O
arthritis	O
-	O
related	O
QTL	O
identified	O
by	O
us	O
in	O
the	O
same	O
F2	O
progeny	O
[	O
10	O
]	O
.	O

Locus	O
2	O
was	O
located	O
at	O
the	O
same	O
genomic	O
region	O
as	O
Cia27	O
,	O
a	O
QTL	O
controlling	O
IgG2a	O
antibody	O
levels	O
to	O
collagen	O
II	O
.	O

Recently	O
,	O
we	O
have	O
refined	O
this	O
QTL	O
into	O
a	O
4	O
.	O
1	O
Mb	O
genomic	O
region	O
and	O
showed	O
that	O
a	O
gene	O
within	O
this	O
region	O
regulates	O
CIA	O
severity	O
by	O
controlling	O
the	O
IgG2a	O
antibody	O
levels	O
to	O
collagen	O
II	O
[	O
31	O
]	O
.	O

Locus	O
7	O
on	O
chromosome	O
16	O
overlaps	O
with	O
Lp1	O
,	O
which	O
controls	O
lymphocyte	O
proliferation	O
.	O

Furthermore	O
,	O
according	O
to	O
our	O
unpublished	O
data	O
,	O
loci	O
8	O
on	O
chromosome	O
17	O
controls	O
lymphocyte	O
adherence	O
during	O
development	O
of	O
CIA	O
.	O

Therefore	O
,	O
the	O
gene	O
within	O
the	O
small	O
-	O
effect	O
QTL	O
could	O
affect	O
CIA	O
severity	O
through	O
controlling	O
arthritis	O
-	O
related	O
phenotypes	O
.	O

Several	O
studies	O
have	O
been	O
carried	O
out	O
to	O
detect	O
gene	O
expression	O
during	O
CIA	O
,	O
all	O
of	O
which	O
used	O
joints	O
as	O
the	O
target	O
tissue	O
[	O
15	O
,	O
16	O
,	O
21	O
,	O
22	O
]	O
.	O

This	O
study	O
,	O
for	O
the	O
first	O
time	O
,	O
detected	O
gene	O
expression	O
in	O
LNs	O
during	O
CIA	O
.	O

We	O
present	O
an	O
extensive	O
study	O
of	O
gene	O
expression	O
patterns	O
in	O
LNs	O
of	O
both	O
genetically	O
susceptible	O
and	O
resistant	O
strains	O
at	O
four	O
different	O
phases	O
of	O
CIA	O
.	O

In	O
both	O
strains	O
,	O
differentially	O
regulated	O
genes	O
were	O
highly	O
concentrated	O
at	O
the	O
PI	O
and	O
CA	O
phases	O
,	O
and	O
only	O
a	O
small	O
number	O
of	O
genes	O
were	O
differentially	O
expressed	O
in	O
two	O
or	O
three	O
phases	O
.	O

This	O
indicates	O
that	O
biological	O
responses	O
in	O
LNs	O
were	O
stronger	O
in	O
the	O
PI	O
and	O
CA	O
phases	O
than	O
in	O
the	O
OA	O
phase	O
,	O
and	O
the	O
responses	O
at	O
different	O
phases	O
were	O
different	O
.	O

When	O
comparing	O
the	O
susceptible	O
to	O
the	O
resistant	O
strain	O
,	O
the	O
biggest	O
difference	O
was	O
found	O
in	O
one	O
cluster	O
of	O
genes	O
(	O
cluster	O
IV	O
,	O
Figure	O
2	O
)	O
.	O

These	O
genes	O
had	O
a	O
higher	O
expression	O
in	O
DBA	O
/	O
1	O
than	O
in	O
FVB	O
/	O
N	O
at	O
the	O
early	O
phases	O
of	O
CIA	O
(	O
NC	O
,	O
PI	O
and	O
OA	O
)	O
and	O
the	O
opposite	O
expression	O
pattern	O
in	O
the	O
CA	O
phase	O
.	O

GO	O
term	O
classification	O
revealed	O
that	O
these	O
genes	O
were	O
related	O
to	O
lymphocyte	O
proliferation	O
and	O
activation	O
,	O
suggesting	O
that	O
lymphocytes	O
in	O
the	O
DBA	O
/	O
1	O
strain	O
are	O
more	O
activated	O
than	O
those	O
in	O
the	O
FVB	O
/	O
N	O
strain	O
.	O

However	O
,	O
this	O
difference	O
is	O
not	O
CIA	O
specific	O
because	O
the	O
expression	O
difference	O
between	O
the	O
two	O
strains	O
existed	O
in	O
mice	O
without	O
immunisation	O
.	O

Additionally	O
,	O
some	O
genes	O
related	O
to	O
the	O
immune	O
response	O
were	O
upregulated	O
in	O
the	O
DBA	O
/	O
1	O
strain	O
but	O
not	O
in	O
the	O
FVB	O
/	O
N	O
strain	O
during	O
CIA	O
.	O

These	O
differences	O
could	O
explain	O
why	O
a	O
higher	O
antibody	O
response	O
to	O
collagen	O
II	O
occurred	O
in	O
the	O
DBA	O
/	O
1	O
strain	O
compared	O
to	O
the	O
FVB	O
/	O
N	O
strain	O
,	O
and	O
might	O
partially	O
explain	O
the	O
difference	O
of	O
the	O
susceptibility	O
to	O
CIA	O
between	O
both	O
strains	O
.	O

Twenty	O
-	O
one	O
genes	O
were	O
identified	O
as	O
potential	O
candidate	O
genes	O
for	O
six	O
of	O
the	O
eight	O
small	O
-	O
effect	O
QTL	O
according	O
to	O
their	O
gene	O
expression	O
patterns	O
during	O
CIA	O
and	O
their	O
genomic	O
locations	O
.	O

No	O
candidate	O
genes	O
were	O
located	O
in	O
QTL	O
4	O
and	O
7	O
,	O
suggesting	O
that	O
QTG	O
polymorphisms	O
of	O
the	O
susceptibility	O
genes	O
inside	O
these	O
two	O
QTL	O
might	O
not	O
affect	O
the	O
phenotype	O
by	O
regulating	O
gene	O
expression	O
.	O

Two	O
of	O
the	O
21	O
candidate	O
genes	O
were	O
reported	O
to	O
be	O
involved	O
in	O
arthritis	O
.	O

Mapk14	O
,	O
a	O
candidate	O
gene	O
for	O
locus	O
8	O
and	O
also	O
called	O
p38	O
mitogen	O
-	O
activated	O
protein	B-CHEBI
kinase	O
(	O
MAPK	O
)	O
alpha	O
,	O
regulates	O
the	O
production	O
of	O
arthritis	O
-	O
essential	O
cytokines	O
,	O
such	O
as	O
tumour	O
necrosis	O
factor	O
and	O
interleukin	O
-	O
1	O
[	O
32	O
]	O
.	O

Moreover	O
,	O
inhibitors	B-CHEBI
of	O
p38	O
MAPK	O
could	O
attenuate	O
CIA	O
in	O
rats	O
[	O
33	O
]	O
,	O
and	O
p38	O
MAPK	O
is	O
becoming	O
a	O
potential	O
therapeutic	O
target	O
in	O
RA	O
[	O
32	O
]	O
.	O

Stat5a	O
,	O
a	O
candidate	O
gene	O
for	O
loci	O
6	O
,	O
is	O
an	O
essential	O
molecule	B-CHEBI
for	O
lymphoid	O
development	O
and	O
differentiation	O
[	O
34	O
]	O
.	O

Stat5a	O
-	O
deficient	O
mice	O
were	O
reported	O
to	O
lose	O
tolerance	O
,	O
resulting	O
in	O
the	O
development	O
of	O
autoimmune	O
diseases	O
.	O

Stat5a	O
is	O
suggested	O
to	O
contribute	O
to	O
tolerance	O
through	O
maintenance	O
of	O
the	O
CD4	O
+	O
CD25	O
+	O
regulatory	O
T	O
cell	O
population	O
[	O
35	O
]	O
.	O

Therefore	O
,	O
we	O
have	O
presented	O
a	O
strategy	O
to	O
identify	O
small	O
-	O
effect	O
QTL	O
and	O
search	O
for	O
potential	O
candidate	O
genes	O
within	O
them	O
.	O

However	O
,	O
it	O
is	O
noteworthy	O
that	O
the	O
low	O
statistical	O
threshold	O
and	O
small	O
number	O
of	O
animals	O
per	O
group	O
could	O
lead	O
to	O
some	O
false	O
positive	O
results	O
.	O

On	O
the	O
genome	O
level	O
,	O
some	O
of	O
the	O
eight	O
small	O
-	O
effect	O
QTL	O
identified	O
using	O
a	O
very	O
low	O
threshold	O
value	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
could	O
be	O
false	O
positives	O
.	O

For	O
example	O
,	O
locus	O
4	O
was	O
identified	O
with	O
a	O
low	O
P	O
value	O
and	O
does	O
not	O
overlap	O
with	O
any	O
previously	O
identified	O
arthritis	O
QTL	O
.	O

On	O
the	O
transcriptome	O
level	O
,	O
the	O
small	O
number	O
of	O
animals	O
per	O
group	O
and	O
the	O
low	O
threshold	O
used	O
to	O
detect	O
gene	O
expression	O
could	O
also	O
result	O
in	O
false	O
positives	O
in	O
the	O
differentially	O
expressed	O
genes	O
.	O

Furthermore	O
,	O
the	O
differential	O
expression	O
of	O
a	O
gene	O
could	O
result	O
not	O
only	O
from	O
allele	O
difference	O
between	O
two	O
strains	O
,	O
but	O
also	O
from	O
other	O
factors	O
.	O

Therefore	O
,	O
our	O
findings	O
should	O
be	O
confirmed	O
in	O
future	O
studies	O
.	O

Conclusion	O

We	O
present	O
a	O
strategy	O
to	O
search	O
candidate	O
genes	O
for	O
small	O
-	O
effect	O
QTL	O
.	O

With	O
this	O
strategy	O
,	O
we	O
identified	O
21	O
candidate	O
genes	O
for	O
8	O
small	O
-	O
effect	O
QTL	O
regulating	O
CIA	O
susceptibility	O
.	O

Our	O
future	O
studies	O
will	O
be	O
carried	O
out	O
using	O
two	O
approaches	O
.	O

The	O
first	O
is	O
generating	O
congenic	O
animals	O
for	O
promising	O
small	O
-	O
effect	O
QTL	O
that	O
have	O
relatively	O
high	O
P	O
values	O
and	O
overlap	O
with	O
previously	O
-	O
identified	O
arthritis	O
QTL	O
.	O

The	O
second	O
approach	O
is	O
investigating	O
candidate	O
genes	O
using	O
both	O
mouse	O
and	O
human	O
studies	O
.	O

Candidate	O
genes	O
will	O
be	O
selected	O
according	O
to	O
their	O
function	O
and	O
polymorphism	O
between	O
the	O
two	O
strains	O
.	O

Thereafter	O
,	O
we	O
will	O
generate	O
knock	O
-	O
out	O
mice	O
to	O
investigate	O
the	O
role	O
of	O
the	O
genes	O
in	O
CIA	O
.	O

For	O
the	O
loci	O
whose	O
counterparts	O
on	O
the	O
human	O
genome	O
are	O
linked	O
to	O
RA	O
,	O
we	O
will	O
investigate	O
the	O
candidate	O
genes	O
using	O
case	O
-	O
control	O
association	O
studies	O
in	O
RA	O
cohorts	O
.	O

Abbreviations	O

CA	O
=	O
chronic	O
arthritis	O
;	O
CIA	O
=	O
collagen	O
-	O
induced	O
arthritis	O
;	O
CV	O
=	O
coefficiant	O
of	O
variation	O
;	O
GO	O
=	O
Gene	O
Ontology	O
;	O
LN	O
=	O
lymph	O
node	O
;	O
LOD	O
=	O
logarithm	O
of	O
the	O
odds	O
;	O
MAPK	O
=	O
mitogen	O
-	O
activated	O
protein	B-CHEBI
kinase	O
;	O
NC	O
=	O
naive	O
control	O
;	O
OA	O
=	O
onset	O
of	O
arthritis	O
;	O
PI	O
=	O
post	O
-	O
immunisation	O
;	O
QTG	O
=	O
quantitative	O
trait	O
gene	O
;	O
QTL	O
=	O
quantitative	O
trait	O
loci	O
;	O
RA	O
=	O
rheumatoid	O
arthritis	O
.	O

Competing	O
interests	O

The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

Authors	O
'	O
contributions	O

XY	O
and	O
KB	O
performed	O
the	O
animal	O
experiments	O
.	O

DK	O
and	O
HJT	O
performed	O
gene	O
expression	O
profiling	O
experiments	O
.	O

XY	O
and	O
DK	O
performed	O
the	O
bioinformatic	O
analysis	O
.	O

SI	O
conceived	O
and	O
designed	O
the	O
experiment	O
.	O

XY	O
and	O
SI	O
drafted	O
the	O
manuscript	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Supplementary	O
Material	O

Additional	O
file	O
1	O

Summary	O
information	O
on	O
the	O
509	O
genes	O
differentially	O
expressed	O
between	O
DBA	O
/	O
1	O
and	O
FVB	O
/	O
N	O
strains	O
.	O

Comparison	O
was	O
performed	O
between	O
two	O
strains	O
at	O
four	O
stages	O
of	O
CIA	O
,	O
NA	O
,	O
PI	O
,	O
OA	O
and	O
CA	O
.	O

Three	O
criteria	O
were	O
applied	O
for	O
selecting	O
the	O
differentially	O
expressed	O
genes	O
:	O
the	O
lower	O
90	O
%	O
confidence	O
bound	O
of	O
fold	O
change	O
between	O
the	O
group	O
means	O
exceeded	O
twofold	O
;	O
the	O
absolute	O
difference	O
between	O
the	O
two	O
groups	O
exceeded	O
100	O
;	O
the	O
P	O
value	O
threshold	O
of	O
the	O
unpaired	O
t	O
-	O
test	O
was	O
0	O
.	O
05	O

Click	O
here	O
for	O
file	O

Additional	O
file	O
2	O

Summary	O
information	O
on	O
the	O
311	O
genes	O
differentially	O
expressed	O
in	O
joints	O
in	O
the	O
DBA	O
/	O
1	O
strain	O
during	O
CIA	O
.	O

Pairwise	O
comparisons	O
were	O
performed	O
by	O
comparing	O
PI	O
,	O
OA	O
and	O
CA	O
with	O
NA	O
.	O

Three	O
criteria	O
were	O
applied	O
for	O
selecting	O
the	O
differentially	O
expressed	O
genes	O
:	O
the	O
lower	O
90	O
%	O
confidence	O
bound	O
of	O
fold	O
change	O
between	O
the	O
group	O
means	O
exceeded	O
twofold	O
;	O
the	O
absolute	O
difference	O
between	O
the	O
two	O
groups	O
exceeded	O
100	O
;	O
the	O
P	O
value	O
threshold	O
of	O
the	O
unpaired	O
t	O
-	O
test	O
was	O
0	O
.	O
05	O

Click	O
here	O
for	O
file	O

Additional	O
file	O
3	O

Summary	O
information	O
on	O
the	O
117	O
genes	O
that	O
were	O
strain	O
-	O
specific	O
differentially	O
expressed	O
and	O
were	O
dysregulated	O
in	O
the	O
DBA	O
/	O
1	O
strain	O
during	O
CIA	O
.	O

The	O
physical	O
positions	O
of	O
the	O
genes	O
were	O
retrieved	O
from	O
Ensembl	O
[	O
30	O
]	O

Click	O
here	O
for	O
file	O

Acknowledgements	O

The	O
authors	O
wish	O
to	O
thank	O
Ilona	O
Klamfuss	O
for	O
animal	O
care	O
.	O

This	O
work	O
was	O
supported	O
by	O
a	O
grant	O
from	O
the	O
EU	O
FP6	O
(	O
MRTN	O
-	O
CT	O
-	O
2004	O
-	O
005693	O
,	O
EURO	O
-	O
RA	O
)	O
.	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Differentially	O
expressed	O
genes	O
between	O
collagen	O
-	O
induced	O
arthritis	O
(	O
CIA	O
)	O
susceptible	O
and	O
resistant	O
strains	O
.	O

Comparison	O
of	O
the	O
gene	O
expression	O
between	O
the	O
DBA	O
/	O
1	O
and	O
FVB	O
/	O
N	O
strains	O
was	O
performed	O
at	O
four	O
phases	O
of	O
CIA	O
.	O

Of	O
the	O
22	O
,	O
000	O
screened	O
genes	O
,	O
509	O
were	O
differentially	O
expressed	O
between	O
both	O
strains	O
at	O
one	O
or	O
more	O
phases	O
of	O
CIA	O
,	O
including	O
361	O
genes	O
at	O
the	O
naive	O
control	O
(	O
NC	O
)	O
phase	O
,	O
141	O
genes	O
at	O
post	O
-	O
immunisation	O
(	O
PI	O
)	O
phase	O
,	O
184	O
genes	O
at	O
the	O
onset	O
of	O
arthritis	O
(	O
OA	O
)	O
phase	O
and	O
85	O
genes	O
at	O
the	O
chronic	O
arthritis	O
(	O
CA	O
)	O
phase	O
.	O

The	O
Venn	O
diagram	O
indicates	O
the	O
number	O
of	O
overlapping	O
genes	O
differentially	O
expressed	O
at	O
different	O
phases	O
of	O
CIA	O
.	O

Figure	O
2	O

Differentially	O
expressed	O
genes	O
in	O
the	O
DBA	O
/	O
1	O
strain	O
during	O
collagen	O
-	O
induced	O
arthritis	O
(	O
CIA	O
)	O
.	O

Three	O
experimental	O
conditions	O
,	O
post	O
-	O
immunisation	O
(	O
PI	O
)	O
,	O
onset	O
of	O
arthritis	O
(	O
OA	O
)	O
and	O
chronic	O
arthritis	O
(	O
CA	O
)	O
,	O
were	O
compared	O
with	O
na	O
i	O
ve	O
control	O
(	O
NC	O
)	O
to	O
search	O
for	O
differentially	O
expressed	O
genes	O
.	O

(	O
a	O
)	O
Venn	O
diagram	O
indicating	O
the	O
number	O
of	O
overlapping	O
genes	O
differentially	O
expressed	O
at	O
three	O
phases	O
of	O
CIA	O
.	O

(	O
b	O
)	O
Hierarchical	O
clustering	O
of	O
the	O
310	O
differentially	O
expressed	O
genes	O
.	O

The	O
left	O
panel	O
shows	O
the	O
distribution	O
of	O
relative	O
gene	O
expression	O
across	O
the	O
hierarchical	O
tree	O
structure	O
.	O

Rows	O
represent	O
individual	O
genes	O
;	O
columns	O
represent	O
individual	O
value	O
of	O
triplicate	O
samples	O
for	O
each	O
experimental	O
group	O
.	O

Each	O
cell	O
in	O
the	O
matrix	O
represents	O
the	O
expression	O
level	O
of	O
a	O
gene	O
,	O
with	O
red	O
and	O
green	O
indicating	O
transcription	O
levels	O
above	O
and	O
below	O
the	O
normal	O
values	O
for	O
that	O
gene	O
,	O
respectively	O
.	O

Four	O
sample	O
groups	O
are	O
indicated	O
above	O
the	O
expression	O
matrix	O
.	O

Six	O
basic	O
gene	O
clusters	O
(	O
clusters	O
I	O
to	O
VI	O
)	O
were	O
yielded	O
by	O
the	O
analysis	O
according	O
to	O
the	O
gene	O
expression	O
pattern	O
during	O
CIA	O
.	O

The	O
expression	O
patterns	O
of	O
the	O
gene	O
cluster	O
are	O
graphed	O
and	O
the	O
major	O
biological	O
activities	O
for	O
each	O
cluster	O
that	O
were	O
examined	O
by	O
functional	O
clustering	O
analysis	O
are	O
indicated	O
on	O
the	O
right	O
.	O

Figure	O
3	O

Visualisation	O
of	O
all	O
the	O
chromosomal	O
locations	O
of	O
the	O
small	O
-	O
effect	O
QTL	O
identified	O
in	O
this	O
study	O
(	O
blue	O
bar	O
)	O
as	O
well	O
as	O
120	O
genes	O
of	O
interest	O
from	O
gene	O
expression	O
profiling	O
(	O
black	O
letters	O
)	O
.	O

The	O
positions	O
of	O
the	O
120	O
genes	O
and	O
the	O
peak	O
markers	O
of	O
the	O
QTL	O
were	O
retrieved	O
from	O
Ensembl	O
[	O
30	O
]	O
.	O

Confidence	O
intervals	O
of	O
all	O
the	O
QTL	O
were	O
set	O
as	O
40	O
Mb	O
.	O

Table	O
1	O

Experimental	O
groups	O
used	O
for	O
gene	O
expression	O
profiling	O

CA	O
,	O
chronic	O
arthritis	O
;	O
CFA	O
;	O
complete	O
Freund	O
'	O
s	O
adjuvant	O
;	O
CV	O
,	O
coefficient	O
of	O
variation	O
;	O
LN	O
,	O
lymph	O
node	O
;	O
NC	O
,	O
naive	O
control	O
;	O
OA	O
,	O
onset	O
of	O
arthritis	O
;	O
PI	O
,	O
post	O
-	O
immunisation	O
.	O

Table	O
2	O

Summary	O
of	O
the	O
small	O
-	O
effect	O
QTL	O
identified	O
in	O
this	O
study	O

aIdentified	O
in	O
all	O
F2	O
290	O
progeny	O
.	O

bIdentified	O
in	O
76	O
C5	O
+	O
/	O
+	O
F2	O
progeny	O
.	O

cIdentified	O
in	O
133	O
C5	O
+	O
/	O
-	O
F2	O
progeny	O
.	O

QTL	O
,	O
quantitative	O
trait	O
loci	O
;	O
RA	O
,	O
rheumatoid	O
arthritis	O
.	O

Table	O
3	O

Summary	O
of	O
the	O
small	O
-	O
effect	O
QTL	O
candidate	O
genes	O

aFold	O
change	O
calculated	O
by	O
comparing	O
DBA	O
/	O
1	O
with	O
FVB	O
/	O
N	O
.	O

bFold	O
change	O
calculated	O
by	O
comparing	O
post	O
-	O
immunisation	O
(	O
PI	O
)	O
,	O
onset	O
of	O
arthritis	O
(	O
OA	O
)	O
and	O
chronic	O
arthritis	O
(	O
CA	O
)	O
with	O
naive	O
control	O
(	O
NC	O
)	O
,	O
respectively	O
.	O

Chr	O
.	O
,	O
chromosome	O
;	O
CIA	O
,	O
collagen	O
-	O
induced	O
arthritis	O
.	O

Pygo1	O
and	O
Pygo2	O
roles	O
in	O
Wnt	O
signaling	O
in	O
mammalian	O
kidney	O
development	O

Abstract	O

Background	O

The	O
pygopus	O
gene	O
of	O
Drosophila	O
encodes	O
an	O
essential	O
component	O
of	O
the	O
Armadillo	O
(	O
beta	O
-	O
catenin	O
)	O
transcription	O
factor	O
complex	O
of	O
canonical	O
Wnt	O
signaling	O
.	O

To	O
better	O
understand	O
the	O
functions	O
of	O
Pygopus	O
-	O
mediated	O
canonical	O
Wnt	O
signaling	O
in	O
kidney	O
development	O
,	O
targeted	O
mutations	O
were	O
made	O
in	O
the	O
two	O
mammalian	O
orthologs	O
,	O
Pygo1	O
and	O
Pygo2	O
.	O

Results	O

Each	O
mutation	O
deleted	O
>	O
80	O
%	O
of	O
the	O
coding	O
sequence	O
,	O
including	O
the	O
critical	O
PHD	O
domain	O
,	O
and	O
almost	O
certainly	O
resulted	O
in	O
null	O
function	O
.	O

Pygo2	O
homozygous	O
mutants	O
,	O
with	O
rare	O
exception	O
,	O
died	O
shortly	O
after	O
birth	O
,	O
with	O
a	O
phenotype	O
including	O
lens	O
agenesis	O
,	O
growth	O
retardation	O
,	O
altered	O
kidney	O
development	O
,	O
and	O
in	O
some	O
cases	O
exencephaly	O
and	O
cleft	O
palate	O
.	O

Pygo1	O
homozygous	O
mutants	O
,	O
however	O
,	O
were	O
viable	O
and	O
fertile	O
,	O
with	O
no	O
detectable	O
developmental	O
defects	O
.	O

Double	O
Pygo1	O
/	O
Pygo2	O
homozygous	O
mutants	O
showed	O
no	O
apparent	O
synergy	O
in	O
phenotype	O
severity	O
.	O

The	O
BAT	O
-	O
gal	O
transgene	O
reporter	O
of	O
canonical	O
Wnt	O
signaling	O
showed	O
reduced	O
levels	O
of	O
expression	O
in	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
mutants	O
,	O
with	O
tissue	O
-	O
specific	O
variation	O
in	O
degree	O
of	O
diminution	O
.	O

The	O
Pygo1	O
and	O
Pygo2	O
genes	O
both	O
showed	O
widespread	O
expression	O
in	O
the	O
developing	O
kidney	O
,	O
with	O
raised	O
levels	O
in	O
the	O
stromal	O
cell	O
compartment	O
.	O

Confocal	O
analysis	O
of	O
the	O
double	O
mutant	O
kidneys	O
showed	O
disturbance	O
of	O
both	O
the	O
ureteric	O
bud	O
and	O
metanephric	O
mesenchyme	O
-	O
derived	O
compartments	O
.	O

Branching	O
morphogenesis	O
of	O
the	O
ureteric	O
bud	O
was	O
altered	O
,	O
with	O
expanded	O
tips	O
and	O
reduced	O
tip	O
density	O
,	O
probably	O
contributing	O
to	O
the	O
smaller	O
size	O
of	O
the	O
mutant	O
kidney	O
.	O

In	O
addition	O
,	O
there	O
was	O
an	O
expansion	O
of	O
the	O
zone	O
of	O
condensed	O
mesenchyme	O
capping	O
the	O
ureteric	O
bud	O
.	O

Nephron	O
formation	O
,	O
however	O
,	O
proceeded	O
normally	O
.	O

Microarray	O
analysis	O
showed	O
changed	O
expression	O
of	O
several	O
genes	O
,	O
including	O
Cxcl13	O
,	O
Slc5a2	O
,	O
Klk5	O
,	O
Ren2	O
and	O
Timeless	O
,	O
which	O
represent	O
candidate	O
Wnt	O
targets	O
in	O
kidney	O
development	O
.	O

Conclusion	O

The	O
mammalian	O
Pygopus	O
genes	O
are	O
required	O
for	O
normal	O
branching	O
morphogenesis	O
of	O
the	O
ureteric	O
bud	O
during	O
kidney	O
development	O
.	O

Nevertheless	O
,	O
the	O
relatively	O
mild	O
phenotype	O
observed	O
in	O
the	O
kidney	O
,	O
as	O
well	O
as	O
other	O
organ	O
systems	O
,	O
indicates	O
a	O
striking	O
evolutionary	O
divergence	O
of	O
Pygopus	O
function	O
between	O
mammals	O
and	O
Drosophila	O
.	O

In	O
mammals	O
,	O
the	O
Pygo1	O
/	O
Pygo2	O
genes	O
are	O
not	O
absolutely	O
required	O
for	O
canonical	O
Wnt	O
signaling	O
in	O
most	O
developing	O
systems	O
,	O
but	O
rather	O
function	O
as	O
quantitative	O
transducers	O
,	O
or	O
modulators	O
,	O
of	O
Wnt	O
signal	O
intensity	O
.	O

Background	O

Wnt	O
signaling	O
is	O
of	O
critical	O
importance	O
in	O
several	O
stages	O
of	O
kidney	O
development	O
.	O

Mutual	O
inductive	O
interactions	O
between	O
the	O
ureteric	O
bud	O
and	O
metanephric	O
mesenchyme	O
drive	O
nephrogenesis	O
[	O
1	O
]	O
.	O

The	O
ureteric	O
bud	O
synthesizes	O
Wnt9b	O
,	O
which	O
is	O
essential	O
for	O
induction	O
of	O
the	O
mesenchyme	O
to	O
form	O
nephrons	O
[	O
2	O
]	O
.	O

Wnt4	O
is	O
made	O
by	O
the	O
induced	O
metanephric	O
mesenchyme	O
and	O
is	O
also	O
required	O
for	O
nephrogenesis	O
[	O
3	O
]	O
.	O

Furthermore	O
,	O
Wnt11	O
,	O
secreted	O
by	O
the	O
ureteric	O
bud	O
tips	O
,	O
participates	O
in	O
a	O
positive	O
feedback	O
loop	O
promoting	O
glial	O
cell	O
line	O
-	O
derived	O
neurotrophic	O
factor	O
(	O
GDNF	O
)	O
expression	O
by	O
the	O
metanephric	O
mesenchyme	O
[	O
4	O
]	O
.	O

Mutations	O
in	O
Wnt9b	O
or	O
Wnt4	O
result	O
in	O
a	O
dramatic	O
block	O
in	O
nephron	O
formation	O
,	O
while	O
Wnt11	O
mutants	O
show	O
a	O
significant	O
reduction	O
in	O
nephron	O
number	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
Wnt4	O
and	O
Wnt11	O
have	O
been	O
shown	O
to	O
signal	O
,	O
at	O
least	O
in	O
some	O
cases	O
,	O
through	O
noncanonical	O
pathways	O
[	O
5	O
-	O
7	O
]	O
,	O
while	O
there	O
is	O
evidence	O
indicating	O
that	O
Wnt9b	O
activates	O
canonical	O
Wnt	O
signaling	O
in	O
the	O
kidney	O
[	O
2	O
]	O
.	O

Genetic	O
studies	O
in	O
Drosophila	O
have	O
identified	O
the	O
Pygopus	O
(	O
Pygo	O
)	O
gene	O
as	O
a	O
critical	O
component	O
of	O
canonical	O
Wnt	O
signaling	O
[	O
8	O
-	O
11	O
]	O
.	O

Pygo	O
and	O
Lgs	O
interact	O
with	O
beta	O
-	O
catenin	O
during	O
the	O
formation	O
of	O
the	O
canonical	O
transcriptional	O
complex	O
and	O
are	O
required	O
for	O
accumulation	O
of	O
beta	O
-	O
catenin	O
in	O
the	O
nucleus	O
[	O
12	O
]	O
.	O

Lgs	O
binds	O
the	O
central	O
armadillo	O
repeats	O
of	O
beta	O
-	O
catenin	O
,	O
while	O
Pygo	O
interacts	O
with	O
Lgs	O
,	O
mediating	O
activation	O
of	O
Wnt	O
targets	O
[	O
9	O
,	O
13	O
]	O
.	O

The	O
N	B-CHEBI
-	O
terminal	O
domain	O
of	O
Pygo	O
is	O
required	O
for	O
Wnt	O
transcriptional	O
activation	O
,	O
while	O
the	O
PHD	O
motif	O
is	O
required	O
for	O
the	O
association	O
of	O
Pygo	O
with	O
Lgs	O
[	O
9	O
,	O
13	O
]	O
.	O

Additionally	O
,	O
a	O
putative	O
nuclear	O
localization	O
signal	O
(	O
NLS	O
)	O
was	O
identified	O
within	O
the	O
N	B-CHEBI
-	O
terminal	O
domain	O
of	O
Pygo	O
,	O
suggesting	O
a	O
possible	O
role	O
of	O
nuclear	O
importation	O
of	O
beta	O
-	O
catenin	O
[	O
8	O
,	O
11	O
]	O
.	O

Analyses	O
of	O
multiple	O
aspects	O
of	O
the	O
pygopus	O
mutant	O
phenotype	O
indicate	O
that	O
this	O
gene	O
is	O
dedicated	O
to	O
,	O
and	O
required	O
for	O
,	O
canonical	O
Wnt	O
signaling	O
during	O
Drosophila	O
development	O
[	O
9	O
]	O
.	O

The	O
mammalian	O
genome	O
carries	O
two	O
,	O
and	O
only	O
two	O
,	O
orthologs	O
of	O
Drosophila	O
Pygo	O
,	O
Pygo1	O
and	O
Pygo2	O
[	O
8	O
,	O
9	O
,	O
14	O
]	O
.	O

In	O
this	O
report	O
,	O
we	O
generated	O
targeted	O
mutations	O
of	O
Pygo1	O
and	O
Pygo2	O
to	O
determine	O
their	O
functions	O
,	O
with	O
a	O
particular	O
interest	O
in	O
the	O
contributions	O
of	O
these	O
genes	O
to	O
canonical	O
Wnt	O
signaling	O
during	O
kidney	O
development	O
.	O

The	O
resulting	O
double	O
-	O
homozygous	O
mutant	O
embryos	O
showed	O
a	O
context	O
-	O
dependent	O
reduction	O
in	O
canonical	O
Wnt	O
signaling	O
as	O
measured	O
by	O
Wnt	O
reporter	O
transgene	O
expression	O
.	O

Development	O
remained	O
,	O
however	O
,	O
surprisingly	O
normal	O
,	O
with	O
survival	O
to	O
birth	O
and	O
few	O
apparent	O
defects	O
in	O
most	O
organ	O
systems	O
.	O

Our	O
phenotypic	O
analysis	O
focused	O
on	O
the	O
kidney	O
,	O
which	O
showed	O
altered	O
branching	O
morphogenesis	O
of	O
the	O
ureteric	O
bud	O
,	O
and	O
expansion	O
of	O
the	O
zone	O
of	O
condensed	O
mesenchyme	O
surrounding	O
the	O
ureteric	O
bud	O
,	O
yet	O
relatively	O
normal	O
nephron	O
formation	O
,	O
as	O
measured	O
by	O
histology	O
,	O
confocal	O
analysis	O
,	O
in	O
situ	O
hybridization	O
and	O
microarray	O
analysis	O
.	O

The	O
obvious	O
conclusion	O
is	O
that	O
in	O
mammals	O
,	O
unlike	O
Drosophila	O
,	O
Pygopus	O
-	O
mediated	O
canonical	O
Wnt	O
signaling	O
is	O
not	O
absolutely	O
necessary	O
in	O
most	O
developing	O
organ	O
systems	O
.	O

Results	O

Pygo1	O
and	O
Pygo2	O
targeted	O
mutations	O

We	O
targeted	O
both	O
the	O
Pygo1	O
and	O
Pygo2	O
genes	O
by	O
inserting	O
LoxP	O
sequences	O
to	O
flank	O
critical	O
coding	O
regions	O
including	O
the	O
PHD	O
domains	O
.	O

The	O
resulting	O
targeted	O
mice	O
were	O
mated	O
with	O
transgenic	O
CMV	O
-	O
Cre	O
mice	O
[	O
15	O
]	O
to	O
drive	O
germline	O
LoxP	O
recombination	O
,	O
resulting	O
in	O
the	O
null	O
mutant	O
alleles	O
that	O
were	O
used	O
for	O
this	O
study	O
.	O

PCR	O
confirmed	O
the	O
deletion	O
of	O
the	O
bulk	O
of	O
the	O
coding	O
sequences	O
for	O
both	O
genes	O
,	O
including	O
89	O
%	O
of	O
coding	O
sequence	O
for	O
Pygo1	O
and	O
87	O
%	O
of	O
coding	O
sequence	O
for	O
Pygo2	O
.	O

Previous	O
studies	O
in	O
Drosophila	O
have	O
shown	O
that	O
even	O
a	O
single	O
missense	O
mutation	O
in	O
the	O
PHD	O
domain	O
can	O
eliminate	O
Pygo	O
function	O
in	O
Wnt	O
signaling	O
[	O
8	O
]	O
.	O

Pygo1	O
and	O
Pygo2	O
mutant	O
phenotypes	O

Pygo1	O
homozygous	O
null	O
mice	O
were	O
viable	O
and	O
fertile	O
with	O
no	O
developmental	O
defects	O
detectable	O
.	O

This	O
was	O
surprising	O
given	O
the	O
importance	O
of	O
the	O
pygopus	O
gene	O
in	O
Wnt	O
signaling	O
in	O
Drosophila	O
,	O
and	O
the	O
reported	O
expression	O
during	O
development	O
of	O
the	O
mouse	O
Pygo1	O
gene	O
in	O
,	O
for	O
example	O
,	O
the	O
brain	O
,	O
limbs	O
,	O
kidney	O
and	O
branchial	O
arches	O
[	O
14	O
,	O
16	O
]	O
(	O
Yu	O
J	O
,	O
Valerius	O
MT	O
,	O
McMahon	O
AP	O
,	O
contribution	O
to	O
GUDMAP	O
,	O
)	O
.	O

The	O
Pygo2	O
homozygous	O
null	O
mice	O
survived	O
to	O
birth	O
,	O
but	O
with	O
rare	O
exceptions	O
,	O
died	O
shortly	O
afterwards	O
.	O

The	O
gut	O
,	O
heart	O
and	O
limbs	O
developed	O
without	O
detectable	O
abnormality	O
(	O
data	O
not	O
shown	O
)	O
despite	O
known	O
requirements	O
for	O
Wnt	O
signaling	O
.	O

The	O
Pygo2	O
mutants	O
did	O
,	O
however	O
,	O
show	O
growth	O
retardation	O
,	O
lens	O
agenesis	O
and	O
a	O
kidney	O
phenotype	O
with	O
high	O
penetrance	O
,	O
exencephaly	O
,	O
and	O
cleft	O
palate	O
with	O
incomplete	O
penetrance	O
.	O

Double	O
-	O
homozygous	O
mutant	O
Pygo1	O
and	O
Pygo2	O
mice	O
had	O
a	O
phenotype	O
similar	O
to	O
that	O
of	O
single	O
Pygo2	O
nulls	O
(	O
Figure	O
1	O
,	O
Table	O
1	O
)	O
.	O

There	O
was	O
no	O
significant	O
synergism	O
of	O
developmental	O
abnormalities	O
in	O
the	O
double	O
mutants	O
.	O

Together	O
these	O
results	O
suggest	O
that	O
Pygo2	O
is	O
required	O
for	O
the	O
proper	O
development	O
of	O
a	O
limited	O
number	O
of	O
structures	O
,	O
whereas	O
Pygo1	O
is	O
not	O
necessary	O
for	O
normal	O
development	O
.	O

Figure	O
1	O

Pygo1	O
/	O
Pygo2	O
mutant	O
embryos	O
.	O

(	O
A	O
)	O
E18	O
.	O
5	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
-	O
embryos	O
,	O
with	O
only	O
one	O
wild	O
-	O
type	O
Pygo2	O
allele	O
,	O
appeared	O
normal	O
.	O

(	O
B	O
,	O
C	O
)	O
Double	O
homozygous	O
mutant	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
embryos	O
were	O
smaller	O
,	O
with	O
eye	O
defects	O
including	O
absent	O
or	O
rudimentary	O
lens	O
and	O
folded	O
pigmented	O
retina	O
(	O
arrows	O
)	O
.	O

(	O
C	O
)	O
A	O
small	O
percentage	O
of	O
Pygo1	O
/	O
Pygo2	O
null	O
embryos	O
also	O
displayed	O
exencephaly	O
.	O

Table	O
1	O

Phenotypes	O
of	O
Pygo2	O
wild	O
-	O
type	O
,	O
heterozyogous	O
,	O
and	O
null	O
E18	O
.	O
5	O
embryos	O
on	O
a	O
Pygo1	O
null	O
background	O
.	O

*	O
Denotes	O
a	O
significant	O
change	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
of	O
the	O
average	O
weight	O
of	O
the	O
Pygo2	O
null	O
group	O
compared	O
with	O
both	O
the	O
Pygo	O
wild	O
-	O
type	O
and	O
heterozygous	O
groups	O
.	O

Expression	O
of	O
Pygo1	O
and	O
Pygo2	O
in	O
the	O
developing	O
kidney	O

In	O
situ	O
hybridization	O
has	O
been	O
used	O
previously	O
to	O
characterize	O
expression	O
of	O
Pygo1	O
[	O
14	O
,	O
16	O
]	O
(	O
Yu	O
J	O
,	O
Valerius	O
MT	O
,	O
McMahon	O
AP	O
,	O
contribution	O
to	O
GUDMAP	O
,	O
)	O
.	O

In	O
this	O
report	O
,	O
we	O
used	O
immunofluorescence	O
to	O
better	O
define	O
the	O
expression	O
patterns	O
of	O
the	O
Pygo1	O
and	O
Pygo2	O
genes	O
in	O
the	O
developing	O
kidney	O
.	O

Both	O
genes	O
were	O
widely	O
expressed	O
,	O
showing	O
nuclear	O
localization	O
of	O
encoded	O
proteins	B-CHEBI
in	O
the	O
ureteric	O
bud	O
,	O
capping	O
mesenchyme	O
,	O
and	O
stromal	O
cells	O
(	O
Figure	O
2	O
)	O
.	O

Raised	O
expression	O
of	O
Pygo1	O
,	O
and	O
to	O
a	O
lesser	O
degree	O
of	O
Pygo2	O
,	O
was	O
seen	O
in	O
stromal	O
cells	O
,	O
and	O
significant	O
nuclear	O
staining	O
was	O
detected	O
in	O
essentially	O
all	O
cells	O
of	O
the	O
developing	O
kidney	O
for	O
both	O
proteins	B-CHEBI
.	O

Figure	O
2	O

Pygo1	O
and	O
Pygo2	O
expression	O
in	O
the	O
E18	O
.	O
5	O
developing	O
kidney	O
.	O

Immunofluorescence	O
was	O
used	O
to	O
determine	O
expression	O
patterns	O
of	O
the	O
Pygo1	O
and	O
Pygo2	O
proteins	B-CHEBI
in	O
the	O
cortex	O
of	O
the	O
E18	O
.	O
5	O
kidney	O
.	O

Both	O
Pygo1	O
and	O
Pygo2	O
(	O
red	O
)	O
were	O
localized	O
in	O
the	O
nucleus	O
,	O
as	O
expected	O
.	O

Both	O
genes	O
showed	O
widespread	O
expression	O
,	O
with	O
signal	O
detected	O
in	O
all	O
components	O
of	O
the	O
developing	O
kidney	O
,	O
but	O
with	O
elevated	O
levels	O
in	O
the	O
stromal	O
cell	O
compartment	O
(	O
arrows	O
)	O
.	O

Epithelial	O
cells	O
,	O
primarily	O
ureteric	O
bud	O
in	O
these	O
sections	O
,	O
were	O
labeled	O
blue	O
using	O
E	O
-	O
cadherin	O
antibody	O
.	O

Original	O
magnification	O
x	O
200	O
.	O

Confocal	O
analysis	O
of	O
Pygo1	O
/	O
Pygo2	O
mutant	O
kidneys	O

Histological	O
examination	O
of	O
Pygo2	O
null	O
and	O
Pygo1	O
/	O
Pygo2	O
double	O
-	O
null	O
mutant	O
kidneys	O
did	O
not	O
reveal	O
any	O
abnormalities	O
in	O
nephrogenesis	O
(	O
data	O
not	O
shown	O
)	O
.	O

Confocal	O
analysis	O
was	O
therefore	O
performed	O
to	O
characterize	O
renal	O
development	O
in	O
E18	O
.	O
5	O
Pygo1	O
/	O
Pygo2	O
null	O
kidneys	O
more	O
precisely	O
(	O
Figure	O
3	O
)	O
.	O

Wt1	O
(	O
red	O
)	O
and	O
Cited1	O
(	O
red	O
)	O
antibodies	O
both	O
stain	O
the	O
capping	O
metanephric	O
mesenchyme	O
around	O
the	O
ureteric	O
bud	O
tips	O
[	O
17	O
]	O
.	O

WT1	O
antibody	O
also	O
stains	O
renal	O
vesicles	O
and	O
glomerular	O
anlage	O
.	O

Antibodies	O
to	O
Cdh1	O
,	O
also	O
known	O
as	O
E	O
-	O
cadherin	O
(	O
blue	O
)	O
,	O
were	O
used	O
to	O
identify	O
epithelial	O
structures	O
,	O
including	O
the	O
branching	O
ureteric	O
bud	O
and	O
nascent	O
nephrons	O
of	O
the	O
developing	O
kidney	O
[	O
18	O
]	O
.	O

Dolichos	O
biflorus	O
(	O
DBA	O
)	O
lectin	O
[	O
16	O
]	O
was	O
used	O
to	O
selectively	O
stain	O
ureteric	O
bud	O
-	O
derived	O
structures	O
[	O
19	O
]	O
.	O

Figure	O
3	O

Confocal	O
analysis	O
of	O
Pygo1	O
/	O
Pygo2	O
mutant	O
E18	O
.	O
5	O
kidneys	O
.	O

(	O
B	O
,	O
D	O
)	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
mutant	O
E18	O
.	O
5	O
kidneys	O
and	O
(	O
A	O
,	O
C	O
)	O
kidneys	O
of	O
normal	O
littermates	O
were	O
stained	O
using	O
antibodies	O
to	O
(	O
C	O
,	O
D	O
)	O
Cited1	O
or	O
(	O
A	O
,	O
B	O
)	O
Wt1	O
,	O
both	O
expressed	O
in	O
the	O
condensing	O
metanephric	O
mesenchyme	O
,	O
and	O
colored	O
as	O
red	O
,	O
Cdh1	O
,	O
a	O
general	O
marker	O
of	O
epithelia	O
(	O
blue	O
)	O
,	O
and	O
DBA	O
lectin	O
staining	O
the	O
ureteric	O
tree	O
[	O
16	O
]	O
.	O

Confocal	O
Z	O
-	O
sections	O
were	O
obtained	O
every	O
5	O
mu	O
m	O
for	O
75	O
-	O
80	O
mu	O
m	O
.	O

A	O
reduced	O
number	O
of	O
ureteric	O
tips	O
per	O
area	O
was	O
observed	O
in	O
(	O
B	O
,	O
D	O
)	O
the	O
Pygo1	O
/	O
Pygo2	O
null	O
kidneys	O
compared	O
with	O
(	O
A	O
,	O
C	O
)	O
control	O
littermates	O
.	O

In	O
addition	O
,	O
ureteric	O
bud	O
tips	O
were	O
often	O
more	O
dilated	O
in	O
Pygo1	O
/	O
2	O
null	O
mutants	O
compared	O
with	O
controls	O
.	O

The	O
condensed	O
mesenchyme	O
surrounding	O
the	O
ureteric	O
bud	O
was	O
also	O
significantly	O
expanded	O
in	O
the	O
mutants	O
.	O

Original	O
magnification	O
x	O
200	O
.	O

Wt1	O
and	O
Cited1	O
(	O
red	O
)	O
staining	O
revealed	O
an	O
increase	O
of	O
approximately	O
30	O
%	O
in	O
the	O
thickness	O
of	O
the	O
capping	O
mesenchyme	O
surrounding	O
the	O
mutant	O
ureteric	O
buds	O
(	O
Figure	O
3	O
,	O
Table	O
2	O
)	O
.	O

Nevertheless	O
,	O
the	O
mutant	O
metanephric	O
mesenchyme	O
underwent	O
relatively	O
normal	O
nephrogenesis	O
.	O

Cdh1	O
-	O
staining	O
nephrons	O
(	O
blue	O
)	O
were	O
identified	O
connecting	O
to	O
the	O
ureteric	O
bud	O
tips	O
[	O
16	O
]	O
and	O
extending	O
into	O
the	O
medulla	O
of	O
the	O
kidney	O
,	O
as	O
normal	O
.	O

Intermediate	O
structures	O
of	O
nephrogenesis	O
,	O
including	O
renal	O
vesicles	O
,	O
comma	O
-	O
shaped	O
bodies	O
,	O
and	O
S	O
-	O
shaped	O
bodies	O
appeared	O
normal	O
.	O

Table	O
2	O

Confocal	O
analysis	O
of	O
Pygo2	O
wild	O
-	O
type	O
,	O
heterozygous	O
,	O
and	O
null	O
E18	O
.	O
5	O
kidneys	O
on	O
the	O
Pygo1	O
null	O
background	O
.	O

*	O
Significant	O
change	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
between	O
the	O
three	O
groups	O
.	O

SD	O
,	O
Standard	O
deviation	O
;	O
n	O
,	O
number	O

Confocal	O
analysis	O
also	O
showed	O
that	O
the	O
ureteric	O
bud	O
tips	O
[	O
16	O
]	O
of	O
Pygo1	O
/	O
Pygo2	O
null	O
kidneys	O
were	O
dilated	O
and	O
misshaped	O
compared	O
with	O
those	O
of	O
littermates	O
with	O
at	O
least	O
one	O
wild	O
-	O
type	O
Pygo2	O
allele	O
(	O
Figure	O
3	O
)	O
.	O

In	O
addition	O
,	O
the	O
Pygo1	O
/	O
Pygo2	O
double	O
-	O
homozygous	O
mutant	O
kidneys	O
also	O
had	O
a	O
decrease	O
of	O
approximately	O
25	O
%	O
in	O
the	O
number	O
of	O
ureteric	O
bud	O
tips	O
per	O
area	O
compared	O
with	O
littermates	O
with	O
at	O
least	O
one	O
wild	O
-	O
type	O
copy	O
of	O
Pygo2	O
(	O
Table	O
2	O
)	O
.	O

No	O
significant	O
difference	O
in	O
ureteric	O
bud	O
-	O
tip	O
density	O
was	O
seen	O
between	O
Pygo2	O
+	O
/	O
-	O
and	O
Pygo2	O
+	O
/	O
+	O
embryos	O
(	O
P	O
=	O
0	O
.	O
33	O
)	O
.	O

In	O
situ	O
hybridization	O

We	O
examined	O
expression	O
of	O
three	O
Wnt	O
genes	O
in	O
Pygo	O
mutants	O
.	O

Wnt7b	O
is	O
expressed	O
in	O
the	O
stalks	O
[	O
20	O
]	O
,	O
Wnt11	O
in	O
the	O
tips	O
[	O
4	O
]	O
,	O
and	O
Wnt9b	O
in	O
the	O
stalks	O
and	O
weakly	O
in	O
the	O
tips	O
of	O
the	O
branching	O
ureteric	O
bud	O
[	O
2	O
]	O
.	O

All	O
three	O
genes	O
showed	O
similar	O
expression	O
patterns	O
in	O
Pygo2	O
+	O
/	O
+	O
and	O
Pygo1	O
/	O
Pygo2	O
double	O
-	O
mutant	O
kidneys	O
(	O
Figure	O
4	O
)	O
.	O

In	O
addition	O
,	O
these	O
in	O
situ	O
hybridization	O
patterns	O
confirmed	O
the	O
confocal	O
microscopy	O
results	O
,	O
showing	O
a	O
reduced	O
number	O
of	O
tips	O
(	O
Wnt11	O
-	O
positive	O
)	O
per	O
surface	O
area	O
in	O
the	O
Pygo1	O
/	O
Pygo2	O
double	O
-	O
homozygous	O
mutants	O
.	O

Figure	O
4	O

Expression	O
of	O
Wnt7b	O
,	O
Wnt9b	O
,	O
and	O
Wnt11	O
in	O
E18	O
.	O
5	O
Pygo1	O
/	O
Pygo2	O
compound	O
null	O
kidneys	O
.	O

Whole	O
-	O
mount	O
in	O
situ	O
of	O
hybridizations	O
of	O
(	O
A	O
-	O
C	O
)	O
E18	O
.	O
5	O
wild	O
-	O
type	O
kidneys	O
and	O
(	O
D	O
-	O
F	O
)	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
mutant	O
kidneys	O
with	O
the	O
ureteric	O
bud	O
derivative	O
markers	O
:	O
(	O
A	O
,	O
D	O
)	O
Wnt7b	O
,	O
(	O
B	O
,	O
E	O
)	O
Wnt9b	O
,	O
and	O
(	O
C	O
,	O
F	O
)	O
Wnt11	O
.	O

The	O
mutant	O
kidneys	O
showed	O
normal	O
expression	O
patterns	O
for	O
the	O
ureteric	O
stalk	O
markers	O
Wnt7b	O
and	O
Wnt9b	O
,	O
and	O
reduced	O
density	O
of	O
ureteric	O
tips	O
as	O
measured	O
by	O
Wnt11	O
.	O

Original	O
magnification	O
x	O
32	O
.	O

Reduced	O
canonical	O
Wnt	O
signaling	O
in	O
Pygo1	O
/	O
Pygo2	O
mutant	O
mice	O

The	O
BAT	O
-	O
gal	O
transgene	O
reporter	O
of	O
canonical	O
Wnt	O
signaling	O
[	O
21	O
]	O
was	O
used	O
to	O
examine	O
changes	O
in	O
Wnt	O
signaling	O
in	O
the	O
mutant	O
mice	O
.	O

Both	O
Pygo2	O
-	O
/	O
-	O
and	O
Pygo1	O
/	O
Pygo2	O
double	O
-	O
null	O
E10	O
.	O
5	O
embryos	O
showed	O
a	O
decrease	O
in	O
canonical	O
Wnt	O
signaling	O
(	O
Figure	O
5	O
)	O
.	O

There	O
was	O
,	O
however	O
,	O
tissue	O
-	O
specific	O
variability	O
in	O
the	O
degree	O
of	O
reduction	O
,	O
with	O
the	O
somites	O
,	O
for	O
example	O
,	O
showing	O
strong	O
reduction	O
,	O
while	O
the	O
mutant	O
telencephalon	O
still	O
showed	O
robust	O
Wnt	O
signaling	O
.	O

These	O
results	O
suggest	O
that	O
the	O
mammalian	O
Pygo	O
genes	O
are	O
significant	O
modulators	O
of	O
canonical	O
Wnt	O
signaling	O
in	O
some	O
,	O
but	O
not	O
in	O
all	O
developing	O
systems	O
.	O

Figure	O
5	O

Reduced	O
canonical	O
Wnt	O
signaling	O
in	O
Pygo2	O
and	O
Pygo1	O
/	O
Pygo2	O
mutant	O
embryos	O
.	O

E10	O
.	O
5	O
embryos	O
,	O
all	O
with	O
the	O
BAT	O
-	O
gal	O
transgene	O
reporter	O
of	O
canonical	O
Wnt	O
signaling	O
.	O

(	O
A	O
)	O
Pygo1	O
+	O
/	O
+	O
/	O
Pygo2	O
+	O
/	O
-	O
embryos	O
showed	O
normal	O
X	O
-	O
gal	O
staining	O
in	O
the	O
developing	O
brain	O
,	O
pharyngeal	O
pouches	O
,	O
otic	O
vesicle	O
,	O
apical	O
ectodermal	O
ridges	O
of	O
the	O
fore	O
and	O
hind	O
limb	O
buds	O
,	O
and	O
in	O
somites	O
.	O

(	O
B	O
)	O
Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
embryos	O
,	O
with	O
loss	O
of	O
both	O
Pygo2	O
alleles	O
,	O
showed	O
reduced	O
but	O
not	O
absent	O
BAT	O
-	O
gal	O
reporter	O
expression	O
in	O
many	O
developing	O
structures	O
,	O
including	O
pharyngeal	O
pouches	O
,	O
otic	O
vesicle	O
,	O
and	O
somites	O
.	O

(	O
C	O
)	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
-	O
embryo	O
,	O
with	O
mutation	O
of	O
both	O
Pygo1	O
alleles	O
,	O
but	O
one	O
wild	O
-	O
type	O
Pygo2	O
allele	O
,	O
showed	O
normal	O
BAT	O
-	O
gal	O
expression	O
.	O

(	O
D	O
)	O
Double	O
-	O
homozygous	O
mutant	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
embryos	O
still	O
showed	O
some	O
remaining	O
BAT	O
-	O
gal	O
expression	O
,	O
suggesting	O
residual	O
canonical	O
Wnt	O
signaling	O
.	O

Embryos	O
in	O
panels	O
(	O
A	O
)	O
and	O
(	O
B	O
)	O
were	O
from	O
the	O
same	O
litter	O
and	O
were	O
processed	O
in	O
parallel	O
,	O
while	O
embryos	O
in	O
(	O
C	O
)	O
and	O
(	O
D	O
)	O
were	O
from	O
a	O
separate	O
litter	O
,	O
also	O
processed	O
in	O
parallel	O
,	O
and	O
were	O
slightly	O
more	O
developmentally	O
advanced	O
.	O

Original	O
magnification	O
(	O
A	O
,	O
B	O
)	O
x	O
20	O
;	O
(	O
C	O
,	O
D	O
)	O
x	O
16	O
.	O

We	O
also	O
examined	O
BAT	O
-	O
gal	O
reporter	O
expression	O
in	O
more	O
detail	O
in	O
the	O
developing	O
urogenital	O
system	O
of	O
Pygo	O
mutants	O
.	O

The	O
results	O
suggested	O
that	O
the	O
Pygo2	O
gene	O
is	O
required	O
for	O
canonical	O
Wnt	O
signaling	O
in	O
the	O
nephric	O
duct	O
.	O

Both	O
Pygo2	O
null	O
and	O
Pygo1	O
/	O
Pygo2	O
double	O
-	O
null	O
E10	O
.	O
5	O
embryos	O
showed	O
an	O
absence	O
of	O
reporter	O
expression	O
in	O
the	O
nephric	O
duct	O
,	O
while	O
control	O
littermates	O
showed	O
strong	O
expression	O
(	O
Figure	O
6A	O
-	O
C	O
)	O
.	O

In	O
Pygo1	O
/	O
Pygo2	O
double	O
-	O
null	O
mutants	O
,	O
the	O
nephric	O
duct	O
did	O
form	O
,	O
however	O
,	O
and	O
give	O
rise	O
to	O
the	O
ureteric	O
bud	O
outgrowth	O
,	O
which	O
showed	O
reduced	O
but	O
not	O
absent	O
BAT	O
-	O
gal	O
reporter	O
expression	O
(	O
Figure	O
6A	O
-	O
C	O
)	O
.	O

Figure	O
6	O

Pygo2	O
is	O
required	O
for	O
BAT	O
-	O
gal	O
reporter	O
expression	O
in	O
ureteric	O
bud	O
-	O
derived	O
structures	O
of	O
the	O
developing	O
kidney	O
.	O

X	O
-	O
Gal	O
staining	O
of	O
BAT	O
-	O
gal	O
transgenic	O
(	O
A	O
-	O
C	O
)	O
E10	O
.	O
5	O
,	O
and	O
(	O
E	O
-	O
L	O
)	O
E13	O
.	O
5	O
urogenital	O
tracts	O
,	O
and	O
(	O
M	O
-	O
O	O
)	O
E18	O
.	O
5	O
kidneys	O
.	O

(	O
A	O
)	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
+	O
(	O
left	O
)	O
and	O
Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
(	O
right	O
)	O
.	O

Note	O
the	O
loss	O
of	O
reporter	O
activity	O
in	O
the	O
nephric	O
duct	O
(	O
black	O
arrowhead	O
)	O
and	O
reduction	O
of	O
staining	O
in	O
the	O
ureteric	O
bud	O
(	O
white	O
arrow	O
)	O
of	O
the	O
Pygo2	O
null	O
embryo	O
(	O
Right	O
)	O
.	O

(	O
B	O
)	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
-	O
E10	O
.	O
5	O
embryo	O
with	O
BAT	O
-	O
gal	O
reporter	O
activity	O
in	O
the	O
nephric	O
duct	O
(	O
black	O
arrowhead	O
)	O
and	O
ureteric	O
bud	O
(	O
white	O
arrow	O
)	O
.	O

(	O
C	O
)	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo	O
-	O
/	O
-	O
embryo	O
,	O
with	O
reporter	O
expression	O
lost	O
in	O
the	O
nephric	O
duct	O
and	O
reduced	O
in	O
the	O
ureteric	O
bud	O
(	O
white	O
arrow	O
)	O
.	O

(	O
D	O
)	O
Control	O
background	O
X	O
-	O
gal	O
staining	O
of	O
a	O
urogenital	O
tract	O
from	O
an	O
E13	O
.	O
5	O
embryo	O
without	O
the	O
BAT	O
-	O
gal	O
transgene	O
(	O
Non	O
-	O
Tg	O
)	O
,	O
showing	O
absence	O
of	O
endogenous	O
beta	O
-	O
galactosidase	O
activity	O
.	O

(	O
E	O
)	O
Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
+	O
,	O
with	O
BAT	O
-	O
gal	O
reporter	O
activity	O
in	O
the	O
ureteric	O
compartment	O
of	O
the	O
developing	O
kidney	O
,	O
including	O
the	O
ureteric	O
tips	O
,	O
ureteric	O
tree	O
,	O
and	O
ureter	O
.	O

(	O
F	O
)	O
Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
,	O
with	O
marked	O
reduction	O
of	O
BAT	O
-	O
gal	O
reporter	O
activity	O
in	O
the	O
ureteric	O
compartment	O
.	O

(	O
G	O
)	O
Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
-	O
,	O
with	O
reporter	O
expression	O
in	O
the	O
paramesonephric	O
duct	O
(	O
white	O
arrowhead	O
)	O
and	O
ureteric	O
tree	O
.	O

(	O
H	O
,	O
I	O
)	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
-	O
,	O
with	O
(	O
H	O
)	O
ventral	O
view	O
showing	O
reporter	O
expression	O
in	O
the	O
paramesonephric	O
duct	O
(	O
white	O
arrowhead	O
)	O
,	O
and	O
(	O
I	O
)	O
dorsal	O
view	O
showing	O
ureteric	O
tree	O
expression	O
in	O
the	O
kidney	O
.	O

(	O
J	O
)	O
Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
-	O
,	O
a	O
control	O
processed	O
in	O
parallel	O
with	O
(	O
K	O
)	O
and	O
(	O
L	O
)	O
,	O
with	O
expression	O
in	O
ureteric	O
tree	O
and	O
paramesonephric	O
duct	O
.	O

(	O
K	O
,	O
L	O
)	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
,	O
reporter	O
activity	O
was	O
lost	O
in	O
the	O
paramesonephric	O
duct	O
(	O
white	O
arrowhead	O
)	O
,	O
and	O
in	O
the	O
ureter	O
and	O
ureteric	O
compartment	O
of	O
the	O
developing	O
kidneys	O
(	O
dashed	O
circles	O
)	O
,	O
except	O
for	O
(	O
K	O
)	O
a	O
few	O
faintly	O
staining	O
cells	O
.	O

(	O
M	O
,	O
N	O
)	O
Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
-	O
(	O
left	O
)	O
and	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
(	O
right	O
)	O
E18	O
.	O
5	O
kidneys	O
.	O

The	O
kidneys	O
in	O
(	O
N	O
)	O
were	O
bisected	O
.	O

BAT	O
-	O
gal	O
reporter	O
expression	O
was	O
seen	O
in	O
the	O
ureteric	O
tree	O
components	O
of	O
the	O
cortex	O
and	O
medulla	O
of	O
the	O
double	O
heterozygotes	O
but	O
was	O
almost	O
completely	O
lost	O
in	O
the	O
double	O
-	O
homozygous	O
mutants	O
.	O

(	O
O	O
)	O
Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
+	O
(	O
left	O
)	O
,	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
-	O
(	O
middle	O
)	O
,	O
and	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
(	O
right	O
)	O
E18	O
.	O
5	O
kidneys	O
.	O

Reporter	O
activity	O
was	O
present	O
in	O
the	O
ureteric	O
compartments	O
of	O
the	O
Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
+	O
(	O
left	O
)	O
and	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
-	O
(	O
middle	O
)	O
kidneys	O
,	O
but	O
lost	O
in	O
the	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
(	O
right	O
)	O
kidney	O
.	O

Original	O
magnification	O
:	O
(	O
A	O
-	O
C	O
)	O
x	O
32	O
,	O
(	O
D	O
-	O
F	O
)	O
x	O
63	O
,	O
(	O
G	O
-	O
I	O
)	O
x	O
40	O
,	O
(	O
J	O
-	O
L	O
)	O
x	O
50	O
,	O
(	O
M	O
,	O
N	O
)	O
x	O
10	O
,	O
and	O
(	O
O	O
)	O
x	O
12	O
.	O
5	O
.	O

At	O
E13	O
.	O
5	O
,	O
the	O
Pygo2	O
gene	O
appeared	O
to	O
play	O
a	O
major	O
role	O
,	O
and	O
the	O
Pygo1	O
gene	O
a	O
minor	O
role	O
,	O
in	O
canonical	O
Wnt	O
signaling	O
in	O
the	O
ureteric	O
tree	O
,	O
as	O
measured	O
by	O
BAT	O
-	O
gal	O
expression	O
.	O

A	O
negative	O
control	O
kidney	O
,	O
without	O
the	O
BAT	O
-	O
gal	O
transgene	O
,	O
showed	O
minimal	O
background	O
X	O
-	O
gal	O
staining	O
(	O
Figure	O
6D	O
)	O
,	O
whereas	O
a	O
BAT	O
-	O
gal	O
transgenic	O
kidney	O
with	O
at	O
least	O
one	O
wild	O
-	O
type	O
Pygo2	O
gene	O
showed	O
strong	O
X	O
-	O
gal	O
staining	O
in	O
the	O
ureteric	O
tree	O
(	O
Figure	O
6E	O
)	O
.	O

In	O
contrast	O
,	O
Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
E13	O
.	O
5	O
kidneys	O
showed	O
very	O
weak	O
reporter	O
expression	O
(	O
Figure	O
6F	O
)	O
,	O
suggesting	O
a	O
significant	O
loss	O
of	O
canonical	O
Wnt	O
signaling	O
.	O

Homozygous	O
loss	O
of	O
the	O
Pygo1	O
gene	O
alone	O
,	O
however	O
,	O
had	O
a	O
small	O
effect	O
on	O
reporter	O
expression	O
(	O
Figure	O
6G	O
-	O
H	O
)	O
.	O

Homozygous	O
mutation	O
of	O
both	O
the	O
Pygo1	O
and	O
Pygo2	O
genes	O
gave	O
a	O
more	O
dramatic	O
reduction	O
of	O
BAT	O
-	O
gal	O
expression	O
than	O
loss	O
of	O
Pygo2	O
alone	O
(	O
Figure	O
6F	O
,	O
L	O
)	O
.	O

The	O
Pygo1	O
and	O
Pygo2	O
genes	O
were	O
also	O
required	O
for	O
BAT	O
-	O
gal	O
reporter	O
expression	O
in	O
the	O
paramesonephric	O
(	O
Mullerian	O
)	O
ducts	O
.	O

In	O
Pygo2	O
-	O
/	O
-	O
mice	O
,	O
there	O
was	O
a	O
significant	O
loss	O
of	O
reporter	O
expression	O
(	O
data	O
not	O
shown	O
)	O
,	O
and	O
double	O
-	O
homozygous	O
mutants	O
showed	O
loss	O
of	O
X	O
-	O
gal	O
staining	O
in	O
the	O
paramesonephric	O
ducts	O
(	O
Figure	O
6K	O
)	O
,	O
whereas	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
-	O
and	O
Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
-	O
mice	O
showed	O
normal	O
levels	O
of	O
BAT	O
-	O
gal	O
expression	O
(	O
Figure	O
6G	O
,	O
H	O
,	O
J	O
)	O
.	O

BAT	O
-	O
gal	O
reporter	O
analysis	O
of	O
the	O
Pygo	O
mutants	O
at	O
a	O
later	O
developmental	O
stage	O
,	O
E18	O
.	O
5	O
,	O
also	O
identified	O
a	O
significant	O
decrease	O
in	O
canonical	O
Wnt	O
signaling	O
in	O
the	O
cortical	O
ureteric	O
branches	O
and	O
renal	O
pelvis	O
of	O
the	O
developing	O
kidney	O
(	O
Figure	O
6M	O
-	O
O	O
)	O
.	O

Cortical	O
X	O
-	O
gal	O
staining	O
was	O
seen	O
in	O
the	O
ureteric	O
branches	O
of	O
a	O
Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
-	O
kidney	O
(	O
Figure	O
6M	O
,	O
left	O
)	O
,	O
but	O
was	O
completely	O
absent	O
in	O
the	O
cortex	O
of	O
a	O
Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
kidney	O
(	O
Figure	O
6M	O
,	O
right	O
)	O
.	O

Bisection	O
revealed	O
a	O
significant	O
loss	O
of	O
X	O
-	O
gal	O
staining	O
cells	O
in	O
the	O
collecting	O
ducts	O
and	O
renal	O
pelvis	O
of	O
the	O
Pygo2	O
null	O
kidney	O
compared	O
with	O
control	O
littermates	O
(	O
Figure	O
6N	O
)	O
.	O

Side	O
by	O
side	O
comparison	O
of	O
Pygo1	O
+	O
/	O
+	O
/	O
Pygo2	O
+	O
/	O
-	O
(	O
Figure	O
6O	O
,	O
left	O
)	O
,	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
-	O
(	O
Figure	O
6O	O
,	O
middle	O
)	O
,	O
and	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
(	O
Figure	O
6O	O
,	O
right	O
)	O
E18	O
.	O
5	O
kidneys	O
suggested	O
a	O
significant	O
role	O
for	O
the	O
Pygo2	O
gene	O
in	O
canonical	O
Wnt	O
signaling	O
in	O
the	O
ureteric	O
tree	O
and	O
its	O
derivatives	O
.	O

In	O
order	O
to	O
validate	O
and	O
quantify	O
the	O
BAT	O
-	O
gal	O
reporter	O
expression	O
changes	O
in	O
the	O
Pygo2	O
null	O
and	O
Pygo1	O
/	O
Pygo2	O
nulls	O
,	O
we	O
performed	O
ELISA	O
measurements	O
of	O
transgene	O
specific	O
beta	O
-	O
galactosidase	O
levels	O
in	O
E18	O
.	O
5	O
kidneys	O
(	O
Figure	O
7	O
)	O
.	O

Loss	O
of	O
the	O
Pygo2	O
gene	O
(	O
Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
and	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
)	O
gave	O
greater	O
than	O
90	O
%	O
reduction	O
in	O
BAT	O
-	O
gal	O
expression	O
.	O

Loss	O
of	O
Pygo1	O
alone	O
(	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
+	O
)	O
did	O
not	O
result	O
in	O
a	O
significant	O
change	O
.	O

Interestingly	O
,	O
however	O
,	O
the	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
-	O
showed	O
only	O
50	O
%	O
of	O
wild	O
-	O
type	O
BAT	O
-	O
gal	O
expression	O
,	O
suggesting	O
a	O
minor	O
contribution	O
by	O
Pygo1	O
in	O
canonical	O
Wnt	O
signaling	O
.	O

Although	O
BAT	O
-	O
gal	O
expression	O
was	O
decreased	O
in	O
the	O
E18	O
.	O
5	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
-	O
kidney	O
,	O
confocal	O
analysis	O
of	O
kidneys	O
with	O
this	O
genotype	O
revealed	O
no	O
dilated	O
ureteric	O
tips	O
or	O
significant	O
changes	O
in	O
ureteric	O
tip	O
number	O
per	O
area	O
compared	O
with	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
+	O
kidneys	O
(	O
data	O
not	O
shown	O
)	O
.	O

Collectively	O
,	O
these	O
BAT	O
-	O
gal	O
reporter	O
results	O
suggest	O
a	O
significant	O
role	O
for	O
the	O
Pygo1	O
and	O
Pygo2	O
genes	O
in	O
canonical	O
Wnt	O
signaling	O
during	O
development	O
of	O
the	O
ureteric	O
tree	O
of	O
the	O
kidney	O
.	O

Figure	O
7	O

Quantitative	O
analysis	O
of	O
BAT	O
-	O
gal	O
reporter	O
expression	O
in	O
Pygo1	O
/	O
Pygo2	O
E18	O
.	O
5	O
kidney	O
extracts	O
.	O

Transgene	O
-	O
specific	O
beta	O
-	O
galactosidase	O
was	O
quantified	O
by	O
ELISA	O
analysis	O
.	O

Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
+	O
,	O
Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
-	O
and	O
Pygo1	O
+	O
/	O
-	O
/	O
Pygo2	O
+	O
/	O
+	O
kidneys	O
all	O
showed	O
similar	O
levels	O
of	O
BAT	O
-	O
gal	O
expression	O
.	O

In	O
the	O
Pygo2	O
hetereozygote	O
,	O
Pygo1	O
homozygous	O
mutants	O
,	O
however	O
,	O
reporter	O
expression	O
was	O
reduced	O
by	O
about	O
50	O
%	O
.	O

In	O
Pygo2	O
homozygous	O
mutants	O
BAT	O
-	O
gal	O
expression	O
was	O
uniformly	O
low	O
,	O
with	O
or	O
without	O
wild	O
-	O
type	O
Pygo1	O
alleles	O
.	O

Each	O
experimental	O
group	O
included	O
a	O
sample	O
size	O
of	O
at	O
least	O
four	O
.	O

Interestingly	O
,	O
however	O
,	O
even	O
in	O
wild	O
-	O
type	O
mice	O
the	O
BAT	O
-	O
gal	O
reporter	O
showed	O
no	O
expression	O
in	O
the	O
developing	O
metanephric	O
mesenchyme	O
,	O
or	O
metanephric	O
mesenchyme	O
-	O
derived	O
structures	O
,	O
such	O
as	O
renal	O
vesicles	O
,	O
S	O
-	O
shaped	O
bodies	O
,	O
tubules	O
,	O
and	O
glomeruli	O
.	O

This	O
has	O
been	O
reported	O
previously	O
,	O
and	O
was	O
interpreted	O
to	O
indicate	O
the	O
absence	O
of	O
canonical	O
Wnt	O
signaling	O
in	O
the	O
metanephric	O
mesenchyme	O
[	O
21	O
]	O
.	O

Results	O
from	O
other	O
studies	O
,	O
however	O
,	O
argue	O
for	O
the	O
presence	O
of	O
canonical	O
Wnt	O
signaling	O
in	O
the	O
metanephric	O
mesenchyme	O
.	O

For	O
example	O
,	O
ureteric	O
bud	O
expression	O
of	O
Wnt1	O
,	O
thought	O
to	O
act	O
through	O
canonical	O
Wnt	O
signaling	O
,	O
can	O
rescue	O
Wnt9b	O
mutants	O
and	O
induce	O
nephrogenesis	O
of	O
the	O
metanephric	O
mesenchyme	O
[	O
2	O
]	O
.	O

This	O
suggests	O
that	O
the	O
BAT	O
-	O
gal	O
transgene	O
might	O
not	O
accurately	O
report	O
canonical	O
Wnt	O
signaling	O
in	O
the	O
metanephric	O
mesenchyme	O
.	O

To	O
address	O
this	O
question	O
,	O
we	O
incubated	O
E11	O
.	O
5	O
metanephric	O
mesenchyme	O
in	O
lithium	B-CHEBI
chloride	I-CHEBI
(	O
LiCl	B-CHEBI
)	O
,	O
which	O
activates	O
canonical	O
Wnt	O
signaling	O
through	O
inhibition	O
of	O
GSK3	O
,	O
and	O
also	O
functions	O
as	O
an	O
inducer	O
of	O
nephrogenesis	O
in	O
kidney	O
organ	O
culture	O
[	O
22	O
]	O
.	O

We	O
observed	O
that	O
LiCl	B-CHEBI
-	O
treated	O
metanephric	O
mesenchyme	O
did	O
undergo	O
nephrogenesis	O
,	O
as	O
expected	O
,	O
but	O
failed	O
to	O
show	O
BAT	O
-	O
gal	O
expression	O
(	O
data	O
not	O
shown	O
)	O
,	O
suggesting	O
that	O
this	O
transgene	O
is	O
not	O
an	O
accurate	O
reporter	O
of	O
canonical	O
Wnt	O
signaling	O
in	O
the	O
metanephric	O
mesenchyme	O
of	O
the	O
developing	O
kidney	O
.	O

Microarray	O
analysis	O
of	O
Pygo1	O
/	O
Pygo2	O
null	O
kidneys	O

To	O
further	O
examine	O
possible	O
disturbance	O
of	O
gene	O
expression	O
in	O
the	O
Pygo1	O
/	O
Pygo2	O
mutant	O
kidneys	O
,	O
we	O
used	O
microarrays	O
to	O
perform	O
a	O
global	O
analysis	O
of	O
gene	O
expression	O
changes	O
.	O

Whereas	O
the	O
BAT	O
-	O
gal	O
transgene	O
reporter	O
monitors	O
the	O
response	O
of	O
one	O
promoter	O
to	O
Wnt	O
signaling	O
,	O
microarrays	O
can	O
be	O
used	O
to	O
follow	O
expression	O
changes	O
of	O
all	O
genes	O
,	O
including	O
all	O
known	O
Wnt	O
targets	O
.	O

E18	O
.	O
5	O
wild	O
-	O
type	O
and	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
kidneys	O
were	O
examined	O
in	O
biological	O
triplicate	O
.	O

In	O
total	O
,	O
45	O
genes	O
were	O
identified	O
as	O
significantly	O
changed	O
,	O
using	O
a	O
relatively	O
low	O
stringency	O
screen	O
of	O
the	O
data	O
,	O
with	O
a	O
p	O
-	O
value	O
cutoff	O
of	O
<	O
0	O
.	O
05	O
,	O
and	O
fold	O
change	O
>	O
2	O
(	O
Table	O
3	O
)	O
.	O

Notably	O
,	O
both	O
Pygo1	O
and	O
Pygo2	O
were	O
identified	O
as	O
downregulated	O
(	O
-	O
5	O
.	O
3	O
-	O
fold	O
and	O
-	O
3	O
.	O
9	O
-	O
fold	O
,	O
respectively	O
)	O
in	O
the	O
mutant	O
kidneys	O
.	O

Other	O
genes	O
with	O
significant	O
decreases	O
in	O
mutant	O
kidneys	O
included	O
Cxcl13	O
(	O
-	O
2	O
.	O
3	O
-	O
fold	O
)	O
,	O
Slc5a2	O
(	O
-	O
2	O
.	O
8	O
-	O
fold	O
)	O
,	O
and	O
Slco1a4	O
(	O
-	O
2	O
.	O
1	O
-	O
fold	O
)	O
.	O

Slc5a2	O
is	O
expressed	O
in	O
the	O
proximal	O
tubules	O
of	O
the	O
adult	O
nephron	O
and	O
has	O
been	O
implicated	O
in	O
autosomal	O
recessive	O
renal	O
glucosuria	O
,	O
characterized	O
by	O
loss	O
of	O
glucose	B-CHEBI
uptake	O
by	O
the	O
nephron	O
[	O
23	O
]	O
.	O

The	O
organic	B-CHEBI
anion	I-CHEBI
transporter	O
,	O
Slco1a4	O
,	O
is	O
also	O
strongly	O
expressed	O
in	O
the	O
tubules	O
of	O
the	O
adult	O
kidney	O
[	O
24	O
]	O
.	O

These	O
results	O
suggest	O
that	O
the	O
Pygo1	O
/	O
Pygo2	O
genes	O
might	O
play	O
a	O
role	O
in	O
nephron	O
maturation	O
and	O
subsequent	O
function	O
.	O

Table	O
3	O

Genes	O
differentially	O
expressed	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
two	O
-	O
fold	O
change	O
or	O
greater	O
)	O
in	O
the	O
Pygo1	O
/	O
Pygo2	O
null	O
E18	O
.	O
5	O
kidney	O
normalized	O
to	O
wild	O
-	O
type	O
samples	O
.	O

Noteworthy	O
genes	O
upregulated	O
in	O
the	O
Pygo1	O
/	O
Pygo2	O
null	O
kidney	O
included	O
Klk5	O
(	O
2	O
.	O
8	O
-	O
fold	O
)	O
,	O
Klk6	O
(	O
2	O
.	O
7	O
-	O
fold	O
)	O
,	O
Ren2	O
(	O
2	O
.	O
2	O
-	O
fold	O
)	O
,	O
and	O
Timeless	O
(	O
2	O
.	O
4	O
-	O
fold	O
)	O
.	O

Klk5	O
and	O
Klk6	O
are	O
members	O
of	O
the	O
kallikrein	O
family	O
of	O
trypsin	O
-	O
like	O
serine	B-CHEBI
proteases	O
.	O

Kallikreins	O
have	O
diverse	O
functions	O
in	O
cancer	O
,	O
tissue	O
remodeling	O
,	O
and	O
regulation	O
of	O
blood	O
pressure	O
[	O
25	O
]	O
.	O

Ren2	O
,	O
a	O
homolog	O
of	O
the	O
endopeptidase	O
Renin	O
1	O
,	O
activates	O
the	O
renin	O
-	O
angiotensin	O
system	O
,	O
increasing	O
blood	O
pressure	O
[	O
26	O
]	O
.	O

Disruption	O
of	O
the	O
renin	O
-	O
angiotensin	O
system	O
during	O
development	O
results	O
in	O
congenital	O
abnormalities	O
of	O
the	O
ureter	O
and	O
collecting	O
-	O
duct	O
system	O
[	O
27	O
]	O
.	O

Timeless	O
,	O
a	O
transcription	O
factor	O
involved	O
in	O
the	O
regulation	O
of	O
circadian	O
rhythms	O
,	O
and	O
expressed	O
in	O
the	O
branching	O
ureteric	O
tips	O
,	O
has	O
also	O
been	O
shown	O
to	O
regulate	O
ureteric	O
branching	O
morphogenesis	O
[	O
28	O
]	O
.	O

We	O
were	O
interested	O
in	O
the	O
possible	O
altered	O
expression	O
of	O
previously	O
known	O
Wnt	O
targets	O
in	O
the	O
Pygo1	O
-	O
/	O
-	O
/	O
Pygo2	O
-	O
/	O
-	O
mutant	O
kidneys	O
.	O

A	O
list	O
of	O
known	O
Wnt	O
targets	O
was	O
compiled	O
from	O
.	O

Both	O
Pygo1	O
and	O
Pygo2	O
probe	O
sets	O
were	O
included	O
as	O
references	O
to	O
illustrate	O
significant	O
down	O
regulation	O
.	O

Remarkably	O
,	O
the	O
known	O
Wnt	O
target	O
genes	O
showed	O
very	O
few	O
differences	O
in	O
expression	O
between	O
wild	O
-	O
type	O
and	O
mutant	O
kidneys	O
(	O
Figure	O
8	O
)	O
.	O

Only	O
the	O
expression	O
of	O
Ccnd1	O
encoding	O
cyclin	O
D1	O
[	O
29	O
]	O
,	O
and	O
Wisp1	O
[	O
30	O
]	O
were	O
significantly	O
changed	O
,	O
with	O
expression	O
level	O
changes	O
of	O
<	O
1	O
.	O
5	O
-	O
fold	O
in	O
Pygo1	O
/	O
Pygo2	O
null	O
kidneys	O
.	O

These	O
results	O
indicate	O
an	O
absence	O
of	O
dramatic	O
changes	O
in	O
expression	O
of	O
previously	O
known	O
Wnt	O
signaling	O
target	O
genes	O
in	O
the	O
Pygo1	O
/	O
Pygo2	O
mutant	O
kidneys	O
.	O

Figure	O
8	O

Gene	O
expression	O
changes	O
of	O
common	O
Wnt	O
signaling	O
targets	O
in	O
the	O
E18	O
.	O
5	O
Pygo1	O
/	O
Pygo2	O
null	O
kidney	O
.	O

Microarray	O
analysis	O
was	O
performed	O
in	O
triplicate	O
on	O
wild	O
-	O
type	O
and	O
Pygo1	O
/	O
2	O
compound	O
null	O
E18	O
.	O
5	O
kidneys	O
.	O

Possible	O
Wnt	O
targets	O
were	O
selected	O
from	O
those	O
compiled	O
at	O
[	O
39	O
]	O
.	O

An	O
initial	O
gene	O
list	O
of	O
82	O
Wnt	O
targets	O
was	O
created	O
and	O
then	O
reduced	O
to	O
a	O
total	O
of	O
40	O
genes	O
using	O
an	O
expression	O
level	O
restriction	O
requiring	O
the	O
raw	O
expression	O
intensity	O
to	O
be	O
>	O
100	O
in	O
at	O
least	O
3	O
samples	O
.	O

Pygo1	O
and	O
Pygo2	O
probes	O
were	O
included	O
to	O
demonstrate	O
significant	O
changes	O
in	O
expression	O
levels	O
.	O

We	O
used	O
quantitative	O
real	O
-	O
time	O
PCR	O
,	O
with	O
independent	O
biological	O
samples	O
,	O
to	O
validate	O
the	O
microarray	O
results	O
.	O

Nine	O
genes	O
were	O
tested	O
,	O
and	O
for	O
seven	O
we	O
did	O
observe	O
a	O
significant	O
fold	O
change	O
in	O
the	O
same	O
direction	O
predicted	O
by	O
the	O
microarray	O
results	O
(	O
Table	O
4	O
)	O
.	O

It	O
is	O
not	O
surprising	O
that	O
two	O
of	O
the	O
nine	O
genes	O
could	O
not	O
be	O
validated	O
,	O
considering	O
the	O
relatively	O
low	O
stringency	O
used	O
in	O
screening	O
the	O
microarray	O
data	O
.	O

Table	O
4	O

Validation	O
of	O
gene	O
expression	O
changes	O
in	O
the	O
E18	O
.	O
5	O
Pygo1	O
/	O
Pygo2	O
null	O
kidneys	O
normalized	O
to	O
E18	O
.	O
5	O
wild	O
-	O
type	O
kidneys	O
.	O

Discussion	O

In	O
Drosophila	O
,	O
the	O
Pygopus	O
gene	O
is	O
a	O
key	O
mediator	O
of	O
canonical	O
Wnt	O
signaling	O
.	O

In	O
one	O
study	O
,	O
12	O
distinct	O
measures	O
of	O
Wnt	O
signaling	O
in	O
Pygo	O
mutants	O
were	O
performed	O
,	O
including	O
analysis	O
of	O
leg	O
,	O
wing	O
,	O
and	O
eye	O
imaginal	O
discs	O
.	O

In	O
2	O
cases	O
there	O
was	O
a	O
significant	O
reduction	O
of	O
Wnt	O
signaling	O
and	O
in	O
10	O
cases	O
a	O
complete	O
block	O
[	O
10	O
]	O
.	O

A	O
second	O
study	O
in	O
Drosophila	O
examined	O
the	O
effects	O
of	O
Pygo	O
mutation	O
on	O
cuticle	O
patterning	O
,	O
midgut	O
constriction	O
,	O
central	O
nervous	O
system	O
,	O
and	O
cardiac	O
development	O
,	O
and	O
concluded	O
that	O
"	O
Pygo	O
is	O
an	O
essential	O
component	O
in	O
the	O
Wg	O
signal	O
transduction	O
pathway	O
"	O
.	O

[	O
8	O
]	O
.	O

Given	O
these	O
results	O
in	O
Drosophila	O
,	O
the	O
relatively	O
mild	O
phenotypes	O
of	O
mice	O
with	O
targeted	O
Pygo1	O
,	O
Pygo2	O
,	O
or	O
double	O
Pygo1	O
/	O
Pygo2	O
mutations	O
were	O
striking	O
.	O

Pygo2	O
mutants	O
developed	O
to	O
birth	O
and	O
showed	O
limited	O
abnormalities	O
,	O
while	O
Pygo1	O
homozygous	O
mutants	O
were	O
normal	O
and	O
fertile	O
.	O

Furthermore	O
,	O
there	O
was	O
no	O
detected	O
synergism	O
in	O
the	O
phenotype	O
of	O
the	O
double	O
Pygo1	O
/	O
Pygo2	O
mutant	O
,	O
although	O
in	O
several	O
tissues	O
the	O
BAT	O
-	O
gal	O
Wnt	O
reporter	O
did	O
show	O
more	O
a	O
severe	O
reduction	O
in	O
expression	O
.	O

One	O
possible	O
explanation	O
of	O
these	O
unexpected	O
results	O
is	O
a	O
failure	O
of	O
the	O
gene	O
targeting	O
to	O
eliminate	O
functioning	O
of	O
the	O
Pygo1	O
and	O
Pygo2	O
genes	O
.	O

The	O
Pygopus	O
deletion	O
alleles	O
described	O
in	O
this	O
report	O
,	O
however	O
,	O
are	O
almost	O
certainly	O
functional	O
nulls	O
.	O

In	O
Drosophila	O
,	O
it	O
has	O
been	O
shown	O
that	O
the	O
PHD	O
domain	O
is	O
absolutely	O
necessary	O
for	O
Pygopus	O
function	O
in	O
Wg	O
signaling	O
.	O

The	O
PHD	O
domain	O
is	O
60	O
amino	B-CHEBI
acids	I-CHEBI
with	O
seven	O
cysteines	B-CHEBI
and	O
a	O
histidine	B-CHEBI
,	O
predicted	O
to	O
chelate	O
two	O
zinc	B-CHEBI
ions	I-CHEBI
.	O

PHD	O
domains	O
are	O
found	O
in	O
diverse	O
proteins	B-CHEBI
,	O
including	O
transcription	O
factors	O
,	O
and	O
have	O
been	O
implicated	O
in	O
chromatin	O
remodeling	O
and	O
protein	B-CHEBI
-	O
protein	B-CHEBI
interactions	O
[	O
8	O
]	O
.	O

In	O
Drosophila	O
the	O
pygoF107	O
allele	O
,	O
with	O
a	O
single	O
missense	O
mutation	O
converting	O
amino	B-CHEBI
acid	I-CHEBI
802	O
in	O
the	O
PHD	O
domain	O
from	O
cysteine	B-CHEBI
to	O
tyrosine	B-CHEBI
,	O
loses	O
Wnt	O
signaling	O
function	O
in	O
both	O
embryogenesis	O
and	O
imaginal	O
disc	O
development	O
[	O
8	O
]	O
.	O

The	O
Pygo1	O
/	O
Pygo2	O
mutant	O
alleles	O
made	O
in	O
this	O
report	O
carried	O
deletions	O
of	O
the	O
entire	O
PHD	O
domains	O
,	O
as	O
well	O
as	O
most	O
other	O
coding	O
sequences	O
.	O

For	O
the	O
Pygo1	O
gene	O
,	O
the	O
coding	O
region	O
for	O
372	O
of	O
417	O
total	O
amino	B-CHEBI
acids	I-CHEBI
was	O
deleted	O
,	O
and	O
for	O
the	O
Pygo2	O
gene	O
,	O
we	O
deleted	O
coding	O
for	O
354	O
of	O
405	O
amino	B-CHEBI
acids	I-CHEBI
.	O

It	O
is	O
therefore	O
very	O
unlikely	O
that	O
the	O
relatively	O
mild	O
phenotypes	O
observed	O
were	O
the	O
result	O
of	O
residual	O
function	O
of	O
the	O
targeted	O
alleles	O
.	O

We	O
focused	O
our	O
analysis	O
on	O
the	O
developing	O
kidney	O
,	O
in	O
which	O
Wnt	O
signaling	O
has	O
been	O
shown	O
to	O
be	O
of	O
critical	O
importance	O
in	O
several	O
stages	O
of	O
nephrogenesis	O
.	O

Wnt9b	O
is	O
made	O
by	O
the	O
ureteric	O
bud	O
and	O
induces	O
the	O
metanephric	O
mesenchyme	O
to	O
undergo	O
nephrogenesis	O
[	O
2	O
]	O
.	O

Downstream	O
of	O
Wnt9b	O
is	O
Wnt4	O
[	O
2	O
]	O
,	O
which	O
is	O
made	O
by	O
the	O
metanephric	O
mesenchyme	O
,	O
and	O
is	O
also	O
required	O
for	O
nephrogenesis	O
[	O
3	O
]	O
.	O

In	O
addition	O
,	O
Wnt11	O
is	O
produced	O
by	O
the	O
ureteric	O
bud	O
tips	O
and	O
induces	O
GDNF	O
expression	O
in	O
the	O
metanephric	O
mesenchyme	O
[	O
4	O
]	O
.	O

In	O
this	O
report	O
we	O
describe	O
a	O
novel	O
Wnt	O
function	O
in	O
kidney	O
development	O
.	O

The	O
BAT	O
-	O
gal	O
transgene	O
reporter	O
indicated	O
the	O
presence	O
of	O
canonical	O
Wnt	O
signaling	O
in	O
the	O
ureteric	O
bud	O
and	O
its	O
derivatives	O
in	O
the	O
developing	O
kidney	O
.	O

Further	O
,	O
in	O
the	O
Pygo2	O
mutants	O
this	O
signal	O
was	O
lost	O
,	O
suggesting	O
significant	O
reduction	O
of	O
Wnt	O
signaling	O
.	O

In	O
addition	O
,	O
we	O
observed	O
a	O
resulting	O
decrease	O
in	O
ureteric	O
tip	O
density	O
,	O
reduced	O
kidney	O
size	O
and	O
altered	O
morphology	O
of	O
the	O
ureteric	O
tree	O
in	O
mutants	O
,	O
indicating	O
a	O
role	O
for	O
canonical	O
Wnt	O
signaling	O
in	O
branching	O
morphogenesis	O
of	O
the	O
ureteric	O
bud	O
.	O

While	O
the	O
simplest	O
interpretation	O
is	O
direct	O
Wnt	O
signaling	O
to	O
the	O
ureteric	O
bud	O
,	O
it	O
remains	O
possible	O
that	O
the	O
observed	O
abnormalities	O
are	O
the	O
result	O
of	O
indirect	O
effects	O
,	O
with	O
altered	O
Wnt	O
signaling	O
to	O
the	O
metanephric	O
mesenchyme	O
then	O
affecting	O
mesenchyme	O
to	O
ureteric	O
bud	O
signaling	O
.	O

The	O
Pygo1	O
/	O
Pygo2	O
mutant	O
phenotype	O
of	O
reduced	O
branching	O
morphogenesis	O
of	O
the	O
ureteric	O
bud	O
is	O
surprisingly	O
similar	O
to	O
that	O
previously	O
reported	O
for	O
Wnt11	O
mutants	O
[	O
4	O
]	O
.	O

The	O
underlying	O
mechanisms	O
,	O
however	O
,	O
are	O
likely	O
to	O
be	O
distinct	O
.	O

Wnt11	O
is	O
generally	O
thought	O
to	O
act	O
through	O
a	O
noncanonical	O
pathway	O
,	O
(	O
although	O
exceptions	O
have	O
been	O
noted	O
[	O
31	O
]	O
)	O
,	O
whereas	O
the	O
Pygopus	O
genes	O
promote	O
canonical	O
Wnt	O
signaling	O
.	O

Further	O
,	O
the	O
Wnt11	O
mutants	O
showed	O
an	O
altered	O
feedback	O
loop	O
between	O
Wnt	O
signaling	O
from	O
the	O
ureteric	O
bud	O
to	O
the	O
mesenchyme	O
and	O
GDNF	O
signaling	O
from	O
the	O
mesenchyme	O
to	O
the	O
bud	O
,	O
whereas	O
in	O
the	O
Pygo1	O
/	O
Pygo2	O
mutants	O
,	O
we	O
observed	O
disrupted	O
Wnt	O
signaling	O
in	O
the	O
ureteric	O
bud	O
.	O

The	O
Pygo1	O
/	O
2	O
mutants	O
also	O
showed	O
an	O
expansion	O
of	O
the	O
zone	O
of	O
thickened	O
mesenchyme	O
that	O
caps	O
the	O
ureteric	O
bud	O
.	O

Nevertheless	O
,	O
the	O
mutant	O
metanephric	O
mesenchyme	O
formed	O
nephrons	O
normally	O
.	O

This	O
was	O
particularly	O
interesting	O
,	O
as	O
Wnt9b	O
signaling	O
from	O
the	O
ureteric	O
bud	O
to	O
the	O
metanephric	O
mesenchyme	O
has	O
been	O
shown	O
to	O
induce	O
nephrogenesis	O
via	O
canonical	O
Wnt	O
signaling	O
[	O
2	O
]	O
.	O

The	O
results	O
in	O
this	O
report	O
indicate	O
a	O
striking	O
and	O
surprising	O
evolutionary	O
divergence	O
of	O
Pygopus	O
function	O
between	O
Drosophila	O
and	O
mammals	O
.	O

In	O
Drosophila	O
,	O
the	O
Pygopus	O
gene	O
is	O
often	O
required	O
for	O
canonical	O
Wnt	O
signaling	O
,	O
while	O
in	O
mammals	O
the	O
Pygo1	O
/	O
Pygo2	O
genes	O
appear	O
to	O
play	O
a	O
smaller	O
role	O
in	O
canonical	O
Wnt	O
signaling	O
.	O

The	O
BAT	O
-	O
gal	O
transgene	O
reporter	O
of	O
canonical	O
Wnt	O
signaling	O
showed	O
reduced	O
but	O
generally	O
not	O
absent	O
signal	O
in	O
Pygo1	O
/	O
Pygo2	O
mutant	O
embryos	O
,	O
with	O
tissue	O
-	O
specific	O
variation	O
in	O
level	O
of	O
diminution	O
.	O

In	O
addition	O
,	O
the	O
kidneys	O
were	O
not	O
unique	O
in	O
showing	O
surprisingly	O
normal	O
development	O
in	O
Pygo1	O
/	O
Pygo2	O
mutants	O
.	O

Indeed	O
,	O
organogenesis	O
generally	O
proceeded	O
without	O
detectable	O
abnormality	O
,	O
with	O
few	O
exceptions	O
.	O

These	O
results	O
suggest	O
that	O
the	O
proteins	B-CHEBI
encoded	O
by	O
mammalian	O
Pygopus	O
genes	O
are	O
often	O
mere	O
modulators	O
of	O
canonical	O
Wnt	O
signaling	O
intensity	O
,	O
and	O
not	O
essential	O
components	O
.	O

The	O
microarray	O
results	O
further	O
support	O
this	O
conclusion	O
.	O

Whereas	O
the	O
BAT	O
-	O
gal	O
transgene	O
reporter	O
monitors	O
the	O
expression	O
level	O
of	O
only	O
one	O
Wnt	O
responsive	O
promoter	O
,	O
the	O
microarray	O
allows	O
the	O
analysis	O
of	O
the	O
activity	O
levels	O
of	O
promoters	O
of	O
all	O
genes	O
.	O

Interestingly	O
,	O
the	O
mutant	O
kidneys	O
showed	O
gene	O
-	O
expression	O
profiles	O
surprisingly	O
similar	O
to	O
wild	O
type	O
.	O

Some	O
genes	O
did	O
,	O
however	O
,	O
show	O
expression	O
differences	O
,	O
and	O
a	O
high	O
percentage	O
of	O
these	O
differences	O
could	O
be	O
validated	O
by	O
real	O
-	O
time	O
PCR	O
with	O
independent	O
biological	O
samples	O
.	O

Assuming	O
that	O
the	O
Pygopus	O
genes	O
in	O
mammals	O
are	O
dedicated	O
to	O
canonical	O
Wnt	O
signaling	O
,	O
as	O
has	O
been	O
previously	O
shown	O
in	O
Drosophila	O
,	O
the	O
genes	O
with	O
expression	O
differences	O
represent	O
candidate	O
Wnt	O
targets	O
(	O
direct	O
or	O
indirect	O
)	O
in	O
kidney	O
development	O
.	O

We	O
would	O
predict	O
these	O
genes	O
to	O
show	O
greater	O
changes	O
in	O
expression	O
level	O
in	O
a	O
developing	O
kidney	O
with	O
a	O
more	O
complete	O
removal	O
of	O
canonical	O
Wnt	O
signaling	O
.	O

Conclusion	O

In	O
conclusion	O
,	O
the	O
mammalian	O
Pygo2	O
gene	O
is	O
required	O
for	O
normal	O
branching	O
morphogenesis	O
of	O
the	O
ureteric	O
bud	O
,	O
with	O
mutants	O
showing	O
dilated	O
tips	O
and	O
reduced	O
numbers	O
of	O
tips	O
.	O

In	O
addition	O
,	O
in	O
Pygo2	O
mutants	O
there	O
was	O
an	O
expansion	O
of	O
the	O
zone	O
of	O
metanephric	O
mesenchyme	O
that	O
caps	O
the	O
ureteric	O
buds	O
.	O

Nevertheless	O
,	O
nephron	O
formation	O
proceeded	O
remarkably	O
normally	O
,	O
even	O
in	O
Pygo1	O
/	O
Pygo2	O
double	O
-	O
homozygous	O
mutants	O
.	O

This	O
was	O
surprising	O
considering	O
the	O
importance	O
of	O
the	O
Pygopus	O
gene	O
in	O
canonical	O
Wnt	O
signaling	O
in	O
Drosophila	O
,	O
and	O
the	O
importance	O
of	O
canonical	O
Wnt	O
signaling	O
in	O
nephrogenesis	O
.	O

The	O
results	O
argue	O
that	O
the	O
mammalian	O
Pygopus	O
genes	O
are	O
,	O
in	O
most	O
developing	O
systems	O
,	O
only	O
quantitative	O
transducers	O
of	O
Wnt	O
signaling	O
.	O

Previous	O
cell	O
culture	O
studies	O
[	O
32	O
,	O
33	O
]	O
and	O
the	O
reduced	O
BAT	O
-	O
gal	O
transgene	O
reporter	O
expression	O
in	O
the	O
Pygo1	O
/	O
Pygo2	O
knockout	O
mice	O
described	O
in	O
this	O
report	O
,	O
do	O
confirm	O
an	O
evolutionarily	O
conserved	O
function	O
in	O
canonical	O
Wnt	O
signaling	O
.	O

In	O
mammals	O
,	O
however	O
,	O
the	O
phenotypic	O
effects	O
of	O
Pygopus	O
mutation	O
are	O
much	O
milder	O
than	O
in	O
Drosophila	O
.	O

The	O
degree	O
of	O
importance	O
of	O
the	O
Pyg1	O
/	O
2	O
genes	O
in	O
Wnt	O
signaling	O
was	O
context	O
-	O
dependent	O
,	O
but	O
in	O
general	O
,	O
mammalian	O
organogenesis	O
remained	O
intact	O
in	O
Pygopus	O
mutants	O
.	O

Perhaps	O
the	O
simplest	O
explanation	O
is	O
that	O
in	O
mammals	O
,	O
other	O
genes	O
show	O
partial	O
functional	O
redundancy	O
with	O
the	O
two	O
Pygopus	O
genes	O
.	O

The	O
beta	O
-	O
catenin	O
transcription	O
-	O
factor	O
complex	O
includes	O
a	O
large	O
and	O
growing	O
number	O
of	O
proteins	B-CHEBI
,	O
some	O
of	O
which	O
may	O
share	O
the	O
nuclear	O
localization	O
and	O
/	O
or	O
transcription	O
activation	O
functions	O
of	O
Pygo1	O
/	O
Pygo2	O
in	O
mammals	O
.	O

The	O
identities	O
and	O
roles	O
of	O
these	O
Pygopus	O
redundant	O
genes	O
remain	O
to	O
be	O
determined	O
.	O

Methods	O

Targeting	O
of	O
Pygo1	O
and	O
Pygo2	O

Pygo1	O
and	O
Pygo2	O
genes	O
were	O
each	O
targeted	O
by	O
flanking	O
the	O
critical	O
coding	O
regions	O
of	O
the	O
third	O
exon	O
containing	O
the	O
PHD	O
motif	O
with	O
LoxP	O
sequences	O
.	O

Targeting	O
constructs	O
were	O
made	O
using	O
the	O
Flp	O
/	O
Cre	O
vector	O
previously	O
described	O
[	O
34	O
]	O
,	O
which	O
carries	O
a	O
neomycin	B-CHEBI
-	O
resistance	O
gene	O
flanked	O
by	O
FRT	O
sequences	O
,	O
and	O
three	O
unique	O
restriction	O
sites	O
for	O
subcloning	O
the	O
two	O
blocks	O
of	O
homology	O
for	O
driving	O
recombination	O
,	O
and	O
the	O
critical	O
region	O
to	O
be	O
flanked	O
by	O
LoxP	O
sequences	O
.	O

For	O
each	O
construct	O
,	O
the	O
three	O
genomic	O
segments	O
required	O
for	O
subcloning	O
were	O
made	O
by	O
PCR	O
from	O
RI	O
ES	O
cell	O
DNA	O
.	O

The	O
resulting	O
targeting	O
constructs	O
were	O
confirmed	O
by	O
sequencing	O
.	O

For	O
Pygo1	O
,	O
the	O
genomic	O
sequences	O
used	O
for	O
PCR	O
were	O
:	O
5	O
'	O
forward	O
,	O
GTGAAGGAGAGATGGATAAGTATG	O
;	O
5	O
'	O
back	O
,	O
TAGACCCTAACCACCTACAAG	O
;	O
exon	O
forward	O
,	O
GGTTAGGGTCTATGTGCTGG	O
;	O
exon	O
back	O
,	O
TCACCAAATCTCTGTTCTACAC	O
;	O
3	O
'	O
forward	O
,	O
TGTGTAGAACAGAGATTTGGTG	O
;	O
3	O
'	O
back	O
,	O
CAGTGAAGAAAGAGGGTCAG	O
.	O

For	O
Pygo2	O
,	O
the	O
genomic	O
sequences	O
used	O
for	O
PCR	O
were	O
:	O
GCCTGGGTTGCTTGTCTTCTG	O
and	O
CCACCTTACTTGTGTGTGAGGATACATAC	O
,	O
CCAAGTCCCAGCATCTCTTAC	O
and	O
CCAGTCATACCAGCAACAAG	O
,	O
and	O
exon	O
sequences	O
TGGGTGCTGGGAACAGAAC	O
and	O
CAACAACAACAGAAGACAAGC	O
.	O

Linearized	O
constructs	O
were	O
electroporated	O
into	O
RI	O
ES	O
cells	O
,	O
and	O
resulting	O
targeted	O
ES	O
cells	O
used	O
for	O
C57	O
/	O
Bl6	O
blastocyst	O
injections	O
according	O
to	O
standard	O
protocols	O
.	O

Resulting	O
chimeras	O
were	O
mated	O
with	O
Swiss	O
Black	O
mice	O
,	O
and	O
the	O
targeted	O
stocks	O
maintained	O
on	O
a	O
mixed	O
129	O
/	O
Swiss	O
Black	O
background	O
.	O

Germline	O
null	O
alleles	O
of	O
both	O
Pygo1	O
and	O
Pygo2	O
were	O
generated	O
by	O
mating	O
heterozygous	O
floxed	O
mice	O
with	O
the	O
CMV	O
-	O
Cre	O
mice	O
[	O
15	O
]	O
.	O

The	O
sequences	O
of	O
the	O
primers	O
used	O
for	O
genotyping	O
PCR	O
were	O
:	O
Pygo2	O
null	O
allele	O
,	O
forward	O
(	O
F	O
)	O
CCTGGATTCTTGTTGCTGGTATG	O
;	O
reverse	O
(	O
R	O
)	O
AAGGTATTTGGTGCTCCGAGGG	O
;	O
Pygo2	O
WT	O
or	O
floxed	O
allele	O
,	O
F	O
TGTCTTGATGACAGCGTTTAGCC	O
,	O
R	O
AGATTCAGTAAGCTGAGCCTGGTG	O
;	O
Pygo1	O
null	O
allele	O
,	O
F	O
AGTTTGAAATAGCGACGAGTTTGAG	O
,	O
R	O
5	O
'	O
-	O
CACTTCTGCCCCTCTCTTTGC	O
;	O
Pygo1	O
WT	O
or	O
floxed	O
allele	O
,	O
F	O
AAGCGTGCCTCATCTCCATCCCTAAG	O
,	O
R	O
GCCCTCCCCGACGTTTATATTG	O
.	O

The	O
noon	O
of	O
the	O
day	O
that	O
vaginal	O
plugs	O
were	O
observed	O
was	O
designated	O
E0	O
.	O
5	O
.	O

Confocal	O
microscopy	O

Kidneys	O
were	O
dissected	O
,	O
fixed	O
in	O
paraformaldehyde	O
,	O
treated	O
with	O
methanol	B-CHEBI
,	O
and	O
washed	O
with	O
PBS	O
containing	O
Tween	O
-	O
20	O
(	O
PBS	O
-	O
T	O
)	O
prior	O
to	O
treatment	O
with	O
lectins	O
and	O
antibodies	O
.	O

PBS	O
-	O
T	O
was	O
used	O
for	O
incubations	O
of	O
the	O
tissues	O
with	O
fluoroscein	B-CHEBI
-	O
conjugated	O
Dilichos	O
biflorus	O
aggutinin	O
(	O
DBA	O
,	O
Vector	O
;	O
Burlingame	O
,	O
USA	O
)	O
,	O
and	O
PBS	O
-	O
T	O
plus	O
2	O
%	O
goat	O
serum	O
was	O
used	O
for	O
incubations	O
with	O
the	O
antibodies	O
.	O

The	O
primary	O
antibodies	O
were	O
anti	O
-	O
WT1	O
(	O
c	O
-	O
19	O
;	O
Santa	O
Cruz	O
Biotechnology	O
,	O
Santa	O
Cruz	O
,	O
CA	O
,	O
USA	O
)	O
,	O
anti	O
-	O
uvomorulin	O
(	O
e	O
-	O
cadherin	O
,	O
Cdh1	O
,	O
Sigma	O
-	O
Aldrich	O
St	O
.	O
Louis	O
,	O
MO	O
,	O
USA	O
)	O
,	O
and	O
anti	O
-	O
Cited1	O
(	O
Neomarkers	O
-	O
Lab	O
Vision	O
Corporation	O
,	O
Fremont	O
,	O
CA	O
,	O
USA	O
)	O
.	O

The	O
secondary	O
antibodies	O
were	O
Alexa	O
555	O
-	O
conjugated	O
anti	O
-	O
rabbit	O
and	O
Alexa	O
633	O
-	O
conjugated	O
anti	O
-	O
rat	O
antibodies	O
(	O
Molecular	B-CHEBI
Probes	O
,	O
Eugene	O
,	O
OR	O
,	O
USA	O
)	O
.	O

The	O
tissues	O
were	O
imaged	O
with	O
a	O
laser	O
scanning	O
microscope	O
(	O
Carl	O
Zeiss	O
,	O
Thornwood	O
,	O
New	O
York	O
,	O
USA	O
)	O
equipped	O
with	O
an	O
argon	B-CHEBI
(	O
488	O
nm	O
)	O
and	O
two	O
HeNe	O
lasers	O
(	O
543	O
nm	O
and	O
633	O
nm	O
)	O
.	O

Optical	O
sections	O
approximately	O
2	O
mu	O
m	O
thick	O
were	O
obtained	O
every	O
5	O
mu	O
m	O
to	O
a	O
depth	O
of	O
at	O
least	O
65	O
mu	O
m	O
.	O

The	O
sections	O
began	O
at	O
the	O
surface	O
of	O
the	O
kidney	O
and	O
were	O
on	O
a	O
plane	O
tangential	O
to	O
it	O
.	O

Two	O
Z	O
-	O
stack	O
series	O
were	O
obtained	O
,	O
one	O
from	O
each	O
of	O
the	O
two	O
kidneys	O
of	O
each	O
embryo	O
.	O

Ureteric	O
bud	O
tips	O
identified	O
by	O
section	O
tracing	O
were	O
counted	O
within	O
a	O
defined	O
area	O
of	O
the	O
confocal	O
image	O
.	O

In	O
situ	O
hybridization	O

Whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
was	O
performed	O
as	O
previously	O
described	O
[	O
35	O
]	O
.	O

Riboprobes	O
to	O
Wnt11	O
and	O
Wnt7b	O
were	O
described	O
previously	O
[	O
35	O
]	O
.	O

The	O
Wnt9b	O
riboprobe	O
was	O
provided	O
by	O
T	O
.	O

Carroll	O
[	O
2	O
]	O
.	O

Pygo1	O
and	O
Pygo2	O
antibody	O
production	O

To	O
generate	O
anti	O
-	O
human	O
Pygo2	O
(	O
anti	O
-	O
hPygo2	O
)	O
and	O
anti	O
-	O
mouse	O
Pygo1	O
(	O
anti	O
-	O
mPygo1	O
)	O
polyclonal	O
antibodies	O
,	O
we	O
subcloned	O
cDNA	O
by	O
PCR	O
corresponding	O
to	O
amino	B-CHEBI
-	I-CHEBI
acid	I-CHEBI
residues	I-CHEBI
80	O
-	O
327	O
of	O
human	O
Pygo	O
2	O
or	O
amino	B-CHEBI
-	I-CHEBI
acid	I-CHEBI
residues	I-CHEBI
76	O
-	O
263	O
of	O
mouse	O
Pygo1	O
into	O
pGEX4T1	O
(	O
Amersham	O
Health	O
,	O
Piscataway	O
,	O
NJ	O
,	O
USA	O
)	O
.	O

The	O
PCR	O
fragments	O
of	O
hPygo	O
2	O
and	O
mPygo	O
1	O
lack	O
both	O
NHD	O
and	O
PHD	O
conserved	O
regions	O
of	O
hPygo2	O
and	O
mPygo1	O
.	O

GST	O
-	O
hPygo2	O
and	O
GST	O
-	O
mPygo1	O
proteins	B-CHEBI
were	O
expressed	O
in	O
bacteria	O
,	O
purified	O
,	O
and	O
injected	O
into	O
rabbits	O
for	O
antibody	O
production	O
by	O
(	O
Proteintech	O
Group	O
Inc	O
.	O
,	O
Chicago	O
,	O
IL	O
,	O
USA	O
)	O
.	O

The	O
rabbit	O
antisera	O
of	O
anti	O
-	O
mPygo1	O
and	O
anti	O
-	O
hPygo2	O
were	O
initially	O
allowed	O
to	O
bind	O
to	O
the	O
GST	O
affinity	O
matrix	O
to	O
remove	O
any	O
antibodies	O
against	O
GST	O
.	O

The	O
anti	O
-	O
hPygo2	O
and	O
anti	O
-	O
mPygo1	O
antisera	O
were	O
then	O
separated	O
from	O
the	O
GST	O
affinity	O
matrix	O
and	O
allowed	O
to	O
bind	O
to	O
the	O
GST	O
-	O
hPygo2	O
or	O
GST	O
-	O
mPygo1	O
affinity	O
columns	O
,	O
respectively	O
.	O

The	O
bound	O
antibodes	O
were	O
eluted	O
with	O
elution	O
buffer	O
.	O

To	O
further	O
ensure	O
antibody	O
specficity	O
,	O
the	O
purified	O
antibodies	O
were	O
extensively	O
incubated	O
with	O
Pygo1	O
/	O
2	O
double	O
-	O
homozygous	O
mutant	O
embryo	O
extract	O
before	O
use	O
.	O

BAT	O
-	O
gal	O
transgene	O
reporter	O
assay	O
of	O
canonical	O
Wnt	O
signaling	O

X	O
-	O
gal	O
staining	O
of	O
both	O
embryos	O
and	O
developing	O
kidneys	O
was	O
performed	O
as	O
previously	O
described	O
[	O
21	O
]	O
.	O

Care	O
was	O
taken	O
to	O
reduce	O
endogenous	O
beta	O
-	O
galactosidase	O
activity	O
within	O
the	O
developing	O
kidney	O
by	O
increasing	O
pH	O
of	O
the	O
X	O
-	O
gal	O
staining	O
solution	O
to	O
8	O
.	O
0	O
.	O

Changes	O
in	O
transgene	O
beta	O
-	O
Gal	O
expression	O
were	O
quantitated	O
using	O
a	O
beta	O
-	O
Gal	O
ELISA	O
(	O
Enzyme	O
-	O
linked	O
immunoassay	O
)	O
kit	O
(	O
Roche	O
,	O
Indianapolis	O
,	O
IN	O
)	O
,	O
normalizing	O
according	O
to	O
total	O
protein	B-CHEBI
.	O

Each	O
genotype	O
was	O
represented	O
by	O
a	O
sample	O
size	O
of	O
4	O
except	O
the	O
non	O
-	O
transgenic	O
(	O
n	O
=	O
5	O
)	O
,	O
Pygo1	O
+	O
/	O
-	O
;	O
Pygo2	O
+	O
/	O
+	O
(	O
n	O
=	O
6	O
)	O
,	O
Pygo1	O
-	O
/	O
-	O
;	O
Pygo2	O
+	O
/	O
-	O
(	O
n	O
=	O
8	O
)	O
,	O
and	O
Pygo1	O
-	O
/	O
-	O
;	O
Pygo2	O
-	O
/	O
-	O
(	O
n	O
=	O
6	O
)	O
groups	O
.	O

Microarray	O
analysis	O

Total	O
RNA	O
was	O
isolated	O
from	O
E18	O
.	O
5	O
kidneys	O
dissected	O
from	O
normal	O
and	O
Pygo1	O
/	O
Pygo2	O
compound	O
null	O
embryos	O
using	O
a	O
commercial	O
kit	O
(	O
Stratagene	O
Absolutely	O
RNA	O
Microprep	O
Kit	O
;	O
La	O
Jolla	O
,	O
CA	O
,	O
USA	O
)	O
.	O

An	O
aliquot	O
(	O
300	O
ng	O
)	O
of	O
total	O
RNA	O
was	O
processed	O
and	O
labeled	O
using	O
a	O
commercial	O
kit	O
(	O
TargetAmp	O
1	O
-	O
Round	O
Aminoallyl	O
-	O
aRNA	O
Ki	O
;	O
Epicentre	O
,	O
Madison	O
,	O
WI	O
,	O
USA	O
)	O
.	O

Labeled	O
RNA	O
was	O
hybridized	O
to	O
microarrays	O
(	O
Sentrix	O
Mouse	O
-	O
6	O
expression	O
Beadchip	O
;	O
Illumina	O
,	O
San	O
Diego	O
,	O
CA	O
)	O
providing	O
coverage	O
of	O
over	O
47000	O
genes	O
and	O
expressed	O
sequence	O
tags	O
as	O
previously	O
described	O
[	O
36	O
]	O
.	O

Microarray	O
analysis	O
of	O
Pygo1	O
/	O
Pygo2	O
null	O
and	O
normal	O
wild	O
-	O
type	O
kidneys	O
was	O
performed	O
in	O
biological	O
triplicate	O
.	O

Raw	O
signal	O
intensities	O
of	O
each	O
probe	O
were	O
obtained	O
from	O
data	O
analysis	O
software	O
(	O
Beadstudio	O
;	O
Illumina	O
)	O
and	O
imported	O
into	O
GeneSpring	O
GX	O
7	O
.	O
3	O
(	O
Agilent	O
Technologies	O
,	O
Palo	O
Alto	O
,	O
CA	O
,	O
USA	O
)	O
.	O

Genes	O
were	O
selected	O
on	O
the	O
basis	O
of	O
greater	O
than	O
two	O
-	O
fold	O
average	O
fold	O
change	O
and	O
statistical	O
significance	O
(	O
p	O
-	O
value	O
<	O
0	O
.	O
05	O
)	O
.	O

Previously	O
described	O
Wnt	O
target	O
genes	O
were	O
obtained	O
from	O
.	O

Quantitative	O
PCR	O
validation	O
of	O
microarray	O
results	O

Total	O
RNA	O
from	O
E18	O
.	O
5	O
Pygo1	O
/	O
Pygo2	O
null	O
and	O
control	O
kidneys	O
(	O
both	O
represented	O
in	O
duplicate	O
and	O
distinct	O
from	O
the	O
kidneys	O
used	O
for	O
microrray	O
analysis	O
)	O
was	O
purified	O
using	O
a	O
commercial	O
kit	O
(	O
Absolutely	O
RNA	O
Microprep	O
Kit	O
;	O
Stratagene	O
,	O
La	O
Jolla	O
,	O
CA	O
USA	O
)	O
including	O
DNAse1	O
treatment	O
.	O

cDNA	O
was	O
generated	O
using	O
random	O
hexamers	O
according	O
to	O
conventional	O
protocols	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
CA	O
,	O
USA	O
)	O
.	O

The	O
following	O
primers	O
were	O
generated	O
to	O
include	O
the	O
sequence	O
obtained	O
from	O
the	O
Illumina	O
probe	O
:	O
Actb	O
(	O
TTGCTGACAGGATGCAGAAG	O
,	O
ACATCTGCTGGAAGGTGGAC	O
)	O
;	O
Aldh1a7	O
(	O
CCAGAAAGTGGTGTTTTGCT	O
,	O
GAGTTACAGAGAGCTTGCACCTT	O
)	O
;	O
Col8a1	O
(	O
GCAGACAGGCATCTTCACCT	O
,	O
TGTGTACATCATGGGCTCGT	O
)	O
;	O
Csrp1	O
(	O
CAGCATAGCCCAGGGTAGAG	O
,	O
TGGGCAAGGTAGTGAAGGTT	O
)	O
;	O
Klk5	O
(	O
GCAGCATTACACCCGTCATA	O
,	O
TTGCCTCCATCCATATCTCC	O
)	O
;	O
Picalm	O
(	O
GGGAGGGAACAGAAATCCTT	O
,	O
GCACCGATCAACAGTGCAG	O
)	O
;	O
Pygo2	O
(	O
TTCTGGGAACTTGTGCACTG	O
,	O
AACTTCCTCCAGCCCATTTT	O
)	O
;	O
Ren2	O
(	O
TTGTGAGCTGTAGCCAGGTG	O
,	O
TGTGCACAGCTTGTCTCTCC	O
)	O
and	O
Tia1	O
(	O
TGATTGAAGGGCTACTAGAGTGGT	O
,	O
AGCCCCAGAGGACAATTTTT	O
)	O
using	O
Primer3	O
software	O
[	O
37	O
]	O
.	O

Relative	O
quantitative	O
PCR	O
was	O
performed	O
according	O
to	O
the	O
conventional	O
SYBR	O
Green	O
protocol	O
(	O
Stratagene	O
)	O
using	O
a	O
quantitative	O
PCR	O
system	O
(	O
Mx3000p	O
;	O
Stratagene	O
)	O
.	O

Dissociation	O
curve	O
and	O
agarose	B-CHEBI
-	O
gel	O
analysis	O
of	O
each	O
primer	O
set	O
were	O
used	O
to	O
insure	O
specificity	O
of	O
the	O
amplicon	O
.	O

All	O
data	O
were	O
normalized	O
to	O
an	O
internal	O
housekeeping	O
control	O
(	O
Actb	O
)	O
and	O
analyzed	O
using	O
the	O
2	O
(	O
-	O
Delta	O
Delta	O
C	O
(	O
T	O
)	O
)	O
method	O
[	O
38	O
]	O
.	O

Authors	O
'	O
contributions	O

SP	O
designed	O
and	O
did	O
most	O
of	O
the	O
work	O
for	O
targeting	O
the	O
Pygo	O
genes	O
,	O
provided	O
oversight	O
for	O
the	O
project	O
and	O
helped	O
write	O
the	O
paper	O
.	O

KS	O
did	O
most	O
of	O
the	O
experiments	O
,	O
including	O
confocal	O
analysis	O
with	O
LP	O
,	O
in	O
situ	O
hybridizations	O
with	O
HH	O
,	O
and	O
helped	O
write	O
the	O
paper	O
.	O

XL	O
made	O
and	O
tested	O
the	O
Pygo	O
antibodies	O
.	O

NS	O
and	O
RL	O
provided	O
useful	O
suggestions	O
and	O
helped	O
with	O
the	O
immunostaining	O
and	O
Bat	O
-	O
Gal	O
analyses	O
.	O

Acknowledgements	O

L	O
.	O

McClain	O
provided	O
essential	O
technical	O
assistance	O
and	O
we	O
thank	O
P	O
.	O

Groen	O
and	O
D	O
.	O

Witte	O
for	O
initial	O
histology	O
and	O
embryological	O
analyses	O
.	O

D	O
.	O

Ash	O
helped	O
make	O
targeting	O
constructs	O
.	O

We	O
thank	O
T	O
.	O

Carroll	O
for	O
providing	O
a	O
Wnt9b	O
riboprobe	O
construct	O
.	O

We	O
thank	O
H	O
.	O

Liang	O
for	O
generation	O
of	O
microarray	O
data	O
.	O

This	O
work	O
was	O
supported	O
by	O
grant	O
DK61916	O
from	O
the	O
National	O
Institutes	O
of	O
Health	O
(	O
S	O
.	O
S	O
.	O
P	O
.	O
)	O
.	O

A	O
Mammal	O
-	O
Specific	O
Doublesex	O
Homolog	O
Associates	O
with	O
Male	O
Sex	O
Chromatin	O
and	O
Is	O
Required	O
for	O
Male	O
Meiosis	O

Abstract	O

Gametogenesis	O
is	O
a	O
sexually	O
dimorphic	O
process	O
requiring	O
profound	O
differences	O
in	O
germ	O
cell	O
differentiation	O
between	O
the	O
sexes	O
.	O

In	O
mammals	O
,	O
the	O
presence	O
of	O
heteromorphic	O
sex	O
chromosomes	O
in	O
males	O
creates	O
additional	O
sex	O
-	O
specific	O
challenges	O
,	O
including	O
incomplete	O
X	O
and	O
Y	O
pairing	O
during	O
meiotic	O
prophase	O
.	O

This	O
triggers	O
formation	O
of	O
a	O
heterochromatin	O
domain	O
,	O
the	O
XY	O
body	O
.	O

The	O
XY	O
body	O
disassembles	O
after	O
prophase	O
,	O
but	O
specialized	O
sex	O
chromatin	O
persists	O
,	O
with	O
further	O
modification	O
,	O
through	O
meiosis	O
.	O

Here	O
,	O
we	O
investigate	O
the	O
function	O
of	O
DMRT7	O
,	O
a	O
mammal	O
-	O
specific	O
protein	B-CHEBI
related	O
to	O
the	O
invertebrate	O
sexual	O
regulators	O
Doublesex	O
and	O
MAB	O
-	O
3	O
.	O

We	O
find	O
that	O
DMRT7	O
preferentially	O
localizes	O
to	O
the	O
XY	O
body	O
in	O
the	O
pachytene	O
stage	O
of	O
meiotic	O
prophase	O
and	O
is	O
required	O
for	O
male	O
meiosis	O
.	O

In	O
Dmrt7	O
mutants	O
,	O
meiotic	O
pairing	O
and	O
recombination	O
appear	O
normal	O
,	O
and	O
a	O
transcriptionally	O
silenced	O
XY	O
body	O
with	O
appropriate	O
chromatin	O
marks	O
is	O
formed	O
,	O
but	O
most	O
germ	O
cells	O
undergo	O
apoptosis	O
during	O
pachynema	O
.	O

A	O
minority	O
of	O
mutant	O
cells	O
can	O
progress	O
to	O
diplonema	O
,	O
but	O
many	O
of	O
these	O
escaping	O
cells	O
have	O
abnormal	O
sex	O
chromatin	O
lacking	O
histone	B-CHEBI
H3K9	O
di	O
-	O
and	O
trimethylation	O
and	O
heterochromatin	O
protein	B-CHEBI
1	O
beta	O
accumulation	O
,	O
modifications	O
that	O
normally	O
occur	O
between	O
pachynema	O
and	O
diplonema	O
.	O

Based	O
on	O
the	O
localization	O
of	O
DMRT7	O
to	O
the	O
XY	O
body	O
and	O
the	O
sex	O
chromatin	O
defects	O
observed	O
in	O
Dmrt7	O
mutants	O
,	O
we	O
conclude	O
that	O
DMRT7	O
plays	O
a	O
role	O
in	O
the	O
sex	O
chromatin	O
transformation	O
that	O
occurs	O
between	O
pachynema	O
and	O
diplonema	O
.	O

We	O
suggest	O
that	O
DMRT7	O
may	O
help	O
control	O
the	O
transition	O
from	O
meiotic	O
sex	O
chromosome	O
inactivation	O
to	O
postmeiotic	O
sex	O
chromatin	O
in	O
males	O
.	O

In	O
addition	O
,	O
because	O
it	O
is	O
found	O
in	O
all	O
branches	O
of	O
mammals	O
,	O
but	O
not	O
in	O
other	O
vertebrates	O
,	O
Dmrt7	O
may	O
shed	O
light	O
on	O
evolution	O
of	O
meiosis	O
and	O
of	O
sex	O
chromatin	O
.	O

Author	O
Summary	O

Genes	O
related	O
to	O
the	O
sexual	O
regulator	O
Doublesex	O
of	O
Drosophila	O
have	O
been	O
found	O
to	O
control	O
sexual	O
development	O
in	O
a	O
wide	O
variety	O
of	O
animals	O
,	O
ranging	O
from	O
roundworms	O
to	O
mammals	O
.	O

In	O
this	O
paper	O
,	O
we	O
investigate	O
the	O
function	O
of	O
the	O
Dmrt7	O
gene	O
,	O
one	O
of	O
seven	O
related	O
genes	O
in	O
the	O
mouse	O
.	O

Female	O
mammals	O
are	O
XX	O
and	O
males	O
are	O
XY	O
,	O
a	O
chromosomal	O
difference	O
that	O
presents	O
specific	O
challenges	O
during	O
the	O
meiotic	O
phase	O
of	O
male	O
germ	O
cell	O
development	O
.	O

Some	O
of	O
these	O
are	O
thought	O
to	O
be	O
overcome	O
by	O
incorporating	O
the	O
X	O
and	O
Y	O
chromosomes	O
into	O
a	O
specialized	O
structure	O
called	O
the	O
XY	O
body	O
.	O

We	O
find	O
that	O
DMRT7	O
protein	B-CHEBI
is	O
present	O
in	O
germ	O
cells	O
,	O
localizes	O
to	O
the	O
male	O
XY	O
body	O
during	O
meiosis	O
,	O
and	O
is	O
essential	O
for	O
male	O
but	O
not	O
female	O
fertility	O
.	O

The	O
XY	O
body	O
normally	O
is	O
altered	O
by	O
recruitment	O
of	O
additional	O
proteins	B-CHEBI
and	O
by	O
specific	O
modifications	O
to	O
histone	B-CHEBI
proteins	I-CHEBI
between	O
the	O
pachytene	O
and	O
diplotene	O
stages	O
of	O
meiosis	O
,	O
but	O
modification	O
of	O
the	O
"	O
sex	O
chromatin	O
"	O
in	O
Dmrt7	O
mutant	O
cells	O
is	O
abnormal	O
during	O
this	O
period	O
.	O

Because	O
Dmrt7	O
is	O
found	O
in	O
all	O
branches	O
of	O
mammals	O
,	O
but	O
not	O
in	O
other	O
vertebrates	O
,	O
these	O
results	O
may	O
indicate	O
some	O
commonality	O
in	O
regulation	O
of	O
sex	O
chromatin	O
among	O
the	O
mammals	O
.	O

Introduction	O

Sexual	O
differentiation	O
generates	O
anatomical	O
,	O
physiological	O
,	O
and	O
behavioral	O
dimorphisms	O
that	O
are	O
essential	O
for	O
sexual	O
reproduction	O
.	O

Many	O
of	O
these	O
dimorphisms	O
affect	O
somatic	O
cells	O
,	O
but	O
the	O
sexual	O
dimorphisms	O
that	O
most	O
directly	O
mediate	O
sexual	O
reproduction	O
are	O
those	O
of	O
the	O
gametes	O
themselves	O
.	O

Gametes	O
differ	O
between	O
the	O
sexes	O
in	O
size	O
and	O
morphology	O
,	O
sometimes	O
dramatically	O
so	O
,	O
reflecting	O
their	O
very	O
different	O
roles	O
in	O
zygote	O
formation	O
.	O

Indeed	O
,	O
the	O
morphology	O
of	O
the	O
gametes	O
is	O
what	O
defines	O
sex	O
:	O
females	O
are	O
the	O
sex	O
that	O
produces	O
the	O
larger	O
gametes	O
and	O
males	O
produce	O
the	O
smaller	O
ones	O
.	O

Mammalian	O
meiosis	O
is	O
regulated	O
sex	O
-	O
specifically	O
starting	O
in	O
embryogenesis	O
and	O
continuing	O
through	O
much	O
of	O
adult	O
life	O
(	O
reviewed	O
in	O
[	O
1	O
]	O
)	O
.	O

For	O
example	O
,	O
the	O
timing	O
and	O
synchrony	O
of	O
meiosis	O
are	O
very	O
different	O
in	O
the	O
two	O
sexes	O
.	O

In	O
females	O
,	O
germ	O
cells	O
synchronously	O
initiate	O
meiosis	O
in	O
the	O
embryo	O
and	O
arrest	O
during	O
meiotic	O
prophase	O
I	O
.	O

After	O
puberty	O
,	O
oocytes	O
are	O
selectively	O
recruited	O
for	O
ovulation	O
,	O
when	O
they	O
proceed	O
to	O
metaphase	O
II	O
and	O
then	O
complete	O
meiosis	O
after	O
fertilization	O
occurs	O
[	O
2	O
]	O
.	O

In	O
contrast	O
,	O
male	O
meiosis	O
occurs	O
entirely	O
postnatally	O
,	O
without	O
the	O
arrest	O
periods	O
found	O
in	O
females	O
.	O

In	O
females	O
,	O
each	O
meiosis	O
can	O
produce	O
a	O
single	O
haploid	O
oocyte	O
(	O
and	O
two	O
extruded	O
polar	O
bodies	O
)	O
,	O
whereas	O
each	O
male	O
meiosis	O
can	O
produce	O
four	O
haploid	O
spermatocytes	O
.	O

Other	O
meiotic	O
processes	O
,	O
such	O
as	O
recombination	O
and	O
chromosome	O
pairing	O
(	O
synapsis	O
)	O
,	O
occur	O
in	O
both	O
sexes	O
but	O
operate	O
somewhat	O
differently	O
.	O

For	O
example	O
,	O
there	O
is	O
a	O
higher	O
failure	O
rate	O
for	O
meiosis	O
in	O
females	O
,	O
with	O
human	O
oocyte	O
aneuploidy	O
rates	O
up	O
to	O
25	O
%	O
versus	O
about	O
2	O
%	O
in	O
human	O
sperm	O
[	O
3	O
]	O
,	O
and	O
this	O
may	O
indicate	O
that	O
the	O
checkpoints	O
controlling	O
and	O
monitoring	O
the	O
events	O
of	O
meiotic	O
progression	O
in	O
males	O
are	O
more	O
stringent	O
.	O

Consistent	O
with	O
this	O
idea	O
,	O
genetic	O
analysis	O
of	O
a	O
number	O
of	O
meiotic	O
regulatory	O
genes	O
in	O
the	O
mouse	O
has	O
demonstrated	O
a	O
much	O
stronger	O
requirement	O
in	O
males	O
than	O
in	O
females	O
[	O
1	O
,	O
4	O
]	O
.	O

The	O
existence	O
of	O
heteromorphic	O
sex	O
chromosomes	O
,	O
such	O
as	O
the	O
XX	O
/	O
XY	O
system	O
of	O
mammals	O
,	O
creates	O
sex	O
-	O
specific	O
challenges	O
.	O

One	O
is	O
the	O
need	O
for	O
mechanisms	O
to	O
balance	O
expression	O
of	O
sex	O
-	O
linked	O
genes	O
between	O
the	O
sexes	O
,	O
which	O
in	O
mammals	O
is	O
accomplished	O
by	O
X	O
chromosome	O
inactivation	O
in	O
females	O
[	O
5	O
,	O
6	O
]	O
.	O

In	O
male	O
germ	O
cells	O
there	O
is	O
another	O
sex	O
-	O
specific	O
consideration	O
during	O
meiosis	O
.	O

In	O
prophase	O
I	O
,	O
when	O
the	O
homologous	O
chromosomes	O
synapse	O
and	O
homologous	O
recombination	O
occurs	O
,	O
X	O
and	O
Y	O
chromosome	O
pairing	O
is	O
limited	O
to	O
a	O
region	O
termed	O
the	O
pseudoautosomal	O
region	O
,	O
leaving	O
large	O
portions	O
of	O
each	O
chromosome	O
unpaired	O
.	O

In	O
eutherian	O
and	O
marsupial	O
mammals	O
,	O
these	O
unpaired	O
chromosome	O
regions	O
are	O
associated	O
with	O
a	O
specialized	O
chromatin	O
domain	O
termed	O
the	O
XY	O
body	O
or	O
sex	O
body	O
.	O

The	O
function	O
of	O
the	O
XY	O
body	O
is	O
uncertain	O
[	O
7	O
-	O
11	O
]	O
,	O
but	O
there	O
is	O
evidence	O
that	O
it	O
is	O
essential	O
for	O
male	O
meiotic	O
progression	O
[	O
12	O
]	O
.	O

Several	O
proteins	B-CHEBI
are	O
reported	O
to	O
localize	O
to	O
the	O
XY	O
body	O
,	O
including	O
BRCA1	O
,	O
ATR	O
,	O
the	O
histone	B-CHEBI
variant	O
H3	O
.	O
3	O
,	O
and	O
modified	O
histones	B-CHEBI
such	O
as	O
ubiquitinated	O
H2A	O
(	O
Ub	O
-	O
H2A	O
)	O
and	O
phosphorylated	O
H2AX	O
(	O
gamma	O
H2AX	O
)	O
[	O
12	O
-	O
15	O
]	O
.	O

In	O
the	O
XY	O
body	O
,	O
the	O
sex	O
chromosomes	O
are	O
transcriptionally	O
silenced	O
in	O
a	O
process	O
termed	O
meiotic	O
sex	O
chromosome	O
inactivation	O
(	O
MSCI	O
)	O
.	O

The	O
XY	O
body	O
disappears	O
after	O
pachynema	O
;	O
however	O
,	O
many	O
sex	O
-	O
linked	O
genes	O
remain	O
transcriptionally	O
silent	O
into	O
spermiogenesis	O
[	O
16	O
]	O
.	O

This	O
maintenance	O
of	O
silencing	O
is	O
associated	O
with	O
a	O
distinct	O
set	O
of	O
chromatin	O
marks	O
that	O
define	O
a	O
sex	O
chromatin	O
domain	O
termed	O
postmeiotic	O
sex	O
chromatin	O
(	O
PMSC	O
)	O
[	O
16	O
,	O
17	O
]	O
.	O

Regulators	O
of	O
sexual	O
differentiation	O
have	O
been	O
identified	O
in	O
a	O
number	O
of	O
organisms	O
,	O
but	O
in	O
contrast	O
to	O
many	O
other	O
developmental	O
processes	O
,	O
such	O
as	O
axial	O
patterning	O
or	O
development	O
of	O
many	O
body	O
parts	O
,	O
the	O
molecular	B-CHEBI
mechanisms	O
that	O
regulate	O
sexual	O
differentiation	O
are	O
highly	O
variable	O
between	O
phyla	O
.	O

A	O
notable	O
exception	O
involves	O
genes	O
related	O
to	O
doublesex	O
(	O
dsx	O
)	O
of	O
Drosophila	O
,	O
which	O
share	O
a	O
Doublesex	O
/	O
MAB	O
-	O
3	O
DNA	O
-	O
binding	O
motif	O
called	O
the	O
DM	O
domain	O
[	O
18	O
,	O
19	O
]	O
.	O

DM	O
domain	O
-	O
encoding	O
genes	O
have	O
been	O
shown	O
to	O
regulate	O
various	O
aspects	O
of	O
sexual	O
differentiation	O
in	O
insects	O
,	O
nematodes	O
,	O
and	O
mammals	O
[	O
20	O
]	O
.	O

The	O
mab	O
-	O
3	O
gene	O
of	O
Caenorhabditis	O
elegans	O
has	O
been	O
shown	O
to	O
function	O
analogously	O
to	O
DSX	O
in	O
several	O
respects	O
and	O
can	O
be	O
functionally	O
replaced	O
by	O
the	O
male	O
isoform	O
of	O
DSX	O
,	O
suggesting	O
that	O
the	O
similarity	O
in	O
the	O
sequence	O
of	O
these	O
genes	O
may	O
stem	O
from	O
conservation	O
of	O
an	O
ancestral	O
DM	O
domain	O
sexual	O
regulator	O
[	O
18	O
,	O
21	O
,	O
22	O
]	O
.	O

Vertebrates	O
also	O
have	O
DM	O
domain	O
genes	O
,	O
and	O
analysis	O
to	O
date	O
,	O
although	O
limited	O
,	O
has	O
shown	O
that	O
these	O
genes	O
also	O
control	O
sexual	O
differentiation	O
.	O

Mammals	O
have	O
seven	O
DM	O
domain	O
genes	O
(	O
Dmrt	O
genes	O
)	O
,	O
several	O
of	O
which	O
exhibit	O
sexually	O
dimorphic	O
mRNA	B-CHEBI
expression	O
[	O
23	O
,	O
24	O
]	O
.	O

The	O
best	O
studied	O
of	O
these	O
genes	O
,	O
Dmrt1	O
,	O
is	O
expressed	O
in	O
the	O
differentiating	O
male	O
genital	O
ridges	O
and	O
adult	O
testis	O
of	O
mammals	O
,	O
birds	O
,	O
fish	O
,	O
and	O
reptiles	O
,	O
and	O
a	O
recently	O
duplicated	O
Dmrt1	O
gene	O
functions	O
as	O
the	O
Y	O
-	O
linked	O
testis	O
-	O
determining	O
gene	O
in	O
the	O
Medaka	O
fish	O
[	O
25	O
-	O
29	O
]	O
.	O

Human	O
DMRT1	O
maps	O
to	O
an	O
autosomal	O
locus	O
,	O
which	O
,	O
when	O
hemizygous	O
,	O
is	O
associated	O
with	O
defective	O
testicular	O
development	O
and	O
consequent	O
XY	O
feminization	O
[	O
30	O
]	O
.	O

Similarly	O
,	O
mice	O
homozygous	O
for	O
a	O
null	O
mutation	O
in	O
Dmrt1	O
have	O
severe	O
defects	O
in	O
testis	O
differentiation	O
involving	O
both	O
germ	O
cells	O
and	O
Sertoli	O
cells	O
[	O
31	O
]	O
.	O

Female	O
mice	O
mutant	O
in	O
Dmrt4	O
have	O
polyovular	O
follicles	O
,	O
indicating	O
that	O
this	O
gene	O
also	O
plays	O
a	O
role	O
in	O
gonadal	O
development	O
[	O
32	O
]	O
.	O

It	O
appears	O
from	O
these	O
studies	O
that	O
the	O
involvement	O
of	O
DM	O
domain	O
genes	O
in	O
sexual	O
differentiation	O
is	O
ancient	O
and	O
conserved	O
.	O

However	O
,	O
vertebrate	O
Dmrt	O
gene	O
function	O
is	O
not	O
limited	O
to	O
sexual	O
differentiation	O
:	O
Dmrt2	O
is	O
required	O
in	O
both	O
sexes	O
for	O
segmentation	O
in	O
mice	O
and	O
fish	O
[	O
33	O
-	O
35	O
]	O
.	O

Here	O
,	O
we	O
have	O
investigated	O
the	O
expression	O
and	O
function	O
of	O
the	O
Dmrt7	O
gene	O
in	O
the	O
mouse	O
.	O

Dmrt7	O
is	O
expressed	O
only	O
in	O
the	O
gonad	O
,	O
and	O
,	O
unlike	O
the	O
other	O
Dmrt	O
genes	O
,	O
appears	O
to	O
be	O
present	O
exclusively	O
in	O
mammals	O
and	O
not	O
in	O
nonmammalian	O
vertebrates	O
[	O
23	O
,	O
36	O
]	O
.	O

We	O
find	O
that	O
DMRT7	O
protein	B-CHEBI
is	O
expressed	O
only	O
in	O
germ	O
cells	O
and	O
is	O
selectively	O
localized	O
to	O
the	O
XY	O
body	O
of	O
male	O
pachytene	O
germ	O
cells	O
.	O

To	O
test	O
its	O
function	O
,	O
we	O
generated	O
a	O
conditional	O
null	O
mutation	O
of	O
Dmrt7	O
in	O
the	O
mouse	O
.	O

We	O
find	O
that	O
Dmrt7	O
is	O
required	O
in	O
males	O
for	O
progression	O
beyond	O
the	O
pachytene	O
stage	O
of	O
meiotic	O
prophase	O
but	O
is	O
not	O
required	O
in	O
females	O
.	O

In	O
rare	O
mutant	O
cells	O
that	O
survive	O
to	O
diplonema	O
,	O
we	O
observed	O
sex	O
chromatin	O
abnormalities	O
.	O

Based	O
on	O
these	O
observations	O
,	O
we	O
suggest	O
that	O
Dmrt7	O
plays	O
a	O
critical	O
role	O
in	O
a	O
male	O
-	O
specific	O
chromatin	O
transition	O
between	O
pachynema	O
and	O
diplonema	O
during	O
meiotic	O
prophase	O
.	O

Results	O

Expression	O
of	O
DMRT7	O
Proteins	B-CHEBI
in	O
Testis	O

Our	O
previous	O
mRNA	B-CHEBI
expression	O
analysis	O
suggested	O
a	O
possible	O
meiotic	O
function	O
for	O
Dmrt7	O
,	O
based	O
on	O
the	O
expression	O
of	O
Dmrt7	O
mRNA	B-CHEBI
in	O
the	O
fetal	O
gonads	O
of	O
the	O
two	O
sexes	O
[	O
23	O
]	O
.	O

In	O
the	O
fetal	O
ovary	O
,	O
Dmrt7	O
mRNA	B-CHEBI
was	O
detected	O
primarily	O
from	O
E13	O
.	O
5	O
to	O
E15	O
.	O
5	O
,	O
the	O
time	O
during	O
which	O
meiosis	O
progresses	O
from	O
pre	O
-	O
meiotic	O
replication	O
to	O
the	O
pachytene	O
stage	O
[	O
4	O
]	O
,	O
whereas	O
Dmrt7	O
expression	O
in	O
the	O
non	O
-	O
meiotic	O
fetal	O
testis	O
was	O
very	O
low	O
.	O

Because	O
this	O
earlier	O
work	O
did	O
not	O
examine	O
adult	O
Dmrt7	O
expression	O
,	O
we	O
first	O
performed	O
reverse	O
transcriptase	O
(	O
RT	O
)	O
-	O
PCR	O
on	O
mRNA	B-CHEBI
from	O
ten	O
adult	O
organs	O
and	O
detected	O
strong	O
Dmrt7	O
mRNA	B-CHEBI
expression	O
in	O
the	O
testis	O
and	O
a	O
trace	O
of	O
expression	O
in	O
heart	O
,	O
but	O
not	O
in	O
any	O
other	O
tissue	O
tested	O
(	O
Figure	O
1A	O
)	O
.	O

We	O
examined	O
the	O
timing	O
of	O
Dmrt7	O
mRNA	B-CHEBI
expression	O
during	O
postnatal	O
testis	O
development	O
and	O
detected	O
strong	O
expression	O
beginning	O
at	O
2	O
wk	O
,	O
which	O
roughly	O
coincides	O
with	O
the	O
onset	O
of	O
the	O
pachytene	O
stage	O
during	O
the	O
first	O
synchronous	O
wave	O
of	O
spermatogenesis	O
(	O
Figure	O
1B	O
)	O
[	O
37	O
]	O
.	O

Figure	O
1	O

Expression	O
of	O
Dmrt7	O
mRNA	B-CHEBI
and	O
Protein	B-CHEBI

(	O
A	O
)	O
RT	O
-	O
PCR	O
analysis	O
of	O
Dmrt7	O
mRNA	B-CHEBI
from	O
ten	O
organs	O
of	O
adult	O
mouse	O
.	O

cDNA	O
from	O
each	O
organ	O
was	O
amplified	O
with	O
primers	O
specific	O
for	O
Dmrt7	O
(	O
top	O
row	O
)	O
and	O
beta	O
-	O
actin	O
(	O
bottom	O
row	O
)	O
.	O

(	O
B	O
)	O
Dmrt7	O
mRNA	B-CHEBI
expression	O
during	O
the	O
first	O
round	O
of	O
spermatogenesis	O
.	O

cDNAs	O
obtained	O
from	O
testis	O
at	O
the	O
indicated	O
days	O
after	O
birth	O
were	O
amplified	O
as	O
in	O
(	O
A	O
)	O
.	O

(	O
C	O
)	O
DMRT7	O
protein	B-CHEBI
expression	O
.	O

Immunofluorescence	O
of	O
testis	O
sections	O
from	O
6	O
-	O
wk	O
-	O
old	O
male	O
stained	O
with	O
antibody	O
to	O
DMRT7	O
(	O
green	O
)	O
and	O
DAPI	O
(	O
blue	O
)	O
.	O

(	O
D	O
)	O
DMRT7	O
subcellular	O
localization	O
to	O
XY	O
body	O
.	O

Testis	O
sections	O
from	O
6	O
-	O
wk	O
-	O
old	O
male	O
stained	O
with	O
antibodies	O
to	O
DMRT7	O
(	O
red	O
)	O
and	O
SUMO	O
-	O
1	O
(	O
green	O
)	O
.	O

SUMO	O
-	O
1	O
is	O
localized	O
to	O
the	O
XY	O
body	O
.	O

Right	O
-	O
most	O
panel	O
shows	O
merge	O
of	O
other	O
two	O
panels	O
.	O

Inserts	O
show	O
higher	O
magnification	O
of	O
pachytene	O
spermatocytes	O
with	O
XY	O
bodies	O
.	O

To	O
investigate	O
DMRT7	O
protein	B-CHEBI
expression	O
,	O
we	O
generated	O
an	O
antibody	O
against	O
the	O
C	B-CHEBI
-	O
terminal	O
portion	O
of	O
the	O
protein	B-CHEBI
.	O

The	O
antibody	O
was	O
raised	O
against	O
a	O
unique	O
region	O
lacking	O
the	O
DM	O
domain	O
in	O
order	O
to	O
avoid	O
cross	O
-	O
reaction	O
with	O
other	O
DM	O
domain	O
proteins	B-CHEBI
.	O

Immunofluorescent	O
staining	O
with	O
purified	O
DMRT7	O
antisera	O
showed	O
that	O
DMRT7	O
protein	B-CHEBI
is	O
expressed	O
predominantly	O
in	O
mid	O
-	O
to	O
late	O
-	O
pachytene	O
spermatocytes	O
(	O
Figure	O
1C	O
)	O
,	O
as	O
well	O
as	O
in	O
sperm	O
,	O
and	O
is	O
not	O
detectable	O
in	O
other	O
germ	O
cell	O
types	O
including	O
spermatogonia	O
and	O
round	O
spermatids	O
.	O

We	O
did	O
not	O
detect	O
DMRT7	O
protein	B-CHEBI
in	O
somatic	O
cells	O
such	O
as	O
Sertoli	O
cells	O
,	O
peritubular	O
myoid	O
cells	O
,	O
or	O
Leydig	O
cells	O
.	O

To	O
more	O
precisely	O
determine	O
the	O
pachytene	O
stages	O
of	O
DMRT7	O
expression	O
,	O
we	O
double	O
-	O
stained	O
with	O
an	O
antibody	O
to	O
GATA1	O
,	O
which	O
is	O
expressed	O
in	O
Sertoli	O
cells	O
from	O
stages	O
VII	O
to	O
IX	O
[	O
38	O
]	O
.	O

This	O
confirmed	O
that	O
DMRT7	O
is	O
expressed	O
in	O
mid	O
-	O
to	O
late	O
-	O
pachytene	O
spermatocytes	O
,	O
starting	O
slightly	O
earlier	O
than	O
stage	O
VII	O
and	O
extending	O
through	O
stage	O
IX	O
(	O
unpublished	O
data	O
)	O
.	O

Within	O
pachytene	O
spermatocytes	O
,	O
DMRT7	O
is	O
concentrated	O
in	O
the	O
XY	O
body	O
,	O
or	O
sex	O
body	O
,	O
a	O
densely	O
staining	O
chromatin	O
domain	O
that	O
harbors	O
the	O
sex	O
chromosomes	O
.	O

These	O
undergo	O
transcriptional	O
inactivation	O
and	O
heterochromatinization	O
as	O
a	O
result	O
of	O
their	O
incomplete	O
pairing	O
during	O
prophase	O
of	O
mammalian	O
male	O
meiosis	O
[	O
17	O
]	O
.	O

To	O
verify	O
DMRT7	O
protein	B-CHEBI
expression	O
in	O
the	O
XY	O
body	O
,	O
we	O
double	O
-	O
stained	O
mouse	O
testis	O
sections	O
for	O
DMRT7	O
and	O
small	O
ubiquitin	O
-	O
related	O
modifier	O
1	O
(	O
SUMO	O
-	O
1	O
)	O
,	O
which	O
is	O
concentrated	O
in	O
the	O
XY	O
body	O
during	O
pachynema	O
[	O
39	O
,	O
40	O
]	O
.	O

DMRT7	O
and	O
SUMO	O
-	O
1	O
were	O
colocalized	O
,	O
confirming	O
that	O
DMRT7	O
protein	B-CHEBI
is	O
preferentially	O
localized	O
to	O
the	O
XY	O
body	O
(	O
Figure	O
1D	O
)	O
.	O

We	O
also	O
confirmed	O
XY	O
body	O
localization	O
of	O
DMRT7	O
by	O
double	O
staining	O
for	O
other	O
markers	O
including	O
Ub	O
-	O
H2A	O
and	O
gamma	O
H2AX	O
(	O
unpublished	O
data	O
)	O
.	O

DMRT7	O
is	O
not	O
preferentially	O
localized	O
to	O
the	O
XY	O
body	O
at	O
all	O
stages	O
but	O
instead	O
is	O
dynamic	O
.	O

Based	O
on	O
epithelial	O
staging	O
,	O
it	O
appears	O
that	O
DMRT7	O
localizes	O
to	O
the	O
XY	O
body	O
from	O
mid	O
-	O
to	O
late	O
-	O
pachynema	O
,	O
becomes	O
diffusely	O
distributed	O
in	O
late	O
-	O
pachynema	O
,	O
and	O
disappears	O
in	O
diplonema	O
(	O
unpublished	O
data	O
)	O
.	O

This	O
localization	O
was	O
confirmed	O
by	O
staining	O
of	O
meiotic	O
spreads	O
(	O
Figure	O
S1	O
)	O
.	O

DMRT7	O
also	O
is	O
specifically	O
localized	O
in	O
sperm	O
,	O
with	O
antibody	O
staining	O
mainly	O
in	O
the	O
perinuclear	O
ring	O
of	O
the	O
sperm	O
head	O
manchette	O
.	O

This	O
staining	O
coincided	O
with	O
the	O
epithelial	O
stages	O
in	O
which	O
DMRT7	O
localizes	O
to	O
the	O
XY	O
body	O
in	O
spermatocytes	O
(	O
Figure	O
1C	O
and	O
1D	O
)	O
.	O

Targeted	O
Deletion	O
of	O
Dmrt7	O

To	O
establish	O
the	O
functional	O
requirement	O
for	O
Dmrt7	O
,	O
we	O
generated	O
Dmrt7	O
-	O
/	O
-	O
mice	O
by	O
targeted	O
disruption	O
in	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
using	O
a	O
strategy	O
diagrammed	O
in	O
Figure	O
S2A	O
.	O

The	O
Dmrt7	O
gene	O
has	O
nine	O
exons	O
with	O
the	O
DM	O
domain	O
encoded	O
by	O
the	O
second	O
and	O
third	O
exons	O
.	O

Because	O
the	O
DM	O
domain	O
is	O
essential	O
for	O
function	O
of	O
other	O
genes	O
,	O
including	O
mab	O
-	O
3	O
,	O
mab	O
-	O
23	O
,	O
and	O
dsx	O
[	O
18	O
,	O
19	O
,	O
41	O
]	O
,	O
we	O
generated	O
a	O
conditionally	O
targeted	O
"	O
floxed	O
"	O
allele	O
in	O
which	O
the	O
DM	O
domain	O
-	O
containing	O
exons	O
of	O
Dmrt7	O
are	O
flanked	O
by	O
recognition	O
sites	O
for	O
the	O
Cre	O
recombinase	O
(	O
loxP	O
sites	O
)	O
.	O

The	O
targeting	O
vector	O
also	O
contained	O
a	O
neomycin	B-CHEBI
resistance	O
cassette	O
(	O
neo	O
)	O
flanked	O
by	O
Flpe	O
recognition	O
sites	O
.	O

The	O
removal	O
of	O
these	O
sequences	O
by	O
Cre	O
-	O
mediated	O
recombination	O
eliminates	O
the	O
DM	O
domain	O
and	O
the	O
translational	O
start	O
site	O
,	O
thus	O
generating	O
a	O
putative	O
null	O
allele	O
.	O

We	O
identified	O
three	O
homologously	O
targeted	O
ES	O
cell	O
clones	O
by	O
Southern	O
blotting	O
(	O
Figure	O
S2B	O
)	O
and	O
injected	O
cells	O
from	O
two	O
clones	O
into	O
C57BL	O
/	O
6	O
blastocysts	O
.	O

Chimeric	O
animals	O
from	O
both	O
cell	O
lines	O
transmitted	O
the	O
targeted	O
allele	O
through	O
the	O
germ	O
line	O
.	O

Targeted	O
animals	O
were	O
bred	O
to	O
beta	O
-	O
actin	O
Cre	O
mice	O
to	O
delete	O
the	O
DM	O
domain	O
-	O
encoding	O
exons	O
,	O
generating	O
the	O
Dmrt7	O
-	O
allele	O
,	O
or	O
to	O
Flpe	O
transgenic	O
mice	O
to	O
delete	O
the	O
neo	O
cassette	O
,	O
generating	O
the	O
Dmrt7flox	O
allele	O
.	O

Dmrt7	O
+	O
/	O
-	O
mice	O
were	O
interbred	O
to	O
generate	O
Dmrt7	O
-	O
/	O
-	O
mice	O
.	O

To	O
confirm	O
the	O
lack	O
of	O
functional	O
DMRT7	O
protein	B-CHEBI
in	O
Dmrt7	O
-	O
/	O
-	O
testes	O
,	O
we	O
stained	O
meiotic	O
spreads	O
from	O
Dmrt7	O
mutants	O
(	O
Figure	O
S1	O
)	O
and	O
sections	O
from	O
mutant	O
testes	O
(	O
Figure	O
S2C	O
)	O
and	O
carried	O
out	O
western	O
blot	O
analysis	O
(	O
unpublished	O
data	O
)	O
.	O

In	O
each	O
case	O
,	O
we	O
detected	O
no	O
DMRT7	O
protein	B-CHEBI
in	O
the	O
mutant	O
testes	O
.	O

Dmrt7	O
Is	O
Required	O
for	O
Male	O
but	O
Not	O
Female	O
Gametogenesis	O

Breeding	O
of	O
Dmrt7	O
heterozygotes	O
produced	O
homozygous	O
mutant	O
progeny	O
of	O
both	O
sexes	O
at	O
the	O
expected	O
frequency	O
(	O
63	O
/	O
264	O
;	O
23	O
%	O
)	O
.	O

Male	O
and	O
female	O
homozygous	O
mutants	O
were	O
viable	O
,	O
grew	O
to	O
adulthood	O
normally	O
,	O
and	O
exhibited	O
normal	O
sexual	O
behavior	O
.	O

Female	O
homozygotes	O
were	O
fertile	O
,	O
produced	O
litters	O
of	O
normal	O
size	O
,	O
and	O
had	O
no	O
obvious	O
ovarian	O
abnormalities	O
as	O
judged	O
by	O
histological	O
analysis	O
(	O
unpublished	O
data	O
)	O
.	O

In	O
contrast	O
,	O
Dmrt7	O
homozygous	O
mutant	O
males	O
were	O
completely	O
infertile	O
and	O
had	O
testes	O
about	O
one	O
-	O
third	O
the	O
weight	O
of	O
those	O
of	O
heterozygous	O
or	O
wild	O
-	O
type	O
adult	O
littermates	O
(	O
Figure	O
2	O
)	O
.	O

To	O
determine	O
when	O
defective	O
testis	O
development	O
begins	O
in	O
Dmrt7	O
mutants	O
,	O
we	O
compared	O
the	O
testes	O
of	O
wild	O
-	O
type	O
and	O
mutant	O
littermates	O
during	O
the	O
first	O
wave	O
of	O
spermatogenesis	O
.	O

Prior	O
to	O
postnatal	O
day	O
14	O
(	O
P14	O
)	O
,	O
mutant	O
testes	O
appeared	O
histologically	O
normal	O
and	O
the	O
testis	O
weights	O
were	O
similar	O
to	O
those	O
of	O
heterozygous	O
and	O
wild	O
-	O
type	O
littermates	O
,	O
indicating	O
that	O
spermatogonia	O
and	O
early	O
meiotic	O
germ	O
cells	O
form	O
normally	O
(	O
Figure	O
2B	O
;	O
unpublished	O
data	O
)	O
.	O

Thereafter	O
,	O
the	O
testes	O
of	O
the	O
Dmrt7	O
mutant	O
mice	O
ceased	O
to	O
grow	O
and	O
the	O
weight	O
difference	O
was	O
significant	O
.	O

Microscopic	O
examination	O
of	O
P21	O
and	O
P42	O
Dmrt7	O
mutant	O
testes	O
revealed	O
that	O
germ	O
cells	O
arrest	O
in	O
pachynema	O
,	O
and	O
later	O
stages	O
of	O
germ	O
cells	O
are	O
largely	O
missing	O
(	O
Figure	O
2C	O
and	O
2D	O
)	O
.	O

Dmrt7	O
mutant	O
mice	O
are	O
deficient	O
in	O
postmeiotic	O
spermatids	O
and	O
lack	O
epididymal	O
spermatozoa	O
,	O
although	O
a	O
few	O
cells	O
develop	O
to	O
the	O
round	O
spermatid	O
stage	O
.	O

These	O
meiotic	O
defects	O
are	O
in	O
agreement	O
with	O
a	O
recent	O
preliminary	O
analysis	O
of	O
another	O
Dmrt7	O
mutation	O
[	O
42	O
]	O
.	O

While	O
some	O
Dmrt7	O
mutant	O
tubules	O
are	O
highly	O
vacuolated	O
and	O
contain	O
primarily	O
Sertoli	O
cells	O
and	O
spermatogonia	O
,	O
others	O
have	O
abundant	O
primary	O
spermatocytes	O
.	O

In	O
addition	O
,	O
some	O
tubules	O
contain	O
multinucleated	O
cells	O
and	O
cells	O
with	O
darkly	O
stained	O
nuclei	O
that	O
are	O
typical	O
of	O
apoptotic	O
cells	O
(	O
Figure	O
2D	O
)	O
.	O

Figure	O
2	O

Reduced	O
Testis	O
Size	O
and	O
Germ	O
Cell	O
Apoptosis	O
in	O
Mice	O
with	O
Targeted	O
Deletion	O
in	O
Dmrt7	O

(	O
A	O
)	O
Testes	O
from	O
a	O
6	O
-	O
wk	O
-	O
old	O
wild	O
-	O
type	O
(	O
+	O
/	O
+	O
)	O
mouse	O
and	O
a	O
homozygous	O
(	O
-	O
/	O
-	O
)	O
Dmrt7	O
mutant	O
littermate	O
.	O

(	O
B	O
-	O
D	O
)	O
Sections	O
of	O
testes	O
from	O
14	O
-	O
d	O
-	O
old	O
(	O
B	O
)	O
,	O
21	O
-	O
d	O
-	O
old	O
(	O
C	O
)	O
,	O
and	O
42	O
-	O
d	O
-	O
old	O
mice	O
(	O
D	O
)	O
stained	O
with	O
hematoxylin	O
and	O
eosin	O
.	O

Wild	O
-	O
type	O
is	O
in	O
left	O
column	O
and	O
mutant	O
in	O
right	O
.	O

No	O
significant	O
difference	O
is	O
observed	O
at	O
14	O
d	O
(	O
B	O
)	O
,	O
but	O
by	O
21	O
d	O
some	O
tubules	O
are	O
lacking	O
abundant	O
spermatocytes	O
(	O
C	O
,	O
asterisk	O
)	O
or	O
cells	O
with	O
typical	O
apoptotic	O
morphology	O
are	O
present	O
(	O
open	O
arrowhead	O
,	O
C	O
and	O
D	O
)	O
.	O

Mutant	O
tubules	O
contain	O
multinucleate	O
cells	O
(	O
closed	O
arrowhead	O
,	O
D	O
)	O
.	O

(	O
E	O
and	O
F	O
)	O
TUNEL	O
labeling	O
of	O
Dmrt7	O
-	O
deficient	O
mouse	O
testes	O
.	O

Testes	O
from	O
wild	O
-	O
type	O
and	O
homozygous	O
mutant	O
littermates	O
were	O
analyzed	O
by	O
TUNEL	O
labeling	O
to	O
detect	O
apoptotic	O
cells	O
.	O

Testis	O
sections	O
from	O
21	O
-	O
d	O
-	O
old	O
(	O
E	O
)	O
and	O
6	O
-	O
wk	O
-	O
old	O
mice	O
(	O
F	O
)	O
.	O

Apoptotic	O
cells	O
(	O
brown	O
)	O
are	O
much	O
more	O
abundant	O
in	O
seminiferous	O
tubules	O
of	O
homozygous	O
Dmrt7	O
mutant	O
mice	O
relative	O
to	O
wild	O
-	O
type	O
.	O

Bars	O
in	O
(	O
B	O
-	O
F	O
)	O
represent	O
100	O
mu	O
m	O
.	O

Since	O
Dmrt7	O
mutant	O
testes	O
lack	O
most	O
post	O
-	O
pachytene	O
cells	O
,	O
we	O
used	O
TUNEL	O
analysis	O
to	O
test	O
whether	O
the	O
missing	O
cells	O
are	O
eliminated	O
by	O
apoptosis	O
.	O

At	O
3	O
wk	O
,	O
Dmrt7	O
mutant	O
testes	O
contain	O
significantly	O
more	O
apoptotic	O
cells	O
than	O
those	O
of	O
wild	O
-	O
type	O
controls	O
.	O

The	O
percentage	O
of	O
tubule	O
sections	O
with	O
five	O
or	O
more	O
apoptotic	O
nuclei	O
was	O
about	O
three	O
times	O
higher	O
in	O
Dmrt7	O
mutants	O
compared	O
with	O
wild	O
-	O
type	O
(	O
20	O
%	O
versus	O
7	O
%	O
;	O
Figure	O
2E	O
)	O
.	O

A	O
similar	O
elevation	O
of	O
apoptosis	O
was	O
apparent	O
in	O
mutant	O
testes	O
at	O
7	O
wk	O
(	O
Figure	O
2F	O
)	O
.	O

In	O
mutants	O
,	O
many	O
apoptotic	O
cells	O
were	O
in	O
the	O
middle	O
of	O
the	O
tubules	O
,	O
whereas	O
the	O
apoptotic	O
cells	O
in	O
wild	O
-	O
type	O
occur	O
mainly	O
near	O
the	O
seminiferous	O
tubule	O
periphery	O
.	O

The	O
numbers	O
of	O
Sertoli	O
cells	O
were	O
not	O
significantly	O
different	O
between	O
wild	O
-	O
type	O
and	O
mutant	O
testes	O
,	O
and	O
we	O
observed	O
no	O
difference	O
in	O
somatic	O
cell	O
apoptosis	O
in	O
mutants	O
(	O
unpublished	O
data	O
)	O
.	O

From	O
these	O
results	O
,	O
we	O
conclude	O
that	O
loss	O
of	O
Dmrt7	O
causes	O
a	O
block	O
in	O
meiotic	O
progression	O
,	O
mainly	O
in	O
pachynema	O
,	O
leading	O
to	O
the	O
elimination	O
,	O
by	O
apoptosis	O
,	O
of	O
the	O
arrested	O
cells	O
.	O

Pachytene	O
Arrest	O
of	O
Dmrt7	O
Mutant	O
Germ	O
Cells	O

To	O
better	O
define	O
the	O
spermatogenic	O
stage	O
at	O
which	O
Dmrt7	O
-	O
/	O
-	O
male	O
germ	O
cells	O
arrest	O
and	O
die	O
,	O
we	O
used	O
antibodies	O
against	O
several	O
stage	O
-	O
specific	O
germ	O
cell	O
markers	O
.	O

TRA98	O
is	O
expressed	O
in	O
PGCs	O
and	O
spermatogonia	O
[	O
43	O
]	O
.	O

In	O
the	O
wild	O
-	O
type	O
adult	O
testis	O
,	O
strongly	O
staining	O
TRA98	O
-	O
positive	O
cells	O
form	O
a	O
layer	O
one	O
cell	O
deep	O
;	O
however	O
,	O
in	O
the	O
mutant	O
TRA98	O
,	O
strongly	O
positive	O
cells	O
were	O
abnormally	O
organized	O
,	O
and	O
some	O
tubules	O
had	O
a	O
layer	O
several	O
cells	O
deep	O
(	O
Figure	O
3A	O
)	O
.	O

The	O
BC7	O
antibody	O
recognizes	O
spermatocytes	O
in	O
the	O
leptotene	O
to	O
early	O
-	O
pachytene	O
stages	O
[	O
44	O
]	O
.	O

Dmrt7	O
mutant	O
testes	O
had	O
BC7	O
-	O
positive	O
cells	O
in	O
approximately	O
normal	O
numbers	O
,	O
but	O
again	O
abnormally	O
organized	O
,	O
with	O
many	O
positive	O
cells	O
in	O
the	O
center	O
rather	O
than	O
the	O
periphery	O
of	O
the	O
tubules	O
(	O
Figure	O
3B	O
)	O
.	O

The	O
TRA369	O
antibody	O
recognizes	O
a	O
calmegin	O
protein	B-CHEBI
expressed	O
in	O
pachytene	O
spermatocytes	O
through	O
elongated	O
spermatids	O
[	O
45	O
]	O
.	O

In	O
contrast	O
to	O
the	O
earlier	O
stages	O
,	O
far	O
fewer	O
TRA369	O
-	O
positive	O
cells	O
were	O
present	O
in	O
mutant	O
testes	O
relative	O
to	O
wild	O
-	O
type	O
(	O
Figure	O
3C	O
)	O
.	O

We	O
also	O
quantitated	O
the	O
number	O
of	O
cells	O
at	O
each	O
meiotic	O
stage	O
using	O
spermatocyte	O
spreads	O
,	O
assaying	O
chromosome	O
-	O
pairing	O
status	O
by	O
staining	O
for	O
SYCP3	O
,	O
a	O
component	O
of	O
the	O
synaptonemal	O
complex	O
(	O
Figure	O
4	O
)	O
.	O

We	O
found	O
that	O
Dmrt7	O
mutants	O
accumulate	O
pachytene	O
cells	O
but	O
have	O
greatly	O
reduced	O
numbers	O
of	O
cells	O
in	O
late	O
-	O
pachynema	O
and	O
beyond	O
.	O

Together	O
,	O
these	O
results	O
confirm	O
that	O
the	O
meiotic	O
arrest	O
in	O
Dmrt7	O
mutants	O
occurs	O
primarily	O
during	O
pachynema	O
and	O
results	O
in	O
efficient	O
elimination	O
of	O
arrested	O
cells	O
.	O

Figure	O
3	O

Prophase	O
I	O
Arrest	O
of	O
Dmrt7	O
Mutant	O
Germ	O
Cells	O

Testis	O
sections	O
from	O
6	O
-	O
wk	O
-	O
old	O
wild	O
-	O
type	O
(	O
+	O
/	O
+	O
)	O
and	O
Dmrt7	O
mutant	O
(	O
-	O
/	O
-	O
)	O
littermates	O
stained	O
with	O
stage	O
-	O
specific	O
antibodies	O
specific	O
to	O
spermatogenic	O
cells	O
.	O

(	O
A	O
)	O
TRA98	O
antibody	O
strongly	O
stains	O
spermatogonia	O
,	O
which	O
are	O
present	O
in	O
wild	O
-	O
type	O
and	O
mutant	O
.	O

(	O
B	O
)	O
BC7	O
antibody	O
stains	O
spermatocytes	O
,	O
which	O
are	O
present	O
in	O
wild	O
-	O
type	O
and	O
mutant	O
.	O

(	O
C	O
)	O
TRA369	O
antibody	O
stains	O
pachytene	O
and	O
later	O
germ	O
cells	O
,	O
which	O
are	O
severely	O
deficient	O
in	O
the	O
mutant	O
testis	O
.	O

Figure	O
4	O

Profile	O
of	O
Meiotic	O
Arrest	O
in	O
Dmrt7	O
Mutant	O
Testis	O

Graph	O
of	O
distribution	O
of	O
meiotic	O
stages	O
of	O
germ	O
cells	O
from	O
heterozygous	O
(	O
n	O
=	O
1	O
,	O
970	O
)	O
and	O
homozygous	O
mutant	O
(	O
n	O
=	O
2	O
,	O
084	O
)	O
P26	O
testes	O
,	O
spread	O
and	O
stained	O
for	O
the	O
synaptonemal	O
complex	O
protein	B-CHEBI
SYCP3	O
to	O
permit	O
precise	O
staging	O
,	O
which	O
was	O
performed	O
as	O
described	O
[	O
64	O
,	O
65	O
]	O
.	O

Normal	O
Meiotic	O
Prophase	O
in	O
Dmrt7	O
Mutant	O
Germ	O
Cells	O

Defects	O
in	O
chromosome	O
pairing	O
,	O
synapsis	O
,	O
or	O
recombination	O
can	O
trigger	O
pachytene	O
arrest	O
and	O
apoptosis	O
[	O
46	O
]	O
.	O

We	O
therefore	O
examined	O
these	O
events	O
in	O
Dmrt7	O
mutant	O
testes	O
.	O

To	O
assess	O
homolog	O
synapsis	O
,	O
we	O
used	O
antibodies	O
to	O
SYCP1	O
,	O
a	O
synaptonemal	O
complex	O
transverse	O
element	O
component	O
,	O
and	O
SYCP3	O
,	O
a	O
component	O
of	O
the	O
axial	O
element	O
,	O
which	O
remains	O
on	O
the	O
desynapsed	O
axes	O
during	O
diplonema	O
[	O
47	O
,	O
48	O
]	O
.	O

Formation	O
of	O
synaptonemal	O
complexes	O
in	O
the	O
mutant	O
was	O
indistinguishable	O
from	O
that	O
in	O
wild	O
-	O
type	O
,	O
as	O
indicated	O
by	O
the	O
proper	O
accumulation	O
of	O
SYCP1	O
(	O
unpublished	O
data	O
)	O
and	O
SYCP3	O
(	O
Figure	O
5A	O
)	O
.	O

Likewise	O
,	O
the	O
Dmrt7	O
mutant	O
zygotene	O
spermatocytes	O
showed	O
normal	O
accumulation	O
of	O
the	O
early	O
recombination	O
repair	O
marker	O
RAD51	O
,	O
suggesting	O
that	O
early	O
meiotic	O
recombination	O
is	O
not	O
significantly	O
affected	O
(	O
Figure	O
5B	O
)	O
.	O

Dmrt7	O
mutant	O
spermatocytes	O
exhibited	O
the	O
expected	O
decline	O
in	O
the	O
presence	O
of	O
RAD51	O
foci	O
associated	O
with	O
the	O
autosomal	O
synaptonemal	O
complexes	O
(	O
Figure	O
5B	O
;	O
unpublished	O
data	O
)	O
[	O
49	O
]	O
.	O

The	O
few	O
surviving	O
cells	O
that	O
progressed	O
beyond	O
pachynema	O
also	O
underwent	O
apparently	O
normal	O
desynapsis	O
during	O
diplonema	O
(	O
Figure	O
5A	O
)	O
.	O

From	O
these	O
results	O
,	O
we	O
conclude	O
that	O
chromosomal	O
pairing	O
,	O
synapsis	O
,	O
recombination	O
,	O
and	O
desynapsis	O
during	O
prophase	O
I	O
in	O
Dmrt7	O
mutant	O
males	O
are	O
grossly	O
normal	O
.	O

Figure	O
5	O

Normal	O
Synapsis	O
and	O
Recombination	O
in	O
Dmrt7	O
Mutant	O
Germ	O
Cells	O

(	O
A	O
)	O
Testicular	O
cells	O
from	O
Dmrt7	O
heterozygous	O
(	O
+	O
/	O
-	O
)	O
or	O
homozygous	O
(	O
-	O
/	O
-	O
)	O
mutant	O
mice	O
were	O
spread	O
and	O
stained	O
with	O
antibody	O
to	O
SYCP3	O
(	O
red	O
)	O
.	O

The	O
developmental	O
stages	O
of	O
meiotic	O
prophase	O
based	O
on	O
SYCP3	O
organization	O
are	O
indicated	O
in	O
each	O
panel	O
.	O

By	O
pachynema	O
,	O
all	O
autosomes	O
are	O
fully	O
synapsed	O
,	O
and	O
the	O
XY	O
bivalent	O
is	O
synapsed	O
only	O
at	O
the	O
pseudoautosomal	O
region	O
in	O
both	O
wild	O
-	O
type	O
and	O
mutant	O
cells	O
.	O

(	O
B	O
)	O
Testicular	O
cells	O
in	O
zygonema	O
and	O
pachynema	O
spread	O
and	O
stained	O
with	O
antibodies	O
to	O
RAD51	O
(	O
green	O
)	O
and	O
SYCP3	O
(	O
red	O
)	O
.	O

Size	O
and	O
distribution	O
of	O
RAD51	O
foci	O
are	O
similar	O
between	O
wild	O
-	O
type	O
and	O
mutant	O
spermatocytes	O
.	O

Abnormal	O
Cellular	O
Organization	O
and	O
the	O
Role	O
of	O
Sertoli	O
Cells	O

Sertoli	O
cells	O
interact	O
with	O
germ	O
cells	O
during	O
spermatogenesis	O
and	O
the	O
interaction	O
is	O
critical	O
for	O
germ	O
cell	O
maturation	O
[	O
50	O
]	O
.	O

Although	O
we	O
did	O
not	O
detect	O
DMRT7	O
expression	O
in	O
Sertoli	O
cells	O
by	O
antibody	O
staining	O
,	O
we	O
nevertheless	O
considered	O
the	O
possibility	O
that	O
Sertoli	O
cell	O
defects	O
might	O
contribute	O
to	O
the	O
male	O
-	O
specific	O
germ	O
line	O
failure	O
of	O
Dmrt7	O
mutants	O
.	O

To	O
characterize	O
Sertoli	O
cell	O
differentiation	O
,	O
we	O
examined	O
expression	O
of	O
the	O
Sertoli	O
cell	O
markers	O
GATA4	O
(	O
a	O
marker	O
of	O
immature	O
postnatal	O
Sertoli	O
cells	O
)	O
and	O
GATA1	O
(	O
a	O
mature	O
Sertoli	O
cell	O
marker	O
)	O
.	O

The	O
levels	O
of	O
these	O
proteins	B-CHEBI
appeared	O
normal	O
relative	O
to	O
wild	O
-	O
type	O
at	O
P14	O
and	O
P42	O
(	O
Figure	O
6A	O
-	O
6C	O
)	O
,	O
as	O
did	O
the	O
androgen	O
receptor	O
(	O
Figure	O
S3	O
;	O
unpublished	O
data	O
)	O
.	O

However	O
,	O
the	O
organization	O
of	O
Sertoli	O
cells	O
in	O
Dmrt7	O
mutant	O
testes	O
was	O
abnormal	O
:	O
in	O
some	O
tubules	O
GATA1	O
-	O
positive	O
Sertoli	O
cell	O
nuclei	O
were	O
displaced	O
from	O
their	O
usual	O
close	O
apposition	O
with	O
the	O
basement	O
membrane	O
(	O
Figure	O
6C	O
)	O
.	O

In	O
such	O
tubules	O
,	O
nuclei	O
of	O
pre	O
-	O
meiotic	O
germ	O
cells	O
and	O
spermatocytes	O
were	O
packed	O
close	O
to	O
the	O
basal	O
membrane	O
and	O
few	O
germ	O
cells	O
were	O
found	O
in	O
the	O
adlumenal	O
region	O
.	O

Figure	O
6	O

Abnormal	O
Sertoli	O
Cell	O
Organization	O
in	O
Dmrt7	O
Mutant	O
Testes	O

(	O
A	O
)	O
Testes	O
from	O
P14	O
wild	O
-	O
type	O
and	O
Dmrt7	O
mutant	O
mice	O
were	O
sectioned	O
and	O
stained	O
with	O
antibody	O
to	O
GATA4	O
.	O

(	O
B	O
)	O
P14	O
testis	O
sections	O
stained	O
with	O
antibody	O
to	O
GATA1	O
.	O

At	O
P14	O
,	O
GATA4	O
and	O
GATA1	O
levels	O
are	O
similar	O
in	O
wild	O
-	O
type	O
and	O
mutant	O
Sertoli	O
cell	O
.	O

(	O
C	O
)	O
Wild	O
-	O
type	O
and	O
mutant	O
testis	O
sections	O
double	O
-	O
stained	O
with	O
antibody	O
to	O
GATA1	O
(	O
red	O
)	O
and	O
DAPI	O
(	O
blue	O
)	O
.	O

Most	O
Sertoli	O
cell	O
nuclei	O
were	O
adjacent	O
to	O
the	O
basal	O
membrane	O
in	O
wild	O
-	O
type	O
,	O
but	O
mutant	O
Sertoli	O
cells	O
were	O
displaced	O
in	O
some	O
tubules	O
(	O
arrowhead	O
)	O
.	O

White	O
dotted	O
line	O
indicates	O
position	O
of	O
basal	O
membranes	O
.	O

(	O
D	O
)	O
Testis	O
sections	O
from	O
10	O
-	O
wk	O
-	O
old	O
wild	O
-	O
type	O
and	O
Sertoli	O
cell	O
-	O
specific	O
Dmrt7	O
mutant	O
(	O
SC	O
-	O
Dmrt7KO	O
)	O
mice	O
stained	O
with	O
hematoxylin	O
and	O
eosin	O
.	O

Spermatogenesis	O
and	O
spermiogenesis	O
are	O
normal	O
in	O
SC	O
-	O
Dmrt7KO	O
testis	O
.	O

(	O
E	O
)	O
Testis	O
sections	O
from	O
10	O
-	O
wk	O
-	O
old	O
wild	O
-	O
type	O
and	O
SC	O
-	O
Dmrt7KO	O
mice	O
stained	O
with	O
antibodies	O
to	O
GATA1	O
(	O
red	O
)	O
and	O
smooth	O
muscle	O
actin	O
(	O
to	O
outline	O
seminiferous	O
tubules	O
;	O
green	O
)	O
.	O

Sertoli	O
cell	O
nuclei	O
are	O
positioned	O
normally	O
near	O
the	O
basal	O
membrane	O
in	O
SC	O
-	O
Dmrt7KO	O
mice	O
.	O

The	O
aberrant	O
Sertoli	O
cell	O
organization	O
in	O
Dmrt7	O
mutant	O
testes	O
raised	O
the	O
possibility	O
that	O
the	O
germ	O
cell	O
phenotype	O
might	O
indirectly	O
result	O
from	O
defects	O
in	O
Sertoli	O
cell	O
function	O
.	O

To	O
test	O
this	O
possibility	O
,	O
we	O
deleted	O
Dmrt7	O
just	O
in	O
the	O
Sertoli	O
cell	O
lineage	O
by	O
crossing	O
mice	O
carrying	O
the	O
floxed	O
Dmrt7	O
allele	O
with	O
Dhh	O
-	O
Cre	O
transgenic	O
mice	O
[	O
51	O
]	O
.	O

The	O
Desert	O
hedgehog	O
(	O
Dhh	O
)	O
promoter	O
is	O
active	O
starting	O
at	O
about	O
E12	O
.	O
5	O
in	O
pre	O
-	O
Sertoli	O
cells	O
but	O
not	O
in	O
germ	O
cells	O
,	O
allowing	O
deletion	O
of	O
Dmrt7	O
in	O
Sertoli	O
cells	O
well	O
before	O
any	O
likely	O
requirement	O
for	O
its	O
function	O
[	O
52	O
]	O
.	O

Testicular	O
size	O
in	O
Sertoli	O
-	O
targeted	O
(	O
SC	O
-	O
Dmrt7KO	O
)	O
animals	O
was	O
slightly	O
reduced	O
from	O
that	O
of	O
wild	O
-	O
type	O
,	O
but	O
histological	O
analysis	O
revealed	O
no	O
obvious	O
difference	O
between	O
wild	O
-	O
type	O
and	O
SC	O
-	O
Dmrt7KO	O
testes	O
(	O
Figure	O
6D	O
)	O
.	O

Spermatogenesis	O
appeared	O
normal	O
,	O
mature	O
sperm	O
were	O
present	O
,	O
and	O
SC	O
-	O
Dmrt7KO	O
mice	O
were	O
fertile	O
.	O

In	O
addition	O
,	O
GATA1	O
staining	O
showed	O
that	O
Sertoli	O
cell	O
nuclei	O
were	O
located	O
adjacent	O
to	O
the	O
basement	O
membrane	O
as	O
in	O
wild	O
-	O
type	O
(	O
Figure	O
6E	O
)	O
.	O

These	O
results	O
suggest	O
the	O
germ	O
cell	O
defects	O
of	O
Dmrt7	O
mutants	O
are	O
not	O
caused	O
by	O
lack	O
of	O
Dmrt7	O
in	O
Sertoli	O
cells	O
.	O

Rather	O
,	O
the	O
abnormal	O
organization	O
of	O
Sertoli	O
cells	O
appears	O
to	O
result	O
from	O
lack	O
of	O
Dmrt7	O
in	O
the	O
germ	O
line	O
.	O

XY	O
Bodies	O
Form	O
Normally	O
in	O
Dmrt7	O
Mutant	O
Cells	O

The	O
data	O
presented	O
so	O
far	O
indicate	O
that	O
Dmrt7	O
mutant	O
germ	O
cells	O
undergo	O
apparently	O
normal	O
early	O
meiosis	O
and	O
then	O
arrest	O
during	O
pachynema	O
due	O
to	O
a	O
strict	O
requirement	O
for	O
Dmrt7	O
in	O
the	O
germ	O
line	O
.	O

To	O
better	O
understand	O
the	O
basis	O
of	O
the	O
meiotic	O
arrest	O
,	O
we	O
more	O
closely	O
examined	O
meiotic	O
germ	O
cells	O
in	O
the	O
mutant	O
.	O

We	O
focused	O
on	O
the	O
XY	O
body	O
,	O
which	O
is	O
thought	O
to	O
be	O
essential	O
for	O
meiotic	O
progression	O
and	O
is	O
the	O
site	O
of	O
preferential	O
DMRT7	O
localization	O
.	O

Condensation	O
of	O
the	O
X	O
and	O
Y	O
chromosomes	O
begins	O
in	O
late	O
-	O
zygotene	O
cells	O
,	O
and	O
,	O
by	O
mid	O
-	O
pachynema	O
(	O
when	O
homologous	O
chromosome	O
pairs	O
are	O
fully	O
aligned	O
)	O
the	O
sex	O
chromatin	O
forms	O
a	O
microscopically	O
visible	O
spherical	O
structure	O
near	O
the	O
nuclear	O
periphery	O
[	O
53	O
]	O
.	O

We	O
first	O
asked	O
whether	O
DMRT7	O
is	O
required	O
for	O
XY	O
body	O
formation	O
by	O
evaluating	O
several	O
characteristic	O
XY	O
body	O
chromatin	O
features	O
.	O

First	O
,	O
we	O
tested	O
gamma	O
H2AX	O
expression	O
by	O
immunofluorescent	O
staining	O
.	O

H2AX	O
is	O
a	O
variant	O
of	O
H2A	O
that	O
is	O
crucial	O
for	O
XY	O
body	O
formation	O
and	O
MSCI	O
[	O
12	O
]	O
.	O

gamma	O
H2AX	O
localized	O
normally	O
to	O
the	O
XY	O
body	O
of	O
DMRT7	O
mutant	O
cells	O
in	O
meiotic	O
spreads	O
(	O
Figure	O
7A	O
)	O
,	O
and	O
many	O
gamma	O
H2AX	O
-	O
positive	O
puncta	O
were	O
present	O
in	O
germ	O
cells	O
of	O
Dmrt7	O
mutant	O
testes	O
(	O
Figure	O
7B	O
)	O
.	O

Next	O
,	O
we	O
examined	O
SUMO	O
-	O
1	O
localization	O
in	O
the	O
mutant	O
testis	O
.	O

SUMO	O
-	O
1	O
expression	O
normally	O
increases	O
in	O
the	O
XY	O
body	O
of	O
early	O
-	O
to	O
mid	O
-	O
pachytene	O
spermatocytes	O
at	O
the	O
time	O
of	O
sex	O
chromosome	O
condensation	O
.	O

Prior	O
to	O
the	O
completion	O
of	O
the	O
first	O
meiotic	O
division	O
,	O
SUMO	O
-	O
1	O
disappears	O
from	O
the	O
XY	O
body	O
as	O
the	O
X	O
and	O
Y	O
chromosomes	O
desynapse	O
[	O
40	O
]	O
.	O

Punctate	O
SUMO	O
-	O
1	O
localization	O
was	O
present	O
in	O
Dmrt7	O
mutant	O
germ	O
cells	O
,	O
again	O
consistent	O
with	O
formation	O
of	O
a	O
correctly	O
marked	O
XY	O
body	O
(	O
Figure	O
7C	O
)	O
.	O

However	O
,	O
some	O
tubules	O
in	O
mutants	O
had	O
multiple	O
layers	O
of	O
cells	O
with	O
SUMO	O
-	O
1	O
-	O
condensed	O
spots	O
(	O
Figure	O
7C	O
)	O
,	O
rather	O
than	O
the	O
normal	O
single	O
layer	O
of	O
cells	O
.	O

This	O
accumulation	O
of	O
XY	O
body	O
-	O
containing	O
cells	O
also	O
was	O
apparent	O
with	O
gamma	O
H2AX	O
staining	O
and	O
is	O
consistent	O
with	O
a	O
developmental	O
arrest	O
of	O
mutant	O
cells	O
in	O
mid	O
-	O
to	O
late	O
-	O
pachytene	O
.	O

We	O
also	O
examined	O
Ub	O
-	O
H2A	O
localization	O
in	O
Dmrt7	O
mutant	O
testes	O
.	O

In	O
early	O
-	O
pachytene	O
,	O
Ub	O
-	O
H2A	O
is	O
concentrated	O
in	O
the	O
XY	O
body	O
;	O
by	O
mid	O
-	O
pachytene	O
Ub	O
-	O
H2A	O
is	O
observed	O
throughout	O
the	O
entire	O
nucleus	O
,	O
but	O
it	O
again	O
becomes	O
limited	O
to	O
the	O
XY	O
body	O
in	O
late	O
-	O
pachytene	O
spermatocytes	O
[	O
13	O
]	O
.	O

Analysis	O
of	O
nuclear	O
spreads	O
revealed	O
that	O
Ub	O
-	O
H2A	O
localizes	O
normally	O
to	O
the	O
XY	O
body	O
in	O
Dmrt7	O
mutants	O
(	O
Figure	O
S4	O
)	O
.	O

Collectively	O
,	O
these	O
results	O
indicate	O
that	O
Dmrt7	O
mutant	O
germ	O
cells	O
can	O
establish	O
an	O
XY	O
body	O
with	O
at	O
least	O
some	O
of	O
the	O
normal	O
chromatin	O
marks	O
.	O

Figure	O
7	O

XY	O
Body	O
Forms	O
Normally	O
during	O
Pachynema	O
in	O
Dmrt7	O
Mutant	O
Mice	O

(	O
A	O
)	O
Testicular	O
cells	O
spread	O
and	O
stained	O
with	O
antibodies	O
to	O
gamma	O
H2AX	O
(	O
red	O
)	O
and	O
SYCP3	O
(	O
green	O
)	O
.	O

In	O
pachytene	O
cells	O
,	O
gamma	O
H2AX	O
is	O
concentrated	O
in	O
the	O
XY	O
body	O
both	O
in	O
wild	O
-	O
type	O
and	O
Dmrt7	O
mutant	O
.	O

(	O
B	O
)	O
Testes	O
from	O
6	O
-	O
wk	O
-	O
old	O
mice	O
sectioned	O
and	O
stained	O
with	O
antibody	O
to	O
gamma	O
H2AX	O
(	O
red	O
)	O
.	O

(	O
C	O
)	O
Testes	O
from	O
6	O
-	O
wk	O
-	O
old	O
mice	O
sectioned	O
and	O
stained	O
with	O
antibody	O
to	O
SUMO	O
-	O
1	O
(	O
green	O
)	O
.	O

Abundant	O
pachytene	O
cells	O
with	O
XY	O
bodies	O
are	O
present	O
in	O
wild	O
-	O
type	O
and	O
mutant	O
testes	O
.	O

Abnormal	O
Sex	O
Chromatin	O
in	O
Dmrt7	O
Mutant	O
Germ	O
Cells	O

Although	O
the	O
XY	O
body	O
can	O
form	O
during	O
pachynema	O
in	O
Dmrt7	O
mutants	O
,	O
we	O
considered	O
the	O
possibility	O
that	O
transcriptional	O
silencing	O
might	O
not	O
be	O
properly	O
established	O
.	O

This	O
would	O
be	O
consistent	O
with	O
the	O
Dmrt7	O
phenotype	O
:	O
pachytene	O
cells	O
that	O
escape	O
from	O
MSCI	O
normally	O
are	O
eliminated	O
prior	O
to	O
late	O
-	O
pachytene	O
[	O
17	O
]	O
.	O

Recently	O
,	O
MSCI	O
has	O
been	O
shown	O
to	O
continue	O
into	O
meiosis	O
II	O
and	O
spermiogenesis	O
,	O
apparently	O
mediated	O
by	O
a	O
distinct	O
chromatin	O
compartment	O
termed	O
postmeiotic	O
sex	O
chromatin	O
(	O
PMSC	O
)	O
that	O
is	O
established	O
starting	O
in	O
diplonema	O
[	O
16	O
]	O
.	O

We	O
therefore	O
asked	O
whether	O
the	O
pachytene	O
germ	O
cell	O
death	O
in	O
Dmrt7	O
mutants	O
is	O
associated	O
with	O
a	O
failure	O
either	O
to	O
initiate	O
or	O
to	O
maintain	O
sex	O
chromosome	O
inactivation	O
.	O

First	O
,	O
we	O
examined	O
the	O
mid	O
-	O
pachytene	O
XY	O
body	O
.	O

To	O
examine	O
XY	O
transcriptional	O
status	O
,	O
we	O
carried	O
out	O
Cot	O
-	O
1	O
RNA	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
to	O
detect	O
nascent	O
RNA	O
polymerase	O
II	O
transcription	O
,	O
combined	O
with	O
DAPI	O
staining	O
to	O
locate	O
the	O
XY	O
body	O
on	O
spreads	O
of	O
seminiferous	O
tubules	O
(	O
Figure	O
8A	O
and	O
8B	O
)	O
.	O

In	O
Dmrt7	O
mutants	O
,	O
the	O
XY	O
body	O
was	O
formed	O
and	O
excluded	O
Cot	O
-	O
1	O
hybridization	O
(	O
Figure	O
8B	O
)	O
,	O
indicating	O
that	O
transcriptional	O
silencing	O
is	O
established	O
normally	O
in	O
mutant	O
pachytene	O
cells	O
.	O

We	O
also	O
examined	O
expression	O
of	O
the	O
Y	O
-	O
linked	O
gene	O
Rbmy	O
,	O
which	O
normally	O
is	O
inactivated	O
during	O
pachytene	O
and	O
reactivated	O
after	O
secondary	O
meiosis	O
begins	O
[	O
54	O
,	O
55	O
]	O
.	O

Rbmy	O
was	O
inactivated	O
normally	O
in	O
pachytene	O
cells	O
of	O
Dmrt7	O
mutants	O
,	O
based	O
on	O
immunofluorescent	O
staining	O
with	O
an	O
anti	O
-	O
RBMY	O
antibody	O
(	O
Figure	O
S5	O
)	O
.	O

We	O
also	O
examined	O
heterochromatin	O
protein	B-CHEBI
1	O
beta	O
(	O
HP1	O
beta	O
)	O
,	O
which	O
normally	O
localizes	O
to	O
the	O
X	O
centromere	O
at	O
mid	O
-	O
pachynema	O
and	O
then	O
spreads	O
through	O
the	O
XY	O
body	O
as	O
it	O
internalizes	O
during	O
diplonema	O
[	O
56	O
]	O
.	O

We	O
found	O
that	O
HP1	O
beta	O
localization	O
is	O
normal	O
in	O
DMRT7	O
mutant	O
cells	O
in	O
mid	O
-	O
pachynema	O
(	O
Figure	O
8C	O
and	O
8D	O
)	O
.	O

These	O
results	O
suggest	O
that	O
XY	O
body	O
formation	O
and	O
initiation	O
of	O
MSCI	O
both	O
occur	O
normally	O
in	O
Dmrt7	O
mutant	O
germ	O
cells	O
.	O

Figure	O
8	O

Chromatin	O
Abnormalities	O
in	O
Dmrt7	O
Mutant	O
Diplotene	O
Germ	O
Cells	O

(	O
A	O
and	O
B	O
)	O
MSCI	O
occurs	O
normally	O
in	O
mid	O
-	O
pachytene	O
spermatocyte	O
of	O
Dmrt7	O
mutant	O
.	O

Arrows	O
indicate	O
XY	O
body	O
in	O
all	O
panels	O
.	O

Cot	O
-	O
1	O
RNA	O
FISH	O
(	O
red	O
)	O
reveals	O
normal	O
silencing	O
of	O
sex	O
chromosome	O
transcription	O
in	O
XY	O
body	O
.	O

This	O
is	O
consistent	O
with	O
wild	O
-	O
type	O
mid	O
-	O
pachynema	O
as	O
described	O
previously	O
[	O
16	O
]	O
.	O

(	O
C	O
and	O
D	O
)	O
HP1	O
beta	O
localization	O
in	O
mid	O
-	O
pachytene	O
spermatocytes	O
.	O

HP1	O
beta	O
localizes	O
to	O
X	O
chromosome	O
centromere	O
(	O
arrowhead	O
)	O
in	O
wild	O
-	O
type	O
(	O
C	O
)	O
and	O
mutant	O
(	O
D	O
)	O
.	O

(	O
E	O
and	O
F	O
)	O
Cot	O
-	O
1	O
hybridization	O
in	O
diplotene	O
.	O

Presumptive	O
XY	O
body	O
,	O
based	O
on	O
DAPI	O
and	O
gamma	O
H2AX	O
localization	O
,	O
is	O
indicated	O
by	O
arrow	O
in	O
(	O
F	O
)	O
.	O

(	O
G	O
and	O
H	O
)	O
HP1	O
beta	O
in	O
diplotene	O
.	O

Wild	O
-	O
type	O
cell	O
(	O
E	O
)	O
has	O
HP1	O
beta	O
throughout	O
XY	O
body	O
,	O
whereas	O
mutant	O
cell	O
(	O
H	O
)	O
only	O
has	O
localization	O
to	O
X	O
chromosome	O
centromere	O
(	O
arrowhead	O
)	O
.	O

(	O
I	O
and	O
J	O
)	O
H3	O
-	O
2meK9	O
localization	O
in	O
diplotene	O
cells	O
.	O

Mutant	O
cell	O
(	O
J	O
)	O
lacks	O
strong	O
concentration	O
of	O
this	O
mark	O
to	O
the	O
XY	O
body	O
seen	O
in	O
wild	O
-	O
type	O
(	O
I	O
)	O
.	O

(	O
K	O
and	O
L	O
)	O
H3	O
-	O
3meK9	O
localization	O
in	O
diplotene	O
cells	O
.	O

Mutant	O
cell	O
(	O
L	O
)	O
has	O
no	O
localization	O
of	O
this	O
mark	O
to	O
the	O
XY	O
body	O
.	O

gamma	O
H2AX	O
localizes	O
to	O
autosomes	O
in	O
mutant	O
cell	O
,	O
possibly	O
indicating	O
onset	O
of	O
apoptosis	O
.	O

(	O
M	O
)	O
Example	O
of	O
mutant	O
diplotene	O
cell	O
with	O
normal	O
HP1	O
beta	O
accumulation	O
to	O
the	O
XY	O
body	O
.	O

All	O
images	O
except	O
those	O
in	O
(	O
M	O
)	O
are	O
single	O
Z	O
sections	O
.	O

We	O
next	O
considered	O
the	O
possibility	O
that	O
sex	O
chromatin	O
is	O
established	O
normally	O
but	O
is	O
not	O
properly	O
modified	O
as	O
cells	O
exit	O
pachynema	O
and	O
begin	O
to	O
form	O
PMSC	O
.	O

Although	O
most	O
Dmrt7	O
mutant	O
cells	O
are	O
eliminated	O
by	O
apoptosis	O
prior	O
to	O
diplonema	O
,	O
we	O
were	O
able	O
to	O
examine	O
epigenetic	O
markers	O
of	O
PMSC	O
in	O
rare	O
Dmrt7	O
mutant	O
spermatocytes	O
that	O
escaped	O
pachytene	O
arrest	O
and	O
progressed	O
into	O
diplonema	O
.	O

First	O
,	O
we	O
examined	O
nascent	O
transcription	O
by	O
Cot	O
-	O
1	O
hybridization	O
.	O

Although	O
heterochromatic	O
regions	O
generally	O
showed	O
lower	O
Cot	O
-	O
1	O
signal	O
than	O
euchromatic	O
regions	O
(	O
Figure	O
8E	O
and	O
8F	O
)	O
,	O
in	O
some	O
mutant	O
cells	O
the	O
sex	O
chromatin	O
appeared	O
to	O
be	O
incompletely	O
silenced	O
relative	O
to	O
wild	O
-	O
type	O
(	O
Figure	O
8F	O
)	O
.	O

We	O
also	O
examined	O
three	O
epigenetic	O
signatures	O
of	O
PMSC	O
:	O
histone	B-CHEBI
H3	O
dimethylated	O
or	O
trimethylated	O
at	O
lysine	B-CHEBI
-	O
9	O
(	O
H3	O
-	O
2meK9	O
,	O
H3	O
-	O
3meK9	O
)	O
and	O
spreading	O
of	O
HP1	O
beta	O
through	O
the	O
XY	O
body	O
[	O
16	O
,	O
57	O
,	O
58	O
]	O
(	O
S	O
.	O
H	O
.	O
Namekawa	O
,	O
unpublished	O
data	O
)	O
.	O

We	O
observed	O
defects	O
in	O
sex	O
chromatin	O
localization	O
of	O
all	O
three	O
markers	O
in	O
Dmrt7	O
diplotene	O
cells	O
.	O

Although	O
HP1	O
beta	O
localization	O
to	O
the	O
X	O
chromosome	O
centromere	O
initially	O
appeared	O
normal	O
at	O
mid	O
-	O
pachynema	O
,	O
we	O
observed	O
Dmrt7	O
mutant	O
diplotene	O
cells	O
that	O
failed	O
to	O
show	O
spreading	O
of	O
HP1	O
beta	O
to	O
the	O
entire	O
XY	O
body	O
(	O
Figure	O
8G	O
and	O
8H	O
)	O
.	O

Similarly	O
,	O
we	O
found	O
Dmrt7	O
mutant	O
diplotene	O
cells	O
lacking	O
accumulation	O
of	O
H3	O
-	O
2meK9	O
and	O
H3	O
-	O
3meK9	O
marks	O
onto	O
the	O
sex	O
chromatin	O
(	O
Figure	O
8I	O
-	O
8L	O
)	O
.	O

Not	O
all	O
Dmrt7	O
mutant	O
diplotene	O
cells	O
showed	O
abnormal	O
localization	O
of	O
HP1	O
beta	O
to	O
the	O
sex	O
chromatin	O
(	O
Figure	O
8M	O
)	O
.	O

In	O
one	O
experiment	O
,	O
11	O
/	O
27	O
mutant	O
cells	O
in	O
diplonema	O
lacked	O
HP1	O
beta	O
on	O
the	O
XY	O
body	O
,	O
as	O
compared	O
with	O
2	O
/	O
22	O
wild	O
-	O
type	O
cells	O
.	O

We	O
hypothesize	O
that	O
the	O
mutant	O
cells	O
with	O
normal	O
HP1	O
beta	O
may	O
be	O
those	O
that	O
can	O
complete	O
meiosis	O
(	O
Figures	O
4	O
and	O
5	O
)	O
.	O

Some	O
of	O
the	O
mutant	O
diplotene	O
cells	O
showing	O
abnormal	O
sex	O
chromatin	O
also	O
had	O
abnormal	O
autosomal	O
gamma	O
H2AX	O
staining	O
(	O
Figure	O
8L	O
)	O
.	O

gamma	O
H2AX	O
localizes	O
to	O
double	O
-	O
strand	O
DNA	O
breaks	O
,	O
so	O
this	O
staining	O
may	O
indicate	O
that	O
some	O
diplotene	O
mutant	O
cells	O
are	O
approaching	O
or	O
entering	O
apoptosis	O
[	O
59	O
]	O
.	O

We	O
did	O
not	O
observe	O
sex	O
chromatin	O
defects	O
prior	O
to	O
diplonema	O
,	O
but	O
we	O
cannot	O
exclude	O
the	O
possibility	O
that	O
earlier	O
defects	O
exist	O
and	O
the	O
affected	O
cells	O
are	O
rapidly	O
eliminated	O
.	O

In	O
the	O
preceding	O
experiments	O
,	O
we	O
staged	O
cells	O
based	O
on	O
XY	O
body	O
internalization	O
.	O

Because	O
this	O
process	O
could	O
be	O
abnormal	O
in	O
the	O
mutant	O
cells	O
,	O
we	O
also	O
staged	O
mutant	O
cells	O
by	O
chromosome	O
morphology	O
using	O
an	O
antibody	O
to	O
SYCP3	O
(	O
Figure	O
9	O
)	O
.	O

This	O
independently	O
identified	O
Dmrt7	O
mutant	O
diplotene	O
cells	O
lacking	O
HP1	O
beta	O
accumulation	O
in	O
the	O
XY	O
body	O
,	O
such	O
as	O
the	O
example	O
in	O
Figure	O
9B	O
.	O

From	O
these	O
results	O
,	O
we	O
conclude	O
that	O
Dmrt7	O
mutant	O
cells	O
establish	O
a	O
normal	O
XY	O
body	O
in	O
mid	O
-	O
pachynema	O
,	O
but	O
then	O
have	O
multiple	O
epigenetic	O
defects	O
in	O
the	O
sex	O
chromatin	O
transition	O
from	O
pachynema	O
to	O
diplonema	O
.	O

Figure	O
9	O

Abnormal	O
Sex	O
Chromatin	O
in	O
Cells	O
Staged	O
by	O
Chromosome	O
Pairing	O
Status	O

(	O
A	O
)	O
Spread	O
of	O
wild	O
-	O
type	O
germ	O
cell	O
stained	O
with	O
DAPI	O
,	O
anti	O
-	O
SYCP3	O
,	O
and	O
anti	O
-	O
HP1	O
beta	O
showing	O
chromosome	O
morphology	O
typical	O
of	O
diplonema	O
and	O
internalized	O
XY	O
body	O
with	O
HP1	O
beta	O
accumulation	O
.	O

(	O
B	O
)	O
Spread	O
of	O
Dmrt7	O
mutant	O
germ	O
cell	O
showing	O
normal	O
diplotene	O
chromosome	O
morphology	O
and	O
internalized	O
XY	O
body	O
,	O
but	O
no	O
HP1	O
beta	O
accumulation	O
in	O
the	O
XY	O
body	O
.	O

XY	O
chromosome	O
pairs	O
are	O
indicated	O
by	O
arrow	O
.	O

Discussion	O

In	O
this	O
study	O
,	O
we	O
find	O
that	O
the	O
DM	O
domain	O
protein	B-CHEBI
DMRT7	O
is	O
required	O
for	O
male	O
germ	O
cells	O
to	O
complete	O
meiotic	O
prophase	O
but	O
is	O
dispensable	O
in	O
the	O
female	O
germ	O
line	O
.	O

In	O
males	O
,	O
DMRT7	O
expression	O
is	O
highest	O
in	O
pachytene	O
spermatocytes	O
,	O
and	O
the	O
protein	B-CHEBI
preferentially	O
localizes	O
to	O
the	O
XY	O
body	O
.	O

Consistent	O
with	O
this	O
expression	O
,	O
we	O
found	O
that	O
most	O
mutant	O
male	O
germ	O
cells	O
arrest	O
in	O
pachynema	O
and	O
undergo	O
apoptosis	O
,	O
although	O
a	O
small	O
proportion	O
can	O
progress	O
to	O
diplonema	O
and	O
sometimes	O
beyond	O
.	O

Examination	O
of	O
chromatin	O
and	O
nascent	O
transcription	O
in	O
mutant	O
cells	O
that	O
progressed	O
to	O
diplonema	O
revealed	O
sex	O
chromatin	O
abnormalities	O
,	O
as	O
discussed	O
below	O
.	O

The	O
pachytene	O
stage	O
of	O
prophase	O
involves	O
tremendous	O
chromosomal	O
changes	O
as	O
the	O
homologs	O
align	O
,	O
synapse	O
,	O
and	O
recombine	O
.	O

During	O
this	O
period	O
,	O
at	O
least	O
one	O
pachytene	O
surveillance	O
system	O
exists	O
to	O
monitor	O
key	O
events	O
of	O
meiotic	O
progression	O
.	O

Cells	O
in	O
which	O
any	O
of	O
these	O
events	O
is	O
anomalous	O
are	O
efficiently	O
eliminated	O
by	O
apoptosis	O
[	O
46	O
]	O
.	O

Another	O
key	O
event	O
of	O
pachynema	O
in	O
male	O
mammals	O
is	O
the	O
packaging	O
of	O
the	O
sex	O
chromosomes	O
into	O
the	O
XY	O
body	O
and	O
the	O
establishment	O
of	O
MSCI	O
.	O

Examination	O
of	O
male	O
meiosis	O
in	O
XYY	O
mice	O
and	O
mice	O
carrying	O
a	O
sex	O
-	O
chromosome	O
-	O
to	O
-	O
autosome	O
translocation	O
showed	O
that	O
cells	O
in	O
which	O
a	O
sex	O
chromosome	O
escapes	O
MSCI	O
are	O
eliminated	O
prior	O
to	O
late	O
-	O
pachynema	O
[	O
17	O
]	O
.	O

This	O
indicates	O
that	O
the	O
establishment	O
of	O
MSCI	O
also	O
is	O
subject	O
to	O
surveillance	O
.	O

Since	O
the	O
arrest	O
and	O
apoptosis	O
of	O
Dmrt7	O
mutant	O
spermatocytes	O
could	O
result	O
from	O
perturbation	O
of	O
any	O
of	O
the	O
critical	O
pachytene	O
events	O
mentioned	O
above	O
,	O
we	O
tested	O
whether	O
they	O
occur	O
abnormally	O
in	O
the	O
mutant	O
cells	O
.	O

We	O
found	O
that	O
chromosomal	O
synapsis	O
and	O
recombination	O
appear	O
normal	O
in	O
Dmrt7	O
mutant	O
cells	O
.	O

We	O
therefore	O
focused	O
on	O
the	O
XY	O
body	O
,	O
the	O
most	O
prominent	O
site	O
of	O
DMRT7	O
accumulation	O
.	O

First	O
,	O
we	O
tested	O
whether	O
the	O
XY	O
body	O
forms	O
and	O
MSCI	O
is	O
established	O
in	O
Dmrt7	O
mutant	O
cells	O
.	O

Surprisingly	O
,	O
we	O
found	O
that	O
these	O
cells	O
form	O
an	O
XY	O
body	O
with	O
normal	O
morphology	O
and	O
proper	O
accumulation	O
of	O
all	O
the	O
chromatin	O
marks	O
we	O
examined	O
.	O

Moreover	O
,	O
Cot	O
-	O
1	O
hybridization	O
and	O
analysis	O
of	O
RBMY	O
expression	O
demonstrated	O
that	O
MSCI	O
initiates	O
normally	O
in	O
the	O
XY	O
body	O
of	O
mid	O
-	O
pachytene	O
Dmrt7	O
mutant	O
cells	O
.	O

We	O
did	O
,	O
however	O
,	O
observe	O
three	O
specific	O
defects	O
in	O
the	O
sex	O
chromatin	O
of	O
Dmrt7	O
mutant	O
germ	O
cells	O
that	O
avoided	O
arrest	O
in	O
pachynema	O
and	O
were	O
able	O
to	O
enter	O
diplonema	O
.	O

Normally	O
cells	O
accumulate	O
H3	O
-	O
2meK9	O
and	O
H3	O
-	O
3meK9	O
marks	O
and	O
HP1	O
beta	O
protein	B-CHEBI
on	O
the	O
sex	O
chromatin	O
as	O
they	O
progress	O
to	O
diplonema	O
,	O
but	O
we	O
observed	O
mutant	O
diplotene	O
cells	O
lacking	O
these	O
features	O
.	O

Thus	O
,	O
although	O
a	O
minority	O
of	O
Dmrt7	O
mutant	O
germ	O
cells	O
can	O
progress	O
from	O
pachynema	O
to	O
diplonema	O
,	O
there	O
are	O
defects	O
in	O
sex	O
chromatin	O
modification	O
during	O
the	O
transition	O
.	O

A	O
function	O
in	O
male	O
sex	O
chromatin	O
can	O
reconcile	O
the	O
findings	O
that	O
DMRT7	O
is	O
required	O
for	O
meiosis	O
,	O
but	O
only	O
in	O
males	O
,	O
and	O
is	O
present	O
only	O
in	O
mammals	O
.	O

A	O
proportion	O
of	O
mutant	O
diplotene	O
cells	O
have	O
apparently	O
normal	O
sex	O
chromatin	O
(	O
for	O
example	O
,	O
Figure	O
8M	O
)	O
;	O
these	O
are	O
likely	O
to	O
be	O
the	O
cells	O
that	O
can	O
progress	O
beyond	O
diplonema	O
.	O

Because	O
most	O
Dmrt7	O
mutant	O
germ	O
cells	O
are	O
eliminated	O
by	O
apoptosis	O
around	O
the	O
time	O
at	O
which	O
we	O
observed	O
sex	O
chromatin	O
defects	O
,	O
a	O
simple	O
model	O
is	O
that	O
the	O
apoptosis	O
is	O
a	O
consequence	O
of	O
the	O
sex	O
chromatin	O
defects	O
.	O

The	O
reciprocal	O
situation	O
(	O
sex	O
chromatin	O
defects	O
caused	O
by	O
apoptosis	O
)	O
is	O
possible	O
,	O
but	O
seems	O
unlikely	O
,	O
because	O
we	O
observed	O
mutant	O
cells	O
with	O
sex	O
chromatin	O
defects	O
but	O
no	O
indications	O
of	O
apoptosis	O
.	O

Alternatively	O
,	O
apoptosis	O
and	O
abnormal	O
sex	O
chromatin	O
may	O
be	O
two	O
independent	O
consequences	O
of	O
Dmrt7	O
loss	O
.	O

This	O
question	O
cannot	O
be	O
answered	O
definitively	O
until	O
we	O
know	O
the	O
detailed	O
molecular	B-CHEBI
mechanism	O
of	O
DMRT7	O
.	O

A	O
number	O
of	O
other	O
proteins	B-CHEBI
have	O
been	O
identified	O
that	O
interact	O
with	O
the	O
XY	O
body	O
,	O
including	O
histone	B-CHEBI
variants	O
and	O
modified	O
histones	B-CHEBI
,	O
a	O
testis	O
-	O
specific	O
histone	B-CHEBI
methyl	B-CHEBI
transferase	O
,	O
chromobox	O
proteins	B-CHEBI
,	O
an	O
orphan	O
receptor	O
germ	O
-	O
cell	O
nuclear	O
factor	O
,	O
and	O
recombination	O
-	O
related	O
proteins	B-CHEBI
[	O
60	O
]	O
.	O

A	O
common	O
feature	O
of	O
these	O
proteins	B-CHEBI
is	O
involvement	O
with	O
heterochromatin	O
and	O
/	O
or	O
transcriptional	O
repression	O
.	O

DMRT7	O
is	O
unusual	O
among	O
XY	O
body	O
proteins	B-CHEBI
in	O
being	O
related	O
to	O
highly	O
site	O
-	O
specific	O
transcriptional	O
regulators	O
.	O

An	O
attractive	O
speculation	O
is	O
that	O
DMRT7	O
may	O
provide	O
sequence	O
specificity	O
in	O
recruiting	O
other	O
proteins	B-CHEBI
,	O
such	O
as	O
chromatin	O
modifiers	O
,	O
to	O
the	O
XY	O
body	O
as	O
part	O
of	O
the	O
transition	O
to	O
PMSC	O
.	O

Chromatin	O
regulation	O
may	O
be	O
a	O
common	O
mechanism	O
for	O
DM	O
domain	O
proteins	B-CHEBI
,	O
as	O
we	O
find	O
that	O
other	O
DM	O
domain	O
proteins	B-CHEBI
associate	O
with	O
chromatin	O
modifying	O
complexes	O
(	O
M	O
.	O
W	O
.	O
Murphy	O
,	O
D	O
.	O
Zarkower	O
,	O
and	O
V	O
.	O
J	O
.	O
Bardwell	O
,	O
unpublished	O
data	O
)	O
.	O

The	O
finding	O
that	O
Dmrt7	O
is	O
essential	O
for	O
mammalian	O
meiosis	O
expands	O
the	O
known	O
functions	O
of	O
this	O
gene	O
family	O
.	O

Invertebrate	O
DM	O
domain	O
genes	O
so	O
far	O
have	O
only	O
been	O
found	O
to	O
function	O
in	O
somatic	O
cells	O
.	O

Two	O
other	O
DM	O
domain	O
genes	O
,	O
Dmrt1	O
and	O
Dmrt4	O
,	O
do	O
affect	O
germ	O
cell	O
development	O
in	O
the	O
mouse	O
.	O

Dmrt1	O
is	O
required	O
in	O
pre	O
-	O
meiotic	O
male	O
germ	O
cells	O
for	O
differentiation	O
of	O
gonocytes	O
into	O
spermatogonia	O
,	O
as	O
well	O
as	O
in	O
Sertoli	O
cells	O
,	O
but	O
it	O
is	O
not	O
expressed	O
in	O
meiotic	O
cells	O
[	O
31	O
]	O
(	O
S	O
.	O
Kim	O
and	O
D	O
.	O
Zarkower	O
,	O
unpublished	O
data	O
)	O
.	O

The	O
requirement	O
for	O
DMRT1	O
in	O
pre	O
-	O
meiotic	O
germ	O
cells	O
and	O
DMRT7	O
in	O
meiotic	O
germ	O
cells	O
demonstrates	O
that	O
DM	O
domain	O
proteins	B-CHEBI
act	O
at	O
multiple	O
critical	O
points	O
of	O
male	O
germ	O
cell	O
development	O
.	O

Ovaries	O
of	O
Dmrt4	O
mutant	O
females	O
have	O
polyovular	O
follicles	O
(	O
follicles	O
containing	O
multiple	O
oocytes	O
)	O
,	O
but	O
it	O
is	O
unknown	O
whether	O
this	O
reflects	O
a	O
defect	O
in	O
the	O
germ	O
line	O
or	O
the	O
soma	O
.	O

It	O
is	O
notable	O
that	O
at	O
least	O
three	O
mammalian	O
DM	O
domain	O
genes	O
affect	O
gonadal	O
development	O
only	O
in	O
one	O
sex	O
,	O
given	O
the	O
similar	O
roles	O
of	O
related	O
proteins	B-CHEBI
in	O
directing	O
sex	O
-	O
specific	O
somatic	O
development	O
in	O
other	O
phyla	O
.	O

Strikingly	O
,	O
Dmrt7	O
is	O
present	O
,	O
not	O
only	O
in	O
placental	O
mammals	O
,	O
but	O
also	O
in	O
marsupials	O
and	O
a	O
monotreme	O
(	O
egg	O
-	O
laying	O
mammal	O
)	O
,	O
the	O
platypus	O
,	O
which	O
has	O
a	O
clear	O
Dmrt7	O
ortholog	O
[	O
36	O
]	O
.	O

However	O
,	O
no	O
close	O
Dmrt7	O
ortholog	O
has	O
been	O
reported	O
in	O
nonmammalian	O
vertebrates	O
,	O
and	O
our	O
database	O
searches	O
did	O
not	O
reveal	O
one	O
.	O

Thus	O
,	O
Dmrt7	O
likely	O
arose	O
,	O
presumably	O
by	O
duplication	O
and	O
divergence	O
of	O
another	O
Dmrt	O
gene	O
,	O
shortly	O
before	O
or	O
coincident	O
with	O
the	O
mammalian	O
radiation	O
.	O

Monotremes	O
have	O
five	O
X	O
and	O
five	O
Y	O
chromosomes	O
,	O
which	O
form	O
an	O
extended	O
pairing	O
chain	O
during	O
meiosis	O
and	O
appear	O
unrelated	O
to	O
the	O
sex	O
chromosomes	O
of	O
the	O
other	O
mammals	O
[	O
61	O
]	O
.	O

The	O
presence	O
of	O
Dmrt7	O
in	O
both	O
lineages	O
may	O
support	O
a	O
common	O
origin	O
for	O
either	O
the	O
sex	O
chromosomes	O
or	O
the	O
sex	O
chromatin	O
of	O
monotremes	O
and	O
other	O
mammals	O
.	O

A	O
plausible	O
model	O
is	O
that	O
Dmrt7	O
evolved	O
during	O
the	O
establishment	O
of	O
mammalian	O
sex	O
determination	O
to	O
help	O
cope	O
with	O
ancestral	O
differences	O
in	O
gene	O
dosage	O
,	O
chromosome	O
pairing	O
,	O
recombination	O
,	O
or	O
other	O
meiotic	O
issues	O
arising	O
from	O
sex	O
chromosome	O
heteromorphy	O
.	O

In	O
this	O
regard	O
,	O
we	O
speculate	O
that	O
the	O
recruitment	O
of	O
Dmrt7	O
during	O
mammalian	O
evolution	O
may	O
be	O
analogous	O
to	O
the	O
recruitment	O
of	O
chromatin	O
regulatory	O
complexes	O
to	O
achieve	O
somatic	O
dosage	O
compensation	O
during	O
evolution	O
of	O
heteromorphic	O
sex	O
chromosomes	O
in	O
several	O
phyla	O
(	O
reviewed	O
in	O
[	O
62	O
]	O
)	O
.	O

It	O
will	O
be	O
of	O
interest	O
to	O
determine	O
whether	O
DMRT7	O
localizes	O
to	O
sex	O
chromosomes	O
during	O
monotreme	O
meiosis	O
.	O

In	O
summary	O
,	O
we	O
have	O
found	O
that	O
the	O
mammal	O
-	O
specific	O
DM	O
domain	O
protein	B-CHEBI
DMRT7	O
is	O
essential	O
for	O
meiotic	O
prophase	O
progression	O
in	O
males	O
.	O

DMRT7	O
localizes	O
to	O
the	O
sex	O
chromosomes	O
after	O
they	O
are	O
assembled	O
into	O
specialized	O
heterochromatin	O
,	O
and	O
many	O
Dmrt7	O
mutant	O
cells	O
have	O
epigenetic	O
defects	O
in	O
the	O
modification	O
of	O
the	O
sex	O
chromatin	O
between	O
pachytene	O
and	O
diplotene	O
.	O

Although	O
Dmrt7	O
belongs	O
to	O
an	O
ancient	O
and	O
conserved	O
gene	O
family	O
,	O
it	O
is	O
found	O
only	O
in	O
mammals	O
,	O
and	O
to	O
our	O
knowledge	O
DMRT7	O
is	O
the	O
only	O
example	O
of	O
a	O
mammal	O
-	O
specific	O
protein	B-CHEBI
that	O
is	O
essential	O
for	O
meiosis	O
.	O

It	O
will	O
be	O
important	O
to	O
determine	O
the	O
precise	O
mechanism	O
by	O
which	O
DMRT7	O
affects	O
sex	O
chromatin	O
regulation	O
during	O
male	O
meiosis	O
.	O

Materials	O
and	O
Methods	O

Generation	O
of	O
Dmrt7	O
mice	O
.	O

A	O
mouse	O
Dmrt7	O
cDNA	O
fragment	O
containing	O
sequences	O
from	O
exon	O
8	O
was	O
used	O
to	O
screen	O
a	O
mouse	O
BAC	O
library	O
from	O
the	O
129	O
/	O
SvJ	O
strain	O
(	O
Stratagene	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
stratagene	O
.	O
com	O
)	O
,	O
and	O
clones	O
containing	O
promoter	O
sequences	O
were	O
isolated	O
and	O
sequenced	O
to	O
obtain	O
Dmrt7	O
genomic	O
sequence	O
.	O

The	O
targeting	O
vector	O
pDZ169	O
(	O
diagrammed	O
in	O
Figure	O
S2	O
)	O
was	O
constructed	O
by	O
the	O
following	O
scheme	O
:	O
The	O
vector	O
pDZ157	O
was	O
used	O
as	O
a	O
backbone	O
vector	O
[	O
31	O
]	O
.	O

3	O
'	O
to	O
Pgk	O
-	O
neo	O
and	O
the	O
loxP	O
site	O
,	O
we	O
inserted	O
,	O
as	O
a	O
XmaI	O
/	O
XmaI	O
DNA	O
fragment	O
,	O
the	O
third	O
intron	O
of	O
Dmrt7	O
(	O
from	O
366	O
bp	O
to	O
2	O
,	O
773	O
bp	O
downstream	O
of	O
exon	O
3	O
)	O
generated	O
by	O
PCR	O
.	O

5	O
'	O
to	O
Pgk	O
-	O
neo	O
,	O
we	O
inserted	O
an	O
EcoRI	O
/	O
NotI	O
PCR	O
fragment	O
extending	O
from	O
4	O
,	O
107	O
bp	O
to	O
336	O
bp	O
5	O
'	O
of	O
the	O
Dmrt7	O
translational	O
start	O
.	O

Finally	O
,	O
we	O
inserted	O
a	O
loxP	O
site	O
and	O
NotI	O
site	O
336	O
bp	O
5	O
'	O
of	O
the	O
Dmrt7	O
translational	O
start	O
.	O

In	O
the	O
resulting	O
vector	O
,	O
the	O
second	O
and	O
third	O
exons	O
of	O
Dmrt7	O
are	O
flanked	O
by	O
loxP	O
sites	O
(	O
floxed	O
)	O
.	O

The	O
Dmrt7	O
-	O
containing	O
portions	O
of	O
pDZ169	O
were	O
completely	O
sequenced	O
.	O

pDZ169	O
was	O
linearized	O
with	O
PmeI	O
and	O
electroporated	O
into	O
CJ7	O
ES	O
cells	O
(	O
originally	O
derived	O
from	O
the	O
129S1	O
strain	O
)	O
.	O

Three	O
homologous	O
recombinants	O
were	O
identified	O
from	O
296	O
G418	O
-	O
resistant	O
colonies	O
by	O
Southern	O
hybridization	O
by	O
use	O
of	O
a	O
DNA	O
probe	O
from	O
the	O
sequences	O
upstream	O
of	O
exon	O
1	O
to	O
screen	O
genomic	O
DNA	O
digested	O
with	O
EcoRI	O
.	O

Homologous	O
recombination	O
was	O
confirmed	O
on	O
both	O
ends	O
of	O
the	O
targeted	O
region	O
by	O
Southern	O
hybridization	O
.	O

Probes	O
for	O
Southern	O
hybridization	O
were	O
made	O
by	O
PCR	O
using	O
primers	O
DM5S10	O
/	O
DM5S11	O
(	O
5	O
'	O
probe	O
)	O
and	O
DM5PR1	O
/	O
DM5PR2	O
(	O
3	O
'	O
probe	O
)	O
,	O
listed	O
below	O
.	O

Two	O
targeted	O
ES	O
cell	O
clones	O
containing	O
the	O
floxed	O
allele	O
Dmrt7neo	O
were	O
injected	O
into	O
C57Bl	O
/	O
6	O
blastocysts	O
to	O
generate	O
chimeras	O
.	O

Chimeric	O
males	O
were	O
bred	O
with	O
C57Bl	O
/	O
6	O
females	O
to	O
generate	O
heterozygotes	O
carrying	O
Dmrt7neo	O
.	O

Dmrt7	O
+	O
/	O
Dmrt7neo	O
females	O
were	O
bred	O
with	O
male	O
beta	O
-	O
actin	O
-	O
Cre	O
transgenic	O
mice	O
to	O
delete	O
the	O
floxed	O
sequences	O
and	O
generate	O
heterozygous	O
Dmrt7	O
-	O
/	O
+	O
deletion	O
mutants	O
,	O
which	O
were	O
interbred	O
to	O
generate	O
homozygous	O
Dmrt7	O
-	O
/	O
-	O
mutants	O
.	O

Genotyping	O
and	O
RT	O
-	O
PCR	O
.	O

For	O
genotyping	O
,	O
tail	O
-	O
clip	O
DNA	O
was	O
amplified	O
for	O
35	O
cycles	O
.	O

Chromosomal	O
sex	O
was	O
determined	O
by	O
PCR	O
with	O
primers	O
to	O
the	O
Y	O
chromosome	O
gene	O
Zfy	O
(	O
below	O
)	O
.	O

The	O
wild	O
-	O
type	O
Dmrt7	O
allele	O
Dmrt7	O
+	O
was	O
detected	O
by	O
PCR	O
with	O
DM5S4	O
/	O
DM5S5	O
,	O
with	O
an	O
annealing	O
temperature	O
of	O
60	O
degrees	O
C	O
.	O

The	O
Dmrt7flox	O
allele	O
was	O
detected	O
by	O
PCR	O
with	O
DM5S5F	O
/	O
DM7KO7R	O
with	O
an	O
annealing	O
temperature	O
of	O
62	O
degrees	O
C	O
.	O

The	O
deleted	O
Dmrt7	O
allele	O
Dmrt7	O
-	O
was	O
detected	O
with	O
DM5S3	O
/	O
DM7KO7R	O
with	O
an	O
annealing	O
temperature	O
of	O
62	O
degrees	O
C	O
.	O

RT	O
-	O
PCR	O
for	O
Dmrt7	O
expression	O
analysis	O
was	O
as	O
described	O
[	O
23	O
]	O
using	O
primers	O
SK111	O
/	O
SK112	O
with	O
an	O
annealing	O
temperature	O
of	O
62	O
degrees	O
C	O
.	O

Primers	O
.	O

DM5S3	O
:	O
5	O
'	O
-	O
AGAGTGGATTGAATCGGATAGCTC	O
-	O
3	O
'	O

DM5S4	O
:	O
5	O
'	O
-	O
AGGATCTTAGTGTCGAATGAATAC	O
-	O
3	O
'	O

DM5S5	O
:	O
5	O
'	O
-	O
CCCTTATCCTCCTGCATCCAGATC	O
-	O
3	O
'	O

DM5S10	O
:	O
5	O
'	O
-	O
CAGGCTATGGTTAGACTTGAGCAC	O
-	O
3	O
'	O

DM5S11	O
:	O
5	O
'	O
-	O
CATCACTCGCGGACAAAGATGCAG	O
-	O
3	O
'	O

DM5PR1	O
:	O
5	O
'	O
-	O
CTTCTGCTACAGCCACAGGTCTGG	O
-	O
3	O
'	O

DM5PR2	O
:	O
5	O
'	O
-	O
GAATTCAACTAGTATCTGTCCC	O
-	O
3	O
'	O

DM7KO7R	O
:	O
5	O
'	O
-	O
CGAGGATCAAGCTCAGGTCACTAGG	O
-	O
3	O
'	O

DM5S5F	O
:	O
5	O
'	O
-	O
GATCTGGATGCAGGAGGATAAGGG	O
-	O
3	O
'	O

ZFYF	O
:	O
5	O
'	O
-	O
CCTATTGCATGGACAGCAGTCTTATG	O
-	O
3	O
'	O

ZFYR	O
:	O
5	O
'	O
-	O
GACTAGACATGTTCTTAACATCTGTCC	O
-	O
3	O
'	O

SK111	O
:	O
5	O
'	O
-	O
CCCTTCTGGAAAAGAGAACATAGC	O
-	O
3	O
'	O

SK112	O
:	O
5	O
'	O
-	O
GCTCCAGGGGCCTGTGGCTGTAGC	O
-	O
3	O
'	O

beta	O
-	O
actinF	O
:	O
5	O
'	O
-	O
TGCGTGACATCAAAGAGAAG	O
-	O
3	O
'	O

beta	O
-	O
actinR	O
:	O
5	O
'	O
-	O
GATGCCACAGGATTCCATA	O
-	O
3	O
'	O

Histological	O
analysis	O
and	O
TUNEL	O
assay	O
.	O

Dissected	O
testes	O
were	O
fixed	O
in	O
Bouin	O
'	O
s	O
fixative	O
or	O
phosphate	B-CHEBI
-	O
buffered	B-CHEBI
formalin	O
overnight	O
at	O
4	O
degrees	O
C	O
,	O
progressively	O
dehydrated	O
in	O
a	O
graded	O
ethanol	B-CHEBI
series	O
,	O
and	O
embedded	O
in	O
paraffin	O
wax	O
.	O

Sections	O
(	O
6	O
mu	O
m	O
)	O
were	O
deparaffinized	O
,	O
rehydrated	O
,	O
and	O
stained	O
with	O
hematoxylin	O
and	O
eosin	O
.	O

For	O
TUNEL	O
analyses	O
,	O
deparaffinized	O
sections	O
were	O
treated	O
with	O
proteinase	O
K	O
for	O
15	O
min	O
and	O
quenched	O
in	O
3	O
.	O
0	O
%	O
hydrogen	B-CHEBI
peroxide	I-CHEBI
in	O
PBS	O
for	O
5	O
min	O
at	O
room	O
temperature	O
.	O

Subsequently	O
,	O
nuclear	O
staining	O
in	O
apoptotic	O
cells	O
was	O
detected	O
using	O
ApopTag	O
kit	O
(	O
Chemicon	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
chemicon	O
.	O
com	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Tissue	O
immunofluorescent	O
staining	O
.	O

Slides	O
with	O
paraffin	O
sections	O
were	O
washed	O
in	O
PBT	O
(	O
0	O
.	O
1	O
%	O
Tween	O
20	O
in	O
PBS	O
)	O
and	O
autoclaved	O
in	O
10	O
mM	O
citric	B-CHEBI
acid	I-CHEBI
(	O
pH	O
6	O
.	O
0	O
)	O
to	O
retrieve	O
antigenicity	O
.	O

Slides	O
were	O
blocked	O
in	O
5	O
%	O
serum	O
(	O
matched	O
to	O
the	O
species	O
of	O
the	O
secondary	O
antibody	O
)	O
in	O
PBS	O
for	O
1	O
h	O
at	O
room	O
temperature	O
and	O
incubated	O
with	O
primary	O
antibodies	O
overnight	O
at	O
4	O
degrees	O
C	O
prior	O
to	O
detection	O
with	O
secondary	O
antibodies	O
.	O

Antibodies	O
.	O

Rabbit	O
polyclonal	O
antibodies	O
to	O
DMRT7	O
were	O
raised	O
against	O
a	O
purified	O
fusion	O
protein	B-CHEBI
containing	O
glutathione	B-CHEBI
-	O
S	B-CHEBI
-	O
transferase	O
(	O
GST	O
)	O
fused	O
to	O
the	O
C	B-CHEBI
-	O
terminal	O
279	O
amino	B-CHEBI
acids	I-CHEBI
of	O
DMRT7	O
.	O

Antibodies	O
to	O
GST	O
were	O
removed	O
by	O
GST	O
-	O
affigel	O
10	O
chromatography	O
and	O
the	O
antiserum	O
was	O
then	O
purified	O
by	O
GST	O
-	O
DMRT7	O
-	O
affigel	O
15	O
chromatography	O
.	O

DMRT7	O
antibody	O
was	O
used	O
at	O
1	O
:	O
200	O
dilution	O
with	O
a	O
goat	O
anti	O
-	O
rabbit	O
secondary	O
antibody	O
(	O
Molecular	B-CHEBI
Probes	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
invitrogen	O
.	O
com	O
)	O
at	O
1	O
:	O
200	O
dilution	O
.	O

Other	O
primary	O
antibodies	O
used	O
for	O
immunofluorescence	O
were	O
rat	O
anti	O
-	O
GATA1	O
(	O
1	O
:	O
200	O
,	O
Santa	O
Cruz	O
Biotechnology	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
scbt	O
.	O
com	O
,	O
sc	O
-	O
265	O
)	O
,	O
goat	O
anti	O
-	O
GATA4	O
(	O
1	O
:	O
200	O
,	O
Santa	O
Cruz	O
Biotechnology	O
,	O
sc	O
-	O
1237	O
)	O
,	O
rat	O
anti	O
-	O
TRA98	O
(	O
1	O
:	O
200	O
,	O
gift	O
of	O
H	O
.	O
Tanaka	O
and	O
Y	O
.	O
Nishimune	O
)	O
,	O
rat	O
anti	O
-	O
BC7	O
(	O
1	O
:	O
50	O
,	O
gift	O
of	O
H	O
.	O
Tanaka	O
and	O
Y	O
.	O
Nishimune	O
)	O
,	O
rat	O
anti	O
-	O
TRA369	O
(	O
1	O
:	O
200	O
,	O
gift	O
of	O
H	O
.	O
Tanaka	O
and	O
Y	O
.	O
Nishimune	O
)	O
,	O
rabbit	O
anti	O
-	O
RAD51	O
(	O
1	O
:	O
600	O
Calbiochem	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
calbiochem	O
.	O
com	O
,	O
PC130	O
)	O
,	O
mouse	O
anti	O
-	O
GMP	O
-	O
1	O
/	O
SUMO	O
-	O
1	O
(	O
1	O
:	O
200	O
,	O
Zymed	O
,	O
http	O
:	O
/	O
/	O
invitrogen	O
.	O
com	O
,	O
33	O
-	O
2400	O
)	O
,	O
rabbit	O
anti	O
-	O
phospho	B-CHEBI
-	O
H2AX	O
(	O
Ser139	O
)	O
(	O
1	O
:	O
200	O
,	O
Upstate	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
millipore	O
.	O
com	O
,	O
01	O
-	O
164	O
)	O
,	O
mouse	O
anti	O
-	O
phospho	B-CHEBI
-	O
H2AX	O
(	O
1	O
:	O
200	O
,	O
Upstate	O
,	O
05	O
-	O
636	O
)	O
,	O
mouse	O
anti	O
-	O
SYCP3	O
(	O
1	O
:	O
200	O
,	O
Abcam	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
abcam	O
.	O
com	O
,	O
ab12452	O
)	O
,	O
rabbit	O
anti	O
-	O
HP1	O
beta	O
(	O
1	O
:	O
100	O
,	O
Abcam	O
,	O
ab10478	O
)	O
,	O
rabbit	O
anti	O
-	O
H3	O
-	O
2meK9	O
(	O
1	O
:	O
100	O
,	O
Upstate	O
,	O
07	O
-	O
441	O
)	O
,	O
rabbit	O
anti	O
-	O
H3	O
-	O
3meK9	O
(	O
1	O
:	O
200	O
,	O
Upstate	O
,	O
07	O
-	O
442	O
)	O
,	O
rabbit	O
anti	O
-	O
AR	O
(	O
N	O
-	O
20	O
)	O
(	O
1	O
:	O
200	O
,	O
Santa	O
Cruz	O
Biotechnology	O
,	O
sc	O
-	O
816	O
)	O
,	O
and	O
mouse	O
anti	O
-	O
alpha	O
SMA	O
clone	O
1A4	O
(	O
1	O
:	O
800	O
,	O
Sigma	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
sigmaaldrich	O
.	O
com	O
,	O
A2547	O
)	O
.	O

Secondary	O
antibodies	O
used	O
were	O
goat	O
anti	O
-	O
rabbit	O
Alexa	O
488	O
,	O
goat	O
anti	O
-	O
rabbit	O
Alexa	O
594	O
,	O
goat	O
anti	O
-	O
rat	O
Alexa	O
594	O
,	O
and	O
goat	O
anti	O
-	O
mouse	O
Alexa	O
488	O
(	O
Molecular	B-CHEBI
Probes	O
)	O
used	O
at	O
1	O
:	O
250	O
.	O

Donkey	O
anti	O
-	O
goat	O
FITC	B-CHEBI
(	O
Jackson	O
ImmunoResearch	O
Laboratories	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
jacksonimmuno	O
.	O
com	O
)	O
and	O
donkey	O
anti	O
-	O
rabbit	O
Texas	O
Red	O
(	O
Jackson	O
)	O
were	O
used	O
at	O
1	O
:	O
50	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Meiotic	O
chromosome	O
spread	O
preparations	O
and	O
FISH	O
.	O

Meiotic	O
chromosome	O
spread	O
preparations	O
were	O
made	O
from	O
3	O
-	O
wk	O
-	O
old	O
mice	O
,	O
prepared	O
as	O
described	O
by	O
Reinholdt	O
et	O
al	O
.	O

[	O
63	O
]	O
.	O

For	O
analysis	O
of	O
PMSC	O
and	O
Cot	O
-	O
1	O
RNA	O
FISH	O
,	O
meiotic	O
slides	O
were	O
prepared	O
as	O
previously	O
described	O
[	O
16	O
]	O
.	O

Slides	O
containing	O
chromosome	O
spreads	O
or	O
meiotic	O
spermatocytes	O
were	O
subjected	O
to	O
immunofluorescent	O
staining	O
or	O
RNA	O
FISH	O
,	O
as	O
previously	O
described	O
[	O
16	O
,	O
63	O
]	O
.	O

For	O
combined	O
RNA	O
FISH	O
/	O
immunostaining	O
,	O
we	O
carried	O
out	O
RNA	O
FISH	O
first	O
,	O
followed	O
by	O
immunofluorescence	O
.	O

DNA	O
FISH	O
was	O
performed	O
using	O
chromosome	O
painting	O
(	O
Cambio	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
cambio	O
.	O
co	O
.	O
uk	O
)	O
.	O

Z	O
-	O
sections	O
were	O
captured	O
by	O
Zeiss	O
Axioplan	O
microscope	O
(	O
Zeiss	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
zeiss	O
.	O
com	O
)	O
and	O
processed	O
by	O
Openlab	O
(	O
Improvision	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
improvision	O
.	O
com	O
)	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Wild	O
-	O
Type	O
and	O
Dmrt7	O
Mutant	O
Meiotic	O
Spreads	O

Arrows	O
indicate	O
the	O
location	O
of	O
XY	O
body	O
.	O

SYCP3	O
antibody	O
staining	O
(	O
green	O
)	O
shows	O
normal	O
synapsis	O
of	O
homologous	O
chromosome	O
synapse	O
in	O
Dmrt7	O
mutant	O
cell	O
.	O

DMRT7	O
protein	B-CHEBI
(	O
red	O
)	O
is	O
localized	O
to	O
the	O
XY	O
body	O
in	O
wild	O
-	O
type	O
(	O
top	O
row	O
)	O
and	O
is	O
not	O
detected	O
in	O
Dmrt7	O
mutant	O
(	O
bottom	O
row	O
)	O
.	O

(	O
726	O
KB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

Targeted	O
Disruption	O
of	O
Dmrt7	O

(	O
A	O
)	O
Diagram	O
of	O
targeting	O
strategy	O
.	O

Homologous	O
recombination	O
of	O
the	O
targeting	O
vector	O
with	O
the	O
wild	O
-	O
type	O
Dmrt7	O
allele	O
(	O
Dmrt7	O
+	O
)	O
resulted	O
in	O
the	O
targeted	O
allele	O
Dmrtneo	O
.	O

This	O
allele	O
contains	O
loxP	O
sites	O
flanking	O
the	O
translational	O
start	O
and	O
the	O
second	O
and	O
third	O
exons	O
(	O
containing	O
the	O
DM	O
domain	O
,	O
gray	O
)	O
,	O
as	O
well	O
as	O
a	O
neomycine	B-CHEBI
-	O
resistance	O
cassette	O
flanked	O
by	O
Flp	O
recombinase	O
recognition	O
sites	O
(	O
frt	O
sites	O
)	O
.	O

Mice	O
heterozygous	O
for	O
the	O
Dmrt1neo	O
allele	O
were	O
mated	O
with	O
transgenic	O
mice	O
expressing	O
Cre	O
recombinase	O
,	O
resulting	O
in	O
deletion	O
of	O
the	O
sequence	O
between	O
the	O
two	O
loxP	O
sites	O
,	O
including	O
the	O
neo	O
cassette	O
.	O

The	O
resulting	O
deletion	O
allele	O
is	O
called	O
Dmrt7	O
-	O
.	O

Mating	O
of	O
Dmrt7neo	O
mice	O
with	O
transgenic	O
mice	O
expressing	O
the	O
Flpe	O
recombinase	O
excised	O
the	O
neo	O
cassette	O
,	O
generating	O
the	O
Dmrt7flox	O
allele	O
.	O

(	O
B	O
)	O
Southern	O
blots	O
of	O
targeted	O
and	O
wild	O
-	O
type	O
ES	O
cell	O
clones	O
.	O

Genomic	O
DNAs	O
from	O
ES	O
cell	O
clones	O
were	O
digested	O
with	O
NsiI	O
/	O
NotI	O
and	O
EcoRI	O
.	O

The	O
5	O
'	O
external	O
probe	O
hybridizes	O
to	O
14	O
.	O
2	O
-	O
kb	O
(	O
wild	O
-	O
type	O
)	O
and	O
6	O
-	O
kb	O
(	O
targeted	O
)	O
NsiI	O
/	O
NotI	O
fragments	O
.	O

The	O
3	O
'	O
probe	O
hybridizes	O
to	O
14	O
.	O
6	O
-	O
kb	O
(	O
wild	O
-	O
type	O
)	O
and	O
4	O
.	O
7	O
-	O
kb	O
(	O
targeted	O
)	O
EcoRI	O
fragments	O
.	O

(	O
C	O
)	O
Testis	O
sections	O
from	O
adult	O
mice	O
.	O

SUMO	O
-	O
1	O
(	O
green	O
)	O
on	O
XY	O
body	O
is	O
detected	O
in	O
both	O
wild	O
-	O
type	O
(	O
top	O
)	O
and	O
Dmrt7	O
mutant	O
(	O
bottom	O
)	O
section	O
.	O

DMRT7	O
is	O
detected	O
in	O
wild	O
-	O
type	O
but	O
not	O
detected	O
in	O
Dmrt7	O
mutant	O
in	O
SUMO	O
-	O
1	O
-	O
positive	O
cells	O
.	O

(	O
Wild	O
-	O
type	O
images	O
are	O
the	O
same	O
as	O
in	O
Figure	O
1D	O
.	O
)	O

(	O
3	O
.	O
4	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

Normal	O
Androgen	O
Receptor	O
Expression	O
in	O
Dmrt7	O
Mutant	O
Sertoli	O
Cells	O

Testis	O
sections	O
from	O
adult	O
mice	O
stained	O
with	O
antibody	O
to	O
androgen	O
receptor	O
(	O
red	O
)	O
and	O
counterstained	O
with	O
DAPI	O
(	O
blue	O
)	O
.	O

In	O
both	O
wild	O
-	O
type	O
(	O
top	O
)	O
and	O
mutant	O
(	O
bottom	O
)	O
testis	O
sections	O
,	O
androgen	O
receptor	O
protein	B-CHEBI
is	O
expressed	O
in	O
Sertoli	O
cell	O
and	O
peritubular	O
myoid	O
cell	O
.	O

Mutant	O
testis	O
section	O
shows	O
abnormal	O
localization	O
of	O
Sertoli	O
cell	O
nuclei	O
,	O
which	O
are	O
displaced	O
from	O
basement	O
membrane	O
.	O

AR	O
,	O
androgen	O
receptor	O
.	O

(	O
2	O
.	O
3	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S4	O

Ub	O
-	O
H2A	O
Localization	O
to	O
XY	O
Body	O
in	O
Dmrt7	O
Mutant	O
Spermatocyte	O

Spread	O
pachytene	O
spermatocytes	O
from	O
wild	O
-	O
type	O
(	O
top	O
)	O
and	O
Dmrt7	O
mutant	O
(	O
bottom	O
)	O
mice	O
,	O
stained	O
with	O
antibody	O
to	O
Ub	O
-	O
H2A	O
(	O
green	O
)	O
and	O
DAPI	O
(	O
blue	O
)	O
.	O

Arrows	O
indicate	O
XY	O
body	O
.	O

Both	O
wild	O
-	O
type	O
and	O
mutant	O
pachytene	O
cells	O
have	O
Ub	O
-	O
H2A	O
properly	O
localized	O
to	O
XY	O
body	O
.	O

(	O
722	O
KB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S5	O

RBMY	O
Silencing	O
in	O
Dmrt7	O
Mutant	O
Spermatocytes	O

(	O
A	O
)	O
SYCP3	O
(	O
green	O
)	O
and	O
RBMY	O
(	O
red	O
)	O
immunostaining	O
of	O
spread	O
wild	O
-	O
type	O
and	O
Dmrt7	O
mutant	O
testicular	O
cells	O
.	O

In	O
wild	O
-	O
type	O
and	O
mutant	O
cells	O
,	O
RBMY	O
is	O
expressed	O
at	O
low	O
levels	O
in	O
leptotene	O
stage	O
.	O

In	O
pachytene	O
spermatocytes	O
,	O
RBMY	O
has	O
fallen	O
to	O
background	O
levels	O
in	O
both	O
wild	O
-	O
type	O
and	O
mutant	O
.	O

(	O
B	O
)	O
SUMO	O
-	O
1	O
(	O
green	O
)	O
and	O
RBMY	O
(	O
red	O
)	O
immunostaining	O
of	O
adult	O
testis	O
sections	O
from	O
wild	O
-	O
type	O
and	O
Dmrt7	O
mutant	O
.	O

Pre	O
-	O
meiotic	O
cells	O
near	O
the	O
basal	O
membrane	O
express	O
high	O
level	O
of	O
RBMY	O
whereas	O
SUMO	O
-	O
1	O
-	O
positive	O
pachytene	O
cells	O
do	O
not	O
express	O
RBMY	O
,	O
in	O
both	O
wild	O
-	O
type	O
and	O
mutant	O
,	O
indicating	O
proper	O
silencing	O
.	O

(	O
5	O
.	O
4	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Acknowledgements	O

We	O
thank	O
members	O
of	O
the	O
Zarkower	O
and	O
Bardwell	O
labs	O
for	O
many	O
helpful	O
discussions	O
;	O
Dan	O
Camerini	O
-	O
Otero	O
,	O
John	O
Logsdon	O
,	O
and	O
Scott	O
Hawley	O
for	O
insights	O
into	O
evolution	O
of	O
meiotic	O
regulators	O
;	O
Hiromitsu	O
Tanaka	O
,	O
Yoshitake	O
Nishimune	O
,	O
and	O
David	O
Elliot	O
for	O
generously	O
sharing	O
antibodies	O
;	O
and	O
Dies	O
Meijer	O
for	O
sharing	O
Dhh	O
-	O
Cre	O
mice	O
.	O

We	O
thank	O
the	O
University	O
of	O
Minnesota	O
Mouse	O
Genetics	O
Laboratory	O
for	O
ES	O
cell	O
injection	O
.	O

Some	O
images	O
were	O
obtained	O
using	O
the	O
Middlebury	O
Biology	O
Imaging	O
Facility	O
,	O
equipped	O
in	O
part	O
through	O
the	O
National	O
Science	O
Foundation	O
(	O
Course	O
,	O
Curriculum	O
,	O
and	O
Laboratory	O
Improvement	O
,	O
0088412	O
)	O
.	O

SHN	O
is	O
a	O
research	O
fellow	O
of	O
the	O
Japan	O
Society	O
for	O
Promotion	O
of	O
Science	O
.	O

Abbreviations	O

DM	O
-	O
Doublesex	O
/	O
MAB	O
-	O
3	O
domain	O

ES	O
-	O
embryonic	O
stem	O

FISH	O
-	O
fluorescence	O
in	O
situ	O
hybridization	O

GST	O
-	O
glutathione	B-CHEBI
-	O
S	B-CHEBI
-	O
transferase	O

HP1	O
beta	O
-	O
heterochromatin	O
protein	B-CHEBI
1	O
beta	O

gamma	O
H2AX	O
-	O
phosphorylated	O
H2AX	O

MSCI	O
-	O
meiotic	O
sex	O
chromosome	O
inactivation	O

P14	O
-	O
postnatal	O
day	O
14	O

PMSC	O
-	O
postmeiotic	O
sex	O
chromatin	O

RT	O
-	O
PCR	O
-	O
reverse	O
transcriptase	O
-	O
PCR	O

SUMO	O
-	O
1	O
-	O
small	O
ubiquitin	O
-	O
related	O
modifier	O
1	O

Ub	O
-	O
H2A	O
-	O
ubiquitinated	O
H2A	O

Footnotes	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

A	O
previous	O
version	O
of	O
this	O
article	O
appeared	O
as	O
an	O
Early	O
Online	O
Release	O
on	O
March	O
7	O
,	O
2007	O
(	O
doi	O
:	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pgen	O
.	O
0030062	O
.	O
eor	O
)	O
.	O

Author	O
contributions	O
.	O

All	O
authors	O
conceived	O
and	O
designed	O
the	O
experiments	O
and	O
analyzed	O
the	O
data	O
.	O

SK	O
,	O
SHN	O
,	O
LMN	O
,	O
and	O
JOW	O
performed	O
the	O
experiments	O
.	O

JOW	O
contributed	O
reagents	B-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

SK	O
,	O
SHN	O
,	O
JOW	O
,	O
JTL	O
,	O
VJB	O
,	O
and	O
DZ	O
wrote	O
the	O
paper	O
.	O

Funding	O
.	O

This	O
work	O
was	O
supported	O
by	O
the	O
US	O
National	O
Institutes	O
of	O
Health	O
(	O
GM059152	O
)	O
and	O
the	O
Minnesota	O
Medical	O
Foundation	O
.	O

LMN	O
was	O
supported	O
by	O
the	O
Bicentennial	O
Fund	O
of	O
Middlebury	O
College	O
.	O

Mouse	O
Pachytene	O
Checkpoint	O
2	O
(	O
Trip13	O
)	O
Is	O
Required	O
for	O
Completing	O
Meiotic	O
Recombination	O
but	O
Not	O
Synapsis	O

Abstract	O

In	O
mammalian	O
meiosis	O
,	O
homologous	O
chromosome	O
synapsis	O
is	O
coupled	O
with	O
recombination	O
.	O

As	O
in	O
most	O
eukaryotes	O
,	O
mammalian	O
meiocytes	O
have	O
checkpoints	O
that	O
monitor	O
the	O
fidelity	O
of	O
these	O
processes	O
.	O

We	O
report	O
that	O
the	O
mouse	O
ortholog	O
(	O
Trip13	O
)	O
of	O
pachytene	O
checkpoint	O
2	O
(	O
PCH2	O
)	O
,	O
an	O
essential	O
component	O
of	O
the	O
synapsis	O
checkpoint	O
in	O
Saccharomyces	O
cerevisiae	O
and	O
Caenorhabditis	O
elegans	O
,	O
is	O
required	O
for	O
completion	O
of	O
meiosis	O
in	O
both	O
sexes	O
.	O

TRIP13	O
-	O
deficient	O
mice	O
exhibit	O
spermatocyte	O
death	O
in	O
pachynema	O
and	O
loss	O
of	O
oocytes	O
around	O
birth	O
.	O

The	O
chromosomes	O
of	O
mutant	O
spermatocytes	O
synapse	O
fully	O
,	O
yet	O
retain	O
several	O
markers	O
of	O
recombination	O
intermediates	O
,	O
including	O
RAD51	O
,	O
BLM	O
,	O
and	O
RPA	O
.	O

These	O
chromosomes	O
also	O
exhibited	O
the	O
chiasmata	O
markers	O
MLH1	O
and	O
MLH3	O
,	O
and	O
okadaic	B-CHEBI
acid	I-CHEBI
treatment	O
of	O
mutant	O
spermatocytes	O
caused	O
progression	O
to	O
metaphase	O
I	O
with	O
bivalent	O
chromosomes	O
.	O

Double	O
mutant	O
analysis	O
demonstrated	O
that	O
the	O
recombination	O
and	O
synapsis	O
genes	O
Spo11	O
,	O
Mei1	O
,	O
Rec8	O
,	O
and	O
Dmc1	O
are	O
all	O
epistatic	O
to	O
Trip13	O
,	O
suggesting	O
that	O
TRIP13	O
does	O
not	O
have	O
meiotic	O
checkpoint	O
function	O
in	O
mice	O
.	O

Our	O
data	O
indicate	O
that	O
TRIP13	O
is	O
required	O
after	O
strand	O
invasion	O
for	O
completing	O
a	O
subset	O
of	O
recombination	O
events	O
,	O
but	O
possibly	O
not	O
those	O
destined	O
to	O
be	O
crossovers	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
model	O
to	O
separate	O
recombination	O
defects	O
from	O
asynapsis	O
in	O
mammalian	O
meiosis	O
,	O
and	O
provides	O
the	O
first	O
evidence	O
that	O
unrepaired	O
DNA	O
damage	O
alone	O
can	O
trigger	O
the	O
pachytene	O
checkpoint	O
response	O
in	O
mice	O
.	O

Author	O
Summary	O

It	O
is	O
critical	O
that	O
the	O
chromosomes	O
carried	O
by	O
sperm	O
and	O
eggs	O
contain	O
faithful	O
representations	O
of	O
the	O
genome	O
of	O
the	O
individual	O
that	O
produced	O
them	O
.	O

During	O
the	O
process	O
of	O
meiosis	O
,	O
the	O
maternal	O
and	O
paternal	O
copies	O
of	O
each	O
chromosome	O
"	O
synapse	O
"	O
with	O
each	O
other	O
(	O
become	O
tightly	O
associated	O
)	O
,	O
exchange	O
genetic	O
material	O
via	O
the	O
process	O
of	O
recombination	O
,	O
then	O
separate	O
into	O
daughter	O
cells	O
in	O
the	O
first	O
of	O
two	O
meiotic	O
cell	O
divisions	O
.	O

The	O
intricate	O
chromosome	O
behavior	O
is	O
subject	O
to	O
errors	O
,	O
so	O
most	O
organisms	O
have	O
evolved	O
meiotic	O
"	O
checkpoints	O
"	O
that	O
monitor	O
fidelity	O
of	O
chromosome	O
synapsis	O
and	O
repair	O
of	O
DNA	O
damage	O
.	O

These	O
checkpoints	O
cause	O
defective	O
cells	O
to	O
self	O
destruct	O
rather	O
than	O
generate	O
defective	O
sperm	O
or	O
eggs	O
.	O

We	O
studied	O
the	O
effects	O
of	O
deleting	O
mouse	O
Trip13	O
,	O
a	O
gene	O
that	O
in	O
distant	O
organisms	O
plays	O
a	O
key	O
role	O
in	O
meiotic	O
checkpoint	O
control	O
.	O

These	O
experiments	O
revealed	O
that	O
instead	O
of	O
having	O
a	O
checkpoint	O
role	O
,	O
Trip13	O
is	O
required	O
for	O
one	O
of	O
the	O
two	O
major	O
classes	O
of	O
recombination	O
in	O
meiosis	O
that	O
is	O
required	O
for	O
repairing	O
broken	O
DNA	O
molecules	B-CHEBI
.	O

The	O
chromosomes	O
still	O
synapsed	O
normally	O
,	O
but	O
animals	O
were	O
sterile	O
due	O
to	O
massive	O
death	O
of	O
oocytes	O
and	O
spermatocytes	O
.	O

These	O
results	O
indicate	O
that	O
,	O
in	O
addition	O
to	O
a	O
checkpoint	O
that	O
responds	O
to	O
failed	O
synapsis	O
,	O
one	O
exists	O
to	O
specifically	O
detect	O
unrepaired	O
DNA	O
damage	O
that	O
is	O
due	O
to	O
failed	O
recombination	O
.	O

Introduction	O

The	O
genesis	O
of	O
gametes	O
containing	O
an	O
intact	O
,	O
haploid	O
genome	O
is	O
critical	O
for	O
the	O
prevention	O
of	O
birth	O
defects	O
,	O
and	O
is	O
highly	O
dependent	O
upon	O
the	O
fidelity	O
of	O
chromosome	O
dynamics	O
before	O
the	O
first	O
meiotic	O
division	O
.	O

Homologous	O
chromosomes	O
must	O
pair	O
,	O
synapse	O
,	O
undergo	O
recombination	O
,	O
and	O
segregate	O
properly	O
to	O
opposite	O
poles	O
.	O

Recombination	O
,	O
which	O
repairs	O
repair	O
double	O
strand	O
breaks	O
(	O
DSBs	O
)	O
that	O
are	O
genetically	O
induced	O
in	O
leptonema	O
,	O
is	O
coupled	O
with	O
synapsis	O
in	O
budding	O
yeast	O
and	O
mammals	O
.	O

While	O
our	O
knowledge	O
of	O
the	O
assembly	O
and	O
nature	O
of	O
recombination	O
machinery	O
is	O
extensive	O
,	O
little	O
is	O
known	O
about	O
the	O
disassembly	O
of	O
recombination	O
intermediates	O
,	O
recruitment	O
of	O
DNA	O
replication	O
machinery	O
during	O
recombinational	O
repair	O
,	O
and	O
how	O
the	O
choice	O
between	O
different	O
repair	O
pathways	O
is	O
made	O
.	O

Defects	O
in	O
recombination	O
can	O
preclude	O
homologous	O
chromosome	O
pairing	O
,	O
leave	O
unrepaired	O
chromosome	O
breaks	O
,	O
and	O
cause	O
aneuploidy	O
by	O
abrogating	O
crossing	O
over	O
.	O

To	O
avoid	O
such	O
deleterious	O
outcomes	O
,	O
surveillance	O
systems	O
(	O
"	O
checkpoints	O
"	O
)	O
exist	O
to	O
sense	O
meiotic	O
errors	O
and	O
eliminate	O
cells	O
containing	O
unresolved	O
defects	O
.	O

In	O
many	O
organisms	O
,	O
including	O
S	O
.	O
cerevisiae	O
,	O
Drosophila	O
melanogaster	O
,	O
C	O
.	O
elegans	O
,	O
and	O
mice	O
[	O
1	O
-	O
4	O
]	O
,	O
meiocytes	O
with	O
defects	O
in	O
recombination	O
and	O
/	O
or	O
chromosome	O
synapsis	O
trigger	O
meiotic	O
arrest	O
in	O
the	O
pachytene	O
stage	O
of	O
meiotic	O
prophase	O
I	O
.	O

This	O
response	O
to	O
meiotic	O
defects	O
is	O
referred	O
to	O
as	O
the	O
"	O
pachytene	O
checkpoint	O
"	O
(	O
reviewed	O
in	O
[	O
5	O
]	O
)	O
.	O

Genetic	O
experiments	O
in	O
S	O
.	O
cerevisiae	O
have	O
identified	O
elements	O
of	O
the	O
pachytene	O
checkpoint	O
machinery	O
(	O
reviewed	O
in	O
[	O
5	O
]	O
)	O
.	O

In	O
addition	O
to	O
meiosis	O
-	O
specific	O
proteins	B-CHEBI
,	O
these	O
include	O
factors	O
that	O
play	O
roles	O
in	O
DNA	O
damage	O
signaling	O
in	O
mitotic	O
cells	O
[	O
6	O
-	O
10	O
]	O
.	O

Arabidopsis	O
thaliana	O
does	O
not	O
appear	O
to	O
have	O
a	O
pachytene	O
checkpoint	O
akin	O
to	O
that	O
in	O
yeast	O
[	O
11	O
]	O
,	O
nor	O
do	O
male	O
Drosophila	O
.	O

The	O
pachytene	O
checkpoint	O
is	O
known	O
to	O
monitor	O
two	O
aspects	O
of	O
meiotic	O
chromosome	O
metabolism	O
in	O
S	O
.	O
cerevisiae	O
and	O
C	O
.	O
elegans	O
:	O
(	O
1	O
)	O
DSB	O
repair	O
and	O
(	O
2	O
)	O
chromosome	O
synapsis	O
[	O
2	O
,	O
12	O
]	O
.	O

In	O
mice	O
,	O
both	O
spermatocytes	O
and	O
oocytes	O
harboring	O
mutations	O
that	O
disrupt	O
DSB	O
repair	O
(	O
such	O
as	O
Dmc1	O
,	O
Msh5	O
,	O
and	O
Atm	O
)	O
are	O
efficiently	O
eliminated	O
in	O
pachynema	O
,	O
but	O
spermatocytes	O
are	O
much	O
more	O
sensitive	O
to	O
DSB	O
repair	O
-	O
independent	O
synapsis	O
defects	O
than	O
oocytes	O
[	O
13	O
-	O
15	O
]	O
.	O

However	O
,	O
because	O
recombination	O
is	O
required	O
for	O
synapsis	O
in	O
mice	O
(	O
mutations	O
in	O
recombination	O
genes	O
such	O
as	O
Dmc1	O
cause	O
extensive	O
asynapsis	O
[	O
16	O
]	O
)	O
,	O
it	O
has	O
remained	O
formally	O
uncertain	O
whether	O
there	O
is	O
a	O
distinct	O
pachytene	O
checkpoint	O
that	O
responds	O
to	O
defects	O
in	O
meiotic	O
recombination	O
,	O
and	O
if	O
so	O
,	O
whether	O
it	O
would	O
be	O
identical	O
to	O
that	O
used	O
in	O
somatic	O
cells	O
.	O

The	O
mechanisms	O
of	O
putative	O
pachytene	O
checkpoint	O
control	O
remain	O
unknown	O
in	O
mammals	O
,	O
since	O
no	O
mutations	O
have	O
been	O
identified	O
that	O
abolish	O
it	O
.	O

PCH2	O
,	O
encoding	O
a	O
nucleolar	O
-	O
localized	O
AAA	O
-	O
ATPase	O
that	O
was	O
originally	O
identified	O
in	O
an	O
S	O
.	O
cerevisiae	O
genetic	O
screen	O
for	O
mutants	O
that	O
relieve	O
pachytene	O
arrest	O
of	O
asynaptic	O
zip1	O
mutants	O
[	O
8	O
]	O
,	O
was	O
recently	O
determined	O
to	O
be	O
an	O
essential	O
component	O
of	O
the	O
pachytene	O
synapsis	O
(	O
but	O
not	O
DSB	O
repair	O
)	O
checkpoint	O
in	O
yeast	O
and	O
worms	O
[	O
2	O
,	O
12	O
]	O
.	O

PCH2	O
orthologs	O
are	O
present	O
in	O
organisms	O
that	O
undergo	O
synaptic	O
meiosis	O
,	O
but	O
not	O
asynaptic	O
meiosis	O
,	O
prompting	O
the	O
suggestion	O
that	O
a	O
Pch2	O
-	O
dependent	O
checkpoint	O
evolved	O
to	O
monitor	O
synaptonemal	O
complex	O
(	O
SC	O
)	O
defects	O
from	O
yeast	O
to	O
humans	O
[	O
12	O
]	O
.	O

Here	O
,	O
we	O
generated	O
mice	O
deficient	O
for	O
the	O
Trip13	O
,	O
the	O
ortholog	O
of	O
PCH2	O
,	O
and	O
evaluated	O
whether	O
it	O
also	O
plays	O
a	O
role	O
in	O
the	O
pachytene	O
checkpoint	O
.	O

Surprisingly	O
,	O
while	O
we	O
found	O
no	O
evidence	O
for	O
checkpoint	O
function	O
,	O
we	O
did	O
uncover	O
a	O
potential	O
role	O
for	O
this	O
protein	B-CHEBI
in	O
noncrossover	O
(	O
NCO	O
)	O
repair	O
of	O
meiotic	O
DSBs	O
.	O

Results	O

Trip13	O
Is	O
a	O
Widely	O
Expressed	O
Mammalian	O
Ortholog	O
of	O
PCH2	O
with	O
Unusual	O
Phylogenetic	O
Relationships	O

The	O
mammalian	O
ortholog	O
of	O
PCH2	O
,	O
Trip13	O
(	O
thyroid	O
hormone	B-CHEBI
receptor	O
interacting	O
protein	B-CHEBI
13	O
)	O
,	O
encodes	O
a	O
protein	B-CHEBI
with	O
extensive	O
amino	B-CHEBI
acid	I-CHEBI
homology	O
in	O
regions	O
alignable	O
to	O
the	O
yeast	O
and	O
worm	O
orthologs	O
(	O
Figure	O
S1	O
)	O
[	O
12	O
]	O
)	O
.	O

Interestingly	O
,	O
phylogenetic	O
analysis	O
of	O
TRIP13	O
/	O
Pch2p	O
shows	O
that	O
the	O
mammalian	O
protein	B-CHEBI
clusters	O
more	O
closely	O
to	O
plants	O
than	O
it	O
does	O
to	O
the	O
evolutionarily	O
more	O
closely	O
related	O
worms	O
and	O
flies	O
(	O
Figure	O
1A	O
;	O
see	O
Discussion	O
)	O
.	O

Semi	O
-	O
quantitative	O
reverse	O
-	O
transcriptase	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
analysis	O
showed	O
Trip13	O
mRNA	B-CHEBI
to	O
be	O
expressed	O
in	O
a	O
variety	O
of	O
embryonic	O
and	O
adult	O
tissues	O
,	O
including	O
testis	O
(	O
Figure	O
1B	O
)	O
,	O
consistent	O
with	O
mouse	O
and	O
human	O
EST	O
data	O
summarized	O
in	O
Unigene	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
UniGene	O
)	O
.	O

It	O
is	O
also	O
highly	O
expressed	O
in	O
human	O
and	O
mouse	O
oocytes	O
[	O
17	O
]	O
.	O

Figure	O
1	O

The	O
Mouse	O
PCH2	O
Ortholog	O
TRIP13	O
and	O
Expression	O
in	O
Wild	O
Type	O
and	O
Mutant	O

(	O
A	O
)	O
Phylogenetic	O
tree	O
of	O
presumed	O
PCH2	O
/	O
TRIP13	O
orthologs	O
.	O

The	O
database	O
sequence	O
accession	O
number	O
of	O
each	O
protein	B-CHEBI
is	O
presented	O
in	O
Table	O
S1	O
.	O

Numbers	O
shown	O
are	O
bootstrap	O
values	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

The	O
clustering	O
was	O
the	O
same	O
regardless	O
of	O
whether	O
the	O
whole	O
entire	O
AA	B-CHEBI
sequence	O
or	O
trimmed	O
sequences	O
(	O
where	O
regions	O
showing	O
little	O
conservation	O
were	O
removed	O
)	O
were	O
used	O
for	O
the	O
analysis	O
.	O

Major	O
eukaryotic	O
groups	O
are	O
indicated	O
in	O
color	O
,	O
with	O
deuterostomia	O
in	O
blue	O
,	O
plants	O
in	O
green	O
,	O
protostomia	O
in	O
purple	O
,	O
and	O
fungi	O
in	O
maroon	O
.	O

(	O
B	O
)	O
Amplification	O
products	O
of	O
cDNA	O
from	O
the	O
following	O
tissues	O
:	O
1	O
,	O
heart	O
;	O
2	O
,	O
brain	O
;	O
3	O
,	O
spleen	O
;	O
4	O
,	O
lung	O
;	O
5	O
,	O
liver	O
;	O
6	O
,	O
skeletal	O
muscle	O
;	O
7	O
,	O
kidney	O
;	O
8	O
,	O
testis	O
;	O
9	O
,	O
E7	O
embryo	O
;	O
10	O
,	O
E11	O
embryo	O
;	O
11	O
,	O
E15	O
embryo	O
;	O
and	O
12	O
,	O
E17	O
embryo	O
.	O

(	O
C	O
)	O
Intron	O
-	O
exon	O
structure	O
of	O
TRIP13	O
and	O
insertion	O
site	O
of	O
gene	O
-	O
trap	O
vector	O
.	O

See	O
Materials	O
and	O
Methods	O
for	O
details	O
on	O
how	O
the	O
precise	O
insertion	O
site	O
was	O
identified	O
.	O

(	O
D	O
)	O
RT	O
-	O
PCR	O
of	O
Trip13	O
and	O
a	O
control	O
gene	O
Med31	O
from	O
testis	O
RNA	O
.	O

The	O
Trip13	O
primers	O
are	O
situated	O
in	O
the	O
first	O
and	O
last	O
exons	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

(	O
E	O
)	O
Western	O
blot	O
analysis	O
of	O
testis	O
protein	B-CHEBI
with	O
anti	O
-	O
TRIP13	O
antibody	O
.	O

The	O
blot	O
was	O
later	O
probed	O
with	O
anti	O
-	O
alpha	O
tubulin	O
actin	O
as	O
a	O
loading	O
control	O
.	O

The	O
expected	O
TRIP13	O
protein	B-CHEBI
is	O
~	O
48	O
KDa	O
.	O

(	O
F	O
)	O
Localization	O
of	O
TRIP13	O
in	O
testes	O
.	O

Wild	O
-	O
type	O
(	O
top	O
)	O
and	O
mutant	O
(	O
bottom	O
)	O
testis	O
sections	O
were	O
probed	O
with	O
chicken	O
anti	O
-	O
TRIP13	O
,	O
and	O
detected	O
with	O
HRP	O
-	O
conjugated	O
anti	O
-	O
chicken	O
IgG	O
(	O
brown	O
/	O
red	O
staining	O
)	O
.	O

Expression	O
in	O
WT	O
was	O
most	O
prominent	O
in	O
the	O
nuclei	O
of	O
Type	O
B	O
spermatogonia	O
(	O
Sg	O
)	O
,	O
leptotene	O
spermatocytes	O
(	O
LS	O
)	O
,	O
and	O
early	O
pachytene	O
spermatocytes	O
(	O
PS	O
)	O
,	O
but	O
not	O
late	O
pachytene	O
spermatocytes	O
(	O
LP	O
)	O
.	O

No	O
nuclear	O
staining	O
was	O
seen	O
in	O
mutant	O
testis	O
sections	O
,	O
although	O
reddish	O
cytoplasmic	O
background	O
is	O
present	O
.	O

Identification	O
of	O
cell	O
types	O
was	O
judged	O
in	O
part	O
by	O
estimating	O
the	O
epithelial	O
stage	O
of	O
the	O
tubules	O
as	O
described	O
[	O
67	O
]	O
.	O

(	O
G	O
)	O
TRIP13	O
localization	O
in	O
surface	O
-	O
spread	O
spermatocytes	O
.	O

Preparations	O
were	O
immunolabeled	O
with	O
anti	O
-	O
SYCP3	O
(	O
S	O
)	O
and	O
TRIP13	O
(	O
T	O
)	O
.	O

Both	O
individual	O
and	O
merged	O
images	O
are	O
shown	O
for	O
leptotene	O
(	O
Lep	O
)	O
,	O
zygotene	O
(	O
Zyg	O
)	O
,	O
and	O
pachytene	O
(	O
Pac	O
)	O
spermatocytes	O
.	O

Nuclear	O
staining	O
was	O
absent	O
in	O
the	O
mutant	O
.	O

Generation	O
of	O
Trip13	O
Mutant	O
Mice	O

To	O
explore	O
the	O
function	O
of	O
TRIP13	O
in	O
mammals	O
,	O
we	O
generated	O
mice	O
with	O
a	O
gene	O
trap	O
-	O
disrupted	O
allele	O
,	O
Trip13RRB047	O
(	O
Figure	O
1C	O
;	O
abbreviated	O
as	O
Trip13Gt	O
)	O
.	O

Heterozygotes	O
were	O
normal	O
in	O
all	O
respects	O
,	O
but	O
homozygotes	O
were	O
present	O
at	O
~	O
2	O
/	O
3	O
the	O
expected	O
ratio	O
from	O
intercrosses	O
between	O
heterozygotes	O
(	O
91	O
Trip13	O
+	O
/	O
+	O
,	O
183	O
Trip13Gt	O
/	O
+	O
,	O
and	O
61	O
Trip13Gt	O
/	O
Gt	O
)	O
.	O

Since	O
>	O
90	O
%	O
of	O
prewean	O
mice	O
that	O
died	O
were	O
mutant	O
homozygotes	O
,	O
this	O
discrepancy	O
is	O
apparently	O
due	O
to	O
a	O
partially	O
penetrant	O
lethality	O
.	O

Most	O
surviving	O
Trip13Gt	O
/	O
Gt	O
animals	O
were	O
grossly	O
normal	O
.	O

However	O
,	O
homozygotes	O
that	O
were	O
semi	O
-	O
congenic	O
(	O
N4	O
)	O
on	O
the	O
C57BL	O
/	O
6J	O
strain	O
were	O
often	O
markedly	O
smaller	O
and	O
/	O
or	O
had	O
kinked	O
or	O
shorter	O
tails	O
(	O
Figure	O
2A	O
and	O
2B	O
)	O
.	O

Figure	O
2	O

Developmental	O
Phenotypes	O
of	O
Trip13	O
Mutant	O
Mice	O

(	O
A	O
)	O
Shown	O
are	O
21	O
-	O
d	O
-	O
old	O
littermates	O
.	O

Note	O
the	O
shortened	O
tail	O
in	O
the	O
mutant	O
,	O
but	O
overall	O
similar	O
body	O
size	O
.	O

(	O
B	O
)	O
Shown	O
are	O
23	O
-	O
d	O
-	O
old	O
littermates	O
.	O

The	O
mutant	O
is	O
smaller	O
in	O
this	O
case	O
,	O
but	O
the	O
tail	O
is	O
not	O
as	O
truncated	O
as	O
the	O
mouse	O
in	O
(	O
A	O
)	O
.	O

(	O
C	O
)	O
Wild	O
-	O
type	O
(	O
WT	O
)	O
and	O
homozygous	O
Trip13	O
mutant	O
(	O
MUT	O
)	O
testes	O
.	O

(	O
D	O
)	O
and	O
(	O
E	O
)	O
are	O
cross	O
sections	O
through	O
17	O
.	O
5	O
-	O
d	O
-	O
old	O
heterozygous	O
(	O
"	O
WT	O
"	O
)	O
and	O
homozygous	O
mutant	O
Trip13	O
testes	O
,	O
respectively	O
.	O

Whereas	O
the	O
tubules	O
in	O
WT	O
show	O
coordinated	O
spermatogenesis	O
with	O
pachytene	O
spermatocytes	O
present	O
in	O
all	O
tubules	O
(	O
proximal	O
to	O
the	O
lumen	O
)	O
,	O
developmental	O
progression	O
in	O
the	O
mutant	O
is	O
not	O
synchronized	O
between	O
tubules	O
.	O

Some	O
tubules	O
have	O
no	O
pachytene	O
spermatocyes	O
(	O
asterisks	O
)	O
,	O
while	O
in	O
others	O
,	O
development	O
is	O
somewhat	O
disorganized	O
(	O
#	O
)	O
.	O

RT	O
-	O
PCR	O
analysis	O
of	O
Trip13Gt	O
expression	O
(	O
Figure	O
1D	O
)	O
revealed	O
a	O
low	O
level	O
of	O
normally	O
spliced	O
transcripts	O
in	O
testes	O
of	O
homozygotes	O
that	O
is	O
presumably	O
a	O
consequence	O
of	O
incomplete	O
usage	O
of	O
the	O
gene	O
trap	O
'	O
s	O
splice	O
acceptor	O
.	O

Western	O
blot	O
analysis	O
,	O
using	O
a	O
polyclonal	O
antibody	O
raised	O
against	O
a	O
peptide	O
encoded	O
by	O
exon	O
3	O
,	O
revealed	O
multiple	O
species	O
in	O
wild	O
-	O
type	O
and	O
heterozygous	O
testes	O
,	O
one	O
of	O
which	O
corresponds	O
to	O
the	O
expected	O
size	O
of	O
48	O
kDa	O
(	O
Figure	O
1E	O
)	O
.	O

This	O
and	O
three	O
other	O
species	O
were	O
undetectable	O
in	O
homozygous	O
mutant	O
testes	O
,	O
but	O
a	O
reduced	O
amount	O
of	O
an	O
intense	O
~	O
38	O
kDa	O
smaller	O
band	O
was	O
present	O
.	O

It	O
is	O
not	O
clear	O
if	O
this	O
corresponds	O
to	O
TRIP13	O
.	O

The	O
greatly	O
decreased	O
Trip13	O
mRNA	B-CHEBI
and	O
predicted	O
correct	O
-	O
length	O
protein	B-CHEBI
in	O
mutants	O
indicate	O
that	O
the	O
Trip13RRB047	O
allele	O
is	O
severely	O
hypomorphic	O
.	O

To	O
determine	O
the	O
germ	O
cell	O
types	O
in	O
which	O
TRIP13	O
is	O
expressed	O
,	O
and	O
to	O
assess	O
possible	O
expression	O
in	O
the	O
mutant	O
by	O
means	O
other	O
than	O
Western	O
analysis	O
,	O
testis	O
sections	O
were	O
immunolabeled	O
for	O
TRIP13	O
using	O
a	O
polyclonal	O
chicken	O
antipeptide	O
antibody	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

The	O
most	O
intensely	O
labeled	O
cells	O
in	O
control	O
testes	O
were	O
Type	O
B	O
spermatogonia	O
and	O
leptotene	O
spermatocytes	O
(	O
Figure	O
1F	O
)	O
.	O

Zygotene	O
/	O
pachytene	O
spermatocytes	O
stained	O
less	O
strongly	O
,	O
and	O
there	O
was	O
no	O
detectable	O
staining	O
in	O
late	O
pachytene	O
spermatocytes	O
.	O

TRIP13	O
appeared	O
to	O
be	O
nuclear	O
localized	O
.	O

There	O
was	O
no	O
such	O
staining	O
of	O
nuclei	O
in	O
mutant	O
seminiferous	O
tubules	O
(	O
Figure	O
1F	O
)	O
.	O

To	O
further	O
assess	O
the	O
nuclear	O
localization	O
,	O
TRIP13	O
was	O
used	O
to	O
probe	O
meiotic	O
chromosomes	O
prepared	O
by	O
surface	O
spreading	O
of	O
spermatocyte	O
nuclei	O
.	O

In	O
wild	O
type	O
,	O
there	O
was	O
diffuse	O
nuclear	O
staining	O
,	O
and	O
no	O
evidence	O
of	O
concentration	O
on	O
SC	O
cores	O
(	O
marked	O
by	O
the	O
axial	O
element	O
protein	B-CHEBI
SYCP3	O
)	O
at	O
any	O
meiotic	O
substage	O
(	O
Figure	O
1G	O
)	O
.	O

TRIP13	O
signal	O
was	O
noticeably	O
absent	O
in	O
mutant	O
meiotic	O
nuclei	O
.	O

Infertility	O
Due	O
to	O
Meiotic	O
Disruption	O
in	O
TRIP13	O
-	O
Deficient	O
Meiocytes	O

Homozygotes	O
of	O
both	O
sexes	O
had	O
small	O
gonads	O
(	O
Figure	O
2C	O
;	O
see	O
below	O
)	O
and	O
were	O
invariably	O
sterile	O
.	O

Ovaries	O
of	O
adult	O
Trip13Gt	O
/	O
Gt	O
females	O
were	O
severely	O
dysmorphic	O
and	O
had	O
few	O
or	O
no	O
follicles	O
(	O
Figure	O
3A	O
and	O
3B	O
)	O
.	O

The	O
majority	O
of	O
oocyte	O
loss	O
occurred	O
in	O
late	O
embryogenesis	O
or	O
early	O
in	O
postnatal	O
development	O
,	O
since	O
2	O
d	O
postpartum	O
ovaries	O
were	O
markedly	O
smaller	O
than	O
those	O
of	O
control	O
littermates	O
,	O
and	O
were	O
lacking	O
oocytes	O
or	O
newly	O
forming	O
follicles	O
(	O
Figure	O
3C	O
and	O
3D	O
)	O
.	O

Thus	O
,	O
oocytes	O
failed	O
to	O
progress	O
to	O
the	O
dictyate	O
(	O
resting	O
)	O
phase	O
.	O

Since	O
we	O
observed	O
oocytes	O
with	O
pachytene	O
stage	O
chromosomes	O
in	O
17	O
.	O
5	O
d	O
Trip13Gt	O
/	O
Gt	O
embryonic	O
ovaries	O
(	O
unpublished	O
data	O
)	O
,	O
this	O
indicates	O
that	O
oocytes	O
were	O
eliminated	O
somewhere	O
between	O
pachynema	O
and	O
dictyate	O
.	O

Figure	O
3	O

Histology	O
of	O
Mutant	O
Gonads	O

All	O
are	O
hematoxylin	O
/	O
eosin	O
-	O
stained	O
paraffin	O
sections	O
.	O

Testes	O
are	O
from	O
6	O
-	O
wk	O
-	O
old	O
males	O
,	O
except	O
as	O
indicated	O
below	O
.	O

(	O
A	O
)	O
Wild	O
-	O
type	O
25	O
-	O
d	O
-	O
old	O
ovary	O
.	O

(	O
B	O
)	O
Trip13Gt	O
/	O
Gt	O
25	O
-	O
d	O
-	O
old	O
ovary	O
,	O
showing	O
dysgenesis	O
from	O
an	O
absence	O
of	O
oocytes	O
.	O

(	O
C	O
)	O
Trip13Gt	O
/	O
+	O
2	O
-	O
d	O
-	O
old	O
control	O
ovary	O
.	O

Arrows	O
point	O
to	O
oocytes	O
in	O
newly	O
forming	O
follicles	O
.	O

(	O
D	O
)	O
Trip13Gt	O
/	O
Gt	O
2	O
-	O
d	O
-	O
old	O
ovary	O
,	O
dysgenic	O
due	O
to	O
lack	O
of	O
oocytes	O
.	O

Magnification	O
is	O
the	O
same	O
as	O
its	O
littermate	O
in	O
"	O
C	O
.	O
"	O

(	O
E	O
)	O
Wild	O
-	O
type	O
testis	O
.	O

(	O
F	O
)	O
Trip13Gt	O
/	O
Gt	O
testis	O
with	O
uniform	O
pachytene	O
arrest	O
.	O

(	O
G	O
)	O
Trip13Gt	O
/	O
Gt	O
3	O
-	O
mo	O
-	O
old	O
testis	O
with	O
some	O
postmeiotic	O
spermatids	O
(	O
arrows	O
)	O
.	O

(	O
H	O
)	O
Spo11	O
-	O
/	O
-	O
testis	O
.	O

A	O
tubule	O
with	O
spermatocytes	O
at	O
leptotene	O
/	O
zygotene	O
transition	O
is	O
labeled	O
ZP	O
,	O
and	O
tubules	O
with	O
apoptotic	O
spermatocytes	O
are	O
marked	O
with	O
an	O
asterisk	O
.	O

The	O
specimen	O
was	O
taken	O
from	O
a	O
littermate	O
of	O
that	O
in	O
(	O
I	O
)	O
.	O

(	O
I	O
)	O
Spo11	O
-	O
/	O
-	O
Trip13Gt	O
/	O
Gt	O
testis	O
.	O

Labeling	O
is	O
the	O
same	O
as	O
in	O
(	O
H	O
)	O
.	O

The	O
inset	O
contains	O
a	O
tubule	O
with	O
leptotene	O
-	O
zygotene	O
spermatocytes	O
.	O

(	O
J	O
)	O
Mei1	O
-	O
/	O
-	O
Trip13Gt	O
/	O
+	O
testis	O
.	O

The	O
specimen	O
was	O
taken	O
from	O
a	O
littermate	O
of	O
that	O
in	O
(	O
K	O
)	O
.	O

(	O
K	O
)	O
Mei1	O
-	O
/	O
-	O
Trip13Gt	O
/	O
Gt	O
testis	O
.	O

(	O
L	O
)	O
Rec8Mei8	O
/	O
Rec8Mei8	O
Trip13Gt	O
/	O
+	O
testis	O
.	O

The	O
Rec8Mei8	O
allele	O
was	O
described	O
[	O
39	O
]	O
.	O

The	O
specimen	O
was	O
taken	O
from	O
a	O
littermate	O
of	O
that	O
in	O
(	O
M	O
)	O
.	O

(	O
M	O
)	O
Rec8Mei8	O
/	O
Rec8Mei8	O
Trip13Gt	O
/	O
Gt	O
testis	O
.	O

(	O
N	O
)	O
Dmc1	O
-	O
/	O
-	O
Trip13Gt	O
/	O
Gt	O
testis	O
.	O

(	O
O	O
)	O
Spo11	O
-	O
/	O
-	O
Trip13Gt	O
/	O
+	O
25	O
-	O
d	O
-	O
old	O
ovary	O
.	O

The	O
specimen	O
was	O
taken	O
from	O
a	O
littermate	O
of	O
that	O
in	O
(	O
P	O
)	O
.	O

(	O
P	O
)	O
Spo11	O
-	O
/	O
-	O
Trip13Gt	O
/	O
Gt	O
25	O
-	O
d	O
-	O
old	O
ovary	O
.	O

(	O
Q	O
)	O
Mei1	O
-	O
/	O
-	O
Trip13Gt	O
/	O
+	O
25	O
-	O
d	O
-	O
old	O
ovary	O
.	O

The	O
specimen	O
was	O
taken	O
from	O
a	O
littermate	O
of	O
that	O
in	O
(	O
R	O
)	O
.	O

(	O
R	O
)	O
Mei1	O
-	O
/	O
-	O
Trip13Gt	O
/	O
Gt	O
25	O
-	O
d	O
-	O
old	O
ovary	O
.	O

(	O
S	O
)	O
Rec8Mei8	O
/	O
Rec8Mei8	O
Trip13Gt	O
/	O
+	O
25	O
-	O
d	O
-	O
old	O
ovary	O
.	O

The	O
specimen	O
was	O
taken	O
from	O
a	O
littermate	O
of	O
that	O
in	O
(	O
T	O
)	O
.	O

(	O
T	O
)	O
Rec8Mei8	O
/	O
Rec8Mei8	O
Trip13Gt	O
/	O
Gt	O
25	O
-	O
d	O
-	O
old	O
ovary	O
.	O

Histological	O
sections	O
of	O
mutant	O
testes	O
revealed	O
a	O
lack	O
of	O
postmeiotic	O
cell	O
types	O
that	O
are	O
characteristic	O
of	O
wild	O
-	O
type	O
seminiferous	O
tubules	O
(	O
Figure	O
3E	O
)	O
.	O

The	O
most	O
developmentally	O
advanced	O
seminiferous	O
tubules	O
contained	O
adluminal	O
spermatocytes	O
with	O
condensed	O
chromatin	O
characteristic	O
of	O
pachynema	O
(	O
Figure	O
3F	O
)	O
.	O

The	O
absence	O
of	O
coordinated	O
spermatogenic	O
progression	O
beyond	O
this	O
stage	O
is	O
indicative	O
of	O
a	O
pachytene	O
arrest	O
.	O

This	O
was	O
revealed	O
more	O
clearly	O
by	O
chromosome	O
analysis	O
(	O
see	O
below	O
)	O
.	O

Some	O
sections	O
of	O
adult	O
seminiferous	O
tubules	O
contained	O
postmeiotic	O
spermatids	O
(	O
Figure	O
3G	O
)	O
,	O
although	O
we	O
saw	O
no	O
motile	O
epididymal	O
sperm	O
.	O

These	O
drastic	O
meiotic	O
defects	O
stand	O
in	O
contrast	O
to	O
yeast	O
and	O
C	O
.	O
elegans	O
,	O
in	O
which	O
deletion	O
of	O
Pch2	O
alone	O
has	O
minor	O
effects	O
on	O
spore	O
/	O
gamete	O
development	O
[	O
2	O
,	O
8	O
]	O
.	O

TRIP13	O
-	O
Deficient	O
Meiocytes	O
Undergo	O
Homologous	O
Chromosome	O
Synapsis	O
Despite	O
the	O
Presence	O
of	O
Unrepaired	O
DSBs	O
in	O
Pachynema	O

To	O
better	O
characterize	O
the	O
degree	O
of	O
meiotic	O
progression	O
in	O
Trip13Gt	O
/	O
Gt	O
spermatocytes	O
,	O
we	O
immunostained	O
chromosome	O
spreads	O
for	O
SYCP3	O
and	O
SYCP1	O
,	O
components	O
of	O
the	O
axial	O
/	O
lateral	O
elements	O
and	O
transverse	O
filaments	O
,	O
respectively	O
,	O
of	O
the	O
synaptonemal	O
complex	O
(	O
SC	O
)	O
.	O

Pachytene	O
spermatocyte	O
nuclei	O
from	O
postpubertal	O
mutant	O
testes	O
could	O
assemble	O
normal	O
SC	O
cores	O
and	O
exhibited	O
full	O
synapsis	O
of	O
chromosomes	O
as	O
judged	O
by	O
colabeling	O
of	O
SYCP1	O
and	O
SYCP3	O
along	O
the	O
full	O
lengths	O
of	O
all	O
autosomes	O
(	O
Figure	O
4A	O
)	O
.	O

Additionally	O
,	O
the	O
X	O
and	O
Y	O
chromosomes	O
were	O
normally	O
synapsed	O
at	O
their	O
pseudoautosomal	O
region	O
.	O

More	O
prepubertal	O
(	O
17	O
.	O
5	O
d	O
postpartum	O
)	O
mutant	O
spermatocytes	O
contained	O
asynaptic	O
or	O
terminally	O
asynapsed	O
chromosomes	O
than	O
age	O
-	O
matched	O
controls	O
(	O
62	O
.	O
5	O
%	O
versus	O
25	O
%	O
,	O
respectively	O
;	O
Figure	O
4B	O
)	O
.	O

We	O
attribute	O
this	O
to	O
a	O
delay	O
in	O
the	O
first	O
wave	O
of	O
postnatal	O
spermatogenesis	O
(	O
Figure	O
2D	O
and	O
2E	O
)	O
,	O
likely	O
related	O
to	O
systemic	O
developmental	O
retardation	O
(	O
Figure	O
2A	O
and	O
2B	O
)	O
.	O

Nevertheless	O
,	O
since	O
Trip13Gt	O
/	O
Gt	O
spermatocytes	O
progress	O
to	O
pachynema	O
with	O
no	O
gross	O
SC	O
abnormalities	O
,	O
and	O
oocytes	O
were	O
eliminated	O
soon	O
after	O
birth	O
(	O
a	O
characteristic	O
of	O
DNA	O
repair	O
mutants	O
[	O
13	O
]	O
)	O
,	O
this	O
suggested	O
that	O
unrepaired	O
DSBs	O
are	O
responsible	O
for	O
eventual	O
meiotic	O
arrest	O
and	O
elimination	O
.	O

Figure	O
4	O

Immunohistochemical	O
Analysis	O
of	O
Pachytene	O
Spermatocyte	O
Chromosomes	O

Surface	O
-	O
spread	O
chromosomes	O
were	O
immunolabeled	O
with	O
the	O
indicated	O
antibodies	O
and	O
fluorophores	B-CHEBI
.	O

As	O
indicated	O
in	O
the	O
upper	O
right	O
of	O
each	O
panel	O
,	O
cells	O
were	O
from	O
wild	O
type	O
(	O
WT	O
,	O
either	O
+	O
/	O
+	O
or	O
Trip13Gt	O
/	O
+	O
)	O
or	O
Trip13Gt	O
/	O
Gt	O
(	O
Mut	O
)	O
.	O

There	O
were	O
no	O
differences	O
seen	O
between	O
heterozygotes	O
and	O
+	O
/	O
+	O
spermatocytes	O
.	O

(	O
A	O
)	O
A	O
mutant	O
pachytene	O
nucleus	O
with	O
full	O
synapsis	O
.	O

Areas	O
of	O
SYCP1	O
/	O
SYCP3	O
colabeling	O
are	O
yellow	O
.	O

(	O
B	O
-	O
E	O
)	O
Spermatocytes	O
nucleus	O
from	O
17	O
.	O
5	O
d	O
postpartum	O
mutant	O
.	O

Asynapsed	O
chromosomes	O
or	O
regions	O
of	O
chromosomes	O
are	O
indicated	O
by	O
white	O
and	O
yellow	O
arrows	O
,	O
respectively	O
.	O

Unlike	O
the	O
normal	O
distribution	O
in	O
wild	O
-	O
type	O
pachytene	O
spermatocytes	O
(	O
C	O
)	O
,	O
BLM	O
foci	O
are	O
present	O
on	O
synapsed	O
pachytene	O
chromosomes	O
in	O
the	O
mutant	O
(	O
D	O
)	O
.	O

RAD51	O
foci	O
,	O
which	O
are	O
abundant	O
earlier	O
in	O
prophase	O
,	O
disappear	O
from	O
autosomes	O
in	O
wild	O
-	O
type	O
pachytene	O
nuclei	O
(	O
E	O
)	O
and	O
the	O
bulk	O
of	O
staining	O
is	O
over	O
the	O
XY	O
body	O
(	O
arrow	O
)	O
.	O

(	O
F	O
)	O
RAD51	O
persists	O
on	O
the	O
synapsed	O
mutant	O
chromosomes	O
(	O
arrows	O
)	O
.	O

(	O
G	O
)	O
H2AX	O
phosphorylation	O
is	O
restricted	O
to	O
the	O
XY	O
body	O
in	O
WT	O
.	O

(	O
H	O
)	O
In	O
addition	O
to	O
a	O
large	O
area	O
of	O
gamma	O
H2AX	O
staining	O
(	O
arrow	O
)	O
over	O
the	O
XY	O
body	O
,	O
there	O
is	O
extensive	O
autosomal	O
H2AX	O
phosphorylation	O
(	O
arrows	O
)	O
.	O

(	O
I	O
,	O
J	O
)	O
Note	O
that	O
in	O
wild	O
-	O
type	O
pachytene	O
spermatocytes	O
,	O
TOPBP1	O
is	O
present	O
only	O
over	O
the	O
XY	O
body	O
(	O
yellow	O
arrow	O
)	O
.	O

In	O
the	O
mutant	O
(	O
J	O
)	O
,	O
an	O
arrow	O
denotes	O
one	O
area	O
of	O
intensive	O
staining	O
that	O
may	O
be	O
over	O
the	O
sex	O
chromosomes	O
,	O
but	O
many	O
other	O
chromosome	O
cores	O
are	O
positively	O
stained	O
.	O

(	O
K	O
,	O
L	O
)	O
RPA	O
persists	O
along	O
synapsed	O
cores	O
in	O
the	O
mutant	O
,	O
not	O
WT	O
.	O

(	O
M	O
,	O
N	O
)	O
Arrows	O
indicate	O
examples	O
of	O
MLH3	O
foci	O
on	O
SCs	O
.	O

(	O
O	O
)	O
In	O
WT	O
late	O
pachytene	O
spermatocytes	O
,	O
RAD51	O
is	O
present	O
only	O
at	O
background	O
levels	O
.	O

(	O
P	O
)	O
As	O
in	O
(	O
F	O
)	O
,	O
extensive	O
RAD51	O
staining	O
delineates	O
SCs	O
in	O
mutant	O
pachytene	O
nuclei	O
(	O
indicated	O
by	O
white	O
arcs	O
)	O
.	O

MLH1	O
foci	O
colocalize	O
with	O
these	O
tracts	O
(	O
arrows	O
)	O
at	O
the	O
typical	O
1	O
-	O
2	O
foci	O
per	O
chromosome	O
as	O
in	O
(	O
M	O
)	O
.	O

To	O
elucidate	O
the	O
cause	O
of	O
meiotic	O
arrest	O
,	O
we	O
analyzed	O
meiotic	O
chromosomes	O
with	O
a	O
variety	O
of	O
markers	O
that	O
are	O
diagnostic	O
of	O
recombination	O
and	O
synapsis	O
.	O

Recombination	O
in	O
Trip13Gt	O
/	O
Gt	O
spermatocytes	O
appeared	O
to	O
initiate	O
normally	O
as	O
judged	O
by	O
the	O
presence	O
of	O
gamma	O
H2AX	O
in	O
leptonema	O
(	O
Figure	O
S2A	O
and	O
S2B	O
)	O
,	O
which	O
reflects	O
the	O
presence	O
of	O
meiotically	O
induced	O
DSBs	O
[	O
18	O
]	O
.	O

RAD51	O
and	O
/	O
or	O
DMC1	O
,	O
components	O
of	O
early	O
recombination	O
nodules	O
(	O
ERNs	O
)	O
,	O
was	O
also	O
present	O
as	O
abundant	O
foci	O
in	O
Trip13Gt	O
/	O
Gt	O
zygotene	O
spermatocytes	O
(	O
unpublished	O
data	O
;	O
the	O
anti	O
-	O
RAD51	O
antibody	O
cross	O
-	O
reacts	O
with	O
DMC1	O
)	O
,	O
indicating	O
that	O
recombinational	O
repair	O
of	O
DSBs	O
is	O
initiated	O
.	O

The	O
cohesin	O
complex	O
,	O
which	O
is	O
essential	O
for	O
completion	O
and	O
/	O
or	O
maintenance	O
of	O
synaptic	O
associations	O
,	O
appeared	O
to	O
assemble	O
normally	O
as	O
judged	O
by	O
immunolabeling	O
for	O
the	O
meiosis	O
-	O
specific	O
cohesins	O
STAG3	O
(	O
Figure	O
S2C	O
and	O
S2D	O
)	O
and	O
REC8	O
(	O
unpublished	O
data	O
)	O
.	O

Because	O
yeast	O
PCH2	O
localizes	O
to	O
telomeres	O
in	O
a	O
Sir3p	O
-	O
dependent	O
manner	O
,	O
we	O
tested	O
for	O
possible	O
telomere	O
defects	O
by	O
immunolabeling	O
for	O
TRF2	O
,	O
a	O
component	O
of	O
a	O
protein	B-CHEBI
complex	O
that	O
plays	O
an	O
essential	O
role	O
in	O
telomere	O
protection	O
[	O
19	O
]	O
.	O

It	O
was	O
localized	O
to	O
telomeres	O
of	O
both	O
fully	O
synapsed	O
and	O
telomerically	O
asynaptic	O
mutant	O
chromosomes	O
(	O
Figure	O
S2E	O
and	O
S2F	O
)	O
.	O

Defects	O
in	O
DSB	O
repair	O
became	O
apparent	O
in	O
pachynema	O
upon	O
probing	O
of	O
mutant	O
spermatocyte	O
nuclei	O
with	O
antibodies	O
against	O
molecules	B-CHEBI
involved	O
in	O
various	O
stages	O
of	O
recombination	O
.	O

In	O
>	O
99	O
%	O
of	O
Trip13Gt	O
/	O
Gt	O
chromosome	O
spreads	O
,	O
BLM	O
helicase	O
(	O
Figure	O
4C	O
and	O
4D	O
)	O
,	O
RAD51	O
/	O
DMC1	O
(	O
Figure	O
4E	O
and	O
4F	O
)	O
,	O
gamma	O
H2AX	O
(	O
Figure	O
4G	O
and	O
4H	O
)	O
,	O
and	O
TOPBP1	O
(	O
Figure	O
4I	O
and	O
4J	O
)	O
all	O
persisted	O
abnormally	O
on	O
synapsed	O
chromosomes	O
.	O

For	O
RAD51	O
/	O
DMC1	O
,	O
mutant	O
pachytene	O
spermatocytes	O
contained	O
138	O
+/-	O
6	O
foci	O
(	O
compared	O
to	O
11	O
+/-	O
3	O
foci	O
in	O
wild	O
type	O
,	O
most	O
of	O
which	O
were	O
on	O
the	O
XY	O
body	O
)	O
,	O
down	O
from	O
218	O
+/-	O
13	O
in	O
zygonema	O
(	O
compared	O
to	O
220	O
+/-	O
13	O
foci	O
in	O
wild	O
type	O
)	O
.	O

TOPBP1	O
is	O
a	O
DNA	O
damage	O
-	O
checkpoint	O
protein	B-CHEBI
involved	O
in	O
ATM	O
protein	B-CHEBI
-	O
dependent	O
activation	O
of	O
ATR	O
protein	B-CHEBI
[	O
20	O
,	O
21	O
]	O
.	O

It	O
binds	O
sites	O
of	O
DSBs	O
and	O
unsynapsed	O
regions	O
of	O
meiotic	O
chromosomes	O
[	O
22	O
,	O
23	O
]	O
.	O

BLM	O
has	O
been	O
reported	O
to	O
colocalize	O
with	O
markers	O
(	O
RPA	O
and	O
MSH4	O
)	O
of	O
recombination	O
at	O
sites	O
distinct	O
from	O
those	O
that	O
become	O
resolved	O
as	O
crossovers	O
(	O
CO	O
)	O
[	O
24	O
]	O
.	O

We	O
therefore	O
assessed	O
the	O
distribution	O
of	O
RPA	O
,	O
the	O
ssDNA	O
binding	O
protein	B-CHEBI
,	O
which	O
is	O
normally	O
present	O
at	O
focal	O
sites	O
of	O
synapsing	O
meiotic	O
chromosomes	O
before	O
disappearing	O
in	O
mid	O
-	O
pachynema	O
[	O
25	O
]	O
.	O

It	O
is	O
thought	O
to	O
bind	O
D	O
-	O
loops	O
of	O
recombination	O
intermediates	O
[	O
26	O
]	O
.	O

RPA	O
also	O
persisted	O
on	O
pachytene	O
mutant	O
chromosomes	O
(	O
Figure	O
4K	O
and	O
4L	O
)	O
.	O

These	O
data	O
indicate	O
that	O
unrepaired	O
DSBs	O
,	O
or	O
unresolved	O
recombination	O
intermediates	O
,	O
remain	O
in	O
pachynema	O
and	O
activate	O
a	O
DNA	O
damage	O
checkpoint	O
system	O
.	O

It	O
should	O
be	O
noted	O
that	O
chromosomes	O
affected	O
by	O
meiotic	O
sex	O
chromosome	O
inactivation	O
(	O
MSCI	O
)	O
and	O
meiotic	O
silencing	O
of	O
unpaired	O
chromatin	O
(	O
MSUC	O
)	O
are	O
heavily	O
stained	O
by	O
antibodies	O
for	O
several	O
DSB	O
repair	O
-	O
associated	O
molecules	B-CHEBI
,	O
including	O
gamma	O
H2AX	O
.	O

H2AX	O
phosphorylation	O
due	O
to	O
MSCI	O
and	O
MSUC	O
is	O
conducted	O
by	O
ATR	O
,	O
not	O
ATM	O
[	O
27	O
-	O
29	O
]	O
.	O

Since	O
mutant	O
chromosomes	O
are	O
fully	O
synapsed	O
,	O
and	O
MSUC	O
is	O
known	O
to	O
occur	O
only	O
as	O
a	O
result	O
of	O
asynapsis	O
,	O
the	O
decoration	O
of	O
Trip13Gt	O
/	O
Gt	O
chromosomes	O
with	O
DNA	O
repair	O
markers	O
is	O
probably	O
attributable	O
to	O
incomplete	O
DNA	O
repair	O
rather	O
than	O
transcriptional	O
silencing	O
.	O

Consistent	O
with	O
the	O
presence	O
of	O
rare	O
(	O
<	O
1	O
%	O
)	O
Trip13Gt	O
/	O
Gt	O
pachytene	O
spermatocytes	O
devoid	O
of	O
persistent	O
DNA	O
repair	O
markers	O
,	O
and	O
testis	O
histology	O
showing	O
some	O
degree	O
of	O
postmeiotic	O
progression	O
(	O
Figure	O
3G	O
)	O
,	O
we	O
observed	O
both	O
diplotene	O
nuclei	O
that	O
lacked	O
autosomal	O
RAD51	O
/	O
DMC1	O
and	O
gamma	O
H2AX	O
(	O
Figure	O
S3A	O
-	O
S3D	O
)	O
,	O
and	O
also	O
metaphase	O
I	O
spreads	O
with	O
20	O
bivalents	O
(	O
Figure	O
S3E	O
-	O
S3F	O
)	O
.	O

Since	O
Trip13Gt	O
may	O
not	O
be	O
a	O
complete	O
null	O
,	O
these	O
diplotene	O
and	O
metaphase	O
I	O
spermatocytes	O
might	O
arise	O
by	O
virtue	O
of	O
having	O
sufficient	O
wild	O
-	O
type	O
TRIP13	O
.	O

CO	O
-	O
Associated	O
Markers	O
Appear	O
Normally	O
in	O
the	O
Absence	O
of	O
TRIP13	O

The	O
persistence	O
of	O
BLM	O
on	O
Trip13Gt	O
/	O
Gt	O
spermatocyte	O
chromosomes	O
suggests	O
that	O
at	O
least	O
a	O
subset	O
of	O
the	O
unrepaired	O
DSBs	O
correspond	O
to	O
sites	O
of	O
defective	O
NCO	O
recombinational	O
repair	O
.	O

To	O
assess	O
whether	O
CO	O
recombination	O
occurs	O
in	O
the	O
mutant	O
,	O
we	O
examined	O
the	O
distribution	O
of	O
the	O
mismatch	O
repair	O
proteins	B-CHEBI
MLH1	O
and	O
MLH3	O
,	O
which	O
are	O
normally	O
detectable	O
as	O
foci	O
in	O
mid	O
-	O
late	O
pachynema	O
and	O
mark	O
the	O
locations	O
of	O
chiasmata	O
[	O
30	O
,	O
31	O
]	O
.	O

Remarkably	O
,	O
MLH1	O
/	O
3	O
foci	O
were	O
formed	O
;	O
we	O
observed	O
1	O
-	O
2	O
foci	O
/	O
chromosome	O
as	O
in	O
wild	O
type	O
and	O
at	O
typical	O
overall	O
levels	O
(	O
MLH3	O
=	O
23	O
+/-	O
2	O
,	O
N	O
=	O
10	O
;	O
[	O
30	O
,	O
32	O
]	O
)	O
on	O
mid	O
-	O
late	O
pachytene	O
chromosomes	O
(	O
Figure	O
4M	O
and	O
4N	O
;	O
MLH1	O
not	O
shown	O
)	O
.	O

Since	O
<	O
1	O
%	O
of	O
Trip13Gt	O
/	O
Gt	O
pachytene	O
nuclei	O
had	O
normal	O
repair	O
(	O
as	O
judged	O
by	O
absence	O
of	O
persistent	O
DSB	O
repair	O
markers	O
;	O
see	O
above	O
)	O
,	O
but	O
most	O
of	O
the	O
pachytene	O
nuclei	O
had	O
MLH1	O
/	O
3	O
foci	O
,	O
it	O
was	O
unlikely	O
that	O
the	O
MLH1	O
/	O
3	O
foci	O
formed	O
only	O
on	O
chromosomes	O
with	O
fully	O
repaired	O
DSBs	O
.	O

To	O
test	O
this	O
directly	O
,	O
we	O
conducted	O
double	O
staining	O
for	O
MLH1	O
and	O
RAD51	O
/	O
DMC1	O
.	O

MLH1	O
foci	O
were	O
present	O
on	O
chromosomes	O
that	O
also	O
contained	O
numerous	O
RAD51	O
/	O
DMC1	O
foci	O
(	O
Figure	O
4O	O
and	O
4P	O
)	O
.	O

To	O
assess	O
whether	O
these	O
MLH1	O
/	O
3	O
foci	O
in	O
Trip13Gt	O
/	O
Gt	O
pachytene	O
spermatocytes	O
represent	O
CO	O
events	O
completed	O
to	O
a	O
point	O
where	O
they	O
could	O
maintain	O
interhomolog	O
attachments	O
though	O
the	O
end	O
of	O
prophase	O
I	O
,	O
we	O
treated	O
testicular	O
cells	O
from	O
17	O
.	O
5	O
-	O
20	O
.	O
5	O
-	O
d	O
-	O
old	O
control	O
(	O
+	O
/	O
+	O
)	O
,	O
Trip13Gt	O
/	O
Gt	O
,	O
and	O
Dmc1	O
-	O
/	O
-	O
mice	O
with	O
the	O
protein	B-CHEBI
phosphatase	O
inhibitor	B-CHEBI
okadaic	B-CHEBI
acid	I-CHEBI
(	O
OA	B-CHEBI
)	O
,	O
a	O
chemical	B-CHEBI
that	O
induces	O
degradation	O
of	O
the	O
SC	O
,	O
chromosome	O
condensation	O
,	O
and	O
premature	O
progression	O
to	O
metaphase	O
I	O
[	O
33	O
]	O
.	O

Fifteen	O
metaphase	O
spreads	O
were	O
identified	O
for	O
each	O
genotype	O
.	O

Whereas	O
all	O
of	O
the	O
Dmc1	O
-	O
/	O
-	O
spreads	O
had	O
~	O
35	O
or	O
more	O
condensed	O
chromosomes	O
,	O
all	O
of	O
the	O
+	O
/	O
+	O
and	O
Trip13Gt	O
/	O
Gt	O
spreads	O
had	O
20	O
-	O
25	O
,	O
suggesting	O
that	O
the	O
MLH1	O
/	O
3	O
foci	O
in	O
Trip13Gt	O
/	O
Gt	O
pachytene	O
spermatocytes	O
represent	O
sites	O
of	O
completed	O
,	O
or	O
near	O
-	O
completed	O
,	O
COs	O
.	O

Because	O
the	O
preparations	O
were	O
made	O
from	O
whole	O
testes	O
,	O
it	O
is	O
possible	O
that	O
the	O
univalent	O
-	O
containing	O
metaphases	O
from	O
Dmc1	O
-	O
/	O
-	O
mice	O
were	O
from	O
spermatogonia	O
,	O
not	O
spermatocytes	O
.	O

TRIP13	O
Deficiency	O
Does	O
Not	O
Alleviate	O
Meiotic	O
Arrest	O
Phenotypes	O
of	O
Mutants	O
Defective	O
in	O
Synapsis	O

To	O
determine	O
if	O
TRIP13	O
deficiency	O
prevents	O
apoptosis	O
triggered	O
by	O
asynapsis	O
as	O
in	O
C	O
.	O
elegans	O
,	O
we	O
analyzed	O
mice	O
that	O
were	O
doubly	O
mutant	O
for	O
Spo11	O
and	O
Trip13	O
.	O

SPO11	O
is	O
a	O
transesterase	O
that	O
is	O
essential	O
for	O
the	O
creation	O
of	O
genetically	O
programmed	O
DSB	O
during	O
leptonema	O
of	O
many	O
organisms	O
,	O
including	O
mice	O
[	O
18	O
]	O
.	O

In	O
C	O
.	O
elegans	O
,	O
spo	O
-	O
11	O
mutant	O
gametes	O
have	O
extensive	O
asynapsis	O
,	O
which	O
triggers	O
PCH	O
-	O
2	O
dependent	O
apoptosis	O
in	O
pachynema	O
[	O
2	O
]	O
.	O

In	O
mice	O
,	O
Spo11	O
-	O
/	O
-	O
spermatocytes	O
are	O
severely	O
defective	O
in	O
homologous	O
chromosome	O
synapsis	O
[	O
34	O
,	O
35	O
]	O
,	O
and	O
arrest	O
with	O
chromosomes	O
in	O
a	O
state	O
characteristic	O
of	O
the	O
zygotene	O
/	O
pachytene	O
transition	O
(	O
Figure	O
3H	O
)	O
.	O

Spermatocytes	O
in	O
Trip13Gt	O
/	O
Gt	O
Spo11	O
-	O
/	O
-	O
testes	O
progressed	O
maximally	O
to	O
that	O
point	O
before	O
undergoing	O
death	O
(	O
Figs	O
3I	O
)	O
,	O
well	O
before	O
the	O
spindle	O
checkpoint	O
that	O
eliminates	O
achiasmate	O
spermatocytes	O
[	O
36	O
]	O
.	O

There	O
was	O
no	O
evidence	O
of	O
metaphase	O
I	O
spermatocytes	O
or	O
postmeiotic	O
spermatids	O
in	O
these	O
testes	O
,	O
unlike	O
those	O
seen	O
in	O
Trip13	O
single	O
mutants	O
(	O
Figure	O
3G	O
)	O
.	O

In	O
contrast	O
to	O
the	O
complete	O
synapsis	O
in	O
Trip13Gt	O
/	O
Gt	O
pachytene	O
spermatocytes	O
(	O
Figure	O
5A	O
)	O
,	O
in	O
which	O
SPO11	O
is	O
available	O
in	O
leptonema	O
to	O
initiate	O
(	O
via	O
DSB	O
induction	O
,	O
Figure	O
S2A	O
and	O
S2B	O
)	O
a	O
recombination	O
-	O
driven	O
homolog	O
search	O
,	O
chromosome	O
synapsis	O
in	O
doubly	O
mutant	O
spermatocytes	O
was	O
highly	O
disrupted	O
as	O
in	O
Spo11	O
single	O
mutants	O
(	O
Figure	O
5B	O
and	O
5C	O
)	O
.	O

Identical	O
studies	O
were	O
performed	O
with	O
mice	O
deficient	O
for	O
Mei1	O
,	O
a	O
vertebrate	O
-	O
specific	O
gene	O
also	O
required	O
for	O
DSB	O
formation	O
and	O
chromosome	O
synapsis	O
[	O
37	O
]	O
,	O
with	O
similar	O
results	O
(	O
Figure	O
3J	O
and	O
3K	O
;	O
immunocytology	O
not	O
shown	O
)	O
.	O

Figure	O
5	O

Immunocytological	O
Analysis	O
of	O
Trip13	O
Compound	O
Mutants	O

Surface	O
-	O
spread	O
chromosomes	O
were	O
immunolabeled	O
with	O
the	O
indicated	O
antibodies	O
and	O
fluorophores	B-CHEBI
.	O

Genotypes	O
are	O
indicated	O
,	O
as	O
are	O
those	O
panels	O
in	O
which	O
dual	O
staining	O
patterns	O
are	O
merged	O
.	O

Note	O
that	O
(	O
H	O
)	O
and	O
(	O
I	O
)	O
are	O
at	O
lower	O
magnification	O
to	O
show	O
multiple	O
nuclei	O
.	O

In	O
yeast	O
,	O
deletion	O
of	O
PCH2	O
alleviates	O
the	O
pachytene	O
arrest	O
caused	O
by	O
asynaptic	O
mutants	O
zip1	O
and	O
zip2	O
[	O
8	O
]	O
.	O

Although	O
mouse	O
SYCP1	O
might	O
be	O
a	O
functional	O
equivalent	O
of	O
Zip1p	O
,	O
because	O
Sycp1	O
mutant	O
spermatocytes	O
arrest	O
at	O
approximately	O
the	O
same	O
point	O
as	O
Trip13	O
mutants	O
,	O
there	O
would	O
be	O
no	O
opportunity	O
to	O
observe	O
bypass	O
of	O
Sycp1	O
-	O
/	O
-	O
.	O

Since	O
Zip2p	O
is	O
present	O
at	O
sites	O
of	O
axial	O
associations	O
,	O
even	O
in	O
zip1	O
mutants	O
,	O
it	O
has	O
been	O
suggested	O
that	O
Zip2p	O
promotes	O
initiation	O
of	O
chromosome	O
synapsis	O
[	O
38	O
]	O
.	O

These	O
observations	O
raise	O
the	O
possibility	O
that	O
in	O
yeast	O
,	O
Pch2p	O
responds	O
to	O
synapsis	O
polymerization	O
rather	O
than	O
initiation	O
.	O

To	O
test	O
this	O
,	O
we	O
performed	O
epistasis	O
analysis	O
with	O
a	O
Rec8	O
allele	O
(	O
Rec8Mei8	O
,	O
abbreviated	O
as	O
Rec8	O
-	O
)	O
.	O

Meiotic	O
chromosomes	O
of	O
Rec8	O
mutant	O
spermatocytes	O
undergo	O
apparent	O
homolog	O
pairing	O
and	O
interhomolog	O
synaptic	O
initiation	O
,	O
but	O
are	O
defective	O
in	O
DSB	O
repair	O
and	O
fail	O
to	O
maintain	O
interhomolog	O
synapsis	O
[	O
39	O
,	O
40	O
]	O
.	O

Rather	O
,	O
sister	O
chromatids	O
appear	O
to	O
synapse	O
and	O
are	O
bound	O
by	O
SYCP1	O
along	O
their	O
axes	O
.	O

Rec8	O
mutants	O
do	O
not	O
progress	O
to	O
diplonema	O
or	O
metaphase	O
I	O
.	O

Double	O
mutant	O
analysis	O
indicated	O
that	O
Rec8	O
is	O
epistatic	O
to	O
Trip13	O
.	O

As	O
in	O
the	O
Spo11	O
and	O
Mei1	O
experiments	O
,	O
histology	O
of	O
testes	O
deficient	O
for	O
both	O
REC8	O
and	O
TRIP13	O
resembled	O
the	O
Rec8	O
mutant	O
,	O
with	O
no	O
evidence	O
of	O
progression	O
to	O
metaphase	O
I	O
that	O
occurs	O
in	O
Trip13Gt	O
/	O
Gt	O
mice	O
(	O
Figure	O
3L	O
and	O
3M	O
)	O
.	O

Immunocytological	O
analysis	O
of	O
spread	O
chromosomes	O
showed	O
a	O
failure	O
of	O
homologous	O
chromosome	O
synapsis	O
in	O
both	O
the	O
Rec8	O
-	O
/	O
-	O
and	O
Rec8	O
-	O
/	O
-	O
Trip13Gt	O
/	O
Gt	O
spermatocytes	O
,	O
as	O
previously	O
reported	O
for	O
Rec8	O
mutants	O
(	O
Figure	O
5D	O
and	O
5E	O
)	O
[	O
39	O
,	O
40	O
]	O
.	O

Although	O
subsequent	O
reports	O
indicate	O
otherwise	O
[	O
10	O
,	O
12	O
]	O
,	O
deletion	O
of	O
PCH2	O
in	O
yeast	O
was	O
originally	O
reported	O
to	O
alleviate	O
meiotic	O
arrest	O
caused	O
by	O
deficiency	O
for	O
the	O
meiosis	O
-	O
specific	O
RecA	O
homolog	O
DMC1	O
[	O
8	O
]	O
.	O

To	O
investigate	O
this	O
relationship	O
in	O
mice	O
,	O
we	O
constructed	O
animals	O
doubly	O
mutant	O
for	O
Trip13	O
and	O
Dmc1	O
.	O

As	O
in	O
Dmc1	O
-	O
/	O
-	O
mice	O
,	O
in	O
which	O
spermatocytes	O
undergo	O
meiotic	O
arrest	O
from	O
defective	O
DSB	O
repair	O
and	O
failed	O
chromosome	O
synapsis	O
[	O
16	O
]	O
,	O
spermatogenesis	O
in	O
Dmc1	O
-	O
/	O
-	O
Trip13Gt	O
/	O
Gt	O
testes	O
was	O
uniformly	O
arrested	O
at	O
the	O
point	O
where	O
spermatocytes	O
contained	O
chromatin	O
characteristic	O
of	O
zygonema	O
/	O
pachynema	O
(	O
Figure	O
3N	O
)	O
.	O

Immunocytological	O
analysis	O
indicated	O
that	O
both	O
Dmc1	O
-	O
/	O
-	O
and	O
Dmc1	O
-	O
/	O
-	O
Trip13Gt	O
/	O
Gt	O
chromosomes	O
had	O
extensive	O
asynapsis	O
compared	O
to	O
Trip13Gt	O
single	O
mutants	O
(	O
Figure	O
5F	O
-	O
5H	O
)	O
,	O
and	O
all	O
had	O
persistent	O
RAD51	O
/	O
DMC1	O
foci	O
and	O
phosphorylated	O
H2AX	O
(	O
gamma	O
H2AX	O
;	O
Figure	O
5I	O
-	O
5L	O
)	O
,	O
confirming	O
that	O
Dmc1	O
is	O
epistatic	O
to	O
Trip13	O
.	O

Doubly	O
mutant	O
females	O
had	O
residual	O
ovaries	O
,	O
phenocopying	O
Dmc1	O
-	O
/	O
-	O
and	O
Trip13Gt	O
/	O
Gt	O
single	O
mutants	O
(	O
unpublished	O
data	O
)	O
.	O

Meiotic	O
Defects	O
in	O
Trip13Gt	O
/	O
Gt	O
Oocytes	O
Are	O
DSB	O
-	O
Dependent	O

Epistasis	O
analysis	O
of	O
females	O
was	O
insightful	O
with	O
respect	O
to	O
the	O
cause	O
of	O
arrest	O
in	O
Trip13	O
mutants	O
.	O

Both	O
Mei1	O
-	O
/	O
-	O
/	O
Trip13Gt	O
/	O
Gt	O
and	O
Spo11	O
-	O
/	O
-	O
/	O
Trip13Gt	O
/	O
Gt	O
females	O
had	O
ovaries	O
with	O
numerous	O
follicles	O
,	O
identical	O
to	O
Mei1	O
and	O
Spo11	O
single	O
mutants	O
(	O
Figure	O
3O	O
-	O
3R	O
)	O
.	O

Thus	O
,	O
Spo11	O
and	O
Mei1	O
are	O
epistatic	O
to	O
Trip13	O
in	O
oogenesis	O
,	O
just	O
as	O
they	O
are	O
to	O
Dmc1	O
[	O
13	O
,	O
41	O
]	O
.	O

This	O
demonstrates	O
that	O
oocyte	O
loss	O
in	O
Trip13Gt	O
/	O
Gt	O
females	O
is	O
dependent	O
on	O
DSB	O
formation	O
.	O

In	O
conjunction	O
with	O
the	O
immunohistochemical	O
data	O
,	O
these	O
data	O
provide	O
strong	O
evidence	O
that	O
meiotic	O
arrest	O
in	O
Trip13	O
mutant	O
mice	O
is	O
due	O
to	O
defects	O
in	O
DSB	O
repair	O
.	O

As	O
expected	O
,	O
ovaries	O
of	O
Rec8	O
Trip13	O
double	O
mutants	O
were	O
devoid	O
of	O
oocytes	O
as	O
were	O
those	O
from	O
either	O
single	O
mutant	O
(	O
Figure	O
3B	O
,	O
3S	O
,	O
and	O
3T	O
)	O
.	O

Discussion	O

Genetic	O
experiments	O
in	O
S	O
.	O
cerevisiae	O
provided	O
evidence	O
that	O
the	O
pachytene	O
checkpoint	O
monitors	O
and	O
responds	O
to	O
recombinational	O
DSB	O
repair	O
and	O
synapsis	O
independently	O
.	O

Wu	O
and	O
Burgess	O
concluded	O
that	O
the	O
repair	O
checkpoint	O
is	O
RAD17	O
-	O
SAE2	O
dependent	O
,	O
while	O
the	O
synapsis	O
checkpoint	O
is	O
PCH2	O
-	O
ZIP1	O
dependent	O
[	O
12	O
]	O
.	O

Of	O
these	O
four	O
genes	O
,	O
SAE2	O
and	O
ZIP1	O
do	O
not	O
have	O
clear	O
mammalian	O
orthologs	O
(	O
although	O
SYCP1	O
may	O
be	O
a	O
functional	O
ortholog	O
of	O
ZIP1	O
)	O
,	O
and	O
mutation	O
of	O
the	O
mouse	O
RAD17	O
ortholog	O
,	O
Rad1	O
,	O
presumably	O
causes	O
embryonic	O
lethality	O
[	O
42	O
]	O
.	O

Thus	O
,	O
mutational	O
analysis	O
of	O
mouse	O
Pch2	O
(	O
Trip13	O
)	O
,	O
which	O
is	O
also	O
critical	O
for	O
the	O
synapsis	O
checkpoint	O
in	O
C	O
.	O
elegans	O
[	O
2	O
]	O
,	O
was	O
the	O
best	O
remaining	O
option	O
to	O
evaluate	O
potential	O
functional	O
conservation	O
in	O
mammalian	O
meiotic	O
checkpoint	O
control	O
.	O

Our	O
results	O
demonstrate	O
that	O
in	O
mice	O
,	O
the	O
primary	O
meiotic	O
function	O
of	O
TRIP13	O
is	O
in	O
recombination	O
itself	O
.	O

We	O
found	O
no	O
evidence	O
that	O
it	O
is	O
involved	O
in	O
pachytene	O
checkpoint	O
control	O
.	O

Our	O
data	O
suggest	O
that	O
while	O
recombination	O
events	O
destined	O
to	O
be	O
resolved	O
as	O
COs	O
can	O
proceed	O
normally	O
in	O
Trip13	O
mutants	O
,	O
DSBs	O
that	O
enter	O
the	O
NCO	O
repair	O
pathway	O
are	O
incompletely	O
resolved	O
or	O
processed	O
inefficiently	O
.	O

This	O
hypothesis	O
is	O
compatible	O
with	O
current	O
knowledge	O
of	O
meiotic	O
recombination	O
pathways	O
.	O

In	O
S	O
.	O
cerevisiae	O
,	O
CO	O
and	O
NCO	O
pathways	O
are	O
distinct	O
[	O
43	O
]	O
;	O
they	O
have	O
different	O
recombination	O
intermediates	O
,	O
and	O
are	O
dependent	O
upon	O
different	O
proteins	B-CHEBI
[	O
44	O
,	O
45	O
]	O
.	O

Mice	O
also	O
appear	O
to	O
have	O
independent	O
CO	O
versus	O
NCO	O
recombination	O
pathways	O
[	O
46	O
]	O
.	O

As	O
in	O
yeast	O
,	O
both	O
require	O
SPO11	O
-	O
induced	O
breaks	O
,	O
but	O
only	O
the	O
CO	O
pathway	O
requires	O
MLH1	O
.	O

Both	O
types	O
of	O
recombinant	O
products	O
are	O
formed	O
by	O
mid	O
-	O
late	O
pachynema	O
.	O

Another	O
possibility	O
is	O
that	O
the	O
recombination	O
defects	O
are	O
a	O
result	O
of	O
defective	O
intersister	O
recombination	O
.	O

However	O
,	O
this	O
type	O
of	O
DSB	O
repair	O
is	O
suppressed	O
in	O
meiotic	O
cells	O
.	O

Ablation	O
of	O
RAD54	O
,	O
which	O
mediates	O
intersister	O
recombination	O
in	O
yeast	O
,	O
does	O
not	O
significantly	O
disrupt	O
meiosis	O
in	O
either	O
yeast	O
or	O
mice	O
[	O
47	O
,	O
48	O
]	O
.	O

Interestingly	O
,	O
RAD54	O
-	O
deficient	O
spermatocytes	O
display	O
abnormal	O
persistence	O
of	O
RAD51	O
foci	O
on	O
pachytene	O
chromosomes	O
,	O
similar	O
to	O
those	O
in	O
TRIP13	O
mice	O
,	O
but	O
there	O
are	O
no	O
deleterious	O
effects	O
on	O
meiotic	O
progression	O
or	O
fertility	O
[	O
49	O
]	O
.	O

Data	O
from	O
budding	O
yeast	O
also	O
indicate	O
that	O
Pch2p	O
functions	O
in	O
recombination	O
.	O

Deletion	O
of	O
PCH2	O
delays	O
meiotic	O
progression	O
by	O
~	O
2	O
h	O
in	O
SK1	O
yeast	O
,	O
and	O
causes	O
a	O
minor	O
decrease	O
in	O
ascus	O
formation	O
[	O
50	O
]	O
.	O

DSBs	O
persist	O
>	O
2	O
h	O
longer	O
in	O
pch2	O
Delta	O
yeast	O
than	O
in	O
wild	O
type	O
,	O
and	O
hyperresection	O
of	O
DSBs	O
in	O
dmc1	O
Delta	O
pch2	O
Delta	O
double	O
mutants	O
is	O
lower	O
than	O
in	O
dmc1	O
Delta	O
cells	O
[	O
10	O
]	O
.	O

Additionally	O
,	O
it	O
was	O
reported	O
that	O
pch2	O
Delta	O
yeast	O
had	O
a	O
meiosis	O
I	O
delay	O
dependent	O
on	O
the	O
RAD17	O
-	O
SAE2	O
checkpoint	O
that	O
monitors	O
recombination	O
intermediates	O
[	O
12	O
]	O
.	O

However	O
,	O
the	O
exact	O
role	O
of	O
TRIP13	O
(	O
or	O
Pch2	O
)	O
in	O
recombination	O
is	O
unclear	O
.	O

Because	O
synapsis	O
occurs	O
in	O
TRIP13	O
-	O
deficient	O
spermatocytes	O
and	O
is	O
dependent	O
on	O
DSB	O
formation	O
(	O
activity	O
of	O
SPO11	O
and	O
MEI1	O
)	O
,	O
we	O
suggest	O
that	O
TRIP13	O
functions	O
after	O
homology	O
recognition	O
and	O
strand	O
exchange	O
,	O
and	O
that	O
recombination	O
events	O
entering	O
the	O
CO	O
repair	O
pathway	O
are	O
either	O
completed	O
or	O
nearly	O
so	O
(	O
because	O
OA	B-CHEBI
treated	O
resulted	O
in	O
bivalent	O
chromosomes	O
)	O
.	O

One	O
possibility	O
for	O
TRIP13	O
'	O
s	O
role	O
in	O
recombination	O
is	O
that	O
it	O
is	O
directly	O
involved	O
in	O
a	O
step	O
specific	O
to	O
resolution	O
of	O
NCO	O
recombination	O
intermediates	O
.	O

Another	O
possibility	O
is	O
that	O
TRIP13	O
is	O
required	O
for	O
disassembly	O
of	O
NCO	O
recombinational	O
repair	O
complexes	O
[	O
51	O
]	O
containing	O
those	O
proteins	B-CHEBI
that	O
persist	O
abnormally	O
on	O
Trip13Gt	O
/	O
Gt	O
pachytene	O
chromosomes	O
.	O

Notably	O
,	O
TRIP13	O
has	O
two	O
putative	O
ATPase	O
domains	O
,	O
a	O
signature	O
of	O
AAA	O
-	O
ATPase	O
ClpA	O
/	O
B	O
chaperones	O
that	O
perform	O
protein	B-CHEBI
or	O
protein	B-CHEBI
/	O
DNA	O
complex	O
disassembly	O
[	O
52	O
]	O
.	O

These	O
potential	O
recombination	O
roles	O
might	O
not	O
be	O
limited	O
to	O
meiosis	O
,	O
since	O
Trip13	O
is	O
widely	O
transcribed	O
and	O
the	O
mutant	O
animals	O
exhibited	O
developmental	O
defects	O
.	O

Finally	O
,	O
TRIP13	O
might	O
play	O
an	O
indirect	O
role	O
,	O
such	O
as	O
providing	O
a	O
"	O
licensing	O
"	O
signal	O
for	O
the	O
resolution	O
of	O
NCO	O
intermediates	O
and	O
completion	O
of	O
meiosis	O
.	O

Regarding	O
the	O
cause	O
of	O
cell	O
death	O
in	O
Trip13	O
mutants	O
,	O
our	O
data	O
indicate	O
that	O
this	O
is	O
triggered	O
by	O
defective	O
DSB	O
repair	O
rather	O
than	O
asynapsis	O
.	O

We	O
base	O
this	O
conclusion	O
on	O
two	O
observations	O
:	O
(	O
1	O
)	O
oocyte	O
elimination	O
is	O
dependent	O
upon	O
DSB	O
formation	O
and	O
(	O
2	O
)	O
synapsis	O
is	O
normal	O
in	O
spermatocytes	O
of	O
adult	O
testes	O
.	O

Indeed	O
,	O
this	O
mutant	O
is	O
unique	O
in	O
that	O
recombination	O
defects	O
occur	O
in	O
the	O
absence	O
of	O
asynapsis	O
(	O
e	O
.	O
g	O
.	O
,	O
as	O
in	O
Dmc1	O
knockouts	O
)	O
.	O

Thus	O
,	O
the	O
Trip13	O
mutant	O
provides	O
the	O
first	O
evidence	O
that	O
unrepaired	O
DNA	O
damage	O
alone	O
can	O
trigger	O
the	O
mammalian	O
pachytene	O
checkpoint	O
response	O
.	O

Furthermore	O
,	O
our	O
results	O
allow	O
us	O
to	O
conclude	O
that	O
oocytes	O
and	O
spermatocytes	O
share	O
a	O
similar	O
,	O
if	O
not	O
identical	O
,	O
DNA	O
damage	O
pachytene	O
checkpoint	O
that	O
is	O
decoupled	O
from	O
a	O
synapsis	O
checkpoint	O
.	O

Interestingly	O
,	O
we	O
found	O
that	O
OA	B-CHEBI
treatment	O
of	O
Trip13Gt	O
/	O
Gt	O
spermatocytes	O
could	O
propel	O
them	O
into	O
MI	O
,	O
despite	O
a	O
report	O
that	O
the	O
same	O
did	O
not	O
occur	O
when	O
wild	O
-	O
type	O
pachytene	O
spermatocytes	O
were	O
treated	O
with	O
the	O
DSB	O
-	O
inducing	O
agents	O
gamma	O
radiation	O
or	O
etoposide	B-CHEBI
[	O
53	O
]	O
.	O

It	O
is	O
possible	O
that	O
the	O
nascent	O
induction	O
of	O
DSBs	O
in	O
pachynema	O
evokes	O
a	O
checkpoint	O
response	O
that	O
cannot	O
be	O
bypassed	O
by	O
OA	B-CHEBI
,	O
whereas	O
the	O
post	O
-	O
strand	O
invasion	O
lesions	O
in	O
TRIP13	O
-	O
deficient	O
spermatocytes	O
do	O
not	O
.	O

TRIP13	O
was	O
originally	O
discovered	O
to	O
be	O
an	O
interactor	O
with	O
rat	O
thyroid	O
receptor	O
beta	O
(	O
THRB	O
;	O
[	O
54	O
]	O
)	O
,	O
but	O
the	O
relationship	O
between	O
THRB	O
and	O
TRIP13	O
in	O
meiosis	O
is	O
unknown	O
.	O

Interestingly	O
,	O
we	O
observed	O
that	O
THRB	O
is	O
distributed	O
diffusely	O
throughout	O
wild	O
-	O
type	O
spermatocyte	O
nuclei	O
but	O
is	O
excluded	O
from	O
the	O
XY	O
(	O
sex	O
)	O
body	O
(	O
unpublished	O
observations	O
)	O
,	O
a	O
compartmentalized	O
nuclear	O
domain	O
beginning	O
in	O
pachynema	O
,	O
in	O
which	O
the	O
sex	O
chromosomes	O
become	O
heterochromatinized	O
and	O
transcriptionally	O
silenced	O
in	O
the	O
process	O
of	O
MSCI	O
[	O
55	O
]	O
.	O

However	O
,	O
the	O
XY	O
body	O
appeared	O
intact	O
in	O
most	O
mutant	O
spermatocytes	O
upon	O
probing	O
with	O
several	O
markers	O
of	O
XY	O
heterochromatinization	O
(	O
unpublished	O
observations	O
)	O
.	O

Considering	O
that	O
THRB	O
knockout	O
mice	O
are	O
viable	O
and	O
fertile	O
[	O
56	O
]	O
,	O
the	O
functional	O
relationship	O
between	O
TRIP13	O
and	O
its	O
receptor	O
THRB	O
in	O
meiosis	O
is	O
unclear	O
.	O

Given	O
the	O
high	O
similarity	O
of	O
PCH2	O
orthologs	O
throughout	O
the	O
eukaryotic	O
world	O
,	O
one	O
or	O
more	O
essential	O
functions	O
of	O
this	O
protein	B-CHEBI
must	O
be	O
conserved	O
.	O

Since	O
TRIP13	O
does	O
not	O
exhibit	O
checkpoint	O
function	O
in	O
mice	O
,	O
we	O
surmise	O
that	O
the	O
TRIP13	O
/	O
PCH2	O
ancestral	O
protein	B-CHEBI
had	O
a	O
function	O
in	O
recombination	O
that	O
persists	O
to	O
the	O
present	O
.	O

Notably	O
,	O
A	O
.	O
thaliana	O
does	O
not	O
appear	O
to	O
have	O
a	O
meiotic	O
checkpoint	O
activity	O
that	O
eliminates	O
mutant	O
meiocytes	O
in	O
a	O
manner	O
analogous	O
to	O
organisms	O
such	O
as	O
mice	O
,	O
budding	O
yeast	O
,	O
and	O
female	O
Drosophila	O
[	O
11	O
,	O
57	O
]	O
,	O
and	O
mammalian	O
TRIP13	O
is	O
more	O
similar	O
to	O
Arabidopsis	O
PCH2	O
than	O
the	O
fly	O
or	O
worm	O
proteins	B-CHEBI
(	O
Figures	O
1A	O
and	O
S1	O
)	O
.	O

The	O
unusual	O
relatedness	O
between	O
mammalian	O
and	O
plant	O
PCH2	O
may	O
therefore	O
be	O
attributable	O
to	O
both	O
the	O
presence	O
of	O
a	O
common	O
conserved	O
function	O
(	O
namely	O
recombination	O
,	O
although	O
the	O
role	O
of	O
PCH2	O
in	O
plants	O
has	O
yet	O
to	O
be	O
determined	O
)	O
,	O
and	O
the	O
absence	O
of	O
checkpoint	O
function	O
.	O

Nevertheless	O
,	O
the	O
evolutionary	O
relationships	O
between	O
animals	O
,	O
fungi	O
,	O
and	O
plants	O
(	O
which	O
are	O
discordant	O
with	O
PCH2	O
sequence	O
phylogeny	O
)	O
do	O
not	O
allow	O
parsimonious	O
models	O
addressing	O
the	O
points	O
in	O
time	O
that	O
checkpoint	O
functions	O
in	O
PCH2	O
were	O
gained	O
or	O
lost	O
.	O

It	O
is	O
possible	O
that	O
its	O
checkpoint	O
function	O
evolved	O
independently	O
in	O
worms	O
and	O
budding	O
yeast	O
.	O

The	O
picture	O
will	O
become	O
clearer	O
as	O
the	O
function	O
of	O
PCH2	O
in	O
other	O
organisms	O
is	O
elucidated	O
.	O

The	O
nature	O
of	O
the	O
synapsis	O
checkpoint	O
in	O
male	O
mice	O
remains	O
unidentified	O
.	O

One	O
possible	O
candidate	O
is	O
Dot1	O
(	O
PCH1	O
in	O
yeast	O
)	O
,	O
a	O
histone	B-CHEBI
methyltransferase	O
silencing	O
factor	O
that	O
is	O
required	O
for	O
pachytene	O
arrest	O
of	O
zip1	O
and	O
dmc1	O
mutants	O
in	O
yeast	O
[	O
58	O
]	O
,	O
and	O
for	O
preventing	O
RAD54	O
-	O
mediated	O
recombinational	O
DSB	O
repair	O
between	O
sister	O
chromatids	O
.	O

However	O
,	O
DOT1	O
acts	O
upstream	O
of	O
PCH2	O
.	O

Given	O
that	O
TRIP13	O
doesn	O
'	O
t	O
have	O
checkpoint	O
function	O
in	O
mice	O
,	O
a	O
potential	O
role	O
for	O
mammalian	O
DOT1	O
in	O
the	O
pachytene	O
checkpoint	O
is	O
dubious	O
but	O
awaits	O
investigation	O
.	O

Recently	O
,	O
it	O
was	O
shown	O
that	O
the	O
TRP53	O
homolog	O
TRP63	O
is	O
required	O
for	O
DNA	O
damage	O
-	O
induced	O
death	O
of	O
dictyate	O
-	O
stage	O
primordial	O
oocytes	O
,	O
leading	O
to	O
the	O
suggestion	O
that	O
it	O
is	O
involved	O
in	O
monitoring	O
genome	O
integrity	O
[	O
59	O
]	O
.	O

However	O
,	O
this	O
activity	O
occurs	O
subsequent	O
to	O
a	O
pachytene	O
checkpoint	O
.	O

As	O
alluded	O
to	O
earlier	O
,	O
a	O
complicating	O
problem	O
for	O
studying	O
potential	O
meiotic	O
checkpoint	O
genes	O
in	O
mice	O
is	O
that	O
as	O
in	O
yeast	O
,	O
such	O
genes	O
often	O
have	O
mitotic	O
functions	O
(	O
such	O
as	O
RAD24	O
[	O
7	O
]	O
)	O
,	O
and	O
their	O
ablation	O
can	O
cause	O
lethality	O
[	O
42	O
]	O
.	O

Unless	O
mammalian	O
pachytene	O
checkpoint	O
components	O
have	O
orthologs	O
with	O
similar	O
functions	O
in	O
organisms	O
such	O
as	O
yeast	O
,	O
their	O
identities	O
are	O
likely	O
to	O
remain	O
elusive	O
.	O

Materials	O
and	O
Methods	O

PCR	O
analysis	O
of	O
Trip13	O
cDNA	O
.	O

Trip13	O
was	O
amplified	O
from	O
samples	O
of	O
Clontech	O
'	O
s	O
Mouse	O
Multiple	O
Tissue	O
cDNA	O
Panel	O
I	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
clontech	O
.	O
com	O
)	O
,	O
using	O
the	O
following	O
primers	O
:	O
5	O
'	O
-	O
GCACCATTGCACTTCACATC	O
-	O
3	O
'	O
(	O
TRP3	O
-	O
6F	O
)	O
and	O
5	O
'	O
-	O
TGACCATCAGACTGTCGAGC	O
-	O
3	O
'	O
(	O
TRP3	O
-	O
6R	O
)	O
.	O

These	O
primers	O
correspond	O
to	O
exons	O
3	O
and	O
6	O
,	O
respectively	O
,	O
and	O
amplify	O
a	O
330	O
-	O
bp	O
cDNA	O
product	O
.	O

The	O
cDNAs	O
in	O
this	O
panel	O
are	O
equalized	O
to	O
allow	O
quantitative	O
analysis	O
by	O
RT	O
-	O
PCR	O
.	O

Generation	O
of	O
Trip13	O
-	O
deficient	O
mice	O
.	O

The	O
mouse	O
embryonic	O
stem	O
cell	O
line	O
RRB047	O
(	O
strain	O
129	O
/	O
Ola	O
)	O
containing	O
a	O
gene	O
trap	O
insertion	O
in	O
Trip13	O
was	O
obtained	O
from	O
BayGenomics	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
baygenomics	O
.	O
ucsf	O
.	O
edu	O
/	O
)	O
.	O

The	O
gene	O
-	O
trapping	O
vector	O
used	O
to	O
create	O
this	O
line	O
,	O
pGT1lxf	O
,	O
was	O
designed	O
to	O
create	O
an	O
in	O
-	O
frame	O
fusion	O
between	O
the	O
5	O
'	O
exons	O
of	O
the	O
trapped	O
gene	O
and	O
a	O
reporter	O
,	O
beta	O
geo	O
(	O
a	O
fusion	O
of	O
beta	O
-	O
galactosidase	O
and	O
neomycin	B-CHEBI
phosphotransferase	O
II	O
)	O
.	O

The	O
gene	O
-	O
trapped	O
locus	O
creates	O
a	O
fusion	O
transcript	O
containing	O
exons	O
1	O
-	O
3	O
of	O
Trip13	O
and	O
beta	O
geo	O
.	O

To	O
identify	O
the	O
exact	O
insertion	O
site	O
within	O
intron	O
3	O
,	O
PCR	O
was	O
performed	O
using	O
one	O
primer	O
within	O
the	O
gene	O
trap	O
vector	O
,	O
and	O
the	O
other	O
primer	O
at	O
various	O
positions	O
in	O
intron	O
3	O
pointing	O
towards	O
the	O
3	O
'	O
end	O
of	O
the	O
gene	O
.	O

Product	O
from	O
a	O
productive	O
reaction	O
was	O
sequenced	O
,	O
revealing	O
that	O
the	O
insertion	O
site	O
was	O
445	O
bp	O
into	O
intron	O
3	O
.	O

Genotyping	O
of	O
mice	O
.	O

Three	O
primers	O
were	O
used	O
to	O
distinguish	O
wild	O
-	O
type	O
and	O
mutant	O
alleles	O
of	O
Trip13	O
:	O
primer	O
1	O
,	O
5	O
'	O
-	O
CGTCGCTCCATTGCTTTGTGC	O
-	O
3	O
'	O
;	O
primer	O
2	O
,	O
5	O
'	O
-	O
AGTAGTGGTACACTGTATTTTTGCTTTCATTGA	O
-	O
3	O
'	O
;	O
and	O
primer	O
3	O
,	O
5	O
'	O
-	O
GTAGATCCCGGCGCTCTTACCAA	O
-	O
3	O
'	O
.	O

Primers	O
1	O
and	O
2	O
are	O
located	O
upstream	O
and	O
downstream	O
,	O
respectively	O
,	O
of	O
the	O
gene	O
trap	O
insertion	O
within	O
the	O
intron	O
3	O
.	O

Primer	O
3	O
corresponds	O
to	O
pGTlxf	O
sequence	O
.	O

Primers	O
1	O
and	O
2	O
amplify	O
a	O
700	O
-	O
bp	O
band	O
from	O
a	O
wild	O
-	O
type	O
allele	O
;	O
primers	O
1	O
and	O
3	O
amplify	O
a	O
540	O
-	O
bp	O
fragment	O
from	O
a	O
mutant	O
allele	O
.	O

Separate	O
reactions	O
were	O
used	O
to	O
assay	O
the	O
presence	O
or	O
absence	O
of	O
each	O
amplicon	O
from	O
a	O
DNA	O
sample	O
.	O

The	O
cycling	O
conditions	O
were	O
:	O
94	O
degrees	O
C	O
2	O
min	O
;	O
35	O
cycles	O
of	O
94	O
degrees	O
C	O
30	O
s	O
,	O
57	O
degrees	O
C	O
45	O
s	O
,	O
and	O
72	O
degrees	O
C	O
50	O
s	O
;	O
and	O
72	O
degrees	O
C	O
2	O
min	O
.	O

RT	O
-	O
PCR	O
.	O

Total	O
RNA	O
was	O
isolated	O
from	O
adult	O
testes	O
with	O
the	O
RNeasy	O
Mini	O
Kit	O
(	O
Qiagen	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
qiagen	O
.	O
com	O
)	O
,	O
and	O
4	O
.	O
0	O
mu	O
g	O
was	O
oligo	O
dT	O
-	O
primed	O
and	O
reverse	O
-	O
transcribed	O
with	O
Superscript	O
II	O
(	O
Stratagene	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
stratagene	O
.	O
com	O
)	O
.	O

The	O
entire	O
Trip13	O
protein	B-CHEBI
-	O
coding	O
sequence	O
was	O
amplified	O
with	O
primers	O
5	O
'	O
-	O
ATGGACGAGGCGGTG	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
TCAAACATAAGCTGAAAGTT	O
-	O
3	O
'	O
.	O

The	O
cycling	O
conditions	O
were	O
:	O
94	O
degrees	O
C	O
2	O
min	O
;	O
94	O
degrees	O
C	O
30s	O
,	O
55	O
degrees	O
C	O
45	O
s	O
,	O
and	O
72	O
degrees	O
C	O
80	O
s	O
for	O
35	O
cycles	O
;	O
and	O
72	O
degrees	O
C	O
2	O
min	O
.	O

The	O
primers	O
for	O
amplifying	O
the	O
Med31	O
coding	O
sequence	O
as	O
control	O
were	O
:	O
5	O
'	O
-	O
ATGGCCGCGGCCGTCGCTATGG	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
TCATTTCCCTGCTGTGTTATTCTGCTGCTGCTGC	O
-	O
3	O
'	O
.	O

The	O
cycling	O
conditions	O
were	O
:	O
94	O
degrees	O
C	O
2	O
min	O
;	O
94	O
degrees	O
C	O
30	O
s	O
,	O
55	O
degrees	O
C	O
30	O
s	O
,	O
and	O
72	O
degrees	O
C	O
35	O
s	O
for	O
35	O
cycles	O
;	O
and	O
72	O
degrees	O
C	O
2	O
min	O
.	O

Development	O
and	O
purification	O
of	O
chicken	O
antibodies	O
.	O

A	O
peptide	O
corresponding	O
to	O
amino	B-CHEBI
acids	I-CHEBI
25	O
-	O
40	O
of	O
TRIP13	O
,	O
VLQRSGSTAKKEDIK	O
,	O
was	O
conjugated	O
to	O
KLH	O
and	O
used	O
to	O
immunize	O
chickens	O
(	O
done	O
by	O
Sigma	O
Genosys	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
sigmaaldrich	O
.	O
com	O
)	O
.	O

Polyclonal	O
IgY	O
was	O
isolated	O
from	O
eggs	O
with	O
the	O
Eggcellent	O
Chicken	O
IgY	O
Purification	O
kit	O
(	O
Pierce	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
piercenet	O
.	O
com	O
)	O
.	O

IgY	O
antibodies	O
were	O
then	O
affinity	O
purified	O
using	O
the	O
immunizing	O
synthetic	O
peptide	O
.	O

Western	O
blotting	O
.	O

50	O
mu	O
g	O
of	O
testis	O
extract	O
in	O
RIPA	O
buffer	O
was	O
separated	O
by	O
8	O
%	O
SDS	B-CHEBI
-	O
PAGE	O
and	O
electrotransferred	O
onto	O
a	O
Pure	O
Nitrocellulose	O
membrane	O
(	O
Bio	O
-	O
Rad	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
biorad	O
.	O
com	O
)	O
.	O

The	O
membrane	O
was	O
incubated	O
with	O
a	O
polyclonal	O
rabbit	O
anti	O
-	O
human	O
TRIP13	O
antibody	O
(	O
18	O
-	O
003	O
-	O
42687	O
;	O
Genway	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
genwaybio	O
.	O
com	O
)	O
.	O

According	O
to	O
the	O
manufacturer	O
,	O
the	O
immunogen	O
was	O
a	O
synthetic	O
peptide	O
embedded	O
in	O
sequence	O
we	O
deduced	O
to	O
correspond	O
to	O
exon	O
3	O
.	O

Binding	O
was	O
detected	O
by	O
chemiluminescence	O
ECL	O
kit	O
(	O
Pierce	O
)	O
using	O
a	O
rabbit	O
anti	O
-	O
chicken	O
IgG	O
horseradish	O
peroxidase	O
conjugate	O
(	O
Pierce	O
)	O
.	O

Histological	O
analyses	O
.	O

Testes	O
or	O
ovaries	O
were	O
fixed	O
in	O
Bouin	O
'	O
s	O
,	O
embedded	O
in	O
paraffin	O
,	O
sectioned	O
at	O
6	O
mu	O
m	O
,	O
and	O
stained	O
by	O
hematoxylin	O
and	O
eosin	O
.	O

Antigen	O
retrieval	O
for	O
immunohistochemistry	O
of	O
testis	O
sections	O
was	O
as	O
described	O
[	O
60	O
]	O
.	O

Oocyte	O
and	O
follicle	O
numbers	O
were	O
counted	O
as	O
described	O
[	O
61	O
]	O
.	O

Only	O
follicles	O
containing	O
an	O
oocyte	O
with	O
a	O
clearly	O
visible	O
nucleus	O
were	O
scored	O
.	O

Immunocytochemistry	O
.	O

Immunolabeling	O
of	O
surface	O
-	O
spread	O
spermatocytes	O
and	O
oocytes	O
was	O
performed	O
as	O
described	O
[	O
39	O
,	O
62	O
]	O
.	O

To	O
reach	O
conclusions	O
on	O
the	O
pattern	O
of	O
staining	O
for	O
various	O
proteins	B-CHEBI
,	O
30	O
(	O
unless	O
otherwise	O
indicated	O
)	O
well	O
-	O
spread	O
nuclei	O
of	O
particular	O
meiotic	O
stages	O
were	O
first	O
identified	O
under	O
the	O
fluorescent	O
microscope	O
on	O
the	O
basis	O
of	O
SYCP3	O
or	O
STAG3	O
staining	O
,	O
then	O
imaged	O
at	O
both	O
appropriate	O
wavelengths	O
to	O
determine	O
the	O
pattern	O
of	O
second	O
proteins	B-CHEBI
with	O
focal	O
patterns	O
such	O
as	O
RAD51	O
or	O
RPA	O
.	O

Unless	O
otherwise	O
indicated	O
,	O
the	O
panels	O
shown	O
in	O
the	O
figures	O
were	O
the	O
exclusive	O
or	O
predominant	O
patterns	O
seen	O
.	O

The	O
exception	O
for	O
this	O
approach	O
was	O
in	O
the	O
case	O
of	O
staining	O
for	O
MLH1	O
or	O
MLH3	O
plus	O
RAD51	O
(	O
in	O
which	O
case	O
SYCP3	O
or	O
STAG3	O
was	O
not	O
available	O
to	O
find	O
chromosome	O
cores	O
)	O
.	O

Nuclei	O
in	O
this	O
situation	O
were	O
identified	O
first	O
by	O
MLH1	O
/	O
3	O
foci	O
clustering	O
,	O
then	O
imaged	O
for	O
both	O
fluorescent	O
wavelengths	O
.	O

Primary	O
antibodies	O
used	O
in	O
this	O
study	O
were	O
as	O
follows	O
:	O
mouse	O
anti	O
-	O
SCP3	O
(	O
1	O
:	O
500	O
;	O
Abcam	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
abcam	O
.	O
com	O
)	O
;	O
rabbit	O
anti	O
-	O
SYCP1	O
(	O
1	O
:	O
1	O
,	O
000	O
;	O
a	O
gift	O
from	O
C	O
.	O
Heyting	O
)	O
[	O
63	O
]	O
;	O
rabbit	O
anti	O
-	O
REC8	O
(	O
1	O
:	O
100	O
;	O
a	O
gift	O
from	O
C	O
.	O
Heyting	O
)	O
;	O
rabbit	O
anti	O
-	O
RAD51	O
(	O
1	O
:	O
250	O
,	O
this	O
polyclonal	O
antibody	O
recognizes	O
both	O
RAD51	O
and	O
DMC1	O
;	O
Oncogene	O
Research	O
Products	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
merckbiosciences	O
.	O
co	O
.	O
uk	O
)	O
;	O
rabbit	O
anti	O
-	O
gamma	O
H2AX	O
(	O
1	O
:	O
500	O
;	O
Upstate	O
Biotechnology	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
upstate	O
.	O
com	O
/	O
)	O
;	O
rabbit	O
anti	O
-	O
STAG3	O
(	O
1	O
:	O
1	O
,	O
000	O
;	O
a	O
gift	O
from	O
R	O
.	O
Jessberger	O
)	O
;	O
rabbit	O
anti	O
-	O
MLH3	O
(	O
1	O
:	O
400	O
;	O
a	O
gift	O
from	O
P	O
.	O
Cohen	O
)	O
;	O
mouse	O
-	O
anti	O
-	O
human	O
MLH1	O
(	O
1	O
:	O
50	O
;	O
BD	O
Biosciences	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
bdbiosciences	O
.	O
com	O
)	O
;	O
rabbit	O
-	O
anti	O
-	O
TopBP1	O
(	O
1	O
:	O
100	O
;	O
a	O
gift	O
from	O
J	O
.	O
Chen	O
)	O
[	O
22	O
]	O
;	O
mouse	O
-	O
anti	O
-	O
ubiquityl	O
-	O
histone	B-CHEBI
H2A	O
(	O
1	O
:	O
200	O
;	O
Upstate	O
Biotechnology	O
)	O
;	O
rabbit	O
-	O
anti	O
-	O
TRF2	O
(	O
1	O
:	O
500	O
;	O
a	O
gift	O
from	O
T	O
.	O
de	O
Lange	O
)	O
;	O
and	O
rabbit	O
-	O
anti	O
-	O
BLM	O
(	O
1	O
:	O
50	O
;	O
a	O
gift	O
from	O
R	O
.	O
Freire	O
)	O
.	O

All	O
secondary	O
antibodies	O
conjugated	O
with	O
either	O
Alexa	O
Fluor	O
488	O
or	O
594	O
(	O
Molecular	B-CHEBI
Probes	O
,	O
http	O
:	O
/	O
/	O
probes	O
.	O
invitrogen	O
.	O
com	O
/	O
)	O
were	O
used	O
at	O
a	O
dilution	O
of	O
1	O
:	O
1	O
,	O
000	O
.	O

All	O
images	O
were	O
taken	O
with	O
a	O
100	O
x	O
objective	O
lens	O
under	O
immersion	O
oil	O
.	O

Metaphase	O
I	O
spermatocyte	O
spreads	O
and	O
OA	B-CHEBI
treatment	O
.	O

Metaphase	O
fixed	O
spermatocytes	O
from	O
8	O
-	O
mo	O
-	O
old	O
Trip13RRB047	O
homozygotes	O
,	O
using	O
23	O
-	O
d	O
-	O
old	O
wild	O
-	O
type	O
mice	O
as	O
control	O
,	O
were	O
prepared	O
and	O
stained	O
with	O
Giemsa	O
as	O
described	O
[	O
64	O
]	O
.	O

For	O
OA	B-CHEBI
treatment	O
,	O
cells	O
were	O
exposed	O
to	O
5	O
mu	O
M	O
OA	B-CHEBI
(	O
Calbiochem	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
emdbiosciences	O
.	O
com	O
)	O
for	O
6	O
h	O
at	O
32	O
degrees	O
C	O
in	O
a	O
humidified	O
environment	O
of	O
5	O
%	O
CO2	B-CHEBI
before	O
spreading	O
[	O
65	O
]	O
.	O

These	O
preparations	O
were	O
stained	O
with	O
DAPI	O
to	O
visualize	O
metaphase	O
nuclei	O
and	O
chromosomes	O
.	O

Phylogenetic	O
analyses	O
.	O

TRIP13	O
orthologs	O
were	O
identified	O
by	O
BLASTP	O
searches	O
of	O
Genbank	O
and	O
other	O
sources	O
providing	O
gene	O
models	O
such	O
as	O
Ensembl	O
.	O

The	O
selected	O
orthologs	O
can	O
be	O
found	O
in	O
Table	O
S1	O
.	O

Amino	B-CHEBI
acid	I-CHEBI
alignments	O
were	O
done	O
with	O
Clustal	O
W	O
,	O
using	O
the	O
default	O
settings	O
with	O
and	O
without	O
removing	O
the	O
regions	O
outside	O
of	O
the	O
AAA	O
-	O
ATPase	O
central	O
domain	O
.	O

The	O
trees	O
were	O
constructed	O
by	O
using	O
the	O
neighbor	O
-	O
joining	O
method	O
with	O
Poisson	O
correction	O
.	O

The	O
reliability	O
of	O
internal	O
branches	O
was	O
assessed	O
by	O
using	O
500	O
bootstrap	O
replicates	O
,	O
and	O
sites	O
with	O
gaps	O
were	O
ignored	O
in	O
this	O
analysis	O
.	O

Neighbor	O
-	O
joining	O
searches	O
were	O
conducted	O
by	O
using	O
the	O
computer	O
program	O
MEGA3	O
[	O
66	O
]	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Depiction	O
of	O
Conserved	O
Regions	O
of	O
Mouse	O
TRIP13	O
and	O
Its	O
PCH2	O
Orthologs	O

(	O
75	O
KB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

Surface	O
-	O
Spread	O
Chromosomes	O
Immunolabeled	O
with	O
the	O
Indicated	O
Antibodies	O
and	O
Fluorophores	B-CHEBI

(	O
947	O
KB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

Trip13	O
Mutant	O
Spermatocytes	O
That	O
Progress	O
Beyond	O
Pachynema	O
Have	O
Repaired	O
DSBs	O
and	O
Form	O
Bivalents	O
at	O
Metaphase	O
I	O

(	O
1	O
.	O
5	O
MB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S1	O

Sources	O
of	O
TRIP13	O
Amino	B-CHEBI
Acid	I-CHEBI
Sequences	O
Used	O
to	O
Construct	O
the	O
Phylogenetic	O
Tree	O
in	O
Figure	O
1	O

(	O
22	O
KB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Acknowledgements	O

We	O
thank	O
P	O
.	O

Burgoyne	O
,	O
P	O
.	O

Cohen	O
,	O
E	O
.	O

Alani	O
,	O
and	O
P	O
.	O

Moens	O
for	O
helpful	O
discussions	O
,	O
R	O
.	O

Viswanatha	O
for	O
helpful	O
comments	O
on	O
the	O
manuscript	O
,	O
W	O
.	O

Pawlowski	O
and	O
T	O
.	O

Pawlowska	O
for	O
input	O
on	O
the	O
evolutionary	O
tree	O
of	O
PCH2	O
,	O
R	O
.	O

Freire	O
and	O
J	O
.	O

Chen	O
for	O
antibodies	O
,	O
M	O
.	O

Jasin	O
for	O
Spo11	O
-	O
embryonic	O
stem	O
cells	O
,	O
and	O
R	O
.	O

Munroe	O
for	O
generating	O
chimeric	O
mice	O
.	O

We	O
also	O
thank	O
an	O
anonymous	O
reviewer	O
for	O
pointing	O
out	O
that	O
Pch2p	O
might	O
be	O
sensing	O
synaptic	O
polymerization	O
in	O
yeast	O
,	O
not	O
initiation	O
.	O

Abbreviations	O

CO	O
-	O
crossover	O

DSB	O
-	O
double	O
strand	O
break	O

MSCI	O
-	O
meiotic	O
sex	O
chromosome	O
inactivation	O

MSUC	O
-	O
meiotic	O
silencing	O
of	O
unpaired	O
chromatin	O

NCO	O
-	O
noncrossover	O

OA	B-CHEBI
-	O
okadaic	B-CHEBI
acid	I-CHEBI

RT	O
-	O
PCR	O
-	O
reverse	O
-	O
transcriptase	O
PCR	O

SC	O
-	O
synaptonemal	O
complex	O

Footnotes	O

A	O
previous	O
version	O
of	O
this	O
article	O
appeared	O
as	O
an	O
Early	O
Online	O
Release	O
on	O
June	O
21	O
,	O
2007	O
(	O
doi	O
:	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pgen	O
.	O
0030130	O
.	O
eor	O
)	O
.	O

Author	O
contributions	O
.	O

XL	O
and	O
JCS	O
conceived	O
and	O
designed	O
the	O
experiments	O
and	O
analyzed	O
the	O
data	O
.	O

XL	O
performed	O
the	O
experiments	O
.	O

JCS	O
wrote	O
the	O
paper	O
.	O

Funding	O
.	O

This	O
work	O
was	O
supported	O
by	O
NIH	O
grant	O
GM45415	O
to	O
JS	O
.	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

